data_1yyc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1yyc _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.462 ' O ' HG22 ' A' ' 17' ' ' VAL . 7.8 m-20 . . . . . 0 N--CA 1.475 0.776 0 CA-C-O 120.928 0.394 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.22 -40.66 86.53 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -177.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -70.28 -53.81 15.29 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.955 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.413 ' HA ' ' CG ' ' A' ' 19' ' ' GLU . 33.4 m -62.7 -27.96 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 94' ' ' ILE . 73.3 t -62.92 -41.23 91.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.024 175.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -66.93 -36.3 81.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.79 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.413 ' CG ' ' HA ' ' A' ' 16' ' ' VAL . 7.5 mm-40 -53.3 -54.0 42.8 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.36 0.664 . . . . 0.0 109.719 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -65.94 -47.86 73.29 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.258 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.69 -43.48 80.53 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.095 -176.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -57.19 -45.81 83.39 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 123.59 0.556 . . . . 0.0 111.045 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.01 -42.02 79.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.418 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 73.9 mt -58.22 -46.97 88.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.891 177.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.7 m -61.99 -30.87 71.24 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.868 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.6 m -67.69 -40.18 84.38 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.076 0.465 . . . . 0.0 110.575 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.635 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 6.5 tt -72.74 -33.62 66.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.071 0.462 . . . . 0.0 109.993 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 96.5 mt -65.86 -38.72 89.57 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.428 0.632 . . . . 0.0 109.485 175.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -66.31 -34.38 77.85 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.225 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.635 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -64.11 -33.55 76.02 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-O 121.533 0.682 . . . . 0.0 109.432 178.264 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.556 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -77.64 -32.47 53.36 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.933 -178.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -53.46 -52.91 57.98 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.21 -24.93 75.66 Favored Glycine 0 N--CA 1.468 0.806 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.667 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.6 ' CZ ' ' HD2' ' A' ' 38' ' ' LYS . 10.9 t80 -68.79 -40.1 79.78 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 124.165 0.986 . . . . 0.0 110.263 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.424 ' CD1' HD11 ' A' ' 39' ' ' LEU . 20.2 m-85 -62.27 -45.57 92.68 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.313 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.74 -48.72 63.54 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 124.505 1.128 . . . . 0.0 113.061 -174.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -104.61 -36.13 7.59 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 119.414 -0.914 . . . . 0.0 113.349 -176.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.6 ' HD2' ' CZ ' ' A' ' 34' ' ' PHE . 21.6 ttmm -87.01 -43.49 12.3 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.342 -173.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.424 HD11 ' CD1' ' A' ' 35' ' ' PHE . 22.7 mt -87.28 19.04 3.37 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.204 -0.998 . . . . 0.0 111.907 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.89 -18.24 13.98 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.427 ' N ' HD21 ' A' ' 41' ' ' ASN . 0.8 OUTLIER -107.46 -21.07 13.05 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.788 177.151 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.3 mm -111.59 107.21 56.8 Favored Pre-proline 0 N--CA 1.442 -0.845 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.449 ' HB2' ' OH ' ' A' ' 74' ' ' TYR . 24.8 Cg_exo -64.26 118.0 4.99 Favored 'Trans proline' 0 C--O 1.251 1.149 0 C-N-CA 122.643 2.229 . . . . 0.0 112.294 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.1 p -128.73 150.32 74.53 Favored Pre-proline 0 C--N 1.299 -1.629 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.213 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.48 149.23 91.61 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.988 2.459 . . . . 0.0 112.155 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -110.85 137.79 48.06 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.448 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.52 ' O ' HG13 ' A' ' 159' ' ' VAL . . . -115.65 165.33 13.15 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.331 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.4 t -161.89 147.39 13.28 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 110.518 -0.178 . . . . 0.0 110.518 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.509 ' HB ' ' OG1' ' A' ' 161' ' ' THR . 89.8 t -91.32 140.93 15.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 174.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -116.07 -60.94 1.8 Allowed 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -175.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -161.66 165.91 27.54 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -167.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.1 m -124.15 137.72 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -96.18 126.63 41.54 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.436 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -58.61 109.19 0.75 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 168.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.433 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -127.51 -53.29 1.36 Allowed 'General case' 0 N--CA 1.426 -1.668 0 C-N-CA 119.029 -1.068 . . . . 0.0 112.677 -172.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.91 -172.88 31.93 Favored Glycine 0 N--CA 1.425 -2.078 0 C-N-CA 119.184 -1.484 . . . . 0.0 112.309 -174.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.451 ' HB ' ' CD1' ' A' ' 173' ' ' PHE . 12.2 p -128.77 155.69 40.85 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-O 121.129 0.49 . . . . 0.0 110.927 -175.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 48.4 m -125.88 149.47 48.66 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 173.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.405 ' O ' ' HB2' ' A' ' 60' ' ' ASP . 37.3 mmt180 -79.0 77.2 5.47 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 118.621 -1.232 . . . . 0.0 112.22 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 59' ' ' ARG . 9.9 t70 171.74 -48.08 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.163 1.385 . . . . 0.0 107.668 176.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -150.19 177.95 27.97 Favored Glycine 0 C--O 1.223 -0.549 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 119' ' ' VAL . 6.5 m -87.83 156.09 3.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 118.743 1.272 . . . . 0.0 110.842 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -111.5 105.37 13.93 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.312 0.577 . . . . 0.0 109.75 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -110.64 159.76 17.29 Favored 'General case' 0 CA--C 1.48 -1.726 0 CA-C-O 122.084 0.945 . . . . 0.0 112.588 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -107.61 106.63 17.08 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.87 144.81 27.06 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -94.72 135.53 36.09 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.175 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.9 t -130.93 108.49 15.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 174.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.0 m -102.38 133.64 46.98 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.057 -175.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.3 t -123.32 133.33 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -119.93 128.22 53.4 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.499 HD22 ' HB2' ' A' ' 74' ' ' TYR . 6.0 t30 -142.89 114.92 5.99 Favored Pre-proline 0 C--N 1.284 -2.257 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.585 -175.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -94.17 96.17 0.13 Allowed 'Trans proline' 0 N--CA 1.422 -2.726 0 C-N-CA 121.835 1.69 . . . . 0.0 110.248 172.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.499 ' HB2' HD22 ' A' ' 72' ' ' ASN . 68.9 m-85 -176.33 127.55 0.2 Allowed 'General case' 0 CA--C 1.482 -1.671 0 C-N-CA 128.105 2.562 . . . . 0.0 104.788 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.4 m -84.32 68.83 10.35 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.442 0.639 . . . . 0.0 111.012 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -151.8 145.77 25.22 Favored 'General case' 0 N--CA 1.407 -2.612 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.82 176.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 44.6 p -86.76 101.56 13.44 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.776 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 28.1 mt -94.72 117.61 66.91 Favored Pre-proline 0 N--CA 1.441 -0.891 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -83.65 146.96 12.16 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 121.915 1.743 . . . . 0.0 110.59 176.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.1 mp -85.53 91.46 3.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.255 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.679 ' O ' ' HB ' ' A' ' 146' ' ' THR . 58.6 m -78.27 105.72 9.69 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.459 ' HB3' ' O ' ' A' ' 81' ' ' CYS . 24.7 tt0 76.3 109.66 0.07 Allowed 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.14 0.9 . . . . 0.0 111.754 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.603 ' CG2' ' HB ' ' A' ' 99' ' ' ILE . 15.5 tt -117.8 125.04 73.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.538 -0.726 . . . . 0.0 109.342 174.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.9 t -86.84 125.07 33.73 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-O 121.25 0.548 . . . . 0.0 109.86 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.528 ' OH ' ' HA ' ' A' ' 117' ' ' VAL . 56.5 t80 -107.69 120.38 42.06 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.26 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.5 mt -130.24 107.18 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 CA-C-O 122.063 0.935 . . . . 0.0 109.332 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.644 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 1.3 tm? -100.66 134.82 43.05 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 114.616 -1.174 . . . . 0.0 107.862 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.475 ' HB2' ' HB2' ' A' ' 140' ' ' GLN . 96.5 mttt -128.31 158.02 39.36 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -177.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.49 ' OG ' ' HB3' ' A' ' 122' ' ' SER . 57.5 m -143.91 97.67 3.1 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 52.71 -90.13 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 175.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.9 m -108.24 -53.99 2.56 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.097 0.475 . . . . 0.0 111.755 -171.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -126.06 154.84 42.45 Favored 'General case' 0 CA--C 1.472 -2.044 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 27.6 m 71.87 135.89 0.04 OUTLIER 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 113.363 -1.744 . . . . 0.0 112.895 175.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.644 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 38.4 pt -136.84 -179.2 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.382 0 CA-C-N 114.616 -1.175 . . . . 0.0 107.937 176.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.75 121.31 25.19 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 172.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 36.8 p -112.49 159.06 19.15 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.534 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.21 178.3 47.55 Favored Glycine 0 N--CA 1.424 -2.15 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.9 m -146.25 120.06 9.27 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.603 ' HB ' ' CG2' ' A' ' 83' ' ' ILE . 71.5 mt -98.6 126.11 40.31 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -177.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -80.49 114.86 3.07 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.914 1.742 . . . . 0.0 111.278 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.8 t70 53.23 87.6 0.14 Allowed Pre-proline 0 N--CA 1.485 1.292 0 C-N-CA 124.937 1.295 . . . . 0.0 112.753 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -91.15 -7.05 3.75 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.847 2.365 . . . . 0.0 112.188 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 160.93 -179.04 36.65 Favored Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.3 m -142.71 157.67 44.42 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.275 0.559 . . . . 0.0 111.038 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.434 HD21 ' CB ' ' A' ' 72' ' ' ASN . 7.5 mp -76.73 135.13 39.02 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.483 176.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 27.3 m -71.06 -17.5 20.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.11 113.1 1.51 Allowed Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 61.9 m 53.46 83.87 0.06 Allowed 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.916 0.886 . . . . 0.0 113.308 -177.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 155.71 -176.93 33.09 Favored Glycine 0 N--CA 1.432 -1.575 0 C-N-CA 119.956 -1.116 . . . . 0.0 112.391 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.7 t -105.38 135.71 46.26 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.5 t -139.44 130.37 26.29 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 120.865 0.364 . . . . 0.0 110.407 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.9 m -93.48 122.47 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-O 121.686 0.755 . . . . 0.0 110.024 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.9 mt -108.34 158.06 17.83 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -134.09 149.03 51.09 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 119.664 -0.815 . . . . 0.0 112.277 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.3 m -131.49 144.63 54.19 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.649 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -74.06 111.76 3.38 Favored 'Trans proline' 0 C--O 1.247 0.953 0 C-N-CA 122.12 1.88 . . . . 0.0 110.675 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.528 ' HA ' ' OH ' ' A' ' 85' ' ' TYR . 96.5 t -107.26 127.09 63.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-O 121.553 0.692 . . . . 0.0 112.814 -175.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.442 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 8.5 mmpt? -89.06 96.64 10.81 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.593 ' O ' HG22 ' A' ' 62' ' ' VAL . 99.7 t -93.52 138.94 19.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 72.19 -16.84 0.4 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.058 0.943 . . . . 0.0 111.416 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.536 ' H ' ' C ' ' A' ' 119' ' ' VAL . 53.1 t80 -51.49 -39.86 58.4 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 125.94 1.696 . . . . 0.0 110.1 176.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.49 ' HB3' ' OG ' ' A' ' 89' ' ' SER . 33.9 t -65.55 -51.79 57.26 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.557 -177.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.5 tt -67.25 -28.87 43.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.327 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.43 -50.65 62.66 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.77 -30.2 49.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.956 0.408 . . . . 0.0 110.928 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.0 t -70.69 -73.43 0.17 Allowed 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -125.43 -41.33 2.04 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 24.1 ttt 64.15 100.03 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 124.299 1.04 . . . . 0.0 109.395 -172.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.543 ' HG3' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -48.89 -63.78 1.0 Allowed 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.732 -177.048 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.543 ' H ' ' HG3' ' A' ' 129' ' ' LYS . 21.4 t70 151.85 107.93 0.0 OUTLIER 'General case' 0 CA--C 1.471 -2.094 0 N-CA-C 102.649 -3.093 . . . . 0.0 102.649 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 13.1 tpt -53.07 123.58 12.05 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 123.519 0.512 . . . . 0.0 111.627 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 49.1 t -99.32 -158.74 0.69 Allowed 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.238 -176.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 21.8 p -131.01 114.11 14.79 Favored 'General case' 0 N--CA 1.385 -3.713 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.2 t70 70.43 89.9 0.1 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -172.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -133.58 115.74 15.05 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.522 -172.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.14 104.55 15.82 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.026 176.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.3 tt -102.2 138.2 27.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.55 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -82.49 100.14 9.9 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.753 0.787 . . . . 0.0 109.449 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.499 ' HH ' HG11 ' A' ' 117' ' ' VAL . 9.1 t80 -113.95 148.34 37.01 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.344 -176.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 88' ' ' LYS . 1.8 mp0 -136.08 154.01 51.15 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.5 tp -141.86 123.07 14.73 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 123.246 0.618 . . . . 0.0 109.58 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -126.33 128.0 46.42 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 43.9 mt -130.4 130.34 65.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 C-N-CA 120.209 -0.596 . . . . 0.0 112.336 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 157' ' ' ILE . . . -114.88 90.76 0.54 Allowed Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.433 HD12 ' CE2' ' A' ' 147' ' ' PHE . 2.9 pp -84.57 151.54 24.46 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.897 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.679 ' HB ' ' O ' ' A' ' 81' ' ' CYS . 8.6 m -109.09 120.69 43.29 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.8 -176.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.433 ' CE2' HD12 ' A' ' 145' ' ' LEU . 73.6 m-85 -100.4 141.26 33.5 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 170.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -110.39 133.36 53.34 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 174.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.76 139.45 29.05 Favored Pre-proline 0 C--N 1.301 -1.53 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.659 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -63.46 -17.02 58.12 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.856 2.371 . . . . 0.0 112.051 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.67 -45.52 98.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.998 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 40.4 t -130.15 -78.04 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.059 0.457 . . . . 0.0 109.904 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 173.81 -112.66 0.43 Allowed Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -101.24 125.97 47.92 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.935 0.397 . . . . 0.0 111.202 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 146' ' ' THR . 34.1 pt -121.28 114.92 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 CA-C-O 121.008 0.433 . . . . 0.0 110.522 173.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.532 HG21 ' OG1' ' A' ' 146' ' ' THR . 37.9 p -96.1 105.27 17.29 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.691 175.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.469 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 60.7 mt -91.5 107.1 19.4 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 156' ' ' THR . 8.0 Cg_endo -85.42 100.74 0.69 Allowed 'Trans proline' 0 N--CA 1.43 -2.26 0 C-N-CA 122.6 2.2 . . . . 0.0 111.719 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 47' ' ' ALA . 18.0 m -94.74 110.03 23.19 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 CA-C-O 122.015 0.912 . . . . 0.0 109.542 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.5 p -88.89 146.13 25.12 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-N 114.352 -1.295 . . . . 0.0 111.318 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.509 ' OG1' ' HB ' ' A' ' 49' ' ' VAL . 98.5 m -146.64 127.39 14.34 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.134 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -121.4 143.07 49.42 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -164.42 -139.63 2.68 Favored Glycine 0 N--CA 1.422 -2.24 0 C-N-CA 119.728 -1.225 . . . . 0.0 112.121 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.21 148.59 15.14 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.444 HG12 ' HB3' ' A' ' 139' ' ' TYR . 47.8 mm -126.18 139.37 51.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -106.06 111.76 24.52 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.76 0.79 . . . . 0.0 110.146 175.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 15.6 tp -93.84 106.28 20.99 Favored Pre-proline 0 C--N 1.296 -1.751 0 CA-C-N 113.998 -1.455 . . . . 0.0 108.276 -174.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.65 156.89 58.65 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.416 2.744 . . . . 0.0 116.054 -171.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 31.1 p -48.41 25.32 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 129.19 2.996 . . . . 0.0 117.603 174.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 59.8 mt -71.63 -42.32 67.75 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 72.31 -27.12 0.18 Allowed 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 126.47 1.908 . . . . 0.0 112.48 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -113.74 61.2 0.66 Allowed 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 122.719 1.247 . . . . 0.0 108.121 173.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.51 ' O ' HG11 ' A' ' 62' ' ' VAL . 85.9 t80 . . . . . 0 C--N 1.298 -1.662 0 CA-C-N 113.398 -1.728 . . . . 0.0 106.569 174.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.546 ' O ' HG22 ' A' ' 17' ' ' VAL . 18.7 m-20 . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.8 -34.71 65.56 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -178.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -75.29 -54.86 6.38 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 123.45 0.7 . . . . 0.0 110.314 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.8 t -58.57 -45.81 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.05 0.94 . . . . 0.0 113.499 -174.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 13' ' ' ASP . 35.9 m -66.14 -27.28 40.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.656 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -76.6 -30.2 56.85 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.603 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -54.91 -42.99 72.88 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.509 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.28 -37.42 87.44 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.607 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.53 -36.33 82.43 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.6 t -61.91 -45.18 94.86 Favored 'General case' 0 C--O 1.252 1.231 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.859 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.03 -37.84 54.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.479 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.409 HD13 ' OG ' ' A' ' 96' ' ' SER . 79.3 mt -65.68 -41.1 89.77 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.746 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.5 t -58.41 -36.35 73.45 Favored 'General case' 0 C--O 1.243 0.715 0 O-C-N 123.54 0.525 . . . . 0.0 110.959 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.2 m -67.04 -39.58 87.0 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.053 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.555 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 5.2 tt -80.36 -40.54 26.41 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -54.09 -43.87 70.71 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.33 1.052 . . . . 0.0 109.673 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -65.0 -39.32 93.29 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.042 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -70.93 -37.41 72.87 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.077 -179.593 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.517 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -69.58 -32.46 71.23 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.662 -177.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.48 -40.24 82.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.2 175.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.14 -49.84 73.75 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.297 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.456 ' HD1' ' O ' ' A' ' 30' ' ' LYS . 10.5 m-85 -59.13 -46.89 87.18 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 120.562 0.22 . . . . 0.0 110.643 177.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.452 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 65.1 t80 -62.79 -41.16 99.15 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -176.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.3 -44.25 79.69 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -108.67 -27.65 9.7 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -173.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -101.26 -46.62 4.98 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.467 -171.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 36.8 mt -78.94 -0.48 31.14 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.79 -171.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.01 -33.15 63.67 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -101.42 -47.82 4.56 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 114.348 -1.296 . . . . 0.0 110.52 -173.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.69 126.54 92.85 Favored Pre-proline 0 C--O 1.24 0.601 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.313 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.63 106.67 0.17 Allowed 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 123.109 2.539 . . . . 0.0 112.578 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.43 HG22 HD23 ' A' ' 39' ' ' LEU . 8.3 p -130.85 166.4 27.68 Favored Pre-proline 0 N--CA 1.429 -1.484 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.725 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -79.6 138.35 13.54 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.819 2.346 . . . . 0.0 110.511 175.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -96.89 108.09 20.72 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.091 0.472 . . . . 0.0 109.823 -176.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.5 146.65 25.56 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.04 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.2 t -145.93 138.59 25.65 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 121.073 0.463 . . . . 0.0 110.553 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.423 HG12 ' CG2' ' A' ' 159' ' ' VAL . 12.7 m -90.53 142.55 12.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.207 175.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -130.22 -63.08 0.91 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.083 -1.047 . . . . 0.0 112.979 -174.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -161.13 164.52 30.58 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 -173.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.517 HG23 ' HB3' ' A' ' 64' ' ' TYR . 11.1 p -125.28 114.26 39.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 176.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -99.21 132.51 44.47 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -169.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.536 ' O ' ' HE3' ' A' ' 55' ' ' LYS . 50.2 p90 -58.52 129.1 40.46 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 123.969 0.793 . . . . 0.0 111.743 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.557 ' HE3' ' HA ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -130.0 -64.57 0.86 Allowed 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.689 -173.028 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -140.39 175.27 22.09 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.983 -175.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.422 HG22 ' CD1' ' A' ' 173' ' ' PHE . 28.8 t -99.07 147.46 7.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -175.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 74.2 m -129.58 160.29 33.71 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 174.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -45.95 62.09 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -104.15 97.76 7.68 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.549 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.476 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . 85.11 -170.53 45.28 Favored Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.535 HG22 ' CE2' ' A' ' 173' ' ' PHE . 7.1 p -124.4 153.14 30.76 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -93.99 112.18 23.98 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-O 121.581 0.705 . . . . 0.0 110.957 -175.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.517 ' HB3' HG23 ' A' ' 52' ' ' VAL . 3.5 m-30 -116.17 166.17 12.33 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.452 174.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.524 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 12.2 m-70 -116.93 112.87 21.62 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.513 174.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.47 123.43 26.56 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.981 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -87.48 108.46 19.03 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.301 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.2 t -122.39 108.81 22.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.4 m -100.05 134.0 43.61 Favored 'General case' 0 C--N 1.284 -2.266 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.509 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.72 112.43 36.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-O 121.251 0.548 . . . . 0.0 110.13 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 39.3 ttpt -95.25 110.75 22.7 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 175.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -119.18 116.93 33.66 Favored Pre-proline 0 N--CA 1.42 -1.963 0 C-N-CA 118.64 -1.224 . . . . 0.0 111.278 -174.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -95.75 98.83 0.1 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.451 0 C-N-CA 121.756 1.637 . . . . 0.0 109.551 169.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.7 t80 178.4 108.13 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.7 m -50.88 16.66 0.0 OUTLIER 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 119.342 3.09 . . . . 0.0 119.342 -166.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.459 HE21 HG12 ' A' ' 78' ' ' ILE . 7.3 pt20 -142.89 166.35 24.88 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 119.583 1.083 . . . . 0.0 111.45 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.1 p -88.51 101.13 13.63 Favored 'General case' 0 N--CA 1.417 -2.096 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 174.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.459 HG12 HE21 ' A' ' 76' ' ' GLN . 67.7 mt -73.65 129.58 85.12 Favored Pre-proline 0 C--N 1.31 -1.121 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.33 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.96 122.29 10.97 Favored 'Trans proline' 0 C--O 1.254 1.305 0 C-N-CA 122.726 2.284 . . . . 0.0 112.369 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.442 HG12 ' CE1' ' A' ' 147' ' ' PHE . 45.0 mt -89.91 107.87 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 57.3 m -53.98 -59.57 4.47 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 123.076 0.551 . . . . 0.0 110.37 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -165.45 150.21 8.82 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 98' ' ' THR . 15.7 tt -96.69 124.32 49.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 174.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.0 m -100.61 118.66 37.21 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -175.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -119.91 139.86 51.77 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.293 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.417 ' HB ' ' HB2' ' A' ' 142' ' ' ASP . 64.7 mt -123.87 108.37 20.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 171.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.464 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . 1.5 tm? -91.65 122.43 34.21 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -125.56 140.01 53.11 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -175.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 93' ' ' THR . 30.2 t -104.98 145.66 30.12 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.959 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.52 -12.93 55.61 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.872 175.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 68.8 p -97.51 17.8 16.82 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.152 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 81.21 163.01 0.16 Allowed 'General case' 0 C--O 1.25 1.081 0 C-N-CA 125.542 1.537 . . . . 0.0 111.984 -176.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' A' ' 122' ' ' SER . 53.9 m 72.24 137.84 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.726 1.21 . . . . 0.0 110.259 -174.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.516 HD13 ' C ' ' A' ' 94' ' ' ILE . 1.6 pp -129.87 172.75 15.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.464 ' HB1' ' HB3' ' A' ' 87' ' ' LEU . . . -127.11 121.78 32.38 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 174.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.409 ' OG ' HD13 ' A' ' 24' ' ' ILE . 23.0 t -134.62 158.25 44.52 Favored 'General case' 0 C--N 1.282 -2.352 0 C-N-CA 118.641 -1.224 . . . . 0.0 110.726 -176.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.54 179.53 44.26 Favored Glycine 0 N--CA 1.429 -1.831 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 23.0 p -135.11 134.17 39.99 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.747 0.273 . . . . 0.0 110.519 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.4 mp -104.79 107.35 58.18 Favored Pre-proline 0 C--O 1.244 0.782 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.475 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -66.05 121.8 9.21 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.736 2.291 . . . . 0.0 110.387 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 53.85 78.66 0.38 Allowed Pre-proline 0 N--CA 1.483 1.22 0 C-N-CA 123.921 0.888 . . . . 0.0 111.572 -175.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -97.96 6.01 1.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.932 2.421 . . . . 0.0 112.689 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 164.9 -168.76 39.26 Favored Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 56.1 m -143.27 159.13 42.89 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 120.795 0.331 . . . . 0.0 110.291 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.415 ' HA ' HG22 ' A' ' 111' ' ' THR . 82.7 mt -88.71 156.83 18.77 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.502 177.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 27.7 m -99.1 1.79 10.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 121.016 0.436 . . . . 0.0 111.841 -176.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.21 -52.22 4.63 Favored Glycine 0 C--O 1.217 -0.96 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.905 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.5 t -146.23 103.35 3.7 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 150.29 -175.0 29.54 Favored Glycine 0 N--CA 1.421 -2.359 0 C-N-CA 120.291 -0.957 . . . . 0.0 111.376 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 25.6 m -102.67 108.32 19.54 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 105' ' ' LEU . 5.5 t -99.98 114.52 27.85 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 121.766 0.793 . . . . 0.0 109.466 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.2 t -85.36 113.76 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.5 mt -96.17 147.8 23.37 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -136.91 123.03 20.38 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.443 0.639 . . . . 0.0 110.696 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 69.3 t -102.26 122.22 47.49 Favored Pre-proline 0 C--N 1.299 -1.604 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.225 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -68.51 109.97 2.18 Favored 'Trans proline' 0 N--CA 1.439 -1.703 0 N-CA-C 105.815 -2.417 . . . . 0.0 105.815 167.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.7 p -126.94 148.39 31.76 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -172.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.407 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 9.0 mmpt? -88.86 98.26 11.63 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.411 HG12 HD21 ' A' ' 87' ' ' LEU . 10.6 m -94.65 149.02 4.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.518 ' HA ' HD13 ' A' ' 123' ' ' ILE . . . 72.15 0.72 3.67 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.031 0.533 . . . . 0.0 111.359 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.407 ' H ' ' C ' ' A' ' 119' ' ' VAL . 55.2 t80 -59.93 -51.26 70.46 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 173.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 93' ' ' THR . 15.1 m -62.37 -27.44 69.07 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.152 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.518 HD13 ' HA ' ' A' ' 120' ' ' ALA . 2.6 mp -79.1 -47.8 22.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.905 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.78 -36.93 82.5 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.351 0.407 . . . . 0.0 110.994 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 54.0 t -65.68 -37.27 79.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.997 176.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 63.0 m -82.42 -75.81 0.29 Allowed 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.418 HD11 ' N ' ' A' ' 128' ' ' MET . 2.6 pp -124.56 -23.3 4.43 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -173.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.504 ' SD ' ' HD3' ' A' ' 129' ' ' LYS . 11.7 tpt 74.51 133.56 0.05 OUTLIER 'General case' 0 C--O 1.211 -0.971 0 C-N-CA 123.944 0.898 . . . . 0.0 112.039 -177.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.529 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -87.54 7.54 29.08 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.757 -175.293 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.43 ' H ' ' HG3' ' A' ' 128' ' ' MET . 10.3 m-20 67.74 -0.84 1.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 172.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.84 30.31 16.62 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 53.4 t -56.26 129.96 42.49 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 123.675 0.61 . . . . 0.0 109.998 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 52.5 p -77.82 130.52 36.78 Favored 'General case' 0 N--CA 1.414 -2.258 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 65.22 82.33 0.19 Allowed 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -174.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.488 ' HE1' ' HB2' ' A' ' 129' ' ' LYS . 64.0 t-105 -155.03 156.62 36.25 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.173 -170.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -148.5 148.05 29.79 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 176.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.9 tt -142.1 147.92 20.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.226 -174.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -63.14 122.14 15.37 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-O 121.931 0.872 . . . . 0.0 112.463 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.428 ' HE1' ' CD2' ' A' ' 87' ' ' LEU . 4.8 t80 -139.35 145.4 38.97 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.135 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -141.17 155.43 46.07 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.083 -0.385 . . . . 0.0 110.738 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.7 pp -139.12 151.31 46.57 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-O 121.245 0.545 . . . . 0.0 110.815 173.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.417 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 10.3 m-20 -133.19 111.96 11.32 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 173.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 60.8 mt -125.06 138.28 54.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.17 -177.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 157' ' ' ILE . . . -121.54 130.18 8.02 Favored Glycine 0 N--CA 1.418 -2.526 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.084 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -97.75 111.11 23.53 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.0 m -97.24 112.35 24.19 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.556 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.442 ' CE1' HG12 ' A' ' 80' ' ' ILE . 91.7 m-85 -115.19 140.07 49.4 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 154' ' ' ASP . 29.0 t70 -93.97 109.06 20.81 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 66.3 mt -118.99 117.5 33.57 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -52.48 -19.15 9.42 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 124.172 3.248 . . . . 0.0 114.982 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.24 -29.17 31.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 120.861 0.362 . . . . 0.0 111.009 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 61.1 t -131.94 -53.25 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.271 0.557 . . . . 0.0 110.725 -176.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 142.45 -155.59 25.77 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 108.451 -1.859 . . . . 0.0 108.451 -176.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 148' ' ' ASP . 4.9 p-10 -86.48 117.66 25.4 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 117.908 0.854 . . . . 0.0 109.748 175.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 2.1 pp -128.24 141.2 47.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.443 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 37.7 m -99.43 123.92 44.12 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.437 -178.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.402 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 2.0 mp -86.57 112.0 43.5 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 174.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -86.7 114.95 1.22 Allowed 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.672 2.248 . . . . 0.0 113.18 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.423 ' CG2' HG12 ' A' ' 49' ' ' VAL . 9.9 m -125.74 127.86 71.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.251 176.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.4 t -128.28 156.31 43.22 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.658 -174.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.1 t -166.55 149.16 6.73 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -100.26 127.53 46.53 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 172.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -113.28 133.14 11.08 Favored Glycine 0 N--CA 1.405 -3.393 0 C-N-CA 119.924 -1.131 . . . . 0.0 112.811 -172.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -101.95 120.12 39.89 Favored 'General case' 0 C--N 1.269 -2.9 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.3 pt -114.9 111.69 36.92 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 CA-C-O 121.75 0.786 . . . . 0.0 110.89 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.557 ' HZ1' ' HB2' ' A' ' 166' ' ' LYS . 4.9 ttmp? -81.06 119.75 23.94 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.712 -177.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.9 tt -102.24 98.8 11.12 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 166' ' ' LYS . 1.4 Cg_endo -83.57 81.27 2.29 Favored 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 122.677 2.251 . . . . 0.0 112.561 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 46.6 t 70.81 -76.48 0.06 Allowed 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.654 -1.157 . . . . 0.0 113.602 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.436 ' HG ' ' CD2' ' A' ' 173' ' ' PHE . 3.6 mm? 63.89 -65.7 0.12 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.28 1.032 . . . . 0.0 113.088 -176.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 63.9 91.62 0.07 Allowed 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.578 1.151 . . . . 0.0 110.405 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 74.37 90.76 0.08 Allowed 'General case' 0 CA--C 1.491 -1.317 0 C-N-CA 124.709 1.204 . . . . 0.0 109.349 -176.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.535 ' CE2' HG22 ' A' ' 62' ' ' VAL . 77.6 t80 . . . . . 0 C--N 1.284 -2.245 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 -175.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.4 t70 . . . . . 0 CA--C 1.517 -0.29 0 CA-C-O 120.733 0.301 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.434 ' OE1' HG21 ' A' ' 93' ' ' THR . 12.4 mm-40 -54.6 -41.52 70.05 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.301 0.572 . . . . 0.0 110.84 176.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -65.52 -53.45 42.06 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.521 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.6 m -64.32 -33.72 64.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.8 t -69.6 -45.44 78.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 176.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -58.67 -48.0 82.55 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.094 -176.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.469 ' O ' HG22 ' A' ' 23' ' ' VAL . 12.3 pt-20 -66.37 -40.61 89.85 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.149 -177.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -64.4 -40.93 96.74 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.59 -37.16 85.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.252 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.3 t -66.18 -44.07 85.04 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.32 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 19' ' ' GLU . 89.3 t -59.97 -43.84 93.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 CA-C-O 121.044 0.45 . . . . 0.0 110.018 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.4 HG21 ' HB2' ' A' ' 84' ' ' SER . 65.5 mt -70.95 -35.58 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.66 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.3 t -60.64 -41.36 94.75 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 122.267 -0.271 . . . . 0.0 110.294 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.524 ' HA ' ' OD2' ' A' ' 29' ' ' ASP . 50.9 m -65.32 -29.12 69.84 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.355 0.597 . . . . 0.0 110.384 176.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.65 ' O ' ' HB3' ' A' ' 30' ' ' LYS . 4.5 tt -69.97 -38.33 76.03 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 175.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.545 ' O ' ' HG3' ' A' ' 32' ' ' LYS 0.34 7.8 mp -67.37 -27.79 67.4 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 119.149 -1.02 . . . . 0.0 113.094 175.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.524 ' OD2' ' HA ' ' A' ' 26' ' ' SER . 53.1 m-20 -61.04 -45.44 94.76 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 172.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.65 ' HB3' ' O ' ' A' ' 27' ' ' LEU . 21.0 ttmm -54.99 -51.39 66.37 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.913 173.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.07 -44.77 91.89 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.44 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 95.0 mttt -60.07 -32.21 70.73 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.94 0.496 . . . . 0.0 110.33 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.492 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -62.67 -51.32 56.77 Favored Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.723 177.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -72.83 -38.64 67.06 Favored 'General case' 0 C--O 1.203 -1.393 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.752 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -62.41 -35.41 79.13 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -175.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.65 -27.1 64.76 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.655 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.499 ' HG3' ' N ' ' A' ' 38' ' ' LYS . 8.6 pt-20 -112.09 -57.28 2.29 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -175.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.499 ' N ' ' HG3' ' A' ' 37' ' ' GLU . 8.9 tppt? -73.69 -48.23 33.69 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-O 122.757 1.265 . . . . 0.0 109.803 -164.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.464 ' CD1' HG12 ' A' ' 157' ' ' ILE . 69.4 mt -83.07 4.86 24.47 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 113.11 -1.859 . . . . 0.0 111.575 -171.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.91 -7.9 11.96 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.981 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -110.42 -39.7 4.86 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.176 0.513 . . . . 0.0 110.19 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 54.7 mt -91.53 139.53 25.14 Favored Pre-proline 0 N--CA 1.432 -1.344 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.13 98.3 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.831 1.688 . . . . 0.0 108.328 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 m -127.62 148.94 68.81 Favored Pre-proline 0 C--N 1.297 -1.682 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -172.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 9.4 Cg_endo -51.88 129.06 28.86 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.857 2.372 . . . . 0.0 112.112 176.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 43.3 mt-10 -115.02 113.24 23.82 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.929 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.5 148.54 30.1 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.464 -176.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.1 t -154.74 142.93 20.33 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.766 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.541 ' H ' HG13 ' A' ' 159' ' ' VAL . 11.7 p -108.39 141.09 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 176.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -157.04 -23.04 0.09 Allowed 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.646 -171.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.546 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . 9.6 t0 -121.26 117.23 26.5 Favored 'General case' 0 CA--C 1.485 -1.547 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.24 -168.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.571 HG13 ' CD2' ' A' ' 64' ' ' TYR . 48.4 t -119.36 110.64 30.2 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -130.03 127.97 41.04 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.186 -175.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.599 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 51.1 p90 -64.75 139.26 58.74 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -176.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.488 ' HD3' ' HB2' ' A' ' 65' ' ' HIS . 14.7 mmmm -88.51 -24.85 22.82 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.392 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.49 -158.55 31.46 Favored Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.4 m -101.03 145.84 10.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 117.134 0.467 . . . . 0.0 111.27 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.3 m -155.06 135.54 13.36 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -75.84 -42.25 50.13 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -173.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -61.94 -56.58 17.69 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.702 0.763 . . . . 0.0 110.808 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.81 137.3 4.89 Favored Glycine 0 N--CA 1.409 -3.126 0 N-CA-C 107.022 -2.431 . . . . 0.0 107.022 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.517 HG11 ' CZ ' ' A' ' 173' ' ' PHE . 23.3 t -72.79 131.86 34.23 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-N 117.209 0.505 . . . . 0.0 110.115 -173.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -81.79 117.21 21.91 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.899 -177.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.599 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 9.4 m-85 -118.09 154.55 31.89 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.488 ' HB2' ' HD3' ' A' ' 55' ' ' LYS . 49.9 t-80 -91.03 108.43 19.86 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 176.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -91.71 107.56 19.29 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.546 ' HB3' ' HB3' ' A' ' 51' ' ' ASP . 40.4 ttmt -87.38 110.97 20.63 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.907 0.384 . . . . 0.0 110.557 -176.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.4 t -113.15 108.38 25.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.6 p -102.7 140.36 37.08 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.883 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 3.1 p -142.02 126.56 16.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.927 -178.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 45' ' ' PRO . 25.5 pttm -99.15 141.73 31.53 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 174.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -134.39 116.89 13.15 Favored Pre-proline 0 C--N 1.287 -2.141 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.641 -174.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -91.8 95.52 0.2 Allowed 'Trans proline' 0 N--CA 1.42 -2.838 0 N-CA-C 109.106 -1.152 . . . . 0.0 109.106 170.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.464 ' HB3' ' HG2' ' A' ' 76' ' ' GLN . 50.1 m-85 170.54 130.14 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 129.19 2.996 . . . . 0.0 104.723 -176.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.8 m -81.96 -2.78 52.59 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 118.362 0.528 . . . . 0.0 112.104 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.464 ' HG2' ' HB3' ' A' ' 74' ' ' TYR . 18.8 pt20 -83.2 132.08 35.08 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 121.206 0.527 . . . . 0.0 111.095 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.4 p -75.95 93.78 3.29 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 172.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.445 ' HB ' ' CD2' ' A' ' 105' ' ' LEU . 75.0 mt -72.66 123.37 89.47 Favored Pre-proline 0 C--N 1.3 -1.553 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.007 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -79.12 118.26 4.0 Favored 'Trans proline' 0 N--CA 1.44 -1.644 0 C-N-CA 122.115 1.877 . . . . 0.0 110.856 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.4 mp -72.44 111.53 6.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 57.0 m -50.31 -59.08 4.33 Favored 'General case' 0 C--O 1.244 0.791 0 O-C-N 123.899 0.749 . . . . 0.0 111.204 -176.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -150.94 154.02 36.35 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.446 HG22 ' HB ' ' A' ' 99' ' ' ILE . 11.1 tp -104.1 124.08 58.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 174.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.4 ' HB2' HG21 ' A' ' 24' ' ' ILE . 65.7 p -95.07 118.62 32.18 Favored 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 119.529 -0.869 . . . . 0.0 109.883 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.517 ' CE2' HG13 ' A' ' 117' ' ' VAL . 15.5 t80 -104.16 121.39 43.16 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 126.238 1.815 . . . . 0.0 111.067 -169.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' A' ' 142' ' ' ASP . 3.2 mp -127.25 108.08 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.598 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 1.8 tm? -101.71 121.58 42.31 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.423 ' HA ' HG23 ' A' ' 94' ' ' ILE . 39.8 ttmt -127.25 133.59 50.19 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 120.158 -0.617 . . . . 0.0 112.372 -175.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.5 m -123.18 147.3 47.0 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.434 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.98 -0.19 2.21 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.5 p -90.83 16.33 9.55 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 123.461 0.704 . . . . 0.0 110.834 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 70.86 -41.63 0.51 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 125.972 1.709 . . . . 0.0 113.388 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.579 ' O ' ' HB3' ' A' ' 122' ' ' SER . 99.9 m -62.26 137.75 58.31 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.598 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 47.1 pt -137.55 178.23 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.254 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . . . -127.88 130.11 48.0 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 174.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.7 t -126.78 147.13 50.02 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.89 172.21 37.14 Favored Glycine 0 N--CA 1.42 -2.403 0 C-N-CA 119.818 -1.182 . . . . 0.0 112.426 -176.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 63.2 m -153.07 109.76 3.43 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.446 ' HB ' HG22 ' A' ' 83' ' ' ILE . 3.1 mp -103.47 110.03 63.03 Favored Pre-proline 0 N--CA 1.467 0.424 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.674 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -68.11 127.45 15.97 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.611 2.207 . . . . 0.0 109.727 173.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.0 t70 57.29 81.42 0.26 Allowed Pre-proline 0 N--CA 1.482 1.154 0 CA-C-O 121.674 0.749 . . . . 0.0 110.234 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -107.72 13.74 0.13 Allowed 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 123.028 2.485 . . . . 0.0 113.088 -177.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 152.78 -172.26 31.85 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.6 p -135.2 143.72 46.55 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.957 0.378 . . . . 0.0 110.719 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.445 ' CD2' ' HB ' ' A' ' 78' ' ' ILE . 19.9 tp -82.42 129.48 34.9 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 11.6 p -57.61 -35.05 48.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -174.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.97 118.68 0.1 OUTLIER Glycine 0 CA--C 1.54 1.615 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.541 -174.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 34.5 t 67.56 11.51 8.41 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.669 1.188 . . . . 0.0 113.137 175.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -150.8 -164.52 12.05 Favored Glycine 0 CA--C 1.496 -1.141 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.558 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 10.0 t -116.68 138.54 51.38 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.505 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 7.0 t -133.65 138.8 46.1 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.03 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.3 m -91.62 106.93 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-O 122.057 0.932 . . . . 0.0 110.269 177.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.7 mt -92.2 153.9 19.01 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.504 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 4.8 p-10 -144.58 148.16 34.05 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.482 -0.887 . . . . 0.0 112.013 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.8 t -126.7 128.44 24.28 Favored Pre-proline 0 C--N 1.289 -2.056 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 171.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 22.7 Cg_exo -69.16 109.43 2.19 Favored 'Trans proline' 0 N--CA 1.432 -2.144 0 N-CA-C 108.206 -1.498 . . . . 0.0 108.206 172.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.517 HG13 ' CE2' ' A' ' 85' ' ' TYR . 30.3 m -98.41 150.3 4.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.384 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.553 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -95.1 97.46 9.95 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.062 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.426 ' C ' ' H ' ' A' ' 121' ' ' TYR . 4.5 m -93.15 147.12 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.482 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -177.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 69.9 -3.9 1.61 Allowed 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.968 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.426 ' H ' ' C ' ' A' ' 119' ' ' VAL . 84.2 t80 -57.99 -47.35 83.27 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.579 ' HB3' ' O ' ' A' ' 93' ' ' THR . 19.1 m -66.79 -26.3 66.89 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.996 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.5 mt -79.14 -49.64 19.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.727 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.16 -49.3 78.41 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 122.962 0.505 . . . . 0.0 110.34 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.2 t -54.97 -43.26 68.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.223 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 44.0 t -75.04 -78.84 0.1 Allowed 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.044 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.545 HD11 ' N ' ' A' ' 128' ' ' MET . 3.8 pp -126.24 -40.09 2.01 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 115.111 1.522 . . . . 0.0 115.111 -173.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.545 ' N ' HD11 ' A' ' 127' ' ' LEU . 24.9 ttt 66.01 116.52 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.355 1.062 . . . . 0.0 110.632 -173.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.71 -72.8 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.741 0.816 . . . . 0.0 112.133 -178.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 24.0 t70 172.87 -30.56 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 -174.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.573 ' HE1' ' O ' ' A' ' 170' ' ' LEU . 13.2 tpt 65.61 106.17 0.04 OUTLIER 'General case' 0 C--O 1.242 0.666 0 CA-C-N 113.235 -1.802 . . . . 0.0 112.573 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 44.7 t -128.53 173.52 10.17 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.108 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 30.8 p -82.69 115.74 21.76 Favored 'General case' 0 N--CA 1.413 -2.312 0 C-N-CA 123.257 0.623 . . . . 0.0 110.95 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.6 t70 74.21 95.61 0.07 Allowed 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 124.9 1.28 . . . . 0.0 108.835 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 -154.44 148.03 25.25 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.901 -170.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -118.62 143.58 46.71 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 67.2 mt -131.53 130.1 62.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 174.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 164' ' ' GLU . 9.5 p-10 -99.34 120.41 39.53 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.74 170.56 12.59 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 88' ' ' LYS . 1.6 mp0 -113.99 136.36 52.99 Favored 'General case' 0 C--N 1.279 -2.496 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.398 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.4 tp -122.05 116.21 23.86 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.76 176.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.479 ' HB3' ' HB ' ' A' ' 86' ' ' ILE . 15.4 t70 -126.63 120.89 30.65 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -175.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 43.0 mm -131.2 137.28 56.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 121.209 0.528 . . . . 0.0 110.594 -175.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -114.52 122.02 5.55 Favored Glycine 0 N--CA 1.419 -2.454 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 175.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.494 HD23 ' CE2' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -115.37 160.2 20.15 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.387 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.7 t -136.02 142.24 44.43 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 119.834 -0.747 . . . . 0.0 111.799 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.494 ' CE2' HD23 ' A' ' 145' ' ' LEU . 68.1 m-85 -135.6 138.51 43.02 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 174.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -116.91 132.77 56.62 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.883 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.06 143.11 29.98 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -66.91 5.01 0.88 Allowed 'Trans proline' 0 N--CA 1.488 1.184 0 C-N-CA 123.411 2.741 . . . . 0.0 113.415 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.46 -28.88 36.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 11.7 p -160.19 -28.49 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.67 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 140.51 -143.56 13.66 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.347 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -94.97 132.09 40.2 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 2.9 mp -122.54 129.73 75.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 33.9 p -95.77 140.44 30.55 Favored 'General case' 0 N--CA 1.406 -2.654 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 172.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.464 HG12 ' CD1' ' A' ' 39' ' ' LEU . 31.0 mt -114.11 129.26 24.98 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -90.69 116.86 0.55 Allowed 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 122.734 2.289 . . . . 0.0 112.314 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.541 HG13 ' H ' ' A' ' 49' ' ' VAL . 21.9 t -118.96 103.76 14.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 59.0 p -107.91 128.56 54.73 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 95.3 m -145.88 131.02 18.37 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.152 0.501 . . . . 0.0 112.158 -173.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -99.53 124.48 44.75 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -126.94 128.04 6.12 Favored Glycine 0 N--CA 1.42 -2.428 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.095 -176.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 138' ' ' ASP . 39.3 tt0 -95.98 120.57 36.5 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 176.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 9.6 pt -112.53 140.84 30.26 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.635 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.926 -176.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -102.54 143.96 31.57 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 121.82 0.819 . . . . 0.0 112.15 -174.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.4 mp -112.39 86.03 7.72 Favored Pre-proline 0 C--N 1.285 -2.203 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -80.12 85.98 1.74 Allowed 'Trans proline' 0 C--N 1.367 1.52 0 C-N-CA 123.353 2.702 . . . . 0.0 116.034 -167.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . 0.26 46.2 t 63.72 -1.57 0.61 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 175.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.573 ' O ' ' HE1' ' A' ' 131' ' ' MET . 4.2 mm? -70.33 96.9 1.18 Allowed 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 168.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -69.08 -23.6 64.04 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 118.754 -1.178 . . . . 0.0 109.802 176.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -117.79 102.16 8.89 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.517 ' CZ ' HG11 ' A' ' 62' ' ' VAL . 57.8 t80 . . . . . 0 C--N 1.289 -2.052 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 -174.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.0 t70 . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 121.287 0.565 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -78.2 -47.99 16.83 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.851 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -64.36 -36.15 83.19 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 116.761 -0.199 . . . . 0.0 110.73 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.431 ' HA ' ' HG3' ' A' ' 19' ' ' GLU . 34.2 m -69.18 -20.39 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.275 0.56 . . . . 0.0 111.153 -177.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.452 HG11 ' O ' ' A' ' 94' ' ' ILE . 55.3 t -73.36 -52.22 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 171.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -65.21 -43.67 90.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.311 -175.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.431 ' HG3' ' HA ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -64.64 -33.28 75.56 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.546 -178.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -79.13 -43.43 24.04 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.719 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.09 82.89 Favored 'General case' 0 C--O 1.21 -0.981 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.32 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -59.35 -45.4 91.48 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.23 -49.79 81.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.087 0.47 . . . . 0.0 109.953 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.58 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 73.2 mt -62.3 -46.17 97.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.263 -178.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.4 t -66.97 -36.97 83.38 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.624 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.2 t -63.23 -37.63 87.98 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.18 0.514 . . . . 0.0 109.665 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -66.05 -45.26 82.01 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 87.7 mt -57.04 -41.21 78.22 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.239 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -55.46 -48.92 73.75 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -79.38 -36.38 39.31 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.88 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.703 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . . . -68.35 -35.99 78.57 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.634 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -63.68 -35.74 81.56 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.33 -53.03 49.01 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.923 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.703 ' CE2' ' HA ' ' A' ' 31' ' ' ALA . 30.3 p90 -76.39 -24.56 54.11 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.383 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -57.19 -50.18 73.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.726 0.298 . . . . 0.0 110.834 175.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.1 -18.15 63.94 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.123 0.487 . . . . 0.0 110.987 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -91.69 -66.23 0.94 Allowed 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.446 ' HE2' ' HB2' ' A' ' 34' ' ' PHE . 49.7 mtmt -93.44 -35.66 12.86 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 121.189 0.518 . . . . 0.0 110.487 -171.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.1 mt -82.52 2.26 33.82 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.527 0.68 . . . . 0.0 111.63 -174.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.62 -26.83 21.7 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -98.31 -32.93 11.28 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.129 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 74.5 mt -93.0 114.26 62.17 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.64 101.4 0.55 Allowed 'Trans proline' 0 C--O 1.24 0.62 0 C-N-CA 122.509 2.139 . . . . 0.0 112.975 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.0 p -112.56 167.92 8.46 Favored Pre-proline 0 C--N 1.298 -1.665 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.299 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.93 120.21 7.88 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 122.775 2.317 . . . . 0.0 111.463 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -102.45 114.27 28.33 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -174.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -97.63 148.98 22.75 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.94 -173.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.404 ' HA ' HG21 ' A' ' 159' ' ' VAL . 5.2 t -147.51 124.47 11.32 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.187 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.442 ' HB ' ' CG2' ' A' ' 161' ' ' THR . 22.1 t -86.9 140.92 15.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -113.59 -72.65 0.69 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 -172.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -160.32 169.85 22.3 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.984 -162.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.5 HG23 ' CD1' ' A' ' 165' ' ' ILE . 34.5 m -129.53 146.61 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.379 0 C-N-CA 123.991 0.916 . . . . 0.0 109.872 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -123.72 126.33 46.34 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 118.204 -0.903 . . . . 0.0 108.618 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.446 ' O ' ' HE3' ' A' ' 55' ' ' LYS . 47.6 p90 -58.5 122.4 13.27 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 175.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.496 ' HA ' ' CE ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -124.7 -20.37 5.08 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.972 -169.406 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.98 -159.51 20.55 Favored Glycine 0 N--CA 1.427 -1.939 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.153 -177.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.22 137.65 33.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.202 0.525 . . . . 0.0 111.241 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.3 m -117.95 170.05 9.15 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -83.73 -33.77 25.02 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 118.701 -1.2 . . . . 0.0 110.558 175.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.491 ' O ' ' HD1' ' A' ' 121' ' ' TYR . 24.8 m-20 -111.28 97.72 6.98 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 171.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.58 -168.36 27.89 Favored Glycine 0 C--N 1.303 -1.257 0 C-N-CA 120.493 -0.86 . . . . 0.0 110.965 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 m -147.12 140.74 19.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 C-N-CA 123.265 0.626 . . . . 0.0 110.718 -177.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -71.31 127.11 31.48 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 123.874 0.734 . . . . 0.0 112.026 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -131.62 143.87 50.63 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 124.513 1.125 . . . . 0.0 111.199 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -92.6 108.0 19.64 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -101.55 140.42 35.86 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.2 137.39 54.22 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.554 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.7 t -123.79 111.44 29.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.3 p -97.7 147.14 24.66 Favored 'General case' 0 C--N 1.277 -2.58 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.911 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.61 134.74 29.76 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 CA-C-O 121.36 0.6 . . . . 0.0 110.317 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 22.2 ptmt -105.77 144.48 32.45 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.472 ' ND2' HD11 ' A' ' 105' ' ' LEU . 1.5 p-10 -149.37 124.88 4.97 Favored Pre-proline 0 C--N 1.28 -2.437 0 C-N-CA 118.532 -1.267 . . . . 0.0 109.686 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -97.64 97.98 0.07 OUTLIER 'Trans proline' 0 N--CA 1.417 -3.009 0 C-N-CA 121.563 1.509 . . . . 0.0 110.696 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -138.63 -85.52 0.26 Allowed 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.9 p 170.24 -47.43 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.861 0.865 . . . . 0.0 110.9 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.597 ' O ' ' HA2' ' A' ' 107' ' ' GLY . 15.6 pt20 -104.01 163.69 12.21 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.845 -174.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.5 p -78.38 130.85 36.61 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 170.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 75.3 mt -120.59 128.34 25.84 Favored Pre-proline 0 C--N 1.285 -2.213 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.47 150.3 69.79 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.298 1.999 . . . . 0.0 111.689 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.654 HG21 ' CE1' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -88.49 151.71 3.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 55.0 m -71.01 -50.94 28.69 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 174.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -166.03 163.35 18.27 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.62 -1.173 . . . . 0.0 107.977 171.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.6 tt -124.5 119.6 56.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 21.9 t -103.97 139.83 38.56 Favored 'General case' 0 N--CA 1.421 -1.899 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.667 -174.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.435 ' O ' ' HA ' ' A' ' 96' ' ' SER . 37.5 p90 -120.78 125.52 47.78 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 174.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 66.5 mt -118.64 107.35 21.48 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 174.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.484 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 3.0 pp -104.38 146.25 29.1 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.424 -175.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -116.77 155.45 28.9 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.192 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.9 m -140.11 109.55 6.23 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 66.47 -69.84 0.11 Allowed 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 125.612 1.565 . . . . 0.0 113.788 175.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.8 t -154.31 -46.27 0.09 Allowed 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -175.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -129.97 145.7 51.64 Favored 'General case' 0 C--N 1.314 -0.965 0 O-C-N 121.795 -0.566 . . . . 0.0 111.595 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 47.4 m 77.25 130.2 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 124.858 1.263 . . . . 0.0 112.22 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 42.5 pt -131.88 177.76 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.72 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.229 -178.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.99 148.74 51.17 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 173.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 70.2 p -143.01 160.75 39.76 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -177.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -176.87 164.51 34.05 Favored Glycine 0 N--CA 1.433 -1.527 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.435 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.9 p -132.15 115.47 15.77 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 124.217 1.007 . . . . 0.0 109.55 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.407 ' CD1' HG12 ' A' ' 115' ' ' VAL . 56.6 mt -94.95 125.09 52.22 Favored Pre-proline 0 C--O 1.244 0.78 0 C-N-CA 118.937 -1.105 . . . . 0.0 112.685 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -83.31 118.43 2.59 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.924 2.416 . . . . 0.0 111.739 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 48.36 68.55 3.41 Favored Pre-proline 0 N--CA 1.484 1.233 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -83.59 -21.44 4.24 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 N-CA-C 108.955 -1.21 . . . . 0.0 108.955 170.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -177.06 -166.63 34.29 Favored Glycine 0 N--CA 1.418 -2.51 0 N-CA-C 107.709 -2.157 . . . . 0.0 107.709 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 21.2 m -142.82 171.85 13.49 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.472 HD11 ' ND2' ' A' ' 72' ' ' ASN . 2.1 pp -75.96 153.2 36.75 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 117.697 -1.601 . . . . 0.0 108.791 172.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 8.9 p -70.98 -42.01 76.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -170.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.597 ' HA2' ' O ' ' A' ' 76' ' ' GLN . . . 129.58 -72.44 0.48 Allowed Glycine 0 N--CA 1.409 -3.124 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 -175.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.6 t -145.23 87.65 1.83 Allowed 'General case' 0 C--N 1.278 -2.52 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 160.83 -146.22 12.12 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 8.9 t -125.75 135.34 51.95 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 117.418 0.609 . . . . 0.0 111.008 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.5 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 2.7 t -127.5 138.98 53.07 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 122.924 0.49 . . . . 0.0 110.602 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.9 m -99.21 118.49 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-O 121.557 0.694 . . . . 0.0 110.551 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.8 mt -103.93 162.12 13.4 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -150.51 149.26 29.73 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.62 0.724 . . . . 0.0 112.383 -176.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.407 HG12 ' CD1' ' A' ' 99' ' ' ILE . 53.2 t -129.78 127.77 22.89 Favored Pre-proline 0 C--N 1.302 -1.457 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.084 176.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -79.18 110.01 2.65 Favored 'Trans proline' 0 N--CA 1.419 -2.884 0 N-CA-C 107.008 -1.958 . . . . 0.0 107.008 168.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.0 m -115.95 150.27 17.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . 0.315 0.0 OUTLIER -97.87 122.6 41.17 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 118.245 -1.382 . . . . 0.0 109.976 166.014 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.2 m -91.99 142.14 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.211 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -174.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 69.23 10.81 7.99 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.876 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.491 ' HD1' ' O ' ' A' ' 60' ' ' ASP . 67.6 t80 -54.7 -40.89 69.63 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.895 0.878 . . . . 0.0 108.949 171.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.3 m -61.34 -45.47 94.28 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.591 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.7 tt -75.81 -34.5 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.248 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -53.73 -48.46 69.61 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 123.413 0.685 . . . . 0.0 112.1 176.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.5 m -71.87 -21.83 21.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.0 t -88.79 -69.06 0.73 Allowed 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 120.718 0.294 . . . . 0.0 111.253 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -124.84 -29.05 3.43 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.898 -0.501 . . . . 0.0 111.986 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.408 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 25.7 ttt 76.35 88.32 0.08 Allowed 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.584 ' HE3' ' CD1' ' A' ' 135' ' ' TRP . 87.5 tttt 41.87 -86.54 0.01 OUTLIER 'General case' 0 C--N 1.345 0.375 0 O-C-N 125.138 1.524 . . . . 0.0 114.584 167.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 29.7 t70 152.95 -25.36 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.136 1.774 . . . . 0.0 106.348 -175.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.6 tpt 43.86 78.19 0.06 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-N 113.115 -1.857 . . . . 0.0 112.244 -169.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 54.0 t -110.22 140.87 43.9 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 176.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 19.3 p -68.69 122.93 19.57 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.1 t70 68.95 103.9 0.06 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.462 1.105 . . . . 0.0 108.694 -169.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.584 ' CD1' ' HE3' ' A' ' 129' ' ' LYS . 59.6 t-105 -150.69 134.81 16.88 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.752 -170.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -107.37 123.69 48.73 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.465 ' HB ' ' NE1' ' A' ' 135' ' ' TRP . 16.2 tt -123.53 134.34 66.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.743 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -85.11 114.35 22.18 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.511 -175.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.468 ' HH ' HD23 ' A' ' 141' ' ' LEU . 3.5 t80 -133.11 155.9 48.41 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.737 0.815 . . . . 0.0 110.945 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -151.14 155.1 38.21 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.468 HD23 ' HH ' ' A' ' 139' ' ' TYR . 1.7 pt? -136.94 117.06 13.38 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.568 0.699 . . . . 0.0 109.152 169.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -91.86 117.26 29.63 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 158' ' ' PRO . 41.4 mm -106.96 140.03 26.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.586 -0.845 . . . . 0.0 110.793 -173.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -127.99 102.54 0.59 Allowed Glycine 0 N--CA 1.423 -2.172 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 145' ' ' LEU . 1.1 pp -94.97 137.76 33.6 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.219 -0.592 . . . . 0.0 111.051 178.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.2 m -116.89 127.23 54.07 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.74 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.654 ' CE1' HG21 ' A' ' 80' ' ' ILE . 87.0 m-85 -128.56 143.9 51.05 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.785 175.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -104.04 110.26 22.36 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 66.1 mt -123.54 114.55 28.65 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -41.79 -36.13 3.25 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 124.827 3.684 . . . . 0.0 115.08 -175.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 56.9 t -55.25 -40.55 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 122.942 0.497 . . . . 0.0 111.544 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 51.9 t -117.72 -45.93 3.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.925 0.393 . . . . 0.0 110.639 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 129.69 -150.89 19.12 Favored Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -81.07 116.99 21.28 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 177.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 28.7 pt -124.0 128.53 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 37.3 m -104.62 116.6 32.35 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 174.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 70.1 mt -101.92 112.73 65.66 Favored Pre-proline 0 C--N 1.293 -1.891 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.005 -176.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 6.6 Cg_endo -82.98 132.8 6.4 Favored 'Trans proline' 0 CA--C 1.482 -2.12 0 C-N-CA 122.863 2.375 . . . . 0.0 112.532 176.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.434 HG13 ' HB ' ' A' ' 143' ' ' ILE . 2.7 p -134.51 123.35 42.17 Favored 'Isoleucine or valine' 1 N--CA 1.372 -4.335 0 CA-C-N 112.582 -2.099 . . . . 0.0 108.918 -179.353 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 15.4 m -116.43 156.76 26.23 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.578 -174.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.442 ' CG2' ' HB ' ' A' ' 49' ' ' VAL . 9.9 t -173.82 171.36 3.75 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -113.5 145.82 40.59 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 120.915 0.388 . . . . 0.0 110.442 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -118.4 103.4 1.03 Allowed Glycine 0 N--CA 1.426 -2.023 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -88.61 121.13 30.66 Favored 'General case' 0 C--N 1.268 -2.978 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.5 ' CD1' HG23 ' A' ' 52' ' ' VAL . 30.4 mm -110.28 109.27 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.432 -173.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -94.4 126.23 39.54 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.65 172.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 95.2 mt -115.51 88.23 19.01 Favored Pre-proline 0 C--N 1.293 -1.858 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.066 -176.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -82.95 86.57 1.45 Allowed 'Trans proline' 0 N--CA 1.434 -2.0 0 C-N-CA 122.52 2.147 . . . . 0.0 113.109 -176.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 57.3 p 55.1 92.83 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 175.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 5.1 mp -108.51 -61.16 1.64 Allowed 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.326 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . 0.299 86.1 mtm180 62.26 109.11 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -176.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . 0.319 21.4 m-20 85.05 -9.34 0.85 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.171 1.788 . . . . 0.0 114.4 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 . . . . . 0 C--N 1.31 -1.134 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 169.098 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.405 ' HA ' HG23 ' A' ' 16' ' ' VAL . 26.3 m-20 . . . . . 0 CA--C 1.506 -0.734 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.73 -48.44 77.76 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.524 -1.217 . . . . 0.0 109.036 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -69.19 -47.09 65.84 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.487 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.405 HG23 ' HA ' ' A' ' 13' ' ' ASP . 35.2 m -65.51 -32.38 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -176.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.5 p -73.07 -28.63 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.845 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -70.25 -37.48 74.94 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.424 ' O ' HG22 ' A' ' 23' ' ' VAL . 18.2 mm-40 -56.27 -41.69 76.25 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.449 174.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.533 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 9.9 mmpt? -64.11 -46.56 83.64 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.577 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.87 -43.14 85.79 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.576 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.1 t -59.22 -31.77 69.34 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 19' ' ' GLU . 64.4 t -75.46 -48.78 29.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.6 mt -61.35 -52.32 62.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.924 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.5 m -65.63 -22.46 66.66 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.602 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.7 t -66.23 -44.85 82.61 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.8 tt -75.73 -40.14 56.09 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.437 ' HA ' ' OG1' ' A' ' 156' ' ' THR . 6.1 tt -61.58 -35.18 77.09 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.686 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -67.11 -47.34 71.46 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.017 0.527 . . . . 0.0 112.018 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -66.18 -33.59 76.11 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.234 0.54 . . . . 0.0 110.947 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.86 -32.12 61.81 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.978 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.96 -46.45 89.22 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.611 0.243 . . . . 0.0 111.003 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.66 -32.59 82.04 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.971 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -78.98 -48.96 13.52 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.435 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 68.4 t80 -53.56 -38.75 64.17 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.59 -46.88 58.15 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 123.917 0.761 . . . . 0.0 113.006 -176.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -116.89 -36.51 3.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.362 0.601 . . . . 0.0 112.507 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -77.43 -33.49 54.88 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -168.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.435 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 89.9 mt -100.06 13.46 34.0 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.874 0.845 . . . . 0.0 109.816 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.51 -37.07 12.11 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 172.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -73.53 -50.08 23.25 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.722 176.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.6 mt -80.49 119.46 76.4 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.917 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.54 120.27 8.0 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.45 2.1 . . . . 0.0 111.983 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 p -127.24 156.75 74.23 Favored Pre-proline 0 C--N 1.288 -2.079 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.266 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.66 133.12 40.74 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.372 2.048 . . . . 0.0 110.839 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.0 110.02 22.65 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -177.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.5 140.32 41.99 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.343 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 t -142.32 136.59 29.85 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 121.336 0.589 . . . . 0.0 110.738 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.5 t -83.98 141.25 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -115.42 -59.61 1.98 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.346 -0.942 . . . . 0.0 113.342 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -169.59 -173.61 1.69 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -175.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . 36.0 m -131.51 154.99 41.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 118.41 0.55 . . . . 0.0 111.069 -176.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -129.84 116.18 18.32 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.381 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.574 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 46.6 p90 -82.36 141.28 32.96 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.527 ' HE2' ' C ' ' A' ' 54' ' ' PHE . 0.4 OUTLIER -89.69 -78.15 0.37 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.986 175.196 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.59 -117.7 0.41 Allowed Glycine 0 C--O 1.211 -1.314 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.253 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.8 t -99.3 140.54 18.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 60' ' ' ASP . 57.4 m -147.08 149.77 33.71 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -72.3 -19.32 61.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.335 0.588 . . . . 0.0 111.336 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.454 ' H ' HG22 ' A' ' 58' ' ' THR . 7.4 m-20 -122.97 86.38 2.57 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.204 175.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.48 -133.89 30.5 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.356 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 93.0 t -134.45 143.2 38.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -89.65 105.49 17.83 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.675 0.75 . . . . 0.0 110.171 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.784 ' CD1' ' HB ' ' A' ' 119' ' ' VAL . 7.8 m-85 -102.63 141.46 35.42 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.479 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 15.6 m-70 -101.13 108.9 20.69 Favored 'General case' 0 C--N 1.282 -2.351 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.053 170.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -78.54 135.22 37.26 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.436 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -90.03 117.75 29.05 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.606 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.8 t -129.61 111.89 23.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.2 p -100.45 137.16 39.24 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.252 0.549 . . . . 0.0 111.979 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.6 t -127.66 132.41 69.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.881 -177.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -116.8 142.87 46.35 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.485 HD21 ' HA2' ' A' ' 107' ' ' GLY . 38.1 t30 -140.93 115.76 7.27 Favored Pre-proline 0 C--N 1.286 -2.177 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.677 -175.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -90.33 97.38 0.27 Allowed 'Trans proline' 0 N--CA 1.426 -2.45 0 C-N-CA 121.406 1.404 . . . . 0.0 112.228 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.471 ' HB3' ' H ' ' A' ' 76' ' ' GLN . 18.8 m-85 -167.78 -168.65 1.03 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 126.967 2.107 . . . . 0.0 107.372 177.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.1 t -132.98 7.48 4.01 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 170.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.471 ' H ' ' HB3' ' A' ' 74' ' ' TYR . 11.5 pt20 -97.63 142.19 29.75 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.594 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.5 p -79.62 102.58 8.99 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-O 120.944 0.402 . . . . 0.0 110.33 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.469 ' HB ' HD21 ' A' ' 105' ' ' LEU . 78.7 mt -92.6 117.67 67.69 Favored Pre-proline 0 C--N 1.31 -1.145 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 177.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -78.22 130.37 10.13 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 122.162 1.908 . . . . 0.0 112.747 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.463 ' HB ' ' CE1' ' A' ' 147' ' ' PHE . 9.9 tt -82.6 94.38 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 174.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 57.9 m -58.79 -42.13 88.33 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.845 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -156.87 148.55 22.55 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.617 -171.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.5 tt -128.58 116.36 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 173.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 28.6 p -120.26 118.72 31.18 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.717 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.489 ' CE1' HG13 ' A' ' 117' ' ' VAL . 43.6 p90 -109.04 147.98 31.5 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.414 -176.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.422 HD12 ' N ' ' A' ' 86' ' ' ILE . 3.0 mp -120.31 113.26 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 175.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.677 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 0.9 OUTLIER -99.51 137.25 38.27 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.521 ' N ' HD22 ' A' ' 87' ' ' LEU . 45.4 mtpt -129.1 153.89 47.22 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 172.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.5 t -158.97 140.4 13.21 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 119.027 -1.069 . . . . 0.0 113.2 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 60.38 -79.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.805 1.642 . . . . 0.0 114.595 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -167.32 -32.48 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.099 0.476 . . . . 0.0 109.89 -175.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -129.09 141.94 51.05 Favored 'General case' 0 CA--C 1.49 -1.343 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.883 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 122' ' ' SER . 7.2 m 75.39 134.21 0.05 Allowed 'General case' 0 C--N 1.307 -1.25 0 O-C-N 125.177 1.548 . . . . 0.0 112.354 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.677 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.6 pp -138.2 174.79 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.199 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.412 ' HB1' HD13 ' A' ' 87' ' ' LEU . . . -132.63 162.01 32.42 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 119.095 0.862 . . . . 0.0 111.026 175.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.0 m -143.36 153.68 42.95 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -154.96 149.93 21.33 Favored Glycine 0 N--CA 1.419 -2.472 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 93.2 m -141.32 108.51 5.49 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.4 mt -115.03 110.21 46.16 Favored Pre-proline 0 C--N 1.306 -1.316 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.776 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -72.16 131.06 17.33 Favored 'Trans proline' 0 C--O 1.238 0.502 0 C-N-CA 122.533 2.155 . . . . 0.0 109.645 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.314 4.0 p30 44.72 77.94 0.42 Allowed Pre-proline 0 N--CA 1.487 1.394 0 C-N-CA 124.622 1.169 . . . . 0.0 114.107 -175.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -87.91 -8.71 5.77 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.874 2.383 . . . . 0.0 113.556 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 173.36 -161.77 32.71 Favored Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.592 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 46.2 m -119.86 142.03 49.02 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.209 0.528 . . . . 0.0 110.719 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.469 HD21 ' HB ' ' A' ' 78' ' ' ILE . 41.5 tp -97.04 141.37 30.28 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 61.0 t -89.77 107.46 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.247 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 171.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.485 ' HA2' HD21 ' A' ' 72' ' ' ASN . . . -57.06 -22.49 42.79 Favored Glycine 0 C--N 1.292 -1.89 0 CA-C-N 114.317 -1.311 . . . . 0.0 113.627 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.4 p -120.23 11.72 11.63 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -156.57 -161.93 11.1 Favored Glycine 0 CA--C 1.498 -1.009 0 C-N-CA 117.135 -2.459 . . . . 0.0 114.996 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.4 m -101.7 129.85 47.95 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.0 t -127.47 133.21 49.91 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 40.1 t -97.78 115.92 39.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.1 mt -102.81 160.93 14.16 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.453 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 7.3 p-10 -133.45 130.81 39.14 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 9.6 t -104.78 126.18 31.91 Favored Pre-proline 0 C--N 1.305 -1.368 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -71.04 110.47 2.82 Favored 'Trans proline' 0 N--CA 1.433 -2.054 0 N-CA-C 106.818 -2.031 . . . . 0.0 106.818 168.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.489 HG13 ' CE1' ' A' ' 85' ' ' TYR . 97.6 t -116.69 141.39 34.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.568 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -87.17 88.4 7.69 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.17 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.784 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 94.5 t -94.04 145.99 7.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.664 -176.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 72.41 -1.99 2.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.141 0.976 . . . . 0.0 111.245 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -68.45 -43.38 77.19 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.419 ' O ' ' HB ' ' A' ' 93' ' ' THR . 14.4 m -62.0 -28.0 69.26 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 122.491 1.138 . . . . 0.0 109.578 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.434 HD12 ' HZ1' ' A' ' 129' ' ' LYS . 60.6 mt -78.18 -49.45 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.22 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.455 -177.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.03 -36.27 72.47 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.324 0.649 . . . . 0.0 111.517 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.0 t -67.81 -34.72 69.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.421 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.0 t -93.39 -66.77 0.9 Allowed 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -176.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.405 ' H ' HD23 ' A' ' 127' ' ' LEU . 1.8 pt? -124.91 -23.85 4.2 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -176.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 24.2 ttt 56.89 35.59 26.55 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.283 1.033 . . . . 0.0 109.349 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.434 ' HZ1' HD12 ' A' ' 123' ' ' ILE . 61.6 mmtt 69.3 -70.5 0.14 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.033 1.733 . . . . 0.0 106.672 -172.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.411 ' H ' ' H ' ' A' ' 131' ' ' MET . 24.4 t70 149.58 18.71 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 130.855 3.662 . . . . 0.0 102.862 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.563 ' SD ' ' HA ' ' A' ' 171' ' ' ARG . 0.0 OUTLIER 58.53 76.79 0.33 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 113.05 -1.887 . . . . 0.0 106.778 -163.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 64.9 m -106.43 127.62 53.42 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.631 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 169' ' ' SER . 19.0 p -93.29 119.4 32.39 Favored 'General case' 0 N--CA 1.399 -2.982 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.078 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 5.9 m-20 72.85 89.14 0.1 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 176.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -173.15 158.66 3.71 Favored 'General case' 0 C--O 1.246 0.894 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.254 174.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.513 ' HA ' ' HA ' ' A' ' 166' ' ' LYS . 5.1 p-10 -98.45 143.38 28.96 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.441 HD11 ' N ' ' A' ' 137' ' ' ILE . 3.1 mp -124.23 140.46 47.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -177.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -75.81 112.7 12.47 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 122.674 1.226 . . . . 0.0 111.791 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.474 ' CE2' ' HG ' ' A' ' 87' ' ' LEU . 1.2 t80 -125.23 152.01 45.13 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 113.501 -1.682 . . . . 0.0 107.261 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.495 ' HA ' ' HA ' ' A' ' 162' ' ' GLN . 17.4 tt0 -134.08 150.46 51.18 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.1 tp -131.89 117.7 18.84 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 121.703 0.763 . . . . 0.0 110.163 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.4 ' HB3' ' HB ' ' A' ' 86' ' ' ILE . 13.3 t70 -124.76 130.2 51.94 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 -177.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.9 mt -136.81 140.48 42.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.159 -1.016 . . . . 0.0 111.761 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -108.32 93.15 0.78 Allowed Glycine 0 N--CA 1.426 -1.976 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.463 ' HB3' ' CE2' ' A' ' 147' ' ' PHE . 3.1 mm? -68.42 118.96 12.16 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 16.7 m -100.89 108.52 20.31 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.267 -177.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.463 ' CE1' ' HB ' ' A' ' 80' ' ' ILE . 96.3 m-85 -119.26 149.22 42.14 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 176.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 154' ' ' ASP . 4.5 p-10 -102.48 115.97 31.66 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.121 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.3 mp -108.02 105.46 56.44 Favored Pre-proline 0 C--N 1.296 -1.737 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -30.15 -51.14 0.2 Allowed 'Trans proline' 0 N--CA 1.485 1.029 1 C-N-CA 125.694 4.263 . . . . 0.0 116.984 -172.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.404 HG21 HG23 ' A' ' 152' ' ' VAL . 29.7 m -62.29 -21.17 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -177.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.404 HG23 HG21 ' A' ' 151' ' ' VAL . 48.4 t -121.86 -40.73 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.817 0.818 . . . . 0.0 109.754 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 112.8 -148.8 18.49 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 148' ' ' ASP . 6.7 p-10 -86.46 124.42 32.77 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.612 0.72 . . . . 0.0 110.811 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 146' ' ' THR . 2.2 pp -125.35 145.07 33.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.489 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' A' ' 28' ' ' LEU . 46.4 p -94.7 119.57 33.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.652 0.263 . . . . 0.0 110.771 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 55.3 mt -92.78 119.32 67.93 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -70.71 125.48 11.7 Favored 'Trans proline' 0 C--O 1.24 0.579 0 C-N-CA 123.596 2.864 . . . . 0.0 113.409 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 39.0 t -132.81 115.03 23.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 173.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.7 m -125.36 142.8 51.3 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 121.046 -0.262 . . . . 0.0 110.808 -174.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.1 t -176.97 157.11 1.39 Allowed 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.495 ' HA ' ' HA ' ' A' ' 140' ' ' GLN . 30.2 pt20 -99.62 152.45 20.03 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.267 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -120.37 119.57 4.24 Favored Glycine 0 N--CA 1.417 -2.597 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -96.7 120.59 37.3 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 4.2 pt -131.16 112.82 22.42 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 CA-C-O 121.446 0.641 . . . . 0.0 112.191 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 136' ' ' ASP . 40.1 ttmt -90.87 128.24 36.68 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.102 178.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 134' ' ' ASP . 88.4 mt -110.38 107.23 58.4 Favored Pre-proline 0 C--N 1.286 -2.161 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.568 -173.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -71.58 105.09 1.7 Allowed 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.788 2.325 . . . . 0.0 111.835 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 133' ' ' THR 0.268 89.5 p 60.46 -83.96 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 126.025 1.73 . . . . 0.0 114.557 -175.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 10.9 mp 63.44 26.74 14.99 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-O 121.044 0.449 . . . . 0.0 112.189 -176.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.563 ' HA ' ' SD ' ' A' ' 131' ' ' MET . 47.1 ttt180 -77.23 99.08 5.34 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . 0.276 1.8 m-20 80.28 79.45 0.05 OUTLIER 'General case' 0 CA--C 1.49 -1.359 0 CA-C-O 123.089 1.423 . . . . 0.0 109.514 -168.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 28.2 t80 . . . . . 0 C--N 1.275 -2.661 0 N-CA-C 100.718 -3.808 . . . . 0.0 100.718 -177.157 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.9 t70 . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.94 -28.44 62.43 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.218 0.532 . . . . 0.0 111.295 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.51 ' HE2' ' OE1' ' A' ' 19' ' ' GLU . 81.9 tttt -67.69 -55.3 13.75 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.539 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.401 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 32.3 m -60.27 -33.64 54.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -173.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -73.36 -33.43 40.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.093 0.473 . . . . 0.0 110.21 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -72.65 -49.34 32.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.144 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.51 ' OE1' ' HE2' ' A' ' 15' ' ' LYS . 8.9 pt-20 -64.36 -31.73 73.05 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.978 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.486 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 1.1 tpmt? -61.98 -48.78 78.82 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.83 -39.48 94.47 Favored 'General case' 0 C--O 1.21 -0.991 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.829 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.5 t -60.53 -44.51 95.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 66.6 t -69.47 -43.87 80.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 20' ' ' LYS . 78.7 mt -61.03 -45.25 98.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.397 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.7 t -57.42 -41.71 80.92 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 123.041 0.536 . . . . 0.0 110.055 177.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.8 t -66.79 -26.27 66.87 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-O 121.013 0.435 . . . . 0.0 110.912 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 tt -76.36 -55.19 5.78 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.571 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 8.4 mp -59.3 -36.39 75.51 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -51.23 -45.7 62.05 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.09 0.556 . . . . 0.0 111.843 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -82.95 -31.2 27.79 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 177.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.96 -32.27 73.56 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.116 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.571 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 61.4 mtpt -57.18 -27.85 62.3 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.484 0.713 . . . . 0.0 110.819 175.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.55 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -74.12 -55.77 5.58 Favored Glycine 0 N--CA 1.438 -1.228 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 178.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -56.1 -40.98 74.52 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.763 0.316 . . . . 0.0 110.836 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.409 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 48.7 t80 -67.21 -37.48 83.7 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.27 -34.75 63.66 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.987 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 33' ' ' GLY . 11.1 pt-20 -104.72 -44.37 4.88 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -176.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -87.93 -43.94 11.4 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.682 0.753 . . . . 0.0 109.659 -170.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 67.2 mt -87.16 12.13 12.35 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.647 -176.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.05 -40.72 15.47 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 173.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.529 ' OD1' HG13 ' A' ' 42' ' ' ILE . 8.4 p30 -87.72 -36.43 17.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.452 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.529 HG13 ' OD1' ' A' ' 41' ' ' ASN . 85.4 mt -88.84 113.8 57.38 Favored Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -79.0 101.04 1.4 Allowed 'Trans proline' 0 N--CA 1.435 -1.97 0 C-N-CA 121.955 1.77 . . . . 0.0 113.628 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.9 p -93.04 149.94 38.4 Favored Pre-proline 0 N--CA 1.419 -1.987 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.442 ' HB3' ' HA ' ' A' ' 72' ' ' ASN . 10.9 Cg_endo -53.37 141.87 59.52 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.279 1.986 . . . . 0.0 110.246 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -96.53 141.99 29.15 Favored 'General case' 0 CA--C 1.484 -1.563 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.685 -172.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.48 137.35 53.24 Favored 'General case' 0 N--CA 1.414 -2.254 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.877 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.2 t -134.34 126.03 28.82 Favored 'General case' 0 C--N 1.272 -2.779 0 CA-C-O 121.635 0.731 . . . . 0.0 109.985 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.501 HG13 ' CG1' ' A' ' 143' ' ' ILE . 35.5 m -107.38 141.72 21.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.164 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.491 ' HB2' ' O ' ' A' ' 49' ' ' VAL . 27.5 t70 161.8 66.81 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 124.898 1.374 . . . . 0.0 112.684 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -177.47 117.86 0.1 Allowed 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 168.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.2 t -132.03 112.69 20.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -121.53 141.88 50.62 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.9 -176.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -77.0 128.14 33.96 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.732 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -120.22 -3.09 10.05 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.656 -0.818 . . . . 0.0 112.047 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.0 158.29 25.92 Favored Glycine 0 CA--C 1.489 -1.567 0 C-N-CA 119.214 -1.469 . . . . 0.0 112.84 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.48 ' HB ' ' CE1' ' A' ' 173' ' ' PHE . 7.5 p -106.8 116.29 50.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.716 0.77 . . . . 0.0 112.336 -176.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.553 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 88.4 m -132.55 130.67 40.65 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 174.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -82.01 -12.2 58.43 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.211 0.529 . . . . 0.0 111.196 -174.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -114.33 69.16 0.7 Allowed 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 172.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.553 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . 100.33 101.37 2.41 Favored Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.117 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.0 p -76.2 143.07 13.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 121.164 0.507 . . . . 0.0 110.889 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -89.45 114.89 26.44 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -172.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.635 ' CD1' ' HB ' ' A' ' 119' ' ' VAL . 32.9 m-85 -120.87 151.26 39.87 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.056 173.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -120.51 109.19 14.99 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.93 144.75 34.53 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.933 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -102.4 118.76 37.56 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.599 -176.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.6 t -111.06 108.37 25.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 175.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.6 p -99.85 123.83 44.51 Favored 'General case' 0 C--N 1.285 -2.201 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.713 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.7 t -114.96 128.01 72.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.722 -176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 71' ' ' LYS . 19.2 ptpt -102.35 110.48 22.45 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.591 ' O ' ' HA ' ' A' ' 108' ' ' SER . 34.1 t30 -109.98 113.9 56.67 Favored Pre-proline 0 C--N 1.265 -3.075 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.107 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -97.67 95.97 0.07 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.686 0 C-N-CA 121.605 1.537 . . . . 0.0 109.65 169.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -176.19 156.29 1.63 Allowed 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 127.468 2.307 . . . . 0.0 106.54 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.5 m -82.92 -18.59 39.57 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.656 0.741 . . . . 0.0 109.242 176.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.507 HE21 HG12 ' A' ' 78' ' ' ILE . 11.0 pt20 -96.83 146.78 24.6 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.674 -178.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.4 m -84.59 106.43 16.15 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 171.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.507 HG12 HE21 ' A' ' 76' ' ' GLN . 59.1 mt -76.19 116.15 53.4 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -56.99 137.02 80.12 Favored 'Trans proline' 0 C--O 1.239 0.569 0 C-N-CA 123.228 2.618 . . . . 0.0 113.757 -175.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 146' ' ' THR . 9.4 pt -112.64 98.59 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.952 175.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 51.6 t -52.6 -54.9 26.84 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.188 -177.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -145.71 160.64 41.43 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.511 ' CG2' ' HB ' ' A' ' 99' ' ' ILE . 14.9 tt -134.87 113.83 16.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 175.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 55.0 p -94.63 123.3 37.99 Favored 'General case' 0 C--N 1.287 -2.144 0 O-C-N 121.956 -0.465 . . . . 0.0 111.421 -175.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.426 ' HA ' HD11 ' A' ' 143' ' ' ILE . 36.4 p90 -103.81 129.86 51.3 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 2.5 mp -117.12 107.17 21.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 176.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.578 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 1.3 tt -92.35 132.56 36.63 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.464 ' N ' HD23 ' A' ' 87' ' ' LEU . 62.1 tttm -130.46 143.48 50.79 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.1 p -144.05 95.39 2.72 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 55.59 -81.84 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 171.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.6 p -83.98 -71.68 0.5 Allowed 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 -168.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -137.31 -64.92 0.55 Allowed 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 m -66.76 139.55 57.81 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 121.513 0.673 . . . . 0.0 112.086 -173.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.578 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.7 pp -139.7 170.65 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.484 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 -178.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.421 ' HB3' HD11 ' A' ' 87' ' ' LEU . . . -138.06 136.5 36.89 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.3 t -149.08 159.85 43.86 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.909 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.56 161.08 24.35 Favored Glycine 0 N--CA 1.422 -2.262 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 64.6 p -101.34 127.23 48.06 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.511 ' HB ' ' CG2' ' A' ' 83' ' ' ILE . 66.4 mt -97.15 110.07 52.44 Favored Pre-proline 0 C--N 1.306 -1.303 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.853 175.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -78.31 115.56 3.73 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.097 1.864 . . . . 0.0 110.828 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.7 t70 60.4 86.05 0.16 Allowed Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.868 -176.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -97.05 5.42 1.58 Allowed 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.903 2.402 . . . . 0.0 111.581 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 145.59 -164.71 28.06 Favored Glycine 0 N--CA 1.419 -2.484 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.3 m -137.95 155.59 48.73 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.43 HD21 ' CE1' ' A' ' 147' ' ' PHE . 6.9 mp -72.02 150.84 43.64 Favored 'General case' 0 CA--C 1.485 -1.555 0 CA-C-O 121.803 0.811 . . . . 0.0 111.149 176.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.447 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 11.1 p -88.2 139.13 17.85 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.143 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.274 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -66.49 90.77 0.16 Allowed Glycine 0 C--N 1.304 -1.231 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 72' ' ' ASN 0.252 79.6 p 63.09 86.74 0.11 Allowed 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 125.973 1.709 . . . . 0.0 113.537 -178.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 169.35 -163.86 37.46 Favored Glycine 0 N--CA 1.431 -1.669 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.5 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.7 m -119.29 115.99 25.31 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.447 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 5.1 t -110.23 132.2 54.38 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.106 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.2 t -95.72 113.09 29.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.6 mt -92.67 150.09 20.91 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.312 -177.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -105.02 119.66 39.57 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.365 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.54 117.84 30.01 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-O 121.17 0.51 . . . . 0.0 111.319 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.37 123.13 10.2 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.208 1.939 . . . . 0.0 111.143 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 57.4 t -125.26 136.64 60.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -88.17 93.56 9.54 Favored 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.635 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 96.2 t -93.76 146.44 6.55 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.826 -171.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 72.31 -4.29 2.07 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.121 1.368 . . . . 0.0 112.799 174.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.438 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . 44.9 t80 -67.13 -32.46 73.6 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.7 p -64.86 -35.2 80.36 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.041 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.8 mm -71.78 -46.98 58.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.021 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.4 -48.02 83.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.471 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.8 p -72.26 -25.46 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 CA-C-O 121.013 0.435 . . . . 0.0 111.35 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 39.2 t -80.8 -76.04 0.25 Allowed 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.825 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.571 HD13 ' N ' ' A' ' 128' ' ' MET . 2.5 pp -124.68 -37.26 2.5 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -175.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.571 ' N ' HD13 ' A' ' 127' ' ' LEU . 9.8 tpt 61.94 109.97 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.486 0.714 . . . . 0.0 111.49 -176.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -78.47 -30.07 47.16 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.411 ' HA ' ' HE3' ' A' ' 128' ' ' MET . 14.1 m-20 80.15 97.78 0.06 Allowed 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 113.533 -1.667 . . . . 0.0 110.76 -175.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.402 ' HE1' ' O ' ' A' ' 168' ' ' PRO . 0.1 OUTLIER -64.33 139.83 58.81 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.133 -1.394 . . . . 0.0 110.395 -176.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 49.7 t -138.37 -81.54 0.32 Allowed 'General case' 0 CA--C 1.56 1.364 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.607 ' HA ' ' CB ' ' A' ' 169' ' ' SER . 14.1 p -144.29 130.81 19.95 Favored 'General case' 0 N--CA 1.426 -1.645 0 C-N-CA 125.541 1.536 . . . . 0.0 109.652 -171.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 44.56 89.56 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 C-N-CA 124.632 1.173 . . . . 0.0 110.138 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 69.5 t-105 -128.99 150.21 50.5 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -162.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -136.94 136.26 38.44 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.031 0.932 . . . . 0.0 109.893 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 22.6 pt -132.41 136.66 55.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 173.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -87.18 121.14 29.23 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.52 ' CE2' ' HG ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -149.61 161.74 41.56 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -175.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -164.16 158.94 19.71 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 117.889 0.313 . . . . 0.0 110.822 171.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.599 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 1.5 pt? -136.12 132.29 35.88 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-O 121.0 0.429 . . . . 0.0 109.96 176.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.456 ' HA ' ' HB3' ' A' ' 160' ' ' SER . 15.2 t70 -101.84 120.84 41.02 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 175.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.501 ' CG1' HG13 ' A' ' 49' ' ' VAL . 45.8 mm -100.66 133.07 45.02 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 CA-C-O 120.832 0.349 . . . . 0.0 110.693 -176.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -114.75 86.41 0.41 Allowed Glycine 0 N--CA 1.41 -3.096 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 174.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.557 HD12 ' H ' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -81.05 146.42 30.64 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.304 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 30.3 m -127.84 114.45 17.24 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 119.051 -1.06 . . . . 0.0 112.248 -176.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.437 ' CZ ' ' HG2' ' A' ' 45' ' ' PRO . 50.3 m-85 -99.14 160.3 14.37 Favored 'General case' 0 C--O 1.246 0.875 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 174.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -121.37 126.85 50.41 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.846 174.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.7 125.33 18.36 Favored Pre-proline 0 C--N 1.301 -1.512 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.092 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.54 -28.68 22.5 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 C-N-CA 123.953 3.102 . . . . 0.0 113.737 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.94 -38.39 76.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.506 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 41.3 t -124.84 -45.29 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.264 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 129.15 -133.58 7.62 Favored Glycine 0 N--CA 1.428 -1.847 0 C-N-CA 121.026 -0.607 . . . . 0.0 111.758 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -100.33 117.34 34.32 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.857 0.863 . . . . 0.0 108.931 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.405 ' N ' HD12 ' A' ' 155' ' ' ILE . 2.7 mp -128.75 119.5 49.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.494 178.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 86.4 m -82.07 112.11 18.83 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 173.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.463 ' O ' HD12 ' A' ' 145' ' ' LEU . 70.0 mt -93.5 117.15 67.29 Favored Pre-proline 0 C--N 1.299 -1.587 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.285 -176.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.7 Cg_endo -82.83 133.87 7.03 Favored 'Trans proline' 0 CA--C 1.489 -1.774 0 C-N-CA 122.88 2.387 . . . . 0.0 112.728 176.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.28 131.4 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.106 0 CA-C-N 113.097 -1.865 . . . . 0.0 109.062 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.456 ' HB3' ' HA ' ' A' ' 142' ' ' ASP . 12.3 p -147.29 162.43 38.96 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.4 t -153.5 178.22 10.06 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -98.69 132.41 44.1 Favored 'General case' 0 N--CA 1.422 -1.864 0 C-N-CA 118.661 -1.215 . . . . 0.0 108.801 176.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.485 ' O ' ' HD1' ' A' ' 139' ' ' TYR . . . -97.1 76.82 0.67 Allowed Glycine 0 N--CA 1.399 -3.821 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -87.82 119.88 28.6 Favored 'General case' 0 C--N 1.271 -2.842 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.7 pt -117.55 108.38 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.765 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.236 -176.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 16.7 pttt -98.41 98.61 9.81 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 113.195 -1.82 . . . . 0.0 109.571 -177.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 88.4 mt -87.14 127.62 58.6 Favored Pre-proline 0 C--N 1.282 -2.346 0 CA-C-N 112.228 -2.26 . . . . 0.0 111.935 -169.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.402 ' O ' ' HE1' ' A' ' 131' ' ' MET . 37.5 Cg_endo -69.79 150.74 68.43 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.079 1.853 . . . . 0.0 108.334 173.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.607 ' CB ' ' HA ' ' A' ' 133' ' ' THR . 2.3 m -51.16 99.35 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -177.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -101.52 -27.31 13.18 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 170.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.53 -65.6 0.2 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.066 1.746 . . . . 0.0 109.943 -178.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -116.24 95.33 5.03 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 122.168 0.985 . . . . 0.0 109.592 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.48 ' CE1' ' HB ' ' A' ' 57' ' ' VAL . 72.7 t80 . . . . . 0 C--N 1.279 -2.494 0 N-CA-C 103.164 -2.902 . . . . 0.0 103.164 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 . . . . . 0 CA--C 1.495 -1.153 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -53.7 -35.14 60.8 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.324 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -74.88 -56.18 5.04 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.25 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.83 -34.72 57.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -172.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 p -68.46 -32.5 55.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.203 0.525 . . . . 0.0 110.349 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -74.89 -47.13 31.64 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.488 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.41 ' O ' HG21 ' A' ' 23' ' ' VAL . 13.4 pt-20 -71.15 -36.99 72.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.413 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -65.17 -39.4 92.87 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.48 -37.72 88.38 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.986 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -59.94 -50.62 73.04 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.655 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 19' ' ' GLU . 95.7 t -59.66 -51.06 77.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.902 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.519 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 50.4 mm -63.28 -36.1 74.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.195 -177.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.8 t -62.77 -35.68 80.6 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.424 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.5 m -72.25 -35.85 68.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.097 0.475 . . . . 0.0 110.145 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.522 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 5.3 tt -66.78 -40.25 88.1 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 85.5 mt -61.8 -41.09 97.32 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -57.87 -45.82 85.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.669 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -66.23 -30.67 71.16 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-O 121.099 0.476 . . . . 0.0 110.955 -179.544 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.513 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -78.02 -34.73 50.54 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 120.987 0.423 . . . . 0.0 111.787 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 29.0 mtpp -69.11 9.44 0.42 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -177.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -113.08 -18.34 7.32 Favored Glycine 0 C--N 1.313 -0.723 0 C-N-CA 120.341 -0.933 . . . . 0.0 111.371 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.442 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 68.4 m-85 -80.25 -25.53 39.47 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.44 ' HA ' HD12 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -56.19 -29.96 61.62 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -171.592 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.71 -34.04 25.0 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -115.79 -46.81 2.82 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 34' ' ' PHE . 5.4 tmmm? -82.71 -20.75 35.46 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-O 120.898 0.38 . . . . 0.0 110.311 -173.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 35' ' ' PHE . 42.7 mt -96.3 0.06 50.3 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.299 176.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.88 -57.07 2.85 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.819 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -81.64 -2.81 51.65 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.228 0.537 . . . . 0.0 111.979 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 75.6 mt -121.46 125.17 26.94 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.97 107.03 0.32 Allowed 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.739 2.293 . . . . 0.0 111.704 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.7 p -134.33 153.06 79.13 Favored Pre-proline 0 C--N 1.302 -1.487 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.963 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -79.25 164.41 24.36 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.544 2.163 . . . . 0.0 113.58 -176.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -112.86 143.01 44.85 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.93 152.22 50.5 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.128 -175.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.3 t -147.69 128.97 14.76 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.265 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -94.09 141.7 14.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 175.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -118.05 -66.81 1.04 Allowed 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -170.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -158.58 167.07 30.56 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -171.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.56 HG12 ' OH ' ' A' ' 139' ' ' TYR . 14.5 p -126.97 132.68 69.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.723 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -104.71 135.84 45.34 Favored 'General case' 0 C--O 1.251 1.15 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.343 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.502 ' O ' ' HE2' ' A' ' 55' ' ' LYS . 48.7 p90 -60.45 140.76 57.1 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 174.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.502 ' HE2' ' O ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -136.11 -66.72 0.54 Allowed 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.914 -171.157 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.09 -164.76 15.3 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.202 -176.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.24 128.31 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-O 121.452 0.644 . . . . 0.0 111.515 -177.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 44.9 m -152.29 126.51 9.23 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 173.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -69.82 -32.44 70.87 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -169.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -108.6 11.42 26.64 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.02 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.503 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . 170.1 86.95 0.06 OUTLIER Glycine 0 CA--C 1.492 -1.374 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -177.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.76 140.39 19.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.534 0.683 . . . . 0.0 110.991 -173.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -96.26 106.75 19.0 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 121.691 0.757 . . . . 0.0 112.02 -175.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.479 ' HB3' HG21 ' A' ' 52' ' ' VAL . 3.3 m-85 -100.97 165.36 11.37 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.246 174.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.456 ' CD2' ' HG2' ' A' ' 55' ' ' LYS . 20.0 m-70 -124.89 110.26 14.03 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.284 0.564 . . . . 0.0 109.553 176.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . . . -78.45 144.91 35.36 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.589 -177.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -90.46 112.61 24.3 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.556 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.2 t -118.33 114.61 45.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.4 m -98.2 131.29 44.68 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -177.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 95.4 t -118.84 133.0 67.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.533 0.682 . . . . 0.0 111.077 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -102.78 109.97 21.73 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -130.33 113.2 16.94 Favored Pre-proline 0 C--N 1.302 -1.497 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.95 -175.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -102.88 97.59 0.04 OUTLIER 'Trans proline' 0 N--CA 1.421 -2.755 0 C-N-CA 122.319 2.013 . . . . 0.0 113.081 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -176.52 150.78 0.9 Allowed 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 170.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.5 t -77.87 8.03 5.15 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 118.039 0.381 . . . . 0.0 111.487 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.41 ' CD ' HG12 ' A' ' 78' ' ' ILE . 6.4 tt0 -101.56 137.64 39.61 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.7 p -94.08 95.57 9.09 Favored 'General case' 0 N--CA 1.399 -2.98 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 170.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.431 ' HB ' HD12 ' A' ' 105' ' ' LEU . 33.6 mt -77.88 126.36 84.12 Favored Pre-proline 0 N--CA 1.434 -1.235 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -174.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.0 133.95 30.51 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.308 2.006 . . . . 0.0 110.538 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 67.7 mt -83.93 107.04 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 55.5 m -55.76 -51.82 66.06 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.853 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -160.55 155.2 23.85 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.253 0.549 . . . . 0.0 110.274 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.422 HG21 HG22 ' A' ' 143' ' ' ILE . 24.8 mm -114.95 113.85 44.81 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 172.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.3 m -93.48 117.28 29.88 Favored 'General case' 0 C--N 1.274 -2.687 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -107.89 129.56 55.08 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.519 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 142' ' ' ASP . 3.0 mp -118.11 108.0 23.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.493 HD23 ' CE2' ' A' ' 139' ' ' TYR . 3.1 tm? -109.96 124.65 51.77 Favored 'General case' 0 C--N 1.27 -2.88 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.847 -175.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.549 ' O ' ' HB2' ' A' ' 139' ' ' TYR . 29.9 mmtm -93.7 142.81 26.93 Favored 'General case' 0 CA--C 1.479 -1.774 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.738 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 92' ' ' ARG . 45.9 t -97.92 145.54 26.35 Favored 'General case' 0 C--N 1.267 -2.996 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.65 143.83 56.91 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.296 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.4 m 74.1 -61.03 0.51 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.455 1.102 . . . . 0.0 111.001 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.406 ' O ' ' HB3' ' A' ' 89' ' ' SER . 53.3 mtt180 -155.01 172.1 18.66 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.088 0.555 . . . . 0.0 110.165 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.0 m 77.52 160.33 0.21 Allowed 'General case' 0 CA--C 1.563 1.456 0 O-C-N 124.261 0.976 . . . . 0.0 113.207 172.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.417 HD13 ' N ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -147.91 149.26 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 123.727 0.811 . . . . 0.0 109.228 -176.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.488 ' HB2' ' OG ' ' A' ' 122' ' ' SER . . . -118.64 134.93 54.75 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.666 0.787 . . . . 0.0 109.221 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.0 p -129.64 158.86 38.16 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.95 162.61 26.03 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.8 p -124.89 128.77 49.16 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 117.054 0.427 . . . . 0.0 110.335 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.8 mt -99.64 105.35 33.43 Favored Pre-proline 0 C--N 1.308 -1.221 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -76.92 116.08 4.16 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.502 2.134 . . . . 0.0 111.722 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.5 t70 53.96 83.33 0.23 Allowed Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 124.95 1.3 . . . . 0.0 112.745 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -101.08 7.8 0.58 Allowed 'Trans proline' 0 N--CA 1.441 -1.613 0 C-N-CA 122.697 2.265 . . . . 0.0 112.015 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 153.77 -164.78 31.35 Favored Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 32.2 p -145.28 158.89 43.72 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.431 HD12 ' HB ' ' A' ' 78' ' ' ILE . 78.4 mt -73.08 157.13 37.9 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 121.209 0.528 . . . . 0.0 111.611 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.6 p -90.4 139.16 18.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.238 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.4 93.82 0.46 Allowed Glycine 0 C--N 1.3 -1.447 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.784 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 67.3 p 60.36 83.15 0.14 Allowed 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 125.697 1.599 . . . . 0.0 113.998 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.88 -160.06 33.61 Favored Glycine 0 N--CA 1.429 -1.785 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.0 t -118.89 142.0 48.15 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.4 t -134.87 138.87 44.56 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.577 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.9 m -91.04 126.24 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 173.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.8 mt -103.04 145.18 30.28 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.718 -176.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -100.79 116.33 32.42 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.175 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 29.2 m -126.74 117.77 22.56 Favored Pre-proline 0 C--N 1.316 -0.864 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.37 124.5 12.58 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.625 2.216 . . . . 0.0 111.579 174.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 97.3 t -124.67 141.01 46.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 120.854 0.359 . . . . 0.0 110.155 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.615 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -87.8 102.12 14.36 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.988 0.899 . . . . 0.0 111.045 178.275 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.45 ' C ' ' H ' ' A' ' 121' ' ' TYR . 48.1 t -97.6 148.39 5.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 75.07 -14.96 0.7 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.909 0.883 . . . . 0.0 111.932 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.45 ' H ' ' C ' ' A' ' 119' ' ' VAL . 34.4 t80 -56.06 -58.13 9.23 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 124.119 0.967 . . . . 0.0 109.961 -175.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.488 ' OG ' ' HB2' ' A' ' 95' ' ' ALA . 41.4 m -74.93 -26.84 59.91 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.96 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 58.4 mt -71.47 -50.24 41.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.116 -173.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.61 -49.37 75.49 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 123.516 0.51 . . . . 0.0 110.363 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 52.2 t -57.9 -39.39 71.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.217 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.8 t -82.25 -82.6 0.13 Allowed 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.439 HD13 ' N ' ' A' ' 128' ' ' MET . 2.0 pp -125.6 -27.0 3.45 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -173.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.439 ' N ' HD13 ' A' ' 127' ' ' LEU . 10.1 tpt 69.9 125.76 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.955 0.902 . . . . 0.0 111.458 -174.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -72.34 -36.28 68.78 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-O 122.057 0.932 . . . . 0.0 110.431 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.8 t70 78.0 76.05 0.06 Allowed 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 112.072 -2.331 . . . . 0.0 106.512 -171.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.509 ' HG2' ' CD1' ' A' ' 135' ' ' TRP . 5.8 tmm? -69.69 114.69 8.13 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 112.859 -1.973 . . . . 0.0 109.599 -171.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 55.6 m -91.2 -179.67 5.48 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.124 -174.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 22.4 p -80.2 105.1 11.22 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-O 121.839 0.828 . . . . 0.0 110.785 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.5 t70 78.24 98.52 0.06 Allowed 'General case' 0 CA--C 1.487 -1.456 0 C-N-CA 126.553 1.941 . . . . 0.0 107.555 -170.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.509 ' CD1' ' HG2' ' A' ' 131' ' ' MET . 32.9 t-105 -148.89 148.45 29.86 Favored 'General case' 0 C--N 1.276 -2.591 0 CA-C-N 113.976 -1.466 . . . . 0.0 108.716 -171.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -125.87 141.16 52.11 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.56 132.29 54.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -105.58 109.65 21.69 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.56 ' OH ' HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -113.01 172.07 7.16 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.287 -0.965 . . . . 0.0 108.971 173.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 88' ' ' LYS . 63.2 mt-30 -118.29 130.79 56.24 Favored 'General case' 0 C--N 1.274 -2.685 0 C-N-CA 120.414 -0.514 . . . . 0.0 109.719 -174.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 35.6 tp -116.45 125.69 52.35 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.246 0.546 . . . . 0.0 112.043 -177.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.538 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 13.7 m-20 -120.0 119.69 34.16 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.422 HG22 HG21 ' A' ' 83' ' ' ILE . 42.4 mm -112.97 123.75 68.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -96.13 103.85 3.0 Favored Glycine 0 N--CA 1.418 -2.514 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 176.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 156' ' ' THR . 2.9 mm? -76.83 101.75 6.01 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 123.195 0.598 . . . . 0.0 110.026 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.9 m -91.37 115.58 28.14 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.101 0.477 . . . . 0.0 111.487 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.558 ' CE2' ' HB3' ' A' ' 145' ' ' LEU . 60.4 m-85 -126.67 153.03 45.94 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -158.31 140.83 14.43 Favored 'General case' 0 CA--C 1.479 -1.762 0 CA-C-O 121.463 0.649 . . . . 0.0 112.221 173.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 50.0 mm -121.6 128.31 25.69 Favored Pre-proline 0 C--N 1.292 -1.911 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -46.73 -43.55 23.22 Favored 'Trans proline' 0 N--CA 1.483 0.907 0 C-N-CA 123.633 2.889 . . . . 0.0 114.207 -176.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.18 -52.49 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 121.722 0.772 . . . . 0.0 109.313 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.429 HG23 ' HD3' ' A' ' 38' ' ' LYS . 7.2 p 173.04 140.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 C-N-CA 125.488 1.515 . . . . 0.0 107.072 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 150.54 15.22 0.08 OUTLIER Glycine 0 C--N 1.291 -1.969 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -73.21 118.05 15.69 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 126.031 1.733 . . . . 0.0 110.254 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.401 HG12 HD13 ' A' ' 39' ' ' LEU . 8.2 tp -162.59 144.14 3.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.499 -178.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 96.3 m -123.02 104.1 9.01 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 166.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 58.2 mt -87.88 112.94 52.3 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.328 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 156' ' ' THR . 26.9 Cg_endo -84.06 111.07 1.61 Allowed 'Trans proline' 0 N--CA 1.436 -1.864 0 C-N-CA 122.214 1.943 . . . . 0.0 111.587 176.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.4 m -106.49 134.95 46.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 29.6 p -126.1 157.44 38.03 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -175.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.6 t -170.47 170.67 6.85 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 176.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -99.67 132.19 45.17 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -101.72 104.64 2.71 Favored Glycine 0 N--CA 1.415 -2.73 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -90.04 119.46 30.41 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.518 HD12 ' CE1' ' A' ' 139' ' ' TYR . 5.7 mm -106.82 119.08 55.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 -174.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.489 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 62.9 tttp -92.99 117.72 30.38 Favored 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.153 175.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 95.6 mt -108.44 93.1 10.97 Favored Pre-proline 0 C--N 1.284 -2.26 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.841 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 166' ' ' LYS . 10.0 Cg_endo -86.42 82.34 1.36 Allowed 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 122.885 2.39 . . . . 0.0 112.861 -174.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 79.3 p 55.91 15.9 1.89 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.083 1.353 . . . . 0.0 113.777 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 49.7 tp -59.57 -56.68 18.86 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.134 0.574 . . . . 0.0 111.238 -176.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.437 ' O ' ' HD1' ' A' ' 173' ' ' PHE . 47.8 mtm105 65.28 145.24 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 179.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 76.79 -4.68 2.31 Favored 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 124.794 1.237 . . . . 0.0 114.023 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.437 ' HD1' ' O ' ' A' ' 171' ' ' ARG . 27.1 m-85 . . . . . 0 C--N 1.303 -1.43 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 . . . . . 0 CA--C 1.507 -0.711 0 CA-C-O 121.068 0.461 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.416 ' O ' ' HG3' ' A' ' 18' ' ' GLU . 1.5 mp0 -66.81 -31.1 71.5 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.386 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -74.51 -41.0 61.44 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -176.283 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.6 m -66.83 -29.44 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.1 m -73.03 -29.59 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.86 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 48.6 mt-10 -69.09 -34.59 75.35 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 176.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 7.7 mm-40 -59.25 -46.98 87.04 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.58 175.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.16 -45.45 93.36 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.653 177.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.15 -36.33 77.31 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.739 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.4 t -65.45 -35.55 81.25 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.82 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.438 ' HA ' ' HG ' ' A' ' 26' ' ' SER . 91.2 t -70.71 -33.29 52.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.573 0.702 . . . . 0.0 110.027 177.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.563 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 59.0 mt -69.56 -40.98 80.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 174.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.1 m -66.86 -29.0 68.79 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.106 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.438 ' HG ' ' HA ' ' A' ' 23' ' ' VAL . 14.3 p -70.54 -34.78 72.66 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 120.914 0.388 . . . . 0.0 110.532 175.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . 0.263 7.9 mp -79.38 -18.57 52.07 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 119.227 -0.989 . . . . 0.0 112.991 172.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 81.2 mt -68.62 -34.24 75.41 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 171.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.48 -40.45 70.23 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.324 176.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -52.01 -59.75 3.99 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.986 173.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 35' ' ' PHE . . . -59.75 -39.9 86.34 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.365 177.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -55.36 -31.96 62.18 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 123.345 0.658 . . . . 0.0 111.165 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.479 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -95.36 -77.83 1.38 Allowed Glycine 0 N--CA 1.425 -2.044 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.975 177.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.453 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 48.1 t80 -63.64 -39.96 95.67 Favored 'General case' 0 C--O 1.209 -1.074 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -174.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.463 ' HA ' HD23 ' A' ' 39' ' ' LEU . 82.1 t80 -69.87 -42.42 73.53 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 118.25 -1.38 . . . . 0.0 111.016 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 40' ' ' ALA . . . -62.07 -44.68 96.15 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 33' ' ' GLY . 14.3 pt-20 -94.74 -41.74 9.1 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -176.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 34' ' ' PHE . 15.2 tppt? -75.32 -45.4 39.82 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 121.824 0.821 . . . . 0.0 109.28 -173.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 35' ' ' PHE . 3.8 mm? -86.8 7.29 27.58 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.297 -1.319 . . . . 0.0 112.82 -174.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 36' ' ' ALA . . . -76.02 -10.6 59.55 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.606 0.717 . . . . 0.0 109.843 176.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -112.99 2.12 15.65 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.117 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.4 mp -124.45 118.11 26.37 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -71.61 94.11 0.69 Allowed 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 122.36 2.04 . . . . 0.0 112.927 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.429 ' HB ' ' HD2' ' A' ' 45' ' ' PRO . 21.8 p -91.5 170.59 9.3 Favored Pre-proline 0 C--N 1.307 -1.248 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.414 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 44' ' ' THR . 55.6 Cg_endo -65.36 146.78 86.55 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.559 1.506 . . . . 0.0 110.547 174.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -97.45 126.11 42.52 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.528 ' O ' HG11 ' A' ' 159' ' ' VAL . . . -97.38 146.13 25.48 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.8 t -161.23 120.85 2.6 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.075 0.464 . . . . 0.0 110.712 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -83.84 138.02 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -97.51 -59.01 1.87 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.106 -1.037 . . . . 0.0 110.922 -168.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -173.85 -178.04 1.49 Allowed 'General case' 0 C--O 1.249 1.052 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.535 ' CG2' ' HB3' ' A' ' 64' ' ' TYR . 7.6 p -130.53 132.35 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.907 0 CA-C-O 121.315 0.579 . . . . 0.0 109.52 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -107.97 136.31 47.89 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.238 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.653 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 45.5 p90 -92.08 141.18 28.88 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.47 ' N ' ' HD3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -124.74 -70.36 0.76 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.066 0.46 . . . . 0.0 110.881 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -112.36 -165.11 17.03 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.984 -174.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.44 ' HB ' ' CD2' ' A' ' 173' ' ' PHE . 13.6 p -117.92 159.99 17.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.129 -0.536 . . . . 0.0 110.042 -176.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 34.0 m -148.19 152.22 36.87 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 173.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.0 ttt-85 -58.94 -40.85 85.89 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.403 0.621 . . . . 0.0 110.446 177.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -117.13 94.39 4.55 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.3 166.42 31.24 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.57 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.8 t -104.4 148.73 8.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.4 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 29.6 t70 -84.85 107.01 16.79 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.127 0.489 . . . . 0.0 111.877 -175.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.653 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 28.7 m-85 -117.46 158.16 24.99 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.768 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -133.18 112.92 12.12 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . . . -90.41 144.66 25.59 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -177.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.499 ' HB2' ' HZ2' ' A' ' 67' ' ' LYS . 10.8 mtmp? -104.34 119.52 39.15 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.93 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.0 t -117.61 109.05 26.22 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.415 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.2 m -100.43 143.28 30.81 Favored 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 119.769 -0.772 . . . . 0.0 111.049 -175.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.31 119.14 51.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -96.28 109.69 22.14 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.564 ' ND2' HD23 ' A' ' 105' ' ' LEU . 6.5 t30 -123.02 115.23 29.2 Favored Pre-proline 0 C--N 1.292 -1.924 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -171.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -97.74 96.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.672 0 C-N-CA 121.742 1.628 . . . . 0.0 110.871 172.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.513 ' HB2' HD22 ' A' ' 72' ' ' ASN . 61.3 m-85 -175.84 119.25 0.16 Allowed 'General case' 0 CA--C 1.488 -1.414 0 C-N-CA 128.086 2.555 . . . . 0.0 105.152 178.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.4 m -69.85 -18.1 63.41 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 123.553 0.533 . . . . 0.0 112.108 -177.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -80.18 134.45 36.14 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-O 121.072 0.463 . . . . 0.0 110.726 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.2 p -80.01 97.19 6.68 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.476 ' HB ' HD12 ' A' ' 105' ' ' LEU . 42.3 mt -81.88 127.05 73.68 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -177.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.73 123.38 13.67 Favored 'Trans proline' 0 C--O 1.241 0.675 0 C-N-CA 122.588 2.192 . . . . 0.0 110.827 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.404 HG12 ' CE2' ' A' ' 147' ' ' PHE . 60.7 mt -69.77 103.51 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-O 121.309 0.576 . . . . 0.0 109.95 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 49.2 t -66.78 -56.82 8.73 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.885 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.527 ' HG3' ' CG2' ' A' ' 98' ' ' THR . 25.8 tt0 -152.24 130.17 11.75 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -175.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.6 mm -118.84 113.91 43.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 170.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.3 t -118.5 142.69 47.34 Favored 'General case' 0 C--N 1.288 -2.085 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.317 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.407 ' CZ ' ' HA3' ' A' ' 97' ' ' GLY . 54.8 p90 -128.27 144.57 51.14 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 121.301 0.572 . . . . 0.0 111.442 -176.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.404 ' HB ' ' HB2' ' A' ' 142' ' ' ASP . 56.0 mt -120.9 119.65 60.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 174.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.534 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 0.4 OUTLIER -103.09 122.29 44.36 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 178.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.535 ' HB2' ' HB2' ' A' ' 140' ' ' GLN . 98.5 mttt -123.21 157.3 33.36 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.678 175.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.8 t -152.24 109.02 3.48 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 68.6 -77.49 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.232 1.013 . . . . 0.0 110.993 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t 172.5 -28.71 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.155 0.582 . . . . 0.0 110.438 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -64.85 -56.93 10.47 Favored 'General case' 0 C--N 1.345 0.392 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -174.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 51.3 m -125.22 143.92 50.71 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.911 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.534 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 2.1 pp -141.37 178.64 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.209 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -176.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -135.95 147.11 47.93 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 172.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 39.1 t -131.44 153.12 50.06 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -176.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.407 ' HA3' ' CZ ' ' A' ' 85' ' ' TYR . . . -174.46 165.48 36.94 Favored Glycine 0 N--CA 1.426 -1.992 0 C-N-CA 119.697 -1.24 . . . . 0.0 112.131 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.527 ' CG2' ' HG3' ' A' ' 82' ' ' GLN . 86.7 m -149.99 131.72 15.0 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.409 ' CG2' ' HB3' ' A' ' 102' ' ' PRO . 2.8 mp -107.6 115.86 58.57 Favored Pre-proline 0 C--O 1.248 0.996 0 C-N-CA 119.071 -1.052 . . . . 0.0 109.77 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.28 114.75 3.81 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.021 1.814 . . . . 0.0 109.604 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.3 t70 55.15 77.94 0.41 Allowed Pre-proline 0 N--CA 1.482 1.175 0 C-N-CA 124.068 0.947 . . . . 0.0 111.285 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.409 ' HB3' ' CG2' ' A' ' 99' ' ' ILE . 59.5 Cg_endo -92.62 3.61 3.62 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.576 2.184 . . . . 0.0 111.875 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 175.32 -157.38 24.02 Favored Glycine 0 N--CA 1.424 -2.166 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.9 p -136.48 139.53 42.39 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 117.196 0.498 . . . . 0.0 110.847 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.564 HD23 ' ND2' ' A' ' 72' ' ' ASN . 7.3 tt -69.67 127.16 32.0 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.818 178.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 7.3 p -52.74 -45.3 49.16 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -173.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.474 ' H ' HD21 ' A' ' 105' ' ' LEU . . . 86.01 82.86 1.1 Allowed Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 109.201 -1.559 . . . . 0.0 109.201 -172.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.6 m 62.18 90.32 0.07 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.402 1.081 . . . . 0.0 112.561 -176.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 155.19 -173.96 33.4 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 176.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.7 m -108.1 123.66 49.04 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.464 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 3.6 t -117.41 132.01 56.65 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.087 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.6 t -95.99 109.98 23.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.1 mt -91.44 167.1 12.5 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -144.77 149.05 34.83 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.562 -174.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.403 HG12 ' HB1' ' A' ' 66' ' ' ALA . 4.4 p -136.6 127.18 16.36 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.69 176.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.17 113.12 3.6 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.971 1.78 . . . . 0.0 108.774 171.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.1 t -123.1 126.04 72.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -175.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.4 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 14.3 mmmm -88.51 103.93 16.34 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.335 -0.946 . . . . 0.0 108.492 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.627 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 97.5 t -93.72 146.13 6.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.988 -173.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 78.0 -5.93 2.03 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.952 1.301 . . . . 0.0 110.516 -176.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.486 ' O ' HG22 ' A' ' 125' ' ' VAL . 82.4 t80 -58.07 -57.11 14.29 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.825 176.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.2 m -56.27 -39.34 72.47 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.758 -176.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 10.8 tp -77.83 -30.21 16.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.244 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.67 -42.64 86.25 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 172.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 121' ' ' TYR . 68.9 t -57.35 -33.19 43.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.529 175.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -75.49 -81.07 0.08 Allowed 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.0 176.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -126.65 -22.83 3.84 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -177.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 70.13 121.83 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -170.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.674 ' C ' ' H ' ' A' ' 131' ' ' MET . 0.0 OUTLIER -59.48 -32.31 70.14 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -172.689 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.8 t70 80.95 -16.41 0.65 Allowed 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 -169.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.674 ' H ' ' C ' ' A' ' 129' ' ' LYS 0.343 13.9 tmm? 72.32 -102.1 0.03 OUTLIER 'General case' 0 N--CA 1.416 -2.131 0 C-N-CA 128.456 2.702 . . . . 0.0 113.277 175.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 131' ' ' MET . 48.7 t 150.58 -138.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 102.682 -3.081 . . . . 0.0 102.682 -175.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.9 p -133.92 99.1 4.34 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 164.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.667 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 16.2 t70 71.86 92.73 0.08 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.663 1.185 . . . . 0.0 112.805 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -154.96 159.77 40.64 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 165' ' ' ILE . 5.7 p-10 -103.55 142.49 34.2 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.22 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.445 HD11 ' O ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -115.62 158.28 16.06 Favored 'Isoleucine or valine' 0 C--O 1.248 1.013 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.763 177.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.66 115.37 10.77 Favored 'General case' 0 C--O 1.252 1.204 0 CA-C-O 121.635 0.731 . . . . 0.0 112.186 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -133.39 151.35 51.82 Favored 'General case' 0 N--CA 1.411 -2.384 0 CA-C-N 114.02 -1.446 . . . . 0.0 107.989 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.535 ' HB2' ' HB2' ' A' ' 88' ' ' LYS . 58.1 mt-30 -139.45 150.2 44.92 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.8 tp -139.18 118.96 13.17 Favored 'General case' 0 N--CA 1.419 -1.989 0 O-C-N 124.002 0.814 . . . . 0.0 109.822 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.404 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 22.6 m-20 -122.31 136.35 54.89 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.5 mm -122.05 129.29 75.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.567 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -117.91 88.0 0.44 Allowed Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 176.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 156' ' ' THR . 2.3 pp -84.31 149.2 26.22 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.825 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' A' ' 82' ' ' GLN . 8.7 m -127.02 120.59 29.39 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -176.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.404 ' CE2' HG12 ' A' ' 80' ' ' ILE . 68.9 m-85 -132.67 141.66 48.71 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -108.46 124.79 50.96 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.634 0.731 . . . . 0.0 110.709 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.403 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -124.88 125.84 25.36 Favored Pre-proline 0 C--N 1.297 -1.711 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.058 178.516 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -41.06 -34.21 1.43 Allowed 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 124.915 3.744 . . . . 0.0 115.88 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 13.5 p -59.3 -35.22 56.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.4 HG22 HD13 ' A' ' 39' ' ' LEU . 31.3 m -132.03 -25.66 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 121.875 -0.516 . . . . 0.0 112.355 -178.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 111.04 -141.7 16.58 Favored Glycine 0 N--CA 1.421 -2.346 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -177.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -92.41 120.42 32.89 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.908 0.385 . . . . 0.0 111.456 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 2.3 pp -130.35 146.24 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.356 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 174.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 4.6 p -95.32 151.06 19.58 Favored 'General case' 0 N--CA 1.397 -3.088 0 CA-C-N 113.978 -1.465 . . . . 0.0 109.98 174.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 57.4 mt -125.34 110.35 26.37 Favored Pre-proline 0 C--N 1.295 -1.787 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 176.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -89.88 114.58 0.57 Allowed 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 123.005 2.47 . . . . 0.0 113.662 -174.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.528 HG11 ' O ' ' A' ' 47' ' ' ALA . 29.1 m -118.13 128.16 75.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.955 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 63.0 p -114.24 144.2 43.61 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.931 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 53.3 m -153.13 136.69 15.95 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 121.114 0.483 . . . . 0.0 110.098 -177.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -98.99 119.47 37.83 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -100.53 115.05 5.19 Favored Glycine 0 N--CA 1.411 -2.974 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.399 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -89.71 118.6 29.44 Favored 'General case' 0 C--N 1.27 -2.86 0 N-CA-C 105.601 -1.999 . . . . 0.0 105.601 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 136' ' ' ASP . 50.3 mm -112.95 108.68 26.16 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.442 -172.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 136' ' ' ASP . 60.5 pttt -86.54 133.65 33.72 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.015 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.667 ' O ' ' HA ' ' A' ' 134' ' ' ASP . 0.4 OUTLIER -103.41 96.91 9.22 Favored Pre-proline 0 C--N 1.295 -1.779 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 173.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.66 78.84 0.95 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.28 1.987 . . . . 0.0 113.62 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 76.2 p 39.26 79.55 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.707 1.603 . . . . 0.0 114.291 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.403 ' HG ' ' HB2' ' A' ' 173' ' ' PHE . 2.5 mm? -103.65 -61.84 1.37 Allowed 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.004 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 70.22 4.86 5.06 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 121.31 0.576 . . . . 0.0 112.177 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -136.29 -41.19 0.64 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.339 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.44 ' CD2' ' HB ' ' A' ' 57' ' ' VAL . 3.0 m-85 . . . . . 0 CA--C 1.494 -1.178 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 176.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.44 ' O ' HG22 ' A' ' 17' ' ' VAL . 24.2 t70 . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 121.21 0.528 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -77.78 -50.42 12.37 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.021 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.421 ' C ' ' HD3' ' A' ' 15' ' ' LYS . 12.7 tmtt? -57.32 -47.15 82.27 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.771 1.229 . . . . 0.0 112.539 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.0 m -63.22 -21.82 29.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 94' ' ' ILE . 92.8 t -67.34 -49.02 75.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 120.913 0.387 . . . . 0.0 110.14 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.95 -33.61 72.15 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.509 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -77.12 -39.26 50.04 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.831 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -75.45 -35.44 60.91 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 120.747 0.308 . . . . 0.0 111.0 -177.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.78 -35.78 73.36 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.46 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.4 t -63.08 -44.85 94.61 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.915 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.3 t -65.34 -48.55 82.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.965 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.533 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 64.0 mt -61.21 -44.62 98.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.238 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.7 m -62.95 -37.83 88.63 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.677 0.275 . . . . 0.0 111.161 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.5 m -66.03 -36.49 83.38 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.788 0.328 . . . . 0.0 110.629 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.433 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 5.0 tt -67.11 -43.21 83.06 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 83.5 mt -57.78 -46.46 84.55 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.661 177.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.74 -44.12 97.08 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.517 ' HD2' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -64.83 -33.24 75.53 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.583 -178.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.517 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -79.38 -40.44 30.11 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.396 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -51.07 -52.65 41.34 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.381 1.073 . . . . 0.0 112.598 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.38 -17.88 79.61 Favored Glycine 0 C--N 1.318 -0.439 0 C-N-CA 120.026 -1.083 . . . . 0.0 112.02 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -75.39 -26.23 58.28 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 123.448 0.699 . . . . 0.0 109.952 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.428 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 27.2 m-85 -79.15 -12.08 59.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -178.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.29 -51.35 70.34 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -174.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.552 ' HG2' ' HD3' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -117.27 -43.45 2.83 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -178.387 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.552 ' HD3' ' HG2' ' A' ' 37' ' ' GLU . 3.7 mppt? -64.52 -34.28 77.87 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.271 -175.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 2.8 mm? -102.95 17.97 22.73 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.725 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.83 -28.07 16.08 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 171.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -94.47 -48.31 6.17 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.815 175.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 75.1 mt -73.99 121.29 84.84 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.96 114.38 3.72 Favored 'Trans proline' 0 C--O 1.246 0.925 0 C-N-CA 122.445 2.097 . . . . 0.0 113.518 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.3 p -114.33 140.41 25.05 Favored Pre-proline 0 N--CA 1.429 -1.498 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.868 173.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -56.12 138.95 84.6 Favored 'Trans proline' 0 C--O 1.24 0.603 0 C-N-CA 122.465 2.11 . . . . 0.0 111.418 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -96.45 109.9 22.36 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-O 121.327 0.584 . . . . 0.0 110.251 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.411 ' CB ' ' HG ' ' A' ' 145' ' ' LEU . . . -98.8 140.26 33.24 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.617 -178.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.5 t -141.98 133.7 27.01 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.315 177.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.3 m -89.45 141.61 14.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -130.93 -48.44 1.02 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -170.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -161.99 169.57 20.85 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.822 -171.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 65' ' ' HIS . 13.0 m -132.24 112.73 20.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.487 0.66 . . . . 0.0 111.562 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -92.34 129.5 38.27 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.243 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -59.27 138.26 57.67 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.982 0.176 . . . . 0.0 111.01 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.604 ' HD3' ' C ' ' A' ' 55' ' ' LYS . 11.7 tmtt? -119.44 -55.7 2.11 Favored 'General case' 0 N--CA 1.411 -2.413 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.033 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.47 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . -176.63 -170.87 39.72 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 118.865 -1.636 . . . . 0.0 113.432 -173.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.6 p -102.61 151.99 5.85 Favored 'Isoleucine or valine' 0 C--O 1.249 1.057 0 CA-C-O 121.709 0.766 . . . . 0.0 112.308 -172.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.754 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 31.3 m -159.97 159.41 32.18 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 103.047 -2.946 . . . . 0.0 103.047 173.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.1 mtm180 -73.15 134.24 44.36 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 118.954 -1.099 . . . . 0.0 110.235 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 76.39 -66.21 0.27 Allowed 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 125.533 1.533 . . . . 0.0 110.989 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.754 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . -107.52 128.22 9.11 Favored Glycine 0 CA--C 1.479 -2.191 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 56' ' ' GLY . 35.5 m -99.75 152.83 4.54 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.451 ' CG ' ' HZ3' ' A' ' 118' ' ' LYS . 45.8 m-20 -81.12 131.11 35.28 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -174.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -132.14 156.69 45.93 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 125.069 1.347 . . . . 0.0 109.491 174.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.429 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 18.0 m-70 -95.68 108.31 20.59 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 173.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.68 122.06 27.15 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 170.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -86.27 107.95 18.18 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.788 -174.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.6 t -114.02 109.17 27.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 56.3 p -103.05 128.74 49.79 Favored 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.555 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.2 t -114.66 120.58 64.72 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.262 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 36.2 ttpt -95.88 110.24 22.46 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 175.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -103.6 113.35 65.63 Favored Pre-proline 0 C--N 1.293 -1.878 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.853 -175.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -99.43 97.25 0.05 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.685 0 C-N-CA 122.007 1.805 . . . . 0.0 108.958 169.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -179.35 153.74 0.6 Allowed 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 102.951 -2.981 . . . . 0.0 102.951 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.1 t -79.22 -35.42 41.67 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -172.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -89.45 157.78 17.98 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.796 -0.762 . . . . 0.0 112.218 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.4 m -85.73 111.26 19.97 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 173.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.6 mt -87.97 128.95 52.03 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -175.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -87.19 118.86 1.41 Allowed 'Trans proline' 0 N--CA 1.433 -2.032 0 C-N-CA 122.098 1.865 . . . . 0.0 111.255 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.7 pt -72.04 113.06 8.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 48.5 t -58.43 -47.38 84.12 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.519 ' O ' ' HB ' ' A' ' 146' ' ' THR . 5.0 pp0? -156.29 157.95 36.64 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 174.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.454 ' CG2' HG21 ' A' ' 99' ' ' ILE . 11.8 tt -124.74 127.58 72.8 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.354 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 175.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.4 m -80.64 128.91 34.16 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-O 121.625 0.726 . . . . 0.0 110.963 -171.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -104.23 119.42 38.91 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.458 -175.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.0 mp -131.05 107.05 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 172.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.635 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 1.6 tm? -100.06 130.05 46.17 Favored 'General case' 0 C--N 1.268 -2.943 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -122.29 161.29 23.59 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.5 m -149.97 146.18 26.88 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -41.17 -71.42 0.08 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -174.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.546 ' C ' ' HD2' ' A' ' 92' ' ' ARG . 4.9 t -150.86 80.17 1.32 Allowed 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.546 ' HD2' ' C ' ' A' ' 91' ' ' THR . 3.8 mpt_? -140.0 -63.89 0.49 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 172.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.2 t 179.75 -174.18 0.24 Allowed 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.635 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 38.4 pt -132.1 -174.92 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.416 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . . . -132.0 130.33 41.28 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 33.5 p -106.25 179.68 4.2 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.789 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.02 170.14 12.77 Favored Glycine 0 N--CA 1.421 -2.355 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.005 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.9 p -134.46 128.96 34.5 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.454 HG21 ' CG2' ' A' ' 83' ' ' ILE . 7.5 tt -102.8 111.22 64.71 Favored Pre-proline 0 C--N 1.307 -1.255 0 C-N-CA 118.767 -1.173 . . . . 0.0 110.873 177.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.92 118.06 5.14 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 123.321 2.68 . . . . 0.0 113.563 -175.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.3 t70 45.19 79.15 0.35 Allowed Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 125.551 1.541 . . . . 0.0 113.546 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.401 ' HG3' ' CG2' ' A' ' 83' ' ' ILE . 68.4 Cg_endo -92.68 3.2 3.65 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.747 2.298 . . . . 0.0 111.915 175.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 165.85 -177.28 41.06 Favored Glycine 0 N--CA 1.427 -1.961 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.7 m -143.12 150.05 38.95 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.51 142.76 33.72 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.235 -178.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.3 m -80.18 165.77 2.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 O-C-N 124.123 0.89 . . . . 0.0 110.504 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.39 133.16 11.56 Favored Glycine 0 N--CA 1.427 -1.902 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.7 p 54.78 75.85 0.28 Allowed 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 124.548 1.139 . . . . 0.0 113.015 -177.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.81 174.84 36.44 Favored Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.792 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 9.0 t -101.83 136.49 41.58 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.7 t -135.82 131.23 35.14 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 121.228 0.537 . . . . 0.0 110.204 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.3 t -95.74 119.28 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.7 mt -102.73 146.96 27.45 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.262 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -113.0 112.69 24.33 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.522 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.8 m -112.61 127.25 27.08 Favored Pre-proline 0 C--N 1.305 -1.364 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.249 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.65 111.2 2.72 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.236 1.957 . . . . 0.0 110.598 176.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.7 t -108.91 134.47 50.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.904 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.451 ' HZ3' ' CG ' ' A' ' 63' ' ' ASP . 24.3 mmmt -91.25 102.19 14.9 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.0 m -93.07 140.12 16.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.388 -174.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 68.55 11.29 8.3 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.749 1.22 . . . . 0.0 109.852 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.407 ' O ' HG12 ' A' ' 125' ' ' VAL . 84.1 t80 -61.04 -44.13 97.86 Favored 'General case' 0 CA--C 1.485 -1.526 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.74 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.1 m -64.8 -31.56 72.84 Favored 'General case' 0 N--CA 1.436 -1.144 0 O-C-N 123.555 0.534 . . . . 0.0 111.878 -177.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.455 HG21 ' O ' ' A' ' 128' ' ' MET . 49.4 mt -77.33 -49.5 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.577 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -66.95 -43.78 82.25 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -177.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 121' ' ' TYR . 8.1 p -65.21 -26.24 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.075 0.464 . . . . 0.0 110.079 -177.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.1 t -79.49 -62.17 1.77 Allowed 'General case' 0 N--CA 1.416 -2.167 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -125.71 -64.19 1.08 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.886 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.577 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER 173.84 151.21 0.09 Allowed 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 103.352 -2.833 . . . . 0.0 103.352 178.846 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.486 ' N ' ' SD ' ' A' ' 128' ' ' MET . 83.5 mttt -51.4 -51.25 56.3 Favored 'General case' 0 CA--C 1.465 -2.323 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 34.7 t70 174.54 -38.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 125.55 1.782 . . . . 0.0 111.555 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.579 ' HA ' ' CE ' ' A' ' 131' ' ' MET 0.33 2.7 mmt 64.05 99.16 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -171.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 84.4 m -156.03 179.87 8.8 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 173.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.446 ' CA ' ' HA ' ' A' ' 169' ' ' SER . 35.3 p -117.49 102.04 8.87 Favored 'General case' 0 N--CA 1.392 -3.354 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 172.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.618 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 19.2 t70 87.65 97.66 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.827 1.651 . . . . 0.0 110.907 -175.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.447 ' CZ2' HD22 ' A' ' 167' ' ' LEU . 6.9 p90 -156.21 159.46 38.96 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -122.08 151.24 41.1 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.4 pp -132.73 158.69 43.34 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -74.62 99.36 3.63 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.897 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.465 ' HE1' ' CD2' ' A' ' 87' ' ' LEU . 17.7 t80 -112.96 157.84 20.99 Favored 'General case' 0 N--CA 1.416 -2.127 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.15 176.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -164.26 159.16 19.69 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 171.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.463 HD11 HG12 ' A' ' 143' ' ' ILE . 1.0 OUTLIER -125.98 152.67 45.38 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.548 177.087 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.1 111.16 14.35 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 169.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.463 HG12 HD11 ' A' ' 141' ' ' LEU . 35.0 mm -115.23 140.7 35.28 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.988 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -119.98 104.04 0.99 Allowed Glycine 0 N--CA 1.434 -1.443 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.224 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.447 ' HB3' ' CE2' ' A' ' 147' ' ' PHE . 4.3 mm? -72.72 108.41 5.7 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 122.551 0.341 . . . . 0.0 110.573 177.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.519 ' HB ' ' O ' ' A' ' 82' ' ' GLN . 43.0 m -101.57 108.58 20.18 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-O 121.384 0.612 . . . . 0.0 110.251 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.447 ' CE2' ' HB3' ' A' ' 145' ' ' LEU . 68.2 m-85 -109.41 136.1 49.38 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.258 3.9 p30 -115.89 110.21 18.68 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 122.233 1.016 . . . . 0.0 110.521 175.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 67.3 mt -117.33 122.31 31.19 Favored Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.36 -19.81 18.29 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 123.713 2.942 . . . . 0.0 113.629 -176.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 62.1 t -72.17 -34.41 49.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.143 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 9.2 p -123.28 -34.39 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 121.82 -153.7 16.74 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -95.34 116.37 28.68 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 155' ' ' ILE . 2.3 pp -126.82 134.01 67.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 55.6 m -111.06 112.12 23.7 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.478 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.9 mp -85.8 117.45 68.75 Favored Pre-proline 0 C--O 1.238 0.471 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -82.37 120.05 3.18 Favored 'Trans proline' 0 CA--C 1.484 -2.001 0 C-N-CA 122.31 2.006 . . . . 0.0 111.496 175.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 3.1 p -126.95 114.98 39.8 Favored 'Isoleucine or valine' 1 N--CA 1.376 -4.135 0 CA-C-N 112.768 -2.015 . . . . 0.0 109.137 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 33.3 p -127.05 162.53 25.82 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.304 -173.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.0 t -169.27 155.22 6.27 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -102.26 141.15 35.56 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -147.11 155.25 26.44 Favored Glycine 0 N--CA 1.422 -2.25 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -101.77 129.99 48.09 Favored 'General case' 0 C--N 1.273 -2.74 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.333 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 37.1 mm -97.86 108.43 21.8 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.641 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -105.56 114.35 28.46 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 134' ' ' ASP . 3.3 mp -104.25 105.6 49.99 Favored Pre-proline 0 C--N 1.307 -1.272 0 O-C-N 123.633 0.583 . . . . 0.0 110.459 -174.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -73.37 99.0 1.07 Allowed 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.749 2.299 . . . . 0.0 112.354 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.446 ' HA ' ' CA ' ' A' ' 133' ' ' THR . 47.6 t 64.37 -82.27 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 125.972 1.709 . . . . 0.0 113.624 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.432 ' HB3' ' HB3' ' A' ' 173' ' ' PHE . 42.7 mt 62.66 -72.65 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.695 1.598 . . . . 0.0 112.517 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 64.45 -68.25 0.1 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.125 1.77 . . . . 0.0 111.71 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -100.08 10.37 41.37 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.404 -0.81 . . . . 0.0 110.101 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.432 ' HB3' ' HB3' ' A' ' 170' ' ' LEU . 22.2 t80 . . . . . 0 C--N 1.3 -1.585 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -177.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 120.836 0.351 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.571 ' O ' ' HG3' ' A' ' 18' ' ' GLU . 9.8 pt-20 -58.25 -42.96 87.56 Favored 'General case' 0 C--O 1.206 -1.229 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.95 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.51 ' C ' ' HD2' ' A' ' 15' ' ' LYS . 3.3 tmmm? -72.02 -40.75 68.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.476 0.655 . . . . 0.0 110.004 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.7 t -61.89 -44.57 99.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.802 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.3 p -71.22 -27.7 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.99 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 47.0 mt-10 -75.64 -39.28 57.98 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.204 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.06 -37.94 89.25 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 120.7 0.286 . . . . 0.0 110.572 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -67.1 -45.48 77.08 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.959 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.59 -36.95 72.39 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.11 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.9 t -63.05 -44.9 94.56 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.445 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.06 -42.02 94.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 121.308 0.575 . . . . 0.0 110.072 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.3 mm -68.1 -44.59 84.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.391 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.414 ' HA ' HD11 ' A' ' 28' ' ' LEU . 23.2 t -61.72 -41.58 97.81 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.576 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.8 t -57.34 -37.12 72.05 Favored 'General case' 0 C--O 1.247 0.944 0 C-N-CA 122.9 0.48 . . . . 0.0 110.642 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 tt -73.7 -45.64 51.11 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.414 HD11 ' HA ' ' A' ' 25' ' ' SER . 86.3 mt -54.1 -45.5 71.84 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.175 0.59 . . . . 0.0 111.074 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -53.86 -45.42 70.97 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.508 ' HD2' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -79.09 -31.73 44.44 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.269 -0.972 . . . . 0.0 111.735 -178.216 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.508 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -75.13 -32.05 61.25 Favored 'General case' 0 C--O 1.21 -1.006 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.95 -177.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -58.58 -47.05 85.6 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.045 0.45 . . . . 0.0 111.02 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.49 -32.99 67.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.124 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -74.57 -40.55 61.58 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 122.615 0.366 . . . . 0.0 110.718 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.407 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 48.6 t80 -64.48 -46.24 83.87 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.89 -14.69 63.02 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.045 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.76 -66.88 1.04 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.001 0.905 . . . . 0.0 110.947 -176.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.41 ' HB2' ' HE2' ' A' ' 38' ' ' LYS . 6.6 tppt? -74.51 -39.32 62.47 Favored 'General case' 0 CA--C 1.453 -2.782 0 CA-C-O 122.937 1.351 . . . . 0.0 107.632 -166.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.407 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 71.7 mt -89.66 0.56 56.88 Favored 'General case' 0 C--N 1.255 -3.516 0 CA-C-N 112.118 -2.31 . . . . 0.0 111.507 -171.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.12 -18.26 29.21 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 173.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -104.71 -39.91 6.17 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.187 -1.369 . . . . 0.0 109.782 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 84.1 mt -83.64 126.4 71.15 Favored Pre-proline 0 C--N 1.312 -1.037 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.73 113.08 1.22 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.987 2.458 . . . . 0.0 112.672 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.2 p -140.43 145.59 41.63 Favored Pre-proline 0 C--N 1.299 -1.602 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.115 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.497 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 37.5 Cg_endo -62.96 135.51 51.92 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.649 2.233 . . . . 0.0 111.888 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.27 106.34 17.98 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 -174.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -102.41 143.01 32.7 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 115.023 -0.989 . . . . 0.0 112.796 -173.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.405 ' HA ' ' CG2' ' A' ' 159' ' ' VAL . 11.8 t -138.32 144.15 40.26 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.002 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.437 ' HB ' HG22 ' A' ' 161' ' ' THR . 50.6 t -91.95 141.75 14.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 172.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -125.75 -46.54 1.71 Allowed 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 117.261 -1.776 . . . . 0.0 114.075 -169.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -173.96 167.11 4.33 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -172.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.536 ' HB ' ' CD2' ' A' ' 64' ' ' TYR . 2.5 m -127.9 126.71 67.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 C-N-CA 123.254 0.622 . . . . 0.0 111.437 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -104.82 144.75 31.34 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 123.766 0.826 . . . . 0.0 111.249 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.561 ' HA ' ' CE1' ' A' ' 64' ' ' TYR . 44.5 p90 -58.85 130.33 46.44 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.541 ' HD3' ' C ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -118.81 -52.06 2.34 Favored 'General case' 0 N--CA 1.391 -3.422 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -175.242 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.441 ' O ' ' HE1' ' A' ' 173' ' ' PHE . . . -145.17 -173.08 16.09 Favored Glycine 0 CA--C 1.472 -2.651 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 177.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.0 m -125.81 129.45 72.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 117.804 0.802 . . . . 0.0 110.177 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.0 m -161.15 135.5 7.11 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.33 154.44 19.22 Favored 'General case' 0 C--N 1.286 -2.186 0 C-N-CA 117.268 -1.773 . . . . 0.0 109.662 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 78.44 15.86 1.25 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 125.47 1.508 . . . . 0.0 111.042 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.16 98.41 0.46 Allowed Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.9 p -103.81 142.55 17.24 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-O 120.94 0.4 . . . . 0.0 111.475 -174.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -76.07 111.73 11.77 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 176.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.561 ' CE1' ' HA ' ' A' ' 54' ' ' PHE . 6.9 t80 -121.02 155.99 33.16 Favored 'General case' 0 N--CA 1.41 -2.47 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -169.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -90.98 108.43 19.86 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -174.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.42 118.69 36.59 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -94.18 125.05 38.58 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.899 -174.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.1 m -124.56 144.97 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 176.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.2 m -130.12 143.46 50.8 Favored 'General case' 0 C--N 1.268 -2.951 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.336 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.497 ' CG2' ' HB2' ' A' ' 45' ' ' PRO . 7.4 p -141.67 134.33 28.94 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.513 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 20.6 pttp -107.29 119.35 39.16 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.78 0.8 . . . . 0.0 109.843 175.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 49.0 t30 -106.87 116.3 58.89 Favored Pre-proline 0 C--N 1.28 -2.431 0 CA-C-N 114.015 -1.448 . . . . 0.0 111.495 -174.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -89.43 97.16 0.32 Allowed 'Trans proline' 0 N--CA 1.428 -2.35 0 C-N-CA 121.547 1.498 . . . . 0.0 110.943 173.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 179.64 -169.07 0.11 Allowed 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 128.007 2.523 . . . . 0.0 106.15 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.476 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 48.7 m -135.3 17.37 3.41 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -112.14 128.92 56.36 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.974 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.5 p -75.29 98.51 3.82 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 173.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.513 ' H ' HD12 ' A' ' 105' ' ' LEU . 69.1 mt -72.22 121.9 85.96 Favored Pre-proline 0 C--N 1.302 -1.462 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.876 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.39 139.69 29.21 Favored 'Trans proline' 0 N--CA 1.44 -1.655 0 C-N-CA 122.264 1.976 . . . . 0.0 111.584 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.488 ' H ' HD12 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -84.42 134.83 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.952 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.458 178.272 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 52.8 t -82.65 -41.36 19.52 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -174.0 154.04 2.23 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.389 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.7 mp -114.61 113.86 44.93 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 173.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.431 ' OG ' HG22 ' A' ' 98' ' ' THR . 19.8 m -93.63 117.53 30.21 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -112.47 140.35 47.28 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.556 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 2.0 mp -116.94 108.01 23.87 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.887 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 174.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.48 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 1.2 tm? -90.52 120.36 31.55 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 -172.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -125.92 155.96 40.48 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -172.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.4 t -109.59 147.58 32.78 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 112.133 -2.303 . . . . 0.0 105.483 174.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -50.8 -26.26 5.47 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -176.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 87.6 m -149.65 -53.19 0.16 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -106.55 120.71 42.66 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -170.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 27.5 m 72.42 132.45 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.908 1.283 . . . . 0.0 114.306 173.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.455 HD13 ' C ' ' A' ' 94' ' ' ILE . 1.7 pp -135.03 165.37 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . . . -119.98 156.64 30.47 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 174.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 27.2 t -160.43 148.41 16.4 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.44 165.45 35.27 Favored Glycine 0 N--CA 1.426 -1.973 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.431 HG22 ' OG ' ' A' ' 84' ' ' SER . 68.3 p -115.62 120.4 39.27 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 61.2 mt -101.87 119.81 55.87 Favored Pre-proline 0 C--N 1.305 -1.331 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.623 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.73 124.7 5.22 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.805 2.336 . . . . 0.0 111.723 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.2 t70 52.1 72.08 1.3 Allowed Pre-proline 0 N--CA 1.481 1.099 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -178.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -103.75 6.19 0.34 Allowed 'Trans proline' 0 N--CA 1.435 -1.944 0 C-N-CA 122.768 2.312 . . . . 0.0 111.595 173.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 156.26 135.04 1.9 Allowed Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.3 m -111.89 146.73 37.21 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.771 0.319 . . . . 0.0 110.397 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.513 HD12 ' H ' ' A' ' 78' ' ' ILE . 3.3 pp -80.41 146.33 31.52 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.78 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 27.5 m -54.84 -46.09 75.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 136.93 -43.28 1.24 Allowed Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.476 ' OG ' ' HA ' ' A' ' 75' ' ' SER . 28.9 m -136.17 115.91 13.02 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 122.164 0.186 . . . . 0.0 111.276 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 105.38 -167.21 14.69 Favored Glycine 0 C--N 1.306 -1.098 0 C-N-CA 120.242 -0.98 . . . . 0.0 114.118 172.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.411 ' OG1' ' HB3' ' A' ' 71' ' ' LYS . 42.1 m -84.62 121.17 27.26 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 121.409 0.623 . . . . 0.0 110.373 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.5 t -125.94 138.22 53.75 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.5 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.3 m -94.27 128.69 45.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.412 0.625 . . . . 0.0 110.781 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.1 mt -125.56 157.92 35.88 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -143.54 141.18 30.61 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.476 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 43.0 t -112.3 130.19 23.58 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -77.61 109.89 2.85 Favored 'Trans proline' 0 N--CA 1.419 -2.862 0 N-CA-C 107.578 -1.739 . . . . 0.0 107.578 169.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.6 m -113.17 151.6 15.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -87.22 101.29 13.38 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.6 m -93.06 146.89 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.485 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -177.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 69.35 3.56 4.2 Favored 'General case' 0 C--O 1.205 -1.238 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.597 -178.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.431 ' O ' ' HB ' ' A' ' 125' ' ' VAL . 8.3 t80 -67.86 -37.62 82.07 Favored 'General case' 0 C--O 1.203 -1.349 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.5 p -79.27 -29.87 42.76 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.327 0.585 . . . . 0.0 110.271 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.0 mt -79.88 -50.95 17.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.08 -174.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.35 -38.97 85.69 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 123.339 0.656 . . . . 0.0 111.028 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 121' ' ' TYR . 25.1 t -71.5 -36.34 60.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.924 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.0 t -85.01 -69.19 0.67 Allowed 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.936 -176.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.401 ' H ' HD21 ' A' ' 127' ' ' LEU . 1.9 pt? -125.09 -29.26 3.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -172.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 68.31 166.86 0.26 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.707 0.765 . . . . 0.0 112.904 -173.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.435 ' N ' ' HD3' ' A' ' 129' ' ' LYS . 1.9 mppt? -101.66 -66.31 0.93 Allowed 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 177.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 162.49 -24.85 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 -177.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.9 tpt 65.52 93.11 0.07 Allowed 'General case' 0 C--N 1.347 0.461 0 CA-C-N 112.819 -1.991 . . . . 0.0 112.367 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 135' ' ' TRP . 77.2 m -95.1 149.79 20.9 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.575 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.813 ' HB ' ' OG ' ' A' ' 169' ' ' SER . 22.1 p -82.27 118.49 23.17 Favored 'General case' 1 N--CA 1.339 -6.021 0 C-N-CA 124.89 1.276 . . . . 0.0 107.604 175.318 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 70.57 83.05 0.15 Allowed 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -173.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.47 ' HB2' ' HB2' ' A' ' 132' ' ' CYS . 42.4 t-105 -154.89 143.53 20.65 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.125 -167.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -108.82 144.08 37.16 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 175.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.407 ' CG2' ' HB ' ' A' ' 165' ' ' ILE . 0.0 OUTLIER -139.68 130.51 32.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.53 105.02 16.52 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 122.914 1.34 . . . . 0.0 111.811 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.455 ' HH ' HD21 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -108.08 161.14 15.23 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 113.826 -1.534 . . . . 0.0 107.954 177.402 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -138.47 158.55 44.06 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 121.42 -0.8 . . . . 0.0 111.079 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.556 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 2.3 pt? -154.53 122.88 6.05 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.857 167.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -102.25 140.29 36.72 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 158' ' ' PRO . 46.7 mt -125.28 149.17 29.77 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 C-N-CA 120.321 -0.551 . . . . 0.0 111.702 -173.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -119.41 89.94 0.47 Allowed Glycine 0 N--CA 1.421 -2.363 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 174.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -68.76 107.78 3.16 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.594 ' OG1' HG22 ' A' ' 156' ' ' THR . 11.0 m -92.12 107.94 19.57 Favored 'General case' 0 N--CA 1.421 -1.919 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.068 -176.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -109.25 141.2 41.88 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -109.8 109.92 20.75 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.445 HD12 ' O ' ' A' ' 153' ' ' GLY . 0.2 OUTLIER -115.12 145.98 35.31 Favored Pre-proline 0 C--N 1.314 -0.972 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.181 -178.394 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.63 -14.73 41.75 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.96 2.44 . . . . 0.0 113.159 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 43.4 t -71.7 -43.17 70.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 120.801 0.334 . . . . 0.0 110.667 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 49.0 t -127.81 -66.31 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.215 0.531 . . . . 0.0 110.59 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.445 ' O ' HD12 ' A' ' 149' ' ' ILE . . . 157.85 -139.9 6.68 Favored Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -177.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -90.0 117.52 28.86 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.722 0.772 . . . . 0.0 110.34 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 146' ' ' THR . 21.3 pt -117.35 128.53 74.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.483 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.594 HG22 ' OG1' ' A' ' 146' ' ' THR . 74.4 p -89.56 107.22 18.96 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 173.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 64.5 mt -80.42 112.75 33.67 Favored Pre-proline 0 C--N 1.295 -1.799 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 74.3 Cg_endo -82.17 151.81 16.03 Favored 'Trans proline' 0 CA--C 1.477 -2.346 0 C-N-CA 122.379 2.053 . . . . 0.0 112.804 -178.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.405 ' CG2' ' HA ' ' A' ' 48' ' ' THR . 2.7 p -161.7 123.15 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.387 -3.591 0 CA-C-N 112.721 -2.036 . . . . 0.0 108.149 -173.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 79.8 p -131.61 134.41 45.99 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.156 0.503 . . . . 0.0 111.716 -176.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.437 HG22 ' HB ' ' A' ' 49' ' ' VAL . 9.0 t -168.69 177.96 4.9 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 176.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -100.1 166.35 11.06 Favored 'General case' 0 N--CA 1.416 -2.156 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.213 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.423 ' O ' ' HD1' ' A' ' 139' ' ' TYR . . . -130.03 113.92 1.56 Allowed Glycine 0 N--CA 1.408 -3.199 0 N-CA-C 107.691 -2.164 . . . . 0.0 107.691 176.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -88.96 128.75 35.7 Favored 'General case' 0 C--N 1.262 -3.214 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -177.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.407 ' HB ' ' CG2' ' A' ' 137' ' ' ILE . 29.6 mm -97.18 114.03 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.064 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.493 ' HD2' ' H ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -86.58 99.07 11.44 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 114.317 -1.31 . . . . 0.0 109.435 -178.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 90.3 mt -103.01 106.09 49.0 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 114.877 -1.056 . . . . 0.0 113.224 -173.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 166' ' ' LYS . 10.2 Cg_exo -75.67 -177.85 3.88 Favored 'Trans proline' 0 CA--C 1.55 1.305 0 C-N-CA 122.259 1.973 . . . . 0.0 109.586 170.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.813 ' OG ' ' HB ' ' A' ' 133' ' ' THR . 20.2 m -64.43 90.62 0.07 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 175.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.63 -38.39 4.91 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.855 175.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 66.07 -55.78 0.37 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.976 0.91 . . . . 0.0 112.497 -173.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -115.93 99.51 7.33 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.441 ' HE1' ' O ' ' A' ' 56' ' ' GLY . 53.7 t80 . . . . . 0 N--CA 1.478 0.969 0 C-N-CA 123.545 0.738 . . . . 0.0 111.052 -174.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.42 ' HA ' HG22 ' A' ' 16' ' ' VAL . 23.3 t70 . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 120.755 0.312 . . . . 0.0 110.745 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 18' ' ' GLU . 1.2 mp0 -59.44 -40.09 85.66 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.704 175.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -66.96 -55.85 12.76 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.068 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.42 HG22 ' HA ' ' A' ' 13' ' ' ASP . 33.3 m -58.11 -39.66 73.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.042 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 p -66.69 -39.8 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.676 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 45.3 mt-10 -65.56 -39.22 91.44 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -74.29 -38.01 63.49 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.428 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 16' ' ' VAL . 75.1 mmtt -64.99 -45.49 85.42 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.832 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.44 ' HB1' HD12 ' A' ' 94' ' ' ILE . . . -58.04 -41.59 83.56 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.159 178.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.2 t -56.44 -44.34 80.37 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 123.836 0.71 . . . . 0.0 110.073 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.7 t -73.97 -51.14 25.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.555 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.5 mt -57.83 -48.22 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.836 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.7 t -62.32 -35.16 78.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.609 0.243 . . . . 0.0 110.51 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.3 m -71.63 -21.3 61.85 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.319 0.581 . . . . 0.0 110.907 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.604 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 6.6 tt -79.82 -41.15 27.01 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.428 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 6.2 mp -65.61 -33.18 75.31 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 118.824 -1.15 . . . . 0.0 108.553 173.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -57.9 -37.15 73.48 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.146 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.604 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -70.81 -30.76 67.29 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.471 0.653 . . . . 0.0 110.582 179.407 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.483 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -78.67 -32.07 46.95 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.276 -177.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 98.5 mttt -48.49 -46.42 38.2 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.164 0.586 . . . . 0.0 111.988 -178.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.98 -33.57 84.4 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.207 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -81.47 -45.65 15.69 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.455 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 49.6 t80 -62.18 -51.92 65.87 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -175.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.6 -44.79 62.96 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -174.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -117.05 -38.87 3.31 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -177.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.15 -32.17 15.93 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.9 -164.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 83.8 mt -85.27 -11.44 54.79 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.33 -178.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.3 -29.82 71.07 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.118 0.485 . . . . 0.0 111.368 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -105.89 16.85 24.56 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.442 0.639 . . . . 0.0 110.099 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.5 mt -127.31 124.61 23.75 Favored Pre-proline 0 C--N 1.309 -1.179 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -57.87 96.38 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.402 2.068 . . . . 0.0 112.782 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.9 p -128.43 144.49 52.17 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -51.79 120.05 6.52 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.21 1.94 . . . . 0.0 110.941 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.425 ' HB3' ' CG ' ' A' ' 71' ' ' LYS . 35.1 tt0 -96.43 111.62 23.66 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -173.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.84 146.85 35.72 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.216 -173.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.419 ' HA ' HG21 ' A' ' 159' ' ' VAL . 9.7 t -141.04 155.03 46.24 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 176.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.428 HG22 HG23 ' A' ' 159' ' ' VAL . 92.4 t -82.14 141.49 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 173.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -106.95 -56.09 2.24 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -166.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.423 ' CG ' ' H ' ' A' ' 52' ' ' VAL . 19.2 t70 -170.21 -173.68 1.55 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -174.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.628 HG13 ' CD2' ' A' ' 64' ' ' TYR . 89.4 t -136.8 103.41 3.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 C-N-CA 123.342 0.657 . . . . 0.0 109.921 -175.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -93.45 104.99 17.1 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.357 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.568 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 63.5 t80 -74.62 105.34 5.67 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.611 0.764 . . . . 0.0 109.344 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.568 ' HD2' ' C ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -147.75 116.04 6.57 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.119 0.568 . . . . 0.0 111.165 -176.646 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.11 163.29 15.54 Favored Glycine 0 C--N 1.295 -1.723 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.855 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.2 p -145.13 153.11 14.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.1 t -155.07 -177.28 6.42 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.419 ' NH2' ' HB3' ' A' ' 60' ' ' ASP . 3.2 tmm_? -80.74 -46.94 14.68 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -178.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.419 ' HB3' ' NH2' ' A' ' 59' ' ' ARG . 7.5 p-10 -99.77 95.16 6.74 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.726 0.774 . . . . 0.0 111.156 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.5 -166.14 29.08 Favored Glycine 0 N--CA 1.416 -2.659 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.508 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 81.4 t -143.89 124.72 9.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 178.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -68.04 137.84 55.36 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.248 0.546 . . . . 0.0 110.992 -178.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.706 ' CD1' ' HB ' ' A' ' 119' ' ' VAL . 29.4 p90 -144.3 167.05 23.38 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 172.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 -103.5 114.32 28.51 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -77.57 106.02 9.09 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 178.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -87.8 125.74 34.61 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.867 -171.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.98 144.66 34.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.5 p -122.95 132.2 54.05 Favored 'General case' 0 C--N 1.282 -2.333 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.073 177.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.1 t -126.02 134.32 66.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.481 -174.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 22.1 ptmt -105.89 146.65 29.69 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 173.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.627 ' HB3' ' O ' ' A' ' 107' ' ' GLY . 46.7 t-20 -128.51 121.96 21.54 Favored Pre-proline 0 C--N 1.28 -2.417 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.972 -173.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -98.46 96.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.568 0 C-N-CA 121.582 1.521 . . . . 0.0 109.549 167.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.453 ' HB2' ' OD1' ' A' ' 72' ' ' ASN . 26.1 m-85 175.77 179.58 0.16 Allowed 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 128.727 2.811 . . . . 0.0 105.356 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.3 t -126.02 5.58 7.23 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 120.316 -0.554 . . . . 0.0 109.699 176.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -100.95 140.16 35.63 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.869 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 63.1 m -76.7 97.87 4.59 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 171.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 64.9 mt -72.83 124.69 91.03 Favored Pre-proline 0 C--N 1.307 -1.279 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.719 -177.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -69.38 127.7 15.29 Favored 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 121.817 1.678 . . . . 0.0 109.38 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 58.1 mt -80.72 113.88 20.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 49.6 t -56.2 -53.02 62.14 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.635 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -167.8 162.4 13.73 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.595 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 13.4 tt -124.11 115.31 44.52 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 175.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.5 p -94.08 118.1 31.05 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -108.41 135.09 50.28 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.307 178.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.9 mp -118.27 111.32 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 175.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.534 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -91.67 120.99 32.92 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -123.54 139.38 54.07 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.407 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.533 ' OG ' ' HB2' ' A' ' 122' ' ' SER . 49.5 m -115.42 145.13 42.85 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.806 176.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.6 113.42 2.69 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.282 -176.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.7 m 69.23 9.81 7.51 Favored 'General case' 0 CA--C 1.57 1.718 0 C-N-CA 124.408 1.083 . . . . 0.0 112.252 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -121.46 -170.79 2.09 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 121.502 -0.748 . . . . 0.0 111.098 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.0 t -74.51 -172.96 1.63 Allowed 'General case' 0 C--O 1.253 1.277 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.534 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.6 pp -138.07 168.44 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -176.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -119.09 140.62 49.78 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.7 p -141.25 140.33 33.89 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.689 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -165.63 153.35 23.3 Favored Glycine 0 N--CA 1.434 -1.498 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.4 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 27.2 p -118.28 122.6 43.32 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 178.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.91 108.26 57.8 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 118.301 -1.359 . . . . 0.0 109.717 176.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 98' ' ' THR . 11.7 Cg_exo -71.93 118.25 5.54 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.213 1.942 . . . . 0.0 109.389 174.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.9 t70 62.04 81.89 0.23 Allowed Pre-proline 0 N--CA 1.472 0.673 0 O-C-N 124.235 0.959 . . . . 0.0 111.577 -174.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -104.63 11.35 0.25 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.474 2.783 . . . . 0.0 110.461 176.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.1 -167.44 26.84 Favored Glycine 0 N--CA 1.422 -2.256 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 46.1 p -151.75 169.49 22.08 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 117.434 0.617 . . . . 0.0 110.641 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.451 HD21 ' H ' ' A' ' 105' ' ' LEU . 1.0 OUTLIER -115.56 131.41 56.94 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.338 0.589 . . . . 0.0 112.085 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.0 29.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 126.432 1.893 . . . . 0.0 115.087 -171.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.627 ' O ' ' HB3' ' A' ' 72' ' ' ASN . . . 71.79 -150.39 46.21 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.129 -177.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.62 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 29.7 p -54.42 90.04 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 124.498 1.119 . . . . 0.0 113.657 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 170.9 -166.4 39.59 Favored Glycine 0 CA--C 1.478 -2.262 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 174.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -119.51 135.9 54.57 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.0 t -134.58 137.88 44.12 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.105 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.8 m -91.26 124.2 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.832 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.3 mt -120.91 158.9 26.66 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.419 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 4.9 p-10 -147.36 148.47 31.38 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 177.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.6 p -130.54 136.15 28.51 Favored Pre-proline 0 C--N 1.292 -1.897 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.817 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.45 130.5 21.14 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.875 2.383 . . . . 0.0 112.637 178.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.457 HG11 ' CZ ' ' A' ' 64' ' ' TYR . 1.8 p -161.48 150.55 4.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 124.157 0.983 . . . . 0.0 109.262 178.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 13.3 mptt -88.93 133.76 34.19 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.966 0.413 . . . . 0.0 111.708 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.706 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 12.8 p -95.12 145.75 7.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 68.87 0.74 2.84 Favored 'General case' 0 C--O 1.216 -0.694 0 C-N-CA 124.426 1.09 . . . . 0.0 112.482 175.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -49.85 -46.47 51.42 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.784 1.233 . . . . 0.0 111.144 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.533 ' HB2' ' OG ' ' A' ' 89' ' ' SER . 17.0 m -69.75 -38.54 76.84 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.166 -175.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 19.7 tt -80.25 -27.46 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 O-C-N 121.94 -0.475 . . . . 0.0 111.342 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -52.63 -51.57 59.45 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 124.207 1.003 . . . . 0.0 112.046 177.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.5 m -61.32 -21.88 26.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -175.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.8 m -95.79 -78.08 0.46 Allowed 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 120.746 -0.382 . . . . 0.0 112.004 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.457 ' H ' HD22 ' A' ' 127' ' ' LEU . 2.1 pt? -120.72 -0.89 10.1 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.554 -174.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.511 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 25.1 ttt 53.55 76.03 0.23 Allowed 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 124.159 0.984 . . . . 0.0 112.107 -178.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.753 ' HE2' ' SD ' ' A' ' 131' ' ' MET . 55.4 pttt 54.77 -74.25 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 126.591 1.956 . . . . 0.0 113.021 -177.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 36.6 t70 161.56 81.54 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 101.223 -3.621 . . . . 0.0 101.223 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.753 ' SD ' ' HE2' ' A' ' 129' ' ' LYS . 8.9 tpt -56.01 110.96 0.82 Allowed 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -166.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . 0.574 ' SG ' ' HB2' ' A' ' 135' ' ' TRP . 7.1 p -147.09 -176.08 5.07 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 113.707 -1.588 . . . . 0.0 108.874 176.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.613 HG23 ' CB ' ' A' ' 169' ' ' SER . 5.6 m -126.59 107.58 10.34 Favored 'General case' 1 N--CA 1.367 -4.578 0 N-CA-C 103.145 -2.909 . . . . 0.0 103.145 -170.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.9 t70 84.51 101.01 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 125.139 1.376 . . . . 0.0 108.343 -171.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.574 ' HB2' ' SG ' ' A' ' 132' ' ' CYS . 4.8 t-105 -163.94 136.17 4.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.232 -166.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -105.12 145.7 30.19 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.9 tt -155.28 151.08 10.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -114.7 123.25 48.81 Favored 'General case' 0 CA--C 1.498 -1.029 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.789 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -105.09 172.73 6.63 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -119.35 139.96 51.12 Favored 'General case' 0 C--N 1.274 -2.713 0 O-C-N 121.178 -0.951 . . . . 0.0 111.864 -175.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.8 tp -128.45 130.69 47.94 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.697 -178.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.544 ' OD1' ' HB3' ' A' ' 160' ' ' SER . 21.5 t70 -135.41 123.97 23.58 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.2 mm -115.01 148.41 17.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -121.54 99.1 0.68 Allowed Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 174.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.433 ' HB3' ' CE2' ' A' ' 147' ' ' PHE . 2.9 mm? -79.22 114.78 18.43 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.462 ' OG1' HG21 ' A' ' 156' ' ' THR . 8.2 m -96.36 108.3 20.8 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.433 ' CE2' ' HB3' ' A' ' 145' ' ' LEU . 75.4 m-85 -116.57 146.89 42.33 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -103.28 130.62 50.58 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.532 0.682 . . . . 0.0 110.123 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.01 130.0 16.16 Favored Pre-proline 0 C--N 1.291 -1.967 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -59.41 -21.57 61.8 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 C-N-CA 123.373 2.715 . . . . 0.0 113.668 -172.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.87 -28.27 40.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.598 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 97.2 t -134.37 -44.79 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.559 0.695 . . . . 0.0 110.613 -177.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 118.79 -115.97 3.24 Favored Glycine 0 C--N 1.29 -1.983 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -174.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -102.32 117.64 35.17 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.081 0.467 . . . . 0.0 112.133 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.545 HD13 ' O ' ' A' ' 155' ' ' ILE 0.265 2.6 pp -123.59 118.57 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-O 121.316 0.579 . . . . 0.0 110.941 170.459 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.462 HG21 ' OG1' ' A' ' 146' ' ' THR . 23.3 p -85.85 108.88 18.34 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.677 177.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 68.5 mt -76.41 114.64 40.13 Favored Pre-proline 0 C--N 1.292 -1.932 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.768 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -82.98 137.22 8.48 Favored 'Trans proline' 0 CA--C 1.475 -2.452 0 C-N-CA 122.849 2.366 . . . . 0.0 111.954 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.428 HG23 HG22 ' A' ' 49' ' ' VAL . 5.7 p -149.52 112.98 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.38 -3.962 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.096 -174.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.544 ' HB3' ' OD1' ' A' ' 142' ' ' ASP . 58.3 p -120.49 155.36 33.75 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.599 -177.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.3 t -163.0 171.79 15.99 Favored 'General case' 0 C--O 1.255 1.358 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -99.43 126.89 45.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -94.09 85.86 1.06 Allowed Glycine 0 N--CA 1.413 -2.885 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -88.5 119.55 29.05 Favored 'General case' 0 N--CA 1.42 -1.972 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 8.4 pt -140.11 177.07 4.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.542 -171.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.407 ' HD2' ' H ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -130.19 143.83 51.01 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.447 -176.326 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.0 mp -125.59 97.98 35.41 Favored Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 171.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.611 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 33.1 Cg_endo -64.06 170.11 9.52 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.613 2.209 . . . . 0.0 111.332 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.613 ' CB ' HG23 ' A' ' 133' ' ' THR . 26.5 p -40.37 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 173.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 168' ' ' PRO . 3.5 pp -162.01 132.12 4.77 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.951 177.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.45 ' NH2' ' HA ' ' A' ' 132' ' ' CYS . 64.9 mtt180 -132.86 85.67 2.24 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 172.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 23.9 t70 177.19 -38.34 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 O-C-N 123.835 0.709 . . . . 0.0 110.608 -174.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 CA--C 1.49 -1.333 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 176.564 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.636 ' O ' HG23 ' A' ' 17' ' ' VAL . 38.6 t70 . . . . . 0 CA--C 1.511 -0.539 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -58.79 -39.96 82.64 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.188 175.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 40.4 tttp -64.13 -56.9 11.56 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.698 176.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.507 ' HA ' ' CG ' ' A' ' 19' ' ' GLU . 25.6 m -58.96 -24.65 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 13' ' ' ASP . 67.2 t -67.26 -50.23 64.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 172.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -62.34 -30.12 70.94 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.336 -177.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.507 ' CG ' ' HA ' ' A' ' 16' ' ' VAL . 40.0 mm-40 -54.77 -52.15 63.48 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.624 176.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -78.49 -31.37 47.75 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 120.109 -0.636 . . . . 0.0 111.908 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.9 -42.79 80.55 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 123.271 0.357 . . . . 0.0 110.19 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.2 t -59.43 -41.72 90.2 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.667 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 67.2 t -66.93 -49.39 74.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-O 120.836 0.35 . . . . 0.0 110.45 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.515 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 68.0 mt -60.89 -42.77 93.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.22 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.8 m -65.58 -32.51 74.14 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.38 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.8 t -71.44 -34.67 70.48 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.531 HD22 ' OG1' ' A' ' 156' ' ' THR . 3.2 tt -65.84 -41.89 91.19 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 176.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 83.4 mt -57.77 -38.71 75.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.116 177.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -61.16 -41.98 97.73 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 27' ' ' LEU . 65.6 pttt -71.81 -38.81 70.15 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.838 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.05 -31.76 68.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.25 -176.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -62.58 -42.2 99.41 Favored 'General case' 0 C--O 1.246 0.888 0 CA-C-O 121.023 0.44 . . . . 0.0 110.809 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.95 -33.56 36.5 Favored Glycine 0 CA--C 1.51 -0.281 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -57.17 -46.31 82.9 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.527 ' HA ' HD11 ' A' ' 39' ' ' LEU . 10.5 t80 -52.9 -53.31 51.06 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.066 1.347 . . . . 0.0 111.326 174.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.37 -33.22 58.71 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -174.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -99.15 -64.25 1.05 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.281 0.562 . . . . 0.0 112.457 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.3 mtmm -79.95 -22.45 42.62 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -169.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.527 HD11 ' HA ' ' A' ' 35' ' ' PHE . 5.7 mp -98.86 6.96 46.53 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-O 121.679 0.752 . . . . 0.0 109.805 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.95 -35.72 11.88 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -90.48 -18.21 25.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.398 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.8 mt -115.12 112.95 44.01 Favored Pre-proline 0 C--N 1.309 -1.194 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.6 97.36 0.88 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.187 1.925 . . . . 0.0 113.076 -176.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.3 p -93.01 159.34 35.86 Favored Pre-proline 0 N--CA 1.43 -1.43 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.982 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.05 147.35 90.68 Favored 'Trans proline' 0 C--O 1.239 0.556 0 C-N-CA 122.946 2.43 . . . . 0.0 111.596 174.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 38.4 tt0 -110.27 109.63 20.15 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.45 138.42 35.69 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.581 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.8 t -135.14 129.23 33.53 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.318 0.58 . . . . 0.0 110.957 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.485 ' H ' HG11 ' A' ' 159' ' ' VAL . 48.1 t -105.48 141.01 21.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 177.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -158.08 -31.96 0.07 Allowed 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -170.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -145.69 151.65 38.37 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 118.923 -1.111 . . . . 0.0 111.755 -171.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . 28.9 m -124.28 152.19 29.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 123.433 0.693 . . . . 0.0 110.712 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.513 ' CG ' ' HZ3' ' A' ' 67' ' ' LYS . 18.2 m-20 -114.86 117.0 29.47 Favored 'General case' 0 C--O 1.246 0.888 0 C-N-CA 122.841 0.456 . . . . 0.0 111.802 177.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -64.69 107.94 1.57 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 167.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 63' ' ' ASP . 14.6 ptmm? -107.05 -16.4 14.44 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.103 -0.639 . . . . 0.0 112.663 -176.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 159.65 -178.51 35.72 Favored Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 119.296 -1.431 . . . . 0.0 112.67 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.88 151.37 18.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 123.22 0.608 . . . . 0.0 110.007 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.4 t -153.19 -176.66 5.88 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -79.16 -53.52 6.9 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -175.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -97.78 80.61 2.79 Favored 'General case' 0 C--N 1.313 -1.015 0 O-C-N 122.167 -0.333 . . . . 0.0 111.683 -176.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.81 120.01 0.13 Allowed Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.146 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 173' ' ' PHE . 33.9 m -70.74 156.34 7.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 121.248 0.547 . . . . 0.0 111.812 -177.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 19.7 m-20 -96.06 126.23 41.15 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.08 -172.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.545 ' CD1' HG13 ' A' ' 119' ' ' VAL . 2.7 m-85 -121.04 122.62 40.47 Favored 'General case' 0 CA--C 1.471 -2.084 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.571 171.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -92.4 108.04 19.66 Favored 'General case' 0 C--N 1.273 -2.727 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . . . -93.34 144.84 24.94 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.513 ' HZ3' ' CG ' ' A' ' 53' ' ' ASP . 12.5 mptt -86.88 133.12 33.65 Favored 'General case' 0 C--O 1.251 1.143 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.734 176.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.6 t -130.97 106.52 12.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 168.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.2 p -106.91 134.84 49.46 Favored 'General case' 0 C--N 1.277 -2.552 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.424 -176.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 4.8 p -132.52 126.54 55.22 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.95 -176.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 89.1 tttt -96.6 119.38 34.98 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 175.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.4 ' HB2' HD11 ' A' ' 105' ' ' LEU . 52.7 t30 -111.45 115.7 51.56 Favored Pre-proline 0 C--N 1.301 -1.51 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.72 -175.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -95.81 96.92 0.1 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.612 0 C-N-CA 121.904 1.736 . . . . 0.0 111.025 172.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.405 ' HB3' ' H ' ' A' ' 75' ' ' SER . 30.6 m-85 -170.19 -166.09 0.52 Allowed 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 126.515 1.926 . . . . 0.0 107.011 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.405 ' H ' ' HB3' ' A' ' 74' ' ' TYR . 47.3 t -142.5 21.13 2.03 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 173.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.549 ' O ' ' HA2' ' A' ' 107' ' ' GLY . 17.2 pt20 -115.14 140.73 48.83 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.412 -178.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.3 p -83.15 95.19 8.03 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-O 121.656 0.741 . . . . 0.0 109.308 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 72.5 mt -74.93 122.95 88.6 Favored Pre-proline 0 N--CA 1.433 -1.287 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.726 -176.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.78 122.64 6.45 Favored 'Trans proline' 0 N--CA 1.444 -1.438 0 C-N-CA 122.197 1.932 . . . . 0.0 110.666 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 50.0 mt -88.33 102.82 13.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 62.3 m -57.55 -60.37 3.76 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 124.133 0.895 . . . . 0.0 110.624 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -150.68 157.35 42.85 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-O 121.52 0.676 . . . . 0.0 111.868 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.47 ' HB ' HG21 ' A' ' 99' ' ' ILE . 46.4 mm -107.15 116.94 51.95 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 176.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.0 m -80.78 118.35 22.23 Favored 'General case' 0 N--CA 1.412 -2.375 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -103.06 121.42 42.55 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.992 -170.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 69.9 mt -134.9 109.8 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.24 177.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.607 ' O ' HD11 ' A' ' 94' ' ' ILE . 0.9 OUTLIER -113.03 120.61 41.95 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 176.588 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.576 ' HD2' ' O ' ' A' ' 93' ' ' THR . 53.4 tptt -121.38 135.53 55.06 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.5 m -142.38 145.36 33.79 Favored 'General case' 0 C--O 1.25 1.082 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.55 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 62.28 18.27 10.05 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.119 0.968 . . . . 0.0 111.197 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 m 59.16 14.01 3.3 Favored 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 123.986 0.915 . . . . 0.0 109.888 -175.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -127.63 -65.65 0.91 Allowed 'General case' 0 N--CA 1.432 -1.336 0 O-C-N 121.325 -0.859 . . . . 0.0 111.057 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.576 ' O ' ' HD2' ' A' ' 88' ' ' LYS . 11.1 t -76.92 165.56 24.51 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.823 -172.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.607 HD11 ' O ' ' A' ' 87' ' ' LEU . 3.8 tp -163.38 139.02 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.015 0 C-N-CA 123.195 0.598 . . . . 0.0 109.703 -168.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.11 121.47 26.42 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 171.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 78.0 p -139.76 160.12 40.62 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.292 0.568 . . . . 0.0 111.63 -176.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 167.41 -170.25 41.52 Favored Glycine 0 N--CA 1.417 -2.614 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.3 p -127.86 122.2 31.99 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.47 HG21 ' HB ' ' A' ' 83' ' ' ILE . 10.0 tt -102.86 108.45 58.33 Favored Pre-proline 0 C--N 1.318 -0.771 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.02 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -82.55 146.31 13.51 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 C-N-CA 122.889 2.393 . . . . 0.0 113.63 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 44.75 67.41 4.11 Favored Pre-proline 0 N--CA 1.477 0.911 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -101.24 1.05 0.58 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.465 2.11 . . . . 0.0 111.911 176.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 148.94 -179.0 26.12 Favored Glycine 0 N--CA 1.428 -1.874 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.6 m -150.38 175.72 11.57 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 117.509 0.655 . . . . 0.0 110.708 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.532 ' H ' HD23 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -104.62 131.96 51.43 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.443 0.64 . . . . 0.0 112.654 -175.093 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.2 m -63.59 18.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 -171.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.549 ' HA2' ' O ' ' A' ' 76' ' ' GLN . . . 85.09 -52.66 4.71 Favored Glycine 0 C--O 1.214 -1.1 0 C-N-CA 120.407 -0.902 . . . . 0.0 113.32 177.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.7 t -148.29 117.17 6.72 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -177.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 133.99 177.37 14.89 Favored Glycine 0 CA--C 1.49 -1.479 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.12 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 9.9 t -96.53 113.35 24.92 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 121.753 0.787 . . . . 0.0 109.421 177.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.9 t -112.28 138.07 49.51 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.376 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 25.0 t -96.94 107.56 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.8 mt -86.8 166.39 15.27 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 178.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -140.43 145.84 37.52 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.396 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.4 t -120.95 128.2 25.87 Favored Pre-proline 0 C--N 1.3 -1.581 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -74.54 109.6 2.94 Favored 'Trans proline' 0 N--CA 1.43 -2.224 0 N-CA-C 106.986 -1.967 . . . . 0.0 106.986 168.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.464 HG12 ' HH ' ' A' ' 139' ' ' TYR . 59.2 t -103.66 127.27 57.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -176.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -88.98 91.12 8.71 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.545 HG13 ' CD1' ' A' ' 64' ' ' TYR . 12.1 p -94.03 147.29 5.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.173 -172.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.408 ' HA ' HD11 ' A' ' 123' ' ' ILE . . . 72.47 -5.63 1.77 Allowed 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.211 1.004 . . . . 0.0 111.318 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.461 ' H ' ' C ' ' A' ' 119' ' ' VAL . 76.1 t80 -63.55 -54.42 36.39 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.377 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.52 ' HB2' ' OG1' ' A' ' 93' ' ' THR . 13.1 p -63.42 -36.87 85.16 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.922 -176.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.438 ' CD1' HG21 ' A' ' 137' ' ' ILE . 52.7 mt -64.6 -49.42 80.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.097 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.74 -36.12 82.67 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 123.484 0.49 . . . . 0.0 110.775 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 121' ' ' TYR . 52.6 t -62.11 -51.4 72.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.514 176.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.6 m -66.74 -73.83 0.13 Allowed 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.493 HD13 ' N ' ' A' ' 128' ' ' MET . 2.0 pp -125.16 -32.14 3.01 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -171.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.493 ' N ' HD13 ' A' ' 127' ' ' LEU . 0.0 OUTLIER 63.37 110.93 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -171.2 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.45 ' C ' ' H ' ' A' ' 131' ' ' MET . 0.0 OUTLIER -68.07 -0.02 4.07 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -171.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 17.8 t70 84.79 -26.41 0.11 Allowed 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 125.624 1.57 . . . . 0.0 110.592 173.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.554 ' HE2' ' O ' ' A' ' 170' ' ' LEU . 9.1 tpt 70.89 149.7 0.09 Allowed 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 125.475 1.51 . . . . 0.0 113.47 174.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 72.0 m -153.69 160.76 42.45 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.436 ' CA ' ' HA ' ' A' ' 169' ' ' SER . 40.2 p -78.78 125.74 29.78 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 175.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.4 t70 69.47 89.02 0.1 Allowed 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -176.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.429 ' HE1' ' HG3' ' A' ' 129' ' ' LYS . 54.5 t-105 -158.19 149.79 21.39 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 114.032 -1.44 . . . . 0.0 109.732 -166.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -140.59 149.34 42.24 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.904 0.383 . . . . 0.0 110.386 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.438 HG21 ' CD1' ' A' ' 123' ' ' ILE . 2.9 mp -118.7 141.68 37.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -81.08 102.67 10.39 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 122.048 0.928 . . . . 0.0 109.473 174.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.527 ' CE2' ' HG ' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -130.69 144.58 51.53 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.251 -177.292 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.4 ' CB ' ' HA ' ' A' ' 162' ' ' GLN . 20.7 pt20 -131.52 157.8 42.6 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 38.2 tp -124.89 123.89 40.89 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -121.88 120.3 34.12 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.171 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 46.6 mm -120.62 127.76 75.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.891 -178.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -95.6 89.94 1.19 Allowed Glycine 0 N--CA 1.427 -1.903 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 173.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.26 110.69 7.74 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.567 ' OG1' HG22 ' A' ' 156' ' ' THR . 27.8 m -95.89 108.4 20.76 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 120.861 0.363 . . . . 0.0 111.18 -176.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -101.76 132.04 47.72 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 176.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -101.98 109.36 21.07 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 65.0 mt -127.99 114.29 20.38 Favored Pre-proline 0 C--N 1.29 -1.995 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.21 -24.1 32.42 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.841 2.361 . . . . 0.0 113.662 -176.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.38 -36.18 76.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.222 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 10.2 p -125.3 -32.1 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -174.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 120.56 -151.51 17.14 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -101.02 125.18 47.62 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.264 -1.014 . . . . 0.0 108.264 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.44 127.64 57.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.567 HG22 ' OG1' ' A' ' 146' ' ' THR . 74.8 p -91.84 108.95 20.28 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.407 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . 51.8 mt -77.77 114.47 41.65 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 157' ' ' ILE . 5.5 Cg_exo -76.58 101.02 1.45 Allowed 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 122.436 2.091 . . . . 0.0 111.587 -178.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.485 HG11 ' H ' ' A' ' 49' ' ' VAL . 18.0 t -101.83 113.18 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 53.1 p -110.14 145.22 37.56 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.194 -175.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.9 t -156.77 113.65 3.08 Favored 'General case' 0 N--CA 1.424 -1.768 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.296 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.4 ' HA ' ' CB ' ' A' ' 140' ' ' GLN . 11.4 pt20 -98.25 119.26 36.6 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -134.77 -130.92 3.02 Favored Glycine 0 N--CA 1.407 -3.284 0 C-N-CA 119.792 -1.194 . . . . 0.0 113.023 -174.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -158.14 133.1 8.52 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 115.219 -0.49 . . . . 0.0 109.918 -171.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 43.2 mm -107.02 108.59 25.56 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 171.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -110.94 128.89 55.98 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 121.791 0.805 . . . . 0.0 111.441 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 96.0 mt -118.57 91.48 41.86 Favored Pre-proline 0 N--CA 1.411 -2.39 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.758 -172.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.46 ' O ' HD21 ' A' ' 170' ' ' LEU . 9.1 Cg_exo -71.64 100.82 1.09 Allowed 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.575 2.85 . . . . 0.0 112.992 -177.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.436 ' HA ' ' CA ' ' A' ' 133' ' ' THR . 91.3 p 62.9 9.72 3.88 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 126.682 1.993 . . . . 0.0 115.528 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.554 ' O ' ' HE2' ' A' ' 131' ' ' MET . 3.5 mm? -71.73 138.66 48.65 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.146 -0.621 . . . . 0.0 111.848 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -142.54 140.99 31.98 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 167.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 37.5 t70 74.85 5.44 4.38 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.385 1.088 . . . . 0.0 110.762 -174.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.465 ' CD1' HD13 ' A' ' 170' ' ' LEU . 78.0 m-85 . . . . . 0 C--N 1.315 -0.932 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.887 174.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 C--O 1.219 -0.506 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.77 -43.77 98.19 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.826 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -63.86 -50.69 67.83 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.388 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.2 t -66.29 -44.63 91.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 114.979 -1.009 . . . . 0.0 113.354 -176.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.0 p -64.19 -26.59 40.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -75.45 -44.01 46.5 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.571 -177.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.481 ' O ' HG21 ' A' ' 23' ' ' VAL . 10.8 pt-20 -64.0 -40.25 95.95 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.649 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -65.85 -40.68 91.93 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.375 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.69 -42.7 99.29 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.179 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.8 t -61.76 -41.85 98.22 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.979 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 19' ' ' GLU . 93.5 t -60.75 -49.63 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.234 0.54 . . . . 0.0 109.779 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 67.6 mt -67.34 -39.91 83.73 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.768 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.003 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.9 t -61.72 -41.08 97.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.878 0.37 . . . . 0.0 110.105 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.451 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 32.6 m -70.34 -32.09 69.66 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.122 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.593 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 4.4 tt -69.84 -47.53 62.35 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 176.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.577 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 96.3 mt -59.95 -32.74 71.08 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.9 0.381 . . . . 0.0 110.152 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.451 ' HB3' ' O ' ' A' ' 26' ' ' SER . 12.4 t70 -57.69 -46.22 84.59 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.893 175.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -74.77 -33.63 62.32 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.238 0.542 . . . . 0.0 109.757 179.613 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.505 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -62.21 -39.63 93.41 Favored 'General case' 0 C--O 1.204 -1.337 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.729 -178.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.577 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 29.0 mtpp -60.76 -33.97 73.76 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.41 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -84.2 -51.1 4.06 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.066 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -61.92 -32.59 73.01 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 123.61 0.764 . . . . 0.0 112.592 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -72.62 -34.95 67.69 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 121.905 -0.497 . . . . 0.0 110.637 175.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.72 -27.33 58.12 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.731 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.439 ' HG3' ' N ' ' A' ' 38' ' ' LYS . 10.7 pt-20 -98.35 -49.32 4.72 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.439 ' N ' ' HG3' ' A' ' 37' ' ' GLU . 14.5 tppt? -76.84 -47.15 22.22 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 122.13 0.967 . . . . 0.0 109.333 -170.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 42.1 mt -89.36 16.93 6.68 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.45 -175.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.22 -20.21 19.41 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 172.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -97.69 -35.11 10.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.66 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.5 mt -103.47 118.56 57.35 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.078 -177.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.95 112.24 2.88 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.542 2.161 . . . . 0.0 111.092 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.422 ' HB ' ' CD ' ' A' ' 45' ' ' PRO . 4.0 p -116.88 171.22 5.04 Favored Pre-proline 0 C--N 1.301 -1.52 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.263 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.45 ' HB3' ' CB ' ' A' ' 72' ' ' ASN . 7.9 Cg_exo -72.95 145.97 41.04 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.477 2.118 . . . . 0.0 112.516 -177.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -97.75 119.02 35.58 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.999 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.21 141.28 37.01 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.1 t -136.46 143.03 43.64 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.5 t -97.91 132.34 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 175.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -112.69 -60.11 1.92 Allowed 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.059 -1.057 . . . . 0.0 113.745 -169.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -163.88 161.36 22.98 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -172.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.515 HG21 ' HB3' ' A' ' 64' ' ' TYR . 10.0 p -135.49 112.2 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.76 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -106.82 159.03 16.55 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.951 -175.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -71.36 126.81 30.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.419 0.628 . . . . 0.0 112.212 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.446 ' HD2' ' OD2' ' A' ' 63' ' ' ASP . 10.2 tmtt? -110.91 -44.84 3.55 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.352 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -178.5 -176.44 46.4 Favored Glycine 0 CA--C 1.484 -1.897 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 177.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.464 ' HA ' HG22 ' A' ' 62' ' ' VAL . 27.2 m -107.81 148.75 11.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.772 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.4 m -150.78 125.24 9.53 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 174.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -82.71 88.62 6.72 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 122.265 1.031 . . . . 0.0 113.407 -170.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -178.66 37.02 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 102.271 -3.233 . . . . 0.0 102.271 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.82 -133.07 10.63 Favored Glycine 0 N--CA 1.415 -2.723 0 N-CA-C 106.038 -2.825 . . . . 0.0 106.038 -170.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 57' ' ' VAL . 9.8 p -152.24 136.89 9.84 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 172.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.446 ' OD2' ' HD2' ' A' ' 55' ' ' LYS . 35.3 t70 -85.62 105.04 15.9 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-O 121.629 0.728 . . . . 0.0 112.237 -169.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.515 ' HB3' HG21 ' A' ' 52' ' ' VAL . 3.2 m-85 -109.47 161.61 15.16 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 121.65 0.738 . . . . 0.0 112.144 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 39.2 t60 -102.51 106.44 17.15 Favored 'General case' 0 N--CA 1.413 -2.298 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.631 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.22 124.87 35.23 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.801 174.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -100.41 125.27 46.67 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.386 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.0 m -121.44 144.58 30.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.3 m -120.83 136.0 55.02 Favored 'General case' 0 C--N 1.277 -2.581 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.033 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t -129.98 127.73 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-O 121.029 0.442 . . . . 0.0 110.27 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 19.3 ptpt -113.2 143.03 45.08 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 174.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.665 ' O ' ' HA ' ' A' ' 108' ' ' SER . 1.8 p-10 -142.63 138.49 16.27 Favored Pre-proline 0 C--N 1.287 -2.134 0 C-N-CA 118.906 -1.118 . . . . 0.0 110.266 -177.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -99.62 95.4 0.05 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.462 0 C-N-CA 120.852 1.035 . . . . 0.0 110.152 170.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -174.47 138.91 0.55 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.7 m -85.71 -5.3 59.28 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 118.827 0.74 . . . . 0.0 111.182 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -88.19 143.62 26.94 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.381 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.2 p -90.35 102.33 15.06 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.11 0.481 . . . . 0.0 109.902 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.8 mt -92.01 130.25 38.92 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -177.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -75.92 142.5 25.24 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.897 1.731 . . . . 0.0 108.943 171.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 103' ' ' GLY . 18.3 pt -82.5 102.62 8.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.318 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 6.6 m -43.47 -65.93 0.44 Allowed 'General case' 0 C--O 1.244 0.799 0 C-N-CA 126.945 2.098 . . . . 0.0 113.032 -172.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.534 ' C ' HD12 ' A' ' 83' ' ' ILE . 10.0 pt20 -147.34 150.82 35.49 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.534 HD12 ' C ' ' A' ' 82' ' ' GLN . 1.8 mp -120.39 117.97 55.15 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.141 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.8 m -80.08 119.98 23.62 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.476 ' CE2' HG13 ' A' ' 117' ' ' VAL . 4.8 t80 -103.04 120.76 41.24 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.634 -170.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 39.8 mm -131.17 108.47 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.515 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 0.2 OUTLIER -106.22 126.98 52.89 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 179.433 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -124.41 147.1 48.49 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.965 -0.694 . . . . 0.0 112.314 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.7 m -151.93 97.9 2.39 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 64.73 -173.03 0.18 Allowed 'General case' 0 CA--C 1.541 0.609 0 O-C-N 123.975 0.797 . . . . 0.0 109.5 -174.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.3 p -98.54 14.55 27.93 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.805 -0.56 . . . . 0.0 111.681 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.6 -65.58 0.99 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.27 -177.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 122' ' ' SER . 35.1 m -130.54 141.3 50.48 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 122.05 -0.406 . . . . 0.0 111.177 -175.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.515 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.8 pp -137.06 168.79 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -178.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.61 147.81 49.17 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 176.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.7 p -144.16 164.81 29.62 Favored 'General case' 0 C--N 1.313 -0.992 0 O-C-N 122.438 -0.164 . . . . 0.0 110.859 -177.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 156.36 -170.57 33.97 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 176.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 35.5 p -132.99 127.39 34.06 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 117.331 0.566 . . . . 0.0 109.721 176.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.4 tt -103.36 116.91 61.36 Favored Pre-proline 0 C--N 1.318 -0.796 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.964 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -88.63 128.04 2.02 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.973 2.449 . . . . 0.0 113.561 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.2 t70 50.98 72.96 1.07 Allowed Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.482 ' HD2' HG13 ' A' ' 80' ' ' ILE . 84.2 Cg_endo -104.09 18.8 0.16 Allowed 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 123.729 2.953 . . . . 0.0 110.706 174.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.533 ' O ' HG12 ' A' ' 80' ' ' ILE . . . 155.23 172.7 23.15 Favored Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.9 m -145.65 149.12 33.91 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.438 ' H ' HD11 ' A' ' 105' ' ' LEU 0.37 0.0 OUTLIER -81.18 157.62 25.2 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 119.519 -0.873 . . . . 0.0 113.259 179.118 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.4 m -83.53 -3.14 7.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -172.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.97 75.95 0.93 Allowed Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.646 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.665 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 48.8 m 78.91 91.46 0.06 Allowed 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 124.852 1.261 . . . . 0.0 111.756 -178.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 158.55 172.42 25.66 Favored Glycine 0 N--CA 1.425 -2.037 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 45.4 p -100.26 113.42 26.11 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.9 t -124.22 138.75 54.37 Favored 'General case' 0 N--CA 1.42 -1.937 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.333 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.2 m -86.36 134.62 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-O 121.416 0.627 . . . . 0.0 109.837 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.0 mt -125.24 167.01 15.46 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -140.31 148.51 41.5 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.464 -0.895 . . . . 0.0 112.848 -175.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 91.8 t -133.93 122.58 16.5 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 173.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -77.6 109.03 2.68 Favored 'Trans proline' 0 N--CA 1.41 -3.383 0 N-CA-C 108.059 -1.554 . . . . 0.0 108.059 171.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.476 HG13 ' CE2' ' A' ' 85' ' ' TYR . 33.8 m -98.87 149.66 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 177.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -101.99 99.17 9.31 Favored 'General case' 0 C--N 1.273 -2.725 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.2 m -91.72 149.94 3.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.92 -171.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 76.05 12.46 2.83 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.282 0.633 . . . . 0.0 110.907 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.552 ' O ' HG23 ' A' ' 125' ' ' VAL . 81.4 t80 -59.88 -39.61 85.9 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 172.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.404 ' HB3' ' HB ' ' A' ' 93' ' ' THR . 16.4 m -58.83 -32.71 69.64 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 122.317 1.056 . . . . 0.0 109.58 178.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.576 HG23 ' HA ' ' A' ' 128' ' ' MET . 1.8 mp -80.58 -48.39 19.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 126.141 1.776 . . . . 0.0 112.803 -175.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.69 -29.37 26.23 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.208 1.003 . . . . 0.0 111.866 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 121' ' ' TYR . 91.6 t -53.7 -19.75 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.849 0 C-N-CA 125.722 1.609 . . . . 0.0 112.307 175.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.2 t 105.17 25.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 127.191 2.196 . . . . 0.0 110.427 -175.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 127' ' ' LEU . 27.7 tp -98.14 1.09 47.14 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.459 175.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.576 ' HA ' HG23 ' A' ' 123' ' ' ILE . 83.8 mtp -30.36 106.54 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 125.979 1.711 . . . . 0.0 111.646 179.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -41.62 66.05 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 114.0 -1.454 . . . . 0.0 112.602 -178.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.4 t70 176.1 -58.14 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.456 0.473 . . . . 0.0 111.104 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.519 ' SD ' ' HA ' ' A' ' 171' ' ' ARG 0.257 15.7 tpp 65.0 97.07 0.05 OUTLIER 'General case' 0 C--O 1.244 0.775 0 CA-C-O 122.146 0.974 . . . . 0.0 112.817 -173.436 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 45.4 t -141.88 164.43 30.22 Favored 'General case' 0 N--CA 1.415 -2.187 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 34.4 p -73.58 119.5 17.9 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.7 t70 71.81 88.2 0.1 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.25 1.02 . . . . 0.0 108.438 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 41.0 t-105 -160.36 158.64 30.0 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.658 -170.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -143.96 162.16 36.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 118.111 0.414 . . . . 0.0 111.139 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 5.5 tt -140.68 146.43 24.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 C-N-CA 123.442 0.697 . . . . 0.0 109.383 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -88.99 108.13 19.41 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.436 ' HB3' HG12 ' A' ' 165' ' ' ILE . 0.2 OUTLIER -125.58 155.97 39.86 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 124.137 0.975 . . . . 0.0 109.377 -179.222 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.0 pm0 -146.71 148.78 32.35 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.307 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 27.8 tp -121.02 126.72 50.61 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.275 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -127.94 130.08 47.86 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -176.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.491 HG22 HG23 ' A' ' 83' ' ' ILE . 37.7 mm -130.19 144.25 38.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 121.511 0.672 . . . . 0.0 112.484 -173.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -114.16 92.39 0.6 Allowed Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 172.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.9 121.85 24.7 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -174.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.579 ' OG1' HG22 ' A' ' 156' ' ' THR . 19.1 m -105.95 127.83 53.4 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 120.054 -0.658 . . . . 0.0 112.008 -177.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -121.13 140.28 52.21 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 173.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -121.54 122.58 40.0 Favored 'General case' 0 CA--C 1.486 -1.514 0 C-N-CA 119.046 -1.062 . . . . 0.0 110.343 175.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 10.3 pt -140.43 143.34 32.63 Favored Pre-proline 0 C--N 1.301 -1.517 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.038 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.75 -5.3 10.15 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 123.472 2.781 . . . . 0.0 112.602 -178.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.16 -25.59 30.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.178 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 5.4 p -161.43 -39.44 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 140.56 -155.51 24.79 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -99.02 120.08 38.87 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.298 0.571 . . . . 0.0 109.743 177.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 146' ' ' THR . 50.0 mt -123.35 132.23 71.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.136 -174.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.579 HG22 ' OG1' ' A' ' 146' ' ' THR . 44.1 p -91.0 113.46 25.73 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.425 174.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.0 mp -90.3 117.81 68.31 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -80.28 127.39 6.66 Favored 'Trans proline' 0 CA--C 1.487 -1.832 0 C-N-CA 122.104 1.869 . . . . 0.0 112.036 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.87 130.61 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.716 0 CA-C-N 112.706 -2.043 . . . . 0.0 108.669 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 11.9 m -134.61 153.59 51.9 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.201 -174.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.4 t -147.24 137.21 23.13 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -99.57 122.44 42.63 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -139.3 -154.57 6.39 Favored Glycine 0 N--CA 1.405 -3.409 0 C-N-CA 119.465 -1.35 . . . . 0.0 110.71 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.04 159.5 29.39 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.436 HG12 ' HB3' ' A' ' 139' ' ' TYR . 52.0 mm -118.29 108.05 23.36 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.544 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 16.0 pttm -95.22 131.47 41.23 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.339 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 90.0 mt -110.73 91.8 13.16 Favored Pre-proline 0 C--N 1.283 -2.294 0 CA-C-N 114.64 -1.163 . . . . 0.0 110.212 -172.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 166' ' ' LYS . 1.7 Cg_endo -83.0 82.93 2.05 Favored 'Trans proline' 0 N--CA 1.426 -2.448 0 C-N-CA 122.618 2.212 . . . . 0.0 112.251 -177.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 65.4 p 57.61 24.99 11.1 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.684 1.194 . . . . 0.0 114.182 174.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.451 ' HB3' ' CD1' ' A' ' 173' ' ' PHE . 38.7 mt -60.76 -62.0 2.18 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 120.665 0.269 . . . . 0.0 110.54 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.519 ' HA ' ' SD ' ' A' ' 131' ' ' MET . 78.3 mtp180 63.95 141.34 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 O-C-N 124.668 1.23 . . . . 0.0 111.5 -173.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 38.0 t70 78.08 1.84 2.79 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.69 0.796 . . . . 0.0 111.126 -177.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.451 ' CD1' ' HB3' ' A' ' 170' ' ' LEU . 72.5 m-85 . . . . . 0 C--O 1.22 -0.5 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.0 t70 . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 121.296 0.57 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 18' ' ' GLU . 42.7 tt0 -57.43 -47.31 82.11 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.516 176.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.552 ' C ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -74.57 -19.43 60.33 Favored 'General case' 0 CA--C 1.487 -1.464 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.531 -178.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.0 t -71.19 -32.93 49.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 94' ' ' ILE . 59.9 t -69.24 -43.22 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 170.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 41.9 mt-10 -64.52 -46.75 81.59 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.863 -173.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.422 ' O ' HG22 ' A' ' 23' ' ' VAL . 8.0 pt-20 -55.53 -48.23 75.02 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 119.929 -0.709 . . . . 0.0 111.214 173.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.412 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 24.9 ttmm -65.5 -47.8 74.76 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 122.808 0.443 . . . . 0.0 111.43 -176.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.68 -39.22 76.63 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.118 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.1 t -66.52 -42.31 87.49 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.605 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 19' ' ' GLU . 65.5 t -62.92 -46.65 95.79 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 CA-C-O 121.116 0.484 . . . . 0.0 109.73 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.467 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 69.1 mt -64.08 -49.88 79.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.863 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.0 t -60.06 -35.09 74.4 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 122.664 0.386 . . . . 0.0 111.018 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.6 m -68.91 -30.47 68.96 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.12 0.486 . . . . 0.0 110.877 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.1 tt -75.82 -42.29 50.25 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 87.0 mt -63.05 -31.1 72.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.528 178.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -68.29 -49.31 61.36 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.426 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.531 ' HD2' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -67.37 -36.49 81.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.29 -177.21 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.531 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -77.46 -31.85 54.03 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.479 -178.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.53 ' HB2' ' HZ2' ' A' ' 32' ' ' LYS . 5.0 ttmp? -55.48 -53.45 56.19 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.166 0.291 . . . . 0.0 110.532 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.652 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -62.27 -53.08 44.91 Favored Glycine 0 N--CA 1.437 -1.269 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.477 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -53.83 -41.95 67.95 Favored 'General case' 0 C--O 1.252 1.204 0 C-N-CA 124.316 1.046 . . . . 0.0 111.674 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.436 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 90.8 t80 -66.43 -51.88 52.31 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.76 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.58 -22.98 67.19 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -176.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.652 ' HG2' ' O ' ' A' ' 33' ' ' GLY . 10.9 pt-20 -93.1 -51.49 5.01 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.449 ' HD3' ' HG3' ' A' ' 37' ' ' GLU . 3.9 mppt? -103.35 -39.13 6.92 Favored 'General case' 0 CA--C 1.484 -1.574 0 C-N-CA 118.553 -1.259 . . . . 0.0 112.764 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.436 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 2.7 mm? -79.63 -1.53 38.53 Favored 'General case' 0 C--N 1.286 -2.19 0 C-N-CA 119.783 -0.767 . . . . 0.0 112.535 -174.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.12 -8.87 58.44 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 172.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -109.22 -48.78 3.21 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.245 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.9 mp -77.15 117.83 67.83 Favored Pre-proline 0 C--O 1.244 0.808 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.77 118.73 4.74 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.357 2.705 . . . . 0.0 113.504 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.0 p -141.38 165.14 30.73 Favored Pre-proline 0 C--N 1.304 -1.392 0 C-N-CA 125.18 1.392 . . . . 0.0 108.185 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -70.21 135.08 28.53 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.022 1.815 . . . . 0.0 112.347 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -97.48 112.83 24.51 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.957 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.26 125.78 43.49 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.178 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -127.39 132.21 50.18 Favored 'General case' 0 N--CA 1.417 -2.093 0 CA-C-O 121.639 0.733 . . . . 0.0 110.588 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.428 HG22 ' OG1' ' A' ' 161' ' ' THR . 11.7 m -83.44 144.17 10.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.663 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -119.34 -67.2 1.0 Allowed 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.433 -174.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -172.43 174.09 3.93 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -177.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.56 HG22 ' HB3' ' A' ' 64' ' ' TYR . 10.5 p -116.48 126.62 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -95.73 119.52 34.38 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.532 -172.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.689 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 37.2 p90 -63.12 125.8 25.27 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.911 0.386 . . . . 0.0 111.761 175.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.533 ' HG3' ' CD2' ' A' ' 65' ' ' HIS . 29.5 mmmt -109.11 -66.3 1.07 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.777 -176.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.32 177.84 21.9 Favored Glycine 0 N--CA 1.431 -1.67 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.864 -175.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 173' ' ' PHE . 6.5 p -98.4 136.94 27.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -177.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.637 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 59.6 m -137.45 146.13 43.95 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -59.35 -43.44 92.78 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.981 0.912 . . . . 0.0 112.235 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.41 ' HB3' ' CD1' ' A' ' 121' ' ' TYR . 19.6 m-20 -61.96 -56.68 16.63 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.171 0.986 . . . . 0.0 109.59 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.637 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . -165.77 165.89 38.26 Favored Glycine 0 N--CA 1.407 -3.299 0 N-CA-C 105.857 -2.897 . . . . 0.0 105.857 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.94 141.87 17.14 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-N 117.689 0.745 . . . . 0.0 111.733 -176.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -87.46 111.79 21.52 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.25 -173.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.689 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 7.0 m-85 -120.1 161.24 21.32 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-O 121.761 0.791 . . . . 0.0 111.479 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.533 ' CD2' ' HG3' ' A' ' 55' ' ' LYS . 19.7 m170 -116.9 117.92 31.02 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.015 172.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.469 ' HB3' ' HB ' ' A' ' 115' ' ' VAL . . . -77.78 122.79 25.88 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.404 ' HG3' ' CG1' ' A' ' 112' ' ' VAL . 40.1 ttmt -87.44 107.84 18.74 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.636 -175.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.4 t -112.47 109.15 27.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 114.538 -1.21 . . . . 0.0 107.931 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.0 p -101.16 119.34 38.61 Favored 'General case' 0 C--N 1.277 -2.556 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.967 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 110' ' ' THR . 78.0 t -106.28 119.48 55.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.267 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -97.91 109.57 22.3 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' A' ' 108' ' ' SER . 41.6 t30 -112.27 119.46 43.78 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -175.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -93.83 97.62 0.14 Allowed 'Trans proline' 0 N--CA 1.434 -2.025 0 C-N-CA 121.861 1.707 . . . . 0.0 112.089 173.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.567 ' O ' ' HB2' ' A' ' 108' ' ' SER . 34.1 m-85 -169.92 -160.3 0.23 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 127.209 2.204 . . . . 0.0 106.678 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.5 m -143.37 19.7 1.89 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.538 0.685 . . . . 0.0 109.297 172.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.429 ' O ' ' HA2' ' A' ' 107' ' ' GLY . 17.9 pt20 -113.68 143.62 44.29 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.842 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.1 p -85.41 86.05 7.4 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.091 0.472 . . . . 0.0 110.588 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 64.6 mt -72.88 119.52 75.88 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.461 -177.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -88.91 124.19 1.49 Allowed 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 122.27 1.98 . . . . 0.0 110.876 175.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 24.2 pt -77.29 130.26 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.292 177.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 41.8 t -72.34 -40.17 67.59 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.327 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -153.68 155.83 36.72 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.5 tt -124.27 120.31 58.92 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 172.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.9 m -99.41 128.85 45.56 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -174.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -127.39 141.11 51.77 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.189 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.511 ' HB ' ' HB3' ' A' ' 142' ' ' ASP . 68.0 mt -119.37 108.18 23.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 172.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 119' ' ' VAL . 0.8 OUTLIER -101.74 122.65 44.34 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -179.095 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.401 ' HE2' ' O ' ' A' ' 91' ' ' THR . 67.5 tttt -123.29 154.37 38.94 Favored 'General case' 0 C--N 1.277 -2.547 0 C-N-CA 118.38 -1.328 . . . . 0.0 108.249 176.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.1 m -141.43 126.97 18.89 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.057 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 59.18 14.29 3.47 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.234 1.014 . . . . 0.0 111.094 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.401 ' O ' ' HE2' ' A' ' 88' ' ' LYS . 41.1 m 68.17 -2.69 1.44 Allowed 'General case' 0 CA--C 1.584 2.267 0 C-N-CA 124.451 1.101 . . . . 0.0 112.489 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.24 -80.81 0.24 Allowed 'General case' 0 C--O 1.237 0.408 0 O-C-N 121.199 -0.938 . . . . 0.0 111.346 176.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 29.1 m -84.72 166.05 17.34 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.274 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.523 HD13 ' N ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -159.88 148.54 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.468 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 -167.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.523 ' N ' HD13 ' A' ' 94' ' ' ILE . . . -128.87 127.21 41.37 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 176.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.7 t -137.73 151.14 47.89 Favored 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.438 -177.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.85 174.4 46.53 Favored Glycine 0 N--CA 1.411 -3.027 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.401 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 41.4 p -128.46 137.26 51.73 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.41 HD11 ' N ' ' A' ' 99' ' ' ILE . 3.2 mp -102.09 108.03 55.07 Favored Pre-proline 0 C--N 1.308 -1.197 0 C-N-CA 118.15 -1.42 . . . . 0.0 108.575 173.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 98' ' ' THR . 10.3 Cg_exo -74.12 129.51 13.25 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 122.345 2.03 . . . . 0.0 109.848 175.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 56.21 68.77 2.1 Favored Pre-proline 0 N--CA 1.477 0.916 0 C-N-CA 124.153 0.981 . . . . 0.0 111.14 -175.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -102.89 -0.25 0.36 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.384 2.723 . . . . 0.0 114.166 -176.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 152.31 179.29 27.79 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 56.3 m -149.82 156.46 41.84 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 116.934 0.367 . . . . 0.0 110.493 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.413 ' HA ' HG23 ' A' ' 111' ' ' THR . 7.5 mp -79.5 143.4 34.93 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.343 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 27.0 m -68.33 -16.32 20.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.878 -1.056 . . . . 0.0 113.356 -177.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 76' ' ' GLN . . . 129.16 -57.92 0.71 Allowed Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.567 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 24.9 t -156.68 139.58 15.28 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 175.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 119.57 -177.8 16.44 Favored Glycine 0 C--N 1.292 -1.907 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 9.9 t -89.56 117.95 28.84 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.815 0.817 . . . . 0.0 110.407 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.413 HG23 ' HA ' ' A' ' 105' ' ' LEU . 5.0 t -114.87 132.83 56.39 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.095 177.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.404 ' CG1' ' HG3' ' A' ' 67' ' ' LYS . 39.6 t -92.46 121.69 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.831 -177.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.9 mt -106.96 148.14 29.01 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.152 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -110.7 122.31 47.49 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 86.0 t -100.22 116.6 64.33 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 169.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.76 108.96 2.54 Favored 'Trans proline' 0 N--CA 1.43 -2.244 0 N-CA-C 106.171 -2.281 . . . . 0.0 106.171 169.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.0 p -126.63 139.12 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.381 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -175.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -94.04 94.97 8.72 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.483 ' C ' ' H ' ' A' ' 121' ' ' TYR . 4.5 m -94.21 148.5 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.583 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -175.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 73.44 -4.28 2.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.369 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.483 ' H ' ' C ' ' A' ' 119' ' ' VAL . 61.7 t80 -58.94 -41.05 86.45 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 171.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.7 p -62.34 -32.19 72.92 Favored 'General case' 0 N--CA 1.417 -2.077 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.913 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 45.6 mm -80.9 -49.83 17.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.242 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.63 -42.85 95.2 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.438 0.461 . . . . 0.0 111.204 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.3 t -66.95 -29.04 44.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.562 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.6 t -86.47 -72.37 0.5 Allowed 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.628 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 128' ' ' MET . 3.0 pp -124.72 -35.3 2.73 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -172.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.574 ' N ' HD12 ' A' ' 127' ' ' LEU . 12.5 tpt 58.92 114.49 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.506 1.123 . . . . 0.0 112.398 -174.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -65.27 -75.42 0.09 Allowed 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.516 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.5 t70 159.78 -32.82 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 105.194 -2.151 . . . . 0.0 105.194 -175.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.421 ' HE2' ' O ' ' A' ' 168' ' ' PRO . 0.4 OUTLIER 69.47 127.44 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 112.288 -2.233 . . . . 0.0 110.91 -177.206 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 42.0 t -128.16 150.72 49.87 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.473 HG22 ' HA ' ' A' ' 169' ' ' SER . 66.9 p -61.78 117.61 6.08 Favored 'General case' 0 N--CA 1.407 -2.608 0 C-N-CA 124.339 1.056 . . . . 0.0 109.678 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 75.86 80.91 0.1 Allowed 'General case' 0 CA--C 1.507 -0.673 0 CA-C-O 121.926 0.87 . . . . 0.0 110.63 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 15.8 t-105 -146.15 116.26 7.4 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.816 -1.538 . . . . 0.0 111.214 -175.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -98.09 126.11 43.38 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 15.6 tt -112.28 145.82 17.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.3 -175.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -74.67 105.91 5.98 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 122.376 1.084 . . . . 0.0 111.043 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.47 150.85 51.99 Favored 'General case' 0 C--N 1.265 -3.095 0 CA-C-N 113.297 -1.774 . . . . 0.0 106.934 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . 0.304 0.1 OUTLIER -146.19 157.34 43.82 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.209 176.526 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.467 ' HB3' ' HB ' ' A' ' 161' ' ' THR . 28.4 tp -135.53 143.31 45.68 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -171.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.511 ' HB3' ' HB ' ' A' ' 86' ' ' ILE . 17.9 t70 -142.32 114.08 8.0 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 177.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 158' ' ' PRO . 49.1 mt -116.24 142.82 28.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.305 -174.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -120.62 108.39 1.4 Allowed Glycine 0 N--CA 1.421 -2.33 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 176.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 156' ' ' THR . 3.8 mm? -84.33 115.84 22.7 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 122.566 0.346 . . . . 0.0 110.873 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.415 ' OG1' HG22 ' A' ' 156' ' ' THR . 32.3 m -90.47 107.15 18.98 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.635 ' O ' ' HA ' ' A' ' 154' ' ' ASP . 93.8 m-85 -111.5 142.04 44.29 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 176.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -108.51 110.05 21.45 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.0 mp -121.7 126.58 26.37 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.19 -12.73 0.84 Allowed 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 124.481 3.454 . . . . 0.0 116.176 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 24.6 m -73.69 -22.98 18.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 O-C-N 122.065 -0.397 . . . . 0.0 111.203 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.2 p -148.46 -32.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.496 0.665 . . . . 0.0 111.417 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 115.39 -136.63 13.22 Favored Glycine 0 N--CA 1.416 -2.699 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 -175.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.635 ' HA ' ' O ' ' A' ' 147' ' ' PHE . 5.7 p-10 -95.73 131.03 42.44 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 121.376 0.608 . . . . 0.0 110.983 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.47 131.46 54.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 176.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 73.8 p -87.72 118.58 27.32 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.699 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.447 HD13 ' CD2' ' A' ' 147' ' ' PHE . 2.3 mp -81.35 110.99 21.12 Favored Pre-proline 0 C--N 1.316 -0.854 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 173.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.518 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 19.2 Cg_endo -88.02 113.38 0.81 Allowed 'Trans proline' 0 CA--C 1.475 -2.428 0 C-N-CA 122.489 2.126 . . . . 0.0 111.555 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.9 p -116.93 108.32 24.66 Favored 'Isoleucine or valine' 2 N--CA 1.361 -4.923 0 CA-C-N 112.174 -2.285 . . . . 0.0 109.231 -176.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 27.3 m -89.59 152.47 21.38 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.23 -173.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 141' ' ' LEU . 1.6 m -140.56 139.6 35.03 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -177.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -99.62 118.61 36.54 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 164.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -108.75 93.28 0.77 Allowed Glycine 0 N--CA 1.413 -2.869 0 C-N-CA 118.77 -1.681 . . . . 0.0 112.697 -171.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -89.22 118.91 29.25 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 175.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.8 pt -124.33 121.05 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 CA-C-O 121.617 0.723 . . . . 0.0 110.678 -178.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -91.46 104.05 16.6 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 114.229 -1.35 . . . . 0.0 110.95 -177.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 7.1 mp -82.45 111.93 32.5 Favored Pre-proline 0 C--N 1.295 -1.785 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 176.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.421 ' O ' ' HE2' ' A' ' 131' ' ' MET . 87.8 Cg_endo -82.06 -160.89 0.13 Allowed 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 122.259 1.973 . . . . 0.0 110.189 -177.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.473 ' HA ' HG22 ' A' ' 133' ' ' THR . 28.9 t -56.04 92.82 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 167.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 21.6 tp -144.9 27.54 1.31 Allowed 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 -177.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.472 ' NH1' ' HB2' ' A' ' 172' ' ' ASP . 2.5 tmm_? -63.41 122.56 16.54 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.534 -1.212 . . . . 0.0 107.897 -176.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.472 ' HB2' ' NH1' ' A' ' 171' ' ' ARG . 25.5 t70 79.97 73.78 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.815 0 C-N-CA 125.136 1.374 . . . . 0.0 108.954 -175.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.45 ' O ' HG22 ' A' ' 57' ' ' VAL . 12.1 t80 . . . . . 0 C--N 1.293 -1.874 0 N-CA-C 101.097 -3.668 . . . . 0.0 101.097 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.4 t70 . . . . . 0 C--O 1.238 0.477 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 18' ' ' GLU . 45.6 mt-10 -57.2 -41.61 79.7 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.053 176.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.502 ' C ' ' HD3' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -67.45 -49.0 65.58 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.291 0.567 . . . . 0.0 110.02 177.604 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.61 -35.85 75.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.333 -0.849 . . . . 0.0 113.023 -173.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 p -66.15 -29.59 47.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 65.1 mt-10 -76.79 -44.95 30.67 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 122.057 0.932 . . . . 0.0 108.597 178.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -55.3 -46.94 76.24 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.497 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.552 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -70.75 -36.17 73.0 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.275 177.6 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.67 90.88 Favored 'General case' 0 C--O 1.213 -0.817 0 O-C-N 123.282 0.363 . . . . 0.0 110.574 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.8 m -61.01 -38.19 85.2 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 120.727 0.299 . . . . 0.0 111.582 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.8 -34.94 73.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 20' ' ' LYS . 78.8 mt -69.27 -49.67 59.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.45 -0.795 . . . . 0.0 108.967 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.0 m -57.4 -33.82 68.25 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.992 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.2 t -57.68 -35.23 70.32 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.17 0.588 . . . . 0.0 111.721 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.5 tt -80.33 -43.77 20.63 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.445 HD23 ' HB3' ' A' ' 158' ' ' PRO . 9.1 mp -62.3 -34.56 76.83 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -62.41 -34.05 75.97 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -18.66 38.53 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.712 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.22 -32.08 64.54 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.705 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -50.67 -52.75 36.96 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.679 0.791 . . . . 0.0 112.327 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -90.32 7.32 81.69 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.905 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 29.1 t80 -85.46 -26.18 26.48 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.514 ' CD1' HD13 ' A' ' 39' ' ' LEU . 44.8 m-85 -70.35 -41.08 73.63 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -174.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.29 -50.77 49.44 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -168.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.415 ' HG2' ' HG3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -117.78 -31.62 5.08 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.259 -0.576 . . . . 0.0 112.072 179.374 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 34' ' ' PHE . 36.7 mtmm -84.84 -9.71 57.88 Favored 'General case' 0 CA--C 1.486 -1.49 0 CA-C-O 121.484 0.659 . . . . 0.0 111.534 -168.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.514 HD13 ' CD1' ' A' ' 35' ' ' PHE . 88.5 mt -128.43 17.98 6.43 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.194 174.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.66 -44.32 21.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.735 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -95.26 11.37 32.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.623 0.725 . . . . 0.0 110.061 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.3 mm -115.57 117.2 40.66 Favored Pre-proline 0 N--CA 1.435 -1.204 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -65.03 113.92 2.59 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 121.991 1.794 . . . . 0.0 111.158 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.3 p -118.19 139.23 26.44 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.917 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -74.71 143.88 30.65 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.563 2.175 . . . . 0.0 112.289 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -97.48 130.19 44.6 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -113.0 134.29 54.57 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.9 t -115.83 123.98 49.55 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 121.989 0.9 . . . . 0.0 111.416 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.485 HG23 ' CG2' ' A' ' 161' ' ' THR . 26.0 m -102.39 143.87 14.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 114.288 -1.323 . . . . 0.0 109.958 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.575 24.2 t70 117.25 78.61 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 117.821 2.526 . . . . 0.0 117.821 176.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.506 ' HB2' ' HB3' ' A' ' 67' ' ' LYS . 31.9 m-20 -161.3 111.0 1.63 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 102.809 -3.034 . . . . 0.0 102.809 170.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.41 HG12 ' CD2' ' A' ' 64' ' ' TYR . 31.8 t -137.94 134.01 44.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.309 -168.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -137.42 137.26 38.6 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.256 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 37.8 p90 -91.83 141.82 28.25 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.093 0.557 . . . . 0.0 111.154 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.631 ' HD2' ' N ' ' A' ' 55' ' ' LYS . 3.0 mptp? -107.75 -52.23 2.79 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.89 178.55 40.55 Favored Glycine 0 C--N 1.293 -1.856 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.054 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.71 148.99 5.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 117.039 0.419 . . . . 0.0 110.508 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.6 p -131.28 179.15 6.19 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 176.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -75.6 -32.19 60.21 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.564 0.697 . . . . 0.0 109.328 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.22 83.44 3.6 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.81 176.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.92 -162.67 38.63 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.006 -176.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 p -107.59 145.04 15.37 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.703 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -84.97 121.74 28.2 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.628 0.728 . . . . 0.0 112.373 -170.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.641 ' CD1' ' HB ' ' A' ' 119' ' ' VAL . 28.2 m-85 -129.3 172.24 11.68 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.547 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -138.85 117.34 12.06 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 176.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.19 145.75 24.26 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.724 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 51' ' ' ASP . 47.8 tttm -116.43 124.34 49.76 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.03 -177.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.1 m -128.43 111.64 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-O 121.784 0.802 . . . . 0.0 109.242 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.9 m -98.5 130.63 45.09 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.364 -175.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.18 124.97 66.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.035 0.445 . . . . 0.0 110.814 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -117.34 125.51 51.16 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.061 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.511 ' O ' ' HA ' ' A' ' 108' ' ' SER . 4.7 t30 -152.45 114.56 2.85 Favored Pre-proline 0 C--N 1.286 -2.165 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.277 176.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -99.41 96.37 0.05 OUTLIER 'Trans proline' 0 N--CA 1.418 -2.941 0 C-N-CA 121.812 1.674 . . . . 0.0 109.779 169.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 93.3 t80 178.23 111.9 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 177.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.7 p -56.86 85.12 0.01 OUTLIER 'General case' 0 C--O 1.242 0.686 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -156.07 105.0 2.31 Favored 'General case' 1 N--CA 1.369 -4.486 0 C-N-CA 126.552 1.941 . . . . 0.0 106.527 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.6 p -89.53 97.01 10.95 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.411 ' CD1' HD21 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -103.85 134.93 19.46 Favored Pre-proline 0 C--N 1.31 -1.131 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.787 178.665 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -89.19 159.87 5.7 Favored 'Trans proline' 0 N--CA 1.438 -1.784 0 C-N-CA 122.427 2.085 . . . . 0.0 110.891 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 54.2 mt -91.03 114.91 29.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 100' ' ' PRO . 47.2 t -67.93 -37.94 82.27 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.267 0.556 . . . . 0.0 110.252 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -152.89 112.72 3.93 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.708 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 98' ' ' THR . 18.3 tt -95.77 119.43 43.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 175.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 143' ' ' ILE . 10.5 m -111.31 121.75 46.05 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.754 -172.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.426 ' CE1' HG11 ' A' ' 117' ' ' VAL . 23.7 p90 -109.65 136.41 49.05 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 175.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.571 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 63.7 mt -117.06 108.1 24.04 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.668 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 174.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -90.83 120.75 32.11 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 -174.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.506 ' HZ3' ' HB3' ' A' ' 88' ' ' LYS . 8.5 mtpm? -118.83 163.78 16.38 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -172.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.1 t -105.57 147.41 28.43 Favored 'General case' 0 N--CA 1.41 -2.447 0 CA-C-N 112.181 -2.281 . . . . 0.0 106.59 172.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.13 -15.43 63.59 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 123.424 0.453 . . . . 0.0 110.873 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.0 t -143.93 -38.22 0.31 Allowed 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -176.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -148.31 128.27 13.56 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 118.785 -1.166 . . . . 0.0 112.687 -172.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.493 ' O ' ' HB3' ' A' ' 122' ' ' SER . 90.6 m 74.13 137.98 0.06 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.37 1.068 . . . . 0.0 113.093 177.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.452 ' C ' HD11 ' A' ' 94' ' ' ILE . 1.9 pp -134.06 171.76 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.5 172.82 12.39 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 176.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 64.1 p -152.82 175.59 12.72 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 122.079 -0.388 . . . . 0.0 110.7 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.03 144.45 4.51 Favored Glycine 0 N--CA 1.435 -1.376 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 41.9 p -132.36 136.63 46.97 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 117.023 0.411 . . . . 0.0 110.529 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.1 mp -113.3 107.11 54.02 Favored Pre-proline 0 C--N 1.313 -1.001 0 C-N-CA 119.419 -0.913 . . . . 0.0 109.167 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 81' ' ' CYS . 18.6 Cg_exo -69.4 116.65 4.62 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.515 2.143 . . . . 0.0 110.031 173.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.2 t70 62.35 79.1 0.27 Allowed Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 123.51 0.724 . . . . 0.0 111.533 -177.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -107.08 12.49 0.15 Allowed 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 124.291 3.327 . . . . 0.0 112.563 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.41 ' C ' ' HG ' ' A' ' 104' ' ' SER . . . 141.68 -174.22 23.14 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -175.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.41 ' HG ' ' C ' ' A' ' 103' ' ' GLY . 44.8 m -151.07 170.82 18.47 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 117.578 0.689 . . . . 0.0 110.679 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.411 HD21 ' CD1' ' A' ' 78' ' ' ILE . 10.3 mp -74.02 157.58 35.87 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 114.762 1.394 . . . . 0.0 114.762 177.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.516 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 7.1 p -79.0 -20.68 12.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 CA-C-N 112.338 -2.21 . . . . 0.0 110.737 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 106.15 -60.97 0.35 Allowed Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 23.2 t -152.81 84.57 1.23 Allowed 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.435 0.636 . . . . 0.0 109.548 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 161.95 -151.74 21.91 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 108.989 -1.645 . . . . 0.0 108.989 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.0 t -122.82 136.77 54.98 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.193 0.521 . . . . 0.0 110.135 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.516 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 4.4 t -130.79 138.3 49.84 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.694 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 50.8 t -91.55 113.53 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-O 121.048 0.452 . . . . 0.0 110.982 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.9 mt -103.3 166.92 10.15 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -147.28 149.83 33.62 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 119.804 -0.759 . . . . 0.0 112.501 -171.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.0 t -125.92 132.62 24.37 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -77.01 110.81 3.11 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 N-CA-C 107.417 -1.801 . . . . 0.0 107.417 167.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.426 HG11 ' CE1' ' A' ' 85' ' ' TYR . 66.3 t -119.99 136.18 57.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.326 -174.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -88.77 99.0 12.02 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 173.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.641 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 82.6 t -93.44 146.54 6.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.603 -173.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 72.7 1.07 3.86 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 124.646 1.179 . . . . 0.0 111.759 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.51 ' O ' HG12 ' A' ' 125' ' ' VAL . 83.8 t80 -54.26 -49.38 69.67 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 175.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.493 ' HB3' ' O ' ' A' ' 93' ' ' THR . 29.0 m -64.3 -29.34 70.42 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.727 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.6 mm -79.51 -50.68 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.11 -49.33 74.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -175.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 121' ' ' TYR . 8.0 p -72.24 -22.28 20.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.938 0.399 . . . . 0.0 111.584 -175.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.0 t -99.51 -62.52 1.23 Allowed 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.415 ' H ' HD23 ' A' ' 127' ' ' LEU . 1.8 pt? -124.91 -41.61 2.09 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -171.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 81.3 mtp 65.88 -177.97 0.19 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -169.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -137.31 -78.31 0.39 Allowed 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.3 t70 178.59 93.28 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.181 0 CA-C-N 114.494 -1.23 . . . . 0.0 107.728 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.568 ' SD ' ' HB2' ' A' ' 170' ' ' LEU . 0.3 OUTLIER -52.18 101.66 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.344 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.822 175.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 82.1 m -108.27 167.66 9.86 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.433 0.635 . . . . 0.0 112.176 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.472 HG22 ' HB3' ' A' ' 169' ' ' SER . 40.3 p -77.63 127.55 32.66 Favored 'General case' 0 N--CA 1.404 -2.752 0 C-N-CA 124.921 1.288 . . . . 0.0 108.561 169.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.6 t70 54.91 91.69 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.65 1.18 . . . . 0.0 109.625 -172.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -148.69 158.97 44.52 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.908 -169.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -142.19 148.24 37.89 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.455 HG12 HD22 ' A' ' 167' ' ' LEU . 27.8 pt -128.97 145.3 35.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 120.865 0.364 . . . . 0.0 110.874 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -97.41 111.86 23.94 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -128.12 163.13 25.31 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.566 ' HG3' ' O ' ' A' ' 161' ' ' THR . 34.3 tt0 -136.45 150.01 48.51 Favored 'General case' 0 C--N 1.283 -2.314 0 O-C-N 121.68 -0.637 . . . . 0.0 111.053 -178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.571 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 2.0 pt? -141.25 120.44 12.96 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 172.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.14 122.63 29.1 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.502 ' HA ' ' O ' ' A' ' 84' ' ' SER . 34.5 mm -108.24 117.28 53.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 C-N-CA 118.799 -1.16 . . . . 0.0 109.644 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -94.07 96.84 2.11 Favored Glycine 0 N--CA 1.419 -2.46 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 156' ' ' THR . 2.7 mm? -79.16 108.72 12.87 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.435 ' OG1' HG22 ' A' ' 156' ' ' THR . 26.1 m -89.85 107.36 19.06 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.294 -0.962 . . . . 0.0 108.83 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.413 ' CE2' ' HB3' ' A' ' 145' ' ' LEU . 73.4 m-85 -114.55 131.31 56.71 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -108.78 112.17 24.3 Favored 'General case' 0 C--N 1.287 -2.122 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.757 173.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.408 HD11 ' N ' ' A' ' 149' ' ' ILE . 2.5 mp -104.2 120.09 52.0 Favored Pre-proline 0 C--N 1.292 -1.904 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 176.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -41.85 -32.21 1.63 Allowed 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 124.386 3.391 . . . . 0.0 115.455 -174.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 33.8 m -74.78 -21.98 17.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 13.9 p -126.18 -28.69 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.818 -177.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 107.34 -156.47 15.92 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -90.53 120.25 31.46 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.48 0.657 . . . . 0.0 111.47 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.457 HD13 ' O ' ' A' ' 155' ' ' ILE . 2.4 pp -128.83 138.05 55.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.61 175.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 67.3 p -94.21 127.29 39.96 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.196 177.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 51.2 mt -101.15 105.15 37.44 Favored Pre-proline 0 C--N 1.295 -1.79 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.445 ' HB3' HD23 ' A' ' 28' ' ' LEU . 3.2 Cg_exo -76.97 109.9 2.93 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 122.646 2.231 . . . . 0.0 111.305 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.414 HG12 HG21 ' A' ' 49' ' ' VAL . 19.0 t -103.97 124.6 58.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 175.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 14.7 m -126.78 152.14 47.32 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.154 -173.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.566 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 14.0 t -174.62 162.22 3.34 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.257 0.0 OUTLIER -99.46 135.84 40.29 Favored 'General case' 0 N--CA 1.409 -2.494 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.972 172.332 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -108.38 113.01 3.7 Favored Glycine 0 N--CA 1.397 -3.905 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -177.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -89.55 119.67 30.18 Favored 'General case' 0 N--CA 1.405 -2.702 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 174.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 10.0 pt -118.34 140.67 40.99 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.909 -176.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -90.72 136.49 33.03 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.536 -173.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.455 HD22 HG12 ' A' ' 137' ' ' ILE . 2.0 mm? -115.34 94.84 40.89 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.1 49.48 2.56 Favored 'Trans proline' 0 N--CA 1.486 1.08 0 C-N-CA 123.359 2.706 . . . . 0.0 112.944 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.472 ' HB3' HG22 ' A' ' 133' ' ' THR . 2.9 m 67.11 93.39 0.07 Allowed 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 125.108 1.363 . . . . 0.0 110.758 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.681 ' HB3' ' CD1' ' A' ' 173' ' ' PHE . 3.0 mm? -98.77 -59.48 1.73 Allowed 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.093 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 61.21 104.62 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.187 0.995 . . . . 0.0 111.602 -174.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 33.5 t70 70.49 64.19 0.2 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.866 1.266 . . . . 0.0 112.075 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.681 ' CD1' ' HB3' ' A' ' 170' ' ' LEU . 57.6 m-85 . . . . . 0 C--N 1.311 -1.08 0 C-N-CA 125.933 1.693 . . . . 0.0 106.565 178.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.539 ' O ' HG21 ' A' ' 17' ' ' VAL . 10.1 m-20 . . . . . 0 N--CA 1.443 -0.804 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -67.86 -29.86 69.1 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-O 121.355 0.598 . . . . 0.0 110.778 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 11.7 tmtt? -75.26 -54.25 7.42 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.792 0.806 . . . . 0.0 110.139 177.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.5 t -59.95 -41.76 87.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 CA-C-N 114.946 -1.025 . . . . 0.0 112.682 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.539 HG21 ' O ' ' A' ' 13' ' ' ASP . 40.2 t -68.5 -27.51 36.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 C-N-CA 118.842 -1.143 . . . . 0.0 109.077 176.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.444 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 33.0 tt0 -63.09 -34.78 78.33 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.974 0.892 . . . . 0.0 108.651 -177.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.38 -49.72 72.7 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.265 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -65.08 -43.05 93.44 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.2 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.74 -37.99 80.5 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.205 -178.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.2 t -60.73 -40.37 92.1 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 123.303 0.377 . . . . 0.0 110.29 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.13 -49.76 73.91 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.529 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 64.1 mt -68.85 -39.81 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.963 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 56.2 m -61.01 -37.8 83.83 Favored 'General case' 0 C--O 1.215 -0.744 0 O-C-N 122.299 -0.251 . . . . 0.0 110.643 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.9 m -67.19 -20.91 65.78 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.111 0.482 . . . . 0.0 111.348 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -78.04 -51.53 10.18 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.447 HD22 ' HB3' ' A' ' 158' ' ' PRO . 8.1 mp -60.85 -34.0 73.91 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.409 177.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -53.33 -49.47 67.0 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.524 0.73 . . . . 0.0 111.465 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -82.13 -31.64 30.51 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.07 -32.49 70.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.713 0.292 . . . . 0.0 111.638 177.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.475 ' CG ' ' HG2' ' A' ' 158' ' ' PRO . 56.6 mtmt -61.82 -25.77 67.71 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.568 176.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.469 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -73.48 -50.84 10.71 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 175.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -58.37 -40.67 82.89 Favored 'General case' 0 C--O 1.198 -1.611 0 CA-C-O 120.397 0.141 . . . . 0.0 111.113 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -60.11 -35.49 75.36 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.999 -0.681 . . . . 0.0 111.81 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.09 -39.2 50.54 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 33' ' ' GLY . 10.9 pt-20 -96.29 -40.07 9.33 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -176.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -90.67 -47.93 7.36 Favored 'General case' 0 CA--C 1.479 -1.781 0 CA-C-O 122.74 1.257 . . . . 0.0 107.927 -167.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 58.6 mt -82.91 6.2 19.32 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 112.91 -1.95 . . . . 0.0 111.331 -173.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.25 -38.54 30.75 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 173.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -88.41 -39.97 13.87 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.863 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.6 mt -73.5 135.91 78.39 Favored Pre-proline 0 N--CA 1.435 -1.178 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -72.6 94.65 0.78 Allowed 'Trans proline' 0 N--CA 1.441 -1.574 0 N-CA-C 106.404 -2.191 . . . . 0.0 106.404 171.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.9 m -100.27 137.16 19.95 Favored Pre-proline 0 N--CA 1.415 -2.216 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.814 -167.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.53 ' HB3' ' OD1' ' A' ' 72' ' ' ASN . 23.4 Cg_endo -60.11 124.59 15.56 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.041 2.494 . . . . 0.0 110.733 176.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -97.69 106.38 18.68 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.454 0.645 . . . . 0.0 110.843 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . . . -100.14 144.49 29.1 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.862 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 t -146.35 149.03 33.0 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.951 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.455 ' H ' HG12 ' A' ' 159' ' ' VAL . 90.0 t -82.52 141.22 15.28 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 175.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -133.08 -41.19 0.91 Allowed 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -170.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -160.42 163.33 33.17 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.38 -171.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.567 HG11 ' CD2' ' A' ' 64' ' ' TYR . 97.7 t -132.01 106.66 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 123.489 0.716 . . . . 0.0 110.72 -177.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.461 ' HB2' ' CD2' ' A' ' 65' ' ' HIS . 34.9 m-20 -100.83 107.51 19.08 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.446 ' HA ' ' CB ' ' A' ' 64' ' ' TYR . 49.6 p90 -63.48 138.94 58.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.562 ' HG2' ' HA ' ' A' ' 64' ' ' TYR . 14.5 mmmm -89.7 -72.91 0.54 Allowed 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -176.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.71 -88.06 0.06 OUTLIER Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 117.724 -2.179 . . . . 0.0 115.17 -175.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.72 138.71 25.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.67 0.747 . . . . 0.0 112.522 -173.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.668 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 39.8 m -152.75 157.36 40.73 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 105.021 -2.214 . . . . 0.0 105.021 173.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -102.31 -25.02 13.82 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.7 0.762 . . . . 0.0 109.884 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -99.66 23.0 10.11 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.217 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.668 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . 146.09 -162.9 28.39 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 -177.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.4 t -135.26 116.05 19.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 173.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -68.2 137.02 54.49 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.12 0.486 . . . . 0.0 110.98 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.704 ' CD1' HG11 ' A' ' 119' ' ' VAL . 23.9 p90 -143.02 173.02 11.92 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.461 ' CD2' ' HB2' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -124.57 122.06 36.5 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.823 -1.151 . . . . 0.0 108.815 173.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -78.83 131.02 36.32 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.74 -175.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -89.27 111.65 22.52 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.5 p -127.94 108.72 18.42 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-O 122.146 0.974 . . . . 0.0 108.458 175.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.8 p -101.16 133.94 44.94 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.658 -175.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 25.2 t -109.72 130.55 62.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.749 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -111.47 111.7 22.91 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 175.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.53 ' OD1' ' HB3' ' A' ' 45' ' ' PRO . 7.1 t30 -132.74 124.89 19.08 Favored Pre-proline 0 C--N 1.307 -1.249 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.656 -172.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -97.56 97.73 0.07 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.779 0 C-N-CA 122.078 1.852 . . . . 0.0 112.947 175.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.545 ' O ' ' HB2' ' A' ' 108' ' ' SER . 52.9 m-85 -157.84 -165.13 1.67 Allowed 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 126.425 1.89 . . . . 0.0 106.39 175.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.7 m -131.77 13.86 4.86 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-O 121.877 0.846 . . . . 0.0 109.425 175.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.438 ' O ' ' HA2' ' A' ' 107' ' ' GLY . 10.3 pt20 -118.55 134.96 54.69 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.258 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 105' ' ' LEU . 23.8 m -73.81 97.12 2.68 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.56 174.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.485 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 54.3 mt -85.19 120.95 73.91 Favored Pre-proline 0 C--O 1.244 0.813 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -84.1 158.46 13.37 Favored 'Trans proline' 0 N--CA 1.436 -1.893 0 C-N-CA 121.796 1.664 . . . . 0.0 110.022 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 29.7 pt -102.55 144.43 13.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.179 178.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 48.8 t -62.4 -55.58 26.46 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -177.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -154.31 145.74 23.08 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 171.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.435 ' CG2' ' HG3' ' A' ' 102' ' ' PRO . 14.2 tt -97.36 117.41 41.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.0 t -100.63 118.33 36.56 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -108.08 134.86 50.36 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.48 ' HB ' ' HB2' ' A' ' 142' ' ' ASP . 2.7 mp -117.45 107.31 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.028 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 178.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.452 ' CD2' ' HE2' ' A' ' 139' ' ' TYR . 2.0 tm? -101.92 121.34 41.94 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.428 -170.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 140' ' ' GLN . 0.6 OUTLIER -102.41 150.08 23.72 Favored 'General case' 0 CA--C 1.487 -1.458 0 O-C-N 122.007 -0.433 . . . . 0.0 110.427 179.209 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.435 ' OG ' ' HB3' ' A' ' 122' ' ' SER . 68.6 m -132.87 94.42 3.38 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 177.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 53.03 -77.43 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 170.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.2 m -70.23 -72.93 0.18 Allowed 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -171.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -153.63 -16.27 0.14 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.91 0.484 . . . . 0.0 109.858 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.463 HG21 ' OG ' ' A' ' 122' ' ' SER . 2.7 m -69.9 151.7 45.36 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.642 -171.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.464 HD13 HG21 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -145.11 149.42 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -174.158 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.461 ' N ' HD11 ' A' ' 94' ' ' ILE . . . -129.04 151.46 49.71 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 124.902 1.281 . . . . 0.0 108.07 175.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 35.0 p -136.67 166.48 23.46 Favored 'General case' 0 C--N 1.29 -2.006 0 O-C-N 122.232 -0.293 . . . . 0.0 111.107 -175.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 174.08 136.25 2.19 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.43 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.0 p -113.15 112.69 24.23 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.429 HD12 HG21 ' A' ' 115' ' ' VAL . 63.0 mt -99.27 109.75 55.71 Favored Pre-proline 0 C--N 1.32 -0.699 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.057 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.29 116.72 4.81 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 123.221 2.614 . . . . 0.0 111.613 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.7 t70 51.05 87.36 0.13 Allowed Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 124.929 1.291 . . . . 0.0 112.505 -177.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.435 ' HG3' ' CG2' ' A' ' 83' ' ' ILE . 11.8 Cg_endo -99.54 9.2 0.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.922 2.414 . . . . 0.0 110.766 175.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 147.32 -163.09 28.71 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -177.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.5 m -151.27 160.63 43.7 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 78' ' ' ILE . 3.8 pp -83.96 147.38 27.5 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 36.0 m -57.39 -45.52 85.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -175.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 76' ' ' GLN . . . 140.52 -55.37 0.63 Allowed Glycine 0 N--CA 1.418 -2.548 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -176.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.545 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 37.1 t -136.75 118.49 15.05 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.9 -162.6 12.31 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.933 174.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.5 t -89.26 138.83 31.09 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-O 121.729 0.776 . . . . 0.0 109.662 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.1 t -138.87 117.93 12.55 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.8 t -87.25 115.83 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.188 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.516 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.4 mt -100.87 149.9 23.39 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.422 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 7.7 p-10 -140.83 116.34 10.14 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.033 0.921 . . . . 0.0 112.467 -177.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.429 HG21 HD12 ' A' ' 99' ' ' ILE . 4.2 p -95.32 130.55 31.98 Favored Pre-proline 0 C--N 1.307 -1.24 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.479 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -72.41 112.58 3.49 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 121.833 1.689 . . . . 0.0 109.735 173.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.633 ' HB ' ' CE1' ' A' ' 64' ' ' TYR . 2.3 t -130.81 153.92 39.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 -175.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -116.46 133.33 56.14 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.704 HG11 ' CD1' ' A' ' 64' ' ' TYR . 15.7 m -92.86 148.81 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.764 0 C-N-CA 123.993 0.917 . . . . 0.0 108.84 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 76.27 -10.08 1.36 Allowed 'General case' 0 N--CA 1.481 1.121 0 O-C-N 124.136 0.898 . . . . 0.0 110.639 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.482 ' H ' ' C ' ' A' ' 119' ' ' VAL . 69.0 t80 -56.2 -52.31 64.86 Favored 'General case' 0 CA--C 1.484 -1.561 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.823 -178.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.463 ' OG ' HG21 ' A' ' 93' ' ' THR . 35.4 t -72.42 -43.2 64.19 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.475 -174.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 12.9 tt -71.77 -49.51 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 C-N-CA 119.192 -1.003 . . . . 0.0 112.891 -176.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.82 -32.51 71.89 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -176.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.0 p -71.92 -30.41 36.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.532 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.4 t -106.95 -43.87 4.55 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 119.358 -0.937 . . . . 0.0 112.24 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.9 tp -123.96 -52.95 1.76 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -175.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 25.1 ttt 76.03 138.08 0.06 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.103 1.361 . . . . 0.0 111.093 -176.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -61.45 -73.08 0.1 Allowed 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.4 t70 169.98 -13.26 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 O-C-N 124.218 0.949 . . . . 0.0 109.808 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.527 ' HA ' ' CE ' ' A' ' 131' ' ' MET . 0.0 OUTLIER 66.3 88.82 0.1 Allowed 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.99 0.9 . . . . 0.0 112.705 -169.435 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 47.2 t -105.86 155.69 19.08 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.5 -1.227 . . . . 0.0 107.718 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 20.9 p -96.57 100.57 12.14 Favored 'General case' 0 N--CA 1.402 -2.866 0 CA-C-O 121.089 0.471 . . . . 0.0 110.611 177.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 31.4 t70 74.95 99.96 0.07 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.18 0.992 . . . . 0.0 111.383 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -159.48 158.93 32.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.669 -1.151 . . . . 0.0 108.076 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -107.38 147.17 30.7 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.305 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 29.6 mm -128.68 130.59 68.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.923 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -102.04 101.53 11.91 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 172.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.462 ' HD1' ' O ' ' A' ' 163' ' ' GLY . 0.6 OUTLIER -104.66 170.4 7.9 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 179.723 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 88' ' ' LYS . 2.3 mp0 -120.42 147.23 45.36 Favored 'General case' 0 C--N 1.273 -2.726 0 C-N-CA 118.466 -1.294 . . . . 0.0 111.899 -177.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.4 tp -130.47 117.51 19.75 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-O 121.892 0.853 . . . . 0.0 110.368 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.48 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 3.9 m-20 -122.55 123.56 41.51 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 45.7 mt -122.14 131.1 73.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 119.004 -1.078 . . . . 0.0 111.028 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -106.18 86.95 0.5 Allowed Glycine 1 N--CA 1.394 -4.115 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 174.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.512 HD12 ' H ' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -85.81 141.4 29.67 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 176.292 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.1 t -128.63 122.01 29.92 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.409 -0.916 . . . . 0.0 111.457 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.43 ' CE2' HD23 ' A' ' 145' ' ' LEU . 77.7 m-85 -103.75 138.74 39.95 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -92.44 108.5 20.01 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 172.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.421 HG22 ' H ' ' A' ' 151' ' ' VAL . 51.2 mm -100.83 125.26 39.17 Favored Pre-proline 0 C--N 1.282 -2.359 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -178.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.11 -3.98 6.94 Favored 'Trans proline' 0 N--CA 1.481 0.788 0 C-N-CA 123.396 2.73 . . . . 0.0 113.46 -176.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.421 ' H ' HG22 ' A' ' 149' ' ' ILE . 59.9 t -76.0 -51.28 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.2 p -176.12 83.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 177.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 103.4 155.22 24.44 Favored Glycine 0 N--CA 1.413 -2.859 0 C-N-CA 120.589 -0.815 . . . . 0.0 114.27 165.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -97.52 114.19 26.03 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 170.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.51 HD13 ' H ' ' A' ' 155' ' ' ILE . 0.2 OUTLIER -121.44 150.84 24.61 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.888 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.672 -179.48 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 10.5 t -97.5 151.19 20.26 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 176.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 59.9 mt -113.97 110.73 48.57 Favored Pre-proline 0 N--CA 1.434 -1.226 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 176.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.475 ' HG2' ' CG ' ' A' ' 32' ' ' LYS . 26.3 Cg_exo -68.46 105.33 1.24 Allowed 'Trans proline' 0 C--O 1.241 0.671 0 C-N-CA 123.064 2.509 . . . . 0.0 112.836 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.455 HG12 ' H ' ' A' ' 49' ' ' VAL . 21.8 t -105.3 116.01 48.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 175.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 47.7 p -127.82 118.99 24.72 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -174.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.6 t -156.9 172.2 19.07 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -100.33 151.72 21.17 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.446 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.462 ' O ' ' HD1' ' A' ' 139' ' ' TYR . . . -111.74 101.83 1.33 Allowed Glycine 0 N--CA 1.406 -3.362 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 175.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -95.28 120.51 35.63 Favored 'General case' 0 C--N 1.266 -3.031 0 CA-C-O 121.888 0.851 . . . . 0.0 109.755 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 6.6 pt -130.49 133.56 63.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.869 -172.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -99.6 128.63 45.71 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 134' ' ' ASP . 91.4 mt -114.19 117.76 43.02 Favored Pre-proline 0 C--N 1.297 -1.694 0 C-N-CA 120.454 -0.499 . . . . 0.0 111.191 -174.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -84.96 108.98 1.22 Allowed 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 122.567 2.178 . . . . 0.0 111.802 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 133' ' ' THR 0.27 79.2 p 52.31 -81.38 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 179.142 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 85.4 mt 69.51 -62.05 0.42 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.728 1.211 . . . . 0.0 111.686 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 76.8 mtm180 65.28 -3.15 0.67 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 173.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -142.94 1.33 1.27 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.35 0.595 . . . . 0.0 110.07 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 . . . . . 0 CA--C 1.551 0.999 0 N-CA-C 115.929 1.825 . . . . 0.0 115.929 -165.345 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 . . . . . 0 CA--C 1.511 -0.547 0 CA-C-O 120.336 0.113 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -59.34 -48.8 80.26 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.4 ' HD2' ' C ' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -60.77 -40.17 91.56 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.598 176.696 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.458 HG13 ' HE2' ' A' ' 20' ' ' LYS . 40.7 t -64.65 -40.87 90.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.665 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.508 HG11 ' O ' ' A' ' 94' ' ' ILE . 54.6 t -59.13 -33.26 49.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.102 0.477 . . . . 0.0 110.004 175.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.06 -45.78 55.45 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -57.51 -52.47 65.26 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.733 176.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.458 ' HE2' HG13 ' A' ' 16' ' ' VAL . 68.1 mttm -58.12 -48.91 78.77 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.819 -178.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.11 -45.13 83.68 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 123.463 0.477 . . . . 0.0 111.395 -176.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 62.9 m -62.33 -49.51 75.32 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.015 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.8 t -61.57 -38.07 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.204 0.526 . . . . 0.0 110.296 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.495 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 86.0 mt -69.95 -46.86 72.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.172 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.1 t -59.68 -36.61 76.82 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.699 0.4 . . . . 0.0 110.676 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.1 t -62.84 -38.24 89.98 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.684 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.557 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 5.1 tt -76.72 -42.1 42.62 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 87.7 mt -57.05 -36.55 70.64 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.288 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -56.77 -41.44 77.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.814 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.557 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -83.29 -33.33 25.98 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.624 -178.227 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.21 -50.7 11.42 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -175.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -60.26 -47.04 87.67 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 122.514 0.326 . . . . 0.0 111.077 -175.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.644 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -59.63 -56.01 27.31 Favored Glycine 0 N--CA 1.444 -0.813 0 O-C-N 123.683 0.614 . . . . 0.0 111.996 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -58.4 -39.76 80.55 Favored 'General case' 0 C--O 1.255 1.348 0 C-N-CA 123.268 0.627 . . . . 0.0 110.923 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.486 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 89.1 t80 -67.76 -53.34 27.98 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.4 178.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.15 -29.69 68.82 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -174.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.644 ' HG2' ' O ' ' A' ' 33' ' ' GLY . 10.7 pt-20 -90.37 -42.39 10.96 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -177.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -107.4 -48.3 3.47 Favored 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 118.812 -1.155 . . . . 0.0 112.534 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 2.9 mm? -75.71 -12.67 60.24 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -169.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.56 -23.14 64.46 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 120.971 0.415 . . . . 0.0 110.095 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -115.22 17.48 16.62 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.222 0.534 . . . . 0.0 110.19 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.403 ' HB ' ' HA ' ' A' ' 39' ' ' LEU . 72.7 mt -127.98 134.6 26.4 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -40.82 103.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.317 0 C-N-CA 123.903 3.068 . . . . 0.0 114.591 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.0 p -146.5 155.08 49.43 Favored Pre-proline 0 C--N 1.31 -1.151 0 C-N-CA 124.802 1.241 . . . . 0.0 108.409 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.9 124.89 14.3 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.125 1.884 . . . . 0.0 111.468 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -97.03 111.55 23.72 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.37 143.18 33.9 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.86 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.48 ' HA ' HG22 ' A' ' 159' ' ' VAL . 10.4 t -143.18 140.59 30.83 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.418 HG21 HG21 ' A' ' 159' ' ' VAL . 45.3 t -83.63 141.26 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.829 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -108.23 -62.11 1.5 Allowed 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.844 -1.142 . . . . 0.0 114.023 -168.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.439 ' HB3' ' HD2' ' A' ' 67' ' ' LYS . 24.5 t70 -166.79 166.16 15.87 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.562 -169.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.638 HG13 ' CD2' ' A' ' 64' ' ' TYR . 97.4 t -118.55 119.54 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 124.248 1.019 . . . . 0.0 111.462 -176.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -121.95 106.4 11.2 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -82.06 134.02 35.32 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -176.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.406 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -137.08 78.84 1.72 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -175.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 122.64 -149.62 16.92 Favored Glycine 0 C--N 1.268 -3.212 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.217 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.4 p -143.54 154.88 16.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.0 m -135.35 164.1 28.51 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -58.31 -41.41 84.42 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.08 0.466 . . . . 0.0 110.6 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -133.23 105.0 6.75 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.76 -161.1 21.87 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.284 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 69.9 t -150.78 121.91 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -177.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.428 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 20.3 t70 -68.4 129.65 40.55 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.638 ' CD2' HG13 ' A' ' 52' ' ' VAL . 43.7 p90 -131.65 169.64 15.87 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -90.69 109.5 20.67 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 174.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.81 112.23 19.44 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 175.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.439 ' HD2' ' HB3' ' A' ' 51' ' ' ASP . 93.7 mttt -86.74 120.58 28.18 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.172 -176.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.0 t -127.04 109.1 19.89 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.673 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.6 p -99.55 123.66 44.03 Favored 'General case' 0 C--N 1.283 -2.314 0 C-N-CA 120.394 -0.523 . . . . 0.0 111.017 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.2 t -117.88 125.43 74.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.826 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.408 ' HG2' ' OG1' ' A' ' 110' ' ' THR . 51.7 mtpt -95.07 110.25 22.2 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.498 HD21 HD13 ' A' ' 105' ' ' LEU . 47.4 t-20 -108.39 113.79 59.92 Favored Pre-proline 0 C--N 1.302 -1.48 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.241 -176.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -111.55 97.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.152 0 C-N-CA 123.017 2.478 . . . . 0.0 110.408 166.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -168.94 -19.96 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.7 t 70.99 24.57 3.95 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.333 1.053 . . . . 0.0 109.651 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.501 ' HG3' ' CG1' ' A' ' 78' ' ' ILE . 9.5 tp60 -121.68 110.67 16.25 Favored 'General case' 0 N--CA 1.396 -3.173 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.987 -178.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.3 m -75.09 87.4 2.39 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.501 ' CG1' ' HG3' ' A' ' 76' ' ' GLN . 82.3 mt -72.77 122.02 86.51 Favored Pre-proline 0 C--N 1.294 -1.839 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.775 -170.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -70.86 109.95 2.65 Favored 'Trans proline' 0 N--CA 1.431 -2.187 0 N-CA-C 106.721 -2.069 . . . . 0.0 106.721 168.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.3 mt -62.95 119.49 7.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -173.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 41.8 t -56.64 -53.21 60.35 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -167.94 147.76 4.89 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.428 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 12.4 tt -110.85 113.93 45.65 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 175.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.5 t -92.65 148.17 22.28 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -140.57 139.42 34.97 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 176.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.528 ' HA ' ' O ' ' A' ' 95' ' ' ALA . 11.8 tt -143.56 110.55 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 174.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.427 HD13 ' O ' ' A' ' 87' ' ' LEU . 3.4 pp -110.9 141.04 44.85 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.586 -178.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.406 ' HA ' HG23 ' A' ' 94' ' ' ILE . 97.3 mttt -103.62 153.08 21.01 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.837 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 55.8 m -135.29 132.18 37.43 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.682 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.78 86.87 2.79 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 121.951 0.881 . . . . 0.0 112.018 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.8 m -161.58 -53.61 0.05 OUTLIER 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 163.86 -52.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 125.268 1.605 . . . . 0.0 110.479 177.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.2 m -70.81 142.11 51.32 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.948 -177.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.508 ' O ' HG11 ' A' ' 17' ' ' VAL . 2.5 pp -125.04 177.25 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.036 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 86' ' ' ILE . . . -131.95 134.03 45.18 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 118.296 0.498 . . . . 0.0 109.778 177.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.4 p -135.09 158.47 44.28 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 176.22 168.42 36.38 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.574 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.5 p -135.02 116.58 14.79 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 122.717 0.407 . . . . 0.0 109.959 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 60.6 mt -98.57 108.78 50.0 Favored Pre-proline 0 C--N 1.323 -0.572 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.166 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.65 121.99 7.48 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.607 2.204 . . . . 0.0 111.692 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.4 t70 56.12 83.4 0.22 Allowed Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 124.008 0.923 . . . . 0.0 112.249 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -101.48 8.28 0.53 Allowed 'Trans proline' 0 CA--C 1.548 1.212 0 C-N-CA 123.073 2.515 . . . . 0.0 113.075 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 165.14 -124.33 1.24 Allowed Glycine 0 N--CA 1.441 -1.033 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.7 m -151.84 146.67 25.85 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 176.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.523 ' HG ' ' CE1' ' A' ' 147' ' ' PHE . 1.0 OUTLIER -104.44 98.13 7.95 Favored 'General case' 0 N--CA 1.423 -1.791 0 C-N-CA 117.859 -1.536 . . . . 0.0 109.119 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.477 ' HB ' ' HB ' ' A' ' 111' ' ' THR 0.255 14.8 p 10.55 -72.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 128.811 2.844 . . . . 0.0 117.501 178.308 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 76' ' ' GLN . . . 125.37 -51.12 0.84 Allowed Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -174.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.5 p -154.09 94.89 1.78 Allowed 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.334 0.587 . . . . 0.0 111.862 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 143.98 -175.17 24.0 Favored Glycine 0 CA--C 1.497 -1.081 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.883 176.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.408 ' OG1' ' HG2' ' A' ' 71' ' ' LYS . 56.3 m -95.35 116.93 29.45 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.477 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 9.6 t -113.78 137.12 52.08 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 25.5 t -99.4 115.08 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.3 mt -89.82 148.27 23.3 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.395 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -114.23 121.0 42.38 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.769 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.3 p -128.18 125.55 23.42 Favored Pre-proline 0 C--N 1.302 -1.462 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.34 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.29 111.72 3.24 Favored 'Trans proline' 0 C--O 1.246 0.909 0 C-N-CA 123.117 2.545 . . . . 0.0 112.589 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.429 HG21 ' CE1' ' A' ' 64' ' ' TYR . 26.3 m -143.36 151.44 16.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 3.3 mppt? -95.9 135.72 37.27 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.616 ' HB ' ' CE1' ' A' ' 64' ' ' TYR . 13.2 p -94.9 145.78 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 66.44 13.33 9.2 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 123.548 0.739 . . . . 0.0 110.332 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.496 ' O ' HG21 ' A' ' 125' ' ' VAL . 84.4 t80 -56.77 -50.38 72.48 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 124.786 1.235 . . . . 0.0 108.961 176.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.8 m -62.1 -40.74 96.89 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.856 -176.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 14.0 tt -79.06 -34.01 16.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.352 -177.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -60.85 -35.95 77.89 Favored 'General case' 0 C--N 1.358 0.937 0 CA-C-O 120.893 0.377 . . . . 0.0 110.031 174.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.496 HG21 ' O ' ' A' ' 121' ' ' TYR . 43.2 t -56.54 -37.79 53.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.42 175.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.2 m -95.52 -77.24 0.48 Allowed 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.505 HD13 ' H ' ' A' ' 129' ' ' LYS . 3.9 pp -119.03 -12.11 9.56 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -172.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.5 ' O ' ' HG2' ' A' ' 128' ' ' MET . 25.0 ttt 60.93 41.17 14.59 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.931 0.892 . . . . 0.0 113.399 173.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.505 ' H ' HD13 ' A' ' 127' ' ' LEU . 15.0 mtmt 60.1 -83.12 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.128 0.571 . . . . 0.0 111.28 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 164.21 -23.13 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 126.806 2.043 . . . . 0.0 106.469 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.48 ' SD ' ' HB2' ' A' ' 170' ' ' LEU . 0.3 OUTLIER 59.16 100.38 0.02 OUTLIER 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.253 -176.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 49.0 t -132.17 170.09 15.49 Favored 'General case' 0 CA--C 1.556 1.209 0 O-C-N 121.609 -0.682 . . . . 0.0 112.503 -175.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 21.6 p -67.79 133.0 48.47 Favored 'General case' 0 N--CA 1.42 -1.949 0 C-N-CA 125.125 1.37 . . . . 0.0 109.886 170.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.6 t70 42.17 72.37 0.17 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.457 1.103 . . . . 0.0 110.206 -171.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.448 ' CZ2' ' HB3' ' A' ' 129' ' ' LYS . 33.1 t-105 -101.29 115.23 30.02 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.816 -173.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -107.39 126.26 52.25 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.114 -174.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.444 ' N ' HD13 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -139.86 168.21 18.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-O 121.545 0.688 . . . . 0.0 112.083 -179.673 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -142.0 133.07 26.08 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.382 177.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.34 172.76 11.8 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 178.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -129.69 124.18 32.96 Favored 'General case' 0 C--N 1.287 -2.112 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.143 -175.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.2 tp -107.06 129.73 54.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.295 -174.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.465 ' OD1' ' HB3' ' A' ' 160' ' ' SER . 10.7 m-20 -122.79 137.41 54.93 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 158' ' ' PRO . 42.1 mm -124.09 145.96 30.36 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -122.39 97.67 0.6 Allowed Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 177.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.496 ' HB3' ' CE2' ' A' ' 147' ' ' PHE . 2.9 mm? -81.68 110.26 16.86 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 -178.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 28.7 m -96.35 108.17 20.64 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.613 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.523 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 53.6 m-85 -120.7 144.79 48.03 Favored 'General case' 0 CA--C 1.494 -1.208 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -116.37 116.09 27.08 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.499 -0.88 . . . . 0.0 109.327 176.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.498 HD11 ' H ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -106.02 130.43 23.0 Favored Pre-proline 0 C--N 1.298 -1.645 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.618 -177.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -42.75 -32.89 2.69 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 125.03 3.82 . . . . 0.0 115.572 -176.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.4 m -60.21 -34.37 56.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 60.0 t -135.78 -68.06 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.026 0.441 . . . . 0.0 109.976 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 163.06 -146.14 11.38 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.15 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -83.7 120.26 25.79 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.554 0.692 . . . . 0.0 112.571 -176.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.496 HD11 ' O ' ' A' ' 155' ' ' ILE . 2.5 pp -127.12 124.05 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.817 173.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.498 ' O ' ' HD3' ' A' ' 158' ' ' PRO . 56.9 m -88.12 117.38 26.96 Favored 'General case' 0 N--CA 1.424 -1.775 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.823 176.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 60.5 mt -95.81 104.77 17.57 Favored Pre-proline 0 C--N 1.303 -1.42 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.875 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.548 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.0 OUTLIER -85.39 138.85 6.62 Favored 'Trans proline' 0 CA--C 1.485 -1.971 0 C-N-CA 122.66 2.24 . . . . 0.0 111.762 176.883 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.48 HG22 ' HA ' ' A' ' 48' ' ' THR . 2.6 p -138.05 132.9 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.556 0 CA-C-N 112.953 -1.93 . . . . 0.0 109.661 -173.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.465 ' HB3' ' OD1' ' A' ' 142' ' ' ASP . 58.1 p -120.59 161.93 20.5 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.491 -176.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.3 t -166.09 165.41 17.8 Favored 'General case' 0 C--O 1.252 1.216 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -98.48 126.71 44.13 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -108.69 82.64 0.31 Allowed Glycine 0 N--CA 1.419 -2.476 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.43 120.37 30.7 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.433 ' CD1' HG22 ' A' ' 119' ' ' VAL . 5.7 pt -145.14 121.22 3.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.119 -170.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -104.18 139.75 38.78 Favored 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 117.887 -1.525 . . . . 0.0 109.511 174.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.4 HD11 HD12 ' A' ' 137' ' ' ILE . 6.8 mp -108.8 103.39 51.6 Favored Pre-proline 0 N--CA 1.405 -2.678 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.631 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.26 92.76 0.82 Allowed 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 123.165 2.576 . . . . 0.0 114.893 -172.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 5.0 m 50.37 89.33 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 125.399 1.48 . . . . 0.0 114.086 171.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.48 ' HB2' ' SD ' ' A' ' 131' ' ' MET . 99.1 mt -108.69 -39.83 5.25 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.048 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.44 ' HA ' ' HG3' ' A' ' 131' ' ' MET . 36.4 mmt180 54.88 18.82 2.35 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 177.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -178.7 -29.73 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -176.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 C--N 1.315 -0.915 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -172.872 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.471 ' O ' HG22 ' A' ' 17' ' ' VAL . 1.9 p30 . . . . . 0 CA--C 1.533 0.325 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.16 -42.42 99.41 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 123.504 0.722 . . . . 0.0 110.821 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -65.71 -46.25 79.68 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.9 m -71.79 -23.07 21.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.299 -176.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 13' ' ' ASP . 77.4 t -61.72 -47.22 94.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 172.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -59.53 -37.19 77.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.762 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -60.51 -56.78 17.29 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.36 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -65.97 -39.2 90.16 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.893 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.57 -37.31 80.88 Favored 'General case' 0 C--O 1.221 -0.439 0 O-C-N 123.286 0.366 . . . . 0.0 110.805 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.0 t -63.39 -50.34 70.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.865 0.364 . . . . 0.0 110.451 178.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.05 -45.11 99.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.391 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.481 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 83.7 mt -66.18 -43.23 92.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.171 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.2 t -62.02 -35.57 78.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.796 0.332 . . . . 0.0 110.463 177.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.8 t -63.45 -41.28 98.64 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.97 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.539 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 3.9 tt -71.09 -41.68 70.3 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 96.3 mt -59.24 -39.68 83.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.092 0.473 . . . . 0.0 110.366 177.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -62.54 -41.9 99.18 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 27' ' ' LEU . 61.4 pttt -63.52 -34.38 77.66 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 119.921 -0.711 . . . . 0.0 109.523 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.66 -31.66 52.75 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.692 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.542 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 39.7 ttmt -51.12 -40.08 57.68 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.059 0.944 . . . . 0.0 112.884 -175.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.46 -8.86 54.32 Favored Glycine 0 C--N 1.313 -0.698 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.614 178.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 19.3 t80 -81.45 -25.9 35.72 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 124.435 1.094 . . . . 0.0 108.418 -175.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.542 ' CE2' ' HA ' ' A' ' 32' ' ' LYS . 22.5 m-85 -56.96 -36.57 70.44 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.627 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.64 -50.05 55.34 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.766 0.666 . . . . 0.0 112.396 -173.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -98.88 -43.71 6.63 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.277 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.548 ' N ' ' HD3' ' A' ' 38' ' ' LYS 0.295 2.7 mppt? -75.19 -3.92 35.8 Favored 'General case' 0 C--O 1.206 -1.22 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 -171.042 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.3 mt -117.38 1.0 12.33 Favored 'General case' 0 C--N 1.284 -2.251 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.808 173.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.44 -55.74 2.42 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.09 0.471 . . . . 0.0 110.521 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -86.14 -4.5 59.18 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.496 -177.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.7 mm -119.06 126.85 26.83 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.03 104.21 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.448 2.099 . . . . 0.0 110.415 176.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.428 HG21 ' CD1' ' A' ' 149' ' ' ILE . 5.8 p -128.26 154.37 78.93 Favored Pre-proline 0 C--N 1.302 -1.493 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.464 -174.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.444 ' HB3' ' OD1' ' A' ' 72' ' ' ASN . 65.6 Cg_endo -84.73 154.94 11.75 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.888 2.392 . . . . 0.0 112.02 178.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -121.04 136.93 54.87 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.39 167.6 13.1 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.98 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.4 t -155.49 145.21 21.31 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 123.506 0.503 . . . . 0.0 110.518 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.4 t -83.99 141.9 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 173.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -122.2 -54.18 1.91 Allowed 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -172.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -162.03 162.59 28.87 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -172.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.3 m -122.98 108.15 20.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 121.438 0.637 . . . . 0.0 110.024 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -90.9 121.08 32.44 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.601 -177.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.513 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 53.3 p90 -69.3 120.21 14.77 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.536 177.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -83.36 -49.4 9.39 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.423 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 178.95 -147.36 7.72 Favored Glycine 0 N--CA 1.41 -3.046 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.428 HG21 ' O ' ' A' ' 173' ' ' PHE . 7.5 p -111.67 138.42 40.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-O 121.02 0.438 . . . . 0.0 110.487 -174.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 24.5 m -127.15 145.13 50.86 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 175.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -104.61 78.36 1.45 Allowed 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 118.661 -1.216 . . . . 0.0 108.327 178.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -175.32 -70.33 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 -175.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.421 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . -138.2 -138.53 3.72 Favored Glycine 0 N--CA 1.411 -3.024 0 N-CA-C 104.298 -3.521 . . . . 0.0 104.298 167.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.04 134.28 41.52 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-N 118.675 1.238 . . . . 0.0 110.288 174.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -93.43 107.27 19.14 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.063 -175.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.513 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 4.5 m-85 -100.45 161.09 13.83 Favored 'General case' 0 CA--C 1.486 -1.511 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.005 176.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.407 ' CD2' ' HB3' ' A' ' 114' ' ' ASP . 3.3 t-160 -114.75 107.73 15.83 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 178.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -92.86 140.78 29.15 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.0 0.428 . . . . 0.0 112.022 -176.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -89.64 121.33 31.72 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.77 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.88 111.28 29.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.5 m -98.85 139.25 34.81 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 120.319 -0.553 . . . . 0.0 109.94 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.2 t -131.45 131.61 62.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -114.59 132.32 56.38 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 175.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.843 ' O ' ' HA ' ' A' ' 108' ' ' SER . 5.8 t30 -142.73 114.75 6.07 Favored Pre-proline 0 C--N 1.294 -1.835 0 C-N-CA 119.743 -0.783 . . . . 0.0 112.949 -175.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -94.36 99.62 0.12 Allowed 'Trans proline' 0 N--CA 1.436 -1.865 0 C-N-CA 122.365 2.043 . . . . 0.0 109.487 170.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.495 ' HB3' HD22 ' A' ' 72' ' ' ASN . 48.8 t80 -170.32 -14.82 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -176.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.1 t 83.14 -56.24 0.16 Allowed 'General case' 0 C--O 1.233 0.232 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 172.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.536 HE21 HG12 ' A' ' 78' ' ' ILE . 6.6 pt20 -69.46 152.89 44.33 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-N 118.719 0.691 . . . . 0.0 112.744 -176.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.6 p -77.14 111.82 13.15 Favored 'General case' 0 N--CA 1.411 -2.375 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.279 174.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.536 HG12 HE21 ' A' ' 76' ' ' GLN . 70.0 mt -93.27 114.9 64.09 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -65.07 139.16 59.88 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.374 2.05 . . . . 0.0 110.241 175.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 54.5 mt -88.2 114.83 27.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 58.3 m -55.76 -56.14 24.05 Favored 'General case' 0 C--N 1.319 -0.742 0 O-C-N 123.811 0.695 . . . . 0.0 109.521 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -167.81 160.72 12.7 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.113 176.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.406 ' CG2' HG23 ' A' ' 143' ' ' ILE . 25.0 mt -120.14 113.75 41.6 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.959 176.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.8 p -88.29 117.22 27.05 Favored 'General case' 0 N--CA 1.405 -2.72 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -111.45 143.05 42.92 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.414 HG22 ' HB3' ' A' ' 142' ' ' ASP . 9.9 tt -137.13 108.74 6.38 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 CA-C-O 121.727 0.775 . . . . 0.0 109.15 176.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.439 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -106.84 145.91 31.57 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.506 -179.443 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.402 ' HA ' HG22 ' A' ' 94' ' ' ILE . 40.1 ttmt -118.43 152.58 35.61 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.831 -175.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.7 t -126.96 97.86 5.12 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 175.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.427 ' HA ' ' OD2' ' A' ' 138' ' ' ASP . . . 53.51 -94.96 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.98 1.312 . . . . 0.0 111.357 -175.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 85.5 m -166.34 85.13 0.3 Allowed 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 124.669 1.187 . . . . 0.0 108.513 175.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -160.06 -62.9 0.07 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 49.6 m -136.73 151.94 49.79 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.439 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 37.2 pt -134.72 -176.34 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.393 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.433 ' HB2' HD13 ' A' ' 87' ' ' LEU . . . -145.54 146.2 31.32 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 172.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.0 t -148.38 144.52 27.55 Favored 'General case' 0 N--CA 1.412 -2.357 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -166.73 166.38 39.0 Favored Glycine 0 N--CA 1.426 -2.025 0 C-N-CA 120.648 -0.786 . . . . 0.0 111.296 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.5 p -110.18 119.89 40.72 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.2 tt -103.3 104.55 41.65 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.912 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.79 128.06 12.93 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.058 2.505 . . . . 0.0 111.97 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.3 t70 52.08 79.48 0.34 Allowed Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 124.633 1.173 . . . . 0.0 111.997 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -101.47 8.82 0.52 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.788 2.325 . . . . 0.0 111.487 176.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 149.58 -168.39 29.8 Favored Glycine 0 N--CA 1.422 -2.236 0 N-CA-C 108.221 -1.952 . . . . 0.0 108.221 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.5 m -145.51 149.89 35.46 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 118.3 1.05 . . . . 0.0 111.956 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.74 118.38 22.23 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 177.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 29.2 m -66.11 -35.96 76.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -174.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 140.31 -137.45 8.35 Favored Glycine 0 N--CA 1.416 -2.676 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.843 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 65.4 m -77.68 101.44 6.62 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.474 0.655 . . . . 0.0 111.555 178.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 164.99 -172.29 40.62 Favored Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.4 t -114.43 114.34 25.71 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.776 0.798 . . . . 0.0 109.684 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.6 t -110.26 132.94 53.73 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.157 -177.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 20.5 m -99.63 106.54 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-O 121.791 0.805 . . . . 0.0 110.031 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 66.4 mt -95.46 164.58 12.75 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.84 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 4.9 m-20 -133.99 135.62 43.56 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.143 -178.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.65 132.23 24.1 Favored Pre-proline 0 C--N 1.305 -1.353 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -73.46 110.63 3.1 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 N-CA-C 107.122 -1.915 . . . . 0.0 107.122 168.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.7 t -113.28 140.17 34.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.627 -172.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.545 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -88.1 98.95 11.82 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.2 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.414 ' C ' ' H ' ' A' ' 121' ' ' TYR . 10.3 m -102.58 147.49 9.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 71.78 -22.88 0.19 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.887 0.875 . . . . 0.0 113.212 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.414 ' H ' ' C ' ' A' ' 119' ' ' VAL . 52.6 t80 -55.7 -36.5 67.23 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.002 0.521 . . . . 0.0 110.963 177.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.9 p -59.12 -46.3 88.67 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.647 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 14.2 tt -79.08 -32.56 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.282 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -57.38 -43.31 83.49 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.704 0.802 . . . . 0.0 112.643 -178.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.3 m -72.09 -22.33 21.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.3 m -93.51 -73.03 0.58 Allowed 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -177.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -124.52 -12.96 7.17 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -176.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.452 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER 73.63 140.61 0.06 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.507 1.123 . . . . 0.0 109.826 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.576 ' C ' ' H ' ' A' ' 131' ' ' MET . 46.6 pttt -59.42 -19.88 50.67 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.138 0.575 . . . . 0.0 111.43 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 23.8 t70 82.23 -22.73 0.24 Allowed 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 125.226 1.41 . . . . 0.0 109.577 177.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.609 ' HE3' ' O ' ' A' ' 170' ' ' LEU . 15.4 tpt 51.08 97.24 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 112.678 -2.055 . . . . 0.0 115.388 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 64.4 m -92.94 140.41 29.52 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 171.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.8 p -71.19 100.71 2.13 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-O 121.482 0.658 . . . . 0.0 110.606 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.571 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 14.0 t70 86.37 88.55 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.627 0 C-N-CA 126.852 2.061 . . . . 0.0 110.312 -174.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -158.5 158.88 34.9 Favored 'General case' 0 N--CA 1.412 -2.33 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 176.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -117.7 134.6 54.73 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.475 ' CG2' ' HB ' ' A' ' 165' ' ' ILE . 9.8 tt -97.4 133.22 39.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 C-N-CA 120.594 -0.442 . . . . 0.0 109.856 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.427 ' OD2' ' HA ' ' A' ' 90' ' ' ALA . 38.9 t70 -70.39 90.44 0.71 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.532 178.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -108.77 152.81 24.35 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.526 177.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -137.86 146.64 43.65 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 41.2 tp -128.74 126.52 40.19 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 123.461 0.475 . . . . 0.0 110.391 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.48 ' OD2' ' HB3' ' A' ' 160' ' ' SER . 14.1 t70 -127.32 125.82 41.48 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.406 HG23 ' CG2' ' A' ' 83' ' ' ILE . 42.6 mm -111.83 118.76 58.41 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 CA-C-O 120.953 0.406 . . . . 0.0 109.98 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -95.95 86.85 0.95 Allowed Glycine 0 N--CA 1.42 -2.422 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 173.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 156' ' ' THR . 0.0 OUTLIER -74.73 134.26 41.91 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.438 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.8 m -110.74 108.32 18.15 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.477 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 154' ' ' ASP . 80.0 m-85 -114.66 129.7 56.71 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 175.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -94.49 109.69 21.55 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.428 ' CD1' HG21 ' A' ' 44' ' ' THR . 64.6 mt -98.15 129.38 30.94 Favored Pre-proline 0 C--N 1.291 -1.974 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.7 -176.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -52.26 -34.84 61.44 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 123.854 3.036 . . . . 0.0 112.944 -178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.43 -51.07 76.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.374 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 39.0 t -119.9 -69.28 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.418 -175.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 163.37 -141.14 6.93 Favored Glycine 0 N--CA 1.431 -1.644 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.524 ' HA ' ' O ' ' A' ' 147' ' ' PHE . 4.2 p30 -94.25 131.17 40.12 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 117.331 0.566 . . . . 0.0 111.914 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.27 115.7 33.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 176.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 24.8 p -86.16 115.92 24.03 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.098 175.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 54.4 mt -97.11 106.93 34.79 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -74.27 107.24 2.39 Favored 'Trans proline' 0 C--O 1.251 1.162 0 C-N-CA 121.929 1.753 . . . . 0.0 111.106 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 142' ' ' ASP . 30.6 m -110.48 126.95 67.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.841 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.48 ' HB3' ' OD2' ' A' ' 142' ' ' ASP . 48.3 p -129.38 162.7 27.43 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.143 0.497 . . . . 0.0 112.209 -176.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.9 t -159.51 -177.83 6.69 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 177.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -97.81 119.19 35.97 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -103.56 97.27 1.43 Allowed Glycine 0 N--CA 1.415 -2.746 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -178.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -88.95 119.47 29.5 Favored 'General case' 0 C--N 1.265 -3.103 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 -176.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.475 ' HB ' ' CG2' ' A' ' 137' ' ' ILE . 38.4 mm -101.77 107.14 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.418 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 176.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -113.29 126.72 55.71 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.215 0.531 . . . . 0.0 110.161 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 134' ' ' ASP . 67.1 mt -121.93 95.09 47.89 Favored Pre-proline 0 C--N 1.289 -2.046 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.851 -172.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.4 92.14 0.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.882 2.388 . . . . 0.0 112.978 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 78.0 p 53.34 27.42 6.22 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.435 1.494 . . . . 0.0 113.267 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.609 ' O ' ' HE3' ' A' ' 131' ' ' MET . 22.7 tp -75.45 83.39 2.53 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -83.13 105.39 14.07 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.639 -173.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.1 t70 75.0 91.84 0.08 Allowed 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 124.694 1.198 . . . . 0.0 110.023 177.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.503 ' CD1' HD23 ' A' ' 170' ' ' LEU . 37.4 t80 . . . . . 0 C--N 1.303 -1.439 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 -175.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.9 t70 . . . . . 0 CA--C 1.543 0.698 0 CA-C-O 121.057 0.456 . . . . 0.0 111.328 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.68 ' O ' HG13 ' A' ' 17' ' ' VAL . 41.1 tt0 -73.52 -32.35 64.2 Favored 'General case' 0 C--O 1.209 -1.059 0 CA-C-O 121.852 0.834 . . . . 0.0 108.923 177.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -71.14 -33.55 70.18 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.626 0.727 . . . . 0.0 109.916 174.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.8 t -69.77 -29.28 40.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.993 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.68 HG13 ' O ' ' A' ' 14' ' ' GLU . 9.1 p -66.03 -25.53 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 120.001 -0.679 . . . . 0.0 109.208 177.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -72.08 -45.72 59.61 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.51 -38.22 89.05 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.684 175.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.46 ' O ' HG13 ' A' ' 24' ' ' ILE . 58.5 tptt -55.72 -48.86 74.44 Favored 'General case' 0 N--CA 1.425 -1.705 0 C-N-CA 123.257 0.623 . . . . 0.0 109.415 174.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.1 -35.75 82.13 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.734 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -62.53 -45.2 94.07 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.153 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.3 m -70.75 -32.32 48.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.84 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 20' ' ' LYS . 85.3 mt -65.18 -46.01 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 173.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.1 m -65.21 -35.36 80.83 Favored 'General case' 0 C--O 1.186 -2.243 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.689 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -59.57 -44.79 93.2 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-O 121.069 0.462 . . . . 0.0 109.999 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.53 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 5.2 tt -74.41 -44.03 53.76 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.14 -31.55 72.72 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-O 120.927 0.394 . . . . 0.0 110.78 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -66.77 -45.73 77.58 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 123.172 0.589 . . . . 0.0 111.17 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -71.05 -30.55 66.75 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.84 -44.22 70.34 Favored 'General case' 0 C--O 1.198 -1.627 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.788 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -60.61 -48.68 80.69 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -177.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.22 -30.96 79.27 Favored Glycine 0 C--O 1.239 0.411 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.413 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -75.98 -43.34 45.02 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 177.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.452 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 65.7 t80 -58.82 -53.81 54.14 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.768 1.227 . . . . 0.0 113.789 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.79 -19.18 49.02 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -174.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.407 ' HB2' ' HD3' ' A' ' 38' ' ' LYS . 31.2 mt-10 -116.39 -54.98 2.43 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.633 ' O ' HG12 ' A' ' 42' ' ' ILE . 3.2 mppt? -87.62 -27.44 22.5 Favored 'General case' 0 CA--C 1.466 -2.286 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.134 -170.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 86.6 mt -87.07 9.15 20.65 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 118.731 -1.188 . . . . 0.0 111.671 -176.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.07 -25.9 31.61 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.263 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -113.23 10.58 18.56 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.03 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.633 HG12 ' O ' ' A' ' 38' ' ' LYS . 47.5 mm -114.9 115.83 43.23 Favored Pre-proline 0 C--O 1.244 0.769 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -57.56 110.52 0.63 Allowed 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 122.728 2.285 . . . . 0.0 111.027 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.7 p -139.3 158.5 68.86 Favored Pre-proline 0 C--N 1.308 -1.202 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.333 -177.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -70.04 128.21 15.45 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.33 2.02 . . . . 0.0 109.92 174.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -100.99 130.72 47.02 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.456 ' CB ' ' HG ' ' A' ' 145' ' ' LEU . . . -121.59 153.2 38.38 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.1 t -147.15 143.69 28.44 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.392 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.557 ' H ' HG13 ' A' ' 159' ' ' VAL . 14.9 p -119.79 142.28 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -165.07 -18.85 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.656 -171.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.461 ' HB3' ' CG ' ' A' ' 67' ' ' LYS . 19.1 t70 -120.1 128.1 53.15 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.877 -176.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 67.9 t -110.94 120.31 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.802 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 178.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -112.14 125.5 54.19 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 123.327 0.651 . . . . 0.0 111.912 -175.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -70.25 141.09 52.49 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 124.151 0.98 . . . . 0.0 113.148 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 59.1 mtpt -122.13 -79.04 0.6 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.295 176.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.6 -147.87 6.54 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 119.63 -1.271 . . . . 0.0 113.323 -176.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.1 p -98.42 149.79 5.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.155 0.502 . . . . 0.0 111.477 -173.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.1 t -152.71 -174.53 4.95 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -67.04 -63.84 0.98 Allowed 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 120.931 0.396 . . . . 0.0 110.372 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -92.15 95.68 9.89 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.943 -172.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.17 -131.18 10.7 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.353 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.431 HG21 ' O ' ' A' ' 173' ' ' PHE . 6.8 t -127.02 135.03 64.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -178.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.587 ' O ' ' HB2' ' A' ' 55' ' ' LYS . 13.8 t70 -90.01 120.08 30.91 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 2.5 m-85 -122.4 172.77 8.09 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.934 0.873 . . . . 0.0 113.128 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.469 ' HB2' ' HD2' ' A' ' 55' ' ' LYS . 8.4 t-160 -126.0 108.84 11.78 Favored 'General case' 0 N--CA 1.421 -1.875 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.602 -177.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.34 143.43 26.76 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.461 ' CG ' ' HB3' ' A' ' 51' ' ' ASP . 44.8 mmtm -92.02 114.65 27.24 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 176.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 64.7 t -111.86 108.67 26.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.2 m -104.02 129.05 51.61 Favored 'General case' 0 C--N 1.284 -2.242 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.217 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 t -116.32 128.84 73.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.846 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 59.0 pttt -120.61 121.91 39.37 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.606 0.717 . . . . 0.0 109.317 178.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.708 ' O ' ' HA ' ' A' ' 108' ' ' SER . 24.3 p-10 -129.94 115.64 17.85 Favored Pre-proline 0 C--N 1.277 -2.572 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.595 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -93.41 97.77 0.15 Allowed 'Trans proline' 0 N--CA 1.425 -2.533 0 N-CA-C 107.166 -1.898 . . . . 0.0 107.166 165.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.413 ' CD2' HD12 ' A' ' 78' ' ' ILE . 25.9 t80 -157.39 -5.72 0.09 Allowed 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.684 -174.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.2 m 73.34 -2.38 2.76 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 174.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.482 HE21 HG12 ' A' ' 78' ' ' ILE . 9.3 pt20 -132.85 147.12 52.3 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.301 -0.875 . . . . 0.0 112.33 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.9 m -83.68 107.37 16.08 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.482 HG12 HE21 ' A' ' 76' ' ' GLN . 45.9 mt -94.39 122.39 61.33 Favored Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -177.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -66.74 113.33 2.71 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.075 1.85 . . . . 0.0 109.623 174.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 10.4 tt -72.0 134.98 28.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 54.9 m -61.1 -58.85 6.65 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.504 0.669 . . . . 0.0 109.733 -177.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -163.6 150.05 11.87 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.435 -177.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.9 mt -101.67 114.15 40.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 171.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.4 m -102.68 117.4 34.57 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.414 ' CD1' HG23 ' A' ' 117' ' ' VAL . 54.8 p90 -106.35 136.73 45.58 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.409 -178.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 54.6 mt -123.34 108.8 21.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 176.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.594 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 0.5 OUTLIER -91.86 121.19 33.24 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -174.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 140' ' ' GLN . 1.0 OUTLIER -94.27 116.29 28.66 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.284 0.564 . . . . 0.0 109.632 172.734 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.484 ' CB ' ' HB3' ' A' ' 122' ' ' SER . 22.7 t -100.16 94.07 6.04 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -176.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 61.37 -80.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.262 1.025 . . . . 0.0 110.662 -174.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.5 m -158.8 -36.17 0.06 Allowed 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -87.03 104.51 16.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.964 -177.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.46 ' HB ' ' OG ' ' A' ' 122' ' ' SER . 29.7 m 70.83 164.61 0.28 Allowed 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.289 1.036 . . . . 0.0 112.01 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.594 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 2.1 pp -144.09 170.68 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.749 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -173.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -121.96 154.88 36.61 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 172.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 t -159.87 168.05 26.69 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.172 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.59 151.57 8.76 Favored Glycine 0 N--CA 1.427 -1.941 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.534 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 20.3 p -109.06 116.84 32.73 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 54.6 mt -98.66 101.61 12.38 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 98' ' ' THR . 3.1 Cg_exo -78.28 123.24 5.99 Favored 'Trans proline' 0 C--O 1.241 0.661 0 C-N-CA 123.035 2.49 . . . . 0.0 111.21 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.3 t70 54.43 79.51 0.34 Allowed Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 124.83 1.252 . . . . 0.0 111.007 -174.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -104.74 25.06 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.676 2.918 . . . . 0.0 110.685 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.41 -172.9 18.09 Favored Glycine 0 N--CA 1.409 -3.122 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 -175.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 64.7 m -151.47 170.09 20.47 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 176.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.562 HD22 ' ND2' ' A' ' 72' ' ' ASN 0.312 0.0 OUTLIER -98.88 158.15 15.83 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 179.863 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 22.9 m -72.2 -176.65 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 124.328 1.017 . . . . 0.0 110.989 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.42 -47.88 54.84 Favored Glycine 0 C--N 1.307 -1.068 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.24 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.708 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 21.3 t -160.07 94.01 1.09 Allowed 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 176.64 -168.83 41.05 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.318 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.5 m -113.04 114.06 26.33 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.539 HG22 ' HA ' ' A' ' 105' ' ' LEU . 10.2 t -113.34 138.41 50.09 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 26.4 t -96.89 118.04 42.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 121.013 0.435 . . . . 0.0 109.884 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.0 mt -98.25 159.56 14.86 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.967 -178.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -104.76 130.09 52.89 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.337 -175.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.2 t -125.72 114.36 24.84 Favored Pre-proline 0 CA--C 1.5 -0.978 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.431 172.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 2.7 Cg_exo -77.77 110.16 2.88 Favored 'Trans proline' 0 N--CA 1.423 -2.635 0 N-CA-C 107.528 -1.758 . . . . 0.0 107.528 168.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.414 HG23 ' CD1' ' A' ' 85' ' ' TYR . 12.3 p -115.81 137.52 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -94.78 99.88 11.88 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.4 m -94.32 149.3 4.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -168.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.453 ' HB1' ' HZ2' ' A' ' 129' ' ' LYS . . . 76.8 -12.8 1.0 Allowed 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 124.724 1.209 . . . . 0.0 113.334 172.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -48.2 -50.38 29.47 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 124.223 0.952 . . . . 0.0 112.987 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.484 ' HB3' ' CB ' ' A' ' 89' ' ' SER . 34.6 t -66.65 -43.49 84.48 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.438 -0.905 . . . . 0.0 112.382 -169.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.434 HG21 ' HG ' ' A' ' 89' ' ' SER . 24.3 pt -79.02 -27.73 13.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.444 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -58.48 -41.14 84.59 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 174.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.6 t -56.98 -39.43 65.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.694 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 36.4 t -89.88 -84.94 0.22 Allowed 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.468 HD21 ' H ' ' A' ' 127' ' ' LEU . 1.9 pt? -106.84 -17.79 14.11 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 120.854 0.359 . . . . 0.0 111.963 -175.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.536 ' C ' ' HD3' ' A' ' 129' ' ' LYS . 23.8 ttt 58.22 39.24 25.99 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.02 0.928 . . . . 0.0 111.031 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.578 ' HG3' ' NE1' ' A' ' 135' ' ' TRP 0.306 0.0 OUTLIER 48.98 -73.1 0.0 OUTLIER 'General case' 0 C--N 1.363 1.156 0 C-N-CA 125.125 1.37 . . . . 0.0 114.169 -177.244 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -178.57 -32.15 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.605 ' SD ' ' HA ' ' A' ' 171' ' ' ARG . 0.7 OUTLIER 62.66 81.93 0.19 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.374 -178.127 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 29.0 m -108.98 172.31 6.92 Favored 'General case' 0 C--O 1.251 1.173 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.696 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 30.5 p -81.81 108.12 15.09 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 169.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 76.36 98.04 0.07 Allowed 'General case' 0 CA--C 1.496 -1.118 0 O-C-N 124.167 0.917 . . . . 0.0 109.836 -175.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.578 ' NE1' ' HG3' ' A' ' 129' ' ' LYS . 69.9 t-105 -140.02 119.83 13.42 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.362 -174.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 166' ' ' LYS . 22.7 t70 -91.01 111.82 23.45 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 174.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.405 HD12 HG21 ' A' ' 137' ' ' ILE . 8.2 tt -97.42 149.27 5.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.238 -170.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -86.47 103.07 14.66 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.398 177.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.424 ' HD1' ' O ' ' A' ' 163' ' ' GLY . 7.0 t80 -137.66 150.24 47.21 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.494 ' HB2' ' HB2' ' A' ' 88' ' ' LYS . 48.9 mt-30 -139.74 158.82 43.47 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.9 tp -141.67 130.49 22.96 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.45 0.643 . . . . 0.0 112.232 -175.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 2.3 m-20 -125.92 129.51 49.45 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 54.3 mt -130.36 131.86 65.17 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.486 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.392 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -105.42 109.95 3.35 Favored Glycine 0 N--CA 1.405 -3.391 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 156' ' ' THR . 2.6 mm? -89.13 110.18 20.95 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 32.1 m -95.5 108.97 21.24 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.572 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -114.47 152.66 31.27 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -120.25 114.35 21.76 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 175.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 49.6 mm -110.94 116.28 52.02 Favored Pre-proline 0 C--N 1.287 -2.116 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -45.82 -33.0 9.86 Favored 'Trans proline' 0 N--CA 1.485 1.009 0 C-N-CA 123.892 3.061 . . . . 0.0 113.891 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 44.6 t -69.81 -23.66 25.97 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 123.198 0.599 . . . . 0.0 112.166 -177.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 9.1 p -136.86 -33.29 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -175.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 122.01 -151.11 16.95 Favored Glycine 0 N--CA 1.434 -1.498 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.185 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -87.52 117.9 26.62 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.429 0.633 . . . . 0.0 110.647 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.4 123.36 49.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.33 0.586 . . . . 0.0 110.711 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 40.9 m -99.19 127.12 45.12 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.551 177.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.1 mp -89.68 122.1 68.45 Favored Pre-proline 0 C--N 1.318 -0.804 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -83.4 113.59 2.04 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.818 2.345 . . . . 0.0 112.362 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.557 HG13 ' H ' ' A' ' 49' ' ' VAL . 21.9 t -111.89 119.12 59.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 173.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 67.9 p -128.41 127.15 42.02 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 123.13 0.269 . . . . 0.0 111.073 -175.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.1 t -158.64 177.36 11.29 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -98.66 148.75 23.51 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.424 ' O ' ' HD1' ' A' ' 139' ' ' TYR . . . -118.62 83.32 0.35 Allowed Glycine 0 N--CA 1.416 -2.669 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -88.82 119.92 29.75 Favored 'General case' 0 C--N 1.273 -2.729 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 4.9 pt -133.66 123.11 45.01 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-O 121.304 0.573 . . . . 0.0 111.915 -175.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.524 ' HD3' ' H ' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -89.69 109.81 20.76 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.925 178.249 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -90.5 107.44 20.15 Favored Pre-proline 0 C--N 1.288 -2.101 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.077 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -86.35 94.13 0.55 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 122.654 2.236 . . . . 0.0 112.996 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 78.2 p 50.83 105.24 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.351 1.46 . . . . 0.0 114.854 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -128.78 -70.82 0.66 Allowed 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.605 ' HA ' ' SD ' ' A' ' 131' ' ' MET . 81.0 mtp180 59.08 79.29 0.23 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 114.231 1.196 . . . . 0.0 114.231 177.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 32.5 t70 172.8 -77.71 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 123.978 0.799 . . . . 0.0 111.332 173.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.431 ' O ' HG21 ' A' ' 62' ' ' VAL . 52.6 p90 . . . . . 0 C--N 1.315 -0.899 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -174.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.5 t70 . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 121.124 0.488 . . . . 0.0 110.389 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -64.88 -46.11 83.17 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.682 176.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -54.29 -49.52 69.41 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 123.977 0.911 . . . . 0.0 111.679 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.3 m -77.96 -27.3 14.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.8 -31.42 36.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 119.534 -0.867 . . . . 0.0 109.756 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -60.59 -42.18 96.21 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -59.13 -52.49 65.48 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.657 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -62.61 -44.58 95.93 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.55 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.83 -40.57 93.32 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.453 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.5 t -60.78 -44.89 96.21 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 123.439 0.462 . . . . 0.0 110.374 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.7 t -60.45 -46.0 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.213 0.53 . . . . 0.0 110.172 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.1 mm -64.95 -47.91 86.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.085 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.1 m -62.88 -29.67 70.94 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.048 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.2 t -65.19 -31.42 72.59 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 120.997 0.427 . . . . 0.0 110.207 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.2 tt -73.92 -42.1 61.1 Favored 'General case' 0 C--O 1.246 0.916 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.49 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 8.6 mp -58.89 -35.08 72.42 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.153 175.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -51.02 -49.27 60.82 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.408 ' HD2' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -75.56 -27.95 58.81 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.391 -178.316 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.408 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -77.36 -34.31 55.09 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.179 -176.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 99.5 mttt -59.14 -37.42 77.22 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 121.08 0.467 . . . . 0.0 109.779 177.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.99 -44.06 97.95 Favored Glycine 0 N--CA 1.431 -1.661 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.758 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -80.47 -39.27 28.38 Favored 'General case' 0 C--O 1.198 -1.648 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.685 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -58.57 -31.7 68.23 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.4 -37.38 83.02 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.754 0.311 . . . . 0.0 111.799 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -116.9 -48.32 2.66 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -175.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -69.56 -48.55 59.9 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 122.364 1.078 . . . . 0.0 109.195 -169.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.443 HD21 HG21 ' A' ' 44' ' ' THR . 39.4 mt -88.51 0.87 55.85 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.187 -171.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.17 -20.03 18.23 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.712 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -110.4 -24.9 10.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.945 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 72.1 mt -93.54 142.03 24.64 Favored Pre-proline 0 N--CA 1.431 -1.395 0 N-CA-C 106.789 -1.559 . . . . 0.0 106.789 177.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -67.24 105.25 0.99 Allowed 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 121.888 1.725 . . . . 0.0 108.376 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.443 HG21 HD21 ' A' ' 39' ' ' LEU . 4.2 m -125.11 141.46 38.6 Favored Pre-proline 0 N--CA 1.415 -2.185 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -173.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 16.8 Cg_endo -57.38 113.06 1.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.903 1.735 . . . . 0.0 111.079 176.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -96.84 121.98 39.3 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.185 0.517 . . . . 0.0 110.396 -174.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.412 ' HB2' HD23 ' A' ' 145' ' ' LEU . . . -98.71 157.88 15.98 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.076 -179.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -148.72 129.1 13.84 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.924 176.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.0 p -113.69 137.16 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 175.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -151.04 -35.67 0.14 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.735 -168.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -116.61 147.59 41.74 Favored 'General case' 0 CA--C 1.463 -2.373 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.49 -173.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.511 HG23 ' CB ' ' A' ' 64' ' ' TYR . 8.2 p -150.85 103.05 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.404 -2.765 0 CA-C-O 122.58 1.181 . . . . 0.0 107.885 175.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -96.51 129.56 43.86 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.095 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 44.3 p90 -59.62 122.19 13.48 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.261 0.553 . . . . 0.0 111.026 175.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -85.43 -56.05 3.71 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.138 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.48 -137.63 2.59 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -178.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.1 p -112.65 141.85 26.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.6 m -114.53 166.1 12.06 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -55.84 -54.83 39.77 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -99.25 -62.84 1.18 Allowed 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.635 -177.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -108.64 -130.07 6.08 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 175.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.555 HG21 ' CZ ' ' A' ' 173' ' ' PHE . 7.1 p -140.16 137.38 37.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.269 0.557 . . . . 0.0 111.271 177.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -104.04 122.97 46.36 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.789 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.511 ' CB ' HG23 ' A' ' 52' ' ' VAL . 3.7 m-30 -109.09 167.33 10.18 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.27 0.557 . . . . 0.0 110.665 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -106.29 106.79 17.47 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.08 144.87 26.69 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.604 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.518 ' HZ3' ' HB2' ' A' ' 67' ' ' LYS . 4.5 ttmp? -107.83 125.12 51.06 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.042 178.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.2 t -126.89 107.78 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 176.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.5 m -98.57 139.7 33.91 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 110' ' ' THR . 22.8 t -124.56 127.13 72.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.486 -178.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -110.85 117.7 34.13 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.542 ' HB3' ' O ' ' A' ' 107' ' ' GLY . 37.0 t30 -118.99 127.13 26.69 Favored Pre-proline 0 CA--C 1.507 -0.676 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.088 -173.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -94.01 96.02 0.13 Allowed 'Trans proline' 0 N--CA 1.428 -2.326 0 C-N-CA 121.42 1.414 . . . . 0.0 110.074 169.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.434 ' HB2' HD22 ' A' ' 72' ' ' ASN . 42.7 m-85 175.81 162.27 0.32 Allowed 'General case' 0 CA--C 1.492 -1.273 0 C-N-CA 129.173 2.989 . . . . 0.0 104.21 -178.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 51.7 p -100.85 -16.43 17.26 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.605 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -79.77 149.92 30.94 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 121.573 0.701 . . . . 0.0 112.048 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.8 p -80.38 104.97 11.29 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.433 172.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 52.9 mt -91.05 117.61 68.01 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -85.34 152.46 10.62 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.945 1.763 . . . . 0.0 112.531 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.533 ' H ' HD12 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -88.29 143.7 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.598 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 51.0 t -78.47 -35.52 46.49 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -170.23 157.22 6.17 Favored 'General case' 0 C--O 1.252 1.223 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.5 mt -118.33 115.62 48.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 171.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 20.8 p -112.81 118.57 35.31 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.316 -176.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 96' ' ' SER . 37.9 p90 -104.15 143.2 33.25 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 58.2 mt -132.76 108.08 12.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 173.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.466 ' O ' HD12 ' A' ' 87' ' ' LEU . 4.2 pp -105.55 134.44 48.67 Favored 'General case' 0 C--N 1.282 -2.369 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.359 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.442 ' HA ' HG21 ' A' ' 94' ' ' ILE . 40.3 ttmt -110.93 123.98 51.21 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.06 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.456 ' OG ' ' HB2' ' A' ' 122' ' ' SER . 53.2 p -104.26 98.63 8.4 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 64.5 -79.94 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.264 1.426 . . . . 0.0 114.819 174.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.8 t -135.11 -29.65 1.1 Allowed 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -172.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -143.91 145.63 32.41 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.582 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 m 71.19 130.41 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.197 0 O-C-N 125.28 1.612 . . . . 0.0 110.836 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.522 HD13 ' C ' ' A' ' 94' ' ' ILE . 1.8 pp -127.4 165.35 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.11 122.02 36.72 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 61.3 p -120.81 147.19 45.7 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -163.37 144.98 10.01 Favored Glycine 0 N--CA 1.432 -1.626 0 C-N-CA 119.844 -1.17 . . . . 0.0 112.248 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.8 p -107.97 115.63 30.48 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.5 tt -101.81 114.45 65.58 Favored Pre-proline 0 C--N 1.307 -1.25 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.764 177.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -85.71 129.49 3.56 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 122.617 2.211 . . . . 0.0 111.457 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.9 t70 50.45 79.38 0.35 Allowed Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 124.608 1.163 . . . . 0.0 113.21 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -99.71 2.45 0.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.126 2.55 . . . . 0.0 112.09 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 151.94 -166.62 30.97 Favored Glycine 0 N--CA 1.42 -2.382 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.3 p -137.76 155.7 48.77 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.255 0.55 . . . . 0.0 110.763 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.496 ' HA ' HG21 ' A' ' 111' ' ' THR . 6.3 tt -90.64 125.36 35.63 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 33.7 m -65.36 -30.7 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -172.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.542 ' O ' ' HB3' ' A' ' 72' ' ' ASN . . . 135.26 -113.24 1.09 Allowed Glycine 0 N--CA 1.417 -2.598 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -176.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.8 p -91.85 97.85 11.24 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 124.25 1.02 . . . . 0.0 111.136 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 140.53 -164.07 26.37 Favored Glycine 0 N--CA 1.418 -2.555 0 C-N-CA 119.947 -1.12 . . . . 0.0 111.485 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 11.0 t -95.7 139.94 31.23 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-O 121.919 0.866 . . . . 0.0 111.104 -178.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.496 HG21 ' HA ' ' A' ' 105' ' ' LEU . 4.9 t -134.78 121.0 20.09 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 176.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.7 t -87.74 110.45 20.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.582 -177.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.3 mt -97.48 162.29 13.38 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -141.54 144.02 34.07 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.479 -0.489 . . . . 0.0 111.46 -175.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 51.7 t -135.01 136.41 24.92 Favored Pre-proline 0 C--O 1.241 0.606 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.557 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -79.5 111.34 2.81 Favored 'Trans proline' 0 N--CA 1.432 -2.135 0 N-CA-C 107.586 -1.736 . . . . 0.0 107.586 168.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 24.6 m -112.67 133.88 57.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -89.01 92.0 9.06 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.783 0.802 . . . . 0.0 110.183 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.528 ' C ' ' H ' ' A' ' 121' ' ' TYR . 3.2 m -95.24 149.73 4.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.383 -172.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 74.36 -20.15 0.33 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.54 0.736 . . . . 0.0 111.87 175.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.528 ' H ' ' C ' ' A' ' 119' ' ' VAL . 21.4 t80 -46.11 -45.29 16.29 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 126.461 1.904 . . . . 0.0 109.782 176.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.456 ' HB2' ' OG ' ' A' ' 89' ' ' SER . 18.0 m -68.21 -52.42 34.44 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-N 115.275 -0.875 . . . . 0.0 113.039 -174.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 12.6 tt -74.61 -36.08 39.86 Favored 'Isoleucine or valine' 0 C--O 1.251 1.178 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -174.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.38 -50.66 72.71 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 122.269 0.227 . . . . 0.0 111.294 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.2 m -72.7 -22.67 20.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.9 t -77.27 -69.86 0.5 Allowed 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.808 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -124.1 -23.72 4.51 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -177.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.473 ' O ' ' HD2' ' A' ' 129' ' ' LYS . 0.0 OUTLIER 66.3 -176.55 0.19 Allowed 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -177.223 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.473 ' HD2' ' O ' ' A' ' 128' ' ' MET . 12.2 mmmm -133.31 -71.25 0.52 Allowed 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 178.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.8 t70 152.85 80.93 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 128.978 2.911 . . . . 0.0 104.419 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -91.31 115.47 28.06 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.509 -178.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 169' ' ' SER . 83.1 m -131.09 -81.04 0.53 Allowed 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -178.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 41.5 p -142.01 116.86 9.86 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 123.287 0.635 . . . . 0.0 109.915 -169.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.6 t70 59.97 82.07 0.16 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 122.08 0.943 . . . . 0.0 109.419 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -140.86 158.96 43.22 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.5 -172.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -147.72 154.89 41.14 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 118.683 0.674 . . . . 0.0 110.864 175.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.5 tt -148.63 149.68 14.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.139 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -114.14 134.17 55.08 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -125.49 170.76 11.09 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 178.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -119.17 137.41 53.63 Favored 'General case' 0 C--N 1.273 -2.741 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.297 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 28.5 tp -119.57 128.23 53.71 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.975 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.611 ' OD1' ' HB3' ' A' ' 160' ' ' SER . 17.1 t70 -130.71 112.2 12.87 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 35.4 mt -113.31 122.57 67.7 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.31 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.962 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -106.68 101.95 1.81 Allowed Glycine 0 N--CA 1.398 -3.892 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 156' ' ' THR . 0.8 OUTLIER -91.77 143.07 26.91 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.87 174.289 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.8 m -114.4 111.34 21.29 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.316 -175.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.491 ' CE1' HG23 ' A' ' 80' ' ' ILE . 90.1 m-85 -106.71 163.43 12.92 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 172.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -146.64 131.44 18.01 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.357 177.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.26 135.71 15.28 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 176.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -48.92 -18.34 1.64 Allowed 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 124.393 3.395 . . . . 0.0 114.927 -178.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 55.7 t -57.23 -39.07 65.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 121.133 0.492 . . . . 0.0 110.332 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 5.8 p -136.69 -36.15 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.238 0.542 . . . . 0.0 111.238 -178.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 120.53 -142.52 15.89 Favored Glycine 0 N--CA 1.419 -2.499 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -178.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -92.04 126.45 37.13 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.164 0.507 . . . . 0.0 110.01 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.405 ' N ' HD13 ' A' ' 155' ' ' ILE . 0.2 OUTLIER -139.85 133.56 36.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.37 176.849 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 11.4 t -100.5 147.98 25.29 Favored 'General case' 0 N--CA 1.412 -2.345 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 173.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 60.0 mt -110.48 109.35 58.25 Favored Pre-proline 0 C--N 1.291 -1.94 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.414 ' HB3' HD23 ' A' ' 28' ' ' LEU . 17.1 Cg_exo -70.82 102.64 1.22 Allowed 'Trans proline' 0 C--O 1.244 0.806 0 C-N-CA 122.693 2.262 . . . . 0.0 111.376 177.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 142' ' ' ASP . 14.2 t -103.83 108.77 25.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.611 ' HB3' ' OD1' ' A' ' 142' ' ' ASP . 52.1 p -109.04 150.89 27.11 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.817 -177.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.8 t -168.07 151.97 6.11 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -107.69 119.23 38.84 Favored 'General case' 0 N--CA 1.42 -1.934 0 C-N-CA 119.296 -0.962 . . . . 0.0 109.345 174.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -92.96 118.76 5.7 Favored Glycine 0 N--CA 1.409 -3.126 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.696 -174.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -89.68 119.59 30.23 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 176.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.3 pt -129.59 111.95 23.38 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 CA-C-O 121.521 0.677 . . . . 0.0 111.524 -174.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -78.85 130.11 35.31 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.604 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 87.7 mt -106.39 109.17 62.94 Favored Pre-proline 0 C--N 1.293 -1.859 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.006 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.8 172.05 17.03 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.185 1.924 . . . . 0.0 111.765 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 49.1 p -53.28 105.65 0.14 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 123.253 0.621 . . . . 0.0 111.495 175.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.402 HD22 ' O ' ' A' ' 169' ' ' SER . 79.7 mt -137.38 -50.31 0.62 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 62.75 113.93 0.02 OUTLIER 'General case' 0 C--N 1.355 0.843 0 O-C-N 124.213 0.945 . . . . 0.0 112.815 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 33.1 t70 87.23 8.95 0.18 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.762 1.225 . . . . 0.0 111.094 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.555 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 72.5 t80 . . . . . 0 CA--C 1.54 0.572 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.34 174.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.857 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -100.98 -15.67 17.41 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 117.305 0.553 . . . . 0.0 111.256 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 127' ' ' LEU . 44.6 m-70 -80.2 72.76 7.04 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.683 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -157.11 154.06 28.8 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 59.94 64.75 1.22 Allowed 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 124.239 1.016 . . . . 0.0 111.248 -178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -149.38 118.47 6.75 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 175.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . 0.256 21.1 p80 -132.57 89.56 2.66 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.7 tt -137.24 93.96 2.88 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 171.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 52.41 41.88 30.91 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.61 -1.632 . . . . 0.0 108.761 -173.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 74.4 -67.55 0.25 Allowed 'General case' 0 C--N 1.356 0.874 0 C-N-CA 126.124 1.77 . . . . 0.0 109.758 -173.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.5 m -158.89 122.38 3.82 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 176.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.57 -43.0 75.52 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.528 0.518 . . . . 0.0 112.122 -175.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.462 ' O ' HG22 ' A' ' 17' ' ' VAL . 7.8 m-20 -63.77 -49.96 70.92 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.928 0.394 . . . . 0.0 111.019 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.22 -40.66 86.53 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -177.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -70.28 -53.81 15.29 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.955 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.413 ' HA ' ' CG ' ' A' ' 19' ' ' GLU . 33.4 m -62.7 -27.96 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 94' ' ' ILE . 73.3 t -62.92 -41.23 91.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.024 175.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -66.93 -36.3 81.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.79 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.413 ' CG ' ' HA ' ' A' ' 16' ' ' VAL . 7.5 mm-40 -53.3 -54.0 42.8 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.36 0.664 . . . . 0.0 109.719 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -65.94 -47.86 73.29 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.258 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.69 -43.48 80.53 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.095 -176.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -57.19 -45.81 83.39 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 123.59 0.556 . . . . 0.0 111.045 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.01 -42.02 79.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.418 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 73.9 mt -58.22 -46.97 88.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.891 177.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.7 m -61.99 -30.87 71.24 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.868 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.6 m -67.69 -40.18 84.38 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.076 0.465 . . . . 0.0 110.575 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.635 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 6.5 tt -72.74 -33.62 66.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.071 0.462 . . . . 0.0 109.993 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 96.5 mt -65.86 -38.72 89.57 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.428 0.632 . . . . 0.0 109.485 175.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -66.31 -34.38 77.85 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.225 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.635 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -64.11 -33.55 76.02 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-O 121.533 0.682 . . . . 0.0 109.432 178.264 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.556 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -77.64 -32.47 53.36 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.933 -178.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -53.46 -52.91 57.98 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.21 -24.93 75.66 Favored Glycine 0 N--CA 1.468 0.806 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.667 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.6 ' CZ ' ' HD2' ' A' ' 38' ' ' LYS . 10.9 t80 -68.79 -40.1 79.78 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 124.165 0.986 . . . . 0.0 110.263 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.424 ' CD1' HD11 ' A' ' 39' ' ' LEU . 20.2 m-85 -62.27 -45.57 92.68 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.313 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.74 -48.72 63.54 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 124.505 1.128 . . . . 0.0 113.061 -174.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -104.61 -36.13 7.59 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 119.414 -0.914 . . . . 0.0 113.349 -176.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.6 ' HD2' ' CZ ' ' A' ' 34' ' ' PHE . 21.6 ttmm -87.01 -43.49 12.3 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.342 -173.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.424 HD11 ' CD1' ' A' ' 35' ' ' PHE . 22.7 mt -87.28 19.04 3.37 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.204 -0.998 . . . . 0.0 111.907 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.89 -18.24 13.98 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.427 ' N ' HD21 ' A' ' 41' ' ' ASN . 0.8 OUTLIER -107.46 -21.07 13.05 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.788 177.151 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.3 mm -111.59 107.21 56.8 Favored Pre-proline 0 N--CA 1.442 -0.845 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.449 ' HB2' ' OH ' ' A' ' 74' ' ' TYR . 24.8 Cg_exo -64.26 118.0 4.99 Favored 'Trans proline' 0 C--O 1.251 1.149 0 C-N-CA 122.643 2.229 . . . . 0.0 112.294 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.1 p -128.73 150.32 74.53 Favored Pre-proline 0 C--N 1.299 -1.629 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.213 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.48 149.23 91.61 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.988 2.459 . . . . 0.0 112.155 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -110.85 137.79 48.06 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.448 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.52 ' O ' HG13 ' A' ' 159' ' ' VAL . . . -115.65 165.33 13.15 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.331 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.4 t -161.89 147.39 13.28 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 110.518 -0.178 . . . . 0.0 110.518 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.509 ' HB ' ' OG1' ' A' ' 161' ' ' THR . 89.8 t -91.32 140.93 15.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 174.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -116.07 -60.94 1.8 Allowed 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -175.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -161.66 165.91 27.54 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -167.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.1 m -124.15 137.72 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -96.18 126.63 41.54 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.436 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -58.61 109.19 0.75 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 168.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.433 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -127.51 -53.29 1.36 Allowed 'General case' 0 N--CA 1.426 -1.668 0 C-N-CA 119.029 -1.068 . . . . 0.0 112.677 -172.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.91 -172.88 31.93 Favored Glycine 0 N--CA 1.425 -2.078 0 C-N-CA 119.184 -1.484 . . . . 0.0 112.309 -174.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.451 ' HB ' ' CD1' ' A' ' 173' ' ' PHE . 12.2 p -128.77 155.69 40.85 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-O 121.129 0.49 . . . . 0.0 110.927 -175.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 48.4 m -125.88 149.47 48.66 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 173.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.405 ' O ' ' HB2' ' A' ' 60' ' ' ASP . 37.3 mmt180 -79.0 77.2 5.47 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 118.621 -1.232 . . . . 0.0 112.22 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 59' ' ' ARG . 9.9 t70 171.74 -48.08 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.163 1.385 . . . . 0.0 107.668 176.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -150.19 177.95 27.97 Favored Glycine 0 C--O 1.223 -0.549 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 119' ' ' VAL . 6.5 m -87.83 156.09 3.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 118.743 1.272 . . . . 0.0 110.842 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -111.5 105.37 13.93 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.312 0.577 . . . . 0.0 109.75 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -110.64 159.76 17.29 Favored 'General case' 0 CA--C 1.48 -1.726 0 CA-C-O 122.084 0.945 . . . . 0.0 112.588 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -107.61 106.63 17.08 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.87 144.81 27.06 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -94.72 135.53 36.09 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.175 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.9 t -130.93 108.49 15.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 174.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.0 m -102.38 133.64 46.98 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.057 -175.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.3 t -123.32 133.33 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -119.93 128.22 53.4 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.499 HD22 ' HB2' ' A' ' 74' ' ' TYR . 6.0 t30 -142.89 114.92 5.99 Favored Pre-proline 0 C--N 1.284 -2.257 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.585 -175.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -94.17 96.17 0.13 Allowed 'Trans proline' 0 N--CA 1.422 -2.726 0 C-N-CA 121.835 1.69 . . . . 0.0 110.248 172.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.499 ' HB2' HD22 ' A' ' 72' ' ' ASN . 68.9 m-85 -176.33 127.55 0.2 Allowed 'General case' 0 CA--C 1.482 -1.671 0 C-N-CA 128.105 2.562 . . . . 0.0 104.788 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.4 m -84.32 68.83 10.35 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.442 0.639 . . . . 0.0 111.012 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -151.8 145.77 25.22 Favored 'General case' 0 N--CA 1.407 -2.612 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.82 176.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 44.6 p -86.76 101.56 13.44 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.776 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 28.1 mt -94.72 117.61 66.91 Favored Pre-proline 0 N--CA 1.441 -0.891 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -83.65 146.96 12.16 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 121.915 1.743 . . . . 0.0 110.59 176.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.1 mp -85.53 91.46 3.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.255 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.679 ' O ' ' HB ' ' A' ' 146' ' ' THR . 58.6 m -78.27 105.72 9.69 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.459 ' HB3' ' O ' ' A' ' 81' ' ' CYS . 24.7 tt0 76.3 109.66 0.07 Allowed 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.14 0.9 . . . . 0.0 111.754 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.603 ' CG2' ' HB ' ' A' ' 99' ' ' ILE . 15.5 tt -117.8 125.04 73.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.538 -0.726 . . . . 0.0 109.342 174.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.9 t -86.84 125.07 33.73 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-O 121.25 0.548 . . . . 0.0 109.86 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.528 ' OH ' ' HA ' ' A' ' 117' ' ' VAL . 56.5 t80 -107.69 120.38 42.06 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.26 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.5 mt -130.24 107.18 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 CA-C-O 122.063 0.935 . . . . 0.0 109.332 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.644 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 1.3 tm? -100.66 134.82 43.05 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 114.616 -1.174 . . . . 0.0 107.862 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.475 ' HB2' ' HB2' ' A' ' 140' ' ' GLN . 96.5 mttt -128.31 158.02 39.36 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -177.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.49 ' OG ' ' HB3' ' A' ' 122' ' ' SER . 57.5 m -143.91 97.67 3.1 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 52.71 -90.13 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 175.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.9 m -108.24 -53.99 2.56 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.097 0.475 . . . . 0.0 111.755 -171.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -126.06 154.84 42.45 Favored 'General case' 0 CA--C 1.472 -2.044 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 27.6 m 71.87 135.89 0.04 OUTLIER 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 113.363 -1.744 . . . . 0.0 112.895 175.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.644 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 38.4 pt -136.84 -179.2 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.382 0 CA-C-N 114.616 -1.175 . . . . 0.0 107.937 176.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.75 121.31 25.19 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 172.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 36.8 p -112.49 159.06 19.15 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.534 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.21 178.3 47.55 Favored Glycine 0 N--CA 1.424 -2.15 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.9 m -146.25 120.06 9.27 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.603 ' HB ' ' CG2' ' A' ' 83' ' ' ILE . 71.5 mt -98.6 126.11 40.31 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -177.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -80.49 114.86 3.07 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.914 1.742 . . . . 0.0 111.278 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.8 t70 53.23 87.6 0.14 Allowed Pre-proline 0 N--CA 1.485 1.292 0 C-N-CA 124.937 1.295 . . . . 0.0 112.753 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -91.15 -7.05 3.75 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.847 2.365 . . . . 0.0 112.188 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 160.93 -179.04 36.65 Favored Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.3 m -142.71 157.67 44.42 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.275 0.559 . . . . 0.0 111.038 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.434 HD21 ' CB ' ' A' ' 72' ' ' ASN . 7.5 mp -76.73 135.13 39.02 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.483 176.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 27.3 m -71.06 -17.5 20.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.11 113.1 1.51 Allowed Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 61.9 m 53.46 83.87 0.06 Allowed 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.916 0.886 . . . . 0.0 113.308 -177.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 155.71 -176.93 33.09 Favored Glycine 0 N--CA 1.432 -1.575 0 C-N-CA 119.956 -1.116 . . . . 0.0 112.391 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.7 t -105.38 135.71 46.26 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.5 t -139.44 130.37 26.29 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 120.865 0.364 . . . . 0.0 110.407 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.9 m -93.48 122.47 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-O 121.686 0.755 . . . . 0.0 110.024 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.9 mt -108.34 158.06 17.83 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -134.09 149.03 51.09 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 119.664 -0.815 . . . . 0.0 112.277 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.3 m -131.49 144.63 54.19 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.649 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -74.06 111.76 3.38 Favored 'Trans proline' 0 C--O 1.247 0.953 0 C-N-CA 122.12 1.88 . . . . 0.0 110.675 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.528 ' HA ' ' OH ' ' A' ' 85' ' ' TYR . 96.5 t -107.26 127.09 63.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-O 121.553 0.692 . . . . 0.0 112.814 -175.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.442 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 8.5 mmpt? -89.06 96.64 10.81 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.593 ' O ' HG22 ' A' ' 62' ' ' VAL . 99.7 t -93.52 138.94 19.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 72.19 -16.84 0.4 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.058 0.943 . . . . 0.0 111.416 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.536 ' H ' ' C ' ' A' ' 119' ' ' VAL . 53.1 t80 -51.49 -39.86 58.4 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 125.94 1.696 . . . . 0.0 110.1 176.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.49 ' HB3' ' OG ' ' A' ' 89' ' ' SER . 33.9 t -65.55 -51.79 57.26 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.557 -177.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.5 tt -67.25 -28.87 43.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.327 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.559 ' HB3' ' CE1' ' A' ' 174' ' ' PHE . . . -66.43 -50.65 62.66 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 177.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.77 -30.2 49.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.956 0.408 . . . . 0.0 110.928 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.0 t -70.69 -73.43 0.17 Allowed 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 3' ' ' HIS . 1.9 pt? -125.43 -41.33 2.04 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 24.1 ttt 64.15 100.03 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 124.299 1.04 . . . . 0.0 109.395 -172.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.543 ' HG3' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -48.89 -63.78 1.0 Allowed 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.732 -177.048 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.543 ' H ' ' HG3' ' A' ' 129' ' ' LYS . 21.4 t70 151.85 107.93 0.0 OUTLIER 'General case' 0 CA--C 1.471 -2.094 0 N-CA-C 102.649 -3.093 . . . . 0.0 102.649 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 13.1 tpt -53.07 123.58 12.05 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 123.519 0.512 . . . . 0.0 111.627 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 49.1 t -99.32 -158.74 0.69 Allowed 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.238 -176.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 21.8 p -131.01 114.11 14.79 Favored 'General case' 0 N--CA 1.385 -3.713 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.2 t70 70.43 89.9 0.1 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -172.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -133.58 115.74 15.05 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.522 -172.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.14 104.55 15.82 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.026 176.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.3 tt -102.2 138.2 27.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.55 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -82.49 100.14 9.9 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.753 0.787 . . . . 0.0 109.449 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.499 ' HH ' HG11 ' A' ' 117' ' ' VAL . 9.1 t80 -113.95 148.34 37.01 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.344 -176.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 88' ' ' LYS . 1.8 mp0 -136.08 154.01 51.15 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.5 tp -141.86 123.07 14.73 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 123.246 0.618 . . . . 0.0 109.58 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -126.33 128.0 46.42 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 43.9 mt -130.4 130.34 65.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 C-N-CA 120.209 -0.596 . . . . 0.0 112.336 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 157' ' ' ILE . . . -114.88 90.76 0.54 Allowed Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.433 HD12 ' CE2' ' A' ' 147' ' ' PHE . 2.9 pp -84.57 151.54 24.46 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.897 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.679 ' HB ' ' O ' ' A' ' 81' ' ' CYS . 8.6 m -109.09 120.69 43.29 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.8 -176.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.433 ' CE2' HD12 ' A' ' 145' ' ' LEU . 73.6 m-85 -100.4 141.26 33.5 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 170.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -110.39 133.36 53.34 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 174.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.76 139.45 29.05 Favored Pre-proline 0 C--N 1.301 -1.53 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.659 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -63.46 -17.02 58.12 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.856 2.371 . . . . 0.0 112.051 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.67 -45.52 98.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.998 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 40.4 t -130.15 -78.04 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.059 0.457 . . . . 0.0 109.904 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 173.81 -112.66 0.43 Allowed Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -101.24 125.97 47.92 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.935 0.397 . . . . 0.0 111.202 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 146' ' ' THR . 34.1 pt -121.28 114.92 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 CA-C-O 121.008 0.433 . . . . 0.0 110.522 173.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.532 HG21 ' OG1' ' A' ' 146' ' ' THR . 37.9 p -96.1 105.27 17.29 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.691 175.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.469 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 60.7 mt -91.5 107.1 19.4 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 156' ' ' THR . 8.0 Cg_endo -85.42 100.74 0.69 Allowed 'Trans proline' 0 N--CA 1.43 -2.26 0 C-N-CA 122.6 2.2 . . . . 0.0 111.719 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 47' ' ' ALA . 18.0 m -94.74 110.03 23.19 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 CA-C-O 122.015 0.912 . . . . 0.0 109.542 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.5 p -88.89 146.13 25.12 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-N 114.352 -1.295 . . . . 0.0 111.318 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.509 ' OG1' ' HB ' ' A' ' 49' ' ' VAL . 98.5 m -146.64 127.39 14.34 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.134 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -121.4 143.07 49.42 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -164.42 -139.63 2.68 Favored Glycine 0 N--CA 1.422 -2.24 0 C-N-CA 119.728 -1.225 . . . . 0.0 112.121 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.21 148.59 15.14 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.444 HG12 ' HB3' ' A' ' 139' ' ' TYR . 47.8 mm -126.18 139.37 51.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -106.06 111.76 24.52 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.76 0.79 . . . . 0.0 110.146 175.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 15.6 tp -93.84 106.28 20.99 Favored Pre-proline 0 C--N 1.296 -1.751 0 CA-C-N 113.998 -1.455 . . . . 0.0 108.276 -174.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.65 156.89 58.65 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.416 2.744 . . . . 0.0 116.054 -171.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 31.1 p -48.41 25.32 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 129.19 2.996 . . . . 0.0 117.603 174.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 59.8 mt -71.63 -42.32 67.75 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 72.31 -27.12 0.18 Allowed 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 126.47 1.908 . . . . 0.0 112.48 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -113.74 61.2 0.66 Allowed 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 122.719 1.247 . . . . 0.0 108.121 173.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.51 ' O ' HG11 ' A' ' 62' ' ' VAL . 85.9 t80 -135.77 -1.18 2.51 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 113.398 -1.728 . . . . 0.0 106.569 174.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.559 ' CE1' ' HB3' ' A' ' 124' ' ' ALA . 27.6 t80 . . . . . 0 N--CA 1.411 -2.379 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.14 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -76.5 -20.47 56.91 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 117.244 0.522 . . . . 0.0 111.362 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -71.72 106.5 4.13 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -130.58 112.42 13.15 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -59.1 126.99 29.94 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -134.28 106.19 7.0 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.372 0.606 . . . . 0.0 111.841 -176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -133.22 71.91 1.48 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.568 0.699 . . . . 0.0 110.861 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.2 mt -94.17 -70.1 0.72 Allowed 'General case' 0 CA--C 1.464 -2.328 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 171.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -89.96 149.51 22.55 Favored 'General case' 1 N--CA 1.364 -4.759 0 N-CA-C 103.533 -2.766 . . . . 0.0 103.533 168.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.76 93.38 0.17 Allowed 'General case' 1 C--N 1.236 -4.326 0 CA-C-O 121.511 0.672 . . . . 0.0 111.945 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.9 p -125.48 85.55 2.42 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.481 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.498 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -103.56 -31.76 9.77 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.546 ' O ' HG22 ' A' ' 17' ' ' VAL . 18.7 m-20 -56.05 -48.98 75.0 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -169.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.8 -34.71 65.56 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -178.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -75.29 -54.86 6.38 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 123.45 0.7 . . . . 0.0 110.314 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 12' ' ' ALA . 55.8 t -58.57 -45.81 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.05 0.94 . . . . 0.0 113.499 -174.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 13' ' ' ASP . 35.9 m -66.14 -27.28 40.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.656 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -76.6 -30.2 56.85 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.603 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -54.91 -42.99 72.88 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.509 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.28 -37.42 87.44 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.607 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.53 -36.33 82.43 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.6 t -61.91 -45.18 94.86 Favored 'General case' 0 C--O 1.252 1.231 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.859 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.03 -37.84 54.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.479 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.409 HD13 ' OG ' ' A' ' 96' ' ' SER . 79.3 mt -65.68 -41.1 89.77 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.746 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.5 t -58.41 -36.35 73.45 Favored 'General case' 0 C--O 1.243 0.715 0 O-C-N 123.54 0.525 . . . . 0.0 110.959 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.2 m -67.04 -39.58 87.0 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.053 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.555 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 5.2 tt -80.36 -40.54 26.41 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -54.09 -43.87 70.71 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.33 1.052 . . . . 0.0 109.673 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -65.0 -39.32 93.29 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.042 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -70.93 -37.41 72.87 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.077 -179.593 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.517 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -69.58 -32.46 71.23 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.662 -177.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.48 -40.24 82.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.2 175.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.14 -49.84 73.75 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.297 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.456 ' HD1' ' O ' ' A' ' 30' ' ' LYS . 10.5 m-85 -59.13 -46.89 87.18 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 120.562 0.22 . . . . 0.0 110.643 177.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.452 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 65.1 t80 -62.79 -41.16 99.15 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -176.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.3 -44.25 79.69 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -108.67 -27.65 9.7 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -173.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -101.26 -46.62 4.98 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.467 -171.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 36.8 mt -78.94 -0.48 31.14 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.79 -171.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.01 -33.15 63.67 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -101.42 -47.82 4.56 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 114.348 -1.296 . . . . 0.0 110.52 -173.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.69 126.54 92.85 Favored Pre-proline 0 C--O 1.24 0.601 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.313 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.63 106.67 0.17 Allowed 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 123.109 2.539 . . . . 0.0 112.578 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.43 HG22 HD23 ' A' ' 39' ' ' LEU . 8.3 p -130.85 166.4 27.68 Favored Pre-proline 0 N--CA 1.429 -1.484 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.725 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -79.6 138.35 13.54 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.819 2.346 . . . . 0.0 110.511 175.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -96.89 108.09 20.72 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.091 0.472 . . . . 0.0 109.823 -176.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.5 146.65 25.56 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.04 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.2 t -145.93 138.59 25.65 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 121.073 0.463 . . . . 0.0 110.553 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.423 HG12 ' CG2' ' A' ' 159' ' ' VAL . 12.7 m -90.53 142.55 12.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.207 175.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -130.22 -63.08 0.91 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.083 -1.047 . . . . 0.0 112.979 -174.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -161.13 164.52 30.58 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 -173.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.517 HG23 ' HB3' ' A' ' 64' ' ' TYR . 11.1 p -125.28 114.26 39.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 176.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -99.21 132.51 44.47 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -169.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.536 ' O ' ' HE3' ' A' ' 55' ' ' LYS . 50.2 p90 -58.52 129.1 40.46 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 123.969 0.793 . . . . 0.0 111.743 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.557 ' HE3' ' HA ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -130.0 -64.57 0.86 Allowed 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.689 -173.028 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -140.39 175.27 22.09 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.983 -175.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.422 HG22 ' CD1' ' A' ' 173' ' ' PHE . 28.8 t -99.07 147.46 7.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -175.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 74.2 m -129.58 160.29 33.71 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 174.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -45.95 62.09 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -104.15 97.76 7.68 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.549 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.476 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . 85.11 -170.53 45.28 Favored Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.535 HG22 ' CE2' ' A' ' 173' ' ' PHE . 7.1 p -124.4 153.14 30.76 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -93.99 112.18 23.98 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-O 121.581 0.705 . . . . 0.0 110.957 -175.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.517 ' HB3' HG23 ' A' ' 52' ' ' VAL . 3.5 m-30 -116.17 166.17 12.33 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.452 174.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.524 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 12.2 m-70 -116.93 112.87 21.62 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.513 174.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.47 123.43 26.56 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.981 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -87.48 108.46 19.03 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.301 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.2 t -122.39 108.81 22.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.4 m -100.05 134.0 43.61 Favored 'General case' 0 C--N 1.284 -2.266 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.509 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.72 112.43 36.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-O 121.251 0.548 . . . . 0.0 110.13 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 39.3 ttpt -95.25 110.75 22.7 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 175.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -119.18 116.93 33.66 Favored Pre-proline 0 N--CA 1.42 -1.963 0 C-N-CA 118.64 -1.224 . . . . 0.0 111.278 -174.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -95.75 98.83 0.1 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.451 0 C-N-CA 121.756 1.637 . . . . 0.0 109.551 169.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.7 t80 178.4 108.13 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.7 m -50.88 16.66 0.0 OUTLIER 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 119.342 3.09 . . . . 0.0 119.342 -166.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.459 HE21 HG12 ' A' ' 78' ' ' ILE . 7.3 pt20 -142.89 166.35 24.88 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 119.583 1.083 . . . . 0.0 111.45 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.1 p -88.51 101.13 13.63 Favored 'General case' 0 N--CA 1.417 -2.096 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 174.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.459 HG12 HE21 ' A' ' 76' ' ' GLN . 67.7 mt -73.65 129.58 85.12 Favored Pre-proline 0 C--N 1.31 -1.121 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.33 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.96 122.29 10.97 Favored 'Trans proline' 0 C--O 1.254 1.305 0 C-N-CA 122.726 2.284 . . . . 0.0 112.369 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.442 HG12 ' CE1' ' A' ' 147' ' ' PHE . 45.0 mt -89.91 107.87 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 57.3 m -53.98 -59.57 4.47 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 123.076 0.551 . . . . 0.0 110.37 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -165.45 150.21 8.82 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 98' ' ' THR . 15.7 tt -96.69 124.32 49.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 174.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.0 m -100.61 118.66 37.21 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -175.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -119.91 139.86 51.77 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.293 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.417 ' HB ' ' HB2' ' A' ' 142' ' ' ASP . 64.7 mt -123.87 108.37 20.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 171.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.464 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . 1.5 tm? -91.65 122.43 34.21 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -125.56 140.01 53.11 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -175.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 93' ' ' THR . 30.2 t -104.98 145.66 30.12 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.959 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.52 -12.93 55.61 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.872 175.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 68.8 p -97.51 17.8 16.82 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.152 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 81.21 163.01 0.16 Allowed 'General case' 0 C--O 1.25 1.081 0 C-N-CA 125.542 1.537 . . . . 0.0 111.984 -176.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' A' ' 122' ' ' SER . 53.9 m 72.24 137.84 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.726 1.21 . . . . 0.0 110.259 -174.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.516 HD13 ' C ' ' A' ' 94' ' ' ILE . 1.6 pp -129.87 172.75 15.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.464 ' HB1' ' HB3' ' A' ' 87' ' ' LEU . . . -127.11 121.78 32.38 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 174.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.409 ' OG ' HD13 ' A' ' 24' ' ' ILE . 23.0 t -134.62 158.25 44.52 Favored 'General case' 0 C--N 1.282 -2.352 0 C-N-CA 118.641 -1.224 . . . . 0.0 110.726 -176.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.54 179.53 44.26 Favored Glycine 0 N--CA 1.429 -1.831 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 23.0 p -135.11 134.17 39.99 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.747 0.273 . . . . 0.0 110.519 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.4 mp -104.79 107.35 58.18 Favored Pre-proline 0 C--O 1.244 0.782 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.475 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -66.05 121.8 9.21 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.736 2.291 . . . . 0.0 110.387 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 53.85 78.66 0.38 Allowed Pre-proline 0 N--CA 1.483 1.22 0 C-N-CA 123.921 0.888 . . . . 0.0 111.572 -175.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -97.96 6.01 1.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.932 2.421 . . . . 0.0 112.689 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 164.9 -168.76 39.26 Favored Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 56.1 m -143.27 159.13 42.89 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 120.795 0.331 . . . . 0.0 110.291 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.415 ' HA ' HG22 ' A' ' 111' ' ' THR . 82.7 mt -88.71 156.83 18.77 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.502 177.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 27.7 m -99.1 1.79 10.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 121.016 0.436 . . . . 0.0 111.841 -176.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.21 -52.22 4.63 Favored Glycine 0 C--O 1.217 -0.96 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.905 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.5 t -146.23 103.35 3.7 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 150.29 -175.0 29.54 Favored Glycine 0 N--CA 1.421 -2.359 0 C-N-CA 120.291 -0.957 . . . . 0.0 111.376 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 25.6 m -102.67 108.32 19.54 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 105' ' ' LEU . 5.5 t -99.98 114.52 27.85 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 121.766 0.793 . . . . 0.0 109.466 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.2 t -85.36 113.76 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.5 mt -96.17 147.8 23.37 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -136.91 123.03 20.38 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.443 0.639 . . . . 0.0 110.696 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 69.3 t -102.26 122.22 47.49 Favored Pre-proline 0 C--N 1.299 -1.604 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.225 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -68.51 109.97 2.18 Favored 'Trans proline' 0 N--CA 1.439 -1.703 0 N-CA-C 105.815 -2.417 . . . . 0.0 105.815 167.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.7 p -126.94 148.39 31.76 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -172.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.407 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 9.0 mmpt? -88.86 98.26 11.63 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.411 HG12 HD21 ' A' ' 87' ' ' LEU . 10.6 m -94.65 149.02 4.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.518 ' HA ' HD13 ' A' ' 123' ' ' ILE . . . 72.15 0.72 3.67 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.031 0.533 . . . . 0.0 111.359 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.407 ' H ' ' C ' ' A' ' 119' ' ' VAL . 55.2 t80 -59.93 -51.26 70.46 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 173.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 93' ' ' THR . 15.1 m -62.37 -27.44 69.07 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.152 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.518 HD13 ' HA ' ' A' ' 120' ' ' ALA . 2.6 mp -79.1 -47.8 22.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.905 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.78 -36.93 82.5 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.351 0.407 . . . . 0.0 110.994 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 54.0 t -65.68 -37.27 79.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.997 176.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 63.0 m -82.42 -75.81 0.29 Allowed 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.418 HD11 ' N ' ' A' ' 128' ' ' MET . 2.6 pp -124.56 -23.3 4.43 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -173.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.504 ' SD ' ' HD3' ' A' ' 129' ' ' LYS . 11.7 tpt 74.51 133.56 0.05 OUTLIER 'General case' 0 C--O 1.211 -0.971 0 C-N-CA 123.944 0.898 . . . . 0.0 112.039 -177.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.529 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -87.54 7.54 29.08 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.757 -175.293 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.43 ' H ' ' HG3' ' A' ' 128' ' ' MET . 10.3 m-20 67.74 -0.84 1.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 172.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.84 30.31 16.62 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 53.4 t -56.26 129.96 42.49 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 123.675 0.61 . . . . 0.0 109.998 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 52.5 p -77.82 130.52 36.78 Favored 'General case' 0 N--CA 1.414 -2.258 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 65.22 82.33 0.19 Allowed 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -174.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.488 ' HE1' ' HB2' ' A' ' 129' ' ' LYS . 64.0 t-105 -155.03 156.62 36.25 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.173 -170.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -148.5 148.05 29.79 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 176.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.9 tt -142.1 147.92 20.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.226 -174.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -63.14 122.14 15.37 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-O 121.931 0.872 . . . . 0.0 112.463 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.428 ' HE1' ' CD2' ' A' ' 87' ' ' LEU . 4.8 t80 -139.35 145.4 38.97 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.135 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -141.17 155.43 46.07 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.083 -0.385 . . . . 0.0 110.738 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.7 pp -139.12 151.31 46.57 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-O 121.245 0.545 . . . . 0.0 110.815 173.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.417 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 10.3 m-20 -133.19 111.96 11.32 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 173.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 60.8 mt -125.06 138.28 54.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.17 -177.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 157' ' ' ILE . . . -121.54 130.18 8.02 Favored Glycine 0 N--CA 1.418 -2.526 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.084 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -97.75 111.11 23.53 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.0 m -97.24 112.35 24.19 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.556 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.442 ' CE1' HG12 ' A' ' 80' ' ' ILE . 91.7 m-85 -115.19 140.07 49.4 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 154' ' ' ASP . 29.0 t70 -93.97 109.06 20.81 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 66.3 mt -118.99 117.5 33.57 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -52.48 -19.15 9.42 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 124.172 3.248 . . . . 0.0 114.982 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.24 -29.17 31.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 120.861 0.362 . . . . 0.0 111.009 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 61.1 t -131.94 -53.25 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.271 0.557 . . . . 0.0 110.725 -176.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 142.45 -155.59 25.77 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 108.451 -1.859 . . . . 0.0 108.451 -176.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 148' ' ' ASP . 4.9 p-10 -86.48 117.66 25.4 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 117.908 0.854 . . . . 0.0 109.748 175.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 2.1 pp -128.24 141.2 47.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.443 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 37.7 m -99.43 123.92 44.12 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.437 -178.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.402 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 2.0 mp -86.57 112.0 43.5 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 174.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -86.7 114.95 1.22 Allowed 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.672 2.248 . . . . 0.0 113.18 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.423 ' CG2' HG12 ' A' ' 49' ' ' VAL . 9.9 m -125.74 127.86 71.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.251 176.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.4 t -128.28 156.31 43.22 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.658 -174.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.1 t -166.55 149.16 6.73 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -100.26 127.53 46.53 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 172.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -113.28 133.14 11.08 Favored Glycine 0 N--CA 1.405 -3.393 0 C-N-CA 119.924 -1.131 . . . . 0.0 112.811 -172.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -101.95 120.12 39.89 Favored 'General case' 0 C--N 1.269 -2.9 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.3 pt -114.9 111.69 36.92 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 CA-C-O 121.75 0.786 . . . . 0.0 110.89 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.557 ' HZ1' ' HB2' ' A' ' 166' ' ' LYS . 4.9 ttmp? -81.06 119.75 23.94 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.712 -177.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.9 tt -102.24 98.8 11.12 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 166' ' ' LYS . 1.4 Cg_endo -83.57 81.27 2.29 Favored 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 122.677 2.251 . . . . 0.0 112.561 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 46.6 t 70.81 -76.48 0.06 Allowed 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.654 -1.157 . . . . 0.0 113.602 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.436 ' HG ' ' CD2' ' A' ' 173' ' ' PHE . 3.6 mm? 63.89 -65.7 0.12 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.28 1.032 . . . . 0.0 113.088 -176.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 63.9 91.62 0.07 Allowed 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.578 1.151 . . . . 0.0 110.405 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 74.37 90.76 0.08 Allowed 'General case' 0 CA--C 1.491 -1.317 0 C-N-CA 124.709 1.204 . . . . 0.0 109.349 -176.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.535 ' CE2' HG22 ' A' ' 62' ' ' VAL . 77.6 t80 -164.58 -35.1 0.03 OUTLIER 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 -175.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 CA--C 1.495 -1.147 0 C-N-CA 126.204 1.802 . . . . 0.0 112.978 175.563 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.253 0 N-CA-C 112.731 -0.148 . . . . 0.0 112.731 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -85.64 161.07 19.42 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 60.83 29.3 18.92 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -64.71 131.05 45.83 Favored 'General case' 0 C--O 1.246 0.888 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.618 -177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.0 t60 62.93 81.53 0.2 Allowed 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.854 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -123.6 150.67 43.84 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 102.507 -3.146 . . . . 0.0 102.507 172.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 69.81 -167.0 0.17 Allowed 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -168.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -91.22 -60.08 1.99 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 173.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -144.12 -29.27 0.5 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.878 173.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.37 115.07 1.18 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.842 0.857 . . . . 0.0 113.091 -177.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.1 m 67.09 6.64 4.88 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.804 1.242 . . . . 0.0 112.727 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -92.68 -43.1 9.25 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.9 0.381 . . . . 0.0 110.008 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -75.55 -42.59 52.0 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.258 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.434 ' OE1' HG21 ' A' ' 93' ' ' THR . 12.4 mm-40 -54.6 -41.52 70.05 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.301 0.572 . . . . 0.0 110.84 176.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -65.52 -53.45 42.06 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.521 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.6 m -64.32 -33.72 64.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.8 t -69.6 -45.44 78.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 176.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -58.67 -48.0 82.55 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.094 -176.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.469 ' O ' HG22 ' A' ' 23' ' ' VAL . 12.3 pt-20 -66.37 -40.61 89.85 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.149 -177.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -64.4 -40.93 96.74 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.59 -37.16 85.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.252 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.3 t -66.18 -44.07 85.04 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.32 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 19' ' ' GLU . 89.3 t -59.97 -43.84 93.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 CA-C-O 121.044 0.45 . . . . 0.0 110.018 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.4 HG21 ' HB2' ' A' ' 84' ' ' SER . 65.5 mt -70.95 -35.58 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.66 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.3 t -60.64 -41.36 94.75 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 122.267 -0.271 . . . . 0.0 110.294 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.524 ' HA ' ' OD2' ' A' ' 29' ' ' ASP . 50.9 m -65.32 -29.12 69.84 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.355 0.597 . . . . 0.0 110.384 176.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.65 ' O ' ' HB3' ' A' ' 30' ' ' LYS . 4.5 tt -69.97 -38.33 76.03 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 175.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.545 ' O ' ' HG3' ' A' ' 32' ' ' LYS 0.34 7.8 mp -67.37 -27.79 67.4 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 119.149 -1.02 . . . . 0.0 113.094 175.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.524 ' OD2' ' HA ' ' A' ' 26' ' ' SER . 53.1 m-20 -61.04 -45.44 94.76 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 172.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.65 ' HB3' ' O ' ' A' ' 27' ' ' LEU . 21.0 ttmm -54.99 -51.39 66.37 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.913 173.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.07 -44.77 91.89 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.44 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 95.0 mttt -60.07 -32.21 70.73 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.94 0.496 . . . . 0.0 110.33 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.492 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -62.67 -51.32 56.77 Favored Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.723 177.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -72.83 -38.64 67.06 Favored 'General case' 0 C--O 1.203 -1.393 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.752 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -62.41 -35.41 79.13 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -175.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.65 -27.1 64.76 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.655 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.499 ' HG3' ' N ' ' A' ' 38' ' ' LYS . 8.6 pt-20 -112.09 -57.28 2.29 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -175.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.499 ' N ' ' HG3' ' A' ' 37' ' ' GLU . 8.9 tppt? -73.69 -48.23 33.69 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-O 122.757 1.265 . . . . 0.0 109.803 -164.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.464 ' CD1' HG12 ' A' ' 157' ' ' ILE . 69.4 mt -83.07 4.86 24.47 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 113.11 -1.859 . . . . 0.0 111.575 -171.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.91 -7.9 11.96 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.981 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -110.42 -39.7 4.86 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.176 0.513 . . . . 0.0 110.19 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 54.7 mt -91.53 139.53 25.14 Favored Pre-proline 0 N--CA 1.432 -1.344 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.13 98.3 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.831 1.688 . . . . 0.0 108.328 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 m -127.62 148.94 68.81 Favored Pre-proline 0 C--N 1.297 -1.682 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -172.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 9.4 Cg_endo -51.88 129.06 28.86 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.857 2.372 . . . . 0.0 112.112 176.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 43.3 mt-10 -115.02 113.24 23.82 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.929 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.5 148.54 30.1 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.464 -176.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.1 t -154.74 142.93 20.33 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.766 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.541 ' H ' HG13 ' A' ' 159' ' ' VAL . 11.7 p -108.39 141.09 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 176.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -157.04 -23.04 0.09 Allowed 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.646 -171.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.546 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . 9.6 t0 -121.26 117.23 26.5 Favored 'General case' 0 CA--C 1.485 -1.547 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.24 -168.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.571 HG13 ' CD2' ' A' ' 64' ' ' TYR . 48.4 t -119.36 110.64 30.2 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -130.03 127.97 41.04 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.186 -175.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.599 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 51.1 p90 -64.75 139.26 58.74 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -176.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.488 ' HD3' ' HB2' ' A' ' 65' ' ' HIS . 14.7 mmmm -88.51 -24.85 22.82 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.392 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.49 -158.55 31.46 Favored Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.4 m -101.03 145.84 10.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 117.134 0.467 . . . . 0.0 111.27 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.3 m -155.06 135.54 13.36 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -75.84 -42.25 50.13 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -173.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -61.94 -56.58 17.69 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.702 0.763 . . . . 0.0 110.808 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.81 137.3 4.89 Favored Glycine 0 N--CA 1.409 -3.126 0 N-CA-C 107.022 -2.431 . . . . 0.0 107.022 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.517 HG11 ' CZ ' ' A' ' 173' ' ' PHE . 23.3 t -72.79 131.86 34.23 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-N 117.209 0.505 . . . . 0.0 110.115 -173.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -81.79 117.21 21.91 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.899 -177.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.599 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 9.4 m-85 -118.09 154.55 31.89 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.488 ' HB2' ' HD3' ' A' ' 55' ' ' LYS . 49.9 t-80 -91.03 108.43 19.86 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 176.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -91.71 107.56 19.29 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.546 ' HB3' ' HB3' ' A' ' 51' ' ' ASP . 40.4 ttmt -87.38 110.97 20.63 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.907 0.384 . . . . 0.0 110.557 -176.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.4 t -113.15 108.38 25.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.6 p -102.7 140.36 37.08 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.883 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 3.1 p -142.02 126.56 16.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.927 -178.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 45' ' ' PRO . 25.5 pttm -99.15 141.73 31.53 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 174.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -134.39 116.89 13.15 Favored Pre-proline 0 C--N 1.287 -2.141 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.641 -174.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -91.8 95.52 0.2 Allowed 'Trans proline' 0 N--CA 1.42 -2.838 0 N-CA-C 109.106 -1.152 . . . . 0.0 109.106 170.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.464 ' HB3' ' HG2' ' A' ' 76' ' ' GLN . 50.1 m-85 170.54 130.14 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 129.19 2.996 . . . . 0.0 104.723 -176.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.8 m -81.96 -2.78 52.59 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 118.362 0.528 . . . . 0.0 112.104 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.464 ' HG2' ' HB3' ' A' ' 74' ' ' TYR . 18.8 pt20 -83.2 132.08 35.08 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 121.206 0.527 . . . . 0.0 111.095 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.4 p -75.95 93.78 3.29 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 172.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.445 ' HB ' ' CD2' ' A' ' 105' ' ' LEU . 75.0 mt -72.66 123.37 89.47 Favored Pre-proline 0 C--N 1.3 -1.553 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.007 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -79.12 118.26 4.0 Favored 'Trans proline' 0 N--CA 1.44 -1.644 0 C-N-CA 122.115 1.877 . . . . 0.0 110.856 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.4 mp -72.44 111.53 6.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 57.0 m -50.31 -59.08 4.33 Favored 'General case' 0 C--O 1.244 0.791 0 O-C-N 123.899 0.749 . . . . 0.0 111.204 -176.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -150.94 154.02 36.35 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.446 HG22 ' HB ' ' A' ' 99' ' ' ILE . 11.1 tp -104.1 124.08 58.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 174.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.4 ' HB2' HG21 ' A' ' 24' ' ' ILE . 65.7 p -95.07 118.62 32.18 Favored 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 119.529 -0.869 . . . . 0.0 109.883 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.517 ' CE2' HG13 ' A' ' 117' ' ' VAL . 15.5 t80 -104.16 121.39 43.16 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 126.238 1.815 . . . . 0.0 111.067 -169.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' A' ' 142' ' ' ASP . 3.2 mp -127.25 108.08 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.598 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 1.8 tm? -101.71 121.58 42.31 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.423 ' HA ' HG23 ' A' ' 94' ' ' ILE . 39.8 ttmt -127.25 133.59 50.19 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 120.158 -0.617 . . . . 0.0 112.372 -175.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.5 m -123.18 147.3 47.0 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.434 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.98 -0.19 2.21 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.5 p -90.83 16.33 9.55 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 123.461 0.704 . . . . 0.0 110.834 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 70.86 -41.63 0.51 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 125.972 1.709 . . . . 0.0 113.388 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.579 ' O ' ' HB3' ' A' ' 122' ' ' SER . 99.9 m -62.26 137.75 58.31 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.598 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 47.1 pt -137.55 178.23 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.254 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . . . -127.88 130.11 48.0 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 174.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.7 t -126.78 147.13 50.02 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.89 172.21 37.14 Favored Glycine 0 N--CA 1.42 -2.403 0 C-N-CA 119.818 -1.182 . . . . 0.0 112.426 -176.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 63.2 m -153.07 109.76 3.43 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.446 ' HB ' HG22 ' A' ' 83' ' ' ILE . 3.1 mp -103.47 110.03 63.03 Favored Pre-proline 0 N--CA 1.467 0.424 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.674 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -68.11 127.45 15.97 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.611 2.207 . . . . 0.0 109.727 173.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.0 t70 57.29 81.42 0.26 Allowed Pre-proline 0 N--CA 1.482 1.154 0 CA-C-O 121.674 0.749 . . . . 0.0 110.234 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -107.72 13.74 0.13 Allowed 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 123.028 2.485 . . . . 0.0 113.088 -177.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 152.78 -172.26 31.85 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.6 p -135.2 143.72 46.55 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.957 0.378 . . . . 0.0 110.719 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.445 ' CD2' ' HB ' ' A' ' 78' ' ' ILE . 19.9 tp -82.42 129.48 34.9 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 11.6 p -57.61 -35.05 48.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -174.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.97 118.68 0.1 OUTLIER Glycine 0 CA--C 1.54 1.615 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.541 -174.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 34.5 t 67.56 11.51 8.41 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.669 1.188 . . . . 0.0 113.137 175.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -150.8 -164.52 12.05 Favored Glycine 0 CA--C 1.496 -1.141 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.558 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 10.0 t -116.68 138.54 51.38 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.505 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 7.0 t -133.65 138.8 46.1 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.03 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.3 m -91.62 106.93 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-O 122.057 0.932 . . . . 0.0 110.269 177.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.7 mt -92.2 153.9 19.01 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.504 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 4.8 p-10 -144.58 148.16 34.05 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.482 -0.887 . . . . 0.0 112.013 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.8 t -126.7 128.44 24.28 Favored Pre-proline 0 C--N 1.289 -2.056 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 171.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 22.7 Cg_exo -69.16 109.43 2.19 Favored 'Trans proline' 0 N--CA 1.432 -2.144 0 N-CA-C 108.206 -1.498 . . . . 0.0 108.206 172.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.517 HG13 ' CE2' ' A' ' 85' ' ' TYR . 30.3 m -98.41 150.3 4.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.384 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.553 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -95.1 97.46 9.95 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.062 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.426 ' C ' ' H ' ' A' ' 121' ' ' TYR . 4.5 m -93.15 147.12 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.482 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -177.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.449 ' HB2' ' CE1' ' A' ' 174' ' ' PHE . . . 69.9 -3.9 1.61 Allowed 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.968 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.426 ' H ' ' C ' ' A' ' 119' ' ' VAL . 84.2 t80 -57.99 -47.35 83.27 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.579 ' HB3' ' O ' ' A' ' 93' ' ' THR . 19.1 m -66.79 -26.3 66.89 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.996 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.5 mt -79.14 -49.64 19.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.727 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.16 -49.3 78.41 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 122.962 0.505 . . . . 0.0 110.34 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.2 t -54.97 -43.26 68.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.223 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 44.0 t -75.04 -78.84 0.1 Allowed 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.044 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.545 HD11 ' N ' ' A' ' 128' ' ' MET . 3.8 pp -126.24 -40.09 2.01 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 115.111 1.522 . . . . 0.0 115.111 -173.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.545 ' N ' HD11 ' A' ' 127' ' ' LEU . 24.9 ttt 66.01 116.52 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.355 1.062 . . . . 0.0 110.632 -173.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.71 -72.8 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.741 0.816 . . . . 0.0 112.133 -178.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 24.0 t70 172.87 -30.56 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 -174.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.573 ' HE1' ' O ' ' A' ' 170' ' ' LEU . 13.2 tpt 65.61 106.17 0.04 OUTLIER 'General case' 0 C--O 1.242 0.666 0 CA-C-N 113.235 -1.802 . . . . 0.0 112.573 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 44.7 t -128.53 173.52 10.17 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.108 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 30.8 p -82.69 115.74 21.76 Favored 'General case' 0 N--CA 1.413 -2.312 0 C-N-CA 123.257 0.623 . . . . 0.0 110.95 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.6 t70 74.21 95.61 0.07 Allowed 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 124.9 1.28 . . . . 0.0 108.835 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 -154.44 148.03 25.25 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.901 -170.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -118.62 143.58 46.71 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 67.2 mt -131.53 130.1 62.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 174.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 164' ' ' GLU . 9.5 p-10 -99.34 120.41 39.53 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.74 170.56 12.59 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 88' ' ' LYS . 1.6 mp0 -113.99 136.36 52.99 Favored 'General case' 0 C--N 1.279 -2.496 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.398 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.4 tp -122.05 116.21 23.86 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.76 176.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.479 ' HB3' ' HB ' ' A' ' 86' ' ' ILE . 15.4 t70 -126.63 120.89 30.65 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -175.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 43.0 mm -131.2 137.28 56.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 121.209 0.528 . . . . 0.0 110.594 -175.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -114.52 122.02 5.55 Favored Glycine 0 N--CA 1.419 -2.454 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 175.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.494 HD23 ' CE2' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -115.37 160.2 20.15 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.387 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.7 t -136.02 142.24 44.43 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 119.834 -0.747 . . . . 0.0 111.799 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.494 ' CE2' HD23 ' A' ' 145' ' ' LEU . 68.1 m-85 -135.6 138.51 43.02 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 174.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -116.91 132.77 56.62 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.883 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.06 143.11 29.98 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -66.91 5.01 0.88 Allowed 'Trans proline' 0 N--CA 1.488 1.184 0 C-N-CA 123.411 2.741 . . . . 0.0 113.415 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.46 -28.88 36.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 11.7 p -160.19 -28.49 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.67 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 140.51 -143.56 13.66 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.347 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -94.97 132.09 40.2 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 2.9 mp -122.54 129.73 75.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 33.9 p -95.77 140.44 30.55 Favored 'General case' 0 N--CA 1.406 -2.654 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 172.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.464 HG12 ' CD1' ' A' ' 39' ' ' LEU . 31.0 mt -114.11 129.26 24.98 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -90.69 116.86 0.55 Allowed 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 122.734 2.289 . . . . 0.0 112.314 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.541 HG13 ' H ' ' A' ' 49' ' ' VAL . 21.9 t -118.96 103.76 14.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 59.0 p -107.91 128.56 54.73 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 95.3 m -145.88 131.02 18.37 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.152 0.501 . . . . 0.0 112.158 -173.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -99.53 124.48 44.75 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -126.94 128.04 6.12 Favored Glycine 0 N--CA 1.42 -2.428 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.095 -176.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 138' ' ' ASP . 39.3 tt0 -95.98 120.57 36.5 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 176.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 9.6 pt -112.53 140.84 30.26 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.635 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.926 -176.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -102.54 143.96 31.57 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 121.82 0.819 . . . . 0.0 112.15 -174.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.4 mp -112.39 86.03 7.72 Favored Pre-proline 0 C--N 1.285 -2.203 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -80.12 85.98 1.74 Allowed 'Trans proline' 0 C--N 1.367 1.52 0 C-N-CA 123.353 2.702 . . . . 0.0 116.034 -167.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . 0.26 46.2 t 63.72 -1.57 0.61 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 175.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.573 ' O ' ' HE1' ' A' ' 131' ' ' MET . 4.2 mm? -70.33 96.9 1.18 Allowed 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 168.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -69.08 -23.6 64.04 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 118.754 -1.178 . . . . 0.0 109.802 176.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -117.79 102.16 8.89 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.517 ' CZ ' HG11 ' A' ' 62' ' ' VAL . 57.8 t80 -161.42 -43.65 0.04 OUTLIER 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 -174.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.544 ' HB3' ' SD ' ' A' ' 131' ' ' MET . 16.9 t80 . . . . . 0 C--N 1.292 -1.911 0 CA-C-N 112.945 -1.934 . . . . 0.0 107.287 175.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.761 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 62.7 t60 68.45 -65.13 0.28 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.66 1.184 . . . . 0.0 112.88 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -80.18 109.16 14.39 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.257 0.551 . . . . 0.0 110.94 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -140.2 126.69 20.2 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.443 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -87.31 79.35 8.53 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.878 0.847 . . . . 0.0 111.527 -175.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -128.23 22.52 6.1 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 122.268 1.032 . . . . 0.0 110.224 173.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -115.08 -178.75 3.44 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.335 173.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.2 mp 69.44 -85.95 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -172.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.42 98.16 0.9 Allowed 'General case' 0 N--CA 1.4 -2.928 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 171.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.48 22.14 0.82 Allowed 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.5 m -109.58 -47.2 3.41 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.324 -175.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.4 ' O ' ' HG2' ' A' ' 15' ' ' LYS . . . -80.77 -45.84 16.36 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -57.94 -30.83 66.28 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.287 0.565 . . . . 0.0 110.268 178.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -78.2 -47.99 16.83 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.851 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 12' ' ' ALA . 49.7 pttt -64.36 -36.15 83.19 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 116.761 -0.199 . . . . 0.0 110.73 -174.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.431 ' HA ' ' HG3' ' A' ' 19' ' ' GLU . 34.2 m -69.18 -20.39 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.275 0.56 . . . . 0.0 111.153 -177.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.452 HG11 ' O ' ' A' ' 94' ' ' ILE . 55.3 t -73.36 -52.22 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 171.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -65.21 -43.67 90.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.311 -175.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.431 ' HG3' ' HA ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -64.64 -33.28 75.56 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.546 -178.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -79.13 -43.43 24.04 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.719 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.09 82.89 Favored 'General case' 0 C--O 1.21 -0.981 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.32 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -59.35 -45.4 91.48 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.23 -49.79 81.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.087 0.47 . . . . 0.0 109.953 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.58 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 73.2 mt -62.3 -46.17 97.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.263 -178.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.4 t -66.97 -36.97 83.38 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.624 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.2 t -63.23 -37.63 87.98 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.18 0.514 . . . . 0.0 109.665 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -66.05 -45.26 82.01 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 87.7 mt -57.04 -41.21 78.22 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.239 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -55.46 -48.92 73.75 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -79.38 -36.38 39.31 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.88 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.703 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . . . -68.35 -35.99 78.57 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.634 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -63.68 -35.74 81.56 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.33 -53.03 49.01 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.923 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.703 ' CE2' ' HA ' ' A' ' 31' ' ' ALA . 30.3 p90 -76.39 -24.56 54.11 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.383 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -57.19 -50.18 73.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.726 0.298 . . . . 0.0 110.834 175.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.1 -18.15 63.94 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.123 0.487 . . . . 0.0 110.987 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -91.69 -66.23 0.94 Allowed 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.446 ' HE2' ' HB2' ' A' ' 34' ' ' PHE . 49.7 mtmt -93.44 -35.66 12.86 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 121.189 0.518 . . . . 0.0 110.487 -171.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.1 mt -82.52 2.26 33.82 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.527 0.68 . . . . 0.0 111.63 -174.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.62 -26.83 21.7 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -98.31 -32.93 11.28 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.129 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 74.5 mt -93.0 114.26 62.17 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.64 101.4 0.55 Allowed 'Trans proline' 0 C--O 1.24 0.62 0 C-N-CA 122.509 2.139 . . . . 0.0 112.975 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.0 p -112.56 167.92 8.46 Favored Pre-proline 0 C--N 1.298 -1.665 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.299 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.93 120.21 7.88 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 122.775 2.317 . . . . 0.0 111.463 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -102.45 114.27 28.33 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -174.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -97.63 148.98 22.75 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.94 -173.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.404 ' HA ' HG21 ' A' ' 159' ' ' VAL . 5.2 t -147.51 124.47 11.32 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.187 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.442 ' HB ' ' CG2' ' A' ' 161' ' ' THR . 22.1 t -86.9 140.92 15.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -113.59 -72.65 0.69 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 -172.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -160.32 169.85 22.3 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.984 -162.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.5 HG23 ' CD1' ' A' ' 165' ' ' ILE . 34.5 m -129.53 146.61 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.379 0 C-N-CA 123.991 0.916 . . . . 0.0 109.872 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -123.72 126.33 46.34 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 118.204 -0.903 . . . . 0.0 108.618 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.446 ' O ' ' HE3' ' A' ' 55' ' ' LYS . 47.6 p90 -58.5 122.4 13.27 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 175.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.496 ' HA ' ' CE ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -124.7 -20.37 5.08 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.972 -169.406 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.98 -159.51 20.55 Favored Glycine 0 N--CA 1.427 -1.939 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.153 -177.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.22 137.65 33.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.202 0.525 . . . . 0.0 111.241 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.3 m -117.95 170.05 9.15 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -83.73 -33.77 25.02 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 118.701 -1.2 . . . . 0.0 110.558 175.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.491 ' O ' ' HD1' ' A' ' 121' ' ' TYR . 24.8 m-20 -111.28 97.72 6.98 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 171.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.58 -168.36 27.89 Favored Glycine 0 C--N 1.303 -1.257 0 C-N-CA 120.493 -0.86 . . . . 0.0 110.965 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 m -147.12 140.74 19.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 C-N-CA 123.265 0.626 . . . . 0.0 110.718 -177.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -71.31 127.11 31.48 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 123.874 0.734 . . . . 0.0 112.026 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -131.62 143.87 50.63 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 124.513 1.125 . . . . 0.0 111.199 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -92.6 108.0 19.64 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -101.55 140.42 35.86 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.2 137.39 54.22 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.554 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.7 t -123.79 111.44 29.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.3 p -97.7 147.14 24.66 Favored 'General case' 0 C--N 1.277 -2.58 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.911 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.61 134.74 29.76 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 CA-C-O 121.36 0.6 . . . . 0.0 110.317 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 22.2 ptmt -105.77 144.48 32.45 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.472 ' ND2' HD11 ' A' ' 105' ' ' LEU . 1.5 p-10 -149.37 124.88 4.97 Favored Pre-proline 0 C--N 1.28 -2.437 0 C-N-CA 118.532 -1.267 . . . . 0.0 109.686 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -97.64 97.98 0.07 OUTLIER 'Trans proline' 0 N--CA 1.417 -3.009 0 C-N-CA 121.563 1.509 . . . . 0.0 110.696 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -138.63 -85.52 0.26 Allowed 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.9 p 170.24 -47.43 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.861 0.865 . . . . 0.0 110.9 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.597 ' O ' ' HA2' ' A' ' 107' ' ' GLY . 15.6 pt20 -104.01 163.69 12.21 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.845 -174.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.5 p -78.38 130.85 36.61 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 170.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 75.3 mt -120.59 128.34 25.84 Favored Pre-proline 0 C--N 1.285 -2.213 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.47 150.3 69.79 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.298 1.999 . . . . 0.0 111.689 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.654 HG21 ' CE1' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -88.49 151.71 3.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 55.0 m -71.01 -50.94 28.69 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 174.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -166.03 163.35 18.27 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.62 -1.173 . . . . 0.0 107.977 171.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.6 tt -124.5 119.6 56.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 21.9 t -103.97 139.83 38.56 Favored 'General case' 0 N--CA 1.421 -1.899 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.667 -174.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.435 ' O ' ' HA ' ' A' ' 96' ' ' SER . 37.5 p90 -120.78 125.52 47.78 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 174.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 66.5 mt -118.64 107.35 21.48 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 174.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.484 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 3.0 pp -104.38 146.25 29.1 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.424 -175.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -116.77 155.45 28.9 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.192 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.9 m -140.11 109.55 6.23 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 66.47 -69.84 0.11 Allowed 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 125.612 1.565 . . . . 0.0 113.788 175.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.8 t -154.31 -46.27 0.09 Allowed 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -175.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -129.97 145.7 51.64 Favored 'General case' 0 C--N 1.314 -0.965 0 O-C-N 121.795 -0.566 . . . . 0.0 111.595 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 47.4 m 77.25 130.2 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 124.858 1.263 . . . . 0.0 112.22 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 42.5 pt -131.88 177.76 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.72 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.229 -178.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.99 148.74 51.17 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 173.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 70.2 p -143.01 160.75 39.76 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -177.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -176.87 164.51 34.05 Favored Glycine 0 N--CA 1.433 -1.527 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.435 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.9 p -132.15 115.47 15.77 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 124.217 1.007 . . . . 0.0 109.55 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.407 ' CD1' HG12 ' A' ' 115' ' ' VAL . 56.6 mt -94.95 125.09 52.22 Favored Pre-proline 0 C--O 1.244 0.78 0 C-N-CA 118.937 -1.105 . . . . 0.0 112.685 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -83.31 118.43 2.59 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.924 2.416 . . . . 0.0 111.739 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 48.36 68.55 3.41 Favored Pre-proline 0 N--CA 1.484 1.233 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -83.59 -21.44 4.24 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 N-CA-C 108.955 -1.21 . . . . 0.0 108.955 170.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -177.06 -166.63 34.29 Favored Glycine 0 N--CA 1.418 -2.51 0 N-CA-C 107.709 -2.157 . . . . 0.0 107.709 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 21.2 m -142.82 171.85 13.49 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.472 HD11 ' ND2' ' A' ' 72' ' ' ASN . 2.1 pp -75.96 153.2 36.75 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 117.697 -1.601 . . . . 0.0 108.791 172.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 8.9 p -70.98 -42.01 76.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -170.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.597 ' HA2' ' O ' ' A' ' 76' ' ' GLN . . . 129.58 -72.44 0.48 Allowed Glycine 0 N--CA 1.409 -3.124 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 -175.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.6 t -145.23 87.65 1.83 Allowed 'General case' 0 C--N 1.278 -2.52 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 160.83 -146.22 12.12 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 8.9 t -125.75 135.34 51.95 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 117.418 0.609 . . . . 0.0 111.008 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.5 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 2.7 t -127.5 138.98 53.07 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 122.924 0.49 . . . . 0.0 110.602 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.9 m -99.21 118.49 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-O 121.557 0.694 . . . . 0.0 110.551 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.8 mt -103.93 162.12 13.4 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -150.51 149.26 29.73 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.62 0.724 . . . . 0.0 112.383 -176.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.407 HG12 ' CD1' ' A' ' 99' ' ' ILE . 53.2 t -129.78 127.77 22.89 Favored Pre-proline 0 C--N 1.302 -1.457 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.084 176.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -79.18 110.01 2.65 Favored 'Trans proline' 0 N--CA 1.419 -2.884 0 N-CA-C 107.008 -1.958 . . . . 0.0 107.008 168.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.0 m -115.95 150.27 17.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . 0.315 0.0 OUTLIER -97.87 122.6 41.17 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 118.245 -1.382 . . . . 0.0 109.976 166.014 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.2 m -91.99 142.14 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.211 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -174.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 69.23 10.81 7.99 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.876 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.491 ' HD1' ' O ' ' A' ' 60' ' ' ASP . 67.6 t80 -54.7 -40.89 69.63 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.895 0.878 . . . . 0.0 108.949 171.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.3 m -61.34 -45.47 94.28 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.591 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.7 tt -75.81 -34.5 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.248 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -53.73 -48.46 69.61 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 123.413 0.685 . . . . 0.0 112.1 176.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.5 m -71.87 -21.83 21.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.0 t -88.79 -69.06 0.73 Allowed 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 120.718 0.294 . . . . 0.0 111.253 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -124.84 -29.05 3.43 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.898 -0.501 . . . . 0.0 111.986 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.408 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 25.7 ttt 76.35 88.32 0.08 Allowed 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.63 ' HB2' ' CZ ' ' A' ' 174' ' ' PHE . 87.5 tttt 41.87 -86.54 0.01 OUTLIER 'General case' 0 C--N 1.345 0.375 0 O-C-N 125.138 1.524 . . . . 0.0 114.584 167.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 29.7 t70 152.95 -25.36 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.136 1.774 . . . . 0.0 106.348 -175.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.6 tpt 43.86 78.19 0.06 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-N 113.115 -1.857 . . . . 0.0 112.244 -169.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 54.0 t -110.22 140.87 43.9 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 176.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 19.3 p -68.69 122.93 19.57 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.1 t70 68.95 103.9 0.06 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.462 1.105 . . . . 0.0 108.694 -169.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.584 ' CD1' ' HE3' ' A' ' 129' ' ' LYS . 59.6 t-105 -150.69 134.81 16.88 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.752 -170.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -107.37 123.69 48.73 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.465 ' HB ' ' NE1' ' A' ' 135' ' ' TRP . 16.2 tt -123.53 134.34 66.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.743 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -85.11 114.35 22.18 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.511 -175.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.468 ' HH ' HD23 ' A' ' 141' ' ' LEU . 3.5 t80 -133.11 155.9 48.41 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.737 0.815 . . . . 0.0 110.945 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -151.14 155.1 38.21 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.468 HD23 ' HH ' ' A' ' 139' ' ' TYR . 1.7 pt? -136.94 117.06 13.38 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.568 0.699 . . . . 0.0 109.152 169.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -91.86 117.26 29.63 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 158' ' ' PRO . 41.4 mm -106.96 140.03 26.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.586 -0.845 . . . . 0.0 110.793 -173.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -127.99 102.54 0.59 Allowed Glycine 0 N--CA 1.423 -2.172 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 145' ' ' LEU . 1.1 pp -94.97 137.76 33.6 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.219 -0.592 . . . . 0.0 111.051 178.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.2 m -116.89 127.23 54.07 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.74 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.654 ' CE1' HG21 ' A' ' 80' ' ' ILE . 87.0 m-85 -128.56 143.9 51.05 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.785 175.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -104.04 110.26 22.36 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 66.1 mt -123.54 114.55 28.65 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -41.79 -36.13 3.25 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 124.827 3.684 . . . . 0.0 115.08 -175.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 56.9 t -55.25 -40.55 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 122.942 0.497 . . . . 0.0 111.544 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 51.9 t -117.72 -45.93 3.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.925 0.393 . . . . 0.0 110.639 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 129.69 -150.89 19.12 Favored Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -81.07 116.99 21.28 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 177.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 28.7 pt -124.0 128.53 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 37.3 m -104.62 116.6 32.35 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 174.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 70.1 mt -101.92 112.73 65.66 Favored Pre-proline 0 C--N 1.293 -1.891 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.005 -176.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 6.6 Cg_endo -82.98 132.8 6.4 Favored 'Trans proline' 0 CA--C 1.482 -2.12 0 C-N-CA 122.863 2.375 . . . . 0.0 112.532 176.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.434 HG13 ' HB ' ' A' ' 143' ' ' ILE . 2.7 p -134.51 123.35 42.17 Favored 'Isoleucine or valine' 1 N--CA 1.372 -4.335 0 CA-C-N 112.582 -2.099 . . . . 0.0 108.918 -179.353 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 15.4 m -116.43 156.76 26.23 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.578 -174.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.442 ' CG2' ' HB ' ' A' ' 49' ' ' VAL . 9.9 t -173.82 171.36 3.75 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -113.5 145.82 40.59 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 120.915 0.388 . . . . 0.0 110.442 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -118.4 103.4 1.03 Allowed Glycine 0 N--CA 1.426 -2.023 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -88.61 121.13 30.66 Favored 'General case' 0 C--N 1.268 -2.978 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.5 ' CD1' HG23 ' A' ' 52' ' ' VAL . 30.4 mm -110.28 109.27 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.432 -173.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -94.4 126.23 39.54 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.65 172.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 95.2 mt -115.51 88.23 19.01 Favored Pre-proline 0 C--N 1.293 -1.858 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.066 -176.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -82.95 86.57 1.45 Allowed 'Trans proline' 0 N--CA 1.434 -2.0 0 C-N-CA 122.52 2.147 . . . . 0.0 113.109 -176.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 57.3 p 55.1 92.83 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 175.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 5.1 mp -108.51 -61.16 1.64 Allowed 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.326 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . 0.299 86.1 mtm180 62.26 109.11 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -176.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . 0.319 21.4 m-20 85.05 -9.34 0.85 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.171 1.788 . . . . 0.0 114.4 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -81.8 -69.09 0.64 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 169.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.63 ' CZ ' ' HB2' ' A' ' 129' ' ' LYS . 88.8 t80 . . . . . 0 N--CA 1.427 -1.579 0 C-N-CA 126.195 1.798 . . . . 0.0 106.456 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.308 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -96.81 102.33 14.09 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.745 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -147.87 107.07 3.87 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -82.72 46.36 1.07 Allowed 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.816 0.817 . . . . 0.0 109.059 -175.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.5 t60 -67.48 113.16 5.1 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.807 -177.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -130.16 155.18 46.65 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -173.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.3 m80 71.63 149.3 0.09 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.149 1.38 . . . . 0.0 112.216 -177.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.6 tp 71.84 -61.6 0.49 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.834 1.254 . . . . 0.0 112.461 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -73.85 -49.02 27.02 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.286 -176.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.68 99.47 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.215 0.531 . . . . 0.0 110.544 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.0 p -71.41 -19.25 62.28 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.894 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.82 -44.11 70.65 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 177.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.405 ' HA ' HG23 ' A' ' 16' ' ' VAL . 26.3 m-20 -68.78 -37.78 79.56 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.73 -48.44 77.76 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.524 -1.217 . . . . 0.0 109.036 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -69.19 -47.09 65.84 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.487 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.405 HG23 ' HA ' ' A' ' 13' ' ' ASP . 35.2 m -65.51 -32.38 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -176.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.5 p -73.07 -28.63 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.845 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -70.25 -37.48 74.94 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.424 ' O ' HG22 ' A' ' 23' ' ' VAL . 18.2 mm-40 -56.27 -41.69 76.25 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.449 174.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.533 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 9.9 mmpt? -64.11 -46.56 83.64 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.577 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.87 -43.14 85.79 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.576 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.1 t -59.22 -31.77 69.34 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 19' ' ' GLU . 64.4 t -75.46 -48.78 29.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.6 mt -61.35 -52.32 62.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.924 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.5 m -65.63 -22.46 66.66 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.602 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.7 t -66.23 -44.85 82.61 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.8 tt -75.73 -40.14 56.09 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.437 ' HA ' ' OG1' ' A' ' 156' ' ' THR . 6.1 tt -61.58 -35.18 77.09 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.686 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -67.11 -47.34 71.46 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.017 0.527 . . . . 0.0 112.018 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -66.18 -33.59 76.11 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.234 0.54 . . . . 0.0 110.947 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.86 -32.12 61.81 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.978 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.96 -46.45 89.22 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.611 0.243 . . . . 0.0 111.003 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.66 -32.59 82.04 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.971 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -78.98 -48.96 13.52 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.435 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 68.4 t80 -53.56 -38.75 64.17 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.59 -46.88 58.15 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 123.917 0.761 . . . . 0.0 113.006 -176.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -116.89 -36.51 3.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.362 0.601 . . . . 0.0 112.507 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -77.43 -33.49 54.88 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -168.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.435 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 89.9 mt -100.06 13.46 34.0 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.874 0.845 . . . . 0.0 109.816 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.51 -37.07 12.11 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 172.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -73.53 -50.08 23.25 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.722 176.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.6 mt -80.49 119.46 76.4 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.917 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.54 120.27 8.0 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.45 2.1 . . . . 0.0 111.983 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 p -127.24 156.75 74.23 Favored Pre-proline 0 C--N 1.288 -2.079 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.266 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.66 133.12 40.74 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.372 2.048 . . . . 0.0 110.839 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.0 110.02 22.65 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -177.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.5 140.32 41.99 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.343 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 t -142.32 136.59 29.85 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 121.336 0.589 . . . . 0.0 110.738 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.5 t -83.98 141.25 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -115.42 -59.61 1.98 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.346 -0.942 . . . . 0.0 113.342 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -169.59 -173.61 1.69 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -175.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . 36.0 m -131.51 154.99 41.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 118.41 0.55 . . . . 0.0 111.069 -176.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -129.84 116.18 18.32 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.381 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.574 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 46.6 p90 -82.36 141.28 32.96 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.527 ' HE2' ' C ' ' A' ' 54' ' ' PHE . 0.4 OUTLIER -89.69 -78.15 0.37 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.986 175.196 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.59 -117.7 0.41 Allowed Glycine 0 C--O 1.211 -1.314 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.253 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.8 t -99.3 140.54 18.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 60' ' ' ASP . 57.4 m -147.08 149.77 33.71 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -72.3 -19.32 61.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.335 0.588 . . . . 0.0 111.336 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.454 ' H ' HG22 ' A' ' 58' ' ' THR . 7.4 m-20 -122.97 86.38 2.57 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.204 175.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.48 -133.89 30.5 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.356 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 93.0 t -134.45 143.2 38.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -89.65 105.49 17.83 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.675 0.75 . . . . 0.0 110.171 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.784 ' CD1' ' HB ' ' A' ' 119' ' ' VAL . 7.8 m-85 -102.63 141.46 35.42 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.479 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 15.6 m-70 -101.13 108.9 20.69 Favored 'General case' 0 C--N 1.282 -2.351 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.053 170.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -78.54 135.22 37.26 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.436 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -90.03 117.75 29.05 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.606 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.8 t -129.61 111.89 23.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.2 p -100.45 137.16 39.24 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.252 0.549 . . . . 0.0 111.979 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.6 t -127.66 132.41 69.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.881 -177.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -116.8 142.87 46.35 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.485 HD21 ' HA2' ' A' ' 107' ' ' GLY . 38.1 t30 -140.93 115.76 7.27 Favored Pre-proline 0 C--N 1.286 -2.177 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.677 -175.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -90.33 97.38 0.27 Allowed 'Trans proline' 0 N--CA 1.426 -2.45 0 C-N-CA 121.406 1.404 . . . . 0.0 112.228 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.471 ' HB3' ' H ' ' A' ' 76' ' ' GLN . 18.8 m-85 -167.78 -168.65 1.03 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 126.967 2.107 . . . . 0.0 107.372 177.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.1 t -132.98 7.48 4.01 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 170.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.471 ' H ' ' HB3' ' A' ' 74' ' ' TYR . 11.5 pt20 -97.63 142.19 29.75 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.594 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.5 p -79.62 102.58 8.99 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-O 120.944 0.402 . . . . 0.0 110.33 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.469 ' HB ' HD21 ' A' ' 105' ' ' LEU . 78.7 mt -92.6 117.67 67.69 Favored Pre-proline 0 C--N 1.31 -1.145 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 177.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -78.22 130.37 10.13 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 122.162 1.908 . . . . 0.0 112.747 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.463 ' HB ' ' CE1' ' A' ' 147' ' ' PHE . 9.9 tt -82.6 94.38 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 174.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 57.9 m -58.79 -42.13 88.33 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.845 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -156.87 148.55 22.55 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.617 -171.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.5 tt -128.58 116.36 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 173.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 28.6 p -120.26 118.72 31.18 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.717 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.489 ' CE1' HG13 ' A' ' 117' ' ' VAL . 43.6 p90 -109.04 147.98 31.5 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.414 -176.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.422 HD12 ' N ' ' A' ' 86' ' ' ILE . 3.0 mp -120.31 113.26 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 175.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.677 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 0.9 OUTLIER -99.51 137.25 38.27 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.521 ' N ' HD22 ' A' ' 87' ' ' LEU . 45.4 mtpt -129.1 153.89 47.22 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 172.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.5 t -158.97 140.4 13.21 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 119.027 -1.069 . . . . 0.0 113.2 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 60.38 -79.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.805 1.642 . . . . 0.0 114.595 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -167.32 -32.48 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.099 0.476 . . . . 0.0 109.89 -175.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -129.09 141.94 51.05 Favored 'General case' 0 CA--C 1.49 -1.343 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.883 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 122' ' ' SER . 7.2 m 75.39 134.21 0.05 Allowed 'General case' 0 C--N 1.307 -1.25 0 O-C-N 125.177 1.548 . . . . 0.0 112.354 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.677 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.6 pp -138.2 174.79 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.199 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.412 ' HB1' HD13 ' A' ' 87' ' ' LEU . . . -132.63 162.01 32.42 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 119.095 0.862 . . . . 0.0 111.026 175.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.0 m -143.36 153.68 42.95 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -154.96 149.93 21.33 Favored Glycine 0 N--CA 1.419 -2.472 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 93.2 m -141.32 108.51 5.49 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.4 mt -115.03 110.21 46.16 Favored Pre-proline 0 C--N 1.306 -1.316 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.776 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -72.16 131.06 17.33 Favored 'Trans proline' 0 C--O 1.238 0.502 0 C-N-CA 122.533 2.155 . . . . 0.0 109.645 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.314 4.0 p30 44.72 77.94 0.42 Allowed Pre-proline 0 N--CA 1.487 1.394 0 C-N-CA 124.622 1.169 . . . . 0.0 114.107 -175.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -87.91 -8.71 5.77 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.874 2.383 . . . . 0.0 113.556 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 173.36 -161.77 32.71 Favored Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.592 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 46.2 m -119.86 142.03 49.02 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.209 0.528 . . . . 0.0 110.719 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.469 HD21 ' HB ' ' A' ' 78' ' ' ILE . 41.5 tp -97.04 141.37 30.28 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 61.0 t -89.77 107.46 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.247 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 171.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.485 ' HA2' HD21 ' A' ' 72' ' ' ASN . . . -57.06 -22.49 42.79 Favored Glycine 0 C--N 1.292 -1.89 0 CA-C-N 114.317 -1.311 . . . . 0.0 113.627 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.4 p -120.23 11.72 11.63 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -156.57 -161.93 11.1 Favored Glycine 0 CA--C 1.498 -1.009 0 C-N-CA 117.135 -2.459 . . . . 0.0 114.996 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.4 m -101.7 129.85 47.95 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.0 t -127.47 133.21 49.91 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 40.1 t -97.78 115.92 39.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.1 mt -102.81 160.93 14.16 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.453 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 7.3 p-10 -133.45 130.81 39.14 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 9.6 t -104.78 126.18 31.91 Favored Pre-proline 0 C--N 1.305 -1.368 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -71.04 110.47 2.82 Favored 'Trans proline' 0 N--CA 1.433 -2.054 0 N-CA-C 106.818 -2.031 . . . . 0.0 106.818 168.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.489 HG13 ' CE1' ' A' ' 85' ' ' TYR . 97.6 t -116.69 141.39 34.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.568 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -87.17 88.4 7.69 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.17 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.784 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 94.5 t -94.04 145.99 7.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.664 -176.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 72.41 -1.99 2.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.141 0.976 . . . . 0.0 111.245 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -68.45 -43.38 77.19 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.419 ' O ' ' HB ' ' A' ' 93' ' ' THR . 14.4 m -62.0 -28.0 69.26 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 122.491 1.138 . . . . 0.0 109.578 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.434 HD12 ' HZ1' ' A' ' 129' ' ' LYS . 60.6 mt -78.18 -49.45 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.22 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.455 -177.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.03 -36.27 72.47 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.324 0.649 . . . . 0.0 111.517 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.0 t -67.81 -34.72 69.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.421 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.0 t -93.39 -66.77 0.9 Allowed 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -176.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.405 ' H ' HD23 ' A' ' 127' ' ' LEU . 1.8 pt? -124.91 -23.85 4.2 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -176.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 24.2 ttt 56.89 35.59 26.55 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.283 1.033 . . . . 0.0 109.349 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.434 ' HZ1' HD12 ' A' ' 123' ' ' ILE . 61.6 mmtt 69.3 -70.5 0.14 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.033 1.733 . . . . 0.0 106.672 -172.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.411 ' H ' ' H ' ' A' ' 131' ' ' MET . 24.4 t70 149.58 18.71 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 130.855 3.662 . . . . 0.0 102.862 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.563 ' SD ' ' HA ' ' A' ' 171' ' ' ARG . 0.0 OUTLIER 58.53 76.79 0.33 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 113.05 -1.887 . . . . 0.0 106.778 -163.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 64.9 m -106.43 127.62 53.42 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.631 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 169' ' ' SER . 19.0 p -93.29 119.4 32.39 Favored 'General case' 0 N--CA 1.399 -2.982 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.078 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 5.9 m-20 72.85 89.14 0.1 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 176.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -173.15 158.66 3.71 Favored 'General case' 0 C--O 1.246 0.894 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.254 174.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.513 ' HA ' ' HA ' ' A' ' 166' ' ' LYS . 5.1 p-10 -98.45 143.38 28.96 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.441 HD11 ' N ' ' A' ' 137' ' ' ILE . 3.1 mp -124.23 140.46 47.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -177.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -75.81 112.7 12.47 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 122.674 1.226 . . . . 0.0 111.791 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.474 ' CE2' ' HG ' ' A' ' 87' ' ' LEU . 1.2 t80 -125.23 152.01 45.13 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 113.501 -1.682 . . . . 0.0 107.261 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.495 ' HA ' ' HA ' ' A' ' 162' ' ' GLN . 17.4 tt0 -134.08 150.46 51.18 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.1 tp -131.89 117.7 18.84 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 121.703 0.763 . . . . 0.0 110.163 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.4 ' HB3' ' HB ' ' A' ' 86' ' ' ILE . 13.3 t70 -124.76 130.2 51.94 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 -177.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.9 mt -136.81 140.48 42.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.159 -1.016 . . . . 0.0 111.761 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -108.32 93.15 0.78 Allowed Glycine 0 N--CA 1.426 -1.976 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.463 ' HB3' ' CE2' ' A' ' 147' ' ' PHE . 3.1 mm? -68.42 118.96 12.16 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 16.7 m -100.89 108.52 20.31 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.267 -177.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.463 ' CE1' ' HB ' ' A' ' 80' ' ' ILE . 96.3 m-85 -119.26 149.22 42.14 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 176.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 154' ' ' ASP . 4.5 p-10 -102.48 115.97 31.66 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.121 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.3 mp -108.02 105.46 56.44 Favored Pre-proline 0 C--N 1.296 -1.737 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -30.15 -51.14 0.2 Allowed 'Trans proline' 0 N--CA 1.485 1.029 1 C-N-CA 125.694 4.263 . . . . 0.0 116.984 -172.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.404 HG21 HG23 ' A' ' 152' ' ' VAL . 29.7 m -62.29 -21.17 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -177.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.404 HG23 HG21 ' A' ' 151' ' ' VAL . 48.4 t -121.86 -40.73 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.817 0.818 . . . . 0.0 109.754 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 112.8 -148.8 18.49 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 148' ' ' ASP . 6.7 p-10 -86.46 124.42 32.77 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.612 0.72 . . . . 0.0 110.811 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 146' ' ' THR . 2.2 pp -125.35 145.07 33.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.489 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' A' ' 28' ' ' LEU . 46.4 p -94.7 119.57 33.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.652 0.263 . . . . 0.0 110.771 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 55.3 mt -92.78 119.32 67.93 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -70.71 125.48 11.7 Favored 'Trans proline' 0 C--O 1.24 0.579 0 C-N-CA 123.596 2.864 . . . . 0.0 113.409 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 39.0 t -132.81 115.03 23.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 173.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.7 m -125.36 142.8 51.3 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 121.046 -0.262 . . . . 0.0 110.808 -174.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.1 t -176.97 157.11 1.39 Allowed 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.495 ' HA ' ' HA ' ' A' ' 140' ' ' GLN . 30.2 pt20 -99.62 152.45 20.03 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.267 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -120.37 119.57 4.24 Favored Glycine 0 N--CA 1.417 -2.597 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -96.7 120.59 37.3 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 4.2 pt -131.16 112.82 22.42 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 CA-C-O 121.446 0.641 . . . . 0.0 112.191 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 136' ' ' ASP . 40.1 ttmt -90.87 128.24 36.68 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.102 178.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 134' ' ' ASP . 88.4 mt -110.38 107.23 58.4 Favored Pre-proline 0 C--N 1.286 -2.161 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.568 -173.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -71.58 105.09 1.7 Allowed 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.788 2.325 . . . . 0.0 111.835 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 133' ' ' THR 0.268 89.5 p 60.46 -83.96 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 126.025 1.73 . . . . 0.0 114.557 -175.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 10.9 mp 63.44 26.74 14.99 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-O 121.044 0.449 . . . . 0.0 112.189 -176.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.563 ' HA ' ' SD ' ' A' ' 131' ' ' MET . 47.1 ttt180 -77.23 99.08 5.34 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . 0.276 1.8 m-20 80.28 79.45 0.05 OUTLIER 'General case' 0 CA--C 1.49 -1.359 0 CA-C-O 123.089 1.423 . . . . 0.0 109.514 -168.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -170.16 -40.67 0.02 OUTLIER 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 100.718 -3.808 . . . . 0.0 100.718 -177.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 . . . . . 0 N--CA 1.425 -1.703 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 164.372 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.27 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 63.33 87.62 0.11 Allowed 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.573 0.749 . . . . 0.0 109.889 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 72.45 119.22 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.7 -172.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -64.49 -18.53 64.88 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.838 0.351 . . . . 0.0 110.373 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.3 m80 73.61 -74.84 0.08 Allowed 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 125.407 1.483 . . . . 0.0 111.898 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -144.03 179.5 7.16 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.911 0.386 . . . . 0.0 110.787 -177.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -152.94 -57.21 0.13 Allowed 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 171.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 50.1 tp 61.16 -77.58 0.02 OUTLIER 'General case' 0 C--N 1.355 0.82 0 C-N-CA 126.042 1.737 . . . . 0.0 112.571 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -126.08 108.34 11.26 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.19 103.82 3.46 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.184 -173.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.5 p -135.65 -67.03 0.54 Allowed 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 114.594 -1.184 . . . . 0.0 108.99 177.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.36 -33.38 37.31 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.198 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -56.65 -53.85 52.85 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.289 0.636 . . . . 0.0 112.268 -177.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.94 -28.44 62.43 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.218 0.532 . . . . 0.0 111.295 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.51 ' HE2' ' OE1' ' A' ' 19' ' ' GLU . 81.9 tttt -67.69 -55.3 13.75 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.539 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.401 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 32.3 m -60.27 -33.64 54.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -173.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -73.36 -33.43 40.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.093 0.473 . . . . 0.0 110.21 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -72.65 -49.34 32.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.144 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.51 ' OE1' ' HE2' ' A' ' 15' ' ' LYS . 8.9 pt-20 -64.36 -31.73 73.05 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.978 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.486 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 1.1 tpmt? -61.98 -48.78 78.82 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.83 -39.48 94.47 Favored 'General case' 0 C--O 1.21 -0.991 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.829 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.5 t -60.53 -44.51 95.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 66.6 t -69.47 -43.87 80.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 20' ' ' LYS . 78.7 mt -61.03 -45.25 98.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.397 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.7 t -57.42 -41.71 80.92 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 123.041 0.536 . . . . 0.0 110.055 177.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.8 t -66.79 -26.27 66.87 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-O 121.013 0.435 . . . . 0.0 110.912 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 tt -76.36 -55.19 5.78 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.571 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 8.4 mp -59.3 -36.39 75.51 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -51.23 -45.7 62.05 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.09 0.556 . . . . 0.0 111.843 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -82.95 -31.2 27.79 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 177.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.96 -32.27 73.56 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.116 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.571 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 61.4 mtpt -57.18 -27.85 62.3 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.484 0.713 . . . . 0.0 110.819 175.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.55 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -74.12 -55.77 5.58 Favored Glycine 0 N--CA 1.438 -1.228 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 178.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -56.1 -40.98 74.52 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.763 0.316 . . . . 0.0 110.836 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.409 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 48.7 t80 -67.21 -37.48 83.7 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.27 -34.75 63.66 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.987 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 33' ' ' GLY . 11.1 pt-20 -104.72 -44.37 4.88 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -176.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -87.93 -43.94 11.4 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.682 0.753 . . . . 0.0 109.659 -170.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 67.2 mt -87.16 12.13 12.35 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.647 -176.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.05 -40.72 15.47 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 173.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.529 ' OD1' HG13 ' A' ' 42' ' ' ILE . 8.4 p30 -87.72 -36.43 17.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.452 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.529 HG13 ' OD1' ' A' ' 41' ' ' ASN . 85.4 mt -88.84 113.8 57.38 Favored Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -79.0 101.04 1.4 Allowed 'Trans proline' 0 N--CA 1.435 -1.97 0 C-N-CA 121.955 1.77 . . . . 0.0 113.628 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.9 p -93.04 149.94 38.4 Favored Pre-proline 0 N--CA 1.419 -1.987 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.442 ' HB3' ' HA ' ' A' ' 72' ' ' ASN . 10.9 Cg_endo -53.37 141.87 59.52 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.279 1.986 . . . . 0.0 110.246 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -96.53 141.99 29.15 Favored 'General case' 0 CA--C 1.484 -1.563 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.685 -172.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.48 137.35 53.24 Favored 'General case' 0 N--CA 1.414 -2.254 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.877 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.2 t -134.34 126.03 28.82 Favored 'General case' 0 C--N 1.272 -2.779 0 CA-C-O 121.635 0.731 . . . . 0.0 109.985 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.501 HG13 ' CG1' ' A' ' 143' ' ' ILE . 35.5 m -107.38 141.72 21.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.164 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.491 ' HB2' ' O ' ' A' ' 49' ' ' VAL . 27.5 t70 161.8 66.81 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 124.898 1.374 . . . . 0.0 112.684 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -177.47 117.86 0.1 Allowed 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 168.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.2 t -132.03 112.69 20.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -121.53 141.88 50.62 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.9 -176.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -77.0 128.14 33.96 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.732 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -120.22 -3.09 10.05 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.656 -0.818 . . . . 0.0 112.047 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.0 158.29 25.92 Favored Glycine 0 CA--C 1.489 -1.567 0 C-N-CA 119.214 -1.469 . . . . 0.0 112.84 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.48 ' HB ' ' CE1' ' A' ' 173' ' ' PHE . 7.5 p -106.8 116.29 50.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.716 0.77 . . . . 0.0 112.336 -176.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.553 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 88.4 m -132.55 130.67 40.65 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 174.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -82.01 -12.2 58.43 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.211 0.529 . . . . 0.0 111.196 -174.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -114.33 69.16 0.7 Allowed 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 172.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.553 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . 100.33 101.37 2.41 Favored Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.117 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.0 p -76.2 143.07 13.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 121.164 0.507 . . . . 0.0 110.889 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -89.45 114.89 26.44 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -172.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.635 ' CD1' ' HB ' ' A' ' 119' ' ' VAL . 32.9 m-85 -120.87 151.26 39.87 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.056 173.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -120.51 109.19 14.99 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.93 144.75 34.53 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.933 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -102.4 118.76 37.56 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.599 -176.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.6 t -111.06 108.37 25.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 175.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.6 p -99.85 123.83 44.51 Favored 'General case' 0 C--N 1.285 -2.201 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.713 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.7 t -114.96 128.01 72.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.722 -176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 71' ' ' LYS . 19.2 ptpt -102.35 110.48 22.45 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.591 ' O ' ' HA ' ' A' ' 108' ' ' SER . 34.1 t30 -109.98 113.9 56.67 Favored Pre-proline 0 C--N 1.265 -3.075 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.107 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -97.67 95.97 0.07 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.686 0 C-N-CA 121.605 1.537 . . . . 0.0 109.65 169.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -176.19 156.29 1.63 Allowed 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 127.468 2.307 . . . . 0.0 106.54 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.5 m -82.92 -18.59 39.57 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.656 0.741 . . . . 0.0 109.242 176.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.507 HE21 HG12 ' A' ' 78' ' ' ILE . 11.0 pt20 -96.83 146.78 24.6 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.674 -178.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.4 m -84.59 106.43 16.15 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 171.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.507 HG12 HE21 ' A' ' 76' ' ' GLN . 59.1 mt -76.19 116.15 53.4 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -56.99 137.02 80.12 Favored 'Trans proline' 0 C--O 1.239 0.569 0 C-N-CA 123.228 2.618 . . . . 0.0 113.757 -175.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 146' ' ' THR . 9.4 pt -112.64 98.59 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.952 175.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 51.6 t -52.6 -54.9 26.84 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.188 -177.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -145.71 160.64 41.43 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.511 ' CG2' ' HB ' ' A' ' 99' ' ' ILE . 14.9 tt -134.87 113.83 16.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 175.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 55.0 p -94.63 123.3 37.99 Favored 'General case' 0 C--N 1.287 -2.144 0 O-C-N 121.956 -0.465 . . . . 0.0 111.421 -175.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.426 ' HA ' HD11 ' A' ' 143' ' ' ILE . 36.4 p90 -103.81 129.86 51.3 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 2.5 mp -117.12 107.17 21.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 176.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.578 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 1.3 tt -92.35 132.56 36.63 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.464 ' N ' HD23 ' A' ' 87' ' ' LEU . 62.1 tttm -130.46 143.48 50.79 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.1 p -144.05 95.39 2.72 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 55.59 -81.84 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 171.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.6 p -83.98 -71.68 0.5 Allowed 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 -168.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -137.31 -64.92 0.55 Allowed 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 m -66.76 139.55 57.81 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 121.513 0.673 . . . . 0.0 112.086 -173.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.578 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.7 pp -139.7 170.65 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.484 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 -178.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.421 ' HB3' HD11 ' A' ' 87' ' ' LEU . . . -138.06 136.5 36.89 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.3 t -149.08 159.85 43.86 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.909 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.56 161.08 24.35 Favored Glycine 0 N--CA 1.422 -2.262 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 64.6 p -101.34 127.23 48.06 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.511 ' HB ' ' CG2' ' A' ' 83' ' ' ILE . 66.4 mt -97.15 110.07 52.44 Favored Pre-proline 0 C--N 1.306 -1.303 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.853 175.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -78.31 115.56 3.73 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.097 1.864 . . . . 0.0 110.828 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.7 t70 60.4 86.05 0.16 Allowed Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.868 -176.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -97.05 5.42 1.58 Allowed 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.903 2.402 . . . . 0.0 111.581 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 145.59 -164.71 28.06 Favored Glycine 0 N--CA 1.419 -2.484 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.3 m -137.95 155.59 48.73 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.43 HD21 ' CE1' ' A' ' 147' ' ' PHE . 6.9 mp -72.02 150.84 43.64 Favored 'General case' 0 CA--C 1.485 -1.555 0 CA-C-O 121.803 0.811 . . . . 0.0 111.149 176.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.447 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 11.1 p -88.2 139.13 17.85 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.143 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.274 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -66.49 90.77 0.16 Allowed Glycine 0 C--N 1.304 -1.231 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 72' ' ' ASN 0.252 79.6 p 63.09 86.74 0.11 Allowed 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 125.973 1.709 . . . . 0.0 113.537 -178.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 169.35 -163.86 37.46 Favored Glycine 0 N--CA 1.431 -1.669 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.5 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.7 m -119.29 115.99 25.31 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.447 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 5.1 t -110.23 132.2 54.38 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.106 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.2 t -95.72 113.09 29.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.6 mt -92.67 150.09 20.91 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.312 -177.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -105.02 119.66 39.57 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.365 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.54 117.84 30.01 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-O 121.17 0.51 . . . . 0.0 111.319 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.37 123.13 10.2 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.208 1.939 . . . . 0.0 111.143 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 57.4 t -125.26 136.64 60.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -88.17 93.56 9.54 Favored 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.635 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 96.2 t -93.76 146.44 6.55 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.826 -171.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 72.31 -4.29 2.07 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.121 1.368 . . . . 0.0 112.799 174.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.438 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . 44.9 t80 -67.13 -32.46 73.6 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.7 p -64.86 -35.2 80.36 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.041 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.8 mm -71.78 -46.98 58.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.021 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.4 -48.02 83.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.471 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.8 p -72.26 -25.46 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 CA-C-O 121.013 0.435 . . . . 0.0 111.35 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 39.2 t -80.8 -76.04 0.25 Allowed 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.825 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.571 HD13 ' N ' ' A' ' 128' ' ' MET . 2.5 pp -124.68 -37.26 2.5 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -175.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.571 ' N ' HD13 ' A' ' 127' ' ' LEU . 9.8 tpt 61.94 109.97 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.486 0.714 . . . . 0.0 111.49 -176.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -78.47 -30.07 47.16 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.411 ' HA ' ' HE3' ' A' ' 128' ' ' MET . 14.1 m-20 80.15 97.78 0.06 Allowed 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 113.533 -1.667 . . . . 0.0 110.76 -175.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.402 ' HE1' ' O ' ' A' ' 168' ' ' PRO . 0.1 OUTLIER -64.33 139.83 58.81 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.133 -1.394 . . . . 0.0 110.395 -176.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 49.7 t -138.37 -81.54 0.32 Allowed 'General case' 0 CA--C 1.56 1.364 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.607 ' HA ' ' CB ' ' A' ' 169' ' ' SER . 14.1 p -144.29 130.81 19.95 Favored 'General case' 0 N--CA 1.426 -1.645 0 C-N-CA 125.541 1.536 . . . . 0.0 109.652 -171.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 44.56 89.56 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 C-N-CA 124.632 1.173 . . . . 0.0 110.138 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 69.5 t-105 -128.99 150.21 50.5 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -162.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -136.94 136.26 38.44 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.031 0.932 . . . . 0.0 109.893 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 22.6 pt -132.41 136.66 55.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 173.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -87.18 121.14 29.23 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.52 ' CE2' ' HG ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -149.61 161.74 41.56 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -175.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -164.16 158.94 19.71 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 117.889 0.313 . . . . 0.0 110.822 171.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.599 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 1.5 pt? -136.12 132.29 35.88 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-O 121.0 0.429 . . . . 0.0 109.96 176.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.456 ' HA ' ' HB3' ' A' ' 160' ' ' SER . 15.2 t70 -101.84 120.84 41.02 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 175.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.501 ' CG1' HG13 ' A' ' 49' ' ' VAL . 45.8 mm -100.66 133.07 45.02 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 CA-C-O 120.832 0.349 . . . . 0.0 110.693 -176.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -114.75 86.41 0.41 Allowed Glycine 0 N--CA 1.41 -3.096 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 174.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.557 HD12 ' H ' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -81.05 146.42 30.64 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.304 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 30.3 m -127.84 114.45 17.24 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 119.051 -1.06 . . . . 0.0 112.248 -176.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.437 ' CZ ' ' HG2' ' A' ' 45' ' ' PRO . 50.3 m-85 -99.14 160.3 14.37 Favored 'General case' 0 C--O 1.246 0.875 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 174.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -121.37 126.85 50.41 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.846 174.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.7 125.33 18.36 Favored Pre-proline 0 C--N 1.301 -1.512 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.092 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.54 -28.68 22.5 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 C-N-CA 123.953 3.102 . . . . 0.0 113.737 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.94 -38.39 76.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.506 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 41.3 t -124.84 -45.29 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.264 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 129.15 -133.58 7.62 Favored Glycine 0 N--CA 1.428 -1.847 0 C-N-CA 121.026 -0.607 . . . . 0.0 111.758 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -100.33 117.34 34.32 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.857 0.863 . . . . 0.0 108.931 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.405 ' N ' HD12 ' A' ' 155' ' ' ILE . 2.7 mp -128.75 119.5 49.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.494 178.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 86.4 m -82.07 112.11 18.83 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 173.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.463 ' O ' HD12 ' A' ' 145' ' ' LEU . 70.0 mt -93.5 117.15 67.29 Favored Pre-proline 0 C--N 1.299 -1.587 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.285 -176.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.7 Cg_endo -82.83 133.87 7.03 Favored 'Trans proline' 0 CA--C 1.489 -1.774 0 C-N-CA 122.88 2.387 . . . . 0.0 112.728 176.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.28 131.4 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.106 0 CA-C-N 113.097 -1.865 . . . . 0.0 109.062 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.456 ' HB3' ' HA ' ' A' ' 142' ' ' ASP . 12.3 p -147.29 162.43 38.96 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.4 t -153.5 178.22 10.06 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -98.69 132.41 44.1 Favored 'General case' 0 N--CA 1.422 -1.864 0 C-N-CA 118.661 -1.215 . . . . 0.0 108.801 176.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.485 ' O ' ' HD1' ' A' ' 139' ' ' TYR . . . -97.1 76.82 0.67 Allowed Glycine 0 N--CA 1.399 -3.821 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -87.82 119.88 28.6 Favored 'General case' 0 C--N 1.271 -2.842 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.7 pt -117.55 108.38 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.765 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.236 -176.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 16.7 pttt -98.41 98.61 9.81 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 113.195 -1.82 . . . . 0.0 109.571 -177.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 88.4 mt -87.14 127.62 58.6 Favored Pre-proline 0 C--N 1.282 -2.346 0 CA-C-N 112.228 -2.26 . . . . 0.0 111.935 -169.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.402 ' O ' ' HE1' ' A' ' 131' ' ' MET . 37.5 Cg_endo -69.79 150.74 68.43 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.079 1.853 . . . . 0.0 108.334 173.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.607 ' CB ' ' HA ' ' A' ' 133' ' ' THR . 2.3 m -51.16 99.35 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -177.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -101.52 -27.31 13.18 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 170.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.53 -65.6 0.2 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.066 1.746 . . . . 0.0 109.943 -178.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -116.24 95.33 5.03 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 122.168 0.985 . . . . 0.0 109.592 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.48 ' CE1' ' HB ' ' A' ' 57' ' ' VAL . 72.7 t80 -157.47 -47.61 0.07 Allowed 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 103.164 -2.902 . . . . 0.0 103.164 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 41.4 t80 . . . . . 0 N--CA 1.416 -2.173 0 CA-C-N 113.206 -1.816 . . . . 0.0 106.3 167.929 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.958 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -148.13 137.91 22.42 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -177.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 72.3 -47.59 0.67 Allowed 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 175.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 33.7 p80 51.83 94.09 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.878 1.271 . . . . 0.0 112.193 -175.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -71.84 65.37 0.52 Allowed 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -173.09 154.93 2.88 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 127.472 2.309 . . . . 0.0 108.029 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 47.6 m80 66.76 35.45 5.07 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 123.964 0.79 . . . . 0.0 110.858 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.458 HD23 ' HG3' ' A' ' 9' ' ' GLU . 4.4 tt -65.3 -59.27 4.23 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.458 ' HG3' HD23 ' A' ' 8' ' ' LEU . 48.2 mt-10 -121.65 -21.38 6.19 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.93 174.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 63.24 82.39 0.18 Allowed 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -172.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.0 m -78.27 163.97 25.29 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.58 -173.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.26 -35.51 81.27 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.81 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -57.25 -55.67 31.74 Favored 'General case' 0 CA--C 1.495 -1.153 0 O-C-N 123.76 0.662 . . . . 0.0 109.428 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -53.7 -35.14 60.8 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.324 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -74.88 -56.18 5.04 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.25 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.83 -34.72 57.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -172.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 p -68.46 -32.5 55.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.203 0.525 . . . . 0.0 110.349 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -74.89 -47.13 31.64 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.488 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.41 ' O ' HG21 ' A' ' 23' ' ' VAL . 13.4 pt-20 -71.15 -36.99 72.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.413 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -65.17 -39.4 92.87 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.48 -37.72 88.38 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.986 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -59.94 -50.62 73.04 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.655 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 19' ' ' GLU . 95.7 t -59.66 -51.06 77.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.902 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.519 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 50.4 mm -63.28 -36.1 74.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.195 -177.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.8 t -62.77 -35.68 80.6 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.424 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.5 m -72.25 -35.85 68.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.097 0.475 . . . . 0.0 110.145 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.522 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 5.3 tt -66.78 -40.25 88.1 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 85.5 mt -61.8 -41.09 97.32 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -57.87 -45.82 85.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.669 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -66.23 -30.67 71.16 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-O 121.099 0.476 . . . . 0.0 110.955 -179.544 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.513 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -78.02 -34.73 50.54 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 120.987 0.423 . . . . 0.0 111.787 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 29.0 mtpp -69.11 9.44 0.42 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -177.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -113.08 -18.34 7.32 Favored Glycine 0 C--N 1.313 -0.723 0 C-N-CA 120.341 -0.933 . . . . 0.0 111.371 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.442 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 68.4 m-85 -80.25 -25.53 39.47 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.44 ' HA ' HD12 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -56.19 -29.96 61.62 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -171.592 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.71 -34.04 25.0 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -115.79 -46.81 2.82 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 34' ' ' PHE . 5.4 tmmm? -82.71 -20.75 35.46 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-O 120.898 0.38 . . . . 0.0 110.311 -173.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 35' ' ' PHE . 42.7 mt -96.3 0.06 50.3 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.299 176.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.88 -57.07 2.85 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.819 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -81.64 -2.81 51.65 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.228 0.537 . . . . 0.0 111.979 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 75.6 mt -121.46 125.17 26.94 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.97 107.03 0.32 Allowed 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.739 2.293 . . . . 0.0 111.704 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.7 p -134.33 153.06 79.13 Favored Pre-proline 0 C--N 1.302 -1.487 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.963 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -79.25 164.41 24.36 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.544 2.163 . . . . 0.0 113.58 -176.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -112.86 143.01 44.85 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.93 152.22 50.5 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.128 -175.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.3 t -147.69 128.97 14.76 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.265 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -94.09 141.7 14.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 175.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -118.05 -66.81 1.04 Allowed 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -170.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -158.58 167.07 30.56 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -171.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.56 HG12 ' OH ' ' A' ' 139' ' ' TYR . 14.5 p -126.97 132.68 69.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.723 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -104.71 135.84 45.34 Favored 'General case' 0 C--O 1.251 1.15 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.343 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.502 ' O ' ' HE2' ' A' ' 55' ' ' LYS . 48.7 p90 -60.45 140.76 57.1 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 174.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.502 ' HE2' ' O ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -136.11 -66.72 0.54 Allowed 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.914 -171.157 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.09 -164.76 15.3 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.202 -176.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.24 128.31 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-O 121.452 0.644 . . . . 0.0 111.515 -177.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 44.9 m -152.29 126.51 9.23 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 173.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -69.82 -32.44 70.87 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -169.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -108.6 11.42 26.64 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.02 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.503 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . 170.1 86.95 0.06 OUTLIER Glycine 0 CA--C 1.492 -1.374 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -177.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.76 140.39 19.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.534 0.683 . . . . 0.0 110.991 -173.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -96.26 106.75 19.0 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 121.691 0.757 . . . . 0.0 112.02 -175.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.479 ' HB3' HG21 ' A' ' 52' ' ' VAL . 3.3 m-85 -100.97 165.36 11.37 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.246 174.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.456 ' CD2' ' HG2' ' A' ' 55' ' ' LYS . 20.0 m-70 -124.89 110.26 14.03 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.284 0.564 . . . . 0.0 109.553 176.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . . . -78.45 144.91 35.36 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.589 -177.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -90.46 112.61 24.3 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.556 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.2 t -118.33 114.61 45.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.4 m -98.2 131.29 44.68 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -177.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 95.4 t -118.84 133.0 67.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.533 0.682 . . . . 0.0 111.077 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -102.78 109.97 21.73 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -130.33 113.2 16.94 Favored Pre-proline 0 C--N 1.302 -1.497 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.95 -175.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -102.88 97.59 0.04 OUTLIER 'Trans proline' 0 N--CA 1.421 -2.755 0 C-N-CA 122.319 2.013 . . . . 0.0 113.081 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -176.52 150.78 0.9 Allowed 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 170.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.5 t -77.87 8.03 5.15 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 118.039 0.381 . . . . 0.0 111.487 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.41 ' CD ' HG12 ' A' ' 78' ' ' ILE . 6.4 tt0 -101.56 137.64 39.61 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.7 p -94.08 95.57 9.09 Favored 'General case' 0 N--CA 1.399 -2.98 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 170.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.431 ' HB ' HD12 ' A' ' 105' ' ' LEU . 33.6 mt -77.88 126.36 84.12 Favored Pre-proline 0 N--CA 1.434 -1.235 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -174.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.0 133.95 30.51 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.308 2.006 . . . . 0.0 110.538 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 67.7 mt -83.93 107.04 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 55.5 m -55.76 -51.82 66.06 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.853 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -160.55 155.2 23.85 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.253 0.549 . . . . 0.0 110.274 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.422 HG21 HG22 ' A' ' 143' ' ' ILE . 24.8 mm -114.95 113.85 44.81 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 172.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.3 m -93.48 117.28 29.88 Favored 'General case' 0 C--N 1.274 -2.687 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -107.89 129.56 55.08 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.519 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 142' ' ' ASP . 3.0 mp -118.11 108.0 23.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.493 HD23 ' CE2' ' A' ' 139' ' ' TYR . 3.1 tm? -109.96 124.65 51.77 Favored 'General case' 0 C--N 1.27 -2.88 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.847 -175.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.549 ' O ' ' HB2' ' A' ' 139' ' ' TYR . 29.9 mmtm -93.7 142.81 26.93 Favored 'General case' 0 CA--C 1.479 -1.774 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.738 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 92' ' ' ARG . 45.9 t -97.92 145.54 26.35 Favored 'General case' 0 C--N 1.267 -2.996 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.65 143.83 56.91 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.296 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.4 m 74.1 -61.03 0.51 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.455 1.102 . . . . 0.0 111.001 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.406 ' O ' ' HB3' ' A' ' 89' ' ' SER . 53.3 mtt180 -155.01 172.1 18.66 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.088 0.555 . . . . 0.0 110.165 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.0 m 77.52 160.33 0.21 Allowed 'General case' 0 CA--C 1.563 1.456 0 O-C-N 124.261 0.976 . . . . 0.0 113.207 172.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.417 HD13 ' N ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -147.91 149.26 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 123.727 0.811 . . . . 0.0 109.228 -176.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.488 ' HB2' ' OG ' ' A' ' 122' ' ' SER . . . -118.64 134.93 54.75 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.666 0.787 . . . . 0.0 109.221 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.0 p -129.64 158.86 38.16 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.95 162.61 26.03 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.8 p -124.89 128.77 49.16 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 117.054 0.427 . . . . 0.0 110.335 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.8 mt -99.64 105.35 33.43 Favored Pre-proline 0 C--N 1.308 -1.221 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -76.92 116.08 4.16 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.502 2.134 . . . . 0.0 111.722 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.5 t70 53.96 83.33 0.23 Allowed Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 124.95 1.3 . . . . 0.0 112.745 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -101.08 7.8 0.58 Allowed 'Trans proline' 0 N--CA 1.441 -1.613 0 C-N-CA 122.697 2.265 . . . . 0.0 112.015 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 153.77 -164.78 31.35 Favored Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 32.2 p -145.28 158.89 43.72 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.431 HD12 ' HB ' ' A' ' 78' ' ' ILE . 78.4 mt -73.08 157.13 37.9 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 121.209 0.528 . . . . 0.0 111.611 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.6 p -90.4 139.16 18.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.238 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.4 93.82 0.46 Allowed Glycine 0 C--N 1.3 -1.447 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.784 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 67.3 p 60.36 83.15 0.14 Allowed 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 125.697 1.599 . . . . 0.0 113.998 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.88 -160.06 33.61 Favored Glycine 0 N--CA 1.429 -1.785 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.0 t -118.89 142.0 48.15 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.4 t -134.87 138.87 44.56 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.577 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.9 m -91.04 126.24 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 173.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.8 mt -103.04 145.18 30.28 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.718 -176.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -100.79 116.33 32.42 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.175 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 29.2 m -126.74 117.77 22.56 Favored Pre-proline 0 C--N 1.316 -0.864 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.37 124.5 12.58 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.625 2.216 . . . . 0.0 111.579 174.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 97.3 t -124.67 141.01 46.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 120.854 0.359 . . . . 0.0 110.155 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.615 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -87.8 102.12 14.36 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.988 0.899 . . . . 0.0 111.045 178.275 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.45 ' C ' ' H ' ' A' ' 121' ' ' TYR . 48.1 t -97.6 148.39 5.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.433 ' HB3' ' OXT' ' A' ' 174' ' ' PHE . . . 75.07 -14.96 0.7 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.909 0.883 . . . . 0.0 111.932 -178.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.45 ' H ' ' C ' ' A' ' 119' ' ' VAL . 34.4 t80 -56.06 -58.13 9.23 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 124.119 0.967 . . . . 0.0 109.961 -175.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.488 ' OG ' ' HB2' ' A' ' 95' ' ' ALA . 41.4 m -74.93 -26.84 59.91 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.96 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 58.4 mt -71.47 -50.24 41.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.116 -173.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.61 -49.37 75.49 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 123.516 0.51 . . . . 0.0 110.363 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 52.2 t -57.9 -39.39 71.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.217 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.8 t -82.25 -82.6 0.13 Allowed 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.439 HD13 ' N ' ' A' ' 128' ' ' MET . 2.0 pp -125.6 -27.0 3.45 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -173.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.439 ' N ' HD13 ' A' ' 127' ' ' LEU . 10.1 tpt 69.9 125.76 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.955 0.902 . . . . 0.0 111.458 -174.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -72.34 -36.28 68.78 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-O 122.057 0.932 . . . . 0.0 110.431 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.8 t70 78.0 76.05 0.06 Allowed 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 112.072 -2.331 . . . . 0.0 106.512 -171.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.509 ' HG2' ' CD1' ' A' ' 135' ' ' TRP . 5.8 tmm? -69.69 114.69 8.13 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 112.859 -1.973 . . . . 0.0 109.599 -171.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 55.6 m -91.2 -179.67 5.48 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.124 -174.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 22.4 p -80.2 105.1 11.22 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-O 121.839 0.828 . . . . 0.0 110.785 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.5 t70 78.24 98.52 0.06 Allowed 'General case' 0 CA--C 1.487 -1.456 0 C-N-CA 126.553 1.941 . . . . 0.0 107.555 -170.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.509 ' CD1' ' HG2' ' A' ' 131' ' ' MET . 32.9 t-105 -148.89 148.45 29.86 Favored 'General case' 0 C--N 1.276 -2.591 0 CA-C-N 113.976 -1.466 . . . . 0.0 108.716 -171.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -125.87 141.16 52.11 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.56 132.29 54.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -105.58 109.65 21.69 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.56 ' OH ' HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -113.01 172.07 7.16 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.287 -0.965 . . . . 0.0 108.971 173.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 88' ' ' LYS . 63.2 mt-30 -118.29 130.79 56.24 Favored 'General case' 0 C--N 1.274 -2.685 0 C-N-CA 120.414 -0.514 . . . . 0.0 109.719 -174.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 35.6 tp -116.45 125.69 52.35 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.246 0.546 . . . . 0.0 112.043 -177.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.538 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 13.7 m-20 -120.0 119.69 34.16 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.422 HG22 HG21 ' A' ' 83' ' ' ILE . 42.4 mm -112.97 123.75 68.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -96.13 103.85 3.0 Favored Glycine 0 N--CA 1.418 -2.514 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 176.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 156' ' ' THR . 2.9 mm? -76.83 101.75 6.01 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 123.195 0.598 . . . . 0.0 110.026 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.9 m -91.37 115.58 28.14 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.101 0.477 . . . . 0.0 111.487 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.558 ' CE2' ' HB3' ' A' ' 145' ' ' LEU . 60.4 m-85 -126.67 153.03 45.94 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -158.31 140.83 14.43 Favored 'General case' 0 CA--C 1.479 -1.762 0 CA-C-O 121.463 0.649 . . . . 0.0 112.221 173.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 50.0 mm -121.6 128.31 25.69 Favored Pre-proline 0 C--N 1.292 -1.911 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -46.73 -43.55 23.22 Favored 'Trans proline' 0 N--CA 1.483 0.907 0 C-N-CA 123.633 2.889 . . . . 0.0 114.207 -176.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.18 -52.49 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 121.722 0.772 . . . . 0.0 109.313 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.429 HG23 ' HD3' ' A' ' 38' ' ' LYS . 7.2 p 173.04 140.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 C-N-CA 125.488 1.515 . . . . 0.0 107.072 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 150.54 15.22 0.08 OUTLIER Glycine 0 C--N 1.291 -1.969 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -73.21 118.05 15.69 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 126.031 1.733 . . . . 0.0 110.254 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.401 HG12 HD13 ' A' ' 39' ' ' LEU . 8.2 tp -162.59 144.14 3.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.499 -178.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 96.3 m -123.02 104.1 9.01 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 166.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 58.2 mt -87.88 112.94 52.3 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.328 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 156' ' ' THR . 26.9 Cg_endo -84.06 111.07 1.61 Allowed 'Trans proline' 0 N--CA 1.436 -1.864 0 C-N-CA 122.214 1.943 . . . . 0.0 111.587 176.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.4 m -106.49 134.95 46.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 29.6 p -126.1 157.44 38.03 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -175.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.6 t -170.47 170.67 6.85 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 176.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -99.67 132.19 45.17 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -101.72 104.64 2.71 Favored Glycine 0 N--CA 1.415 -2.73 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -90.04 119.46 30.41 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.518 HD12 ' CE1' ' A' ' 139' ' ' TYR . 5.7 mm -106.82 119.08 55.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 -174.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.489 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 62.9 tttp -92.99 117.72 30.38 Favored 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.153 175.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 95.6 mt -108.44 93.1 10.97 Favored Pre-proline 0 C--N 1.284 -2.26 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.841 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 166' ' ' LYS . 10.0 Cg_endo -86.42 82.34 1.36 Allowed 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 122.885 2.39 . . . . 0.0 112.861 -174.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 79.3 p 55.91 15.9 1.89 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.083 1.353 . . . . 0.0 113.777 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 49.7 tp -59.57 -56.68 18.86 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.134 0.574 . . . . 0.0 111.238 -176.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.437 ' O ' ' HD1' ' A' ' 173' ' ' PHE . 47.8 mtm105 65.28 145.24 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 179.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 76.79 -4.68 2.31 Favored 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 124.794 1.237 . . . . 0.0 114.023 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.437 ' HD1' ' O ' ' A' ' 171' ' ' ARG . 27.1 m-85 -111.57 -66.69 1.06 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.439 ' HB3' ' HG3' ' A' ' 131' ' ' MET 0.331 8.4 p90 . . . . . 0 C--O 1.26 1.622 0 C-N-CA 126.03 1.732 . . . . 0.0 114.244 -178.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.422 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -142.63 101.14 3.81 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -162.09 98.42 1.05 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.313 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -130.18 -175.27 3.57 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.345 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 61.3 t60 74.67 -29.82 0.2 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.647 1.579 . . . . 0.0 113.843 175.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -74.07 77.62 1.73 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.738 0.78 . . . . 0.0 112.508 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.2 p80 177.47 97.05 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 125.914 1.686 . . . . 0.0 107.749 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -72.82 -48.47 37.64 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -116.11 -57.87 2.16 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.544 171.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -155.75 -60.94 0.11 Allowed 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.481 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.461 ' HB3' ' HB2' ' A' ' 14' ' ' GLU . 67.7 m -87.46 98.52 11.43 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -176.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -101.75 -47.86 4.48 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 172.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -68.12 -43.35 78.59 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.051 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 11' ' ' SER . 1.5 mp0 -66.81 -31.1 71.5 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.386 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -74.51 -41.0 61.44 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -176.283 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.6 m -66.83 -29.44 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.1 m -73.03 -29.59 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.86 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 48.6 mt-10 -69.09 -34.59 75.35 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 176.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 7.7 mm-40 -59.25 -46.98 87.04 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.58 175.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.16 -45.45 93.36 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.653 177.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.15 -36.33 77.31 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.739 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.4 t -65.45 -35.55 81.25 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.82 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.438 ' HA ' ' HG ' ' A' ' 26' ' ' SER . 91.2 t -70.71 -33.29 52.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.573 0.702 . . . . 0.0 110.027 177.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.563 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 59.0 mt -69.56 -40.98 80.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 174.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.1 m -66.86 -29.0 68.79 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.106 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.438 ' HG ' ' HA ' ' A' ' 23' ' ' VAL . 14.3 p -70.54 -34.78 72.66 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 120.914 0.388 . . . . 0.0 110.532 175.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . 0.263 7.9 mp -79.38 -18.57 52.07 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 119.227 -0.989 . . . . 0.0 112.991 172.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 81.2 mt -68.62 -34.24 75.41 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 171.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.48 -40.45 70.23 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.324 176.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -52.01 -59.75 3.99 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.986 173.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 35' ' ' PHE . . . -59.75 -39.9 86.34 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.365 177.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -55.36 -31.96 62.18 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 123.345 0.658 . . . . 0.0 111.165 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.479 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -95.36 -77.83 1.38 Allowed Glycine 0 N--CA 1.425 -2.044 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.975 177.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.453 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 48.1 t80 -63.64 -39.96 95.67 Favored 'General case' 0 C--O 1.209 -1.074 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -174.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.463 ' HA ' HD23 ' A' ' 39' ' ' LEU . 82.1 t80 -69.87 -42.42 73.53 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 118.25 -1.38 . . . . 0.0 111.016 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 40' ' ' ALA . . . -62.07 -44.68 96.15 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 33' ' ' GLY . 14.3 pt-20 -94.74 -41.74 9.1 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -176.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 34' ' ' PHE . 15.2 tppt? -75.32 -45.4 39.82 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 121.824 0.821 . . . . 0.0 109.28 -173.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 35' ' ' PHE . 3.8 mm? -86.8 7.29 27.58 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.297 -1.319 . . . . 0.0 112.82 -174.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 36' ' ' ALA . . . -76.02 -10.6 59.55 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.606 0.717 . . . . 0.0 109.843 176.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -112.99 2.12 15.65 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.117 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.4 mp -124.45 118.11 26.37 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -71.61 94.11 0.69 Allowed 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 122.36 2.04 . . . . 0.0 112.927 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.429 ' HB ' ' HD2' ' A' ' 45' ' ' PRO . 21.8 p -91.5 170.59 9.3 Favored Pre-proline 0 C--N 1.307 -1.248 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.414 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 44' ' ' THR . 55.6 Cg_endo -65.36 146.78 86.55 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.559 1.506 . . . . 0.0 110.547 174.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -97.45 126.11 42.52 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.528 ' O ' HG11 ' A' ' 159' ' ' VAL . . . -97.38 146.13 25.48 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.8 t -161.23 120.85 2.6 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.075 0.464 . . . . 0.0 110.712 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -83.84 138.02 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -97.51 -59.01 1.87 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.106 -1.037 . . . . 0.0 110.922 -168.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -173.85 -178.04 1.49 Allowed 'General case' 0 C--O 1.249 1.052 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.535 ' CG2' ' HB3' ' A' ' 64' ' ' TYR . 7.6 p -130.53 132.35 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.907 0 CA-C-O 121.315 0.579 . . . . 0.0 109.52 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -107.97 136.31 47.89 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.238 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.653 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 45.5 p90 -92.08 141.18 28.88 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.47 ' N ' ' HD3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -124.74 -70.36 0.76 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.066 0.46 . . . . 0.0 110.881 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -112.36 -165.11 17.03 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.984 -174.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.44 ' HB ' ' CD2' ' A' ' 173' ' ' PHE . 13.6 p -117.92 159.99 17.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.129 -0.536 . . . . 0.0 110.042 -176.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 34.0 m -148.19 152.22 36.87 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 173.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.0 ttt-85 -58.94 -40.85 85.89 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.403 0.621 . . . . 0.0 110.446 177.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -117.13 94.39 4.55 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.3 166.42 31.24 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.57 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.8 t -104.4 148.73 8.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.4 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 29.6 t70 -84.85 107.01 16.79 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.127 0.489 . . . . 0.0 111.877 -175.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.653 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 28.7 m-85 -117.46 158.16 24.99 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.768 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -133.18 112.92 12.12 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . . . -90.41 144.66 25.59 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -177.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.499 ' HB2' ' HZ2' ' A' ' 67' ' ' LYS . 10.8 mtmp? -104.34 119.52 39.15 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.93 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.0 t -117.61 109.05 26.22 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.415 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.2 m -100.43 143.28 30.81 Favored 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 119.769 -0.772 . . . . 0.0 111.049 -175.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.31 119.14 51.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -96.28 109.69 22.14 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.564 ' ND2' HD23 ' A' ' 105' ' ' LEU . 6.5 t30 -123.02 115.23 29.2 Favored Pre-proline 0 C--N 1.292 -1.924 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -171.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -97.74 96.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.672 0 C-N-CA 121.742 1.628 . . . . 0.0 110.871 172.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.513 ' HB2' HD22 ' A' ' 72' ' ' ASN . 61.3 m-85 -175.84 119.25 0.16 Allowed 'General case' 0 CA--C 1.488 -1.414 0 C-N-CA 128.086 2.555 . . . . 0.0 105.152 178.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.4 m -69.85 -18.1 63.41 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 123.553 0.533 . . . . 0.0 112.108 -177.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -80.18 134.45 36.14 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-O 121.072 0.463 . . . . 0.0 110.726 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.2 p -80.01 97.19 6.68 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.476 ' HB ' HD12 ' A' ' 105' ' ' LEU . 42.3 mt -81.88 127.05 73.68 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -177.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.73 123.38 13.67 Favored 'Trans proline' 0 C--O 1.241 0.675 0 C-N-CA 122.588 2.192 . . . . 0.0 110.827 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.404 HG12 ' CE2' ' A' ' 147' ' ' PHE . 60.7 mt -69.77 103.51 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-O 121.309 0.576 . . . . 0.0 109.95 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 49.2 t -66.78 -56.82 8.73 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.885 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.527 ' HG3' ' CG2' ' A' ' 98' ' ' THR . 25.8 tt0 -152.24 130.17 11.75 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -175.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.6 mm -118.84 113.91 43.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 170.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.3 t -118.5 142.69 47.34 Favored 'General case' 0 C--N 1.288 -2.085 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.317 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.407 ' CZ ' ' HA3' ' A' ' 97' ' ' GLY . 54.8 p90 -128.27 144.57 51.14 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 121.301 0.572 . . . . 0.0 111.442 -176.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.404 ' HB ' ' HB2' ' A' ' 142' ' ' ASP . 56.0 mt -120.9 119.65 60.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 174.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.534 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 0.4 OUTLIER -103.09 122.29 44.36 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 178.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.535 ' HB2' ' HB2' ' A' ' 140' ' ' GLN . 98.5 mttt -123.21 157.3 33.36 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.678 175.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.8 t -152.24 109.02 3.48 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 68.6 -77.49 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.232 1.013 . . . . 0.0 110.993 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t 172.5 -28.71 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.155 0.582 . . . . 0.0 110.438 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -64.85 -56.93 10.47 Favored 'General case' 0 C--N 1.345 0.392 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -174.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 51.3 m -125.22 143.92 50.71 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.911 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.534 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 2.1 pp -141.37 178.64 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.209 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -176.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -135.95 147.11 47.93 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 172.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 39.1 t -131.44 153.12 50.06 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -176.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.407 ' HA3' ' CZ ' ' A' ' 85' ' ' TYR . . . -174.46 165.48 36.94 Favored Glycine 0 N--CA 1.426 -1.992 0 C-N-CA 119.697 -1.24 . . . . 0.0 112.131 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.527 ' CG2' ' HG3' ' A' ' 82' ' ' GLN . 86.7 m -149.99 131.72 15.0 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.409 ' CG2' ' HB3' ' A' ' 102' ' ' PRO . 2.8 mp -107.6 115.86 58.57 Favored Pre-proline 0 C--O 1.248 0.996 0 C-N-CA 119.071 -1.052 . . . . 0.0 109.77 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.28 114.75 3.81 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.021 1.814 . . . . 0.0 109.604 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.3 t70 55.15 77.94 0.41 Allowed Pre-proline 0 N--CA 1.482 1.175 0 C-N-CA 124.068 0.947 . . . . 0.0 111.285 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.409 ' HB3' ' CG2' ' A' ' 99' ' ' ILE . 59.5 Cg_endo -92.62 3.61 3.62 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.576 2.184 . . . . 0.0 111.875 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 175.32 -157.38 24.02 Favored Glycine 0 N--CA 1.424 -2.166 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.9 p -136.48 139.53 42.39 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 117.196 0.498 . . . . 0.0 110.847 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.564 HD23 ' ND2' ' A' ' 72' ' ' ASN . 7.3 tt -69.67 127.16 32.0 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.818 178.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 7.3 p -52.74 -45.3 49.16 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -173.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.474 ' H ' HD21 ' A' ' 105' ' ' LEU . . . 86.01 82.86 1.1 Allowed Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 109.201 -1.559 . . . . 0.0 109.201 -172.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.6 m 62.18 90.32 0.07 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.402 1.081 . . . . 0.0 112.561 -176.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 155.19 -173.96 33.4 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 176.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.7 m -108.1 123.66 49.04 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.464 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 3.6 t -117.41 132.01 56.65 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.087 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.6 t -95.99 109.98 23.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.1 mt -91.44 167.1 12.5 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -144.77 149.05 34.83 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.562 -174.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.403 HG12 ' HB1' ' A' ' 66' ' ' ALA . 4.4 p -136.6 127.18 16.36 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.69 176.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.17 113.12 3.6 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.971 1.78 . . . . 0.0 108.774 171.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.1 t -123.1 126.04 72.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -175.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.4 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 14.3 mmmm -88.51 103.93 16.34 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.335 -0.946 . . . . 0.0 108.492 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.627 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 97.5 t -93.72 146.13 6.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.988 -173.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 78.0 -5.93 2.03 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.952 1.301 . . . . 0.0 110.516 -176.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.486 ' O ' HG22 ' A' ' 125' ' ' VAL . 82.4 t80 -58.07 -57.11 14.29 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.825 176.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.2 m -56.27 -39.34 72.47 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.758 -176.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 10.8 tp -77.83 -30.21 16.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.244 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.67 -42.64 86.25 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 172.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 121' ' ' TYR . 68.9 t -57.35 -33.19 43.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.529 175.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -75.49 -81.07 0.08 Allowed 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.0 176.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -126.65 -22.83 3.84 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -177.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 70.13 121.83 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -170.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.674 ' C ' ' H ' ' A' ' 131' ' ' MET . 0.0 OUTLIER -59.48 -32.31 70.14 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -172.689 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.8 t70 80.95 -16.41 0.65 Allowed 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 -169.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.674 ' H ' ' C ' ' A' ' 129' ' ' LYS 0.343 13.9 tmm? 72.32 -102.1 0.03 OUTLIER 'General case' 0 N--CA 1.416 -2.131 0 C-N-CA 128.456 2.702 . . . . 0.0 113.277 175.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 131' ' ' MET . 48.7 t 150.58 -138.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 102.682 -3.081 . . . . 0.0 102.682 -175.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.9 p -133.92 99.1 4.34 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 164.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.667 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 16.2 t70 71.86 92.73 0.08 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.663 1.185 . . . . 0.0 112.805 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -154.96 159.77 40.64 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 165' ' ' ILE . 5.7 p-10 -103.55 142.49 34.2 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.22 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.445 HD11 ' O ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -115.62 158.28 16.06 Favored 'Isoleucine or valine' 0 C--O 1.248 1.013 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.763 177.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.66 115.37 10.77 Favored 'General case' 0 C--O 1.252 1.204 0 CA-C-O 121.635 0.731 . . . . 0.0 112.186 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -133.39 151.35 51.82 Favored 'General case' 0 N--CA 1.411 -2.384 0 CA-C-N 114.02 -1.446 . . . . 0.0 107.989 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.535 ' HB2' ' HB2' ' A' ' 88' ' ' LYS . 58.1 mt-30 -139.45 150.2 44.92 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.8 tp -139.18 118.96 13.17 Favored 'General case' 0 N--CA 1.419 -1.989 0 O-C-N 124.002 0.814 . . . . 0.0 109.822 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.404 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 22.6 m-20 -122.31 136.35 54.89 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.5 mm -122.05 129.29 75.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.567 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -117.91 88.0 0.44 Allowed Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 176.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 156' ' ' THR . 2.3 pp -84.31 149.2 26.22 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.825 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' A' ' 82' ' ' GLN . 8.7 m -127.02 120.59 29.39 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -176.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.404 ' CE2' HG12 ' A' ' 80' ' ' ILE . 68.9 m-85 -132.67 141.66 48.71 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -108.46 124.79 50.96 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.634 0.731 . . . . 0.0 110.709 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.403 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -124.88 125.84 25.36 Favored Pre-proline 0 C--N 1.297 -1.711 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.058 178.516 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -41.06 -34.21 1.43 Allowed 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 124.915 3.744 . . . . 0.0 115.88 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 13.5 p -59.3 -35.22 56.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.4 HG22 HD13 ' A' ' 39' ' ' LEU . 31.3 m -132.03 -25.66 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 121.875 -0.516 . . . . 0.0 112.355 -178.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 111.04 -141.7 16.58 Favored Glycine 0 N--CA 1.421 -2.346 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -177.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -92.41 120.42 32.89 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.908 0.385 . . . . 0.0 111.456 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 2.3 pp -130.35 146.24 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.356 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 174.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 4.6 p -95.32 151.06 19.58 Favored 'General case' 0 N--CA 1.397 -3.088 0 CA-C-N 113.978 -1.465 . . . . 0.0 109.98 174.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 57.4 mt -125.34 110.35 26.37 Favored Pre-proline 0 C--N 1.295 -1.787 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 176.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -89.88 114.58 0.57 Allowed 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 123.005 2.47 . . . . 0.0 113.662 -174.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.528 HG11 ' O ' ' A' ' 47' ' ' ALA . 29.1 m -118.13 128.16 75.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.955 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 63.0 p -114.24 144.2 43.61 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.931 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 53.3 m -153.13 136.69 15.95 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 121.114 0.483 . . . . 0.0 110.098 -177.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -98.99 119.47 37.83 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -100.53 115.05 5.19 Favored Glycine 0 N--CA 1.411 -2.974 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.399 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -89.71 118.6 29.44 Favored 'General case' 0 C--N 1.27 -2.86 0 N-CA-C 105.601 -1.999 . . . . 0.0 105.601 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 136' ' ' ASP . 50.3 mm -112.95 108.68 26.16 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.442 -172.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 136' ' ' ASP . 60.5 pttt -86.54 133.65 33.72 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.015 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.667 ' O ' ' HA ' ' A' ' 134' ' ' ASP . 0.4 OUTLIER -103.41 96.91 9.22 Favored Pre-proline 0 C--N 1.295 -1.779 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 173.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.66 78.84 0.95 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.28 1.987 . . . . 0.0 113.62 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 76.2 p 39.26 79.55 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.707 1.603 . . . . 0.0 114.291 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.403 ' HG ' ' HB2' ' A' ' 173' ' ' PHE . 2.5 mm? -103.65 -61.84 1.37 Allowed 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.004 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 70.22 4.86 5.06 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 121.31 0.576 . . . . 0.0 112.177 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -136.29 -41.19 0.64 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.339 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.44 ' CD2' ' HB ' ' A' ' 57' ' ' VAL . 3.0 m-85 -81.04 -43.43 19.55 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 176.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.4 -2.953 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.187 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -130.88 98.94 4.75 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.369 0.604 . . . . 0.0 110.609 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -121.27 100.96 7.34 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.496 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -101.45 101.78 12.45 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.741 0.781 . . . . 0.0 112.709 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -151.71 140.35 20.74 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 102.625 -3.102 . . . . 0.0 102.625 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . 0.37 24.1 p-80 -75.63 72.6 2.59 Favored 'General case' 0 C--O 1.217 -0.607 0 N-CA-C 116.353 1.982 . . . . 0.0 116.353 -169.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -136.61 75.14 1.52 Allowed 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.478 171.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.419 HD21 ' O ' ' A' ' 8' ' ' LEU 0.286 0.0 OUTLIER -135.9 83.0 1.98 Allowed 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.875 176.116 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 64.09 18.34 11.17 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 113.502 -1.681 . . . . 0.0 109.666 -173.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.99 142.02 50.99 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.883 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.8 m 71.6 -38.89 0.43 Allowed 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 124.439 1.096 . . . . 0.0 111.78 -175.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.37 -39.73 89.31 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 173.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.44 ' O ' HG22 ' A' ' 17' ' ' VAL . 24.2 t70 -60.54 -29.79 69.35 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.146 177.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -77.78 -50.42 12.37 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.021 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.421 ' C ' ' HD3' ' A' ' 15' ' ' LYS . 12.7 tmtt? -57.32 -47.15 82.27 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.771 1.229 . . . . 0.0 112.539 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.0 m -63.22 -21.82 29.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 94' ' ' ILE . 92.8 t -67.34 -49.02 75.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 120.913 0.387 . . . . 0.0 110.14 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.95 -33.61 72.15 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.509 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -77.12 -39.26 50.04 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.831 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -75.45 -35.44 60.91 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 120.747 0.308 . . . . 0.0 111.0 -177.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.78 -35.78 73.36 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.46 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.4 t -63.08 -44.85 94.61 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.915 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.3 t -65.34 -48.55 82.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.965 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.533 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 64.0 mt -61.21 -44.62 98.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.238 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.7 m -62.95 -37.83 88.63 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.677 0.275 . . . . 0.0 111.161 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.5 m -66.03 -36.49 83.38 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.788 0.328 . . . . 0.0 110.629 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.433 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 5.0 tt -67.11 -43.21 83.06 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 83.5 mt -57.78 -46.46 84.55 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.661 177.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.74 -44.12 97.08 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.517 ' HD2' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -64.83 -33.24 75.53 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.583 -178.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.517 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -79.38 -40.44 30.11 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.396 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -51.07 -52.65 41.34 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.381 1.073 . . . . 0.0 112.598 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.38 -17.88 79.61 Favored Glycine 0 C--N 1.318 -0.439 0 C-N-CA 120.026 -1.083 . . . . 0.0 112.02 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -75.39 -26.23 58.28 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 123.448 0.699 . . . . 0.0 109.952 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.428 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 27.2 m-85 -79.15 -12.08 59.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -178.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.29 -51.35 70.34 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -174.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.552 ' HG2' ' HD3' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -117.27 -43.45 2.83 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -178.387 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.552 ' HD3' ' HG2' ' A' ' 37' ' ' GLU . 3.7 mppt? -64.52 -34.28 77.87 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.271 -175.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 2.8 mm? -102.95 17.97 22.73 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.725 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.83 -28.07 16.08 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 171.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -94.47 -48.31 6.17 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.815 175.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 75.1 mt -73.99 121.29 84.84 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.96 114.38 3.72 Favored 'Trans proline' 0 C--O 1.246 0.925 0 C-N-CA 122.445 2.097 . . . . 0.0 113.518 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.3 p -114.33 140.41 25.05 Favored Pre-proline 0 N--CA 1.429 -1.498 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.868 173.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -56.12 138.95 84.6 Favored 'Trans proline' 0 C--O 1.24 0.603 0 C-N-CA 122.465 2.11 . . . . 0.0 111.418 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -96.45 109.9 22.36 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-O 121.327 0.584 . . . . 0.0 110.251 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.411 ' CB ' ' HG ' ' A' ' 145' ' ' LEU . . . -98.8 140.26 33.24 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.617 -178.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.5 t -141.98 133.7 27.01 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.315 177.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.3 m -89.45 141.61 14.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -130.93 -48.44 1.02 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -170.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -161.99 169.57 20.85 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.822 -171.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 65' ' ' HIS . 13.0 m -132.24 112.73 20.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.487 0.66 . . . . 0.0 111.562 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -92.34 129.5 38.27 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.243 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -59.27 138.26 57.67 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.982 0.176 . . . . 0.0 111.01 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.604 ' HD3' ' C ' ' A' ' 55' ' ' LYS . 11.7 tmtt? -119.44 -55.7 2.11 Favored 'General case' 0 N--CA 1.411 -2.413 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.033 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.47 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . -176.63 -170.87 39.72 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 118.865 -1.636 . . . . 0.0 113.432 -173.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.6 p -102.61 151.99 5.85 Favored 'Isoleucine or valine' 0 C--O 1.249 1.057 0 CA-C-O 121.709 0.766 . . . . 0.0 112.308 -172.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.754 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 31.3 m -159.97 159.41 32.18 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 103.047 -2.946 . . . . 0.0 103.047 173.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.465 ' HA ' ' CE2' ' A' ' 174' ' ' PHE . 34.1 mtm180 -73.15 134.24 44.36 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 118.954 -1.099 . . . . 0.0 110.235 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 76.39 -66.21 0.27 Allowed 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 125.533 1.533 . . . . 0.0 110.989 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.754 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . -107.52 128.22 9.11 Favored Glycine 0 CA--C 1.479 -2.191 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 56' ' ' GLY . 35.5 m -99.75 152.83 4.54 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.451 ' CG ' ' HZ3' ' A' ' 118' ' ' LYS . 45.8 m-20 -81.12 131.11 35.28 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -174.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -132.14 156.69 45.93 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 125.069 1.347 . . . . 0.0 109.491 174.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.429 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 18.0 m-70 -95.68 108.31 20.59 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 173.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.68 122.06 27.15 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 170.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -86.27 107.95 18.18 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.788 -174.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.6 t -114.02 109.17 27.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 56.3 p -103.05 128.74 49.79 Favored 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.555 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.2 t -114.66 120.58 64.72 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.262 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 36.2 ttpt -95.88 110.24 22.46 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 175.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -103.6 113.35 65.63 Favored Pre-proline 0 C--N 1.293 -1.878 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.853 -175.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -99.43 97.25 0.05 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.685 0 C-N-CA 122.007 1.805 . . . . 0.0 108.958 169.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -179.35 153.74 0.6 Allowed 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 102.951 -2.981 . . . . 0.0 102.951 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.1 t -79.22 -35.42 41.67 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -172.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -89.45 157.78 17.98 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.796 -0.762 . . . . 0.0 112.218 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.4 m -85.73 111.26 19.97 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 173.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.6 mt -87.97 128.95 52.03 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -175.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -87.19 118.86 1.41 Allowed 'Trans proline' 0 N--CA 1.433 -2.032 0 C-N-CA 122.098 1.865 . . . . 0.0 111.255 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.7 pt -72.04 113.06 8.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 48.5 t -58.43 -47.38 84.12 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.519 ' O ' ' HB ' ' A' ' 146' ' ' THR . 5.0 pp0? -156.29 157.95 36.64 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 174.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.454 ' CG2' HG21 ' A' ' 99' ' ' ILE . 11.8 tt -124.74 127.58 72.8 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.354 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 175.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.4 m -80.64 128.91 34.16 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-O 121.625 0.726 . . . . 0.0 110.963 -171.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -104.23 119.42 38.91 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.458 -175.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.0 mp -131.05 107.05 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 172.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.635 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 1.6 tm? -100.06 130.05 46.17 Favored 'General case' 0 C--N 1.268 -2.943 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -122.29 161.29 23.59 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.5 m -149.97 146.18 26.88 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -41.17 -71.42 0.08 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -174.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.546 ' C ' ' HD2' ' A' ' 92' ' ' ARG . 4.9 t -150.86 80.17 1.32 Allowed 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.546 ' HD2' ' C ' ' A' ' 91' ' ' THR . 3.8 mpt_? -140.0 -63.89 0.49 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 172.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.2 t 179.75 -174.18 0.24 Allowed 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.635 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 38.4 pt -132.1 -174.92 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.416 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . . . -132.0 130.33 41.28 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 33.5 p -106.25 179.68 4.2 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.789 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.02 170.14 12.77 Favored Glycine 0 N--CA 1.421 -2.355 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.005 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.9 p -134.46 128.96 34.5 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.454 HG21 ' CG2' ' A' ' 83' ' ' ILE . 7.5 tt -102.8 111.22 64.71 Favored Pre-proline 0 C--N 1.307 -1.255 0 C-N-CA 118.767 -1.173 . . . . 0.0 110.873 177.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.92 118.06 5.14 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 123.321 2.68 . . . . 0.0 113.563 -175.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.3 t70 45.19 79.15 0.35 Allowed Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 125.551 1.541 . . . . 0.0 113.546 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.401 ' HG3' ' CG2' ' A' ' 83' ' ' ILE . 68.4 Cg_endo -92.68 3.2 3.65 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.747 2.298 . . . . 0.0 111.915 175.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 165.85 -177.28 41.06 Favored Glycine 0 N--CA 1.427 -1.961 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.7 m -143.12 150.05 38.95 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.51 142.76 33.72 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.235 -178.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.3 m -80.18 165.77 2.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 O-C-N 124.123 0.89 . . . . 0.0 110.504 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.39 133.16 11.56 Favored Glycine 0 N--CA 1.427 -1.902 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.7 p 54.78 75.85 0.28 Allowed 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 124.548 1.139 . . . . 0.0 113.015 -177.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.81 174.84 36.44 Favored Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.792 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 9.0 t -101.83 136.49 41.58 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.7 t -135.82 131.23 35.14 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 121.228 0.537 . . . . 0.0 110.204 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.3 t -95.74 119.28 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.7 mt -102.73 146.96 27.45 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.262 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -113.0 112.69 24.33 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.522 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.8 m -112.61 127.25 27.08 Favored Pre-proline 0 C--N 1.305 -1.364 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.249 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.65 111.2 2.72 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.236 1.957 . . . . 0.0 110.598 176.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.7 t -108.91 134.47 50.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.904 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.451 ' HZ3' ' CG ' ' A' ' 63' ' ' ASP . 24.3 mmmt -91.25 102.19 14.9 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.0 m -93.07 140.12 16.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.388 -174.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 68.55 11.29 8.3 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.749 1.22 . . . . 0.0 109.852 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.407 ' O ' HG12 ' A' ' 125' ' ' VAL . 84.1 t80 -61.04 -44.13 97.86 Favored 'General case' 0 CA--C 1.485 -1.526 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.74 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.1 m -64.8 -31.56 72.84 Favored 'General case' 0 N--CA 1.436 -1.144 0 O-C-N 123.555 0.534 . . . . 0.0 111.878 -177.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.455 HG21 ' O ' ' A' ' 128' ' ' MET . 49.4 mt -77.33 -49.5 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.577 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -66.95 -43.78 82.25 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -177.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 121' ' ' TYR . 8.1 p -65.21 -26.24 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.075 0.464 . . . . 0.0 110.079 -177.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.1 t -79.49 -62.17 1.77 Allowed 'General case' 0 N--CA 1.416 -2.167 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -125.71 -64.19 1.08 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.886 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.577 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER 173.84 151.21 0.09 Allowed 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 103.352 -2.833 . . . . 0.0 103.352 178.846 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.486 ' N ' ' SD ' ' A' ' 128' ' ' MET . 83.5 mttt -51.4 -51.25 56.3 Favored 'General case' 0 CA--C 1.465 -2.323 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 34.7 t70 174.54 -38.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 125.55 1.782 . . . . 0.0 111.555 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.579 ' HA ' ' CE ' ' A' ' 131' ' ' MET 0.33 2.7 mmt 64.05 99.16 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -171.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 84.4 m -156.03 179.87 8.8 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 173.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.446 ' CA ' ' HA ' ' A' ' 169' ' ' SER . 35.3 p -117.49 102.04 8.87 Favored 'General case' 0 N--CA 1.392 -3.354 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 172.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.618 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 19.2 t70 87.65 97.66 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.827 1.651 . . . . 0.0 110.907 -175.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.447 ' CZ2' HD22 ' A' ' 167' ' ' LEU . 6.9 p90 -156.21 159.46 38.96 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -122.08 151.24 41.1 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.4 pp -132.73 158.69 43.34 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -74.62 99.36 3.63 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.897 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.465 ' HE1' ' CD2' ' A' ' 87' ' ' LEU . 17.7 t80 -112.96 157.84 20.99 Favored 'General case' 0 N--CA 1.416 -2.127 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.15 176.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -164.26 159.16 19.69 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 171.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.463 HD11 HG12 ' A' ' 143' ' ' ILE . 1.0 OUTLIER -125.98 152.67 45.38 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.548 177.087 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.1 111.16 14.35 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 169.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.463 HG12 HD11 ' A' ' 141' ' ' LEU . 35.0 mm -115.23 140.7 35.28 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.988 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -119.98 104.04 0.99 Allowed Glycine 0 N--CA 1.434 -1.443 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.224 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.447 ' HB3' ' CE2' ' A' ' 147' ' ' PHE . 4.3 mm? -72.72 108.41 5.7 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 122.551 0.341 . . . . 0.0 110.573 177.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.519 ' HB ' ' O ' ' A' ' 82' ' ' GLN . 43.0 m -101.57 108.58 20.18 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-O 121.384 0.612 . . . . 0.0 110.251 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.447 ' CE2' ' HB3' ' A' ' 145' ' ' LEU . 68.2 m-85 -109.41 136.1 49.38 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.258 3.9 p30 -115.89 110.21 18.68 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 122.233 1.016 . . . . 0.0 110.521 175.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 67.3 mt -117.33 122.31 31.19 Favored Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.36 -19.81 18.29 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 123.713 2.942 . . . . 0.0 113.629 -176.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 62.1 t -72.17 -34.41 49.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.143 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 9.2 p -123.28 -34.39 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 121.82 -153.7 16.74 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -95.34 116.37 28.68 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 155' ' ' ILE . 2.3 pp -126.82 134.01 67.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 55.6 m -111.06 112.12 23.7 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.478 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.9 mp -85.8 117.45 68.75 Favored Pre-proline 0 C--O 1.238 0.471 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -82.37 120.05 3.18 Favored 'Trans proline' 0 CA--C 1.484 -2.001 0 C-N-CA 122.31 2.006 . . . . 0.0 111.496 175.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 3.1 p -126.95 114.98 39.8 Favored 'Isoleucine or valine' 1 N--CA 1.376 -4.135 0 CA-C-N 112.768 -2.015 . . . . 0.0 109.137 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 33.3 p -127.05 162.53 25.82 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.304 -173.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.0 t -169.27 155.22 6.27 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -102.26 141.15 35.56 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -147.11 155.25 26.44 Favored Glycine 0 N--CA 1.422 -2.25 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -101.77 129.99 48.09 Favored 'General case' 0 C--N 1.273 -2.74 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.333 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 37.1 mm -97.86 108.43 21.8 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.641 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -105.56 114.35 28.46 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 134' ' ' ASP . 3.3 mp -104.25 105.6 49.99 Favored Pre-proline 0 C--N 1.307 -1.272 0 O-C-N 123.633 0.583 . . . . 0.0 110.459 -174.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -73.37 99.0 1.07 Allowed 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.749 2.299 . . . . 0.0 112.354 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.446 ' HA ' ' CA ' ' A' ' 133' ' ' THR . 47.6 t 64.37 -82.27 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 125.972 1.709 . . . . 0.0 113.624 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.432 ' HB3' ' HB3' ' A' ' 173' ' ' PHE . 42.7 mt 62.66 -72.65 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.695 1.598 . . . . 0.0 112.517 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 64.45 -68.25 0.1 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.125 1.77 . . . . 0.0 111.71 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -100.08 10.37 41.37 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.404 -0.81 . . . . 0.0 110.101 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.432 ' HB3' ' HB3' ' A' ' 170' ' ' LEU . 22.2 t80 -113.92 10.24 17.61 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.465 ' CE2' ' HA ' ' A' ' 59' ' ' ARG . 75.0 m-85 . . . . . 0 CA--C 1.493 -1.228 0 CA-C-N 114.077 -1.42 . . . . 0.0 112.977 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.427 0 CA-C-O 120.238 -0.201 . . . . 0.0 113.044 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -139.95 124.44 18.07 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 117.199 0.499 . . . . 0.0 111.127 -175.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 66.43 80.46 0.22 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.913 0.885 . . . . 0.0 110.378 -176.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -83.01 95.05 7.91 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.022 -174.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.455 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . 38.9 m-70 -113.89 165.32 12.71 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.961 172.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -44.0 -59.68 2.19 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.028 1.331 . . . . 0.0 113.57 -174.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -114.99 -2.79 12.74 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.919 -178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.455 ' CB ' ' HB2' ' A' ' 5' ' ' HIS . 5.4 tt -64.5 -49.89 69.55 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -117.09 -84.06 0.64 Allowed 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 173.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.0 153.44 4.71 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.3 m -137.84 -66.76 0.49 Allowed 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.018 0.437 . . . . 0.0 109.883 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.523 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -98.57 -17.85 18.44 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.569 0.7 . . . . 0.0 109.515 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -56.58 -35.06 67.78 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.674 1.59 . . . . 0.0 110.923 -174.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.571 ' O ' ' HG3' ' A' ' 18' ' ' GLU . 9.8 pt-20 -58.25 -42.96 87.56 Favored 'General case' 0 C--O 1.206 -1.229 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.95 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.51 ' C ' ' HD2' ' A' ' 15' ' ' LYS . 3.3 tmmm? -72.02 -40.75 68.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.476 0.655 . . . . 0.0 110.004 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 12' ' ' ALA . 40.7 t -61.89 -44.57 99.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.802 -174.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.3 p -71.22 -27.7 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.99 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 47.0 mt-10 -75.64 -39.28 57.98 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.204 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.06 -37.94 89.25 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 120.7 0.286 . . . . 0.0 110.572 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -67.1 -45.48 77.08 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.959 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.59 -36.95 72.39 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.11 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.9 t -63.05 -44.9 94.56 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.445 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.06 -42.02 94.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 121.308 0.575 . . . . 0.0 110.072 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.3 mm -68.1 -44.59 84.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.391 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.414 ' HA ' HD11 ' A' ' 28' ' ' LEU . 23.2 t -61.72 -41.58 97.81 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.576 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.8 t -57.34 -37.12 72.05 Favored 'General case' 0 C--O 1.247 0.944 0 C-N-CA 122.9 0.48 . . . . 0.0 110.642 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 tt -73.7 -45.64 51.11 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.414 HD11 ' HA ' ' A' ' 25' ' ' SER . 86.3 mt -54.1 -45.5 71.84 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.175 0.59 . . . . 0.0 111.074 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -53.86 -45.42 70.97 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.508 ' HD2' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -79.09 -31.73 44.44 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.269 -0.972 . . . . 0.0 111.735 -178.216 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.508 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -75.13 -32.05 61.25 Favored 'General case' 0 C--O 1.21 -1.006 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.95 -177.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -58.58 -47.05 85.6 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.045 0.45 . . . . 0.0 111.02 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.49 -32.99 67.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.124 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -74.57 -40.55 61.58 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 122.615 0.366 . . . . 0.0 110.718 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.407 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 48.6 t80 -64.48 -46.24 83.87 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.89 -14.69 63.02 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.045 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.76 -66.88 1.04 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.001 0.905 . . . . 0.0 110.947 -176.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.41 ' HB2' ' HE2' ' A' ' 38' ' ' LYS . 6.6 tppt? -74.51 -39.32 62.47 Favored 'General case' 0 CA--C 1.453 -2.782 0 CA-C-O 122.937 1.351 . . . . 0.0 107.632 -166.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.407 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 71.7 mt -89.66 0.56 56.88 Favored 'General case' 0 C--N 1.255 -3.516 0 CA-C-N 112.118 -2.31 . . . . 0.0 111.507 -171.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.12 -18.26 29.21 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 173.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -104.71 -39.91 6.17 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.187 -1.369 . . . . 0.0 109.782 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 84.1 mt -83.64 126.4 71.15 Favored Pre-proline 0 C--N 1.312 -1.037 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.73 113.08 1.22 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.987 2.458 . . . . 0.0 112.672 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.2 p -140.43 145.59 41.63 Favored Pre-proline 0 C--N 1.299 -1.602 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.115 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.497 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 37.5 Cg_endo -62.96 135.51 51.92 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.649 2.233 . . . . 0.0 111.888 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.27 106.34 17.98 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 -174.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -102.41 143.01 32.7 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 115.023 -0.989 . . . . 0.0 112.796 -173.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.405 ' HA ' ' CG2' ' A' ' 159' ' ' VAL . 11.8 t -138.32 144.15 40.26 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.002 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.437 ' HB ' HG22 ' A' ' 161' ' ' THR . 50.6 t -91.95 141.75 14.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 172.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -125.75 -46.54 1.71 Allowed 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 117.261 -1.776 . . . . 0.0 114.075 -169.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -173.96 167.11 4.33 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -172.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.536 ' HB ' ' CD2' ' A' ' 64' ' ' TYR . 2.5 m -127.9 126.71 67.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 C-N-CA 123.254 0.622 . . . . 0.0 111.437 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -104.82 144.75 31.34 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 123.766 0.826 . . . . 0.0 111.249 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.561 ' HA ' ' CE1' ' A' ' 64' ' ' TYR . 44.5 p90 -58.85 130.33 46.44 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.541 ' HD3' ' C ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -118.81 -52.06 2.34 Favored 'General case' 0 N--CA 1.391 -3.422 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -175.242 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.441 ' O ' ' HE1' ' A' ' 173' ' ' PHE . . . -145.17 -173.08 16.09 Favored Glycine 0 CA--C 1.472 -2.651 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 177.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.0 m -125.81 129.45 72.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 117.804 0.802 . . . . 0.0 110.177 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.0 m -161.15 135.5 7.11 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.33 154.44 19.22 Favored 'General case' 0 C--N 1.286 -2.186 0 C-N-CA 117.268 -1.773 . . . . 0.0 109.662 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 78.44 15.86 1.25 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 125.47 1.508 . . . . 0.0 111.042 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.16 98.41 0.46 Allowed Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.9 p -103.81 142.55 17.24 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-O 120.94 0.4 . . . . 0.0 111.475 -174.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -76.07 111.73 11.77 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 176.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.561 ' CE1' ' HA ' ' A' ' 54' ' ' PHE . 6.9 t80 -121.02 155.99 33.16 Favored 'General case' 0 N--CA 1.41 -2.47 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -169.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -90.98 108.43 19.86 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -174.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.42 118.69 36.59 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -94.18 125.05 38.58 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.899 -174.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.1 m -124.56 144.97 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 176.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.2 m -130.12 143.46 50.8 Favored 'General case' 0 C--N 1.268 -2.951 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.336 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.497 ' CG2' ' HB2' ' A' ' 45' ' ' PRO . 7.4 p -141.67 134.33 28.94 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.513 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 20.6 pttp -107.29 119.35 39.16 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.78 0.8 . . . . 0.0 109.843 175.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 49.0 t30 -106.87 116.3 58.89 Favored Pre-proline 0 C--N 1.28 -2.431 0 CA-C-N 114.015 -1.448 . . . . 0.0 111.495 -174.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -89.43 97.16 0.32 Allowed 'Trans proline' 0 N--CA 1.428 -2.35 0 C-N-CA 121.547 1.498 . . . . 0.0 110.943 173.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 179.64 -169.07 0.11 Allowed 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 128.007 2.523 . . . . 0.0 106.15 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.476 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 48.7 m -135.3 17.37 3.41 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -112.14 128.92 56.36 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.974 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.5 p -75.29 98.51 3.82 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 173.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.513 ' H ' HD12 ' A' ' 105' ' ' LEU . 69.1 mt -72.22 121.9 85.96 Favored Pre-proline 0 C--N 1.302 -1.462 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.876 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.39 139.69 29.21 Favored 'Trans proline' 0 N--CA 1.44 -1.655 0 C-N-CA 122.264 1.976 . . . . 0.0 111.584 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.488 ' H ' HD12 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -84.42 134.83 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.952 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.458 178.272 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 52.8 t -82.65 -41.36 19.52 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -174.0 154.04 2.23 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.389 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.7 mp -114.61 113.86 44.93 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 173.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.431 ' OG ' HG22 ' A' ' 98' ' ' THR . 19.8 m -93.63 117.53 30.21 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -112.47 140.35 47.28 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.556 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 2.0 mp -116.94 108.01 23.87 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.887 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 174.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.48 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 1.2 tm? -90.52 120.36 31.55 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 -172.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -125.92 155.96 40.48 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -172.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.4 t -109.59 147.58 32.78 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 112.133 -2.303 . . . . 0.0 105.483 174.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -50.8 -26.26 5.47 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -176.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 87.6 m -149.65 -53.19 0.16 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -106.55 120.71 42.66 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -170.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 27.5 m 72.42 132.45 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.908 1.283 . . . . 0.0 114.306 173.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.455 HD13 ' C ' ' A' ' 94' ' ' ILE . 1.7 pp -135.03 165.37 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . . . -119.98 156.64 30.47 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 174.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 27.2 t -160.43 148.41 16.4 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.44 165.45 35.27 Favored Glycine 0 N--CA 1.426 -1.973 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.431 HG22 ' OG ' ' A' ' 84' ' ' SER . 68.3 p -115.62 120.4 39.27 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 61.2 mt -101.87 119.81 55.87 Favored Pre-proline 0 C--N 1.305 -1.331 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.623 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.73 124.7 5.22 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.805 2.336 . . . . 0.0 111.723 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.2 t70 52.1 72.08 1.3 Allowed Pre-proline 0 N--CA 1.481 1.099 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -178.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -103.75 6.19 0.34 Allowed 'Trans proline' 0 N--CA 1.435 -1.944 0 C-N-CA 122.768 2.312 . . . . 0.0 111.595 173.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 156.26 135.04 1.9 Allowed Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.3 m -111.89 146.73 37.21 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.771 0.319 . . . . 0.0 110.397 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.513 HD12 ' H ' ' A' ' 78' ' ' ILE . 3.3 pp -80.41 146.33 31.52 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.78 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 27.5 m -54.84 -46.09 75.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 136.93 -43.28 1.24 Allowed Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.476 ' OG ' ' HA ' ' A' ' 75' ' ' SER . 28.9 m -136.17 115.91 13.02 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 122.164 0.186 . . . . 0.0 111.276 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 105.38 -167.21 14.69 Favored Glycine 0 C--N 1.306 -1.098 0 C-N-CA 120.242 -0.98 . . . . 0.0 114.118 172.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.411 ' OG1' ' HB3' ' A' ' 71' ' ' LYS . 42.1 m -84.62 121.17 27.26 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 121.409 0.623 . . . . 0.0 110.373 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.5 t -125.94 138.22 53.75 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.5 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.3 m -94.27 128.69 45.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.412 0.625 . . . . 0.0 110.781 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.1 mt -125.56 157.92 35.88 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -143.54 141.18 30.61 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.476 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 43.0 t -112.3 130.19 23.58 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -77.61 109.89 2.85 Favored 'Trans proline' 0 N--CA 1.419 -2.862 0 N-CA-C 107.578 -1.739 . . . . 0.0 107.578 169.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.6 m -113.17 151.6 15.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -87.22 101.29 13.38 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.6 m -93.06 146.89 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.485 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -177.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.537 ' HB3' ' CE1' ' A' ' 174' ' ' PHE . . . 69.35 3.56 4.2 Favored 'General case' 0 C--O 1.205 -1.238 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.597 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.431 ' O ' ' HB ' ' A' ' 125' ' ' VAL . 8.3 t80 -67.86 -37.62 82.07 Favored 'General case' 0 C--O 1.203 -1.349 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.5 p -79.27 -29.87 42.76 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.327 0.585 . . . . 0.0 110.271 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.0 mt -79.88 -50.95 17.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.08 -174.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.35 -38.97 85.69 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 123.339 0.656 . . . . 0.0 111.028 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 121' ' ' TYR . 25.1 t -71.5 -36.34 60.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.924 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.0 t -85.01 -69.19 0.67 Allowed 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.936 -176.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.401 ' H ' HD21 ' A' ' 127' ' ' LEU . 1.9 pt? -125.09 -29.26 3.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -172.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.426 ' HE2' ' O ' ' A' ' 174' ' ' PHE . 0.8 OUTLIER 68.31 166.86 0.26 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.707 0.765 . . . . 0.0 112.904 -173.738 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.435 ' N ' ' HD3' ' A' ' 129' ' ' LYS . 1.9 mppt? -101.66 -66.31 0.93 Allowed 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 177.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 162.49 -24.85 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 -177.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.9 tpt 65.52 93.11 0.07 Allowed 'General case' 0 C--N 1.347 0.461 0 CA-C-N 112.819 -1.991 . . . . 0.0 112.367 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 135' ' ' TRP . 77.2 m -95.1 149.79 20.9 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.575 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.813 ' HB ' ' OG ' ' A' ' 169' ' ' SER . 22.1 p -82.27 118.49 23.17 Favored 'General case' 1 N--CA 1.339 -6.021 0 C-N-CA 124.89 1.276 . . . . 0.0 107.604 175.318 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 70.57 83.05 0.15 Allowed 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -173.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.47 ' HB2' ' HB2' ' A' ' 132' ' ' CYS . 42.4 t-105 -154.89 143.53 20.65 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.125 -167.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -108.82 144.08 37.16 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 175.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.407 ' CG2' ' HB ' ' A' ' 165' ' ' ILE . 0.0 OUTLIER -139.68 130.51 32.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.53 105.02 16.52 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 122.914 1.34 . . . . 0.0 111.811 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.455 ' HH ' HD21 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -108.08 161.14 15.23 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 113.826 -1.534 . . . . 0.0 107.954 177.402 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -138.47 158.55 44.06 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 121.42 -0.8 . . . . 0.0 111.079 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.556 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 2.3 pt? -154.53 122.88 6.05 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.857 167.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -102.25 140.29 36.72 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 158' ' ' PRO . 46.7 mt -125.28 149.17 29.77 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 C-N-CA 120.321 -0.551 . . . . 0.0 111.702 -173.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -119.41 89.94 0.47 Allowed Glycine 0 N--CA 1.421 -2.363 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 174.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -68.76 107.78 3.16 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.594 ' OG1' HG22 ' A' ' 156' ' ' THR . 11.0 m -92.12 107.94 19.57 Favored 'General case' 0 N--CA 1.421 -1.919 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.068 -176.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -109.25 141.2 41.88 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -109.8 109.92 20.75 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.445 HD12 ' O ' ' A' ' 153' ' ' GLY . 0.2 OUTLIER -115.12 145.98 35.31 Favored Pre-proline 0 C--N 1.314 -0.972 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.181 -178.394 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.63 -14.73 41.75 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.96 2.44 . . . . 0.0 113.159 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 43.4 t -71.7 -43.17 70.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 120.801 0.334 . . . . 0.0 110.667 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 49.0 t -127.81 -66.31 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.215 0.531 . . . . 0.0 110.59 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.445 ' O ' HD12 ' A' ' 149' ' ' ILE . . . 157.85 -139.9 6.68 Favored Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -177.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -90.0 117.52 28.86 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.722 0.772 . . . . 0.0 110.34 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 146' ' ' THR . 21.3 pt -117.35 128.53 74.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.483 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.594 HG22 ' OG1' ' A' ' 146' ' ' THR . 74.4 p -89.56 107.22 18.96 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 173.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 64.5 mt -80.42 112.75 33.67 Favored Pre-proline 0 C--N 1.295 -1.799 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 74.3 Cg_endo -82.17 151.81 16.03 Favored 'Trans proline' 0 CA--C 1.477 -2.346 0 C-N-CA 122.379 2.053 . . . . 0.0 112.804 -178.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.405 ' CG2' ' HA ' ' A' ' 48' ' ' THR . 2.7 p -161.7 123.15 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.387 -3.591 0 CA-C-N 112.721 -2.036 . . . . 0.0 108.149 -173.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 79.8 p -131.61 134.41 45.99 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.156 0.503 . . . . 0.0 111.716 -176.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.437 HG22 ' HB ' ' A' ' 49' ' ' VAL . 9.0 t -168.69 177.96 4.9 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 176.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -100.1 166.35 11.06 Favored 'General case' 0 N--CA 1.416 -2.156 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.213 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.423 ' O ' ' HD1' ' A' ' 139' ' ' TYR . . . -130.03 113.92 1.56 Allowed Glycine 0 N--CA 1.408 -3.199 0 N-CA-C 107.691 -2.164 . . . . 0.0 107.691 176.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -88.96 128.75 35.7 Favored 'General case' 0 C--N 1.262 -3.214 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -177.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.44 HG21 ' CE1' ' A' ' 174' ' ' PHE . 29.6 mm -97.18 114.03 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.064 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.493 ' HD2' ' H ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -86.58 99.07 11.44 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 114.317 -1.31 . . . . 0.0 109.435 -178.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.41 HD11 ' CD2' ' A' ' 174' ' ' PHE . 90.3 mt -103.01 106.09 49.0 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 114.877 -1.056 . . . . 0.0 113.224 -173.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 166' ' ' LYS . 10.2 Cg_exo -75.67 -177.85 3.88 Favored 'Trans proline' 0 CA--C 1.55 1.305 0 C-N-CA 122.259 1.973 . . . . 0.0 109.586 170.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.813 ' OG ' ' HB ' ' A' ' 133' ' ' THR . 20.2 m -64.43 90.62 0.07 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 175.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.63 -38.39 4.91 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.855 175.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 66.07 -55.78 0.37 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.976 0.91 . . . . 0.0 112.497 -173.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -115.93 99.51 7.33 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.441 ' HE1' ' O ' ' A' ' 56' ' ' GLY . 53.7 t80 179.42 -37.16 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.545 0.738 . . . . 0.0 111.052 -174.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.537 ' CE1' ' HB3' ' A' ' 120' ' ' ALA . 39.7 t80 . . . . . 0 C--O 1.259 1.594 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.959 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 70.71 158.06 0.18 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -176.92 143.43 0.42 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -74.7 109.62 8.33 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.207 0.527 . . . . 0.0 111.281 -178.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -88.6 108.19 19.31 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -99.09 177.12 5.33 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 120.855 0.359 . . . . 0.0 110.731 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 62.92 57.75 1.63 Allowed 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.9 mp -91.39 -51.69 5.16 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 170.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -78.1 82.12 4.45 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 113.654 -1.612 . . . . 0.0 107.227 174.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 165.04 93.4 0.0 OUTLIER 'General case' 0 C--O 1.243 0.74 0 C-N-CA 126.219 1.808 . . . . 0.0 108.004 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.8 m 72.35 -52.52 0.7 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.598 1.159 . . . . 0.0 112.567 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.99 -56.67 13.44 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -174.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.42 ' HA ' HG22 ' A' ' 16' ' ' VAL . 23.3 t70 -63.78 -40.08 95.81 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.755 0.312 . . . . 0.0 110.745 -177.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 18' ' ' GLU . 1.2 mp0 -59.44 -40.09 85.66 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.704 175.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -66.96 -55.85 12.76 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.068 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.42 HG22 ' HA ' ' A' ' 13' ' ' ASP . 33.3 m -58.11 -39.66 73.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.042 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 p -66.69 -39.8 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.676 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 45.3 mt-10 -65.56 -39.22 91.44 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -74.29 -38.01 63.49 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.428 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 16' ' ' VAL . 75.1 mmtt -64.99 -45.49 85.42 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.832 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.44 ' HB1' HD12 ' A' ' 94' ' ' ILE . . . -58.04 -41.59 83.56 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.159 178.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.2 t -56.44 -44.34 80.37 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 123.836 0.71 . . . . 0.0 110.073 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.7 t -73.97 -51.14 25.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.555 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.5 mt -57.83 -48.22 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.836 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.7 t -62.32 -35.16 78.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.609 0.243 . . . . 0.0 110.51 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.3 m -71.63 -21.3 61.85 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.319 0.581 . . . . 0.0 110.907 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.604 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 6.6 tt -79.82 -41.15 27.01 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.428 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 6.2 mp -65.61 -33.18 75.31 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 118.824 -1.15 . . . . 0.0 108.553 173.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -57.9 -37.15 73.48 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.146 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.604 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -70.81 -30.76 67.29 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.471 0.653 . . . . 0.0 110.582 179.407 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.483 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -78.67 -32.07 46.95 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.276 -177.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 98.5 mttt -48.49 -46.42 38.2 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.164 0.586 . . . . 0.0 111.988 -178.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.98 -33.57 84.4 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.207 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -81.47 -45.65 15.69 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.455 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 49.6 t80 -62.18 -51.92 65.87 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -175.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.6 -44.79 62.96 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -174.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -117.05 -38.87 3.31 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -177.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.15 -32.17 15.93 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.9 -164.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 83.8 mt -85.27 -11.44 54.79 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.33 -178.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.3 -29.82 71.07 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.118 0.485 . . . . 0.0 111.368 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -105.89 16.85 24.56 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.442 0.639 . . . . 0.0 110.099 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.5 mt -127.31 124.61 23.75 Favored Pre-proline 0 C--N 1.309 -1.179 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -57.87 96.38 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.402 2.068 . . . . 0.0 112.782 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.9 p -128.43 144.49 52.17 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -51.79 120.05 6.52 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.21 1.94 . . . . 0.0 110.941 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.425 ' HB3' ' CG ' ' A' ' 71' ' ' LYS . 35.1 tt0 -96.43 111.62 23.66 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -173.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.84 146.85 35.72 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.216 -173.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.419 ' HA ' HG21 ' A' ' 159' ' ' VAL . 9.7 t -141.04 155.03 46.24 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 176.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.428 HG22 HG23 ' A' ' 159' ' ' VAL . 92.4 t -82.14 141.49 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 173.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -106.95 -56.09 2.24 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -166.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.423 ' CG ' ' H ' ' A' ' 52' ' ' VAL . 19.2 t70 -170.21 -173.68 1.55 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -174.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.628 HG13 ' CD2' ' A' ' 64' ' ' TYR . 89.4 t -136.8 103.41 3.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 C-N-CA 123.342 0.657 . . . . 0.0 109.921 -175.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -93.45 104.99 17.1 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.357 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.568 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 63.5 t80 -74.62 105.34 5.67 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.611 0.764 . . . . 0.0 109.344 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.568 ' HD2' ' C ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -147.75 116.04 6.57 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.119 0.568 . . . . 0.0 111.165 -176.646 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.11 163.29 15.54 Favored Glycine 0 C--N 1.295 -1.723 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.855 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.2 p -145.13 153.11 14.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.1 t -155.07 -177.28 6.42 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.419 ' NH2' ' HB3' ' A' ' 60' ' ' ASP . 3.2 tmm_? -80.74 -46.94 14.68 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -178.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.419 ' HB3' ' NH2' ' A' ' 59' ' ' ARG . 7.5 p-10 -99.77 95.16 6.74 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.726 0.774 . . . . 0.0 111.156 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.5 -166.14 29.08 Favored Glycine 0 N--CA 1.416 -2.659 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.508 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 81.4 t -143.89 124.72 9.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 178.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -68.04 137.84 55.36 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.248 0.546 . . . . 0.0 110.992 -178.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.706 ' CD1' ' HB ' ' A' ' 119' ' ' VAL . 29.4 p90 -144.3 167.05 23.38 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 172.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 -103.5 114.32 28.51 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -77.57 106.02 9.09 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 178.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -87.8 125.74 34.61 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.867 -171.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.98 144.66 34.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.5 p -122.95 132.2 54.05 Favored 'General case' 0 C--N 1.282 -2.333 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.073 177.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.1 t -126.02 134.32 66.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.481 -174.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 22.1 ptmt -105.89 146.65 29.69 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 173.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.627 ' HB3' ' O ' ' A' ' 107' ' ' GLY . 46.7 t-20 -128.51 121.96 21.54 Favored Pre-proline 0 C--N 1.28 -2.417 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.972 -173.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -98.46 96.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.568 0 C-N-CA 121.582 1.521 . . . . 0.0 109.549 167.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.453 ' HB2' ' OD1' ' A' ' 72' ' ' ASN . 26.1 m-85 175.77 179.58 0.16 Allowed 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 128.727 2.811 . . . . 0.0 105.356 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.3 t -126.02 5.58 7.23 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 120.316 -0.554 . . . . 0.0 109.699 176.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -100.95 140.16 35.63 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.869 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 63.1 m -76.7 97.87 4.59 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 171.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 64.9 mt -72.83 124.69 91.03 Favored Pre-proline 0 C--N 1.307 -1.279 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.719 -177.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -69.38 127.7 15.29 Favored 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 121.817 1.678 . . . . 0.0 109.38 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 58.1 mt -80.72 113.88 20.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 49.6 t -56.2 -53.02 62.14 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.635 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -167.8 162.4 13.73 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.595 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 13.4 tt -124.11 115.31 44.52 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 175.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.5 p -94.08 118.1 31.05 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -108.41 135.09 50.28 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.307 178.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.9 mp -118.27 111.32 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 175.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.534 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -91.67 120.99 32.92 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -123.54 139.38 54.07 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.407 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.533 ' OG ' ' HB2' ' A' ' 122' ' ' SER . 49.5 m -115.42 145.13 42.85 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.806 176.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.6 113.42 2.69 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.282 -176.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.7 m 69.23 9.81 7.51 Favored 'General case' 0 CA--C 1.57 1.718 0 C-N-CA 124.408 1.083 . . . . 0.0 112.252 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -121.46 -170.79 2.09 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 121.502 -0.748 . . . . 0.0 111.098 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.0 t -74.51 -172.96 1.63 Allowed 'General case' 0 C--O 1.253 1.277 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.534 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.6 pp -138.07 168.44 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -176.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -119.09 140.62 49.78 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.7 p -141.25 140.33 33.89 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.689 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -165.63 153.35 23.3 Favored Glycine 0 N--CA 1.434 -1.498 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.4 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 27.2 p -118.28 122.6 43.32 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 178.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.91 108.26 57.8 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 118.301 -1.359 . . . . 0.0 109.717 176.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 98' ' ' THR . 11.7 Cg_exo -71.93 118.25 5.54 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.213 1.942 . . . . 0.0 109.389 174.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.9 t70 62.04 81.89 0.23 Allowed Pre-proline 0 N--CA 1.472 0.673 0 O-C-N 124.235 0.959 . . . . 0.0 111.577 -174.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -104.63 11.35 0.25 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.474 2.783 . . . . 0.0 110.461 176.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.1 -167.44 26.84 Favored Glycine 0 N--CA 1.422 -2.256 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 46.1 p -151.75 169.49 22.08 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 117.434 0.617 . . . . 0.0 110.641 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.451 HD21 ' H ' ' A' ' 105' ' ' LEU . 1.0 OUTLIER -115.56 131.41 56.94 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.338 0.589 . . . . 0.0 112.085 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.0 29.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 126.432 1.893 . . . . 0.0 115.087 -171.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.627 ' O ' ' HB3' ' A' ' 72' ' ' ASN . . . 71.79 -150.39 46.21 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.129 -177.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.62 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 29.7 p -54.42 90.04 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 124.498 1.119 . . . . 0.0 113.657 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 170.9 -166.4 39.59 Favored Glycine 0 CA--C 1.478 -2.262 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 174.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -119.51 135.9 54.57 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.0 t -134.58 137.88 44.12 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.105 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.8 m -91.26 124.2 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.832 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.3 mt -120.91 158.9 26.66 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.419 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 4.9 p-10 -147.36 148.47 31.38 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 177.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.6 p -130.54 136.15 28.51 Favored Pre-proline 0 C--N 1.292 -1.897 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.817 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.45 130.5 21.14 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.875 2.383 . . . . 0.0 112.637 178.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.457 HG11 ' CZ ' ' A' ' 64' ' ' TYR . 1.8 p -161.48 150.55 4.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 124.157 0.983 . . . . 0.0 109.262 178.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 13.3 mptt -88.93 133.76 34.19 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.966 0.413 . . . . 0.0 111.708 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.706 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 12.8 p -95.12 145.75 7.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 68.87 0.74 2.84 Favored 'General case' 0 C--O 1.216 -0.694 0 C-N-CA 124.426 1.09 . . . . 0.0 112.482 175.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -49.85 -46.47 51.42 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.784 1.233 . . . . 0.0 111.144 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.533 ' HB2' ' OG ' ' A' ' 89' ' ' SER . 17.0 m -69.75 -38.54 76.84 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.166 -175.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 19.7 tt -80.25 -27.46 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 O-C-N 121.94 -0.475 . . . . 0.0 111.342 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -52.63 -51.57 59.45 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 124.207 1.003 . . . . 0.0 112.046 177.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.5 m -61.32 -21.88 26.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -175.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.8 m -95.79 -78.08 0.46 Allowed 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 120.746 -0.382 . . . . 0.0 112.004 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.457 ' H ' HD22 ' A' ' 127' ' ' LEU . 2.1 pt? -120.72 -0.89 10.1 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.554 -174.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.511 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 25.1 ttt 53.55 76.03 0.23 Allowed 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 124.159 0.984 . . . . 0.0 112.107 -178.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.753 ' HE2' ' SD ' ' A' ' 131' ' ' MET . 55.4 pttt 54.77 -74.25 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 126.591 1.956 . . . . 0.0 113.021 -177.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 36.6 t70 161.56 81.54 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 101.223 -3.621 . . . . 0.0 101.223 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.753 ' SD ' ' HE2' ' A' ' 129' ' ' LYS . 8.9 tpt -56.01 110.96 0.82 Allowed 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -166.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.574 ' SG ' ' HB2' ' A' ' 135' ' ' TRP . 7.1 p -147.09 -176.08 5.07 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 113.707 -1.588 . . . . 0.0 108.874 176.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.613 HG23 ' CB ' ' A' ' 169' ' ' SER . 5.6 m -126.59 107.58 10.34 Favored 'General case' 1 N--CA 1.367 -4.578 0 N-CA-C 103.145 -2.909 . . . . 0.0 103.145 -170.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.9 t70 84.51 101.01 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 125.139 1.376 . . . . 0.0 108.343 -171.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.574 ' HB2' ' SG ' ' A' ' 132' ' ' CYS . 4.8 t-105 -163.94 136.17 4.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.232 -166.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -105.12 145.7 30.19 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.9 tt -155.28 151.08 10.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -114.7 123.25 48.81 Favored 'General case' 0 CA--C 1.498 -1.029 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.789 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -105.09 172.73 6.63 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -119.35 139.96 51.12 Favored 'General case' 0 C--N 1.274 -2.713 0 O-C-N 121.178 -0.951 . . . . 0.0 111.864 -175.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.8 tp -128.45 130.69 47.94 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.697 -178.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.544 ' OD1' ' HB3' ' A' ' 160' ' ' SER . 21.5 t70 -135.41 123.97 23.58 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.2 mm -115.01 148.41 17.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -121.54 99.1 0.68 Allowed Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 174.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.433 ' HB3' ' CE2' ' A' ' 147' ' ' PHE . 2.9 mm? -79.22 114.78 18.43 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.462 ' OG1' HG21 ' A' ' 156' ' ' THR . 8.2 m -96.36 108.3 20.8 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.433 ' CE2' ' HB3' ' A' ' 145' ' ' LEU . 75.4 m-85 -116.57 146.89 42.33 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -103.28 130.62 50.58 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.532 0.682 . . . . 0.0 110.123 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.01 130.0 16.16 Favored Pre-proline 0 C--N 1.291 -1.967 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -59.41 -21.57 61.8 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 C-N-CA 123.373 2.715 . . . . 0.0 113.668 -172.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.87 -28.27 40.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.598 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 97.2 t -134.37 -44.79 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.559 0.695 . . . . 0.0 110.613 -177.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 118.79 -115.97 3.24 Favored Glycine 0 C--N 1.29 -1.983 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -174.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -102.32 117.64 35.17 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.081 0.467 . . . . 0.0 112.133 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.545 HD13 ' O ' ' A' ' 155' ' ' ILE 0.265 2.6 pp -123.59 118.57 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-O 121.316 0.579 . . . . 0.0 110.941 170.459 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.462 HG21 ' OG1' ' A' ' 146' ' ' THR . 23.3 p -85.85 108.88 18.34 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.677 177.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 68.5 mt -76.41 114.64 40.13 Favored Pre-proline 0 C--N 1.292 -1.932 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.768 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -82.98 137.22 8.48 Favored 'Trans proline' 0 CA--C 1.475 -2.452 0 C-N-CA 122.849 2.366 . . . . 0.0 111.954 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.428 HG23 HG22 ' A' ' 49' ' ' VAL . 5.7 p -149.52 112.98 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.38 -3.962 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.096 -174.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.544 ' HB3' ' OD1' ' A' ' 142' ' ' ASP . 58.3 p -120.49 155.36 33.75 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.599 -177.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.3 t -163.0 171.79 15.99 Favored 'General case' 0 C--O 1.255 1.358 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -99.43 126.89 45.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -94.09 85.86 1.06 Allowed Glycine 0 N--CA 1.413 -2.885 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -88.5 119.55 29.05 Favored 'General case' 0 N--CA 1.42 -1.972 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 8.4 pt -140.11 177.07 4.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.542 -171.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.407 ' HD2' ' H ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -130.19 143.83 51.01 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.447 -176.326 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.0 mp -125.59 97.98 35.41 Favored Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 171.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.611 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 33.1 Cg_endo -64.06 170.11 9.52 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.613 2.209 . . . . 0.0 111.332 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.613 ' CB ' HG23 ' A' ' 133' ' ' THR . 26.5 p -40.37 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 173.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 168' ' ' PRO . 3.5 pp -162.01 132.12 4.77 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.951 177.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.45 ' NH2' ' HA ' ' A' ' 132' ' ' CYS . 64.9 mtt180 -132.86 85.67 2.24 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 172.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 23.9 t70 177.19 -38.34 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 O-C-N 123.835 0.709 . . . . 0.0 110.608 -174.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -81.81 -51.66 7.91 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 176.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.459 ' HB2' HG22 ' A' ' 62' ' ' VAL . 39.7 t80 . . . . . 0 N--CA 1.399 -3.024 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 172.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.935 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -96.57 -18.85 19.49 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 117.899 0.849 . . . . 0.0 112.587 -178.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -86.54 100.98 12.78 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.898 0.38 . . . . 0.0 111.091 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 -119.77 88.97 3.04 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -93.17 79.0 4.52 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.78 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -151.45 -72.98 0.15 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.232 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -140.52 20.11 2.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.753 0.311 . . . . 0.0 110.353 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.47 -37.32 86.5 Favored 'General case' 0 C--O 1.201 -1.498 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -87.12 16.75 4.77 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.224 0.535 . . . . 0.0 110.589 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -129.46 97.85 4.68 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.428 ' HA ' ' OE2' ' A' ' 14' ' ' GLU . 35.4 m 76.13 -37.84 0.32 Allowed 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 125.713 1.605 . . . . 0.0 113.025 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.6 -30.28 64.23 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.636 ' O ' HG23 ' A' ' 17' ' ' VAL . 38.6 t70 -70.94 -34.71 71.75 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.428 ' OE2' ' HA ' ' A' ' 11' ' ' SER . 44.1 mt-10 -58.79 -39.96 82.64 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.188 175.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 40.4 tttp -64.13 -56.9 11.56 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.698 176.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.507 ' HA ' ' CG ' ' A' ' 19' ' ' GLU . 25.6 m -58.96 -24.65 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 13' ' ' ASP . 67.2 t -67.26 -50.23 64.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 172.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -62.34 -30.12 70.94 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.336 -177.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.507 ' CG ' ' HA ' ' A' ' 16' ' ' VAL . 40.0 mm-40 -54.77 -52.15 63.48 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.624 176.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -78.49 -31.37 47.75 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 120.109 -0.636 . . . . 0.0 111.908 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.9 -42.79 80.55 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 123.271 0.357 . . . . 0.0 110.19 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.2 t -59.43 -41.72 90.2 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.667 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 67.2 t -66.93 -49.39 74.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-O 120.836 0.35 . . . . 0.0 110.45 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.515 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 68.0 mt -60.89 -42.77 93.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.22 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.8 m -65.58 -32.51 74.14 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.38 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.8 t -71.44 -34.67 70.48 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.531 HD22 ' OG1' ' A' ' 156' ' ' THR . 3.2 tt -65.84 -41.89 91.19 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 176.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 83.4 mt -57.77 -38.71 75.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.116 177.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -61.16 -41.98 97.73 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 27' ' ' LEU . 65.6 pttt -71.81 -38.81 70.15 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.838 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.05 -31.76 68.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.25 -176.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -62.58 -42.2 99.41 Favored 'General case' 0 C--O 1.246 0.888 0 CA-C-O 121.023 0.44 . . . . 0.0 110.809 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.95 -33.56 36.5 Favored Glycine 0 CA--C 1.51 -0.281 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -57.17 -46.31 82.9 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.527 ' HA ' HD11 ' A' ' 39' ' ' LEU . 10.5 t80 -52.9 -53.31 51.06 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.066 1.347 . . . . 0.0 111.326 174.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.37 -33.22 58.71 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -174.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -99.15 -64.25 1.05 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.281 0.562 . . . . 0.0 112.457 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.3 mtmm -79.95 -22.45 42.62 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -169.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.527 HD11 ' HA ' ' A' ' 35' ' ' PHE . 5.7 mp -98.86 6.96 46.53 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-O 121.679 0.752 . . . . 0.0 109.805 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.95 -35.72 11.88 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -90.48 -18.21 25.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.398 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.8 mt -115.12 112.95 44.01 Favored Pre-proline 0 C--N 1.309 -1.194 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.6 97.36 0.88 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.187 1.925 . . . . 0.0 113.076 -176.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.3 p -93.01 159.34 35.86 Favored Pre-proline 0 N--CA 1.43 -1.43 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.982 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.05 147.35 90.68 Favored 'Trans proline' 0 C--O 1.239 0.556 0 C-N-CA 122.946 2.43 . . . . 0.0 111.596 174.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 38.4 tt0 -110.27 109.63 20.15 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.45 138.42 35.69 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.581 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.8 t -135.14 129.23 33.53 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.318 0.58 . . . . 0.0 110.957 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.485 ' H ' HG11 ' A' ' 159' ' ' VAL . 48.1 t -105.48 141.01 21.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 177.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -158.08 -31.96 0.07 Allowed 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -170.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -145.69 151.65 38.37 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 118.923 -1.111 . . . . 0.0 111.755 -171.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . 28.9 m -124.28 152.19 29.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 123.433 0.693 . . . . 0.0 110.712 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.513 ' CG ' ' HZ3' ' A' ' 67' ' ' LYS . 18.2 m-20 -114.86 117.0 29.47 Favored 'General case' 0 C--O 1.246 0.888 0 C-N-CA 122.841 0.456 . . . . 0.0 111.802 177.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -64.69 107.94 1.57 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 167.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 63' ' ' ASP . 14.6 ptmm? -107.05 -16.4 14.44 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.103 -0.639 . . . . 0.0 112.663 -176.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 159.65 -178.51 35.72 Favored Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 119.296 -1.431 . . . . 0.0 112.67 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.88 151.37 18.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 123.22 0.608 . . . . 0.0 110.007 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.4 t -153.19 -176.66 5.88 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -79.16 -53.52 6.9 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -175.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -97.78 80.61 2.79 Favored 'General case' 0 C--N 1.313 -1.015 0 O-C-N 122.167 -0.333 . . . . 0.0 111.683 -176.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.81 120.01 0.13 Allowed Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.146 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 173' ' ' PHE . 33.9 m -70.74 156.34 7.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 121.248 0.547 . . . . 0.0 111.812 -177.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 19.7 m-20 -96.06 126.23 41.15 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.08 -172.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.545 ' CD1' HG13 ' A' ' 119' ' ' VAL . 2.7 m-85 -121.04 122.62 40.47 Favored 'General case' 0 CA--C 1.471 -2.084 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.571 171.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -92.4 108.04 19.66 Favored 'General case' 0 C--N 1.273 -2.727 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . . . -93.34 144.84 24.94 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.513 ' HZ3' ' CG ' ' A' ' 53' ' ' ASP . 12.5 mptt -86.88 133.12 33.65 Favored 'General case' 0 C--O 1.251 1.143 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.734 176.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.6 t -130.97 106.52 12.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 168.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.2 p -106.91 134.84 49.46 Favored 'General case' 0 C--N 1.277 -2.552 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.424 -176.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 4.8 p -132.52 126.54 55.22 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.95 -176.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 89.1 tttt -96.6 119.38 34.98 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 175.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.4 ' HB2' HD11 ' A' ' 105' ' ' LEU . 52.7 t30 -111.45 115.7 51.56 Favored Pre-proline 0 C--N 1.301 -1.51 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.72 -175.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -95.81 96.92 0.1 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.612 0 C-N-CA 121.904 1.736 . . . . 0.0 111.025 172.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.405 ' HB3' ' H ' ' A' ' 75' ' ' SER . 30.6 m-85 -170.19 -166.09 0.52 Allowed 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 126.515 1.926 . . . . 0.0 107.011 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.405 ' H ' ' HB3' ' A' ' 74' ' ' TYR . 47.3 t -142.5 21.13 2.03 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 173.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.549 ' O ' ' HA2' ' A' ' 107' ' ' GLY . 17.2 pt20 -115.14 140.73 48.83 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.412 -178.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.3 p -83.15 95.19 8.03 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-O 121.656 0.741 . . . . 0.0 109.308 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 72.5 mt -74.93 122.95 88.6 Favored Pre-proline 0 N--CA 1.433 -1.287 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.726 -176.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.78 122.64 6.45 Favored 'Trans proline' 0 N--CA 1.444 -1.438 0 C-N-CA 122.197 1.932 . . . . 0.0 110.666 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 50.0 mt -88.33 102.82 13.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 62.3 m -57.55 -60.37 3.76 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 124.133 0.895 . . . . 0.0 110.624 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -150.68 157.35 42.85 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-O 121.52 0.676 . . . . 0.0 111.868 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.47 ' HB ' HG21 ' A' ' 99' ' ' ILE . 46.4 mm -107.15 116.94 51.95 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 176.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.0 m -80.78 118.35 22.23 Favored 'General case' 0 N--CA 1.412 -2.375 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -103.06 121.42 42.55 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.992 -170.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 69.9 mt -134.9 109.8 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.24 177.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.607 ' O ' HD11 ' A' ' 94' ' ' ILE . 0.9 OUTLIER -113.03 120.61 41.95 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 176.588 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.576 ' HD2' ' O ' ' A' ' 93' ' ' THR . 53.4 tptt -121.38 135.53 55.06 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.5 m -142.38 145.36 33.79 Favored 'General case' 0 C--O 1.25 1.082 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.55 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 62.28 18.27 10.05 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.119 0.968 . . . . 0.0 111.197 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 m 59.16 14.01 3.3 Favored 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 123.986 0.915 . . . . 0.0 109.888 -175.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -127.63 -65.65 0.91 Allowed 'General case' 0 N--CA 1.432 -1.336 0 O-C-N 121.325 -0.859 . . . . 0.0 111.057 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.576 ' O ' ' HD2' ' A' ' 88' ' ' LYS . 11.1 t -76.92 165.56 24.51 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.823 -172.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.607 HD11 ' O ' ' A' ' 87' ' ' LEU . 3.8 tp -163.38 139.02 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.015 0 C-N-CA 123.195 0.598 . . . . 0.0 109.703 -168.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.11 121.47 26.42 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 171.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 78.0 p -139.76 160.12 40.62 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.292 0.568 . . . . 0.0 111.63 -176.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 167.41 -170.25 41.52 Favored Glycine 0 N--CA 1.417 -2.614 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.3 p -127.86 122.2 31.99 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.47 HG21 ' HB ' ' A' ' 83' ' ' ILE . 10.0 tt -102.86 108.45 58.33 Favored Pre-proline 0 C--N 1.318 -0.771 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.02 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -82.55 146.31 13.51 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 C-N-CA 122.889 2.393 . . . . 0.0 113.63 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 44.75 67.41 4.11 Favored Pre-proline 0 N--CA 1.477 0.911 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -101.24 1.05 0.58 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.465 2.11 . . . . 0.0 111.911 176.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 148.94 -179.0 26.12 Favored Glycine 0 N--CA 1.428 -1.874 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.6 m -150.38 175.72 11.57 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 117.509 0.655 . . . . 0.0 110.708 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.532 ' H ' HD23 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -104.62 131.96 51.43 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.443 0.64 . . . . 0.0 112.654 -175.093 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.2 m -63.59 18.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 -171.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.549 ' HA2' ' O ' ' A' ' 76' ' ' GLN . . . 85.09 -52.66 4.71 Favored Glycine 0 C--O 1.214 -1.1 0 C-N-CA 120.407 -0.902 . . . . 0.0 113.32 177.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.7 t -148.29 117.17 6.72 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -177.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 133.99 177.37 14.89 Favored Glycine 0 CA--C 1.49 -1.479 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.12 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 9.9 t -96.53 113.35 24.92 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 121.753 0.787 . . . . 0.0 109.421 177.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.9 t -112.28 138.07 49.51 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.376 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 25.0 t -96.94 107.56 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.8 mt -86.8 166.39 15.27 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 178.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -140.43 145.84 37.52 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.396 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.4 t -120.95 128.2 25.87 Favored Pre-proline 0 C--N 1.3 -1.581 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -74.54 109.6 2.94 Favored 'Trans proline' 0 N--CA 1.43 -2.224 0 N-CA-C 106.986 -1.967 . . . . 0.0 106.986 168.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.464 HG12 ' HH ' ' A' ' 139' ' ' TYR . 59.2 t -103.66 127.27 57.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -176.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -88.98 91.12 8.71 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.545 HG13 ' CD1' ' A' ' 64' ' ' TYR . 12.1 p -94.03 147.29 5.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.173 -172.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.408 ' HA ' HD11 ' A' ' 123' ' ' ILE . . . 72.47 -5.63 1.77 Allowed 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.211 1.004 . . . . 0.0 111.318 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.461 ' H ' ' C ' ' A' ' 119' ' ' VAL . 76.1 t80 -63.55 -54.42 36.39 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.377 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.52 ' HB2' ' OG1' ' A' ' 93' ' ' THR . 13.1 p -63.42 -36.87 85.16 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.922 -176.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.438 ' CD1' HG21 ' A' ' 137' ' ' ILE . 52.7 mt -64.6 -49.42 80.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.097 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.74 -36.12 82.67 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 123.484 0.49 . . . . 0.0 110.775 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 121' ' ' TYR . 52.6 t -62.11 -51.4 72.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.514 176.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.6 m -66.74 -73.83 0.13 Allowed 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.493 HD13 ' N ' ' A' ' 128' ' ' MET . 2.0 pp -125.16 -32.14 3.01 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -171.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.493 ' N ' HD13 ' A' ' 127' ' ' LEU . 0.0 OUTLIER 63.37 110.93 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -171.2 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.56 ' HZ2' ' C ' ' A' ' 174' ' ' PHE . 0.0 OUTLIER -68.07 -0.02 4.07 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -171.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 17.8 t70 84.79 -26.41 0.11 Allowed 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 125.624 1.57 . . . . 0.0 110.592 173.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.554 ' HE2' ' O ' ' A' ' 170' ' ' LEU . 9.1 tpt 70.89 149.7 0.09 Allowed 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 125.475 1.51 . . . . 0.0 113.47 174.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 72.0 m -153.69 160.76 42.45 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.436 ' CA ' ' HA ' ' A' ' 169' ' ' SER . 40.2 p -78.78 125.74 29.78 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 175.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.4 t70 69.47 89.02 0.1 Allowed 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -176.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.429 ' HE1' ' HG3' ' A' ' 129' ' ' LYS . 54.5 t-105 -158.19 149.79 21.39 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 114.032 -1.44 . . . . 0.0 109.732 -166.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -140.59 149.34 42.24 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.904 0.383 . . . . 0.0 110.386 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.438 HG21 ' CD1' ' A' ' 123' ' ' ILE . 2.9 mp -118.7 141.68 37.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -81.08 102.67 10.39 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 122.048 0.928 . . . . 0.0 109.473 174.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.527 ' CE2' ' HG ' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -130.69 144.58 51.53 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.251 -177.292 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.4 ' CB ' ' HA ' ' A' ' 162' ' ' GLN . 20.7 pt20 -131.52 157.8 42.6 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 38.2 tp -124.89 123.89 40.89 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -121.88 120.3 34.12 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.171 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 46.6 mm -120.62 127.76 75.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.891 -178.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -95.6 89.94 1.19 Allowed Glycine 0 N--CA 1.427 -1.903 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 173.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.26 110.69 7.74 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.567 ' OG1' HG22 ' A' ' 156' ' ' THR . 27.8 m -95.89 108.4 20.76 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 120.861 0.363 . . . . 0.0 111.18 -176.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -101.76 132.04 47.72 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 176.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -101.98 109.36 21.07 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 65.0 mt -127.99 114.29 20.38 Favored Pre-proline 0 C--N 1.29 -1.995 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.21 -24.1 32.42 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.841 2.361 . . . . 0.0 113.662 -176.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.38 -36.18 76.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.222 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 10.2 p -125.3 -32.1 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -174.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 120.56 -151.51 17.14 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -101.02 125.18 47.62 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.264 -1.014 . . . . 0.0 108.264 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.44 127.64 57.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.567 HG22 ' OG1' ' A' ' 146' ' ' THR . 74.8 p -91.84 108.95 20.28 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.407 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . 51.8 mt -77.77 114.47 41.65 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 157' ' ' ILE . 5.5 Cg_exo -76.58 101.02 1.45 Allowed 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 122.436 2.091 . . . . 0.0 111.587 -178.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.485 HG11 ' H ' ' A' ' 49' ' ' VAL . 18.0 t -101.83 113.18 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 53.1 p -110.14 145.22 37.56 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.194 -175.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.9 t -156.77 113.65 3.08 Favored 'General case' 0 N--CA 1.424 -1.768 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.296 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.4 ' HA ' ' CB ' ' A' ' 140' ' ' GLN . 11.4 pt20 -98.25 119.26 36.6 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -134.77 -130.92 3.02 Favored Glycine 0 N--CA 1.407 -3.284 0 C-N-CA 119.792 -1.194 . . . . 0.0 113.023 -174.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -158.14 133.1 8.52 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 115.219 -0.49 . . . . 0.0 109.918 -171.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 43.2 mm -107.02 108.59 25.56 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 171.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -110.94 128.89 55.98 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 121.791 0.805 . . . . 0.0 111.441 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 96.0 mt -118.57 91.48 41.86 Favored Pre-proline 0 N--CA 1.411 -2.39 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.758 -172.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.46 ' O ' HD21 ' A' ' 170' ' ' LEU . 9.1 Cg_exo -71.64 100.82 1.09 Allowed 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.575 2.85 . . . . 0.0 112.992 -177.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.436 ' HA ' ' CA ' ' A' ' 133' ' ' THR . 91.3 p 62.9 9.72 3.88 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 126.682 1.993 . . . . 0.0 115.528 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.554 ' O ' ' HE2' ' A' ' 131' ' ' MET . 3.5 mm? -71.73 138.66 48.65 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.146 -0.621 . . . . 0.0 111.848 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -142.54 140.99 31.98 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 167.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 37.5 t70 74.85 5.44 4.38 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.385 1.088 . . . . 0.0 110.762 -174.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.465 ' CD1' HD13 ' A' ' 170' ' ' LEU . 78.0 m-85 -104.45 5.1 33.93 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.887 174.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.56 ' C ' ' HZ2' ' A' ' 129' ' ' LYS . 80.3 m-85 . . . . . 0 CA--C 1.487 -1.454 0 CA-C-N 114.051 -1.431 . . . . 0.0 113.887 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.969 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -88.34 123.28 32.76 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -99.99 133.5 44.28 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 120.85 0.357 . . . . 0.0 110.669 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -141.08 92.0 2.45 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.748 0.785 . . . . 0.0 109.561 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -134.52 -70.11 0.51 Allowed 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.109 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 47.5 m80 62.06 170.91 0.12 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.972 0.909 . . . . 0.0 111.69 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -179.57 -36.37 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.199 0 C-N-CA 123.546 0.738 . . . . 0.0 111.364 174.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.26 34.9 mt 42.28 71.26 0.23 Allowed 'General case' 0 CA--C 1.483 -1.625 0 CA-C-O 123.036 1.398 . . . . 0.0 112.172 -175.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 71.94 -70.52 0.16 Allowed 'General case' 0 C--N 1.261 -3.24 0 CA-C-N 111.31 -2.677 . . . . 0.0 111.785 -174.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 66.26 34.93 6.23 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 121.763 0.792 . . . . 0.0 110.373 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.9 t -144.33 -54.78 0.34 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.113 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.44 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -57.18 -36.93 71.41 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-O 121.016 0.436 . . . . 0.0 110.299 176.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -56.15 -44.95 79.76 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 124.357 1.063 . . . . 0.0 110.355 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.77 -43.77 98.19 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.826 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -63.86 -50.69 67.83 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.388 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 12' ' ' ALA . 90.2 t -66.29 -44.63 91.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 114.979 -1.009 . . . . 0.0 113.354 -176.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.0 p -64.19 -26.59 40.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -75.45 -44.01 46.5 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.571 -177.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.481 ' O ' HG21 ' A' ' 23' ' ' VAL . 10.8 pt-20 -64.0 -40.25 95.95 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.649 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -65.85 -40.68 91.93 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.375 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.69 -42.7 99.29 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.179 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.8 t -61.76 -41.85 98.22 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.979 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 19' ' ' GLU . 93.5 t -60.75 -49.63 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.234 0.54 . . . . 0.0 109.779 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 67.6 mt -67.34 -39.91 83.73 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.768 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.003 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.9 t -61.72 -41.08 97.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.878 0.37 . . . . 0.0 110.105 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.451 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 32.6 m -70.34 -32.09 69.66 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.122 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.593 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 4.4 tt -69.84 -47.53 62.35 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 176.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.577 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 96.3 mt -59.95 -32.74 71.08 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.9 0.381 . . . . 0.0 110.152 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.451 ' HB3' ' O ' ' A' ' 26' ' ' SER . 12.4 t70 -57.69 -46.22 84.59 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.893 175.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -74.77 -33.63 62.32 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.238 0.542 . . . . 0.0 109.757 179.613 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.505 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -62.21 -39.63 93.41 Favored 'General case' 0 C--O 1.204 -1.337 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.729 -178.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.577 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 29.0 mtpp -60.76 -33.97 73.76 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.41 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -84.2 -51.1 4.06 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.066 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -61.92 -32.59 73.01 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 123.61 0.764 . . . . 0.0 112.592 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -72.62 -34.95 67.69 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 121.905 -0.497 . . . . 0.0 110.637 175.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.72 -27.33 58.12 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.731 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.439 ' HG3' ' N ' ' A' ' 38' ' ' LYS . 10.7 pt-20 -98.35 -49.32 4.72 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.439 ' N ' ' HG3' ' A' ' 37' ' ' GLU . 14.5 tppt? -76.84 -47.15 22.22 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 122.13 0.967 . . . . 0.0 109.333 -170.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 42.1 mt -89.36 16.93 6.68 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.45 -175.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.22 -20.21 19.41 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 172.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -97.69 -35.11 10.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.66 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.5 mt -103.47 118.56 57.35 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.078 -177.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.95 112.24 2.88 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.542 2.161 . . . . 0.0 111.092 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.422 ' HB ' ' CD ' ' A' ' 45' ' ' PRO . 4.0 p -116.88 171.22 5.04 Favored Pre-proline 0 C--N 1.301 -1.52 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.263 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.45 ' HB3' ' CB ' ' A' ' 72' ' ' ASN . 7.9 Cg_exo -72.95 145.97 41.04 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.477 2.118 . . . . 0.0 112.516 -177.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -97.75 119.02 35.58 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.999 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.21 141.28 37.01 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.1 t -136.46 143.03 43.64 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.5 t -97.91 132.34 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 175.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -112.69 -60.11 1.92 Allowed 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.059 -1.057 . . . . 0.0 113.745 -169.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -163.88 161.36 22.98 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -172.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.515 HG21 ' HB3' ' A' ' 64' ' ' TYR . 10.0 p -135.49 112.2 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.76 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -106.82 159.03 16.55 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.951 -175.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -71.36 126.81 30.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.419 0.628 . . . . 0.0 112.212 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.446 ' HD2' ' OD2' ' A' ' 63' ' ' ASP . 10.2 tmtt? -110.91 -44.84 3.55 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.352 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -178.5 -176.44 46.4 Favored Glycine 0 CA--C 1.484 -1.897 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 177.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.464 ' HA ' HG22 ' A' ' 62' ' ' VAL . 27.2 m -107.81 148.75 11.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.772 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.4 m -150.78 125.24 9.53 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 174.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -82.71 88.62 6.72 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 122.265 1.031 . . . . 0.0 113.407 -170.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -178.66 37.02 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 102.271 -3.233 . . . . 0.0 102.271 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.82 -133.07 10.63 Favored Glycine 0 N--CA 1.415 -2.723 0 N-CA-C 106.038 -2.825 . . . . 0.0 106.038 -170.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 57' ' ' VAL . 9.8 p -152.24 136.89 9.84 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 172.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.446 ' OD2' ' HD2' ' A' ' 55' ' ' LYS . 35.3 t70 -85.62 105.04 15.9 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-O 121.629 0.728 . . . . 0.0 112.237 -169.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.515 ' HB3' HG21 ' A' ' 52' ' ' VAL . 3.2 m-85 -109.47 161.61 15.16 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 121.65 0.738 . . . . 0.0 112.144 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 39.2 t60 -102.51 106.44 17.15 Favored 'General case' 0 N--CA 1.413 -2.298 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.631 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.22 124.87 35.23 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.801 174.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -100.41 125.27 46.67 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.386 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.0 m -121.44 144.58 30.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.3 m -120.83 136.0 55.02 Favored 'General case' 0 C--N 1.277 -2.581 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.033 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t -129.98 127.73 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-O 121.029 0.442 . . . . 0.0 110.27 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 19.3 ptpt -113.2 143.03 45.08 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 174.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.665 ' O ' ' HA ' ' A' ' 108' ' ' SER . 1.8 p-10 -142.63 138.49 16.27 Favored Pre-proline 0 C--N 1.287 -2.134 0 C-N-CA 118.906 -1.118 . . . . 0.0 110.266 -177.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -99.62 95.4 0.05 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.462 0 C-N-CA 120.852 1.035 . . . . 0.0 110.152 170.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -174.47 138.91 0.55 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.7 m -85.71 -5.3 59.28 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 118.827 0.74 . . . . 0.0 111.182 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -88.19 143.62 26.94 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.381 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.2 p -90.35 102.33 15.06 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.11 0.481 . . . . 0.0 109.902 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.8 mt -92.01 130.25 38.92 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -177.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -75.92 142.5 25.24 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.897 1.731 . . . . 0.0 108.943 171.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 103' ' ' GLY . 18.3 pt -82.5 102.62 8.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.318 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 6.6 m -43.47 -65.93 0.44 Allowed 'General case' 0 C--O 1.244 0.799 0 C-N-CA 126.945 2.098 . . . . 0.0 113.032 -172.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.534 ' C ' HD12 ' A' ' 83' ' ' ILE . 10.0 pt20 -147.34 150.82 35.49 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.534 HD12 ' C ' ' A' ' 82' ' ' GLN . 1.8 mp -120.39 117.97 55.15 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.141 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.8 m -80.08 119.98 23.62 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.476 ' CE2' HG13 ' A' ' 117' ' ' VAL . 4.8 t80 -103.04 120.76 41.24 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.634 -170.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 39.8 mm -131.17 108.47 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.515 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 0.2 OUTLIER -106.22 126.98 52.89 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 179.433 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -124.41 147.1 48.49 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.965 -0.694 . . . . 0.0 112.314 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.7 m -151.93 97.9 2.39 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 64.73 -173.03 0.18 Allowed 'General case' 0 CA--C 1.541 0.609 0 O-C-N 123.975 0.797 . . . . 0.0 109.5 -174.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.3 p -98.54 14.55 27.93 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.805 -0.56 . . . . 0.0 111.681 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.6 -65.58 0.99 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.27 -177.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 122' ' ' SER . 35.1 m -130.54 141.3 50.48 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 122.05 -0.406 . . . . 0.0 111.177 -175.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.515 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.8 pp -137.06 168.79 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -178.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.61 147.81 49.17 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 176.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.7 p -144.16 164.81 29.62 Favored 'General case' 0 C--N 1.313 -0.992 0 O-C-N 122.438 -0.164 . . . . 0.0 110.859 -177.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 156.36 -170.57 33.97 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 176.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 35.5 p -132.99 127.39 34.06 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 117.331 0.566 . . . . 0.0 109.721 176.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.4 tt -103.36 116.91 61.36 Favored Pre-proline 0 C--N 1.318 -0.796 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.964 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -88.63 128.04 2.02 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.973 2.449 . . . . 0.0 113.561 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.2 t70 50.98 72.96 1.07 Allowed Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.482 ' HD2' HG13 ' A' ' 80' ' ' ILE . 84.2 Cg_endo -104.09 18.8 0.16 Allowed 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 123.729 2.953 . . . . 0.0 110.706 174.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.533 ' O ' HG12 ' A' ' 80' ' ' ILE . . . 155.23 172.7 23.15 Favored Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.9 m -145.65 149.12 33.91 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.438 ' H ' HD11 ' A' ' 105' ' ' LEU 0.37 0.0 OUTLIER -81.18 157.62 25.2 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 119.519 -0.873 . . . . 0.0 113.259 179.118 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.4 m -83.53 -3.14 7.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -172.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.97 75.95 0.93 Allowed Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.646 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.665 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 48.8 m 78.91 91.46 0.06 Allowed 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 124.852 1.261 . . . . 0.0 111.756 -178.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 158.55 172.42 25.66 Favored Glycine 0 N--CA 1.425 -2.037 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 45.4 p -100.26 113.42 26.11 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.9 t -124.22 138.75 54.37 Favored 'General case' 0 N--CA 1.42 -1.937 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.333 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.2 m -86.36 134.62 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-O 121.416 0.627 . . . . 0.0 109.837 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.0 mt -125.24 167.01 15.46 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -140.31 148.51 41.5 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.464 -0.895 . . . . 0.0 112.848 -175.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 91.8 t -133.93 122.58 16.5 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 173.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -77.6 109.03 2.68 Favored 'Trans proline' 0 N--CA 1.41 -3.383 0 N-CA-C 108.059 -1.554 . . . . 0.0 108.059 171.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.476 HG13 ' CE2' ' A' ' 85' ' ' TYR . 33.8 m -98.87 149.66 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 177.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -101.99 99.17 9.31 Favored 'General case' 0 C--N 1.273 -2.725 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.2 m -91.72 149.94 3.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.92 -171.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 76.05 12.46 2.83 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.282 0.633 . . . . 0.0 110.907 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.552 ' O ' HG23 ' A' ' 125' ' ' VAL . 81.4 t80 -59.88 -39.61 85.9 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 172.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.404 ' HB3' ' HB ' ' A' ' 93' ' ' THR . 16.4 m -58.83 -32.71 69.64 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 122.317 1.056 . . . . 0.0 109.58 178.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.576 HG23 ' HA ' ' A' ' 128' ' ' MET . 1.8 mp -80.58 -48.39 19.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 126.141 1.776 . . . . 0.0 112.803 -175.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.69 -29.37 26.23 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.208 1.003 . . . . 0.0 111.866 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 121' ' ' TYR . 91.6 t -53.7 -19.75 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.849 0 C-N-CA 125.722 1.609 . . . . 0.0 112.307 175.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.2 t 105.17 25.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 127.191 2.196 . . . . 0.0 110.427 -175.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 127' ' ' LEU . 27.7 tp -98.14 1.09 47.14 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.459 175.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.576 ' HA ' HG23 ' A' ' 123' ' ' ILE . 83.8 mtp -30.36 106.54 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 125.979 1.711 . . . . 0.0 111.646 179.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -41.62 66.05 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 114.0 -1.454 . . . . 0.0 112.602 -178.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.4 t70 176.1 -58.14 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.456 0.473 . . . . 0.0 111.104 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.519 ' SD ' ' HA ' ' A' ' 171' ' ' ARG 0.257 15.7 tpp 65.0 97.07 0.05 OUTLIER 'General case' 0 C--O 1.244 0.775 0 CA-C-O 122.146 0.974 . . . . 0.0 112.817 -173.436 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 45.4 t -141.88 164.43 30.22 Favored 'General case' 0 N--CA 1.415 -2.187 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 34.4 p -73.58 119.5 17.9 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.7 t70 71.81 88.2 0.1 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.25 1.02 . . . . 0.0 108.438 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 41.0 t-105 -160.36 158.64 30.0 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.658 -170.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -143.96 162.16 36.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 118.111 0.414 . . . . 0.0 111.139 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 5.5 tt -140.68 146.43 24.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 C-N-CA 123.442 0.697 . . . . 0.0 109.383 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -88.99 108.13 19.41 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.436 ' HB3' HG12 ' A' ' 165' ' ' ILE . 0.2 OUTLIER -125.58 155.97 39.86 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 124.137 0.975 . . . . 0.0 109.377 -179.222 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.0 pm0 -146.71 148.78 32.35 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.307 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 27.8 tp -121.02 126.72 50.61 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.275 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -127.94 130.08 47.86 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -176.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.491 HG22 HG23 ' A' ' 83' ' ' ILE . 37.7 mm -130.19 144.25 38.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 121.511 0.672 . . . . 0.0 112.484 -173.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -114.16 92.39 0.6 Allowed Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 172.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.9 121.85 24.7 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -174.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.579 ' OG1' HG22 ' A' ' 156' ' ' THR . 19.1 m -105.95 127.83 53.4 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 120.054 -0.658 . . . . 0.0 112.008 -177.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -121.13 140.28 52.21 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 173.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -121.54 122.58 40.0 Favored 'General case' 0 CA--C 1.486 -1.514 0 C-N-CA 119.046 -1.062 . . . . 0.0 110.343 175.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 10.3 pt -140.43 143.34 32.63 Favored Pre-proline 0 C--N 1.301 -1.517 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.038 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.75 -5.3 10.15 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 123.472 2.781 . . . . 0.0 112.602 -178.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.16 -25.59 30.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.178 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 5.4 p -161.43 -39.44 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 140.56 -155.51 24.79 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -99.02 120.08 38.87 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.298 0.571 . . . . 0.0 109.743 177.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 146' ' ' THR . 50.0 mt -123.35 132.23 71.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.136 -174.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.579 HG22 ' OG1' ' A' ' 146' ' ' THR . 44.1 p -91.0 113.46 25.73 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.425 174.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.0 mp -90.3 117.81 68.31 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -80.28 127.39 6.66 Favored 'Trans proline' 0 CA--C 1.487 -1.832 0 C-N-CA 122.104 1.869 . . . . 0.0 112.036 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.87 130.61 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.716 0 CA-C-N 112.706 -2.043 . . . . 0.0 108.669 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 11.9 m -134.61 153.59 51.9 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.201 -174.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.4 t -147.24 137.21 23.13 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -99.57 122.44 42.63 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -139.3 -154.57 6.39 Favored Glycine 0 N--CA 1.405 -3.409 0 C-N-CA 119.465 -1.35 . . . . 0.0 110.71 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.04 159.5 29.39 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.436 HG12 ' HB3' ' A' ' 139' ' ' TYR . 52.0 mm -118.29 108.05 23.36 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.544 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 16.0 pttm -95.22 131.47 41.23 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.339 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 90.0 mt -110.73 91.8 13.16 Favored Pre-proline 0 C--N 1.283 -2.294 0 CA-C-N 114.64 -1.163 . . . . 0.0 110.212 -172.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 166' ' ' LYS . 1.7 Cg_endo -83.0 82.93 2.05 Favored 'Trans proline' 0 N--CA 1.426 -2.448 0 C-N-CA 122.618 2.212 . . . . 0.0 112.251 -177.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 65.4 p 57.61 24.99 11.1 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.684 1.194 . . . . 0.0 114.182 174.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.451 ' HB3' ' CD1' ' A' ' 173' ' ' PHE . 38.7 mt -60.76 -62.0 2.18 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 120.665 0.269 . . . . 0.0 110.54 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.519 ' HA ' ' SD ' ' A' ' 131' ' ' MET . 78.3 mtp180 63.95 141.34 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 O-C-N 124.668 1.23 . . . . 0.0 111.5 -173.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 38.0 t70 78.08 1.84 2.79 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.69 0.796 . . . . 0.0 111.126 -177.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.451 ' CD1' ' HB3' ' A' ' 170' ' ' LEU . 72.5 m-85 -111.74 -6.49 14.31 Favored 'General case' 0 C--O 1.22 -0.5 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 175.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.521 ' CB ' ' HE3' ' A' ' 128' ' ' MET 0.318 42.9 p90 . . . . . 0 N--CA 1.439 -1.002 0 N-CA-C 118.544 2.794 . . . . 0.0 118.544 173.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.093 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -142.0 122.38 14.02 Favored 'General case' 0 CA--C 1.498 -1.036 0 C-N-CA 122.883 0.473 . . . . 0.0 109.848 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -100.55 105.65 17.09 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.565 0.697 . . . . 0.0 110.231 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -161.22 172.49 16.59 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -157.34 148.84 22.02 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.02 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -68.48 140.9 55.72 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 71.3 92.9 0.08 Allowed 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 123.955 0.902 . . . . 0.0 110.485 -174.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -68.44 98.72 0.87 Allowed 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 41.68 70.54 0.27 Allowed 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 125.765 1.626 . . . . 0.0 114.031 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -132.46 165.96 23.11 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.901 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.3 m -59.81 -31.76 70.01 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -174.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.536 ' O ' HG21 ' A' ' 16' ' ' VAL . . . -74.93 -17.75 60.51 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -177.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -58.88 -27.3 65.07 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.296 0.57 . . . . 0.0 110.831 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 18' ' ' GLU . 42.7 tt0 -57.43 -47.31 82.11 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.516 176.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.552 ' C ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -74.57 -19.43 60.33 Favored 'General case' 0 CA--C 1.487 -1.464 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.531 -178.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.536 HG21 ' O ' ' A' ' 12' ' ' ALA . 22.0 t -71.19 -32.93 49.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 94' ' ' ILE . 59.9 t -69.24 -43.22 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 170.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 41.9 mt-10 -64.52 -46.75 81.59 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.863 -173.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.422 ' O ' HG22 ' A' ' 23' ' ' VAL . 8.0 pt-20 -55.53 -48.23 75.02 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 119.929 -0.709 . . . . 0.0 111.214 173.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.412 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 24.9 ttmm -65.5 -47.8 74.76 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 122.808 0.443 . . . . 0.0 111.43 -176.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.68 -39.22 76.63 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.118 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.1 t -66.52 -42.31 87.49 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.605 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 19' ' ' GLU . 65.5 t -62.92 -46.65 95.79 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 CA-C-O 121.116 0.484 . . . . 0.0 109.73 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.467 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 69.1 mt -64.08 -49.88 79.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.863 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.0 t -60.06 -35.09 74.4 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 122.664 0.386 . . . . 0.0 111.018 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.6 m -68.91 -30.47 68.96 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.12 0.486 . . . . 0.0 110.877 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.1 tt -75.82 -42.29 50.25 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 87.0 mt -63.05 -31.1 72.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.528 178.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -68.29 -49.31 61.36 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.426 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.531 ' HD2' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -67.37 -36.49 81.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.29 -177.21 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.531 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -77.46 -31.85 54.03 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.479 -178.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.53 ' HB2' ' HZ2' ' A' ' 32' ' ' LYS . 5.0 ttmp? -55.48 -53.45 56.19 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.166 0.291 . . . . 0.0 110.532 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.652 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -62.27 -53.08 44.91 Favored Glycine 0 N--CA 1.437 -1.269 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.477 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -53.83 -41.95 67.95 Favored 'General case' 0 C--O 1.252 1.204 0 C-N-CA 124.316 1.046 . . . . 0.0 111.674 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.436 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 90.8 t80 -66.43 -51.88 52.31 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.76 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.58 -22.98 67.19 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -176.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.652 ' HG2' ' O ' ' A' ' 33' ' ' GLY . 10.9 pt-20 -93.1 -51.49 5.01 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.449 ' HD3' ' HG3' ' A' ' 37' ' ' GLU . 3.9 mppt? -103.35 -39.13 6.92 Favored 'General case' 0 CA--C 1.484 -1.574 0 C-N-CA 118.553 -1.259 . . . . 0.0 112.764 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.436 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 2.7 mm? -79.63 -1.53 38.53 Favored 'General case' 0 C--N 1.286 -2.19 0 C-N-CA 119.783 -0.767 . . . . 0.0 112.535 -174.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.12 -8.87 58.44 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 172.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -109.22 -48.78 3.21 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.245 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.9 mp -77.15 117.83 67.83 Favored Pre-proline 0 C--O 1.244 0.808 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.77 118.73 4.74 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.357 2.705 . . . . 0.0 113.504 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.0 p -141.38 165.14 30.73 Favored Pre-proline 0 C--N 1.304 -1.392 0 C-N-CA 125.18 1.392 . . . . 0.0 108.185 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -70.21 135.08 28.53 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.022 1.815 . . . . 0.0 112.347 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -97.48 112.83 24.51 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.957 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.26 125.78 43.49 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.178 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -127.39 132.21 50.18 Favored 'General case' 0 N--CA 1.417 -2.093 0 CA-C-O 121.639 0.733 . . . . 0.0 110.588 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.428 HG22 ' OG1' ' A' ' 161' ' ' THR . 11.7 m -83.44 144.17 10.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.663 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -119.34 -67.2 1.0 Allowed 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.433 -174.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -172.43 174.09 3.93 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -177.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.56 HG22 ' HB3' ' A' ' 64' ' ' TYR . 10.5 p -116.48 126.62 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -95.73 119.52 34.38 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.532 -172.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.689 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 37.2 p90 -63.12 125.8 25.27 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.911 0.386 . . . . 0.0 111.761 175.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.533 ' HG3' ' CD2' ' A' ' 65' ' ' HIS . 29.5 mmmt -109.11 -66.3 1.07 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.777 -176.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.32 177.84 21.9 Favored Glycine 0 N--CA 1.431 -1.67 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.864 -175.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 173' ' ' PHE . 6.5 p -98.4 136.94 27.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -177.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.637 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 59.6 m -137.45 146.13 43.95 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -59.35 -43.44 92.78 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.981 0.912 . . . . 0.0 112.235 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.41 ' HB3' ' CD1' ' A' ' 121' ' ' TYR . 19.6 m-20 -61.96 -56.68 16.63 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.171 0.986 . . . . 0.0 109.59 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.637 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . -165.77 165.89 38.26 Favored Glycine 0 N--CA 1.407 -3.299 0 N-CA-C 105.857 -2.897 . . . . 0.0 105.857 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.94 141.87 17.14 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-N 117.689 0.745 . . . . 0.0 111.733 -176.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -87.46 111.79 21.52 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.25 -173.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.689 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 7.0 m-85 -120.1 161.24 21.32 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-O 121.761 0.791 . . . . 0.0 111.479 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.533 ' CD2' ' HG3' ' A' ' 55' ' ' LYS . 19.7 m170 -116.9 117.92 31.02 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.015 172.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.469 ' HB3' ' HB ' ' A' ' 115' ' ' VAL . . . -77.78 122.79 25.88 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.404 ' HG3' ' CG1' ' A' ' 112' ' ' VAL . 40.1 ttmt -87.44 107.84 18.74 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.636 -175.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.4 t -112.47 109.15 27.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 114.538 -1.21 . . . . 0.0 107.931 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.0 p -101.16 119.34 38.61 Favored 'General case' 0 C--N 1.277 -2.556 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.967 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 110' ' ' THR . 78.0 t -106.28 119.48 55.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.267 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -97.91 109.57 22.3 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' A' ' 108' ' ' SER . 41.6 t30 -112.27 119.46 43.78 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -175.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -93.83 97.62 0.14 Allowed 'Trans proline' 0 N--CA 1.434 -2.025 0 C-N-CA 121.861 1.707 . . . . 0.0 112.089 173.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.567 ' O ' ' HB2' ' A' ' 108' ' ' SER . 34.1 m-85 -169.92 -160.3 0.23 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 127.209 2.204 . . . . 0.0 106.678 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.5 m -143.37 19.7 1.89 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.538 0.685 . . . . 0.0 109.297 172.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.429 ' O ' ' HA2' ' A' ' 107' ' ' GLY . 17.9 pt20 -113.68 143.62 44.29 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.842 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.1 p -85.41 86.05 7.4 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.091 0.472 . . . . 0.0 110.588 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 64.6 mt -72.88 119.52 75.88 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.461 -177.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -88.91 124.19 1.49 Allowed 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 122.27 1.98 . . . . 0.0 110.876 175.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 24.2 pt -77.29 130.26 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.292 177.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 41.8 t -72.34 -40.17 67.59 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.327 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -153.68 155.83 36.72 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.5 tt -124.27 120.31 58.92 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 172.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.9 m -99.41 128.85 45.56 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -174.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -127.39 141.11 51.77 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.189 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.511 ' HB ' ' HB3' ' A' ' 142' ' ' ASP . 68.0 mt -119.37 108.18 23.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 172.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 119' ' ' VAL . 0.8 OUTLIER -101.74 122.65 44.34 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -179.095 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.401 ' HE2' ' O ' ' A' ' 91' ' ' THR . 67.5 tttt -123.29 154.37 38.94 Favored 'General case' 0 C--N 1.277 -2.547 0 C-N-CA 118.38 -1.328 . . . . 0.0 108.249 176.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.1 m -141.43 126.97 18.89 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.057 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 59.18 14.29 3.47 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.234 1.014 . . . . 0.0 111.094 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.401 ' O ' ' HE2' ' A' ' 88' ' ' LYS . 41.1 m 68.17 -2.69 1.44 Allowed 'General case' 0 CA--C 1.584 2.267 0 C-N-CA 124.451 1.101 . . . . 0.0 112.489 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.24 -80.81 0.24 Allowed 'General case' 0 C--O 1.237 0.408 0 O-C-N 121.199 -0.938 . . . . 0.0 111.346 176.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 29.1 m -84.72 166.05 17.34 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.274 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.523 HD13 ' N ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -159.88 148.54 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.468 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 -167.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.523 ' N ' HD13 ' A' ' 94' ' ' ILE . . . -128.87 127.21 41.37 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 176.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.7 t -137.73 151.14 47.89 Favored 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.438 -177.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.85 174.4 46.53 Favored Glycine 0 N--CA 1.411 -3.027 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.401 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 41.4 p -128.46 137.26 51.73 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.41 HD11 ' N ' ' A' ' 99' ' ' ILE . 3.2 mp -102.09 108.03 55.07 Favored Pre-proline 0 C--N 1.308 -1.197 0 C-N-CA 118.15 -1.42 . . . . 0.0 108.575 173.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 98' ' ' THR . 10.3 Cg_exo -74.12 129.51 13.25 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 122.345 2.03 . . . . 0.0 109.848 175.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 56.21 68.77 2.1 Favored Pre-proline 0 N--CA 1.477 0.916 0 C-N-CA 124.153 0.981 . . . . 0.0 111.14 -175.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -102.89 -0.25 0.36 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.384 2.723 . . . . 0.0 114.166 -176.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 152.31 179.29 27.79 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 56.3 m -149.82 156.46 41.84 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 116.934 0.367 . . . . 0.0 110.493 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.413 ' HA ' HG23 ' A' ' 111' ' ' THR . 7.5 mp -79.5 143.4 34.93 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.343 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 27.0 m -68.33 -16.32 20.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.878 -1.056 . . . . 0.0 113.356 -177.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 76' ' ' GLN . . . 129.16 -57.92 0.71 Allowed Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.567 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 24.9 t -156.68 139.58 15.28 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 175.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 119.57 -177.8 16.44 Favored Glycine 0 C--N 1.292 -1.907 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 9.9 t -89.56 117.95 28.84 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.815 0.817 . . . . 0.0 110.407 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.413 HG23 ' HA ' ' A' ' 105' ' ' LEU . 5.0 t -114.87 132.83 56.39 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.095 177.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.404 ' CG1' ' HG3' ' A' ' 67' ' ' LYS . 39.6 t -92.46 121.69 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.831 -177.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.9 mt -106.96 148.14 29.01 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.152 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -110.7 122.31 47.49 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 86.0 t -100.22 116.6 64.33 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 169.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.76 108.96 2.54 Favored 'Trans proline' 0 N--CA 1.43 -2.244 0 N-CA-C 106.171 -2.281 . . . . 0.0 106.171 169.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.0 p -126.63 139.12 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.381 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -175.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -94.04 94.97 8.72 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.483 ' C ' ' H ' ' A' ' 121' ' ' TYR . 4.5 m -94.21 148.5 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.583 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -175.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 73.44 -4.28 2.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.369 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.483 ' H ' ' C ' ' A' ' 119' ' ' VAL . 61.7 t80 -58.94 -41.05 86.45 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 171.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.7 p -62.34 -32.19 72.92 Favored 'General case' 0 N--CA 1.417 -2.077 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.913 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 45.6 mm -80.9 -49.83 17.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.242 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.63 -42.85 95.2 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.438 0.461 . . . . 0.0 111.204 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.3 t -66.95 -29.04 44.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.562 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.6 t -86.47 -72.37 0.5 Allowed 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.628 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 128' ' ' MET . 3.0 pp -124.72 -35.3 2.73 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -172.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.574 ' N ' HD12 ' A' ' 127' ' ' LEU . 12.5 tpt 58.92 114.49 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.506 1.123 . . . . 0.0 112.398 -174.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -65.27 -75.42 0.09 Allowed 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.516 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.5 t70 159.78 -32.82 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 105.194 -2.151 . . . . 0.0 105.194 -175.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.421 ' HE2' ' O ' ' A' ' 168' ' ' PRO . 0.4 OUTLIER 69.47 127.44 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 112.288 -2.233 . . . . 0.0 110.91 -177.206 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 42.0 t -128.16 150.72 49.87 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.473 HG22 ' HA ' ' A' ' 169' ' ' SER . 66.9 p -61.78 117.61 6.08 Favored 'General case' 0 N--CA 1.407 -2.608 0 C-N-CA 124.339 1.056 . . . . 0.0 109.678 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 75.86 80.91 0.1 Allowed 'General case' 0 CA--C 1.507 -0.673 0 CA-C-O 121.926 0.87 . . . . 0.0 110.63 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 15.8 t-105 -146.15 116.26 7.4 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.816 -1.538 . . . . 0.0 111.214 -175.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -98.09 126.11 43.38 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 15.6 tt -112.28 145.82 17.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.3 -175.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -74.67 105.91 5.98 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 122.376 1.084 . . . . 0.0 111.043 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.47 150.85 51.99 Favored 'General case' 0 C--N 1.265 -3.095 0 CA-C-N 113.297 -1.774 . . . . 0.0 106.934 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . 0.304 0.1 OUTLIER -146.19 157.34 43.82 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.209 176.526 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.467 ' HB3' ' HB ' ' A' ' 161' ' ' THR . 28.4 tp -135.53 143.31 45.68 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -171.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.511 ' HB3' ' HB ' ' A' ' 86' ' ' ILE . 17.9 t70 -142.32 114.08 8.0 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 177.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 158' ' ' PRO . 49.1 mt -116.24 142.82 28.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.305 -174.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -120.62 108.39 1.4 Allowed Glycine 0 N--CA 1.421 -2.33 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 176.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 156' ' ' THR . 3.8 mm? -84.33 115.84 22.7 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 122.566 0.346 . . . . 0.0 110.873 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.415 ' OG1' HG22 ' A' ' 156' ' ' THR . 32.3 m -90.47 107.15 18.98 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.635 ' O ' ' HA ' ' A' ' 154' ' ' ASP . 93.8 m-85 -111.5 142.04 44.29 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 176.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -108.51 110.05 21.45 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.0 mp -121.7 126.58 26.37 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.19 -12.73 0.84 Allowed 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 124.481 3.454 . . . . 0.0 116.176 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 24.6 m -73.69 -22.98 18.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 O-C-N 122.065 -0.397 . . . . 0.0 111.203 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.2 p -148.46 -32.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.496 0.665 . . . . 0.0 111.417 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 115.39 -136.63 13.22 Favored Glycine 0 N--CA 1.416 -2.699 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 -175.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.635 ' HA ' ' O ' ' A' ' 147' ' ' PHE . 5.7 p-10 -95.73 131.03 42.44 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 121.376 0.608 . . . . 0.0 110.983 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.47 131.46 54.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 176.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 73.8 p -87.72 118.58 27.32 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.699 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.447 HD13 ' CD2' ' A' ' 147' ' ' PHE . 2.3 mp -81.35 110.99 21.12 Favored Pre-proline 0 C--N 1.316 -0.854 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 173.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.518 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 19.2 Cg_endo -88.02 113.38 0.81 Allowed 'Trans proline' 0 CA--C 1.475 -2.428 0 C-N-CA 122.489 2.126 . . . . 0.0 111.555 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.9 p -116.93 108.32 24.66 Favored 'Isoleucine or valine' 2 N--CA 1.361 -4.923 0 CA-C-N 112.174 -2.285 . . . . 0.0 109.231 -176.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 27.3 m -89.59 152.47 21.38 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.23 -173.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 141' ' ' LEU . 1.6 m -140.56 139.6 35.03 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -177.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -99.62 118.61 36.54 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 164.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -108.75 93.28 0.77 Allowed Glycine 0 N--CA 1.413 -2.869 0 C-N-CA 118.77 -1.681 . . . . 0.0 112.697 -171.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -89.22 118.91 29.25 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 175.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.8 pt -124.33 121.05 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 CA-C-O 121.617 0.723 . . . . 0.0 110.678 -178.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -91.46 104.05 16.6 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 114.229 -1.35 . . . . 0.0 110.95 -177.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 7.1 mp -82.45 111.93 32.5 Favored Pre-proline 0 C--N 1.295 -1.785 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 176.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.421 ' O ' ' HE2' ' A' ' 131' ' ' MET . 87.8 Cg_endo -82.06 -160.89 0.13 Allowed 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 122.259 1.973 . . . . 0.0 110.189 -177.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.473 ' HA ' HG22 ' A' ' 133' ' ' THR . 28.9 t -56.04 92.82 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 167.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 21.6 tp -144.9 27.54 1.31 Allowed 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 -177.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.472 ' NH1' ' HB2' ' A' ' 172' ' ' ASP . 2.5 tmm_? -63.41 122.56 16.54 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.534 -1.212 . . . . 0.0 107.897 -176.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.472 ' HB2' ' NH1' ' A' ' 171' ' ' ARG . 25.5 t70 79.97 73.78 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.815 0 C-N-CA 125.136 1.374 . . . . 0.0 108.954 -175.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.45 ' O ' HG22 ' A' ' 57' ' ' VAL . 12.1 t80 -171.91 -47.97 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 101.097 -3.668 . . . . 0.0 101.097 -178.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 35.2 t80 . . . . . 0 N--CA 1.423 -1.786 0 CA-C-N 113.058 -1.883 . . . . 0.0 106.408 163.374 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.743 0 N-CA-C 111.701 -0.56 . . . . 0.0 111.701 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -140.97 29.34 1.87 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -177.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -61.2 115.43 3.8 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -102.1 119.54 38.96 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 116.758 2.133 . . . . 0.0 116.758 -165.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -115.72 21.55 13.81 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.88 169.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -71.84 87.6 1.0 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -109.23 76.41 1.0 Allowed 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.102 -169.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.5 mp 39.62 -94.24 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.524 1.93 . . . . 0.0 115.795 173.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -101.99 96.12 6.82 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.782 -177.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.45 152.11 1.67 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.46 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.426 ' HA ' ' OE2' ' A' ' 14' ' ' GLU . 57.4 m -73.96 -17.54 60.99 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.297 0.57 . . . . 0.0 110.327 176.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.546 ' O ' HG21 ' A' ' 16' ' ' VAL . . . -64.41 -47.28 79.78 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 171.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -57.5 -43.67 84.37 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.884 0.874 . . . . 0.0 109.749 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 18' ' ' GLU . 45.6 mt-10 -57.2 -41.61 79.7 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.053 176.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.502 ' C ' ' HD3' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -67.45 -49.0 65.58 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.291 0.567 . . . . 0.0 110.02 177.604 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.546 HG21 ' O ' ' A' ' 12' ' ' ALA . 57.7 t -64.61 -35.85 75.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.333 -0.849 . . . . 0.0 113.023 -173.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 p -66.15 -29.59 47.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 65.1 mt-10 -76.79 -44.95 30.67 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 122.057 0.932 . . . . 0.0 108.597 178.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -55.3 -46.94 76.24 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.497 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.552 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -70.75 -36.17 73.0 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.275 177.6 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.67 90.88 Favored 'General case' 0 C--O 1.213 -0.817 0 O-C-N 123.282 0.363 . . . . 0.0 110.574 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.8 m -61.01 -38.19 85.2 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 120.727 0.299 . . . . 0.0 111.582 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.8 -34.94 73.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 20' ' ' LYS . 78.8 mt -69.27 -49.67 59.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.45 -0.795 . . . . 0.0 108.967 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.0 m -57.4 -33.82 68.25 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.992 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.2 t -57.68 -35.23 70.32 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.17 0.588 . . . . 0.0 111.721 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.5 tt -80.33 -43.77 20.63 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.445 HD23 ' HB3' ' A' ' 158' ' ' PRO . 9.1 mp -62.3 -34.56 76.83 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -62.41 -34.05 75.97 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -18.66 38.53 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.712 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.22 -32.08 64.54 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.705 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -50.67 -52.75 36.96 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.679 0.791 . . . . 0.0 112.327 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -90.32 7.32 81.69 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.905 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 29.1 t80 -85.46 -26.18 26.48 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.514 ' CD1' HD13 ' A' ' 39' ' ' LEU . 44.8 m-85 -70.35 -41.08 73.63 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -174.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.29 -50.77 49.44 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -168.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.415 ' HG2' ' HG3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -117.78 -31.62 5.08 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.259 -0.576 . . . . 0.0 112.072 179.374 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 34' ' ' PHE . 36.7 mtmm -84.84 -9.71 57.88 Favored 'General case' 0 CA--C 1.486 -1.49 0 CA-C-O 121.484 0.659 . . . . 0.0 111.534 -168.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.514 HD13 ' CD1' ' A' ' 35' ' ' PHE . 88.5 mt -128.43 17.98 6.43 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.194 174.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.66 -44.32 21.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.735 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -95.26 11.37 32.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.623 0.725 . . . . 0.0 110.061 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.3 mm -115.57 117.2 40.66 Favored Pre-proline 0 N--CA 1.435 -1.204 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -65.03 113.92 2.59 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 121.991 1.794 . . . . 0.0 111.158 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.3 p -118.19 139.23 26.44 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.917 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -74.71 143.88 30.65 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.563 2.175 . . . . 0.0 112.289 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -97.48 130.19 44.6 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -113.0 134.29 54.57 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.9 t -115.83 123.98 49.55 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 121.989 0.9 . . . . 0.0 111.416 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.485 HG23 ' CG2' ' A' ' 161' ' ' THR . 26.0 m -102.39 143.87 14.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 114.288 -1.323 . . . . 0.0 109.958 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.575 24.2 t70 117.25 78.61 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 117.821 2.526 . . . . 0.0 117.821 176.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.506 ' HB2' ' HB3' ' A' ' 67' ' ' LYS . 31.9 m-20 -161.3 111.0 1.63 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 102.809 -3.034 . . . . 0.0 102.809 170.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.41 HG12 ' CD2' ' A' ' 64' ' ' TYR . 31.8 t -137.94 134.01 44.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.309 -168.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -137.42 137.26 38.6 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.256 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 37.8 p90 -91.83 141.82 28.25 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.093 0.557 . . . . 0.0 111.154 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.631 ' HD2' ' N ' ' A' ' 55' ' ' LYS . 3.0 mptp? -107.75 -52.23 2.79 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.89 178.55 40.55 Favored Glycine 0 C--N 1.293 -1.856 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.054 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.71 148.99 5.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 117.039 0.419 . . . . 0.0 110.508 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.6 p -131.28 179.15 6.19 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 176.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -75.6 -32.19 60.21 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.564 0.697 . . . . 0.0 109.328 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.22 83.44 3.6 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.81 176.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.92 -162.67 38.63 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.006 -176.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 p -107.59 145.04 15.37 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.703 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -84.97 121.74 28.2 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.628 0.728 . . . . 0.0 112.373 -170.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.641 ' CD1' ' HB ' ' A' ' 119' ' ' VAL . 28.2 m-85 -129.3 172.24 11.68 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.547 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -138.85 117.34 12.06 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 176.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.19 145.75 24.26 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.724 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 51' ' ' ASP . 47.8 tttm -116.43 124.34 49.76 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.03 -177.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.1 m -128.43 111.64 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-O 121.784 0.802 . . . . 0.0 109.242 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.9 m -98.5 130.63 45.09 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.364 -175.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.18 124.97 66.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.035 0.445 . . . . 0.0 110.814 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -117.34 125.51 51.16 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.061 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.511 ' O ' ' HA ' ' A' ' 108' ' ' SER . 4.7 t30 -152.45 114.56 2.85 Favored Pre-proline 0 C--N 1.286 -2.165 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.277 176.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -99.41 96.37 0.05 OUTLIER 'Trans proline' 0 N--CA 1.418 -2.941 0 C-N-CA 121.812 1.674 . . . . 0.0 109.779 169.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 93.3 t80 178.23 111.9 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 177.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.7 p -56.86 85.12 0.01 OUTLIER 'General case' 0 C--O 1.242 0.686 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -156.07 105.0 2.31 Favored 'General case' 1 N--CA 1.369 -4.486 0 C-N-CA 126.552 1.941 . . . . 0.0 106.527 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.6 p -89.53 97.01 10.95 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.411 ' CD1' HD21 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -103.85 134.93 19.46 Favored Pre-proline 0 C--N 1.31 -1.131 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.787 178.665 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -89.19 159.87 5.7 Favored 'Trans proline' 0 N--CA 1.438 -1.784 0 C-N-CA 122.427 2.085 . . . . 0.0 110.891 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 54.2 mt -91.03 114.91 29.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 100' ' ' PRO . 47.2 t -67.93 -37.94 82.27 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.267 0.556 . . . . 0.0 110.252 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -152.89 112.72 3.93 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.708 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 98' ' ' THR . 18.3 tt -95.77 119.43 43.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 175.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 143' ' ' ILE . 10.5 m -111.31 121.75 46.05 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.754 -172.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.426 ' CE1' HG11 ' A' ' 117' ' ' VAL . 23.7 p90 -109.65 136.41 49.05 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 175.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.571 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 63.7 mt -117.06 108.1 24.04 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.668 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 174.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -90.83 120.75 32.11 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 -174.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.506 ' HZ3' ' HB3' ' A' ' 88' ' ' LYS . 8.5 mtpm? -118.83 163.78 16.38 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -172.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.1 t -105.57 147.41 28.43 Favored 'General case' 0 N--CA 1.41 -2.447 0 CA-C-N 112.181 -2.281 . . . . 0.0 106.59 172.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.13 -15.43 63.59 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 123.424 0.453 . . . . 0.0 110.873 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.0 t -143.93 -38.22 0.31 Allowed 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -176.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -148.31 128.27 13.56 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 118.785 -1.166 . . . . 0.0 112.687 -172.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.493 ' O ' ' HB3' ' A' ' 122' ' ' SER . 90.6 m 74.13 137.98 0.06 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.37 1.068 . . . . 0.0 113.093 177.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.452 ' C ' HD11 ' A' ' 94' ' ' ILE . 1.9 pp -134.06 171.76 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.5 172.82 12.39 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 176.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 64.1 p -152.82 175.59 12.72 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 122.079 -0.388 . . . . 0.0 110.7 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.03 144.45 4.51 Favored Glycine 0 N--CA 1.435 -1.376 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 41.9 p -132.36 136.63 46.97 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 117.023 0.411 . . . . 0.0 110.529 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.1 mp -113.3 107.11 54.02 Favored Pre-proline 0 C--N 1.313 -1.001 0 C-N-CA 119.419 -0.913 . . . . 0.0 109.167 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 81' ' ' CYS . 18.6 Cg_exo -69.4 116.65 4.62 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.515 2.143 . . . . 0.0 110.031 173.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.2 t70 62.35 79.1 0.27 Allowed Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 123.51 0.724 . . . . 0.0 111.533 -177.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -107.08 12.49 0.15 Allowed 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 124.291 3.327 . . . . 0.0 112.563 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.41 ' C ' ' HG ' ' A' ' 104' ' ' SER . . . 141.68 -174.22 23.14 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -175.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.41 ' HG ' ' C ' ' A' ' 103' ' ' GLY . 44.8 m -151.07 170.82 18.47 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 117.578 0.689 . . . . 0.0 110.679 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.411 HD21 ' CD1' ' A' ' 78' ' ' ILE . 10.3 mp -74.02 157.58 35.87 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 114.762 1.394 . . . . 0.0 114.762 177.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.516 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 7.1 p -79.0 -20.68 12.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 CA-C-N 112.338 -2.21 . . . . 0.0 110.737 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 106.15 -60.97 0.35 Allowed Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 23.2 t -152.81 84.57 1.23 Allowed 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.435 0.636 . . . . 0.0 109.548 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 161.95 -151.74 21.91 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 108.989 -1.645 . . . . 0.0 108.989 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.0 t -122.82 136.77 54.98 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.193 0.521 . . . . 0.0 110.135 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.516 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 4.4 t -130.79 138.3 49.84 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.694 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 50.8 t -91.55 113.53 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-O 121.048 0.452 . . . . 0.0 110.982 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.9 mt -103.3 166.92 10.15 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -147.28 149.83 33.62 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 119.804 -0.759 . . . . 0.0 112.501 -171.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.0 t -125.92 132.62 24.37 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -77.01 110.81 3.11 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 N-CA-C 107.417 -1.801 . . . . 0.0 107.417 167.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.426 HG11 ' CE1' ' A' ' 85' ' ' TYR . 66.3 t -119.99 136.18 57.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.326 -174.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -88.77 99.0 12.02 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 173.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.641 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 82.6 t -93.44 146.54 6.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.603 -173.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 72.7 1.07 3.86 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 124.646 1.179 . . . . 0.0 111.759 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.51 ' O ' HG12 ' A' ' 125' ' ' VAL . 83.8 t80 -54.26 -49.38 69.67 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 175.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.493 ' HB3' ' O ' ' A' ' 93' ' ' THR . 29.0 m -64.3 -29.34 70.42 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.727 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.6 mm -79.51 -50.68 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.11 -49.33 74.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -175.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 121' ' ' TYR . 8.0 p -72.24 -22.28 20.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.938 0.399 . . . . 0.0 111.584 -175.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.0 t -99.51 -62.52 1.23 Allowed 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.415 ' H ' HD23 ' A' ' 127' ' ' LEU . 1.8 pt? -124.91 -41.61 2.09 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -171.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 81.3 mtp 65.88 -177.97 0.19 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -169.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -137.31 -78.31 0.39 Allowed 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.3 t70 178.59 93.28 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.181 0 CA-C-N 114.494 -1.23 . . . . 0.0 107.728 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.568 ' SD ' ' HB2' ' A' ' 170' ' ' LEU . 0.3 OUTLIER -52.18 101.66 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.344 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.822 175.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 82.1 m -108.27 167.66 9.86 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.433 0.635 . . . . 0.0 112.176 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.472 HG22 ' HB3' ' A' ' 169' ' ' SER . 40.3 p -77.63 127.55 32.66 Favored 'General case' 0 N--CA 1.404 -2.752 0 C-N-CA 124.921 1.288 . . . . 0.0 108.561 169.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.6 t70 54.91 91.69 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.65 1.18 . . . . 0.0 109.625 -172.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -148.69 158.97 44.52 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.908 -169.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -142.19 148.24 37.89 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.455 HG12 HD22 ' A' ' 167' ' ' LEU . 27.8 pt -128.97 145.3 35.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 120.865 0.364 . . . . 0.0 110.874 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -97.41 111.86 23.94 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -128.12 163.13 25.31 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.566 ' HG3' ' O ' ' A' ' 161' ' ' THR . 34.3 tt0 -136.45 150.01 48.51 Favored 'General case' 0 C--N 1.283 -2.314 0 O-C-N 121.68 -0.637 . . . . 0.0 111.053 -178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.571 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 2.0 pt? -141.25 120.44 12.96 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 172.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.14 122.63 29.1 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.502 ' HA ' ' O ' ' A' ' 84' ' ' SER . 34.5 mm -108.24 117.28 53.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 C-N-CA 118.799 -1.16 . . . . 0.0 109.644 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -94.07 96.84 2.11 Favored Glycine 0 N--CA 1.419 -2.46 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 156' ' ' THR . 2.7 mm? -79.16 108.72 12.87 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.435 ' OG1' HG22 ' A' ' 156' ' ' THR . 26.1 m -89.85 107.36 19.06 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.294 -0.962 . . . . 0.0 108.83 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.413 ' CE2' ' HB3' ' A' ' 145' ' ' LEU . 73.4 m-85 -114.55 131.31 56.71 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -108.78 112.17 24.3 Favored 'General case' 0 C--N 1.287 -2.122 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.757 173.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.408 HD11 ' N ' ' A' ' 149' ' ' ILE . 2.5 mp -104.2 120.09 52.0 Favored Pre-proline 0 C--N 1.292 -1.904 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 176.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -41.85 -32.21 1.63 Allowed 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 124.386 3.391 . . . . 0.0 115.455 -174.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 33.8 m -74.78 -21.98 17.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 13.9 p -126.18 -28.69 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.818 -177.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 107.34 -156.47 15.92 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -90.53 120.25 31.46 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.48 0.657 . . . . 0.0 111.47 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.457 HD13 ' O ' ' A' ' 155' ' ' ILE . 2.4 pp -128.83 138.05 55.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.61 175.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 67.3 p -94.21 127.29 39.96 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.196 177.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 51.2 mt -101.15 105.15 37.44 Favored Pre-proline 0 C--N 1.295 -1.79 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.445 ' HB3' HD23 ' A' ' 28' ' ' LEU . 3.2 Cg_exo -76.97 109.9 2.93 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 122.646 2.231 . . . . 0.0 111.305 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.414 HG12 HG21 ' A' ' 49' ' ' VAL . 19.0 t -103.97 124.6 58.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 175.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 14.7 m -126.78 152.14 47.32 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.154 -173.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.566 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 14.0 t -174.62 162.22 3.34 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.257 0.0 OUTLIER -99.46 135.84 40.29 Favored 'General case' 0 N--CA 1.409 -2.494 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.972 172.332 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -108.38 113.01 3.7 Favored Glycine 0 N--CA 1.397 -3.905 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -177.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -89.55 119.67 30.18 Favored 'General case' 0 N--CA 1.405 -2.702 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 174.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 10.0 pt -118.34 140.67 40.99 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.909 -176.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -90.72 136.49 33.03 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.536 -173.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.455 HD22 HG12 ' A' ' 137' ' ' ILE . 2.0 mm? -115.34 94.84 40.89 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.1 49.48 2.56 Favored 'Trans proline' 0 N--CA 1.486 1.08 0 C-N-CA 123.359 2.706 . . . . 0.0 112.944 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.472 ' HB3' HG22 ' A' ' 133' ' ' THR . 2.9 m 67.11 93.39 0.07 Allowed 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 125.108 1.363 . . . . 0.0 110.758 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.681 ' HB3' ' CD1' ' A' ' 173' ' ' PHE . 3.0 mm? -98.77 -59.48 1.73 Allowed 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.093 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 61.21 104.62 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.187 0.995 . . . . 0.0 111.602 -174.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 33.5 t70 70.49 64.19 0.2 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.866 1.266 . . . . 0.0 112.075 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.681 ' CD1' ' HB3' ' A' ' 170' ' ' LEU . 57.6 m-85 -153.83 -47.7 0.09 Allowed 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 125.933 1.693 . . . . 0.0 106.565 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.53 ' HB3' ' SD ' ' A' ' 131' ' ' MET . 87.9 t80 . . . . . 0 N--CA 1.433 -1.293 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 173.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.768 0 N-CA-C 111.689 -0.565 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -120.0 104.09 9.85 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 122.412 -0.464 . . . . 0.0 110.561 178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.6 m80 -104.14 131.36 51.51 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 175.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -73.01 131.35 42.03 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -152.15 113.66 4.33 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.394 0.616 . . . . 0.0 112.032 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -138.04 112.01 8.42 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.615 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . 0.303 89.8 m-70 61.59 83.19 0.15 Allowed 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.23 39.68 3.07 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 174.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 83.86 -84.24 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 111.836 -2.438 . . . . 0.0 105.753 -163.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 153.43 148.52 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.626 1.57 . . . . 0.0 109.098 174.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 40.5 m -80.17 86.54 5.58 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 166.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.56 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -49.58 -56.09 11.19 Favored 'General case' 0 CA--C 1.495 -1.141 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.873 -168.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.539 ' O ' HG21 ' A' ' 17' ' ' VAL . 10.1 m-20 -56.78 -43.5 80.91 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -174.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -67.86 -29.86 69.1 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-O 121.355 0.598 . . . . 0.0 110.778 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 11.7 tmtt? -75.26 -54.25 7.42 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.792 0.806 . . . . 0.0 110.139 177.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 12' ' ' ALA . 47.5 t -59.95 -41.76 87.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 CA-C-N 114.946 -1.025 . . . . 0.0 112.682 -177.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.539 HG21 ' O ' ' A' ' 13' ' ' ASP . 40.2 t -68.5 -27.51 36.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 C-N-CA 118.842 -1.143 . . . . 0.0 109.077 176.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.444 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 33.0 tt0 -63.09 -34.78 78.33 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.974 0.892 . . . . 0.0 108.651 -177.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.38 -49.72 72.7 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.265 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -65.08 -43.05 93.44 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.2 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.74 -37.99 80.5 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.205 -178.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.2 t -60.73 -40.37 92.1 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 123.303 0.377 . . . . 0.0 110.29 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.13 -49.76 73.91 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.529 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 64.1 mt -68.85 -39.81 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.963 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 56.2 m -61.01 -37.8 83.83 Favored 'General case' 0 C--O 1.215 -0.744 0 O-C-N 122.299 -0.251 . . . . 0.0 110.643 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.9 m -67.19 -20.91 65.78 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.111 0.482 . . . . 0.0 111.348 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -78.04 -51.53 10.18 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.447 HD22 ' HB3' ' A' ' 158' ' ' PRO . 8.1 mp -60.85 -34.0 73.91 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.409 177.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -53.33 -49.47 67.0 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.524 0.73 . . . . 0.0 111.465 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -82.13 -31.64 30.51 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.07 -32.49 70.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.713 0.292 . . . . 0.0 111.638 177.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.475 ' CG ' ' HG2' ' A' ' 158' ' ' PRO . 56.6 mtmt -61.82 -25.77 67.71 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.568 176.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.469 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -73.48 -50.84 10.71 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 175.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -58.37 -40.67 82.89 Favored 'General case' 0 C--O 1.198 -1.611 0 CA-C-O 120.397 0.141 . . . . 0.0 111.113 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -60.11 -35.49 75.36 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.999 -0.681 . . . . 0.0 111.81 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.09 -39.2 50.54 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 33' ' ' GLY . 10.9 pt-20 -96.29 -40.07 9.33 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -176.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -90.67 -47.93 7.36 Favored 'General case' 0 CA--C 1.479 -1.781 0 CA-C-O 122.74 1.257 . . . . 0.0 107.927 -167.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 58.6 mt -82.91 6.2 19.32 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 112.91 -1.95 . . . . 0.0 111.331 -173.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.25 -38.54 30.75 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 173.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -88.41 -39.97 13.87 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.863 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.6 mt -73.5 135.91 78.39 Favored Pre-proline 0 N--CA 1.435 -1.178 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -72.6 94.65 0.78 Allowed 'Trans proline' 0 N--CA 1.441 -1.574 0 N-CA-C 106.404 -2.191 . . . . 0.0 106.404 171.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.9 m -100.27 137.16 19.95 Favored Pre-proline 0 N--CA 1.415 -2.216 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.814 -167.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.53 ' HB3' ' OD1' ' A' ' 72' ' ' ASN . 23.4 Cg_endo -60.11 124.59 15.56 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.041 2.494 . . . . 0.0 110.733 176.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -97.69 106.38 18.68 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.454 0.645 . . . . 0.0 110.843 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . . . -100.14 144.49 29.1 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.862 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 t -146.35 149.03 33.0 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.951 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.455 ' H ' HG12 ' A' ' 159' ' ' VAL . 90.0 t -82.52 141.22 15.28 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 175.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -133.08 -41.19 0.91 Allowed 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -170.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -160.42 163.33 33.17 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.38 -171.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.567 HG11 ' CD2' ' A' ' 64' ' ' TYR . 97.7 t -132.01 106.66 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 123.489 0.716 . . . . 0.0 110.72 -177.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.461 ' HB2' ' CD2' ' A' ' 65' ' ' HIS . 34.9 m-20 -100.83 107.51 19.08 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.446 ' HA ' ' CB ' ' A' ' 64' ' ' TYR . 49.6 p90 -63.48 138.94 58.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.562 ' HG2' ' HA ' ' A' ' 64' ' ' TYR . 14.5 mmmm -89.7 -72.91 0.54 Allowed 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -176.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.71 -88.06 0.06 OUTLIER Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 117.724 -2.179 . . . . 0.0 115.17 -175.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.72 138.71 25.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.67 0.747 . . . . 0.0 112.522 -173.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.668 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 39.8 m -152.75 157.36 40.73 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 105.021 -2.214 . . . . 0.0 105.021 173.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -102.31 -25.02 13.82 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.7 0.762 . . . . 0.0 109.884 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -99.66 23.0 10.11 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.217 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.668 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . 146.09 -162.9 28.39 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 -177.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.4 t -135.26 116.05 19.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 173.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -68.2 137.02 54.49 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.12 0.486 . . . . 0.0 110.98 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.704 ' CD1' HG11 ' A' ' 119' ' ' VAL . 23.9 p90 -143.02 173.02 11.92 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.461 ' CD2' ' HB2' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -124.57 122.06 36.5 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.823 -1.151 . . . . 0.0 108.815 173.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -78.83 131.02 36.32 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.74 -175.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -89.27 111.65 22.52 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.5 p -127.94 108.72 18.42 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-O 122.146 0.974 . . . . 0.0 108.458 175.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.8 p -101.16 133.94 44.94 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.658 -175.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 25.2 t -109.72 130.55 62.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.749 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -111.47 111.7 22.91 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 175.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.53 ' OD1' ' HB3' ' A' ' 45' ' ' PRO . 7.1 t30 -132.74 124.89 19.08 Favored Pre-proline 0 C--N 1.307 -1.249 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.656 -172.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -97.56 97.73 0.07 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.779 0 C-N-CA 122.078 1.852 . . . . 0.0 112.947 175.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.545 ' O ' ' HB2' ' A' ' 108' ' ' SER . 52.9 m-85 -157.84 -165.13 1.67 Allowed 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 126.425 1.89 . . . . 0.0 106.39 175.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.7 m -131.77 13.86 4.86 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-O 121.877 0.846 . . . . 0.0 109.425 175.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.438 ' O ' ' HA2' ' A' ' 107' ' ' GLY . 10.3 pt20 -118.55 134.96 54.69 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.258 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 105' ' ' LEU . 23.8 m -73.81 97.12 2.68 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.56 174.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.485 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 54.3 mt -85.19 120.95 73.91 Favored Pre-proline 0 C--O 1.244 0.813 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -84.1 158.46 13.37 Favored 'Trans proline' 0 N--CA 1.436 -1.893 0 C-N-CA 121.796 1.664 . . . . 0.0 110.022 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 29.7 pt -102.55 144.43 13.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.179 178.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 48.8 t -62.4 -55.58 26.46 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -177.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -154.31 145.74 23.08 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 171.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.435 ' CG2' ' HG3' ' A' ' 102' ' ' PRO . 14.2 tt -97.36 117.41 41.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.0 t -100.63 118.33 36.56 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -108.08 134.86 50.36 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.48 ' HB ' ' HB2' ' A' ' 142' ' ' ASP . 2.7 mp -117.45 107.31 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.028 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 178.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.452 ' CD2' ' HE2' ' A' ' 139' ' ' TYR . 2.0 tm? -101.92 121.34 41.94 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.428 -170.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 140' ' ' GLN . 0.6 OUTLIER -102.41 150.08 23.72 Favored 'General case' 0 CA--C 1.487 -1.458 0 O-C-N 122.007 -0.433 . . . . 0.0 110.427 179.209 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.435 ' OG ' ' HB3' ' A' ' 122' ' ' SER . 68.6 m -132.87 94.42 3.38 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 177.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 53.03 -77.43 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 170.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.2 m -70.23 -72.93 0.18 Allowed 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -171.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -153.63 -16.27 0.14 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.91 0.484 . . . . 0.0 109.858 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.463 HG21 ' OG ' ' A' ' 122' ' ' SER . 2.7 m -69.9 151.7 45.36 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.642 -171.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.464 HD13 HG21 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -145.11 149.42 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -174.158 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.461 ' N ' HD11 ' A' ' 94' ' ' ILE . . . -129.04 151.46 49.71 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 124.902 1.281 . . . . 0.0 108.07 175.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 35.0 p -136.67 166.48 23.46 Favored 'General case' 0 C--N 1.29 -2.006 0 O-C-N 122.232 -0.293 . . . . 0.0 111.107 -175.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 174.08 136.25 2.19 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.43 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.0 p -113.15 112.69 24.23 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.429 HD12 HG21 ' A' ' 115' ' ' VAL . 63.0 mt -99.27 109.75 55.71 Favored Pre-proline 0 C--N 1.32 -0.699 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.057 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.29 116.72 4.81 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 123.221 2.614 . . . . 0.0 111.613 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.7 t70 51.05 87.36 0.13 Allowed Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 124.929 1.291 . . . . 0.0 112.505 -177.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.435 ' HG3' ' CG2' ' A' ' 83' ' ' ILE . 11.8 Cg_endo -99.54 9.2 0.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.922 2.414 . . . . 0.0 110.766 175.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 147.32 -163.09 28.71 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -177.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.5 m -151.27 160.63 43.7 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 78' ' ' ILE . 3.8 pp -83.96 147.38 27.5 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 36.0 m -57.39 -45.52 85.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -175.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 76' ' ' GLN . . . 140.52 -55.37 0.63 Allowed Glycine 0 N--CA 1.418 -2.548 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -176.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.545 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 37.1 t -136.75 118.49 15.05 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.9 -162.6 12.31 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.933 174.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.5 t -89.26 138.83 31.09 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-O 121.729 0.776 . . . . 0.0 109.662 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.1 t -138.87 117.93 12.55 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.8 t -87.25 115.83 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.188 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.516 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.4 mt -100.87 149.9 23.39 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.422 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 7.7 p-10 -140.83 116.34 10.14 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.033 0.921 . . . . 0.0 112.467 -177.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.429 HG21 HD12 ' A' ' 99' ' ' ILE . 4.2 p -95.32 130.55 31.98 Favored Pre-proline 0 C--N 1.307 -1.24 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.479 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -72.41 112.58 3.49 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 121.833 1.689 . . . . 0.0 109.735 173.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.633 ' HB ' ' CE1' ' A' ' 64' ' ' TYR . 2.3 t -130.81 153.92 39.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 -175.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -116.46 133.33 56.14 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.704 HG11 ' CD1' ' A' ' 64' ' ' TYR . 15.7 m -92.86 148.81 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.764 0 C-N-CA 123.993 0.917 . . . . 0.0 108.84 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.535 ' HB2' ' CD2' ' A' ' 174' ' ' PHE . . . 76.27 -10.08 1.36 Allowed 'General case' 0 N--CA 1.481 1.121 0 O-C-N 124.136 0.898 . . . . 0.0 110.639 -177.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.482 ' H ' ' C ' ' A' ' 119' ' ' VAL . 69.0 t80 -56.2 -52.31 64.86 Favored 'General case' 0 CA--C 1.484 -1.561 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.823 -178.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.463 ' OG ' HG21 ' A' ' 93' ' ' THR . 35.4 t -72.42 -43.2 64.19 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.475 -174.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 12.9 tt -71.77 -49.51 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 C-N-CA 119.192 -1.003 . . . . 0.0 112.891 -176.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.82 -32.51 71.89 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -176.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.0 p -71.92 -30.41 36.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.532 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.4 t -106.95 -43.87 4.55 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 119.358 -0.937 . . . . 0.0 112.24 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.9 tp -123.96 -52.95 1.76 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -175.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.405 ' HE2' ' OXT' ' A' ' 174' ' ' PHE . 25.1 ttt 76.03 138.08 0.06 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.103 1.361 . . . . 0.0 111.093 -176.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -61.45 -73.08 0.1 Allowed 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.4 t70 169.98 -13.26 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 O-C-N 124.218 0.949 . . . . 0.0 109.808 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.527 ' HA ' ' CE ' ' A' ' 131' ' ' MET . 0.0 OUTLIER 66.3 88.82 0.1 Allowed 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.99 0.9 . . . . 0.0 112.705 -169.435 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 47.2 t -105.86 155.69 19.08 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.5 -1.227 . . . . 0.0 107.718 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 20.9 p -96.57 100.57 12.14 Favored 'General case' 0 N--CA 1.402 -2.866 0 CA-C-O 121.089 0.471 . . . . 0.0 110.611 177.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 31.4 t70 74.95 99.96 0.07 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.18 0.992 . . . . 0.0 111.383 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -159.48 158.93 32.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.669 -1.151 . . . . 0.0 108.076 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -107.38 147.17 30.7 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.305 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 29.6 mm -128.68 130.59 68.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.923 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -102.04 101.53 11.91 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 172.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.462 ' HD1' ' O ' ' A' ' 163' ' ' GLY . 0.6 OUTLIER -104.66 170.4 7.9 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 179.723 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 88' ' ' LYS . 2.3 mp0 -120.42 147.23 45.36 Favored 'General case' 0 C--N 1.273 -2.726 0 C-N-CA 118.466 -1.294 . . . . 0.0 111.899 -177.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.4 tp -130.47 117.51 19.75 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-O 121.892 0.853 . . . . 0.0 110.368 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.48 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 3.9 m-20 -122.55 123.56 41.51 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 45.7 mt -122.14 131.1 73.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 119.004 -1.078 . . . . 0.0 111.028 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -106.18 86.95 0.5 Allowed Glycine 1 N--CA 1.394 -4.115 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 174.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.512 HD12 ' H ' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -85.81 141.4 29.67 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 176.292 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.1 t -128.63 122.01 29.92 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.409 -0.916 . . . . 0.0 111.457 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.43 ' CE2' HD23 ' A' ' 145' ' ' LEU . 77.7 m-85 -103.75 138.74 39.95 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -92.44 108.5 20.01 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 172.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.421 HG22 ' H ' ' A' ' 151' ' ' VAL . 51.2 mm -100.83 125.26 39.17 Favored Pre-proline 0 C--N 1.282 -2.359 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -178.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.11 -3.98 6.94 Favored 'Trans proline' 0 N--CA 1.481 0.788 0 C-N-CA 123.396 2.73 . . . . 0.0 113.46 -176.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.421 ' H ' HG22 ' A' ' 149' ' ' ILE . 59.9 t -76.0 -51.28 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.2 p -176.12 83.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 177.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 103.4 155.22 24.44 Favored Glycine 0 N--CA 1.413 -2.859 0 C-N-CA 120.589 -0.815 . . . . 0.0 114.27 165.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -97.52 114.19 26.03 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 170.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.51 HD13 ' H ' ' A' ' 155' ' ' ILE . 0.2 OUTLIER -121.44 150.84 24.61 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.888 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.672 -179.48 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 10.5 t -97.5 151.19 20.26 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 176.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 59.9 mt -113.97 110.73 48.57 Favored Pre-proline 0 N--CA 1.434 -1.226 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 176.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.475 ' HG2' ' CG ' ' A' ' 32' ' ' LYS . 26.3 Cg_exo -68.46 105.33 1.24 Allowed 'Trans proline' 0 C--O 1.241 0.671 0 C-N-CA 123.064 2.509 . . . . 0.0 112.836 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.455 HG12 ' H ' ' A' ' 49' ' ' VAL . 21.8 t -105.3 116.01 48.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 175.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 47.7 p -127.82 118.99 24.72 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -174.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.6 t -156.9 172.2 19.07 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -100.33 151.72 21.17 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.446 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.462 ' O ' ' HD1' ' A' ' 139' ' ' TYR . . . -111.74 101.83 1.33 Allowed Glycine 0 N--CA 1.406 -3.362 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 175.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -95.28 120.51 35.63 Favored 'General case' 0 C--N 1.266 -3.031 0 CA-C-O 121.888 0.851 . . . . 0.0 109.755 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 6.6 pt -130.49 133.56 63.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.869 -172.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -99.6 128.63 45.71 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 134' ' ' ASP . 91.4 mt -114.19 117.76 43.02 Favored Pre-proline 0 C--N 1.297 -1.694 0 C-N-CA 120.454 -0.499 . . . . 0.0 111.191 -174.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -84.96 108.98 1.22 Allowed 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 122.567 2.178 . . . . 0.0 111.802 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 133' ' ' THR 0.27 79.2 p 52.31 -81.38 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 179.142 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 85.4 mt 69.51 -62.05 0.42 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.728 1.211 . . . . 0.0 111.686 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 76.8 mtm180 65.28 -3.15 0.67 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 173.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -142.94 1.33 1.27 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.35 0.595 . . . . 0.0 110.07 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -114.21 -13.14 12.39 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 115.929 1.825 . . . . 0.0 115.929 -165.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.535 ' CD2' ' HB2' ' A' ' 120' ' ' ALA . 4.1 t80 . . . . . 0 C--O 1.268 2.048 0 C-N-CA 118.178 -1.409 . . . . 0.0 111.123 -173.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 5' ' ' HIS . . . . . . . . 0 CA--C 1.503 -0.682 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 64.97 -82.15 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.937 0.895 . . . . 0.0 112.694 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -106.76 -24.7 12.01 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -147.12 147.26 30.39 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.45 ' O ' ' HA2' ' A' ' 1' ' ' GLY . 67.5 m-70 78.7 87.79 0.06 Allowed 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 124.381 1.072 . . . . 0.0 110.67 -173.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 71.1 -26.87 0.17 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.179 1.392 . . . . 0.0 114.332 175.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.3 t60 68.66 -73.87 0.08 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.664 1.186 . . . . 0.0 111.534 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 pp -88.32 -19.13 27.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -174.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -80.58 66.92 6.27 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.665 0.745 . . . . 0.0 111.162 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -171.9 17.63 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 125.692 1.597 . . . . 0.0 107.181 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.9 m 58.07 71.19 0.59 Allowed 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.658 -174.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.641 ' O ' HG21 ' A' ' 16' ' ' VAL . . . -73.25 -42.99 61.9 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.007 -178.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -57.77 -35.8 71.25 Favored 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 123.626 0.579 . . . . 0.0 111.072 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -59.34 -48.8 80.26 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.4 ' HD2' ' C ' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -60.77 -40.17 91.56 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.598 176.696 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 12' ' ' ALA . 40.7 t -64.65 -40.87 90.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.665 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.508 HG11 ' O ' ' A' ' 94' ' ' ILE . 54.6 t -59.13 -33.26 49.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.102 0.477 . . . . 0.0 110.004 175.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.06 -45.78 55.45 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -57.51 -52.47 65.26 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.733 176.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.458 ' HE2' HG13 ' A' ' 16' ' ' VAL . 68.1 mttm -58.12 -48.91 78.77 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.819 -178.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.11 -45.13 83.68 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 123.463 0.477 . . . . 0.0 111.395 -176.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 62.9 m -62.33 -49.51 75.32 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.015 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.8 t -61.57 -38.07 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.204 0.526 . . . . 0.0 110.296 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.495 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 86.0 mt -69.95 -46.86 72.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.172 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.1 t -59.68 -36.61 76.82 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.699 0.4 . . . . 0.0 110.676 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.1 t -62.84 -38.24 89.98 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.684 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.557 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 5.1 tt -76.72 -42.1 42.62 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 87.7 mt -57.05 -36.55 70.64 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.288 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -56.77 -41.44 77.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.814 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.557 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -83.29 -33.33 25.98 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.624 -178.227 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.21 -50.7 11.42 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -175.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -60.26 -47.04 87.67 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 122.514 0.326 . . . . 0.0 111.077 -175.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.644 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -59.63 -56.01 27.31 Favored Glycine 0 N--CA 1.444 -0.813 0 O-C-N 123.683 0.614 . . . . 0.0 111.996 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -58.4 -39.76 80.55 Favored 'General case' 0 C--O 1.255 1.348 0 C-N-CA 123.268 0.627 . . . . 0.0 110.923 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.486 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 89.1 t80 -67.76 -53.34 27.98 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.4 178.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.15 -29.69 68.82 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -174.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.644 ' HG2' ' O ' ' A' ' 33' ' ' GLY . 10.7 pt-20 -90.37 -42.39 10.96 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -177.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -107.4 -48.3 3.47 Favored 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 118.812 -1.155 . . . . 0.0 112.534 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 2.9 mm? -75.71 -12.67 60.24 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -169.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.56 -23.14 64.46 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 120.971 0.415 . . . . 0.0 110.095 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -115.22 17.48 16.62 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.222 0.534 . . . . 0.0 110.19 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.403 ' HB ' ' HA ' ' A' ' 39' ' ' LEU . 72.7 mt -127.98 134.6 26.4 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -40.82 103.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.317 0 C-N-CA 123.903 3.068 . . . . 0.0 114.591 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.0 p -146.5 155.08 49.43 Favored Pre-proline 0 C--N 1.31 -1.151 0 C-N-CA 124.802 1.241 . . . . 0.0 108.409 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.9 124.89 14.3 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.125 1.884 . . . . 0.0 111.468 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -97.03 111.55 23.72 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.37 143.18 33.9 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.86 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.48 ' HA ' HG22 ' A' ' 159' ' ' VAL . 10.4 t -143.18 140.59 30.83 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.418 HG21 HG21 ' A' ' 159' ' ' VAL . 45.3 t -83.63 141.26 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.829 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -108.23 -62.11 1.5 Allowed 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.844 -1.142 . . . . 0.0 114.023 -168.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.439 ' HB3' ' HD2' ' A' ' 67' ' ' LYS . 24.5 t70 -166.79 166.16 15.87 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.562 -169.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.638 HG13 ' CD2' ' A' ' 64' ' ' TYR . 97.4 t -118.55 119.54 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 124.248 1.019 . . . . 0.0 111.462 -176.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -121.95 106.4 11.2 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -82.06 134.02 35.32 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -176.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.406 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -137.08 78.84 1.72 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -175.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 122.64 -149.62 16.92 Favored Glycine 0 C--N 1.268 -3.212 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.217 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.4 p -143.54 154.88 16.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.0 m -135.35 164.1 28.51 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -58.31 -41.41 84.42 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.08 0.466 . . . . 0.0 110.6 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -133.23 105.0 6.75 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.76 -161.1 21.87 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.284 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 69.9 t -150.78 121.91 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -177.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.428 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 20.3 t70 -68.4 129.65 40.55 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.638 ' CD2' HG13 ' A' ' 52' ' ' VAL . 43.7 p90 -131.65 169.64 15.87 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -90.69 109.5 20.67 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 174.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.81 112.23 19.44 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 175.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.439 ' HD2' ' HB3' ' A' ' 51' ' ' ASP . 93.7 mttt -86.74 120.58 28.18 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.172 -176.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.0 t -127.04 109.1 19.89 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.673 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.6 p -99.55 123.66 44.03 Favored 'General case' 0 C--N 1.283 -2.314 0 C-N-CA 120.394 -0.523 . . . . 0.0 111.017 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.2 t -117.88 125.43 74.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.826 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.408 ' HG2' ' OG1' ' A' ' 110' ' ' THR . 51.7 mtpt -95.07 110.25 22.2 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.498 HD21 HD13 ' A' ' 105' ' ' LEU . 47.4 t-20 -108.39 113.79 59.92 Favored Pre-proline 0 C--N 1.302 -1.48 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.241 -176.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -111.55 97.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.152 0 C-N-CA 123.017 2.478 . . . . 0.0 110.408 166.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -168.94 -19.96 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.7 t 70.99 24.57 3.95 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.333 1.053 . . . . 0.0 109.651 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.501 ' HG3' ' CG1' ' A' ' 78' ' ' ILE . 9.5 tp60 -121.68 110.67 16.25 Favored 'General case' 0 N--CA 1.396 -3.173 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.987 -178.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.3 m -75.09 87.4 2.39 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.501 ' CG1' ' HG3' ' A' ' 76' ' ' GLN . 82.3 mt -72.77 122.02 86.51 Favored Pre-proline 0 C--N 1.294 -1.839 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.775 -170.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -70.86 109.95 2.65 Favored 'Trans proline' 0 N--CA 1.431 -2.187 0 N-CA-C 106.721 -2.069 . . . . 0.0 106.721 168.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.3 mt -62.95 119.49 7.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -173.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 41.8 t -56.64 -53.21 60.35 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -167.94 147.76 4.89 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.428 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 12.4 tt -110.85 113.93 45.65 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 175.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.5 t -92.65 148.17 22.28 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -140.57 139.42 34.97 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 176.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.528 ' HA ' ' O ' ' A' ' 95' ' ' ALA . 11.8 tt -143.56 110.55 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 174.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.427 HD13 ' O ' ' A' ' 87' ' ' LEU . 3.4 pp -110.9 141.04 44.85 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.586 -178.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.406 ' HA ' HG23 ' A' ' 94' ' ' ILE . 97.3 mttt -103.62 153.08 21.01 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.837 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 55.8 m -135.29 132.18 37.43 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.682 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.78 86.87 2.79 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 121.951 0.881 . . . . 0.0 112.018 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.8 m -161.58 -53.61 0.05 OUTLIER 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 163.86 -52.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 125.268 1.605 . . . . 0.0 110.479 177.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.2 m -70.81 142.11 51.32 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.948 -177.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.508 ' O ' HG11 ' A' ' 17' ' ' VAL . 2.5 pp -125.04 177.25 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.036 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 86' ' ' ILE . . . -131.95 134.03 45.18 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 118.296 0.498 . . . . 0.0 109.778 177.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.4 p -135.09 158.47 44.28 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 176.22 168.42 36.38 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.574 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.5 p -135.02 116.58 14.79 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 122.717 0.407 . . . . 0.0 109.959 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 60.6 mt -98.57 108.78 50.0 Favored Pre-proline 0 C--N 1.323 -0.572 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.166 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.65 121.99 7.48 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.607 2.204 . . . . 0.0 111.692 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.4 t70 56.12 83.4 0.22 Allowed Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 124.008 0.923 . . . . 0.0 112.249 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -101.48 8.28 0.53 Allowed 'Trans proline' 0 CA--C 1.548 1.212 0 C-N-CA 123.073 2.515 . . . . 0.0 113.075 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 165.14 -124.33 1.24 Allowed Glycine 0 N--CA 1.441 -1.033 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.7 m -151.84 146.67 25.85 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 176.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.523 ' HG ' ' CE1' ' A' ' 147' ' ' PHE . 1.0 OUTLIER -104.44 98.13 7.95 Favored 'General case' 0 N--CA 1.423 -1.791 0 C-N-CA 117.859 -1.536 . . . . 0.0 109.119 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.477 ' HB ' ' HB ' ' A' ' 111' ' ' THR 0.255 14.8 p 10.55 -72.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 128.811 2.844 . . . . 0.0 117.501 178.308 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 76' ' ' GLN . . . 125.37 -51.12 0.84 Allowed Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -174.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.5 p -154.09 94.89 1.78 Allowed 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.334 0.587 . . . . 0.0 111.862 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 143.98 -175.17 24.0 Favored Glycine 0 CA--C 1.497 -1.081 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.883 176.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.408 ' OG1' ' HG2' ' A' ' 71' ' ' LYS . 56.3 m -95.35 116.93 29.45 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.477 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 9.6 t -113.78 137.12 52.08 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 25.5 t -99.4 115.08 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.3 mt -89.82 148.27 23.3 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.395 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -114.23 121.0 42.38 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.769 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.3 p -128.18 125.55 23.42 Favored Pre-proline 0 C--N 1.302 -1.462 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.34 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.29 111.72 3.24 Favored 'Trans proline' 0 C--O 1.246 0.909 0 C-N-CA 123.117 2.545 . . . . 0.0 112.589 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.429 HG21 ' CE1' ' A' ' 64' ' ' TYR . 26.3 m -143.36 151.44 16.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 3.3 mppt? -95.9 135.72 37.27 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.616 ' HB ' ' CE1' ' A' ' 64' ' ' TYR . 13.2 p -94.9 145.78 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 66.44 13.33 9.2 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 123.548 0.739 . . . . 0.0 110.332 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.496 ' O ' HG21 ' A' ' 125' ' ' VAL . 84.4 t80 -56.77 -50.38 72.48 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 124.786 1.235 . . . . 0.0 108.961 176.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.8 m -62.1 -40.74 96.89 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.856 -176.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 14.0 tt -79.06 -34.01 16.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.352 -177.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -60.85 -35.95 77.89 Favored 'General case' 0 C--N 1.358 0.937 0 CA-C-O 120.893 0.377 . . . . 0.0 110.031 174.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.496 HG21 ' O ' ' A' ' 121' ' ' TYR . 43.2 t -56.54 -37.79 53.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.42 175.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.2 m -95.52 -77.24 0.48 Allowed 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.505 HD13 ' H ' ' A' ' 129' ' ' LYS . 3.9 pp -119.03 -12.11 9.56 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -172.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.5 ' O ' ' HG2' ' A' ' 128' ' ' MET . 25.0 ttt 60.93 41.17 14.59 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.931 0.892 . . . . 0.0 113.399 173.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.505 ' H ' HD13 ' A' ' 127' ' ' LEU . 15.0 mtmt 60.1 -83.12 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.128 0.571 . . . . 0.0 111.28 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 164.21 -23.13 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 126.806 2.043 . . . . 0.0 106.469 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.523 ' SD ' ' HB3' ' A' ' 174' ' ' PHE . 0.3 OUTLIER 59.16 100.38 0.02 OUTLIER 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.253 -176.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 49.0 t -132.17 170.09 15.49 Favored 'General case' 0 CA--C 1.556 1.209 0 O-C-N 121.609 -0.682 . . . . 0.0 112.503 -175.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 21.6 p -67.79 133.0 48.47 Favored 'General case' 0 N--CA 1.42 -1.949 0 C-N-CA 125.125 1.37 . . . . 0.0 109.886 170.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.6 t70 42.17 72.37 0.17 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.457 1.103 . . . . 0.0 110.206 -171.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.448 ' CZ2' ' HB3' ' A' ' 129' ' ' LYS . 33.1 t-105 -101.29 115.23 30.02 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.816 -173.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -107.39 126.26 52.25 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.114 -174.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.444 ' N ' HD13 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -139.86 168.21 18.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-O 121.545 0.688 . . . . 0.0 112.083 -179.673 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -142.0 133.07 26.08 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.382 177.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.34 172.76 11.8 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 178.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -129.69 124.18 32.96 Favored 'General case' 0 C--N 1.287 -2.112 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.143 -175.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.2 tp -107.06 129.73 54.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.295 -174.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.465 ' OD1' ' HB3' ' A' ' 160' ' ' SER . 10.7 m-20 -122.79 137.41 54.93 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 158' ' ' PRO . 42.1 mm -124.09 145.96 30.36 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -122.39 97.67 0.6 Allowed Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 177.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.496 ' HB3' ' CE2' ' A' ' 147' ' ' PHE . 2.9 mm? -81.68 110.26 16.86 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 -178.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 28.7 m -96.35 108.17 20.64 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.613 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.523 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 53.6 m-85 -120.7 144.79 48.03 Favored 'General case' 0 CA--C 1.494 -1.208 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -116.37 116.09 27.08 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.499 -0.88 . . . . 0.0 109.327 176.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.498 HD11 ' H ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -106.02 130.43 23.0 Favored Pre-proline 0 C--N 1.298 -1.645 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.618 -177.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -42.75 -32.89 2.69 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 125.03 3.82 . . . . 0.0 115.572 -176.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.4 m -60.21 -34.37 56.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 60.0 t -135.78 -68.06 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.026 0.441 . . . . 0.0 109.976 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 163.06 -146.14 11.38 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.15 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -83.7 120.26 25.79 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.554 0.692 . . . . 0.0 112.571 -176.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.496 HD11 ' O ' ' A' ' 155' ' ' ILE . 2.5 pp -127.12 124.05 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.817 173.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.498 ' O ' ' HD3' ' A' ' 158' ' ' PRO . 56.9 m -88.12 117.38 26.96 Favored 'General case' 0 N--CA 1.424 -1.775 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.823 176.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 60.5 mt -95.81 104.77 17.57 Favored Pre-proline 0 C--N 1.303 -1.42 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.875 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.548 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.0 OUTLIER -85.39 138.85 6.62 Favored 'Trans proline' 0 CA--C 1.485 -1.971 0 C-N-CA 122.66 2.24 . . . . 0.0 111.762 176.883 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.48 HG22 ' HA ' ' A' ' 48' ' ' THR . 2.6 p -138.05 132.9 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.556 0 CA-C-N 112.953 -1.93 . . . . 0.0 109.661 -173.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.465 ' HB3' ' OD1' ' A' ' 142' ' ' ASP . 58.1 p -120.59 161.93 20.5 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.491 -176.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.3 t -166.09 165.41 17.8 Favored 'General case' 0 C--O 1.252 1.216 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -98.48 126.71 44.13 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -108.69 82.64 0.31 Allowed Glycine 0 N--CA 1.419 -2.476 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.43 120.37 30.7 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.433 ' CD1' HG22 ' A' ' 119' ' ' VAL . 5.7 pt -145.14 121.22 3.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.119 -170.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -104.18 139.75 38.78 Favored 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 117.887 -1.525 . . . . 0.0 109.511 174.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.564 HD23 ' CG ' ' A' ' 174' ' ' PHE . 6.8 mp -108.8 103.39 51.6 Favored Pre-proline 0 N--CA 1.405 -2.678 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.631 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.26 92.76 0.82 Allowed 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 123.165 2.576 . . . . 0.0 114.893 -172.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 5.0 m 50.37 89.33 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 125.399 1.48 . . . . 0.0 114.086 171.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.48 ' HB2' ' SD ' ' A' ' 131' ' ' MET . 99.1 mt -108.69 -39.83 5.25 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.048 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.44 ' HA ' ' HG3' ' A' ' 131' ' ' MET . 36.4 mmt180 54.88 18.82 2.35 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 177.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -178.7 -29.73 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -176.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -99.95 21.1 13.17 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -172.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.564 ' CG ' HD23 ' A' ' 167' ' ' LEU . 40.6 t80 . . . . . 0 CA--C 1.501 -0.917 0 C-N-CA 119.062 -1.055 . . . . 0.0 113.383 -177.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.889 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -123.5 87.1 2.68 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -156.33 112.81 3.08 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -86.76 144.2 27.18 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 177.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.9 t60 -67.52 151.09 47.96 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -60.03 110.66 1.25 Allowed 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -107.28 -9.68 16.01 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.59 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 tt 73.41 -48.39 0.68 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.716 1.206 . . . . 0.0 109.91 -177.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -75.67 -54.18 7.38 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 174.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 56.45 71.65 0.55 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.769 1.227 . . . . 0.0 113.395 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.4 m 53.31 88.62 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.856 1.262 . . . . 0.0 113.034 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.42 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -56.62 -44.67 81.41 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.546 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.471 ' O ' HG22 ' A' ' 17' ' ' VAL . 1.9 p30 -56.57 -56.26 23.51 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 124.052 0.845 . . . . 0.0 112.172 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.16 -42.42 99.41 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 123.504 0.722 . . . . 0.0 110.821 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -65.71 -46.25 79.68 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 12' ' ' ALA . 29.9 m -71.79 -23.07 21.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.299 -176.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 13' ' ' ASP . 77.4 t -61.72 -47.22 94.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 172.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -59.53 -37.19 77.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.762 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -60.51 -56.78 17.29 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.36 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -65.97 -39.2 90.16 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.893 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.57 -37.31 80.88 Favored 'General case' 0 C--O 1.221 -0.439 0 O-C-N 123.286 0.366 . . . . 0.0 110.805 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.0 t -63.39 -50.34 70.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.865 0.364 . . . . 0.0 110.451 178.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.05 -45.11 99.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.391 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.481 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 83.7 mt -66.18 -43.23 92.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.171 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.2 t -62.02 -35.57 78.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.796 0.332 . . . . 0.0 110.463 177.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.8 t -63.45 -41.28 98.64 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.97 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.539 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 3.9 tt -71.09 -41.68 70.3 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 96.3 mt -59.24 -39.68 83.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.092 0.473 . . . . 0.0 110.366 177.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -62.54 -41.9 99.18 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 27' ' ' LEU . 61.4 pttt -63.52 -34.38 77.66 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 119.921 -0.711 . . . . 0.0 109.523 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.66 -31.66 52.75 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.692 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.542 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 39.7 ttmt -51.12 -40.08 57.68 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.059 0.944 . . . . 0.0 112.884 -175.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.46 -8.86 54.32 Favored Glycine 0 C--N 1.313 -0.698 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.614 178.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 19.3 t80 -81.45 -25.9 35.72 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 124.435 1.094 . . . . 0.0 108.418 -175.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.542 ' CE2' ' HA ' ' A' ' 32' ' ' LYS . 22.5 m-85 -56.96 -36.57 70.44 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.627 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.64 -50.05 55.34 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.766 0.666 . . . . 0.0 112.396 -173.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -98.88 -43.71 6.63 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.277 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.548 ' N ' ' HD3' ' A' ' 38' ' ' LYS 0.295 2.7 mppt? -75.19 -3.92 35.8 Favored 'General case' 0 C--O 1.206 -1.22 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 -171.042 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.3 mt -117.38 1.0 12.33 Favored 'General case' 0 C--N 1.284 -2.251 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.808 173.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.44 -55.74 2.42 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.09 0.471 . . . . 0.0 110.521 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -86.14 -4.5 59.18 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.496 -177.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.7 mm -119.06 126.85 26.83 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.03 104.21 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.448 2.099 . . . . 0.0 110.415 176.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.428 HG21 ' CD1' ' A' ' 149' ' ' ILE . 5.8 p -128.26 154.37 78.93 Favored Pre-proline 0 C--N 1.302 -1.493 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.464 -174.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.444 ' HB3' ' OD1' ' A' ' 72' ' ' ASN . 65.6 Cg_endo -84.73 154.94 11.75 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.888 2.392 . . . . 0.0 112.02 178.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -121.04 136.93 54.87 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.39 167.6 13.1 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.98 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.4 t -155.49 145.21 21.31 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 123.506 0.503 . . . . 0.0 110.518 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.4 t -83.99 141.9 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 173.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -122.2 -54.18 1.91 Allowed 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -172.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -162.03 162.59 28.87 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -172.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.3 m -122.98 108.15 20.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 121.438 0.637 . . . . 0.0 110.024 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -90.9 121.08 32.44 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.601 -177.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.513 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 53.3 p90 -69.3 120.21 14.77 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.536 177.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -83.36 -49.4 9.39 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.423 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 178.95 -147.36 7.72 Favored Glycine 0 N--CA 1.41 -3.046 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.428 HG21 ' O ' ' A' ' 173' ' ' PHE . 7.5 p -111.67 138.42 40.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-O 121.02 0.438 . . . . 0.0 110.487 -174.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 24.5 m -127.15 145.13 50.86 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 175.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -104.61 78.36 1.45 Allowed 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 118.661 -1.216 . . . . 0.0 108.327 178.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -175.32 -70.33 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 -175.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.421 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . -138.2 -138.53 3.72 Favored Glycine 0 N--CA 1.411 -3.024 0 N-CA-C 104.298 -3.521 . . . . 0.0 104.298 167.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.04 134.28 41.52 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-N 118.675 1.238 . . . . 0.0 110.288 174.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -93.43 107.27 19.14 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.063 -175.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.513 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 4.5 m-85 -100.45 161.09 13.83 Favored 'General case' 0 CA--C 1.486 -1.511 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.005 176.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.407 ' CD2' ' HB3' ' A' ' 114' ' ' ASP . 3.3 t-160 -114.75 107.73 15.83 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 178.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -92.86 140.78 29.15 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.0 0.428 . . . . 0.0 112.022 -176.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -89.64 121.33 31.72 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.77 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.88 111.28 29.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.5 m -98.85 139.25 34.81 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 120.319 -0.553 . . . . 0.0 109.94 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.2 t -131.45 131.61 62.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -114.59 132.32 56.38 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 175.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.843 ' O ' ' HA ' ' A' ' 108' ' ' SER . 5.8 t30 -142.73 114.75 6.07 Favored Pre-proline 0 C--N 1.294 -1.835 0 C-N-CA 119.743 -0.783 . . . . 0.0 112.949 -175.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -94.36 99.62 0.12 Allowed 'Trans proline' 0 N--CA 1.436 -1.865 0 C-N-CA 122.365 2.043 . . . . 0.0 109.487 170.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.495 ' HB3' HD22 ' A' ' 72' ' ' ASN . 48.8 t80 -170.32 -14.82 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -176.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.1 t 83.14 -56.24 0.16 Allowed 'General case' 0 C--O 1.233 0.232 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 172.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.536 HE21 HG12 ' A' ' 78' ' ' ILE . 6.6 pt20 -69.46 152.89 44.33 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-N 118.719 0.691 . . . . 0.0 112.744 -176.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.6 p -77.14 111.82 13.15 Favored 'General case' 0 N--CA 1.411 -2.375 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.279 174.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.536 HG12 HE21 ' A' ' 76' ' ' GLN . 70.0 mt -93.27 114.9 64.09 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -65.07 139.16 59.88 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.374 2.05 . . . . 0.0 110.241 175.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 54.5 mt -88.2 114.83 27.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 58.3 m -55.76 -56.14 24.05 Favored 'General case' 0 C--N 1.319 -0.742 0 O-C-N 123.811 0.695 . . . . 0.0 109.521 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -167.81 160.72 12.7 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.113 176.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.406 ' CG2' HG23 ' A' ' 143' ' ' ILE . 25.0 mt -120.14 113.75 41.6 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.959 176.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.8 p -88.29 117.22 27.05 Favored 'General case' 0 N--CA 1.405 -2.72 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -111.45 143.05 42.92 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.414 HG22 ' HB3' ' A' ' 142' ' ' ASP . 9.9 tt -137.13 108.74 6.38 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 CA-C-O 121.727 0.775 . . . . 0.0 109.15 176.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.439 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -106.84 145.91 31.57 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.506 -179.443 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.402 ' HA ' HG22 ' A' ' 94' ' ' ILE . 40.1 ttmt -118.43 152.58 35.61 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.831 -175.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.7 t -126.96 97.86 5.12 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 175.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.427 ' HA ' ' OD2' ' A' ' 138' ' ' ASP . . . 53.51 -94.96 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.98 1.312 . . . . 0.0 111.357 -175.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 85.5 m -166.34 85.13 0.3 Allowed 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 124.669 1.187 . . . . 0.0 108.513 175.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -160.06 -62.9 0.07 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 49.6 m -136.73 151.94 49.79 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.439 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 37.2 pt -134.72 -176.34 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.393 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.433 ' HB2' HD13 ' A' ' 87' ' ' LEU . . . -145.54 146.2 31.32 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 172.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.0 t -148.38 144.52 27.55 Favored 'General case' 0 N--CA 1.412 -2.357 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -166.73 166.38 39.0 Favored Glycine 0 N--CA 1.426 -2.025 0 C-N-CA 120.648 -0.786 . . . . 0.0 111.296 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.5 p -110.18 119.89 40.72 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.2 tt -103.3 104.55 41.65 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.912 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.79 128.06 12.93 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.058 2.505 . . . . 0.0 111.97 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.3 t70 52.08 79.48 0.34 Allowed Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 124.633 1.173 . . . . 0.0 111.997 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -101.47 8.82 0.52 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.788 2.325 . . . . 0.0 111.487 176.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 149.58 -168.39 29.8 Favored Glycine 0 N--CA 1.422 -2.236 0 N-CA-C 108.221 -1.952 . . . . 0.0 108.221 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.5 m -145.51 149.89 35.46 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 118.3 1.05 . . . . 0.0 111.956 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.74 118.38 22.23 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 177.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 29.2 m -66.11 -35.96 76.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -174.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 140.31 -137.45 8.35 Favored Glycine 0 N--CA 1.416 -2.676 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.843 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 65.4 m -77.68 101.44 6.62 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.474 0.655 . . . . 0.0 111.555 178.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 164.99 -172.29 40.62 Favored Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.4 t -114.43 114.34 25.71 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.776 0.798 . . . . 0.0 109.684 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.6 t -110.26 132.94 53.73 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.157 -177.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 20.5 m -99.63 106.54 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-O 121.791 0.805 . . . . 0.0 110.031 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 66.4 mt -95.46 164.58 12.75 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.84 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 4.9 m-20 -133.99 135.62 43.56 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.143 -178.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.65 132.23 24.1 Favored Pre-proline 0 C--N 1.305 -1.353 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -73.46 110.63 3.1 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 N-CA-C 107.122 -1.915 . . . . 0.0 107.122 168.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.7 t -113.28 140.17 34.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.627 -172.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.545 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -88.1 98.95 11.82 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.2 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.414 ' C ' ' H ' ' A' ' 121' ' ' TYR . 10.3 m -102.58 147.49 9.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 71.78 -22.88 0.19 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.887 0.875 . . . . 0.0 113.212 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.414 ' H ' ' C ' ' A' ' 119' ' ' VAL . 52.6 t80 -55.7 -36.5 67.23 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.002 0.521 . . . . 0.0 110.963 177.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.9 p -59.12 -46.3 88.67 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.647 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 14.2 tt -79.08 -32.56 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.282 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -57.38 -43.31 83.49 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.704 0.802 . . . . 0.0 112.643 -178.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.3 m -72.09 -22.33 21.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.3 m -93.51 -73.03 0.58 Allowed 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -177.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -124.52 -12.96 7.17 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -176.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.452 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER 73.63 140.61 0.06 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.507 1.123 . . . . 0.0 109.826 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.576 ' C ' ' H ' ' A' ' 131' ' ' MET . 46.6 pttt -59.42 -19.88 50.67 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.138 0.575 . . . . 0.0 111.43 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 23.8 t70 82.23 -22.73 0.24 Allowed 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 125.226 1.41 . . . . 0.0 109.577 177.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.609 ' HE3' ' O ' ' A' ' 170' ' ' LEU . 15.4 tpt 51.08 97.24 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 112.678 -2.055 . . . . 0.0 115.388 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 64.4 m -92.94 140.41 29.52 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 171.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.8 p -71.19 100.71 2.13 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-O 121.482 0.658 . . . . 0.0 110.606 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.571 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 14.0 t70 86.37 88.55 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.627 0 C-N-CA 126.852 2.061 . . . . 0.0 110.312 -174.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -158.5 158.88 34.9 Favored 'General case' 0 N--CA 1.412 -2.33 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 176.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -117.7 134.6 54.73 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.475 ' CG2' ' HB ' ' A' ' 165' ' ' ILE . 9.8 tt -97.4 133.22 39.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 C-N-CA 120.594 -0.442 . . . . 0.0 109.856 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.427 ' OD2' ' HA ' ' A' ' 90' ' ' ALA . 38.9 t70 -70.39 90.44 0.71 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.532 178.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -108.77 152.81 24.35 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.526 177.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -137.86 146.64 43.65 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 41.2 tp -128.74 126.52 40.19 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 123.461 0.475 . . . . 0.0 110.391 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.48 ' OD2' ' HB3' ' A' ' 160' ' ' SER . 14.1 t70 -127.32 125.82 41.48 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.406 HG23 ' CG2' ' A' ' 83' ' ' ILE . 42.6 mm -111.83 118.76 58.41 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 CA-C-O 120.953 0.406 . . . . 0.0 109.98 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -95.95 86.85 0.95 Allowed Glycine 0 N--CA 1.42 -2.422 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 173.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 156' ' ' THR . 0.0 OUTLIER -74.73 134.26 41.91 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.438 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.8 m -110.74 108.32 18.15 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.477 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 154' ' ' ASP . 80.0 m-85 -114.66 129.7 56.71 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 175.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -94.49 109.69 21.55 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.428 ' CD1' HG21 ' A' ' 44' ' ' THR . 64.6 mt -98.15 129.38 30.94 Favored Pre-proline 0 C--N 1.291 -1.974 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.7 -176.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -52.26 -34.84 61.44 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 123.854 3.036 . . . . 0.0 112.944 -178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.43 -51.07 76.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.374 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 39.0 t -119.9 -69.28 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.418 -175.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 163.37 -141.14 6.93 Favored Glycine 0 N--CA 1.431 -1.644 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.524 ' HA ' ' O ' ' A' ' 147' ' ' PHE . 4.2 p30 -94.25 131.17 40.12 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 117.331 0.566 . . . . 0.0 111.914 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.27 115.7 33.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 176.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 24.8 p -86.16 115.92 24.03 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.098 175.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 54.4 mt -97.11 106.93 34.79 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -74.27 107.24 2.39 Favored 'Trans proline' 0 C--O 1.251 1.162 0 C-N-CA 121.929 1.753 . . . . 0.0 111.106 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 142' ' ' ASP . 30.6 m -110.48 126.95 67.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.841 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.48 ' HB3' ' OD2' ' A' ' 142' ' ' ASP . 48.3 p -129.38 162.7 27.43 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.143 0.497 . . . . 0.0 112.209 -176.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.9 t -159.51 -177.83 6.69 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 177.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -97.81 119.19 35.97 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -103.56 97.27 1.43 Allowed Glycine 0 N--CA 1.415 -2.746 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -178.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -88.95 119.47 29.5 Favored 'General case' 0 C--N 1.265 -3.103 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 -176.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.475 ' HB ' ' CG2' ' A' ' 137' ' ' ILE . 38.4 mm -101.77 107.14 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.418 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 176.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -113.29 126.72 55.71 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.215 0.531 . . . . 0.0 110.161 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 134' ' ' ASP . 67.1 mt -121.93 95.09 47.89 Favored Pre-proline 0 C--N 1.289 -2.046 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.851 -172.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.4 92.14 0.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.882 2.388 . . . . 0.0 112.978 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 78.0 p 53.34 27.42 6.22 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.435 1.494 . . . . 0.0 113.267 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.609 ' O ' ' HE3' ' A' ' 131' ' ' MET . 22.7 tp -75.45 83.39 2.53 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -83.13 105.39 14.07 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.639 -173.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.1 t70 75.0 91.84 0.08 Allowed 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 124.694 1.198 . . . . 0.0 110.023 177.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.503 ' CD1' HD23 ' A' ' 170' ' ' LEU . 37.4 t80 -173.02 -43.26 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 -175.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.514 ' HA ' ' HZ2' ' A' ' 129' ' ' LYS 0.301 58.9 m-85 . . . . . 0 CA--C 1.492 -1.277 0 CA-C-N 113.033 -1.894 . . . . 0.0 112.787 173.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.188 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -110.66 134.22 52.63 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.8 t60 72.71 -37.68 0.4 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.306 1.042 . . . . 0.0 111.986 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -156.11 155.04 31.87 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.1 p80 -128.59 173.5 10.22 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -84.12 161.13 20.74 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.132 0.491 . . . . 0.0 111.268 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -133.51 118.28 18.13 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.728 176.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.6 tp -71.29 -71.35 0.26 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.359 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -159.54 106.7 1.71 Allowed 'General case' 0 N--CA 1.407 -2.589 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -179.11 164.89 1.46 Allowed 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.2 m -84.58 25.22 0.92 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.245 0.545 . . . . 0.0 110.735 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.614 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -58.92 -46.16 88.62 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.604 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -61.2 -31.28 71.04 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.038 0.935 . . . . 0.0 111.328 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.68 ' O ' HG13 ' A' ' 17' ' ' VAL . 41.1 tt0 -73.52 -32.35 64.2 Favored 'General case' 0 C--O 1.209 -1.059 0 CA-C-O 121.852 0.834 . . . . 0.0 108.923 177.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -71.14 -33.55 70.18 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.626 0.727 . . . . 0.0 109.916 174.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 12' ' ' ALA . 90.8 t -69.77 -29.28 40.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.993 -178.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.68 HG13 ' O ' ' A' ' 14' ' ' GLU . 9.1 p -66.03 -25.53 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 120.001 -0.679 . . . . 0.0 109.208 177.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -72.08 -45.72 59.61 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.51 -38.22 89.05 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.684 175.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.46 ' O ' HG13 ' A' ' 24' ' ' ILE . 58.5 tptt -55.72 -48.86 74.44 Favored 'General case' 0 N--CA 1.425 -1.705 0 C-N-CA 123.257 0.623 . . . . 0.0 109.415 174.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.1 -35.75 82.13 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.734 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -62.53 -45.2 94.07 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.153 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.3 m -70.75 -32.32 48.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.84 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 20' ' ' LYS . 85.3 mt -65.18 -46.01 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 173.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.1 m -65.21 -35.36 80.83 Favored 'General case' 0 C--O 1.186 -2.243 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.689 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -59.57 -44.79 93.2 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-O 121.069 0.462 . . . . 0.0 109.999 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.53 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 5.2 tt -74.41 -44.03 53.76 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.14 -31.55 72.72 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-O 120.927 0.394 . . . . 0.0 110.78 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -66.77 -45.73 77.58 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 123.172 0.589 . . . . 0.0 111.17 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -71.05 -30.55 66.75 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.84 -44.22 70.34 Favored 'General case' 0 C--O 1.198 -1.627 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.788 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -60.61 -48.68 80.69 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -177.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.22 -30.96 79.27 Favored Glycine 0 C--O 1.239 0.411 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.413 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -75.98 -43.34 45.02 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 177.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.452 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 65.7 t80 -58.82 -53.81 54.14 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.768 1.227 . . . . 0.0 113.789 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.79 -19.18 49.02 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -174.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.407 ' HB2' ' HD3' ' A' ' 38' ' ' LYS . 31.2 mt-10 -116.39 -54.98 2.43 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.633 ' O ' HG12 ' A' ' 42' ' ' ILE . 3.2 mppt? -87.62 -27.44 22.5 Favored 'General case' 0 CA--C 1.466 -2.286 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.134 -170.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 86.6 mt -87.07 9.15 20.65 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 118.731 -1.188 . . . . 0.0 111.671 -176.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.07 -25.9 31.61 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.263 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -113.23 10.58 18.56 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.03 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.633 HG12 ' O ' ' A' ' 38' ' ' LYS . 47.5 mm -114.9 115.83 43.23 Favored Pre-proline 0 C--O 1.244 0.769 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -57.56 110.52 0.63 Allowed 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 122.728 2.285 . . . . 0.0 111.027 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.7 p -139.3 158.5 68.86 Favored Pre-proline 0 C--N 1.308 -1.202 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.333 -177.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -70.04 128.21 15.45 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.33 2.02 . . . . 0.0 109.92 174.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -100.99 130.72 47.02 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.456 ' CB ' ' HG ' ' A' ' 145' ' ' LEU . . . -121.59 153.2 38.38 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.1 t -147.15 143.69 28.44 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.392 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.557 ' H ' HG13 ' A' ' 159' ' ' VAL . 14.9 p -119.79 142.28 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -165.07 -18.85 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.656 -171.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.461 ' HB3' ' CG ' ' A' ' 67' ' ' LYS . 19.1 t70 -120.1 128.1 53.15 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.877 -176.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 67.9 t -110.94 120.31 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.802 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 178.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -112.14 125.5 54.19 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 123.327 0.651 . . . . 0.0 111.912 -175.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -70.25 141.09 52.49 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 124.151 0.98 . . . . 0.0 113.148 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 59.1 mtpt -122.13 -79.04 0.6 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.295 176.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.6 -147.87 6.54 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 119.63 -1.271 . . . . 0.0 113.323 -176.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.1 p -98.42 149.79 5.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.155 0.502 . . . . 0.0 111.477 -173.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.1 t -152.71 -174.53 4.95 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -67.04 -63.84 0.98 Allowed 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 120.931 0.396 . . . . 0.0 110.372 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -92.15 95.68 9.89 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.943 -172.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.17 -131.18 10.7 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.353 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.431 HG21 ' O ' ' A' ' 173' ' ' PHE . 6.8 t -127.02 135.03 64.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -178.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.587 ' O ' ' HB2' ' A' ' 55' ' ' LYS . 13.8 t70 -90.01 120.08 30.91 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 2.5 m-85 -122.4 172.77 8.09 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.934 0.873 . . . . 0.0 113.128 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.469 ' HB2' ' HD2' ' A' ' 55' ' ' LYS . 8.4 t-160 -126.0 108.84 11.78 Favored 'General case' 0 N--CA 1.421 -1.875 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.602 -177.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.34 143.43 26.76 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.461 ' CG ' ' HB3' ' A' ' 51' ' ' ASP . 44.8 mmtm -92.02 114.65 27.24 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 176.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 64.7 t -111.86 108.67 26.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.2 m -104.02 129.05 51.61 Favored 'General case' 0 C--N 1.284 -2.242 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.217 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 t -116.32 128.84 73.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.846 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 59.0 pttt -120.61 121.91 39.37 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.606 0.717 . . . . 0.0 109.317 178.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.708 ' O ' ' HA ' ' A' ' 108' ' ' SER . 24.3 p-10 -129.94 115.64 17.85 Favored Pre-proline 0 C--N 1.277 -2.572 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.595 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -93.41 97.77 0.15 Allowed 'Trans proline' 0 N--CA 1.425 -2.533 0 N-CA-C 107.166 -1.898 . . . . 0.0 107.166 165.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.413 ' CD2' HD12 ' A' ' 78' ' ' ILE . 25.9 t80 -157.39 -5.72 0.09 Allowed 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.684 -174.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.2 m 73.34 -2.38 2.76 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 174.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.482 HE21 HG12 ' A' ' 78' ' ' ILE . 9.3 pt20 -132.85 147.12 52.3 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.301 -0.875 . . . . 0.0 112.33 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.9 m -83.68 107.37 16.08 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.482 HG12 HE21 ' A' ' 76' ' ' GLN . 45.9 mt -94.39 122.39 61.33 Favored Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -177.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -66.74 113.33 2.71 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.075 1.85 . . . . 0.0 109.623 174.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 10.4 tt -72.0 134.98 28.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 54.9 m -61.1 -58.85 6.65 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.504 0.669 . . . . 0.0 109.733 -177.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -163.6 150.05 11.87 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.435 -177.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.9 mt -101.67 114.15 40.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 171.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.4 m -102.68 117.4 34.57 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.414 ' CD1' HG23 ' A' ' 117' ' ' VAL . 54.8 p90 -106.35 136.73 45.58 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.409 -178.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 54.6 mt -123.34 108.8 21.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 176.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.594 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 0.5 OUTLIER -91.86 121.19 33.24 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -174.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 140' ' ' GLN . 1.0 OUTLIER -94.27 116.29 28.66 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.284 0.564 . . . . 0.0 109.632 172.734 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.484 ' CB ' ' HB3' ' A' ' 122' ' ' SER . 22.7 t -100.16 94.07 6.04 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -176.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 61.37 -80.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.262 1.025 . . . . 0.0 110.662 -174.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.5 m -158.8 -36.17 0.06 Allowed 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -87.03 104.51 16.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.964 -177.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.46 ' HB ' ' OG ' ' A' ' 122' ' ' SER . 29.7 m 70.83 164.61 0.28 Allowed 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.289 1.036 . . . . 0.0 112.01 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.594 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 2.1 pp -144.09 170.68 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.749 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -173.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -121.96 154.88 36.61 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 172.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 t -159.87 168.05 26.69 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.172 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.59 151.57 8.76 Favored Glycine 0 N--CA 1.427 -1.941 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.534 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 20.3 p -109.06 116.84 32.73 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 54.6 mt -98.66 101.61 12.38 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 98' ' ' THR . 3.1 Cg_exo -78.28 123.24 5.99 Favored 'Trans proline' 0 C--O 1.241 0.661 0 C-N-CA 123.035 2.49 . . . . 0.0 111.21 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.3 t70 54.43 79.51 0.34 Allowed Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 124.83 1.252 . . . . 0.0 111.007 -174.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -104.74 25.06 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.676 2.918 . . . . 0.0 110.685 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.41 -172.9 18.09 Favored Glycine 0 N--CA 1.409 -3.122 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 -175.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 64.7 m -151.47 170.09 20.47 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 176.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.562 HD22 ' ND2' ' A' ' 72' ' ' ASN 0.312 0.0 OUTLIER -98.88 158.15 15.83 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 179.863 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 22.9 m -72.2 -176.65 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 124.328 1.017 . . . . 0.0 110.989 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.42 -47.88 54.84 Favored Glycine 0 C--N 1.307 -1.068 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.24 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.708 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 21.3 t -160.07 94.01 1.09 Allowed 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 176.64 -168.83 41.05 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.318 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.5 m -113.04 114.06 26.33 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.539 HG22 ' HA ' ' A' ' 105' ' ' LEU . 10.2 t -113.34 138.41 50.09 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 26.4 t -96.89 118.04 42.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 121.013 0.435 . . . . 0.0 109.884 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.0 mt -98.25 159.56 14.86 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.967 -178.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -104.76 130.09 52.89 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.337 -175.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.2 t -125.72 114.36 24.84 Favored Pre-proline 0 CA--C 1.5 -0.978 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.431 172.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 2.7 Cg_exo -77.77 110.16 2.88 Favored 'Trans proline' 0 N--CA 1.423 -2.635 0 N-CA-C 107.528 -1.758 . . . . 0.0 107.528 168.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.414 HG23 ' CD1' ' A' ' 85' ' ' TYR . 12.3 p -115.81 137.52 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -94.78 99.88 11.88 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.4 m -94.32 149.3 4.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -168.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.453 ' HB1' ' HZ2' ' A' ' 129' ' ' LYS . . . 76.8 -12.8 1.0 Allowed 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 124.724 1.209 . . . . 0.0 113.334 172.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -48.2 -50.38 29.47 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 124.223 0.952 . . . . 0.0 112.987 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.484 ' HB3' ' CB ' ' A' ' 89' ' ' SER . 34.6 t -66.65 -43.49 84.48 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.438 -0.905 . . . . 0.0 112.382 -169.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.434 HG21 ' HG ' ' A' ' 89' ' ' SER . 24.3 pt -79.02 -27.73 13.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.444 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -58.48 -41.14 84.59 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 174.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.6 t -56.98 -39.43 65.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.694 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 36.4 t -89.88 -84.94 0.22 Allowed 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.468 HD21 ' H ' ' A' ' 127' ' ' LEU . 1.9 pt? -106.84 -17.79 14.11 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 120.854 0.359 . . . . 0.0 111.963 -175.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.536 ' C ' ' HD3' ' A' ' 129' ' ' LYS . 23.8 ttt 58.22 39.24 25.99 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.02 0.928 . . . . 0.0 111.031 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.611 ' HZ3' ' C ' ' A' ' 174' ' ' PHE 0.306 0.0 OUTLIER 48.98 -73.1 0.0 OUTLIER 'General case' 0 C--N 1.363 1.156 0 C-N-CA 125.125 1.37 . . . . 0.0 114.169 -177.244 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -178.57 -32.15 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.605 ' SD ' ' HA ' ' A' ' 171' ' ' ARG . 0.7 OUTLIER 62.66 81.93 0.19 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.374 -178.127 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 29.0 m -108.98 172.31 6.92 Favored 'General case' 0 C--O 1.251 1.173 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.696 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 30.5 p -81.81 108.12 15.09 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 169.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 76.36 98.04 0.07 Allowed 'General case' 0 CA--C 1.496 -1.118 0 O-C-N 124.167 0.917 . . . . 0.0 109.836 -175.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.578 ' NE1' ' HG3' ' A' ' 129' ' ' LYS . 69.9 t-105 -140.02 119.83 13.42 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.362 -174.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 166' ' ' LYS . 22.7 t70 -91.01 111.82 23.45 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 174.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.405 HD12 HG21 ' A' ' 137' ' ' ILE . 8.2 tt -97.42 149.27 5.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.238 -170.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -86.47 103.07 14.66 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.398 177.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.424 ' HD1' ' O ' ' A' ' 163' ' ' GLY . 7.0 t80 -137.66 150.24 47.21 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.494 ' HB2' ' HB2' ' A' ' 88' ' ' LYS . 48.9 mt-30 -139.74 158.82 43.47 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.9 tp -141.67 130.49 22.96 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.45 0.643 . . . . 0.0 112.232 -175.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 2.3 m-20 -125.92 129.51 49.45 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 54.3 mt -130.36 131.86 65.17 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.486 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.392 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -105.42 109.95 3.35 Favored Glycine 0 N--CA 1.405 -3.391 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 156' ' ' THR . 2.6 mm? -89.13 110.18 20.95 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 32.1 m -95.5 108.97 21.24 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.572 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -114.47 152.66 31.27 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -120.25 114.35 21.76 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 175.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 49.6 mm -110.94 116.28 52.02 Favored Pre-proline 0 C--N 1.287 -2.116 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -45.82 -33.0 9.86 Favored 'Trans proline' 0 N--CA 1.485 1.009 0 C-N-CA 123.892 3.061 . . . . 0.0 113.891 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 44.6 t -69.81 -23.66 25.97 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 123.198 0.599 . . . . 0.0 112.166 -177.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 9.1 p -136.86 -33.29 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -175.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 122.01 -151.11 16.95 Favored Glycine 0 N--CA 1.434 -1.498 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.185 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -87.52 117.9 26.62 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.429 0.633 . . . . 0.0 110.647 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.4 123.36 49.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.33 0.586 . . . . 0.0 110.711 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 40.9 m -99.19 127.12 45.12 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.551 177.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.1 mp -89.68 122.1 68.45 Favored Pre-proline 0 C--N 1.318 -0.804 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -83.4 113.59 2.04 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.818 2.345 . . . . 0.0 112.362 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.557 HG13 ' H ' ' A' ' 49' ' ' VAL . 21.9 t -111.89 119.12 59.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 173.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 67.9 p -128.41 127.15 42.02 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 123.13 0.269 . . . . 0.0 111.073 -175.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.1 t -158.64 177.36 11.29 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -98.66 148.75 23.51 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.424 ' O ' ' HD1' ' A' ' 139' ' ' TYR . . . -118.62 83.32 0.35 Allowed Glycine 0 N--CA 1.416 -2.669 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -88.82 119.92 29.75 Favored 'General case' 0 C--N 1.273 -2.729 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 4.9 pt -133.66 123.11 45.01 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-O 121.304 0.573 . . . . 0.0 111.915 -175.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.524 ' HD3' ' H ' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -89.69 109.81 20.76 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.925 178.249 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -90.5 107.44 20.15 Favored Pre-proline 0 C--N 1.288 -2.101 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.077 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -86.35 94.13 0.55 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 122.654 2.236 . . . . 0.0 112.996 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 78.2 p 50.83 105.24 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.351 1.46 . . . . 0.0 114.854 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -128.78 -70.82 0.66 Allowed 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.605 ' HA ' ' SD ' ' A' ' 131' ' ' MET . 81.0 mtp180 59.08 79.29 0.23 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 114.231 1.196 . . . . 0.0 114.231 177.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 32.5 t70 172.8 -77.71 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 123.978 0.799 . . . . 0.0 111.332 173.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.431 ' O ' HG21 ' A' ' 62' ' ' VAL . 52.6 p90 -100.14 10.76 40.77 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -174.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.611 ' C ' ' HZ3' ' A' ' 129' ' ' LYS . 62.0 t80 . . . . . 0 C--N 1.3 -1.569 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.789 -176.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.303 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -171.12 89.58 0.13 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.733 0.778 . . . . 0.0 110.092 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.5 m80 -102.69 142.93 33.02 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.378 -177.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 42.9 m-70 -92.95 71.36 4.69 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.724 0.773 . . . . 0.0 110.71 174.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -146.74 92.51 2.16 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-N 114.108 -1.405 . . . . 0.0 108.402 174.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -126.28 -68.86 0.8 Allowed 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.164 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 39.7 m80 65.29 112.25 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 O-C-N 124.36 1.037 . . . . 0.0 111.788 -178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.492 ' H ' HD12 ' A' ' 8' ' ' LEU 0.331 0.0 OUTLIER -63.0 -47.48 82.93 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 179.945 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.422 ' N ' HD23 ' A' ' 8' ' ' LEU . 21.6 mm-40 -99.54 72.98 1.81 Allowed 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 122.542 1.163 . . . . 0.0 111.123 176.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.91 -165.87 1.49 Allowed 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.016 176.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 m -61.7 110.52 1.53 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.436 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . . . -57.04 -56.11 26.01 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 -170.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -65.32 -36.3 83.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.124 0.488 . . . . 0.0 110.389 -175.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -64.88 -46.11 83.17 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.682 176.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.436 ' HE2' ' HA ' ' A' ' 12' ' ' ALA . 37.1 ttpt -54.29 -49.52 69.41 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 123.977 0.911 . . . . 0.0 111.679 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.3 m -77.96 -27.3 14.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.8 -31.42 36.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 119.534 -0.867 . . . . 0.0 109.756 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -60.59 -42.18 96.21 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -59.13 -52.49 65.48 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.657 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -62.61 -44.58 95.93 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.55 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.83 -40.57 93.32 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.453 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.5 t -60.78 -44.89 96.21 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 123.439 0.462 . . . . 0.0 110.374 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.7 t -60.45 -46.0 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.213 0.53 . . . . 0.0 110.172 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.1 mm -64.95 -47.91 86.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.085 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.1 m -62.88 -29.67 70.94 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.048 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.2 t -65.19 -31.42 72.59 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 120.997 0.427 . . . . 0.0 110.207 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.2 tt -73.92 -42.1 61.1 Favored 'General case' 0 C--O 1.246 0.916 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.49 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 8.6 mp -58.89 -35.08 72.42 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.153 175.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -51.02 -49.27 60.82 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.408 ' HD2' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -75.56 -27.95 58.81 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.391 -178.316 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.408 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -77.36 -34.31 55.09 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.179 -176.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 99.5 mttt -59.14 -37.42 77.22 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 121.08 0.467 . . . . 0.0 109.779 177.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.99 -44.06 97.95 Favored Glycine 0 N--CA 1.431 -1.661 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.758 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -80.47 -39.27 28.38 Favored 'General case' 0 C--O 1.198 -1.648 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.685 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -58.57 -31.7 68.23 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.4 -37.38 83.02 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.754 0.311 . . . . 0.0 111.799 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -116.9 -48.32 2.66 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -175.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -69.56 -48.55 59.9 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 122.364 1.078 . . . . 0.0 109.195 -169.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.443 HD21 HG21 ' A' ' 44' ' ' THR . 39.4 mt -88.51 0.87 55.85 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.187 -171.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.17 -20.03 18.23 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.712 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -110.4 -24.9 10.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.945 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 72.1 mt -93.54 142.03 24.64 Favored Pre-proline 0 N--CA 1.431 -1.395 0 N-CA-C 106.789 -1.559 . . . . 0.0 106.789 177.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -67.24 105.25 0.99 Allowed 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 121.888 1.725 . . . . 0.0 108.376 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.443 HG21 HD21 ' A' ' 39' ' ' LEU . 4.2 m -125.11 141.46 38.6 Favored Pre-proline 0 N--CA 1.415 -2.185 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -173.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 16.8 Cg_endo -57.38 113.06 1.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.903 1.735 . . . . 0.0 111.079 176.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -96.84 121.98 39.3 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.185 0.517 . . . . 0.0 110.396 -174.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.412 ' HB2' HD23 ' A' ' 145' ' ' LEU . . . -98.71 157.88 15.98 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.076 -179.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -148.72 129.1 13.84 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.924 176.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.0 p -113.69 137.16 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 175.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -151.04 -35.67 0.14 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.735 -168.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -116.61 147.59 41.74 Favored 'General case' 0 CA--C 1.463 -2.373 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.49 -173.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.511 HG23 ' CB ' ' A' ' 64' ' ' TYR . 8.2 p -150.85 103.05 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.404 -2.765 0 CA-C-O 122.58 1.181 . . . . 0.0 107.885 175.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -96.51 129.56 43.86 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.095 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 44.3 p90 -59.62 122.19 13.48 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.261 0.553 . . . . 0.0 111.026 175.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -85.43 -56.05 3.71 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.138 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.48 -137.63 2.59 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -178.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.1 p -112.65 141.85 26.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.6 m -114.53 166.1 12.06 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -55.84 -54.83 39.77 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -99.25 -62.84 1.18 Allowed 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.635 -177.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -108.64 -130.07 6.08 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 175.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.555 HG21 ' CZ ' ' A' ' 173' ' ' PHE . 7.1 p -140.16 137.38 37.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.269 0.557 . . . . 0.0 111.271 177.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -104.04 122.97 46.36 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.789 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.511 ' CB ' HG23 ' A' ' 52' ' ' VAL . 3.7 m-30 -109.09 167.33 10.18 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.27 0.557 . . . . 0.0 110.665 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -106.29 106.79 17.47 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.08 144.87 26.69 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.604 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.518 ' HZ3' ' HB2' ' A' ' 67' ' ' LYS . 4.5 ttmp? -107.83 125.12 51.06 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.042 178.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.2 t -126.89 107.78 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 176.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.5 m -98.57 139.7 33.91 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 110' ' ' THR . 22.8 t -124.56 127.13 72.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.486 -178.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -110.85 117.7 34.13 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.542 ' HB3' ' O ' ' A' ' 107' ' ' GLY . 37.0 t30 -118.99 127.13 26.69 Favored Pre-proline 0 CA--C 1.507 -0.676 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.088 -173.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -94.01 96.02 0.13 Allowed 'Trans proline' 0 N--CA 1.428 -2.326 0 C-N-CA 121.42 1.414 . . . . 0.0 110.074 169.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.434 ' HB2' HD22 ' A' ' 72' ' ' ASN . 42.7 m-85 175.81 162.27 0.32 Allowed 'General case' 0 CA--C 1.492 -1.273 0 C-N-CA 129.173 2.989 . . . . 0.0 104.21 -178.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 51.7 p -100.85 -16.43 17.26 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.605 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -79.77 149.92 30.94 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 121.573 0.701 . . . . 0.0 112.048 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.8 p -80.38 104.97 11.29 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.433 172.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 52.9 mt -91.05 117.61 68.01 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -85.34 152.46 10.62 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.945 1.763 . . . . 0.0 112.531 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.533 ' H ' HD12 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -88.29 143.7 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.598 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 51.0 t -78.47 -35.52 46.49 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -170.23 157.22 6.17 Favored 'General case' 0 C--O 1.252 1.223 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.5 mt -118.33 115.62 48.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 171.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 20.8 p -112.81 118.57 35.31 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.316 -176.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 96' ' ' SER . 37.9 p90 -104.15 143.2 33.25 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 58.2 mt -132.76 108.08 12.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 173.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.466 ' O ' HD12 ' A' ' 87' ' ' LEU . 4.2 pp -105.55 134.44 48.67 Favored 'General case' 0 C--N 1.282 -2.369 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.359 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.442 ' HA ' HG21 ' A' ' 94' ' ' ILE . 40.3 ttmt -110.93 123.98 51.21 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.06 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.456 ' OG ' ' HB2' ' A' ' 122' ' ' SER . 53.2 p -104.26 98.63 8.4 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 64.5 -79.94 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.264 1.426 . . . . 0.0 114.819 174.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.8 t -135.11 -29.65 1.1 Allowed 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -172.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -143.91 145.63 32.41 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.582 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 m 71.19 130.41 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.197 0 O-C-N 125.28 1.612 . . . . 0.0 110.836 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.522 HD13 ' C ' ' A' ' 94' ' ' ILE . 1.8 pp -127.4 165.35 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.11 122.02 36.72 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 61.3 p -120.81 147.19 45.7 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -163.37 144.98 10.01 Favored Glycine 0 N--CA 1.432 -1.626 0 C-N-CA 119.844 -1.17 . . . . 0.0 112.248 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.8 p -107.97 115.63 30.48 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.5 tt -101.81 114.45 65.58 Favored Pre-proline 0 C--N 1.307 -1.25 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.764 177.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -85.71 129.49 3.56 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 122.617 2.211 . . . . 0.0 111.457 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.9 t70 50.45 79.38 0.35 Allowed Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 124.608 1.163 . . . . 0.0 113.21 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -99.71 2.45 0.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.126 2.55 . . . . 0.0 112.09 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 151.94 -166.62 30.97 Favored Glycine 0 N--CA 1.42 -2.382 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.3 p -137.76 155.7 48.77 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.255 0.55 . . . . 0.0 110.763 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.496 ' HA ' HG21 ' A' ' 111' ' ' THR . 6.3 tt -90.64 125.36 35.63 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 33.7 m -65.36 -30.7 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -172.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.542 ' O ' ' HB3' ' A' ' 72' ' ' ASN . . . 135.26 -113.24 1.09 Allowed Glycine 0 N--CA 1.417 -2.598 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -176.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.8 p -91.85 97.85 11.24 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 124.25 1.02 . . . . 0.0 111.136 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 140.53 -164.07 26.37 Favored Glycine 0 N--CA 1.418 -2.555 0 C-N-CA 119.947 -1.12 . . . . 0.0 111.485 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 11.0 t -95.7 139.94 31.23 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-O 121.919 0.866 . . . . 0.0 111.104 -178.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.496 HG21 ' HA ' ' A' ' 105' ' ' LEU . 4.9 t -134.78 121.0 20.09 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 176.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.7 t -87.74 110.45 20.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.582 -177.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.3 mt -97.48 162.29 13.38 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -141.54 144.02 34.07 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.479 -0.489 . . . . 0.0 111.46 -175.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 51.7 t -135.01 136.41 24.92 Favored Pre-proline 0 C--O 1.241 0.606 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.557 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -79.5 111.34 2.81 Favored 'Trans proline' 0 N--CA 1.432 -2.135 0 N-CA-C 107.586 -1.736 . . . . 0.0 107.586 168.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 24.6 m -112.67 133.88 57.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -89.01 92.0 9.06 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.783 0.802 . . . . 0.0 110.183 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.528 ' C ' ' H ' ' A' ' 121' ' ' TYR . 3.2 m -95.24 149.73 4.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.383 -172.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.52 ' HB3' ' CE1' ' A' ' 174' ' ' PHE . . . 74.36 -20.15 0.33 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.54 0.736 . . . . 0.0 111.87 175.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.528 ' H ' ' C ' ' A' ' 119' ' ' VAL . 21.4 t80 -46.11 -45.29 16.29 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 126.461 1.904 . . . . 0.0 109.782 176.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.456 ' HB2' ' OG ' ' A' ' 89' ' ' SER . 18.0 m -68.21 -52.42 34.44 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-N 115.275 -0.875 . . . . 0.0 113.039 -174.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 12.6 tt -74.61 -36.08 39.86 Favored 'Isoleucine or valine' 0 C--O 1.251 1.178 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -174.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.38 -50.66 72.71 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 122.269 0.227 . . . . 0.0 111.294 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.2 m -72.7 -22.67 20.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.9 t -77.27 -69.86 0.5 Allowed 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.808 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -124.1 -23.72 4.51 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -177.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.488 ' HE2' ' OXT' ' A' ' 174' ' ' PHE . 0.0 OUTLIER 66.3 -176.55 0.19 Allowed 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -177.223 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.473 ' HD2' ' O ' ' A' ' 128' ' ' MET . 12.2 mmmm -133.31 -71.25 0.52 Allowed 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 178.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.8 t70 152.85 80.93 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 128.978 2.911 . . . . 0.0 104.419 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -91.31 115.47 28.06 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.509 -178.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 169' ' ' SER . 83.1 m -131.09 -81.04 0.53 Allowed 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -178.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 41.5 p -142.01 116.86 9.86 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 123.287 0.635 . . . . 0.0 109.915 -169.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.6 t70 59.97 82.07 0.16 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 122.08 0.943 . . . . 0.0 109.419 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -140.86 158.96 43.22 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.5 -172.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -147.72 154.89 41.14 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 118.683 0.674 . . . . 0.0 110.864 175.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.5 tt -148.63 149.68 14.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.139 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -114.14 134.17 55.08 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -125.49 170.76 11.09 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 178.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -119.17 137.41 53.63 Favored 'General case' 0 C--N 1.273 -2.741 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.297 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 28.5 tp -119.57 128.23 53.71 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.975 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.611 ' OD1' ' HB3' ' A' ' 160' ' ' SER . 17.1 t70 -130.71 112.2 12.87 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 35.4 mt -113.31 122.57 67.7 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.31 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.962 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -106.68 101.95 1.81 Allowed Glycine 0 N--CA 1.398 -3.892 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 156' ' ' THR . 0.8 OUTLIER -91.77 143.07 26.91 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.87 174.289 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.8 m -114.4 111.34 21.29 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.316 -175.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.491 ' CE1' HG23 ' A' ' 80' ' ' ILE . 90.1 m-85 -106.71 163.43 12.92 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 172.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -146.64 131.44 18.01 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.357 177.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.26 135.71 15.28 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 176.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -48.92 -18.34 1.64 Allowed 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 124.393 3.395 . . . . 0.0 114.927 -178.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 55.7 t -57.23 -39.07 65.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 121.133 0.492 . . . . 0.0 110.332 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 5.8 p -136.69 -36.15 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.238 0.542 . . . . 0.0 111.238 -178.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 120.53 -142.52 15.89 Favored Glycine 0 N--CA 1.419 -2.499 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -178.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -92.04 126.45 37.13 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.164 0.507 . . . . 0.0 110.01 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.405 ' N ' HD13 ' A' ' 155' ' ' ILE . 0.2 OUTLIER -139.85 133.56 36.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.37 176.849 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 11.4 t -100.5 147.98 25.29 Favored 'General case' 0 N--CA 1.412 -2.345 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 173.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 60.0 mt -110.48 109.35 58.25 Favored Pre-proline 0 C--N 1.291 -1.94 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.414 ' HB3' HD23 ' A' ' 28' ' ' LEU . 17.1 Cg_exo -70.82 102.64 1.22 Allowed 'Trans proline' 0 C--O 1.244 0.806 0 C-N-CA 122.693 2.262 . . . . 0.0 111.376 177.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 142' ' ' ASP . 14.2 t -103.83 108.77 25.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.611 ' HB3' ' OD1' ' A' ' 142' ' ' ASP . 52.1 p -109.04 150.89 27.11 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.817 -177.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.8 t -168.07 151.97 6.11 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -107.69 119.23 38.84 Favored 'General case' 0 N--CA 1.42 -1.934 0 C-N-CA 119.296 -0.962 . . . . 0.0 109.345 174.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -92.96 118.76 5.7 Favored Glycine 0 N--CA 1.409 -3.126 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.696 -174.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -89.68 119.59 30.23 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 176.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.3 pt -129.59 111.95 23.38 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 CA-C-O 121.521 0.677 . . . . 0.0 111.524 -174.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -78.85 130.11 35.31 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.604 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 87.7 mt -106.39 109.17 62.94 Favored Pre-proline 0 C--N 1.293 -1.859 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.006 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.8 172.05 17.03 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.185 1.924 . . . . 0.0 111.765 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 49.1 p -53.28 105.65 0.14 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 123.253 0.621 . . . . 0.0 111.495 175.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.402 HD22 ' O ' ' A' ' 169' ' ' SER . 79.7 mt -137.38 -50.31 0.62 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 62.75 113.93 0.02 OUTLIER 'General case' 0 C--N 1.355 0.843 0 O-C-N 124.213 0.945 . . . . 0.0 112.815 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 33.1 t70 87.23 8.95 0.18 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.762 1.225 . . . . 0.0 111.094 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.555 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 72.5 t80 -80.63 -40.09 26.26 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.34 174.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.52 ' CE1' ' HB3' ' A' ' 120' ' ' ALA . 72.1 t80 . . . . . 0 C--N 1.313 -0.99 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.471 ' O ' HG23 ' A' ' 17' ' ' VAL . 7.8 m-20 . . . . . 0 N--CA 1.475 0.776 0 CA-C-O 120.928 0.394 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.22 -40.66 86.53 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -177.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -70.28 -53.81 15.29 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.955 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.409 ' HA ' ' CG ' ' A' ' 19' ' ' GLU . 33.4 m -62.7 -27.96 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.543 HG11 ' O ' ' A' ' 94' ' ' ILE . 73.3 t -62.92 -41.23 91.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.024 175.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -66.93 -36.3 81.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.79 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.409 ' CG ' ' HA ' ' A' ' 16' ' ' VAL . 7.5 mm-40 -53.3 -54.0 42.8 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.36 0.664 . . . . 0.0 109.719 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -65.94 -47.86 73.29 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.258 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.69 -43.48 80.53 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.095 -176.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -57.19 -45.81 83.39 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 123.59 0.556 . . . . 0.0 111.045 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.01 -42.02 79.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.431 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 73.9 mt -58.22 -46.97 88.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.891 177.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.7 m -61.99 -30.87 71.24 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.868 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.6 m -67.69 -40.18 84.38 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.076 0.465 . . . . 0.0 110.575 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.643 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 6.5 tt -72.74 -33.62 66.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.071 0.462 . . . . 0.0 109.993 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 96.5 mt -65.86 -38.72 89.57 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.428 0.632 . . . . 0.0 109.485 175.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -66.31 -34.38 77.85 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.225 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.643 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -64.11 -33.55 76.02 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-O 121.533 0.682 . . . . 0.0 109.432 178.264 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.561 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -77.64 -32.47 53.36 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.933 -178.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -53.46 -52.91 57.98 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.21 -24.93 75.66 Favored Glycine 0 N--CA 1.468 0.806 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.667 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.612 ' CZ ' ' HD2' ' A' ' 38' ' ' LYS . 10.9 t80 -68.79 -40.1 79.78 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 124.165 0.986 . . . . 0.0 110.263 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.495 ' CD1' HD12 ' A' ' 39' ' ' LEU . 20.2 m-85 -62.27 -45.57 92.68 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.313 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.74 -48.72 63.54 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 124.505 1.128 . . . . 0.0 113.061 -174.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -104.61 -36.13 7.59 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 119.414 -0.914 . . . . 0.0 113.349 -176.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.612 ' HD2' ' CZ ' ' A' ' 34' ' ' PHE . 21.6 ttmm -87.01 -43.49 12.3 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.342 -173.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.495 HD12 ' CD1' ' A' ' 35' ' ' PHE . 22.7 mt -87.28 19.04 3.37 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.204 -0.998 . . . . 0.0 111.907 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.89 -18.24 13.98 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -107.46 -21.07 13.05 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.788 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.3 mm -111.59 107.21 56.8 Favored Pre-proline 0 N--CA 1.442 -0.845 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.454 ' HB2' ' OH ' ' A' ' 74' ' ' TYR . 24.8 Cg_exo -64.26 118.0 4.99 Favored 'Trans proline' 0 C--O 1.251 1.149 0 C-N-CA 122.643 2.229 . . . . 0.0 112.294 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.1 p -128.73 150.32 74.53 Favored Pre-proline 0 C--N 1.299 -1.629 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.213 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.484 ' HB3' ' HB2' ' A' ' 72' ' ' ASN . 34.7 Cg_endo -63.48 149.23 91.61 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.988 2.459 . . . . 0.0 112.155 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -110.85 137.79 48.06 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.448 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.529 ' O ' HG11 ' A' ' 159' ' ' VAL . . . -115.65 165.33 13.15 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.331 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.4 t -161.89 147.39 13.28 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 110.518 -0.178 . . . . 0.0 110.518 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.519 ' HB ' ' OG1' ' A' ' 161' ' ' THR . 89.8 t -91.32 140.93 15.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 174.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -116.07 -60.94 1.8 Allowed 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -175.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -161.66 165.91 27.54 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -167.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.482 HG12 ' HB2' ' A' ' 66' ' ' ALA . 26.1 m -124.15 137.72 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -96.18 126.63 41.54 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.436 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -58.61 109.19 0.75 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 168.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.51 -53.29 1.36 Allowed 'General case' 0 N--CA 1.426 -1.668 0 C-N-CA 119.029 -1.068 . . . . 0.0 112.677 -172.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.91 -172.88 31.93 Favored Glycine 0 N--CA 1.425 -2.078 0 C-N-CA 119.184 -1.484 . . . . 0.0 112.309 -174.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.459 ' HB ' ' CD1' ' A' ' 173' ' ' PHE . 12.2 p -128.77 155.69 40.85 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-O 121.129 0.49 . . . . 0.0 110.927 -175.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 48.4 m -125.88 149.47 48.66 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 173.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 60' ' ' ASP . 37.3 mmt180 -79.0 77.2 5.47 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 118.621 -1.232 . . . . 0.0 112.22 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 59' ' ' ARG . 9.9 t70 171.74 -48.08 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.163 1.385 . . . . 0.0 107.668 176.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -150.19 177.95 27.97 Favored Glycine 0 C--O 1.223 -0.549 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 119' ' ' VAL . 6.5 m -87.83 156.09 3.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 118.743 1.272 . . . . 0.0 110.842 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -111.5 105.37 13.93 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.312 0.577 . . . . 0.0 109.75 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -110.64 159.76 17.29 Favored 'General case' 0 CA--C 1.48 -1.726 0 CA-C-O 122.084 0.945 . . . . 0.0 112.588 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -107.61 106.63 17.08 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.482 ' HB2' HG12 ' A' ' 52' ' ' VAL . . . -97.87 144.81 27.06 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -94.72 135.53 36.09 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.175 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.9 t -130.93 108.49 15.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 174.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.0 m -102.38 133.64 46.98 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.057 -175.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.3 t -123.32 133.33 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -119.93 128.22 53.4 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.532 HD21 ' HB2' ' A' ' 74' ' ' TYR . 6.0 t30 -142.89 114.92 5.99 Favored Pre-proline 0 C--N 1.284 -2.257 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.585 -175.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -94.17 96.17 0.13 Allowed 'Trans proline' 0 N--CA 1.422 -2.726 0 C-N-CA 121.835 1.69 . . . . 0.0 110.248 172.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.532 ' HB2' HD21 ' A' ' 72' ' ' ASN . 68.9 m-85 -176.33 127.55 0.2 Allowed 'General case' 0 CA--C 1.482 -1.671 0 C-N-CA 128.105 2.562 . . . . 0.0 104.788 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.4 m -84.32 68.83 10.35 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.442 0.639 . . . . 0.0 111.012 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -151.8 145.77 25.22 Favored 'General case' 0 N--CA 1.407 -2.612 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.82 176.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 44.6 p -86.76 101.56 13.44 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.776 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.413 ' HB ' HD22 ' A' ' 105' ' ' LEU . 28.1 mt -94.72 117.61 66.91 Favored Pre-proline 0 N--CA 1.441 -0.891 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -83.65 146.96 12.16 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 121.915 1.743 . . . . 0.0 110.59 176.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.435 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 2.1 mp -85.53 91.46 3.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.255 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.683 ' O ' ' HB ' ' A' ' 146' ' ' THR . 58.6 m -78.27 105.72 9.69 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.466 ' HB3' ' O ' ' A' ' 81' ' ' CYS . 24.7 tt0 76.3 109.66 0.07 Allowed 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.14 0.9 . . . . 0.0 111.754 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.617 ' CG2' ' HB ' ' A' ' 99' ' ' ILE . 15.5 tt -117.8 125.04 73.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.538 -0.726 . . . . 0.0 109.342 174.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.9 t -86.84 125.07 33.73 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-O 121.25 0.548 . . . . 0.0 109.86 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.545 ' OH ' ' HA ' ' A' ' 117' ' ' VAL . 56.5 t80 -107.69 120.38 42.06 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.26 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.5 mt -130.24 107.18 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 CA-C-O 122.063 0.935 . . . . 0.0 109.332 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.644 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 1.3 tm? -100.66 134.82 43.05 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 114.616 -1.174 . . . . 0.0 107.862 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.586 ' HB2' ' HB2' ' A' ' 140' ' ' GLN . 96.5 mttt -128.31 158.02 39.36 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -177.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.505 ' OG ' ' HB3' ' A' ' 122' ' ' SER . 57.5 m -143.91 97.67 3.1 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 52.71 -90.13 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 175.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.9 m -108.24 -53.99 2.56 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.097 0.475 . . . . 0.0 111.755 -171.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -126.06 154.84 42.45 Favored 'General case' 0 CA--C 1.472 -2.044 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 27.6 m 71.87 135.89 0.04 OUTLIER 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 113.363 -1.744 . . . . 0.0 112.895 175.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.644 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 38.4 pt -136.84 -179.2 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.382 0 CA-C-N 114.616 -1.175 . . . . 0.0 107.937 176.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . . . -130.75 121.31 25.19 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 172.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 36.8 p -112.49 159.06 19.15 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.534 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.21 178.3 47.55 Favored Glycine 0 N--CA 1.424 -2.15 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.9 m -146.25 120.06 9.27 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.617 ' HB ' ' CG2' ' A' ' 83' ' ' ILE . 71.5 mt -98.6 126.11 40.31 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -177.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -80.49 114.86 3.07 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.914 1.742 . . . . 0.0 111.278 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.8 t70 53.23 87.6 0.14 Allowed Pre-proline 0 N--CA 1.485 1.292 0 C-N-CA 124.937 1.295 . . . . 0.0 112.753 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.435 ' HD2' ' HB ' ' A' ' 80' ' ' ILE . 26.7 Cg_endo -91.15 -7.05 3.75 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.847 2.365 . . . . 0.0 112.188 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 160.93 -179.04 36.65 Favored Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.3 m -142.71 157.67 44.42 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.275 0.559 . . . . 0.0 111.038 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.473 HD23 ' CB ' ' A' ' 72' ' ' ASN . 7.5 mp -76.73 135.13 39.02 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.483 176.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 27.3 m -71.06 -17.5 20.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.11 113.1 1.51 Allowed Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 61.9 m 53.46 83.87 0.06 Allowed 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.916 0.886 . . . . 0.0 113.308 -177.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 155.71 -176.93 33.09 Favored Glycine 0 N--CA 1.432 -1.575 0 C-N-CA 119.956 -1.116 . . . . 0.0 112.391 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.7 t -105.38 135.71 46.26 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.5 t -139.44 130.37 26.29 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 120.865 0.364 . . . . 0.0 110.407 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.9 m -93.48 122.47 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-O 121.686 0.755 . . . . 0.0 110.024 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.9 mt -108.34 158.06 17.83 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -134.09 149.03 51.09 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 119.664 -0.815 . . . . 0.0 112.277 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.3 m -131.49 144.63 54.19 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.649 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -74.06 111.76 3.38 Favored 'Trans proline' 0 C--O 1.247 0.953 0 C-N-CA 122.12 1.88 . . . . 0.0 110.675 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.545 ' HA ' ' OH ' ' A' ' 85' ' ' TYR . 96.5 t -107.26 127.09 63.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-O 121.553 0.692 . . . . 0.0 112.814 -175.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.515 ' HE2' ' HA ' ' A' ' 118' ' ' LYS . 8.5 mmpt? -89.06 96.64 10.81 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.602 ' O ' HG22 ' A' ' 62' ' ' VAL . 99.7 t -93.52 138.94 19.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 72.19 -16.84 0.4 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.058 0.943 . . . . 0.0 111.416 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.512 ' H ' ' C ' ' A' ' 119' ' ' VAL . 53.1 t80 -51.49 -39.86 58.4 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 125.94 1.696 . . . . 0.0 110.1 176.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.505 ' HB3' ' OG ' ' A' ' 89' ' ' SER . 33.9 t -65.55 -51.79 57.26 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.557 -177.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.5 tt -67.25 -28.87 43.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.327 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.43 -50.65 62.66 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.77 -30.2 49.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.956 0.408 . . . . 0.0 110.928 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.0 t -70.69 -73.43 0.17 Allowed 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.48 HD23 ' H ' ' A' ' 127' ' ' LEU . 1.9 pt? -125.43 -41.33 2.04 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 24.1 ttt 64.15 100.03 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 124.299 1.04 . . . . 0.0 109.395 -172.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.568 ' HG3' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -48.89 -63.78 1.0 Allowed 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.732 -177.048 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.568 ' H ' ' HG3' ' A' ' 129' ' ' LYS . 21.4 t70 151.85 107.93 0.0 OUTLIER 'General case' 0 CA--C 1.471 -2.094 0 N-CA-C 102.649 -3.093 . . . . 0.0 102.649 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.471 ' HG3' ' HA ' ' A' ' 171' ' ' ARG . 13.1 tpt -53.07 123.58 12.05 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 123.519 0.512 . . . . 0.0 111.627 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 49.1 t -99.32 -158.74 0.69 Allowed 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.238 -176.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.696 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 21.8 p -131.01 114.11 14.79 Favored 'General case' 0 N--CA 1.385 -3.713 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.2 t70 70.43 89.9 0.1 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -172.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -133.58 115.74 15.05 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.522 -172.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.14 104.55 15.82 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.026 176.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.3 tt -102.2 138.2 27.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.55 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -82.49 100.14 9.9 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.753 0.787 . . . . 0.0 109.449 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.51 ' HB3' HG12 ' A' ' 165' ' ' ILE . 9.1 t80 -113.95 148.34 37.01 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.344 -176.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.586 ' HB2' ' HB2' ' A' ' 88' ' ' LYS . 1.8 mp0 -136.08 154.01 51.15 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.5 tp -141.86 123.07 14.73 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 123.246 0.618 . . . . 0.0 109.58 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -126.33 128.0 46.42 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 43.9 mt -130.4 130.34 65.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 C-N-CA 120.209 -0.596 . . . . 0.0 112.336 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 157' ' ' ILE . . . -114.88 90.76 0.54 Allowed Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.443 HD11 ' CE2' ' A' ' 147' ' ' PHE . 2.9 pp -84.57 151.54 24.46 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.897 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.683 ' HB ' ' O ' ' A' ' 81' ' ' CYS . 8.6 m -109.09 120.69 43.29 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.8 -176.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.443 ' CE2' HD11 ' A' ' 145' ' ' LEU . 73.6 m-85 -100.4 141.26 33.5 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 170.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -110.39 133.36 53.34 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 174.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.76 139.45 29.05 Favored Pre-proline 0 C--N 1.301 -1.53 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.659 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -63.46 -17.02 58.12 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.856 2.371 . . . . 0.0 112.051 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.67 -45.52 98.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.998 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 40.4 t -130.15 -78.04 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.059 0.457 . . . . 0.0 109.904 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 173.81 -112.66 0.43 Allowed Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -101.24 125.97 47.92 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.935 0.397 . . . . 0.0 111.202 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 146' ' ' THR . 34.1 pt -121.28 114.92 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 CA-C-O 121.008 0.433 . . . . 0.0 110.522 173.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.535 HG22 ' OG1' ' A' ' 146' ' ' THR . 37.9 p -96.1 105.27 17.29 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.691 175.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.466 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 60.7 mt -91.5 107.1 19.4 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 156' ' ' THR . 8.0 Cg_endo -85.42 100.74 0.69 Allowed 'Trans proline' 0 N--CA 1.43 -2.26 0 C-N-CA 122.6 2.2 . . . . 0.0 111.719 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.529 HG11 ' O ' ' A' ' 47' ' ' ALA . 18.0 m -94.74 110.03 23.19 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 CA-C-O 122.015 0.912 . . . . 0.0 109.542 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.5 p -88.89 146.13 25.12 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-N 114.352 -1.295 . . . . 0.0 111.318 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.519 ' OG1' ' HB ' ' A' ' 49' ' ' VAL . 98.5 m -146.64 127.39 14.34 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.134 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -121.4 143.07 49.42 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -164.42 -139.63 2.68 Favored Glycine 0 N--CA 1.422 -2.24 0 C-N-CA 119.728 -1.225 . . . . 0.0 112.121 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.21 148.59 15.14 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.51 HG12 ' HB3' ' A' ' 139' ' ' TYR . 47.8 mm -126.18 139.37 51.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -106.06 111.76 24.52 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.76 0.79 . . . . 0.0 110.146 175.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 15.6 tp -93.84 106.28 20.99 Favored Pre-proline 0 C--N 1.296 -1.751 0 CA-C-N 113.998 -1.455 . . . . 0.0 108.276 -174.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 167' ' ' LEU . 23.5 Cg_exo -64.65 156.89 58.65 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.416 2.744 . . . . 0.0 116.054 -171.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.696 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 31.1 p -48.41 25.32 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 129.19 2.996 . . . . 0.0 117.603 174.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 59.8 mt -71.63 -42.32 67.75 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.471 ' HA ' ' HG3' ' A' ' 131' ' ' MET . 59.8 ttt180 72.31 -27.12 0.18 Allowed 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 126.47 1.908 . . . . 0.0 112.48 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -113.74 61.2 0.66 Allowed 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 122.719 1.247 . . . . 0.0 108.121 173.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.517 ' O ' HG12 ' A' ' 62' ' ' VAL . 85.9 t80 . . . . . 0 C--N 1.298 -1.662 0 CA-C-N 113.398 -1.728 . . . . 0.0 106.569 174.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.55 ' O ' HG22 ' A' ' 17' ' ' VAL . 18.7 m-20 . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.8 -34.71 65.56 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -178.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -75.29 -54.86 6.38 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 123.45 0.7 . . . . 0.0 110.314 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.8 t -58.57 -45.81 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.05 0.94 . . . . 0.0 113.499 -174.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 13' ' ' ASP . 35.9 m -66.14 -27.28 40.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.656 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -76.6 -30.2 56.85 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.603 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -54.91 -42.99 72.88 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.509 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.28 -37.42 87.44 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.607 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.53 -36.33 82.43 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.6 t -61.91 -45.18 94.86 Favored 'General case' 0 C--O 1.252 1.231 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.859 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.03 -37.84 54.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.479 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.419 HD12 ' OG ' ' A' ' 96' ' ' SER . 79.3 mt -65.68 -41.1 89.77 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.746 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.5 t -58.41 -36.35 73.45 Favored 'General case' 0 C--O 1.243 0.715 0 O-C-N 123.54 0.525 . . . . 0.0 110.959 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.2 m -67.04 -39.58 87.0 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.053 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.551 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 5.2 tt -80.36 -40.54 26.41 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -54.09 -43.87 70.71 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.33 1.052 . . . . 0.0 109.673 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -65.0 -39.32 93.29 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.042 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.551 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -70.93 -37.41 72.87 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.077 -179.593 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.515 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -69.58 -32.46 71.23 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.662 -177.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.48 -40.24 82.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.2 175.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.14 -49.84 73.75 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.297 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.46 ' HD1' ' O ' ' A' ' 30' ' ' LYS . 10.5 m-85 -59.13 -46.89 87.18 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 120.562 0.22 . . . . 0.0 110.643 177.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.509 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 65.1 t80 -62.79 -41.16 99.15 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -176.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.3 -44.25 79.69 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -108.67 -27.65 9.7 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -173.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -101.26 -46.62 4.98 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.467 -171.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 36.8 mt -78.94 -0.48 31.14 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.79 -171.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.01 -33.15 63.67 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -101.42 -47.82 4.56 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 114.348 -1.296 . . . . 0.0 110.52 -173.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.69 126.54 92.85 Favored Pre-proline 0 C--O 1.24 0.601 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.313 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.63 106.67 0.17 Allowed 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 123.109 2.539 . . . . 0.0 112.578 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.501 HG21 HD22 ' A' ' 39' ' ' LEU . 8.3 p -130.85 166.4 27.68 Favored Pre-proline 0 N--CA 1.429 -1.484 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.725 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -79.6 138.35 13.54 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.819 2.346 . . . . 0.0 110.511 175.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -96.89 108.09 20.72 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.091 0.472 . . . . 0.0 109.823 -176.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.5 146.65 25.56 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.04 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.2 t -145.93 138.59 25.65 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 121.073 0.463 . . . . 0.0 110.553 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.446 HG13 HG23 ' A' ' 159' ' ' VAL . 12.7 m -90.53 142.55 12.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.207 175.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -130.22 -63.08 0.91 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.083 -1.047 . . . . 0.0 112.979 -174.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -161.13 164.52 30.58 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 -173.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.635 HG22 ' HB3' ' A' ' 64' ' ' TYR . 11.1 p -125.28 114.26 39.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 176.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -99.21 132.51 44.47 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -169.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.534 ' O ' ' HE3' ' A' ' 55' ' ' LYS . 50.2 p90 -58.52 129.1 40.46 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 123.969 0.793 . . . . 0.0 111.743 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.622 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -130.0 -64.57 0.86 Allowed 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.689 -173.028 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -140.39 175.27 22.09 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.983 -175.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.431 HG22 ' CD1' ' A' ' 173' ' ' PHE . 28.8 t -99.07 147.46 7.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -175.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 74.2 m -129.58 160.29 33.71 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 174.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -45.95 62.09 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -104.15 97.76 7.68 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.549 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.504 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . 85.11 -170.53 45.28 Favored Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.539 HG21 ' CE2' ' A' ' 173' ' ' PHE . 7.1 p -124.4 153.14 30.76 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -93.99 112.18 23.98 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-O 121.581 0.705 . . . . 0.0 110.957 -175.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.635 ' HB3' HG22 ' A' ' 52' ' ' VAL . 3.5 m-30 -116.17 166.17 12.33 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.452 174.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.525 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 12.2 m-70 -116.93 112.87 21.62 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.513 174.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -77.47 123.43 26.56 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.981 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -87.48 108.46 19.03 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.301 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.2 t -122.39 108.81 22.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.4 m -100.05 134.0 43.61 Favored 'General case' 0 C--N 1.284 -2.266 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.509 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.72 112.43 36.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-O 121.251 0.548 . . . . 0.0 110.13 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 39.3 ttpt -95.25 110.75 22.7 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 175.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -119.18 116.93 33.66 Favored Pre-proline 0 N--CA 1.42 -1.963 0 C-N-CA 118.64 -1.224 . . . . 0.0 111.278 -174.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -95.75 98.83 0.1 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.451 0 C-N-CA 121.756 1.637 . . . . 0.0 109.551 169.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.7 t80 178.4 108.13 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.7 m -50.88 16.66 0.0 OUTLIER 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 119.342 3.09 . . . . 0.0 119.342 -166.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -142.89 166.35 24.88 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 119.583 1.083 . . . . 0.0 111.45 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.1 p -88.51 101.13 13.63 Favored 'General case' 0 N--CA 1.417 -2.096 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 174.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.444 ' HB ' HD12 ' A' ' 105' ' ' LEU . 67.7 mt -73.65 129.58 85.12 Favored Pre-proline 0 C--N 1.31 -1.121 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.33 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.96 122.29 10.97 Favored 'Trans proline' 0 C--O 1.254 1.305 0 C-N-CA 122.726 2.284 . . . . 0.0 112.369 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.446 HG12 ' CE1' ' A' ' 147' ' ' PHE . 45.0 mt -89.91 107.87 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 57.3 m -53.98 -59.57 4.47 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 123.076 0.551 . . . . 0.0 110.37 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -165.45 150.21 8.82 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 98' ' ' THR . 15.7 tt -96.69 124.32 49.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 174.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.422 ' HA ' HG22 ' A' ' 98' ' ' THR . 48.0 m -100.61 118.66 37.21 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -175.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -119.91 139.86 51.77 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.293 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.448 ' HB ' ' HB2' ' A' ' 142' ' ' ASP . 64.7 mt -123.87 108.37 20.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 171.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.6 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 1.5 tm? -91.65 122.43 34.21 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -125.56 140.01 53.11 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -175.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 122' ' ' SER . 30.2 t -104.98 145.66 30.12 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.959 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.52 -12.93 55.61 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.872 175.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 68.8 p -97.51 17.8 16.82 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.152 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 81.21 163.01 0.16 Allowed 'General case' 0 C--O 1.25 1.081 0 C-N-CA 125.542 1.537 . . . . 0.0 111.984 -176.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.492 ' O ' ' HB3' ' A' ' 122' ' ' SER . 53.9 m 72.24 137.84 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.726 1.21 . . . . 0.0 110.259 -174.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.6 pp -129.87 172.75 15.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.6 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . . . -127.11 121.78 32.38 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 174.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.419 ' OG ' HD12 ' A' ' 24' ' ' ILE . 23.0 t -134.62 158.25 44.52 Favored 'General case' 0 C--N 1.282 -2.352 0 C-N-CA 118.641 -1.224 . . . . 0.0 110.726 -176.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.54 179.53 44.26 Favored Glycine 0 N--CA 1.429 -1.831 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.422 HG22 ' HA ' ' A' ' 84' ' ' SER . 23.0 p -135.11 134.17 39.99 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.747 0.273 . . . . 0.0 110.519 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.4 ' HB ' HG22 ' A' ' 83' ' ' ILE . 3.4 mp -104.79 107.35 58.18 Favored Pre-proline 0 C--O 1.244 0.782 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.475 174.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -66.05 121.8 9.21 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.736 2.291 . . . . 0.0 110.387 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 53.85 78.66 0.38 Allowed Pre-proline 0 N--CA 1.483 1.22 0 C-N-CA 123.921 0.888 . . . . 0.0 111.572 -175.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -97.96 6.01 1.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.932 2.421 . . . . 0.0 112.689 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 164.9 -168.76 39.26 Favored Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 56.1 m -143.27 159.13 42.89 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 120.795 0.331 . . . . 0.0 110.291 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.451 ' HA ' HG21 ' A' ' 111' ' ' THR . 82.7 mt -88.71 156.83 18.77 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.502 177.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 27.7 m -99.1 1.79 10.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 121.016 0.436 . . . . 0.0 111.841 -176.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.21 -52.22 4.63 Favored Glycine 0 C--O 1.217 -0.96 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.905 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.5 t -146.23 103.35 3.7 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 150.29 -175.0 29.54 Favored Glycine 0 N--CA 1.421 -2.359 0 C-N-CA 120.291 -0.957 . . . . 0.0 111.376 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 25.6 m -102.67 108.32 19.54 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.451 HG21 ' HA ' ' A' ' 105' ' ' LEU . 5.5 t -99.98 114.52 27.85 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 121.766 0.793 . . . . 0.0 109.466 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.2 t -85.36 113.76 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.5 mt -96.17 147.8 23.37 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 7.2 p-10 -136.91 123.03 20.38 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.443 0.639 . . . . 0.0 110.696 -176.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 69.3 t -102.26 122.22 47.49 Favored Pre-proline 0 C--N 1.299 -1.604 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.225 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -68.51 109.97 2.18 Favored 'Trans proline' 0 N--CA 1.439 -1.703 0 N-CA-C 105.815 -2.417 . . . . 0.0 105.815 167.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.7 p -126.94 148.39 31.76 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -172.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 118' ' ' LYS . 9.0 mmpt? -88.86 98.26 11.63 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.457 HG12 HD21 ' A' ' 87' ' ' LEU . 10.6 m -94.65 149.02 4.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.678 ' HA ' HD13 ' A' ' 123' ' ' ILE . . . 72.15 0.72 3.67 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.031 0.533 . . . . 0.0 111.359 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -59.93 -51.26 70.46 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 173.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' ' 93' ' ' THR . 15.1 m -62.37 -27.44 69.07 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.152 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.678 HD13 ' HA ' ' A' ' 120' ' ' ALA . 2.6 mp -79.1 -47.8 22.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.905 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.78 -36.93 82.5 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.351 0.407 . . . . 0.0 110.994 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 54.0 t -65.68 -37.27 79.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.997 176.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 63.0 m -82.42 -75.81 0.29 Allowed 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.424 HD12 ' N ' ' A' ' 128' ' ' MET . 2.6 pp -124.56 -23.3 4.43 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -173.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.534 ' HG3' ' H ' ' A' ' 130' ' ' ASP . 11.7 tpt 74.51 133.56 0.05 OUTLIER 'General case' 0 C--O 1.211 -0.971 0 C-N-CA 123.944 0.898 . . . . 0.0 112.039 -177.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.703 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -87.54 7.54 29.08 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.757 -175.293 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.534 ' H ' ' HG3' ' A' ' 128' ' ' MET . 10.3 m-20 67.74 -0.84 1.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 172.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.408 ' HA ' ' CE ' ' A' ' 131' ' ' MET . 0.0 OUTLIER 62.84 30.31 16.62 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.216 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 53.4 t -56.26 129.96 42.49 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 123.675 0.61 . . . . 0.0 109.998 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 52.5 p -77.82 130.52 36.78 Favored 'General case' 0 N--CA 1.414 -2.258 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.454 ' H ' ' H ' ' A' ' 169' ' ' SER . 34.7 m-20 65.22 82.33 0.19 Allowed 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -174.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.548 ' HE1' ' HB2' ' A' ' 129' ' ' LYS . 64.0 t-105 -155.03 156.62 36.25 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.173 -170.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -148.5 148.05 29.79 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 176.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.9 tt -142.1 147.92 20.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.226 -174.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -63.14 122.14 15.37 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-O 121.931 0.872 . . . . 0.0 112.463 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.441 ' HE1' ' CD2' ' A' ' 87' ' ' LEU . 4.8 t80 -139.35 145.4 38.97 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.135 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 162' ' ' GLN . 68.2 mt-30 -141.17 155.43 46.07 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.083 -0.385 . . . . 0.0 110.738 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.429 HD13 HG13 ' A' ' 143' ' ' ILE . 1.7 pp -139.12 151.31 46.57 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-O 121.245 0.545 . . . . 0.0 110.815 173.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.448 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 10.3 m-20 -133.19 111.96 11.32 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 173.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.429 HG13 HD13 ' A' ' 141' ' ' LEU . 60.8 mt -125.06 138.28 54.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.17 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 157' ' ' ILE . . . -121.54 130.18 8.02 Favored Glycine 0 N--CA 1.418 -2.526 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.084 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 156' ' ' THR . 2.7 mm? -97.75 111.11 23.53 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.0 m -97.24 112.35 24.19 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.556 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.446 ' CE1' HG12 ' A' ' 80' ' ' ILE . 91.7 m-85 -115.19 140.07 49.4 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 154' ' ' ASP . 29.0 t70 -93.97 109.06 20.81 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 66.3 mt -118.99 117.5 33.57 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -52.48 -19.15 9.42 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 124.172 3.248 . . . . 0.0 114.982 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.24 -29.17 31.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 120.861 0.362 . . . . 0.0 111.009 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 61.1 t -131.94 -53.25 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.271 0.557 . . . . 0.0 110.725 -176.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 142.45 -155.59 25.77 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 108.451 -1.859 . . . . 0.0 108.451 -176.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 148' ' ' ASP . 4.9 p-10 -86.48 117.66 25.4 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 117.908 0.854 . . . . 0.0 109.748 175.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 2.1 pp -128.24 141.2 47.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.473 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 37.7 m -99.43 123.92 44.12 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.437 -178.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.415 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 2.0 mp -86.57 112.0 43.5 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 174.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -86.7 114.95 1.22 Allowed 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.672 2.248 . . . . 0.0 113.18 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.446 HG23 HG13 ' A' ' 49' ' ' VAL . 9.9 m -125.74 127.86 71.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.251 176.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.4 t -128.28 156.31 43.22 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.658 -174.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.1 t -166.55 149.16 6.73 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 140' ' ' GLN . 28.8 pt20 -100.26 127.53 46.53 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 172.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -113.28 133.14 11.08 Favored Glycine 0 N--CA 1.405 -3.393 0 C-N-CA 119.924 -1.131 . . . . 0.0 112.811 -172.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -101.95 120.12 39.89 Favored 'General case' 0 C--N 1.269 -2.9 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.3 pt -114.9 111.69 36.92 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 CA-C-O 121.75 0.786 . . . . 0.0 110.89 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.534 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 4.9 ttmp? -81.06 119.75 23.94 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.712 -177.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.9 tt -102.24 98.8 11.12 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 166' ' ' LYS . 1.4 Cg_endo -83.57 81.27 2.29 Favored 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 122.677 2.251 . . . . 0.0 112.561 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 46.6 t 70.81 -76.48 0.06 Allowed 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.654 -1.157 . . . . 0.0 113.602 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.432 ' HG ' ' CD2' ' A' ' 173' ' ' PHE . 3.6 mm? 63.89 -65.7 0.12 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.28 1.032 . . . . 0.0 113.088 -176.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 63.9 91.62 0.07 Allowed 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.578 1.151 . . . . 0.0 110.405 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 74.37 90.76 0.08 Allowed 'General case' 0 CA--C 1.491 -1.317 0 C-N-CA 124.709 1.204 . . . . 0.0 109.349 -176.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.539 ' CE2' HG21 ' A' ' 62' ' ' VAL . 77.6 t80 . . . . . 0 C--N 1.284 -2.245 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 -175.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.4 t70 . . . . . 0 CA--C 1.517 -0.29 0 CA-C-O 120.733 0.301 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.424 ' OE1' HG23 ' A' ' 93' ' ' THR . 12.4 mm-40 -54.6 -41.52 70.05 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.301 0.572 . . . . 0.0 110.84 176.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -65.52 -53.45 42.06 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.521 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.6 m -64.32 -33.72 64.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.8 t -69.6 -45.44 78.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 176.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -58.67 -48.0 82.55 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.094 -176.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.481 ' O ' HG23 ' A' ' 23' ' ' VAL . 12.3 pt-20 -66.37 -40.61 89.85 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.149 -177.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -64.4 -40.93 96.74 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.59 -37.16 85.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.252 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.3 t -66.18 -44.07 85.04 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.32 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 19' ' ' GLU . 89.3 t -59.97 -43.84 93.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 CA-C-O 121.044 0.45 . . . . 0.0 110.018 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.449 HG21 HD11 ' A' ' 86' ' ' ILE . 65.5 mt -70.95 -35.58 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.66 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.3 t -60.64 -41.36 94.75 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 122.267 -0.271 . . . . 0.0 110.294 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.527 ' HA ' ' OD2' ' A' ' 29' ' ' ASP . 50.9 m -65.32 -29.12 69.84 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.355 0.597 . . . . 0.0 110.384 176.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.659 ' O ' ' HB3' ' A' ' 30' ' ' LYS . 4.5 tt -69.97 -38.33 76.03 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 175.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.545 ' O ' ' HG3' ' A' ' 32' ' ' LYS 0.34 7.8 mp -67.37 -27.79 67.4 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 119.149 -1.02 . . . . 0.0 113.094 175.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.527 ' OD2' ' HA ' ' A' ' 26' ' ' SER . 53.1 m-20 -61.04 -45.44 94.76 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 172.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.659 ' HB3' ' O ' ' A' ' 27' ' ' LEU . 21.0 ttmm -54.99 -51.39 66.37 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.913 173.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.07 -44.77 91.89 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.44 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 95.0 mttt -60.07 -32.21 70.73 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.94 0.496 . . . . 0.0 110.33 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.498 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -62.67 -51.32 56.77 Favored Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.723 177.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -72.83 -38.64 67.06 Favored 'General case' 0 C--O 1.203 -1.393 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.752 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -62.41 -35.41 79.13 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -175.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.65 -27.1 64.76 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.655 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.502 ' HG3' ' N ' ' A' ' 38' ' ' LYS . 8.6 pt-20 -112.09 -57.28 2.29 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -175.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.502 ' N ' ' HG3' ' A' ' 37' ' ' GLU . 8.9 tppt? -73.69 -48.23 33.69 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-O 122.757 1.265 . . . . 0.0 109.803 -164.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.463 ' CD1' HG12 ' A' ' 157' ' ' ILE . 69.4 mt -83.07 4.86 24.47 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 113.11 -1.859 . . . . 0.0 111.575 -171.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.91 -7.9 11.96 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.981 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -110.42 -39.7 4.86 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.176 0.513 . . . . 0.0 110.19 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.438 HD12 ' HG3' ' A' ' 38' ' ' LYS . 54.7 mt -91.53 139.53 25.14 Favored Pre-proline 0 N--CA 1.432 -1.344 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.13 98.3 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.831 1.688 . . . . 0.0 108.328 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 m -127.62 148.94 68.81 Favored Pre-proline 0 C--N 1.297 -1.682 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -172.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.579 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 9.4 Cg_endo -51.88 129.06 28.86 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.857 2.372 . . . . 0.0 112.112 176.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 43.3 mt-10 -115.02 113.24 23.82 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.929 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.421 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . . . -108.5 148.54 30.1 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.464 -176.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.1 t -154.74 142.93 20.33 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.766 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.616 ' H ' HG11 ' A' ' 159' ' ' VAL . 11.7 p -108.39 141.09 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 176.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -157.04 -23.04 0.09 Allowed 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.646 -171.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.689 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . 9.6 t0 -121.26 117.23 26.5 Favored 'General case' 0 CA--C 1.485 -1.547 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.24 -168.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.663 HG12 ' CD2' ' A' ' 64' ' ' TYR . 48.4 t -119.36 110.64 30.2 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -130.03 127.97 41.04 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.186 -175.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 51.1 p90 -64.75 139.26 58.74 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -176.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.646 ' HD3' ' HB2' ' A' ' 65' ' ' HIS . 14.7 mmmm -88.51 -24.85 22.82 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.392 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.49 -158.55 31.46 Favored Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.4 m -101.03 145.84 10.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 117.134 0.467 . . . . 0.0 111.27 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.3 m -155.06 135.54 13.36 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -75.84 -42.25 50.13 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -173.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -61.94 -56.58 17.69 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.702 0.763 . . . . 0.0 110.808 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.431 ' HA3' ' HB2' ' A' ' 121' ' ' TYR . . . -160.81 137.3 4.89 Favored Glycine 0 N--CA 1.409 -3.126 0 N-CA-C 107.022 -2.431 . . . . 0.0 107.022 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.522 HG11 ' CZ ' ' A' ' 173' ' ' PHE . 23.3 t -72.79 131.86 34.23 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-N 117.209 0.505 . . . . 0.0 110.115 -173.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -81.79 117.21 21.91 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.899 -177.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.663 ' CD2' HG12 ' A' ' 52' ' ' VAL . 9.4 m-85 -118.09 154.55 31.89 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.646 ' HB2' ' HD3' ' A' ' 55' ' ' LYS . 49.9 t-80 -91.03 108.43 19.86 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 176.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -91.71 107.56 19.29 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.689 ' HB3' ' HB3' ' A' ' 51' ' ' ASP . 40.4 ttmt -87.38 110.97 20.63 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.907 0.384 . . . . 0.0 110.557 -176.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.4 t -113.15 108.38 25.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.41 ' HB3' HG12 ' A' ' 112' ' ' VAL . 42.6 p -102.7 140.36 37.08 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.883 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 3.1 p -142.02 126.56 16.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.927 -178.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 45' ' ' PRO . 25.5 pttm -99.15 141.73 31.53 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 174.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -134.39 116.89 13.15 Favored Pre-proline 0 C--N 1.287 -2.141 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.641 -174.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -91.8 95.52 0.2 Allowed 'Trans proline' 0 N--CA 1.42 -2.838 0 N-CA-C 109.106 -1.152 . . . . 0.0 109.106 170.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.514 ' HB3' ' HG2' ' A' ' 76' ' ' GLN . 50.1 m-85 170.54 130.14 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 129.19 2.996 . . . . 0.0 104.723 -176.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.8 m -81.96 -2.78 52.59 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 118.362 0.528 . . . . 0.0 112.104 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.514 ' HG2' ' HB3' ' A' ' 74' ' ' TYR . 13.1 pt20 -83.2 132.08 35.08 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 121.206 0.527 . . . . 0.0 111.095 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.4 p -75.95 93.78 3.29 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 172.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.455 ' HB ' ' CD2' ' A' ' 105' ' ' LEU . 75.0 mt -72.66 123.37 89.47 Favored Pre-proline 0 C--N 1.3 -1.553 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.007 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -79.12 118.26 4.0 Favored 'Trans proline' 0 N--CA 1.44 -1.644 0 C-N-CA 122.115 1.877 . . . . 0.0 110.856 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.416 ' N ' HD12 ' A' ' 80' ' ' ILE . 2.4 mp -72.44 111.53 6.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 57.0 m -50.31 -59.08 4.33 Favored 'General case' 0 C--O 1.244 0.791 0 O-C-N 123.899 0.749 . . . . 0.0 111.204 -176.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -150.94 154.02 36.35 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.537 HG22 ' HB ' ' A' ' 99' ' ' ILE . 11.1 tp -104.1 124.08 58.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 174.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.424 ' HB2' HG21 ' A' ' 24' ' ' ILE . 65.7 p -95.07 118.62 32.18 Favored 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 119.529 -0.869 . . . . 0.0 109.883 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.519 ' CE2' HG12 ' A' ' 117' ' ' VAL . 15.5 t80 -104.16 121.39 43.16 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 126.238 1.815 . . . . 0.0 111.067 -169.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' A' ' 142' ' ' ASP . 3.2 mp -127.25 108.08 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.605 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 1.8 tm? -101.71 121.58 42.31 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.552 ' HA ' HG22 ' A' ' 94' ' ' ILE . 39.8 ttmt -127.25 133.59 50.19 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 120.158 -0.617 . . . . 0.0 112.372 -175.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.5 m -123.18 147.3 47.0 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.434 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.98 -0.19 2.21 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.5 p -90.83 16.33 9.55 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 123.461 0.704 . . . . 0.0 110.834 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 70.86 -41.63 0.51 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 125.972 1.709 . . . . 0.0 113.388 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.594 ' O ' ' HB3' ' A' ' 122' ' ' SER . 99.9 m -62.26 137.75 58.31 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.605 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 47.1 pt -137.55 178.23 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.254 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.531 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . . . -127.88 130.11 48.0 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 174.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.7 t -126.78 147.13 50.02 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.89 172.21 37.14 Favored Glycine 0 N--CA 1.42 -2.403 0 C-N-CA 119.818 -1.182 . . . . 0.0 112.426 -176.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 63.2 m -153.07 109.76 3.43 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.537 ' HB ' HG22 ' A' ' 83' ' ' ILE . 3.1 mp -103.47 110.03 63.03 Favored Pre-proline 0 N--CA 1.467 0.424 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.674 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -68.11 127.45 15.97 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.611 2.207 . . . . 0.0 109.727 173.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.0 t70 57.29 81.42 0.26 Allowed Pre-proline 0 N--CA 1.482 1.154 0 CA-C-O 121.674 0.749 . . . . 0.0 110.234 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.448 ' HG3' ' HB ' ' A' ' 83' ' ' ILE . 22.7 Cg_endo -107.72 13.74 0.13 Allowed 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 123.028 2.485 . . . . 0.0 113.088 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 152.78 -172.26 31.85 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.6 p -135.2 143.72 46.55 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.957 0.378 . . . . 0.0 110.719 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.455 ' CD2' ' HB ' ' A' ' 78' ' ' ILE . 19.9 tp -82.42 129.48 34.9 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.549 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 11.6 p -57.61 -35.05 48.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -174.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.97 118.68 0.1 OUTLIER Glycine 0 CA--C 1.54 1.615 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.541 -174.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 34.5 t 67.56 11.51 8.41 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.669 1.188 . . . . 0.0 113.137 175.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -150.8 -164.52 12.05 Favored Glycine 0 CA--C 1.496 -1.141 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.558 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 10.0 t -116.68 138.54 51.38 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.549 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 7.0 t -133.65 138.8 46.1 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.03 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.41 HG12 ' HB3' ' A' ' 69' ' ' SER . 27.3 m -91.62 106.93 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-O 122.057 0.932 . . . . 0.0 110.269 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.7 mt -92.2 153.9 19.01 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 4.8 p-10 -144.58 148.16 34.05 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.482 -0.887 . . . . 0.0 112.013 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.8 t -126.7 128.44 24.28 Favored Pre-proline 0 C--N 1.289 -2.056 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 171.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 22.7 Cg_exo -69.16 109.43 2.19 Favored 'Trans proline' 0 N--CA 1.432 -2.144 0 N-CA-C 108.206 -1.498 . . . . 0.0 108.206 172.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.519 HG12 ' CE2' ' A' ' 85' ' ' TYR . 30.3 m -98.41 150.3 4.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.384 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.633 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -95.1 97.46 9.95 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.062 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.5 m -93.15 147.12 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.482 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -177.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 69.9 -3.9 1.61 Allowed 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.968 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.431 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . 84.2 t80 -57.99 -47.35 83.27 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.594 ' HB3' ' O ' ' A' ' 93' ' ' THR . 19.1 m -66.79 -26.3 66.89 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.996 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.5 mt -79.14 -49.64 19.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.727 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.16 -49.3 78.41 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 122.962 0.505 . . . . 0.0 110.34 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.2 t -54.97 -43.26 68.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.223 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 44.0 t -75.04 -78.84 0.1 Allowed 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.044 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 128' ' ' MET . 3.8 pp -126.24 -40.09 2.01 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 115.111 1.522 . . . . 0.0 115.111 -173.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.553 ' N ' HD12 ' A' ' 127' ' ' LEU . 24.9 ttt 66.01 116.52 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.355 1.062 . . . . 0.0 110.632 -173.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.71 -72.8 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.741 0.816 . . . . 0.0 112.133 -178.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 24.0 t70 172.87 -30.56 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 -174.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 13.2 tpt 65.61 106.17 0.04 OUTLIER 'General case' 0 C--O 1.242 0.666 0 CA-C-N 113.235 -1.802 . . . . 0.0 112.573 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 44.7 t -128.53 173.52 10.17 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.108 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.408 ' CG2' ' HB2' ' A' ' 171' ' ' ARG . 30.8 p -82.69 115.74 21.76 Favored 'General case' 0 N--CA 1.413 -2.312 0 C-N-CA 123.257 0.623 . . . . 0.0 110.95 -178.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.5 ' H ' ' H ' ' A' ' 169' ' ' SER . 24.6 t70 74.21 95.61 0.07 Allowed 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 124.9 1.28 . . . . 0.0 108.835 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 -154.44 148.03 25.25 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.901 -170.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -118.62 143.58 46.71 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 67.2 mt -131.53 130.1 62.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 174.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.569 ' HA ' ' HA ' ' A' ' 164' ' ' GLU . 9.5 p-10 -99.34 120.41 39.53 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.401 ' HE2' ' CD2' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -127.74 170.56 12.59 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -179.226 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.476 ' HB2' ' HB3' ' A' ' 88' ' ' LYS . 1.6 mp0 -113.99 136.36 52.99 Favored 'General case' 0 C--N 1.279 -2.496 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.398 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.485 HD11 HD11 ' A' ' 143' ' ' ILE . 20.4 tp -122.05 116.21 23.86 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.76 176.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.491 ' HB3' ' HB ' ' A' ' 86' ' ' ILE . 15.4 t70 -126.63 120.89 30.65 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -175.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.485 HD11 HD11 ' A' ' 141' ' ' LEU . 43.0 mm -131.2 137.28 56.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 121.209 0.528 . . . . 0.0 110.594 -175.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -114.52 122.02 5.55 Favored Glycine 0 N--CA 1.419 -2.454 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 175.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.552 HD13 ' H ' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -115.37 160.2 20.15 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.387 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.7 t -136.02 142.24 44.43 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 119.834 -0.747 . . . . 0.0 111.799 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.478 ' CE2' HD23 ' A' ' 145' ' ' LEU . 68.1 m-85 -135.6 138.51 43.02 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 174.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -116.91 132.77 56.62 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.883 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.06 143.11 29.98 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -66.91 5.01 0.88 Allowed 'Trans proline' 0 N--CA 1.488 1.184 0 C-N-CA 123.411 2.741 . . . . 0.0 113.415 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.46 -28.88 36.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 11.7 p -160.19 -28.49 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.67 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 140.51 -143.56 13.66 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.347 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -94.97 132.09 40.2 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.42 ' N ' HD12 ' A' ' 155' ' ' ILE . 2.9 mp -122.54 129.73 75.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.454 HG21 HD21 ' A' ' 27' ' ' LEU . 33.9 p -95.77 140.44 30.55 Favored 'General case' 0 N--CA 1.406 -2.654 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 172.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.463 HG12 ' CD1' ' A' ' 39' ' ' LEU . 31.0 mt -114.11 129.26 24.98 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -90.69 116.86 0.55 Allowed 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 122.734 2.289 . . . . 0.0 112.314 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.616 HG11 ' H ' ' A' ' 49' ' ' VAL . 21.9 t -118.96 103.76 14.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 59.0 p -107.91 128.56 54.73 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 95.3 m -145.88 131.02 18.37 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.152 0.501 . . . . 0.0 112.158 -173.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -99.53 124.48 44.75 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -126.94 128.04 6.12 Favored Glycine 0 N--CA 1.42 -2.428 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.095 -176.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 138' ' ' ASP . 39.3 tt0 -95.98 120.57 36.5 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 176.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 9.6 pt -112.53 140.84 30.26 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.635 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.926 -176.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -102.54 143.96 31.57 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 121.82 0.819 . . . . 0.0 112.15 -174.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.4 mp -112.39 86.03 7.72 Favored Pre-proline 0 C--N 1.285 -2.203 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -80.12 85.98 1.74 Allowed 'Trans proline' 0 C--N 1.367 1.52 0 C-N-CA 123.353 2.702 . . . . 0.0 116.034 -167.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.5 ' H ' ' H ' ' A' ' 134' ' ' ASP 0.26 46.2 t 63.72 -1.57 0.61 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 175.706 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.669 ' HB3' ' HB2' ' A' ' 173' ' ' PHE . 4.2 mm? -70.33 96.9 1.18 Allowed 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 168.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.408 ' HB2' ' CG2' ' A' ' 133' ' ' THR . 65.2 ttt180 -69.08 -23.6 64.04 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 118.754 -1.178 . . . . 0.0 109.802 176.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -117.79 102.16 8.89 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.669 ' HB2' ' HB3' ' A' ' 170' ' ' LEU . 57.8 t80 . . . . . 0 C--N 1.289 -2.052 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 -174.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.0 t70 . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 121.287 0.565 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -78.2 -47.99 16.83 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.851 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -64.36 -36.15 83.19 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 116.761 -0.199 . . . . 0.0 110.73 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.51 ' HA ' ' HG3' ' A' ' 19' ' ' GLU . 34.2 m -69.18 -20.39 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.275 0.56 . . . . 0.0 111.153 -177.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.461 HG11 ' O ' ' A' ' 94' ' ' ILE . 55.3 t -73.36 -52.22 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 171.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -65.21 -43.67 90.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.311 -175.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.51 ' HG3' ' HA ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -64.64 -33.28 75.56 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.546 -178.864 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -79.13 -43.43 24.04 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.719 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.09 82.89 Favored 'General case' 0 C--O 1.21 -0.981 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.32 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -59.35 -45.4 91.48 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.23 -49.79 81.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.087 0.47 . . . . 0.0 109.953 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.591 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 73.2 mt -62.3 -46.17 97.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.263 -178.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.4 t -66.97 -36.97 83.38 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.624 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.2 t -63.23 -37.63 87.98 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.18 0.514 . . . . 0.0 109.665 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -66.05 -45.26 82.01 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 87.7 mt -57.04 -41.21 78.22 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.239 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -55.46 -48.92 73.75 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -79.38 -36.38 39.31 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.88 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.723 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . . . -68.35 -35.99 78.57 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.634 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.431 ' HB2' ' HG2' ' A' ' 158' ' ' PRO . 40.4 ttmt -63.68 -35.74 81.56 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.33 -53.03 49.01 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.923 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.723 ' CE2' ' HA ' ' A' ' 31' ' ' ALA . 30.3 p90 -76.39 -24.56 54.11 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.383 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -57.19 -50.18 73.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.726 0.298 . . . . 0.0 110.834 175.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.1 -18.15 63.94 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.123 0.487 . . . . 0.0 110.987 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -91.69 -66.23 0.94 Allowed 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.469 ' HE2' ' HB2' ' A' ' 34' ' ' PHE . 49.7 mtmt -93.44 -35.66 12.86 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 121.189 0.518 . . . . 0.0 110.487 -171.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.47 HD22 HG21 ' A' ' 44' ' ' THR . 71.1 mt -82.52 2.26 33.82 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.527 0.68 . . . . 0.0 111.63 -174.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.62 -26.83 21.7 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -98.31 -32.93 11.28 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.129 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 74.5 mt -93.0 114.26 62.17 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.64 101.4 0.55 Allowed 'Trans proline' 0 C--O 1.24 0.62 0 C-N-CA 122.509 2.139 . . . . 0.0 112.975 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.47 HG21 HD22 ' A' ' 39' ' ' LEU . 2.0 p -112.56 167.92 8.46 Favored Pre-proline 0 C--N 1.298 -1.665 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.299 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.421 ' HD2' ' HB ' ' A' ' 44' ' ' THR . 18.8 Cg_endo -55.93 120.21 7.88 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 122.775 2.317 . . . . 0.0 111.463 177.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -102.45 114.27 28.33 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -174.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.507 ' HB2' HD21 ' A' ' 145' ' ' LEU . . . -97.63 148.98 22.75 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.94 -173.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.477 ' HA ' HG21 ' A' ' 159' ' ' VAL . 5.2 t -147.51 124.47 11.32 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.187 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.586 HG23 HG22 ' A' ' 159' ' ' VAL . 22.1 t -86.9 140.92 15.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -113.59 -72.65 0.69 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 -172.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 12.7 t70 -160.32 169.85 22.3 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.984 -162.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.523 HG21 ' CD1' ' A' ' 165' ' ' ILE . 34.5 m -129.53 146.61 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.379 0 C-N-CA 123.991 0.916 . . . . 0.0 109.872 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -123.72 126.33 46.34 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 118.204 -0.903 . . . . 0.0 108.618 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.476 ' O ' ' HE3' ' A' ' 55' ' ' LYS . 47.6 p90 -58.5 122.4 13.27 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 175.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.476 ' HE3' ' O ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -124.7 -20.37 5.08 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.972 -169.406 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.98 -159.51 20.55 Favored Glycine 0 N--CA 1.427 -1.939 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.153 -177.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.22 137.65 33.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.202 0.525 . . . . 0.0 111.241 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.3 m -117.95 170.05 9.15 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -83.73 -33.77 25.02 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 118.701 -1.2 . . . . 0.0 110.558 175.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.49 ' O ' ' HD1' ' A' ' 121' ' ' TYR . 24.8 m-20 -111.28 97.72 6.98 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 171.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.58 -168.36 27.89 Favored Glycine 0 C--N 1.303 -1.257 0 C-N-CA 120.493 -0.86 . . . . 0.0 110.965 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 3.5 m -147.12 140.74 19.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 C-N-CA 123.265 0.626 . . . . 0.0 110.718 -177.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -71.31 127.11 31.48 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 123.874 0.734 . . . . 0.0 112.026 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -131.62 143.87 50.63 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 124.513 1.125 . . . . 0.0 111.199 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -92.6 108.0 19.64 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.451 ' HB2' HG12 ' A' ' 52' ' ' VAL . . . -101.55 140.42 35.86 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.2 137.39 54.22 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.554 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.7 t -123.79 111.44 29.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.3 p -97.7 147.14 24.66 Favored 'General case' 0 C--N 1.277 -2.58 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.911 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.61 134.74 29.76 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 CA-C-O 121.36 0.6 . . . . 0.0 110.317 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 22.2 ptmt -105.77 144.48 32.45 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.477 ' ND2' HD13 ' A' ' 105' ' ' LEU . 1.5 p-10 -149.37 124.88 4.97 Favored Pre-proline 0 C--N 1.28 -2.437 0 C-N-CA 118.532 -1.267 . . . . 0.0 109.686 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 72' ' ' ASN . 38.0 Cg_endo -97.64 97.98 0.07 OUTLIER 'Trans proline' 0 N--CA 1.417 -3.009 0 C-N-CA 121.563 1.509 . . . . 0.0 110.696 173.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -138.63 -85.52 0.26 Allowed 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.9 p 170.24 -47.43 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.861 0.865 . . . . 0.0 110.9 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.612 ' O ' ' HA2' ' A' ' 107' ' ' GLY . 15.6 pt20 -104.01 163.69 12.21 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.845 -174.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.5 p -78.38 130.85 36.61 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 170.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.423 ' H ' ' CD1' ' A' ' 105' ' ' LEU . 75.3 mt -120.59 128.34 25.84 Favored Pre-proline 0 C--N 1.285 -2.213 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.47 150.3 69.79 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.298 1.999 . . . . 0.0 111.689 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.664 HG22 ' CE1' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -88.49 151.71 3.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.92 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 55.0 m -71.01 -50.94 28.69 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 174.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.03 163.35 18.27 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.62 -1.173 . . . . 0.0 107.977 171.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.6 tt -124.5 119.6 56.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 21.9 t -103.97 139.83 38.56 Favored 'General case' 0 N--CA 1.421 -1.899 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.667 -174.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.493 ' HA ' HD13 ' A' ' 143' ' ' ILE . 37.5 p90 -120.78 125.52 47.78 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 174.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 66.5 mt -118.64 107.35 21.48 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 174.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.49 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 3.0 pp -104.38 146.25 29.1 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.424 -175.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -116.77 155.45 28.9 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.192 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.9 m -140.11 109.55 6.23 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 66.47 -69.84 0.11 Allowed 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 125.612 1.565 . . . . 0.0 113.788 175.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.8 t -154.31 -46.27 0.09 Allowed 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -175.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -129.97 145.7 51.64 Favored 'General case' 0 C--N 1.314 -0.965 0 O-C-N 121.795 -0.566 . . . . 0.0 111.595 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 47.4 m 77.25 130.2 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 124.858 1.263 . . . . 0.0 112.22 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 42.5 pt -131.88 177.76 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.72 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.229 -178.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.461 ' HB3' HD11 ' A' ' 87' ' ' LEU . . . -133.99 148.74 51.17 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 173.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 70.2 p -143.01 160.75 39.76 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -177.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -176.87 164.51 34.05 Favored Glycine 0 N--CA 1.433 -1.527 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.435 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.9 p -132.15 115.47 15.77 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 124.217 1.007 . . . . 0.0 109.55 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.485 HD11 HG13 ' A' ' 115' ' ' VAL . 56.6 mt -94.95 125.09 52.22 Favored Pre-proline 0 C--O 1.244 0.78 0 C-N-CA 118.937 -1.105 . . . . 0.0 112.685 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -83.31 118.43 2.59 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.924 2.416 . . . . 0.0 111.739 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.42 ' HA ' HD11 ' A' ' 80' ' ' ILE . 24.1 m-20 48.36 68.55 3.41 Favored Pre-proline 0 N--CA 1.484 1.233 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -83.59 -21.44 4.24 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 N-CA-C 108.955 -1.21 . . . . 0.0 108.955 170.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -177.06 -166.63 34.29 Favored Glycine 0 N--CA 1.418 -2.51 0 N-CA-C 107.709 -2.157 . . . . 0.0 107.709 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 21.2 m -142.82 171.85 13.49 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.477 HD13 ' ND2' ' A' ' 72' ' ' ASN . 2.1 pp -75.96 153.2 36.75 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 117.697 -1.601 . . . . 0.0 108.791 172.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.56 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 8.9 p -70.98 -42.01 76.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -170.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.612 ' HA2' ' O ' ' A' ' 76' ' ' GLN . . . 129.58 -72.44 0.48 Allowed Glycine 0 N--CA 1.409 -3.124 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 -175.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.6 t -145.23 87.65 1.83 Allowed 'General case' 0 C--N 1.278 -2.52 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 160.83 -146.22 12.12 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 8.9 t -125.75 135.34 51.95 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 117.418 0.609 . . . . 0.0 111.008 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.56 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 2.7 t -127.5 138.98 53.07 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 122.924 0.49 . . . . 0.0 110.602 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.9 m -99.21 118.49 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-O 121.557 0.694 . . . . 0.0 110.551 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.8 mt -103.93 162.12 13.4 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -150.51 149.26 29.73 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.62 0.724 . . . . 0.0 112.383 -176.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.485 HG13 HD11 ' A' ' 99' ' ' ILE . 53.2 t -129.78 127.77 22.89 Favored Pre-proline 0 C--N 1.302 -1.457 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.084 176.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -79.18 110.01 2.65 Favored 'Trans proline' 0 N--CA 1.419 -2.884 0 N-CA-C 107.008 -1.958 . . . . 0.0 107.008 168.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.0 m -115.95 150.27 17.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 118' ' ' LYS 0.315 0.0 OUTLIER -97.87 122.6 41.17 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 118.245 -1.382 . . . . 0.0 109.976 166.014 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.2 m -91.99 142.14 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.211 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -174.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 69.23 10.81 7.99 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.876 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.49 ' HD1' ' O ' ' A' ' 60' ' ' ASP . 67.6 t80 -54.7 -40.89 69.63 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.895 0.878 . . . . 0.0 108.949 171.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.3 m -61.34 -45.47 94.28 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.591 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.7 tt -75.81 -34.5 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.248 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -53.73 -48.46 69.61 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 123.413 0.685 . . . . 0.0 112.1 176.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.5 m -71.87 -21.83 21.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.0 t -88.79 -69.06 0.73 Allowed 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 120.718 0.294 . . . . 0.0 111.253 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -124.84 -29.05 3.43 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.898 -0.501 . . . . 0.0 111.986 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.538 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 25.7 ttt 76.35 88.32 0.08 Allowed 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.614 ' HE3' ' CD1' ' A' ' 135' ' ' TRP . 87.5 tttt 41.87 -86.54 0.01 OUTLIER 'General case' 0 C--N 1.345 0.375 0 O-C-N 125.138 1.524 . . . . 0.0 114.584 167.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 129' ' ' LYS . 29.7 t70 152.95 -25.36 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.136 1.774 . . . . 0.0 106.348 -175.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.406 ' H ' ' HG2' ' A' ' 129' ' ' LYS . 2.6 tpt 43.86 78.19 0.06 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-N 113.115 -1.857 . . . . 0.0 112.244 -169.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 54.0 t -110.22 140.87 43.9 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 176.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 19.3 p -68.69 122.93 19.57 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.1 t70 68.95 103.9 0.06 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.462 1.105 . . . . 0.0 108.694 -169.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.614 ' CD1' ' HE3' ' A' ' 129' ' ' LYS . 59.6 t-105 -150.69 134.81 16.88 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.752 -170.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -107.37 123.69 48.73 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.486 HG23 ' HB ' ' A' ' 165' ' ' ILE . 16.2 tt -123.53 134.34 66.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.743 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -85.11 114.35 22.18 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.511 -175.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -133.11 155.9 48.41 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.737 0.815 . . . . 0.0 110.945 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -151.14 155.1 38.21 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 87' ' ' LEU . 1.7 pt? -136.94 117.06 13.38 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.568 0.699 . . . . 0.0 109.152 169.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -91.86 117.26 29.63 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.493 HD13 ' HA ' ' A' ' 85' ' ' TYR . 41.4 mm -106.96 140.03 26.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.586 -0.845 . . . . 0.0 110.793 -173.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -127.99 102.54 0.59 Allowed Glycine 0 N--CA 1.423 -2.172 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.507 HD21 ' HB2' ' A' ' 47' ' ' ALA . 1.1 pp -94.97 137.76 33.6 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.219 -0.592 . . . . 0.0 111.051 178.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.2 m -116.89 127.23 54.07 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.74 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.664 ' CE1' HG22 ' A' ' 80' ' ' ILE . 87.0 m-85 -128.56 143.9 51.05 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.785 175.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -104.04 110.26 22.36 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 66.1 mt -123.54 114.55 28.65 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -41.79 -36.13 3.25 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 124.827 3.684 . . . . 0.0 115.08 -175.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 56.9 t -55.25 -40.55 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 122.942 0.497 . . . . 0.0 111.544 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 51.9 t -117.72 -45.93 3.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.925 0.393 . . . . 0.0 110.639 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 129.69 -150.89 19.12 Favored Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -81.07 116.99 21.28 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 177.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.408 HG22 ' CE1' ' A' ' 34' ' ' PHE . 28.7 pt -124.0 128.53 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 37.3 m -104.62 116.6 32.35 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 174.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . 70.1 mt -101.92 112.73 65.66 Favored Pre-proline 0 C--N 1.293 -1.891 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.005 -176.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 157' ' ' ILE . 6.6 Cg_endo -82.98 132.8 6.4 Favored 'Trans proline' 0 CA--C 1.482 -2.12 0 C-N-CA 122.863 2.375 . . . . 0.0 112.532 176.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.586 HG22 HG23 ' A' ' 49' ' ' VAL . 2.7 p -134.51 123.35 42.17 Favored 'Isoleucine or valine' 1 N--CA 1.372 -4.335 0 CA-C-N 112.582 -2.099 . . . . 0.0 108.918 -179.353 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 15.4 m -116.43 156.76 26.23 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.578 -174.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.458 ' CG2' ' HB ' ' A' ' 49' ' ' VAL . 9.9 t -173.82 171.36 3.75 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -113.5 145.82 40.59 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 120.915 0.388 . . . . 0.0 110.442 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -118.4 103.4 1.03 Allowed Glycine 0 N--CA 1.426 -2.023 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -88.61 121.13 30.66 Favored 'General case' 0 C--N 1.268 -2.978 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.523 ' CD1' HG21 ' A' ' 52' ' ' VAL . 30.4 mm -110.28 109.27 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.432 -173.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -94.4 126.23 39.54 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.65 172.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 95.2 mt -115.51 88.23 19.01 Favored Pre-proline 0 C--N 1.293 -1.858 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.066 -176.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -82.95 86.57 1.45 Allowed 'Trans proline' 0 N--CA 1.434 -2.0 0 C-N-CA 122.52 2.147 . . . . 0.0 113.109 -176.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 57.3 p 55.1 92.83 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 175.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 5.1 mp -108.51 -61.16 1.64 Allowed 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.326 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . 0.299 86.1 mtm180 62.26 109.11 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -176.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . 0.319 21.4 m-20 85.05 -9.34 0.85 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.171 1.788 . . . . 0.0 114.4 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 . . . . . 0 C--N 1.31 -1.134 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 169.098 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.417 ' HA ' HG22 ' A' ' 16' ' ' VAL . 26.3 m-20 . . . . . 0 CA--C 1.506 -0.734 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.42 ' HG2' ' OG1' ' A' ' 93' ' ' THR . 1.3 tm-20 -56.73 -48.44 77.76 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.524 -1.217 . . . . 0.0 109.036 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -69.19 -47.09 65.84 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.487 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.417 HG22 ' HA ' ' A' ' 13' ' ' ASP . 35.2 m -65.51 -32.38 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -176.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.5 p -73.07 -28.63 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.845 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -70.25 -37.48 74.94 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.433 ' O ' HG23 ' A' ' 23' ' ' VAL . 18.2 mm-40 -56.27 -41.69 76.25 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.449 174.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.639 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 9.9 mmpt? -64.11 -46.56 83.64 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.577 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.87 -43.14 85.79 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.576 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.1 t -59.22 -31.77 69.34 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 19' ' ' GLU . 64.4 t -75.46 -48.78 29.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.6 mt -61.35 -52.32 62.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.924 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.5 m -65.63 -22.46 66.66 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.602 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.7 t -66.23 -44.85 82.61 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.415 ' O ' HD23 ' A' ' 27' ' ' LEU . 3.8 tt -75.73 -40.14 56.09 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.412 ' HA ' ' OG1' ' A' ' 156' ' ' THR . 6.1 tt -61.58 -35.18 77.09 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.686 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -67.11 -47.34 71.46 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.017 0.527 . . . . 0.0 112.018 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -66.18 -33.59 76.11 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.234 0.54 . . . . 0.0 110.947 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.86 -32.12 61.81 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.978 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.96 -46.45 89.22 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.611 0.243 . . . . 0.0 111.003 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.66 -32.59 82.04 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.971 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -78.98 -48.96 13.52 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.484 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 68.4 t80 -53.56 -38.75 64.17 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.59 -46.88 58.15 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 123.917 0.761 . . . . 0.0 113.006 -176.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.433 ' HG3' ' HG2' ' A' ' 38' ' ' LYS . 13.3 pt-20 -116.89 -36.51 3.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.362 0.601 . . . . 0.0 112.507 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.433 ' HG2' ' HG3' ' A' ' 37' ' ' GLU . 19.9 mmmt -77.43 -33.49 54.88 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -168.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 89.9 mt -100.06 13.46 34.0 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.874 0.845 . . . . 0.0 109.816 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.51 -37.07 12.11 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 172.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -73.53 -50.08 23.25 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.722 176.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.6 mt -80.49 119.46 76.4 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.917 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.54 120.27 8.0 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.45 2.1 . . . . 0.0 111.983 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 p -127.24 156.75 74.23 Favored Pre-proline 0 C--N 1.288 -2.079 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.266 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.66 133.12 40.74 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.372 2.048 . . . . 0.0 110.839 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.0 110.02 22.65 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -177.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.5 140.32 41.99 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.343 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 t -142.32 136.59 29.85 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 121.336 0.589 . . . . 0.0 110.738 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.5 t -83.98 141.25 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -115.42 -59.61 1.98 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.346 -0.942 . . . . 0.0 113.342 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -169.59 -173.61 1.69 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -175.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . 36.0 m -131.51 154.99 41.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 118.41 0.55 . . . . 0.0 111.069 -176.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -129.84 116.18 18.32 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.381 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.583 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 46.6 p90 -82.36 141.28 32.96 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.541 ' HE2' ' C ' ' A' ' 54' ' ' PHE . 0.4 OUTLIER -89.69 -78.15 0.37 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.986 175.196 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.59 -117.7 0.41 Allowed Glycine 0 C--O 1.211 -1.314 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.253 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.8 t -99.3 140.54 18.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.525 HG22 ' H ' ' A' ' 60' ' ' ASP . 57.4 m -147.08 149.77 33.71 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -72.3 -19.32 61.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.335 0.588 . . . . 0.0 111.336 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.525 ' H ' HG22 ' A' ' 58' ' ' THR . 7.4 m-20 -122.97 86.38 2.57 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.204 175.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.48 -133.89 30.5 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.356 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 93.0 t -134.45 143.2 38.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -89.65 105.49 17.83 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.675 0.75 . . . . 0.0 110.171 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.785 ' CD1' ' HB ' ' A' ' 119' ' ' VAL . 7.8 m-85 -102.63 141.46 35.42 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.487 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 15.6 m-70 -101.13 108.9 20.69 Favored 'General case' 0 C--N 1.282 -2.351 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.053 170.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -78.54 135.22 37.26 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.436 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -90.03 117.75 29.05 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.606 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.8 t -129.61 111.89 23.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.2 p -100.45 137.16 39.24 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.252 0.549 . . . . 0.0 111.979 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.6 t -127.66 132.41 69.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.881 -177.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 21.4 ptmt -116.8 142.87 46.35 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.589 HD22 ' HA2' ' A' ' 107' ' ' GLY . 38.1 t30 -140.93 115.76 7.27 Favored Pre-proline 0 C--N 1.286 -2.177 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.677 -175.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -90.33 97.38 0.27 Allowed 'Trans proline' 0 N--CA 1.426 -2.45 0 C-N-CA 121.406 1.404 . . . . 0.0 112.228 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.523 ' HB3' ' H ' ' A' ' 76' ' ' GLN . 18.8 m-85 -167.78 -168.65 1.03 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 126.967 2.107 . . . . 0.0 107.372 177.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.1 t -132.98 7.48 4.01 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 170.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.523 ' H ' ' HB3' ' A' ' 74' ' ' TYR . 3.7 pt20 -97.63 142.19 29.75 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.594 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.5 p -79.62 102.58 8.99 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-O 120.944 0.402 . . . . 0.0 110.33 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.547 ' HB ' HD23 ' A' ' 105' ' ' LEU . 78.7 mt -92.6 117.67 67.69 Favored Pre-proline 0 C--N 1.31 -1.145 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 177.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -78.22 130.37 10.13 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 122.162 1.908 . . . . 0.0 112.747 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.473 ' HB ' ' CE1' ' A' ' 147' ' ' PHE . 9.9 tt -82.6 94.38 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 174.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 57.9 m -58.79 -42.13 88.33 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.845 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -156.87 148.55 22.55 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.617 -171.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.5 tt -128.58 116.36 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 173.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 28.6 p -120.26 118.72 31.18 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.717 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.492 ' CE1' HG13 ' A' ' 117' ' ' VAL . 43.6 p90 -109.04 147.98 31.5 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.414 -176.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 86' ' ' ILE . 3.0 mp -120.31 113.26 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 175.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.704 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 0.9 OUTLIER -99.51 137.25 38.27 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.532 ' N ' HD23 ' A' ' 87' ' ' LEU . 45.4 mtpt -129.1 153.89 47.22 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 172.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.5 t -158.97 140.4 13.21 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 119.027 -1.069 . . . . 0.0 113.2 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 60.38 -79.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.805 1.642 . . . . 0.0 114.595 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -167.32 -32.48 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.099 0.476 . . . . 0.0 109.89 -175.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -129.09 141.94 51.05 Favored 'General case' 0 CA--C 1.49 -1.343 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.883 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.42 ' OG1' ' HG2' ' A' ' 14' ' ' GLU . 7.2 m 75.39 134.21 0.05 Allowed 'General case' 0 C--N 1.307 -1.25 0 O-C-N 125.177 1.548 . . . . 0.0 112.354 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.704 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.6 pp -138.2 174.79 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.199 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.668 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -132.63 162.01 32.42 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 119.095 0.862 . . . . 0.0 111.026 175.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.0 m -143.36 153.68 42.95 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -154.96 149.93 21.33 Favored Glycine 0 N--CA 1.419 -2.472 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 93.2 m -141.32 108.51 5.49 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.4 mt -115.03 110.21 46.16 Favored Pre-proline 0 C--N 1.306 -1.316 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.776 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -72.16 131.06 17.33 Favored 'Trans proline' 0 C--O 1.238 0.502 0 C-N-CA 122.533 2.155 . . . . 0.0 109.645 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.314 4.0 p30 44.72 77.94 0.42 Allowed Pre-proline 0 N--CA 1.487 1.394 0 C-N-CA 124.622 1.169 . . . . 0.0 114.107 -175.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -87.91 -8.71 5.77 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.874 2.383 . . . . 0.0 113.556 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 173.36 -161.77 32.71 Favored Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.592 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 46.2 m -119.86 142.03 49.02 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.209 0.528 . . . . 0.0 110.719 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.547 HD23 ' HB ' ' A' ' 78' ' ' ILE . 41.5 tp -97.04 141.37 30.28 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.447 HG23 ' HB ' ' A' ' 111' ' ' THR . 61.0 t -89.77 107.46 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.247 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 171.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.589 ' HA2' HD22 ' A' ' 72' ' ' ASN . . . -57.06 -22.49 42.79 Favored Glycine 0 C--N 1.292 -1.89 0 CA-C-N 114.317 -1.311 . . . . 0.0 113.627 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.4 p -120.23 11.72 11.63 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -156.57 -161.93 11.1 Favored Glycine 0 CA--C 1.498 -1.009 0 C-N-CA 117.135 -2.459 . . . . 0.0 114.996 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 41.4 m -101.7 129.85 47.95 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.447 ' HB ' HG23 ' A' ' 106' ' ' VAL . 10.0 t -127.47 133.21 49.91 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 40.1 t -97.78 115.92 39.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.1 mt -102.81 160.93 14.16 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 7.3 p-10 -133.45 130.81 39.14 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 9.6 t -104.78 126.18 31.91 Favored Pre-proline 0 C--N 1.305 -1.368 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -71.04 110.47 2.82 Favored 'Trans proline' 0 N--CA 1.433 -2.054 0 N-CA-C 106.818 -2.031 . . . . 0.0 106.818 168.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.492 HG13 ' CE1' ' A' ' 85' ' ' TYR . 97.6 t -116.69 141.39 34.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.708 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -87.17 88.4 7.69 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.17 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.785 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 94.5 t -94.04 145.99 7.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.664 -176.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 72.41 -1.99 2.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.141 0.976 . . . . 0.0 111.245 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -68.45 -43.38 77.19 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.41 ' O ' ' HB ' ' A' ' 93' ' ' THR . 14.4 m -62.0 -28.0 69.26 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 122.491 1.138 . . . . 0.0 109.578 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.6 mt -78.18 -49.45 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.22 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.455 -177.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.03 -36.27 72.47 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.324 0.649 . . . . 0.0 111.517 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.0 t -67.81 -34.72 69.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.421 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.0 t -93.39 -66.77 0.9 Allowed 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -176.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 127' ' ' LEU . 1.8 pt? -124.91 -23.85 4.2 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -176.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 24.2 ttt 56.89 35.59 26.55 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.283 1.033 . . . . 0.0 109.349 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.436 ' H ' ' HG ' ' A' ' 127' ' ' LEU . 61.6 mmtt 69.3 -70.5 0.14 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.033 1.733 . . . . 0.0 106.672 -172.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.446 ' H ' ' H ' ' A' ' 131' ' ' MET . 24.4 t70 149.58 18.71 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 130.855 3.662 . . . . 0.0 102.862 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.598 ' SD ' ' HA ' ' A' ' 171' ' ' ARG . 0.0 OUTLIER 58.53 76.79 0.33 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 113.05 -1.887 . . . . 0.0 106.778 -163.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.409 ' HB2' ' NE1' ' A' ' 135' ' ' TRP . 64.9 m -106.43 127.62 53.42 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.631 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 169' ' ' SER . 19.0 p -93.29 119.4 32.39 Favored 'General case' 0 N--CA 1.399 -2.982 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.078 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 5.9 m-20 72.85 89.14 0.1 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 176.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.409 ' NE1' ' HB2' ' A' ' 132' ' ' CYS . 1.2 p-90 -173.15 158.66 3.71 Favored 'General case' 0 C--O 1.246 0.894 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.254 174.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.595 ' HA ' ' HA ' ' A' ' 166' ' ' LYS . 5.1 p-10 -98.45 143.38 28.96 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 137' ' ' ILE . 3.1 mp -124.23 140.46 47.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -177.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -75.81 112.7 12.47 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 122.674 1.226 . . . . 0.0 111.791 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.451 ' CE2' ' HG ' ' A' ' 87' ' ' LEU . 1.2 t80 -125.23 152.01 45.13 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 113.501 -1.682 . . . . 0.0 107.261 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 162' ' ' GLN . 17.4 tt0 -134.08 150.46 51.18 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.1 tp -131.89 117.7 18.84 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 121.703 0.763 . . . . 0.0 110.163 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.424 ' HB3' ' HB ' ' A' ' 86' ' ' ILE . 13.3 t70 -124.76 130.2 51.94 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 -177.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.9 mt -136.81 140.48 42.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.159 -1.016 . . . . 0.0 111.761 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -108.32 93.15 0.78 Allowed Glycine 0 N--CA 1.426 -1.976 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.48 ' HB3' ' CE2' ' A' ' 147' ' ' PHE . 3.1 mm? -68.42 118.96 12.16 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 16.7 m -100.89 108.52 20.31 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.267 -177.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.48 ' CE2' ' HB3' ' A' ' 145' ' ' LEU . 96.3 m-85 -119.26 149.22 42.14 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 176.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 154' ' ' ASP . 4.5 p-10 -102.48 115.97 31.66 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.121 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.3 mp -108.02 105.46 56.44 Favored Pre-proline 0 C--N 1.296 -1.737 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -30.15 -51.14 0.2 Allowed 'Trans proline' 0 N--CA 1.485 1.029 1 C-N-CA 125.694 4.263 . . . . 0.0 116.984 -172.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.448 HG23 HG23 ' A' ' 152' ' ' VAL . 29.7 m -62.29 -21.17 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -177.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.448 HG23 HG23 ' A' ' 151' ' ' VAL . 48.4 t -121.86 -40.73 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.817 0.818 . . . . 0.0 109.754 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 112.8 -148.8 18.49 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 148' ' ' ASP . 6.7 p-10 -86.46 124.42 32.77 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.612 0.72 . . . . 0.0 110.811 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 146' ' ' THR . 2.2 pp -125.35 145.07 33.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.489 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.414 HG22 ' OG1' ' A' ' 146' ' ' THR . 46.4 p -94.7 119.57 33.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.652 0.263 . . . . 0.0 110.771 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.449 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . 55.3 mt -92.78 119.32 67.93 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 157' ' ' ILE . 19.8 Cg_exo -70.71 125.48 11.7 Favored 'Trans proline' 0 C--O 1.24 0.579 0 C-N-CA 123.596 2.864 . . . . 0.0 113.409 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 39.0 t -132.81 115.03 23.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 173.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.7 m -125.36 142.8 51.3 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 121.046 -0.262 . . . . 0.0 110.808 -174.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.1 t -176.97 157.11 1.39 Allowed 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 140' ' ' GLN . 30.2 pt20 -99.62 152.45 20.03 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.267 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -120.37 119.57 4.24 Favored Glycine 0 N--CA 1.417 -2.597 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -96.7 120.59 37.3 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 4.2 pt -131.16 112.82 22.42 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 CA-C-O 121.446 0.641 . . . . 0.0 112.191 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 136' ' ' ASP . 40.1 ttmt -90.87 128.24 36.68 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.102 178.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 134' ' ' ASP . 88.4 mt -110.38 107.23 58.4 Favored Pre-proline 0 C--N 1.286 -2.161 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.568 -173.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -71.58 105.09 1.7 Allowed 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.788 2.325 . . . . 0.0 111.835 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 133' ' ' THR 0.268 89.5 p 60.46 -83.96 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 126.025 1.73 . . . . 0.0 114.557 -175.309 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.401 HD22 HD13 ' A' ' 167' ' ' LEU . 10.9 mp 63.44 26.74 14.99 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-O 121.044 0.449 . . . . 0.0 112.189 -176.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.598 ' HA ' ' SD ' ' A' ' 131' ' ' MET . 47.1 ttt180 -77.23 99.08 5.34 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . 0.276 1.8 m-20 80.28 79.45 0.05 OUTLIER 'General case' 0 CA--C 1.49 -1.359 0 CA-C-O 123.089 1.423 . . . . 0.0 109.514 -168.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 28.2 t80 . . . . . 0 C--N 1.275 -2.661 0 N-CA-C 100.718 -3.808 . . . . 0.0 100.718 -177.157 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.9 t70 . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.94 -28.44 62.43 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.218 0.532 . . . . 0.0 111.295 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.51 ' HE2' ' OE1' ' A' ' 19' ' ' GLU . 81.9 tttt -67.69 -55.3 13.75 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.539 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.453 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 32.3 m -60.27 -33.64 54.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -173.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -73.36 -33.43 40.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.093 0.473 . . . . 0.0 110.21 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -72.65 -49.34 32.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.144 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.51 ' OE1' ' HE2' ' A' ' 15' ' ' LYS . 8.9 pt-20 -64.36 -31.73 73.05 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.978 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.56 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 1.1 tpmt? -61.98 -48.78 78.82 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.83 -39.48 94.47 Favored 'General case' 0 C--O 1.21 -0.991 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.829 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.5 t -60.53 -44.51 95.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 66.6 t -69.47 -43.87 80.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 20' ' ' LYS . 78.7 mt -61.03 -45.25 98.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.397 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.7 t -57.42 -41.71 80.92 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 123.041 0.536 . . . . 0.0 110.055 177.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.8 t -66.79 -26.27 66.87 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-O 121.013 0.435 . . . . 0.0 110.912 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 tt -76.36 -55.19 5.78 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.574 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 8.4 mp -59.3 -36.39 75.51 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -51.23 -45.7 62.05 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.09 0.556 . . . . 0.0 111.843 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -82.95 -31.2 27.79 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 177.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.96 -32.27 73.56 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.116 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.574 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 61.4 mtpt -57.18 -27.85 62.3 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.484 0.713 . . . . 0.0 110.819 175.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.564 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -74.12 -55.77 5.58 Favored Glycine 0 N--CA 1.438 -1.228 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 178.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -56.1 -40.98 74.52 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.763 0.316 . . . . 0.0 110.836 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.456 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 48.7 t80 -67.21 -37.48 83.7 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.27 -34.75 63.66 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.987 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.564 ' HG2' ' O ' ' A' ' 33' ' ' GLY . 11.1 pt-20 -104.72 -44.37 4.88 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -176.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.414 ' HG2' HD12 ' A' ' 42' ' ' ILE . 21.6 ttmm -87.93 -43.94 11.4 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.682 0.753 . . . . 0.0 109.659 -170.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 67.2 mt -87.16 12.13 12.35 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.647 -176.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.05 -40.72 15.47 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 173.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.54 ' OD1' HG13 ' A' ' 42' ' ' ILE . 8.4 p30 -87.72 -36.43 17.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.452 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.54 HG13 ' OD1' ' A' ' 41' ' ' ASN . 85.4 mt -88.84 113.8 57.38 Favored Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -79.0 101.04 1.4 Allowed 'Trans proline' 0 N--CA 1.435 -1.97 0 C-N-CA 121.955 1.77 . . . . 0.0 113.628 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.9 p -93.04 149.94 38.4 Favored Pre-proline 0 N--CA 1.419 -1.987 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.463 ' HB3' ' HA ' ' A' ' 72' ' ' ASN . 10.9 Cg_endo -53.37 141.87 59.52 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.279 1.986 . . . . 0.0 110.246 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -96.53 141.99 29.15 Favored 'General case' 0 CA--C 1.484 -1.563 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.685 -172.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.48 137.35 53.24 Favored 'General case' 0 N--CA 1.414 -2.254 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.877 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.2 t -134.34 126.03 28.82 Favored 'General case' 0 C--N 1.272 -2.779 0 CA-C-O 121.635 0.731 . . . . 0.0 109.985 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.568 HG11 ' CG1' ' A' ' 143' ' ' ILE . 35.5 m -107.38 141.72 21.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.164 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 49' ' ' VAL . 27.5 t70 161.8 66.81 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 124.898 1.374 . . . . 0.0 112.684 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 67' ' ' LYS . 20.5 t70 -177.47 117.86 0.1 Allowed 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 168.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.2 t -132.03 112.69 20.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -121.53 141.88 50.62 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.9 -176.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 41.9 p90 -77.0 128.14 33.96 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.732 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -120.22 -3.09 10.05 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.656 -0.818 . . . . 0.0 112.047 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.0 158.29 25.92 Favored Glycine 0 CA--C 1.489 -1.567 0 C-N-CA 119.214 -1.469 . . . . 0.0 112.84 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.49 ' HB ' ' CE1' ' A' ' 173' ' ' PHE . 7.5 p -106.8 116.29 50.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.716 0.77 . . . . 0.0 112.336 -176.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.564 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 88.4 m -132.55 130.67 40.65 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 174.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -82.01 -12.2 58.43 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.211 0.529 . . . . 0.0 111.196 -174.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.405 ' H ' HG22 ' A' ' 58' ' ' THR . 20.1 t70 -114.33 69.16 0.7 Allowed 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 172.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.564 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . 100.33 101.37 2.41 Favored Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.117 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.0 p -76.2 143.07 13.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 121.164 0.507 . . . . 0.0 110.889 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -89.45 114.89 26.44 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -172.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.635 ' CD1' ' HB ' ' A' ' 119' ' ' VAL . 32.9 m-85 -120.87 151.26 39.87 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.056 173.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -120.51 109.19 14.99 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.93 144.75 34.53 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.933 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 31.6 mmtp -102.4 118.76 37.56 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.599 -176.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.6 t -111.06 108.37 25.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 175.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.6 p -99.85 123.83 44.51 Favored 'General case' 0 C--N 1.285 -2.201 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.713 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.7 t -114.96 128.01 72.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.722 -176.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 71' ' ' LYS . 19.2 ptpt -102.35 110.48 22.45 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.568 ' O ' ' HA ' ' A' ' 108' ' ' SER . 34.1 t30 -109.98 113.9 56.67 Favored Pre-proline 0 C--N 1.265 -3.075 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.107 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -97.67 95.97 0.07 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.686 0 C-N-CA 121.605 1.537 . . . . 0.0 109.65 169.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -176.19 156.29 1.63 Allowed 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 127.468 2.307 . . . . 0.0 106.54 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.5 m -82.92 -18.59 39.57 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.656 0.741 . . . . 0.0 109.242 176.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -96.83 146.78 24.6 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.674 -178.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.4 m -84.59 106.43 16.15 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 171.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 59.1 mt -76.19 116.15 53.4 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -56.99 137.02 80.12 Favored 'Trans proline' 0 C--O 1.239 0.569 0 C-N-CA 123.228 2.618 . . . . 0.0 113.757 -175.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 146' ' ' THR . 9.4 pt -112.64 98.59 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.952 175.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 51.6 t -52.6 -54.9 26.84 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.188 -177.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -145.71 160.64 41.43 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.524 ' CG2' ' HB ' ' A' ' 99' ' ' ILE . 14.9 tt -134.87 113.83 16.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 175.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 55.0 p -94.63 123.3 37.99 Favored 'General case' 0 C--N 1.287 -2.144 0 O-C-N 121.956 -0.465 . . . . 0.0 111.421 -175.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.526 ' HA ' HD13 ' A' ' 143' ' ' ILE . 36.4 p90 -103.81 129.86 51.3 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 2.5 mp -117.12 107.17 21.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 176.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.629 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 1.3 tt -92.35 132.56 36.63 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.474 ' N ' HD23 ' A' ' 87' ' ' LEU . 62.1 tttm -130.46 143.48 50.79 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.483 ' HB2' HD11 ' A' ' 123' ' ' ILE . 58.1 p -144.05 95.39 2.72 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 55.59 -81.84 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 171.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.6 p -83.98 -71.68 0.5 Allowed 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 -168.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -137.31 -64.92 0.55 Allowed 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 m -66.76 139.55 57.81 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 121.513 0.673 . . . . 0.0 112.086 -173.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.629 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.7 pp -139.7 170.65 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.484 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 -178.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.629 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -138.06 136.5 36.89 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.3 t -149.08 159.85 43.86 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.909 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.56 161.08 24.35 Favored Glycine 0 N--CA 1.422 -2.262 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 64.6 p -101.34 127.23 48.06 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.524 ' HB ' ' CG2' ' A' ' 83' ' ' ILE . 66.4 mt -97.15 110.07 52.44 Favored Pre-proline 0 C--N 1.306 -1.303 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.853 175.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -78.31 115.56 3.73 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.097 1.864 . . . . 0.0 110.828 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.7 t70 60.4 86.05 0.16 Allowed Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.868 -176.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.402 ' HG3' ' CG2' ' A' ' 83' ' ' ILE . 19.0 Cg_endo -97.05 5.42 1.58 Allowed 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.903 2.402 . . . . 0.0 111.581 177.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 145.59 -164.71 28.06 Favored Glycine 0 N--CA 1.419 -2.484 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.3 m -137.95 155.59 48.73 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.441 HD21 ' CE1' ' A' ' 147' ' ' PHE . 6.9 mp -72.02 150.84 43.64 Favored 'General case' 0 CA--C 1.485 -1.555 0 CA-C-O 121.803 0.811 . . . . 0.0 111.149 176.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 11.1 p -88.2 139.13 17.85 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.143 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.274 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -66.49 90.77 0.16 Allowed Glycine 0 C--N 1.304 -1.231 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 72' ' ' ASN 0.252 79.6 p 63.09 86.74 0.11 Allowed 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 125.973 1.709 . . . . 0.0 113.537 -178.748 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 169.35 -163.86 37.46 Favored Glycine 0 N--CA 1.431 -1.669 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.5 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.7 m -119.29 115.99 25.31 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.474 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 5.1 t -110.23 132.2 54.38 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.106 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.2 t -95.72 113.09 29.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.6 mt -92.67 150.09 20.91 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.312 -177.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -105.02 119.66 39.57 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.365 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.54 117.84 30.01 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-O 121.17 0.51 . . . . 0.0 111.319 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.37 123.13 10.2 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.208 1.939 . . . . 0.0 111.143 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 57.4 t -125.26 136.64 60.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -88.17 93.56 9.54 Favored 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.635 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 96.2 t -93.76 146.44 6.55 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.826 -171.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 72.31 -4.29 2.07 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.121 1.368 . . . . 0.0 112.799 174.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.52 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . 44.9 t80 -67.13 -32.46 73.6 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.7 p -64.86 -35.2 80.36 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.041 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.483 HD11 ' HB2' ' A' ' 89' ' ' SER . 33.8 mm -71.78 -46.98 58.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.021 176.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.4 -48.02 83.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.471 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.8 p -72.26 -25.46 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 CA-C-O 121.013 0.435 . . . . 0.0 111.35 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 39.2 t -80.8 -76.04 0.25 Allowed 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.825 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.576 HD12 ' N ' ' A' ' 128' ' ' MET . 2.5 pp -124.68 -37.26 2.5 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -175.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.576 ' N ' HD12 ' A' ' 127' ' ' LEU . 9.8 tpt 61.94 109.97 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.486 0.714 . . . . 0.0 111.49 -176.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.513 ' HB2' ' HZ2' ' A' ' 135' ' ' TRP . 1.4 mptp? -78.47 -30.07 47.16 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 80.15 97.78 0.06 Allowed 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 113.533 -1.667 . . . . 0.0 110.76 -175.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.33 139.83 58.81 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.133 -1.394 . . . . 0.0 110.395 -176.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 49.7 t -138.37 -81.54 0.32 Allowed 'General case' 0 CA--C 1.56 1.364 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.615 ' HA ' ' CB ' ' A' ' 169' ' ' SER . 14.1 p -144.29 130.81 19.95 Favored 'General case' 0 N--CA 1.426 -1.645 0 C-N-CA 125.541 1.536 . . . . 0.0 109.652 -171.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 44.56 89.56 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 C-N-CA 124.632 1.173 . . . . 0.0 110.138 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.513 ' HZ2' ' HB2' ' A' ' 129' ' ' LYS . 69.5 t-105 -128.99 150.21 50.5 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -162.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -136.94 136.26 38.44 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.031 0.932 . . . . 0.0 109.893 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 22.6 pt -132.41 136.66 55.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 173.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -87.18 121.14 29.23 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.509 ' CE2' ' HG ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -149.61 161.74 41.56 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -175.699 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -164.16 158.94 19.71 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 117.889 0.313 . . . . 0.0 110.822 171.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.598 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 1.5 pt? -136.12 132.29 35.88 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-O 121.0 0.429 . . . . 0.0 109.96 176.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.566 ' HA ' ' HB3' ' A' ' 160' ' ' SER . 15.2 t70 -101.84 120.84 41.02 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 175.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.568 ' CG1' HG11 ' A' ' 49' ' ' VAL . 45.8 mm -100.66 133.07 45.02 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 CA-C-O 120.832 0.349 . . . . 0.0 110.693 -176.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -114.75 86.41 0.41 Allowed Glycine 0 N--CA 1.41 -3.096 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 174.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.729 HD13 ' H ' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -81.05 146.42 30.64 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.304 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 30.3 m -127.84 114.45 17.24 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 119.051 -1.06 . . . . 0.0 112.248 -176.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.441 ' CE1' HD21 ' A' ' 105' ' ' LEU . 50.3 m-85 -99.14 160.3 14.37 Favored 'General case' 0 C--O 1.246 0.875 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 174.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -121.37 126.85 50.41 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.846 174.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.7 125.33 18.36 Favored Pre-proline 0 C--N 1.301 -1.512 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.092 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.54 -28.68 22.5 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 C-N-CA 123.953 3.102 . . . . 0.0 113.737 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.94 -38.39 76.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.506 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 41.3 t -124.84 -45.29 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.264 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 129.15 -133.58 7.62 Favored Glycine 0 N--CA 1.428 -1.847 0 C-N-CA 121.026 -0.607 . . . . 0.0 111.758 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -100.33 117.34 34.32 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.857 0.863 . . . . 0.0 108.931 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.413 ' N ' HD12 ' A' ' 155' ' ' ILE . 2.7 mp -128.75 119.5 49.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.494 178.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 86.4 m -82.07 112.11 18.83 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 173.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.436 ' O ' HD13 ' A' ' 145' ' ' LEU . 70.0 mt -93.5 117.15 67.29 Favored Pre-proline 0 C--N 1.299 -1.587 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.285 -176.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.446 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.7 Cg_endo -82.83 133.87 7.03 Favored 'Trans proline' 0 CA--C 1.489 -1.774 0 C-N-CA 122.88 2.387 . . . . 0.0 112.728 176.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.443 HG22 HG22 ' A' ' 49' ' ' VAL . 2.7 p -146.28 131.4 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.106 0 CA-C-N 113.097 -1.865 . . . . 0.0 109.062 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.566 ' HB3' ' HA ' ' A' ' 142' ' ' ASP . 12.3 p -147.29 162.43 38.96 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.454 HG21 ' HA ' ' A' ' 50' ' ' ASP . 14.4 t -153.5 178.22 10.06 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 177.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -98.69 132.41 44.1 Favored 'General case' 0 N--CA 1.422 -1.864 0 C-N-CA 118.661 -1.215 . . . . 0.0 108.801 176.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.477 ' O ' ' HD1' ' A' ' 139' ' ' TYR . . . -97.1 76.82 0.67 Allowed Glycine 0 N--CA 1.399 -3.821 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -87.82 119.88 28.6 Favored 'General case' 0 C--N 1.271 -2.842 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.7 pt -117.55 108.38 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.765 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.236 -176.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.413 ' HG2' ' H ' ' A' ' 166' ' ' LYS . 16.7 pttt -98.41 98.61 9.81 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 113.195 -1.82 . . . . 0.0 109.571 -177.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 88.4 mt -87.14 127.62 58.6 Favored Pre-proline 0 C--N 1.282 -2.346 0 CA-C-N 112.228 -2.26 . . . . 0.0 111.935 -169.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -69.79 150.74 68.43 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.079 1.853 . . . . 0.0 108.334 173.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.615 ' CB ' ' HA ' ' A' ' 133' ' ' THR . 2.3 m -51.16 99.35 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -177.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -101.52 -27.31 13.18 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 170.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.53 -65.6 0.2 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.066 1.746 . . . . 0.0 109.943 -178.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -116.24 95.33 5.03 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 122.168 0.985 . . . . 0.0 109.592 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.49 ' CE1' ' HB ' ' A' ' 57' ' ' VAL . 72.7 t80 . . . . . 0 C--N 1.279 -2.494 0 N-CA-C 103.164 -2.902 . . . . 0.0 103.164 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 . . . . . 0 CA--C 1.495 -1.153 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -53.7 -35.14 60.8 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.324 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -74.88 -56.18 5.04 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.25 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.446 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 30.6 m -70.83 -34.72 57.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -172.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 p -68.46 -32.5 55.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.203 0.525 . . . . 0.0 110.349 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -74.89 -47.13 31.64 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.488 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.446 ' HG2' ' HA ' ' A' ' 16' ' ' VAL . 13.4 pt-20 -71.15 -36.99 72.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.413 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.402 ' O ' HG12 ' A' ' 24' ' ' ILE . 40.5 ttmt -65.17 -39.4 92.87 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.48 -37.72 88.38 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.986 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -59.94 -50.62 73.04 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.655 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 19' ' ' GLU . 95.7 t -59.66 -51.06 77.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.902 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.529 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 50.4 mm -63.28 -36.1 74.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.195 -177.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.8 t -62.77 -35.68 80.6 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.424 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.5 m -72.25 -35.85 68.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.097 0.475 . . . . 0.0 110.145 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.505 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 5.3 tt -66.78 -40.25 88.1 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 85.5 mt -61.8 -41.09 97.32 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -57.87 -45.82 85.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.669 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -66.23 -30.67 71.16 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-O 121.099 0.476 . . . . 0.0 110.955 -179.544 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.521 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -78.02 -34.73 50.54 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 120.987 0.423 . . . . 0.0 111.787 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 29.0 mtpp -69.11 9.44 0.42 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -177.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -113.08 -18.34 7.32 Favored Glycine 0 C--N 1.313 -0.723 0 C-N-CA 120.341 -0.933 . . . . 0.0 111.371 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.497 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 68.4 m-85 -80.25 -25.53 39.47 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.555 ' HA ' HD12 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -56.19 -29.96 61.62 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -171.592 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.71 -34.04 25.0 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -115.79 -46.81 2.82 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.497 ' HB3' ' HB3' ' A' ' 34' ' ' PHE . 5.4 tmmm? -82.71 -20.75 35.46 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-O 120.898 0.38 . . . . 0.0 110.311 -173.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.555 HD12 ' HA ' ' A' ' 35' ' ' PHE . 42.7 mt -96.3 0.06 50.3 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.299 176.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.88 -57.07 2.85 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.819 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -81.64 -2.81 51.65 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.228 0.537 . . . . 0.0 111.979 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 75.6 mt -121.46 125.17 26.94 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.97 107.03 0.32 Allowed 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.739 2.293 . . . . 0.0 111.704 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.7 p -134.33 153.06 79.13 Favored Pre-proline 0 C--N 1.302 -1.487 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.963 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.403 ' HB3' ' HB2' ' A' ' 72' ' ' ASN . 52.5 Cg_endo -79.25 164.41 24.36 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.544 2.163 . . . . 0.0 113.58 -176.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 71' ' ' LYS . 36.8 tt0 -112.86 143.01 44.85 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.93 152.22 50.5 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.128 -175.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.3 t -147.69 128.97 14.76 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.265 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.475 HG13 HG22 ' A' ' 161' ' ' THR . 7.5 p -94.09 141.7 14.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 175.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -118.05 -66.81 1.04 Allowed 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -170.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -158.58 167.07 30.56 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -171.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.574 HG11 ' OH ' ' A' ' 139' ' ' TYR . 14.5 p -126.97 132.68 69.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.723 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -104.71 135.84 45.34 Favored 'General case' 0 C--O 1.251 1.15 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.343 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.499 ' O ' ' HE2' ' A' ' 55' ' ' LYS . 48.7 p90 -60.45 140.76 57.1 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 174.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.549 ' HA ' ' HE2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -136.11 -66.72 0.54 Allowed 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.914 -171.157 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.09 -164.76 15.3 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.202 -176.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.24 128.31 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-O 121.452 0.644 . . . . 0.0 111.515 -177.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.505 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 44.9 m -152.29 126.51 9.23 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 173.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -69.82 -32.44 70.87 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -169.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -108.6 11.42 26.64 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.02 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . 170.1 86.95 0.06 OUTLIER Glycine 0 CA--C 1.492 -1.374 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -177.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.429 HG13 ' HB ' ' A' ' 119' ' ' VAL . 7.2 p -67.76 140.39 19.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.534 0.683 . . . . 0.0 110.991 -173.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -96.26 106.75 19.0 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 121.691 0.757 . . . . 0.0 112.02 -175.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.565 ' HB3' HG22 ' A' ' 52' ' ' VAL . 3.3 m-85 -100.97 165.36 11.37 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.246 174.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.452 ' CD2' ' HG2' ' A' ' 55' ' ' LYS . 20.0 m-70 -124.89 110.26 14.03 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.284 0.564 . . . . 0.0 109.553 176.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . . . -78.45 144.91 35.36 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.589 -177.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -90.46 112.61 24.3 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.556 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.2 t -118.33 114.61 45.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.4 m -98.2 131.29 44.68 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -177.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 95.4 t -118.84 133.0 67.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.533 0.682 . . . . 0.0 111.077 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 46' ' ' GLU . 78.3 tttt -102.78 109.97 21.73 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 45' ' ' PRO . 8.9 t30 -130.33 113.2 16.94 Favored Pre-proline 0 C--N 1.302 -1.497 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.95 -175.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -102.88 97.59 0.04 OUTLIER 'Trans proline' 0 N--CA 1.421 -2.755 0 C-N-CA 122.319 2.013 . . . . 0.0 113.081 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -176.52 150.78 0.9 Allowed 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 170.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.5 t -77.87 8.03 5.15 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 118.039 0.381 . . . . 0.0 111.487 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.428 ' CD ' HG12 ' A' ' 78' ' ' ILE . 6.4 tt0 -101.56 137.64 39.61 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.7 p -94.08 95.57 9.09 Favored 'General case' 0 N--CA 1.399 -2.98 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 170.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.533 ' HB ' HD12 ' A' ' 105' ' ' LEU . 33.6 mt -77.88 126.36 84.12 Favored Pre-proline 0 N--CA 1.434 -1.235 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -174.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.0 133.95 30.51 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.308 2.006 . . . . 0.0 110.538 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 67.7 mt -83.93 107.04 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 55.5 m -55.76 -51.82 66.06 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.853 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -160.55 155.2 23.85 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.253 0.549 . . . . 0.0 110.274 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.472 HG23 HG23 ' A' ' 143' ' ' ILE . 24.8 mm -114.95 113.85 44.81 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 172.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.3 m -93.48 117.28 29.88 Favored 'General case' 0 C--N 1.274 -2.687 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -107.89 129.56 55.08 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.519 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.625 ' HB ' ' HB2' ' A' ' 142' ' ' ASP . 3.0 mp -118.11 108.0 23.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.501 HD21 ' CE2' ' A' ' 139' ' ' TYR . 3.1 tm? -109.96 124.65 51.77 Favored 'General case' 0 C--N 1.27 -2.88 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.847 -175.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.575 ' HB2' ' HB2' ' A' ' 140' ' ' GLN . 29.9 mmtm -93.7 142.81 26.93 Favored 'General case' 0 CA--C 1.479 -1.774 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.738 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 92' ' ' ARG . 45.9 t -97.92 145.54 26.35 Favored 'General case' 0 C--N 1.267 -2.996 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.65 143.83 56.91 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.296 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.4 m 74.1 -61.03 0.51 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.455 1.102 . . . . 0.0 111.001 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.405 ' O ' ' HB3' ' A' ' 89' ' ' SER . 53.3 mtt180 -155.01 172.1 18.66 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.088 0.555 . . . . 0.0 110.165 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.0 m 77.52 160.33 0.21 Allowed 'General case' 0 CA--C 1.563 1.456 0 O-C-N 124.261 0.976 . . . . 0.0 113.207 172.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.418 HD13 ' N ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -147.91 149.26 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 123.727 0.811 . . . . 0.0 109.228 -176.393 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.494 ' HB2' ' OG ' ' A' ' 122' ' ' SER . . . -118.64 134.93 54.75 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.666 0.787 . . . . 0.0 109.221 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.0 p -129.64 158.86 38.16 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.95 162.61 26.03 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.8 p -124.89 128.77 49.16 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 117.054 0.427 . . . . 0.0 110.335 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.8 mt -99.64 105.35 33.43 Favored Pre-proline 0 C--N 1.308 -1.221 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -76.92 116.08 4.16 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.502 2.134 . . . . 0.0 111.722 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.5 t70 53.96 83.33 0.23 Allowed Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 124.95 1.3 . . . . 0.0 112.745 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -101.08 7.8 0.58 Allowed 'Trans proline' 0 N--CA 1.441 -1.613 0 C-N-CA 122.697 2.265 . . . . 0.0 112.015 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 153.77 -164.78 31.35 Favored Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 32.2 p -145.28 158.89 43.72 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.533 HD12 ' HB ' ' A' ' 78' ' ' ILE . 78.4 mt -73.08 157.13 37.9 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 121.209 0.528 . . . . 0.0 111.611 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.401 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 14.6 p -90.4 139.16 18.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.238 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.4 93.82 0.46 Allowed Glycine 0 C--N 1.3 -1.447 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.784 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 67.3 p 60.36 83.15 0.14 Allowed 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 125.697 1.599 . . . . 0.0 113.998 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.88 -160.06 33.61 Favored Glycine 0 N--CA 1.429 -1.785 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.0 t -118.89 142.0 48.15 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.401 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 4.4 t -134.87 138.87 44.56 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.577 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.9 m -91.04 126.24 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 173.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.8 mt -103.04 145.18 30.28 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.718 -176.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -100.79 116.33 32.42 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.175 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.403 ' HA ' ' HD2' ' A' ' 116' ' ' PRO . 29.2 m -126.74 117.77 22.56 Favored Pre-proline 0 C--N 1.316 -0.864 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 177.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 115' ' ' VAL . 33.4 Cg_endo -66.37 124.5 12.58 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.625 2.216 . . . . 0.0 111.579 174.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 97.3 t -124.67 141.01 46.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 120.854 0.359 . . . . 0.0 110.155 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.75 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -87.8 102.12 14.36 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.988 0.899 . . . . 0.0 111.045 178.275 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.429 ' HB ' HG13 ' A' ' 62' ' ' VAL . 48.1 t -97.6 148.39 5.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 75.07 -14.96 0.7 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.909 0.883 . . . . 0.0 111.932 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.409 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 34.4 t80 -56.06 -58.13 9.23 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 124.119 0.967 . . . . 0.0 109.961 -175.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.494 ' OG ' ' HB2' ' A' ' 95' ' ' ALA . 41.4 m -74.93 -26.84 59.91 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.96 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.429 HG21 ' HG2' ' A' ' 129' ' ' LYS . 58.4 mt -71.47 -50.24 41.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.116 -173.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.61 -49.37 75.49 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 123.516 0.51 . . . . 0.0 110.363 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 52.2 t -57.9 -39.39 71.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.217 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.8 t -82.25 -82.6 0.13 Allowed 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 128' ' ' MET . 2.0 pp -125.6 -27.0 3.45 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -173.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.445 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.1 tpt 69.9 125.76 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.955 0.902 . . . . 0.0 111.458 -174.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.429 ' HG2' HG21 ' A' ' 123' ' ' ILE . 27.0 mmmt -72.34 -36.28 68.78 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-O 122.057 0.932 . . . . 0.0 110.431 -177.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.8 t70 78.0 76.05 0.06 Allowed 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 112.072 -2.331 . . . . 0.0 106.512 -171.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.512 ' HG2' ' CD1' ' A' ' 135' ' ' TRP . 5.8 tmm? -69.69 114.69 8.13 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 112.859 -1.973 . . . . 0.0 109.599 -171.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 55.6 m -91.2 -179.67 5.48 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.124 -174.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 22.4 p -80.2 105.1 11.22 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-O 121.839 0.828 . . . . 0.0 110.785 178.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.5 t70 78.24 98.52 0.06 Allowed 'General case' 0 CA--C 1.487 -1.456 0 C-N-CA 126.553 1.941 . . . . 0.0 107.555 -170.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.512 ' CD1' ' HG2' ' A' ' 131' ' ' MET . 32.9 t-105 -148.89 148.45 29.86 Favored 'General case' 0 C--N 1.276 -2.591 0 CA-C-N 113.976 -1.466 . . . . 0.0 108.716 -171.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -125.87 141.16 52.11 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.56 132.29 54.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -105.58 109.65 21.69 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.574 ' OH ' HG11 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -113.01 172.07 7.16 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.287 -0.965 . . . . 0.0 108.971 173.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.575 ' HB2' ' HB2' ' A' ' 88' ' ' LYS . 63.2 mt-30 -118.29 130.79 56.24 Favored 'General case' 0 C--N 1.274 -2.685 0 C-N-CA 120.414 -0.514 . . . . 0.0 109.719 -174.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 35.6 tp -116.45 125.69 52.35 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.246 0.546 . . . . 0.0 112.043 -177.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.625 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 13.7 m-20 -120.0 119.69 34.16 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.472 HG23 HG23 ' A' ' 83' ' ' ILE . 42.4 mm -112.97 123.75 68.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -96.13 103.85 3.0 Favored Glycine 0 N--CA 1.418 -2.514 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 176.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 156' ' ' THR . 2.9 mm? -76.83 101.75 6.01 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 123.195 0.598 . . . . 0.0 110.026 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.9 m -91.37 115.58 28.14 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.101 0.477 . . . . 0.0 111.487 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.567 ' CE2' ' HB3' ' A' ' 145' ' ' LEU . 60.4 m-85 -126.67 153.03 45.94 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -158.31 140.83 14.43 Favored 'General case' 0 CA--C 1.479 -1.762 0 CA-C-O 121.463 0.649 . . . . 0.0 112.221 173.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 50.0 mm -121.6 128.31 25.69 Favored Pre-proline 0 C--N 1.292 -1.911 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -46.73 -43.55 23.22 Favored 'Trans proline' 0 N--CA 1.483 0.907 0 C-N-CA 123.633 2.889 . . . . 0.0 114.207 -176.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.18 -52.49 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 121.722 0.772 . . . . 0.0 109.313 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.467 HG22 ' HD3' ' A' ' 38' ' ' LYS . 7.2 p 173.04 140.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 C-N-CA 125.488 1.515 . . . . 0.0 107.072 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.455 ' H ' ' H ' ' A' ' 154' ' ' ASP . . . 150.54 15.22 0.08 OUTLIER Glycine 0 C--N 1.291 -1.969 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -177.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.455 ' H ' ' H ' ' A' ' 153' ' ' GLY . 10.6 p-10 -73.21 118.05 15.69 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 126.031 1.733 . . . . 0.0 110.254 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.538 HG12 HD11 ' A' ' 39' ' ' LEU . 8.2 tp -162.59 144.14 3.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.499 -178.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 96.3 m -123.02 104.1 9.01 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 166.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 58.2 mt -87.88 112.94 52.3 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.328 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 156' ' ' THR . 26.9 Cg_endo -84.06 111.07 1.61 Allowed 'Trans proline' 0 N--CA 1.436 -1.864 0 C-N-CA 122.214 1.943 . . . . 0.0 111.587 176.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.4 m -106.49 134.95 46.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.409 ' HB3' ' OD1' ' A' ' 142' ' ' ASP . 29.6 p -126.1 157.44 38.03 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -175.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.475 HG22 HG13 ' A' ' 49' ' ' VAL . 14.6 t -170.47 170.67 6.85 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 176.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -99.67 132.19 45.17 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -101.72 104.64 2.71 Favored Glycine 0 N--CA 1.415 -2.73 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -90.04 119.46 30.41 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.53 HD11 ' CE1' ' A' ' 139' ' ' TYR . 5.7 mm -106.82 119.08 55.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 -174.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 62.9 tttp -92.99 117.72 30.38 Favored 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.153 175.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 95.6 mt -108.44 93.1 10.97 Favored Pre-proline 0 C--N 1.284 -2.26 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.841 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 166' ' ' LYS . 10.0 Cg_endo -86.42 82.34 1.36 Allowed 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 122.885 2.39 . . . . 0.0 112.861 -174.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 79.3 p 55.91 15.9 1.89 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.083 1.353 . . . . 0.0 113.777 177.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 49.7 tp -59.57 -56.68 18.86 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.134 0.574 . . . . 0.0 111.238 -176.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.438 ' O ' ' HD1' ' A' ' 173' ' ' PHE . 47.8 mtm105 65.28 145.24 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 179.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 76.79 -4.68 2.31 Favored 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 124.794 1.237 . . . . 0.0 114.023 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.438 ' HD1' ' O ' ' A' ' 171' ' ' ARG . 27.1 m-85 . . . . . 0 C--N 1.303 -1.43 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 . . . . . 0 CA--C 1.507 -0.711 0 CA-C-O 121.068 0.461 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 18' ' ' GLU . 1.5 mp0 -66.81 -31.1 71.5 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.386 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -74.51 -41.0 61.44 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -176.283 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.6 m -66.83 -29.44 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.1 m -73.03 -29.59 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.86 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 48.6 mt-10 -69.09 -34.59 75.35 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 176.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 7.7 mm-40 -59.25 -46.98 87.04 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.58 175.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.16 -45.45 93.36 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.653 177.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.15 -36.33 77.31 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.739 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.4 t -65.45 -35.55 81.25 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.82 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 91.2 t -70.71 -33.29 52.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.573 0.702 . . . . 0.0 110.027 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.578 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 59.0 mt -69.56 -40.98 80.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 174.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.1 m -66.86 -29.0 68.79 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.106 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.3 p -70.54 -34.78 72.66 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 120.914 0.388 . . . . 0.0 110.532 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.413 ' HB3' HG21 ' A' ' 156' ' ' THR 0.263 7.9 mp -79.38 -18.57 52.07 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 119.227 -0.989 . . . . 0.0 112.991 172.129 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 81.2 mt -68.62 -34.24 75.41 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 171.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.48 -40.45 70.23 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.324 176.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -52.01 -59.75 3.99 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.986 173.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 35' ' ' PHE . . . -59.75 -39.9 86.34 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.365 177.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -55.36 -31.96 62.18 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 123.345 0.658 . . . . 0.0 111.165 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.484 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -95.36 -77.83 1.38 Allowed Glycine 0 N--CA 1.425 -2.044 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.975 177.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 48.1 t80 -63.64 -39.96 95.67 Favored 'General case' 0 C--O 1.209 -1.074 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -174.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.488 ' HA ' HD23 ' A' ' 39' ' ' LEU . 82.1 t80 -69.87 -42.42 73.53 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 118.25 -1.38 . . . . 0.0 111.016 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 40' ' ' ALA . . . -62.07 -44.68 96.15 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 33' ' ' GLY . 14.3 pt-20 -94.74 -41.74 9.1 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -176.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 34' ' ' PHE . 15.2 tppt? -75.32 -45.4 39.82 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 121.824 0.821 . . . . 0.0 109.28 -173.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.502 HD11 HG21 ' A' ' 152' ' ' VAL . 3.8 mm? -86.8 7.29 27.58 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.297 -1.319 . . . . 0.0 112.82 -174.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 36' ' ' ALA . . . -76.02 -10.6 59.55 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.606 0.717 . . . . 0.0 109.843 176.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -112.99 2.12 15.65 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.117 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.4 mp -124.45 118.11 26.37 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -71.61 94.11 0.69 Allowed 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 122.36 2.04 . . . . 0.0 112.927 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.496 ' HB ' ' HD2' ' A' ' 45' ' ' PRO . 21.8 p -91.5 170.59 9.3 Favored Pre-proline 0 C--N 1.307 -1.248 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.414 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.496 ' HD2' ' HB ' ' A' ' 44' ' ' THR . 55.6 Cg_endo -65.36 146.78 86.55 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.559 1.506 . . . . 0.0 110.547 174.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -97.45 126.11 42.52 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.539 ' O ' HG11 ' A' ' 159' ' ' VAL . . . -97.38 146.13 25.48 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.8 t -161.23 120.85 2.6 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.075 0.464 . . . . 0.0 110.712 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -83.84 138.02 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -97.51 -59.01 1.87 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.106 -1.037 . . . . 0.0 110.922 -168.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -173.85 -178.04 1.49 Allowed 'General case' 0 C--O 1.249 1.052 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.661 HG22 ' HB3' ' A' ' 64' ' ' TYR . 7.6 p -130.53 132.35 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.907 0 CA-C-O 121.315 0.579 . . . . 0.0 109.52 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -107.97 136.31 47.89 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.238 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.661 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 45.5 p90 -92.08 141.18 28.88 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.416 ' N ' ' HD3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -124.74 -70.36 0.76 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.066 0.46 . . . . 0.0 110.881 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -112.36 -165.11 17.03 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.984 -174.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.466 ' HB ' ' CD2' ' A' ' 173' ' ' PHE . 13.6 p -117.92 159.99 17.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.129 -0.536 . . . . 0.0 110.042 -176.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 34.0 m -148.19 152.22 36.87 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 173.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.0 ttt-85 -58.94 -40.85 85.89 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.403 0.621 . . . . 0.0 110.446 177.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -117.13 94.39 4.55 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.414 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . 98.3 166.42 31.24 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.57 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.8 t -104.4 148.73 8.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.46 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 29.6 t70 -84.85 107.01 16.79 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.127 0.489 . . . . 0.0 111.877 -175.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.661 ' HB3' HG22 ' A' ' 52' ' ' VAL . 28.7 m-85 -117.46 158.16 24.99 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.768 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -133.18 112.92 12.12 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.528 ' HB3' HG13 ' A' ' 115' ' ' VAL . . . -90.41 144.66 25.59 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -177.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.8 mtmp? -104.34 119.52 39.15 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.93 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.0 t -117.61 109.05 26.22 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.415 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.2 m -100.43 143.28 30.81 Favored 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 119.769 -0.772 . . . . 0.0 111.049 -175.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.31 119.14 51.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -96.28 109.69 22.14 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.584 ' ND2' HD21 ' A' ' 105' ' ' LEU . 6.5 t30 -123.02 115.23 29.2 Favored Pre-proline 0 C--N 1.292 -1.924 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -171.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -97.74 96.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.672 0 C-N-CA 121.742 1.628 . . . . 0.0 110.871 172.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.572 ' HB2' HD21 ' A' ' 72' ' ' ASN . 61.3 m-85 -175.84 119.25 0.16 Allowed 'General case' 0 CA--C 1.488 -1.414 0 C-N-CA 128.086 2.555 . . . . 0.0 105.152 178.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.4 m -69.85 -18.1 63.41 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 123.553 0.533 . . . . 0.0 112.108 -177.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -80.18 134.45 36.14 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-O 121.072 0.463 . . . . 0.0 110.726 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.2 p -80.01 97.19 6.68 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.563 ' HB ' HD13 ' A' ' 105' ' ' LEU . 42.3 mt -81.88 127.05 73.68 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -177.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.73 123.38 13.67 Favored 'Trans proline' 0 C--O 1.241 0.675 0 C-N-CA 122.588 2.192 . . . . 0.0 110.827 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.425 HG12 ' CE2' ' A' ' 147' ' ' PHE . 60.7 mt -69.77 103.51 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-O 121.309 0.576 . . . . 0.0 109.95 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 49.2 t -66.78 -56.82 8.73 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.885 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.555 ' HG3' ' CG2' ' A' ' 98' ' ' THR . 25.8 tt0 -152.24 130.17 11.75 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -175.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.6 mm -118.84 113.91 43.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 170.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 98' ' ' THR . 12.3 t -118.5 142.69 47.34 Favored 'General case' 0 C--N 1.288 -2.085 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.317 -174.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -128.27 144.57 51.14 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 121.301 0.572 . . . . 0.0 111.442 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.433 ' HB ' ' HB2' ' A' ' 142' ' ' ASP . 56.0 mt -120.9 119.65 60.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 174.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.626 HD13 ' HB3' ' A' ' 95' ' ' ALA . 0.4 OUTLIER -103.09 122.29 44.36 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 178.578 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.593 ' HB2' ' HB2' ' A' ' 140' ' ' GLN . 98.5 mttt -123.21 157.3 33.36 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.678 175.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.8 t -152.24 109.02 3.48 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.409 ' O ' ' HB ' ' A' ' 91' ' ' THR . . . 68.6 -77.49 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.232 1.013 . . . . 0.0 110.993 -177.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.409 ' HB ' ' O ' ' A' ' 90' ' ' ALA . 9.0 t 172.5 -28.71 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.155 0.582 . . . . 0.0 110.438 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -64.85 -56.93 10.47 Favored 'General case' 0 C--N 1.345 0.392 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -174.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 51.3 m -125.22 143.92 50.71 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.911 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.556 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 2.1 pp -141.37 178.64 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.209 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -176.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.626 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -135.95 147.11 47.93 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 172.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 39.1 t -131.44 153.12 50.06 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -176.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.46 165.48 36.94 Favored Glycine 0 N--CA 1.426 -1.992 0 C-N-CA 119.697 -1.24 . . . . 0.0 112.131 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.555 ' CG2' ' HG3' ' A' ' 82' ' ' GLN . 86.7 m -149.99 131.72 15.0 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 99' ' ' ILE . 2.8 mp -107.6 115.86 58.57 Favored Pre-proline 0 C--O 1.248 0.996 0 C-N-CA 119.071 -1.052 . . . . 0.0 109.77 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.28 114.75 3.81 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.021 1.814 . . . . 0.0 109.604 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.3 t70 55.15 77.94 0.41 Allowed Pre-proline 0 N--CA 1.482 1.175 0 C-N-CA 124.068 0.947 . . . . 0.0 111.285 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -92.62 3.61 3.62 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.576 2.184 . . . . 0.0 111.875 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 175.32 -157.38 24.02 Favored Glycine 0 N--CA 1.424 -2.166 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.9 p -136.48 139.53 42.39 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 117.196 0.498 . . . . 0.0 110.847 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.584 HD21 ' ND2' ' A' ' 72' ' ' ASN . 7.3 tt -69.67 127.16 32.0 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.818 178.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.496 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 7.3 p -52.74 -45.3 49.16 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -173.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.566 ' H ' HD23 ' A' ' 105' ' ' LEU . . . 86.01 82.86 1.1 Allowed Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 109.201 -1.559 . . . . 0.0 109.201 -172.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.6 m 62.18 90.32 0.07 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.402 1.081 . . . . 0.0 112.561 -176.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 155.19 -173.96 33.4 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 176.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.7 m -108.1 123.66 49.04 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.496 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 3.6 t -117.41 132.01 56.65 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.087 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.6 t -95.99 109.98 23.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.1 mt -91.44 167.1 12.5 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -144.77 149.05 34.83 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.562 -174.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.528 HG13 ' HB3' ' A' ' 66' ' ' ALA . 4.4 p -136.6 127.18 16.36 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.69 176.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.17 113.12 3.6 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.971 1.78 . . . . 0.0 108.774 171.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.1 t -123.1 126.04 72.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -175.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.46 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 14.3 mmmm -88.51 103.93 16.34 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.335 -0.946 . . . . 0.0 108.492 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.626 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 97.5 t -93.72 146.13 6.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.988 -173.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 78.0 -5.93 2.03 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.952 1.301 . . . . 0.0 110.516 -176.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.503 ' O ' HG23 ' A' ' 125' ' ' VAL . 82.4 t80 -58.07 -57.11 14.29 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.825 176.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.2 m -56.27 -39.34 72.47 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.758 -176.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 10.8 tp -77.83 -30.21 16.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.244 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -66.67 -42.64 86.25 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 172.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 121' ' ' TYR . 68.9 t -57.35 -33.19 43.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.529 175.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -75.49 -81.07 0.08 Allowed 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.0 176.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.469 HD23 ' H ' ' A' ' 127' ' ' LEU . 1.9 pt? -126.65 -22.83 3.84 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -177.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.427 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER 70.13 121.83 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -170.234 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.624 ' C ' ' H ' ' A' ' 131' ' ' MET . 0.0 OUTLIER -59.48 -32.31 70.14 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -172.689 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.8 t70 80.95 -16.41 0.65 Allowed 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 -169.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.624 ' H ' ' C ' ' A' ' 129' ' ' LYS 0.343 13.9 tmm? 72.32 -102.1 0.03 OUTLIER 'General case' 0 N--CA 1.416 -2.131 0 C-N-CA 128.456 2.702 . . . . 0.0 113.277 175.966 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 131' ' ' MET . 48.7 t 150.58 -138.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 102.682 -3.081 . . . . 0.0 102.682 -175.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.9 p -133.92 99.1 4.34 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 164.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.67 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 16.2 t70 71.86 92.73 0.08 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.663 1.185 . . . . 0.0 112.805 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.442 ' HE1' ' HA ' ' A' ' 131' ' ' MET . 1.2 p-90 -154.96 159.77 40.64 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 176.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 166' ' ' LYS . 5.7 p-10 -103.55 142.49 34.2 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.22 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.55 HD12 HD21 ' A' ' 167' ' ' LEU . 0.2 OUTLIER -115.62 158.28 16.06 Favored 'Isoleucine or valine' 0 C--O 1.248 1.013 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.763 177.854 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.66 115.37 10.77 Favored 'General case' 0 C--O 1.252 1.204 0 CA-C-O 121.635 0.731 . . . . 0.0 112.186 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -133.39 151.35 51.82 Favored 'General case' 0 N--CA 1.411 -2.384 0 CA-C-N 114.02 -1.446 . . . . 0.0 107.989 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.593 ' HB2' ' HB2' ' A' ' 88' ' ' LYS . 58.1 mt-30 -139.45 150.2 44.92 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.8 tp -139.18 118.96 13.17 Favored 'General case' 0 N--CA 1.419 -1.989 0 O-C-N 124.002 0.814 . . . . 0.0 109.822 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.433 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 22.6 m-20 -122.31 136.35 54.89 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.5 mm -122.05 129.29 75.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.567 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -117.91 88.0 0.44 Allowed Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 176.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 156' ' ' THR . 2.3 pp -84.31 149.2 26.22 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.825 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.461 ' HB ' ' HB3' ' A' ' 82' ' ' GLN . 8.7 m -127.02 120.59 29.39 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -176.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.425 ' CE2' HG12 ' A' ' 80' ' ' ILE . 68.9 m-85 -132.67 141.66 48.71 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -108.46 124.79 50.96 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.634 0.731 . . . . 0.0 110.709 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.483 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -124.88 125.84 25.36 Favored Pre-proline 0 C--N 1.297 -1.711 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.058 178.516 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -41.06 -34.21 1.43 Allowed 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 124.915 3.744 . . . . 0.0 115.88 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 13.5 p -59.3 -35.22 56.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.502 HG21 HD11 ' A' ' 39' ' ' LEU . 31.3 m -132.03 -25.66 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 121.875 -0.516 . . . . 0.0 112.355 -178.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 111.04 -141.7 16.58 Favored Glycine 0 N--CA 1.421 -2.346 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -177.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -92.41 120.42 32.89 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.908 0.385 . . . . 0.0 111.456 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 2.3 pp -130.35 146.24 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.356 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 174.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 4.6 p -95.32 151.06 19.58 Favored 'General case' 0 N--CA 1.397 -3.088 0 CA-C-N 113.978 -1.465 . . . . 0.0 109.98 174.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 57.4 mt -125.34 110.35 26.37 Favored Pre-proline 0 C--N 1.295 -1.787 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 176.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.447 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 97.3 Cg_endo -89.88 114.58 0.57 Allowed 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 123.005 2.47 . . . . 0.0 113.662 -174.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.539 HG11 ' O ' ' A' ' 47' ' ' ALA . 29.1 m -118.13 128.16 75.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.955 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 63.0 p -114.24 144.2 43.61 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.931 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 53.3 m -153.13 136.69 15.95 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 121.114 0.483 . . . . 0.0 110.098 -177.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -98.99 119.47 37.83 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -100.53 115.05 5.19 Favored Glycine 0 N--CA 1.411 -2.974 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.399 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -89.71 118.6 29.44 Favored 'General case' 0 C--N 1.27 -2.86 0 N-CA-C 105.601 -1.999 . . . . 0.0 105.601 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 136' ' ' ASP . 50.3 mm -112.95 108.68 26.16 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.442 -172.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 136' ' ' ASP . 60.5 pttt -86.54 133.65 33.72 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.015 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 134' ' ' ASP . 0.4 OUTLIER -103.41 96.91 9.22 Favored Pre-proline 0 C--N 1.295 -1.779 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 173.957 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.66 78.84 0.95 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.28 1.987 . . . . 0.0 113.62 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.5 ' HA ' ' HE1' ' A' ' 131' ' ' MET . 76.2 p 39.26 79.55 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.707 1.603 . . . . 0.0 114.291 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.441 ' HG ' ' HB2' ' A' ' 173' ' ' PHE . 2.5 mm? -103.65 -61.84 1.37 Allowed 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.004 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 70.22 4.86 5.06 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 121.31 0.576 . . . . 0.0 112.177 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -136.29 -41.19 0.64 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.339 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.466 ' CD2' ' HB ' ' A' ' 57' ' ' VAL . 3.0 m-85 . . . . . 0 CA--C 1.494 -1.178 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 176.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.447 ' O ' HG23 ' A' ' 17' ' ' VAL . 24.2 t70 . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 121.21 0.528 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -77.78 -50.42 12.37 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.021 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.425 ' HD3' ' C ' ' A' ' 15' ' ' LYS . 12.7 tmtt? -57.32 -47.15 82.27 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.771 1.229 . . . . 0.0 112.539 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.0 m -63.22 -21.82 29.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 94' ' ' ILE . 92.8 t -67.34 -49.02 75.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 120.913 0.387 . . . . 0.0 110.14 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.95 -33.61 72.15 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.509 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -77.12 -39.26 50.04 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.831 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -75.45 -35.44 60.91 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 120.747 0.308 . . . . 0.0 111.0 -177.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.78 -35.78 73.36 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.46 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.4 t -63.08 -44.85 94.61 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.915 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.3 t -65.34 -48.55 82.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.965 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.547 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 64.0 mt -61.21 -44.62 98.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.238 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.7 m -62.95 -37.83 88.63 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.677 0.275 . . . . 0.0 111.161 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.5 m -66.03 -36.49 83.38 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.788 0.328 . . . . 0.0 110.629 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.423 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 5.0 tt -67.11 -43.21 83.06 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 83.5 mt -57.78 -46.46 84.55 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.661 177.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.74 -44.12 97.08 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.52 ' HD2' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -64.83 -33.24 75.53 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.583 -178.747 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.52 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -79.38 -40.44 30.11 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.396 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -51.07 -52.65 41.34 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.381 1.073 . . . . 0.0 112.598 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.38 -17.88 79.61 Favored Glycine 0 C--N 1.318 -0.439 0 C-N-CA 120.026 -1.083 . . . . 0.0 112.02 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -75.39 -26.23 58.28 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 123.448 0.699 . . . . 0.0 109.952 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.404 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 27.2 m-85 -79.15 -12.08 59.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -178.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.29 -51.35 70.34 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -174.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.657 ' HG2' ' HD3' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -117.27 -43.45 2.83 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -178.387 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.657 ' HD3' ' HG2' ' A' ' 37' ' ' GLU . 3.7 mppt? -64.52 -34.28 77.87 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.271 -175.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.413 HD13 ' HB ' ' A' ' 42' ' ' ILE . 2.8 mm? -102.95 17.97 22.73 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.725 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.83 -28.07 16.08 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 171.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -94.47 -48.31 6.17 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.815 175.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.413 ' HB ' HD13 ' A' ' 39' ' ' LEU . 75.1 mt -73.99 121.29 84.84 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.96 114.38 3.72 Favored 'Trans proline' 0 C--O 1.246 0.925 0 C-N-CA 122.445 2.097 . . . . 0.0 113.518 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.403 HG23 HD12 ' A' ' 39' ' ' LEU . 23.3 p -114.33 140.41 25.05 Favored Pre-proline 0 N--CA 1.429 -1.498 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.868 173.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -56.12 138.95 84.6 Favored 'Trans proline' 0 C--O 1.24 0.603 0 C-N-CA 122.465 2.11 . . . . 0.0 111.418 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -96.45 109.9 22.36 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-O 121.327 0.584 . . . . 0.0 110.251 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.437 ' CB ' ' HG ' ' A' ' 145' ' ' LEU . . . -98.8 140.26 33.24 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.617 -178.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.5 t -141.98 133.7 27.01 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.315 177.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.554 HG22 HG22 ' A' ' 159' ' ' VAL . 24.3 m -89.45 141.61 14.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -130.93 -48.44 1.02 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -170.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -161.99 169.57 20.85 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.822 -171.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 65' ' ' HIS . 13.0 m -132.24 112.73 20.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.487 0.66 . . . . 0.0 111.562 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -92.34 129.5 38.27 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.243 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -59.27 138.26 57.67 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.982 0.176 . . . . 0.0 111.01 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.592 ' HD3' ' C ' ' A' ' 55' ' ' LYS . 11.7 tmtt? -119.44 -55.7 2.11 Favored 'General case' 0 N--CA 1.411 -2.413 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.033 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.483 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . -176.63 -170.87 39.72 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 118.865 -1.636 . . . . 0.0 113.432 -173.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.6 p -102.61 151.99 5.85 Favored 'Isoleucine or valine' 0 C--O 1.249 1.057 0 CA-C-O 121.709 0.766 . . . . 0.0 112.308 -172.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.764 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 31.3 m -159.97 159.41 32.18 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 103.047 -2.946 . . . . 0.0 103.047 173.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.1 mtm180 -73.15 134.24 44.36 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 118.954 -1.099 . . . . 0.0 110.235 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 76.39 -66.21 0.27 Allowed 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 125.533 1.533 . . . . 0.0 110.989 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.764 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . -107.52 128.22 9.11 Favored Glycine 0 CA--C 1.479 -2.191 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 56' ' ' GLY . 35.5 m -99.75 152.83 4.54 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.425 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 45.8 m-20 -81.12 131.11 35.28 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -174.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -132.14 156.69 45.93 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 125.069 1.347 . . . . 0.0 109.491 174.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.435 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 18.0 m-70 -95.68 108.31 20.59 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 173.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.423 ' HA ' HG12 ' A' ' 52' ' ' VAL . . . -81.68 122.06 27.15 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 170.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -86.27 107.95 18.18 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.788 -174.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.6 t -114.02 109.17 27.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 56.3 p -103.05 128.74 49.79 Favored 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.555 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.2 t -114.66 120.58 64.72 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.262 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 36.2 ttpt -95.88 110.24 22.46 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 175.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -103.6 113.35 65.63 Favored Pre-proline 0 C--N 1.293 -1.878 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.853 -175.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -99.43 97.25 0.05 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.685 0 C-N-CA 122.007 1.805 . . . . 0.0 108.958 169.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -179.35 153.74 0.6 Allowed 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 102.951 -2.981 . . . . 0.0 102.951 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.1 t -79.22 -35.42 41.67 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -172.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -89.45 157.78 17.98 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.796 -0.762 . . . . 0.0 112.218 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.4 m -85.73 111.26 19.97 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 173.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.6 mt -87.97 128.95 52.03 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -175.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -87.19 118.86 1.41 Allowed 'Trans proline' 0 N--CA 1.433 -2.032 0 C-N-CA 122.098 1.865 . . . . 0.0 111.255 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.7 pt -72.04 113.06 8.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 48.5 t -58.43 -47.38 84.12 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.513 ' O ' ' HB ' ' A' ' 146' ' ' THR . 5.0 pp0? -156.29 157.95 36.64 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 174.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.485 ' CG2' HG23 ' A' ' 99' ' ' ILE . 11.8 tt -124.74 127.58 72.8 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.354 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 175.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.4 m -80.64 128.91 34.16 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-O 121.625 0.726 . . . . 0.0 110.963 -171.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -104.23 119.42 38.91 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.458 -175.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.0 mp -131.05 107.05 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 172.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.643 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 1.6 tm? -100.06 130.05 46.17 Favored 'General case' 0 C--N 1.268 -2.943 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -122.29 161.29 23.59 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.5 m -149.97 146.18 26.88 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -41.17 -71.42 0.08 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -174.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.558 ' C ' ' HD2' ' A' ' 92' ' ' ARG . 4.9 t -150.86 80.17 1.32 Allowed 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.558 ' HD2' ' C ' ' A' ' 91' ' ' THR . 3.8 mpt_? -140.0 -63.89 0.49 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 172.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.2 t 179.75 -174.18 0.24 Allowed 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.643 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 38.4 pt -132.1 -174.92 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . . . -132.0 130.33 41.28 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 33.5 p -106.25 179.68 4.2 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.789 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.02 170.14 12.77 Favored Glycine 0 N--CA 1.421 -2.355 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.005 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.9 p -134.46 128.96 34.5 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.485 HG23 ' CG2' ' A' ' 83' ' ' ILE . 7.5 tt -102.8 111.22 64.71 Favored Pre-proline 0 C--N 1.307 -1.255 0 C-N-CA 118.767 -1.173 . . . . 0.0 110.873 177.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.92 118.06 5.14 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 123.321 2.68 . . . . 0.0 113.563 -175.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.3 t70 45.19 79.15 0.35 Allowed Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 125.551 1.541 . . . . 0.0 113.546 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.428 ' HG3' ' CG2' ' A' ' 83' ' ' ILE . 68.4 Cg_endo -92.68 3.2 3.65 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.747 2.298 . . . . 0.0 111.915 175.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 165.85 -177.28 41.06 Favored Glycine 0 N--CA 1.427 -1.961 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.7 m -143.12 150.05 38.95 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.417 HD23 ' H ' ' A' ' 105' ' ' LEU . 0.4 OUTLIER -103.51 142.76 33.72 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.235 -178.733 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.3 m -80.18 165.77 2.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 O-C-N 124.123 0.89 . . . . 0.0 110.504 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.39 133.16 11.56 Favored Glycine 0 N--CA 1.427 -1.902 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.7 p 54.78 75.85 0.28 Allowed 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 124.548 1.139 . . . . 0.0 113.015 -177.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.81 174.84 36.44 Favored Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.792 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 9.0 t -101.83 136.49 41.58 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.7 t -135.82 131.23 35.14 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 121.228 0.537 . . . . 0.0 110.204 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.3 t -95.74 119.28 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.7 mt -102.73 146.96 27.45 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.262 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -113.0 112.69 24.33 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.522 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 28.8 m -112.61 127.25 27.08 Favored Pre-proline 0 C--N 1.305 -1.364 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.249 175.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 12.8 Cg_exo -69.65 111.2 2.72 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.236 1.957 . . . . 0.0 110.598 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.7 t -108.91 134.47 50.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.904 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -91.25 102.19 14.9 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.0 m -93.07 140.12 16.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.388 -174.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 68.55 11.29 8.3 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.749 1.22 . . . . 0.0 109.852 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.414 ' O ' HG12 ' A' ' 125' ' ' VAL . 84.1 t80 -61.04 -44.13 97.86 Favored 'General case' 0 CA--C 1.485 -1.526 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.74 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.1 m -64.8 -31.56 72.84 Favored 'General case' 0 N--CA 1.436 -1.144 0 O-C-N 123.555 0.534 . . . . 0.0 111.878 -177.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 128' ' ' MET . 49.4 mt -77.33 -49.5 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.568 ' HA ' ' CA ' ' A' ' 128' ' ' MET . . . -66.95 -43.78 82.25 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -177.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 121' ' ' TYR . 8.1 p -65.21 -26.24 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.075 0.464 . . . . 0.0 110.079 -177.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.1 t -79.49 -62.17 1.77 Allowed 'General case' 0 N--CA 1.416 -2.167 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.418 HD23 ' H ' ' A' ' 127' ' ' LEU . 1.4 pt? -125.71 -64.19 1.08 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.886 176.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.568 ' CA ' ' HA ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER 173.84 151.21 0.09 Allowed 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 103.352 -2.833 . . . . 0.0 103.352 178.846 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.486 ' N ' ' SD ' ' A' ' 128' ' ' MET . 83.5 mttt -51.4 -51.25 56.3 Favored 'General case' 0 CA--C 1.465 -2.323 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 34.7 t70 174.54 -38.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 125.55 1.782 . . . . 0.0 111.555 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.609 ' HA ' ' CE ' ' A' ' 131' ' ' MET 0.33 2.7 mmt 64.05 99.16 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -171.394 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 84.4 m -156.03 179.87 8.8 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 173.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.461 ' CA ' ' HA ' ' A' ' 169' ' ' SER . 35.3 p -117.49 102.04 8.87 Favored 'General case' 0 N--CA 1.392 -3.354 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 172.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.6 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 19.2 t70 87.65 97.66 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.827 1.651 . . . . 0.0 110.907 -175.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.452 ' CZ2' HD22 ' A' ' 167' ' ' LEU . 6.9 p90 -156.21 159.46 38.96 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -122.08 151.24 41.1 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.4 pp -132.73 158.69 43.34 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -74.62 99.36 3.63 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.897 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.47 ' HE1' ' CD2' ' A' ' 87' ' ' LEU . 17.7 t80 -112.96 157.84 20.99 Favored 'General case' 0 N--CA 1.416 -2.127 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.15 176.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -164.26 159.16 19.69 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 171.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.567 HD13 HG12 ' A' ' 143' ' ' ILE . 1.0 OUTLIER -125.98 152.67 45.38 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.548 177.087 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.1 111.16 14.35 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 169.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.567 HG12 HD13 ' A' ' 141' ' ' LEU . 35.0 mm -115.23 140.7 35.28 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.988 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -119.98 104.04 0.99 Allowed Glycine 0 N--CA 1.434 -1.443 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.224 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 156' ' ' THR . 4.3 mm? -72.72 108.41 5.7 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 122.551 0.341 . . . . 0.0 110.573 177.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 82' ' ' GLN . 43.0 m -101.57 108.58 20.18 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-O 121.384 0.612 . . . . 0.0 110.251 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.459 ' CE2' ' HB3' ' A' ' 145' ' ' LEU . 68.2 m-85 -109.41 136.1 49.38 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.258 3.9 p30 -115.89 110.21 18.68 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 122.233 1.016 . . . . 0.0 110.521 175.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 67.3 mt -117.33 122.31 31.19 Favored Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.36 -19.81 18.29 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 123.713 2.942 . . . . 0.0 113.629 -176.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 62.1 t -72.17 -34.41 49.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.143 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 9.2 p -123.28 -34.39 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 121.82 -153.7 16.74 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -95.34 116.37 28.68 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.407 ' O ' HD12 ' A' ' 155' ' ' ILE . 2.3 pp -126.82 134.01 67.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 55.6 m -111.06 112.12 23.7 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.478 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.9 mp -85.8 117.45 68.75 Favored Pre-proline 0 C--O 1.238 0.471 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -82.37 120.05 3.18 Favored 'Trans proline' 0 CA--C 1.484 -2.001 0 C-N-CA 122.31 2.006 . . . . 0.0 111.496 175.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.554 HG22 HG22 ' A' ' 49' ' ' VAL . 3.1 p -126.95 114.98 39.8 Favored 'Isoleucine or valine' 1 N--CA 1.376 -4.135 0 CA-C-N 112.768 -2.015 . . . . 0.0 109.137 -178.321 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 33.3 p -127.05 162.53 25.82 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.304 -173.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.0 t -169.27 155.22 6.27 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -102.26 141.15 35.56 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -147.11 155.25 26.44 Favored Glycine 0 N--CA 1.422 -2.25 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -101.77 129.99 48.09 Favored 'General case' 0 C--N 1.273 -2.74 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.333 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.432 HD11 HG21 ' A' ' 52' ' ' VAL . 37.1 mm -97.86 108.43 21.8 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.641 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 174.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -105.56 114.35 28.46 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 134' ' ' ASP . 3.3 mp -104.25 105.6 49.99 Favored Pre-proline 0 C--N 1.307 -1.272 0 O-C-N 123.633 0.583 . . . . 0.0 110.459 -174.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -73.37 99.0 1.07 Allowed 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.749 2.299 . . . . 0.0 112.354 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.461 ' HA ' ' CA ' ' A' ' 133' ' ' THR . 47.6 t 64.37 -82.27 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 125.972 1.709 . . . . 0.0 113.624 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.483 ' HB3' ' HB3' ' A' ' 173' ' ' PHE . 42.7 mt 62.66 -72.65 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.695 1.598 . . . . 0.0 112.517 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 64.45 -68.25 0.1 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.125 1.77 . . . . 0.0 111.71 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -100.08 10.37 41.37 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.404 -0.81 . . . . 0.0 110.101 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.483 ' HB3' ' HB3' ' A' ' 170' ' ' LEU . 22.2 t80 . . . . . 0 C--N 1.3 -1.585 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -177.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 120.836 0.351 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.572 ' O ' ' HG3' ' A' ' 18' ' ' GLU . 9.8 pt-20 -58.25 -42.96 87.56 Favored 'General case' 0 C--O 1.206 -1.229 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.95 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.5 ' C ' ' HD2' ' A' ' 15' ' ' LYS . 3.3 tmmm? -72.02 -40.75 68.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.476 0.655 . . . . 0.0 110.004 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.7 t -61.89 -44.57 99.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.802 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.47 HG21 ' HA ' ' A' ' 95' ' ' ALA . 13.3 p -71.22 -27.7 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.99 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.572 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 47.0 mt-10 -75.64 -39.28 57.98 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.204 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.06 -37.94 89.25 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 120.7 0.286 . . . . 0.0 110.572 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -67.1 -45.48 77.08 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.959 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.59 -36.95 72.39 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.11 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.9 t -63.05 -44.9 94.56 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.445 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.06 -42.02 94.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 121.308 0.575 . . . . 0.0 110.072 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.3 mm -68.1 -44.59 84.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.391 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.44 ' HA ' HD12 ' A' ' 28' ' ' LEU . 23.2 t -61.72 -41.58 97.81 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.576 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.8 t -57.34 -37.12 72.05 Favored 'General case' 0 C--O 1.247 0.944 0 C-N-CA 122.9 0.48 . . . . 0.0 110.642 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 tt -73.7 -45.64 51.11 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 25' ' ' SER . 86.3 mt -54.1 -45.5 71.84 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.175 0.59 . . . . 0.0 111.074 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -53.86 -45.42 70.97 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -79.09 -31.73 44.44 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.269 -0.972 . . . . 0.0 111.735 -178.216 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.521 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -75.13 -32.05 61.25 Favored 'General case' 0 C--O 1.21 -1.006 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.95 -177.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -58.58 -47.05 85.6 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.045 0.45 . . . . 0.0 111.02 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.49 -32.99 67.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.124 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -74.57 -40.55 61.58 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 122.615 0.366 . . . . 0.0 110.718 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.456 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 48.6 t80 -64.48 -46.24 83.87 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.89 -14.69 63.02 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.045 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.76 -66.88 1.04 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.001 0.905 . . . . 0.0 110.947 -176.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.438 ' HE2' ' HB2' ' A' ' 38' ' ' LYS . 6.6 tppt? -74.51 -39.32 62.47 Favored 'General case' 0 CA--C 1.453 -2.782 0 CA-C-O 122.937 1.351 . . . . 0.0 107.632 -166.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.479 HD13 HD12 ' A' ' 155' ' ' ILE . 71.7 mt -89.66 0.56 56.88 Favored 'General case' 0 C--N 1.255 -3.516 0 CA-C-N 112.118 -2.31 . . . . 0.0 111.507 -171.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.12 -18.26 29.21 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 173.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -104.71 -39.91 6.17 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.187 -1.369 . . . . 0.0 109.782 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 84.1 mt -83.64 126.4 71.15 Favored Pre-proline 0 C--N 1.312 -1.037 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.73 113.08 1.22 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.987 2.458 . . . . 0.0 112.672 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.417 HG21 HD22 ' A' ' 39' ' ' LEU . 8.2 p -140.43 145.59 41.63 Favored Pre-proline 0 C--N 1.299 -1.602 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.115 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.502 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 37.5 Cg_endo -62.96 135.51 51.92 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.649 2.233 . . . . 0.0 111.888 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.27 106.34 17.98 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 -174.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -102.41 143.01 32.7 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 115.023 -0.989 . . . . 0.0 112.796 -173.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.582 ' HA ' HG21 ' A' ' 159' ' ' VAL . 11.8 t -138.32 144.15 40.26 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.002 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.497 ' HB ' HG22 ' A' ' 161' ' ' THR . 50.6 t -91.95 141.75 14.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 172.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -125.75 -46.54 1.71 Allowed 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 117.261 -1.776 . . . . 0.0 114.075 -169.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -173.96 167.11 4.33 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -172.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.548 ' HB ' ' CD2' ' A' ' 64' ' ' TYR . 2.5 m -127.9 126.71 67.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 C-N-CA 123.254 0.622 . . . . 0.0 111.437 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -104.82 144.75 31.34 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 123.766 0.826 . . . . 0.0 111.249 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.561 ' HA ' ' CE1' ' A' ' 64' ' ' TYR . 44.5 p90 -58.85 130.33 46.44 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.538 ' HD3' ' C ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -118.81 -52.06 2.34 Favored 'General case' 0 N--CA 1.391 -3.422 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -175.242 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.442 ' O ' ' HE1' ' A' ' 173' ' ' PHE . . . -145.17 -173.08 16.09 Favored Glycine 0 CA--C 1.472 -2.651 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 177.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.0 m -125.81 129.45 72.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 117.804 0.802 . . . . 0.0 110.177 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.0 m -161.15 135.5 7.11 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.33 154.44 19.22 Favored 'General case' 0 C--N 1.286 -2.186 0 C-N-CA 117.268 -1.773 . . . . 0.0 109.662 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 78.44 15.86 1.25 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 125.47 1.508 . . . . 0.0 111.042 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.407 ' HA3' ' CD2' ' A' ' 121' ' ' TYR . . . 138.16 98.41 0.46 Allowed Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.9 p -103.81 142.55 17.24 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-O 120.94 0.4 . . . . 0.0 111.475 -174.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -76.07 111.73 11.77 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 176.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.561 ' CE1' ' HA ' ' A' ' 54' ' ' PHE . 6.9 t80 -121.02 155.99 33.16 Favored 'General case' 0 N--CA 1.41 -2.47 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -169.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -90.98 108.43 19.86 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -174.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.524 ' HA ' HG12 ' A' ' 52' ' ' VAL . . . -99.42 118.69 36.59 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -94.18 125.05 38.58 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.899 -174.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.1 m -124.56 144.97 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 176.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.2 m -130.12 143.46 50.8 Favored 'General case' 0 C--N 1.268 -2.951 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.336 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.502 ' CG2' ' HB2' ' A' ' 45' ' ' PRO . 7.4 p -141.67 134.33 28.94 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.513 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 20.6 pttp -107.29 119.35 39.16 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.78 0.8 . . . . 0.0 109.843 175.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -106.87 116.3 58.89 Favored Pre-proline 0 C--N 1.28 -2.431 0 CA-C-N 114.015 -1.448 . . . . 0.0 111.495 -174.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -89.43 97.16 0.32 Allowed 'Trans proline' 0 N--CA 1.428 -2.35 0 C-N-CA 121.547 1.498 . . . . 0.0 110.943 173.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.411 ' HB3' ' H ' ' A' ' 76' ' ' GLN . 19.3 m-85 179.64 -169.07 0.11 Allowed 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 128.007 2.523 . . . . 0.0 106.15 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.501 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 48.7 m -135.3 17.37 3.41 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.411 ' H ' ' HB3' ' A' ' 74' ' ' TYR . 34.4 tt0 -112.14 128.92 56.36 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.974 -177.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.5 p -75.29 98.51 3.82 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 173.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.613 ' H ' HD11 ' A' ' 105' ' ' LEU . 69.1 mt -72.22 121.9 85.96 Favored Pre-proline 0 C--N 1.302 -1.462 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.876 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.39 139.69 29.21 Favored 'Trans proline' 0 N--CA 1.44 -1.655 0 C-N-CA 122.264 1.976 . . . . 0.0 111.584 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.637 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -84.42 134.83 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.952 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.458 178.272 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 52.8 t -82.65 -41.36 19.52 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -174.0 154.04 2.23 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.389 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.401 HD13 ' CD ' ' A' ' 102' ' ' PRO . 1.7 mp -114.61 113.86 44.93 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 173.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.443 ' OG ' HG22 ' A' ' 98' ' ' THR . 19.8 m -93.63 117.53 30.21 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -112.47 140.35 47.28 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 2.0 mp -116.94 108.01 23.87 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.887 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 174.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.539 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 1.2 tm? -90.52 120.36 31.55 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 -172.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -125.92 155.96 40.48 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -172.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.4 t -109.59 147.58 32.78 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 112.133 -2.303 . . . . 0.0 105.483 174.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -50.8 -26.26 5.47 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -176.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 87.6 m -149.65 -53.19 0.16 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -106.55 120.71 42.66 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -170.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 27.5 m 72.42 132.45 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.908 1.283 . . . . 0.0 114.306 173.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.442 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.7 pp -135.03 165.37 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.539 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . . . -119.98 156.64 30.47 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 174.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 27.2 t -160.43 148.41 16.4 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.44 165.45 35.27 Favored Glycine 0 N--CA 1.426 -1.973 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.443 HG22 ' OG ' ' A' ' 84' ' ' SER . 68.3 p -115.62 120.4 39.27 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 61.2 mt -101.87 119.81 55.87 Favored Pre-proline 0 C--N 1.305 -1.331 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.623 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.73 124.7 5.22 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.805 2.336 . . . . 0.0 111.723 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.4 ' HA ' HD11 ' A' ' 80' ' ' ILE . 30.2 t70 52.1 72.08 1.3 Allowed Pre-proline 0 N--CA 1.481 1.099 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.401 ' CD ' HD13 ' A' ' 83' ' ' ILE . 55.9 Cg_endo -103.75 6.19 0.34 Allowed 'Trans proline' 0 N--CA 1.435 -1.944 0 C-N-CA 122.768 2.312 . . . . 0.0 111.595 173.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 156.26 135.04 1.9 Allowed Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.3 m -111.89 146.73 37.21 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.771 0.319 . . . . 0.0 110.397 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.613 HD11 ' H ' ' A' ' 78' ' ' ILE . 3.3 pp -80.41 146.33 31.52 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.78 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 27.5 m -54.84 -46.09 75.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 136.93 -43.28 1.24 Allowed Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.501 ' OG ' ' HA ' ' A' ' 75' ' ' SER . 28.9 m -136.17 115.91 13.02 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 122.164 0.186 . . . . 0.0 111.276 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 105.38 -167.21 14.69 Favored Glycine 0 C--N 1.306 -1.098 0 C-N-CA 120.242 -0.98 . . . . 0.0 114.118 172.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.424 ' OG1' ' HB3' ' A' ' 71' ' ' LYS . 42.1 m -84.62 121.17 27.26 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 121.409 0.623 . . . . 0.0 110.373 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.432 HG21 ' HB2' ' A' ' 105' ' ' LEU . 5.5 t -125.94 138.22 53.75 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.5 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.3 m -94.27 128.69 45.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.412 0.625 . . . . 0.0 110.781 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.1 mt -125.56 157.92 35.88 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -143.54 141.18 30.61 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.476 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 43.0 t -112.3 130.19 23.58 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -77.61 109.89 2.85 Favored 'Trans proline' 0 N--CA 1.419 -2.862 0 N-CA-C 107.578 -1.739 . . . . 0.0 107.578 169.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.6 m -113.17 151.6 15.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -87.22 101.29 13.38 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.406 HG22 ' HB2' ' A' ' 64' ' ' TYR . 21.6 m -93.06 146.89 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.485 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -177.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 69.35 3.56 4.2 Favored 'General case' 0 C--O 1.205 -1.238 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.597 -178.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.407 ' CD2' ' HA3' ' A' ' 61' ' ' GLY . 8.3 t80 -67.86 -37.62 82.07 Favored 'General case' 0 C--O 1.203 -1.349 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.5 p -79.27 -29.87 42.76 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.327 0.585 . . . . 0.0 110.271 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.0 mt -79.88 -50.95 17.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.08 -174.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.35 -38.97 85.69 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 123.339 0.656 . . . . 0.0 111.028 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 121' ' ' TYR . 25.1 t -71.5 -36.34 60.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.924 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.0 t -85.01 -69.19 0.67 Allowed 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.936 -176.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.515 HD23 ' H ' ' A' ' 127' ' ' LEU . 1.9 pt? -125.09 -29.26 3.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -172.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 68.31 166.86 0.26 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.707 0.765 . . . . 0.0 112.904 -173.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.433 ' HD3' ' N ' ' A' ' 129' ' ' LYS . 1.9 mppt? -101.66 -66.31 0.93 Allowed 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 177.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 162.49 -24.85 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 -177.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.9 tpt 65.52 93.11 0.07 Allowed 'General case' 0 C--N 1.347 0.461 0 CA-C-N 112.819 -1.991 . . . . 0.0 112.367 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.55 ' HB2' ' HB2' ' A' ' 135' ' ' TRP . 77.2 m -95.1 149.79 20.9 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.575 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.825 ' HB ' ' OG ' ' A' ' 169' ' ' SER . 22.1 p -82.27 118.49 23.17 Favored 'General case' 1 N--CA 1.339 -6.021 0 C-N-CA 124.89 1.276 . . . . 0.0 107.604 175.318 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 70.57 83.05 0.15 Allowed 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -173.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.55 ' HB2' ' HB2' ' A' ' 132' ' ' CYS . 42.4 t-105 -154.89 143.53 20.65 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.125 -167.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -108.82 144.08 37.16 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 175.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.417 ' CG2' ' HB ' ' A' ' 165' ' ' ILE . 0.0 OUTLIER -139.68 130.51 32.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.53 105.02 16.52 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 122.914 1.34 . . . . 0.0 111.811 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.42 ' HD1' ' O ' ' A' ' 163' ' ' GLY . 0.1 OUTLIER -108.08 161.14 15.23 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 113.826 -1.534 . . . . 0.0 107.954 177.402 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -138.47 158.55 44.06 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 121.42 -0.8 . . . . 0.0 111.079 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.582 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 2.3 pt? -154.53 122.88 6.05 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.857 167.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -102.25 140.29 36.72 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 158' ' ' PRO . 46.7 mt -125.28 149.17 29.77 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 C-N-CA 120.321 -0.551 . . . . 0.0 111.702 -173.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -119.41 89.94 0.47 Allowed Glycine 0 N--CA 1.421 -2.363 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 174.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -68.76 107.78 3.16 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.604 ' OG1' HG22 ' A' ' 156' ' ' THR . 11.0 m -92.12 107.94 19.57 Favored 'General case' 0 N--CA 1.421 -1.919 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.068 -176.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -109.25 141.2 41.88 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -109.8 109.92 20.75 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.535 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -115.12 145.98 35.31 Favored Pre-proline 0 C--N 1.314 -0.972 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.181 -178.394 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.63 -14.73 41.75 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.96 2.44 . . . . 0.0 113.159 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 43.4 t -71.7 -43.17 70.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 120.801 0.334 . . . . 0.0 110.667 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 49.0 t -127.81 -66.31 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.215 0.531 . . . . 0.0 110.59 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.454 ' O ' HD13 ' A' ' 149' ' ' ILE . . . 157.85 -139.9 6.68 Favored Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -177.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -90.0 117.52 28.86 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.722 0.772 . . . . 0.0 110.34 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 146' ' ' THR . 21.3 pt -117.35 128.53 74.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.483 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.604 HG22 ' OG1' ' A' ' 146' ' ' THR . 74.4 p -89.56 107.22 18.96 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 173.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 64.5 mt -80.42 112.75 33.67 Favored Pre-proline 0 C--N 1.295 -1.799 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 74.3 Cg_endo -82.17 151.81 16.03 Favored 'Trans proline' 0 CA--C 1.477 -2.346 0 C-N-CA 122.379 2.053 . . . . 0.0 112.804 -178.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.582 HG21 ' HA ' ' A' ' 48' ' ' THR . 2.7 p -161.7 123.15 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.387 -3.591 0 CA-C-N 112.721 -2.036 . . . . 0.0 108.149 -173.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 79.8 p -131.61 134.41 45.99 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.156 0.503 . . . . 0.0 111.716 -176.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.497 HG22 ' HB ' ' A' ' 49' ' ' VAL . 9.0 t -168.69 177.96 4.9 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 176.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -100.1 166.35 11.06 Favored 'General case' 0 N--CA 1.416 -2.156 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.213 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.42 ' O ' ' HD1' ' A' ' 139' ' ' TYR . . . -130.03 113.92 1.56 Allowed Glycine 0 N--CA 1.408 -3.199 0 N-CA-C 107.691 -2.164 . . . . 0.0 107.691 176.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -88.96 128.75 35.7 Favored 'General case' 0 C--N 1.262 -3.214 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -177.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.417 ' HB ' ' CG2' ' A' ' 137' ' ' ILE . 29.6 mm -97.18 114.03 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.064 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.615 ' H ' ' HD2' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -86.58 99.07 11.44 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 114.317 -1.31 . . . . 0.0 109.435 -178.86 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 90.3 mt -103.01 106.09 49.0 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 114.877 -1.056 . . . . 0.0 113.224 -173.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 166' ' ' LYS . 10.2 Cg_exo -75.67 -177.85 3.88 Favored 'Trans proline' 0 CA--C 1.55 1.305 0 C-N-CA 122.259 1.973 . . . . 0.0 109.586 170.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.825 ' OG ' ' HB ' ' A' ' 133' ' ' THR . 20.2 m -64.43 90.62 0.07 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 175.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.63 -38.39 4.91 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.855 175.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 66.07 -55.78 0.37 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.976 0.91 . . . . 0.0 112.497 -173.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -115.93 99.51 7.33 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.442 ' HE1' ' O ' ' A' ' 56' ' ' GLY . 53.7 t80 . . . . . 0 N--CA 1.478 0.969 0 C-N-CA 123.545 0.738 . . . . 0.0 111.052 -174.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.455 ' HA ' HG22 ' A' ' 16' ' ' VAL . 23.3 t70 . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 120.755 0.312 . . . . 0.0 110.745 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 18' ' ' GLU . 1.2 mp0 -59.44 -40.09 85.66 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.704 175.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -66.96 -55.85 12.76 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.068 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.455 HG22 ' HA ' ' A' ' 13' ' ' ASP . 33.3 m -58.11 -39.66 73.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.042 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 p -66.69 -39.8 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.676 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 45.3 mt-10 -65.56 -39.22 91.44 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.4 ' HG2' ' HA ' ' A' ' 16' ' ' VAL . 13.1 pt-20 -74.29 -38.01 63.49 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.428 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 16' ' ' VAL . 75.1 mmtt -64.99 -45.49 85.42 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.832 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.544 ' HB2' HD11 ' A' ' 94' ' ' ILE . . . -58.04 -41.59 83.56 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.159 178.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.2 t -56.44 -44.34 80.37 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 123.836 0.71 . . . . 0.0 110.073 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.7 t -73.97 -51.14 25.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.555 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.5 mt -57.83 -48.22 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.836 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.7 t -62.32 -35.16 78.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.609 0.243 . . . . 0.0 110.51 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.3 m -71.63 -21.3 61.85 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.319 0.581 . . . . 0.0 110.907 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.606 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 6.6 tt -79.82 -41.15 27.01 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.439 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 6.2 mp -65.61 -33.18 75.31 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 118.824 -1.15 . . . . 0.0 108.553 173.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -57.9 -37.15 73.48 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.146 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -70.81 -30.76 67.29 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.471 0.653 . . . . 0.0 110.582 179.407 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.492 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -78.67 -32.07 46.95 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.276 -177.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 98.5 mttt -48.49 -46.42 38.2 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.164 0.586 . . . . 0.0 111.988 -178.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.98 -33.57 84.4 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.207 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -81.47 -45.65 15.69 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 49.6 t80 -62.18 -51.92 65.87 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -175.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.6 -44.79 62.96 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -174.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -117.05 -38.87 3.31 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -177.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.15 -32.17 15.93 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.9 -164.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 83.8 mt -85.27 -11.44 54.79 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.33 -178.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.3 -29.82 71.07 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.118 0.485 . . . . 0.0 111.368 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -105.89 16.85 24.56 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.442 0.639 . . . . 0.0 110.099 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.5 mt -127.31 124.61 23.75 Favored Pre-proline 0 C--N 1.309 -1.179 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -57.87 96.38 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.402 2.068 . . . . 0.0 112.782 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.9 p -128.43 144.49 52.17 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -51.79 120.05 6.52 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.21 1.94 . . . . 0.0 110.941 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.439 ' HB3' ' CG ' ' A' ' 71' ' ' LYS . 35.1 tt0 -96.43 111.62 23.66 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -173.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.84 146.85 35.72 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.216 -173.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.58 ' HA ' HG21 ' A' ' 159' ' ' VAL . 9.7 t -141.04 155.03 46.24 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 176.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.558 HG23 HG22 ' A' ' 159' ' ' VAL . 92.4 t -82.14 141.49 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 173.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -106.95 -56.09 2.24 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -166.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -170.21 -173.68 1.55 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -174.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.639 HG13 ' CD2' ' A' ' 64' ' ' TYR . 89.4 t -136.8 103.41 3.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 C-N-CA 123.342 0.657 . . . . 0.0 109.921 -175.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.433 ' HB3' ' HD3' ' A' ' 55' ' ' LYS . 28.0 m-20 -93.45 104.99 17.1 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.357 177.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.607 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 63.5 t80 -74.62 105.34 5.67 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.611 0.764 . . . . 0.0 109.344 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.607 ' HD2' ' C ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -147.75 116.04 6.57 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.119 0.568 . . . . 0.0 111.165 -176.646 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.11 163.29 15.54 Favored Glycine 0 C--N 1.295 -1.723 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.855 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.2 p -145.13 153.11 14.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.1 t -155.07 -177.28 6.42 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.427 ' NH2' ' HB3' ' A' ' 60' ' ' ASP . 3.2 tmm_? -80.74 -46.94 14.68 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -178.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.427 ' HB3' ' NH2' ' A' ' 59' ' ' ARG . 7.5 p-10 -99.77 95.16 6.74 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.726 0.774 . . . . 0.0 111.156 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.5 -166.14 29.08 Favored Glycine 0 N--CA 1.416 -2.659 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.508 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 81.4 t -143.89 124.72 9.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 178.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -68.04 137.84 55.36 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.248 0.546 . . . . 0.0 110.992 -178.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.714 ' CD1' ' HB ' ' A' ' 119' ' ' VAL . 29.4 p90 -144.3 167.05 23.38 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 172.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 39.2 m-70 -103.5 114.32 28.51 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -77.57 106.02 9.09 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 178.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.401 ' HE2' ' HB ' ' A' ' 112' ' ' VAL . 19.9 tptm -87.8 125.74 34.61 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.867 -171.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 49' ' ' VAL . 33.7 m -133.98 144.66 34.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.5 p -122.95 132.2 54.05 Favored 'General case' 0 C--N 1.282 -2.333 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.073 177.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.1 t -126.02 134.32 66.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.481 -174.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 22.1 ptmt -105.89 146.65 29.69 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 173.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.64 ' O ' ' HA ' ' A' ' 108' ' ' SER . 46.7 t-20 -128.51 121.96 21.54 Favored Pre-proline 0 C--N 1.28 -2.417 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.972 -173.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -98.46 96.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.568 0 C-N-CA 121.582 1.521 . . . . 0.0 109.549 167.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.459 ' HB2' ' OD1' ' A' ' 72' ' ' ASN . 26.1 m-85 175.77 179.58 0.16 Allowed 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 128.727 2.811 . . . . 0.0 105.356 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.3 t -126.02 5.58 7.23 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 120.316 -0.554 . . . . 0.0 109.699 176.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -100.95 140.16 35.63 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.869 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 63.1 m -76.7 97.87 4.59 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 171.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 64.9 mt -72.83 124.69 91.03 Favored Pre-proline 0 C--N 1.307 -1.279 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.719 -177.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -69.38 127.7 15.29 Favored 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 121.817 1.678 . . . . 0.0 109.38 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 58.1 mt -80.72 113.88 20.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 100' ' ' PRO . 49.6 t -56.2 -53.02 62.14 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.635 -178.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -167.8 162.4 13.73 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.595 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 98' ' ' THR . 13.4 tt -124.11 115.31 44.52 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 175.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.413 ' HB3' HG22 ' A' ' 98' ' ' THR . 65.5 p -94.08 118.1 31.05 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -108.41 135.09 50.28 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.307 178.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.411 ' HB ' ' HB3' ' A' ' 142' ' ' ASP . 2.9 mp -118.27 111.32 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 175.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.546 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -91.67 120.99 32.92 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 140' ' ' GLN . 39.6 ttmt -123.54 139.38 54.07 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.407 -177.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.547 ' OG ' ' HB2' ' A' ' 122' ' ' SER . 49.5 m -115.42 145.13 42.85 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.806 176.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.6 113.42 2.69 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.282 -176.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.7 m 69.23 9.81 7.51 Favored 'General case' 0 CA--C 1.57 1.718 0 C-N-CA 124.408 1.083 . . . . 0.0 112.252 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -121.46 -170.79 2.09 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 121.502 -0.748 . . . . 0.0 111.098 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.0 t -74.51 -172.96 1.63 Allowed 'General case' 0 C--O 1.253 1.277 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.546 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.6 pp -138.07 168.44 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -176.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . . . -119.09 140.62 49.78 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.7 p -141.25 140.33 33.89 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.689 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -165.63 153.35 23.3 Favored Glycine 0 N--CA 1.434 -1.498 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.416 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 27.2 p -118.28 122.6 43.32 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 178.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.416 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.2 mp -102.91 108.26 57.8 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 118.301 -1.359 . . . . 0.0 109.717 176.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 98' ' ' THR . 11.7 Cg_exo -71.93 118.25 5.54 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.213 1.942 . . . . 0.0 109.389 174.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.9 t70 62.04 81.89 0.23 Allowed Pre-proline 0 N--CA 1.472 0.673 0 O-C-N 124.235 0.959 . . . . 0.0 111.577 -174.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -104.63 11.35 0.25 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.474 2.783 . . . . 0.0 110.461 176.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.1 -167.44 26.84 Favored Glycine 0 N--CA 1.422 -2.256 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 46.1 p -151.75 169.49 22.08 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 117.434 0.617 . . . . 0.0 110.641 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.587 HD23 ' H ' ' A' ' 105' ' ' LEU . 1.0 OUTLIER -115.56 131.41 56.94 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.338 0.589 . . . . 0.0 112.085 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.0 29.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 126.432 1.893 . . . . 0.0 115.087 -171.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.639 ' O ' ' HB3' ' A' ' 72' ' ' ASN . . . 71.79 -150.39 46.21 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.129 -177.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 29.7 p -54.42 90.04 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 124.498 1.119 . . . . 0.0 113.657 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 170.9 -166.4 39.59 Favored Glycine 0 CA--C 1.478 -2.262 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 174.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -119.51 135.9 54.57 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.425 HG21 ' HA ' ' A' ' 105' ' ' LEU . 5.0 t -134.58 137.88 44.12 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.105 -178.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.401 ' HB ' ' HE2' ' A' ' 67' ' ' LYS . 27.8 m -91.26 124.2 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.832 177.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.3 mt -120.91 158.9 26.66 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.437 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 4.9 p-10 -147.36 148.47 31.38 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 177.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.6 p -130.54 136.15 28.51 Favored Pre-proline 0 C--N 1.292 -1.897 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.817 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.45 130.5 21.14 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.875 2.383 . . . . 0.0 112.637 178.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.487 HG13 ' CZ ' ' A' ' 64' ' ' TYR . 1.8 p -161.48 150.55 4.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 124.157 0.983 . . . . 0.0 109.262 178.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 13.3 mptt -88.93 133.76 34.19 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.966 0.413 . . . . 0.0 111.708 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.714 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 12.8 p -95.12 145.75 7.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 68.87 0.74 2.84 Favored 'General case' 0 C--O 1.216 -0.694 0 C-N-CA 124.426 1.09 . . . . 0.0 112.482 175.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -49.85 -46.47 51.42 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.784 1.233 . . . . 0.0 111.144 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.547 ' HB2' ' OG ' ' A' ' 89' ' ' SER . 17.0 m -69.75 -38.54 76.84 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.166 -175.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.499 HD13 ' HA ' ' A' ' 129' ' ' LYS . 19.7 tt -80.25 -27.46 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 O-C-N 121.94 -0.475 . . . . 0.0 111.342 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.649 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -52.63 -51.57 59.45 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 124.207 1.003 . . . . 0.0 112.046 177.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.5 m -61.32 -21.88 26.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -175.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.8 m -95.79 -78.08 0.46 Allowed 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 120.746 -0.382 . . . . 0.0 112.004 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.558 HD23 ' H ' ' A' ' 127' ' ' LEU . 2.1 pt? -120.72 -0.89 10.1 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.554 -174.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.649 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 25.1 ttt 53.55 76.03 0.23 Allowed 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 124.159 0.984 . . . . 0.0 112.107 -178.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.771 ' HE2' ' SD ' ' A' ' 131' ' ' MET . 55.4 pttt 54.77 -74.25 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 126.591 1.956 . . . . 0.0 113.021 -177.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 36.6 t70 161.56 81.54 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 101.223 -3.621 . . . . 0.0 101.223 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.771 ' SD ' ' HE2' ' A' ' 129' ' ' LYS . 8.9 tpt -56.01 110.96 0.82 Allowed 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -166.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.573 ' SG ' ' HB2' ' A' ' 135' ' ' TRP . 7.1 p -147.09 -176.08 5.07 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 113.707 -1.588 . . . . 0.0 108.874 176.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.637 HG22 ' CB ' ' A' ' 169' ' ' SER . 5.6 m -126.59 107.58 10.34 Favored 'General case' 1 N--CA 1.367 -4.578 0 N-CA-C 103.145 -2.909 . . . . 0.0 103.145 -170.996 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 168' ' ' PRO . 28.9 t70 84.51 101.01 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 125.139 1.376 . . . . 0.0 108.343 -171.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.573 ' HB2' ' SG ' ' A' ' 132' ' ' CYS . 4.8 t-105 -163.94 136.17 4.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.232 -166.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -105.12 145.7 30.19 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.9 tt -155.28 151.08 10.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -114.7 123.25 48.81 Favored 'General case' 0 CA--C 1.498 -1.029 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.789 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -105.09 172.73 6.63 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 88' ' ' LYS . 49.0 mt-30 -119.35 139.96 51.12 Favored 'General case' 0 C--N 1.274 -2.713 0 O-C-N 121.178 -0.951 . . . . 0.0 111.864 -175.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.43 HD11 HD11 ' A' ' 143' ' ' ILE . 25.8 tp -128.45 130.69 47.94 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.697 -178.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.551 ' OD1' ' HB3' ' A' ' 160' ' ' SER . 21.5 t70 -135.41 123.97 23.58 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 141' ' ' LEU . 37.2 mm -115.01 148.41 17.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -121.54 99.1 0.68 Allowed Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 174.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.441 ' HB3' ' CE2' ' A' ' 147' ' ' PHE . 2.9 mm? -79.22 114.78 18.43 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.472 ' OG1' HG22 ' A' ' 156' ' ' THR . 8.2 m -96.36 108.3 20.8 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.441 ' CE2' ' HB3' ' A' ' 145' ' ' LEU . 75.4 m-85 -116.57 146.89 42.33 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -103.28 130.62 50.58 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.532 0.682 . . . . 0.0 110.123 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.01 130.0 16.16 Favored Pre-proline 0 C--N 1.291 -1.967 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -59.41 -21.57 61.8 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 C-N-CA 123.373 2.715 . . . . 0.0 113.668 -172.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.427 HG13 HG23 ' A' ' 152' ' ' VAL . 7.1 p -67.87 -28.27 40.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.598 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.427 HG23 HG13 ' A' ' 151' ' ' VAL . 97.2 t -134.37 -44.79 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.559 0.695 . . . . 0.0 110.613 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 118.79 -115.97 3.24 Favored Glycine 0 C--N 1.29 -1.983 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -174.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -102.32 117.64 35.17 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.081 0.467 . . . . 0.0 112.133 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.546 ' O ' HD12 ' A' ' 155' ' ' ILE 0.265 2.6 pp -123.59 118.57 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-O 121.316 0.579 . . . . 0.0 110.941 170.459 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.472 HG22 ' OG1' ' A' ' 146' ' ' THR . 23.3 p -85.85 108.88 18.34 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.677 177.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 68.5 mt -76.41 114.64 40.13 Favored Pre-proline 0 C--N 1.292 -1.932 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.768 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -82.98 137.22 8.48 Favored 'Trans proline' 0 CA--C 1.475 -2.452 0 C-N-CA 122.849 2.366 . . . . 0.0 111.954 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.58 HG21 ' HA ' ' A' ' 48' ' ' THR . 5.7 p -149.52 112.98 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.38 -3.962 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.096 -174.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.551 ' HB3' ' OD1' ' A' ' 142' ' ' ASP . 58.3 p -120.49 155.36 33.75 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.599 -177.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.3 t -163.0 171.79 15.99 Favored 'General case' 0 C--O 1.255 1.358 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -99.43 126.89 45.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -94.09 85.86 1.06 Allowed Glycine 0 N--CA 1.413 -2.885 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -88.5 119.55 29.05 Favored 'General case' 0 N--CA 1.42 -1.972 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 8.4 pt -140.11 177.07 4.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.542 -171.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.476 ' H ' ' HD2' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -130.19 143.83 51.01 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.447 -176.326 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.0 mp -125.59 97.98 35.41 Favored Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 171.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.626 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 33.1 Cg_endo -64.06 170.11 9.52 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.613 2.209 . . . . 0.0 111.332 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.637 ' CB ' HG22 ' A' ' 133' ' ' THR . 26.5 p -40.37 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 173.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 168' ' ' PRO . 3.5 pp -162.01 132.12 4.77 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.951 177.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.429 ' NH2' ' HA ' ' A' ' 132' ' ' CYS . 64.9 mtt180 -132.86 85.67 2.24 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 172.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 23.9 t70 177.19 -38.34 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 O-C-N 123.835 0.709 . . . . 0.0 110.608 -174.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 CA--C 1.49 -1.333 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 176.564 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.648 ' O ' HG23 ' A' ' 17' ' ' VAL . 38.6 t70 . . . . . 0 CA--C 1.511 -0.539 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -58.79 -39.96 82.64 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.188 175.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 40.4 tttp -64.13 -56.9 11.56 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.698 176.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.594 HG22 ' HA ' ' A' ' 13' ' ' ASP . 25.6 m -58.96 -24.65 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 13' ' ' ASP . 67.2 t -67.26 -50.23 64.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 172.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -62.34 -30.12 70.94 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.336 -177.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.509 ' CG ' ' HA ' ' A' ' 16' ' ' VAL . 40.0 mm-40 -54.77 -52.15 63.48 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.624 176.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -78.49 -31.37 47.75 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 120.109 -0.636 . . . . 0.0 111.908 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.9 -42.79 80.55 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 123.271 0.357 . . . . 0.0 110.19 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.2 t -59.43 -41.72 90.2 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.667 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 67.2 t -66.93 -49.39 74.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-O 120.836 0.35 . . . . 0.0 110.45 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.526 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 68.0 mt -60.89 -42.77 93.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.22 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.8 m -65.58 -32.51 74.14 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.38 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.8 t -71.44 -34.67 70.48 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.542 HD22 ' OG1' ' A' ' 156' ' ' THR . 3.2 tt -65.84 -41.89 91.19 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 176.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 83.4 mt -57.77 -38.71 75.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.116 177.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -61.16 -41.98 97.73 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 27' ' ' LEU . 65.6 pttt -71.81 -38.81 70.15 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.838 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.05 -31.76 68.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.25 -176.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -62.58 -42.2 99.41 Favored 'General case' 0 C--O 1.246 0.888 0 CA-C-O 121.023 0.44 . . . . 0.0 110.809 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.95 -33.56 36.5 Favored Glycine 0 CA--C 1.51 -0.281 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.411 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 7.4 t80 -57.17 -46.31 82.9 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.617 ' HA ' HD13 ' A' ' 39' ' ' LEU . 10.5 t80 -52.9 -53.31 51.06 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.066 1.347 . . . . 0.0 111.326 174.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.37 -33.22 58.71 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -174.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -99.15 -64.25 1.05 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.281 0.562 . . . . 0.0 112.457 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.3 mtmm -79.95 -22.45 42.62 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -169.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.617 HD13 ' HA ' ' A' ' 35' ' ' PHE . 5.7 mp -98.86 6.96 46.53 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-O 121.679 0.752 . . . . 0.0 109.805 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.95 -35.72 11.88 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -90.48 -18.21 25.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.398 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.8 mt -115.12 112.95 44.01 Favored Pre-proline 0 C--N 1.309 -1.194 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.6 97.36 0.88 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.187 1.925 . . . . 0.0 113.076 -176.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.3 p -93.01 159.34 35.86 Favored Pre-proline 0 N--CA 1.43 -1.43 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.982 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.05 147.35 90.68 Favored 'Trans proline' 0 C--O 1.239 0.556 0 C-N-CA 122.946 2.43 . . . . 0.0 111.596 174.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 38.4 tt0 -110.27 109.63 20.15 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.45 138.42 35.69 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.581 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.8 t -135.14 129.23 33.53 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.318 0.58 . . . . 0.0 110.957 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.539 ' H ' HG11 ' A' ' 159' ' ' VAL . 48.1 t -105.48 141.01 21.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 177.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -158.08 -31.96 0.07 Allowed 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -170.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -145.69 151.65 38.37 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 118.923 -1.111 . . . . 0.0 111.755 -171.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.462 HG12 ' HB2' ' A' ' 66' ' ' ALA . 28.9 m -124.28 152.19 29.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 123.433 0.693 . . . . 0.0 110.712 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -114.86 117.0 29.47 Favored 'General case' 0 C--O 1.246 0.888 0 C-N-CA 122.841 0.456 . . . . 0.0 111.802 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -64.69 107.94 1.57 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 167.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 63' ' ' ASP . 14.6 ptmm? -107.05 -16.4 14.44 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.103 -0.639 . . . . 0.0 112.663 -176.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 159.65 -178.51 35.72 Favored Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 119.296 -1.431 . . . . 0.0 112.67 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.88 151.37 18.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 123.22 0.608 . . . . 0.0 110.007 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.4 t -153.19 -176.66 5.88 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -79.16 -53.52 6.9 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -175.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -97.78 80.61 2.79 Favored 'General case' 0 C--N 1.313 -1.015 0 O-C-N 122.167 -0.333 . . . . 0.0 111.683 -176.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.81 120.01 0.13 Allowed Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.146 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.456 HG11 ' O ' ' A' ' 173' ' ' PHE . 33.9 m -70.74 156.34 7.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 121.248 0.547 . . . . 0.0 111.812 -177.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 19.7 m-20 -96.06 126.23 41.15 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.08 -172.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.546 ' CD1' HG11 ' A' ' 119' ' ' VAL . 2.7 m-85 -121.04 122.62 40.47 Favored 'General case' 0 CA--C 1.471 -2.084 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.571 171.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -92.4 108.04 19.66 Favored 'General case' 0 C--N 1.273 -2.727 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.462 ' HB2' HG12 ' A' ' 52' ' ' VAL . . . -93.34 144.84 24.94 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -86.88 133.12 33.65 Favored 'General case' 0 C--O 1.251 1.143 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.734 176.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.462 HG22 HG22 ' A' ' 49' ' ' VAL . 48.6 t -130.97 106.52 12.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 168.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.2 p -106.91 134.84 49.46 Favored 'General case' 0 C--N 1.277 -2.552 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.424 -176.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 4.8 p -132.52 126.54 55.22 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.95 -176.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 89.1 tttt -96.6 119.38 34.98 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 175.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.452 ' HB2' HD12 ' A' ' 105' ' ' LEU . 52.7 t30 -111.45 115.7 51.56 Favored Pre-proline 0 C--N 1.301 -1.51 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.72 -175.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -95.81 96.92 0.1 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.612 0 C-N-CA 121.904 1.736 . . . . 0.0 111.025 172.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -170.19 -166.09 0.52 Allowed 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 126.515 1.926 . . . . 0.0 107.011 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.3 t -142.5 21.13 2.03 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 173.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.564 ' O ' ' HA2' ' A' ' 107' ' ' GLY . 12.7 pt20 -115.14 140.73 48.83 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.412 -178.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.3 p -83.15 95.19 8.03 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-O 121.656 0.741 . . . . 0.0 109.308 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.494 ' HB ' HD21 ' A' ' 105' ' ' LEU . 72.5 mt -74.93 122.95 88.6 Favored Pre-proline 0 N--CA 1.433 -1.287 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.726 -176.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 78' ' ' ILE . 4.3 Cg_exo -76.78 122.64 6.45 Favored 'Trans proline' 0 N--CA 1.444 -1.438 0 C-N-CA 122.197 1.932 . . . . 0.0 110.666 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 50.0 mt -88.33 102.82 13.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 62.3 m -57.55 -60.37 3.76 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 124.133 0.895 . . . . 0.0 110.624 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -150.68 157.35 42.85 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-O 121.52 0.676 . . . . 0.0 111.868 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.568 ' HB ' HG23 ' A' ' 99' ' ' ILE . 46.4 mm -107.15 116.94 51.95 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 176.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.0 m -80.78 118.35 22.23 Favored 'General case' 0 N--CA 1.412 -2.375 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -103.06 121.42 42.55 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.992 -170.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' A' ' 142' ' ' ASP . 69.9 mt -134.9 109.8 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.24 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.623 ' O ' HD12 ' A' ' 94' ' ' ILE . 0.9 OUTLIER -113.03 120.61 41.95 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 176.588 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.569 ' HD2' ' O ' ' A' ' 93' ' ' THR . 53.4 tptt -121.38 135.53 55.06 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.5 m -142.38 145.36 33.79 Favored 'General case' 0 C--O 1.25 1.082 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.55 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 62.28 18.27 10.05 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.119 0.968 . . . . 0.0 111.197 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 m 59.16 14.01 3.3 Favored 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 123.986 0.915 . . . . 0.0 109.888 -175.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -127.63 -65.65 0.91 Allowed 'General case' 0 N--CA 1.432 -1.336 0 O-C-N 121.325 -0.859 . . . . 0.0 111.057 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.569 ' O ' ' HD2' ' A' ' 88' ' ' LYS . 11.1 t -76.92 165.56 24.51 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.823 -172.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.623 HD12 ' O ' ' A' ' 87' ' ' LEU . 3.8 tp -163.38 139.02 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.015 0 C-N-CA 123.195 0.598 . . . . 0.0 109.703 -168.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.11 121.47 26.42 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 171.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 78.0 p -139.76 160.12 40.62 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.292 0.568 . . . . 0.0 111.63 -176.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 167.41 -170.25 41.52 Favored Glycine 0 N--CA 1.417 -2.614 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.3 p -127.86 122.2 31.99 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.568 HG23 ' HB ' ' A' ' 83' ' ' ILE . 10.0 tt -102.86 108.45 58.33 Favored Pre-proline 0 C--N 1.318 -0.771 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.02 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -82.55 146.31 13.51 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 C-N-CA 122.889 2.393 . . . . 0.0 113.63 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 44.75 67.41 4.11 Favored Pre-proline 0 N--CA 1.477 0.911 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -101.24 1.05 0.58 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.465 2.11 . . . . 0.0 111.911 176.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 148.94 -179.0 26.12 Favored Glycine 0 N--CA 1.428 -1.874 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.6 m -150.38 175.72 11.57 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 117.509 0.655 . . . . 0.0 110.708 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.678 HD23 ' H ' ' A' ' 105' ' ' LEU . 0.7 OUTLIER -104.62 131.96 51.43 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.443 0.64 . . . . 0.0 112.654 -175.093 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.2 m -63.59 18.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 -171.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 76' ' ' GLN . . . 85.09 -52.66 4.71 Favored Glycine 0 C--O 1.214 -1.1 0 C-N-CA 120.407 -0.902 . . . . 0.0 113.32 177.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.7 t -148.29 117.17 6.72 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -177.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 133.99 177.37 14.89 Favored Glycine 0 CA--C 1.49 -1.479 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.12 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 9.9 t -96.53 113.35 24.92 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 121.753 0.787 . . . . 0.0 109.421 177.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.9 t -112.28 138.07 49.51 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.376 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 25.0 t -96.94 107.56 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.8 mt -86.8 166.39 15.27 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 178.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -140.43 145.84 37.52 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.396 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.4 t -120.95 128.2 25.87 Favored Pre-proline 0 C--N 1.3 -1.581 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -74.54 109.6 2.94 Favored 'Trans proline' 0 N--CA 1.43 -2.224 0 N-CA-C 106.986 -1.967 . . . . 0.0 106.986 168.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.513 HG11 ' OH ' ' A' ' 139' ' ' TYR . 59.2 t -103.66 127.27 57.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -176.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.472 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 1.2 tpmt? -88.98 91.12 8.71 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.546 HG11 ' CD1' ' A' ' 64' ' ' TYR . 12.1 p -94.03 147.29 5.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.173 -172.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.482 ' HA ' HD12 ' A' ' 123' ' ' ILE . . . 72.47 -5.63 1.77 Allowed 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.211 1.004 . . . . 0.0 111.318 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.419 ' O ' HG23 ' A' ' 125' ' ' VAL . 76.1 t80 -63.55 -54.42 36.39 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.377 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.518 ' HB2' ' OG1' ' A' ' 93' ' ' THR . 13.1 p -63.42 -36.87 85.16 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.922 -176.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 120' ' ' ALA . 52.7 mt -64.6 -49.42 80.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.097 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.74 -36.12 82.67 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 123.484 0.49 . . . . 0.0 110.775 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 121' ' ' TYR . 52.6 t -62.11 -51.4 72.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.514 176.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.6 m -66.74 -73.83 0.13 Allowed 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.5 HD12 ' N ' ' A' ' 128' ' ' MET . 2.0 pp -125.16 -32.14 3.01 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -171.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.5 ' N ' HD12 ' A' ' 127' ' ' LEU . 0.0 OUTLIER 63.37 110.93 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -171.2 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.544 ' HG3' ' HE1' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -68.07 -0.02 4.07 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -171.995 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 17.8 t70 84.79 -26.41 0.11 Allowed 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 125.624 1.57 . . . . 0.0 110.592 173.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.643 ' HE1' HD13 ' A' ' 167' ' ' LEU . 9.1 tpt 70.89 149.7 0.09 Allowed 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 125.475 1.51 . . . . 0.0 113.47 174.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 72.0 m -153.69 160.76 42.45 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 40.2 p -78.78 125.74 29.78 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 175.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.621 ' H ' ' H ' ' A' ' 169' ' ' SER . 25.4 t70 69.47 89.02 0.1 Allowed 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -176.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.544 ' HE1' ' HG3' ' A' ' 129' ' ' LYS . 54.5 t-105 -158.19 149.79 21.39 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 114.032 -1.44 . . . . 0.0 109.732 -166.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -140.59 149.34 42.24 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.904 0.383 . . . . 0.0 110.386 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.459 HG21 ' CD1' ' A' ' 123' ' ' ILE . 2.9 mp -118.7 141.68 37.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -81.08 102.67 10.39 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 122.048 0.928 . . . . 0.0 109.473 174.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.513 ' OH ' HG11 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -130.69 144.58 51.53 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.251 -177.292 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.42 ' CB ' ' HA ' ' A' ' 162' ' ' GLN . 20.7 pt20 -131.52 157.8 42.6 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 38.2 tp -124.89 123.89 40.89 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.426 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 6.2 m-20 -121.88 120.3 34.12 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.171 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 46.6 mm -120.62 127.76 75.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.891 -178.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -95.6 89.94 1.19 Allowed Glycine 0 N--CA 1.427 -1.903 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 173.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.26 110.69 7.74 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.576 ' OG1' HG22 ' A' ' 156' ' ' THR . 27.8 m -95.89 108.4 20.76 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 120.861 0.363 . . . . 0.0 111.18 -176.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -101.76 132.04 47.72 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 176.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -101.98 109.36 21.07 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 65.0 mt -127.99 114.29 20.38 Favored Pre-proline 0 C--N 1.29 -1.995 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.21 -24.1 32.42 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.841 2.361 . . . . 0.0 113.662 -176.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.38 -36.18 76.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.222 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 10.2 p -125.3 -32.1 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -174.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 120.56 -151.51 17.14 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -101.02 125.18 47.62 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.264 -1.014 . . . . 0.0 108.264 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.455 HG21 HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -132.44 127.64 57.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.472 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.576 HG22 ' OG1' ' A' ' 146' ' ' THR . 74.8 p -91.84 108.95 20.28 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . 51.8 mt -77.77 114.47 41.65 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 157' ' ' ILE . 5.5 Cg_exo -76.58 101.02 1.45 Allowed 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 122.436 2.091 . . . . 0.0 111.587 -178.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.539 HG11 ' H ' ' A' ' 49' ' ' VAL . 18.0 t -101.83 113.18 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 53.1 p -110.14 145.22 37.56 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.194 -175.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.9 t -156.77 113.65 3.08 Favored 'General case' 0 N--CA 1.424 -1.768 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.296 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.42 ' HA ' ' CB ' ' A' ' 140' ' ' GLN . 11.4 pt20 -98.25 119.26 36.6 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -134.77 -130.92 3.02 Favored Glycine 0 N--CA 1.407 -3.284 0 C-N-CA 119.792 -1.194 . . . . 0.0 113.023 -174.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -158.14 133.1 8.52 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 115.219 -0.49 . . . . 0.0 109.918 -171.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.471 HG12 ' HB3' ' A' ' 139' ' ' TYR . 43.2 mm -107.02 108.59 25.56 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 171.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -110.94 128.89 55.98 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 121.791 0.805 . . . . 0.0 111.441 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.643 HD13 ' HE1' ' A' ' 131' ' ' MET . 96.0 mt -118.57 91.48 41.86 Favored Pre-proline 0 N--CA 1.411 -2.39 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.758 -172.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.468 ' O ' HD22 ' A' ' 170' ' ' LEU . 9.1 Cg_exo -71.64 100.82 1.09 Allowed 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.575 2.85 . . . . 0.0 112.992 -177.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.621 ' H ' ' H ' ' A' ' 134' ' ' ASP . 91.3 p 62.9 9.72 3.88 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 126.682 1.993 . . . . 0.0 115.528 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 168' ' ' PRO . 3.5 mm? -71.73 138.66 48.65 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.146 -0.621 . . . . 0.0 111.848 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -142.54 140.99 31.98 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 167.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 37.5 t70 74.85 5.44 4.38 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.385 1.088 . . . . 0.0 110.762 -174.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.468 ' CD1' HD12 ' A' ' 170' ' ' LEU . 78.0 m-85 . . . . . 0 C--N 1.315 -0.932 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.887 174.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 C--O 1.219 -0.506 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.77 -43.77 98.19 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.826 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -63.86 -50.69 67.83 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.388 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.4 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 90.2 t -66.29 -44.63 91.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 114.979 -1.009 . . . . 0.0 113.354 -176.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.0 p -64.19 -26.59 40.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -75.45 -44.01 46.5 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.571 -177.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.49 ' O ' HG23 ' A' ' 23' ' ' VAL . 10.8 pt-20 -64.0 -40.25 95.95 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.649 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -65.85 -40.68 91.93 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.375 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.69 -42.7 99.29 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.179 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.8 t -61.76 -41.85 98.22 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.979 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 19' ' ' GLU . 93.5 t -60.75 -49.63 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.234 0.54 . . . . 0.0 109.779 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.445 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 67.6 mt -67.34 -39.91 83.73 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.768 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.003 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.9 t -61.72 -41.08 97.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.878 0.37 . . . . 0.0 110.105 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 32.6 m -70.34 -32.09 69.66 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.122 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.561 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 4.4 tt -69.84 -47.53 62.35 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 176.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.578 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 96.3 mt -59.95 -32.74 71.08 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.9 0.381 . . . . 0.0 110.152 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' A' ' 26' ' ' SER . 12.4 t70 -57.69 -46.22 84.59 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.893 175.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.561 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -74.77 -33.63 62.32 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.238 0.542 . . . . 0.0 109.757 179.613 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.505 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -62.21 -39.63 93.41 Favored 'General case' 0 C--O 1.204 -1.337 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.729 -178.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 29.0 mtpp -60.76 -33.97 73.76 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.2 -51.1 4.06 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.066 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -61.92 -32.59 73.01 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 123.61 0.764 . . . . 0.0 112.592 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.443 ' HD1' HD12 ' A' ' 39' ' ' LEU . 49.0 t80 -72.62 -34.95 67.69 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 121.905 -0.497 . . . . 0.0 110.637 175.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.72 -27.33 58.12 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.731 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 38' ' ' LYS . 10.7 pt-20 -98.35 -49.32 4.72 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.437 ' N ' ' HG3' ' A' ' 37' ' ' GLU . 14.5 tppt? -76.84 -47.15 22.22 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 122.13 0.967 . . . . 0.0 109.333 -170.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.443 HD12 ' HD1' ' A' ' 35' ' ' PHE . 42.1 mt -89.36 16.93 6.68 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.45 -175.088 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.22 -20.21 19.41 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 172.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -97.69 -35.11 10.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.66 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.5 mt -103.47 118.56 57.35 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.078 -177.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.95 112.24 2.88 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.542 2.161 . . . . 0.0 111.092 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.423 ' HB ' ' CD ' ' A' ' 45' ' ' PRO . 4.0 p -116.88 171.22 5.04 Favored Pre-proline 0 C--N 1.301 -1.52 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.263 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.448 ' HB3' ' CB ' ' A' ' 72' ' ' ASN . 7.9 Cg_exo -72.95 145.97 41.04 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.477 2.118 . . . . 0.0 112.516 -177.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -97.75 119.02 35.58 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.999 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.21 141.28 37.01 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.1 t -136.46 143.03 43.64 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.5 t -97.91 132.34 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 175.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -112.69 -60.11 1.92 Allowed 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.059 -1.057 . . . . 0.0 113.745 -169.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -163.88 161.36 22.98 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -172.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.659 HG22 ' HB3' ' A' ' 64' ' ' TYR . 10.0 p -135.49 112.2 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.76 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -106.82 159.03 16.55 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.951 -175.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -71.36 126.81 30.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.419 0.628 . . . . 0.0 112.212 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.449 ' HD2' ' OD2' ' A' ' 63' ' ' ASP . 10.2 tmtt? -110.91 -44.84 3.55 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.352 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -178.5 -176.44 46.4 Favored Glycine 0 CA--C 1.484 -1.897 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 177.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.521 ' HA ' HG23 ' A' ' 62' ' ' VAL . 27.2 m -107.81 148.75 11.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.772 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.4 m -150.78 125.24 9.53 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 174.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -82.71 88.62 6.72 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 122.265 1.031 . . . . 0.0 113.407 -170.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -178.66 37.02 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 102.271 -3.233 . . . . 0.0 102.271 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.82 -133.07 10.63 Favored Glycine 0 N--CA 1.415 -2.723 0 N-CA-C 106.038 -2.825 . . . . 0.0 106.038 -170.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.521 HG23 ' HA ' ' A' ' 57' ' ' VAL . 9.8 p -152.24 136.89 9.84 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 172.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.449 ' OD2' ' HD2' ' A' ' 55' ' ' LYS . 35.3 t70 -85.62 105.04 15.9 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-O 121.629 0.728 . . . . 0.0 112.237 -169.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.659 ' HB3' HG22 ' A' ' 52' ' ' VAL . 3.2 m-85 -109.47 161.61 15.16 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 121.65 0.738 . . . . 0.0 112.144 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 39.2 t60 -102.51 106.44 17.15 Favored 'General case' 0 N--CA 1.413 -2.298 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.631 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . . . -90.22 124.87 35.23 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.801 174.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -100.41 125.27 46.67 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.386 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.0 m -121.44 144.58 30.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.3 m -120.83 136.0 55.02 Favored 'General case' 0 C--N 1.277 -2.581 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.033 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t -129.98 127.73 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-O 121.029 0.442 . . . . 0.0 110.27 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 19.3 ptpt -113.2 143.03 45.08 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 174.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.661 ' O ' ' HA ' ' A' ' 108' ' ' SER . 1.8 p-10 -142.63 138.49 16.27 Favored Pre-proline 0 C--N 1.287 -2.134 0 C-N-CA 118.906 -1.118 . . . . 0.0 110.266 -177.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -99.62 95.4 0.05 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.462 0 C-N-CA 120.852 1.035 . . . . 0.0 110.152 170.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -174.47 138.91 0.55 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.7 m -85.71 -5.3 59.28 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 118.827 0.74 . . . . 0.0 111.182 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -88.19 143.62 26.94 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.381 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.2 p -90.35 102.33 15.06 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.11 0.481 . . . . 0.0 109.902 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.402 ' H ' ' CD2' ' A' ' 105' ' ' LEU . 24.8 mt -92.01 130.25 38.92 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -177.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -75.92 142.5 25.24 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.897 1.731 . . . . 0.0 108.943 171.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.6 HG13 ' HD2' ' A' ' 102' ' ' PRO . 18.3 pt -82.5 102.62 8.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.318 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 6.6 m -43.47 -65.93 0.44 Allowed 'General case' 0 C--O 1.244 0.799 0 C-N-CA 126.945 2.098 . . . . 0.0 113.032 -172.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.525 ' C ' HD12 ' A' ' 83' ' ' ILE . 10.0 pt20 -147.34 150.82 35.49 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.588 HG23 HG23 ' A' ' 143' ' ' ILE . 1.8 mp -120.39 117.97 55.15 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.141 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.8 m -80.08 119.98 23.62 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.477 ' CE2' HG12 ' A' ' 117' ' ' VAL . 4.8 t80 -103.04 120.76 41.24 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.634 -170.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.401 ' HB ' ' HB3' ' A' ' 142' ' ' ASP . 39.8 mm -131.17 108.47 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.529 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 0.2 OUTLIER -106.22 126.98 52.89 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 179.433 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -124.41 147.1 48.49 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.965 -0.694 . . . . 0.0 112.314 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.7 m -151.93 97.9 2.39 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 64.73 -173.03 0.18 Allowed 'General case' 0 CA--C 1.541 0.609 0 O-C-N 123.975 0.797 . . . . 0.0 109.5 -174.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.3 p -98.54 14.55 27.93 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.805 -0.56 . . . . 0.0 111.681 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.6 -65.58 0.99 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.27 -177.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 122' ' ' SER . 35.1 m -130.54 141.3 50.48 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 122.05 -0.406 . . . . 0.0 111.177 -175.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.529 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.8 pp -137.06 168.79 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -178.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.61 147.81 49.17 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 176.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.7 p -144.16 164.81 29.62 Favored 'General case' 0 C--N 1.313 -0.992 0 O-C-N 122.438 -0.164 . . . . 0.0 110.859 -177.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 156.36 -170.57 33.97 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 176.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 35.5 p -132.99 127.39 34.06 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 117.331 0.566 . . . . 0.0 109.721 176.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.462 HG23 ' HB ' ' A' ' 83' ' ' ILE . 11.4 tt -103.36 116.91 61.36 Favored Pre-proline 0 C--N 1.318 -0.796 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.964 177.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -88.63 128.04 2.02 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.973 2.449 . . . . 0.0 113.561 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.2 t70 50.98 72.96 1.07 Allowed Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.6 ' HD2' HG13 ' A' ' 80' ' ' ILE . 84.2 Cg_endo -104.09 18.8 0.16 Allowed 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 123.729 2.953 . . . . 0.0 110.706 174.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.535 ' O ' HG12 ' A' ' 80' ' ' ILE . . . 155.23 172.7 23.15 Favored Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.9 m -145.65 149.12 33.91 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.555 HD13 ' H ' ' A' ' 105' ' ' LEU 0.37 0.0 OUTLIER -81.18 157.62 25.2 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 119.519 -0.873 . . . . 0.0 113.259 179.118 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.4 m -83.53 -3.14 7.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -172.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.97 75.95 0.93 Allowed Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.646 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.661 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 48.8 m 78.91 91.46 0.06 Allowed 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 124.852 1.261 . . . . 0.0 111.756 -178.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 158.55 172.42 25.66 Favored Glycine 0 N--CA 1.425 -2.037 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.42 HG22 ' HB3' ' A' ' 71' ' ' LYS . 45.4 p -100.26 113.42 26.11 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.9 t -124.22 138.75 54.37 Favored 'General case' 0 N--CA 1.42 -1.937 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.333 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.2 m -86.36 134.62 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-O 121.416 0.627 . . . . 0.0 109.837 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.459 HD13 HD13 ' A' ' 80' ' ' ILE . 79.0 mt -125.24 167.01 15.46 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -140.31 148.51 41.5 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.464 -0.895 . . . . 0.0 112.848 -175.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 91.8 t -133.93 122.58 16.5 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 173.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -77.6 109.03 2.68 Favored 'Trans proline' 0 N--CA 1.41 -3.383 0 N-CA-C 108.059 -1.554 . . . . 0.0 108.059 171.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.477 HG12 ' CE2' ' A' ' 85' ' ' TYR . 33.8 m -98.87 149.66 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 177.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -101.99 99.17 9.31 Favored 'General case' 0 C--N 1.273 -2.725 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.2 m -91.72 149.94 3.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.92 -171.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.4 ' HB3' HG12 ' A' ' 62' ' ' VAL . . . 76.05 12.46 2.83 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.282 0.633 . . . . 0.0 110.907 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.561 ' O ' HG23 ' A' ' 125' ' ' VAL . 81.4 t80 -59.88 -39.61 85.9 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 172.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.448 ' HB3' ' HB ' ' A' ' 93' ' ' THR . 16.4 m -58.83 -32.71 69.64 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 122.317 1.056 . . . . 0.0 109.58 178.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.855 HG23 ' HA ' ' A' ' 128' ' ' MET . 1.8 mp -80.58 -48.39 19.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 126.141 1.776 . . . . 0.0 112.803 -175.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.69 -29.37 26.23 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.208 1.003 . . . . 0.0 111.866 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 121' ' ' TYR . 91.6 t -53.7 -19.75 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.849 0 C-N-CA 125.722 1.609 . . . . 0.0 112.307 175.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.2 t 105.17 25.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 127.191 2.196 . . . . 0.0 110.427 -175.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.451 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 27.7 tp -98.14 1.09 47.14 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.459 175.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.855 ' HA ' HG23 ' A' ' 123' ' ' ILE . 83.8 mtp -30.36 106.54 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 125.979 1.711 . . . . 0.0 111.646 179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.42 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -53.37 -41.62 66.05 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 114.0 -1.454 . . . . 0.0 112.602 -178.107 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.4 t70 176.1 -58.14 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.456 0.473 . . . . 0.0 111.104 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.536 ' SD ' ' HA ' ' A' ' 171' ' ' ARG 0.257 15.7 tpp 65.0 97.07 0.05 OUTLIER 'General case' 0 C--O 1.244 0.775 0 CA-C-O 122.146 0.974 . . . . 0.0 112.817 -173.436 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 45.4 t -141.88 164.43 30.22 Favored 'General case' 0 N--CA 1.415 -2.187 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 34.4 p -73.58 119.5 17.9 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.7 t70 71.81 88.2 0.1 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.25 1.02 . . . . 0.0 108.438 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 41.0 t-105 -160.36 158.64 30.0 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.658 -170.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -143.96 162.16 36.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 118.111 0.414 . . . . 0.0 111.139 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.41 HD12 ' HD2' ' A' ' 129' ' ' LYS . 5.5 tt -140.68 146.43 24.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 C-N-CA 123.442 0.697 . . . . 0.0 109.383 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -88.99 108.13 19.41 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.499 ' HB3' HG12 ' A' ' 165' ' ' ILE . 0.2 OUTLIER -125.58 155.97 39.86 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 124.137 0.975 . . . . 0.0 109.377 -179.222 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.0 pm0 -146.71 148.78 32.35 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.307 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 27.8 tp -121.02 126.72 50.61 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.275 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.401 ' HB3' ' HB ' ' A' ' 86' ' ' ILE . 15.4 t70 -127.94 130.08 47.86 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -176.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.588 HG23 HG23 ' A' ' 83' ' ' ILE . 37.7 mm -130.19 144.25 38.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 121.511 0.672 . . . . 0.0 112.484 -173.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -114.16 92.39 0.6 Allowed Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 172.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.9 121.85 24.7 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -174.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.574 ' OG1' HG22 ' A' ' 156' ' ' THR . 19.1 m -105.95 127.83 53.4 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 120.054 -0.658 . . . . 0.0 112.008 -177.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -121.13 140.28 52.21 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 173.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 154' ' ' ASP . 2.9 p30 -121.54 122.58 40.0 Favored 'General case' 0 CA--C 1.486 -1.514 0 C-N-CA 119.046 -1.062 . . . . 0.0 110.343 175.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 10.3 pt -140.43 143.34 32.63 Favored Pre-proline 0 C--N 1.301 -1.517 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.038 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.75 -5.3 10.15 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 123.472 2.781 . . . . 0.0 112.602 -178.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.16 -25.59 30.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.178 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 5.4 p -161.43 -39.44 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 140.56 -155.51 24.79 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 148' ' ' ASP . 7.1 p-10 -99.02 120.08 38.87 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.298 0.571 . . . . 0.0 109.743 177.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' ' 146' ' ' THR . 50.0 mt -123.35 132.23 71.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.136 -174.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.574 HG22 ' OG1' ' A' ' 146' ' ' THR . 44.1 p -91.0 113.46 25.73 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.425 174.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.0 mp -90.3 117.81 68.31 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -80.28 127.39 6.66 Favored 'Trans proline' 0 CA--C 1.487 -1.832 0 C-N-CA 122.104 1.869 . . . . 0.0 112.036 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.423 HG13 ' HB ' ' A' ' 143' ' ' ILE . 2.7 p -136.87 130.61 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.716 0 CA-C-N 112.706 -2.043 . . . . 0.0 108.669 -178.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 11.9 m -134.61 153.59 51.9 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.201 -174.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.4 t -147.24 137.21 23.13 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -99.57 122.44 42.63 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -139.3 -154.57 6.39 Favored Glycine 0 N--CA 1.405 -3.409 0 C-N-CA 119.465 -1.35 . . . . 0.0 110.71 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.04 159.5 29.39 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.499 HG12 ' HB3' ' A' ' 139' ' ' TYR . 52.0 mm -118.29 108.05 23.36 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.551 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 16.0 pttm -95.22 131.47 41.23 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.339 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 90.0 mt -110.73 91.8 13.16 Favored Pre-proline 0 C--N 1.283 -2.294 0 CA-C-N 114.64 -1.163 . . . . 0.0 110.212 -172.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' ' 166' ' ' LYS . 1.7 Cg_endo -83.0 82.93 2.05 Favored 'Trans proline' 0 N--CA 1.426 -2.448 0 C-N-CA 122.618 2.212 . . . . 0.0 112.251 -177.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 65.4 p 57.61 24.99 11.1 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.684 1.194 . . . . 0.0 114.182 174.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.463 ' HB3' ' CD1' ' A' ' 173' ' ' PHE . 38.7 mt -60.76 -62.0 2.18 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 120.665 0.269 . . . . 0.0 110.54 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.536 ' HA ' ' SD ' ' A' ' 131' ' ' MET . 78.3 mtp180 63.95 141.34 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 O-C-N 124.668 1.23 . . . . 0.0 111.5 -173.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 38.0 t70 78.08 1.84 2.79 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.69 0.796 . . . . 0.0 111.126 -177.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.463 ' CD1' ' HB3' ' A' ' 170' ' ' LEU . 72.5 m-85 . . . . . 0 C--O 1.22 -0.5 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.0 t70 . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 121.296 0.57 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.535 ' O ' ' HG3' ' A' ' 18' ' ' GLU . 42.7 tt0 -57.43 -47.31 82.11 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.516 176.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.464 ' HD3' ' C ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -74.57 -19.43 60.33 Favored 'General case' 0 CA--C 1.487 -1.464 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.531 -178.991 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.0 t -71.19 -32.93 49.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.455 HG11 ' O ' ' A' ' 94' ' ' ILE . 59.9 t -69.24 -43.22 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 170.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 41.9 mt-10 -64.52 -46.75 81.59 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.863 -173.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.433 ' O ' HG23 ' A' ' 23' ' ' VAL . 8.0 pt-20 -55.53 -48.23 75.02 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 119.929 -0.709 . . . . 0.0 111.214 173.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.415 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 24.9 ttmm -65.5 -47.8 74.76 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 122.808 0.443 . . . . 0.0 111.43 -176.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.68 -39.22 76.63 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.118 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.1 t -66.52 -42.31 87.49 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.605 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 19' ' ' GLU . 65.5 t -62.92 -46.65 95.79 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 CA-C-O 121.116 0.484 . . . . 0.0 109.73 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.485 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 69.1 mt -64.08 -49.88 79.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.863 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.0 t -60.06 -35.09 74.4 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 122.664 0.386 . . . . 0.0 111.018 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.6 m -68.91 -30.47 68.96 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.12 0.486 . . . . 0.0 110.877 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.1 tt -75.82 -42.29 50.25 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 87.0 mt -63.05 -31.1 72.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.528 178.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -68.29 -49.31 61.36 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.426 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.533 ' HD2' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -67.37 -36.49 81.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.29 -177.21 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.533 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -77.46 -31.85 54.03 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.479 -178.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -55.48 -53.45 56.19 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.166 0.291 . . . . 0.0 110.532 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.648 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -62.27 -53.08 44.91 Favored Glycine 0 N--CA 1.437 -1.269 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.477 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -53.83 -41.95 67.95 Favored 'General case' 0 C--O 1.252 1.204 0 C-N-CA 124.316 1.046 . . . . 0.0 111.674 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.486 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 90.8 t80 -66.43 -51.88 52.31 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.76 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.58 -22.98 67.19 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -176.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.648 ' HG2' ' O ' ' A' ' 33' ' ' GLY . 10.9 pt-20 -93.1 -51.49 5.01 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.484 ' HD3' ' HG3' ' A' ' 37' ' ' GLU . 3.9 mppt? -103.35 -39.13 6.92 Favored 'General case' 0 CA--C 1.484 -1.574 0 C-N-CA 118.553 -1.259 . . . . 0.0 112.764 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 2.7 mm? -79.63 -1.53 38.53 Favored 'General case' 0 C--N 1.286 -2.19 0 C-N-CA 119.783 -0.767 . . . . 0.0 112.535 -174.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.12 -8.87 58.44 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 172.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -109.22 -48.78 3.21 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.245 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.9 mp -77.15 117.83 67.83 Favored Pre-proline 0 C--O 1.244 0.808 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.77 118.73 4.74 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.357 2.705 . . . . 0.0 113.504 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.0 p -141.38 165.14 30.73 Favored Pre-proline 0 C--N 1.304 -1.392 0 C-N-CA 125.18 1.392 . . . . 0.0 108.185 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -70.21 135.08 28.53 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.022 1.815 . . . . 0.0 112.347 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -97.48 112.83 24.51 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.957 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.26 125.78 43.49 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.178 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -127.39 132.21 50.18 Favored 'General case' 0 N--CA 1.417 -2.093 0 CA-C-O 121.639 0.733 . . . . 0.0 110.588 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.46 HG13 HG22 ' A' ' 159' ' ' VAL . 11.7 m -83.44 144.17 10.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.663 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -119.34 -67.2 1.0 Allowed 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.433 -174.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -172.43 174.09 3.93 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -177.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.701 HG22 ' HB3' ' A' ' 64' ' ' TYR . 10.5 p -116.48 126.62 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -95.73 119.52 34.38 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.532 -172.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.697 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 37.2 p90 -63.12 125.8 25.27 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.911 0.386 . . . . 0.0 111.761 175.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.549 ' HG3' ' CD2' ' A' ' 65' ' ' HIS . 29.5 mmmt -109.11 -66.3 1.07 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.777 -176.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.32 177.84 21.9 Favored Glycine 0 N--CA 1.431 -1.67 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.864 -175.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 173' ' ' PHE . 6.5 p -98.4 136.94 27.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -177.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.651 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 59.6 m -137.45 146.13 43.95 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -59.35 -43.44 92.78 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.981 0.912 . . . . 0.0 112.235 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.422 ' HB3' ' CD1' ' A' ' 121' ' ' TYR . 19.6 m-20 -61.96 -56.68 16.63 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.171 0.986 . . . . 0.0 109.59 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.651 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . -165.77 165.89 38.26 Favored Glycine 0 N--CA 1.407 -3.299 0 N-CA-C 105.857 -2.897 . . . . 0.0 105.857 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.94 141.87 17.14 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-N 117.689 0.745 . . . . 0.0 111.733 -176.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -87.46 111.79 21.52 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.25 -173.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.701 ' HB3' HG22 ' A' ' 52' ' ' VAL . 7.0 m-85 -120.1 161.24 21.32 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-O 121.761 0.791 . . . . 0.0 111.479 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.549 ' CD2' ' HG3' ' A' ' 55' ' ' LYS . 19.7 m170 -116.9 117.92 31.02 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.015 172.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.566 ' HB3' ' HB ' ' A' ' 115' ' ' VAL . . . -77.78 122.79 25.88 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.433 ' HG3' ' CG1' ' A' ' 112' ' ' VAL . 40.1 ttmt -87.44 107.84 18.74 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.636 -175.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.4 t -112.47 109.15 27.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 114.538 -1.21 . . . . 0.0 107.931 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.0 p -101.16 119.34 38.61 Favored 'General case' 0 C--N 1.277 -2.556 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.967 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 110' ' ' THR . 78.0 t -106.28 119.48 55.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.267 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -97.91 109.57 22.3 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' A' ' 108' ' ' SER . 41.6 t30 -112.27 119.46 43.78 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -175.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -93.83 97.62 0.14 Allowed 'Trans proline' 0 N--CA 1.434 -2.025 0 C-N-CA 121.861 1.707 . . . . 0.0 112.089 173.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.568 ' O ' ' HB2' ' A' ' 108' ' ' SER . 34.1 m-85 -169.92 -160.3 0.23 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 127.209 2.204 . . . . 0.0 106.678 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.5 m -143.37 19.7 1.89 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.538 0.685 . . . . 0.0 109.297 172.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.427 ' O ' ' HA2' ' A' ' 107' ' ' GLY . 13.1 pt20 -113.68 143.62 44.29 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.842 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.1 p -85.41 86.05 7.4 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.091 0.472 . . . . 0.0 110.588 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 64.6 mt -72.88 119.52 75.88 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.461 -177.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -88.91 124.19 1.49 Allowed 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 122.27 1.98 . . . . 0.0 110.876 175.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.421 HG13 ' HD2' ' A' ' 102' ' ' PRO . 24.2 pt -77.29 130.26 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.292 177.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 41.8 t -72.34 -40.17 67.59 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.327 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -153.68 155.83 36.72 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.5 tt -124.27 120.31 58.92 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 172.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.9 m -99.41 128.85 45.56 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -174.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -127.39 141.11 51.77 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.189 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.565 ' HB ' ' HB3' ' A' ' 142' ' ' ASP . 68.0 mt -119.37 108.18 23.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 172.073 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.54 HD13 ' HB3' ' A' ' 95' ' ' ALA . 0.8 OUTLIER -101.74 122.65 44.34 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -179.095 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.438 ' HG3' ' HB ' ' A' ' 94' ' ' ILE . 67.5 tttt -123.29 154.37 38.94 Favored 'General case' 0 C--N 1.277 -2.547 0 C-N-CA 118.38 -1.328 . . . . 0.0 108.249 176.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.1 m -141.43 126.97 18.89 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.057 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 59.18 14.29 3.47 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.234 1.014 . . . . 0.0 111.094 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.41 ' O ' ' HE2' ' A' ' 88' ' ' LYS . 41.1 m 68.17 -2.69 1.44 Allowed 'General case' 0 CA--C 1.584 2.267 0 C-N-CA 124.451 1.101 . . . . 0.0 112.489 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.24 -80.81 0.24 Allowed 'General case' 0 C--O 1.237 0.408 0 O-C-N 121.199 -0.938 . . . . 0.0 111.346 176.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 94' ' ' ILE . 29.1 m -84.72 166.05 17.34 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.274 -176.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.52 HD13 ' N ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -159.88 148.54 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.468 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 -167.854 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.54 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -128.87 127.21 41.37 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 176.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.7 t -137.73 151.14 47.89 Favored 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.438 -177.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.85 174.4 46.53 Favored Glycine 0 N--CA 1.411 -3.027 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.411 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 41.4 p -128.46 137.26 51.73 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.2 mp -102.09 108.03 55.07 Favored Pre-proline 0 C--N 1.308 -1.197 0 C-N-CA 118.15 -1.42 . . . . 0.0 108.575 173.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 98' ' ' THR . 10.3 Cg_exo -74.12 129.51 13.25 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 122.345 2.03 . . . . 0.0 109.848 175.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 56.21 68.77 2.1 Favored Pre-proline 0 N--CA 1.477 0.916 0 C-N-CA 124.153 0.981 . . . . 0.0 111.14 -175.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.421 ' HD2' HG13 ' A' ' 80' ' ' ILE . 64.2 Cg_endo -102.89 -0.25 0.36 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.384 2.723 . . . . 0.0 114.166 -176.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 152.31 179.29 27.79 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 56.3 m -149.82 156.46 41.84 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 116.934 0.367 . . . . 0.0 110.493 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.435 HD23 ' HB2' ' A' ' 72' ' ' ASN . 7.5 mp -79.5 143.4 34.93 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.343 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 27.0 m -68.33 -16.32 20.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.878 -1.056 . . . . 0.0 113.356 -177.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 76' ' ' GLN . . . 129.16 -57.92 0.71 Allowed Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.568 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 24.9 t -156.68 139.58 15.28 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 175.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 119.57 -177.8 16.44 Favored Glycine 0 C--N 1.292 -1.907 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 9.9 t -89.56 117.95 28.84 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.815 0.817 . . . . 0.0 110.407 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.434 HG21 ' HA ' ' A' ' 105' ' ' LEU . 5.0 t -114.87 132.83 56.39 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.095 177.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.433 ' CG1' ' HG3' ' A' ' 67' ' ' LYS . 39.6 t -92.46 121.69 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.831 -177.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.9 mt -106.96 148.14 29.01 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.152 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -110.7 122.31 47.49 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 86.0 t -100.22 116.6 64.33 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 169.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.76 108.96 2.54 Favored 'Trans proline' 0 N--CA 1.43 -2.244 0 N-CA-C 106.171 -2.281 . . . . 0.0 106.171 169.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.439 HG13 HG13 ' A' ' 119' ' ' VAL . 14.0 p -126.63 139.12 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.381 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -175.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -94.04 94.97 8.72 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.535 ' HA ' HD11 ' A' ' 87' ' ' LEU . 4.5 m -94.21 148.5 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.583 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -175.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 73.44 -4.28 2.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.369 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.422 ' CD1' ' HB3' ' A' ' 60' ' ' ASP . 61.7 t80 -58.94 -41.05 86.45 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 171.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.7 p -62.34 -32.19 72.92 Favored 'General case' 0 N--CA 1.417 -2.077 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.913 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 45.6 mm -80.9 -49.83 17.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.242 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.63 -42.85 95.2 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.438 0.461 . . . . 0.0 111.204 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.3 t -66.95 -29.04 44.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.562 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.6 t -86.47 -72.37 0.5 Allowed 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.628 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.583 HD12 ' N ' ' A' ' 128' ' ' MET . 3.0 pp -124.72 -35.3 2.73 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -172.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.583 ' N ' HD12 ' A' ' 127' ' ' LEU . 12.5 tpt 58.92 114.49 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.506 1.123 . . . . 0.0 112.398 -174.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -65.27 -75.42 0.09 Allowed 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.516 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.5 t70 159.78 -32.82 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 105.194 -2.151 . . . . 0.0 105.194 -175.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER 69.47 127.44 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 112.288 -2.233 . . . . 0.0 110.91 -177.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 42.0 t -128.16 150.72 49.87 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.561 HG22 ' HA ' ' A' ' 169' ' ' SER . 66.9 p -61.78 117.61 6.08 Favored 'General case' 0 N--CA 1.407 -2.608 0 C-N-CA 124.339 1.056 . . . . 0.0 109.678 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 75.86 80.91 0.1 Allowed 'General case' 0 CA--C 1.507 -0.673 0 CA-C-O 121.926 0.87 . . . . 0.0 110.63 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 15.8 t-105 -146.15 116.26 7.4 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.816 -1.538 . . . . 0.0 111.214 -175.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' A' ' 165' ' ' ILE . 5.7 p-10 -98.09 126.11 43.38 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 15.6 tt -112.28 145.82 17.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.3 -175.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -74.67 105.91 5.98 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 122.376 1.084 . . . . 0.0 111.043 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.47 150.85 51.99 Favored 'General case' 0 C--N 1.265 -3.095 0 CA-C-N 113.297 -1.774 . . . . 0.0 106.934 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . 0.304 0.1 OUTLIER -146.19 157.34 43.82 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.209 176.526 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.535 ' HB3' ' HB ' ' A' ' 161' ' ' THR . 28.4 tp -135.53 143.31 45.68 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -171.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.565 ' HB3' ' HB ' ' A' ' 86' ' ' ILE . 17.9 t70 -142.32 114.08 8.0 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 177.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 158' ' ' PRO . 49.1 mt -116.24 142.82 28.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.305 -174.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.405 ' HA3' ' CD2' ' A' ' 28' ' ' LEU . . . -120.62 108.39 1.4 Allowed Glycine 0 N--CA 1.421 -2.33 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 176.169 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 156' ' ' THR . 3.8 mm? -84.33 115.84 22.7 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 122.566 0.346 . . . . 0.0 110.873 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.425 ' OG1' HG22 ' A' ' 156' ' ' THR . 32.3 m -90.47 107.15 18.98 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.644 ' O ' ' HA ' ' A' ' 154' ' ' ASP . 93.8 m-85 -111.5 142.04 44.29 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 176.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -108.51 110.05 21.45 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.0 mp -121.7 126.58 26.37 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.19 -12.73 0.84 Allowed 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 124.481 3.454 . . . . 0.0 116.176 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 24.6 m -73.69 -22.98 18.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 O-C-N 122.065 -0.397 . . . . 0.0 111.203 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.2 p -148.46 -32.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.496 0.665 . . . . 0.0 111.417 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 115.39 -136.63 13.22 Favored Glycine 0 N--CA 1.416 -2.699 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 -175.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.644 ' HA ' ' O ' ' A' ' 147' ' ' PHE . 5.7 p-10 -95.73 131.03 42.44 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 121.376 0.608 . . . . 0.0 110.983 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.47 131.46 54.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 176.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.57 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 73.8 p -87.72 118.58 27.32 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.699 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.503 HD13 ' CD2' ' A' ' 147' ' ' PHE . 2.3 mp -81.35 110.99 21.12 Favored Pre-proline 0 C--N 1.316 -0.854 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 173.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 19.2 Cg_endo -88.02 113.38 0.81 Allowed 'Trans proline' 0 CA--C 1.475 -2.428 0 C-N-CA 122.489 2.126 . . . . 0.0 111.555 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.46 HG22 HG13 ' A' ' 49' ' ' VAL . 2.9 p -116.93 108.32 24.66 Favored 'Isoleucine or valine' 2 N--CA 1.361 -4.923 0 CA-C-N 112.174 -2.285 . . . . 0.0 109.231 -176.678 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 27.3 m -89.59 152.47 21.38 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.23 -173.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 141' ' ' LEU . 1.6 m -140.56 139.6 35.03 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -177.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -99.62 118.61 36.54 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 164.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -108.75 93.28 0.77 Allowed Glycine 0 N--CA 1.413 -2.869 0 C-N-CA 118.77 -1.681 . . . . 0.0 112.697 -171.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -89.22 118.91 29.25 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 175.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 136' ' ' ASP . 7.8 pt -124.33 121.05 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 CA-C-O 121.617 0.723 . . . . 0.0 110.678 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -91.46 104.05 16.6 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 114.229 -1.35 . . . . 0.0 110.95 -177.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 7.1 mp -82.45 111.93 32.5 Favored Pre-proline 0 C--N 1.295 -1.785 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 176.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -82.06 -160.89 0.13 Allowed 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 122.259 1.973 . . . . 0.0 110.189 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.561 ' HA ' HG22 ' A' ' 133' ' ' THR . 28.9 t -56.04 92.82 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 167.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 21.6 tp -144.9 27.54 1.31 Allowed 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 -177.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.488 ' NH1' ' HB2' ' A' ' 172' ' ' ASP . 2.5 tmm_? -63.41 122.56 16.54 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.534 -1.212 . . . . 0.0 107.897 -176.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.488 ' HB2' ' NH1' ' A' ' 171' ' ' ARG . 25.5 t70 79.97 73.78 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.815 0 C-N-CA 125.136 1.374 . . . . 0.0 108.954 -175.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.456 ' O ' HG23 ' A' ' 57' ' ' VAL . 12.1 t80 . . . . . 0 C--N 1.293 -1.874 0 N-CA-C 101.097 -3.668 . . . . 0.0 101.097 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.4 t70 . . . . . 0 C--O 1.238 0.477 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 18' ' ' GLU . 45.6 mt-10 -57.2 -41.61 79.7 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.053 176.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.511 ' HD3' ' C ' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -67.45 -49.0 65.58 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.291 0.567 . . . . 0.0 110.02 177.604 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.61 -35.85 75.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.333 -0.849 . . . . 0.0 113.023 -173.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 p -66.15 -29.59 47.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 65.1 mt-10 -76.79 -44.95 30.67 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 122.057 0.932 . . . . 0.0 108.597 178.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -55.3 -46.94 76.24 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.497 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.693 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -70.75 -36.17 73.0 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.275 177.6 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.67 90.88 Favored 'General case' 0 C--O 1.213 -0.817 0 O-C-N 123.282 0.363 . . . . 0.0 110.574 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.8 m -61.01 -38.19 85.2 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 120.727 0.299 . . . . 0.0 111.582 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.8 -34.94 73.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 20' ' ' LYS . 78.8 mt -69.27 -49.67 59.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.45 -0.795 . . . . 0.0 108.967 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.0 m -57.4 -33.82 68.25 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.992 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.2 t -57.68 -35.23 70.32 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.17 0.588 . . . . 0.0 111.721 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.441 HD23 ' HE2' ' A' ' 30' ' ' LYS . 4.5 tt -80.33 -43.77 20.63 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.496 HD23 ' HB3' ' A' ' 158' ' ' PRO . 9.1 mp -62.3 -34.56 76.83 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -62.41 -34.05 75.97 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.441 ' HE2' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -83.19 -18.66 38.53 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.712 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.22 -32.08 64.54 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.705 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -50.67 -52.75 36.96 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.679 0.791 . . . . 0.0 112.327 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -90.32 7.32 81.69 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.905 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.491 ' HA ' ' HE2' ' A' ' 38' ' ' LYS . 29.1 t80 -85.46 -26.18 26.48 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.63 ' CD1' HD12 ' A' ' 39' ' ' LEU . 44.8 m-85 -70.35 -41.08 73.63 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -174.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.29 -50.77 49.44 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -168.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.452 ' HG2' ' HG3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -117.78 -31.62 5.08 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.259 -0.576 . . . . 0.0 112.072 179.374 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 34' ' ' PHE . 36.7 mtmm -84.84 -9.71 57.88 Favored 'General case' 0 CA--C 1.486 -1.49 0 CA-C-O 121.484 0.659 . . . . 0.0 111.534 -168.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.63 HD12 ' CD1' ' A' ' 35' ' ' PHE . 88.5 mt -128.43 17.98 6.43 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.194 174.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.66 -44.32 21.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.735 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -95.26 11.37 32.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.623 0.725 . . . . 0.0 110.061 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.3 mm -115.57 117.2 40.66 Favored Pre-proline 0 N--CA 1.435 -1.204 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -65.03 113.92 2.59 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 121.991 1.794 . . . . 0.0 111.158 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.3 p -118.19 139.23 26.44 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.917 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.446 ' HB3' HD21 ' A' ' 105' ' ' LEU . 64.7 Cg_endo -74.71 143.88 30.65 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.563 2.175 . . . . 0.0 112.289 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -97.48 130.19 44.6 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -113.0 134.29 54.57 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.9 t -115.83 123.98 49.55 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 121.989 0.9 . . . . 0.0 111.416 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.549 HG22 HG12 ' A' ' 159' ' ' VAL . 26.0 m -102.39 143.87 14.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 114.288 -1.323 . . . . 0.0 109.958 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.575 24.2 t70 117.25 78.61 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 117.821 2.526 . . . . 0.0 117.821 176.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.617 ' HB2' ' HB3' ' A' ' 67' ' ' LYS . 31.9 m-20 -161.3 111.0 1.63 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 102.809 -3.034 . . . . 0.0 102.809 170.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.442 HG12 ' CD2' ' A' ' 64' ' ' TYR . 31.8 t -137.94 134.01 44.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.309 -168.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -137.42 137.26 38.6 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.256 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.599 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 37.8 p90 -91.83 141.82 28.25 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.093 0.557 . . . . 0.0 111.154 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.648 ' HD2' ' N ' ' A' ' 55' ' ' LYS . 3.0 mptp? -107.75 -52.23 2.79 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.89 178.55 40.55 Favored Glycine 0 C--N 1.293 -1.856 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.054 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.71 148.99 5.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 117.039 0.419 . . . . 0.0 110.508 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.6 p -131.28 179.15 6.19 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 176.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -75.6 -32.19 60.21 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.564 0.697 . . . . 0.0 109.328 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.22 83.44 3.6 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.81 176.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.92 -162.67 38.63 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.006 -176.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 p -107.59 145.04 15.37 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.703 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -84.97 121.74 28.2 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.628 0.728 . . . . 0.0 112.373 -170.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.652 ' CD1' ' HB ' ' A' ' 119' ' ' VAL . 28.2 m-85 -129.3 172.24 11.68 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.547 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -138.85 117.34 12.06 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 176.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.19 145.75 24.26 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.724 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.617 ' HB3' ' HB2' ' A' ' 51' ' ' ASP . 47.8 tttm -116.43 124.34 49.76 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.03 -177.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.497 HG12 HG12 ' A' ' 49' ' ' VAL . 34.1 m -128.43 111.64 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-O 121.784 0.802 . . . . 0.0 109.242 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.9 m -98.5 130.63 45.09 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.364 -175.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.18 124.97 66.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.035 0.445 . . . . 0.0 110.814 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -117.34 125.51 51.16 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.061 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 108' ' ' SER . 4.7 t30 -152.45 114.56 2.85 Favored Pre-proline 0 C--N 1.286 -2.165 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.277 176.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -99.41 96.37 0.05 OUTLIER 'Trans proline' 0 N--CA 1.418 -2.941 0 C-N-CA 121.812 1.674 . . . . 0.0 109.779 169.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 93.3 t80 178.23 111.9 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 177.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.7 p -56.86 85.12 0.01 OUTLIER 'General case' 0 C--O 1.242 0.686 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -156.07 105.0 2.31 Favored 'General case' 1 N--CA 1.369 -4.486 0 C-N-CA 126.552 1.941 . . . . 0.0 106.527 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.6 p -89.53 97.01 10.95 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.491 ' H ' HD13 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -103.85 134.93 19.46 Favored Pre-proline 0 C--N 1.31 -1.131 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.787 178.665 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -89.19 159.87 5.7 Favored 'Trans proline' 0 N--CA 1.438 -1.784 0 C-N-CA 122.427 2.085 . . . . 0.0 110.891 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 54.2 mt -91.03 114.91 29.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 100' ' ' PRO . 47.2 t -67.93 -37.94 82.27 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.267 0.556 . . . . 0.0 110.252 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -152.89 112.72 3.93 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.708 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 98' ' ' THR . 18.3 tt -95.77 119.43 43.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 175.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 143' ' ' ILE . 10.5 m -111.31 121.75 46.05 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.754 -172.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.438 ' CE1' HG13 ' A' ' 117' ' ' VAL . 23.7 p90 -109.65 136.41 49.05 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 175.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 63.7 mt -117.06 108.1 24.04 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.668 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 174.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -90.83 120.75 32.11 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 -174.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -118.83 163.78 16.38 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -172.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.1 t -105.57 147.41 28.43 Favored 'General case' 0 N--CA 1.41 -2.447 0 CA-C-N 112.181 -2.281 . . . . 0.0 106.59 172.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.13 -15.43 63.59 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 123.424 0.453 . . . . 0.0 110.873 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.0 t -143.93 -38.22 0.31 Allowed 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -176.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -148.31 128.27 13.56 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 118.785 -1.166 . . . . 0.0 112.687 -172.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.501 ' O ' ' HB3' ' A' ' 122' ' ' SER . 90.6 m 74.13 137.98 0.06 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.37 1.068 . . . . 0.0 113.093 177.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.443 ' C ' HD12 ' A' ' 94' ' ' ILE . 1.9 pp -134.06 171.76 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.5 172.82 12.39 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 176.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 64.1 p -152.82 175.59 12.72 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 122.079 -0.388 . . . . 0.0 110.7 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.03 144.45 4.51 Favored Glycine 0 N--CA 1.435 -1.376 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 41.9 p -132.36 136.63 46.97 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 117.023 0.411 . . . . 0.0 110.529 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.1 mp -113.3 107.11 54.02 Favored Pre-proline 0 C--N 1.313 -1.001 0 C-N-CA 119.419 -0.913 . . . . 0.0 109.167 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 81' ' ' CYS . 18.6 Cg_exo -69.4 116.65 4.62 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.515 2.143 . . . . 0.0 110.031 173.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.2 t70 62.35 79.1 0.27 Allowed Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 123.51 0.724 . . . . 0.0 111.533 -177.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -107.08 12.49 0.15 Allowed 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 124.291 3.327 . . . . 0.0 112.563 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 141.68 -174.22 23.14 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.8 m -151.07 170.82 18.47 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 117.578 0.689 . . . . 0.0 110.679 -177.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.446 HD21 ' HB3' ' A' ' 45' ' ' PRO . 10.3 mp -74.02 157.58 35.87 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 114.762 1.394 . . . . 0.0 114.762 177.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.56 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 7.1 p -79.0 -20.68 12.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 CA-C-N 112.338 -2.21 . . . . 0.0 110.737 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 106.15 -60.97 0.35 Allowed Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 23.2 t -152.81 84.57 1.23 Allowed 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.435 0.636 . . . . 0.0 109.548 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 161.95 -151.74 21.91 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 108.989 -1.645 . . . . 0.0 108.989 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.0 t -122.82 136.77 54.98 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.193 0.521 . . . . 0.0 110.135 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.56 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 4.4 t -130.79 138.3 49.84 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.694 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 50.8 t -91.55 113.53 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-O 121.048 0.452 . . . . 0.0 110.982 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.9 mt -103.3 166.92 10.15 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -147.28 149.83 33.62 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 119.804 -0.759 . . . . 0.0 112.501 -171.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.0 t -125.92 132.62 24.37 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -77.01 110.81 3.11 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 N-CA-C 107.417 -1.801 . . . . 0.0 107.417 167.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.438 HG13 ' CE1' ' A' ' 85' ' ' TYR . 66.3 t -119.99 136.18 57.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.326 -174.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -88.77 99.0 12.02 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 173.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.652 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 82.6 t -93.44 146.54 6.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.603 -173.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 72.7 1.07 3.86 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 124.646 1.179 . . . . 0.0 111.759 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.519 ' O ' HG12 ' A' ' 125' ' ' VAL . 83.8 t80 -54.26 -49.38 69.67 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 175.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.501 ' HB3' ' O ' ' A' ' 93' ' ' THR . 29.0 m -64.3 -29.34 70.42 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.727 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.6 mm -79.51 -50.68 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.455 ' HA ' ' HG2' ' A' ' 128' ' ' MET . . . -63.11 -49.33 74.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -175.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.519 HG12 ' O ' ' A' ' 121' ' ' TYR . 8.0 p -72.24 -22.28 20.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.938 0.399 . . . . 0.0 111.584 -175.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.0 t -99.51 -62.52 1.23 Allowed 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.513 HD23 ' H ' ' A' ' 127' ' ' LEU . 1.8 pt? -124.91 -41.61 2.09 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -171.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.455 ' HG2' ' HA ' ' A' ' 124' ' ' ALA . 81.3 mtp 65.88 -177.97 0.19 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -169.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -137.31 -78.31 0.39 Allowed 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.3 t70 178.59 93.28 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.181 0 CA-C-N 114.494 -1.23 . . . . 0.0 107.728 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.58 ' SD ' ' HB2' ' A' ' 170' ' ' LEU . 0.3 OUTLIER -52.18 101.66 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.344 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.822 175.635 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 82.1 m -108.27 167.66 9.86 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.433 0.635 . . . . 0.0 112.176 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.509 HG22 ' HB3' ' A' ' 169' ' ' SER . 40.3 p -77.63 127.55 32.66 Favored 'General case' 0 N--CA 1.404 -2.752 0 C-N-CA 124.921 1.288 . . . . 0.0 108.561 169.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.6 t70 54.91 91.69 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.65 1.18 . . . . 0.0 109.625 -172.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -148.69 158.97 44.52 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.908 -169.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -142.19 148.24 37.89 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.546 HG12 HD21 ' A' ' 167' ' ' LEU . 27.8 pt -128.97 145.3 35.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 120.865 0.364 . . . . 0.0 110.874 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -97.41 111.86 23.94 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -128.12 163.13 25.31 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.583 ' HG3' ' O ' ' A' ' 161' ' ' THR . 34.3 tt0 -136.45 150.01 48.51 Favored 'General case' 0 C--N 1.283 -2.314 0 O-C-N 121.68 -0.637 . . . . 0.0 111.053 -178.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 2.0 pt? -141.25 120.44 12.96 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 172.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.406 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 6.8 m-20 -84.14 122.63 29.1 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 84' ' ' SER . 34.5 mm -108.24 117.28 53.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 C-N-CA 118.799 -1.16 . . . . 0.0 109.644 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -94.07 96.84 2.11 Favored Glycine 0 N--CA 1.419 -2.46 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 156' ' ' THR . 2.7 mm? -79.16 108.72 12.87 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.446 ' OG1' HG22 ' A' ' 156' ' ' THR . 26.1 m -89.85 107.36 19.06 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.294 -0.962 . . . . 0.0 108.83 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.413 ' CE2' ' HB3' ' A' ' 145' ' ' LEU . 73.4 m-85 -114.55 131.31 56.71 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 154' ' ' ASP . 4.6 p-10 -108.78 112.17 24.3 Favored 'General case' 0 C--N 1.287 -2.122 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.757 173.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.454 HG22 HG22 ' A' ' 151' ' ' VAL . 2.5 mp -104.2 120.09 52.0 Favored Pre-proline 0 C--N 1.292 -1.904 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 176.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -41.85 -32.21 1.63 Allowed 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 124.386 3.391 . . . . 0.0 115.455 -174.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.454 HG22 HG22 ' A' ' 149' ' ' ILE . 33.8 m -74.78 -21.98 17.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 13.9 p -126.18 -28.69 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.818 -177.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 148' ' ' ASP . . . 107.34 -156.47 15.92 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 148' ' ' ASP . 7.2 p-10 -90.53 120.25 31.46 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.48 0.657 . . . . 0.0 111.47 -178.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.462 ' O ' HD12 ' A' ' 155' ' ' ILE . 2.4 pp -128.83 138.05 55.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.61 175.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.446 HG22 ' OG1' ' A' ' 146' ' ' THR . 67.3 p -94.21 127.29 39.96 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.196 177.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 51.2 mt -101.15 105.15 37.44 Favored Pre-proline 0 C--N 1.295 -1.79 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.496 ' HB3' HD23 ' A' ' 28' ' ' LEU . 3.2 Cg_exo -76.97 109.9 2.93 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 122.646 2.231 . . . . 0.0 111.305 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.549 HG12 HG22 ' A' ' 49' ' ' VAL . 19.0 t -103.97 124.6 58.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 175.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 14.7 m -126.78 152.14 47.32 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.154 -173.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.583 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 14.0 t -174.62 162.22 3.34 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.257 0.0 OUTLIER -99.46 135.84 40.29 Favored 'General case' 0 N--CA 1.409 -2.494 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.972 172.332 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -108.38 113.01 3.7 Favored Glycine 0 N--CA 1.397 -3.905 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -177.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -89.55 119.67 30.18 Favored 'General case' 0 N--CA 1.405 -2.702 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 174.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 10.0 pt -118.34 140.67 40.99 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.909 -176.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -90.72 136.49 33.03 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.536 -173.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.546 HD21 HG12 ' A' ' 137' ' ' ILE . 2.0 mm? -115.34 94.84 40.89 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.1 49.48 2.56 Favored 'Trans proline' 0 N--CA 1.486 1.08 0 C-N-CA 123.359 2.706 . . . . 0.0 112.944 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.509 ' HB3' HG22 ' A' ' 133' ' ' THR . 2.9 m 67.11 93.39 0.07 Allowed 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 125.108 1.363 . . . . 0.0 110.758 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.685 ' HB3' ' CD1' ' A' ' 173' ' ' PHE . 3.0 mm? -98.77 -59.48 1.73 Allowed 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.093 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 61.21 104.62 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.187 0.995 . . . . 0.0 111.602 -174.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 33.5 t70 70.49 64.19 0.2 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.866 1.266 . . . . 0.0 112.075 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.685 ' CD1' ' HB3' ' A' ' 170' ' ' LEU . 57.6 m-85 . . . . . 0 C--N 1.311 -1.08 0 C-N-CA 125.933 1.693 . . . . 0.0 106.565 178.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.533 ' O ' HG23 ' A' ' 17' ' ' VAL . 10.1 m-20 . . . . . 0 N--CA 1.443 -0.804 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -67.86 -29.86 69.1 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-O 121.355 0.598 . . . . 0.0 110.778 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 11.7 tmtt? -75.26 -54.25 7.42 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.792 0.806 . . . . 0.0 110.139 177.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.5 t -59.95 -41.76 87.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 CA-C-N 114.946 -1.025 . . . . 0.0 112.682 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 13' ' ' ASP . 40.2 t -68.5 -27.51 36.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 C-N-CA 118.842 -1.143 . . . . 0.0 109.077 176.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.457 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 33.0 tt0 -63.09 -34.78 78.33 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.974 0.892 . . . . 0.0 108.651 -177.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.38 -49.72 72.7 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.265 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -65.08 -43.05 93.44 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.2 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.74 -37.99 80.5 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.205 -178.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.2 t -60.73 -40.37 92.1 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 123.303 0.377 . . . . 0.0 110.29 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.13 -49.76 73.91 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.529 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 64.1 mt -68.85 -39.81 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.963 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 56.2 m -61.01 -37.8 83.83 Favored 'General case' 0 C--O 1.215 -0.744 0 O-C-N 122.299 -0.251 . . . . 0.0 110.643 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.9 m -67.19 -20.91 65.78 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.111 0.482 . . . . 0.0 111.348 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -78.04 -51.53 10.18 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.472 HD23 ' HB3' ' A' ' 158' ' ' PRO . 8.1 mp -60.85 -34.0 73.91 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.409 177.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -53.33 -49.47 67.0 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.524 0.73 . . . . 0.0 111.465 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -82.13 -31.64 30.51 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.07 -32.49 70.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.713 0.292 . . . . 0.0 111.638 177.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.487 ' CG ' ' HG2' ' A' ' 158' ' ' PRO . 56.6 mtmt -61.82 -25.77 67.71 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.568 176.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.48 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -73.48 -50.84 10.71 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 175.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -58.37 -40.67 82.89 Favored 'General case' 0 C--O 1.198 -1.611 0 CA-C-O 120.397 0.141 . . . . 0.0 111.113 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -60.11 -35.49 75.36 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.999 -0.681 . . . . 0.0 111.81 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.09 -39.2 50.54 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 33' ' ' GLY . 10.9 pt-20 -96.29 -40.07 9.33 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -176.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.435 ' HB2' ' HE2' ' A' ' 38' ' ' LYS . 8.2 tppt? -90.67 -47.93 7.36 Favored 'General case' 0 CA--C 1.479 -1.781 0 CA-C-O 122.74 1.257 . . . . 0.0 107.927 -167.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.491 HD13 HG21 ' A' ' 44' ' ' THR . 58.6 mt -82.91 6.2 19.32 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 112.91 -1.95 . . . . 0.0 111.331 -173.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.25 -38.54 30.75 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 173.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -88.41 -39.97 13.87 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.863 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.6 mt -73.5 135.91 78.39 Favored Pre-proline 0 N--CA 1.435 -1.178 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -72.6 94.65 0.78 Allowed 'Trans proline' 0 N--CA 1.441 -1.574 0 N-CA-C 106.404 -2.191 . . . . 0.0 106.404 171.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.491 HG21 HD13 ' A' ' 39' ' ' LEU . 4.9 m -100.27 137.16 19.95 Favored Pre-proline 0 N--CA 1.415 -2.216 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.814 -167.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.486 ' HB3' ' OD1' ' A' ' 72' ' ' ASN . 23.4 Cg_endo -60.11 124.59 15.56 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.041 2.494 . . . . 0.0 110.733 176.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -97.69 106.38 18.68 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.454 0.645 . . . . 0.0 110.843 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . . . -100.14 144.49 29.1 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.862 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 t -146.35 149.03 33.0 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.951 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.493 ' H ' HG11 ' A' ' 159' ' ' VAL . 90.0 t -82.52 141.22 15.28 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 175.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -133.08 -41.19 0.91 Allowed 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -170.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -160.42 163.33 33.17 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.38 -171.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.578 HG13 ' CD2' ' A' ' 64' ' ' TYR . 97.7 t -132.01 106.66 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 123.489 0.716 . . . . 0.0 110.72 -177.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.478 ' HB2' ' CD2' ' A' ' 65' ' ' HIS . 34.9 m-20 -100.83 107.51 19.08 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.44 ' HA ' ' CB ' ' A' ' 64' ' ' TYR . 49.6 p90 -63.48 138.94 58.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.581 ' HG2' ' HA ' ' A' ' 64' ' ' TYR . 14.5 mmmm -89.7 -72.91 0.54 Allowed 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -176.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.71 -88.06 0.06 OUTLIER Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 117.724 -2.179 . . . . 0.0 115.17 -175.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.72 138.71 25.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.67 0.747 . . . . 0.0 112.522 -173.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.693 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 39.8 m -152.75 157.36 40.73 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 105.021 -2.214 . . . . 0.0 105.021 173.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -102.31 -25.02 13.82 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.7 0.762 . . . . 0.0 109.884 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.467 ' H ' HG22 ' A' ' 58' ' ' THR . 32.6 t70 -99.66 23.0 10.11 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.217 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.693 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . 146.09 -162.9 28.39 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 -177.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.41 ' CG2' ' HB3' ' A' ' 173' ' ' PHE . 48.4 t -135.26 116.05 19.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 173.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -68.2 137.02 54.49 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.12 0.486 . . . . 0.0 110.98 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.714 ' CD1' HG13 ' A' ' 119' ' ' VAL . 23.9 p90 -143.02 173.02 11.92 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.478 ' CD2' ' HB2' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -124.57 122.06 36.5 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.823 -1.151 . . . . 0.0 108.815 173.902 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -78.83 131.02 36.32 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.74 -175.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -89.27 111.65 22.52 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.5 p -127.94 108.72 18.42 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-O 122.146 0.974 . . . . 0.0 108.458 175.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.435 ' HB3' HG22 ' A' ' 112' ' ' VAL . 28.8 p -101.16 133.94 44.94 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.658 -175.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 25.2 t -109.72 130.55 62.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.749 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -111.47 111.7 22.91 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 175.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.486 ' OD1' ' HB3' ' A' ' 45' ' ' PRO . 7.1 t30 -132.74 124.89 19.08 Favored Pre-proline 0 C--N 1.307 -1.249 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.656 -172.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 72' ' ' ASN . 57.3 Cg_endo -97.56 97.73 0.07 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.779 0 C-N-CA 122.078 1.852 . . . . 0.0 112.947 175.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.547 ' O ' ' HB2' ' A' ' 108' ' ' SER . 52.9 m-85 -157.84 -165.13 1.67 Allowed 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 126.425 1.89 . . . . 0.0 106.39 175.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.7 m -131.77 13.86 4.86 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-O 121.877 0.846 . . . . 0.0 109.425 175.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.453 ' O ' ' HA2' ' A' ' 107' ' ' GLY . 3.8 pt20 -118.55 134.96 54.69 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.258 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 105' ' ' LEU . 23.8 m -73.81 97.12 2.68 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.56 174.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.498 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 54.3 mt -85.19 120.95 73.91 Favored Pre-proline 0 C--O 1.244 0.813 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -84.1 158.46 13.37 Favored 'Trans proline' 0 N--CA 1.436 -1.893 0 C-N-CA 121.796 1.664 . . . . 0.0 110.022 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 29.7 pt -102.55 144.43 13.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.179 178.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 48.8 t -62.4 -55.58 26.46 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -177.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -154.31 145.74 23.08 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 171.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.437 ' CG2' ' HG3' ' A' ' 102' ' ' PRO . 14.2 tt -97.36 117.41 41.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.0 t -100.63 118.33 36.56 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -108.08 134.86 50.36 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.554 HG23 HD11 ' A' ' 94' ' ' ILE . 2.7 mp -117.45 107.31 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.028 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 178.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.462 ' CD2' ' HE2' ' A' ' 139' ' ' TYR . 2.0 tm? -101.92 121.34 41.94 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.428 -170.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.57 ' HB2' ' HB2' ' A' ' 140' ' ' GLN . 0.6 OUTLIER -102.41 150.08 23.72 Favored 'General case' 0 CA--C 1.487 -1.458 0 O-C-N 122.007 -0.433 . . . . 0.0 110.427 179.209 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.449 ' OG ' ' HB3' ' A' ' 122' ' ' SER . 68.6 m -132.87 94.42 3.38 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 177.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 53.03 -77.43 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 170.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.2 m -70.23 -72.93 0.18 Allowed 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -171.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.4 ' H ' ' H ' ' A' ' 93' ' ' THR . 99.5 mtt180 -153.63 -16.27 0.14 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.91 0.484 . . . . 0.0 109.858 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.454 HG22 ' OG ' ' A' ' 122' ' ' SER . 2.7 m -69.9 151.7 45.36 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.642 -171.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.554 HD11 HG23 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -145.11 149.42 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -174.158 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.467 ' N ' HD13 ' A' ' 94' ' ' ILE . . . -129.04 151.46 49.71 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 124.902 1.281 . . . . 0.0 108.07 175.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 35.0 p -136.67 166.48 23.46 Favored 'General case' 0 C--N 1.29 -2.006 0 O-C-N 122.232 -0.293 . . . . 0.0 111.107 -175.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 174.08 136.25 2.19 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.43 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.0 p -113.15 112.69 24.23 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.507 HD12 HG23 ' A' ' 115' ' ' VAL . 63.0 mt -99.27 109.75 55.71 Favored Pre-proline 0 C--N 1.32 -0.699 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.057 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.29 116.72 4.81 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 123.221 2.614 . . . . 0.0 111.613 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.7 t70 51.05 87.36 0.13 Allowed Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 124.929 1.291 . . . . 0.0 112.505 -177.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.437 ' HG3' ' CG2' ' A' ' 83' ' ' ILE . 11.8 Cg_endo -99.54 9.2 0.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.922 2.414 . . . . 0.0 110.766 175.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 147.32 -163.09 28.71 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -177.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.5 m -151.27 160.63 43.7 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 78' ' ' ILE . 3.8 pp -83.96 147.38 27.5 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 36.0 m -57.39 -45.52 85.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -175.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 76' ' ' GLN . . . 140.52 -55.37 0.63 Allowed Glycine 0 N--CA 1.418 -2.548 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -176.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.547 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 37.1 t -136.75 118.49 15.05 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.9 -162.6 12.31 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.933 174.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.5 t -89.26 138.83 31.09 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-O 121.729 0.776 . . . . 0.0 109.662 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.1 t -138.87 117.93 12.55 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.435 HG22 ' HB3' ' A' ' 69' ' ' SER . 47.8 t -87.25 115.83 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.188 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.516 -178.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.4 mt -100.87 149.9 23.39 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.45 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 7.7 p-10 -140.83 116.34 10.14 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.033 0.921 . . . . 0.0 112.467 -177.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.507 HG23 HD12 ' A' ' 99' ' ' ILE . 4.2 p -95.32 130.55 31.98 Favored Pre-proline 0 C--N 1.307 -1.24 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.479 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -72.41 112.58 3.49 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 121.833 1.689 . . . . 0.0 109.735 173.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.628 ' HB ' ' CE1' ' A' ' 64' ' ' TYR . 2.3 t -130.81 153.92 39.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 -175.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -116.46 133.33 56.14 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.714 HG13 ' CD1' ' A' ' 64' ' ' TYR . 15.7 m -92.86 148.81 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.764 0 C-N-CA 123.993 0.917 . . . . 0.0 108.84 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 76.27 -10.08 1.36 Allowed 'General case' 0 N--CA 1.481 1.121 0 O-C-N 124.136 0.898 . . . . 0.0 110.639 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.421 ' H ' ' C ' ' A' ' 119' ' ' VAL . 69.0 t80 -56.2 -52.31 64.86 Favored 'General case' 0 CA--C 1.484 -1.561 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.823 -178.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.454 ' OG ' HG22 ' A' ' 93' ' ' THR . 35.4 t -72.42 -43.2 64.19 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.475 -174.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 12.9 tt -71.77 -49.51 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 C-N-CA 119.192 -1.003 . . . . 0.0 112.891 -176.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -60.82 -32.51 71.89 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -176.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.0 p -71.92 -30.41 36.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.532 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.4 t -106.95 -43.87 4.55 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 119.358 -0.937 . . . . 0.0 112.24 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.9 tp -123.96 -52.95 1.76 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -175.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.413 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 25.1 ttt 76.03 138.08 0.06 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.103 1.361 . . . . 0.0 111.093 -176.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 130' ' ' ASP . 59.5 tptt -61.45 -73.08 0.1 Allowed 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 129' ' ' LYS . 22.4 t70 169.98 -13.26 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 O-C-N 124.218 0.949 . . . . 0.0 109.808 178.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.586 ' HA ' ' CE ' ' A' ' 131' ' ' MET . 0.0 OUTLIER 66.3 88.82 0.1 Allowed 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.99 0.9 . . . . 0.0 112.705 -169.435 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 47.2 t -105.86 155.69 19.08 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.5 -1.227 . . . . 0.0 107.718 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 20.9 p -96.57 100.57 12.14 Favored 'General case' 0 N--CA 1.402 -2.866 0 CA-C-O 121.089 0.471 . . . . 0.0 110.611 177.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.488 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 31.4 t70 74.95 99.96 0.07 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.18 0.992 . . . . 0.0 111.383 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -159.48 158.93 32.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.669 -1.151 . . . . 0.0 108.076 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -107.38 147.17 30.7 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.305 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 29.6 mm -128.68 130.59 68.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.923 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -102.04 101.53 11.91 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 172.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.481 ' HD1' ' O ' ' A' ' 163' ' ' GLY . 0.6 OUTLIER -104.66 170.4 7.9 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 179.723 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 88' ' ' LYS . 2.5 mp0 -120.42 147.23 45.36 Favored 'General case' 0 C--N 1.273 -2.726 0 C-N-CA 118.466 -1.294 . . . . 0.0 111.899 -177.033 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.4 tp -130.47 117.51 19.75 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-O 121.892 0.853 . . . . 0.0 110.368 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.54 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 3.9 m-20 -122.55 123.56 41.51 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 45.7 mt -122.14 131.1 73.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 119.004 -1.078 . . . . 0.0 111.028 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -106.18 86.95 0.5 Allowed Glycine 1 N--CA 1.394 -4.115 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 174.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.613 HD13 ' H ' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -85.81 141.4 29.67 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 176.292 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.1 t -128.63 122.01 29.92 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.409 -0.916 . . . . 0.0 111.457 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.464 ' CE2' HD23 ' A' ' 145' ' ' LEU . 77.7 m-85 -103.75 138.74 39.95 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -92.44 108.5 20.01 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 172.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.525 HG22 ' H ' ' A' ' 151' ' ' VAL . 51.2 mm -100.83 125.26 39.17 Favored Pre-proline 0 C--N 1.282 -2.359 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -178.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.11 -3.98 6.94 Favored 'Trans proline' 0 N--CA 1.481 0.788 0 C-N-CA 123.396 2.73 . . . . 0.0 113.46 -176.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.525 ' H ' HG22 ' A' ' 149' ' ' ILE . 59.9 t -76.0 -51.28 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.2 p -176.12 83.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 177.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 103.4 155.22 24.44 Favored Glycine 0 N--CA 1.413 -2.859 0 C-N-CA 120.589 -0.815 . . . . 0.0 114.27 165.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -97.52 114.19 26.03 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 170.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.648 ' H ' HD13 ' A' ' 155' ' ' ILE . 0.2 OUTLIER -121.44 150.84 24.61 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.888 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.672 -179.48 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 10.5 t -97.5 151.19 20.26 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 176.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 59.9 mt -113.97 110.73 48.57 Favored Pre-proline 0 N--CA 1.434 -1.226 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 176.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.487 ' HG2' ' CG ' ' A' ' 32' ' ' LYS . 26.3 Cg_exo -68.46 105.33 1.24 Allowed 'Trans proline' 0 C--O 1.241 0.671 0 C-N-CA 123.064 2.509 . . . . 0.0 112.836 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.493 HG11 ' H ' ' A' ' 49' ' ' VAL . 21.8 t -105.3 116.01 48.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 175.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 47.7 p -127.82 118.99 24.72 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -174.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.6 t -156.9 172.2 19.07 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -100.33 151.72 21.17 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.446 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.481 ' O ' ' HD1' ' A' ' 139' ' ' TYR . . . -111.74 101.83 1.33 Allowed Glycine 0 N--CA 1.406 -3.362 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 175.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.426 ' H ' ' HG2' ' A' ' 164' ' ' GLU . 7.8 pt-20 -95.28 120.51 35.63 Favored 'General case' 0 C--N 1.266 -3.031 0 CA-C-O 121.888 0.851 . . . . 0.0 109.755 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 6.6 pt -130.49 133.56 63.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.869 -172.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -99.6 128.63 45.71 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 134' ' ' ASP . 91.4 mt -114.19 117.76 43.02 Favored Pre-proline 0 C--N 1.297 -1.694 0 C-N-CA 120.454 -0.499 . . . . 0.0 111.191 -174.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -84.96 108.98 1.22 Allowed 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 122.567 2.178 . . . . 0.0 111.802 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 133' ' ' THR 0.27 79.2 p 52.31 -81.38 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 179.142 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 85.4 mt 69.51 -62.05 0.42 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.728 1.211 . . . . 0.0 111.686 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 76.8 mtm180 65.28 -3.15 0.67 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 173.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -142.94 1.33 1.27 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.35 0.595 . . . . 0.0 110.07 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.41 ' HB3' ' CG2' ' A' ' 62' ' ' VAL . 10.7 m-85 . . . . . 0 CA--C 1.551 0.999 0 N-CA-C 115.929 1.825 . . . . 0.0 115.929 -165.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 . . . . . 0 CA--C 1.511 -0.547 0 CA-C-O 120.336 0.113 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -59.34 -48.8 80.26 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -60.77 -40.17 91.56 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.598 176.696 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.557 HG12 ' HE2' ' A' ' 20' ' ' LYS . 40.7 t -64.65 -40.87 90.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.665 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.517 HG11 ' O ' ' A' ' 94' ' ' ILE . 54.6 t -59.13 -33.26 49.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.102 0.477 . . . . 0.0 110.004 175.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.06 -45.78 55.45 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 26.5 mm-40 -57.51 -52.47 65.26 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.733 176.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.557 ' HE2' HG12 ' A' ' 16' ' ' VAL . 68.1 mttm -58.12 -48.91 78.77 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.819 -178.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.11 -45.13 83.68 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 123.463 0.477 . . . . 0.0 111.395 -176.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 62.9 m -62.33 -49.51 75.32 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.015 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.8 t -61.57 -38.07 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.204 0.526 . . . . 0.0 110.296 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.506 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 86.0 mt -69.95 -46.86 72.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.172 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.1 t -59.68 -36.61 76.82 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.699 0.4 . . . . 0.0 110.676 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.1 t -62.84 -38.24 89.98 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.684 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.556 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 5.1 tt -76.72 -42.1 42.62 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 87.7 mt -57.05 -36.55 70.64 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.288 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -56.77 -41.44 77.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.814 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -83.29 -33.33 25.98 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.624 -178.227 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.21 -50.7 11.42 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -175.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -60.26 -47.04 87.67 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 122.514 0.326 . . . . 0.0 111.077 -175.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.641 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -59.63 -56.01 27.31 Favored Glycine 0 N--CA 1.444 -0.813 0 O-C-N 123.683 0.614 . . . . 0.0 111.996 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -58.4 -39.76 80.55 Favored 'General case' 0 C--O 1.255 1.348 0 C-N-CA 123.268 0.627 . . . . 0.0 110.923 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.538 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 89.1 t80 -67.76 -53.34 27.98 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.4 178.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.15 -29.69 68.82 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -174.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.641 ' HG2' ' O ' ' A' ' 33' ' ' GLY . 10.7 pt-20 -90.37 -42.39 10.96 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -177.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HD3' ' HG3' ' A' ' 37' ' ' GLU . 3.7 mppt? -107.4 -48.3 3.47 Favored 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 118.812 -1.155 . . . . 0.0 112.534 177.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.538 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 2.9 mm? -75.71 -12.67 60.24 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -169.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.56 -23.14 64.46 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 120.971 0.415 . . . . 0.0 110.095 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -115.22 17.48 16.62 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.222 0.534 . . . . 0.0 110.19 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.415 ' HB ' ' HA ' ' A' ' 39' ' ' LEU . 72.7 mt -127.98 134.6 26.4 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -40.82 103.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.317 0 C-N-CA 123.903 3.068 . . . . 0.0 114.591 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.0 p -146.5 155.08 49.43 Favored Pre-proline 0 C--N 1.31 -1.151 0 C-N-CA 124.802 1.241 . . . . 0.0 108.409 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.9 124.89 14.3 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.125 1.884 . . . . 0.0 111.468 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -97.03 111.55 23.72 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -178.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.37 143.18 33.9 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.86 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.594 ' HA ' HG21 ' A' ' 159' ' ' VAL . 10.4 t -143.18 140.59 30.83 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.553 HG23 HG22 ' A' ' 159' ' ' VAL . 45.3 t -83.63 141.26 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.829 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -108.23 -62.11 1.5 Allowed 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.844 -1.142 . . . . 0.0 114.023 -168.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.547 ' HB3' ' HD2' ' A' ' 67' ' ' LYS . 24.5 t70 -166.79 166.16 15.87 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.562 -169.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.649 HG13 ' CD2' ' A' ' 64' ' ' TYR . 97.4 t -118.55 119.54 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 124.248 1.019 . . . . 0.0 111.462 -176.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -121.95 106.4 11.2 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -82.06 134.02 35.32 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -176.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.08 78.84 1.72 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -175.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 122.64 -149.62 16.92 Favored Glycine 0 C--N 1.268 -3.212 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.217 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.4 p -143.54 154.88 16.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.0 m -135.35 164.1 28.51 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -58.31 -41.41 84.42 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.08 0.466 . . . . 0.0 110.6 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -133.23 105.0 6.75 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.76 -161.1 21.87 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.284 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 69.9 t -150.78 121.91 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -177.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.434 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 20.3 t70 -68.4 129.65 40.55 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.649 ' CD2' HG13 ' A' ' 52' ' ' VAL . 43.7 p90 -131.65 169.64 15.87 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -90.69 109.5 20.67 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 174.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.456 ' HB3' HG13 ' A' ' 115' ' ' VAL . . . -82.81 112.23 19.44 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 175.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.547 ' HD2' ' HB3' ' A' ' 51' ' ' ASP . 93.7 mttt -86.74 120.58 28.18 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.172 -176.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.0 t -127.04 109.1 19.89 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.673 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.6 p -99.55 123.66 44.03 Favored 'General case' 0 C--N 1.283 -2.314 0 C-N-CA 120.394 -0.523 . . . . 0.0 111.017 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.2 t -117.88 125.43 74.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.826 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.421 ' HG2' ' OG1' ' A' ' 110' ' ' THR . 51.7 mtpt -95.07 110.25 22.2 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.639 HD22 HD12 ' A' ' 105' ' ' LEU . 47.4 t-20 -108.39 113.79 59.92 Favored Pre-proline 0 C--N 1.302 -1.48 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.241 -176.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -111.55 97.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.152 0 C-N-CA 123.017 2.478 . . . . 0.0 110.408 166.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -168.94 -19.96 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.7 t 70.99 24.57 3.95 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.333 1.053 . . . . 0.0 109.651 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.565 ' HG3' HG12 ' A' ' 78' ' ' ILE . 4.3 tp-100 -121.68 110.67 16.25 Favored 'General case' 0 N--CA 1.396 -3.173 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.987 -178.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.3 m -75.09 87.4 2.39 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.565 HG12 ' HG3' ' A' ' 76' ' ' GLN . 82.3 mt -72.77 122.02 86.51 Favored Pre-proline 0 C--N 1.294 -1.839 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.775 -170.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -70.86 109.95 2.65 Favored 'Trans proline' 0 N--CA 1.431 -2.187 0 N-CA-C 106.721 -2.069 . . . . 0.0 106.721 168.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.3 mt -62.95 119.49 7.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -173.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 41.8 t -56.64 -53.21 60.35 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -167.94 147.76 4.89 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.428 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 12.4 tt -110.85 113.93 45.65 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 175.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 98' ' ' THR . 26.5 t -92.65 148.17 22.28 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -140.57 139.42 34.97 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 176.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.582 HG23 ' HB2' ' A' ' 142' ' ' ASP . 11.8 tt -143.56 110.55 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 174.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.432 ' O ' HD12 ' A' ' 87' ' ' LEU . 3.4 pp -110.9 141.04 44.85 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.586 -178.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.45 ' HA ' HG22 ' A' ' 94' ' ' ILE . 97.3 mttt -103.62 153.08 21.01 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.837 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 55.8 m -135.29 132.18 37.43 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.682 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.78 86.87 2.79 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 121.951 0.881 . . . . 0.0 112.018 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.8 m -161.58 -53.61 0.05 OUTLIER 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 163.86 -52.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 125.268 1.605 . . . . 0.0 110.479 177.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.2 m -70.81 142.11 51.32 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.948 -177.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.517 ' O ' HG11 ' A' ' 17' ' ' VAL . 2.5 pp -125.04 177.25 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.036 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 86' ' ' ILE . . . -131.95 134.03 45.18 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 118.296 0.498 . . . . 0.0 109.778 177.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.4 p -135.09 158.47 44.28 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 176.22 168.42 36.38 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.574 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 40.5 p -135.02 116.58 14.79 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 122.717 0.407 . . . . 0.0 109.959 178.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 60.6 mt -98.57 108.78 50.0 Favored Pre-proline 0 C--N 1.323 -0.572 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.166 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.65 121.99 7.48 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.607 2.204 . . . . 0.0 111.692 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.4 t70 56.12 83.4 0.22 Allowed Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 124.008 0.923 . . . . 0.0 112.249 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -101.48 8.28 0.53 Allowed 'Trans proline' 0 CA--C 1.548 1.212 0 C-N-CA 123.073 2.515 . . . . 0.0 113.075 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 165.14 -124.33 1.24 Allowed Glycine 0 N--CA 1.441 -1.033 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.7 m -151.84 146.67 25.85 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 176.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.639 HD12 HD22 ' A' ' 72' ' ' ASN . 1.0 OUTLIER -104.44 98.13 7.95 Favored 'General case' 0 N--CA 1.423 -1.791 0 C-N-CA 117.859 -1.536 . . . . 0.0 109.119 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.517 ' HB ' ' HB ' ' A' ' 111' ' ' THR 0.255 14.8 p 10.55 -72.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 128.811 2.844 . . . . 0.0 117.501 178.308 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.463 ' H ' HG13 ' A' ' 106' ' ' VAL . . . 125.37 -51.12 0.84 Allowed Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -174.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.5 p -154.09 94.89 1.78 Allowed 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.334 0.587 . . . . 0.0 111.862 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 143.98 -175.17 24.0 Favored Glycine 0 CA--C 1.497 -1.081 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.883 176.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.421 ' OG1' ' HG2' ' A' ' 71' ' ' LYS . 56.3 m -95.35 116.93 29.45 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.517 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 9.6 t -113.78 137.12 52.08 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 25.5 t -99.4 115.08 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.3 mt -89.82 148.27 23.3 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.395 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -114.23 121.0 42.38 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.769 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 66' ' ' ALA . 10.3 p -128.18 125.55 23.42 Favored Pre-proline 0 C--N 1.302 -1.462 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.34 177.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.29 111.72 3.24 Favored 'Trans proline' 0 C--O 1.246 0.909 0 C-N-CA 123.117 2.545 . . . . 0.0 112.589 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.438 HG23 ' CE1' ' A' ' 64' ' ' TYR . 26.3 m -143.36 151.44 16.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.434 ' HG3' ' N ' ' A' ' 63' ' ' ASP . 3.3 mppt? -95.9 135.72 37.27 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.623 ' HB ' ' CE1' ' A' ' 64' ' ' TYR . 13.2 p -94.9 145.78 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 66.44 13.33 9.2 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 123.548 0.739 . . . . 0.0 110.332 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.505 ' O ' HG23 ' A' ' 125' ' ' VAL . 84.4 t80 -56.77 -50.38 72.48 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 124.786 1.235 . . . . 0.0 108.961 176.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.8 m -62.1 -40.74 96.89 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.856 -176.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.436 HD13 ' HG3' ' A' ' 129' ' ' LYS . 14.0 tt -79.06 -34.01 16.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.352 -177.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -60.85 -35.95 77.89 Favored 'General case' 0 C--N 1.358 0.937 0 CA-C-O 120.893 0.377 . . . . 0.0 110.031 174.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 121' ' ' TYR . 43.2 t -56.54 -37.79 53.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.42 175.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.2 m -95.52 -77.24 0.48 Allowed 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.582 HD12 ' H ' ' A' ' 129' ' ' LYS . 3.9 pp -119.03 -12.11 9.56 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -172.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.508 ' O ' ' HG2' ' A' ' 128' ' ' MET . 25.0 ttt 60.93 41.17 14.59 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.931 0.892 . . . . 0.0 113.399 173.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.582 ' H ' HD12 ' A' ' 127' ' ' LEU . 15.0 mtmt 60.1 -83.12 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.128 0.571 . . . . 0.0 111.28 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 164.21 -23.13 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 126.806 2.043 . . . . 0.0 106.469 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.509 ' HG3' ' HA ' ' A' ' 171' ' ' ARG . 0.3 OUTLIER 59.16 100.38 0.02 OUTLIER 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.253 -176.903 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 49.0 t -132.17 170.09 15.49 Favored 'General case' 0 CA--C 1.556 1.209 0 O-C-N 121.609 -0.682 . . . . 0.0 112.503 -175.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.462 HG22 ' HB3' ' A' ' 169' ' ' SER . 21.6 p -67.79 133.0 48.47 Favored 'General case' 0 N--CA 1.42 -1.949 0 C-N-CA 125.125 1.37 . . . . 0.0 109.886 170.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.6 t70 42.17 72.37 0.17 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.457 1.103 . . . . 0.0 110.206 -171.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.453 ' CZ2' ' HB3' ' A' ' 129' ' ' LYS . 33.1 t-105 -101.29 115.23 30.02 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.816 -173.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -107.39 126.26 52.25 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.114 -174.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.455 HD11 HD13 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -139.86 168.21 18.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-O 121.545 0.688 . . . . 0.0 112.083 -179.673 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -142.0 133.07 26.08 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.382 177.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.34 172.76 11.8 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 178.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -129.69 124.18 32.96 Favored 'General case' 0 C--N 1.287 -2.112 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.143 -175.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.2 tp -107.06 129.73 54.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.295 -174.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.582 ' HB2' HG23 ' A' ' 86' ' ' ILE . 10.7 m-20 -122.79 137.41 54.93 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 158' ' ' PRO . 42.1 mm -124.09 145.96 30.36 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -122.39 97.67 0.6 Allowed Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 177.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.508 ' HB3' ' CE2' ' A' ' 147' ' ' PHE . 2.9 mm? -81.68 110.26 16.86 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 -178.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 28.7 m -96.35 108.17 20.64 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.613 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.515 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 53.6 m-85 -120.7 144.79 48.03 Favored 'General case' 0 CA--C 1.494 -1.208 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 154' ' ' ASP . 6.4 p-10 -116.37 116.09 27.08 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.499 -0.88 . . . . 0.0 109.327 176.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.651 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -106.02 130.43 23.0 Favored Pre-proline 0 C--N 1.298 -1.645 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.618 -177.893 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -42.75 -32.89 2.69 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 125.03 3.82 . . . . 0.0 115.572 -176.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.4 m -60.21 -34.37 56.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 60.0 t -135.78 -68.06 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.026 0.441 . . . . 0.0 109.976 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 163.06 -146.14 11.38 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.15 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 148' ' ' ASP . 6.3 p-10 -83.7 120.26 25.79 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.554 0.692 . . . . 0.0 112.571 -176.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.497 ' O ' HD12 ' A' ' 155' ' ' ILE . 2.5 pp -127.12 124.05 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.817 173.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.493 ' O ' ' HD3' ' A' ' 158' ' ' PRO . 56.9 m -88.12 117.38 26.96 Favored 'General case' 0 N--CA 1.424 -1.775 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.823 176.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 60.5 mt -95.81 104.77 17.57 Favored Pre-proline 0 C--N 1.303 -1.42 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.875 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.0 OUTLIER -85.39 138.85 6.62 Favored 'Trans proline' 0 CA--C 1.485 -1.971 0 C-N-CA 122.66 2.24 . . . . 0.0 111.762 176.883 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.594 HG21 ' HA ' ' A' ' 48' ' ' THR . 2.6 p -138.05 132.9 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.556 0 CA-C-N 112.953 -1.93 . . . . 0.0 109.661 -173.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.482 ' HB3' ' OD1' ' A' ' 142' ' ' ASP . 58.1 p -120.59 161.93 20.5 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.491 -176.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.3 t -166.09 165.41 17.8 Favored 'General case' 0 C--O 1.252 1.216 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -98.48 126.71 44.13 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -108.69 82.64 0.31 Allowed Glycine 0 N--CA 1.419 -2.476 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.43 120.37 30.7 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.447 ' CD1' HG21 ' A' ' 119' ' ' VAL . 5.7 pt -145.14 121.22 3.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.119 -170.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -104.18 139.75 38.78 Favored 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 117.887 -1.525 . . . . 0.0 109.511 174.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.455 HD13 HD11 ' A' ' 137' ' ' ILE . 6.8 mp -108.8 103.39 51.6 Favored Pre-proline 0 N--CA 1.405 -2.678 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.631 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.26 92.76 0.82 Allowed 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 123.165 2.576 . . . . 0.0 114.893 -172.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.462 ' HB3' HG22 ' A' ' 133' ' ' THR . 5.0 m 50.37 89.33 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 125.399 1.48 . . . . 0.0 114.086 171.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.49 ' HB2' ' SD ' ' A' ' 131' ' ' MET . 99.1 mt -108.69 -39.83 5.25 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.048 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.509 ' HA ' ' HG3' ' A' ' 131' ' ' MET . 36.4 mmt180 54.88 18.82 2.35 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 177.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -178.7 -29.73 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -176.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 C--N 1.315 -0.915 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -172.872 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 17' ' ' VAL . 1.9 p30 . . . . . 0 CA--C 1.533 0.325 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.16 -42.42 99.41 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 123.504 0.722 . . . . 0.0 110.821 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -65.71 -46.25 79.68 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.9 m -71.79 -23.07 21.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.299 -176.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 13' ' ' ASP . 77.4 t -61.72 -47.22 94.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 172.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -59.53 -37.19 77.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.762 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -60.51 -56.78 17.29 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.36 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -65.97 -39.2 90.16 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.893 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.57 -37.31 80.88 Favored 'General case' 0 C--O 1.221 -0.439 0 O-C-N 123.286 0.366 . . . . 0.0 110.805 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.0 t -63.39 -50.34 70.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.865 0.364 . . . . 0.0 110.451 178.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.05 -45.11 99.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.391 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.491 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 83.7 mt -66.18 -43.23 92.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.171 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.2 t -62.02 -35.57 78.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.796 0.332 . . . . 0.0 110.463 177.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.8 t -63.45 -41.28 98.64 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.97 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.559 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 3.9 tt -71.09 -41.68 70.3 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 96.3 mt -59.24 -39.68 83.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.092 0.473 . . . . 0.0 110.366 177.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -62.54 -41.9 99.18 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.559 ' HG2' ' O ' ' A' ' 27' ' ' LEU . 61.4 pttt -63.52 -34.38 77.66 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 119.921 -0.711 . . . . 0.0 109.523 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.66 -31.66 52.75 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.692 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.554 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 39.7 ttmt -51.12 -40.08 57.68 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.059 0.944 . . . . 0.0 112.884 -175.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.46 -8.86 54.32 Favored Glycine 0 C--N 1.313 -0.698 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.614 178.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 19.3 t80 -81.45 -25.9 35.72 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 124.435 1.094 . . . . 0.0 108.418 -175.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.554 ' CE2' ' HA ' ' A' ' 32' ' ' LYS . 22.5 m-85 -56.96 -36.57 70.44 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.627 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.64 -50.05 55.34 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.766 0.666 . . . . 0.0 112.396 -173.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -98.88 -43.71 6.63 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.277 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.486 ' HD3' ' N ' ' A' ' 38' ' ' LYS 0.295 2.7 mppt? -75.19 -3.92 35.8 Favored 'General case' 0 C--O 1.206 -1.22 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 -171.042 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.3 mt -117.38 1.0 12.33 Favored 'General case' 0 C--N 1.284 -2.251 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.808 173.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.44 -55.74 2.42 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.09 0.471 . . . . 0.0 110.521 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -86.14 -4.5 59.18 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.496 -177.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.7 mm -119.06 126.85 26.83 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.03 104.21 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.448 2.099 . . . . 0.0 110.415 176.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.441 HG22 ' CD1' ' A' ' 149' ' ' ILE . 5.8 p -128.26 154.37 78.93 Favored Pre-proline 0 C--N 1.302 -1.493 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.464 -174.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.467 ' HB3' ' HB2' ' A' ' 72' ' ' ASN . 65.6 Cg_endo -84.73 154.94 11.75 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.888 2.392 . . . . 0.0 112.02 178.069 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -121.04 136.93 54.87 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.39 167.6 13.1 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.98 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.4 t -155.49 145.21 21.31 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 123.506 0.503 . . . . 0.0 110.518 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.479 HG23 HG23 ' A' ' 159' ' ' VAL . 45.4 t -83.99 141.9 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 173.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' A' ' 67' ' ' LYS . 18.4 t70 -122.2 -54.18 1.91 Allowed 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -172.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -162.03 162.59 28.87 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -172.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.3 m -122.98 108.15 20.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 121.438 0.637 . . . . 0.0 110.024 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -90.9 121.08 32.44 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.601 -177.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 53.3 p90 -69.3 120.21 14.77 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.536 177.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -83.36 -49.4 9.39 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.423 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 178.95 -147.36 7.72 Favored Glycine 0 N--CA 1.41 -3.046 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 173' ' ' PHE . 7.5 p -111.67 138.42 40.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-O 121.02 0.438 . . . . 0.0 110.487 -174.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 24.5 m -127.15 145.13 50.86 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 175.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.429 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 17.8 tpt180 -104.61 78.36 1.45 Allowed 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 118.661 -1.216 . . . . 0.0 108.327 178.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -175.32 -70.33 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 -175.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.433 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . -138.2 -138.53 3.72 Favored Glycine 0 N--CA 1.411 -3.024 0 N-CA-C 104.298 -3.521 . . . . 0.0 104.298 167.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.04 134.28 41.52 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-N 118.675 1.238 . . . . 0.0 110.288 174.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -93.43 107.27 19.14 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.063 -175.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.517 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 4.5 m-85 -100.45 161.09 13.83 Favored 'General case' 0 CA--C 1.486 -1.511 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.005 176.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.416 ' CD2' ' HB3' ' A' ' 114' ' ' ASP . 3.3 t-160 -114.75 107.73 15.83 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 178.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -92.86 140.78 29.15 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.0 0.428 . . . . 0.0 112.022 -176.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.413 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . 75.2 mmtt -89.64 121.33 31.72 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.77 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.88 111.28 29.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.5 m -98.85 139.25 34.81 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 120.319 -0.553 . . . . 0.0 109.94 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.2 t -131.45 131.61 62.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 63.5 pttt -114.59 132.32 56.38 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 175.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.848 ' O ' ' HA ' ' A' ' 108' ' ' SER . 5.8 t30 -142.73 114.75 6.07 Favored Pre-proline 0 C--N 1.294 -1.835 0 C-N-CA 119.743 -0.783 . . . . 0.0 112.949 -175.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -94.36 99.62 0.12 Allowed 'Trans proline' 0 N--CA 1.436 -1.865 0 C-N-CA 122.365 2.043 . . . . 0.0 109.487 170.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.539 ' HB3' HD21 ' A' ' 72' ' ' ASN . 48.8 t80 -170.32 -14.82 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -176.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.426 ' H ' ' H ' ' A' ' 74' ' ' TYR . 24.1 t 83.14 -56.24 0.16 Allowed 'General case' 0 C--O 1.233 0.232 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 172.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -69.46 152.89 44.33 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-N 118.719 0.691 . . . . 0.0 112.744 -176.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.6 p -77.14 111.82 13.15 Favored 'General case' 0 N--CA 1.411 -2.375 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.279 174.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 70.0 mt -93.27 114.9 64.09 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -65.07 139.16 59.88 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.374 2.05 . . . . 0.0 110.241 175.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 54.5 mt -88.2 114.83 27.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 58.3 m -55.76 -56.14 24.05 Favored 'General case' 0 C--N 1.319 -0.742 0 O-C-N 123.811 0.695 . . . . 0.0 109.521 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -167.81 160.72 12.7 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.113 176.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.442 HG23 HG23 ' A' ' 143' ' ' ILE . 25.0 mt -120.14 113.75 41.6 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.959 176.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.422 ' HB3' HG22 ' A' ' 98' ' ' THR . 28.8 p -88.29 117.22 27.05 Favored 'General case' 0 N--CA 1.405 -2.72 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -111.45 143.05 42.92 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.501 HG23 ' HB3' ' A' ' 142' ' ' ASP . 9.9 tt -137.13 108.74 6.38 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 CA-C-O 121.727 0.775 . . . . 0.0 109.15 176.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.586 HD11 ' HB3' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -106.84 145.91 31.57 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.506 -179.443 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.469 ' HA ' HG22 ' A' ' 94' ' ' ILE . 40.1 ttmt -118.43 152.58 35.61 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.831 -175.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.7 t -126.96 97.86 5.12 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 175.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.445 ' HA ' ' OD2' ' A' ' 138' ' ' ASP . . . 53.51 -94.96 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.98 1.312 . . . . 0.0 111.357 -175.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 85.5 m -166.34 85.13 0.3 Allowed 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 124.669 1.187 . . . . 0.0 108.513 175.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -160.06 -62.9 0.07 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 49.6 m -136.73 151.94 49.79 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.469 HG22 ' HA ' ' A' ' 88' ' ' LYS . 37.2 pt -134.72 -176.34 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.393 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.586 ' HB3' HD11 ' A' ' 87' ' ' LEU . . . -145.54 146.2 31.32 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 172.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.0 t -148.38 144.52 27.55 Favored 'General case' 0 N--CA 1.412 -2.357 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -166.73 166.38 39.0 Favored Glycine 0 N--CA 1.426 -2.025 0 C-N-CA 120.648 -0.786 . . . . 0.0 111.296 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.422 HG22 ' HB3' ' A' ' 84' ' ' SER . 40.5 p -110.18 119.89 40.72 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.2 tt -103.3 104.55 41.65 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.912 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 98' ' ' THR . 11.5 Cg_exo -72.79 128.06 12.93 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.058 2.505 . . . . 0.0 111.97 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.3 t70 52.08 79.48 0.34 Allowed Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 124.633 1.173 . . . . 0.0 111.997 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -101.47 8.82 0.52 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.788 2.325 . . . . 0.0 111.487 176.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 149.58 -168.39 29.8 Favored Glycine 0 N--CA 1.422 -2.236 0 N-CA-C 108.221 -1.952 . . . . 0.0 108.221 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.5 m -145.51 149.89 35.46 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 118.3 1.05 . . . . 0.0 111.956 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.74 118.38 22.23 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 177.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 29.2 m -66.11 -35.96 76.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -174.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 140.31 -137.45 8.35 Favored Glycine 0 N--CA 1.416 -2.676 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.848 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 65.4 m -77.68 101.44 6.62 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.474 0.655 . . . . 0.0 111.555 178.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 164.99 -172.29 40.62 Favored Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 177.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.4 t -114.43 114.34 25.71 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.776 0.798 . . . . 0.0 109.684 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.6 t -110.26 132.94 53.73 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.157 -177.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 20.5 m -99.63 106.54 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-O 121.791 0.805 . . . . 0.0 110.031 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 66.4 mt -95.46 164.58 12.75 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.84 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 4.9 m-20 -133.99 135.62 43.56 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.143 -178.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.65 132.23 24.1 Favored Pre-proline 0 C--N 1.305 -1.353 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -73.46 110.63 3.1 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 N-CA-C 107.122 -1.915 . . . . 0.0 107.122 168.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.7 t -113.28 140.17 34.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.627 -172.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.663 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -88.1 98.95 11.82 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.2 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.3 m -102.58 147.49 9.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 71.78 -22.88 0.19 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.887 0.875 . . . . 0.0 113.212 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -55.7 -36.5 67.23 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.002 0.521 . . . . 0.0 110.963 177.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.9 p -59.12 -46.3 88.67 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.647 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 14.2 tt -79.08 -32.56 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.282 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.561 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -57.38 -43.31 83.49 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.704 0.802 . . . . 0.0 112.643 -178.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.3 m -72.09 -22.33 21.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.3 m -93.51 -73.03 0.58 Allowed 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -177.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.461 HD23 ' H ' ' A' ' 127' ' ' LEU . 1.8 pt? -124.52 -12.96 7.17 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -176.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.561 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER 73.63 140.61 0.06 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.507 1.123 . . . . 0.0 109.826 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.522 ' HE3' ' HB2' ' A' ' 131' ' ' MET . 46.6 pttt -59.42 -19.88 50.67 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.138 0.575 . . . . 0.0 111.43 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 23.8 t70 82.23 -22.73 0.24 Allowed 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 125.226 1.41 . . . . 0.0 109.577 177.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.522 ' HB2' ' HE3' ' A' ' 129' ' ' LYS . 15.4 tpt 51.08 97.24 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 112.678 -2.055 . . . . 0.0 115.388 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 64.4 m -92.94 140.41 29.52 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 171.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.8 p -71.19 100.71 2.13 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-O 121.482 0.658 . . . . 0.0 110.606 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.546 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 14.0 t70 86.37 88.55 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.627 0 C-N-CA 126.852 2.061 . . . . 0.0 110.312 -174.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.422 ' HZ2' ' HB2' ' A' ' 129' ' ' LYS . 0.8 OUTLIER -158.5 158.88 34.9 Favored 'General case' 0 N--CA 1.412 -2.33 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 176.312 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -117.7 134.6 54.73 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.481 ' CG2' ' HB ' ' A' ' 165' ' ' ILE . 9.8 tt -97.4 133.22 39.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 C-N-CA 120.594 -0.442 . . . . 0.0 109.856 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.445 ' OD2' ' HA ' ' A' ' 90' ' ' ALA . 38.9 t70 -70.39 90.44 0.71 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.532 178.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -108.77 152.81 24.35 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.526 177.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.414 ' HB2' ' HB3' ' A' ' 88' ' ' LYS . 21.8 mp0 -137.86 146.64 43.65 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 41.2 tp -128.74 126.52 40.19 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 123.461 0.475 . . . . 0.0 110.391 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.501 ' HB3' HG23 ' A' ' 86' ' ' ILE . 14.1 t70 -127.32 125.82 41.48 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.442 HG23 HG23 ' A' ' 83' ' ' ILE . 42.6 mm -111.83 118.76 58.41 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 CA-C-O 120.953 0.406 . . . . 0.0 109.98 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -95.95 86.85 0.95 Allowed Glycine 0 N--CA 1.42 -2.422 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 173.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.712 HD13 ' H ' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -74.73 134.26 41.91 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.438 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.8 m -110.74 108.32 18.15 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.477 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.531 ' O ' ' HA ' ' A' ' 154' ' ' ASP . 80.0 m-85 -114.66 129.7 56.71 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 175.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -94.49 109.69 21.55 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.441 ' CD1' HG22 ' A' ' 44' ' ' THR . 64.6 mt -98.15 129.38 30.94 Favored Pre-proline 0 C--N 1.291 -1.974 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.7 -176.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -52.26 -34.84 61.44 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 123.854 3.036 . . . . 0.0 112.944 -178.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.43 -51.07 76.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.374 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 39.0 t -119.9 -69.28 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.418 -175.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 163.37 -141.14 6.93 Favored Glycine 0 N--CA 1.431 -1.644 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.531 ' HA ' ' O ' ' A' ' 147' ' ' PHE . 4.2 p30 -94.25 131.17 40.12 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 117.331 0.566 . . . . 0.0 111.914 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.27 115.7 33.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 176.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.599 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 24.8 p -86.16 115.92 24.03 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.098 175.162 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 54.4 mt -97.11 106.93 34.79 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -74.27 107.24 2.39 Favored 'Trans proline' 0 C--O 1.251 1.162 0 C-N-CA 121.929 1.753 . . . . 0.0 111.106 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.479 HG23 HG23 ' A' ' 49' ' ' VAL . 30.6 m -110.48 126.95 67.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.841 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.473 ' HB3' ' OD2' ' A' ' 142' ' ' ASP . 48.3 p -129.38 162.7 27.43 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.143 0.497 . . . . 0.0 112.209 -176.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.9 t -159.51 -177.83 6.69 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 177.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -97.81 119.19 35.97 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -103.56 97.27 1.43 Allowed Glycine 0 N--CA 1.415 -2.746 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -178.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -88.95 119.47 29.5 Favored 'General case' 0 C--N 1.265 -3.103 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 -176.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.481 ' HB ' ' CG2' ' A' ' 137' ' ' ILE . 38.4 mm -101.77 107.14 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.418 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 176.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -113.29 126.72 55.71 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.215 0.531 . . . . 0.0 110.161 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 134' ' ' ASP . 67.1 mt -121.93 95.09 47.89 Favored Pre-proline 0 C--N 1.289 -2.046 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.851 -172.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.4 92.14 0.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.882 2.388 . . . . 0.0 112.978 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.422 ' H ' ' N ' ' A' ' 134' ' ' ASP . 78.0 p 53.34 27.42 6.22 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.435 1.494 . . . . 0.0 113.267 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.528 HD21 ' CD1' ' A' ' 173' ' ' PHE . 22.7 tp -75.45 83.39 2.53 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -83.13 105.39 14.07 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.639 -173.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.1 t70 75.0 91.84 0.08 Allowed 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 124.694 1.198 . . . . 0.0 110.023 177.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.528 ' CD1' HD21 ' A' ' 170' ' ' LEU . 37.4 t80 . . . . . 0 C--N 1.303 -1.439 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 -175.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.9 t70 . . . . . 0 CA--C 1.543 0.698 0 CA-C-O 121.057 0.456 . . . . 0.0 111.328 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.69 ' O ' HG12 ' A' ' 17' ' ' VAL . 41.1 tt0 -73.52 -32.35 64.2 Favored 'General case' 0 C--O 1.209 -1.059 0 CA-C-O 121.852 0.834 . . . . 0.0 108.923 177.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -71.14 -33.55 70.18 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.626 0.727 . . . . 0.0 109.916 174.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.8 t -69.77 -29.28 40.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.993 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.69 HG12 ' O ' ' A' ' 14' ' ' GLU . 9.1 p -66.03 -25.53 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 120.001 -0.679 . . . . 0.0 109.208 177.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -72.08 -45.72 59.61 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.51 -38.22 89.05 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.684 175.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.459 ' O ' HG13 ' A' ' 24' ' ' ILE . 58.5 tptt -55.72 -48.86 74.44 Favored 'General case' 0 N--CA 1.425 -1.705 0 C-N-CA 123.257 0.623 . . . . 0.0 109.415 174.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.1 -35.75 82.13 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.734 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -62.53 -45.2 94.07 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.153 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.3 m -70.75 -32.32 48.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.84 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 20' ' ' LYS . 85.3 mt -65.18 -46.01 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 173.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.1 m -65.21 -35.36 80.83 Favored 'General case' 0 C--O 1.186 -2.243 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.689 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -59.57 -44.79 93.2 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-O 121.069 0.462 . . . . 0.0 109.999 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.533 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 5.2 tt -74.41 -44.03 53.76 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.499 HD13 HG22 ' A' ' 156' ' ' THR . 56.0 tp -63.14 -31.55 72.72 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-O 120.927 0.394 . . . . 0.0 110.78 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -66.77 -45.73 77.58 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 123.172 0.589 . . . . 0.0 111.17 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -71.05 -30.55 66.75 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.84 -44.22 70.34 Favored 'General case' 0 C--O 1.198 -1.627 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.788 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -60.61 -48.68 80.69 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -177.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.22 -30.96 79.27 Favored Glycine 0 C--O 1.239 0.411 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.413 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.464 ' HA ' ' HE2' ' A' ' 38' ' ' LYS . 61.9 t80 -75.98 -43.34 45.02 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 177.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.505 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 65.7 t80 -58.82 -53.81 54.14 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.768 1.227 . . . . 0.0 113.789 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.79 -19.18 49.02 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -174.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.479 ' HB2' ' HD3' ' A' ' 38' ' ' LYS . 31.2 mt-10 -116.39 -54.98 2.43 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.651 ' O ' HG12 ' A' ' 42' ' ' ILE . 3.2 mppt? -87.62 -27.44 22.5 Favored 'General case' 0 CA--C 1.466 -2.286 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.134 -170.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.505 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 86.6 mt -87.07 9.15 20.65 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 118.731 -1.188 . . . . 0.0 111.671 -176.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.07 -25.9 31.61 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.263 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -113.23 10.58 18.56 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.03 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.651 HG12 ' O ' ' A' ' 38' ' ' LYS . 47.5 mm -114.9 115.83 43.23 Favored Pre-proline 0 C--O 1.244 0.769 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -57.56 110.52 0.63 Allowed 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 122.728 2.285 . . . . 0.0 111.027 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.7 p -139.3 158.5 68.86 Favored Pre-proline 0 C--N 1.308 -1.202 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.333 -177.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.41 ' HB3' ' HB3' ' A' ' 72' ' ' ASN . 18.0 Cg_exo -70.04 128.21 15.45 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.33 2.02 . . . . 0.0 109.92 174.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -100.99 130.72 47.02 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.482 ' CB ' ' HG ' ' A' ' 145' ' ' LEU . . . -121.59 153.2 38.38 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.1 t -147.15 143.69 28.44 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.392 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.63 ' H ' HG11 ' A' ' 159' ' ' VAL . 14.9 p -119.79 142.28 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -165.07 -18.85 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.656 -171.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.467 ' HB3' ' CG ' ' A' ' 67' ' ' LYS . 19.1 t70 -120.1 128.1 53.15 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.877 -176.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 67.9 t -110.94 120.31 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.802 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 178.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -112.14 125.5 54.19 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 123.327 0.651 . . . . 0.0 111.912 -175.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -70.25 141.09 52.49 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 124.151 0.98 . . . . 0.0 113.148 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.593 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 59.1 mtpt -122.13 -79.04 0.6 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.295 176.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.6 -147.87 6.54 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 119.63 -1.271 . . . . 0.0 113.323 -176.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.1 p -98.42 149.79 5.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.155 0.502 . . . . 0.0 111.477 -173.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.1 t -152.71 -174.53 4.95 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -67.04 -63.84 0.98 Allowed 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 120.931 0.396 . . . . 0.0 110.372 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.404 ' HB2' ' HE2' ' A' ' 118' ' ' LYS . 9.1 m-20 -92.15 95.68 9.89 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.943 -172.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.17 -131.18 10.7 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.353 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 173' ' ' PHE . 6.8 t -127.02 135.03 64.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -178.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.593 ' O ' ' HB2' ' A' ' 55' ' ' LYS . 13.8 t70 -90.01 120.08 30.91 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 2.5 m-85 -122.4 172.77 8.09 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.934 0.873 . . . . 0.0 113.128 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.521 ' HB2' ' HD2' ' A' ' 55' ' ' LYS . 8.4 t-160 -126.0 108.84 11.78 Favored 'General case' 0 N--CA 1.421 -1.875 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.602 -177.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.34 143.43 26.76 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.467 ' CG ' ' HB3' ' A' ' 51' ' ' ASP . 44.8 mmtm -92.02 114.65 27.24 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 176.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.403 HG11 HD11 ' A' ' 145' ' ' LEU . 64.7 t -111.86 108.67 26.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.2 m -104.02 129.05 51.61 Favored 'General case' 0 C--N 1.284 -2.242 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.217 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 t -116.32 128.84 73.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.846 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 59.0 pttt -120.61 121.91 39.37 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.606 0.717 . . . . 0.0 109.317 178.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.732 ' O ' ' HA ' ' A' ' 108' ' ' SER . 24.3 p-10 -129.94 115.64 17.85 Favored Pre-proline 0 C--N 1.277 -2.572 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.595 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -93.41 97.77 0.15 Allowed 'Trans proline' 0 N--CA 1.425 -2.533 0 N-CA-C 107.166 -1.898 . . . . 0.0 107.166 165.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.422 ' CD2' HD11 ' A' ' 78' ' ' ILE . 25.9 t80 -157.39 -5.72 0.09 Allowed 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.684 -174.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.2 m 73.34 -2.38 2.76 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 174.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -132.85 147.12 52.3 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.301 -0.875 . . . . 0.0 112.33 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.9 m -83.68 107.37 16.08 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.457 ' H ' ' CD2' ' A' ' 105' ' ' LEU . 45.9 mt -94.39 122.39 61.33 Favored Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -177.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -66.74 113.33 2.71 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.075 1.85 . . . . 0.0 109.623 174.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 10.4 tt -72.0 134.98 28.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 54.9 m -61.1 -58.85 6.65 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.504 0.669 . . . . 0.0 109.733 -177.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -163.6 150.05 11.87 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.435 -177.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.9 mt -101.67 114.15 40.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 171.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.4 m -102.68 117.4 34.57 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.418 ' CD1' HG23 ' A' ' 117' ' ' VAL . 54.8 p90 -106.35 136.73 45.58 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.409 -178.283 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 54.6 mt -123.34 108.8 21.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 176.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.593 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 0.5 OUTLIER -91.86 121.19 33.24 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -174.778 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.692 ' HB2' ' HB2' ' A' ' 140' ' ' GLN . 1.0 OUTLIER -94.27 116.29 28.66 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.284 0.564 . . . . 0.0 109.632 172.734 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.501 ' CB ' ' HB3' ' A' ' 122' ' ' SER . 22.7 t -100.16 94.07 6.04 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -176.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 61.37 -80.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.262 1.025 . . . . 0.0 110.662 -174.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.5 m -158.8 -36.17 0.06 Allowed 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -87.03 104.51 16.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.964 -177.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.498 ' HB ' ' OG ' ' A' ' 122' ' ' SER . 29.7 m 70.83 164.61 0.28 Allowed 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.289 1.036 . . . . 0.0 112.01 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.593 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 2.1 pp -144.09 170.68 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.749 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -173.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.466 ' HB3' ' CD1' ' A' ' 87' ' ' LEU . . . -121.96 154.88 36.61 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 172.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 t -159.87 168.05 26.69 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.172 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.59 151.57 8.76 Favored Glycine 0 N--CA 1.427 -1.941 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.533 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 20.3 p -109.06 116.84 32.73 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 54.6 mt -98.66 101.61 12.38 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 98' ' ' THR . 3.1 Cg_exo -78.28 123.24 5.99 Favored 'Trans proline' 0 C--O 1.241 0.661 0 C-N-CA 123.035 2.49 . . . . 0.0 111.21 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.3 t70 54.43 79.51 0.34 Allowed Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 124.83 1.252 . . . . 0.0 111.007 -174.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -104.74 25.06 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.676 2.918 . . . . 0.0 110.685 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.41 -172.9 18.09 Favored Glycine 0 N--CA 1.409 -3.122 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 -175.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 64.7 m -151.47 170.09 20.47 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 176.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.644 ' HA ' HG21 ' A' ' 111' ' ' THR 0.312 0.0 OUTLIER -98.88 158.15 15.83 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 179.863 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 22.9 m -72.2 -176.65 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 124.328 1.017 . . . . 0.0 110.989 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.42 -47.88 54.84 Favored Glycine 0 C--N 1.307 -1.068 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.24 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.732 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 21.3 t -160.07 94.01 1.09 Allowed 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 176.64 -168.83 41.05 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.318 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.5 m -113.04 114.06 26.33 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.644 HG21 ' HA ' ' A' ' 105' ' ' LEU . 10.2 t -113.34 138.41 50.09 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 26.4 t -96.89 118.04 42.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 121.013 0.435 . . . . 0.0 109.884 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.0 mt -98.25 159.56 14.86 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.967 -178.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -104.76 130.09 52.89 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.337 -175.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.2 t -125.72 114.36 24.84 Favored Pre-proline 0 CA--C 1.5 -0.978 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.431 172.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 2.7 Cg_exo -77.77 110.16 2.88 Favored 'Trans proline' 0 N--CA 1.423 -2.635 0 N-CA-C 107.528 -1.758 . . . . 0.0 107.528 168.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.418 HG23 ' CD1' ' A' ' 85' ' ' TYR . 12.3 p -115.81 137.52 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.404 ' HE2' ' HB2' ' A' ' 60' ' ' ASP . 50.1 mtpt -94.78 99.88 11.88 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -175.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.4 HG13 ' HB2' ' A' ' 64' ' ' TYR . 16.4 m -94.32 149.3 4.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -168.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 76.8 -12.8 1.0 Allowed 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 124.724 1.209 . . . . 0.0 113.334 172.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -48.2 -50.38 29.47 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 124.223 0.952 . . . . 0.0 112.987 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.501 ' HB3' ' CB ' ' A' ' 89' ' ' SER . 34.6 t -66.65 -43.49 84.48 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.438 -0.905 . . . . 0.0 112.382 -169.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.456 HD11 HD11 ' A' ' 137' ' ' ILE . 24.3 pt -79.02 -27.73 13.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.444 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -58.48 -41.14 84.59 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 174.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.6 t -56.98 -39.43 65.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.694 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 36.4 t -89.88 -84.94 0.22 Allowed 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.643 HD23 ' H ' ' A' ' 127' ' ' LEU . 1.9 pt? -106.84 -17.79 14.11 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 120.854 0.359 . . . . 0.0 111.963 -175.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.529 ' C ' ' HD3' ' A' ' 129' ' ' LYS . 23.8 ttt 58.22 39.24 25.99 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.02 0.928 . . . . 0.0 111.031 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.588 ' HG3' ' NE1' ' A' ' 135' ' ' TRP 0.306 0.0 OUTLIER 48.98 -73.1 0.0 OUTLIER 'General case' 0 C--N 1.363 1.156 0 C-N-CA 125.125 1.37 . . . . 0.0 114.169 -177.244 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -178.57 -32.15 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.62 ' SD ' ' HA ' ' A' ' 171' ' ' ARG . 0.7 OUTLIER 62.66 81.93 0.19 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.374 -178.127 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 29.0 m -108.98 172.31 6.92 Favored 'General case' 0 C--O 1.251 1.173 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.696 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 30.5 p -81.81 108.12 15.09 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 169.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.539 ' H ' ' H ' ' A' ' 169' ' ' SER . 24.8 m-20 76.36 98.04 0.07 Allowed 'General case' 0 CA--C 1.496 -1.118 0 O-C-N 124.167 0.917 . . . . 0.0 109.836 -175.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.588 ' NE1' ' HG3' ' A' ' 129' ' ' LYS . 69.9 t-105 -140.02 119.83 13.42 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.362 -174.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 166' ' ' LYS . 22.7 t70 -91.01 111.82 23.45 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 174.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.456 HD11 HD11 ' A' ' 123' ' ' ILE . 8.2 tt -97.42 149.27 5.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.238 -170.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -86.47 103.07 14.66 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.398 177.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.416 ' HD1' ' O ' ' A' ' 163' ' ' GLY . 7.0 t80 -137.66 150.24 47.21 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.692 ' HB2' ' HB2' ' A' ' 88' ' ' LYS . 48.9 mt-30 -139.74 158.82 43.47 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.9 tp -141.67 130.49 22.96 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.45 0.643 . . . . 0.0 112.232 -175.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.462 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 2.3 m-20 -125.92 129.51 49.45 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 54.3 mt -130.36 131.86 65.17 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.486 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.392 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -105.42 109.95 3.35 Favored Glycine 0 N--CA 1.405 -3.391 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 156' ' ' THR . 2.6 mm? -89.13 110.18 20.95 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 32.1 m -95.5 108.97 21.24 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.572 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -114.47 152.66 31.27 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -120.25 114.35 21.76 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 175.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 49.6 mm -110.94 116.28 52.02 Favored Pre-proline 0 C--N 1.287 -2.116 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -45.82 -33.0 9.86 Favored 'Trans proline' 0 N--CA 1.485 1.009 0 C-N-CA 123.892 3.061 . . . . 0.0 113.891 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 44.6 t -69.81 -23.66 25.97 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 123.198 0.599 . . . . 0.0 112.166 -177.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 9.1 p -136.86 -33.29 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -175.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 122.01 -151.11 16.95 Favored Glycine 0 N--CA 1.434 -1.498 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.185 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -87.52 117.9 26.62 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.429 0.633 . . . . 0.0 110.647 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.4 123.36 49.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.33 0.586 . . . . 0.0 110.711 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 40.9 m -99.19 127.12 45.12 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.551 177.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.1 mp -89.68 122.1 68.45 Favored Pre-proline 0 C--N 1.318 -0.804 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -83.4 113.59 2.04 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.818 2.345 . . . . 0.0 112.362 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.63 HG11 ' H ' ' A' ' 49' ' ' VAL . 21.9 t -111.89 119.12 59.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 173.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 67.9 p -128.41 127.15 42.02 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 123.13 0.269 . . . . 0.0 111.073 -175.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.1 t -158.64 177.36 11.29 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -98.66 148.75 23.51 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.416 ' O ' ' HD1' ' A' ' 139' ' ' TYR . . . -118.62 83.32 0.35 Allowed Glycine 0 N--CA 1.416 -2.669 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -88.82 119.92 29.75 Favored 'General case' 0 C--N 1.273 -2.729 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.4 HG13 ' CG2' ' A' ' 137' ' ' ILE . 4.9 pt -133.66 123.11 45.01 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-O 121.304 0.573 . . . . 0.0 111.915 -175.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.642 ' HD3' ' H ' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -89.69 109.81 20.76 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.925 178.249 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -90.5 107.44 20.15 Favored Pre-proline 0 C--N 1.288 -2.101 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.077 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -86.35 94.13 0.55 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 122.654 2.236 . . . . 0.0 112.996 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.539 ' H ' ' H ' ' A' ' 134' ' ' ASP . 78.2 p 50.83 105.24 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.351 1.46 . . . . 0.0 114.854 178.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -128.78 -70.82 0.66 Allowed 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.62 ' HA ' ' SD ' ' A' ' 131' ' ' MET . 81.0 mtp180 59.08 79.29 0.23 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 114.231 1.196 . . . . 0.0 114.231 177.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 171' ' ' ARG . 32.5 t70 172.8 -77.71 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 123.978 0.799 . . . . 0.0 111.332 173.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.446 ' O ' HG22 ' A' ' 62' ' ' VAL . 52.6 p90 . . . . . 0 C--N 1.315 -0.899 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -174.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.5 t70 . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 121.124 0.488 . . . . 0.0 110.389 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.412 ' HA ' HG12 ' A' ' 17' ' ' VAL . 40.8 tt0 -64.88 -46.11 83.17 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.682 176.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -54.29 -49.52 69.41 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 123.977 0.911 . . . . 0.0 111.679 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.3 m -77.96 -27.3 14.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 14' ' ' GLU . 7.1 p -72.8 -31.42 36.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 119.534 -0.867 . . . . 0.0 109.756 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -60.59 -42.18 96.21 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -59.13 -52.49 65.48 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.657 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -62.61 -44.58 95.93 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.55 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.43 ' HB2' HD11 ' A' ' 94' ' ' ILE . . . -60.83 -40.57 93.32 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.453 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.5 t -60.78 -44.89 96.21 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 123.439 0.462 . . . . 0.0 110.374 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.7 t -60.45 -46.0 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.213 0.53 . . . . 0.0 110.172 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.1 mm -64.95 -47.91 86.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.085 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.1 m -62.88 -29.67 70.94 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.048 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.2 t -65.19 -31.42 72.59 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 120.997 0.427 . . . . 0.0 110.207 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.2 tt -73.92 -42.1 61.1 Favored 'General case' 0 C--O 1.246 0.916 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.495 HD23 ' HB3' ' A' ' 158' ' ' PRO . 8.6 mp -58.89 -35.08 72.42 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.153 175.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -51.02 -49.27 60.82 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.414 ' HD2' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -75.56 -27.95 58.81 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.391 -178.316 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.428 ' HB1' ' O ' ' A' ' 156' ' ' THR . . . -77.36 -34.31 55.09 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.179 -176.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 99.5 mttt -59.14 -37.42 77.22 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 121.08 0.467 . . . . 0.0 109.779 177.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.99 -44.06 97.95 Favored Glycine 0 N--CA 1.431 -1.661 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.758 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -80.47 -39.27 28.38 Favored 'General case' 0 C--O 1.198 -1.648 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.685 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -58.57 -31.7 68.23 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.4 -37.38 83.02 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.754 0.311 . . . . 0.0 111.799 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -116.9 -48.32 2.66 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -175.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.436 ' HB2' ' HE2' ' A' ' 38' ' ' LYS . 12.8 tppt? -69.56 -48.55 59.9 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 122.364 1.078 . . . . 0.0 109.195 -169.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.48 HD22 HG21 ' A' ' 44' ' ' THR . 39.4 mt -88.51 0.87 55.85 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.187 -171.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.17 -20.03 18.23 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.712 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -110.4 -24.9 10.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.945 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 72.1 mt -93.54 142.03 24.64 Favored Pre-proline 0 N--CA 1.431 -1.395 0 N-CA-C 106.789 -1.559 . . . . 0.0 106.789 177.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -67.24 105.25 0.99 Allowed 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 121.888 1.725 . . . . 0.0 108.376 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.48 HG21 HD22 ' A' ' 39' ' ' LEU . 4.2 m -125.11 141.46 38.6 Favored Pre-proline 0 N--CA 1.415 -2.185 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -173.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.38 113.06 1.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.903 1.735 . . . . 0.0 111.079 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -96.84 121.98 39.3 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.185 0.517 . . . . 0.0 110.396 -174.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.507 ' HB2' HD21 ' A' ' 145' ' ' LEU . . . -98.71 157.88 15.98 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.076 -179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -148.72 129.1 13.84 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.924 176.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.408 ' H ' HG11 ' A' ' 159' ' ' VAL . 13.0 p -113.69 137.16 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 175.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -151.04 -35.67 0.14 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.735 -168.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -116.61 147.59 41.74 Favored 'General case' 0 CA--C 1.463 -2.373 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.49 -173.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.547 HG22 ' CB ' ' A' ' 64' ' ' TYR . 8.2 p -150.85 103.05 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.404 -2.765 0 CA-C-O 122.58 1.181 . . . . 0.0 107.885 175.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -96.51 129.56 43.86 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.095 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 44.3 p90 -59.62 122.19 13.48 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.261 0.553 . . . . 0.0 111.026 175.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -85.43 -56.05 3.71 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.138 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.48 -137.63 2.59 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -178.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.1 p -112.65 141.85 26.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.6 m -114.53 166.1 12.06 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -55.84 -54.83 39.77 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -99.25 -62.84 1.18 Allowed 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.635 -177.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -108.64 -130.07 6.08 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 175.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.563 HG21 ' CZ ' ' A' ' 173' ' ' PHE . 7.1 p -140.16 137.38 37.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.269 0.557 . . . . 0.0 111.271 177.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -104.04 122.97 46.36 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.789 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.547 ' CB ' HG22 ' A' ' 52' ' ' VAL . 3.7 m-30 -109.09 167.33 10.18 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.27 0.557 . . . . 0.0 110.665 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -106.29 106.79 17.47 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.08 144.87 26.69 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.604 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -107.83 125.12 51.06 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.042 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.2 t -126.89 107.78 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 176.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.5 m -98.57 139.7 33.91 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 110' ' ' THR . 22.8 t -124.56 127.13 72.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.486 -178.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 88.6 tttt -110.85 117.7 34.13 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.549 ' HB3' ' O ' ' A' ' 107' ' ' GLY . 37.0 t30 -118.99 127.13 26.69 Favored Pre-proline 0 CA--C 1.507 -0.676 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.088 -173.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 72' ' ' ASN . 11.3 Cg_endo -94.01 96.02 0.13 Allowed 'Trans proline' 0 N--CA 1.428 -2.326 0 C-N-CA 121.42 1.414 . . . . 0.0 110.074 169.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.502 ' HB2' HD21 ' A' ' 72' ' ' ASN . 42.7 m-85 175.81 162.27 0.32 Allowed 'General case' 0 CA--C 1.492 -1.273 0 C-N-CA 129.173 2.989 . . . . 0.0 104.21 -178.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 51.7 p -100.85 -16.43 17.26 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.605 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -79.77 149.92 30.94 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 121.573 0.701 . . . . 0.0 112.048 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.8 p -80.38 104.97 11.29 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.433 172.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.418 ' H ' HD22 ' A' ' 105' ' ' LEU . 52.9 mt -91.05 117.61 68.01 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -85.34 152.46 10.62 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.945 1.763 . . . . 0.0 112.531 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.636 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -88.29 143.7 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.598 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 51.0 t -78.47 -35.52 46.49 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -170.23 157.22 6.17 Favored 'General case' 0 C--O 1.252 1.223 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.5 mt -118.33 115.62 48.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 171.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 20.8 p -112.81 118.57 35.31 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.316 -176.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 96' ' ' SER . 37.9 p90 -104.15 143.2 33.25 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 58.2 mt -132.76 108.08 12.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 173.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 87' ' ' LEU . 4.2 pp -105.55 134.44 48.67 Favored 'General case' 0 C--N 1.282 -2.369 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.359 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.516 ' HA ' HG22 ' A' ' 94' ' ' ILE . 40.3 ttmt -110.93 123.98 51.21 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.06 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.486 ' OG ' ' HB2' ' A' ' 122' ' ' SER . 53.2 p -104.26 98.63 8.4 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 64.5 -79.94 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.264 1.426 . . . . 0.0 114.819 174.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.8 t -135.11 -29.65 1.1 Allowed 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -172.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -143.91 145.63 32.41 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.582 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 m 71.19 130.41 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.197 0 O-C-N 125.28 1.612 . . . . 0.0 110.836 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.516 HG22 ' HA ' ' A' ' 88' ' ' LYS . 1.8 pp -127.4 165.35 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.11 122.02 36.72 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 61.3 p -120.81 147.19 45.7 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -163.37 144.98 10.01 Favored Glycine 0 N--CA 1.432 -1.626 0 C-N-CA 119.844 -1.17 . . . . 0.0 112.248 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.8 p -107.97 115.63 30.48 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.5 tt -101.81 114.45 65.58 Favored Pre-proline 0 C--N 1.307 -1.25 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.764 177.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -85.71 129.49 3.56 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 122.617 2.211 . . . . 0.0 111.457 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.9 t70 50.45 79.38 0.35 Allowed Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 124.608 1.163 . . . . 0.0 113.21 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -99.71 2.45 0.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.126 2.55 . . . . 0.0 112.09 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 151.94 -166.62 30.97 Favored Glycine 0 N--CA 1.42 -2.382 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.3 p -137.76 155.7 48.77 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.255 0.55 . . . . 0.0 110.763 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.624 ' HA ' HG21 ' A' ' 111' ' ' THR . 6.3 tt -90.64 125.36 35.63 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.412 HG22 ' HB ' ' A' ' 111' ' ' THR . 33.7 m -65.36 -30.7 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -172.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.577 ' H ' HD23 ' A' ' 105' ' ' LEU . . . 135.26 -113.24 1.09 Allowed Glycine 0 N--CA 1.417 -2.598 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -176.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.8 p -91.85 97.85 11.24 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 124.25 1.02 . . . . 0.0 111.136 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 140.53 -164.07 26.37 Favored Glycine 0 N--CA 1.418 -2.555 0 C-N-CA 119.947 -1.12 . . . . 0.0 111.485 176.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 11.0 t -95.7 139.94 31.23 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-O 121.919 0.866 . . . . 0.0 111.104 -178.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.624 HG21 ' HA ' ' A' ' 105' ' ' LEU . 4.9 t -134.78 121.0 20.09 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 176.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.7 t -87.74 110.45 20.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.582 -177.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.3 mt -97.48 162.29 13.38 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -141.54 144.02 34.07 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.479 -0.489 . . . . 0.0 111.46 -175.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 51.7 t -135.01 136.41 24.92 Favored Pre-proline 0 C--O 1.241 0.606 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.557 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -79.5 111.34 2.81 Favored 'Trans proline' 0 N--CA 1.432 -2.135 0 N-CA-C 107.586 -1.736 . . . . 0.0 107.586 168.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 24.6 m -112.67 133.88 57.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -89.01 92.0 9.06 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.783 0.802 . . . . 0.0 110.183 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.492 ' C ' ' H ' ' A' ' 121' ' ' TYR . 3.2 m -95.24 149.73 4.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.383 -172.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 74.36 -20.15 0.33 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.54 0.736 . . . . 0.0 111.87 175.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.492 ' H ' ' C ' ' A' ' 119' ' ' VAL . 21.4 t80 -46.11 -45.29 16.29 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 126.461 1.904 . . . . 0.0 109.782 176.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.486 ' HB2' ' OG ' ' A' ' 89' ' ' SER . 18.0 m -68.21 -52.42 34.44 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-N 115.275 -0.875 . . . . 0.0 113.039 -174.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 12.6 tt -74.61 -36.08 39.86 Favored 'Isoleucine or valine' 0 C--O 1.251 1.178 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -174.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.38 -50.66 72.71 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 122.269 0.227 . . . . 0.0 111.294 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.2 m -72.7 -22.67 20.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.9 t -77.27 -69.86 0.5 Allowed 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.808 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 127' ' ' LEU . 1.7 pt? -124.1 -23.72 4.51 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -177.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.476 ' O ' ' HD2' ' A' ' 129' ' ' LYS . 0.0 OUTLIER 66.3 -176.55 0.19 Allowed 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -177.223 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.476 ' HD2' ' O ' ' A' ' 128' ' ' MET . 12.2 mmmm -133.31 -71.25 0.52 Allowed 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 178.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.409 ' H ' ' HB2' ' A' ' 129' ' ' LYS . 15.8 t70 152.85 80.93 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 128.978 2.911 . . . . 0.0 104.419 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.418 ' HE1' ' HB2' ' A' ' 170' ' ' LEU . 1.0 OUTLIER -91.31 115.47 28.06 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.509 -178.72 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 169' ' ' SER . 83.1 m -131.09 -81.04 0.53 Allowed 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -178.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 41.5 p -142.01 116.86 9.86 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 123.287 0.635 . . . . 0.0 109.915 -169.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.6 t70 59.97 82.07 0.16 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 122.08 0.943 . . . . 0.0 109.419 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -140.86 158.96 43.22 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.5 -172.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -147.72 154.89 41.14 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 118.683 0.674 . . . . 0.0 110.864 175.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.5 tt -148.63 149.68 14.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.139 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -114.14 134.17 55.08 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.452 ' HE2' HD22 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -125.49 170.76 11.09 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 178.014 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 162' ' ' GLN . 24.3 tt0 -119.17 137.41 53.63 Favored 'General case' 0 C--N 1.273 -2.741 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.297 -177.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 28.5 tp -119.57 128.23 53.71 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.975 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.62 ' OD1' ' HB3' ' A' ' 160' ' ' SER . 17.1 t70 -130.71 112.2 12.87 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 35.4 mt -113.31 122.57 67.7 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.31 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.962 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -106.68 101.95 1.81 Allowed Glycine 0 N--CA 1.398 -3.892 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.507 HD21 ' HB2' ' A' ' 47' ' ' ALA . 0.8 OUTLIER -91.77 143.07 26.91 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.87 174.289 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.8 m -114.4 111.34 21.29 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.316 -175.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.495 ' CE1' HG23 ' A' ' 80' ' ' ILE . 90.1 m-85 -106.71 163.43 12.92 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 172.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -146.64 131.44 18.01 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.357 177.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.26 135.71 15.28 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 176.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -48.92 -18.34 1.64 Allowed 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 124.393 3.395 . . . . 0.0 114.927 -178.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 55.7 t -57.23 -39.07 65.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 121.133 0.492 . . . . 0.0 110.332 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 5.8 p -136.69 -36.15 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.238 0.542 . . . . 0.0 111.238 -178.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 120.53 -142.52 15.89 Favored Glycine 0 N--CA 1.419 -2.499 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -178.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -92.04 126.45 37.13 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.164 0.507 . . . . 0.0 110.01 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.41 ' N ' HD13 ' A' ' 155' ' ' ILE . 0.2 OUTLIER -139.85 133.56 36.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.37 176.849 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 11.4 t -100.5 147.98 25.29 Favored 'General case' 0 N--CA 1.412 -2.345 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 173.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 60.0 mt -110.48 109.35 58.25 Favored Pre-proline 0 C--N 1.291 -1.94 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.495 ' HB3' HD23 ' A' ' 28' ' ' LEU . 17.1 Cg_exo -70.82 102.64 1.22 Allowed 'Trans proline' 0 C--O 1.244 0.806 0 C-N-CA 122.693 2.262 . . . . 0.0 111.376 177.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 142' ' ' ASP . 14.2 t -103.83 108.77 25.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.62 ' HB3' ' OD1' ' A' ' 142' ' ' ASP . 52.1 p -109.04 150.89 27.11 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.817 -177.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.8 t -168.07 151.97 6.11 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 140' ' ' GLN . 12.9 pt20 -107.69 119.23 38.84 Favored 'General case' 0 N--CA 1.42 -1.934 0 C-N-CA 119.296 -0.962 . . . . 0.0 109.345 174.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -92.96 118.76 5.7 Favored Glycine 0 N--CA 1.409 -3.126 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.696 -174.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -89.68 119.59 30.23 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 176.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.3 pt -129.59 111.95 23.38 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 CA-C-O 121.521 0.677 . . . . 0.0 111.524 -174.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -78.85 130.11 35.31 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.604 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 87.7 mt -106.39 109.17 62.94 Favored Pre-proline 0 C--N 1.293 -1.859 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.006 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.8 172.05 17.03 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.185 1.924 . . . . 0.0 111.765 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 49.1 p -53.28 105.65 0.14 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 123.253 0.621 . . . . 0.0 111.495 175.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.418 ' HB2' ' HE1' ' A' ' 131' ' ' MET . 79.7 mt -137.38 -50.31 0.62 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 62.75 113.93 0.02 OUTLIER 'General case' 0 C--N 1.355 0.843 0 O-C-N 124.213 0.945 . . . . 0.0 112.815 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 33.1 t70 87.23 8.95 0.18 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.762 1.225 . . . . 0.0 111.094 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.563 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 72.5 t80 . . . . . 0 CA--C 1.54 0.572 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.34 174.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.857 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -100.98 -15.67 17.41 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 117.305 0.553 . . . . 0.0 111.256 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.471 ' HB2' ' O ' ' A' ' 127' ' ' LEU . 44.6 m-70 -80.2 72.76 7.04 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.683 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -157.11 154.06 28.8 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 59.94 64.75 1.22 Allowed 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 124.239 1.016 . . . . 0.0 111.248 -178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -149.38 118.47 6.75 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 175.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . 0.256 21.1 p80 -132.57 89.56 2.66 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.7 tt -137.24 93.96 2.88 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 171.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 52.41 41.88 30.91 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.61 -1.632 . . . . 0.0 108.761 -173.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 74.4 -67.55 0.25 Allowed 'General case' 0 C--N 1.356 0.874 0 C-N-CA 126.124 1.77 . . . . 0.0 109.758 -173.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.5 m -158.89 122.38 3.82 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 176.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.57 -43.0 75.52 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.528 0.518 . . . . 0.0 112.122 -175.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.471 ' O ' HG23 ' A' ' 17' ' ' VAL . 7.8 m-20 -63.77 -49.96 70.92 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.928 0.394 . . . . 0.0 111.019 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.22 -40.66 86.53 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -177.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -70.28 -53.81 15.29 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.955 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.409 ' HA ' ' CG ' ' A' ' 19' ' ' GLU . 33.4 m -62.7 -27.96 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.543 HG11 ' O ' ' A' ' 94' ' ' ILE . 73.3 t -62.92 -41.23 91.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.024 175.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -66.93 -36.3 81.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.79 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.409 ' CG ' ' HA ' ' A' ' 16' ' ' VAL . 7.5 mm-40 -53.3 -54.0 42.8 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.36 0.664 . . . . 0.0 109.719 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -65.94 -47.86 73.29 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.258 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.69 -43.48 80.53 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.095 -176.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -57.19 -45.81 83.39 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 123.59 0.556 . . . . 0.0 111.045 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.01 -42.02 79.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.431 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 73.9 mt -58.22 -46.97 88.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.891 177.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.7 m -61.99 -30.87 71.24 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.868 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.6 m -67.69 -40.18 84.38 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.076 0.465 . . . . 0.0 110.575 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.643 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 6.5 tt -72.74 -33.62 66.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.071 0.462 . . . . 0.0 109.993 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 96.5 mt -65.86 -38.72 89.57 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.428 0.632 . . . . 0.0 109.485 175.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -66.31 -34.38 77.85 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.225 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.643 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -64.11 -33.55 76.02 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-O 121.533 0.682 . . . . 0.0 109.432 178.264 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.561 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -77.64 -32.47 53.36 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.933 -178.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -53.46 -52.91 57.98 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.21 -24.93 75.66 Favored Glycine 0 N--CA 1.468 0.806 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.667 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.612 ' CZ ' ' HD2' ' A' ' 38' ' ' LYS . 10.9 t80 -68.79 -40.1 79.78 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 124.165 0.986 . . . . 0.0 110.263 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.495 ' CD1' HD12 ' A' ' 39' ' ' LEU . 20.2 m-85 -62.27 -45.57 92.68 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.313 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.74 -48.72 63.54 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 124.505 1.128 . . . . 0.0 113.061 -174.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -104.61 -36.13 7.59 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 119.414 -0.914 . . . . 0.0 113.349 -176.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.612 ' HD2' ' CZ ' ' A' ' 34' ' ' PHE . 21.6 ttmm -87.01 -43.49 12.3 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.342 -173.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.495 HD12 ' CD1' ' A' ' 35' ' ' PHE . 22.7 mt -87.28 19.04 3.37 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.204 -0.998 . . . . 0.0 111.907 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.89 -18.24 13.98 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -107.46 -21.07 13.05 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.788 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.3 mm -111.59 107.21 56.8 Favored Pre-proline 0 N--CA 1.442 -0.845 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.454 ' HB2' ' OH ' ' A' ' 74' ' ' TYR . 24.8 Cg_exo -64.26 118.0 4.99 Favored 'Trans proline' 0 C--O 1.251 1.149 0 C-N-CA 122.643 2.229 . . . . 0.0 112.294 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.1 p -128.73 150.32 74.53 Favored Pre-proline 0 C--N 1.299 -1.629 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.213 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.484 ' HB3' ' HB2' ' A' ' 72' ' ' ASN . 34.7 Cg_endo -63.48 149.23 91.61 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.988 2.459 . . . . 0.0 112.155 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -110.85 137.79 48.06 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.448 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.529 ' O ' HG11 ' A' ' 159' ' ' VAL . . . -115.65 165.33 13.15 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.331 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.4 t -161.89 147.39 13.28 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 110.518 -0.178 . . . . 0.0 110.518 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.519 ' HB ' ' OG1' ' A' ' 161' ' ' THR . 89.8 t -91.32 140.93 15.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 174.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -116.07 -60.94 1.8 Allowed 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -175.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -161.66 165.91 27.54 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -167.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.482 HG12 ' HB2' ' A' ' 66' ' ' ALA . 26.1 m -124.15 137.72 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -96.18 126.63 41.54 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.436 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -58.61 109.19 0.75 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 168.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.51 -53.29 1.36 Allowed 'General case' 0 N--CA 1.426 -1.668 0 C-N-CA 119.029 -1.068 . . . . 0.0 112.677 -172.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.91 -172.88 31.93 Favored Glycine 0 N--CA 1.425 -2.078 0 C-N-CA 119.184 -1.484 . . . . 0.0 112.309 -174.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.459 ' HB ' ' CD1' ' A' ' 173' ' ' PHE . 12.2 p -128.77 155.69 40.85 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-O 121.129 0.49 . . . . 0.0 110.927 -175.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 48.4 m -125.88 149.47 48.66 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 173.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 60' ' ' ASP . 37.3 mmt180 -79.0 77.2 5.47 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 118.621 -1.232 . . . . 0.0 112.22 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 59' ' ' ARG . 9.9 t70 171.74 -48.08 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.163 1.385 . . . . 0.0 107.668 176.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -150.19 177.95 27.97 Favored Glycine 0 C--O 1.223 -0.549 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 119' ' ' VAL . 6.5 m -87.83 156.09 3.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 118.743 1.272 . . . . 0.0 110.842 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -111.5 105.37 13.93 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.312 0.577 . . . . 0.0 109.75 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -110.64 159.76 17.29 Favored 'General case' 0 CA--C 1.48 -1.726 0 CA-C-O 122.084 0.945 . . . . 0.0 112.588 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -107.61 106.63 17.08 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.482 ' HB2' HG12 ' A' ' 52' ' ' VAL . . . -97.87 144.81 27.06 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -94.72 135.53 36.09 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.175 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.9 t -130.93 108.49 15.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 174.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.0 m -102.38 133.64 46.98 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.057 -175.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.3 t -123.32 133.33 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -119.93 128.22 53.4 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.532 HD21 ' HB2' ' A' ' 74' ' ' TYR . 6.0 t30 -142.89 114.92 5.99 Favored Pre-proline 0 C--N 1.284 -2.257 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.585 -175.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -94.17 96.17 0.13 Allowed 'Trans proline' 0 N--CA 1.422 -2.726 0 C-N-CA 121.835 1.69 . . . . 0.0 110.248 172.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.532 ' HB2' HD21 ' A' ' 72' ' ' ASN . 68.9 m-85 -176.33 127.55 0.2 Allowed 'General case' 0 CA--C 1.482 -1.671 0 C-N-CA 128.105 2.562 . . . . 0.0 104.788 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.4 m -84.32 68.83 10.35 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.442 0.639 . . . . 0.0 111.012 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -151.8 145.77 25.22 Favored 'General case' 0 N--CA 1.407 -2.612 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.82 176.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 44.6 p -86.76 101.56 13.44 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.776 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.413 ' HB ' HD22 ' A' ' 105' ' ' LEU . 28.1 mt -94.72 117.61 66.91 Favored Pre-proline 0 N--CA 1.441 -0.891 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -83.65 146.96 12.16 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 121.915 1.743 . . . . 0.0 110.59 176.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.435 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 2.1 mp -85.53 91.46 3.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.255 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.683 ' O ' ' HB ' ' A' ' 146' ' ' THR . 58.6 m -78.27 105.72 9.69 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.466 ' HB3' ' O ' ' A' ' 81' ' ' CYS . 24.7 tt0 76.3 109.66 0.07 Allowed 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.14 0.9 . . . . 0.0 111.754 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.617 ' CG2' ' HB ' ' A' ' 99' ' ' ILE . 15.5 tt -117.8 125.04 73.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.538 -0.726 . . . . 0.0 109.342 174.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.9 t -86.84 125.07 33.73 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-O 121.25 0.548 . . . . 0.0 109.86 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.545 ' OH ' ' HA ' ' A' ' 117' ' ' VAL . 56.5 t80 -107.69 120.38 42.06 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.26 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.5 mt -130.24 107.18 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 CA-C-O 122.063 0.935 . . . . 0.0 109.332 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.644 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 1.3 tm? -100.66 134.82 43.05 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 114.616 -1.174 . . . . 0.0 107.862 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.586 ' HB2' ' HB2' ' A' ' 140' ' ' GLN . 96.5 mttt -128.31 158.02 39.36 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -177.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.505 ' OG ' ' HB3' ' A' ' 122' ' ' SER . 57.5 m -143.91 97.67 3.1 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 52.71 -90.13 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 175.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.9 m -108.24 -53.99 2.56 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.097 0.475 . . . . 0.0 111.755 -171.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -126.06 154.84 42.45 Favored 'General case' 0 CA--C 1.472 -2.044 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 27.6 m 71.87 135.89 0.04 OUTLIER 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 113.363 -1.744 . . . . 0.0 112.895 175.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.644 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 38.4 pt -136.84 -179.2 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.382 0 CA-C-N 114.616 -1.175 . . . . 0.0 107.937 176.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . . . -130.75 121.31 25.19 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 172.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 36.8 p -112.49 159.06 19.15 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.534 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.21 178.3 47.55 Favored Glycine 0 N--CA 1.424 -2.15 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.9 m -146.25 120.06 9.27 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.617 ' HB ' ' CG2' ' A' ' 83' ' ' ILE . 71.5 mt -98.6 126.11 40.31 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -177.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -80.49 114.86 3.07 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.914 1.742 . . . . 0.0 111.278 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.8 t70 53.23 87.6 0.14 Allowed Pre-proline 0 N--CA 1.485 1.292 0 C-N-CA 124.937 1.295 . . . . 0.0 112.753 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.435 ' HD2' ' HB ' ' A' ' 80' ' ' ILE . 26.7 Cg_endo -91.15 -7.05 3.75 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.847 2.365 . . . . 0.0 112.188 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 160.93 -179.04 36.65 Favored Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.3 m -142.71 157.67 44.42 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.275 0.559 . . . . 0.0 111.038 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.473 HD23 ' CB ' ' A' ' 72' ' ' ASN . 7.5 mp -76.73 135.13 39.02 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.483 176.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 27.3 m -71.06 -17.5 20.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.11 113.1 1.51 Allowed Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 61.9 m 53.46 83.87 0.06 Allowed 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.916 0.886 . . . . 0.0 113.308 -177.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 155.71 -176.93 33.09 Favored Glycine 0 N--CA 1.432 -1.575 0 C-N-CA 119.956 -1.116 . . . . 0.0 112.391 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.7 t -105.38 135.71 46.26 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.5 t -139.44 130.37 26.29 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 120.865 0.364 . . . . 0.0 110.407 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.9 m -93.48 122.47 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-O 121.686 0.755 . . . . 0.0 110.024 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.9 mt -108.34 158.06 17.83 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -134.09 149.03 51.09 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 119.664 -0.815 . . . . 0.0 112.277 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.3 m -131.49 144.63 54.19 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.649 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -74.06 111.76 3.38 Favored 'Trans proline' 0 C--O 1.247 0.953 0 C-N-CA 122.12 1.88 . . . . 0.0 110.675 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.545 ' HA ' ' OH ' ' A' ' 85' ' ' TYR . 96.5 t -107.26 127.09 63.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-O 121.553 0.692 . . . . 0.0 112.814 -175.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.515 ' HE2' ' HA ' ' A' ' 118' ' ' LYS . 8.5 mmpt? -89.06 96.64 10.81 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.602 ' O ' HG22 ' A' ' 62' ' ' VAL . 99.7 t -93.52 138.94 19.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 72.19 -16.84 0.4 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.058 0.943 . . . . 0.0 111.416 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.512 ' H ' ' C ' ' A' ' 119' ' ' VAL . 53.1 t80 -51.49 -39.86 58.4 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 125.94 1.696 . . . . 0.0 110.1 176.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.505 ' HB3' ' OG ' ' A' ' 89' ' ' SER . 33.9 t -65.55 -51.79 57.26 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.557 -177.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.5 tt -67.25 -28.87 43.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.327 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.572 ' HB2' ' CE1' ' A' ' 174' ' ' PHE . . . -66.43 -50.65 62.66 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 177.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.77 -30.2 49.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.956 0.408 . . . . 0.0 110.928 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.0 t -70.69 -73.43 0.17 Allowed 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.48 HD23 ' H ' ' A' ' 127' ' ' LEU . 1.9 pt? -125.43 -41.33 2.04 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 24.1 ttt 64.15 100.03 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 124.299 1.04 . . . . 0.0 109.395 -172.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.568 ' HG3' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -48.89 -63.78 1.0 Allowed 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.732 -177.048 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.568 ' H ' ' HG3' ' A' ' 129' ' ' LYS . 21.4 t70 151.85 107.93 0.0 OUTLIER 'General case' 0 CA--C 1.471 -2.094 0 N-CA-C 102.649 -3.093 . . . . 0.0 102.649 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.471 ' HG3' ' HA ' ' A' ' 171' ' ' ARG . 13.1 tpt -53.07 123.58 12.05 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 123.519 0.512 . . . . 0.0 111.627 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 49.1 t -99.32 -158.74 0.69 Allowed 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.238 -176.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.696 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 21.8 p -131.01 114.11 14.79 Favored 'General case' 0 N--CA 1.385 -3.713 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.2 t70 70.43 89.9 0.1 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -172.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -133.58 115.74 15.05 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.522 -172.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.14 104.55 15.82 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.026 176.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.3 tt -102.2 138.2 27.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.55 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -82.49 100.14 9.9 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.753 0.787 . . . . 0.0 109.449 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.51 ' HB3' HG12 ' A' ' 165' ' ' ILE . 9.1 t80 -113.95 148.34 37.01 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.344 -176.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.586 ' HB2' ' HB2' ' A' ' 88' ' ' LYS . 1.8 mp0 -136.08 154.01 51.15 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.5 tp -141.86 123.07 14.73 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 123.246 0.618 . . . . 0.0 109.58 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -126.33 128.0 46.42 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 43.9 mt -130.4 130.34 65.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 C-N-CA 120.209 -0.596 . . . . 0.0 112.336 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 157' ' ' ILE . . . -114.88 90.76 0.54 Allowed Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.443 HD11 ' CE2' ' A' ' 147' ' ' PHE . 2.9 pp -84.57 151.54 24.46 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.897 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.683 ' HB ' ' O ' ' A' ' 81' ' ' CYS . 8.6 m -109.09 120.69 43.29 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.8 -176.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.443 ' CE2' HD11 ' A' ' 145' ' ' LEU . 73.6 m-85 -100.4 141.26 33.5 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 170.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -110.39 133.36 53.34 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 174.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.76 139.45 29.05 Favored Pre-proline 0 C--N 1.301 -1.53 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.659 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -63.46 -17.02 58.12 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.856 2.371 . . . . 0.0 112.051 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.67 -45.52 98.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.998 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 40.4 t -130.15 -78.04 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.059 0.457 . . . . 0.0 109.904 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 173.81 -112.66 0.43 Allowed Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -101.24 125.97 47.92 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.935 0.397 . . . . 0.0 111.202 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 146' ' ' THR . 34.1 pt -121.28 114.92 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 CA-C-O 121.008 0.433 . . . . 0.0 110.522 173.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.535 HG22 ' OG1' ' A' ' 146' ' ' THR . 37.9 p -96.1 105.27 17.29 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.691 175.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.466 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 60.7 mt -91.5 107.1 19.4 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 156' ' ' THR . 8.0 Cg_endo -85.42 100.74 0.69 Allowed 'Trans proline' 0 N--CA 1.43 -2.26 0 C-N-CA 122.6 2.2 . . . . 0.0 111.719 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.529 HG11 ' O ' ' A' ' 47' ' ' ALA . 18.0 m -94.74 110.03 23.19 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 CA-C-O 122.015 0.912 . . . . 0.0 109.542 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.5 p -88.89 146.13 25.12 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-N 114.352 -1.295 . . . . 0.0 111.318 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.519 ' OG1' ' HB ' ' A' ' 49' ' ' VAL . 98.5 m -146.64 127.39 14.34 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.134 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -121.4 143.07 49.42 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -164.42 -139.63 2.68 Favored Glycine 0 N--CA 1.422 -2.24 0 C-N-CA 119.728 -1.225 . . . . 0.0 112.121 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.21 148.59 15.14 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.51 HG12 ' HB3' ' A' ' 139' ' ' TYR . 47.8 mm -126.18 139.37 51.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -106.06 111.76 24.52 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.76 0.79 . . . . 0.0 110.146 175.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 15.6 tp -93.84 106.28 20.99 Favored Pre-proline 0 C--N 1.296 -1.751 0 CA-C-N 113.998 -1.455 . . . . 0.0 108.276 -174.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 167' ' ' LEU . 23.5 Cg_exo -64.65 156.89 58.65 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.416 2.744 . . . . 0.0 116.054 -171.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.696 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 31.1 p -48.41 25.32 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 129.19 2.996 . . . . 0.0 117.603 174.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 59.8 mt -71.63 -42.32 67.75 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.471 ' HA ' ' HG3' ' A' ' 131' ' ' MET . 59.8 ttt180 72.31 -27.12 0.18 Allowed 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 126.47 1.908 . . . . 0.0 112.48 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -113.74 61.2 0.66 Allowed 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 122.719 1.247 . . . . 0.0 108.121 173.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.517 ' O ' HG12 ' A' ' 62' ' ' VAL . 85.9 t80 -135.77 -1.18 2.51 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 113.398 -1.728 . . . . 0.0 106.569 174.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.572 ' CE1' ' HB2' ' A' ' 124' ' ' ALA . 27.6 t80 . . . . . 0 N--CA 1.411 -2.379 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.14 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -76.5 -20.47 56.91 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 117.244 0.522 . . . . 0.0 111.362 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -71.72 106.5 4.13 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -130.58 112.42 13.15 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -59.1 126.99 29.94 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -134.28 106.19 7.0 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.372 0.606 . . . . 0.0 111.841 -176.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -133.22 71.91 1.48 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.568 0.699 . . . . 0.0 110.861 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.2 mt -94.17 -70.1 0.72 Allowed 'General case' 0 CA--C 1.464 -2.328 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 171.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -89.96 149.51 22.55 Favored 'General case' 1 N--CA 1.364 -4.759 0 N-CA-C 103.533 -2.766 . . . . 0.0 103.533 168.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.76 93.38 0.17 Allowed 'General case' 1 C--N 1.236 -4.326 0 CA-C-O 121.511 0.672 . . . . 0.0 111.945 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.9 p -125.48 85.55 2.42 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.481 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.519 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -103.56 -31.76 9.77 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.55 ' O ' HG22 ' A' ' 17' ' ' VAL . 18.7 m-20 -56.05 -48.98 75.0 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -169.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.8 -34.71 65.56 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -178.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -75.29 -54.86 6.38 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 123.45 0.7 . . . . 0.0 110.314 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 12' ' ' ALA . 55.8 t -58.57 -45.81 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.05 0.94 . . . . 0.0 113.499 -174.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 13' ' ' ASP . 35.9 m -66.14 -27.28 40.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.656 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -76.6 -30.2 56.85 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.603 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -54.91 -42.99 72.88 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.509 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.28 -37.42 87.44 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.607 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.53 -36.33 82.43 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.6 t -61.91 -45.18 94.86 Favored 'General case' 0 C--O 1.252 1.231 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.859 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.03 -37.84 54.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.479 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.419 HD12 ' OG ' ' A' ' 96' ' ' SER . 79.3 mt -65.68 -41.1 89.77 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.746 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.5 t -58.41 -36.35 73.45 Favored 'General case' 0 C--O 1.243 0.715 0 O-C-N 123.54 0.525 . . . . 0.0 110.959 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.2 m -67.04 -39.58 87.0 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.053 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.551 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 5.2 tt -80.36 -40.54 26.41 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -54.09 -43.87 70.71 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.33 1.052 . . . . 0.0 109.673 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -65.0 -39.32 93.29 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.042 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.551 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -70.93 -37.41 72.87 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.077 -179.593 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.515 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -69.58 -32.46 71.23 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.662 -177.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.48 -40.24 82.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.2 175.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.14 -49.84 73.75 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.297 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.46 ' HD1' ' O ' ' A' ' 30' ' ' LYS . 10.5 m-85 -59.13 -46.89 87.18 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 120.562 0.22 . . . . 0.0 110.643 177.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.509 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 65.1 t80 -62.79 -41.16 99.15 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -176.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.3 -44.25 79.69 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -108.67 -27.65 9.7 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -173.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -101.26 -46.62 4.98 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.467 -171.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 36.8 mt -78.94 -0.48 31.14 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.79 -171.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.01 -33.15 63.67 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -101.42 -47.82 4.56 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 114.348 -1.296 . . . . 0.0 110.52 -173.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.69 126.54 92.85 Favored Pre-proline 0 C--O 1.24 0.601 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.313 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.63 106.67 0.17 Allowed 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 123.109 2.539 . . . . 0.0 112.578 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.501 HG21 HD22 ' A' ' 39' ' ' LEU . 8.3 p -130.85 166.4 27.68 Favored Pre-proline 0 N--CA 1.429 -1.484 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.725 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -79.6 138.35 13.54 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.819 2.346 . . . . 0.0 110.511 175.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -96.89 108.09 20.72 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.091 0.472 . . . . 0.0 109.823 -176.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.5 146.65 25.56 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.04 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.2 t -145.93 138.59 25.65 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 121.073 0.463 . . . . 0.0 110.553 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.446 HG13 HG23 ' A' ' 159' ' ' VAL . 12.7 m -90.53 142.55 12.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.207 175.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -130.22 -63.08 0.91 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.083 -1.047 . . . . 0.0 112.979 -174.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -161.13 164.52 30.58 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 -173.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.635 HG22 ' HB3' ' A' ' 64' ' ' TYR . 11.1 p -125.28 114.26 39.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 176.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -99.21 132.51 44.47 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -169.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.534 ' O ' ' HE3' ' A' ' 55' ' ' LYS . 50.2 p90 -58.52 129.1 40.46 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 123.969 0.793 . . . . 0.0 111.743 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.622 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -130.0 -64.57 0.86 Allowed 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.689 -173.028 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -140.39 175.27 22.09 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.983 -175.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.431 HG22 ' CD1' ' A' ' 173' ' ' PHE . 28.8 t -99.07 147.46 7.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -175.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 74.2 m -129.58 160.29 33.71 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 174.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -45.95 62.09 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -104.15 97.76 7.68 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.549 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.504 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . 85.11 -170.53 45.28 Favored Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.539 HG21 ' CE2' ' A' ' 173' ' ' PHE . 7.1 p -124.4 153.14 30.76 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -93.99 112.18 23.98 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-O 121.581 0.705 . . . . 0.0 110.957 -175.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.635 ' HB3' HG22 ' A' ' 52' ' ' VAL . 3.5 m-30 -116.17 166.17 12.33 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.452 174.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.525 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 12.2 m-70 -116.93 112.87 21.62 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.513 174.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -77.47 123.43 26.56 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.981 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -87.48 108.46 19.03 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.301 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.2 t -122.39 108.81 22.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.4 m -100.05 134.0 43.61 Favored 'General case' 0 C--N 1.284 -2.266 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.509 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.72 112.43 36.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-O 121.251 0.548 . . . . 0.0 110.13 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 39.3 ttpt -95.25 110.75 22.7 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 175.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -119.18 116.93 33.66 Favored Pre-proline 0 N--CA 1.42 -1.963 0 C-N-CA 118.64 -1.224 . . . . 0.0 111.278 -174.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -95.75 98.83 0.1 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.451 0 C-N-CA 121.756 1.637 . . . . 0.0 109.551 169.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.7 t80 178.4 108.13 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.7 m -50.88 16.66 0.0 OUTLIER 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 119.342 3.09 . . . . 0.0 119.342 -166.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -142.89 166.35 24.88 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 119.583 1.083 . . . . 0.0 111.45 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.1 p -88.51 101.13 13.63 Favored 'General case' 0 N--CA 1.417 -2.096 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 174.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.444 ' HB ' HD12 ' A' ' 105' ' ' LEU . 67.7 mt -73.65 129.58 85.12 Favored Pre-proline 0 C--N 1.31 -1.121 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.33 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.96 122.29 10.97 Favored 'Trans proline' 0 C--O 1.254 1.305 0 C-N-CA 122.726 2.284 . . . . 0.0 112.369 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.446 HG12 ' CE1' ' A' ' 147' ' ' PHE . 45.0 mt -89.91 107.87 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 57.3 m -53.98 -59.57 4.47 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 123.076 0.551 . . . . 0.0 110.37 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -165.45 150.21 8.82 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 98' ' ' THR . 15.7 tt -96.69 124.32 49.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 174.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.422 ' HA ' HG22 ' A' ' 98' ' ' THR . 48.0 m -100.61 118.66 37.21 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -175.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -119.91 139.86 51.77 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.293 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.448 ' HB ' ' HB2' ' A' ' 142' ' ' ASP . 64.7 mt -123.87 108.37 20.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 171.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.6 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 1.5 tm? -91.65 122.43 34.21 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -125.56 140.01 53.11 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -175.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 122' ' ' SER . 30.2 t -104.98 145.66 30.12 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.959 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.52 -12.93 55.61 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.872 175.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 68.8 p -97.51 17.8 16.82 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.152 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 81.21 163.01 0.16 Allowed 'General case' 0 C--O 1.25 1.081 0 C-N-CA 125.542 1.537 . . . . 0.0 111.984 -176.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.492 ' O ' ' HB3' ' A' ' 122' ' ' SER . 53.9 m 72.24 137.84 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.726 1.21 . . . . 0.0 110.259 -174.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.6 pp -129.87 172.75 15.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.6 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . . . -127.11 121.78 32.38 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 174.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.419 ' OG ' HD12 ' A' ' 24' ' ' ILE . 23.0 t -134.62 158.25 44.52 Favored 'General case' 0 C--N 1.282 -2.352 0 C-N-CA 118.641 -1.224 . . . . 0.0 110.726 -176.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.54 179.53 44.26 Favored Glycine 0 N--CA 1.429 -1.831 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.422 HG22 ' HA ' ' A' ' 84' ' ' SER . 23.0 p -135.11 134.17 39.99 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.747 0.273 . . . . 0.0 110.519 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.4 ' HB ' HG22 ' A' ' 83' ' ' ILE . 3.4 mp -104.79 107.35 58.18 Favored Pre-proline 0 C--O 1.244 0.782 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.475 174.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -66.05 121.8 9.21 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.736 2.291 . . . . 0.0 110.387 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 53.85 78.66 0.38 Allowed Pre-proline 0 N--CA 1.483 1.22 0 C-N-CA 123.921 0.888 . . . . 0.0 111.572 -175.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -97.96 6.01 1.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.932 2.421 . . . . 0.0 112.689 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 164.9 -168.76 39.26 Favored Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 56.1 m -143.27 159.13 42.89 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 120.795 0.331 . . . . 0.0 110.291 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.451 ' HA ' HG21 ' A' ' 111' ' ' THR . 82.7 mt -88.71 156.83 18.77 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.502 177.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 27.7 m -99.1 1.79 10.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 121.016 0.436 . . . . 0.0 111.841 -176.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.21 -52.22 4.63 Favored Glycine 0 C--O 1.217 -0.96 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.905 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.5 t -146.23 103.35 3.7 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 150.29 -175.0 29.54 Favored Glycine 0 N--CA 1.421 -2.359 0 C-N-CA 120.291 -0.957 . . . . 0.0 111.376 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 25.6 m -102.67 108.32 19.54 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.451 HG21 ' HA ' ' A' ' 105' ' ' LEU . 5.5 t -99.98 114.52 27.85 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 121.766 0.793 . . . . 0.0 109.466 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.2 t -85.36 113.76 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.5 mt -96.17 147.8 23.37 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 7.2 p-10 -136.91 123.03 20.38 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.443 0.639 . . . . 0.0 110.696 -176.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 69.3 t -102.26 122.22 47.49 Favored Pre-proline 0 C--N 1.299 -1.604 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.225 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -68.51 109.97 2.18 Favored 'Trans proline' 0 N--CA 1.439 -1.703 0 N-CA-C 105.815 -2.417 . . . . 0.0 105.815 167.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.7 p -126.94 148.39 31.76 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -172.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 118' ' ' LYS . 9.0 mmpt? -88.86 98.26 11.63 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.457 HG12 HD21 ' A' ' 87' ' ' LEU . 10.6 m -94.65 149.02 4.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.678 ' HA ' HD13 ' A' ' 123' ' ' ILE . . . 72.15 0.72 3.67 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.031 0.533 . . . . 0.0 111.359 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -59.93 -51.26 70.46 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 173.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' ' 93' ' ' THR . 15.1 m -62.37 -27.44 69.07 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.152 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.678 HD13 ' HA ' ' A' ' 120' ' ' ALA . 2.6 mp -79.1 -47.8 22.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.905 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.78 -36.93 82.5 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.351 0.407 . . . . 0.0 110.994 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 54.0 t -65.68 -37.27 79.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.997 176.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 63.0 m -82.42 -75.81 0.29 Allowed 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.424 HD12 ' N ' ' A' ' 128' ' ' MET . 2.6 pp -124.56 -23.3 4.43 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -173.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.534 ' HG3' ' H ' ' A' ' 130' ' ' ASP . 11.7 tpt 74.51 133.56 0.05 OUTLIER 'General case' 0 C--O 1.211 -0.971 0 C-N-CA 123.944 0.898 . . . . 0.0 112.039 -177.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.703 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -87.54 7.54 29.08 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.757 -175.293 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.534 ' H ' ' HG3' ' A' ' 128' ' ' MET . 10.3 m-20 67.74 -0.84 1.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 172.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.408 ' HA ' ' CE ' ' A' ' 131' ' ' MET . 0.0 OUTLIER 62.84 30.31 16.62 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.216 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 53.4 t -56.26 129.96 42.49 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 123.675 0.61 . . . . 0.0 109.998 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 52.5 p -77.82 130.52 36.78 Favored 'General case' 0 N--CA 1.414 -2.258 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.454 ' H ' ' H ' ' A' ' 169' ' ' SER . 34.7 m-20 65.22 82.33 0.19 Allowed 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -174.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.548 ' HE1' ' HB2' ' A' ' 129' ' ' LYS . 64.0 t-105 -155.03 156.62 36.25 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.173 -170.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -148.5 148.05 29.79 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 176.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.9 tt -142.1 147.92 20.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.226 -174.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -63.14 122.14 15.37 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-O 121.931 0.872 . . . . 0.0 112.463 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.441 ' HE1' ' CD2' ' A' ' 87' ' ' LEU . 4.8 t80 -139.35 145.4 38.97 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.135 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 162' ' ' GLN . 68.2 mt-30 -141.17 155.43 46.07 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.083 -0.385 . . . . 0.0 110.738 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.429 HD13 HG13 ' A' ' 143' ' ' ILE . 1.7 pp -139.12 151.31 46.57 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-O 121.245 0.545 . . . . 0.0 110.815 173.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.448 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 10.3 m-20 -133.19 111.96 11.32 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 173.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.429 HG13 HD13 ' A' ' 141' ' ' LEU . 60.8 mt -125.06 138.28 54.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.17 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 157' ' ' ILE . . . -121.54 130.18 8.02 Favored Glycine 0 N--CA 1.418 -2.526 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.084 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 156' ' ' THR . 2.7 mm? -97.75 111.11 23.53 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.0 m -97.24 112.35 24.19 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.556 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.446 ' CE1' HG12 ' A' ' 80' ' ' ILE . 91.7 m-85 -115.19 140.07 49.4 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 154' ' ' ASP . 29.0 t70 -93.97 109.06 20.81 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 66.3 mt -118.99 117.5 33.57 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -52.48 -19.15 9.42 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 124.172 3.248 . . . . 0.0 114.982 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.24 -29.17 31.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 120.861 0.362 . . . . 0.0 111.009 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 61.1 t -131.94 -53.25 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.271 0.557 . . . . 0.0 110.725 -176.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 142.45 -155.59 25.77 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 108.451 -1.859 . . . . 0.0 108.451 -176.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 148' ' ' ASP . 4.9 p-10 -86.48 117.66 25.4 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 117.908 0.854 . . . . 0.0 109.748 175.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 2.1 pp -128.24 141.2 47.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.473 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 37.7 m -99.43 123.92 44.12 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.437 -178.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.415 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 2.0 mp -86.57 112.0 43.5 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 174.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -86.7 114.95 1.22 Allowed 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.672 2.248 . . . . 0.0 113.18 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.446 HG23 HG13 ' A' ' 49' ' ' VAL . 9.9 m -125.74 127.86 71.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.251 176.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.4 t -128.28 156.31 43.22 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.658 -174.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.1 t -166.55 149.16 6.73 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 140' ' ' GLN . 28.8 pt20 -100.26 127.53 46.53 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 172.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -113.28 133.14 11.08 Favored Glycine 0 N--CA 1.405 -3.393 0 C-N-CA 119.924 -1.131 . . . . 0.0 112.811 -172.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -101.95 120.12 39.89 Favored 'General case' 0 C--N 1.269 -2.9 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.3 pt -114.9 111.69 36.92 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 CA-C-O 121.75 0.786 . . . . 0.0 110.89 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.534 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 4.9 ttmp? -81.06 119.75 23.94 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.712 -177.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.9 tt -102.24 98.8 11.12 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 166' ' ' LYS . 1.4 Cg_endo -83.57 81.27 2.29 Favored 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 122.677 2.251 . . . . 0.0 112.561 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 46.6 t 70.81 -76.48 0.06 Allowed 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.654 -1.157 . . . . 0.0 113.602 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.432 ' HG ' ' CD2' ' A' ' 173' ' ' PHE . 3.6 mm? 63.89 -65.7 0.12 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.28 1.032 . . . . 0.0 113.088 -176.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 63.9 91.62 0.07 Allowed 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.578 1.151 . . . . 0.0 110.405 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 74.37 90.76 0.08 Allowed 'General case' 0 CA--C 1.491 -1.317 0 C-N-CA 124.709 1.204 . . . . 0.0 109.349 -176.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.539 ' CE2' HG21 ' A' ' 62' ' ' VAL . 77.6 t80 -164.58 -35.1 0.03 OUTLIER 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 -175.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 CA--C 1.495 -1.147 0 C-N-CA 126.204 1.802 . . . . 0.0 112.978 175.563 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.253 0 N-CA-C 112.731 -0.148 . . . . 0.0 112.731 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -85.64 161.07 19.42 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 60.83 29.3 18.92 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -64.71 131.05 45.83 Favored 'General case' 0 C--O 1.246 0.888 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.618 -177.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.0 t60 62.93 81.53 0.2 Allowed 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.854 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -123.6 150.67 43.84 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 102.507 -3.146 . . . . 0.0 102.507 172.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 69.81 -167.0 0.17 Allowed 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -168.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -91.22 -60.08 1.99 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 173.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -144.12 -29.27 0.5 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.878 173.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.37 115.07 1.18 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.842 0.857 . . . . 0.0 113.091 -177.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.1 m 67.09 6.64 4.88 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.804 1.242 . . . . 0.0 112.727 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -92.68 -43.1 9.25 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.9 0.381 . . . . 0.0 110.008 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -75.55 -42.59 52.0 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.258 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.424 ' OE1' HG23 ' A' ' 93' ' ' THR . 12.4 mm-40 -54.6 -41.52 70.05 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.301 0.572 . . . . 0.0 110.84 176.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -65.52 -53.45 42.06 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.521 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.6 m -64.32 -33.72 64.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.8 t -69.6 -45.44 78.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 176.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -58.67 -48.0 82.55 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.094 -176.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.481 ' O ' HG23 ' A' ' 23' ' ' VAL . 12.3 pt-20 -66.37 -40.61 89.85 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.149 -177.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -64.4 -40.93 96.74 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.59 -37.16 85.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.252 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.3 t -66.18 -44.07 85.04 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.32 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 19' ' ' GLU . 89.3 t -59.97 -43.84 93.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 CA-C-O 121.044 0.45 . . . . 0.0 110.018 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.449 HG21 HD11 ' A' ' 86' ' ' ILE . 65.5 mt -70.95 -35.58 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.66 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.3 t -60.64 -41.36 94.75 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 122.267 -0.271 . . . . 0.0 110.294 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.527 ' HA ' ' OD2' ' A' ' 29' ' ' ASP . 50.9 m -65.32 -29.12 69.84 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.355 0.597 . . . . 0.0 110.384 176.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.659 ' O ' ' HB3' ' A' ' 30' ' ' LYS . 4.5 tt -69.97 -38.33 76.03 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 175.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.545 ' O ' ' HG3' ' A' ' 32' ' ' LYS 0.34 7.8 mp -67.37 -27.79 67.4 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 119.149 -1.02 . . . . 0.0 113.094 175.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.527 ' OD2' ' HA ' ' A' ' 26' ' ' SER . 53.1 m-20 -61.04 -45.44 94.76 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 172.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.659 ' HB3' ' O ' ' A' ' 27' ' ' LEU . 21.0 ttmm -54.99 -51.39 66.37 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.913 173.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.07 -44.77 91.89 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.44 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 95.0 mttt -60.07 -32.21 70.73 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.94 0.496 . . . . 0.0 110.33 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.498 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -62.67 -51.32 56.77 Favored Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.723 177.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -72.83 -38.64 67.06 Favored 'General case' 0 C--O 1.203 -1.393 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.752 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -62.41 -35.41 79.13 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -175.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.65 -27.1 64.76 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.655 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.502 ' HG3' ' N ' ' A' ' 38' ' ' LYS . 8.6 pt-20 -112.09 -57.28 2.29 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -175.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.502 ' N ' ' HG3' ' A' ' 37' ' ' GLU . 8.9 tppt? -73.69 -48.23 33.69 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-O 122.757 1.265 . . . . 0.0 109.803 -164.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.463 ' CD1' HG12 ' A' ' 157' ' ' ILE . 69.4 mt -83.07 4.86 24.47 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 113.11 -1.859 . . . . 0.0 111.575 -171.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.91 -7.9 11.96 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.981 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -110.42 -39.7 4.86 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.176 0.513 . . . . 0.0 110.19 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.438 HD12 ' HG3' ' A' ' 38' ' ' LYS . 54.7 mt -91.53 139.53 25.14 Favored Pre-proline 0 N--CA 1.432 -1.344 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.13 98.3 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.831 1.688 . . . . 0.0 108.328 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 m -127.62 148.94 68.81 Favored Pre-proline 0 C--N 1.297 -1.682 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -172.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.579 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 9.4 Cg_endo -51.88 129.06 28.86 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.857 2.372 . . . . 0.0 112.112 176.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 43.3 mt-10 -115.02 113.24 23.82 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.929 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.421 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . . . -108.5 148.54 30.1 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.464 -176.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.1 t -154.74 142.93 20.33 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.766 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.616 ' H ' HG11 ' A' ' 159' ' ' VAL . 11.7 p -108.39 141.09 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 176.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -157.04 -23.04 0.09 Allowed 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.646 -171.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.689 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . 9.6 t0 -121.26 117.23 26.5 Favored 'General case' 0 CA--C 1.485 -1.547 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.24 -168.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.663 HG12 ' CD2' ' A' ' 64' ' ' TYR . 48.4 t -119.36 110.64 30.2 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -130.03 127.97 41.04 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.186 -175.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 51.1 p90 -64.75 139.26 58.74 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -176.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.646 ' HD3' ' HB2' ' A' ' 65' ' ' HIS . 14.7 mmmm -88.51 -24.85 22.82 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.392 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.49 -158.55 31.46 Favored Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.4 m -101.03 145.84 10.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 117.134 0.467 . . . . 0.0 111.27 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.3 m -155.06 135.54 13.36 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -75.84 -42.25 50.13 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -173.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -61.94 -56.58 17.69 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.702 0.763 . . . . 0.0 110.808 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.431 ' HA3' ' HB2' ' A' ' 121' ' ' TYR . . . -160.81 137.3 4.89 Favored Glycine 0 N--CA 1.409 -3.126 0 N-CA-C 107.022 -2.431 . . . . 0.0 107.022 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.522 HG11 ' CZ ' ' A' ' 173' ' ' PHE . 23.3 t -72.79 131.86 34.23 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-N 117.209 0.505 . . . . 0.0 110.115 -173.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -81.79 117.21 21.91 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.899 -177.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.663 ' CD2' HG12 ' A' ' 52' ' ' VAL . 9.4 m-85 -118.09 154.55 31.89 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.646 ' HB2' ' HD3' ' A' ' 55' ' ' LYS . 49.9 t-80 -91.03 108.43 19.86 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 176.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -91.71 107.56 19.29 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.689 ' HB3' ' HB3' ' A' ' 51' ' ' ASP . 40.4 ttmt -87.38 110.97 20.63 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.907 0.384 . . . . 0.0 110.557 -176.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.4 t -113.15 108.38 25.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.41 ' HB3' HG12 ' A' ' 112' ' ' VAL . 42.6 p -102.7 140.36 37.08 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.883 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 3.1 p -142.02 126.56 16.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.927 -178.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 45' ' ' PRO . 25.5 pttm -99.15 141.73 31.53 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 174.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -134.39 116.89 13.15 Favored Pre-proline 0 C--N 1.287 -2.141 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.641 -174.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -91.8 95.52 0.2 Allowed 'Trans proline' 0 N--CA 1.42 -2.838 0 N-CA-C 109.106 -1.152 . . . . 0.0 109.106 170.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.514 ' HB3' ' HG2' ' A' ' 76' ' ' GLN . 50.1 m-85 170.54 130.14 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 129.19 2.996 . . . . 0.0 104.723 -176.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.8 m -81.96 -2.78 52.59 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 118.362 0.528 . . . . 0.0 112.104 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.514 ' HG2' ' HB3' ' A' ' 74' ' ' TYR . 13.1 pt20 -83.2 132.08 35.08 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 121.206 0.527 . . . . 0.0 111.095 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.4 p -75.95 93.78 3.29 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 172.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.455 ' HB ' ' CD2' ' A' ' 105' ' ' LEU . 75.0 mt -72.66 123.37 89.47 Favored Pre-proline 0 C--N 1.3 -1.553 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.007 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -79.12 118.26 4.0 Favored 'Trans proline' 0 N--CA 1.44 -1.644 0 C-N-CA 122.115 1.877 . . . . 0.0 110.856 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.416 ' N ' HD12 ' A' ' 80' ' ' ILE . 2.4 mp -72.44 111.53 6.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 57.0 m -50.31 -59.08 4.33 Favored 'General case' 0 C--O 1.244 0.791 0 O-C-N 123.899 0.749 . . . . 0.0 111.204 -176.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -150.94 154.02 36.35 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.537 HG22 ' HB ' ' A' ' 99' ' ' ILE . 11.1 tp -104.1 124.08 58.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 174.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.424 ' HB2' HG21 ' A' ' 24' ' ' ILE . 65.7 p -95.07 118.62 32.18 Favored 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 119.529 -0.869 . . . . 0.0 109.883 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.519 ' CE2' HG12 ' A' ' 117' ' ' VAL . 15.5 t80 -104.16 121.39 43.16 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 126.238 1.815 . . . . 0.0 111.067 -169.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' A' ' 142' ' ' ASP . 3.2 mp -127.25 108.08 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.605 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 1.8 tm? -101.71 121.58 42.31 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.552 ' HA ' HG22 ' A' ' 94' ' ' ILE . 39.8 ttmt -127.25 133.59 50.19 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 120.158 -0.617 . . . . 0.0 112.372 -175.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.5 m -123.18 147.3 47.0 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.434 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.98 -0.19 2.21 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.5 p -90.83 16.33 9.55 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 123.461 0.704 . . . . 0.0 110.834 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 70.86 -41.63 0.51 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 125.972 1.709 . . . . 0.0 113.388 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.594 ' O ' ' HB3' ' A' ' 122' ' ' SER . 99.9 m -62.26 137.75 58.31 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.605 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 47.1 pt -137.55 178.23 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.254 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.531 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . . . -127.88 130.11 48.0 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 174.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.7 t -126.78 147.13 50.02 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.89 172.21 37.14 Favored Glycine 0 N--CA 1.42 -2.403 0 C-N-CA 119.818 -1.182 . . . . 0.0 112.426 -176.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 63.2 m -153.07 109.76 3.43 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.537 ' HB ' HG22 ' A' ' 83' ' ' ILE . 3.1 mp -103.47 110.03 63.03 Favored Pre-proline 0 N--CA 1.467 0.424 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.674 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -68.11 127.45 15.97 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.611 2.207 . . . . 0.0 109.727 173.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.0 t70 57.29 81.42 0.26 Allowed Pre-proline 0 N--CA 1.482 1.154 0 CA-C-O 121.674 0.749 . . . . 0.0 110.234 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.448 ' HG3' ' HB ' ' A' ' 83' ' ' ILE . 22.7 Cg_endo -107.72 13.74 0.13 Allowed 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 123.028 2.485 . . . . 0.0 113.088 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 152.78 -172.26 31.85 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.6 p -135.2 143.72 46.55 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.957 0.378 . . . . 0.0 110.719 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.455 ' CD2' ' HB ' ' A' ' 78' ' ' ILE . 19.9 tp -82.42 129.48 34.9 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.549 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 11.6 p -57.61 -35.05 48.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -174.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.97 118.68 0.1 OUTLIER Glycine 0 CA--C 1.54 1.615 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.541 -174.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 34.5 t 67.56 11.51 8.41 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.669 1.188 . . . . 0.0 113.137 175.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -150.8 -164.52 12.05 Favored Glycine 0 CA--C 1.496 -1.141 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.558 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 10.0 t -116.68 138.54 51.38 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.549 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 7.0 t -133.65 138.8 46.1 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.03 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.41 HG12 ' HB3' ' A' ' 69' ' ' SER . 27.3 m -91.62 106.93 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-O 122.057 0.932 . . . . 0.0 110.269 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.7 mt -92.2 153.9 19.01 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 4.8 p-10 -144.58 148.16 34.05 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.482 -0.887 . . . . 0.0 112.013 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.8 t -126.7 128.44 24.28 Favored Pre-proline 0 C--N 1.289 -2.056 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 171.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 22.7 Cg_exo -69.16 109.43 2.19 Favored 'Trans proline' 0 N--CA 1.432 -2.144 0 N-CA-C 108.206 -1.498 . . . . 0.0 108.206 172.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.519 HG12 ' CE2' ' A' ' 85' ' ' TYR . 30.3 m -98.41 150.3 4.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.384 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.633 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -95.1 97.46 9.95 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.062 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.5 m -93.15 147.12 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.482 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -177.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.521 ' HB1' ' CE1' ' A' ' 174' ' ' PHE . . . 69.9 -3.9 1.61 Allowed 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.968 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.431 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . 84.2 t80 -57.99 -47.35 83.27 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.594 ' HB3' ' O ' ' A' ' 93' ' ' THR . 19.1 m -66.79 -26.3 66.89 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.996 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.5 mt -79.14 -49.64 19.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.727 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.16 -49.3 78.41 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 122.962 0.505 . . . . 0.0 110.34 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.2 t -54.97 -43.26 68.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.223 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 44.0 t -75.04 -78.84 0.1 Allowed 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.044 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 128' ' ' MET . 3.8 pp -126.24 -40.09 2.01 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 115.111 1.522 . . . . 0.0 115.111 -173.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.553 ' N ' HD12 ' A' ' 127' ' ' LEU . 24.9 ttt 66.01 116.52 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.355 1.062 . . . . 0.0 110.632 -173.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.71 -72.8 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.741 0.816 . . . . 0.0 112.133 -178.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 24.0 t70 172.87 -30.56 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 -174.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.552 ' SD ' ' HB3' ' A' ' 174' ' ' PHE . 13.2 tpt 65.61 106.17 0.04 OUTLIER 'General case' 0 C--O 1.242 0.666 0 CA-C-N 113.235 -1.802 . . . . 0.0 112.573 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 44.7 t -128.53 173.52 10.17 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.108 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.408 ' CG2' ' HB2' ' A' ' 171' ' ' ARG . 30.8 p -82.69 115.74 21.76 Favored 'General case' 0 N--CA 1.413 -2.312 0 C-N-CA 123.257 0.623 . . . . 0.0 110.95 -178.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.5 ' H ' ' H ' ' A' ' 169' ' ' SER . 24.6 t70 74.21 95.61 0.07 Allowed 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 124.9 1.28 . . . . 0.0 108.835 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 -154.44 148.03 25.25 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.901 -170.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -118.62 143.58 46.71 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 67.2 mt -131.53 130.1 62.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 174.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.569 ' HA ' ' HA ' ' A' ' 164' ' ' GLU . 9.5 p-10 -99.34 120.41 39.53 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.401 ' HE2' ' CD2' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -127.74 170.56 12.59 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -179.226 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.476 ' HB2' ' HB3' ' A' ' 88' ' ' LYS . 1.6 mp0 -113.99 136.36 52.99 Favored 'General case' 0 C--N 1.279 -2.496 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.398 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.485 HD11 HD11 ' A' ' 143' ' ' ILE . 20.4 tp -122.05 116.21 23.86 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.76 176.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.491 ' HB3' ' HB ' ' A' ' 86' ' ' ILE . 15.4 t70 -126.63 120.89 30.65 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -175.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.485 HD11 HD11 ' A' ' 141' ' ' LEU . 43.0 mm -131.2 137.28 56.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 121.209 0.528 . . . . 0.0 110.594 -175.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -114.52 122.02 5.55 Favored Glycine 0 N--CA 1.419 -2.454 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 175.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.552 HD13 ' H ' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -115.37 160.2 20.15 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.387 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.7 t -136.02 142.24 44.43 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 119.834 -0.747 . . . . 0.0 111.799 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.478 ' CE2' HD23 ' A' ' 145' ' ' LEU . 68.1 m-85 -135.6 138.51 43.02 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 174.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -116.91 132.77 56.62 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.883 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.06 143.11 29.98 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -66.91 5.01 0.88 Allowed 'Trans proline' 0 N--CA 1.488 1.184 0 C-N-CA 123.411 2.741 . . . . 0.0 113.415 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.46 -28.88 36.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 11.7 p -160.19 -28.49 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.67 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 140.51 -143.56 13.66 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.347 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -94.97 132.09 40.2 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.42 ' N ' HD12 ' A' ' 155' ' ' ILE . 2.9 mp -122.54 129.73 75.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.454 HG21 HD21 ' A' ' 27' ' ' LEU . 33.9 p -95.77 140.44 30.55 Favored 'General case' 0 N--CA 1.406 -2.654 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 172.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.463 HG12 ' CD1' ' A' ' 39' ' ' LEU . 31.0 mt -114.11 129.26 24.98 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -90.69 116.86 0.55 Allowed 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 122.734 2.289 . . . . 0.0 112.314 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.616 HG11 ' H ' ' A' ' 49' ' ' VAL . 21.9 t -118.96 103.76 14.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 59.0 p -107.91 128.56 54.73 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 95.3 m -145.88 131.02 18.37 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.152 0.501 . . . . 0.0 112.158 -173.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -99.53 124.48 44.75 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -126.94 128.04 6.12 Favored Glycine 0 N--CA 1.42 -2.428 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.095 -176.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 138' ' ' ASP . 39.3 tt0 -95.98 120.57 36.5 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 176.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 9.6 pt -112.53 140.84 30.26 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.635 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.926 -176.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -102.54 143.96 31.57 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 121.82 0.819 . . . . 0.0 112.15 -174.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.4 mp -112.39 86.03 7.72 Favored Pre-proline 0 C--N 1.285 -2.203 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -80.12 85.98 1.74 Allowed 'Trans proline' 0 C--N 1.367 1.52 0 C-N-CA 123.353 2.702 . . . . 0.0 116.034 -167.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.5 ' H ' ' H ' ' A' ' 134' ' ' ASP 0.26 46.2 t 63.72 -1.57 0.61 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 175.706 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.669 ' HB3' ' HB2' ' A' ' 173' ' ' PHE . 4.2 mm? -70.33 96.9 1.18 Allowed 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 168.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.408 ' HB2' ' CG2' ' A' ' 133' ' ' THR . 65.2 ttt180 -69.08 -23.6 64.04 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 118.754 -1.178 . . . . 0.0 109.802 176.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -117.79 102.16 8.89 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.669 ' HB2' ' HB3' ' A' ' 170' ' ' LEU . 57.8 t80 -161.42 -43.65 0.04 OUTLIER 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 -174.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.552 ' HB3' ' SD ' ' A' ' 131' ' ' MET . 16.9 t80 . . . . . 0 C--N 1.292 -1.911 0 CA-C-N 112.945 -1.934 . . . . 0.0 107.287 175.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.761 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 62.7 t60 68.45 -65.13 0.28 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.66 1.184 . . . . 0.0 112.88 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -80.18 109.16 14.39 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.257 0.551 . . . . 0.0 110.94 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -140.2 126.69 20.2 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.443 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -87.31 79.35 8.53 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.878 0.847 . . . . 0.0 111.527 -175.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 10' ' ' ALA . 15.4 m80 -128.23 22.52 6.1 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 122.268 1.032 . . . . 0.0 110.224 173.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -115.08 -178.75 3.44 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.335 173.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.2 mp 69.44 -85.95 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -172.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.42 98.16 0.9 Allowed 'General case' 0 N--CA 1.4 -2.928 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 171.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.416 ' HB3' ' HA ' ' A' ' 6' ' ' HIS . . . -150.48 22.14 0.82 Allowed 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 175.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.5 m -109.58 -47.2 3.41 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.324 -175.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.414 ' O ' ' HG2' ' A' ' 15' ' ' LYS . . . -80.77 -45.84 16.36 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -57.94 -30.83 66.28 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.287 0.565 . . . . 0.0 110.268 178.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -78.2 -47.99 16.83 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.851 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 12' ' ' ALA . 49.7 pttt -64.36 -36.15 83.19 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 116.761 -0.199 . . . . 0.0 110.73 -174.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.51 ' HA ' ' HG3' ' A' ' 19' ' ' GLU . 34.2 m -69.18 -20.39 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.275 0.56 . . . . 0.0 111.153 -177.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.461 HG11 ' O ' ' A' ' 94' ' ' ILE . 55.3 t -73.36 -52.22 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 171.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -65.21 -43.67 90.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.311 -175.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.51 ' HG3' ' HA ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -64.64 -33.28 75.56 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.546 -178.864 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -79.13 -43.43 24.04 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.719 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.09 82.89 Favored 'General case' 0 C--O 1.21 -0.981 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.32 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -59.35 -45.4 91.48 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.23 -49.79 81.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.087 0.47 . . . . 0.0 109.953 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.591 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 73.2 mt -62.3 -46.17 97.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.263 -178.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.4 t -66.97 -36.97 83.38 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.624 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.2 t -63.23 -37.63 87.98 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.18 0.514 . . . . 0.0 109.665 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -66.05 -45.26 82.01 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 87.7 mt -57.04 -41.21 78.22 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.239 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -55.46 -48.92 73.75 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -79.38 -36.38 39.31 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.88 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.723 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . . . -68.35 -35.99 78.57 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.634 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.431 ' HB2' ' HG2' ' A' ' 158' ' ' PRO . 40.4 ttmt -63.68 -35.74 81.56 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.33 -53.03 49.01 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.923 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.723 ' CE2' ' HA ' ' A' ' 31' ' ' ALA . 30.3 p90 -76.39 -24.56 54.11 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.383 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -57.19 -50.18 73.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.726 0.298 . . . . 0.0 110.834 175.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.1 -18.15 63.94 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.123 0.487 . . . . 0.0 110.987 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -91.69 -66.23 0.94 Allowed 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.469 ' HE2' ' HB2' ' A' ' 34' ' ' PHE . 49.7 mtmt -93.44 -35.66 12.86 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 121.189 0.518 . . . . 0.0 110.487 -171.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.47 HD22 HG21 ' A' ' 44' ' ' THR . 71.1 mt -82.52 2.26 33.82 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.527 0.68 . . . . 0.0 111.63 -174.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.62 -26.83 21.7 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -98.31 -32.93 11.28 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.129 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 74.5 mt -93.0 114.26 62.17 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.64 101.4 0.55 Allowed 'Trans proline' 0 C--O 1.24 0.62 0 C-N-CA 122.509 2.139 . . . . 0.0 112.975 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.47 HG21 HD22 ' A' ' 39' ' ' LEU . 2.0 p -112.56 167.92 8.46 Favored Pre-proline 0 C--N 1.298 -1.665 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.299 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.421 ' HD2' ' HB ' ' A' ' 44' ' ' THR . 18.8 Cg_endo -55.93 120.21 7.88 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 122.775 2.317 . . . . 0.0 111.463 177.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -102.45 114.27 28.33 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -174.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.507 ' HB2' HD21 ' A' ' 145' ' ' LEU . . . -97.63 148.98 22.75 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.94 -173.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.477 ' HA ' HG21 ' A' ' 159' ' ' VAL . 5.2 t -147.51 124.47 11.32 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.187 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.586 HG23 HG22 ' A' ' 159' ' ' VAL . 22.1 t -86.9 140.92 15.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -113.59 -72.65 0.69 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 -172.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 12.7 t70 -160.32 169.85 22.3 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.984 -162.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.523 HG21 ' CD1' ' A' ' 165' ' ' ILE . 34.5 m -129.53 146.61 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.379 0 C-N-CA 123.991 0.916 . . . . 0.0 109.872 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -123.72 126.33 46.34 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 118.204 -0.903 . . . . 0.0 108.618 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.476 ' O ' ' HE3' ' A' ' 55' ' ' LYS . 47.6 p90 -58.5 122.4 13.27 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 175.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.476 ' HE3' ' O ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -124.7 -20.37 5.08 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.972 -169.406 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.98 -159.51 20.55 Favored Glycine 0 N--CA 1.427 -1.939 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.153 -177.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.22 137.65 33.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.202 0.525 . . . . 0.0 111.241 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.3 m -117.95 170.05 9.15 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -83.73 -33.77 25.02 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 118.701 -1.2 . . . . 0.0 110.558 175.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.49 ' O ' ' HD1' ' A' ' 121' ' ' TYR . 24.8 m-20 -111.28 97.72 6.98 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 171.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.58 -168.36 27.89 Favored Glycine 0 C--N 1.303 -1.257 0 C-N-CA 120.493 -0.86 . . . . 0.0 110.965 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 3.5 m -147.12 140.74 19.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 C-N-CA 123.265 0.626 . . . . 0.0 110.718 -177.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -71.31 127.11 31.48 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 123.874 0.734 . . . . 0.0 112.026 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -131.62 143.87 50.63 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 124.513 1.125 . . . . 0.0 111.199 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -92.6 108.0 19.64 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.451 ' HB2' HG12 ' A' ' 52' ' ' VAL . . . -101.55 140.42 35.86 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.2 137.39 54.22 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.554 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.7 t -123.79 111.44 29.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.3 p -97.7 147.14 24.66 Favored 'General case' 0 C--N 1.277 -2.58 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.911 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.61 134.74 29.76 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 CA-C-O 121.36 0.6 . . . . 0.0 110.317 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 22.2 ptmt -105.77 144.48 32.45 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.477 ' ND2' HD13 ' A' ' 105' ' ' LEU . 1.5 p-10 -149.37 124.88 4.97 Favored Pre-proline 0 C--N 1.28 -2.437 0 C-N-CA 118.532 -1.267 . . . . 0.0 109.686 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 72' ' ' ASN . 38.0 Cg_endo -97.64 97.98 0.07 OUTLIER 'Trans proline' 0 N--CA 1.417 -3.009 0 C-N-CA 121.563 1.509 . . . . 0.0 110.696 173.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -138.63 -85.52 0.26 Allowed 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.9 p 170.24 -47.43 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.861 0.865 . . . . 0.0 110.9 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.612 ' O ' ' HA2' ' A' ' 107' ' ' GLY . 15.6 pt20 -104.01 163.69 12.21 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.845 -174.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.5 p -78.38 130.85 36.61 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 170.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.423 ' H ' ' CD1' ' A' ' 105' ' ' LEU . 75.3 mt -120.59 128.34 25.84 Favored Pre-proline 0 C--N 1.285 -2.213 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.47 150.3 69.79 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.298 1.999 . . . . 0.0 111.689 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.664 HG22 ' CE1' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -88.49 151.71 3.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.92 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 55.0 m -71.01 -50.94 28.69 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 174.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.03 163.35 18.27 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.62 -1.173 . . . . 0.0 107.977 171.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.6 tt -124.5 119.6 56.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 21.9 t -103.97 139.83 38.56 Favored 'General case' 0 N--CA 1.421 -1.899 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.667 -174.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.493 ' HA ' HD13 ' A' ' 143' ' ' ILE . 37.5 p90 -120.78 125.52 47.78 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 174.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 66.5 mt -118.64 107.35 21.48 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 174.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.49 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 3.0 pp -104.38 146.25 29.1 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.424 -175.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -116.77 155.45 28.9 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.192 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.9 m -140.11 109.55 6.23 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 66.47 -69.84 0.11 Allowed 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 125.612 1.565 . . . . 0.0 113.788 175.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.8 t -154.31 -46.27 0.09 Allowed 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -175.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -129.97 145.7 51.64 Favored 'General case' 0 C--N 1.314 -0.965 0 O-C-N 121.795 -0.566 . . . . 0.0 111.595 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 47.4 m 77.25 130.2 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 124.858 1.263 . . . . 0.0 112.22 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 42.5 pt -131.88 177.76 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.72 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.229 -178.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.461 ' HB3' HD11 ' A' ' 87' ' ' LEU . . . -133.99 148.74 51.17 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 173.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 70.2 p -143.01 160.75 39.76 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -177.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -176.87 164.51 34.05 Favored Glycine 0 N--CA 1.433 -1.527 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.435 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.9 p -132.15 115.47 15.77 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 124.217 1.007 . . . . 0.0 109.55 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.485 HD11 HG13 ' A' ' 115' ' ' VAL . 56.6 mt -94.95 125.09 52.22 Favored Pre-proline 0 C--O 1.244 0.78 0 C-N-CA 118.937 -1.105 . . . . 0.0 112.685 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -83.31 118.43 2.59 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.924 2.416 . . . . 0.0 111.739 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.42 ' HA ' HD11 ' A' ' 80' ' ' ILE . 24.1 m-20 48.36 68.55 3.41 Favored Pre-proline 0 N--CA 1.484 1.233 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -83.59 -21.44 4.24 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 N-CA-C 108.955 -1.21 . . . . 0.0 108.955 170.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -177.06 -166.63 34.29 Favored Glycine 0 N--CA 1.418 -2.51 0 N-CA-C 107.709 -2.157 . . . . 0.0 107.709 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 21.2 m -142.82 171.85 13.49 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.477 HD13 ' ND2' ' A' ' 72' ' ' ASN . 2.1 pp -75.96 153.2 36.75 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 117.697 -1.601 . . . . 0.0 108.791 172.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.56 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 8.9 p -70.98 -42.01 76.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -170.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.612 ' HA2' ' O ' ' A' ' 76' ' ' GLN . . . 129.58 -72.44 0.48 Allowed Glycine 0 N--CA 1.409 -3.124 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 -175.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.6 t -145.23 87.65 1.83 Allowed 'General case' 0 C--N 1.278 -2.52 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 160.83 -146.22 12.12 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 8.9 t -125.75 135.34 51.95 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 117.418 0.609 . . . . 0.0 111.008 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.56 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 2.7 t -127.5 138.98 53.07 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 122.924 0.49 . . . . 0.0 110.602 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.9 m -99.21 118.49 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-O 121.557 0.694 . . . . 0.0 110.551 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.8 mt -103.93 162.12 13.4 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -150.51 149.26 29.73 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.62 0.724 . . . . 0.0 112.383 -176.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.485 HG13 HD11 ' A' ' 99' ' ' ILE . 53.2 t -129.78 127.77 22.89 Favored Pre-proline 0 C--N 1.302 -1.457 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.084 176.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -79.18 110.01 2.65 Favored 'Trans proline' 0 N--CA 1.419 -2.884 0 N-CA-C 107.008 -1.958 . . . . 0.0 107.008 168.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.0 m -115.95 150.27 17.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 118' ' ' LYS 0.315 0.0 OUTLIER -97.87 122.6 41.17 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 118.245 -1.382 . . . . 0.0 109.976 166.014 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.2 m -91.99 142.14 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.211 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -174.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 69.23 10.81 7.99 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.876 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.49 ' HD1' ' O ' ' A' ' 60' ' ' ASP . 67.6 t80 -54.7 -40.89 69.63 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.895 0.878 . . . . 0.0 108.949 171.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.3 m -61.34 -45.47 94.28 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.591 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.7 tt -75.81 -34.5 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.248 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -53.73 -48.46 69.61 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 123.413 0.685 . . . . 0.0 112.1 176.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.5 m -71.87 -21.83 21.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.0 t -88.79 -69.06 0.73 Allowed 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 120.718 0.294 . . . . 0.0 111.253 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -124.84 -29.05 3.43 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.898 -0.501 . . . . 0.0 111.986 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.538 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 25.7 ttt 76.35 88.32 0.08 Allowed 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.645 ' HB2' ' CZ ' ' A' ' 174' ' ' PHE . 87.5 tttt 41.87 -86.54 0.01 OUTLIER 'General case' 0 C--N 1.345 0.375 0 O-C-N 125.138 1.524 . . . . 0.0 114.584 167.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 129' ' ' LYS . 29.7 t70 152.95 -25.36 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.136 1.774 . . . . 0.0 106.348 -175.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.406 ' H ' ' HG2' ' A' ' 129' ' ' LYS . 2.6 tpt 43.86 78.19 0.06 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-N 113.115 -1.857 . . . . 0.0 112.244 -169.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 54.0 t -110.22 140.87 43.9 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 176.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 19.3 p -68.69 122.93 19.57 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.1 t70 68.95 103.9 0.06 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.462 1.105 . . . . 0.0 108.694 -169.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.614 ' CD1' ' HE3' ' A' ' 129' ' ' LYS . 59.6 t-105 -150.69 134.81 16.88 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.752 -170.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -107.37 123.69 48.73 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.486 HG23 ' HB ' ' A' ' 165' ' ' ILE . 16.2 tt -123.53 134.34 66.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.743 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -85.11 114.35 22.18 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.511 -175.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -133.11 155.9 48.41 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.737 0.815 . . . . 0.0 110.945 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -151.14 155.1 38.21 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 87' ' ' LEU . 1.7 pt? -136.94 117.06 13.38 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.568 0.699 . . . . 0.0 109.152 169.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -91.86 117.26 29.63 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.493 HD13 ' HA ' ' A' ' 85' ' ' TYR . 41.4 mm -106.96 140.03 26.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.586 -0.845 . . . . 0.0 110.793 -173.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -127.99 102.54 0.59 Allowed Glycine 0 N--CA 1.423 -2.172 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.507 HD21 ' HB2' ' A' ' 47' ' ' ALA . 1.1 pp -94.97 137.76 33.6 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.219 -0.592 . . . . 0.0 111.051 178.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.2 m -116.89 127.23 54.07 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.74 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.664 ' CE1' HG22 ' A' ' 80' ' ' ILE . 87.0 m-85 -128.56 143.9 51.05 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.785 175.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -104.04 110.26 22.36 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 66.1 mt -123.54 114.55 28.65 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -41.79 -36.13 3.25 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 124.827 3.684 . . . . 0.0 115.08 -175.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 56.9 t -55.25 -40.55 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 122.942 0.497 . . . . 0.0 111.544 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 51.9 t -117.72 -45.93 3.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.925 0.393 . . . . 0.0 110.639 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 129.69 -150.89 19.12 Favored Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -81.07 116.99 21.28 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 177.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.408 HG22 ' CE1' ' A' ' 34' ' ' PHE . 28.7 pt -124.0 128.53 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 37.3 m -104.62 116.6 32.35 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 174.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . 70.1 mt -101.92 112.73 65.66 Favored Pre-proline 0 C--N 1.293 -1.891 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.005 -176.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 157' ' ' ILE . 6.6 Cg_endo -82.98 132.8 6.4 Favored 'Trans proline' 0 CA--C 1.482 -2.12 0 C-N-CA 122.863 2.375 . . . . 0.0 112.532 176.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.586 HG22 HG23 ' A' ' 49' ' ' VAL . 2.7 p -134.51 123.35 42.17 Favored 'Isoleucine or valine' 1 N--CA 1.372 -4.335 0 CA-C-N 112.582 -2.099 . . . . 0.0 108.918 -179.353 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 15.4 m -116.43 156.76 26.23 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.578 -174.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.458 ' CG2' ' HB ' ' A' ' 49' ' ' VAL . 9.9 t -173.82 171.36 3.75 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -113.5 145.82 40.59 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 120.915 0.388 . . . . 0.0 110.442 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -118.4 103.4 1.03 Allowed Glycine 0 N--CA 1.426 -2.023 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -88.61 121.13 30.66 Favored 'General case' 0 C--N 1.268 -2.978 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.523 ' CD1' HG21 ' A' ' 52' ' ' VAL . 30.4 mm -110.28 109.27 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.432 -173.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -94.4 126.23 39.54 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.65 172.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 95.2 mt -115.51 88.23 19.01 Favored Pre-proline 0 C--N 1.293 -1.858 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.066 -176.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -82.95 86.57 1.45 Allowed 'Trans proline' 0 N--CA 1.434 -2.0 0 C-N-CA 122.52 2.147 . . . . 0.0 113.109 -176.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 57.3 p 55.1 92.83 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 175.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 5.1 mp -108.51 -61.16 1.64 Allowed 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.326 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . 0.299 86.1 mtm180 62.26 109.11 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -176.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . 0.319 21.4 m-20 85.05 -9.34 0.85 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.171 1.788 . . . . 0.0 114.4 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -81.8 -69.09 0.64 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 169.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.645 ' CZ ' ' HB2' ' A' ' 129' ' ' LYS . 88.8 t80 . . . . . 0 N--CA 1.427 -1.579 0 C-N-CA 126.195 1.798 . . . . 0.0 106.456 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.308 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -96.81 102.33 14.09 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.745 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -147.87 107.07 3.87 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -82.72 46.36 1.07 Allowed 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.816 0.817 . . . . 0.0 109.059 -175.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.5 t60 -67.48 113.16 5.1 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.807 -177.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -130.16 155.18 46.65 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -173.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.3 m80 71.63 149.3 0.09 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.149 1.38 . . . . 0.0 112.216 -177.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.6 tp 71.84 -61.6 0.49 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.834 1.254 . . . . 0.0 112.461 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -73.85 -49.02 27.02 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.286 -176.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.68 99.47 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.215 0.531 . . . . 0.0 110.544 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.0 p -71.41 -19.25 62.28 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.894 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.82 -44.11 70.65 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 177.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.417 ' HA ' HG22 ' A' ' 16' ' ' VAL . 26.3 m-20 -68.78 -37.78 79.56 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.42 ' HG2' ' OG1' ' A' ' 93' ' ' THR . 1.3 tm-20 -56.73 -48.44 77.76 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.524 -1.217 . . . . 0.0 109.036 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -69.19 -47.09 65.84 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.487 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.417 HG22 ' HA ' ' A' ' 13' ' ' ASP . 35.2 m -65.51 -32.38 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -176.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.5 p -73.07 -28.63 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.845 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -70.25 -37.48 74.94 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.433 ' O ' HG23 ' A' ' 23' ' ' VAL . 18.2 mm-40 -56.27 -41.69 76.25 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.449 174.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.639 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 9.9 mmpt? -64.11 -46.56 83.64 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.577 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.87 -43.14 85.79 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.576 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.1 t -59.22 -31.77 69.34 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 19' ' ' GLU . 64.4 t -75.46 -48.78 29.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.6 mt -61.35 -52.32 62.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.924 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.5 m -65.63 -22.46 66.66 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.602 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.7 t -66.23 -44.85 82.61 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.415 ' O ' HD23 ' A' ' 27' ' ' LEU . 3.8 tt -75.73 -40.14 56.09 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.412 ' HA ' ' OG1' ' A' ' 156' ' ' THR . 6.1 tt -61.58 -35.18 77.09 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.686 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -67.11 -47.34 71.46 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.017 0.527 . . . . 0.0 112.018 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -66.18 -33.59 76.11 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.234 0.54 . . . . 0.0 110.947 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.86 -32.12 61.81 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.978 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.96 -46.45 89.22 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.611 0.243 . . . . 0.0 111.003 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.66 -32.59 82.04 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.971 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -78.98 -48.96 13.52 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.484 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 68.4 t80 -53.56 -38.75 64.17 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.59 -46.88 58.15 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 123.917 0.761 . . . . 0.0 113.006 -176.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.433 ' HG3' ' HG2' ' A' ' 38' ' ' LYS . 13.3 pt-20 -116.89 -36.51 3.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.362 0.601 . . . . 0.0 112.507 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.433 ' HG2' ' HG3' ' A' ' 37' ' ' GLU . 19.9 mmmt -77.43 -33.49 54.88 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -168.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 89.9 mt -100.06 13.46 34.0 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.874 0.845 . . . . 0.0 109.816 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.51 -37.07 12.11 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 172.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -73.53 -50.08 23.25 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.722 176.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.6 mt -80.49 119.46 76.4 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.917 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.54 120.27 8.0 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.45 2.1 . . . . 0.0 111.983 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 p -127.24 156.75 74.23 Favored Pre-proline 0 C--N 1.288 -2.079 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.266 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.66 133.12 40.74 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.372 2.048 . . . . 0.0 110.839 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.0 110.02 22.65 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -177.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.5 140.32 41.99 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.343 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 t -142.32 136.59 29.85 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 121.336 0.589 . . . . 0.0 110.738 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.5 t -83.98 141.25 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -115.42 -59.61 1.98 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.346 -0.942 . . . . 0.0 113.342 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -169.59 -173.61 1.69 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -175.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . 36.0 m -131.51 154.99 41.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 118.41 0.55 . . . . 0.0 111.069 -176.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -129.84 116.18 18.32 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.381 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.583 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 46.6 p90 -82.36 141.28 32.96 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.541 ' HE2' ' C ' ' A' ' 54' ' ' PHE . 0.4 OUTLIER -89.69 -78.15 0.37 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.986 175.196 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.59 -117.7 0.41 Allowed Glycine 0 C--O 1.211 -1.314 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.253 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.8 t -99.3 140.54 18.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.525 HG22 ' H ' ' A' ' 60' ' ' ASP . 57.4 m -147.08 149.77 33.71 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -72.3 -19.32 61.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.335 0.588 . . . . 0.0 111.336 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.525 ' H ' HG22 ' A' ' 58' ' ' THR . 7.4 m-20 -122.97 86.38 2.57 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.204 175.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.48 -133.89 30.5 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.356 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 93.0 t -134.45 143.2 38.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -89.65 105.49 17.83 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.675 0.75 . . . . 0.0 110.171 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.785 ' CD1' ' HB ' ' A' ' 119' ' ' VAL . 7.8 m-85 -102.63 141.46 35.42 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.487 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 15.6 m-70 -101.13 108.9 20.69 Favored 'General case' 0 C--N 1.282 -2.351 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.053 170.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -78.54 135.22 37.26 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.436 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -90.03 117.75 29.05 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.606 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.8 t -129.61 111.89 23.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.2 p -100.45 137.16 39.24 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.252 0.549 . . . . 0.0 111.979 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.6 t -127.66 132.41 69.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.881 -177.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 21.4 ptmt -116.8 142.87 46.35 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.589 HD22 ' HA2' ' A' ' 107' ' ' GLY . 38.1 t30 -140.93 115.76 7.27 Favored Pre-proline 0 C--N 1.286 -2.177 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.677 -175.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -90.33 97.38 0.27 Allowed 'Trans proline' 0 N--CA 1.426 -2.45 0 C-N-CA 121.406 1.404 . . . . 0.0 112.228 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.523 ' HB3' ' H ' ' A' ' 76' ' ' GLN . 18.8 m-85 -167.78 -168.65 1.03 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 126.967 2.107 . . . . 0.0 107.372 177.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.1 t -132.98 7.48 4.01 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 170.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.523 ' H ' ' HB3' ' A' ' 74' ' ' TYR . 3.7 pt20 -97.63 142.19 29.75 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.594 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.5 p -79.62 102.58 8.99 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-O 120.944 0.402 . . . . 0.0 110.33 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.547 ' HB ' HD23 ' A' ' 105' ' ' LEU . 78.7 mt -92.6 117.67 67.69 Favored Pre-proline 0 C--N 1.31 -1.145 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 177.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -78.22 130.37 10.13 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 122.162 1.908 . . . . 0.0 112.747 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.473 ' HB ' ' CE1' ' A' ' 147' ' ' PHE . 9.9 tt -82.6 94.38 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 174.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 57.9 m -58.79 -42.13 88.33 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.845 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -156.87 148.55 22.55 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.617 -171.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.5 tt -128.58 116.36 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 173.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 28.6 p -120.26 118.72 31.18 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.717 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.492 ' CE1' HG13 ' A' ' 117' ' ' VAL . 43.6 p90 -109.04 147.98 31.5 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.414 -176.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 86' ' ' ILE . 3.0 mp -120.31 113.26 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 175.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.704 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 0.9 OUTLIER -99.51 137.25 38.27 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.532 ' N ' HD23 ' A' ' 87' ' ' LEU . 45.4 mtpt -129.1 153.89 47.22 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 172.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.5 t -158.97 140.4 13.21 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 119.027 -1.069 . . . . 0.0 113.2 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 60.38 -79.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.805 1.642 . . . . 0.0 114.595 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -167.32 -32.48 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.099 0.476 . . . . 0.0 109.89 -175.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -129.09 141.94 51.05 Favored 'General case' 0 CA--C 1.49 -1.343 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.883 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.42 ' OG1' ' HG2' ' A' ' 14' ' ' GLU . 7.2 m 75.39 134.21 0.05 Allowed 'General case' 0 C--N 1.307 -1.25 0 O-C-N 125.177 1.548 . . . . 0.0 112.354 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.704 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.6 pp -138.2 174.79 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.199 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.668 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -132.63 162.01 32.42 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 119.095 0.862 . . . . 0.0 111.026 175.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.0 m -143.36 153.68 42.95 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -154.96 149.93 21.33 Favored Glycine 0 N--CA 1.419 -2.472 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 93.2 m -141.32 108.51 5.49 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.4 mt -115.03 110.21 46.16 Favored Pre-proline 0 C--N 1.306 -1.316 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.776 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -72.16 131.06 17.33 Favored 'Trans proline' 0 C--O 1.238 0.502 0 C-N-CA 122.533 2.155 . . . . 0.0 109.645 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.314 4.0 p30 44.72 77.94 0.42 Allowed Pre-proline 0 N--CA 1.487 1.394 0 C-N-CA 124.622 1.169 . . . . 0.0 114.107 -175.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -87.91 -8.71 5.77 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.874 2.383 . . . . 0.0 113.556 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 173.36 -161.77 32.71 Favored Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.592 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 46.2 m -119.86 142.03 49.02 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.209 0.528 . . . . 0.0 110.719 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.547 HD23 ' HB ' ' A' ' 78' ' ' ILE . 41.5 tp -97.04 141.37 30.28 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.447 HG23 ' HB ' ' A' ' 111' ' ' THR . 61.0 t -89.77 107.46 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.247 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 171.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.589 ' HA2' HD22 ' A' ' 72' ' ' ASN . . . -57.06 -22.49 42.79 Favored Glycine 0 C--N 1.292 -1.89 0 CA-C-N 114.317 -1.311 . . . . 0.0 113.627 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.4 p -120.23 11.72 11.63 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -156.57 -161.93 11.1 Favored Glycine 0 CA--C 1.498 -1.009 0 C-N-CA 117.135 -2.459 . . . . 0.0 114.996 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 41.4 m -101.7 129.85 47.95 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.447 ' HB ' HG23 ' A' ' 106' ' ' VAL . 10.0 t -127.47 133.21 49.91 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 40.1 t -97.78 115.92 39.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.1 mt -102.81 160.93 14.16 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 7.3 p-10 -133.45 130.81 39.14 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 9.6 t -104.78 126.18 31.91 Favored Pre-proline 0 C--N 1.305 -1.368 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -71.04 110.47 2.82 Favored 'Trans proline' 0 N--CA 1.433 -2.054 0 N-CA-C 106.818 -2.031 . . . . 0.0 106.818 168.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.492 HG13 ' CE1' ' A' ' 85' ' ' TYR . 97.6 t -116.69 141.39 34.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.708 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -87.17 88.4 7.69 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.17 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.785 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 94.5 t -94.04 145.99 7.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.664 -176.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 72.41 -1.99 2.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.141 0.976 . . . . 0.0 111.245 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -68.45 -43.38 77.19 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.41 ' O ' ' HB ' ' A' ' 93' ' ' THR . 14.4 m -62.0 -28.0 69.26 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 122.491 1.138 . . . . 0.0 109.578 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.6 mt -78.18 -49.45 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.22 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.455 -177.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.03 -36.27 72.47 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.324 0.649 . . . . 0.0 111.517 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.0 t -67.81 -34.72 69.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.421 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.0 t -93.39 -66.77 0.9 Allowed 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -176.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 127' ' ' LEU . 1.8 pt? -124.91 -23.85 4.2 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -176.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 24.2 ttt 56.89 35.59 26.55 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.283 1.033 . . . . 0.0 109.349 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.436 ' H ' ' HG ' ' A' ' 127' ' ' LEU . 61.6 mmtt 69.3 -70.5 0.14 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.033 1.733 . . . . 0.0 106.672 -172.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.446 ' H ' ' H ' ' A' ' 131' ' ' MET . 24.4 t70 149.58 18.71 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 130.855 3.662 . . . . 0.0 102.862 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.598 ' SD ' ' HA ' ' A' ' 171' ' ' ARG . 0.0 OUTLIER 58.53 76.79 0.33 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 113.05 -1.887 . . . . 0.0 106.778 -163.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.409 ' HB2' ' NE1' ' A' ' 135' ' ' TRP . 64.9 m -106.43 127.62 53.42 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.631 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 169' ' ' SER . 19.0 p -93.29 119.4 32.39 Favored 'General case' 0 N--CA 1.399 -2.982 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.078 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 5.9 m-20 72.85 89.14 0.1 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 176.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.409 ' NE1' ' HB2' ' A' ' 132' ' ' CYS . 1.2 p-90 -173.15 158.66 3.71 Favored 'General case' 0 C--O 1.246 0.894 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.254 174.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.595 ' HA ' ' HA ' ' A' ' 166' ' ' LYS . 5.1 p-10 -98.45 143.38 28.96 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 137' ' ' ILE . 3.1 mp -124.23 140.46 47.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -177.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -75.81 112.7 12.47 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 122.674 1.226 . . . . 0.0 111.791 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.451 ' CE2' ' HG ' ' A' ' 87' ' ' LEU . 1.2 t80 -125.23 152.01 45.13 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 113.501 -1.682 . . . . 0.0 107.261 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 162' ' ' GLN . 17.4 tt0 -134.08 150.46 51.18 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.1 tp -131.89 117.7 18.84 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 121.703 0.763 . . . . 0.0 110.163 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.424 ' HB3' ' HB ' ' A' ' 86' ' ' ILE . 13.3 t70 -124.76 130.2 51.94 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 -177.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.9 mt -136.81 140.48 42.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.159 -1.016 . . . . 0.0 111.761 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -108.32 93.15 0.78 Allowed Glycine 0 N--CA 1.426 -1.976 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.48 ' HB3' ' CE2' ' A' ' 147' ' ' PHE . 3.1 mm? -68.42 118.96 12.16 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 16.7 m -100.89 108.52 20.31 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.267 -177.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.48 ' CE2' ' HB3' ' A' ' 145' ' ' LEU . 96.3 m-85 -119.26 149.22 42.14 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 176.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 154' ' ' ASP . 4.5 p-10 -102.48 115.97 31.66 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.121 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.3 mp -108.02 105.46 56.44 Favored Pre-proline 0 C--N 1.296 -1.737 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -30.15 -51.14 0.2 Allowed 'Trans proline' 0 N--CA 1.485 1.029 1 C-N-CA 125.694 4.263 . . . . 0.0 116.984 -172.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.448 HG23 HG23 ' A' ' 152' ' ' VAL . 29.7 m -62.29 -21.17 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -177.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.448 HG23 HG23 ' A' ' 151' ' ' VAL . 48.4 t -121.86 -40.73 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.817 0.818 . . . . 0.0 109.754 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 112.8 -148.8 18.49 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 148' ' ' ASP . 6.7 p-10 -86.46 124.42 32.77 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.612 0.72 . . . . 0.0 110.811 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 146' ' ' THR . 2.2 pp -125.35 145.07 33.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.489 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.414 HG22 ' OG1' ' A' ' 146' ' ' THR . 46.4 p -94.7 119.57 33.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.652 0.263 . . . . 0.0 110.771 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.449 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . 55.3 mt -92.78 119.32 67.93 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 157' ' ' ILE . 19.8 Cg_exo -70.71 125.48 11.7 Favored 'Trans proline' 0 C--O 1.24 0.579 0 C-N-CA 123.596 2.864 . . . . 0.0 113.409 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 39.0 t -132.81 115.03 23.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 173.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.7 m -125.36 142.8 51.3 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 121.046 -0.262 . . . . 0.0 110.808 -174.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.1 t -176.97 157.11 1.39 Allowed 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 140' ' ' GLN . 30.2 pt20 -99.62 152.45 20.03 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.267 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -120.37 119.57 4.24 Favored Glycine 0 N--CA 1.417 -2.597 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -96.7 120.59 37.3 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 4.2 pt -131.16 112.82 22.42 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 CA-C-O 121.446 0.641 . . . . 0.0 112.191 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 136' ' ' ASP . 40.1 ttmt -90.87 128.24 36.68 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.102 178.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 134' ' ' ASP . 88.4 mt -110.38 107.23 58.4 Favored Pre-proline 0 C--N 1.286 -2.161 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.568 -173.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -71.58 105.09 1.7 Allowed 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.788 2.325 . . . . 0.0 111.835 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 133' ' ' THR 0.268 89.5 p 60.46 -83.96 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 126.025 1.73 . . . . 0.0 114.557 -175.309 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.401 HD22 HD13 ' A' ' 167' ' ' LEU . 10.9 mp 63.44 26.74 14.99 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-O 121.044 0.449 . . . . 0.0 112.189 -176.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.598 ' HA ' ' SD ' ' A' ' 131' ' ' MET . 47.1 ttt180 -77.23 99.08 5.34 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . 0.276 1.8 m-20 80.28 79.45 0.05 OUTLIER 'General case' 0 CA--C 1.49 -1.359 0 CA-C-O 123.089 1.423 . . . . 0.0 109.514 -168.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -170.16 -40.67 0.02 OUTLIER 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 100.718 -3.808 . . . . 0.0 100.718 -177.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 . . . . . 0 N--CA 1.425 -1.703 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 164.372 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.27 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 63.33 87.62 0.11 Allowed 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.573 0.749 . . . . 0.0 109.889 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 72.45 119.22 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.7 -172.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -64.49 -18.53 64.88 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.838 0.351 . . . . 0.0 110.373 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.3 m80 73.61 -74.84 0.08 Allowed 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 125.407 1.483 . . . . 0.0 111.898 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -144.03 179.5 7.16 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.911 0.386 . . . . 0.0 110.787 -177.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -152.94 -57.21 0.13 Allowed 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 171.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 50.1 tp 61.16 -77.58 0.02 OUTLIER 'General case' 0 C--N 1.355 0.82 0 C-N-CA 126.042 1.737 . . . . 0.0 112.571 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -126.08 108.34 11.26 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.19 103.82 3.46 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.184 -173.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.5 p -135.65 -67.03 0.54 Allowed 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 114.594 -1.184 . . . . 0.0 108.99 177.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.36 -33.38 37.31 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.198 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -56.65 -53.85 52.85 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.289 0.636 . . . . 0.0 112.268 -177.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.94 -28.44 62.43 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.218 0.532 . . . . 0.0 111.295 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.51 ' HE2' ' OE1' ' A' ' 19' ' ' GLU . 81.9 tttt -67.69 -55.3 13.75 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.539 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.453 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 32.3 m -60.27 -33.64 54.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -173.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -73.36 -33.43 40.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.093 0.473 . . . . 0.0 110.21 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -72.65 -49.34 32.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.144 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.51 ' OE1' ' HE2' ' A' ' 15' ' ' LYS . 8.9 pt-20 -64.36 -31.73 73.05 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.978 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.56 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 1.1 tpmt? -61.98 -48.78 78.82 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.83 -39.48 94.47 Favored 'General case' 0 C--O 1.21 -0.991 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.829 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.5 t -60.53 -44.51 95.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 66.6 t -69.47 -43.87 80.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 20' ' ' LYS . 78.7 mt -61.03 -45.25 98.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.397 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.7 t -57.42 -41.71 80.92 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 123.041 0.536 . . . . 0.0 110.055 177.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.8 t -66.79 -26.27 66.87 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-O 121.013 0.435 . . . . 0.0 110.912 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 tt -76.36 -55.19 5.78 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.574 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 8.4 mp -59.3 -36.39 75.51 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -51.23 -45.7 62.05 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.09 0.556 . . . . 0.0 111.843 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -82.95 -31.2 27.79 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 177.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.96 -32.27 73.56 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.116 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.574 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 61.4 mtpt -57.18 -27.85 62.3 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.484 0.713 . . . . 0.0 110.819 175.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.564 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -74.12 -55.77 5.58 Favored Glycine 0 N--CA 1.438 -1.228 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 178.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -56.1 -40.98 74.52 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.763 0.316 . . . . 0.0 110.836 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.456 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 48.7 t80 -67.21 -37.48 83.7 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.27 -34.75 63.66 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.987 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.564 ' HG2' ' O ' ' A' ' 33' ' ' GLY . 11.1 pt-20 -104.72 -44.37 4.88 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -176.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.414 ' HG2' HD12 ' A' ' 42' ' ' ILE . 21.6 ttmm -87.93 -43.94 11.4 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.682 0.753 . . . . 0.0 109.659 -170.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 67.2 mt -87.16 12.13 12.35 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.647 -176.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.05 -40.72 15.47 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 173.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.54 ' OD1' HG13 ' A' ' 42' ' ' ILE . 8.4 p30 -87.72 -36.43 17.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.452 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.54 HG13 ' OD1' ' A' ' 41' ' ' ASN . 85.4 mt -88.84 113.8 57.38 Favored Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -79.0 101.04 1.4 Allowed 'Trans proline' 0 N--CA 1.435 -1.97 0 C-N-CA 121.955 1.77 . . . . 0.0 113.628 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.9 p -93.04 149.94 38.4 Favored Pre-proline 0 N--CA 1.419 -1.987 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.463 ' HB3' ' HA ' ' A' ' 72' ' ' ASN . 10.9 Cg_endo -53.37 141.87 59.52 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.279 1.986 . . . . 0.0 110.246 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -96.53 141.99 29.15 Favored 'General case' 0 CA--C 1.484 -1.563 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.685 -172.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.48 137.35 53.24 Favored 'General case' 0 N--CA 1.414 -2.254 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.877 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.2 t -134.34 126.03 28.82 Favored 'General case' 0 C--N 1.272 -2.779 0 CA-C-O 121.635 0.731 . . . . 0.0 109.985 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.568 HG11 ' CG1' ' A' ' 143' ' ' ILE . 35.5 m -107.38 141.72 21.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.164 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 49' ' ' VAL . 27.5 t70 161.8 66.81 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 124.898 1.374 . . . . 0.0 112.684 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 67' ' ' LYS . 20.5 t70 -177.47 117.86 0.1 Allowed 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 168.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.2 t -132.03 112.69 20.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -121.53 141.88 50.62 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.9 -176.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 41.9 p90 -77.0 128.14 33.96 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.732 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -120.22 -3.09 10.05 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.656 -0.818 . . . . 0.0 112.047 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.0 158.29 25.92 Favored Glycine 0 CA--C 1.489 -1.567 0 C-N-CA 119.214 -1.469 . . . . 0.0 112.84 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.49 ' HB ' ' CE1' ' A' ' 173' ' ' PHE . 7.5 p -106.8 116.29 50.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.716 0.77 . . . . 0.0 112.336 -176.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.564 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 88.4 m -132.55 130.67 40.65 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 174.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -82.01 -12.2 58.43 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.211 0.529 . . . . 0.0 111.196 -174.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.405 ' H ' HG22 ' A' ' 58' ' ' THR . 20.1 t70 -114.33 69.16 0.7 Allowed 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 172.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.564 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . 100.33 101.37 2.41 Favored Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.117 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.0 p -76.2 143.07 13.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 121.164 0.507 . . . . 0.0 110.889 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -89.45 114.89 26.44 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -172.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.635 ' CD1' ' HB ' ' A' ' 119' ' ' VAL . 32.9 m-85 -120.87 151.26 39.87 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.056 173.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -120.51 109.19 14.99 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.93 144.75 34.53 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.933 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 31.6 mmtp -102.4 118.76 37.56 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.599 -176.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.6 t -111.06 108.37 25.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 175.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.6 p -99.85 123.83 44.51 Favored 'General case' 0 C--N 1.285 -2.201 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.713 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.7 t -114.96 128.01 72.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.722 -176.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 71' ' ' LYS . 19.2 ptpt -102.35 110.48 22.45 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.568 ' O ' ' HA ' ' A' ' 108' ' ' SER . 34.1 t30 -109.98 113.9 56.67 Favored Pre-proline 0 C--N 1.265 -3.075 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.107 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -97.67 95.97 0.07 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.686 0 C-N-CA 121.605 1.537 . . . . 0.0 109.65 169.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -176.19 156.29 1.63 Allowed 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 127.468 2.307 . . . . 0.0 106.54 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.5 m -82.92 -18.59 39.57 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.656 0.741 . . . . 0.0 109.242 176.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -96.83 146.78 24.6 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.674 -178.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.4 m -84.59 106.43 16.15 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 171.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 59.1 mt -76.19 116.15 53.4 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -56.99 137.02 80.12 Favored 'Trans proline' 0 C--O 1.239 0.569 0 C-N-CA 123.228 2.618 . . . . 0.0 113.757 -175.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 146' ' ' THR . 9.4 pt -112.64 98.59 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.952 175.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 51.6 t -52.6 -54.9 26.84 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.188 -177.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -145.71 160.64 41.43 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.524 ' CG2' ' HB ' ' A' ' 99' ' ' ILE . 14.9 tt -134.87 113.83 16.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 175.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 55.0 p -94.63 123.3 37.99 Favored 'General case' 0 C--N 1.287 -2.144 0 O-C-N 121.956 -0.465 . . . . 0.0 111.421 -175.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.526 ' HA ' HD13 ' A' ' 143' ' ' ILE . 36.4 p90 -103.81 129.86 51.3 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 2.5 mp -117.12 107.17 21.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 176.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.629 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 1.3 tt -92.35 132.56 36.63 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.474 ' N ' HD23 ' A' ' 87' ' ' LEU . 62.1 tttm -130.46 143.48 50.79 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.483 ' HB2' HD11 ' A' ' 123' ' ' ILE . 58.1 p -144.05 95.39 2.72 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 55.59 -81.84 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 171.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.6 p -83.98 -71.68 0.5 Allowed 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 -168.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -137.31 -64.92 0.55 Allowed 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 m -66.76 139.55 57.81 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 121.513 0.673 . . . . 0.0 112.086 -173.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.629 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.7 pp -139.7 170.65 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.484 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 -178.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.629 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -138.06 136.5 36.89 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.3 t -149.08 159.85 43.86 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.909 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.56 161.08 24.35 Favored Glycine 0 N--CA 1.422 -2.262 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 64.6 p -101.34 127.23 48.06 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.524 ' HB ' ' CG2' ' A' ' 83' ' ' ILE . 66.4 mt -97.15 110.07 52.44 Favored Pre-proline 0 C--N 1.306 -1.303 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.853 175.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -78.31 115.56 3.73 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.097 1.864 . . . . 0.0 110.828 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.7 t70 60.4 86.05 0.16 Allowed Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.868 -176.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.402 ' HG3' ' CG2' ' A' ' 83' ' ' ILE . 19.0 Cg_endo -97.05 5.42 1.58 Allowed 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.903 2.402 . . . . 0.0 111.581 177.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 145.59 -164.71 28.06 Favored Glycine 0 N--CA 1.419 -2.484 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.3 m -137.95 155.59 48.73 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.441 HD21 ' CE1' ' A' ' 147' ' ' PHE . 6.9 mp -72.02 150.84 43.64 Favored 'General case' 0 CA--C 1.485 -1.555 0 CA-C-O 121.803 0.811 . . . . 0.0 111.149 176.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 11.1 p -88.2 139.13 17.85 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.143 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.274 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -66.49 90.77 0.16 Allowed Glycine 0 C--N 1.304 -1.231 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 72' ' ' ASN 0.252 79.6 p 63.09 86.74 0.11 Allowed 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 125.973 1.709 . . . . 0.0 113.537 -178.748 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 169.35 -163.86 37.46 Favored Glycine 0 N--CA 1.431 -1.669 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.5 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.7 m -119.29 115.99 25.31 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.474 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 5.1 t -110.23 132.2 54.38 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.106 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.2 t -95.72 113.09 29.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.6 mt -92.67 150.09 20.91 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.312 -177.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -105.02 119.66 39.57 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.365 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.54 117.84 30.01 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-O 121.17 0.51 . . . . 0.0 111.319 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.37 123.13 10.2 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.208 1.939 . . . . 0.0 111.143 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 57.4 t -125.26 136.64 60.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -88.17 93.56 9.54 Favored 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.635 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 96.2 t -93.76 146.44 6.55 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.826 -171.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 72.31 -4.29 2.07 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.121 1.368 . . . . 0.0 112.799 174.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.52 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . 44.9 t80 -67.13 -32.46 73.6 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.7 p -64.86 -35.2 80.36 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.041 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.483 HD11 ' HB2' ' A' ' 89' ' ' SER . 33.8 mm -71.78 -46.98 58.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.021 176.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.4 -48.02 83.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.471 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.8 p -72.26 -25.46 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 CA-C-O 121.013 0.435 . . . . 0.0 111.35 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 39.2 t -80.8 -76.04 0.25 Allowed 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.825 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.576 HD12 ' N ' ' A' ' 128' ' ' MET . 2.5 pp -124.68 -37.26 2.5 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -175.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.576 ' N ' HD12 ' A' ' 127' ' ' LEU . 9.8 tpt 61.94 109.97 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.486 0.714 . . . . 0.0 111.49 -176.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.513 ' HB2' ' HZ2' ' A' ' 135' ' ' TRP . 1.4 mptp? -78.47 -30.07 47.16 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 80.15 97.78 0.06 Allowed 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 113.533 -1.667 . . . . 0.0 110.76 -175.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.33 139.83 58.81 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.133 -1.394 . . . . 0.0 110.395 -176.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 49.7 t -138.37 -81.54 0.32 Allowed 'General case' 0 CA--C 1.56 1.364 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.615 ' HA ' ' CB ' ' A' ' 169' ' ' SER . 14.1 p -144.29 130.81 19.95 Favored 'General case' 0 N--CA 1.426 -1.645 0 C-N-CA 125.541 1.536 . . . . 0.0 109.652 -171.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 44.56 89.56 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 C-N-CA 124.632 1.173 . . . . 0.0 110.138 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.513 ' HZ2' ' HB2' ' A' ' 129' ' ' LYS . 69.5 t-105 -128.99 150.21 50.5 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -162.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -136.94 136.26 38.44 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.031 0.932 . . . . 0.0 109.893 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 22.6 pt -132.41 136.66 55.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 173.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -87.18 121.14 29.23 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.509 ' CE2' ' HG ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -149.61 161.74 41.56 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -175.699 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -164.16 158.94 19.71 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 117.889 0.313 . . . . 0.0 110.822 171.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.598 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 1.5 pt? -136.12 132.29 35.88 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-O 121.0 0.429 . . . . 0.0 109.96 176.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.566 ' HA ' ' HB3' ' A' ' 160' ' ' SER . 15.2 t70 -101.84 120.84 41.02 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 175.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.568 ' CG1' HG11 ' A' ' 49' ' ' VAL . 45.8 mm -100.66 133.07 45.02 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 CA-C-O 120.832 0.349 . . . . 0.0 110.693 -176.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -114.75 86.41 0.41 Allowed Glycine 0 N--CA 1.41 -3.096 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 174.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.729 HD13 ' H ' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -81.05 146.42 30.64 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.304 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 30.3 m -127.84 114.45 17.24 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 119.051 -1.06 . . . . 0.0 112.248 -176.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.441 ' CE1' HD21 ' A' ' 105' ' ' LEU . 50.3 m-85 -99.14 160.3 14.37 Favored 'General case' 0 C--O 1.246 0.875 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 174.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -121.37 126.85 50.41 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.846 174.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.7 125.33 18.36 Favored Pre-proline 0 C--N 1.301 -1.512 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.092 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.54 -28.68 22.5 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 C-N-CA 123.953 3.102 . . . . 0.0 113.737 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.94 -38.39 76.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.506 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 41.3 t -124.84 -45.29 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.264 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 129.15 -133.58 7.62 Favored Glycine 0 N--CA 1.428 -1.847 0 C-N-CA 121.026 -0.607 . . . . 0.0 111.758 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -100.33 117.34 34.32 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.857 0.863 . . . . 0.0 108.931 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.413 ' N ' HD12 ' A' ' 155' ' ' ILE . 2.7 mp -128.75 119.5 49.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.494 178.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 86.4 m -82.07 112.11 18.83 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 173.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.436 ' O ' HD13 ' A' ' 145' ' ' LEU . 70.0 mt -93.5 117.15 67.29 Favored Pre-proline 0 C--N 1.299 -1.587 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.285 -176.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.446 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.7 Cg_endo -82.83 133.87 7.03 Favored 'Trans proline' 0 CA--C 1.489 -1.774 0 C-N-CA 122.88 2.387 . . . . 0.0 112.728 176.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.443 HG22 HG22 ' A' ' 49' ' ' VAL . 2.7 p -146.28 131.4 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.106 0 CA-C-N 113.097 -1.865 . . . . 0.0 109.062 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.566 ' HB3' ' HA ' ' A' ' 142' ' ' ASP . 12.3 p -147.29 162.43 38.96 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.454 HG21 ' HA ' ' A' ' 50' ' ' ASP . 14.4 t -153.5 178.22 10.06 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 177.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -98.69 132.41 44.1 Favored 'General case' 0 N--CA 1.422 -1.864 0 C-N-CA 118.661 -1.215 . . . . 0.0 108.801 176.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.477 ' O ' ' HD1' ' A' ' 139' ' ' TYR . . . -97.1 76.82 0.67 Allowed Glycine 0 N--CA 1.399 -3.821 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -87.82 119.88 28.6 Favored 'General case' 0 C--N 1.271 -2.842 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.7 pt -117.55 108.38 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.765 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.236 -176.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.413 ' HG2' ' H ' ' A' ' 166' ' ' LYS . 16.7 pttt -98.41 98.61 9.81 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 113.195 -1.82 . . . . 0.0 109.571 -177.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 88.4 mt -87.14 127.62 58.6 Favored Pre-proline 0 C--N 1.282 -2.346 0 CA-C-N 112.228 -2.26 . . . . 0.0 111.935 -169.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -69.79 150.74 68.43 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.079 1.853 . . . . 0.0 108.334 173.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.615 ' CB ' ' HA ' ' A' ' 133' ' ' THR . 2.3 m -51.16 99.35 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -177.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -101.52 -27.31 13.18 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 170.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.53 -65.6 0.2 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.066 1.746 . . . . 0.0 109.943 -178.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -116.24 95.33 5.03 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 122.168 0.985 . . . . 0.0 109.592 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.49 ' CE1' ' HB ' ' A' ' 57' ' ' VAL . 72.7 t80 -157.47 -47.61 0.07 Allowed 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 103.164 -2.902 . . . . 0.0 103.164 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 41.4 t80 . . . . . 0 N--CA 1.416 -2.173 0 CA-C-N 113.206 -1.816 . . . . 0.0 106.3 167.929 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.958 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -148.13 137.91 22.42 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -177.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 72.3 -47.59 0.67 Allowed 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 175.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 33.7 p80 51.83 94.09 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.878 1.271 . . . . 0.0 112.193 -175.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -71.84 65.37 0.52 Allowed 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -173.09 154.93 2.88 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 127.472 2.309 . . . . 0.0 108.029 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 47.6 m80 66.76 35.45 5.07 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 123.964 0.79 . . . . 0.0 110.858 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.568 HD22 ' HG3' ' A' ' 9' ' ' GLU . 4.4 tt -65.3 -59.27 4.23 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.568 ' HG3' HD22 ' A' ' 8' ' ' LEU . 48.2 mt-10 -121.65 -21.38 6.19 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.93 174.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 63.24 82.39 0.18 Allowed 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -172.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.0 m -78.27 163.97 25.29 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.58 -173.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.26 -35.51 81.27 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.81 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -57.25 -55.67 31.74 Favored 'General case' 0 CA--C 1.495 -1.153 0 O-C-N 123.76 0.662 . . . . 0.0 109.428 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -53.7 -35.14 60.8 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.324 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -74.88 -56.18 5.04 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.25 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.446 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 30.6 m -70.83 -34.72 57.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -172.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 p -68.46 -32.5 55.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.203 0.525 . . . . 0.0 110.349 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -74.89 -47.13 31.64 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.488 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.446 ' HG2' ' HA ' ' A' ' 16' ' ' VAL . 13.4 pt-20 -71.15 -36.99 72.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.413 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.402 ' O ' HG12 ' A' ' 24' ' ' ILE . 40.5 ttmt -65.17 -39.4 92.87 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.48 -37.72 88.38 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.986 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -59.94 -50.62 73.04 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.655 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 19' ' ' GLU . 95.7 t -59.66 -51.06 77.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.902 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.529 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 50.4 mm -63.28 -36.1 74.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.195 -177.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.8 t -62.77 -35.68 80.6 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.424 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.5 m -72.25 -35.85 68.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.097 0.475 . . . . 0.0 110.145 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.505 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 5.3 tt -66.78 -40.25 88.1 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 85.5 mt -61.8 -41.09 97.32 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -57.87 -45.82 85.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.669 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -66.23 -30.67 71.16 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-O 121.099 0.476 . . . . 0.0 110.955 -179.544 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.521 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -78.02 -34.73 50.54 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 120.987 0.423 . . . . 0.0 111.787 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 29.0 mtpp -69.11 9.44 0.42 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -177.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -113.08 -18.34 7.32 Favored Glycine 0 C--N 1.313 -0.723 0 C-N-CA 120.341 -0.933 . . . . 0.0 111.371 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.497 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 68.4 m-85 -80.25 -25.53 39.47 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.555 ' HA ' HD12 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -56.19 -29.96 61.62 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -171.592 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.71 -34.04 25.0 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -115.79 -46.81 2.82 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.497 ' HB3' ' HB3' ' A' ' 34' ' ' PHE . 5.4 tmmm? -82.71 -20.75 35.46 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-O 120.898 0.38 . . . . 0.0 110.311 -173.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.555 HD12 ' HA ' ' A' ' 35' ' ' PHE . 42.7 mt -96.3 0.06 50.3 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.299 176.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.88 -57.07 2.85 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.819 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -81.64 -2.81 51.65 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.228 0.537 . . . . 0.0 111.979 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 75.6 mt -121.46 125.17 26.94 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.97 107.03 0.32 Allowed 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.739 2.293 . . . . 0.0 111.704 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.7 p -134.33 153.06 79.13 Favored Pre-proline 0 C--N 1.302 -1.487 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.963 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.403 ' HB3' ' HB2' ' A' ' 72' ' ' ASN . 52.5 Cg_endo -79.25 164.41 24.36 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.544 2.163 . . . . 0.0 113.58 -176.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 71' ' ' LYS . 36.8 tt0 -112.86 143.01 44.85 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.93 152.22 50.5 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.128 -175.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.3 t -147.69 128.97 14.76 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.265 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.475 HG13 HG22 ' A' ' 161' ' ' THR . 7.5 p -94.09 141.7 14.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 175.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -118.05 -66.81 1.04 Allowed 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -170.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -158.58 167.07 30.56 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -171.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.574 HG11 ' OH ' ' A' ' 139' ' ' TYR . 14.5 p -126.97 132.68 69.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.723 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -104.71 135.84 45.34 Favored 'General case' 0 C--O 1.251 1.15 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.343 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.499 ' O ' ' HE2' ' A' ' 55' ' ' LYS . 48.7 p90 -60.45 140.76 57.1 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 174.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.549 ' HA ' ' HE2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -136.11 -66.72 0.54 Allowed 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.914 -171.157 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.09 -164.76 15.3 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.202 -176.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.24 128.31 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-O 121.452 0.644 . . . . 0.0 111.515 -177.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.505 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 44.9 m -152.29 126.51 9.23 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 173.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -69.82 -32.44 70.87 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -169.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -108.6 11.42 26.64 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.02 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . 170.1 86.95 0.06 OUTLIER Glycine 0 CA--C 1.492 -1.374 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -177.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.429 HG13 ' HB ' ' A' ' 119' ' ' VAL . 7.2 p -67.76 140.39 19.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.534 0.683 . . . . 0.0 110.991 -173.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -96.26 106.75 19.0 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 121.691 0.757 . . . . 0.0 112.02 -175.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.565 ' HB3' HG22 ' A' ' 52' ' ' VAL . 3.3 m-85 -100.97 165.36 11.37 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.246 174.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.452 ' CD2' ' HG2' ' A' ' 55' ' ' LYS . 20.0 m-70 -124.89 110.26 14.03 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.284 0.564 . . . . 0.0 109.553 176.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . . . -78.45 144.91 35.36 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.589 -177.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -90.46 112.61 24.3 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.556 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.2 t -118.33 114.61 45.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.4 m -98.2 131.29 44.68 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -177.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 95.4 t -118.84 133.0 67.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.533 0.682 . . . . 0.0 111.077 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 46' ' ' GLU . 78.3 tttt -102.78 109.97 21.73 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 45' ' ' PRO . 8.9 t30 -130.33 113.2 16.94 Favored Pre-proline 0 C--N 1.302 -1.497 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.95 -175.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -102.88 97.59 0.04 OUTLIER 'Trans proline' 0 N--CA 1.421 -2.755 0 C-N-CA 122.319 2.013 . . . . 0.0 113.081 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -176.52 150.78 0.9 Allowed 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 170.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.5 t -77.87 8.03 5.15 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 118.039 0.381 . . . . 0.0 111.487 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.428 ' CD ' HG12 ' A' ' 78' ' ' ILE . 6.4 tt0 -101.56 137.64 39.61 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.7 p -94.08 95.57 9.09 Favored 'General case' 0 N--CA 1.399 -2.98 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 170.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.533 ' HB ' HD12 ' A' ' 105' ' ' LEU . 33.6 mt -77.88 126.36 84.12 Favored Pre-proline 0 N--CA 1.434 -1.235 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -174.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.0 133.95 30.51 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.308 2.006 . . . . 0.0 110.538 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 67.7 mt -83.93 107.04 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 55.5 m -55.76 -51.82 66.06 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.853 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -160.55 155.2 23.85 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.253 0.549 . . . . 0.0 110.274 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.472 HG23 HG23 ' A' ' 143' ' ' ILE . 24.8 mm -114.95 113.85 44.81 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 172.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.3 m -93.48 117.28 29.88 Favored 'General case' 0 C--N 1.274 -2.687 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -107.89 129.56 55.08 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.519 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.625 ' HB ' ' HB2' ' A' ' 142' ' ' ASP . 3.0 mp -118.11 108.0 23.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.501 HD21 ' CE2' ' A' ' 139' ' ' TYR . 3.1 tm? -109.96 124.65 51.77 Favored 'General case' 0 C--N 1.27 -2.88 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.847 -175.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.575 ' HB2' ' HB2' ' A' ' 140' ' ' GLN . 29.9 mmtm -93.7 142.81 26.93 Favored 'General case' 0 CA--C 1.479 -1.774 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.738 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 92' ' ' ARG . 45.9 t -97.92 145.54 26.35 Favored 'General case' 0 C--N 1.267 -2.996 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.65 143.83 56.91 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.296 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.4 m 74.1 -61.03 0.51 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.455 1.102 . . . . 0.0 111.001 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.405 ' O ' ' HB3' ' A' ' 89' ' ' SER . 53.3 mtt180 -155.01 172.1 18.66 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.088 0.555 . . . . 0.0 110.165 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.0 m 77.52 160.33 0.21 Allowed 'General case' 0 CA--C 1.563 1.456 0 O-C-N 124.261 0.976 . . . . 0.0 113.207 172.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.418 HD13 ' N ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -147.91 149.26 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 123.727 0.811 . . . . 0.0 109.228 -176.393 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.494 ' HB2' ' OG ' ' A' ' 122' ' ' SER . . . -118.64 134.93 54.75 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.666 0.787 . . . . 0.0 109.221 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.0 p -129.64 158.86 38.16 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.95 162.61 26.03 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.8 p -124.89 128.77 49.16 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 117.054 0.427 . . . . 0.0 110.335 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.8 mt -99.64 105.35 33.43 Favored Pre-proline 0 C--N 1.308 -1.221 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -76.92 116.08 4.16 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.502 2.134 . . . . 0.0 111.722 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.5 t70 53.96 83.33 0.23 Allowed Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 124.95 1.3 . . . . 0.0 112.745 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -101.08 7.8 0.58 Allowed 'Trans proline' 0 N--CA 1.441 -1.613 0 C-N-CA 122.697 2.265 . . . . 0.0 112.015 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 153.77 -164.78 31.35 Favored Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 32.2 p -145.28 158.89 43.72 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.533 HD12 ' HB ' ' A' ' 78' ' ' ILE . 78.4 mt -73.08 157.13 37.9 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 121.209 0.528 . . . . 0.0 111.611 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.401 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 14.6 p -90.4 139.16 18.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.238 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.4 93.82 0.46 Allowed Glycine 0 C--N 1.3 -1.447 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.784 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 67.3 p 60.36 83.15 0.14 Allowed 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 125.697 1.599 . . . . 0.0 113.998 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.88 -160.06 33.61 Favored Glycine 0 N--CA 1.429 -1.785 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.0 t -118.89 142.0 48.15 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.401 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 4.4 t -134.87 138.87 44.56 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.577 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.9 m -91.04 126.24 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 173.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.8 mt -103.04 145.18 30.28 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.718 -176.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -100.79 116.33 32.42 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.175 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.403 ' HA ' ' HD2' ' A' ' 116' ' ' PRO . 29.2 m -126.74 117.77 22.56 Favored Pre-proline 0 C--N 1.316 -0.864 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 177.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 115' ' ' VAL . 33.4 Cg_endo -66.37 124.5 12.58 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.625 2.216 . . . . 0.0 111.579 174.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 97.3 t -124.67 141.01 46.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 120.854 0.359 . . . . 0.0 110.155 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.75 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -87.8 102.12 14.36 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.988 0.899 . . . . 0.0 111.045 178.275 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.429 ' HB ' HG13 ' A' ' 62' ' ' VAL . 48.1 t -97.6 148.39 5.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.462 ' HB2' ' OXT' ' A' ' 174' ' ' PHE . . . 75.07 -14.96 0.7 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.909 0.883 . . . . 0.0 111.932 -178.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.409 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 34.4 t80 -56.06 -58.13 9.23 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 124.119 0.967 . . . . 0.0 109.961 -175.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.494 ' OG ' ' HB2' ' A' ' 95' ' ' ALA . 41.4 m -74.93 -26.84 59.91 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.96 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.429 HG21 ' HG2' ' A' ' 129' ' ' LYS . 58.4 mt -71.47 -50.24 41.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.116 -173.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.61 -49.37 75.49 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 123.516 0.51 . . . . 0.0 110.363 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 52.2 t -57.9 -39.39 71.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.217 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.8 t -82.25 -82.6 0.13 Allowed 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 128' ' ' MET . 2.0 pp -125.6 -27.0 3.45 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -173.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.445 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.1 tpt 69.9 125.76 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.955 0.902 . . . . 0.0 111.458 -174.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.429 ' HG2' HG21 ' A' ' 123' ' ' ILE . 27.0 mmmt -72.34 -36.28 68.78 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-O 122.057 0.932 . . . . 0.0 110.431 -177.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.8 t70 78.0 76.05 0.06 Allowed 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 112.072 -2.331 . . . . 0.0 106.512 -171.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.512 ' HG2' ' CD1' ' A' ' 135' ' ' TRP . 5.8 tmm? -69.69 114.69 8.13 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 112.859 -1.973 . . . . 0.0 109.599 -171.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 55.6 m -91.2 -179.67 5.48 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.124 -174.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 22.4 p -80.2 105.1 11.22 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-O 121.839 0.828 . . . . 0.0 110.785 178.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.5 t70 78.24 98.52 0.06 Allowed 'General case' 0 CA--C 1.487 -1.456 0 C-N-CA 126.553 1.941 . . . . 0.0 107.555 -170.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.512 ' CD1' ' HG2' ' A' ' 131' ' ' MET . 32.9 t-105 -148.89 148.45 29.86 Favored 'General case' 0 C--N 1.276 -2.591 0 CA-C-N 113.976 -1.466 . . . . 0.0 108.716 -171.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -125.87 141.16 52.11 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.56 132.29 54.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -105.58 109.65 21.69 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.574 ' OH ' HG11 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -113.01 172.07 7.16 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.287 -0.965 . . . . 0.0 108.971 173.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.575 ' HB2' ' HB2' ' A' ' 88' ' ' LYS . 63.2 mt-30 -118.29 130.79 56.24 Favored 'General case' 0 C--N 1.274 -2.685 0 C-N-CA 120.414 -0.514 . . . . 0.0 109.719 -174.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 35.6 tp -116.45 125.69 52.35 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.246 0.546 . . . . 0.0 112.043 -177.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.625 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 13.7 m-20 -120.0 119.69 34.16 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.472 HG23 HG23 ' A' ' 83' ' ' ILE . 42.4 mm -112.97 123.75 68.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -96.13 103.85 3.0 Favored Glycine 0 N--CA 1.418 -2.514 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 176.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 156' ' ' THR . 2.9 mm? -76.83 101.75 6.01 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 123.195 0.598 . . . . 0.0 110.026 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.9 m -91.37 115.58 28.14 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.101 0.477 . . . . 0.0 111.487 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.567 ' CE2' ' HB3' ' A' ' 145' ' ' LEU . 60.4 m-85 -126.67 153.03 45.94 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -158.31 140.83 14.43 Favored 'General case' 0 CA--C 1.479 -1.762 0 CA-C-O 121.463 0.649 . . . . 0.0 112.221 173.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 50.0 mm -121.6 128.31 25.69 Favored Pre-proline 0 C--N 1.292 -1.911 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -46.73 -43.55 23.22 Favored 'Trans proline' 0 N--CA 1.483 0.907 0 C-N-CA 123.633 2.889 . . . . 0.0 114.207 -176.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.18 -52.49 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 121.722 0.772 . . . . 0.0 109.313 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.467 HG22 ' HD3' ' A' ' 38' ' ' LYS . 7.2 p 173.04 140.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 C-N-CA 125.488 1.515 . . . . 0.0 107.072 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.455 ' H ' ' H ' ' A' ' 154' ' ' ASP . . . 150.54 15.22 0.08 OUTLIER Glycine 0 C--N 1.291 -1.969 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -177.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.455 ' H ' ' H ' ' A' ' 153' ' ' GLY . 10.6 p-10 -73.21 118.05 15.69 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 126.031 1.733 . . . . 0.0 110.254 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.538 HG12 HD11 ' A' ' 39' ' ' LEU . 8.2 tp -162.59 144.14 3.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.499 -178.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 96.3 m -123.02 104.1 9.01 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 166.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 58.2 mt -87.88 112.94 52.3 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.328 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 156' ' ' THR . 26.9 Cg_endo -84.06 111.07 1.61 Allowed 'Trans proline' 0 N--CA 1.436 -1.864 0 C-N-CA 122.214 1.943 . . . . 0.0 111.587 176.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.4 m -106.49 134.95 46.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.409 ' HB3' ' OD1' ' A' ' 142' ' ' ASP . 29.6 p -126.1 157.44 38.03 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -175.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.475 HG22 HG13 ' A' ' 49' ' ' VAL . 14.6 t -170.47 170.67 6.85 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 176.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -99.67 132.19 45.17 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -101.72 104.64 2.71 Favored Glycine 0 N--CA 1.415 -2.73 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -90.04 119.46 30.41 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.53 HD11 ' CE1' ' A' ' 139' ' ' TYR . 5.7 mm -106.82 119.08 55.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 -174.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 62.9 tttp -92.99 117.72 30.38 Favored 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.153 175.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 95.6 mt -108.44 93.1 10.97 Favored Pre-proline 0 C--N 1.284 -2.26 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.841 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 166' ' ' LYS . 10.0 Cg_endo -86.42 82.34 1.36 Allowed 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 122.885 2.39 . . . . 0.0 112.861 -174.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 79.3 p 55.91 15.9 1.89 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.083 1.353 . . . . 0.0 113.777 177.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 49.7 tp -59.57 -56.68 18.86 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.134 0.574 . . . . 0.0 111.238 -176.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.438 ' O ' ' HD1' ' A' ' 173' ' ' PHE . 47.8 mtm105 65.28 145.24 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 179.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 76.79 -4.68 2.31 Favored 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 124.794 1.237 . . . . 0.0 114.023 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.438 ' HD1' ' O ' ' A' ' 171' ' ' ARG . 27.1 m-85 -111.57 -66.69 1.06 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.472 ' HB3' ' HG3' ' A' ' 131' ' ' MET 0.331 8.4 p90 . . . . . 0 C--O 1.26 1.622 0 C-N-CA 126.03 1.732 . . . . 0.0 114.244 -178.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.422 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -142.63 101.14 3.81 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -162.09 98.42 1.05 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.313 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -130.18 -175.27 3.57 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.345 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 61.3 t60 74.67 -29.82 0.2 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.647 1.579 . . . . 0.0 113.843 175.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -74.07 77.62 1.73 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.738 0.78 . . . . 0.0 112.508 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.2 p80 177.47 97.05 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 125.914 1.686 . . . . 0.0 107.749 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -72.82 -48.47 37.64 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -116.11 -57.87 2.16 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.544 171.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -155.75 -60.94 0.11 Allowed 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.481 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.485 ' HB3' ' HB2' ' A' ' 14' ' ' GLU . 67.7 m -87.46 98.52 11.43 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -176.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -101.75 -47.86 4.48 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 172.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -68.12 -43.35 78.59 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.051 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 11' ' ' SER . 1.5 mp0 -66.81 -31.1 71.5 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.386 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -74.51 -41.0 61.44 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -176.283 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.6 m -66.83 -29.44 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.1 m -73.03 -29.59 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.86 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 48.6 mt-10 -69.09 -34.59 75.35 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 176.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 7.7 mm-40 -59.25 -46.98 87.04 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.58 175.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.16 -45.45 93.36 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.653 177.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.15 -36.33 77.31 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.739 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.4 t -65.45 -35.55 81.25 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.82 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 91.2 t -70.71 -33.29 52.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.573 0.702 . . . . 0.0 110.027 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.578 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 59.0 mt -69.56 -40.98 80.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 174.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.1 m -66.86 -29.0 68.79 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.106 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.3 p -70.54 -34.78 72.66 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 120.914 0.388 . . . . 0.0 110.532 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.413 ' HB3' HG21 ' A' ' 156' ' ' THR 0.263 7.9 mp -79.38 -18.57 52.07 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 119.227 -0.989 . . . . 0.0 112.991 172.129 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 81.2 mt -68.62 -34.24 75.41 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 171.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.48 -40.45 70.23 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.324 176.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -52.01 -59.75 3.99 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.986 173.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 35' ' ' PHE . . . -59.75 -39.9 86.34 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.365 177.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -55.36 -31.96 62.18 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 123.345 0.658 . . . . 0.0 111.165 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.484 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -95.36 -77.83 1.38 Allowed Glycine 0 N--CA 1.425 -2.044 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.975 177.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 48.1 t80 -63.64 -39.96 95.67 Favored 'General case' 0 C--O 1.209 -1.074 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -174.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.488 ' HA ' HD23 ' A' ' 39' ' ' LEU . 82.1 t80 -69.87 -42.42 73.53 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 118.25 -1.38 . . . . 0.0 111.016 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 40' ' ' ALA . . . -62.07 -44.68 96.15 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 33' ' ' GLY . 14.3 pt-20 -94.74 -41.74 9.1 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -176.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 34' ' ' PHE . 15.2 tppt? -75.32 -45.4 39.82 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 121.824 0.821 . . . . 0.0 109.28 -173.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.502 HD11 HG21 ' A' ' 152' ' ' VAL . 3.8 mm? -86.8 7.29 27.58 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.297 -1.319 . . . . 0.0 112.82 -174.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 36' ' ' ALA . . . -76.02 -10.6 59.55 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.606 0.717 . . . . 0.0 109.843 176.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -112.99 2.12 15.65 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.117 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.4 mp -124.45 118.11 26.37 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -71.61 94.11 0.69 Allowed 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 122.36 2.04 . . . . 0.0 112.927 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.496 ' HB ' ' HD2' ' A' ' 45' ' ' PRO . 21.8 p -91.5 170.59 9.3 Favored Pre-proline 0 C--N 1.307 -1.248 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.414 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.496 ' HD2' ' HB ' ' A' ' 44' ' ' THR . 55.6 Cg_endo -65.36 146.78 86.55 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.559 1.506 . . . . 0.0 110.547 174.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -97.45 126.11 42.52 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.539 ' O ' HG11 ' A' ' 159' ' ' VAL . . . -97.38 146.13 25.48 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.8 t -161.23 120.85 2.6 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.075 0.464 . . . . 0.0 110.712 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -83.84 138.02 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -97.51 -59.01 1.87 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.106 -1.037 . . . . 0.0 110.922 -168.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -173.85 -178.04 1.49 Allowed 'General case' 0 C--O 1.249 1.052 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.661 HG22 ' HB3' ' A' ' 64' ' ' TYR . 7.6 p -130.53 132.35 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.907 0 CA-C-O 121.315 0.579 . . . . 0.0 109.52 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -107.97 136.31 47.89 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.238 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.661 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 45.5 p90 -92.08 141.18 28.88 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.416 ' N ' ' HD3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -124.74 -70.36 0.76 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.066 0.46 . . . . 0.0 110.881 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -112.36 -165.11 17.03 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.984 -174.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.466 ' HB ' ' CD2' ' A' ' 173' ' ' PHE . 13.6 p -117.92 159.99 17.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.129 -0.536 . . . . 0.0 110.042 -176.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 34.0 m -148.19 152.22 36.87 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 173.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.0 ttt-85 -58.94 -40.85 85.89 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.403 0.621 . . . . 0.0 110.446 177.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -117.13 94.39 4.55 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.414 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . 98.3 166.42 31.24 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.57 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.8 t -104.4 148.73 8.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.46 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 29.6 t70 -84.85 107.01 16.79 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.127 0.489 . . . . 0.0 111.877 -175.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.661 ' HB3' HG22 ' A' ' 52' ' ' VAL . 28.7 m-85 -117.46 158.16 24.99 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.768 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -133.18 112.92 12.12 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.528 ' HB3' HG13 ' A' ' 115' ' ' VAL . . . -90.41 144.66 25.59 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -177.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.8 mtmp? -104.34 119.52 39.15 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.93 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.0 t -117.61 109.05 26.22 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.415 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.2 m -100.43 143.28 30.81 Favored 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 119.769 -0.772 . . . . 0.0 111.049 -175.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.31 119.14 51.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -96.28 109.69 22.14 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.584 ' ND2' HD21 ' A' ' 105' ' ' LEU . 6.5 t30 -123.02 115.23 29.2 Favored Pre-proline 0 C--N 1.292 -1.924 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -171.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -97.74 96.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.672 0 C-N-CA 121.742 1.628 . . . . 0.0 110.871 172.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.572 ' HB2' HD21 ' A' ' 72' ' ' ASN . 61.3 m-85 -175.84 119.25 0.16 Allowed 'General case' 0 CA--C 1.488 -1.414 0 C-N-CA 128.086 2.555 . . . . 0.0 105.152 178.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.4 m -69.85 -18.1 63.41 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 123.553 0.533 . . . . 0.0 112.108 -177.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -80.18 134.45 36.14 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-O 121.072 0.463 . . . . 0.0 110.726 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.2 p -80.01 97.19 6.68 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.563 ' HB ' HD13 ' A' ' 105' ' ' LEU . 42.3 mt -81.88 127.05 73.68 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -177.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.73 123.38 13.67 Favored 'Trans proline' 0 C--O 1.241 0.675 0 C-N-CA 122.588 2.192 . . . . 0.0 110.827 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.425 HG12 ' CE2' ' A' ' 147' ' ' PHE . 60.7 mt -69.77 103.51 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-O 121.309 0.576 . . . . 0.0 109.95 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 49.2 t -66.78 -56.82 8.73 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.885 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.555 ' HG3' ' CG2' ' A' ' 98' ' ' THR . 25.8 tt0 -152.24 130.17 11.75 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -175.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.6 mm -118.84 113.91 43.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 170.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 98' ' ' THR . 12.3 t -118.5 142.69 47.34 Favored 'General case' 0 C--N 1.288 -2.085 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.317 -174.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -128.27 144.57 51.14 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 121.301 0.572 . . . . 0.0 111.442 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.433 ' HB ' ' HB2' ' A' ' 142' ' ' ASP . 56.0 mt -120.9 119.65 60.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 174.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.626 HD13 ' HB3' ' A' ' 95' ' ' ALA . 0.4 OUTLIER -103.09 122.29 44.36 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 178.578 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.593 ' HB2' ' HB2' ' A' ' 140' ' ' GLN . 98.5 mttt -123.21 157.3 33.36 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.678 175.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.8 t -152.24 109.02 3.48 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.409 ' O ' ' HB ' ' A' ' 91' ' ' THR . . . 68.6 -77.49 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.232 1.013 . . . . 0.0 110.993 -177.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.409 ' HB ' ' O ' ' A' ' 90' ' ' ALA . 9.0 t 172.5 -28.71 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.155 0.582 . . . . 0.0 110.438 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -64.85 -56.93 10.47 Favored 'General case' 0 C--N 1.345 0.392 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -174.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 51.3 m -125.22 143.92 50.71 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.911 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.556 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 2.1 pp -141.37 178.64 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.209 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -176.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.626 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -135.95 147.11 47.93 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 172.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 39.1 t -131.44 153.12 50.06 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -176.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.46 165.48 36.94 Favored Glycine 0 N--CA 1.426 -1.992 0 C-N-CA 119.697 -1.24 . . . . 0.0 112.131 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.555 ' CG2' ' HG3' ' A' ' 82' ' ' GLN . 86.7 m -149.99 131.72 15.0 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 99' ' ' ILE . 2.8 mp -107.6 115.86 58.57 Favored Pre-proline 0 C--O 1.248 0.996 0 C-N-CA 119.071 -1.052 . . . . 0.0 109.77 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.28 114.75 3.81 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.021 1.814 . . . . 0.0 109.604 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.3 t70 55.15 77.94 0.41 Allowed Pre-proline 0 N--CA 1.482 1.175 0 C-N-CA 124.068 0.947 . . . . 0.0 111.285 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -92.62 3.61 3.62 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.576 2.184 . . . . 0.0 111.875 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 175.32 -157.38 24.02 Favored Glycine 0 N--CA 1.424 -2.166 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.9 p -136.48 139.53 42.39 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 117.196 0.498 . . . . 0.0 110.847 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.584 HD21 ' ND2' ' A' ' 72' ' ' ASN . 7.3 tt -69.67 127.16 32.0 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.818 178.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.496 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 7.3 p -52.74 -45.3 49.16 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -173.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.566 ' H ' HD23 ' A' ' 105' ' ' LEU . . . 86.01 82.86 1.1 Allowed Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 109.201 -1.559 . . . . 0.0 109.201 -172.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.6 m 62.18 90.32 0.07 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.402 1.081 . . . . 0.0 112.561 -176.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 155.19 -173.96 33.4 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 176.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.7 m -108.1 123.66 49.04 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.496 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 3.6 t -117.41 132.01 56.65 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.087 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.6 t -95.99 109.98 23.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.1 mt -91.44 167.1 12.5 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -144.77 149.05 34.83 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.562 -174.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.528 HG13 ' HB3' ' A' ' 66' ' ' ALA . 4.4 p -136.6 127.18 16.36 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.69 176.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.17 113.12 3.6 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.971 1.78 . . . . 0.0 108.774 171.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.1 t -123.1 126.04 72.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -175.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.46 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 14.3 mmmm -88.51 103.93 16.34 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.335 -0.946 . . . . 0.0 108.492 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.626 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 97.5 t -93.72 146.13 6.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.988 -173.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 78.0 -5.93 2.03 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.952 1.301 . . . . 0.0 110.516 -176.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.503 ' O ' HG23 ' A' ' 125' ' ' VAL . 82.4 t80 -58.07 -57.11 14.29 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.825 176.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.2 m -56.27 -39.34 72.47 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.758 -176.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 10.8 tp -77.83 -30.21 16.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.244 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -66.67 -42.64 86.25 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 172.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 121' ' ' TYR . 68.9 t -57.35 -33.19 43.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.529 175.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -75.49 -81.07 0.08 Allowed 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.0 176.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.469 HD23 ' H ' ' A' ' 127' ' ' LEU . 1.9 pt? -126.65 -22.83 3.84 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -177.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.427 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER 70.13 121.83 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -170.234 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.624 ' C ' ' H ' ' A' ' 131' ' ' MET . 0.0 OUTLIER -59.48 -32.31 70.14 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -172.689 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.8 t70 80.95 -16.41 0.65 Allowed 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 -169.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.624 ' H ' ' C ' ' A' ' 129' ' ' LYS 0.343 13.9 tmm? 72.32 -102.1 0.03 OUTLIER 'General case' 0 N--CA 1.416 -2.131 0 C-N-CA 128.456 2.702 . . . . 0.0 113.277 175.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 131' ' ' MET . 48.7 t 150.58 -138.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 102.682 -3.081 . . . . 0.0 102.682 -175.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.9 p -133.92 99.1 4.34 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 164.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.67 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 16.2 t70 71.86 92.73 0.08 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.663 1.185 . . . . 0.0 112.805 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.442 ' HE1' ' HA ' ' A' ' 131' ' ' MET . 1.2 p-90 -154.96 159.77 40.64 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 176.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 166' ' ' LYS . 5.7 p-10 -103.55 142.49 34.2 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.22 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.55 HD12 HD21 ' A' ' 167' ' ' LEU . 0.2 OUTLIER -115.62 158.28 16.06 Favored 'Isoleucine or valine' 0 C--O 1.248 1.013 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.763 177.854 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.66 115.37 10.77 Favored 'General case' 0 C--O 1.252 1.204 0 CA-C-O 121.635 0.731 . . . . 0.0 112.186 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -133.39 151.35 51.82 Favored 'General case' 0 N--CA 1.411 -2.384 0 CA-C-N 114.02 -1.446 . . . . 0.0 107.989 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.593 ' HB2' ' HB2' ' A' ' 88' ' ' LYS . 58.1 mt-30 -139.45 150.2 44.92 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.8 tp -139.18 118.96 13.17 Favored 'General case' 0 N--CA 1.419 -1.989 0 O-C-N 124.002 0.814 . . . . 0.0 109.822 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.433 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 22.6 m-20 -122.31 136.35 54.89 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.5 mm -122.05 129.29 75.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.567 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -117.91 88.0 0.44 Allowed Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 176.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 156' ' ' THR . 2.3 pp -84.31 149.2 26.22 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.825 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.461 ' HB ' ' HB3' ' A' ' 82' ' ' GLN . 8.7 m -127.02 120.59 29.39 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -176.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.425 ' CE2' HG12 ' A' ' 80' ' ' ILE . 68.9 m-85 -132.67 141.66 48.71 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -108.46 124.79 50.96 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.634 0.731 . . . . 0.0 110.709 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.483 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -124.88 125.84 25.36 Favored Pre-proline 0 C--N 1.297 -1.711 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.058 178.516 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -41.06 -34.21 1.43 Allowed 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 124.915 3.744 . . . . 0.0 115.88 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 13.5 p -59.3 -35.22 56.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.502 HG21 HD11 ' A' ' 39' ' ' LEU . 31.3 m -132.03 -25.66 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 121.875 -0.516 . . . . 0.0 112.355 -178.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 111.04 -141.7 16.58 Favored Glycine 0 N--CA 1.421 -2.346 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -177.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -92.41 120.42 32.89 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.908 0.385 . . . . 0.0 111.456 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 2.3 pp -130.35 146.24 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.356 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 174.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 4.6 p -95.32 151.06 19.58 Favored 'General case' 0 N--CA 1.397 -3.088 0 CA-C-N 113.978 -1.465 . . . . 0.0 109.98 174.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 57.4 mt -125.34 110.35 26.37 Favored Pre-proline 0 C--N 1.295 -1.787 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 176.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.447 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 97.3 Cg_endo -89.88 114.58 0.57 Allowed 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 123.005 2.47 . . . . 0.0 113.662 -174.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.539 HG11 ' O ' ' A' ' 47' ' ' ALA . 29.1 m -118.13 128.16 75.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.955 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 63.0 p -114.24 144.2 43.61 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.931 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 53.3 m -153.13 136.69 15.95 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 121.114 0.483 . . . . 0.0 110.098 -177.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -98.99 119.47 37.83 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -100.53 115.05 5.19 Favored Glycine 0 N--CA 1.411 -2.974 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.399 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -89.71 118.6 29.44 Favored 'General case' 0 C--N 1.27 -2.86 0 N-CA-C 105.601 -1.999 . . . . 0.0 105.601 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 136' ' ' ASP . 50.3 mm -112.95 108.68 26.16 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.442 -172.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 136' ' ' ASP . 60.5 pttt -86.54 133.65 33.72 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.015 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 134' ' ' ASP . 0.4 OUTLIER -103.41 96.91 9.22 Favored Pre-proline 0 C--N 1.295 -1.779 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 173.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.66 78.84 0.95 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.28 1.987 . . . . 0.0 113.62 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 76.2 p 39.26 79.55 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.707 1.603 . . . . 0.0 114.291 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.516 ' H ' ' HE2' ' A' ' 131' ' ' MET . 2.5 mm? -103.65 -61.84 1.37 Allowed 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.004 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 70.22 4.86 5.06 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 121.31 0.576 . . . . 0.0 112.177 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -136.29 -41.19 0.64 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.339 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.466 ' CD2' ' HB ' ' A' ' 57' ' ' VAL . 3.0 m-85 -81.04 -43.43 19.55 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 176.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.4 -2.953 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.187 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -130.88 98.94 4.75 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.369 0.604 . . . . 0.0 110.609 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -121.27 100.96 7.34 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.496 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -101.45 101.78 12.45 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.741 0.781 . . . . 0.0 112.709 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -151.71 140.35 20.74 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 102.625 -3.102 . . . . 0.0 102.625 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . 0.37 24.1 p-80 -75.63 72.6 2.59 Favored 'General case' 0 C--O 1.217 -0.607 0 N-CA-C 116.353 1.982 . . . . 0.0 116.353 -169.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -136.61 75.14 1.52 Allowed 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.478 171.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.43 ' O ' HD22 ' A' ' 8' ' ' LEU 0.286 0.0 OUTLIER -135.9 83.0 1.98 Allowed 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.875 176.116 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 64.09 18.34 11.17 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 113.502 -1.681 . . . . 0.0 109.666 -173.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.99 142.02 50.99 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.883 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.8 m 71.6 -38.89 0.43 Allowed 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 124.439 1.096 . . . . 0.0 111.78 -175.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.37 -39.73 89.31 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 173.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.447 ' O ' HG23 ' A' ' 17' ' ' VAL . 24.2 t70 -60.54 -29.79 69.35 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.146 177.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -77.78 -50.42 12.37 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.021 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.425 ' HD3' ' C ' ' A' ' 15' ' ' LYS . 12.7 tmtt? -57.32 -47.15 82.27 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.771 1.229 . . . . 0.0 112.539 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.0 m -63.22 -21.82 29.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 94' ' ' ILE . 92.8 t -67.34 -49.02 75.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 120.913 0.387 . . . . 0.0 110.14 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.95 -33.61 72.15 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.509 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -77.12 -39.26 50.04 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.831 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -75.45 -35.44 60.91 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 120.747 0.308 . . . . 0.0 111.0 -177.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.78 -35.78 73.36 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.46 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.4 t -63.08 -44.85 94.61 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.915 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.3 t -65.34 -48.55 82.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.965 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.547 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 64.0 mt -61.21 -44.62 98.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.238 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.7 m -62.95 -37.83 88.63 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.677 0.275 . . . . 0.0 111.161 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.5 m -66.03 -36.49 83.38 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.788 0.328 . . . . 0.0 110.629 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.423 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 5.0 tt -67.11 -43.21 83.06 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 83.5 mt -57.78 -46.46 84.55 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.661 177.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.74 -44.12 97.08 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.52 ' HD2' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -64.83 -33.24 75.53 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.583 -178.747 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.52 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -79.38 -40.44 30.11 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.396 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -51.07 -52.65 41.34 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.381 1.073 . . . . 0.0 112.598 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.38 -17.88 79.61 Favored Glycine 0 C--N 1.318 -0.439 0 C-N-CA 120.026 -1.083 . . . . 0.0 112.02 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -75.39 -26.23 58.28 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 123.448 0.699 . . . . 0.0 109.952 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.404 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 27.2 m-85 -79.15 -12.08 59.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -178.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.29 -51.35 70.34 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -174.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.657 ' HG2' ' HD3' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -117.27 -43.45 2.83 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -178.387 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.657 ' HD3' ' HG2' ' A' ' 37' ' ' GLU . 3.7 mppt? -64.52 -34.28 77.87 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.271 -175.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.413 HD13 ' HB ' ' A' ' 42' ' ' ILE . 2.8 mm? -102.95 17.97 22.73 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.725 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.83 -28.07 16.08 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 171.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -94.47 -48.31 6.17 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.815 175.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.413 ' HB ' HD13 ' A' ' 39' ' ' LEU . 75.1 mt -73.99 121.29 84.84 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.96 114.38 3.72 Favored 'Trans proline' 0 C--O 1.246 0.925 0 C-N-CA 122.445 2.097 . . . . 0.0 113.518 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.403 HG23 HD12 ' A' ' 39' ' ' LEU . 23.3 p -114.33 140.41 25.05 Favored Pre-proline 0 N--CA 1.429 -1.498 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.868 173.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -56.12 138.95 84.6 Favored 'Trans proline' 0 C--O 1.24 0.603 0 C-N-CA 122.465 2.11 . . . . 0.0 111.418 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -96.45 109.9 22.36 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-O 121.327 0.584 . . . . 0.0 110.251 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.437 ' CB ' ' HG ' ' A' ' 145' ' ' LEU . . . -98.8 140.26 33.24 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.617 -178.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.5 t -141.98 133.7 27.01 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.315 177.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.554 HG22 HG22 ' A' ' 159' ' ' VAL . 24.3 m -89.45 141.61 14.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -130.93 -48.44 1.02 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -170.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -161.99 169.57 20.85 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.822 -171.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 65' ' ' HIS . 13.0 m -132.24 112.73 20.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.487 0.66 . . . . 0.0 111.562 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -92.34 129.5 38.27 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.243 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -59.27 138.26 57.67 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.982 0.176 . . . . 0.0 111.01 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.592 ' HD3' ' C ' ' A' ' 55' ' ' LYS . 11.7 tmtt? -119.44 -55.7 2.11 Favored 'General case' 0 N--CA 1.411 -2.413 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.033 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.483 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . -176.63 -170.87 39.72 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 118.865 -1.636 . . . . 0.0 113.432 -173.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.6 p -102.61 151.99 5.85 Favored 'Isoleucine or valine' 0 C--O 1.249 1.057 0 CA-C-O 121.709 0.766 . . . . 0.0 112.308 -172.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.764 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 31.3 m -159.97 159.41 32.18 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 103.047 -2.946 . . . . 0.0 103.047 173.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.483 ' HA ' ' CE2' ' A' ' 174' ' ' PHE . 34.1 mtm180 -73.15 134.24 44.36 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 118.954 -1.099 . . . . 0.0 110.235 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 76.39 -66.21 0.27 Allowed 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 125.533 1.533 . . . . 0.0 110.989 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.764 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . -107.52 128.22 9.11 Favored Glycine 0 CA--C 1.479 -2.191 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 56' ' ' GLY . 35.5 m -99.75 152.83 4.54 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.425 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 45.8 m-20 -81.12 131.11 35.28 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -174.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -132.14 156.69 45.93 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 125.069 1.347 . . . . 0.0 109.491 174.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.435 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 18.0 m-70 -95.68 108.31 20.59 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 173.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.423 ' HA ' HG12 ' A' ' 52' ' ' VAL . . . -81.68 122.06 27.15 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 170.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -86.27 107.95 18.18 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.788 -174.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.6 t -114.02 109.17 27.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 56.3 p -103.05 128.74 49.79 Favored 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.555 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.2 t -114.66 120.58 64.72 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.262 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 36.2 ttpt -95.88 110.24 22.46 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 175.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -103.6 113.35 65.63 Favored Pre-proline 0 C--N 1.293 -1.878 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.853 -175.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -99.43 97.25 0.05 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.685 0 C-N-CA 122.007 1.805 . . . . 0.0 108.958 169.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -179.35 153.74 0.6 Allowed 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 102.951 -2.981 . . . . 0.0 102.951 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.1 t -79.22 -35.42 41.67 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -172.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -89.45 157.78 17.98 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.796 -0.762 . . . . 0.0 112.218 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.4 m -85.73 111.26 19.97 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 173.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.6 mt -87.97 128.95 52.03 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -175.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -87.19 118.86 1.41 Allowed 'Trans proline' 0 N--CA 1.433 -2.032 0 C-N-CA 122.098 1.865 . . . . 0.0 111.255 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.7 pt -72.04 113.06 8.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 48.5 t -58.43 -47.38 84.12 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.513 ' O ' ' HB ' ' A' ' 146' ' ' THR . 5.0 pp0? -156.29 157.95 36.64 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 174.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.485 ' CG2' HG23 ' A' ' 99' ' ' ILE . 11.8 tt -124.74 127.58 72.8 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.354 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 175.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.4 m -80.64 128.91 34.16 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-O 121.625 0.726 . . . . 0.0 110.963 -171.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -104.23 119.42 38.91 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.458 -175.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.0 mp -131.05 107.05 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 172.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.643 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 1.6 tm? -100.06 130.05 46.17 Favored 'General case' 0 C--N 1.268 -2.943 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -122.29 161.29 23.59 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.5 m -149.97 146.18 26.88 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -41.17 -71.42 0.08 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -174.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.558 ' C ' ' HD2' ' A' ' 92' ' ' ARG . 4.9 t -150.86 80.17 1.32 Allowed 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.558 ' HD2' ' C ' ' A' ' 91' ' ' THR . 3.8 mpt_? -140.0 -63.89 0.49 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 172.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.2 t 179.75 -174.18 0.24 Allowed 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.643 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 38.4 pt -132.1 -174.92 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . . . -132.0 130.33 41.28 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 33.5 p -106.25 179.68 4.2 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.789 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.02 170.14 12.77 Favored Glycine 0 N--CA 1.421 -2.355 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.005 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.9 p -134.46 128.96 34.5 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.485 HG23 ' CG2' ' A' ' 83' ' ' ILE . 7.5 tt -102.8 111.22 64.71 Favored Pre-proline 0 C--N 1.307 -1.255 0 C-N-CA 118.767 -1.173 . . . . 0.0 110.873 177.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.92 118.06 5.14 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 123.321 2.68 . . . . 0.0 113.563 -175.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.3 t70 45.19 79.15 0.35 Allowed Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 125.551 1.541 . . . . 0.0 113.546 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.428 ' HG3' ' CG2' ' A' ' 83' ' ' ILE . 68.4 Cg_endo -92.68 3.2 3.65 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.747 2.298 . . . . 0.0 111.915 175.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 165.85 -177.28 41.06 Favored Glycine 0 N--CA 1.427 -1.961 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.7 m -143.12 150.05 38.95 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.417 HD23 ' H ' ' A' ' 105' ' ' LEU . 0.4 OUTLIER -103.51 142.76 33.72 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.235 -178.733 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.3 m -80.18 165.77 2.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 O-C-N 124.123 0.89 . . . . 0.0 110.504 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.39 133.16 11.56 Favored Glycine 0 N--CA 1.427 -1.902 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.7 p 54.78 75.85 0.28 Allowed 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 124.548 1.139 . . . . 0.0 113.015 -177.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.81 174.84 36.44 Favored Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.792 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 9.0 t -101.83 136.49 41.58 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.7 t -135.82 131.23 35.14 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 121.228 0.537 . . . . 0.0 110.204 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.3 t -95.74 119.28 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.7 mt -102.73 146.96 27.45 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.262 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -113.0 112.69 24.33 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.522 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 28.8 m -112.61 127.25 27.08 Favored Pre-proline 0 C--N 1.305 -1.364 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.249 175.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 12.8 Cg_exo -69.65 111.2 2.72 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.236 1.957 . . . . 0.0 110.598 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.7 t -108.91 134.47 50.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.904 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -91.25 102.19 14.9 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.0 m -93.07 140.12 16.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.388 -174.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 68.55 11.29 8.3 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.749 1.22 . . . . 0.0 109.852 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.414 ' O ' HG12 ' A' ' 125' ' ' VAL . 84.1 t80 -61.04 -44.13 97.86 Favored 'General case' 0 CA--C 1.485 -1.526 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.74 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.1 m -64.8 -31.56 72.84 Favored 'General case' 0 N--CA 1.436 -1.144 0 O-C-N 123.555 0.534 . . . . 0.0 111.878 -177.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 128' ' ' MET . 49.4 mt -77.33 -49.5 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.568 ' HA ' ' CA ' ' A' ' 128' ' ' MET . . . -66.95 -43.78 82.25 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -177.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 121' ' ' TYR . 8.1 p -65.21 -26.24 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.075 0.464 . . . . 0.0 110.079 -177.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.1 t -79.49 -62.17 1.77 Allowed 'General case' 0 N--CA 1.416 -2.167 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.418 HD23 ' H ' ' A' ' 127' ' ' LEU . 1.4 pt? -125.71 -64.19 1.08 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.886 176.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.568 ' CA ' ' HA ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER 173.84 151.21 0.09 Allowed 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 103.352 -2.833 . . . . 0.0 103.352 178.846 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.486 ' N ' ' SD ' ' A' ' 128' ' ' MET . 83.5 mttt -51.4 -51.25 56.3 Favored 'General case' 0 CA--C 1.465 -2.323 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 34.7 t70 174.54 -38.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 125.55 1.782 . . . . 0.0 111.555 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.609 ' HA ' ' CE ' ' A' ' 131' ' ' MET 0.33 2.7 mmt 64.05 99.16 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -171.394 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 84.4 m -156.03 179.87 8.8 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 173.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.461 ' CA ' ' HA ' ' A' ' 169' ' ' SER . 35.3 p -117.49 102.04 8.87 Favored 'General case' 0 N--CA 1.392 -3.354 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 172.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.6 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 19.2 t70 87.65 97.66 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.827 1.651 . . . . 0.0 110.907 -175.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.452 ' CZ2' HD22 ' A' ' 167' ' ' LEU . 6.9 p90 -156.21 159.46 38.96 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -122.08 151.24 41.1 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.4 pp -132.73 158.69 43.34 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -74.62 99.36 3.63 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.897 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.47 ' HE1' ' CD2' ' A' ' 87' ' ' LEU . 17.7 t80 -112.96 157.84 20.99 Favored 'General case' 0 N--CA 1.416 -2.127 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.15 176.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -164.26 159.16 19.69 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 171.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.567 HD13 HG12 ' A' ' 143' ' ' ILE . 1.0 OUTLIER -125.98 152.67 45.38 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.548 177.087 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.1 111.16 14.35 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 169.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.567 HG12 HD13 ' A' ' 141' ' ' LEU . 35.0 mm -115.23 140.7 35.28 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.988 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -119.98 104.04 0.99 Allowed Glycine 0 N--CA 1.434 -1.443 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.224 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 156' ' ' THR . 4.3 mm? -72.72 108.41 5.7 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 122.551 0.341 . . . . 0.0 110.573 177.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 82' ' ' GLN . 43.0 m -101.57 108.58 20.18 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-O 121.384 0.612 . . . . 0.0 110.251 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.459 ' CE2' ' HB3' ' A' ' 145' ' ' LEU . 68.2 m-85 -109.41 136.1 49.38 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.258 3.9 p30 -115.89 110.21 18.68 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 122.233 1.016 . . . . 0.0 110.521 175.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 67.3 mt -117.33 122.31 31.19 Favored Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.36 -19.81 18.29 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 123.713 2.942 . . . . 0.0 113.629 -176.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 62.1 t -72.17 -34.41 49.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.143 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 9.2 p -123.28 -34.39 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 121.82 -153.7 16.74 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -95.34 116.37 28.68 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.407 ' O ' HD12 ' A' ' 155' ' ' ILE . 2.3 pp -126.82 134.01 67.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 55.6 m -111.06 112.12 23.7 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.478 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.9 mp -85.8 117.45 68.75 Favored Pre-proline 0 C--O 1.238 0.471 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -82.37 120.05 3.18 Favored 'Trans proline' 0 CA--C 1.484 -2.001 0 C-N-CA 122.31 2.006 . . . . 0.0 111.496 175.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.554 HG22 HG22 ' A' ' 49' ' ' VAL . 3.1 p -126.95 114.98 39.8 Favored 'Isoleucine or valine' 1 N--CA 1.376 -4.135 0 CA-C-N 112.768 -2.015 . . . . 0.0 109.137 -178.321 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 33.3 p -127.05 162.53 25.82 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.304 -173.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.0 t -169.27 155.22 6.27 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -102.26 141.15 35.56 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -147.11 155.25 26.44 Favored Glycine 0 N--CA 1.422 -2.25 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -101.77 129.99 48.09 Favored 'General case' 0 C--N 1.273 -2.74 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.333 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.432 HD11 HG21 ' A' ' 52' ' ' VAL . 37.1 mm -97.86 108.43 21.8 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.641 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 174.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -105.56 114.35 28.46 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 134' ' ' ASP . 3.3 mp -104.25 105.6 49.99 Favored Pre-proline 0 C--N 1.307 -1.272 0 O-C-N 123.633 0.583 . . . . 0.0 110.459 -174.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -73.37 99.0 1.07 Allowed 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.749 2.299 . . . . 0.0 112.354 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.461 ' HA ' ' CA ' ' A' ' 133' ' ' THR . 47.6 t 64.37 -82.27 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 125.972 1.709 . . . . 0.0 113.624 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.483 ' HB3' ' HB3' ' A' ' 173' ' ' PHE . 42.7 mt 62.66 -72.65 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.695 1.598 . . . . 0.0 112.517 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 64.45 -68.25 0.1 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.125 1.77 . . . . 0.0 111.71 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -100.08 10.37 41.37 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.404 -0.81 . . . . 0.0 110.101 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.483 ' HB3' ' HB3' ' A' ' 170' ' ' LEU . 22.2 t80 -113.92 10.24 17.61 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.483 ' CE2' ' HA ' ' A' ' 59' ' ' ARG . 75.0 m-85 . . . . . 0 CA--C 1.493 -1.228 0 CA-C-N 114.077 -1.42 . . . . 0.0 112.977 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.427 0 CA-C-O 120.238 -0.201 . . . . 0.0 113.044 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -139.95 124.44 18.07 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 117.199 0.499 . . . . 0.0 111.127 -175.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 66.43 80.46 0.22 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.913 0.885 . . . . 0.0 110.378 -176.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -83.01 95.05 7.91 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.022 -174.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.48 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . 38.9 m-70 -113.89 165.32 12.71 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.961 172.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -44.0 -59.68 2.19 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.028 1.331 . . . . 0.0 113.57 -174.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -114.99 -2.79 12.74 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.919 -178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.48 ' CB ' ' HB2' ' A' ' 5' ' ' HIS . 5.4 tt -64.5 -49.89 69.55 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -117.09 -84.06 0.64 Allowed 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 173.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.0 153.44 4.71 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.3 m -137.84 -66.76 0.49 Allowed 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.018 0.437 . . . . 0.0 109.883 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.548 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -98.57 -17.85 18.44 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.569 0.7 . . . . 0.0 109.515 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -56.58 -35.06 67.78 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.674 1.59 . . . . 0.0 110.923 -174.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.572 ' O ' ' HG3' ' A' ' 18' ' ' GLU . 9.8 pt-20 -58.25 -42.96 87.56 Favored 'General case' 0 C--O 1.206 -1.229 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.95 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.5 ' C ' ' HD2' ' A' ' 15' ' ' LYS . 3.3 tmmm? -72.02 -40.75 68.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.476 0.655 . . . . 0.0 110.004 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 12' ' ' ALA . 40.7 t -61.89 -44.57 99.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.802 -174.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.47 HG21 ' HA ' ' A' ' 95' ' ' ALA . 13.3 p -71.22 -27.7 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.99 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.572 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 47.0 mt-10 -75.64 -39.28 57.98 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.204 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.06 -37.94 89.25 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 120.7 0.286 . . . . 0.0 110.572 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -67.1 -45.48 77.08 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.959 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.59 -36.95 72.39 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.11 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.9 t -63.05 -44.9 94.56 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.445 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.06 -42.02 94.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 121.308 0.575 . . . . 0.0 110.072 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.3 mm -68.1 -44.59 84.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.391 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.44 ' HA ' HD12 ' A' ' 28' ' ' LEU . 23.2 t -61.72 -41.58 97.81 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.576 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.8 t -57.34 -37.12 72.05 Favored 'General case' 0 C--O 1.247 0.944 0 C-N-CA 122.9 0.48 . . . . 0.0 110.642 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 tt -73.7 -45.64 51.11 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 25' ' ' SER . 86.3 mt -54.1 -45.5 71.84 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.175 0.59 . . . . 0.0 111.074 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -53.86 -45.42 70.97 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -79.09 -31.73 44.44 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.269 -0.972 . . . . 0.0 111.735 -178.216 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.521 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -75.13 -32.05 61.25 Favored 'General case' 0 C--O 1.21 -1.006 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.95 -177.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -58.58 -47.05 85.6 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.045 0.45 . . . . 0.0 111.02 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.49 -32.99 67.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.124 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -74.57 -40.55 61.58 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 122.615 0.366 . . . . 0.0 110.718 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.456 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 48.6 t80 -64.48 -46.24 83.87 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.89 -14.69 63.02 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.045 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.76 -66.88 1.04 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.001 0.905 . . . . 0.0 110.947 -176.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.438 ' HE2' ' HB2' ' A' ' 38' ' ' LYS . 6.6 tppt? -74.51 -39.32 62.47 Favored 'General case' 0 CA--C 1.453 -2.782 0 CA-C-O 122.937 1.351 . . . . 0.0 107.632 -166.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.479 HD13 HD12 ' A' ' 155' ' ' ILE . 71.7 mt -89.66 0.56 56.88 Favored 'General case' 0 C--N 1.255 -3.516 0 CA-C-N 112.118 -2.31 . . . . 0.0 111.507 -171.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.12 -18.26 29.21 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 173.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -104.71 -39.91 6.17 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.187 -1.369 . . . . 0.0 109.782 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 84.1 mt -83.64 126.4 71.15 Favored Pre-proline 0 C--N 1.312 -1.037 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.73 113.08 1.22 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.987 2.458 . . . . 0.0 112.672 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.417 HG21 HD22 ' A' ' 39' ' ' LEU . 8.2 p -140.43 145.59 41.63 Favored Pre-proline 0 C--N 1.299 -1.602 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.115 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.502 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 37.5 Cg_endo -62.96 135.51 51.92 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.649 2.233 . . . . 0.0 111.888 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.27 106.34 17.98 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 -174.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -102.41 143.01 32.7 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 115.023 -0.989 . . . . 0.0 112.796 -173.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.582 ' HA ' HG21 ' A' ' 159' ' ' VAL . 11.8 t -138.32 144.15 40.26 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.002 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.497 ' HB ' HG22 ' A' ' 161' ' ' THR . 50.6 t -91.95 141.75 14.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 172.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -125.75 -46.54 1.71 Allowed 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 117.261 -1.776 . . . . 0.0 114.075 -169.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -173.96 167.11 4.33 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -172.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.548 ' HB ' ' CD2' ' A' ' 64' ' ' TYR . 2.5 m -127.9 126.71 67.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 C-N-CA 123.254 0.622 . . . . 0.0 111.437 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -104.82 144.75 31.34 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 123.766 0.826 . . . . 0.0 111.249 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.561 ' HA ' ' CE1' ' A' ' 64' ' ' TYR . 44.5 p90 -58.85 130.33 46.44 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.538 ' HD3' ' C ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -118.81 -52.06 2.34 Favored 'General case' 0 N--CA 1.391 -3.422 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -175.242 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.442 ' O ' ' HE1' ' A' ' 173' ' ' PHE . . . -145.17 -173.08 16.09 Favored Glycine 0 CA--C 1.472 -2.651 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 177.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.0 m -125.81 129.45 72.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 117.804 0.802 . . . . 0.0 110.177 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.0 m -161.15 135.5 7.11 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.33 154.44 19.22 Favored 'General case' 0 C--N 1.286 -2.186 0 C-N-CA 117.268 -1.773 . . . . 0.0 109.662 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 78.44 15.86 1.25 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 125.47 1.508 . . . . 0.0 111.042 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.407 ' HA3' ' CD2' ' A' ' 121' ' ' TYR . . . 138.16 98.41 0.46 Allowed Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.9 p -103.81 142.55 17.24 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-O 120.94 0.4 . . . . 0.0 111.475 -174.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -76.07 111.73 11.77 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 176.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.561 ' CE1' ' HA ' ' A' ' 54' ' ' PHE . 6.9 t80 -121.02 155.99 33.16 Favored 'General case' 0 N--CA 1.41 -2.47 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -169.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -90.98 108.43 19.86 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -174.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.524 ' HA ' HG12 ' A' ' 52' ' ' VAL . . . -99.42 118.69 36.59 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -94.18 125.05 38.58 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.899 -174.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.1 m -124.56 144.97 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 176.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.2 m -130.12 143.46 50.8 Favored 'General case' 0 C--N 1.268 -2.951 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.336 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.502 ' CG2' ' HB2' ' A' ' 45' ' ' PRO . 7.4 p -141.67 134.33 28.94 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.513 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 20.6 pttp -107.29 119.35 39.16 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.78 0.8 . . . . 0.0 109.843 175.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -106.87 116.3 58.89 Favored Pre-proline 0 C--N 1.28 -2.431 0 CA-C-N 114.015 -1.448 . . . . 0.0 111.495 -174.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -89.43 97.16 0.32 Allowed 'Trans proline' 0 N--CA 1.428 -2.35 0 C-N-CA 121.547 1.498 . . . . 0.0 110.943 173.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.411 ' HB3' ' H ' ' A' ' 76' ' ' GLN . 19.3 m-85 179.64 -169.07 0.11 Allowed 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 128.007 2.523 . . . . 0.0 106.15 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.501 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 48.7 m -135.3 17.37 3.41 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.411 ' H ' ' HB3' ' A' ' 74' ' ' TYR . 34.4 tt0 -112.14 128.92 56.36 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.974 -177.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.5 p -75.29 98.51 3.82 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 173.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.613 ' H ' HD11 ' A' ' 105' ' ' LEU . 69.1 mt -72.22 121.9 85.96 Favored Pre-proline 0 C--N 1.302 -1.462 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.876 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.39 139.69 29.21 Favored 'Trans proline' 0 N--CA 1.44 -1.655 0 C-N-CA 122.264 1.976 . . . . 0.0 111.584 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.637 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -84.42 134.83 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.952 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.458 178.272 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 52.8 t -82.65 -41.36 19.52 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -174.0 154.04 2.23 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.389 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.401 HD13 ' CD ' ' A' ' 102' ' ' PRO . 1.7 mp -114.61 113.86 44.93 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 173.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.443 ' OG ' HG22 ' A' ' 98' ' ' THR . 19.8 m -93.63 117.53 30.21 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -112.47 140.35 47.28 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 2.0 mp -116.94 108.01 23.87 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.887 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 174.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.539 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 1.2 tm? -90.52 120.36 31.55 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 -172.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -125.92 155.96 40.48 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -172.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.4 t -109.59 147.58 32.78 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 112.133 -2.303 . . . . 0.0 105.483 174.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -50.8 -26.26 5.47 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -176.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 87.6 m -149.65 -53.19 0.16 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -106.55 120.71 42.66 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -170.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 27.5 m 72.42 132.45 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.908 1.283 . . . . 0.0 114.306 173.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.442 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.7 pp -135.03 165.37 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.539 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . . . -119.98 156.64 30.47 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 174.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 27.2 t -160.43 148.41 16.4 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.44 165.45 35.27 Favored Glycine 0 N--CA 1.426 -1.973 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.443 HG22 ' OG ' ' A' ' 84' ' ' SER . 68.3 p -115.62 120.4 39.27 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 61.2 mt -101.87 119.81 55.87 Favored Pre-proline 0 C--N 1.305 -1.331 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.623 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.73 124.7 5.22 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.805 2.336 . . . . 0.0 111.723 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.4 ' HA ' HD11 ' A' ' 80' ' ' ILE . 30.2 t70 52.1 72.08 1.3 Allowed Pre-proline 0 N--CA 1.481 1.099 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.401 ' CD ' HD13 ' A' ' 83' ' ' ILE . 55.9 Cg_endo -103.75 6.19 0.34 Allowed 'Trans proline' 0 N--CA 1.435 -1.944 0 C-N-CA 122.768 2.312 . . . . 0.0 111.595 173.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 156.26 135.04 1.9 Allowed Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.3 m -111.89 146.73 37.21 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.771 0.319 . . . . 0.0 110.397 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.613 HD11 ' H ' ' A' ' 78' ' ' ILE . 3.3 pp -80.41 146.33 31.52 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.78 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 27.5 m -54.84 -46.09 75.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 136.93 -43.28 1.24 Allowed Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.501 ' OG ' ' HA ' ' A' ' 75' ' ' SER . 28.9 m -136.17 115.91 13.02 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 122.164 0.186 . . . . 0.0 111.276 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 105.38 -167.21 14.69 Favored Glycine 0 C--N 1.306 -1.098 0 C-N-CA 120.242 -0.98 . . . . 0.0 114.118 172.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.424 ' OG1' ' HB3' ' A' ' 71' ' ' LYS . 42.1 m -84.62 121.17 27.26 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 121.409 0.623 . . . . 0.0 110.373 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.432 HG21 ' HB2' ' A' ' 105' ' ' LEU . 5.5 t -125.94 138.22 53.75 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.5 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.3 m -94.27 128.69 45.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.412 0.625 . . . . 0.0 110.781 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.1 mt -125.56 157.92 35.88 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -143.54 141.18 30.61 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.476 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 43.0 t -112.3 130.19 23.58 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -77.61 109.89 2.85 Favored 'Trans proline' 0 N--CA 1.419 -2.862 0 N-CA-C 107.578 -1.739 . . . . 0.0 107.578 169.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.6 m -113.17 151.6 15.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -87.22 101.29 13.38 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.406 HG22 ' HB2' ' A' ' 64' ' ' TYR . 21.6 m -93.06 146.89 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.485 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -177.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 174' ' ' PHE . . . 69.35 3.56 4.2 Favored 'General case' 0 C--O 1.205 -1.238 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.597 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.407 ' CD2' ' HA3' ' A' ' 61' ' ' GLY . 8.3 t80 -67.86 -37.62 82.07 Favored 'General case' 0 C--O 1.203 -1.349 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.5 p -79.27 -29.87 42.76 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.327 0.585 . . . . 0.0 110.271 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.0 mt -79.88 -50.95 17.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.08 -174.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.35 -38.97 85.69 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 123.339 0.656 . . . . 0.0 111.028 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 121' ' ' TYR . 25.1 t -71.5 -36.34 60.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.924 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.0 t -85.01 -69.19 0.67 Allowed 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.936 -176.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.515 HD23 ' H ' ' A' ' 127' ' ' LEU . 1.9 pt? -125.09 -29.26 3.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -172.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 68.31 166.86 0.26 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.707 0.765 . . . . 0.0 112.904 -173.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.433 ' HD3' ' N ' ' A' ' 129' ' ' LYS . 1.9 mppt? -101.66 -66.31 0.93 Allowed 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 177.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 162.49 -24.85 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 -177.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.9 tpt 65.52 93.11 0.07 Allowed 'General case' 0 C--N 1.347 0.461 0 CA-C-N 112.819 -1.991 . . . . 0.0 112.367 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.55 ' HB2' ' HB2' ' A' ' 135' ' ' TRP . 77.2 m -95.1 149.79 20.9 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.575 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.825 ' HB ' ' OG ' ' A' ' 169' ' ' SER . 22.1 p -82.27 118.49 23.17 Favored 'General case' 1 N--CA 1.339 -6.021 0 C-N-CA 124.89 1.276 . . . . 0.0 107.604 175.318 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 70.57 83.05 0.15 Allowed 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -173.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.55 ' HB2' ' HB2' ' A' ' 132' ' ' CYS . 42.4 t-105 -154.89 143.53 20.65 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.125 -167.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -108.82 144.08 37.16 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 175.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.417 ' CG2' ' HB ' ' A' ' 165' ' ' ILE . 0.0 OUTLIER -139.68 130.51 32.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.53 105.02 16.52 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 122.914 1.34 . . . . 0.0 111.811 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.42 ' HD1' ' O ' ' A' ' 163' ' ' GLY . 0.1 OUTLIER -108.08 161.14 15.23 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 113.826 -1.534 . . . . 0.0 107.954 177.402 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -138.47 158.55 44.06 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 121.42 -0.8 . . . . 0.0 111.079 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.582 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 2.3 pt? -154.53 122.88 6.05 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.857 167.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -102.25 140.29 36.72 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 158' ' ' PRO . 46.7 mt -125.28 149.17 29.77 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 C-N-CA 120.321 -0.551 . . . . 0.0 111.702 -173.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -119.41 89.94 0.47 Allowed Glycine 0 N--CA 1.421 -2.363 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 174.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -68.76 107.78 3.16 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.604 ' OG1' HG22 ' A' ' 156' ' ' THR . 11.0 m -92.12 107.94 19.57 Favored 'General case' 0 N--CA 1.421 -1.919 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.068 -176.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -109.25 141.2 41.88 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -109.8 109.92 20.75 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.535 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -115.12 145.98 35.31 Favored Pre-proline 0 C--N 1.314 -0.972 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.181 -178.394 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.63 -14.73 41.75 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.96 2.44 . . . . 0.0 113.159 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 43.4 t -71.7 -43.17 70.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 120.801 0.334 . . . . 0.0 110.667 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 49.0 t -127.81 -66.31 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.215 0.531 . . . . 0.0 110.59 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.454 ' O ' HD13 ' A' ' 149' ' ' ILE . . . 157.85 -139.9 6.68 Favored Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -177.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -90.0 117.52 28.86 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.722 0.772 . . . . 0.0 110.34 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 146' ' ' THR . 21.3 pt -117.35 128.53 74.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.483 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.604 HG22 ' OG1' ' A' ' 146' ' ' THR . 74.4 p -89.56 107.22 18.96 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 173.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 64.5 mt -80.42 112.75 33.67 Favored Pre-proline 0 C--N 1.295 -1.799 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 74.3 Cg_endo -82.17 151.81 16.03 Favored 'Trans proline' 0 CA--C 1.477 -2.346 0 C-N-CA 122.379 2.053 . . . . 0.0 112.804 -178.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.582 HG21 ' HA ' ' A' ' 48' ' ' THR . 2.7 p -161.7 123.15 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.387 -3.591 0 CA-C-N 112.721 -2.036 . . . . 0.0 108.149 -173.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 79.8 p -131.61 134.41 45.99 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.156 0.503 . . . . 0.0 111.716 -176.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.497 HG22 ' HB ' ' A' ' 49' ' ' VAL . 9.0 t -168.69 177.96 4.9 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 176.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -100.1 166.35 11.06 Favored 'General case' 0 N--CA 1.416 -2.156 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.213 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.42 ' O ' ' HD1' ' A' ' 139' ' ' TYR . . . -130.03 113.92 1.56 Allowed Glycine 0 N--CA 1.408 -3.199 0 N-CA-C 107.691 -2.164 . . . . 0.0 107.691 176.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -88.96 128.75 35.7 Favored 'General case' 0 C--N 1.262 -3.214 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -177.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.452 HG21 ' CE1' ' A' ' 174' ' ' PHE . 29.6 mm -97.18 114.03 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.064 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.615 ' H ' ' HD2' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -86.58 99.07 11.44 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 114.317 -1.31 . . . . 0.0 109.435 -178.86 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.403 HD11 ' CD2' ' A' ' 174' ' ' PHE . 90.3 mt -103.01 106.09 49.0 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 114.877 -1.056 . . . . 0.0 113.224 -173.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 166' ' ' LYS . 10.2 Cg_exo -75.67 -177.85 3.88 Favored 'Trans proline' 0 CA--C 1.55 1.305 0 C-N-CA 122.259 1.973 . . . . 0.0 109.586 170.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.825 ' OG ' ' HB ' ' A' ' 133' ' ' THR . 20.2 m -64.43 90.62 0.07 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 175.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.63 -38.39 4.91 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.855 175.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 66.07 -55.78 0.37 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.976 0.91 . . . . 0.0 112.497 -173.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -115.93 99.51 7.33 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.442 ' HE1' ' O ' ' A' ' 56' ' ' GLY . 53.7 t80 179.42 -37.16 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.545 0.738 . . . . 0.0 111.052 -174.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 120' ' ' ALA . 39.7 t80 . . . . . 0 C--O 1.259 1.594 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.959 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 70.71 158.06 0.18 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -176.92 143.43 0.42 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -74.7 109.62 8.33 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.207 0.527 . . . . 0.0 111.281 -178.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -88.6 108.19 19.31 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -99.09 177.12 5.33 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 120.855 0.359 . . . . 0.0 110.731 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 62.92 57.75 1.63 Allowed 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.9 mp -91.39 -51.69 5.16 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 170.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -78.1 82.12 4.45 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 113.654 -1.612 . . . . 0.0 107.227 174.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 165.04 93.4 0.0 OUTLIER 'General case' 0 C--O 1.243 0.74 0 C-N-CA 126.219 1.808 . . . . 0.0 108.004 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.8 m 72.35 -52.52 0.7 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.598 1.159 . . . . 0.0 112.567 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.99 -56.67 13.44 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -174.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.455 ' HA ' HG22 ' A' ' 16' ' ' VAL . 23.3 t70 -63.78 -40.08 95.81 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.755 0.312 . . . . 0.0 110.745 -177.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 18' ' ' GLU . 1.2 mp0 -59.44 -40.09 85.66 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.704 175.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -66.96 -55.85 12.76 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.068 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.455 HG22 ' HA ' ' A' ' 13' ' ' ASP . 33.3 m -58.11 -39.66 73.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.042 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 p -66.69 -39.8 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.676 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 45.3 mt-10 -65.56 -39.22 91.44 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.4 ' HG2' ' HA ' ' A' ' 16' ' ' VAL . 13.1 pt-20 -74.29 -38.01 63.49 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.428 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 16' ' ' VAL . 75.1 mmtt -64.99 -45.49 85.42 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.832 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.544 ' HB2' HD11 ' A' ' 94' ' ' ILE . . . -58.04 -41.59 83.56 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.159 178.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.2 t -56.44 -44.34 80.37 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 123.836 0.71 . . . . 0.0 110.073 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.7 t -73.97 -51.14 25.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.555 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.5 mt -57.83 -48.22 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.836 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.7 t -62.32 -35.16 78.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.609 0.243 . . . . 0.0 110.51 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.3 m -71.63 -21.3 61.85 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.319 0.581 . . . . 0.0 110.907 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.606 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 6.6 tt -79.82 -41.15 27.01 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.439 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 6.2 mp -65.61 -33.18 75.31 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 118.824 -1.15 . . . . 0.0 108.553 173.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -57.9 -37.15 73.48 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.146 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -70.81 -30.76 67.29 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.471 0.653 . . . . 0.0 110.582 179.407 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.492 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -78.67 -32.07 46.95 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.276 -177.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 98.5 mttt -48.49 -46.42 38.2 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.164 0.586 . . . . 0.0 111.988 -178.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.98 -33.57 84.4 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.207 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -81.47 -45.65 15.69 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 49.6 t80 -62.18 -51.92 65.87 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -175.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.6 -44.79 62.96 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -174.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -117.05 -38.87 3.31 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -177.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.15 -32.17 15.93 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.9 -164.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 83.8 mt -85.27 -11.44 54.79 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.33 -178.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.3 -29.82 71.07 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.118 0.485 . . . . 0.0 111.368 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -105.89 16.85 24.56 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.442 0.639 . . . . 0.0 110.099 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.5 mt -127.31 124.61 23.75 Favored Pre-proline 0 C--N 1.309 -1.179 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -57.87 96.38 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.402 2.068 . . . . 0.0 112.782 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.9 p -128.43 144.49 52.17 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -51.79 120.05 6.52 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.21 1.94 . . . . 0.0 110.941 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.439 ' HB3' ' CG ' ' A' ' 71' ' ' LYS . 35.1 tt0 -96.43 111.62 23.66 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -173.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.84 146.85 35.72 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.216 -173.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.58 ' HA ' HG21 ' A' ' 159' ' ' VAL . 9.7 t -141.04 155.03 46.24 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 176.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.558 HG23 HG22 ' A' ' 159' ' ' VAL . 92.4 t -82.14 141.49 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 173.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -106.95 -56.09 2.24 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -166.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -170.21 -173.68 1.55 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -174.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.639 HG13 ' CD2' ' A' ' 64' ' ' TYR . 89.4 t -136.8 103.41 3.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 C-N-CA 123.342 0.657 . . . . 0.0 109.921 -175.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.433 ' HB3' ' HD3' ' A' ' 55' ' ' LYS . 28.0 m-20 -93.45 104.99 17.1 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.357 177.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.607 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 63.5 t80 -74.62 105.34 5.67 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.611 0.764 . . . . 0.0 109.344 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.607 ' HD2' ' C ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -147.75 116.04 6.57 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.119 0.568 . . . . 0.0 111.165 -176.646 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.11 163.29 15.54 Favored Glycine 0 C--N 1.295 -1.723 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.855 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.2 p -145.13 153.11 14.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.1 t -155.07 -177.28 6.42 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.427 ' NH2' ' HB3' ' A' ' 60' ' ' ASP . 3.2 tmm_? -80.74 -46.94 14.68 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -178.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.427 ' HB3' ' NH2' ' A' ' 59' ' ' ARG . 7.5 p-10 -99.77 95.16 6.74 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.726 0.774 . . . . 0.0 111.156 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.5 -166.14 29.08 Favored Glycine 0 N--CA 1.416 -2.659 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.508 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.549 HG21 ' HB2' ' A' ' 174' ' ' PHE . 81.4 t -143.89 124.72 9.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 178.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -68.04 137.84 55.36 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.248 0.546 . . . . 0.0 110.992 -178.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.714 ' CD1' ' HB ' ' A' ' 119' ' ' VAL . 29.4 p90 -144.3 167.05 23.38 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 172.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 39.2 m-70 -103.5 114.32 28.51 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -77.57 106.02 9.09 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 178.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.401 ' HE2' ' HB ' ' A' ' 112' ' ' VAL . 19.9 tptm -87.8 125.74 34.61 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.867 -171.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 49' ' ' VAL . 33.7 m -133.98 144.66 34.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.5 p -122.95 132.2 54.05 Favored 'General case' 0 C--N 1.282 -2.333 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.073 177.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.1 t -126.02 134.32 66.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.481 -174.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 22.1 ptmt -105.89 146.65 29.69 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 173.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.64 ' O ' ' HA ' ' A' ' 108' ' ' SER . 46.7 t-20 -128.51 121.96 21.54 Favored Pre-proline 0 C--N 1.28 -2.417 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.972 -173.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -98.46 96.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.568 0 C-N-CA 121.582 1.521 . . . . 0.0 109.549 167.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.459 ' HB2' ' OD1' ' A' ' 72' ' ' ASN . 26.1 m-85 175.77 179.58 0.16 Allowed 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 128.727 2.811 . . . . 0.0 105.356 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.3 t -126.02 5.58 7.23 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 120.316 -0.554 . . . . 0.0 109.699 176.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -100.95 140.16 35.63 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.869 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 63.1 m -76.7 97.87 4.59 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 171.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 64.9 mt -72.83 124.69 91.03 Favored Pre-proline 0 C--N 1.307 -1.279 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.719 -177.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -69.38 127.7 15.29 Favored 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 121.817 1.678 . . . . 0.0 109.38 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 58.1 mt -80.72 113.88 20.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 100' ' ' PRO . 49.6 t -56.2 -53.02 62.14 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.635 -178.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -167.8 162.4 13.73 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.595 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 98' ' ' THR . 13.4 tt -124.11 115.31 44.52 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 175.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.413 ' HB3' HG22 ' A' ' 98' ' ' THR . 65.5 p -94.08 118.1 31.05 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -108.41 135.09 50.28 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.307 178.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.411 ' HB ' ' HB3' ' A' ' 142' ' ' ASP . 2.9 mp -118.27 111.32 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 175.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.546 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -91.67 120.99 32.92 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 140' ' ' GLN . 39.6 ttmt -123.54 139.38 54.07 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.407 -177.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.547 ' OG ' ' HB2' ' A' ' 122' ' ' SER . 49.5 m -115.42 145.13 42.85 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.806 176.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.6 113.42 2.69 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.282 -176.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.7 m 69.23 9.81 7.51 Favored 'General case' 0 CA--C 1.57 1.718 0 C-N-CA 124.408 1.083 . . . . 0.0 112.252 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -121.46 -170.79 2.09 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 121.502 -0.748 . . . . 0.0 111.098 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.0 t -74.51 -172.96 1.63 Allowed 'General case' 0 C--O 1.253 1.277 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.546 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.6 pp -138.07 168.44 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -176.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . . . -119.09 140.62 49.78 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.7 p -141.25 140.33 33.89 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.689 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -165.63 153.35 23.3 Favored Glycine 0 N--CA 1.434 -1.498 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.416 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 27.2 p -118.28 122.6 43.32 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 178.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.416 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.2 mp -102.91 108.26 57.8 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 118.301 -1.359 . . . . 0.0 109.717 176.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 98' ' ' THR . 11.7 Cg_exo -71.93 118.25 5.54 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.213 1.942 . . . . 0.0 109.389 174.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.9 t70 62.04 81.89 0.23 Allowed Pre-proline 0 N--CA 1.472 0.673 0 O-C-N 124.235 0.959 . . . . 0.0 111.577 -174.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -104.63 11.35 0.25 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.474 2.783 . . . . 0.0 110.461 176.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.1 -167.44 26.84 Favored Glycine 0 N--CA 1.422 -2.256 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 46.1 p -151.75 169.49 22.08 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 117.434 0.617 . . . . 0.0 110.641 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.587 HD23 ' H ' ' A' ' 105' ' ' LEU . 1.0 OUTLIER -115.56 131.41 56.94 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.338 0.589 . . . . 0.0 112.085 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.0 29.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 126.432 1.893 . . . . 0.0 115.087 -171.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.639 ' O ' ' HB3' ' A' ' 72' ' ' ASN . . . 71.79 -150.39 46.21 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.129 -177.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 29.7 p -54.42 90.04 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 124.498 1.119 . . . . 0.0 113.657 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 170.9 -166.4 39.59 Favored Glycine 0 CA--C 1.478 -2.262 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 174.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -119.51 135.9 54.57 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.425 HG21 ' HA ' ' A' ' 105' ' ' LEU . 5.0 t -134.58 137.88 44.12 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.105 -178.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.401 ' HB ' ' HE2' ' A' ' 67' ' ' LYS . 27.8 m -91.26 124.2 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.832 177.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.3 mt -120.91 158.9 26.66 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.437 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 4.9 p-10 -147.36 148.47 31.38 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 177.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.6 p -130.54 136.15 28.51 Favored Pre-proline 0 C--N 1.292 -1.897 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.817 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.45 130.5 21.14 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.875 2.383 . . . . 0.0 112.637 178.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.487 HG13 ' CZ ' ' A' ' 64' ' ' TYR . 1.8 p -161.48 150.55 4.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 124.157 0.983 . . . . 0.0 109.262 178.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 13.3 mptt -88.93 133.76 34.19 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.966 0.413 . . . . 0.0 111.708 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.714 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 12.8 p -95.12 145.75 7.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 68.87 0.74 2.84 Favored 'General case' 0 C--O 1.216 -0.694 0 C-N-CA 124.426 1.09 . . . . 0.0 112.482 175.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -49.85 -46.47 51.42 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.784 1.233 . . . . 0.0 111.144 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.547 ' HB2' ' OG ' ' A' ' 89' ' ' SER . 17.0 m -69.75 -38.54 76.84 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.166 -175.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.499 HD13 ' HA ' ' A' ' 129' ' ' LYS . 19.7 tt -80.25 -27.46 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 O-C-N 121.94 -0.475 . . . . 0.0 111.342 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.649 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -52.63 -51.57 59.45 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 124.207 1.003 . . . . 0.0 112.046 177.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.5 m -61.32 -21.88 26.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -175.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.8 m -95.79 -78.08 0.46 Allowed 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 120.746 -0.382 . . . . 0.0 112.004 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.558 HD23 ' H ' ' A' ' 127' ' ' LEU . 2.1 pt? -120.72 -0.89 10.1 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.554 -174.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.649 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 25.1 ttt 53.55 76.03 0.23 Allowed 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 124.159 0.984 . . . . 0.0 112.107 -178.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.771 ' HE2' ' SD ' ' A' ' 131' ' ' MET . 55.4 pttt 54.77 -74.25 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 126.591 1.956 . . . . 0.0 113.021 -177.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 36.6 t70 161.56 81.54 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 101.223 -3.621 . . . . 0.0 101.223 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.771 ' SD ' ' HE2' ' A' ' 129' ' ' LYS . 8.9 tpt -56.01 110.96 0.82 Allowed 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -166.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.573 ' SG ' ' HB2' ' A' ' 135' ' ' TRP . 7.1 p -147.09 -176.08 5.07 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 113.707 -1.588 . . . . 0.0 108.874 176.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.637 HG22 ' CB ' ' A' ' 169' ' ' SER . 5.6 m -126.59 107.58 10.34 Favored 'General case' 1 N--CA 1.367 -4.578 0 N-CA-C 103.145 -2.909 . . . . 0.0 103.145 -170.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 168' ' ' PRO . 28.9 t70 84.51 101.01 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 125.139 1.376 . . . . 0.0 108.343 -171.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.573 ' HB2' ' SG ' ' A' ' 132' ' ' CYS . 4.8 t-105 -163.94 136.17 4.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.232 -166.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -105.12 145.7 30.19 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.9 tt -155.28 151.08 10.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -114.7 123.25 48.81 Favored 'General case' 0 CA--C 1.498 -1.029 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.789 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -105.09 172.73 6.63 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 88' ' ' LYS . 49.0 mt-30 -119.35 139.96 51.12 Favored 'General case' 0 C--N 1.274 -2.713 0 O-C-N 121.178 -0.951 . . . . 0.0 111.864 -175.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.43 HD11 HD11 ' A' ' 143' ' ' ILE . 25.8 tp -128.45 130.69 47.94 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.697 -178.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.551 ' OD1' ' HB3' ' A' ' 160' ' ' SER . 21.5 t70 -135.41 123.97 23.58 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 141' ' ' LEU . 37.2 mm -115.01 148.41 17.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -121.54 99.1 0.68 Allowed Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 174.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.441 ' HB3' ' CE2' ' A' ' 147' ' ' PHE . 2.9 mm? -79.22 114.78 18.43 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.472 ' OG1' HG22 ' A' ' 156' ' ' THR . 8.2 m -96.36 108.3 20.8 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.441 ' CE2' ' HB3' ' A' ' 145' ' ' LEU . 75.4 m-85 -116.57 146.89 42.33 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -103.28 130.62 50.58 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.532 0.682 . . . . 0.0 110.123 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.01 130.0 16.16 Favored Pre-proline 0 C--N 1.291 -1.967 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -59.41 -21.57 61.8 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 C-N-CA 123.373 2.715 . . . . 0.0 113.668 -172.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.427 HG13 HG23 ' A' ' 152' ' ' VAL . 7.1 p -67.87 -28.27 40.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.598 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.427 HG23 HG13 ' A' ' 151' ' ' VAL . 97.2 t -134.37 -44.79 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.559 0.695 . . . . 0.0 110.613 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 118.79 -115.97 3.24 Favored Glycine 0 C--N 1.29 -1.983 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -174.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -102.32 117.64 35.17 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.081 0.467 . . . . 0.0 112.133 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.546 ' O ' HD12 ' A' ' 155' ' ' ILE 0.265 2.6 pp -123.59 118.57 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-O 121.316 0.579 . . . . 0.0 110.941 170.459 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.472 HG22 ' OG1' ' A' ' 146' ' ' THR . 23.3 p -85.85 108.88 18.34 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.677 177.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 68.5 mt -76.41 114.64 40.13 Favored Pre-proline 0 C--N 1.292 -1.932 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.768 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -82.98 137.22 8.48 Favored 'Trans proline' 0 CA--C 1.475 -2.452 0 C-N-CA 122.849 2.366 . . . . 0.0 111.954 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.58 HG21 ' HA ' ' A' ' 48' ' ' THR . 5.7 p -149.52 112.98 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.38 -3.962 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.096 -174.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.551 ' HB3' ' OD1' ' A' ' 142' ' ' ASP . 58.3 p -120.49 155.36 33.75 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.599 -177.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.3 t -163.0 171.79 15.99 Favored 'General case' 0 C--O 1.255 1.358 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -99.43 126.89 45.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -94.09 85.86 1.06 Allowed Glycine 0 N--CA 1.413 -2.885 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -88.5 119.55 29.05 Favored 'General case' 0 N--CA 1.42 -1.972 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 8.4 pt -140.11 177.07 4.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.542 -171.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.476 ' H ' ' HD2' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -130.19 143.83 51.01 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.447 -176.326 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.0 mp -125.59 97.98 35.41 Favored Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 171.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.626 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 33.1 Cg_endo -64.06 170.11 9.52 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.613 2.209 . . . . 0.0 111.332 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.637 ' CB ' HG22 ' A' ' 133' ' ' THR . 26.5 p -40.37 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 173.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 168' ' ' PRO . 3.5 pp -162.01 132.12 4.77 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.951 177.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.429 ' NH2' ' HA ' ' A' ' 132' ' ' CYS . 64.9 mtt180 -132.86 85.67 2.24 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 172.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 23.9 t70 177.19 -38.34 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 O-C-N 123.835 0.709 . . . . 0.0 110.608 -174.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -81.81 -51.66 7.91 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 176.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.549 ' HB2' HG21 ' A' ' 62' ' ' VAL . 39.7 t80 . . . . . 0 N--CA 1.399 -3.024 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 172.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.935 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -96.57 -18.85 19.49 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 117.899 0.849 . . . . 0.0 112.587 -178.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -86.54 100.98 12.78 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.898 0.38 . . . . 0.0 111.091 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 -119.77 88.97 3.04 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -93.17 79.0 4.52 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.78 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -151.45 -72.98 0.15 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.232 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -140.52 20.11 2.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.753 0.311 . . . . 0.0 110.353 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.47 -37.32 86.5 Favored 'General case' 0 C--O 1.201 -1.498 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -87.12 16.75 4.77 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.224 0.535 . . . . 0.0 110.589 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -129.46 97.85 4.68 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.433 ' HA ' ' OE2' ' A' ' 14' ' ' GLU . 35.4 m 76.13 -37.84 0.32 Allowed 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 125.713 1.605 . . . . 0.0 113.025 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.6 -30.28 64.23 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.648 ' O ' HG23 ' A' ' 17' ' ' VAL . 38.6 t70 -70.94 -34.71 71.75 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.433 ' OE2' ' HA ' ' A' ' 11' ' ' SER . 44.1 mt-10 -58.79 -39.96 82.64 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.188 175.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 40.4 tttp -64.13 -56.9 11.56 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.698 176.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.594 HG22 ' HA ' ' A' ' 13' ' ' ASP . 25.6 m -58.96 -24.65 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 13' ' ' ASP . 67.2 t -67.26 -50.23 64.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 172.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -62.34 -30.12 70.94 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.336 -177.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.509 ' CG ' ' HA ' ' A' ' 16' ' ' VAL . 40.0 mm-40 -54.77 -52.15 63.48 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.624 176.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -78.49 -31.37 47.75 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 120.109 -0.636 . . . . 0.0 111.908 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.9 -42.79 80.55 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 123.271 0.357 . . . . 0.0 110.19 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.2 t -59.43 -41.72 90.2 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.667 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 67.2 t -66.93 -49.39 74.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-O 120.836 0.35 . . . . 0.0 110.45 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.526 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 68.0 mt -60.89 -42.77 93.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.22 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.8 m -65.58 -32.51 74.14 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.38 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.8 t -71.44 -34.67 70.48 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.542 HD22 ' OG1' ' A' ' 156' ' ' THR . 3.2 tt -65.84 -41.89 91.19 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 176.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 83.4 mt -57.77 -38.71 75.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.116 177.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -61.16 -41.98 97.73 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 27' ' ' LEU . 65.6 pttt -71.81 -38.81 70.15 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.838 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.05 -31.76 68.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.25 -176.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -62.58 -42.2 99.41 Favored 'General case' 0 C--O 1.246 0.888 0 CA-C-O 121.023 0.44 . . . . 0.0 110.809 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.95 -33.56 36.5 Favored Glycine 0 CA--C 1.51 -0.281 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.411 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 7.4 t80 -57.17 -46.31 82.9 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.617 ' HA ' HD13 ' A' ' 39' ' ' LEU . 10.5 t80 -52.9 -53.31 51.06 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.066 1.347 . . . . 0.0 111.326 174.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.37 -33.22 58.71 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -174.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -99.15 -64.25 1.05 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.281 0.562 . . . . 0.0 112.457 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.3 mtmm -79.95 -22.45 42.62 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -169.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.617 HD13 ' HA ' ' A' ' 35' ' ' PHE . 5.7 mp -98.86 6.96 46.53 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-O 121.679 0.752 . . . . 0.0 109.805 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.95 -35.72 11.88 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -90.48 -18.21 25.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.398 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.8 mt -115.12 112.95 44.01 Favored Pre-proline 0 C--N 1.309 -1.194 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.6 97.36 0.88 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.187 1.925 . . . . 0.0 113.076 -176.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.3 p -93.01 159.34 35.86 Favored Pre-proline 0 N--CA 1.43 -1.43 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.982 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.05 147.35 90.68 Favored 'Trans proline' 0 C--O 1.239 0.556 0 C-N-CA 122.946 2.43 . . . . 0.0 111.596 174.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 38.4 tt0 -110.27 109.63 20.15 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.45 138.42 35.69 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.581 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.8 t -135.14 129.23 33.53 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.318 0.58 . . . . 0.0 110.957 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.539 ' H ' HG11 ' A' ' 159' ' ' VAL . 48.1 t -105.48 141.01 21.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 177.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -158.08 -31.96 0.07 Allowed 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -170.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -145.69 151.65 38.37 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 118.923 -1.111 . . . . 0.0 111.755 -171.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.462 HG12 ' HB2' ' A' ' 66' ' ' ALA . 28.9 m -124.28 152.19 29.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 123.433 0.693 . . . . 0.0 110.712 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -114.86 117.0 29.47 Favored 'General case' 0 C--O 1.246 0.888 0 C-N-CA 122.841 0.456 . . . . 0.0 111.802 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -64.69 107.94 1.57 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 167.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 63' ' ' ASP . 14.6 ptmm? -107.05 -16.4 14.44 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.103 -0.639 . . . . 0.0 112.663 -176.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 159.65 -178.51 35.72 Favored Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 119.296 -1.431 . . . . 0.0 112.67 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.88 151.37 18.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 123.22 0.608 . . . . 0.0 110.007 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.4 t -153.19 -176.66 5.88 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -79.16 -53.52 6.9 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -175.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -97.78 80.61 2.79 Favored 'General case' 0 C--N 1.313 -1.015 0 O-C-N 122.167 -0.333 . . . . 0.0 111.683 -176.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.81 120.01 0.13 Allowed Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.146 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.456 HG11 ' O ' ' A' ' 173' ' ' PHE . 33.9 m -70.74 156.34 7.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 121.248 0.547 . . . . 0.0 111.812 -177.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 19.7 m-20 -96.06 126.23 41.15 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.08 -172.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.546 ' CD1' HG11 ' A' ' 119' ' ' VAL . 2.7 m-85 -121.04 122.62 40.47 Favored 'General case' 0 CA--C 1.471 -2.084 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.571 171.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -92.4 108.04 19.66 Favored 'General case' 0 C--N 1.273 -2.727 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.462 ' HB2' HG12 ' A' ' 52' ' ' VAL . . . -93.34 144.84 24.94 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -86.88 133.12 33.65 Favored 'General case' 0 C--O 1.251 1.143 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.734 176.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.462 HG22 HG22 ' A' ' 49' ' ' VAL . 48.6 t -130.97 106.52 12.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 168.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.2 p -106.91 134.84 49.46 Favored 'General case' 0 C--N 1.277 -2.552 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.424 -176.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 4.8 p -132.52 126.54 55.22 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.95 -176.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 89.1 tttt -96.6 119.38 34.98 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 175.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.452 ' HB2' HD12 ' A' ' 105' ' ' LEU . 52.7 t30 -111.45 115.7 51.56 Favored Pre-proline 0 C--N 1.301 -1.51 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.72 -175.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -95.81 96.92 0.1 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.612 0 C-N-CA 121.904 1.736 . . . . 0.0 111.025 172.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -170.19 -166.09 0.52 Allowed 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 126.515 1.926 . . . . 0.0 107.011 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.3 t -142.5 21.13 2.03 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 173.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.564 ' O ' ' HA2' ' A' ' 107' ' ' GLY . 12.7 pt20 -115.14 140.73 48.83 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.412 -178.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.3 p -83.15 95.19 8.03 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-O 121.656 0.741 . . . . 0.0 109.308 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.494 ' HB ' HD21 ' A' ' 105' ' ' LEU . 72.5 mt -74.93 122.95 88.6 Favored Pre-proline 0 N--CA 1.433 -1.287 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.726 -176.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 78' ' ' ILE . 4.3 Cg_exo -76.78 122.64 6.45 Favored 'Trans proline' 0 N--CA 1.444 -1.438 0 C-N-CA 122.197 1.932 . . . . 0.0 110.666 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 50.0 mt -88.33 102.82 13.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 62.3 m -57.55 -60.37 3.76 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 124.133 0.895 . . . . 0.0 110.624 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -150.68 157.35 42.85 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-O 121.52 0.676 . . . . 0.0 111.868 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.568 ' HB ' HG23 ' A' ' 99' ' ' ILE . 46.4 mm -107.15 116.94 51.95 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 176.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.0 m -80.78 118.35 22.23 Favored 'General case' 0 N--CA 1.412 -2.375 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -103.06 121.42 42.55 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.992 -170.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' A' ' 142' ' ' ASP . 69.9 mt -134.9 109.8 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.24 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.623 ' O ' HD12 ' A' ' 94' ' ' ILE . 0.9 OUTLIER -113.03 120.61 41.95 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 176.588 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.569 ' HD2' ' O ' ' A' ' 93' ' ' THR . 53.4 tptt -121.38 135.53 55.06 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.5 m -142.38 145.36 33.79 Favored 'General case' 0 C--O 1.25 1.082 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.55 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 62.28 18.27 10.05 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.119 0.968 . . . . 0.0 111.197 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 m 59.16 14.01 3.3 Favored 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 123.986 0.915 . . . . 0.0 109.888 -175.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -127.63 -65.65 0.91 Allowed 'General case' 0 N--CA 1.432 -1.336 0 O-C-N 121.325 -0.859 . . . . 0.0 111.057 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.569 ' O ' ' HD2' ' A' ' 88' ' ' LYS . 11.1 t -76.92 165.56 24.51 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.823 -172.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.623 HD12 ' O ' ' A' ' 87' ' ' LEU . 3.8 tp -163.38 139.02 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.015 0 C-N-CA 123.195 0.598 . . . . 0.0 109.703 -168.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.11 121.47 26.42 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 171.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 78.0 p -139.76 160.12 40.62 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.292 0.568 . . . . 0.0 111.63 -176.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 167.41 -170.25 41.52 Favored Glycine 0 N--CA 1.417 -2.614 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.3 p -127.86 122.2 31.99 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.568 HG23 ' HB ' ' A' ' 83' ' ' ILE . 10.0 tt -102.86 108.45 58.33 Favored Pre-proline 0 C--N 1.318 -0.771 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.02 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -82.55 146.31 13.51 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 C-N-CA 122.889 2.393 . . . . 0.0 113.63 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 44.75 67.41 4.11 Favored Pre-proline 0 N--CA 1.477 0.911 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -101.24 1.05 0.58 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.465 2.11 . . . . 0.0 111.911 176.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 148.94 -179.0 26.12 Favored Glycine 0 N--CA 1.428 -1.874 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.6 m -150.38 175.72 11.57 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 117.509 0.655 . . . . 0.0 110.708 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.678 HD23 ' H ' ' A' ' 105' ' ' LEU . 0.7 OUTLIER -104.62 131.96 51.43 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.443 0.64 . . . . 0.0 112.654 -175.093 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.2 m -63.59 18.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 -171.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 76' ' ' GLN . . . 85.09 -52.66 4.71 Favored Glycine 0 C--O 1.214 -1.1 0 C-N-CA 120.407 -0.902 . . . . 0.0 113.32 177.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.7 t -148.29 117.17 6.72 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -177.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 133.99 177.37 14.89 Favored Glycine 0 CA--C 1.49 -1.479 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.12 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 9.9 t -96.53 113.35 24.92 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 121.753 0.787 . . . . 0.0 109.421 177.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.9 t -112.28 138.07 49.51 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.376 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 25.0 t -96.94 107.56 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.8 mt -86.8 166.39 15.27 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 178.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -140.43 145.84 37.52 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.396 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.4 t -120.95 128.2 25.87 Favored Pre-proline 0 C--N 1.3 -1.581 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -74.54 109.6 2.94 Favored 'Trans proline' 0 N--CA 1.43 -2.224 0 N-CA-C 106.986 -1.967 . . . . 0.0 106.986 168.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.513 HG11 ' OH ' ' A' ' 139' ' ' TYR . 59.2 t -103.66 127.27 57.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -176.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.472 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 1.2 tpmt? -88.98 91.12 8.71 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.546 HG11 ' CD1' ' A' ' 64' ' ' TYR . 12.1 p -94.03 147.29 5.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.173 -172.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.482 ' HA ' HD12 ' A' ' 123' ' ' ILE . . . 72.47 -5.63 1.77 Allowed 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.211 1.004 . . . . 0.0 111.318 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.419 ' O ' HG23 ' A' ' 125' ' ' VAL . 76.1 t80 -63.55 -54.42 36.39 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.377 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.518 ' HB2' ' OG1' ' A' ' 93' ' ' THR . 13.1 p -63.42 -36.87 85.16 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.922 -176.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 120' ' ' ALA . 52.7 mt -64.6 -49.42 80.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.097 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.74 -36.12 82.67 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 123.484 0.49 . . . . 0.0 110.775 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 121' ' ' TYR . 52.6 t -62.11 -51.4 72.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.514 176.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.6 m -66.74 -73.83 0.13 Allowed 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.5 HD12 ' N ' ' A' ' 128' ' ' MET . 2.0 pp -125.16 -32.14 3.01 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -171.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.5 ' N ' HD12 ' A' ' 127' ' ' LEU . 0.0 OUTLIER 63.37 110.93 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -171.2 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.544 ' HG3' ' HE1' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -68.07 -0.02 4.07 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -171.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 17.8 t70 84.79 -26.41 0.11 Allowed 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 125.624 1.57 . . . . 0.0 110.592 173.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.643 ' HE1' HD13 ' A' ' 167' ' ' LEU . 9.1 tpt 70.89 149.7 0.09 Allowed 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 125.475 1.51 . . . . 0.0 113.47 174.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 72.0 m -153.69 160.76 42.45 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 40.2 p -78.78 125.74 29.78 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 175.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.621 ' H ' ' H ' ' A' ' 169' ' ' SER . 25.4 t70 69.47 89.02 0.1 Allowed 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -176.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.544 ' HE1' ' HG3' ' A' ' 129' ' ' LYS . 54.5 t-105 -158.19 149.79 21.39 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 114.032 -1.44 . . . . 0.0 109.732 -166.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -140.59 149.34 42.24 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.904 0.383 . . . . 0.0 110.386 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.459 HG21 ' CD1' ' A' ' 123' ' ' ILE . 2.9 mp -118.7 141.68 37.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -81.08 102.67 10.39 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 122.048 0.928 . . . . 0.0 109.473 174.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.513 ' OH ' HG11 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -130.69 144.58 51.53 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.251 -177.292 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.42 ' CB ' ' HA ' ' A' ' 162' ' ' GLN . 20.7 pt20 -131.52 157.8 42.6 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 38.2 tp -124.89 123.89 40.89 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.426 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 6.2 m-20 -121.88 120.3 34.12 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.171 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 46.6 mm -120.62 127.76 75.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.891 -178.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -95.6 89.94 1.19 Allowed Glycine 0 N--CA 1.427 -1.903 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 173.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.26 110.69 7.74 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.576 ' OG1' HG22 ' A' ' 156' ' ' THR . 27.8 m -95.89 108.4 20.76 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 120.861 0.363 . . . . 0.0 111.18 -176.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -101.76 132.04 47.72 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 176.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -101.98 109.36 21.07 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 65.0 mt -127.99 114.29 20.38 Favored Pre-proline 0 C--N 1.29 -1.995 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.21 -24.1 32.42 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.841 2.361 . . . . 0.0 113.662 -176.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.38 -36.18 76.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.222 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 10.2 p -125.3 -32.1 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -174.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 120.56 -151.51 17.14 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -101.02 125.18 47.62 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.264 -1.014 . . . . 0.0 108.264 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.455 HG21 HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -132.44 127.64 57.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.472 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.576 HG22 ' OG1' ' A' ' 146' ' ' THR . 74.8 p -91.84 108.95 20.28 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . 51.8 mt -77.77 114.47 41.65 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 157' ' ' ILE . 5.5 Cg_exo -76.58 101.02 1.45 Allowed 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 122.436 2.091 . . . . 0.0 111.587 -178.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.539 HG11 ' H ' ' A' ' 49' ' ' VAL . 18.0 t -101.83 113.18 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 53.1 p -110.14 145.22 37.56 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.194 -175.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.9 t -156.77 113.65 3.08 Favored 'General case' 0 N--CA 1.424 -1.768 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.296 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.42 ' HA ' ' CB ' ' A' ' 140' ' ' GLN . 11.4 pt20 -98.25 119.26 36.6 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -134.77 -130.92 3.02 Favored Glycine 0 N--CA 1.407 -3.284 0 C-N-CA 119.792 -1.194 . . . . 0.0 113.023 -174.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -158.14 133.1 8.52 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 115.219 -0.49 . . . . 0.0 109.918 -171.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.471 HG12 ' HB3' ' A' ' 139' ' ' TYR . 43.2 mm -107.02 108.59 25.56 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 171.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -110.94 128.89 55.98 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 121.791 0.805 . . . . 0.0 111.441 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.643 HD13 ' HE1' ' A' ' 131' ' ' MET . 96.0 mt -118.57 91.48 41.86 Favored Pre-proline 0 N--CA 1.411 -2.39 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.758 -172.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.468 ' O ' HD22 ' A' ' 170' ' ' LEU . 9.1 Cg_exo -71.64 100.82 1.09 Allowed 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.575 2.85 . . . . 0.0 112.992 -177.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.621 ' H ' ' H ' ' A' ' 134' ' ' ASP . 91.3 p 62.9 9.72 3.88 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 126.682 1.993 . . . . 0.0 115.528 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 168' ' ' PRO . 3.5 mm? -71.73 138.66 48.65 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.146 -0.621 . . . . 0.0 111.848 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -142.54 140.99 31.98 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 167.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 37.5 t70 74.85 5.44 4.38 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.385 1.088 . . . . 0.0 110.762 -174.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.468 ' CD1' HD12 ' A' ' 170' ' ' LEU . 78.0 m-85 -104.45 5.1 33.93 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.887 174.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.454 ' C ' ' HZ1' ' A' ' 129' ' ' LYS . 80.3 m-85 . . . . . 0 CA--C 1.487 -1.454 0 CA-C-N 114.051 -1.431 . . . . 0.0 113.887 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.969 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -88.34 123.28 32.76 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -99.99 133.5 44.28 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 120.85 0.357 . . . . 0.0 110.669 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -141.08 92.0 2.45 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.748 0.785 . . . . 0.0 109.561 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -134.52 -70.11 0.51 Allowed 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.109 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 47.5 m80 62.06 170.91 0.12 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.972 0.909 . . . . 0.0 111.69 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -179.57 -36.37 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.199 0 C-N-CA 123.546 0.738 . . . . 0.0 111.364 174.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.26 34.9 mt 42.28 71.26 0.23 Allowed 'General case' 0 CA--C 1.483 -1.625 0 CA-C-O 123.036 1.398 . . . . 0.0 112.172 -175.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 71.94 -70.52 0.16 Allowed 'General case' 0 C--N 1.261 -3.24 0 CA-C-N 111.31 -2.677 . . . . 0.0 111.785 -174.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 66.26 34.93 6.23 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 121.763 0.792 . . . . 0.0 110.373 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.9 t -144.33 -54.78 0.34 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.113 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -57.18 -36.93 71.41 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-O 121.016 0.436 . . . . 0.0 110.299 176.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -56.15 -44.95 79.76 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 124.357 1.063 . . . . 0.0 110.355 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.77 -43.77 98.19 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.826 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -63.86 -50.69 67.83 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.388 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 12' ' ' ALA . 90.2 t -66.29 -44.63 91.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 114.979 -1.009 . . . . 0.0 113.354 -176.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.0 p -64.19 -26.59 40.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -75.45 -44.01 46.5 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.571 -177.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.49 ' O ' HG23 ' A' ' 23' ' ' VAL . 10.8 pt-20 -64.0 -40.25 95.95 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.649 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -65.85 -40.68 91.93 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.375 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.69 -42.7 99.29 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.179 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.8 t -61.76 -41.85 98.22 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.979 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 19' ' ' GLU . 93.5 t -60.75 -49.63 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.234 0.54 . . . . 0.0 109.779 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.445 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 67.6 mt -67.34 -39.91 83.73 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.768 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.003 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.9 t -61.72 -41.08 97.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.878 0.37 . . . . 0.0 110.105 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 32.6 m -70.34 -32.09 69.66 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.122 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.561 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 4.4 tt -69.84 -47.53 62.35 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 176.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.578 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 96.3 mt -59.95 -32.74 71.08 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.9 0.381 . . . . 0.0 110.152 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' A' ' 26' ' ' SER . 12.4 t70 -57.69 -46.22 84.59 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.893 175.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.561 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -74.77 -33.63 62.32 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.238 0.542 . . . . 0.0 109.757 179.613 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.505 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -62.21 -39.63 93.41 Favored 'General case' 0 C--O 1.204 -1.337 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.729 -178.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 29.0 mtpp -60.76 -33.97 73.76 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.2 -51.1 4.06 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.066 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -61.92 -32.59 73.01 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 123.61 0.764 . . . . 0.0 112.592 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.443 ' HD1' HD12 ' A' ' 39' ' ' LEU . 49.0 t80 -72.62 -34.95 67.69 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 121.905 -0.497 . . . . 0.0 110.637 175.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.72 -27.33 58.12 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.731 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 38' ' ' LYS . 10.7 pt-20 -98.35 -49.32 4.72 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.437 ' N ' ' HG3' ' A' ' 37' ' ' GLU . 14.5 tppt? -76.84 -47.15 22.22 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 122.13 0.967 . . . . 0.0 109.333 -170.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.443 HD12 ' HD1' ' A' ' 35' ' ' PHE . 42.1 mt -89.36 16.93 6.68 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.45 -175.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.22 -20.21 19.41 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 172.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -97.69 -35.11 10.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.66 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.5 mt -103.47 118.56 57.35 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.078 -177.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.95 112.24 2.88 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.542 2.161 . . . . 0.0 111.092 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.423 ' HB ' ' CD ' ' A' ' 45' ' ' PRO . 4.0 p -116.88 171.22 5.04 Favored Pre-proline 0 C--N 1.301 -1.52 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.263 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.448 ' HB3' ' CB ' ' A' ' 72' ' ' ASN . 7.9 Cg_exo -72.95 145.97 41.04 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.477 2.118 . . . . 0.0 112.516 -177.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -97.75 119.02 35.58 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.999 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.21 141.28 37.01 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.1 t -136.46 143.03 43.64 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.5 t -97.91 132.34 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 175.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -112.69 -60.11 1.92 Allowed 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.059 -1.057 . . . . 0.0 113.745 -169.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -163.88 161.36 22.98 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -172.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.659 HG22 ' HB3' ' A' ' 64' ' ' TYR . 10.0 p -135.49 112.2 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.76 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -106.82 159.03 16.55 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.951 -175.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -71.36 126.81 30.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.419 0.628 . . . . 0.0 112.212 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.449 ' HD2' ' OD2' ' A' ' 63' ' ' ASP . 10.2 tmtt? -110.91 -44.84 3.55 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.352 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -178.5 -176.44 46.4 Favored Glycine 0 CA--C 1.484 -1.897 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 177.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.521 ' HA ' HG23 ' A' ' 62' ' ' VAL . 27.2 m -107.81 148.75 11.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.772 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.4 m -150.78 125.24 9.53 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 174.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -82.71 88.62 6.72 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 122.265 1.031 . . . . 0.0 113.407 -170.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -178.66 37.02 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 102.271 -3.233 . . . . 0.0 102.271 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.82 -133.07 10.63 Favored Glycine 0 N--CA 1.415 -2.723 0 N-CA-C 106.038 -2.825 . . . . 0.0 106.038 -170.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.521 HG23 ' HA ' ' A' ' 57' ' ' VAL . 9.8 p -152.24 136.89 9.84 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 172.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.449 ' OD2' ' HD2' ' A' ' 55' ' ' LYS . 35.3 t70 -85.62 105.04 15.9 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-O 121.629 0.728 . . . . 0.0 112.237 -169.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.659 ' HB3' HG22 ' A' ' 52' ' ' VAL . 3.2 m-85 -109.47 161.61 15.16 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 121.65 0.738 . . . . 0.0 112.144 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 39.2 t60 -102.51 106.44 17.15 Favored 'General case' 0 N--CA 1.413 -2.298 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.631 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . . . -90.22 124.87 35.23 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.801 174.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -100.41 125.27 46.67 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.386 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.0 m -121.44 144.58 30.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.3 m -120.83 136.0 55.02 Favored 'General case' 0 C--N 1.277 -2.581 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.033 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t -129.98 127.73 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-O 121.029 0.442 . . . . 0.0 110.27 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 19.3 ptpt -113.2 143.03 45.08 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 174.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.661 ' O ' ' HA ' ' A' ' 108' ' ' SER . 1.8 p-10 -142.63 138.49 16.27 Favored Pre-proline 0 C--N 1.287 -2.134 0 C-N-CA 118.906 -1.118 . . . . 0.0 110.266 -177.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -99.62 95.4 0.05 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.462 0 C-N-CA 120.852 1.035 . . . . 0.0 110.152 170.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -174.47 138.91 0.55 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.7 m -85.71 -5.3 59.28 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 118.827 0.74 . . . . 0.0 111.182 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -88.19 143.62 26.94 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.381 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.2 p -90.35 102.33 15.06 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.11 0.481 . . . . 0.0 109.902 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.402 ' H ' ' CD2' ' A' ' 105' ' ' LEU . 24.8 mt -92.01 130.25 38.92 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -177.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -75.92 142.5 25.24 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.897 1.731 . . . . 0.0 108.943 171.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.6 HG13 ' HD2' ' A' ' 102' ' ' PRO . 18.3 pt -82.5 102.62 8.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.318 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 6.6 m -43.47 -65.93 0.44 Allowed 'General case' 0 C--O 1.244 0.799 0 C-N-CA 126.945 2.098 . . . . 0.0 113.032 -172.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.525 ' C ' HD12 ' A' ' 83' ' ' ILE . 10.0 pt20 -147.34 150.82 35.49 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.588 HG23 HG23 ' A' ' 143' ' ' ILE . 1.8 mp -120.39 117.97 55.15 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.141 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.8 m -80.08 119.98 23.62 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.477 ' CE2' HG12 ' A' ' 117' ' ' VAL . 4.8 t80 -103.04 120.76 41.24 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.634 -170.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.401 ' HB ' ' HB3' ' A' ' 142' ' ' ASP . 39.8 mm -131.17 108.47 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.529 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 0.2 OUTLIER -106.22 126.98 52.89 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 179.433 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -124.41 147.1 48.49 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.965 -0.694 . . . . 0.0 112.314 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.7 m -151.93 97.9 2.39 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 64.73 -173.03 0.18 Allowed 'General case' 0 CA--C 1.541 0.609 0 O-C-N 123.975 0.797 . . . . 0.0 109.5 -174.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.3 p -98.54 14.55 27.93 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.805 -0.56 . . . . 0.0 111.681 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.6 -65.58 0.99 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.27 -177.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 122' ' ' SER . 35.1 m -130.54 141.3 50.48 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 122.05 -0.406 . . . . 0.0 111.177 -175.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.529 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.8 pp -137.06 168.79 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -178.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.61 147.81 49.17 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 176.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.7 p -144.16 164.81 29.62 Favored 'General case' 0 C--N 1.313 -0.992 0 O-C-N 122.438 -0.164 . . . . 0.0 110.859 -177.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 156.36 -170.57 33.97 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 176.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 35.5 p -132.99 127.39 34.06 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 117.331 0.566 . . . . 0.0 109.721 176.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.462 HG23 ' HB ' ' A' ' 83' ' ' ILE . 11.4 tt -103.36 116.91 61.36 Favored Pre-proline 0 C--N 1.318 -0.796 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.964 177.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -88.63 128.04 2.02 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.973 2.449 . . . . 0.0 113.561 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.2 t70 50.98 72.96 1.07 Allowed Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.6 ' HD2' HG13 ' A' ' 80' ' ' ILE . 84.2 Cg_endo -104.09 18.8 0.16 Allowed 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 123.729 2.953 . . . . 0.0 110.706 174.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.535 ' O ' HG12 ' A' ' 80' ' ' ILE . . . 155.23 172.7 23.15 Favored Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.9 m -145.65 149.12 33.91 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.555 HD13 ' H ' ' A' ' 105' ' ' LEU 0.37 0.0 OUTLIER -81.18 157.62 25.2 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 119.519 -0.873 . . . . 0.0 113.259 179.118 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.4 m -83.53 -3.14 7.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -172.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.97 75.95 0.93 Allowed Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.646 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.661 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 48.8 m 78.91 91.46 0.06 Allowed 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 124.852 1.261 . . . . 0.0 111.756 -178.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 158.55 172.42 25.66 Favored Glycine 0 N--CA 1.425 -2.037 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.42 HG22 ' HB3' ' A' ' 71' ' ' LYS . 45.4 p -100.26 113.42 26.11 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.9 t -124.22 138.75 54.37 Favored 'General case' 0 N--CA 1.42 -1.937 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.333 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.2 m -86.36 134.62 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-O 121.416 0.627 . . . . 0.0 109.837 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.459 HD13 HD13 ' A' ' 80' ' ' ILE . 79.0 mt -125.24 167.01 15.46 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -140.31 148.51 41.5 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.464 -0.895 . . . . 0.0 112.848 -175.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 91.8 t -133.93 122.58 16.5 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 173.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -77.6 109.03 2.68 Favored 'Trans proline' 0 N--CA 1.41 -3.383 0 N-CA-C 108.059 -1.554 . . . . 0.0 108.059 171.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.477 HG12 ' CE2' ' A' ' 85' ' ' TYR . 33.8 m -98.87 149.66 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 177.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -101.99 99.17 9.31 Favored 'General case' 0 C--N 1.273 -2.725 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.2 m -91.72 149.94 3.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.92 -171.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.4 ' HB3' HG12 ' A' ' 62' ' ' VAL . . . 76.05 12.46 2.83 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.282 0.633 . . . . 0.0 110.907 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.561 ' O ' HG23 ' A' ' 125' ' ' VAL . 81.4 t80 -59.88 -39.61 85.9 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 172.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.448 ' HB3' ' HB ' ' A' ' 93' ' ' THR . 16.4 m -58.83 -32.71 69.64 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 122.317 1.056 . . . . 0.0 109.58 178.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.855 HG23 ' HA ' ' A' ' 128' ' ' MET . 1.8 mp -80.58 -48.39 19.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 126.141 1.776 . . . . 0.0 112.803 -175.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.69 -29.37 26.23 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.208 1.003 . . . . 0.0 111.866 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 121' ' ' TYR . 91.6 t -53.7 -19.75 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.849 0 C-N-CA 125.722 1.609 . . . . 0.0 112.307 175.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.2 t 105.17 25.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 127.191 2.196 . . . . 0.0 110.427 -175.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.451 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 27.7 tp -98.14 1.09 47.14 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.459 175.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.855 ' HA ' HG23 ' A' ' 123' ' ' ILE . 83.8 mtp -30.36 106.54 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 125.979 1.711 . . . . 0.0 111.646 179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.42 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -53.37 -41.62 66.05 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 114.0 -1.454 . . . . 0.0 112.602 -178.107 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.4 t70 176.1 -58.14 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.456 0.473 . . . . 0.0 111.104 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.536 ' SD ' ' HA ' ' A' ' 171' ' ' ARG 0.257 15.7 tpp 65.0 97.07 0.05 OUTLIER 'General case' 0 C--O 1.244 0.775 0 CA-C-O 122.146 0.974 . . . . 0.0 112.817 -173.436 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 45.4 t -141.88 164.43 30.22 Favored 'General case' 0 N--CA 1.415 -2.187 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 34.4 p -73.58 119.5 17.9 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.7 t70 71.81 88.2 0.1 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.25 1.02 . . . . 0.0 108.438 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 41.0 t-105 -160.36 158.64 30.0 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.658 -170.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -143.96 162.16 36.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 118.111 0.414 . . . . 0.0 111.139 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.41 HD12 ' HD2' ' A' ' 129' ' ' LYS . 5.5 tt -140.68 146.43 24.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 C-N-CA 123.442 0.697 . . . . 0.0 109.383 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -88.99 108.13 19.41 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.499 ' HB3' HG12 ' A' ' 165' ' ' ILE . 0.2 OUTLIER -125.58 155.97 39.86 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 124.137 0.975 . . . . 0.0 109.377 -179.222 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.0 pm0 -146.71 148.78 32.35 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.307 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 27.8 tp -121.02 126.72 50.61 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.275 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.401 ' HB3' ' HB ' ' A' ' 86' ' ' ILE . 15.4 t70 -127.94 130.08 47.86 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -176.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.588 HG23 HG23 ' A' ' 83' ' ' ILE . 37.7 mm -130.19 144.25 38.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 121.511 0.672 . . . . 0.0 112.484 -173.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -114.16 92.39 0.6 Allowed Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 172.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.9 121.85 24.7 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -174.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.574 ' OG1' HG22 ' A' ' 156' ' ' THR . 19.1 m -105.95 127.83 53.4 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 120.054 -0.658 . . . . 0.0 112.008 -177.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -121.13 140.28 52.21 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 173.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 154' ' ' ASP . 2.9 p30 -121.54 122.58 40.0 Favored 'General case' 0 CA--C 1.486 -1.514 0 C-N-CA 119.046 -1.062 . . . . 0.0 110.343 175.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 10.3 pt -140.43 143.34 32.63 Favored Pre-proline 0 C--N 1.301 -1.517 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.038 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.75 -5.3 10.15 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 123.472 2.781 . . . . 0.0 112.602 -178.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.16 -25.59 30.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.178 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 5.4 p -161.43 -39.44 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 140.56 -155.51 24.79 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 148' ' ' ASP . 7.1 p-10 -99.02 120.08 38.87 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.298 0.571 . . . . 0.0 109.743 177.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' ' 146' ' ' THR . 50.0 mt -123.35 132.23 71.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.136 -174.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.574 HG22 ' OG1' ' A' ' 146' ' ' THR . 44.1 p -91.0 113.46 25.73 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.425 174.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.0 mp -90.3 117.81 68.31 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -80.28 127.39 6.66 Favored 'Trans proline' 0 CA--C 1.487 -1.832 0 C-N-CA 122.104 1.869 . . . . 0.0 112.036 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.423 HG13 ' HB ' ' A' ' 143' ' ' ILE . 2.7 p -136.87 130.61 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.716 0 CA-C-N 112.706 -2.043 . . . . 0.0 108.669 -178.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 11.9 m -134.61 153.59 51.9 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.201 -174.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.4 t -147.24 137.21 23.13 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -99.57 122.44 42.63 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -139.3 -154.57 6.39 Favored Glycine 0 N--CA 1.405 -3.409 0 C-N-CA 119.465 -1.35 . . . . 0.0 110.71 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.04 159.5 29.39 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.499 HG12 ' HB3' ' A' ' 139' ' ' TYR . 52.0 mm -118.29 108.05 23.36 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.551 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 16.0 pttm -95.22 131.47 41.23 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.339 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 90.0 mt -110.73 91.8 13.16 Favored Pre-proline 0 C--N 1.283 -2.294 0 CA-C-N 114.64 -1.163 . . . . 0.0 110.212 -172.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' ' 166' ' ' LYS . 1.7 Cg_endo -83.0 82.93 2.05 Favored 'Trans proline' 0 N--CA 1.426 -2.448 0 C-N-CA 122.618 2.212 . . . . 0.0 112.251 -177.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 65.4 p 57.61 24.99 11.1 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.684 1.194 . . . . 0.0 114.182 174.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.463 ' HB3' ' CD1' ' A' ' 173' ' ' PHE . 38.7 mt -60.76 -62.0 2.18 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 120.665 0.269 . . . . 0.0 110.54 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.536 ' HA ' ' SD ' ' A' ' 131' ' ' MET . 78.3 mtp180 63.95 141.34 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 O-C-N 124.668 1.23 . . . . 0.0 111.5 -173.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 38.0 t70 78.08 1.84 2.79 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.69 0.796 . . . . 0.0 111.126 -177.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.463 ' CD1' ' HB3' ' A' ' 170' ' ' LEU . 72.5 m-85 -111.74 -6.49 14.31 Favored 'General case' 0 C--O 1.22 -0.5 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 175.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.49 ' HB2' ' HE2' ' A' ' 128' ' ' MET 0.318 42.9 p90 . . . . . 0 N--CA 1.439 -1.002 0 N-CA-C 118.544 2.794 . . . . 0.0 118.544 173.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.093 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -142.0 122.38 14.02 Favored 'General case' 0 CA--C 1.498 -1.036 0 C-N-CA 122.883 0.473 . . . . 0.0 109.848 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -100.55 105.65 17.09 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.565 0.697 . . . . 0.0 110.231 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -161.22 172.49 16.59 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -157.34 148.84 22.02 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.02 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -68.48 140.9 55.72 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 71.3 92.9 0.08 Allowed 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 123.955 0.902 . . . . 0.0 110.485 -174.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -68.44 98.72 0.87 Allowed 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 41.68 70.54 0.27 Allowed 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 125.765 1.626 . . . . 0.0 114.031 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -132.46 165.96 23.11 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.901 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.3 m -59.81 -31.76 70.01 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -174.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.575 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -74.93 -17.75 60.51 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -177.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -58.88 -27.3 65.07 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.296 0.57 . . . . 0.0 110.831 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.535 ' O ' ' HG3' ' A' ' 18' ' ' GLU . 42.7 tt0 -57.43 -47.31 82.11 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.516 176.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -74.57 -19.43 60.33 Favored 'General case' 0 CA--C 1.487 -1.464 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.531 -178.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 12' ' ' ALA . 22.0 t -71.19 -32.93 49.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.455 HG11 ' O ' ' A' ' 94' ' ' ILE . 59.9 t -69.24 -43.22 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 170.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 41.9 mt-10 -64.52 -46.75 81.59 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.863 -173.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.433 ' O ' HG23 ' A' ' 23' ' ' VAL . 8.0 pt-20 -55.53 -48.23 75.02 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 119.929 -0.709 . . . . 0.0 111.214 173.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.415 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 24.9 ttmm -65.5 -47.8 74.76 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 122.808 0.443 . . . . 0.0 111.43 -176.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.68 -39.22 76.63 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.118 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.1 t -66.52 -42.31 87.49 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.605 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 19' ' ' GLU . 65.5 t -62.92 -46.65 95.79 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 CA-C-O 121.116 0.484 . . . . 0.0 109.73 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.485 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 69.1 mt -64.08 -49.88 79.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.863 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.0 t -60.06 -35.09 74.4 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 122.664 0.386 . . . . 0.0 111.018 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.6 m -68.91 -30.47 68.96 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.12 0.486 . . . . 0.0 110.877 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.1 tt -75.82 -42.29 50.25 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 87.0 mt -63.05 -31.1 72.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.528 178.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -68.29 -49.31 61.36 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.426 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.533 ' HD2' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -67.37 -36.49 81.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.29 -177.21 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.533 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -77.46 -31.85 54.03 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.479 -178.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -55.48 -53.45 56.19 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.166 0.291 . . . . 0.0 110.532 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.648 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -62.27 -53.08 44.91 Favored Glycine 0 N--CA 1.437 -1.269 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.477 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -53.83 -41.95 67.95 Favored 'General case' 0 C--O 1.252 1.204 0 C-N-CA 124.316 1.046 . . . . 0.0 111.674 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.486 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 90.8 t80 -66.43 -51.88 52.31 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.76 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.58 -22.98 67.19 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -176.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.648 ' HG2' ' O ' ' A' ' 33' ' ' GLY . 10.9 pt-20 -93.1 -51.49 5.01 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.484 ' HD3' ' HG3' ' A' ' 37' ' ' GLU . 3.9 mppt? -103.35 -39.13 6.92 Favored 'General case' 0 CA--C 1.484 -1.574 0 C-N-CA 118.553 -1.259 . . . . 0.0 112.764 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 2.7 mm? -79.63 -1.53 38.53 Favored 'General case' 0 C--N 1.286 -2.19 0 C-N-CA 119.783 -0.767 . . . . 0.0 112.535 -174.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.12 -8.87 58.44 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 172.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -109.22 -48.78 3.21 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.245 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.9 mp -77.15 117.83 67.83 Favored Pre-proline 0 C--O 1.244 0.808 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.77 118.73 4.74 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.357 2.705 . . . . 0.0 113.504 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.0 p -141.38 165.14 30.73 Favored Pre-proline 0 C--N 1.304 -1.392 0 C-N-CA 125.18 1.392 . . . . 0.0 108.185 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -70.21 135.08 28.53 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.022 1.815 . . . . 0.0 112.347 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -97.48 112.83 24.51 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.957 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.26 125.78 43.49 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.178 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -127.39 132.21 50.18 Favored 'General case' 0 N--CA 1.417 -2.093 0 CA-C-O 121.639 0.733 . . . . 0.0 110.588 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.46 HG13 HG22 ' A' ' 159' ' ' VAL . 11.7 m -83.44 144.17 10.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.663 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -119.34 -67.2 1.0 Allowed 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.433 -174.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -172.43 174.09 3.93 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -177.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.701 HG22 ' HB3' ' A' ' 64' ' ' TYR . 10.5 p -116.48 126.62 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -95.73 119.52 34.38 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.532 -172.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.697 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 37.2 p90 -63.12 125.8 25.27 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.911 0.386 . . . . 0.0 111.761 175.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.549 ' HG3' ' CD2' ' A' ' 65' ' ' HIS . 29.5 mmmt -109.11 -66.3 1.07 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.777 -176.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.32 177.84 21.9 Favored Glycine 0 N--CA 1.431 -1.67 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.864 -175.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 173' ' ' PHE . 6.5 p -98.4 136.94 27.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -177.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.651 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 59.6 m -137.45 146.13 43.95 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -59.35 -43.44 92.78 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.981 0.912 . . . . 0.0 112.235 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.422 ' HB3' ' CD1' ' A' ' 121' ' ' TYR . 19.6 m-20 -61.96 -56.68 16.63 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.171 0.986 . . . . 0.0 109.59 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.651 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . -165.77 165.89 38.26 Favored Glycine 0 N--CA 1.407 -3.299 0 N-CA-C 105.857 -2.897 . . . . 0.0 105.857 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.94 141.87 17.14 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-N 117.689 0.745 . . . . 0.0 111.733 -176.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -87.46 111.79 21.52 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.25 -173.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.701 ' HB3' HG22 ' A' ' 52' ' ' VAL . 7.0 m-85 -120.1 161.24 21.32 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-O 121.761 0.791 . . . . 0.0 111.479 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.549 ' CD2' ' HG3' ' A' ' 55' ' ' LYS . 19.7 m170 -116.9 117.92 31.02 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.015 172.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.566 ' HB3' ' HB ' ' A' ' 115' ' ' VAL . . . -77.78 122.79 25.88 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.433 ' HG3' ' CG1' ' A' ' 112' ' ' VAL . 40.1 ttmt -87.44 107.84 18.74 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.636 -175.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.4 t -112.47 109.15 27.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 114.538 -1.21 . . . . 0.0 107.931 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.0 p -101.16 119.34 38.61 Favored 'General case' 0 C--N 1.277 -2.556 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.967 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 110' ' ' THR . 78.0 t -106.28 119.48 55.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.267 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -97.91 109.57 22.3 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' A' ' 108' ' ' SER . 41.6 t30 -112.27 119.46 43.78 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -175.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -93.83 97.62 0.14 Allowed 'Trans proline' 0 N--CA 1.434 -2.025 0 C-N-CA 121.861 1.707 . . . . 0.0 112.089 173.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.568 ' O ' ' HB2' ' A' ' 108' ' ' SER . 34.1 m-85 -169.92 -160.3 0.23 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 127.209 2.204 . . . . 0.0 106.678 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.5 m -143.37 19.7 1.89 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.538 0.685 . . . . 0.0 109.297 172.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.427 ' O ' ' HA2' ' A' ' 107' ' ' GLY . 13.1 pt20 -113.68 143.62 44.29 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.842 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.1 p -85.41 86.05 7.4 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.091 0.472 . . . . 0.0 110.588 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 64.6 mt -72.88 119.52 75.88 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.461 -177.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -88.91 124.19 1.49 Allowed 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 122.27 1.98 . . . . 0.0 110.876 175.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.421 HG13 ' HD2' ' A' ' 102' ' ' PRO . 24.2 pt -77.29 130.26 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.292 177.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 41.8 t -72.34 -40.17 67.59 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.327 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -153.68 155.83 36.72 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.5 tt -124.27 120.31 58.92 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 172.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.9 m -99.41 128.85 45.56 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -174.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -127.39 141.11 51.77 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.189 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.565 ' HB ' ' HB3' ' A' ' 142' ' ' ASP . 68.0 mt -119.37 108.18 23.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 172.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.54 HD13 ' HB3' ' A' ' 95' ' ' ALA . 0.8 OUTLIER -101.74 122.65 44.34 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -179.095 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.438 ' HG3' ' HB ' ' A' ' 94' ' ' ILE . 67.5 tttt -123.29 154.37 38.94 Favored 'General case' 0 C--N 1.277 -2.547 0 C-N-CA 118.38 -1.328 . . . . 0.0 108.249 176.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.1 m -141.43 126.97 18.89 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.057 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 59.18 14.29 3.47 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.234 1.014 . . . . 0.0 111.094 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.41 ' O ' ' HE2' ' A' ' 88' ' ' LYS . 41.1 m 68.17 -2.69 1.44 Allowed 'General case' 0 CA--C 1.584 2.267 0 C-N-CA 124.451 1.101 . . . . 0.0 112.489 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.24 -80.81 0.24 Allowed 'General case' 0 C--O 1.237 0.408 0 O-C-N 121.199 -0.938 . . . . 0.0 111.346 176.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 94' ' ' ILE . 29.1 m -84.72 166.05 17.34 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.274 -176.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.52 HD13 ' N ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -159.88 148.54 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.468 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 -167.854 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.54 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -128.87 127.21 41.37 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 176.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.7 t -137.73 151.14 47.89 Favored 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.438 -177.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.85 174.4 46.53 Favored Glycine 0 N--CA 1.411 -3.027 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.411 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 41.4 p -128.46 137.26 51.73 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.2 mp -102.09 108.03 55.07 Favored Pre-proline 0 C--N 1.308 -1.197 0 C-N-CA 118.15 -1.42 . . . . 0.0 108.575 173.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 98' ' ' THR . 10.3 Cg_exo -74.12 129.51 13.25 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 122.345 2.03 . . . . 0.0 109.848 175.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 56.21 68.77 2.1 Favored Pre-proline 0 N--CA 1.477 0.916 0 C-N-CA 124.153 0.981 . . . . 0.0 111.14 -175.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.421 ' HD2' HG13 ' A' ' 80' ' ' ILE . 64.2 Cg_endo -102.89 -0.25 0.36 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.384 2.723 . . . . 0.0 114.166 -176.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 152.31 179.29 27.79 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 56.3 m -149.82 156.46 41.84 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 116.934 0.367 . . . . 0.0 110.493 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.435 HD23 ' HB2' ' A' ' 72' ' ' ASN . 7.5 mp -79.5 143.4 34.93 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.343 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 27.0 m -68.33 -16.32 20.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.878 -1.056 . . . . 0.0 113.356 -177.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 76' ' ' GLN . . . 129.16 -57.92 0.71 Allowed Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.568 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 24.9 t -156.68 139.58 15.28 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 175.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 119.57 -177.8 16.44 Favored Glycine 0 C--N 1.292 -1.907 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 9.9 t -89.56 117.95 28.84 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.815 0.817 . . . . 0.0 110.407 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.434 HG21 ' HA ' ' A' ' 105' ' ' LEU . 5.0 t -114.87 132.83 56.39 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.095 177.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.433 ' CG1' ' HG3' ' A' ' 67' ' ' LYS . 39.6 t -92.46 121.69 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.831 -177.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.9 mt -106.96 148.14 29.01 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.152 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -110.7 122.31 47.49 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 86.0 t -100.22 116.6 64.33 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 169.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.76 108.96 2.54 Favored 'Trans proline' 0 N--CA 1.43 -2.244 0 N-CA-C 106.171 -2.281 . . . . 0.0 106.171 169.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.439 HG13 HG13 ' A' ' 119' ' ' VAL . 14.0 p -126.63 139.12 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.381 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -175.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -94.04 94.97 8.72 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.535 ' HA ' HD11 ' A' ' 87' ' ' LEU . 4.5 m -94.21 148.5 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.583 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -175.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.473 ' HB1' ' CE1' ' A' ' 174' ' ' PHE . . . 73.44 -4.28 2.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.369 -178.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.422 ' CD1' ' HB3' ' A' ' 60' ' ' ASP . 61.7 t80 -58.94 -41.05 86.45 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 171.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.7 p -62.34 -32.19 72.92 Favored 'General case' 0 N--CA 1.417 -2.077 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.913 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 45.6 mm -80.9 -49.83 17.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.242 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.63 -42.85 95.2 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.438 0.461 . . . . 0.0 111.204 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.3 t -66.95 -29.04 44.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.562 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.6 t -86.47 -72.37 0.5 Allowed 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.628 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.583 HD12 ' N ' ' A' ' 128' ' ' MET . 3.0 pp -124.72 -35.3 2.73 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -172.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.583 ' N ' HD12 ' A' ' 127' ' ' LEU . 12.5 tpt 58.92 114.49 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.506 1.123 . . . . 0.0 112.398 -174.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -65.27 -75.42 0.09 Allowed 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.516 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.5 t70 159.78 -32.82 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 105.194 -2.151 . . . . 0.0 105.194 -175.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER 69.47 127.44 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 112.288 -2.233 . . . . 0.0 110.91 -177.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 42.0 t -128.16 150.72 49.87 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.561 HG22 ' HA ' ' A' ' 169' ' ' SER . 66.9 p -61.78 117.61 6.08 Favored 'General case' 0 N--CA 1.407 -2.608 0 C-N-CA 124.339 1.056 . . . . 0.0 109.678 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 75.86 80.91 0.1 Allowed 'General case' 0 CA--C 1.507 -0.673 0 CA-C-O 121.926 0.87 . . . . 0.0 110.63 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 15.8 t-105 -146.15 116.26 7.4 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.816 -1.538 . . . . 0.0 111.214 -175.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' A' ' 165' ' ' ILE . 5.7 p-10 -98.09 126.11 43.38 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 15.6 tt -112.28 145.82 17.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.3 -175.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -74.67 105.91 5.98 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 122.376 1.084 . . . . 0.0 111.043 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.47 150.85 51.99 Favored 'General case' 0 C--N 1.265 -3.095 0 CA-C-N 113.297 -1.774 . . . . 0.0 106.934 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . 0.304 0.1 OUTLIER -146.19 157.34 43.82 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.209 176.526 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.535 ' HB3' ' HB ' ' A' ' 161' ' ' THR . 28.4 tp -135.53 143.31 45.68 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -171.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.565 ' HB3' ' HB ' ' A' ' 86' ' ' ILE . 17.9 t70 -142.32 114.08 8.0 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 177.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 158' ' ' PRO . 49.1 mt -116.24 142.82 28.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.305 -174.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.405 ' HA3' ' CD2' ' A' ' 28' ' ' LEU . . . -120.62 108.39 1.4 Allowed Glycine 0 N--CA 1.421 -2.33 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 176.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 156' ' ' THR . 3.8 mm? -84.33 115.84 22.7 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 122.566 0.346 . . . . 0.0 110.873 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.425 ' OG1' HG22 ' A' ' 156' ' ' THR . 32.3 m -90.47 107.15 18.98 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.644 ' O ' ' HA ' ' A' ' 154' ' ' ASP . 93.8 m-85 -111.5 142.04 44.29 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 176.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -108.51 110.05 21.45 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.0 mp -121.7 126.58 26.37 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.19 -12.73 0.84 Allowed 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 124.481 3.454 . . . . 0.0 116.176 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 24.6 m -73.69 -22.98 18.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 O-C-N 122.065 -0.397 . . . . 0.0 111.203 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.2 p -148.46 -32.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.496 0.665 . . . . 0.0 111.417 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 115.39 -136.63 13.22 Favored Glycine 0 N--CA 1.416 -2.699 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 -175.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.644 ' HA ' ' O ' ' A' ' 147' ' ' PHE . 5.7 p-10 -95.73 131.03 42.44 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 121.376 0.608 . . . . 0.0 110.983 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.47 131.46 54.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 176.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.57 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 73.8 p -87.72 118.58 27.32 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.699 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.503 HD13 ' CD2' ' A' ' 147' ' ' PHE . 2.3 mp -81.35 110.99 21.12 Favored Pre-proline 0 C--N 1.316 -0.854 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 173.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 19.2 Cg_endo -88.02 113.38 0.81 Allowed 'Trans proline' 0 CA--C 1.475 -2.428 0 C-N-CA 122.489 2.126 . . . . 0.0 111.555 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.46 HG22 HG13 ' A' ' 49' ' ' VAL . 2.9 p -116.93 108.32 24.66 Favored 'Isoleucine or valine' 2 N--CA 1.361 -4.923 0 CA-C-N 112.174 -2.285 . . . . 0.0 109.231 -176.678 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 27.3 m -89.59 152.47 21.38 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.23 -173.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 141' ' ' LEU . 1.6 m -140.56 139.6 35.03 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -177.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -99.62 118.61 36.54 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 164.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -108.75 93.28 0.77 Allowed Glycine 0 N--CA 1.413 -2.869 0 C-N-CA 118.77 -1.681 . . . . 0.0 112.697 -171.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -89.22 118.91 29.25 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 175.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 136' ' ' ASP . 7.8 pt -124.33 121.05 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 CA-C-O 121.617 0.723 . . . . 0.0 110.678 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -91.46 104.05 16.6 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 114.229 -1.35 . . . . 0.0 110.95 -177.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 7.1 mp -82.45 111.93 32.5 Favored Pre-proline 0 C--N 1.295 -1.785 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 176.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -82.06 -160.89 0.13 Allowed 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 122.259 1.973 . . . . 0.0 110.189 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.561 ' HA ' HG22 ' A' ' 133' ' ' THR . 28.9 t -56.04 92.82 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 167.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 21.6 tp -144.9 27.54 1.31 Allowed 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 -177.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.488 ' NH1' ' HB2' ' A' ' 172' ' ' ASP . 2.5 tmm_? -63.41 122.56 16.54 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.534 -1.212 . . . . 0.0 107.897 -176.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.488 ' HB2' ' NH1' ' A' ' 171' ' ' ARG . 25.5 t70 79.97 73.78 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.815 0 C-N-CA 125.136 1.374 . . . . 0.0 108.954 -175.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.456 ' O ' HG23 ' A' ' 57' ' ' VAL . 12.1 t80 -171.91 -47.97 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 101.097 -3.668 . . . . 0.0 101.097 -178.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.473 ' CE1' ' HB1' ' A' ' 120' ' ' ALA . 35.2 t80 . . . . . 0 N--CA 1.423 -1.786 0 CA-C-N 113.058 -1.883 . . . . 0.0 106.408 163.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.743 0 N-CA-C 111.701 -0.56 . . . . 0.0 111.701 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -140.97 29.34 1.87 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -177.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -61.2 115.43 3.8 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -102.1 119.54 38.96 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 116.758 2.133 . . . . 0.0 116.758 -165.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -115.72 21.55 13.81 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.88 169.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -71.84 87.6 1.0 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -109.23 76.41 1.0 Allowed 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.102 -169.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.5 mp 39.62 -94.24 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.524 1.93 . . . . 0.0 115.795 173.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -101.99 96.12 6.82 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.782 -177.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.45 152.11 1.67 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.46 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.426 ' HA ' ' OE2' ' A' ' 14' ' ' GLU . 57.4 m -73.96 -17.54 60.99 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.297 0.57 . . . . 0.0 110.327 176.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.602 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -64.41 -47.28 79.78 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 171.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -57.5 -43.67 84.37 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.884 0.874 . . . . 0.0 109.749 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 18' ' ' GLU . 45.6 mt-10 -57.2 -41.61 79.7 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.053 176.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.511 ' HD3' ' C ' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -67.45 -49.0 65.58 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.291 0.567 . . . . 0.0 110.02 177.604 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 12' ' ' ALA . 57.7 t -64.61 -35.85 75.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.333 -0.849 . . . . 0.0 113.023 -173.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 p -66.15 -29.59 47.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 65.1 mt-10 -76.79 -44.95 30.67 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 122.057 0.932 . . . . 0.0 108.597 178.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -55.3 -46.94 76.24 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.497 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.693 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -70.75 -36.17 73.0 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.275 177.6 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.67 90.88 Favored 'General case' 0 C--O 1.213 -0.817 0 O-C-N 123.282 0.363 . . . . 0.0 110.574 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.8 m -61.01 -38.19 85.2 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 120.727 0.299 . . . . 0.0 111.582 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.8 -34.94 73.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 20' ' ' LYS . 78.8 mt -69.27 -49.67 59.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.45 -0.795 . . . . 0.0 108.967 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.0 m -57.4 -33.82 68.25 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.992 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.2 t -57.68 -35.23 70.32 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.17 0.588 . . . . 0.0 111.721 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.441 HD23 ' HE2' ' A' ' 30' ' ' LYS . 4.5 tt -80.33 -43.77 20.63 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.496 HD23 ' HB3' ' A' ' 158' ' ' PRO . 9.1 mp -62.3 -34.56 76.83 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -62.41 -34.05 75.97 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.441 ' HE2' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -83.19 -18.66 38.53 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.712 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.22 -32.08 64.54 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.705 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -50.67 -52.75 36.96 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.679 0.791 . . . . 0.0 112.327 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -90.32 7.32 81.69 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.905 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.491 ' HA ' ' HE2' ' A' ' 38' ' ' LYS . 29.1 t80 -85.46 -26.18 26.48 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.63 ' CD1' HD12 ' A' ' 39' ' ' LEU . 44.8 m-85 -70.35 -41.08 73.63 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -174.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.29 -50.77 49.44 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -168.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.452 ' HG2' ' HG3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -117.78 -31.62 5.08 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.259 -0.576 . . . . 0.0 112.072 179.374 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 34' ' ' PHE . 36.7 mtmm -84.84 -9.71 57.88 Favored 'General case' 0 CA--C 1.486 -1.49 0 CA-C-O 121.484 0.659 . . . . 0.0 111.534 -168.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.63 HD12 ' CD1' ' A' ' 35' ' ' PHE . 88.5 mt -128.43 17.98 6.43 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.194 174.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.66 -44.32 21.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.735 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -95.26 11.37 32.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.623 0.725 . . . . 0.0 110.061 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.3 mm -115.57 117.2 40.66 Favored Pre-proline 0 N--CA 1.435 -1.204 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -65.03 113.92 2.59 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 121.991 1.794 . . . . 0.0 111.158 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.3 p -118.19 139.23 26.44 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.917 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.446 ' HB3' HD21 ' A' ' 105' ' ' LEU . 64.7 Cg_endo -74.71 143.88 30.65 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.563 2.175 . . . . 0.0 112.289 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -97.48 130.19 44.6 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -113.0 134.29 54.57 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.9 t -115.83 123.98 49.55 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 121.989 0.9 . . . . 0.0 111.416 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.549 HG22 HG12 ' A' ' 159' ' ' VAL . 26.0 m -102.39 143.87 14.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 114.288 -1.323 . . . . 0.0 109.958 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.575 24.2 t70 117.25 78.61 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 117.821 2.526 . . . . 0.0 117.821 176.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.617 ' HB2' ' HB3' ' A' ' 67' ' ' LYS . 31.9 m-20 -161.3 111.0 1.63 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 102.809 -3.034 . . . . 0.0 102.809 170.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.442 HG12 ' CD2' ' A' ' 64' ' ' TYR . 31.8 t -137.94 134.01 44.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.309 -168.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -137.42 137.26 38.6 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.256 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.599 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 37.8 p90 -91.83 141.82 28.25 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.093 0.557 . . . . 0.0 111.154 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.648 ' HD2' ' N ' ' A' ' 55' ' ' LYS . 3.0 mptp? -107.75 -52.23 2.79 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.89 178.55 40.55 Favored Glycine 0 C--N 1.293 -1.856 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.054 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.71 148.99 5.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 117.039 0.419 . . . . 0.0 110.508 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.6 p -131.28 179.15 6.19 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 176.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -75.6 -32.19 60.21 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.564 0.697 . . . . 0.0 109.328 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.22 83.44 3.6 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.81 176.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.92 -162.67 38.63 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.006 -176.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 p -107.59 145.04 15.37 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.703 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -84.97 121.74 28.2 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.628 0.728 . . . . 0.0 112.373 -170.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.652 ' CD1' ' HB ' ' A' ' 119' ' ' VAL . 28.2 m-85 -129.3 172.24 11.68 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.547 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -138.85 117.34 12.06 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 176.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.19 145.75 24.26 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.724 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.617 ' HB3' ' HB2' ' A' ' 51' ' ' ASP . 47.8 tttm -116.43 124.34 49.76 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.03 -177.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.497 HG12 HG12 ' A' ' 49' ' ' VAL . 34.1 m -128.43 111.64 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-O 121.784 0.802 . . . . 0.0 109.242 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.9 m -98.5 130.63 45.09 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.364 -175.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.18 124.97 66.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.035 0.445 . . . . 0.0 110.814 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -117.34 125.51 51.16 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.061 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 108' ' ' SER . 4.7 t30 -152.45 114.56 2.85 Favored Pre-proline 0 C--N 1.286 -2.165 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.277 176.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -99.41 96.37 0.05 OUTLIER 'Trans proline' 0 N--CA 1.418 -2.941 0 C-N-CA 121.812 1.674 . . . . 0.0 109.779 169.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 93.3 t80 178.23 111.9 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 177.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.7 p -56.86 85.12 0.01 OUTLIER 'General case' 0 C--O 1.242 0.686 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -156.07 105.0 2.31 Favored 'General case' 1 N--CA 1.369 -4.486 0 C-N-CA 126.552 1.941 . . . . 0.0 106.527 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.6 p -89.53 97.01 10.95 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.491 ' H ' HD13 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -103.85 134.93 19.46 Favored Pre-proline 0 C--N 1.31 -1.131 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.787 178.665 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -89.19 159.87 5.7 Favored 'Trans proline' 0 N--CA 1.438 -1.784 0 C-N-CA 122.427 2.085 . . . . 0.0 110.891 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 54.2 mt -91.03 114.91 29.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 100' ' ' PRO . 47.2 t -67.93 -37.94 82.27 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.267 0.556 . . . . 0.0 110.252 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -152.89 112.72 3.93 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.708 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 98' ' ' THR . 18.3 tt -95.77 119.43 43.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 175.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 143' ' ' ILE . 10.5 m -111.31 121.75 46.05 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.754 -172.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.438 ' CE1' HG13 ' A' ' 117' ' ' VAL . 23.7 p90 -109.65 136.41 49.05 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 175.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 63.7 mt -117.06 108.1 24.04 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.668 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 174.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -90.83 120.75 32.11 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 -174.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -118.83 163.78 16.38 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -172.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.1 t -105.57 147.41 28.43 Favored 'General case' 0 N--CA 1.41 -2.447 0 CA-C-N 112.181 -2.281 . . . . 0.0 106.59 172.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.13 -15.43 63.59 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 123.424 0.453 . . . . 0.0 110.873 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.0 t -143.93 -38.22 0.31 Allowed 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -176.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -148.31 128.27 13.56 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 118.785 -1.166 . . . . 0.0 112.687 -172.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.501 ' O ' ' HB3' ' A' ' 122' ' ' SER . 90.6 m 74.13 137.98 0.06 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.37 1.068 . . . . 0.0 113.093 177.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.443 ' C ' HD12 ' A' ' 94' ' ' ILE . 1.9 pp -134.06 171.76 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.5 172.82 12.39 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 176.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 64.1 p -152.82 175.59 12.72 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 122.079 -0.388 . . . . 0.0 110.7 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.03 144.45 4.51 Favored Glycine 0 N--CA 1.435 -1.376 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 41.9 p -132.36 136.63 46.97 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 117.023 0.411 . . . . 0.0 110.529 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.1 mp -113.3 107.11 54.02 Favored Pre-proline 0 C--N 1.313 -1.001 0 C-N-CA 119.419 -0.913 . . . . 0.0 109.167 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 81' ' ' CYS . 18.6 Cg_exo -69.4 116.65 4.62 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.515 2.143 . . . . 0.0 110.031 173.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.2 t70 62.35 79.1 0.27 Allowed Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 123.51 0.724 . . . . 0.0 111.533 -177.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -107.08 12.49 0.15 Allowed 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 124.291 3.327 . . . . 0.0 112.563 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 141.68 -174.22 23.14 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.8 m -151.07 170.82 18.47 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 117.578 0.689 . . . . 0.0 110.679 -177.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.446 HD21 ' HB3' ' A' ' 45' ' ' PRO . 10.3 mp -74.02 157.58 35.87 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 114.762 1.394 . . . . 0.0 114.762 177.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.56 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 7.1 p -79.0 -20.68 12.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 CA-C-N 112.338 -2.21 . . . . 0.0 110.737 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 106.15 -60.97 0.35 Allowed Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 23.2 t -152.81 84.57 1.23 Allowed 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.435 0.636 . . . . 0.0 109.548 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 161.95 -151.74 21.91 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 108.989 -1.645 . . . . 0.0 108.989 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.0 t -122.82 136.77 54.98 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.193 0.521 . . . . 0.0 110.135 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.56 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 4.4 t -130.79 138.3 49.84 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.694 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 50.8 t -91.55 113.53 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-O 121.048 0.452 . . . . 0.0 110.982 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.9 mt -103.3 166.92 10.15 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -147.28 149.83 33.62 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 119.804 -0.759 . . . . 0.0 112.501 -171.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.0 t -125.92 132.62 24.37 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -77.01 110.81 3.11 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 N-CA-C 107.417 -1.801 . . . . 0.0 107.417 167.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.438 HG13 ' CE1' ' A' ' 85' ' ' TYR . 66.3 t -119.99 136.18 57.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.326 -174.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -88.77 99.0 12.02 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 173.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.652 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 82.6 t -93.44 146.54 6.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.603 -173.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 72.7 1.07 3.86 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 124.646 1.179 . . . . 0.0 111.759 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.519 ' O ' HG12 ' A' ' 125' ' ' VAL . 83.8 t80 -54.26 -49.38 69.67 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 175.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.501 ' HB3' ' O ' ' A' ' 93' ' ' THR . 29.0 m -64.3 -29.34 70.42 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.727 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.6 mm -79.51 -50.68 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.455 ' HA ' ' HG2' ' A' ' 128' ' ' MET . . . -63.11 -49.33 74.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -175.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.519 HG12 ' O ' ' A' ' 121' ' ' TYR . 8.0 p -72.24 -22.28 20.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.938 0.399 . . . . 0.0 111.584 -175.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.0 t -99.51 -62.52 1.23 Allowed 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.513 HD23 ' H ' ' A' ' 127' ' ' LEU . 1.8 pt? -124.91 -41.61 2.09 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -171.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.455 ' HG2' ' HA ' ' A' ' 124' ' ' ALA . 81.3 mtp 65.88 -177.97 0.19 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -169.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -137.31 -78.31 0.39 Allowed 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.3 t70 178.59 93.28 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.181 0 CA-C-N 114.494 -1.23 . . . . 0.0 107.728 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.58 ' SD ' ' HB2' ' A' ' 170' ' ' LEU . 0.3 OUTLIER -52.18 101.66 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.344 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.822 175.635 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 82.1 m -108.27 167.66 9.86 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.433 0.635 . . . . 0.0 112.176 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.509 HG22 ' HB3' ' A' ' 169' ' ' SER . 40.3 p -77.63 127.55 32.66 Favored 'General case' 0 N--CA 1.404 -2.752 0 C-N-CA 124.921 1.288 . . . . 0.0 108.561 169.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.6 t70 54.91 91.69 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.65 1.18 . . . . 0.0 109.625 -172.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -148.69 158.97 44.52 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.908 -169.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -142.19 148.24 37.89 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.546 HG12 HD21 ' A' ' 167' ' ' LEU . 27.8 pt -128.97 145.3 35.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 120.865 0.364 . . . . 0.0 110.874 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -97.41 111.86 23.94 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -128.12 163.13 25.31 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.583 ' HG3' ' O ' ' A' ' 161' ' ' THR . 34.3 tt0 -136.45 150.01 48.51 Favored 'General case' 0 C--N 1.283 -2.314 0 O-C-N 121.68 -0.637 . . . . 0.0 111.053 -178.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 2.0 pt? -141.25 120.44 12.96 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 172.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.406 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 6.8 m-20 -84.14 122.63 29.1 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 84' ' ' SER . 34.5 mm -108.24 117.28 53.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 C-N-CA 118.799 -1.16 . . . . 0.0 109.644 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -94.07 96.84 2.11 Favored Glycine 0 N--CA 1.419 -2.46 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 156' ' ' THR . 2.7 mm? -79.16 108.72 12.87 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.446 ' OG1' HG22 ' A' ' 156' ' ' THR . 26.1 m -89.85 107.36 19.06 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.294 -0.962 . . . . 0.0 108.83 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.413 ' CE2' ' HB3' ' A' ' 145' ' ' LEU . 73.4 m-85 -114.55 131.31 56.71 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 154' ' ' ASP . 4.6 p-10 -108.78 112.17 24.3 Favored 'General case' 0 C--N 1.287 -2.122 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.757 173.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.454 HG22 HG22 ' A' ' 151' ' ' VAL . 2.5 mp -104.2 120.09 52.0 Favored Pre-proline 0 C--N 1.292 -1.904 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 176.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -41.85 -32.21 1.63 Allowed 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 124.386 3.391 . . . . 0.0 115.455 -174.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.454 HG22 HG22 ' A' ' 149' ' ' ILE . 33.8 m -74.78 -21.98 17.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 13.9 p -126.18 -28.69 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.818 -177.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 148' ' ' ASP . . . 107.34 -156.47 15.92 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 148' ' ' ASP . 7.2 p-10 -90.53 120.25 31.46 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.48 0.657 . . . . 0.0 111.47 -178.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.462 ' O ' HD12 ' A' ' 155' ' ' ILE . 2.4 pp -128.83 138.05 55.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.61 175.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.446 HG22 ' OG1' ' A' ' 146' ' ' THR . 67.3 p -94.21 127.29 39.96 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.196 177.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 51.2 mt -101.15 105.15 37.44 Favored Pre-proline 0 C--N 1.295 -1.79 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.496 ' HB3' HD23 ' A' ' 28' ' ' LEU . 3.2 Cg_exo -76.97 109.9 2.93 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 122.646 2.231 . . . . 0.0 111.305 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.549 HG12 HG22 ' A' ' 49' ' ' VAL . 19.0 t -103.97 124.6 58.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 175.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 14.7 m -126.78 152.14 47.32 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.154 -173.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.583 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 14.0 t -174.62 162.22 3.34 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.257 0.0 OUTLIER -99.46 135.84 40.29 Favored 'General case' 0 N--CA 1.409 -2.494 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.972 172.332 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -108.38 113.01 3.7 Favored Glycine 0 N--CA 1.397 -3.905 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -177.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -89.55 119.67 30.18 Favored 'General case' 0 N--CA 1.405 -2.702 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 174.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 10.0 pt -118.34 140.67 40.99 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.909 -176.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -90.72 136.49 33.03 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.536 -173.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.546 HD21 HG12 ' A' ' 137' ' ' ILE . 2.0 mm? -115.34 94.84 40.89 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.1 49.48 2.56 Favored 'Trans proline' 0 N--CA 1.486 1.08 0 C-N-CA 123.359 2.706 . . . . 0.0 112.944 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.509 ' HB3' HG22 ' A' ' 133' ' ' THR . 2.9 m 67.11 93.39 0.07 Allowed 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 125.108 1.363 . . . . 0.0 110.758 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.685 ' HB3' ' CD1' ' A' ' 173' ' ' PHE . 3.0 mm? -98.77 -59.48 1.73 Allowed 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.093 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 61.21 104.62 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.187 0.995 . . . . 0.0 111.602 -174.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 33.5 t70 70.49 64.19 0.2 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.866 1.266 . . . . 0.0 112.075 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.685 ' CD1' ' HB3' ' A' ' 170' ' ' LEU . 57.6 m-85 -153.83 -47.7 0.09 Allowed 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 125.933 1.693 . . . . 0.0 106.565 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.534 ' HB3' ' SD ' ' A' ' 131' ' ' MET . 87.9 t80 . . . . . 0 N--CA 1.433 -1.293 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 173.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.768 0 N-CA-C 111.689 -0.565 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -120.0 104.09 9.85 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 122.412 -0.464 . . . . 0.0 110.561 178.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.6 m80 -104.14 131.36 51.51 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 175.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -73.01 131.35 42.03 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -152.15 113.66 4.33 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.394 0.616 . . . . 0.0 112.032 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -138.04 112.01 8.42 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.615 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . 0.303 89.8 m-70 61.59 83.19 0.15 Allowed 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.23 39.68 3.07 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 174.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 83.86 -84.24 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 111.836 -2.438 . . . . 0.0 105.753 -163.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 153.43 148.52 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.626 1.57 . . . . 0.0 109.098 174.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 40.5 m -80.17 86.54 5.58 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 166.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.552 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -49.58 -56.09 11.19 Favored 'General case' 0 CA--C 1.495 -1.141 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.873 -168.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.533 ' O ' HG23 ' A' ' 17' ' ' VAL . 10.1 m-20 -56.78 -43.5 80.91 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -174.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -67.86 -29.86 69.1 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-O 121.355 0.598 . . . . 0.0 110.778 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 11.7 tmtt? -75.26 -54.25 7.42 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.792 0.806 . . . . 0.0 110.139 177.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 12' ' ' ALA . 47.5 t -59.95 -41.76 87.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 CA-C-N 114.946 -1.025 . . . . 0.0 112.682 -177.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 13' ' ' ASP . 40.2 t -68.5 -27.51 36.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 C-N-CA 118.842 -1.143 . . . . 0.0 109.077 176.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.457 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 33.0 tt0 -63.09 -34.78 78.33 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.974 0.892 . . . . 0.0 108.651 -177.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.38 -49.72 72.7 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.265 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -65.08 -43.05 93.44 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.2 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.74 -37.99 80.5 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.205 -178.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.2 t -60.73 -40.37 92.1 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 123.303 0.377 . . . . 0.0 110.29 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.13 -49.76 73.91 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.529 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 64.1 mt -68.85 -39.81 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.963 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 56.2 m -61.01 -37.8 83.83 Favored 'General case' 0 C--O 1.215 -0.744 0 O-C-N 122.299 -0.251 . . . . 0.0 110.643 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.9 m -67.19 -20.91 65.78 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.111 0.482 . . . . 0.0 111.348 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -78.04 -51.53 10.18 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.472 HD23 ' HB3' ' A' ' 158' ' ' PRO . 8.1 mp -60.85 -34.0 73.91 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.409 177.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -53.33 -49.47 67.0 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.524 0.73 . . . . 0.0 111.465 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -82.13 -31.64 30.51 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.07 -32.49 70.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.713 0.292 . . . . 0.0 111.638 177.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.487 ' CG ' ' HG2' ' A' ' 158' ' ' PRO . 56.6 mtmt -61.82 -25.77 67.71 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.568 176.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.48 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -73.48 -50.84 10.71 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 175.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -58.37 -40.67 82.89 Favored 'General case' 0 C--O 1.198 -1.611 0 CA-C-O 120.397 0.141 . . . . 0.0 111.113 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -60.11 -35.49 75.36 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.999 -0.681 . . . . 0.0 111.81 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.09 -39.2 50.54 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 33' ' ' GLY . 10.9 pt-20 -96.29 -40.07 9.33 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -176.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.435 ' HB2' ' HE2' ' A' ' 38' ' ' LYS . 8.2 tppt? -90.67 -47.93 7.36 Favored 'General case' 0 CA--C 1.479 -1.781 0 CA-C-O 122.74 1.257 . . . . 0.0 107.927 -167.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.491 HD13 HG21 ' A' ' 44' ' ' THR . 58.6 mt -82.91 6.2 19.32 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 112.91 -1.95 . . . . 0.0 111.331 -173.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.25 -38.54 30.75 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 173.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -88.41 -39.97 13.87 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.863 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.6 mt -73.5 135.91 78.39 Favored Pre-proline 0 N--CA 1.435 -1.178 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -72.6 94.65 0.78 Allowed 'Trans proline' 0 N--CA 1.441 -1.574 0 N-CA-C 106.404 -2.191 . . . . 0.0 106.404 171.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.491 HG21 HD13 ' A' ' 39' ' ' LEU . 4.9 m -100.27 137.16 19.95 Favored Pre-proline 0 N--CA 1.415 -2.216 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.814 -167.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.486 ' HB3' ' OD1' ' A' ' 72' ' ' ASN . 23.4 Cg_endo -60.11 124.59 15.56 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.041 2.494 . . . . 0.0 110.733 176.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -97.69 106.38 18.68 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.454 0.645 . . . . 0.0 110.843 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . . . -100.14 144.49 29.1 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.862 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 t -146.35 149.03 33.0 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.951 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.493 ' H ' HG11 ' A' ' 159' ' ' VAL . 90.0 t -82.52 141.22 15.28 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 175.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -133.08 -41.19 0.91 Allowed 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -170.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -160.42 163.33 33.17 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.38 -171.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.578 HG13 ' CD2' ' A' ' 64' ' ' TYR . 97.7 t -132.01 106.66 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 123.489 0.716 . . . . 0.0 110.72 -177.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.478 ' HB2' ' CD2' ' A' ' 65' ' ' HIS . 34.9 m-20 -100.83 107.51 19.08 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.44 ' HA ' ' CB ' ' A' ' 64' ' ' TYR . 49.6 p90 -63.48 138.94 58.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.581 ' HG2' ' HA ' ' A' ' 64' ' ' TYR . 14.5 mmmm -89.7 -72.91 0.54 Allowed 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -176.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.71 -88.06 0.06 OUTLIER Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 117.724 -2.179 . . . . 0.0 115.17 -175.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.72 138.71 25.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.67 0.747 . . . . 0.0 112.522 -173.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.693 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 39.8 m -152.75 157.36 40.73 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 105.021 -2.214 . . . . 0.0 105.021 173.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -102.31 -25.02 13.82 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.7 0.762 . . . . 0.0 109.884 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.467 ' H ' HG22 ' A' ' 58' ' ' THR . 32.6 t70 -99.66 23.0 10.11 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.217 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.693 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . 146.09 -162.9 28.39 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 -177.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.41 ' CG2' ' HB3' ' A' ' 173' ' ' PHE . 48.4 t -135.26 116.05 19.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 173.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -68.2 137.02 54.49 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.12 0.486 . . . . 0.0 110.98 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.714 ' CD1' HG13 ' A' ' 119' ' ' VAL . 23.9 p90 -143.02 173.02 11.92 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.478 ' CD2' ' HB2' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -124.57 122.06 36.5 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.823 -1.151 . . . . 0.0 108.815 173.902 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -78.83 131.02 36.32 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.74 -175.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -89.27 111.65 22.52 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.5 p -127.94 108.72 18.42 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-O 122.146 0.974 . . . . 0.0 108.458 175.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.435 ' HB3' HG22 ' A' ' 112' ' ' VAL . 28.8 p -101.16 133.94 44.94 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.658 -175.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 25.2 t -109.72 130.55 62.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.749 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -111.47 111.7 22.91 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 175.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.486 ' OD1' ' HB3' ' A' ' 45' ' ' PRO . 7.1 t30 -132.74 124.89 19.08 Favored Pre-proline 0 C--N 1.307 -1.249 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.656 -172.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 72' ' ' ASN . 57.3 Cg_endo -97.56 97.73 0.07 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.779 0 C-N-CA 122.078 1.852 . . . . 0.0 112.947 175.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.547 ' O ' ' HB2' ' A' ' 108' ' ' SER . 52.9 m-85 -157.84 -165.13 1.67 Allowed 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 126.425 1.89 . . . . 0.0 106.39 175.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.7 m -131.77 13.86 4.86 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-O 121.877 0.846 . . . . 0.0 109.425 175.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.453 ' O ' ' HA2' ' A' ' 107' ' ' GLY . 3.8 pt20 -118.55 134.96 54.69 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.258 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 105' ' ' LEU . 23.8 m -73.81 97.12 2.68 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.56 174.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.498 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 54.3 mt -85.19 120.95 73.91 Favored Pre-proline 0 C--O 1.244 0.813 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -84.1 158.46 13.37 Favored 'Trans proline' 0 N--CA 1.436 -1.893 0 C-N-CA 121.796 1.664 . . . . 0.0 110.022 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 29.7 pt -102.55 144.43 13.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.179 178.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 48.8 t -62.4 -55.58 26.46 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -177.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -154.31 145.74 23.08 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 171.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.437 ' CG2' ' HG3' ' A' ' 102' ' ' PRO . 14.2 tt -97.36 117.41 41.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.0 t -100.63 118.33 36.56 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -108.08 134.86 50.36 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.554 HG23 HD11 ' A' ' 94' ' ' ILE . 2.7 mp -117.45 107.31 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.028 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 178.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.462 ' CD2' ' HE2' ' A' ' 139' ' ' TYR . 2.0 tm? -101.92 121.34 41.94 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.428 -170.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.57 ' HB2' ' HB2' ' A' ' 140' ' ' GLN . 0.6 OUTLIER -102.41 150.08 23.72 Favored 'General case' 0 CA--C 1.487 -1.458 0 O-C-N 122.007 -0.433 . . . . 0.0 110.427 179.209 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.449 ' OG ' ' HB3' ' A' ' 122' ' ' SER . 68.6 m -132.87 94.42 3.38 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 177.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 53.03 -77.43 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 170.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.2 m -70.23 -72.93 0.18 Allowed 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -171.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.4 ' H ' ' H ' ' A' ' 93' ' ' THR . 99.5 mtt180 -153.63 -16.27 0.14 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.91 0.484 . . . . 0.0 109.858 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.454 HG22 ' OG ' ' A' ' 122' ' ' SER . 2.7 m -69.9 151.7 45.36 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.642 -171.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.554 HD11 HG23 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -145.11 149.42 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -174.158 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.467 ' N ' HD13 ' A' ' 94' ' ' ILE . . . -129.04 151.46 49.71 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 124.902 1.281 . . . . 0.0 108.07 175.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 35.0 p -136.67 166.48 23.46 Favored 'General case' 0 C--N 1.29 -2.006 0 O-C-N 122.232 -0.293 . . . . 0.0 111.107 -175.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 174.08 136.25 2.19 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.43 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.0 p -113.15 112.69 24.23 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.507 HD12 HG23 ' A' ' 115' ' ' VAL . 63.0 mt -99.27 109.75 55.71 Favored Pre-proline 0 C--N 1.32 -0.699 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.057 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.29 116.72 4.81 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 123.221 2.614 . . . . 0.0 111.613 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.7 t70 51.05 87.36 0.13 Allowed Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 124.929 1.291 . . . . 0.0 112.505 -177.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.437 ' HG3' ' CG2' ' A' ' 83' ' ' ILE . 11.8 Cg_endo -99.54 9.2 0.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.922 2.414 . . . . 0.0 110.766 175.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 147.32 -163.09 28.71 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -177.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.5 m -151.27 160.63 43.7 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 78' ' ' ILE . 3.8 pp -83.96 147.38 27.5 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 36.0 m -57.39 -45.52 85.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -175.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 76' ' ' GLN . . . 140.52 -55.37 0.63 Allowed Glycine 0 N--CA 1.418 -2.548 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -176.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.547 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 37.1 t -136.75 118.49 15.05 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.9 -162.6 12.31 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.933 174.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.5 t -89.26 138.83 31.09 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-O 121.729 0.776 . . . . 0.0 109.662 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.1 t -138.87 117.93 12.55 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.435 HG22 ' HB3' ' A' ' 69' ' ' SER . 47.8 t -87.25 115.83 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.188 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.516 -178.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.4 mt -100.87 149.9 23.39 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.45 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 7.7 p-10 -140.83 116.34 10.14 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.033 0.921 . . . . 0.0 112.467 -177.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.507 HG23 HD12 ' A' ' 99' ' ' ILE . 4.2 p -95.32 130.55 31.98 Favored Pre-proline 0 C--N 1.307 -1.24 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.479 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -72.41 112.58 3.49 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 121.833 1.689 . . . . 0.0 109.735 173.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.628 ' HB ' ' CE1' ' A' ' 64' ' ' TYR . 2.3 t -130.81 153.92 39.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 -175.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -116.46 133.33 56.14 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.714 HG13 ' CD1' ' A' ' 64' ' ' TYR . 15.7 m -92.86 148.81 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.764 0 C-N-CA 123.993 0.917 . . . . 0.0 108.84 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.581 ' HB2' ' CD2' ' A' ' 174' ' ' PHE . . . 76.27 -10.08 1.36 Allowed 'General case' 0 N--CA 1.481 1.121 0 O-C-N 124.136 0.898 . . . . 0.0 110.639 -177.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.421 ' H ' ' C ' ' A' ' 119' ' ' VAL . 69.0 t80 -56.2 -52.31 64.86 Favored 'General case' 0 CA--C 1.484 -1.561 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.823 -178.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.454 ' OG ' HG22 ' A' ' 93' ' ' THR . 35.4 t -72.42 -43.2 64.19 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.475 -174.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 12.9 tt -71.77 -49.51 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 C-N-CA 119.192 -1.003 . . . . 0.0 112.891 -176.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -60.82 -32.51 71.89 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -176.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.0 p -71.92 -30.41 36.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.532 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.4 t -106.95 -43.87 4.55 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 119.358 -0.937 . . . . 0.0 112.24 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.9 tp -123.96 -52.95 1.76 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -175.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.413 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 25.1 ttt 76.03 138.08 0.06 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.103 1.361 . . . . 0.0 111.093 -176.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 130' ' ' ASP . 59.5 tptt -61.45 -73.08 0.1 Allowed 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 129' ' ' LYS . 22.4 t70 169.98 -13.26 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 O-C-N 124.218 0.949 . . . . 0.0 109.808 178.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.586 ' HA ' ' CE ' ' A' ' 131' ' ' MET . 0.0 OUTLIER 66.3 88.82 0.1 Allowed 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.99 0.9 . . . . 0.0 112.705 -169.435 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 47.2 t -105.86 155.69 19.08 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.5 -1.227 . . . . 0.0 107.718 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 20.9 p -96.57 100.57 12.14 Favored 'General case' 0 N--CA 1.402 -2.866 0 CA-C-O 121.089 0.471 . . . . 0.0 110.611 177.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.488 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 31.4 t70 74.95 99.96 0.07 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.18 0.992 . . . . 0.0 111.383 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -159.48 158.93 32.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.669 -1.151 . . . . 0.0 108.076 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -107.38 147.17 30.7 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.305 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 29.6 mm -128.68 130.59 68.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.923 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -102.04 101.53 11.91 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 172.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.481 ' HD1' ' O ' ' A' ' 163' ' ' GLY . 0.6 OUTLIER -104.66 170.4 7.9 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 179.723 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 88' ' ' LYS . 2.5 mp0 -120.42 147.23 45.36 Favored 'General case' 0 C--N 1.273 -2.726 0 C-N-CA 118.466 -1.294 . . . . 0.0 111.899 -177.033 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.4 tp -130.47 117.51 19.75 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-O 121.892 0.853 . . . . 0.0 110.368 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.54 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 3.9 m-20 -122.55 123.56 41.51 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 45.7 mt -122.14 131.1 73.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 119.004 -1.078 . . . . 0.0 111.028 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -106.18 86.95 0.5 Allowed Glycine 1 N--CA 1.394 -4.115 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 174.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.613 HD13 ' H ' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -85.81 141.4 29.67 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 176.292 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.1 t -128.63 122.01 29.92 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.409 -0.916 . . . . 0.0 111.457 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.464 ' CE2' HD23 ' A' ' 145' ' ' LEU . 77.7 m-85 -103.75 138.74 39.95 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -92.44 108.5 20.01 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 172.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.525 HG22 ' H ' ' A' ' 151' ' ' VAL . 51.2 mm -100.83 125.26 39.17 Favored Pre-proline 0 C--N 1.282 -2.359 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -178.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.11 -3.98 6.94 Favored 'Trans proline' 0 N--CA 1.481 0.788 0 C-N-CA 123.396 2.73 . . . . 0.0 113.46 -176.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.525 ' H ' HG22 ' A' ' 149' ' ' ILE . 59.9 t -76.0 -51.28 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.2 p -176.12 83.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 177.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 103.4 155.22 24.44 Favored Glycine 0 N--CA 1.413 -2.859 0 C-N-CA 120.589 -0.815 . . . . 0.0 114.27 165.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -97.52 114.19 26.03 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 170.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.648 ' H ' HD13 ' A' ' 155' ' ' ILE . 0.2 OUTLIER -121.44 150.84 24.61 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.888 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.672 -179.48 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 10.5 t -97.5 151.19 20.26 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 176.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 59.9 mt -113.97 110.73 48.57 Favored Pre-proline 0 N--CA 1.434 -1.226 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 176.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.487 ' HG2' ' CG ' ' A' ' 32' ' ' LYS . 26.3 Cg_exo -68.46 105.33 1.24 Allowed 'Trans proline' 0 C--O 1.241 0.671 0 C-N-CA 123.064 2.509 . . . . 0.0 112.836 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.493 HG11 ' H ' ' A' ' 49' ' ' VAL . 21.8 t -105.3 116.01 48.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 175.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 47.7 p -127.82 118.99 24.72 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -174.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.6 t -156.9 172.2 19.07 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -100.33 151.72 21.17 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.446 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.481 ' O ' ' HD1' ' A' ' 139' ' ' TYR . . . -111.74 101.83 1.33 Allowed Glycine 0 N--CA 1.406 -3.362 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 175.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.426 ' H ' ' HG2' ' A' ' 164' ' ' GLU . 7.8 pt-20 -95.28 120.51 35.63 Favored 'General case' 0 C--N 1.266 -3.031 0 CA-C-O 121.888 0.851 . . . . 0.0 109.755 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 6.6 pt -130.49 133.56 63.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.869 -172.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -99.6 128.63 45.71 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 134' ' ' ASP . 91.4 mt -114.19 117.76 43.02 Favored Pre-proline 0 C--N 1.297 -1.694 0 C-N-CA 120.454 -0.499 . . . . 0.0 111.191 -174.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -84.96 108.98 1.22 Allowed 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 122.567 2.178 . . . . 0.0 111.802 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 133' ' ' THR 0.27 79.2 p 52.31 -81.38 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 179.142 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 85.4 mt 69.51 -62.05 0.42 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.728 1.211 . . . . 0.0 111.686 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 76.8 mtm180 65.28 -3.15 0.67 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 173.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -142.94 1.33 1.27 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.35 0.595 . . . . 0.0 110.07 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.41 ' HB3' ' CG2' ' A' ' 62' ' ' VAL . 10.7 m-85 -114.21 -13.14 12.39 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 115.929 1.825 . . . . 0.0 115.929 -165.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.581 ' CD2' ' HB2' ' A' ' 120' ' ' ALA . 4.1 t80 . . . . . 0 C--O 1.268 2.048 0 C-N-CA 118.178 -1.409 . . . . 0.0 111.123 -173.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 5' ' ' HIS . . . . . . . . 0 CA--C 1.503 -0.682 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 63.1 m80 64.97 -82.15 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.937 0.895 . . . . 0.0 112.694 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -106.76 -24.7 12.01 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -147.12 147.26 30.39 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.455 ' O ' ' HA2' ' A' ' 1' ' ' GLY . 67.5 m-70 78.7 87.79 0.06 Allowed 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 124.381 1.072 . . . . 0.0 110.67 -173.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 46.1 m-70 71.1 -26.87 0.17 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.179 1.392 . . . . 0.0 114.332 175.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.3 t60 68.66 -73.87 0.08 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.664 1.186 . . . . 0.0 111.534 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 pp -88.32 -19.13 27.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -174.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 6' ' ' HIS . 43.9 mt-10 -80.58 66.92 6.27 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.665 0.745 . . . . 0.0 111.162 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -171.9 17.63 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 125.692 1.597 . . . . 0.0 107.181 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.9 m 58.07 71.19 0.59 Allowed 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.658 -174.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.672 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -73.25 -42.99 61.9 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.007 -178.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -57.77 -35.8 71.25 Favored 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 123.626 0.579 . . . . 0.0 111.072 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -59.34 -48.8 80.26 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -60.77 -40.17 91.56 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.598 176.696 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 12' ' ' ALA . 40.7 t -64.65 -40.87 90.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.665 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.517 HG11 ' O ' ' A' ' 94' ' ' ILE . 54.6 t -59.13 -33.26 49.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.102 0.477 . . . . 0.0 110.004 175.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.06 -45.78 55.45 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 26.5 mm-40 -57.51 -52.47 65.26 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.733 176.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.557 ' HE2' HG12 ' A' ' 16' ' ' VAL . 68.1 mttm -58.12 -48.91 78.77 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.819 -178.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.11 -45.13 83.68 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 123.463 0.477 . . . . 0.0 111.395 -176.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 62.9 m -62.33 -49.51 75.32 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.015 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.8 t -61.57 -38.07 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.204 0.526 . . . . 0.0 110.296 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.506 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 86.0 mt -69.95 -46.86 72.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.172 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.1 t -59.68 -36.61 76.82 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.699 0.4 . . . . 0.0 110.676 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.1 t -62.84 -38.24 89.98 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.684 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.556 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 5.1 tt -76.72 -42.1 42.62 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 87.7 mt -57.05 -36.55 70.64 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.288 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -56.77 -41.44 77.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.814 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -83.29 -33.33 25.98 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.624 -178.227 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.21 -50.7 11.42 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -175.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -60.26 -47.04 87.67 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 122.514 0.326 . . . . 0.0 111.077 -175.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.641 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -59.63 -56.01 27.31 Favored Glycine 0 N--CA 1.444 -0.813 0 O-C-N 123.683 0.614 . . . . 0.0 111.996 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -58.4 -39.76 80.55 Favored 'General case' 0 C--O 1.255 1.348 0 C-N-CA 123.268 0.627 . . . . 0.0 110.923 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.538 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 89.1 t80 -67.76 -53.34 27.98 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.4 178.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.15 -29.69 68.82 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -174.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.641 ' HG2' ' O ' ' A' ' 33' ' ' GLY . 10.7 pt-20 -90.37 -42.39 10.96 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -177.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HD3' ' HG3' ' A' ' 37' ' ' GLU . 3.7 mppt? -107.4 -48.3 3.47 Favored 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 118.812 -1.155 . . . . 0.0 112.534 177.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.538 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 2.9 mm? -75.71 -12.67 60.24 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -169.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.56 -23.14 64.46 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 120.971 0.415 . . . . 0.0 110.095 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -115.22 17.48 16.62 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.222 0.534 . . . . 0.0 110.19 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.415 ' HB ' ' HA ' ' A' ' 39' ' ' LEU . 72.7 mt -127.98 134.6 26.4 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -40.82 103.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.317 0 C-N-CA 123.903 3.068 . . . . 0.0 114.591 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.0 p -146.5 155.08 49.43 Favored Pre-proline 0 C--N 1.31 -1.151 0 C-N-CA 124.802 1.241 . . . . 0.0 108.409 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.9 124.89 14.3 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.125 1.884 . . . . 0.0 111.468 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -97.03 111.55 23.72 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -178.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.37 143.18 33.9 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.86 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.594 ' HA ' HG21 ' A' ' 159' ' ' VAL . 10.4 t -143.18 140.59 30.83 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.553 HG23 HG22 ' A' ' 159' ' ' VAL . 45.3 t -83.63 141.26 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.829 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -108.23 -62.11 1.5 Allowed 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.844 -1.142 . . . . 0.0 114.023 -168.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.547 ' HB3' ' HD2' ' A' ' 67' ' ' LYS . 24.5 t70 -166.79 166.16 15.87 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.562 -169.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.649 HG13 ' CD2' ' A' ' 64' ' ' TYR . 97.4 t -118.55 119.54 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 124.248 1.019 . . . . 0.0 111.462 -176.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -121.95 106.4 11.2 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -82.06 134.02 35.32 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -176.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.08 78.84 1.72 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -175.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 122.64 -149.62 16.92 Favored Glycine 0 C--N 1.268 -3.212 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.217 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.4 p -143.54 154.88 16.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.0 m -135.35 164.1 28.51 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -58.31 -41.41 84.42 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.08 0.466 . . . . 0.0 110.6 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -133.23 105.0 6.75 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.76 -161.1 21.87 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.284 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 69.9 t -150.78 121.91 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -177.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.434 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 20.3 t70 -68.4 129.65 40.55 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.649 ' CD2' HG13 ' A' ' 52' ' ' VAL . 43.7 p90 -131.65 169.64 15.87 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -90.69 109.5 20.67 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 174.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.456 ' HB3' HG13 ' A' ' 115' ' ' VAL . . . -82.81 112.23 19.44 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 175.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.547 ' HD2' ' HB3' ' A' ' 51' ' ' ASP . 93.7 mttt -86.74 120.58 28.18 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.172 -176.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.0 t -127.04 109.1 19.89 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.673 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.6 p -99.55 123.66 44.03 Favored 'General case' 0 C--N 1.283 -2.314 0 C-N-CA 120.394 -0.523 . . . . 0.0 111.017 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.2 t -117.88 125.43 74.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.826 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.421 ' HG2' ' OG1' ' A' ' 110' ' ' THR . 51.7 mtpt -95.07 110.25 22.2 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.639 HD22 HD12 ' A' ' 105' ' ' LEU . 47.4 t-20 -108.39 113.79 59.92 Favored Pre-proline 0 C--N 1.302 -1.48 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.241 -176.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -111.55 97.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.152 0 C-N-CA 123.017 2.478 . . . . 0.0 110.408 166.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -168.94 -19.96 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.7 t 70.99 24.57 3.95 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.333 1.053 . . . . 0.0 109.651 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.565 ' HG3' HG12 ' A' ' 78' ' ' ILE . 4.3 tp-100 -121.68 110.67 16.25 Favored 'General case' 0 N--CA 1.396 -3.173 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.987 -178.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.3 m -75.09 87.4 2.39 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.565 HG12 ' HG3' ' A' ' 76' ' ' GLN . 82.3 mt -72.77 122.02 86.51 Favored Pre-proline 0 C--N 1.294 -1.839 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.775 -170.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -70.86 109.95 2.65 Favored 'Trans proline' 0 N--CA 1.431 -2.187 0 N-CA-C 106.721 -2.069 . . . . 0.0 106.721 168.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.3 mt -62.95 119.49 7.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -173.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 41.8 t -56.64 -53.21 60.35 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -167.94 147.76 4.89 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.428 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 12.4 tt -110.85 113.93 45.65 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 175.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 98' ' ' THR . 26.5 t -92.65 148.17 22.28 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -140.57 139.42 34.97 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 176.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.582 HG23 ' HB2' ' A' ' 142' ' ' ASP . 11.8 tt -143.56 110.55 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 174.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.432 ' O ' HD12 ' A' ' 87' ' ' LEU . 3.4 pp -110.9 141.04 44.85 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.586 -178.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.45 ' HA ' HG22 ' A' ' 94' ' ' ILE . 97.3 mttt -103.62 153.08 21.01 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.837 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 55.8 m -135.29 132.18 37.43 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.682 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.78 86.87 2.79 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 121.951 0.881 . . . . 0.0 112.018 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.8 m -161.58 -53.61 0.05 OUTLIER 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 163.86 -52.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 125.268 1.605 . . . . 0.0 110.479 177.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.2 m -70.81 142.11 51.32 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.948 -177.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.517 ' O ' HG11 ' A' ' 17' ' ' VAL . 2.5 pp -125.04 177.25 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.036 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 86' ' ' ILE . . . -131.95 134.03 45.18 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 118.296 0.498 . . . . 0.0 109.778 177.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.4 p -135.09 158.47 44.28 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 176.22 168.42 36.38 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.574 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 40.5 p -135.02 116.58 14.79 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 122.717 0.407 . . . . 0.0 109.959 178.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 60.6 mt -98.57 108.78 50.0 Favored Pre-proline 0 C--N 1.323 -0.572 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.166 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.65 121.99 7.48 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.607 2.204 . . . . 0.0 111.692 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.4 t70 56.12 83.4 0.22 Allowed Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 124.008 0.923 . . . . 0.0 112.249 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -101.48 8.28 0.53 Allowed 'Trans proline' 0 CA--C 1.548 1.212 0 C-N-CA 123.073 2.515 . . . . 0.0 113.075 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 165.14 -124.33 1.24 Allowed Glycine 0 N--CA 1.441 -1.033 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.7 m -151.84 146.67 25.85 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 176.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.639 HD12 HD22 ' A' ' 72' ' ' ASN . 1.0 OUTLIER -104.44 98.13 7.95 Favored 'General case' 0 N--CA 1.423 -1.791 0 C-N-CA 117.859 -1.536 . . . . 0.0 109.119 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.517 ' HB ' ' HB ' ' A' ' 111' ' ' THR 0.255 14.8 p 10.55 -72.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 128.811 2.844 . . . . 0.0 117.501 178.308 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.463 ' H ' HG13 ' A' ' 106' ' ' VAL . . . 125.37 -51.12 0.84 Allowed Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -174.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.5 p -154.09 94.89 1.78 Allowed 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.334 0.587 . . . . 0.0 111.862 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 143.98 -175.17 24.0 Favored Glycine 0 CA--C 1.497 -1.081 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.883 176.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.421 ' OG1' ' HG2' ' A' ' 71' ' ' LYS . 56.3 m -95.35 116.93 29.45 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.517 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 9.6 t -113.78 137.12 52.08 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 25.5 t -99.4 115.08 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.3 mt -89.82 148.27 23.3 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.395 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -114.23 121.0 42.38 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.769 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 66' ' ' ALA . 10.3 p -128.18 125.55 23.42 Favored Pre-proline 0 C--N 1.302 -1.462 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.34 177.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.29 111.72 3.24 Favored 'Trans proline' 0 C--O 1.246 0.909 0 C-N-CA 123.117 2.545 . . . . 0.0 112.589 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.438 HG23 ' CE1' ' A' ' 64' ' ' TYR . 26.3 m -143.36 151.44 16.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.434 ' HG3' ' N ' ' A' ' 63' ' ' ASP . 3.3 mppt? -95.9 135.72 37.27 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.623 ' HB ' ' CE1' ' A' ' 64' ' ' TYR . 13.2 p -94.9 145.78 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 66.44 13.33 9.2 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 123.548 0.739 . . . . 0.0 110.332 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.505 ' O ' HG23 ' A' ' 125' ' ' VAL . 84.4 t80 -56.77 -50.38 72.48 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 124.786 1.235 . . . . 0.0 108.961 176.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.8 m -62.1 -40.74 96.89 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.856 -176.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.436 HD13 ' HG3' ' A' ' 129' ' ' LYS . 14.0 tt -79.06 -34.01 16.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.352 -177.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -60.85 -35.95 77.89 Favored 'General case' 0 C--N 1.358 0.937 0 CA-C-O 120.893 0.377 . . . . 0.0 110.031 174.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 121' ' ' TYR . 43.2 t -56.54 -37.79 53.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.42 175.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.2 m -95.52 -77.24 0.48 Allowed 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.582 HD12 ' H ' ' A' ' 129' ' ' LYS . 3.9 pp -119.03 -12.11 9.56 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -172.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.508 ' O ' ' HG2' ' A' ' 128' ' ' MET . 25.0 ttt 60.93 41.17 14.59 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.931 0.892 . . . . 0.0 113.399 173.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.582 ' H ' HD12 ' A' ' 127' ' ' LEU . 15.0 mtmt 60.1 -83.12 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.128 0.571 . . . . 0.0 111.28 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 164.21 -23.13 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 126.806 2.043 . . . . 0.0 106.469 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.535 ' SD ' ' HB3' ' A' ' 174' ' ' PHE . 0.3 OUTLIER 59.16 100.38 0.02 OUTLIER 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.253 -176.903 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 49.0 t -132.17 170.09 15.49 Favored 'General case' 0 CA--C 1.556 1.209 0 O-C-N 121.609 -0.682 . . . . 0.0 112.503 -175.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.462 HG22 ' HB3' ' A' ' 169' ' ' SER . 21.6 p -67.79 133.0 48.47 Favored 'General case' 0 N--CA 1.42 -1.949 0 C-N-CA 125.125 1.37 . . . . 0.0 109.886 170.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.6 t70 42.17 72.37 0.17 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.457 1.103 . . . . 0.0 110.206 -171.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.453 ' CZ2' ' HB3' ' A' ' 129' ' ' LYS . 33.1 t-105 -101.29 115.23 30.02 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.816 -173.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -107.39 126.26 52.25 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.114 -174.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.455 HD11 HD13 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -139.86 168.21 18.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-O 121.545 0.688 . . . . 0.0 112.083 -179.673 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -142.0 133.07 26.08 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.382 177.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.34 172.76 11.8 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 178.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -129.69 124.18 32.96 Favored 'General case' 0 C--N 1.287 -2.112 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.143 -175.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.2 tp -107.06 129.73 54.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.295 -174.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.582 ' HB2' HG23 ' A' ' 86' ' ' ILE . 10.7 m-20 -122.79 137.41 54.93 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 158' ' ' PRO . 42.1 mm -124.09 145.96 30.36 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -122.39 97.67 0.6 Allowed Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 177.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.508 ' HB3' ' CE2' ' A' ' 147' ' ' PHE . 2.9 mm? -81.68 110.26 16.86 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 -178.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 28.7 m -96.35 108.17 20.64 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.613 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.515 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 53.6 m-85 -120.7 144.79 48.03 Favored 'General case' 0 CA--C 1.494 -1.208 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 154' ' ' ASP . 6.4 p-10 -116.37 116.09 27.08 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.499 -0.88 . . . . 0.0 109.327 176.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.651 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -106.02 130.43 23.0 Favored Pre-proline 0 C--N 1.298 -1.645 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.618 -177.893 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -42.75 -32.89 2.69 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 125.03 3.82 . . . . 0.0 115.572 -176.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.4 m -60.21 -34.37 56.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 60.0 t -135.78 -68.06 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.026 0.441 . . . . 0.0 109.976 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 163.06 -146.14 11.38 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.15 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 148' ' ' ASP . 6.3 p-10 -83.7 120.26 25.79 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.554 0.692 . . . . 0.0 112.571 -176.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.497 ' O ' HD12 ' A' ' 155' ' ' ILE . 2.5 pp -127.12 124.05 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.817 173.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.493 ' O ' ' HD3' ' A' ' 158' ' ' PRO . 56.9 m -88.12 117.38 26.96 Favored 'General case' 0 N--CA 1.424 -1.775 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.823 176.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 60.5 mt -95.81 104.77 17.57 Favored Pre-proline 0 C--N 1.303 -1.42 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.875 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.0 OUTLIER -85.39 138.85 6.62 Favored 'Trans proline' 0 CA--C 1.485 -1.971 0 C-N-CA 122.66 2.24 . . . . 0.0 111.762 176.883 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.594 HG21 ' HA ' ' A' ' 48' ' ' THR . 2.6 p -138.05 132.9 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.556 0 CA-C-N 112.953 -1.93 . . . . 0.0 109.661 -173.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.482 ' HB3' ' OD1' ' A' ' 142' ' ' ASP . 58.1 p -120.59 161.93 20.5 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.491 -176.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.3 t -166.09 165.41 17.8 Favored 'General case' 0 C--O 1.252 1.216 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -98.48 126.71 44.13 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -108.69 82.64 0.31 Allowed Glycine 0 N--CA 1.419 -2.476 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.43 120.37 30.7 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.447 ' CD1' HG21 ' A' ' 119' ' ' VAL . 5.7 pt -145.14 121.22 3.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.119 -170.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -104.18 139.75 38.78 Favored 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 117.887 -1.525 . . . . 0.0 109.511 174.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.574 HD22 ' CG ' ' A' ' 174' ' ' PHE . 6.8 mp -108.8 103.39 51.6 Favored Pre-proline 0 N--CA 1.405 -2.678 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.631 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.26 92.76 0.82 Allowed 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 123.165 2.576 . . . . 0.0 114.893 -172.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.462 ' HB3' HG22 ' A' ' 133' ' ' THR . 5.0 m 50.37 89.33 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 125.399 1.48 . . . . 0.0 114.086 171.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.49 ' HB2' ' SD ' ' A' ' 131' ' ' MET . 99.1 mt -108.69 -39.83 5.25 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.048 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.509 ' HA ' ' HG3' ' A' ' 131' ' ' MET . 36.4 mmt180 54.88 18.82 2.35 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 177.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -178.7 -29.73 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -176.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -99.95 21.1 13.17 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -172.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.574 ' CG ' HD22 ' A' ' 167' ' ' LEU . 40.6 t80 . . . . . 0 CA--C 1.501 -0.917 0 C-N-CA 119.062 -1.055 . . . . 0.0 113.383 -177.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.889 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -123.5 87.1 2.68 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -156.33 112.81 3.08 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -86.76 144.2 27.18 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 177.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.9 t60 -67.52 151.09 47.96 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -60.03 110.66 1.25 Allowed 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -107.28 -9.68 16.01 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.59 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 tt 73.41 -48.39 0.68 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.716 1.206 . . . . 0.0 109.91 -177.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -75.67 -54.18 7.38 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 174.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 56.45 71.65 0.55 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.769 1.227 . . . . 0.0 113.395 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.4 m 53.31 88.62 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.856 1.262 . . . . 0.0 113.034 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.435 ' O ' HG22 ' A' ' 16' ' ' VAL . . . -56.62 -44.67 81.41 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.546 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 17' ' ' VAL . 1.9 p30 -56.57 -56.26 23.51 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 124.052 0.845 . . . . 0.0 112.172 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.16 -42.42 99.41 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 123.504 0.722 . . . . 0.0 110.821 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -65.71 -46.25 79.68 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 12' ' ' ALA . 29.9 m -71.79 -23.07 21.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.299 -176.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 13' ' ' ASP . 77.4 t -61.72 -47.22 94.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 172.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -59.53 -37.19 77.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.762 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -60.51 -56.78 17.29 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.36 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -65.97 -39.2 90.16 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.893 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.57 -37.31 80.88 Favored 'General case' 0 C--O 1.221 -0.439 0 O-C-N 123.286 0.366 . . . . 0.0 110.805 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.0 t -63.39 -50.34 70.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.865 0.364 . . . . 0.0 110.451 178.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.05 -45.11 99.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.391 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.491 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 83.7 mt -66.18 -43.23 92.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.171 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.2 t -62.02 -35.57 78.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.796 0.332 . . . . 0.0 110.463 177.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.8 t -63.45 -41.28 98.64 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.97 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.559 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 3.9 tt -71.09 -41.68 70.3 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 96.3 mt -59.24 -39.68 83.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.092 0.473 . . . . 0.0 110.366 177.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -62.54 -41.9 99.18 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.559 ' HG2' ' O ' ' A' ' 27' ' ' LEU . 61.4 pttt -63.52 -34.38 77.66 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 119.921 -0.711 . . . . 0.0 109.523 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.66 -31.66 52.75 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.692 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.554 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 39.7 ttmt -51.12 -40.08 57.68 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.059 0.944 . . . . 0.0 112.884 -175.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.46 -8.86 54.32 Favored Glycine 0 C--N 1.313 -0.698 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.614 178.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 19.3 t80 -81.45 -25.9 35.72 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 124.435 1.094 . . . . 0.0 108.418 -175.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.554 ' CE2' ' HA ' ' A' ' 32' ' ' LYS . 22.5 m-85 -56.96 -36.57 70.44 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.627 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.64 -50.05 55.34 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.766 0.666 . . . . 0.0 112.396 -173.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -98.88 -43.71 6.63 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.277 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.486 ' HD3' ' N ' ' A' ' 38' ' ' LYS 0.295 2.7 mppt? -75.19 -3.92 35.8 Favored 'General case' 0 C--O 1.206 -1.22 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 -171.042 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.3 mt -117.38 1.0 12.33 Favored 'General case' 0 C--N 1.284 -2.251 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.808 173.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.44 -55.74 2.42 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.09 0.471 . . . . 0.0 110.521 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -86.14 -4.5 59.18 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.496 -177.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.7 mm -119.06 126.85 26.83 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.03 104.21 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.448 2.099 . . . . 0.0 110.415 176.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.441 HG22 ' CD1' ' A' ' 149' ' ' ILE . 5.8 p -128.26 154.37 78.93 Favored Pre-proline 0 C--N 1.302 -1.493 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.464 -174.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.467 ' HB3' ' HB2' ' A' ' 72' ' ' ASN . 65.6 Cg_endo -84.73 154.94 11.75 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.888 2.392 . . . . 0.0 112.02 178.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -121.04 136.93 54.87 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.39 167.6 13.1 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.98 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.4 t -155.49 145.21 21.31 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 123.506 0.503 . . . . 0.0 110.518 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.479 HG23 HG23 ' A' ' 159' ' ' VAL . 45.4 t -83.99 141.9 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 173.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' A' ' 67' ' ' LYS . 18.4 t70 -122.2 -54.18 1.91 Allowed 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -172.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -162.03 162.59 28.87 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -172.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.3 m -122.98 108.15 20.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 121.438 0.637 . . . . 0.0 110.024 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -90.9 121.08 32.44 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.601 -177.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 53.3 p90 -69.3 120.21 14.77 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.536 177.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -83.36 -49.4 9.39 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.423 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 178.95 -147.36 7.72 Favored Glycine 0 N--CA 1.41 -3.046 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 173' ' ' PHE . 7.5 p -111.67 138.42 40.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-O 121.02 0.438 . . . . 0.0 110.487 -174.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 24.5 m -127.15 145.13 50.86 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 175.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.429 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 17.8 tpt180 -104.61 78.36 1.45 Allowed 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 118.661 -1.216 . . . . 0.0 108.327 178.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -175.32 -70.33 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 -175.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.433 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . -138.2 -138.53 3.72 Favored Glycine 0 N--CA 1.411 -3.024 0 N-CA-C 104.298 -3.521 . . . . 0.0 104.298 167.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.04 134.28 41.52 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-N 118.675 1.238 . . . . 0.0 110.288 174.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -93.43 107.27 19.14 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.063 -175.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.517 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 4.5 m-85 -100.45 161.09 13.83 Favored 'General case' 0 CA--C 1.486 -1.511 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.005 176.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.416 ' CD2' ' HB3' ' A' ' 114' ' ' ASP . 3.3 t-160 -114.75 107.73 15.83 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 178.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -92.86 140.78 29.15 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.0 0.428 . . . . 0.0 112.022 -176.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.413 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . 75.2 mmtt -89.64 121.33 31.72 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.77 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.88 111.28 29.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.5 m -98.85 139.25 34.81 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 120.319 -0.553 . . . . 0.0 109.94 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.2 t -131.45 131.61 62.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 63.5 pttt -114.59 132.32 56.38 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 175.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.848 ' O ' ' HA ' ' A' ' 108' ' ' SER . 5.8 t30 -142.73 114.75 6.07 Favored Pre-proline 0 C--N 1.294 -1.835 0 C-N-CA 119.743 -0.783 . . . . 0.0 112.949 -175.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -94.36 99.62 0.12 Allowed 'Trans proline' 0 N--CA 1.436 -1.865 0 C-N-CA 122.365 2.043 . . . . 0.0 109.487 170.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.539 ' HB3' HD21 ' A' ' 72' ' ' ASN . 48.8 t80 -170.32 -14.82 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -176.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.426 ' H ' ' H ' ' A' ' 74' ' ' TYR . 24.1 t 83.14 -56.24 0.16 Allowed 'General case' 0 C--O 1.233 0.232 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 172.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -69.46 152.89 44.33 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-N 118.719 0.691 . . . . 0.0 112.744 -176.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.6 p -77.14 111.82 13.15 Favored 'General case' 0 N--CA 1.411 -2.375 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.279 174.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 70.0 mt -93.27 114.9 64.09 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -65.07 139.16 59.88 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.374 2.05 . . . . 0.0 110.241 175.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 54.5 mt -88.2 114.83 27.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 58.3 m -55.76 -56.14 24.05 Favored 'General case' 0 C--N 1.319 -0.742 0 O-C-N 123.811 0.695 . . . . 0.0 109.521 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -167.81 160.72 12.7 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.113 176.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.442 HG23 HG23 ' A' ' 143' ' ' ILE . 25.0 mt -120.14 113.75 41.6 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.959 176.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.422 ' HB3' HG22 ' A' ' 98' ' ' THR . 28.8 p -88.29 117.22 27.05 Favored 'General case' 0 N--CA 1.405 -2.72 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -111.45 143.05 42.92 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.501 HG23 ' HB3' ' A' ' 142' ' ' ASP . 9.9 tt -137.13 108.74 6.38 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 CA-C-O 121.727 0.775 . . . . 0.0 109.15 176.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.586 HD11 ' HB3' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -106.84 145.91 31.57 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.506 -179.443 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.469 ' HA ' HG22 ' A' ' 94' ' ' ILE . 40.1 ttmt -118.43 152.58 35.61 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.831 -175.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.7 t -126.96 97.86 5.12 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 175.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.445 ' HA ' ' OD2' ' A' ' 138' ' ' ASP . . . 53.51 -94.96 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.98 1.312 . . . . 0.0 111.357 -175.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 85.5 m -166.34 85.13 0.3 Allowed 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 124.669 1.187 . . . . 0.0 108.513 175.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -160.06 -62.9 0.07 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 49.6 m -136.73 151.94 49.79 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.469 HG22 ' HA ' ' A' ' 88' ' ' LYS . 37.2 pt -134.72 -176.34 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.393 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.586 ' HB3' HD11 ' A' ' 87' ' ' LEU . . . -145.54 146.2 31.32 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 172.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.0 t -148.38 144.52 27.55 Favored 'General case' 0 N--CA 1.412 -2.357 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -166.73 166.38 39.0 Favored Glycine 0 N--CA 1.426 -2.025 0 C-N-CA 120.648 -0.786 . . . . 0.0 111.296 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.422 HG22 ' HB3' ' A' ' 84' ' ' SER . 40.5 p -110.18 119.89 40.72 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.2 tt -103.3 104.55 41.65 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.912 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 98' ' ' THR . 11.5 Cg_exo -72.79 128.06 12.93 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.058 2.505 . . . . 0.0 111.97 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.3 t70 52.08 79.48 0.34 Allowed Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 124.633 1.173 . . . . 0.0 111.997 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -101.47 8.82 0.52 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.788 2.325 . . . . 0.0 111.487 176.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 149.58 -168.39 29.8 Favored Glycine 0 N--CA 1.422 -2.236 0 N-CA-C 108.221 -1.952 . . . . 0.0 108.221 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.5 m -145.51 149.89 35.46 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 118.3 1.05 . . . . 0.0 111.956 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.74 118.38 22.23 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 177.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 29.2 m -66.11 -35.96 76.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -174.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 140.31 -137.45 8.35 Favored Glycine 0 N--CA 1.416 -2.676 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.848 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 65.4 m -77.68 101.44 6.62 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.474 0.655 . . . . 0.0 111.555 178.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 164.99 -172.29 40.62 Favored Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 177.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.4 t -114.43 114.34 25.71 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.776 0.798 . . . . 0.0 109.684 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.6 t -110.26 132.94 53.73 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.157 -177.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 20.5 m -99.63 106.54 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-O 121.791 0.805 . . . . 0.0 110.031 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 66.4 mt -95.46 164.58 12.75 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.84 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 4.9 m-20 -133.99 135.62 43.56 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.143 -178.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.65 132.23 24.1 Favored Pre-proline 0 C--N 1.305 -1.353 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -73.46 110.63 3.1 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 N-CA-C 107.122 -1.915 . . . . 0.0 107.122 168.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.7 t -113.28 140.17 34.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.627 -172.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.663 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -88.1 98.95 11.82 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.2 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.3 m -102.58 147.49 9.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 71.78 -22.88 0.19 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.887 0.875 . . . . 0.0 113.212 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -55.7 -36.5 67.23 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.002 0.521 . . . . 0.0 110.963 177.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.9 p -59.12 -46.3 88.67 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.647 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 14.2 tt -79.08 -32.56 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.282 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.561 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -57.38 -43.31 83.49 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.704 0.802 . . . . 0.0 112.643 -178.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.3 m -72.09 -22.33 21.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.3 m -93.51 -73.03 0.58 Allowed 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -177.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.461 HD23 ' H ' ' A' ' 127' ' ' LEU . 1.8 pt? -124.52 -12.96 7.17 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -176.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.561 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER 73.63 140.61 0.06 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.507 1.123 . . . . 0.0 109.826 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.522 ' HE3' ' HB2' ' A' ' 131' ' ' MET . 46.6 pttt -59.42 -19.88 50.67 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.138 0.575 . . . . 0.0 111.43 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 23.8 t70 82.23 -22.73 0.24 Allowed 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 125.226 1.41 . . . . 0.0 109.577 177.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.522 ' HB2' ' HE3' ' A' ' 129' ' ' LYS . 15.4 tpt 51.08 97.24 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 112.678 -2.055 . . . . 0.0 115.388 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 64.4 m -92.94 140.41 29.52 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 171.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.8 p -71.19 100.71 2.13 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-O 121.482 0.658 . . . . 0.0 110.606 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.546 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 14.0 t70 86.37 88.55 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.627 0 C-N-CA 126.852 2.061 . . . . 0.0 110.312 -174.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.422 ' HZ2' ' HB2' ' A' ' 129' ' ' LYS . 0.8 OUTLIER -158.5 158.88 34.9 Favored 'General case' 0 N--CA 1.412 -2.33 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 176.312 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -117.7 134.6 54.73 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.481 ' CG2' ' HB ' ' A' ' 165' ' ' ILE . 9.8 tt -97.4 133.22 39.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 C-N-CA 120.594 -0.442 . . . . 0.0 109.856 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.445 ' OD2' ' HA ' ' A' ' 90' ' ' ALA . 38.9 t70 -70.39 90.44 0.71 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.532 178.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -108.77 152.81 24.35 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.526 177.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.414 ' HB2' ' HB3' ' A' ' 88' ' ' LYS . 21.8 mp0 -137.86 146.64 43.65 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 41.2 tp -128.74 126.52 40.19 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 123.461 0.475 . . . . 0.0 110.391 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.501 ' HB3' HG23 ' A' ' 86' ' ' ILE . 14.1 t70 -127.32 125.82 41.48 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.442 HG23 HG23 ' A' ' 83' ' ' ILE . 42.6 mm -111.83 118.76 58.41 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 CA-C-O 120.953 0.406 . . . . 0.0 109.98 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -95.95 86.85 0.95 Allowed Glycine 0 N--CA 1.42 -2.422 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 173.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.712 HD13 ' H ' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -74.73 134.26 41.91 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.438 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.8 m -110.74 108.32 18.15 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.477 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.531 ' O ' ' HA ' ' A' ' 154' ' ' ASP . 80.0 m-85 -114.66 129.7 56.71 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 175.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -94.49 109.69 21.55 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.441 ' CD1' HG22 ' A' ' 44' ' ' THR . 64.6 mt -98.15 129.38 30.94 Favored Pre-proline 0 C--N 1.291 -1.974 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.7 -176.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -52.26 -34.84 61.44 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 123.854 3.036 . . . . 0.0 112.944 -178.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.43 -51.07 76.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.374 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 39.0 t -119.9 -69.28 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.418 -175.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 163.37 -141.14 6.93 Favored Glycine 0 N--CA 1.431 -1.644 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.531 ' HA ' ' O ' ' A' ' 147' ' ' PHE . 4.2 p30 -94.25 131.17 40.12 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 117.331 0.566 . . . . 0.0 111.914 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.27 115.7 33.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 176.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.599 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 24.8 p -86.16 115.92 24.03 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.098 175.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 54.4 mt -97.11 106.93 34.79 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -74.27 107.24 2.39 Favored 'Trans proline' 0 C--O 1.251 1.162 0 C-N-CA 121.929 1.753 . . . . 0.0 111.106 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.479 HG23 HG23 ' A' ' 49' ' ' VAL . 30.6 m -110.48 126.95 67.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.841 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.473 ' HB3' ' OD2' ' A' ' 142' ' ' ASP . 48.3 p -129.38 162.7 27.43 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.143 0.497 . . . . 0.0 112.209 -176.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.9 t -159.51 -177.83 6.69 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 177.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -97.81 119.19 35.97 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -103.56 97.27 1.43 Allowed Glycine 0 N--CA 1.415 -2.746 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -178.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -88.95 119.47 29.5 Favored 'General case' 0 C--N 1.265 -3.103 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 -176.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.481 ' HB ' ' CG2' ' A' ' 137' ' ' ILE . 38.4 mm -101.77 107.14 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.418 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 176.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -113.29 126.72 55.71 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.215 0.531 . . . . 0.0 110.161 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 134' ' ' ASP . 67.1 mt -121.93 95.09 47.89 Favored Pre-proline 0 C--N 1.289 -2.046 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.851 -172.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.4 92.14 0.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.882 2.388 . . . . 0.0 112.978 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.422 ' H ' ' N ' ' A' ' 134' ' ' ASP . 78.0 p 53.34 27.42 6.22 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.435 1.494 . . . . 0.0 113.267 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.528 HD21 ' CD1' ' A' ' 173' ' ' PHE . 22.7 tp -75.45 83.39 2.53 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -83.13 105.39 14.07 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.639 -173.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.1 t70 75.0 91.84 0.08 Allowed 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 124.694 1.198 . . . . 0.0 110.023 177.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.528 ' CD1' HD21 ' A' ' 170' ' ' LEU . 37.4 t80 -173.02 -43.26 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 -175.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.428 ' HA ' ' NZ ' ' A' ' 129' ' ' LYS 0.301 58.9 m-85 . . . . . 0 CA--C 1.492 -1.277 0 CA-C-N 113.033 -1.894 . . . . 0.0 112.787 173.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.188 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -110.66 134.22 52.63 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.8 t60 72.71 -37.68 0.4 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.306 1.042 . . . . 0.0 111.986 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -156.11 155.04 31.87 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.1 p80 -128.59 173.5 10.22 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -84.12 161.13 20.74 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.132 0.491 . . . . 0.0 111.268 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -133.51 118.28 18.13 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.728 176.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.6 tp -71.29 -71.35 0.26 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.359 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -159.54 106.7 1.71 Allowed 'General case' 0 N--CA 1.407 -2.589 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -179.11 164.89 1.46 Allowed 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.2 m -84.58 25.22 0.92 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.245 0.545 . . . . 0.0 110.735 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.627 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -58.92 -46.16 88.62 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.604 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -61.2 -31.28 71.04 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.038 0.935 . . . . 0.0 111.328 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.69 ' O ' HG12 ' A' ' 17' ' ' VAL . 41.1 tt0 -73.52 -32.35 64.2 Favored 'General case' 0 C--O 1.209 -1.059 0 CA-C-O 121.852 0.834 . . . . 0.0 108.923 177.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -71.14 -33.55 70.18 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.626 0.727 . . . . 0.0 109.916 174.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 12' ' ' ALA . 90.8 t -69.77 -29.28 40.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.993 -178.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.69 HG12 ' O ' ' A' ' 14' ' ' GLU . 9.1 p -66.03 -25.53 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 120.001 -0.679 . . . . 0.0 109.208 177.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -72.08 -45.72 59.61 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.51 -38.22 89.05 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.684 175.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.459 ' O ' HG13 ' A' ' 24' ' ' ILE . 58.5 tptt -55.72 -48.86 74.44 Favored 'General case' 0 N--CA 1.425 -1.705 0 C-N-CA 123.257 0.623 . . . . 0.0 109.415 174.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.1 -35.75 82.13 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.734 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -62.53 -45.2 94.07 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.153 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.3 m -70.75 -32.32 48.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.84 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 20' ' ' LYS . 85.3 mt -65.18 -46.01 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 173.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.1 m -65.21 -35.36 80.83 Favored 'General case' 0 C--O 1.186 -2.243 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.689 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -59.57 -44.79 93.2 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-O 121.069 0.462 . . . . 0.0 109.999 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.533 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 5.2 tt -74.41 -44.03 53.76 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.499 HD13 HG22 ' A' ' 156' ' ' THR . 56.0 tp -63.14 -31.55 72.72 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-O 120.927 0.394 . . . . 0.0 110.78 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -66.77 -45.73 77.58 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 123.172 0.589 . . . . 0.0 111.17 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -71.05 -30.55 66.75 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.84 -44.22 70.34 Favored 'General case' 0 C--O 1.198 -1.627 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.788 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -60.61 -48.68 80.69 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -177.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.22 -30.96 79.27 Favored Glycine 0 C--O 1.239 0.411 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.413 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.464 ' HA ' ' HE2' ' A' ' 38' ' ' LYS . 61.9 t80 -75.98 -43.34 45.02 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 177.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.505 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 65.7 t80 -58.82 -53.81 54.14 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.768 1.227 . . . . 0.0 113.789 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.79 -19.18 49.02 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -174.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.479 ' HB2' ' HD3' ' A' ' 38' ' ' LYS . 31.2 mt-10 -116.39 -54.98 2.43 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.651 ' O ' HG12 ' A' ' 42' ' ' ILE . 3.2 mppt? -87.62 -27.44 22.5 Favored 'General case' 0 CA--C 1.466 -2.286 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.134 -170.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.505 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 86.6 mt -87.07 9.15 20.65 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 118.731 -1.188 . . . . 0.0 111.671 -176.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.07 -25.9 31.61 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.263 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -113.23 10.58 18.56 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.03 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.651 HG12 ' O ' ' A' ' 38' ' ' LYS . 47.5 mm -114.9 115.83 43.23 Favored Pre-proline 0 C--O 1.244 0.769 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -57.56 110.52 0.63 Allowed 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 122.728 2.285 . . . . 0.0 111.027 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.7 p -139.3 158.5 68.86 Favored Pre-proline 0 C--N 1.308 -1.202 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.333 -177.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.41 ' HB3' ' HB3' ' A' ' 72' ' ' ASN . 18.0 Cg_exo -70.04 128.21 15.45 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.33 2.02 . . . . 0.0 109.92 174.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -100.99 130.72 47.02 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.482 ' CB ' ' HG ' ' A' ' 145' ' ' LEU . . . -121.59 153.2 38.38 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.1 t -147.15 143.69 28.44 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.392 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.63 ' H ' HG11 ' A' ' 159' ' ' VAL . 14.9 p -119.79 142.28 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -165.07 -18.85 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.656 -171.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.467 ' HB3' ' CG ' ' A' ' 67' ' ' LYS . 19.1 t70 -120.1 128.1 53.15 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.877 -176.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 67.9 t -110.94 120.31 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.802 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 178.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -112.14 125.5 54.19 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 123.327 0.651 . . . . 0.0 111.912 -175.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -70.25 141.09 52.49 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 124.151 0.98 . . . . 0.0 113.148 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.593 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 59.1 mtpt -122.13 -79.04 0.6 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.295 176.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.6 -147.87 6.54 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 119.63 -1.271 . . . . 0.0 113.323 -176.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.1 p -98.42 149.79 5.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.155 0.502 . . . . 0.0 111.477 -173.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.1 t -152.71 -174.53 4.95 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -67.04 -63.84 0.98 Allowed 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 120.931 0.396 . . . . 0.0 110.372 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.404 ' HB2' ' HE2' ' A' ' 118' ' ' LYS . 9.1 m-20 -92.15 95.68 9.89 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.943 -172.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.17 -131.18 10.7 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.353 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 173' ' ' PHE . 6.8 t -127.02 135.03 64.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -178.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.593 ' O ' ' HB2' ' A' ' 55' ' ' LYS . 13.8 t70 -90.01 120.08 30.91 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 2.5 m-85 -122.4 172.77 8.09 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.934 0.873 . . . . 0.0 113.128 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.521 ' HB2' ' HD2' ' A' ' 55' ' ' LYS . 8.4 t-160 -126.0 108.84 11.78 Favored 'General case' 0 N--CA 1.421 -1.875 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.602 -177.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.34 143.43 26.76 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.467 ' CG ' ' HB3' ' A' ' 51' ' ' ASP . 44.8 mmtm -92.02 114.65 27.24 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 176.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.403 HG11 HD11 ' A' ' 145' ' ' LEU . 64.7 t -111.86 108.67 26.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.2 m -104.02 129.05 51.61 Favored 'General case' 0 C--N 1.284 -2.242 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.217 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 t -116.32 128.84 73.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.846 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 59.0 pttt -120.61 121.91 39.37 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.606 0.717 . . . . 0.0 109.317 178.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.732 ' O ' ' HA ' ' A' ' 108' ' ' SER . 24.3 p-10 -129.94 115.64 17.85 Favored Pre-proline 0 C--N 1.277 -2.572 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.595 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -93.41 97.77 0.15 Allowed 'Trans proline' 0 N--CA 1.425 -2.533 0 N-CA-C 107.166 -1.898 . . . . 0.0 107.166 165.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.422 ' CD2' HD11 ' A' ' 78' ' ' ILE . 25.9 t80 -157.39 -5.72 0.09 Allowed 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.684 -174.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.2 m 73.34 -2.38 2.76 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 174.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -132.85 147.12 52.3 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.301 -0.875 . . . . 0.0 112.33 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.9 m -83.68 107.37 16.08 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.457 ' H ' ' CD2' ' A' ' 105' ' ' LEU . 45.9 mt -94.39 122.39 61.33 Favored Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -177.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -66.74 113.33 2.71 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.075 1.85 . . . . 0.0 109.623 174.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 10.4 tt -72.0 134.98 28.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 54.9 m -61.1 -58.85 6.65 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.504 0.669 . . . . 0.0 109.733 -177.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -163.6 150.05 11.87 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.435 -177.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.9 mt -101.67 114.15 40.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 171.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.4 m -102.68 117.4 34.57 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.418 ' CD1' HG23 ' A' ' 117' ' ' VAL . 54.8 p90 -106.35 136.73 45.58 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.409 -178.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 54.6 mt -123.34 108.8 21.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 176.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.593 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 0.5 OUTLIER -91.86 121.19 33.24 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -174.778 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.692 ' HB2' ' HB2' ' A' ' 140' ' ' GLN . 1.0 OUTLIER -94.27 116.29 28.66 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.284 0.564 . . . . 0.0 109.632 172.734 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.501 ' CB ' ' HB3' ' A' ' 122' ' ' SER . 22.7 t -100.16 94.07 6.04 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -176.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 61.37 -80.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.262 1.025 . . . . 0.0 110.662 -174.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.5 m -158.8 -36.17 0.06 Allowed 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -87.03 104.51 16.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.964 -177.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.498 ' HB ' ' OG ' ' A' ' 122' ' ' SER . 29.7 m 70.83 164.61 0.28 Allowed 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.289 1.036 . . . . 0.0 112.01 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.593 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 2.1 pp -144.09 170.68 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.749 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -173.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.466 ' HB3' ' CD1' ' A' ' 87' ' ' LEU . . . -121.96 154.88 36.61 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 172.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 t -159.87 168.05 26.69 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.172 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.59 151.57 8.76 Favored Glycine 0 N--CA 1.427 -1.941 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.533 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 20.3 p -109.06 116.84 32.73 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 54.6 mt -98.66 101.61 12.38 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 98' ' ' THR . 3.1 Cg_exo -78.28 123.24 5.99 Favored 'Trans proline' 0 C--O 1.241 0.661 0 C-N-CA 123.035 2.49 . . . . 0.0 111.21 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.3 t70 54.43 79.51 0.34 Allowed Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 124.83 1.252 . . . . 0.0 111.007 -174.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -104.74 25.06 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.676 2.918 . . . . 0.0 110.685 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.41 -172.9 18.09 Favored Glycine 0 N--CA 1.409 -3.122 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 -175.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 64.7 m -151.47 170.09 20.47 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 176.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.644 ' HA ' HG21 ' A' ' 111' ' ' THR 0.312 0.0 OUTLIER -98.88 158.15 15.83 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 179.863 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 22.9 m -72.2 -176.65 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 124.328 1.017 . . . . 0.0 110.989 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.42 -47.88 54.84 Favored Glycine 0 C--N 1.307 -1.068 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.24 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.732 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 21.3 t -160.07 94.01 1.09 Allowed 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 176.64 -168.83 41.05 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.318 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.5 m -113.04 114.06 26.33 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.644 HG21 ' HA ' ' A' ' 105' ' ' LEU . 10.2 t -113.34 138.41 50.09 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 26.4 t -96.89 118.04 42.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 121.013 0.435 . . . . 0.0 109.884 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.0 mt -98.25 159.56 14.86 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.967 -178.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -104.76 130.09 52.89 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.337 -175.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.2 t -125.72 114.36 24.84 Favored Pre-proline 0 CA--C 1.5 -0.978 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.431 172.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 2.7 Cg_exo -77.77 110.16 2.88 Favored 'Trans proline' 0 N--CA 1.423 -2.635 0 N-CA-C 107.528 -1.758 . . . . 0.0 107.528 168.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.418 HG23 ' CD1' ' A' ' 85' ' ' TYR . 12.3 p -115.81 137.52 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.404 ' HE2' ' HB2' ' A' ' 60' ' ' ASP . 50.1 mtpt -94.78 99.88 11.88 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -175.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.4 HG13 ' HB2' ' A' ' 64' ' ' TYR . 16.4 m -94.32 149.3 4.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -168.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 76.8 -12.8 1.0 Allowed 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 124.724 1.209 . . . . 0.0 113.334 172.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -48.2 -50.38 29.47 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 124.223 0.952 . . . . 0.0 112.987 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.501 ' HB3' ' CB ' ' A' ' 89' ' ' SER . 34.6 t -66.65 -43.49 84.48 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.438 -0.905 . . . . 0.0 112.382 -169.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.456 HD11 HD11 ' A' ' 137' ' ' ILE . 24.3 pt -79.02 -27.73 13.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.444 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -58.48 -41.14 84.59 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 174.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.6 t -56.98 -39.43 65.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.694 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 36.4 t -89.88 -84.94 0.22 Allowed 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.643 HD23 ' H ' ' A' ' 127' ' ' LEU . 1.9 pt? -106.84 -17.79 14.11 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 120.854 0.359 . . . . 0.0 111.963 -175.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.529 ' C ' ' HD3' ' A' ' 129' ' ' LYS . 23.8 ttt 58.22 39.24 25.99 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.02 0.928 . . . . 0.0 111.031 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.588 ' HG3' ' NE1' ' A' ' 135' ' ' TRP 0.306 0.0 OUTLIER 48.98 -73.1 0.0 OUTLIER 'General case' 0 C--N 1.363 1.156 0 C-N-CA 125.125 1.37 . . . . 0.0 114.169 -177.244 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -178.57 -32.15 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.62 ' SD ' ' HA ' ' A' ' 171' ' ' ARG . 0.7 OUTLIER 62.66 81.93 0.19 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.374 -178.127 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 29.0 m -108.98 172.31 6.92 Favored 'General case' 0 C--O 1.251 1.173 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.696 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 30.5 p -81.81 108.12 15.09 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 169.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.539 ' H ' ' H ' ' A' ' 169' ' ' SER . 24.8 m-20 76.36 98.04 0.07 Allowed 'General case' 0 CA--C 1.496 -1.118 0 O-C-N 124.167 0.917 . . . . 0.0 109.836 -175.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.588 ' NE1' ' HG3' ' A' ' 129' ' ' LYS . 69.9 t-105 -140.02 119.83 13.42 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.362 -174.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 166' ' ' LYS . 22.7 t70 -91.01 111.82 23.45 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 174.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.456 HD11 HD11 ' A' ' 123' ' ' ILE . 8.2 tt -97.42 149.27 5.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.238 -170.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -86.47 103.07 14.66 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.398 177.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.416 ' HD1' ' O ' ' A' ' 163' ' ' GLY . 7.0 t80 -137.66 150.24 47.21 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.692 ' HB2' ' HB2' ' A' ' 88' ' ' LYS . 48.9 mt-30 -139.74 158.82 43.47 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.9 tp -141.67 130.49 22.96 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.45 0.643 . . . . 0.0 112.232 -175.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.462 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 2.3 m-20 -125.92 129.51 49.45 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 54.3 mt -130.36 131.86 65.17 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.486 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.392 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -105.42 109.95 3.35 Favored Glycine 0 N--CA 1.405 -3.391 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 156' ' ' THR . 2.6 mm? -89.13 110.18 20.95 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 32.1 m -95.5 108.97 21.24 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.572 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -114.47 152.66 31.27 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -120.25 114.35 21.76 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 175.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 49.6 mm -110.94 116.28 52.02 Favored Pre-proline 0 C--N 1.287 -2.116 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -45.82 -33.0 9.86 Favored 'Trans proline' 0 N--CA 1.485 1.009 0 C-N-CA 123.892 3.061 . . . . 0.0 113.891 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 44.6 t -69.81 -23.66 25.97 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 123.198 0.599 . . . . 0.0 112.166 -177.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 9.1 p -136.86 -33.29 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -175.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 122.01 -151.11 16.95 Favored Glycine 0 N--CA 1.434 -1.498 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.185 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -87.52 117.9 26.62 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.429 0.633 . . . . 0.0 110.647 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.4 123.36 49.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.33 0.586 . . . . 0.0 110.711 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 40.9 m -99.19 127.12 45.12 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.551 177.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.1 mp -89.68 122.1 68.45 Favored Pre-proline 0 C--N 1.318 -0.804 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -83.4 113.59 2.04 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.818 2.345 . . . . 0.0 112.362 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.63 HG11 ' H ' ' A' ' 49' ' ' VAL . 21.9 t -111.89 119.12 59.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 173.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 67.9 p -128.41 127.15 42.02 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 123.13 0.269 . . . . 0.0 111.073 -175.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.1 t -158.64 177.36 11.29 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -98.66 148.75 23.51 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.416 ' O ' ' HD1' ' A' ' 139' ' ' TYR . . . -118.62 83.32 0.35 Allowed Glycine 0 N--CA 1.416 -2.669 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -88.82 119.92 29.75 Favored 'General case' 0 C--N 1.273 -2.729 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.4 HG13 ' CG2' ' A' ' 137' ' ' ILE . 4.9 pt -133.66 123.11 45.01 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-O 121.304 0.573 . . . . 0.0 111.915 -175.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.642 ' HD3' ' H ' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -89.69 109.81 20.76 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.925 178.249 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -90.5 107.44 20.15 Favored Pre-proline 0 C--N 1.288 -2.101 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.077 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -86.35 94.13 0.55 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 122.654 2.236 . . . . 0.0 112.996 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.539 ' H ' ' H ' ' A' ' 134' ' ' ASP . 78.2 p 50.83 105.24 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.351 1.46 . . . . 0.0 114.854 178.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -128.78 -70.82 0.66 Allowed 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.62 ' HA ' ' SD ' ' A' ' 131' ' ' MET . 81.0 mtp180 59.08 79.29 0.23 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 114.231 1.196 . . . . 0.0 114.231 177.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 171' ' ' ARG . 32.5 t70 172.8 -77.71 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 123.978 0.799 . . . . 0.0 111.332 173.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.446 ' O ' HG22 ' A' ' 62' ' ' VAL . 52.6 p90 -100.14 10.76 40.77 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -174.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.464 ' HB3' ' SD ' ' A' ' 131' ' ' MET . 62.0 t80 . . . . . 0 C--N 1.3 -1.569 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.789 -176.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.303 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -171.12 89.58 0.13 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.733 0.778 . . . . 0.0 110.092 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.5 m80 -102.69 142.93 33.02 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.378 -177.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 42.9 m-70 -92.95 71.36 4.69 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.724 0.773 . . . . 0.0 110.71 174.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -146.74 92.51 2.16 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-N 114.108 -1.405 . . . . 0.0 108.402 174.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -126.28 -68.86 0.8 Allowed 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.164 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 39.7 m80 65.29 112.25 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 O-C-N 124.36 1.037 . . . . 0.0 111.788 -178.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.614 ' H ' HD13 ' A' ' 8' ' ' LEU 0.331 0.0 OUTLIER -63.0 -47.48 82.93 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 179.945 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.428 ' N ' HD22 ' A' ' 8' ' ' LEU . 21.6 mm-40 -99.54 72.98 1.81 Allowed 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 122.542 1.163 . . . . 0.0 111.123 176.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.91 -165.87 1.49 Allowed 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.016 176.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 m -61.7 110.52 1.53 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.469 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . . . -57.04 -56.11 26.01 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 -170.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -65.32 -36.3 83.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.124 0.488 . . . . 0.0 110.389 -175.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.412 ' HA ' HG12 ' A' ' 17' ' ' VAL . 40.8 tt0 -64.88 -46.11 83.17 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.682 176.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.469 ' HE2' ' HA ' ' A' ' 12' ' ' ALA . 37.1 ttpt -54.29 -49.52 69.41 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 123.977 0.911 . . . . 0.0 111.679 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.3 m -77.96 -27.3 14.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 14' ' ' GLU . 7.1 p -72.8 -31.42 36.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 119.534 -0.867 . . . . 0.0 109.756 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -60.59 -42.18 96.21 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -59.13 -52.49 65.48 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.657 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -62.61 -44.58 95.93 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.55 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.43 ' HB2' HD11 ' A' ' 94' ' ' ILE . . . -60.83 -40.57 93.32 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.453 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.5 t -60.78 -44.89 96.21 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 123.439 0.462 . . . . 0.0 110.374 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.7 t -60.45 -46.0 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.213 0.53 . . . . 0.0 110.172 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.1 mm -64.95 -47.91 86.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.085 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.1 m -62.88 -29.67 70.94 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.048 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.2 t -65.19 -31.42 72.59 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 120.997 0.427 . . . . 0.0 110.207 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.2 tt -73.92 -42.1 61.1 Favored 'General case' 0 C--O 1.246 0.916 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.495 HD23 ' HB3' ' A' ' 158' ' ' PRO . 8.6 mp -58.89 -35.08 72.42 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.153 175.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -51.02 -49.27 60.82 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.414 ' HD2' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -75.56 -27.95 58.81 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.391 -178.316 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.428 ' HB1' ' O ' ' A' ' 156' ' ' THR . . . -77.36 -34.31 55.09 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.179 -176.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 99.5 mttt -59.14 -37.42 77.22 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 121.08 0.467 . . . . 0.0 109.779 177.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.99 -44.06 97.95 Favored Glycine 0 N--CA 1.431 -1.661 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.758 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -80.47 -39.27 28.38 Favored 'General case' 0 C--O 1.198 -1.648 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.685 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -58.57 -31.7 68.23 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.4 -37.38 83.02 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.754 0.311 . . . . 0.0 111.799 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -116.9 -48.32 2.66 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -175.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.436 ' HB2' ' HE2' ' A' ' 38' ' ' LYS . 12.8 tppt? -69.56 -48.55 59.9 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 122.364 1.078 . . . . 0.0 109.195 -169.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.48 HD22 HG21 ' A' ' 44' ' ' THR . 39.4 mt -88.51 0.87 55.85 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.187 -171.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.17 -20.03 18.23 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.712 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -110.4 -24.9 10.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.945 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 72.1 mt -93.54 142.03 24.64 Favored Pre-proline 0 N--CA 1.431 -1.395 0 N-CA-C 106.789 -1.559 . . . . 0.0 106.789 177.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -67.24 105.25 0.99 Allowed 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 121.888 1.725 . . . . 0.0 108.376 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.48 HG21 HD22 ' A' ' 39' ' ' LEU . 4.2 m -125.11 141.46 38.6 Favored Pre-proline 0 N--CA 1.415 -2.185 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -173.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.38 113.06 1.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.903 1.735 . . . . 0.0 111.079 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -96.84 121.98 39.3 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.185 0.517 . . . . 0.0 110.396 -174.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.507 ' HB2' HD21 ' A' ' 145' ' ' LEU . . . -98.71 157.88 15.98 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.076 -179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -148.72 129.1 13.84 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.924 176.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.408 ' H ' HG11 ' A' ' 159' ' ' VAL . 13.0 p -113.69 137.16 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 175.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -151.04 -35.67 0.14 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.735 -168.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -116.61 147.59 41.74 Favored 'General case' 0 CA--C 1.463 -2.373 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.49 -173.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.547 HG22 ' CB ' ' A' ' 64' ' ' TYR . 8.2 p -150.85 103.05 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.404 -2.765 0 CA-C-O 122.58 1.181 . . . . 0.0 107.885 175.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -96.51 129.56 43.86 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.095 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 44.3 p90 -59.62 122.19 13.48 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.261 0.553 . . . . 0.0 111.026 175.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -85.43 -56.05 3.71 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.138 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.48 -137.63 2.59 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -178.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.1 p -112.65 141.85 26.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.6 m -114.53 166.1 12.06 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -55.84 -54.83 39.77 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -99.25 -62.84 1.18 Allowed 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.635 -177.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -108.64 -130.07 6.08 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 175.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.563 HG21 ' CZ ' ' A' ' 173' ' ' PHE . 7.1 p -140.16 137.38 37.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.269 0.557 . . . . 0.0 111.271 177.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -104.04 122.97 46.36 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.789 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.547 ' CB ' HG22 ' A' ' 52' ' ' VAL . 3.7 m-30 -109.09 167.33 10.18 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.27 0.557 . . . . 0.0 110.665 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -106.29 106.79 17.47 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.08 144.87 26.69 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.604 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -107.83 125.12 51.06 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.042 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.2 t -126.89 107.78 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 176.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.5 m -98.57 139.7 33.91 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 110' ' ' THR . 22.8 t -124.56 127.13 72.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.486 -178.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 88.6 tttt -110.85 117.7 34.13 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.549 ' HB3' ' O ' ' A' ' 107' ' ' GLY . 37.0 t30 -118.99 127.13 26.69 Favored Pre-proline 0 CA--C 1.507 -0.676 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.088 -173.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 72' ' ' ASN . 11.3 Cg_endo -94.01 96.02 0.13 Allowed 'Trans proline' 0 N--CA 1.428 -2.326 0 C-N-CA 121.42 1.414 . . . . 0.0 110.074 169.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.502 ' HB2' HD21 ' A' ' 72' ' ' ASN . 42.7 m-85 175.81 162.27 0.32 Allowed 'General case' 0 CA--C 1.492 -1.273 0 C-N-CA 129.173 2.989 . . . . 0.0 104.21 -178.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 51.7 p -100.85 -16.43 17.26 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.605 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -79.77 149.92 30.94 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 121.573 0.701 . . . . 0.0 112.048 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.8 p -80.38 104.97 11.29 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.433 172.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.418 ' H ' HD22 ' A' ' 105' ' ' LEU . 52.9 mt -91.05 117.61 68.01 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -85.34 152.46 10.62 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.945 1.763 . . . . 0.0 112.531 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.636 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -88.29 143.7 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.598 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 51.0 t -78.47 -35.52 46.49 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -170.23 157.22 6.17 Favored 'General case' 0 C--O 1.252 1.223 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.5 mt -118.33 115.62 48.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 171.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 20.8 p -112.81 118.57 35.31 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.316 -176.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 96' ' ' SER . 37.9 p90 -104.15 143.2 33.25 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 58.2 mt -132.76 108.08 12.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 173.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 87' ' ' LEU . 4.2 pp -105.55 134.44 48.67 Favored 'General case' 0 C--N 1.282 -2.369 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.359 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.516 ' HA ' HG22 ' A' ' 94' ' ' ILE . 40.3 ttmt -110.93 123.98 51.21 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.06 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.486 ' OG ' ' HB2' ' A' ' 122' ' ' SER . 53.2 p -104.26 98.63 8.4 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 64.5 -79.94 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.264 1.426 . . . . 0.0 114.819 174.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.8 t -135.11 -29.65 1.1 Allowed 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -172.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -143.91 145.63 32.41 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.582 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 m 71.19 130.41 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.197 0 O-C-N 125.28 1.612 . . . . 0.0 110.836 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.516 HG22 ' HA ' ' A' ' 88' ' ' LYS . 1.8 pp -127.4 165.35 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.11 122.02 36.72 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 61.3 p -120.81 147.19 45.7 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -163.37 144.98 10.01 Favored Glycine 0 N--CA 1.432 -1.626 0 C-N-CA 119.844 -1.17 . . . . 0.0 112.248 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.8 p -107.97 115.63 30.48 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.5 tt -101.81 114.45 65.58 Favored Pre-proline 0 C--N 1.307 -1.25 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.764 177.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -85.71 129.49 3.56 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 122.617 2.211 . . . . 0.0 111.457 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.9 t70 50.45 79.38 0.35 Allowed Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 124.608 1.163 . . . . 0.0 113.21 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -99.71 2.45 0.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.126 2.55 . . . . 0.0 112.09 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 151.94 -166.62 30.97 Favored Glycine 0 N--CA 1.42 -2.382 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.3 p -137.76 155.7 48.77 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.255 0.55 . . . . 0.0 110.763 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.624 ' HA ' HG21 ' A' ' 111' ' ' THR . 6.3 tt -90.64 125.36 35.63 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.412 HG22 ' HB ' ' A' ' 111' ' ' THR . 33.7 m -65.36 -30.7 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -172.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.577 ' H ' HD23 ' A' ' 105' ' ' LEU . . . 135.26 -113.24 1.09 Allowed Glycine 0 N--CA 1.417 -2.598 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -176.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.8 p -91.85 97.85 11.24 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 124.25 1.02 . . . . 0.0 111.136 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 140.53 -164.07 26.37 Favored Glycine 0 N--CA 1.418 -2.555 0 C-N-CA 119.947 -1.12 . . . . 0.0 111.485 176.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 11.0 t -95.7 139.94 31.23 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-O 121.919 0.866 . . . . 0.0 111.104 -178.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.624 HG21 ' HA ' ' A' ' 105' ' ' LEU . 4.9 t -134.78 121.0 20.09 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 176.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.7 t -87.74 110.45 20.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.582 -177.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.3 mt -97.48 162.29 13.38 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -141.54 144.02 34.07 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.479 -0.489 . . . . 0.0 111.46 -175.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 51.7 t -135.01 136.41 24.92 Favored Pre-proline 0 C--O 1.241 0.606 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.557 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -79.5 111.34 2.81 Favored 'Trans proline' 0 N--CA 1.432 -2.135 0 N-CA-C 107.586 -1.736 . . . . 0.0 107.586 168.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 24.6 m -112.67 133.88 57.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -89.01 92.0 9.06 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.783 0.802 . . . . 0.0 110.183 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.492 ' C ' ' H ' ' A' ' 121' ' ' TYR . 3.2 m -95.24 149.73 4.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.383 -172.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.504 ' HB1' ' CE1' ' A' ' 174' ' ' PHE . . . 74.36 -20.15 0.33 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.54 0.736 . . . . 0.0 111.87 175.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.492 ' H ' ' C ' ' A' ' 119' ' ' VAL . 21.4 t80 -46.11 -45.29 16.29 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 126.461 1.904 . . . . 0.0 109.782 176.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.486 ' HB2' ' OG ' ' A' ' 89' ' ' SER . 18.0 m -68.21 -52.42 34.44 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-N 115.275 -0.875 . . . . 0.0 113.039 -174.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 12.6 tt -74.61 -36.08 39.86 Favored 'Isoleucine or valine' 0 C--O 1.251 1.178 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -174.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.38 -50.66 72.71 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 122.269 0.227 . . . . 0.0 111.294 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.2 m -72.7 -22.67 20.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.9 t -77.27 -69.86 0.5 Allowed 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.808 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 127' ' ' LEU . 1.7 pt? -124.1 -23.72 4.51 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -177.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.476 ' O ' ' HD2' ' A' ' 129' ' ' LYS . 0.0 OUTLIER 66.3 -176.55 0.19 Allowed 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -177.223 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.476 ' HD2' ' O ' ' A' ' 128' ' ' MET . 12.2 mmmm -133.31 -71.25 0.52 Allowed 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 178.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.409 ' H ' ' HB2' ' A' ' 129' ' ' LYS . 15.8 t70 152.85 80.93 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 128.978 2.911 . . . . 0.0 104.419 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.418 ' HE1' ' HB2' ' A' ' 170' ' ' LEU . 1.0 OUTLIER -91.31 115.47 28.06 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.509 -178.72 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 169' ' ' SER . 83.1 m -131.09 -81.04 0.53 Allowed 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -178.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 41.5 p -142.01 116.86 9.86 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 123.287 0.635 . . . . 0.0 109.915 -169.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.6 t70 59.97 82.07 0.16 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 122.08 0.943 . . . . 0.0 109.419 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -140.86 158.96 43.22 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.5 -172.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -147.72 154.89 41.14 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 118.683 0.674 . . . . 0.0 110.864 175.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.5 tt -148.63 149.68 14.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.139 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -114.14 134.17 55.08 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.452 ' HE2' HD22 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -125.49 170.76 11.09 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 178.014 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 162' ' ' GLN . 24.3 tt0 -119.17 137.41 53.63 Favored 'General case' 0 C--N 1.273 -2.741 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.297 -177.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 28.5 tp -119.57 128.23 53.71 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.975 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.62 ' OD1' ' HB3' ' A' ' 160' ' ' SER . 17.1 t70 -130.71 112.2 12.87 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 35.4 mt -113.31 122.57 67.7 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.31 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.962 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -106.68 101.95 1.81 Allowed Glycine 0 N--CA 1.398 -3.892 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.507 HD21 ' HB2' ' A' ' 47' ' ' ALA . 0.8 OUTLIER -91.77 143.07 26.91 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.87 174.289 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.8 m -114.4 111.34 21.29 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.316 -175.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.495 ' CE1' HG23 ' A' ' 80' ' ' ILE . 90.1 m-85 -106.71 163.43 12.92 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 172.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -146.64 131.44 18.01 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.357 177.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.26 135.71 15.28 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 176.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -48.92 -18.34 1.64 Allowed 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 124.393 3.395 . . . . 0.0 114.927 -178.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 55.7 t -57.23 -39.07 65.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 121.133 0.492 . . . . 0.0 110.332 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 5.8 p -136.69 -36.15 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.238 0.542 . . . . 0.0 111.238 -178.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 120.53 -142.52 15.89 Favored Glycine 0 N--CA 1.419 -2.499 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -178.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -92.04 126.45 37.13 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.164 0.507 . . . . 0.0 110.01 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.41 ' N ' HD13 ' A' ' 155' ' ' ILE . 0.2 OUTLIER -139.85 133.56 36.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.37 176.849 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 11.4 t -100.5 147.98 25.29 Favored 'General case' 0 N--CA 1.412 -2.345 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 173.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 60.0 mt -110.48 109.35 58.25 Favored Pre-proline 0 C--N 1.291 -1.94 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.495 ' HB3' HD23 ' A' ' 28' ' ' LEU . 17.1 Cg_exo -70.82 102.64 1.22 Allowed 'Trans proline' 0 C--O 1.244 0.806 0 C-N-CA 122.693 2.262 . . . . 0.0 111.376 177.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 142' ' ' ASP . 14.2 t -103.83 108.77 25.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.62 ' HB3' ' OD1' ' A' ' 142' ' ' ASP . 52.1 p -109.04 150.89 27.11 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.817 -177.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.8 t -168.07 151.97 6.11 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 140' ' ' GLN . 12.9 pt20 -107.69 119.23 38.84 Favored 'General case' 0 N--CA 1.42 -1.934 0 C-N-CA 119.296 -0.962 . . . . 0.0 109.345 174.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -92.96 118.76 5.7 Favored Glycine 0 N--CA 1.409 -3.126 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.696 -174.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -89.68 119.59 30.23 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 176.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.3 pt -129.59 111.95 23.38 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 CA-C-O 121.521 0.677 . . . . 0.0 111.524 -174.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -78.85 130.11 35.31 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.604 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 87.7 mt -106.39 109.17 62.94 Favored Pre-proline 0 C--N 1.293 -1.859 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.006 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.8 172.05 17.03 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.185 1.924 . . . . 0.0 111.765 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 49.1 p -53.28 105.65 0.14 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 123.253 0.621 . . . . 0.0 111.495 175.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.418 ' HB2' ' HE1' ' A' ' 131' ' ' MET . 79.7 mt -137.38 -50.31 0.62 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 62.75 113.93 0.02 OUTLIER 'General case' 0 C--N 1.355 0.843 0 O-C-N 124.213 0.945 . . . . 0.0 112.815 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 33.1 t70 87.23 8.95 0.18 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.762 1.225 . . . . 0.0 111.094 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.563 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 72.5 t80 -80.63 -40.09 26.26 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.34 174.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.504 ' CE1' ' HB1' ' A' ' 120' ' ' ALA . 72.1 t80 . . . . . 0 C--N 1.313 -0.99 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.471 ' O ' HG23 ' A' ' 17' ' ' VAL . 7.8 m-20 . . . . . 0 N--CA 1.475 0.776 0 CA-C-O 120.928 0.394 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.22 -40.66 86.53 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -177.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -70.28 -53.81 15.29 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.955 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.409 ' HA ' ' CG ' ' A' ' 19' ' ' GLU . 33.4 m -62.7 -27.96 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.543 HG11 ' O ' ' A' ' 94' ' ' ILE . 73.3 t -62.92 -41.23 91.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.024 175.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -66.93 -36.3 81.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.79 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.409 ' CG ' ' HA ' ' A' ' 16' ' ' VAL . 7.5 mm-40 -53.3 -54.0 42.8 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.36 0.664 . . . . 0.0 109.719 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -65.94 -47.86 73.29 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.258 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.69 -43.48 80.53 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.095 -176.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -57.19 -45.81 83.39 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 123.59 0.556 . . . . 0.0 111.045 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.01 -42.02 79.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.431 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 73.9 mt -58.22 -46.97 88.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.891 177.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.7 m -61.99 -30.87 71.24 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.868 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.6 m -67.69 -40.18 84.38 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.076 0.465 . . . . 0.0 110.575 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.643 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 6.5 tt -72.74 -33.62 66.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.071 0.462 . . . . 0.0 109.993 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 96.5 mt -65.86 -38.72 89.57 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.428 0.632 . . . . 0.0 109.485 175.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -66.31 -34.38 77.85 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.225 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.643 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -64.11 -33.55 76.02 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-O 121.533 0.682 . . . . 0.0 109.432 178.264 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.561 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -77.64 -32.47 53.36 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.933 -178.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -53.46 -52.91 57.98 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.21 -24.93 75.66 Favored Glycine 0 N--CA 1.468 0.806 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.667 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.612 ' CZ ' ' HD2' ' A' ' 38' ' ' LYS . 10.9 t80 -68.79 -40.1 79.78 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 124.165 0.986 . . . . 0.0 110.263 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.495 ' CD1' HD12 ' A' ' 39' ' ' LEU . 20.2 m-85 -62.27 -45.57 92.68 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.313 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.74 -48.72 63.54 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 124.505 1.128 . . . . 0.0 113.061 -174.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -104.61 -36.13 7.59 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 119.414 -0.914 . . . . 0.0 113.349 -176.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.612 ' HD2' ' CZ ' ' A' ' 34' ' ' PHE . 21.6 ttmm -87.01 -43.49 12.3 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.342 -173.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.495 HD12 ' CD1' ' A' ' 35' ' ' PHE . 22.7 mt -87.28 19.04 3.37 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.204 -0.998 . . . . 0.0 111.907 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.89 -18.24 13.98 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.43 ' N ' HD22 ' A' ' 41' ' ' ASN . 0.8 OUTLIER -107.46 -21.07 13.05 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.788 177.151 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.3 mm -111.59 107.21 56.8 Favored Pre-proline 0 N--CA 1.442 -0.845 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.454 ' HB2' ' OH ' ' A' ' 74' ' ' TYR . 24.8 Cg_exo -64.26 118.0 4.99 Favored 'Trans proline' 0 C--O 1.251 1.149 0 C-N-CA 122.643 2.229 . . . . 0.0 112.294 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.1 p -128.73 150.32 74.53 Favored Pre-proline 0 C--N 1.299 -1.629 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.213 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.484 ' HB3' ' HB2' ' A' ' 72' ' ' ASN . 34.7 Cg_endo -63.48 149.23 91.61 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.988 2.459 . . . . 0.0 112.155 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -110.85 137.79 48.06 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.448 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.529 ' O ' HG11 ' A' ' 159' ' ' VAL . . . -115.65 165.33 13.15 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.331 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.4 t -161.89 147.39 13.28 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 110.518 -0.178 . . . . 0.0 110.518 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.519 ' HB ' ' OG1' ' A' ' 161' ' ' THR . 89.8 t -91.32 140.93 15.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 174.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -116.07 -60.94 1.8 Allowed 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -175.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -161.66 165.91 27.54 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -167.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.482 HG12 ' HB2' ' A' ' 66' ' ' ALA . 26.1 m -124.15 137.72 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -96.18 126.63 41.54 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.436 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -58.61 109.19 0.75 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 168.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.51 -53.29 1.36 Allowed 'General case' 0 N--CA 1.426 -1.668 0 C-N-CA 119.029 -1.068 . . . . 0.0 112.677 -172.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.91 -172.88 31.93 Favored Glycine 0 N--CA 1.425 -2.078 0 C-N-CA 119.184 -1.484 . . . . 0.0 112.309 -174.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.459 ' HB ' ' CD1' ' A' ' 173' ' ' PHE . 12.2 p -128.77 155.69 40.85 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-O 121.129 0.49 . . . . 0.0 110.927 -175.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 48.4 m -125.88 149.47 48.66 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 173.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 60' ' ' ASP . 37.3 mmt180 -79.0 77.2 5.47 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 118.621 -1.232 . . . . 0.0 112.22 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 59' ' ' ARG . 9.9 t70 171.74 -48.08 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.163 1.385 . . . . 0.0 107.668 176.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -150.19 177.95 27.97 Favored Glycine 0 C--O 1.223 -0.549 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 119' ' ' VAL . 6.5 m -87.83 156.09 3.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 118.743 1.272 . . . . 0.0 110.842 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -111.5 105.37 13.93 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.312 0.577 . . . . 0.0 109.75 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -110.64 159.76 17.29 Favored 'General case' 0 CA--C 1.48 -1.726 0 CA-C-O 122.084 0.945 . . . . 0.0 112.588 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -107.61 106.63 17.08 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.482 ' HB2' HG12 ' A' ' 52' ' ' VAL . . . -97.87 144.81 27.06 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -94.72 135.53 36.09 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.175 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.9 t -130.93 108.49 15.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 174.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.0 m -102.38 133.64 46.98 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.057 -175.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.3 t -123.32 133.33 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -119.93 128.22 53.4 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.532 HD21 ' HB2' ' A' ' 74' ' ' TYR . 6.0 t30 -142.89 114.92 5.99 Favored Pre-proline 0 C--N 1.284 -2.257 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.585 -175.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -94.17 96.17 0.13 Allowed 'Trans proline' 0 N--CA 1.422 -2.726 0 C-N-CA 121.835 1.69 . . . . 0.0 110.248 172.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.532 ' HB2' HD21 ' A' ' 72' ' ' ASN . 68.9 m-85 -176.33 127.55 0.2 Allowed 'General case' 0 CA--C 1.482 -1.671 0 C-N-CA 128.105 2.562 . . . . 0.0 104.788 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.4 m -84.32 68.83 10.35 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.442 0.639 . . . . 0.0 111.012 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.447 HE21 HD11 ' A' ' 78' ' ' ILE . 12.9 pt20 -151.8 145.77 25.22 Favored 'General case' 0 N--CA 1.407 -2.612 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.82 176.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 44.6 p -86.76 101.56 13.44 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.776 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.447 HD11 HE21 ' A' ' 76' ' ' GLN . 28.1 mt -94.72 117.61 66.91 Favored Pre-proline 0 N--CA 1.441 -0.891 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -83.65 146.96 12.16 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 121.915 1.743 . . . . 0.0 110.59 176.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.435 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 2.1 mp -85.53 91.46 3.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.255 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.683 ' O ' ' HB ' ' A' ' 146' ' ' THR . 58.6 m -78.27 105.72 9.69 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.466 ' HB3' ' O ' ' A' ' 81' ' ' CYS . 24.7 tt0 76.3 109.66 0.07 Allowed 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.14 0.9 . . . . 0.0 111.754 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.617 ' CG2' ' HB ' ' A' ' 99' ' ' ILE . 15.5 tt -117.8 125.04 73.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.538 -0.726 . . . . 0.0 109.342 174.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.9 t -86.84 125.07 33.73 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-O 121.25 0.548 . . . . 0.0 109.86 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.545 ' OH ' ' HA ' ' A' ' 117' ' ' VAL . 56.5 t80 -107.69 120.38 42.06 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.26 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.5 mt -130.24 107.18 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 CA-C-O 122.063 0.935 . . . . 0.0 109.332 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.644 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 1.3 tm? -100.66 134.82 43.05 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 114.616 -1.174 . . . . 0.0 107.862 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.586 ' HB2' ' HB2' ' A' ' 140' ' ' GLN . 96.5 mttt -128.31 158.02 39.36 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -177.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.505 ' OG ' ' HB3' ' A' ' 122' ' ' SER . 57.5 m -143.91 97.67 3.1 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 52.71 -90.13 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 175.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.9 m -108.24 -53.99 2.56 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.097 0.475 . . . . 0.0 111.755 -171.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -126.06 154.84 42.45 Favored 'General case' 0 CA--C 1.472 -2.044 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 27.6 m 71.87 135.89 0.04 OUTLIER 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 113.363 -1.744 . . . . 0.0 112.895 175.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.644 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 38.4 pt -136.84 -179.2 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.382 0 CA-C-N 114.616 -1.175 . . . . 0.0 107.937 176.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . . . -130.75 121.31 25.19 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 172.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 36.8 p -112.49 159.06 19.15 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.534 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.21 178.3 47.55 Favored Glycine 0 N--CA 1.424 -2.15 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.9 m -146.25 120.06 9.27 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.617 ' HB ' ' CG2' ' A' ' 83' ' ' ILE . 71.5 mt -98.6 126.11 40.31 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -177.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -80.49 114.86 3.07 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.914 1.742 . . . . 0.0 111.278 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.8 t70 53.23 87.6 0.14 Allowed Pre-proline 0 N--CA 1.485 1.292 0 C-N-CA 124.937 1.295 . . . . 0.0 112.753 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.435 ' HD2' ' HB ' ' A' ' 80' ' ' ILE . 26.7 Cg_endo -91.15 -7.05 3.75 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.847 2.365 . . . . 0.0 112.188 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 160.93 -179.04 36.65 Favored Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.3 m -142.71 157.67 44.42 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.275 0.559 . . . . 0.0 111.038 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.473 HD23 ' CB ' ' A' ' 72' ' ' ASN . 7.5 mp -76.73 135.13 39.02 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.483 176.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 27.3 m -71.06 -17.5 20.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.11 113.1 1.51 Allowed Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 61.9 m 53.46 83.87 0.06 Allowed 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.916 0.886 . . . . 0.0 113.308 -177.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 155.71 -176.93 33.09 Favored Glycine 0 N--CA 1.432 -1.575 0 C-N-CA 119.956 -1.116 . . . . 0.0 112.391 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.7 t -105.38 135.71 46.26 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.5 t -139.44 130.37 26.29 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 120.865 0.364 . . . . 0.0 110.407 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.9 m -93.48 122.47 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-O 121.686 0.755 . . . . 0.0 110.024 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.9 mt -108.34 158.06 17.83 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -134.09 149.03 51.09 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 119.664 -0.815 . . . . 0.0 112.277 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.3 m -131.49 144.63 54.19 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.649 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -74.06 111.76 3.38 Favored 'Trans proline' 0 C--O 1.247 0.953 0 C-N-CA 122.12 1.88 . . . . 0.0 110.675 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.545 ' HA ' ' OH ' ' A' ' 85' ' ' TYR . 96.5 t -107.26 127.09 63.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-O 121.553 0.692 . . . . 0.0 112.814 -175.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.515 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 8.5 mmpt? -89.06 96.64 10.81 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.602 ' O ' HG22 ' A' ' 62' ' ' VAL . 99.7 t -93.52 138.94 19.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 72.19 -16.84 0.4 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.058 0.943 . . . . 0.0 111.416 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.512 ' H ' ' C ' ' A' ' 119' ' ' VAL . 53.1 t80 -51.49 -39.86 58.4 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 125.94 1.696 . . . . 0.0 110.1 176.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.505 ' HB3' ' OG ' ' A' ' 89' ' ' SER . 33.9 t -65.55 -51.79 57.26 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.557 -177.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.5 tt -67.25 -28.87 43.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.327 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.43 -50.65 62.66 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.77 -30.2 49.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.956 0.408 . . . . 0.0 110.928 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.0 t -70.69 -73.43 0.17 Allowed 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.48 ' H ' HD23 ' A' ' 127' ' ' LEU . 1.9 pt? -125.43 -41.33 2.04 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 24.1 ttt 64.15 100.03 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 124.299 1.04 . . . . 0.0 109.395 -172.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.568 ' HG3' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -48.89 -63.78 1.0 Allowed 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.732 -177.048 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.568 ' H ' ' HG3' ' A' ' 129' ' ' LYS . 21.4 t70 151.85 107.93 0.0 OUTLIER 'General case' 0 CA--C 1.471 -2.094 0 N-CA-C 102.649 -3.093 . . . . 0.0 102.649 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.471 ' HG3' ' HA ' ' A' ' 171' ' ' ARG . 13.1 tpt -53.07 123.58 12.05 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 123.519 0.512 . . . . 0.0 111.627 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 49.1 t -99.32 -158.74 0.69 Allowed 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.238 -176.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.696 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 21.8 p -131.01 114.11 14.79 Favored 'General case' 0 N--CA 1.385 -3.713 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.2 t70 70.43 89.9 0.1 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -172.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -133.58 115.74 15.05 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.522 -172.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.14 104.55 15.82 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.026 176.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.3 tt -102.2 138.2 27.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.55 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -82.49 100.14 9.9 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.753 0.787 . . . . 0.0 109.449 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.51 ' HB3' HG12 ' A' ' 165' ' ' ILE . 9.1 t80 -113.95 148.34 37.01 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.344 -176.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.586 ' HB2' ' HB2' ' A' ' 88' ' ' LYS . 1.8 mp0 -136.08 154.01 51.15 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.5 tp -141.86 123.07 14.73 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 123.246 0.618 . . . . 0.0 109.58 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -126.33 128.0 46.42 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 43.9 mt -130.4 130.34 65.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 C-N-CA 120.209 -0.596 . . . . 0.0 112.336 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 157' ' ' ILE . . . -114.88 90.76 0.54 Allowed Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.443 HD11 ' CE2' ' A' ' 147' ' ' PHE . 2.9 pp -84.57 151.54 24.46 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.897 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.683 ' HB ' ' O ' ' A' ' 81' ' ' CYS . 8.6 m -109.09 120.69 43.29 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.8 -176.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.443 ' CE2' HD11 ' A' ' 145' ' ' LEU . 73.6 m-85 -100.4 141.26 33.5 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 170.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -110.39 133.36 53.34 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 174.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.76 139.45 29.05 Favored Pre-proline 0 C--N 1.301 -1.53 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.659 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -63.46 -17.02 58.12 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.856 2.371 . . . . 0.0 112.051 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.67 -45.52 98.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.998 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 40.4 t -130.15 -78.04 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.059 0.457 . . . . 0.0 109.904 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 173.81 -112.66 0.43 Allowed Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -101.24 125.97 47.92 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.935 0.397 . . . . 0.0 111.202 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 146' ' ' THR . 34.1 pt -121.28 114.92 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 CA-C-O 121.008 0.433 . . . . 0.0 110.522 173.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.535 HG22 ' OG1' ' A' ' 146' ' ' THR . 37.9 p -96.1 105.27 17.29 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.691 175.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.466 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 60.7 mt -91.5 107.1 19.4 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 156' ' ' THR . 8.0 Cg_endo -85.42 100.74 0.69 Allowed 'Trans proline' 0 N--CA 1.43 -2.26 0 C-N-CA 122.6 2.2 . . . . 0.0 111.719 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.529 HG11 ' O ' ' A' ' 47' ' ' ALA . 18.0 m -94.74 110.03 23.19 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 CA-C-O 122.015 0.912 . . . . 0.0 109.542 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.5 p -88.89 146.13 25.12 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-N 114.352 -1.295 . . . . 0.0 111.318 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.519 ' OG1' ' HB ' ' A' ' 49' ' ' VAL . 98.5 m -146.64 127.39 14.34 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.134 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -121.4 143.07 49.42 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -164.42 -139.63 2.68 Favored Glycine 0 N--CA 1.422 -2.24 0 C-N-CA 119.728 -1.225 . . . . 0.0 112.121 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.21 148.59 15.14 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.51 HG12 ' HB3' ' A' ' 139' ' ' TYR . 47.8 mm -126.18 139.37 51.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -106.06 111.76 24.52 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.76 0.79 . . . . 0.0 110.146 175.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 15.6 tp -93.84 106.28 20.99 Favored Pre-proline 0 C--N 1.296 -1.751 0 CA-C-N 113.998 -1.455 . . . . 0.0 108.276 -174.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 167' ' ' LEU . 23.5 Cg_exo -64.65 156.89 58.65 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.416 2.744 . . . . 0.0 116.054 -171.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.696 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 31.1 p -48.41 25.32 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 129.19 2.996 . . . . 0.0 117.603 174.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 59.8 mt -71.63 -42.32 67.75 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.471 ' HA ' ' HG3' ' A' ' 131' ' ' MET . 59.8 ttt180 72.31 -27.12 0.18 Allowed 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 126.47 1.908 . . . . 0.0 112.48 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -113.74 61.2 0.66 Allowed 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 122.719 1.247 . . . . 0.0 108.121 173.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.517 ' O ' HG12 ' A' ' 62' ' ' VAL . 85.9 t80 . . . . . 0 C--N 1.298 -1.662 0 CA-C-N 113.398 -1.728 . . . . 0.0 106.569 174.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.55 ' O ' HG22 ' A' ' 17' ' ' VAL . 18.7 m-20 . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.8 -34.71 65.56 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -178.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -75.29 -54.86 6.38 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 123.45 0.7 . . . . 0.0 110.314 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.8 t -58.57 -45.81 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.05 0.94 . . . . 0.0 113.499 -174.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 13' ' ' ASP . 35.9 m -66.14 -27.28 40.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.656 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -76.6 -30.2 56.85 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.603 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -54.91 -42.99 72.88 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.509 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.28 -37.42 87.44 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.607 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.53 -36.33 82.43 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.6 t -61.91 -45.18 94.86 Favored 'General case' 0 C--O 1.252 1.231 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.859 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.03 -37.84 54.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.479 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.419 HD12 ' OG ' ' A' ' 96' ' ' SER . 79.3 mt -65.68 -41.1 89.77 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.746 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.5 t -58.41 -36.35 73.45 Favored 'General case' 0 C--O 1.243 0.715 0 O-C-N 123.54 0.525 . . . . 0.0 110.959 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.2 m -67.04 -39.58 87.0 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.053 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.551 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 5.2 tt -80.36 -40.54 26.41 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -54.09 -43.87 70.71 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.33 1.052 . . . . 0.0 109.673 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -65.0 -39.32 93.29 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.042 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.551 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -70.93 -37.41 72.87 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.077 -179.593 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.515 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -69.58 -32.46 71.23 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.662 -177.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.48 -40.24 82.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.2 175.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.14 -49.84 73.75 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.297 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.46 ' HD1' ' O ' ' A' ' 30' ' ' LYS . 10.5 m-85 -59.13 -46.89 87.18 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 120.562 0.22 . . . . 0.0 110.643 177.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.509 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 65.1 t80 -62.79 -41.16 99.15 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -176.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.3 -44.25 79.69 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -108.67 -27.65 9.7 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -173.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -101.26 -46.62 4.98 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.467 -171.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 36.8 mt -78.94 -0.48 31.14 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.79 -171.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.01 -33.15 63.67 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -101.42 -47.82 4.56 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 114.348 -1.296 . . . . 0.0 110.52 -173.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.69 126.54 92.85 Favored Pre-proline 0 C--O 1.24 0.601 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.313 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.63 106.67 0.17 Allowed 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 123.109 2.539 . . . . 0.0 112.578 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.501 HG21 HD22 ' A' ' 39' ' ' LEU . 8.3 p -130.85 166.4 27.68 Favored Pre-proline 0 N--CA 1.429 -1.484 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.725 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -79.6 138.35 13.54 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.819 2.346 . . . . 0.0 110.511 175.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -96.89 108.09 20.72 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.091 0.472 . . . . 0.0 109.823 -176.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.5 146.65 25.56 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.04 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.2 t -145.93 138.59 25.65 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 121.073 0.463 . . . . 0.0 110.553 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.446 HG13 HG23 ' A' ' 159' ' ' VAL . 12.7 m -90.53 142.55 12.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.207 175.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -130.22 -63.08 0.91 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.083 -1.047 . . . . 0.0 112.979 -174.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -161.13 164.52 30.58 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 -173.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.635 HG22 ' HB3' ' A' ' 64' ' ' TYR . 11.1 p -125.28 114.26 39.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 176.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -99.21 132.51 44.47 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -169.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.534 ' O ' ' HE3' ' A' ' 55' ' ' LYS . 50.2 p90 -58.52 129.1 40.46 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 123.969 0.793 . . . . 0.0 111.743 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.622 ' HE3' ' HA ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -130.0 -64.57 0.86 Allowed 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.689 -173.028 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -140.39 175.27 22.09 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.983 -175.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.431 HG22 ' CD1' ' A' ' 173' ' ' PHE . 28.8 t -99.07 147.46 7.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -175.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 74.2 m -129.58 160.29 33.71 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 174.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -45.95 62.09 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -104.15 97.76 7.68 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.549 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.504 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . 85.11 -170.53 45.28 Favored Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.539 HG21 ' CE2' ' A' ' 173' ' ' PHE . 7.1 p -124.4 153.14 30.76 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -93.99 112.18 23.98 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-O 121.581 0.705 . . . . 0.0 110.957 -175.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.635 ' HB3' HG22 ' A' ' 52' ' ' VAL . 3.5 m-30 -116.17 166.17 12.33 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.452 174.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.525 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 12.2 m-70 -116.93 112.87 21.62 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.513 174.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -77.47 123.43 26.56 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.981 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -87.48 108.46 19.03 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.301 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.2 t -122.39 108.81 22.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.4 m -100.05 134.0 43.61 Favored 'General case' 0 C--N 1.284 -2.266 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.509 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.72 112.43 36.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-O 121.251 0.548 . . . . 0.0 110.13 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 39.3 ttpt -95.25 110.75 22.7 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 175.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -119.18 116.93 33.66 Favored Pre-proline 0 N--CA 1.42 -1.963 0 C-N-CA 118.64 -1.224 . . . . 0.0 111.278 -174.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -95.75 98.83 0.1 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.451 0 C-N-CA 121.756 1.637 . . . . 0.0 109.551 169.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.7 t80 178.4 108.13 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.7 m -50.88 16.66 0.0 OUTLIER 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 119.342 3.09 . . . . 0.0 119.342 -166.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.524 HE21 HG12 ' A' ' 78' ' ' ILE . 7.3 pt20 -142.89 166.35 24.88 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 119.583 1.083 . . . . 0.0 111.45 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.1 p -88.51 101.13 13.63 Favored 'General case' 0 N--CA 1.417 -2.096 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 174.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.524 HG12 HE21 ' A' ' 76' ' ' GLN . 67.7 mt -73.65 129.58 85.12 Favored Pre-proline 0 C--N 1.31 -1.121 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.33 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.96 122.29 10.97 Favored 'Trans proline' 0 C--O 1.254 1.305 0 C-N-CA 122.726 2.284 . . . . 0.0 112.369 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.446 HG12 ' CE1' ' A' ' 147' ' ' PHE . 45.0 mt -89.91 107.87 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 57.3 m -53.98 -59.57 4.47 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 123.076 0.551 . . . . 0.0 110.37 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -165.45 150.21 8.82 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 98' ' ' THR . 15.7 tt -96.69 124.32 49.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 174.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.422 ' HA ' HG22 ' A' ' 98' ' ' THR . 48.0 m -100.61 118.66 37.21 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -175.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -119.91 139.86 51.77 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.293 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.448 ' HB ' ' HB2' ' A' ' 142' ' ' ASP . 64.7 mt -123.87 108.37 20.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 171.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.6 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 1.5 tm? -91.65 122.43 34.21 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -125.56 140.01 53.11 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -175.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 122' ' ' SER . 30.2 t -104.98 145.66 30.12 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.959 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.52 -12.93 55.61 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.872 175.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 68.8 p -97.51 17.8 16.82 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.152 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 81.21 163.01 0.16 Allowed 'General case' 0 C--O 1.25 1.081 0 C-N-CA 125.542 1.537 . . . . 0.0 111.984 -176.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.492 ' O ' ' HB3' ' A' ' 122' ' ' SER . 53.9 m 72.24 137.84 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.726 1.21 . . . . 0.0 110.259 -174.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.6 pp -129.87 172.75 15.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.6 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . . . -127.11 121.78 32.38 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 174.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.419 ' OG ' HD12 ' A' ' 24' ' ' ILE . 23.0 t -134.62 158.25 44.52 Favored 'General case' 0 C--N 1.282 -2.352 0 C-N-CA 118.641 -1.224 . . . . 0.0 110.726 -176.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.54 179.53 44.26 Favored Glycine 0 N--CA 1.429 -1.831 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.422 HG22 ' HA ' ' A' ' 84' ' ' SER . 23.0 p -135.11 134.17 39.99 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.747 0.273 . . . . 0.0 110.519 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.4 ' HB ' HG22 ' A' ' 83' ' ' ILE . 3.4 mp -104.79 107.35 58.18 Favored Pre-proline 0 C--O 1.244 0.782 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.475 174.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -66.05 121.8 9.21 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.736 2.291 . . . . 0.0 110.387 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 53.85 78.66 0.38 Allowed Pre-proline 0 N--CA 1.483 1.22 0 C-N-CA 123.921 0.888 . . . . 0.0 111.572 -175.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -97.96 6.01 1.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.932 2.421 . . . . 0.0 112.689 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 164.9 -168.76 39.26 Favored Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 56.1 m -143.27 159.13 42.89 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 120.795 0.331 . . . . 0.0 110.291 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.451 ' HA ' HG21 ' A' ' 111' ' ' THR . 82.7 mt -88.71 156.83 18.77 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.502 177.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 27.7 m -99.1 1.79 10.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 121.016 0.436 . . . . 0.0 111.841 -176.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.21 -52.22 4.63 Favored Glycine 0 C--O 1.217 -0.96 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.905 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.5 t -146.23 103.35 3.7 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 150.29 -175.0 29.54 Favored Glycine 0 N--CA 1.421 -2.359 0 C-N-CA 120.291 -0.957 . . . . 0.0 111.376 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 25.6 m -102.67 108.32 19.54 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.451 HG21 ' HA ' ' A' ' 105' ' ' LEU . 5.5 t -99.98 114.52 27.85 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 121.766 0.793 . . . . 0.0 109.466 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.2 t -85.36 113.76 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.5 mt -96.17 147.8 23.37 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 7.2 p-10 -136.91 123.03 20.38 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.443 0.639 . . . . 0.0 110.696 -176.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 69.3 t -102.26 122.22 47.49 Favored Pre-proline 0 C--N 1.299 -1.604 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.225 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -68.51 109.97 2.18 Favored 'Trans proline' 0 N--CA 1.439 -1.703 0 N-CA-C 105.815 -2.417 . . . . 0.0 105.815 167.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.7 p -126.94 148.39 31.76 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -172.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.476 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 9.0 mmpt? -88.86 98.26 11.63 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.457 HG12 HD21 ' A' ' 87' ' ' LEU . 10.6 m -94.65 149.02 4.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.678 ' HA ' HD13 ' A' ' 123' ' ' ILE . . . 72.15 0.72 3.67 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.031 0.533 . . . . 0.0 111.359 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -59.93 -51.26 70.46 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 173.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' ' 93' ' ' THR . 15.1 m -62.37 -27.44 69.07 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.152 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.678 HD13 ' HA ' ' A' ' 120' ' ' ALA . 2.6 mp -79.1 -47.8 22.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.905 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.78 -36.93 82.5 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.351 0.407 . . . . 0.0 110.994 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 54.0 t -65.68 -37.27 79.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.997 176.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 63.0 m -82.42 -75.81 0.29 Allowed 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.424 HD12 ' N ' ' A' ' 128' ' ' MET . 2.6 pp -124.56 -23.3 4.43 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -173.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.534 ' HG3' ' H ' ' A' ' 130' ' ' ASP . 11.7 tpt 74.51 133.56 0.05 OUTLIER 'General case' 0 C--O 1.211 -0.971 0 C-N-CA 123.944 0.898 . . . . 0.0 112.039 -177.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.703 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -87.54 7.54 29.08 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.757 -175.293 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.534 ' H ' ' HG3' ' A' ' 128' ' ' MET . 10.3 m-20 67.74 -0.84 1.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 172.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.408 ' HA ' ' CE ' ' A' ' 131' ' ' MET . 0.0 OUTLIER 62.84 30.31 16.62 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.216 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 53.4 t -56.26 129.96 42.49 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 123.675 0.61 . . . . 0.0 109.998 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 52.5 p -77.82 130.52 36.78 Favored 'General case' 0 N--CA 1.414 -2.258 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.454 ' H ' ' H ' ' A' ' 169' ' ' SER . 34.7 m-20 65.22 82.33 0.19 Allowed 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -174.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.548 ' HE1' ' HB2' ' A' ' 129' ' ' LYS . 64.0 t-105 -155.03 156.62 36.25 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.173 -170.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -148.5 148.05 29.79 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 176.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.9 tt -142.1 147.92 20.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.226 -174.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -63.14 122.14 15.37 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-O 121.931 0.872 . . . . 0.0 112.463 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.441 ' HE1' ' CD2' ' A' ' 87' ' ' LEU . 4.8 t80 -139.35 145.4 38.97 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.135 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 162' ' ' GLN . 68.2 mt-30 -141.17 155.43 46.07 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.083 -0.385 . . . . 0.0 110.738 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.429 HD13 HG13 ' A' ' 143' ' ' ILE . 1.7 pp -139.12 151.31 46.57 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-O 121.245 0.545 . . . . 0.0 110.815 173.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.448 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 10.3 m-20 -133.19 111.96 11.32 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 173.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.429 HG13 HD13 ' A' ' 141' ' ' LEU . 60.8 mt -125.06 138.28 54.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.17 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 157' ' ' ILE . . . -121.54 130.18 8.02 Favored Glycine 0 N--CA 1.418 -2.526 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.084 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 156' ' ' THR . 2.7 mm? -97.75 111.11 23.53 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.0 m -97.24 112.35 24.19 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.556 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.446 ' CE1' HG12 ' A' ' 80' ' ' ILE . 91.7 m-85 -115.19 140.07 49.4 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 154' ' ' ASP . 29.0 t70 -93.97 109.06 20.81 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 66.3 mt -118.99 117.5 33.57 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -52.48 -19.15 9.42 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 124.172 3.248 . . . . 0.0 114.982 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.24 -29.17 31.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 120.861 0.362 . . . . 0.0 111.009 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 61.1 t -131.94 -53.25 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.271 0.557 . . . . 0.0 110.725 -176.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 142.45 -155.59 25.77 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 108.451 -1.859 . . . . 0.0 108.451 -176.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 148' ' ' ASP . 4.9 p-10 -86.48 117.66 25.4 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 117.908 0.854 . . . . 0.0 109.748 175.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 2.1 pp -128.24 141.2 47.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.473 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 37.7 m -99.43 123.92 44.12 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.437 -178.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.415 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 2.0 mp -86.57 112.0 43.5 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 174.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -86.7 114.95 1.22 Allowed 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.672 2.248 . . . . 0.0 113.18 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.446 HG23 HG13 ' A' ' 49' ' ' VAL . 9.9 m -125.74 127.86 71.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.251 176.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.4 t -128.28 156.31 43.22 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.658 -174.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.1 t -166.55 149.16 6.73 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 140' ' ' GLN . 28.8 pt20 -100.26 127.53 46.53 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 172.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -113.28 133.14 11.08 Favored Glycine 0 N--CA 1.405 -3.393 0 C-N-CA 119.924 -1.131 . . . . 0.0 112.811 -172.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -101.95 120.12 39.89 Favored 'General case' 0 C--N 1.269 -2.9 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.3 pt -114.9 111.69 36.92 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 CA-C-O 121.75 0.786 . . . . 0.0 110.89 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.534 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 4.9 ttmp? -81.06 119.75 23.94 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.712 -177.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.9 tt -102.24 98.8 11.12 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 166' ' ' LYS . 1.4 Cg_endo -83.57 81.27 2.29 Favored 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 122.677 2.251 . . . . 0.0 112.561 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 46.6 t 70.81 -76.48 0.06 Allowed 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.654 -1.157 . . . . 0.0 113.602 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.432 ' HG ' ' CD2' ' A' ' 173' ' ' PHE . 3.6 mm? 63.89 -65.7 0.12 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.28 1.032 . . . . 0.0 113.088 -176.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 63.9 91.62 0.07 Allowed 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.578 1.151 . . . . 0.0 110.405 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 74.37 90.76 0.08 Allowed 'General case' 0 CA--C 1.491 -1.317 0 C-N-CA 124.709 1.204 . . . . 0.0 109.349 -176.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.539 ' CE2' HG21 ' A' ' 62' ' ' VAL . 77.6 t80 . . . . . 0 C--N 1.284 -2.245 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 -175.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.4 t70 . . . . . 0 CA--C 1.517 -0.29 0 CA-C-O 120.733 0.301 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.424 ' OE1' HG23 ' A' ' 93' ' ' THR . 12.4 mm-40 -54.6 -41.52 70.05 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.301 0.572 . . . . 0.0 110.84 176.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -65.52 -53.45 42.06 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.521 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.6 m -64.32 -33.72 64.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.8 t -69.6 -45.44 78.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 176.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -58.67 -48.0 82.55 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.094 -176.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.481 ' O ' HG23 ' A' ' 23' ' ' VAL . 12.3 pt-20 -66.37 -40.61 89.85 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.149 -177.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -64.4 -40.93 96.74 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.59 -37.16 85.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.252 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.3 t -66.18 -44.07 85.04 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.32 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 19' ' ' GLU . 89.3 t -59.97 -43.84 93.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 CA-C-O 121.044 0.45 . . . . 0.0 110.018 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.449 HG21 HD11 ' A' ' 86' ' ' ILE . 65.5 mt -70.95 -35.58 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.66 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.3 t -60.64 -41.36 94.75 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 122.267 -0.271 . . . . 0.0 110.294 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.527 ' HA ' ' OD2' ' A' ' 29' ' ' ASP . 50.9 m -65.32 -29.12 69.84 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.355 0.597 . . . . 0.0 110.384 176.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.659 ' O ' ' HB3' ' A' ' 30' ' ' LYS . 4.5 tt -69.97 -38.33 76.03 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 175.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.545 ' O ' ' HG3' ' A' ' 32' ' ' LYS 0.34 7.8 mp -67.37 -27.79 67.4 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 119.149 -1.02 . . . . 0.0 113.094 175.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.527 ' OD2' ' HA ' ' A' ' 26' ' ' SER . 53.1 m-20 -61.04 -45.44 94.76 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 172.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.659 ' HB3' ' O ' ' A' ' 27' ' ' LEU . 21.0 ttmm -54.99 -51.39 66.37 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.913 173.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.07 -44.77 91.89 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.44 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 95.0 mttt -60.07 -32.21 70.73 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.94 0.496 . . . . 0.0 110.33 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.498 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -62.67 -51.32 56.77 Favored Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.723 177.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -72.83 -38.64 67.06 Favored 'General case' 0 C--O 1.203 -1.393 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.752 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -62.41 -35.41 79.13 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -175.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.65 -27.1 64.76 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.655 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.502 ' HG3' ' N ' ' A' ' 38' ' ' LYS . 8.6 pt-20 -112.09 -57.28 2.29 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -175.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.502 ' N ' ' HG3' ' A' ' 37' ' ' GLU . 8.9 tppt? -73.69 -48.23 33.69 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-O 122.757 1.265 . . . . 0.0 109.803 -164.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.463 ' CD1' HG12 ' A' ' 157' ' ' ILE . 69.4 mt -83.07 4.86 24.47 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 113.11 -1.859 . . . . 0.0 111.575 -171.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.91 -7.9 11.96 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.981 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -110.42 -39.7 4.86 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.176 0.513 . . . . 0.0 110.19 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.438 HD12 ' HG3' ' A' ' 38' ' ' LYS . 54.7 mt -91.53 139.53 25.14 Favored Pre-proline 0 N--CA 1.432 -1.344 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.13 98.3 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.831 1.688 . . . . 0.0 108.328 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 m -127.62 148.94 68.81 Favored Pre-proline 0 C--N 1.297 -1.682 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -172.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.579 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 9.4 Cg_endo -51.88 129.06 28.86 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.857 2.372 . . . . 0.0 112.112 176.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 43.3 mt-10 -115.02 113.24 23.82 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.929 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.421 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . . . -108.5 148.54 30.1 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.464 -176.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.1 t -154.74 142.93 20.33 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.766 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.616 ' H ' HG11 ' A' ' 159' ' ' VAL . 11.7 p -108.39 141.09 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 176.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -157.04 -23.04 0.09 Allowed 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.646 -171.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.689 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . 9.6 t0 -121.26 117.23 26.5 Favored 'General case' 0 CA--C 1.485 -1.547 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.24 -168.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.663 HG12 ' CD2' ' A' ' 64' ' ' TYR . 48.4 t -119.36 110.64 30.2 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -130.03 127.97 41.04 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.186 -175.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 51.1 p90 -64.75 139.26 58.74 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -176.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.646 ' HD3' ' HB2' ' A' ' 65' ' ' HIS . 14.7 mmmm -88.51 -24.85 22.82 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.392 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.49 -158.55 31.46 Favored Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.4 m -101.03 145.84 10.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 117.134 0.467 . . . . 0.0 111.27 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.3 m -155.06 135.54 13.36 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -75.84 -42.25 50.13 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -173.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -61.94 -56.58 17.69 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.702 0.763 . . . . 0.0 110.808 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.431 ' HA3' ' HB2' ' A' ' 121' ' ' TYR . . . -160.81 137.3 4.89 Favored Glycine 0 N--CA 1.409 -3.126 0 N-CA-C 107.022 -2.431 . . . . 0.0 107.022 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.522 HG11 ' CZ ' ' A' ' 173' ' ' PHE . 23.3 t -72.79 131.86 34.23 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-N 117.209 0.505 . . . . 0.0 110.115 -173.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -81.79 117.21 21.91 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.899 -177.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.663 ' CD2' HG12 ' A' ' 52' ' ' VAL . 9.4 m-85 -118.09 154.55 31.89 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.646 ' HB2' ' HD3' ' A' ' 55' ' ' LYS . 49.9 t-80 -91.03 108.43 19.86 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 176.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -91.71 107.56 19.29 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.689 ' HB3' ' HB3' ' A' ' 51' ' ' ASP . 40.4 ttmt -87.38 110.97 20.63 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.907 0.384 . . . . 0.0 110.557 -176.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.4 t -113.15 108.38 25.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.41 ' HB3' HG12 ' A' ' 112' ' ' VAL . 42.6 p -102.7 140.36 37.08 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.883 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 3.1 p -142.02 126.56 16.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.927 -178.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 45' ' ' PRO . 25.5 pttm -99.15 141.73 31.53 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 174.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -134.39 116.89 13.15 Favored Pre-proline 0 C--N 1.287 -2.141 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.641 -174.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -91.8 95.52 0.2 Allowed 'Trans proline' 0 N--CA 1.42 -2.838 0 N-CA-C 109.106 -1.152 . . . . 0.0 109.106 170.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.514 ' HB3' ' HG2' ' A' ' 76' ' ' GLN . 50.1 m-85 170.54 130.14 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 129.19 2.996 . . . . 0.0 104.723 -176.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.8 m -81.96 -2.78 52.59 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 118.362 0.528 . . . . 0.0 112.104 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.514 ' HG2' ' HB3' ' A' ' 74' ' ' TYR . 18.8 pt20 -83.2 132.08 35.08 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 121.206 0.527 . . . . 0.0 111.095 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.4 p -75.95 93.78 3.29 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 172.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.455 ' HB ' ' CD2' ' A' ' 105' ' ' LEU . 75.0 mt -72.66 123.37 89.47 Favored Pre-proline 0 C--N 1.3 -1.553 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.007 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -79.12 118.26 4.0 Favored 'Trans proline' 0 N--CA 1.44 -1.644 0 C-N-CA 122.115 1.877 . . . . 0.0 110.856 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.416 HD12 ' N ' ' A' ' 80' ' ' ILE . 2.4 mp -72.44 111.53 6.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 57.0 m -50.31 -59.08 4.33 Favored 'General case' 0 C--O 1.244 0.791 0 O-C-N 123.899 0.749 . . . . 0.0 111.204 -176.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -150.94 154.02 36.35 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.537 HG22 ' HB ' ' A' ' 99' ' ' ILE . 11.1 tp -104.1 124.08 58.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 174.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.424 ' HB2' HG21 ' A' ' 24' ' ' ILE . 65.7 p -95.07 118.62 32.18 Favored 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 119.529 -0.869 . . . . 0.0 109.883 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.519 ' CE2' HG12 ' A' ' 117' ' ' VAL . 15.5 t80 -104.16 121.39 43.16 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 126.238 1.815 . . . . 0.0 111.067 -169.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' A' ' 142' ' ' ASP . 3.2 mp -127.25 108.08 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.605 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 1.8 tm? -101.71 121.58 42.31 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.552 ' HA ' HG22 ' A' ' 94' ' ' ILE . 39.8 ttmt -127.25 133.59 50.19 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 120.158 -0.617 . . . . 0.0 112.372 -175.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.5 m -123.18 147.3 47.0 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.434 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.98 -0.19 2.21 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.5 p -90.83 16.33 9.55 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 123.461 0.704 . . . . 0.0 110.834 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 70.86 -41.63 0.51 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 125.972 1.709 . . . . 0.0 113.388 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.594 ' O ' ' HB3' ' A' ' 122' ' ' SER . 99.9 m -62.26 137.75 58.31 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.605 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 47.1 pt -137.55 178.23 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.254 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.531 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . . . -127.88 130.11 48.0 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 174.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.7 t -126.78 147.13 50.02 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.89 172.21 37.14 Favored Glycine 0 N--CA 1.42 -2.403 0 C-N-CA 119.818 -1.182 . . . . 0.0 112.426 -176.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 63.2 m -153.07 109.76 3.43 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.537 ' HB ' HG22 ' A' ' 83' ' ' ILE . 3.1 mp -103.47 110.03 63.03 Favored Pre-proline 0 N--CA 1.467 0.424 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.674 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -68.11 127.45 15.97 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.611 2.207 . . . . 0.0 109.727 173.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.0 t70 57.29 81.42 0.26 Allowed Pre-proline 0 N--CA 1.482 1.154 0 CA-C-O 121.674 0.749 . . . . 0.0 110.234 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.448 ' HG3' ' HB ' ' A' ' 83' ' ' ILE . 22.7 Cg_endo -107.72 13.74 0.13 Allowed 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 123.028 2.485 . . . . 0.0 113.088 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 152.78 -172.26 31.85 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.6 p -135.2 143.72 46.55 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.957 0.378 . . . . 0.0 110.719 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.455 ' CD2' ' HB ' ' A' ' 78' ' ' ILE . 19.9 tp -82.42 129.48 34.9 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.549 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 11.6 p -57.61 -35.05 48.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -174.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.97 118.68 0.1 OUTLIER Glycine 0 CA--C 1.54 1.615 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.541 -174.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 34.5 t 67.56 11.51 8.41 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.669 1.188 . . . . 0.0 113.137 175.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -150.8 -164.52 12.05 Favored Glycine 0 CA--C 1.496 -1.141 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.558 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 10.0 t -116.68 138.54 51.38 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.549 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 7.0 t -133.65 138.8 46.1 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.03 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.41 HG12 ' HB3' ' A' ' 69' ' ' SER . 27.3 m -91.62 106.93 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-O 122.057 0.932 . . . . 0.0 110.269 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.7 mt -92.2 153.9 19.01 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 4.8 p-10 -144.58 148.16 34.05 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.482 -0.887 . . . . 0.0 112.013 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.8 t -126.7 128.44 24.28 Favored Pre-proline 0 C--N 1.289 -2.056 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 171.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 22.7 Cg_exo -69.16 109.43 2.19 Favored 'Trans proline' 0 N--CA 1.432 -2.144 0 N-CA-C 108.206 -1.498 . . . . 0.0 108.206 172.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.519 HG12 ' CE2' ' A' ' 85' ' ' TYR . 30.3 m -98.41 150.3 4.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.384 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.633 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -95.1 97.46 9.95 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.062 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.5 m -93.15 147.12 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.482 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -177.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 69.9 -3.9 1.61 Allowed 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.968 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.431 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . 84.2 t80 -57.99 -47.35 83.27 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.594 ' HB3' ' O ' ' A' ' 93' ' ' THR . 19.1 m -66.79 -26.3 66.89 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.996 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.5 mt -79.14 -49.64 19.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.727 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.16 -49.3 78.41 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 122.962 0.505 . . . . 0.0 110.34 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.2 t -54.97 -43.26 68.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.223 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 44.0 t -75.04 -78.84 0.1 Allowed 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.044 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 128' ' ' MET . 3.8 pp -126.24 -40.09 2.01 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 115.111 1.522 . . . . 0.0 115.111 -173.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.553 ' N ' HD12 ' A' ' 127' ' ' LEU . 24.9 ttt 66.01 116.52 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.355 1.062 . . . . 0.0 110.632 -173.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.71 -72.8 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.741 0.816 . . . . 0.0 112.133 -178.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 24.0 t70 172.87 -30.56 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 -174.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 13.2 tpt 65.61 106.17 0.04 OUTLIER 'General case' 0 C--O 1.242 0.666 0 CA-C-N 113.235 -1.802 . . . . 0.0 112.573 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 44.7 t -128.53 173.52 10.17 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.108 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.408 ' CG2' ' HB2' ' A' ' 171' ' ' ARG . 30.8 p -82.69 115.74 21.76 Favored 'General case' 0 N--CA 1.413 -2.312 0 C-N-CA 123.257 0.623 . . . . 0.0 110.95 -178.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.5 ' H ' ' H ' ' A' ' 169' ' ' SER . 24.6 t70 74.21 95.61 0.07 Allowed 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 124.9 1.28 . . . . 0.0 108.835 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 -154.44 148.03 25.25 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.901 -170.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -118.62 143.58 46.71 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 67.2 mt -131.53 130.1 62.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 174.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.569 ' HA ' ' HA ' ' A' ' 164' ' ' GLU . 9.5 p-10 -99.34 120.41 39.53 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.401 ' HE2' ' CD2' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -127.74 170.56 12.59 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -179.226 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.476 ' HB2' ' HB3' ' A' ' 88' ' ' LYS . 1.6 mp0 -113.99 136.36 52.99 Favored 'General case' 0 C--N 1.279 -2.496 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.398 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.485 HD11 HD11 ' A' ' 143' ' ' ILE . 20.4 tp -122.05 116.21 23.86 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.76 176.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.491 ' HB3' ' HB ' ' A' ' 86' ' ' ILE . 15.4 t70 -126.63 120.89 30.65 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -175.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.485 HD11 HD11 ' A' ' 141' ' ' LEU . 43.0 mm -131.2 137.28 56.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 121.209 0.528 . . . . 0.0 110.594 -175.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -114.52 122.02 5.55 Favored Glycine 0 N--CA 1.419 -2.454 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 175.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.552 HD13 ' H ' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -115.37 160.2 20.15 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.387 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.7 t -136.02 142.24 44.43 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 119.834 -0.747 . . . . 0.0 111.799 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.478 ' CE2' HD23 ' A' ' 145' ' ' LEU . 68.1 m-85 -135.6 138.51 43.02 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 174.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -116.91 132.77 56.62 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.883 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.06 143.11 29.98 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -66.91 5.01 0.88 Allowed 'Trans proline' 0 N--CA 1.488 1.184 0 C-N-CA 123.411 2.741 . . . . 0.0 113.415 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.46 -28.88 36.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 11.7 p -160.19 -28.49 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.67 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 140.51 -143.56 13.66 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.347 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -94.97 132.09 40.2 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 155' ' ' ILE . 2.9 mp -122.54 129.73 75.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.454 HG21 HD21 ' A' ' 27' ' ' LEU . 33.9 p -95.77 140.44 30.55 Favored 'General case' 0 N--CA 1.406 -2.654 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 172.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.463 HG12 ' CD1' ' A' ' 39' ' ' LEU . 31.0 mt -114.11 129.26 24.98 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -90.69 116.86 0.55 Allowed 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 122.734 2.289 . . . . 0.0 112.314 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.616 HG11 ' H ' ' A' ' 49' ' ' VAL . 21.9 t -118.96 103.76 14.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 59.0 p -107.91 128.56 54.73 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 95.3 m -145.88 131.02 18.37 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.152 0.501 . . . . 0.0 112.158 -173.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -99.53 124.48 44.75 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -126.94 128.04 6.12 Favored Glycine 0 N--CA 1.42 -2.428 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.095 -176.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 138' ' ' ASP . 39.3 tt0 -95.98 120.57 36.5 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 176.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 9.6 pt -112.53 140.84 30.26 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.635 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.926 -176.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -102.54 143.96 31.57 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 121.82 0.819 . . . . 0.0 112.15 -174.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.4 mp -112.39 86.03 7.72 Favored Pre-proline 0 C--N 1.285 -2.203 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -80.12 85.98 1.74 Allowed 'Trans proline' 0 C--N 1.367 1.52 0 C-N-CA 123.353 2.702 . . . . 0.0 116.034 -167.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.5 ' H ' ' H ' ' A' ' 134' ' ' ASP 0.26 46.2 t 63.72 -1.57 0.61 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 175.706 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.669 ' HB3' ' HB2' ' A' ' 173' ' ' PHE . 4.2 mm? -70.33 96.9 1.18 Allowed 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 168.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.408 ' HB2' ' CG2' ' A' ' 133' ' ' THR . 65.2 ttt180 -69.08 -23.6 64.04 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 118.754 -1.178 . . . . 0.0 109.802 176.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -117.79 102.16 8.89 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.669 ' HB2' ' HB3' ' A' ' 170' ' ' LEU . 57.8 t80 . . . . . 0 C--N 1.289 -2.052 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 -174.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.0 t70 . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 121.287 0.565 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -78.2 -47.99 16.83 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.851 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -64.36 -36.15 83.19 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 116.761 -0.199 . . . . 0.0 110.73 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.51 ' HA ' ' HG3' ' A' ' 19' ' ' GLU . 34.2 m -69.18 -20.39 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.275 0.56 . . . . 0.0 111.153 -177.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.461 HG11 ' O ' ' A' ' 94' ' ' ILE . 55.3 t -73.36 -52.22 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 171.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -65.21 -43.67 90.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.311 -175.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.51 ' HG3' ' HA ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -64.64 -33.28 75.56 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.546 -178.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -79.13 -43.43 24.04 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.719 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.09 82.89 Favored 'General case' 0 C--O 1.21 -0.981 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.32 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -59.35 -45.4 91.48 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.23 -49.79 81.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.087 0.47 . . . . 0.0 109.953 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.591 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 73.2 mt -62.3 -46.17 97.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.263 -178.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.4 t -66.97 -36.97 83.38 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.624 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.2 t -63.23 -37.63 87.98 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.18 0.514 . . . . 0.0 109.665 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -66.05 -45.26 82.01 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 87.7 mt -57.04 -41.21 78.22 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.239 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -55.46 -48.92 73.75 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -79.38 -36.38 39.31 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.88 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.723 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . . . -68.35 -35.99 78.57 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.634 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.431 ' HB2' ' HG2' ' A' ' 158' ' ' PRO . 40.4 ttmt -63.68 -35.74 81.56 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.33 -53.03 49.01 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.923 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.723 ' CE2' ' HA ' ' A' ' 31' ' ' ALA . 30.3 p90 -76.39 -24.56 54.11 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.383 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -57.19 -50.18 73.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.726 0.298 . . . . 0.0 110.834 175.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.1 -18.15 63.94 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.123 0.487 . . . . 0.0 110.987 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -91.69 -66.23 0.94 Allowed 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.469 ' HE2' ' HB2' ' A' ' 34' ' ' PHE . 49.7 mtmt -93.44 -35.66 12.86 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 121.189 0.518 . . . . 0.0 110.487 -171.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.47 HD22 HG21 ' A' ' 44' ' ' THR . 71.1 mt -82.52 2.26 33.82 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.527 0.68 . . . . 0.0 111.63 -174.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.62 -26.83 21.7 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -98.31 -32.93 11.28 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.129 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 74.5 mt -93.0 114.26 62.17 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.64 101.4 0.55 Allowed 'Trans proline' 0 C--O 1.24 0.62 0 C-N-CA 122.509 2.139 . . . . 0.0 112.975 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.47 HG21 HD22 ' A' ' 39' ' ' LEU . 2.0 p -112.56 167.92 8.46 Favored Pre-proline 0 C--N 1.298 -1.665 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.299 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.421 ' HD2' ' HB ' ' A' ' 44' ' ' THR . 18.8 Cg_endo -55.93 120.21 7.88 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 122.775 2.317 . . . . 0.0 111.463 177.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -102.45 114.27 28.33 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -174.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.507 ' HB2' HD21 ' A' ' 145' ' ' LEU . . . -97.63 148.98 22.75 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.94 -173.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.477 ' HA ' HG21 ' A' ' 159' ' ' VAL . 5.2 t -147.51 124.47 11.32 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.187 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.586 HG23 HG22 ' A' ' 159' ' ' VAL . 22.1 t -86.9 140.92 15.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -113.59 -72.65 0.69 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 -172.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 12.7 t70 -160.32 169.85 22.3 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.984 -162.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.523 HG21 ' CD1' ' A' ' 165' ' ' ILE . 34.5 m -129.53 146.61 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.379 0 C-N-CA 123.991 0.916 . . . . 0.0 109.872 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -123.72 126.33 46.34 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 118.204 -0.903 . . . . 0.0 108.618 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.476 ' O ' ' HE3' ' A' ' 55' ' ' LYS . 47.6 p90 -58.5 122.4 13.27 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 175.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.476 ' HE3' ' O ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -124.7 -20.37 5.08 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.972 -169.406 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.98 -159.51 20.55 Favored Glycine 0 N--CA 1.427 -1.939 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.153 -177.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.22 137.65 33.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.202 0.525 . . . . 0.0 111.241 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.3 m -117.95 170.05 9.15 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -83.73 -33.77 25.02 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 118.701 -1.2 . . . . 0.0 110.558 175.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.49 ' O ' ' HD1' ' A' ' 121' ' ' TYR . 24.8 m-20 -111.28 97.72 6.98 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 171.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.58 -168.36 27.89 Favored Glycine 0 C--N 1.303 -1.257 0 C-N-CA 120.493 -0.86 . . . . 0.0 110.965 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 3.5 m -147.12 140.74 19.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 C-N-CA 123.265 0.626 . . . . 0.0 110.718 -177.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -71.31 127.11 31.48 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 123.874 0.734 . . . . 0.0 112.026 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -131.62 143.87 50.63 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 124.513 1.125 . . . . 0.0 111.199 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -92.6 108.0 19.64 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.451 ' HB2' HG12 ' A' ' 52' ' ' VAL . . . -101.55 140.42 35.86 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.2 137.39 54.22 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.554 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.7 t -123.79 111.44 29.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.3 p -97.7 147.14 24.66 Favored 'General case' 0 C--N 1.277 -2.58 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.911 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.61 134.74 29.76 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 CA-C-O 121.36 0.6 . . . . 0.0 110.317 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 22.2 ptmt -105.77 144.48 32.45 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.477 ' ND2' HD13 ' A' ' 105' ' ' LEU . 1.5 p-10 -149.37 124.88 4.97 Favored Pre-proline 0 C--N 1.28 -2.437 0 C-N-CA 118.532 -1.267 . . . . 0.0 109.686 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 72' ' ' ASN . 38.0 Cg_endo -97.64 97.98 0.07 OUTLIER 'Trans proline' 0 N--CA 1.417 -3.009 0 C-N-CA 121.563 1.509 . . . . 0.0 110.696 173.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -138.63 -85.52 0.26 Allowed 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.9 p 170.24 -47.43 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.861 0.865 . . . . 0.0 110.9 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.612 ' O ' ' HA2' ' A' ' 107' ' ' GLY . 15.6 pt20 -104.01 163.69 12.21 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.845 -174.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.5 p -78.38 130.85 36.61 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 170.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.423 ' H ' ' CD1' ' A' ' 105' ' ' LEU . 75.3 mt -120.59 128.34 25.84 Favored Pre-proline 0 C--N 1.285 -2.213 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.47 150.3 69.79 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.298 1.999 . . . . 0.0 111.689 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.664 HG22 ' CE1' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -88.49 151.71 3.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 55.0 m -71.01 -50.94 28.69 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 174.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -166.03 163.35 18.27 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.62 -1.173 . . . . 0.0 107.977 171.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.6 tt -124.5 119.6 56.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 21.9 t -103.97 139.83 38.56 Favored 'General case' 0 N--CA 1.421 -1.899 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.667 -174.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.493 ' HA ' HD13 ' A' ' 143' ' ' ILE . 37.5 p90 -120.78 125.52 47.78 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 174.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 66.5 mt -118.64 107.35 21.48 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 174.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.49 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 3.0 pp -104.38 146.25 29.1 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.424 -175.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -116.77 155.45 28.9 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.192 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.9 m -140.11 109.55 6.23 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 66.47 -69.84 0.11 Allowed 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 125.612 1.565 . . . . 0.0 113.788 175.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.8 t -154.31 -46.27 0.09 Allowed 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -175.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -129.97 145.7 51.64 Favored 'General case' 0 C--N 1.314 -0.965 0 O-C-N 121.795 -0.566 . . . . 0.0 111.595 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 47.4 m 77.25 130.2 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 124.858 1.263 . . . . 0.0 112.22 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 42.5 pt -131.88 177.76 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.72 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.229 -178.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.461 ' HB3' HD11 ' A' ' 87' ' ' LEU . . . -133.99 148.74 51.17 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 173.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 70.2 p -143.01 160.75 39.76 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -177.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -176.87 164.51 34.05 Favored Glycine 0 N--CA 1.433 -1.527 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.435 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.9 p -132.15 115.47 15.77 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 124.217 1.007 . . . . 0.0 109.55 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.485 HD11 HG13 ' A' ' 115' ' ' VAL . 56.6 mt -94.95 125.09 52.22 Favored Pre-proline 0 C--O 1.244 0.78 0 C-N-CA 118.937 -1.105 . . . . 0.0 112.685 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -83.31 118.43 2.59 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.924 2.416 . . . . 0.0 111.739 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.42 ' HA ' HD11 ' A' ' 80' ' ' ILE . 24.1 m-20 48.36 68.55 3.41 Favored Pre-proline 0 N--CA 1.484 1.233 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -83.59 -21.44 4.24 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 N-CA-C 108.955 -1.21 . . . . 0.0 108.955 170.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -177.06 -166.63 34.29 Favored Glycine 0 N--CA 1.418 -2.51 0 N-CA-C 107.709 -2.157 . . . . 0.0 107.709 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 21.2 m -142.82 171.85 13.49 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.477 HD13 ' ND2' ' A' ' 72' ' ' ASN . 2.1 pp -75.96 153.2 36.75 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 117.697 -1.601 . . . . 0.0 108.791 172.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.56 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 8.9 p -70.98 -42.01 76.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -170.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.612 ' HA2' ' O ' ' A' ' 76' ' ' GLN . . . 129.58 -72.44 0.48 Allowed Glycine 0 N--CA 1.409 -3.124 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 -175.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.6 t -145.23 87.65 1.83 Allowed 'General case' 0 C--N 1.278 -2.52 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 160.83 -146.22 12.12 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 8.9 t -125.75 135.34 51.95 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 117.418 0.609 . . . . 0.0 111.008 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.56 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 2.7 t -127.5 138.98 53.07 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 122.924 0.49 . . . . 0.0 110.602 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.9 m -99.21 118.49 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-O 121.557 0.694 . . . . 0.0 110.551 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.8 mt -103.93 162.12 13.4 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -150.51 149.26 29.73 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.62 0.724 . . . . 0.0 112.383 -176.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.485 HG13 HD11 ' A' ' 99' ' ' ILE . 53.2 t -129.78 127.77 22.89 Favored Pre-proline 0 C--N 1.302 -1.457 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.084 176.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -79.18 110.01 2.65 Favored 'Trans proline' 0 N--CA 1.419 -2.884 0 N-CA-C 107.008 -1.958 . . . . 0.0 107.008 168.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.0 m -115.95 150.27 17.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 118' ' ' LYS 0.315 0.0 OUTLIER -97.87 122.6 41.17 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 118.245 -1.382 . . . . 0.0 109.976 166.014 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.2 m -91.99 142.14 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.211 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -174.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 69.23 10.81 7.99 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.876 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.49 ' HD1' ' O ' ' A' ' 60' ' ' ASP . 67.6 t80 -54.7 -40.89 69.63 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.895 0.878 . . . . 0.0 108.949 171.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.3 m -61.34 -45.47 94.28 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.591 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.7 tt -75.81 -34.5 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.248 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -53.73 -48.46 69.61 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 123.413 0.685 . . . . 0.0 112.1 176.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.5 m -71.87 -21.83 21.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.0 t -88.79 -69.06 0.73 Allowed 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 120.718 0.294 . . . . 0.0 111.253 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -124.84 -29.05 3.43 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.898 -0.501 . . . . 0.0 111.986 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.538 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 25.7 ttt 76.35 88.32 0.08 Allowed 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.614 ' HE3' ' CD1' ' A' ' 135' ' ' TRP . 87.5 tttt 41.87 -86.54 0.01 OUTLIER 'General case' 0 C--N 1.345 0.375 0 O-C-N 125.138 1.524 . . . . 0.0 114.584 167.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 129' ' ' LYS . 29.7 t70 152.95 -25.36 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.136 1.774 . . . . 0.0 106.348 -175.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.406 ' H ' ' HG2' ' A' ' 129' ' ' LYS . 2.6 tpt 43.86 78.19 0.06 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-N 113.115 -1.857 . . . . 0.0 112.244 -169.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 54.0 t -110.22 140.87 43.9 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 176.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 19.3 p -68.69 122.93 19.57 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.1 t70 68.95 103.9 0.06 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.462 1.105 . . . . 0.0 108.694 -169.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.614 ' CD1' ' HE3' ' A' ' 129' ' ' LYS . 59.6 t-105 -150.69 134.81 16.88 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.752 -170.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -107.37 123.69 48.73 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.486 HG23 ' HB ' ' A' ' 165' ' ' ILE . 16.2 tt -123.53 134.34 66.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.743 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -85.11 114.35 22.18 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.511 -175.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -133.11 155.9 48.41 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.737 0.815 . . . . 0.0 110.945 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -151.14 155.1 38.21 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 87' ' ' LEU . 1.7 pt? -136.94 117.06 13.38 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.568 0.699 . . . . 0.0 109.152 169.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -91.86 117.26 29.63 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.493 HD13 ' HA ' ' A' ' 85' ' ' TYR . 41.4 mm -106.96 140.03 26.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.586 -0.845 . . . . 0.0 110.793 -173.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -127.99 102.54 0.59 Allowed Glycine 0 N--CA 1.423 -2.172 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.507 HD21 ' HB2' ' A' ' 47' ' ' ALA . 1.1 pp -94.97 137.76 33.6 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.219 -0.592 . . . . 0.0 111.051 178.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.2 m -116.89 127.23 54.07 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.74 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.664 ' CE1' HG22 ' A' ' 80' ' ' ILE . 87.0 m-85 -128.56 143.9 51.05 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.785 175.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -104.04 110.26 22.36 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 66.1 mt -123.54 114.55 28.65 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -41.79 -36.13 3.25 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 124.827 3.684 . . . . 0.0 115.08 -175.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 56.9 t -55.25 -40.55 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 122.942 0.497 . . . . 0.0 111.544 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 51.9 t -117.72 -45.93 3.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.925 0.393 . . . . 0.0 110.639 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 129.69 -150.89 19.12 Favored Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -81.07 116.99 21.28 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 177.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.408 HG22 ' CE1' ' A' ' 34' ' ' PHE . 28.7 pt -124.0 128.53 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 37.3 m -104.62 116.6 32.35 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 174.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . 70.1 mt -101.92 112.73 65.66 Favored Pre-proline 0 C--N 1.293 -1.891 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.005 -176.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 157' ' ' ILE . 6.6 Cg_endo -82.98 132.8 6.4 Favored 'Trans proline' 0 CA--C 1.482 -2.12 0 C-N-CA 122.863 2.375 . . . . 0.0 112.532 176.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.586 HG22 HG23 ' A' ' 49' ' ' VAL . 2.7 p -134.51 123.35 42.17 Favored 'Isoleucine or valine' 1 N--CA 1.372 -4.335 0 CA-C-N 112.582 -2.099 . . . . 0.0 108.918 -179.353 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 15.4 m -116.43 156.76 26.23 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.578 -174.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.458 ' CG2' ' HB ' ' A' ' 49' ' ' VAL . 9.9 t -173.82 171.36 3.75 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -113.5 145.82 40.59 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 120.915 0.388 . . . . 0.0 110.442 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -118.4 103.4 1.03 Allowed Glycine 0 N--CA 1.426 -2.023 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -88.61 121.13 30.66 Favored 'General case' 0 C--N 1.268 -2.978 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.523 ' CD1' HG21 ' A' ' 52' ' ' VAL . 30.4 mm -110.28 109.27 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.432 -173.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -94.4 126.23 39.54 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.65 172.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 95.2 mt -115.51 88.23 19.01 Favored Pre-proline 0 C--N 1.293 -1.858 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.066 -176.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -82.95 86.57 1.45 Allowed 'Trans proline' 0 N--CA 1.434 -2.0 0 C-N-CA 122.52 2.147 . . . . 0.0 113.109 -176.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 57.3 p 55.1 92.83 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 175.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 5.1 mp -108.51 -61.16 1.64 Allowed 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.326 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . 0.299 86.1 mtm180 62.26 109.11 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -176.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . 0.319 21.4 m-20 85.05 -9.34 0.85 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.171 1.788 . . . . 0.0 114.4 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 . . . . . 0 C--N 1.31 -1.134 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 169.098 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.417 ' HA ' HG22 ' A' ' 16' ' ' VAL . 26.3 m-20 . . . . . 0 CA--C 1.506 -0.734 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.42 ' HG2' ' OG1' ' A' ' 93' ' ' THR . 1.3 tm-20 -56.73 -48.44 77.76 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.524 -1.217 . . . . 0.0 109.036 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -69.19 -47.09 65.84 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.487 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.417 HG22 ' HA ' ' A' ' 13' ' ' ASP . 35.2 m -65.51 -32.38 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -176.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.5 p -73.07 -28.63 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.845 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -70.25 -37.48 74.94 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.433 ' O ' HG23 ' A' ' 23' ' ' VAL . 18.2 mm-40 -56.27 -41.69 76.25 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.449 174.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.639 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 9.9 mmpt? -64.11 -46.56 83.64 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.577 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.87 -43.14 85.79 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.576 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.1 t -59.22 -31.77 69.34 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 19' ' ' GLU . 64.4 t -75.46 -48.78 29.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.6 mt -61.35 -52.32 62.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.924 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.5 m -65.63 -22.46 66.66 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.602 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.7 t -66.23 -44.85 82.61 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.415 ' O ' HD23 ' A' ' 27' ' ' LEU . 3.8 tt -75.73 -40.14 56.09 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.412 ' HA ' ' OG1' ' A' ' 156' ' ' THR . 6.1 tt -61.58 -35.18 77.09 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.686 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -67.11 -47.34 71.46 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.017 0.527 . . . . 0.0 112.018 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -66.18 -33.59 76.11 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.234 0.54 . . . . 0.0 110.947 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.86 -32.12 61.81 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.978 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.96 -46.45 89.22 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.611 0.243 . . . . 0.0 111.003 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.66 -32.59 82.04 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.971 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -78.98 -48.96 13.52 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.484 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 68.4 t80 -53.56 -38.75 64.17 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.59 -46.88 58.15 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 123.917 0.761 . . . . 0.0 113.006 -176.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.433 ' HG3' ' HG2' ' A' ' 38' ' ' LYS . 13.3 pt-20 -116.89 -36.51 3.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.362 0.601 . . . . 0.0 112.507 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.433 ' HG2' ' HG3' ' A' ' 37' ' ' GLU . 19.9 mmmt -77.43 -33.49 54.88 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -168.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 89.9 mt -100.06 13.46 34.0 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.874 0.845 . . . . 0.0 109.816 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.51 -37.07 12.11 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 172.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -73.53 -50.08 23.25 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.722 176.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.6 mt -80.49 119.46 76.4 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.917 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.54 120.27 8.0 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.45 2.1 . . . . 0.0 111.983 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 p -127.24 156.75 74.23 Favored Pre-proline 0 C--N 1.288 -2.079 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.266 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.66 133.12 40.74 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.372 2.048 . . . . 0.0 110.839 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.0 110.02 22.65 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -177.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.5 140.32 41.99 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.343 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 t -142.32 136.59 29.85 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 121.336 0.589 . . . . 0.0 110.738 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.5 t -83.98 141.25 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -115.42 -59.61 1.98 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.346 -0.942 . . . . 0.0 113.342 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -169.59 -173.61 1.69 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -175.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . 36.0 m -131.51 154.99 41.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 118.41 0.55 . . . . 0.0 111.069 -176.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -129.84 116.18 18.32 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.381 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.583 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 46.6 p90 -82.36 141.28 32.96 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.541 ' HE2' ' C ' ' A' ' 54' ' ' PHE . 0.4 OUTLIER -89.69 -78.15 0.37 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.986 175.196 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.59 -117.7 0.41 Allowed Glycine 0 C--O 1.211 -1.314 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.253 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.8 t -99.3 140.54 18.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.525 HG22 ' H ' ' A' ' 60' ' ' ASP . 57.4 m -147.08 149.77 33.71 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -72.3 -19.32 61.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.335 0.588 . . . . 0.0 111.336 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.525 ' H ' HG22 ' A' ' 58' ' ' THR . 7.4 m-20 -122.97 86.38 2.57 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.204 175.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.48 -133.89 30.5 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.356 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 93.0 t -134.45 143.2 38.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -89.65 105.49 17.83 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.675 0.75 . . . . 0.0 110.171 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.785 ' CD1' ' HB ' ' A' ' 119' ' ' VAL . 7.8 m-85 -102.63 141.46 35.42 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.487 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 15.6 m-70 -101.13 108.9 20.69 Favored 'General case' 0 C--N 1.282 -2.351 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.053 170.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -78.54 135.22 37.26 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.436 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -90.03 117.75 29.05 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.606 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.8 t -129.61 111.89 23.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.2 p -100.45 137.16 39.24 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.252 0.549 . . . . 0.0 111.979 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.6 t -127.66 132.41 69.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.881 -177.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 21.4 ptmt -116.8 142.87 46.35 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.589 HD22 ' HA2' ' A' ' 107' ' ' GLY . 38.1 t30 -140.93 115.76 7.27 Favored Pre-proline 0 C--N 1.286 -2.177 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.677 -175.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -90.33 97.38 0.27 Allowed 'Trans proline' 0 N--CA 1.426 -2.45 0 C-N-CA 121.406 1.404 . . . . 0.0 112.228 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.523 ' HB3' ' H ' ' A' ' 76' ' ' GLN . 18.8 m-85 -167.78 -168.65 1.03 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 126.967 2.107 . . . . 0.0 107.372 177.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.1 t -132.98 7.48 4.01 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 170.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.523 ' H ' ' HB3' ' A' ' 74' ' ' TYR . 11.5 pt20 -97.63 142.19 29.75 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.594 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.5 p -79.62 102.58 8.99 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-O 120.944 0.402 . . . . 0.0 110.33 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.547 ' HB ' HD23 ' A' ' 105' ' ' LEU . 78.7 mt -92.6 117.67 67.69 Favored Pre-proline 0 C--N 1.31 -1.145 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 177.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -78.22 130.37 10.13 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 122.162 1.908 . . . . 0.0 112.747 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.473 ' HB ' ' CE1' ' A' ' 147' ' ' PHE . 9.9 tt -82.6 94.38 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 174.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 57.9 m -58.79 -42.13 88.33 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.845 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -156.87 148.55 22.55 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.617 -171.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.5 tt -128.58 116.36 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 173.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 28.6 p -120.26 118.72 31.18 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.717 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.492 ' CE1' HG13 ' A' ' 117' ' ' VAL . 43.6 p90 -109.04 147.98 31.5 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.414 -176.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.429 HD12 ' N ' ' A' ' 86' ' ' ILE . 3.0 mp -120.31 113.26 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 175.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.704 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 0.9 OUTLIER -99.51 137.25 38.27 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.532 ' N ' HD23 ' A' ' 87' ' ' LEU . 45.4 mtpt -129.1 153.89 47.22 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 172.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.5 t -158.97 140.4 13.21 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 119.027 -1.069 . . . . 0.0 113.2 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 60.38 -79.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.805 1.642 . . . . 0.0 114.595 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -167.32 -32.48 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.099 0.476 . . . . 0.0 109.89 -175.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -129.09 141.94 51.05 Favored 'General case' 0 CA--C 1.49 -1.343 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.883 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.42 ' OG1' ' HG2' ' A' ' 14' ' ' GLU . 7.2 m 75.39 134.21 0.05 Allowed 'General case' 0 C--N 1.307 -1.25 0 O-C-N 125.177 1.548 . . . . 0.0 112.354 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.704 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.6 pp -138.2 174.79 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.199 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.668 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -132.63 162.01 32.42 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 119.095 0.862 . . . . 0.0 111.026 175.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.0 m -143.36 153.68 42.95 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -154.96 149.93 21.33 Favored Glycine 0 N--CA 1.419 -2.472 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 93.2 m -141.32 108.51 5.49 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.4 mt -115.03 110.21 46.16 Favored Pre-proline 0 C--N 1.306 -1.316 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.776 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -72.16 131.06 17.33 Favored 'Trans proline' 0 C--O 1.238 0.502 0 C-N-CA 122.533 2.155 . . . . 0.0 109.645 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.314 4.0 p30 44.72 77.94 0.42 Allowed Pre-proline 0 N--CA 1.487 1.394 0 C-N-CA 124.622 1.169 . . . . 0.0 114.107 -175.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -87.91 -8.71 5.77 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.874 2.383 . . . . 0.0 113.556 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 173.36 -161.77 32.71 Favored Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.592 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 46.2 m -119.86 142.03 49.02 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.209 0.528 . . . . 0.0 110.719 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.547 HD23 ' HB ' ' A' ' 78' ' ' ILE . 41.5 tp -97.04 141.37 30.28 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.447 HG23 ' HB ' ' A' ' 111' ' ' THR . 61.0 t -89.77 107.46 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.247 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 171.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.589 ' HA2' HD22 ' A' ' 72' ' ' ASN . . . -57.06 -22.49 42.79 Favored Glycine 0 C--N 1.292 -1.89 0 CA-C-N 114.317 -1.311 . . . . 0.0 113.627 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.4 p -120.23 11.72 11.63 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -156.57 -161.93 11.1 Favored Glycine 0 CA--C 1.498 -1.009 0 C-N-CA 117.135 -2.459 . . . . 0.0 114.996 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 41.4 m -101.7 129.85 47.95 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.447 ' HB ' HG23 ' A' ' 106' ' ' VAL . 10.0 t -127.47 133.21 49.91 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 40.1 t -97.78 115.92 39.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.1 mt -102.81 160.93 14.16 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 7.3 p-10 -133.45 130.81 39.14 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 9.6 t -104.78 126.18 31.91 Favored Pre-proline 0 C--N 1.305 -1.368 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -71.04 110.47 2.82 Favored 'Trans proline' 0 N--CA 1.433 -2.054 0 N-CA-C 106.818 -2.031 . . . . 0.0 106.818 168.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.492 HG13 ' CE1' ' A' ' 85' ' ' TYR . 97.6 t -116.69 141.39 34.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.708 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -87.17 88.4 7.69 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.17 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.785 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 94.5 t -94.04 145.99 7.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.664 -176.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 72.41 -1.99 2.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.141 0.976 . . . . 0.0 111.245 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -68.45 -43.38 77.19 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.41 ' O ' ' HB ' ' A' ' 93' ' ' THR . 14.4 m -62.0 -28.0 69.26 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 122.491 1.138 . . . . 0.0 109.578 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.6 mt -78.18 -49.45 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.22 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.455 -177.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.03 -36.27 72.47 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.324 0.649 . . . . 0.0 111.517 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.0 t -67.81 -34.72 69.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.421 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.0 t -93.39 -66.77 0.9 Allowed 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -176.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.501 ' H ' HD23 ' A' ' 127' ' ' LEU . 1.8 pt? -124.91 -23.85 4.2 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -176.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 24.2 ttt 56.89 35.59 26.55 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.283 1.033 . . . . 0.0 109.349 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.436 ' H ' ' HG ' ' A' ' 127' ' ' LEU . 61.6 mmtt 69.3 -70.5 0.14 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.033 1.733 . . . . 0.0 106.672 -172.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.446 ' H ' ' H ' ' A' ' 131' ' ' MET . 24.4 t70 149.58 18.71 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 130.855 3.662 . . . . 0.0 102.862 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.598 ' SD ' ' HA ' ' A' ' 171' ' ' ARG . 0.0 OUTLIER 58.53 76.79 0.33 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 113.05 -1.887 . . . . 0.0 106.778 -163.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.409 ' HB2' ' NE1' ' A' ' 135' ' ' TRP . 64.9 m -106.43 127.62 53.42 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.631 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 169' ' ' SER . 19.0 p -93.29 119.4 32.39 Favored 'General case' 0 N--CA 1.399 -2.982 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.078 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 5.9 m-20 72.85 89.14 0.1 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 176.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.409 ' NE1' ' HB2' ' A' ' 132' ' ' CYS . 1.2 p-90 -173.15 158.66 3.71 Favored 'General case' 0 C--O 1.246 0.894 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.254 174.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.595 ' HA ' ' HA ' ' A' ' 166' ' ' LYS . 5.1 p-10 -98.45 143.38 28.96 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.453 HD12 ' N ' ' A' ' 137' ' ' ILE . 3.1 mp -124.23 140.46 47.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -177.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -75.81 112.7 12.47 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 122.674 1.226 . . . . 0.0 111.791 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.451 ' CE2' ' HG ' ' A' ' 87' ' ' LEU . 1.2 t80 -125.23 152.01 45.13 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 113.501 -1.682 . . . . 0.0 107.261 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 162' ' ' GLN . 17.4 tt0 -134.08 150.46 51.18 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.1 tp -131.89 117.7 18.84 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 121.703 0.763 . . . . 0.0 110.163 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.424 ' HB3' ' HB ' ' A' ' 86' ' ' ILE . 13.3 t70 -124.76 130.2 51.94 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 -177.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.9 mt -136.81 140.48 42.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.159 -1.016 . . . . 0.0 111.761 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -108.32 93.15 0.78 Allowed Glycine 0 N--CA 1.426 -1.976 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.48 ' HB3' ' CE2' ' A' ' 147' ' ' PHE . 3.1 mm? -68.42 118.96 12.16 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 16.7 m -100.89 108.52 20.31 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.267 -177.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.48 ' CE2' ' HB3' ' A' ' 145' ' ' LEU . 96.3 m-85 -119.26 149.22 42.14 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 176.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 154' ' ' ASP . 4.5 p-10 -102.48 115.97 31.66 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.121 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.3 mp -108.02 105.46 56.44 Favored Pre-proline 0 C--N 1.296 -1.737 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -30.15 -51.14 0.2 Allowed 'Trans proline' 0 N--CA 1.485 1.029 1 C-N-CA 125.694 4.263 . . . . 0.0 116.984 -172.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.448 HG23 HG23 ' A' ' 152' ' ' VAL . 29.7 m -62.29 -21.17 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -177.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.448 HG23 HG23 ' A' ' 151' ' ' VAL . 48.4 t -121.86 -40.73 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.817 0.818 . . . . 0.0 109.754 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 112.8 -148.8 18.49 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 148' ' ' ASP . 6.7 p-10 -86.46 124.42 32.77 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.612 0.72 . . . . 0.0 110.811 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 146' ' ' THR . 2.2 pp -125.35 145.07 33.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.489 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.414 HG22 ' OG1' ' A' ' 146' ' ' THR . 46.4 p -94.7 119.57 33.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.652 0.263 . . . . 0.0 110.771 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.449 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . 55.3 mt -92.78 119.32 67.93 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 157' ' ' ILE . 19.8 Cg_exo -70.71 125.48 11.7 Favored 'Trans proline' 0 C--O 1.24 0.579 0 C-N-CA 123.596 2.864 . . . . 0.0 113.409 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 39.0 t -132.81 115.03 23.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 173.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.7 m -125.36 142.8 51.3 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 121.046 -0.262 . . . . 0.0 110.808 -174.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.1 t -176.97 157.11 1.39 Allowed 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 140' ' ' GLN . 30.2 pt20 -99.62 152.45 20.03 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.267 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -120.37 119.57 4.24 Favored Glycine 0 N--CA 1.417 -2.597 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -96.7 120.59 37.3 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 4.2 pt -131.16 112.82 22.42 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 CA-C-O 121.446 0.641 . . . . 0.0 112.191 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 136' ' ' ASP . 40.1 ttmt -90.87 128.24 36.68 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.102 178.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 134' ' ' ASP . 88.4 mt -110.38 107.23 58.4 Favored Pre-proline 0 C--N 1.286 -2.161 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.568 -173.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -71.58 105.09 1.7 Allowed 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.788 2.325 . . . . 0.0 111.835 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 133' ' ' THR 0.268 89.5 p 60.46 -83.96 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 126.025 1.73 . . . . 0.0 114.557 -175.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.401 HD22 HD13 ' A' ' 167' ' ' LEU . 10.9 mp 63.44 26.74 14.99 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-O 121.044 0.449 . . . . 0.0 112.189 -176.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.598 ' HA ' ' SD ' ' A' ' 131' ' ' MET . 47.1 ttt180 -77.23 99.08 5.34 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . 0.276 1.8 m-20 80.28 79.45 0.05 OUTLIER 'General case' 0 CA--C 1.49 -1.359 0 CA-C-O 123.089 1.423 . . . . 0.0 109.514 -168.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 28.2 t80 . . . . . 0 C--N 1.275 -2.661 0 N-CA-C 100.718 -3.808 . . . . 0.0 100.718 -177.157 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.9 t70 . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.94 -28.44 62.43 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.218 0.532 . . . . 0.0 111.295 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.51 ' HE2' ' OE1' ' A' ' 19' ' ' GLU . 81.9 tttt -67.69 -55.3 13.75 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.539 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.453 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 32.3 m -60.27 -33.64 54.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -173.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -73.36 -33.43 40.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.093 0.473 . . . . 0.0 110.21 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -72.65 -49.34 32.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.144 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.51 ' OE1' ' HE2' ' A' ' 15' ' ' LYS . 8.9 pt-20 -64.36 -31.73 73.05 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.978 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.56 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 1.1 tpmt? -61.98 -48.78 78.82 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.83 -39.48 94.47 Favored 'General case' 0 C--O 1.21 -0.991 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.829 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.5 t -60.53 -44.51 95.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 66.6 t -69.47 -43.87 80.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 20' ' ' LYS . 78.7 mt -61.03 -45.25 98.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.397 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.7 t -57.42 -41.71 80.92 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 123.041 0.536 . . . . 0.0 110.055 177.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.8 t -66.79 -26.27 66.87 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-O 121.013 0.435 . . . . 0.0 110.912 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 tt -76.36 -55.19 5.78 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.574 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 8.4 mp -59.3 -36.39 75.51 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -51.23 -45.7 62.05 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.09 0.556 . . . . 0.0 111.843 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -82.95 -31.2 27.79 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 177.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.96 -32.27 73.56 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.116 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.574 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 61.4 mtpt -57.18 -27.85 62.3 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.484 0.713 . . . . 0.0 110.819 175.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.564 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -74.12 -55.77 5.58 Favored Glycine 0 N--CA 1.438 -1.228 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 178.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -56.1 -40.98 74.52 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.763 0.316 . . . . 0.0 110.836 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.456 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 48.7 t80 -67.21 -37.48 83.7 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.27 -34.75 63.66 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.987 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.564 ' HG2' ' O ' ' A' ' 33' ' ' GLY . 11.1 pt-20 -104.72 -44.37 4.88 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -176.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.414 ' HG2' HD12 ' A' ' 42' ' ' ILE . 21.6 ttmm -87.93 -43.94 11.4 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.682 0.753 . . . . 0.0 109.659 -170.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 67.2 mt -87.16 12.13 12.35 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.647 -176.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.05 -40.72 15.47 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 173.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.54 ' OD1' HG13 ' A' ' 42' ' ' ILE . 8.4 p30 -87.72 -36.43 17.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.452 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.54 HG13 ' OD1' ' A' ' 41' ' ' ASN . 85.4 mt -88.84 113.8 57.38 Favored Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -79.0 101.04 1.4 Allowed 'Trans proline' 0 N--CA 1.435 -1.97 0 C-N-CA 121.955 1.77 . . . . 0.0 113.628 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.9 p -93.04 149.94 38.4 Favored Pre-proline 0 N--CA 1.419 -1.987 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.463 ' HB3' ' HA ' ' A' ' 72' ' ' ASN . 10.9 Cg_endo -53.37 141.87 59.52 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.279 1.986 . . . . 0.0 110.246 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -96.53 141.99 29.15 Favored 'General case' 0 CA--C 1.484 -1.563 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.685 -172.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.48 137.35 53.24 Favored 'General case' 0 N--CA 1.414 -2.254 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.877 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.2 t -134.34 126.03 28.82 Favored 'General case' 0 C--N 1.272 -2.779 0 CA-C-O 121.635 0.731 . . . . 0.0 109.985 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.568 HG11 ' CG1' ' A' ' 143' ' ' ILE . 35.5 m -107.38 141.72 21.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.164 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 49' ' ' VAL . 27.5 t70 161.8 66.81 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 124.898 1.374 . . . . 0.0 112.684 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 67' ' ' LYS . 20.5 t70 -177.47 117.86 0.1 Allowed 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 168.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.2 t -132.03 112.69 20.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -121.53 141.88 50.62 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.9 -176.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 41.9 p90 -77.0 128.14 33.96 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.732 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -120.22 -3.09 10.05 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.656 -0.818 . . . . 0.0 112.047 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.0 158.29 25.92 Favored Glycine 0 CA--C 1.489 -1.567 0 C-N-CA 119.214 -1.469 . . . . 0.0 112.84 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.49 ' HB ' ' CE1' ' A' ' 173' ' ' PHE . 7.5 p -106.8 116.29 50.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.716 0.77 . . . . 0.0 112.336 -176.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.564 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 88.4 m -132.55 130.67 40.65 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 174.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -82.01 -12.2 58.43 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.211 0.529 . . . . 0.0 111.196 -174.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.405 ' H ' HG22 ' A' ' 58' ' ' THR . 20.1 t70 -114.33 69.16 0.7 Allowed 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 172.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.564 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . 100.33 101.37 2.41 Favored Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.117 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.0 p -76.2 143.07 13.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 121.164 0.507 . . . . 0.0 110.889 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -89.45 114.89 26.44 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -172.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.635 ' CD1' ' HB ' ' A' ' 119' ' ' VAL . 32.9 m-85 -120.87 151.26 39.87 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.056 173.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -120.51 109.19 14.99 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.93 144.75 34.53 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.933 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 31.6 mmtp -102.4 118.76 37.56 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.599 -176.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.6 t -111.06 108.37 25.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 175.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.6 p -99.85 123.83 44.51 Favored 'General case' 0 C--N 1.285 -2.201 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.713 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.7 t -114.96 128.01 72.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.722 -176.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 71' ' ' LYS . 19.2 ptpt -102.35 110.48 22.45 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.568 ' O ' ' HA ' ' A' ' 108' ' ' SER . 34.1 t30 -109.98 113.9 56.67 Favored Pre-proline 0 C--N 1.265 -3.075 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.107 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -97.67 95.97 0.07 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.686 0 C-N-CA 121.605 1.537 . . . . 0.0 109.65 169.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -176.19 156.29 1.63 Allowed 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 127.468 2.307 . . . . 0.0 106.54 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.5 m -82.92 -18.59 39.57 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.656 0.741 . . . . 0.0 109.242 176.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.554 HE21 HG12 ' A' ' 78' ' ' ILE . 11.0 pt20 -96.83 146.78 24.6 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.674 -178.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.4 m -84.59 106.43 16.15 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 171.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.554 HG12 HE21 ' A' ' 76' ' ' GLN . 59.1 mt -76.19 116.15 53.4 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -56.99 137.02 80.12 Favored 'Trans proline' 0 C--O 1.239 0.569 0 C-N-CA 123.228 2.618 . . . . 0.0 113.757 -175.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 146' ' ' THR . 9.4 pt -112.64 98.59 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.952 175.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 51.6 t -52.6 -54.9 26.84 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.188 -177.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -145.71 160.64 41.43 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.524 ' CG2' ' HB ' ' A' ' 99' ' ' ILE . 14.9 tt -134.87 113.83 16.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 175.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 55.0 p -94.63 123.3 37.99 Favored 'General case' 0 C--N 1.287 -2.144 0 O-C-N 121.956 -0.465 . . . . 0.0 111.421 -175.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.526 ' HA ' HD13 ' A' ' 143' ' ' ILE . 36.4 p90 -103.81 129.86 51.3 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 2.5 mp -117.12 107.17 21.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 176.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.629 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 1.3 tt -92.35 132.56 36.63 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.474 ' N ' HD23 ' A' ' 87' ' ' LEU . 62.1 tttm -130.46 143.48 50.79 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.483 ' HB2' HD11 ' A' ' 123' ' ' ILE . 58.1 p -144.05 95.39 2.72 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 55.59 -81.84 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 171.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.6 p -83.98 -71.68 0.5 Allowed 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 -168.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -137.31 -64.92 0.55 Allowed 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 m -66.76 139.55 57.81 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 121.513 0.673 . . . . 0.0 112.086 -173.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.629 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.7 pp -139.7 170.65 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.484 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 -178.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.629 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -138.06 136.5 36.89 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.3 t -149.08 159.85 43.86 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.909 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.56 161.08 24.35 Favored Glycine 0 N--CA 1.422 -2.262 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 64.6 p -101.34 127.23 48.06 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.524 ' HB ' ' CG2' ' A' ' 83' ' ' ILE . 66.4 mt -97.15 110.07 52.44 Favored Pre-proline 0 C--N 1.306 -1.303 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.853 175.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -78.31 115.56 3.73 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.097 1.864 . . . . 0.0 110.828 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.7 t70 60.4 86.05 0.16 Allowed Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.868 -176.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.402 ' HG3' ' CG2' ' A' ' 83' ' ' ILE . 19.0 Cg_endo -97.05 5.42 1.58 Allowed 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.903 2.402 . . . . 0.0 111.581 177.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 145.59 -164.71 28.06 Favored Glycine 0 N--CA 1.419 -2.484 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.3 m -137.95 155.59 48.73 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.441 HD21 ' CE1' ' A' ' 147' ' ' PHE . 6.9 mp -72.02 150.84 43.64 Favored 'General case' 0 CA--C 1.485 -1.555 0 CA-C-O 121.803 0.811 . . . . 0.0 111.149 176.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 11.1 p -88.2 139.13 17.85 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.143 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.274 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -66.49 90.77 0.16 Allowed Glycine 0 C--N 1.304 -1.231 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 72' ' ' ASN 0.252 79.6 p 63.09 86.74 0.11 Allowed 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 125.973 1.709 . . . . 0.0 113.537 -178.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 169.35 -163.86 37.46 Favored Glycine 0 N--CA 1.431 -1.669 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.5 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.7 m -119.29 115.99 25.31 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.474 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 5.1 t -110.23 132.2 54.38 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.106 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.2 t -95.72 113.09 29.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.6 mt -92.67 150.09 20.91 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.312 -177.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -105.02 119.66 39.57 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.365 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.54 117.84 30.01 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-O 121.17 0.51 . . . . 0.0 111.319 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.37 123.13 10.2 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.208 1.939 . . . . 0.0 111.143 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 57.4 t -125.26 136.64 60.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -88.17 93.56 9.54 Favored 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.635 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 96.2 t -93.76 146.44 6.55 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.826 -171.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 72.31 -4.29 2.07 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.121 1.368 . . . . 0.0 112.799 174.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.52 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . 44.9 t80 -67.13 -32.46 73.6 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.7 p -64.86 -35.2 80.36 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.041 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.483 HD11 ' HB2' ' A' ' 89' ' ' SER . 33.8 mm -71.78 -46.98 58.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.021 176.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.4 -48.02 83.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.471 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.8 p -72.26 -25.46 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 CA-C-O 121.013 0.435 . . . . 0.0 111.35 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 39.2 t -80.8 -76.04 0.25 Allowed 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.825 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.576 HD12 ' N ' ' A' ' 128' ' ' MET . 2.5 pp -124.68 -37.26 2.5 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -175.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.576 ' N ' HD12 ' A' ' 127' ' ' LEU . 9.8 tpt 61.94 109.97 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.486 0.714 . . . . 0.0 111.49 -176.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.513 ' HB2' ' HZ2' ' A' ' 135' ' ' TRP . 1.4 mptp? -78.47 -30.07 47.16 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 80.15 97.78 0.06 Allowed 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 113.533 -1.667 . . . . 0.0 110.76 -175.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.33 139.83 58.81 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.133 -1.394 . . . . 0.0 110.395 -176.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 49.7 t -138.37 -81.54 0.32 Allowed 'General case' 0 CA--C 1.56 1.364 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.615 ' HA ' ' CB ' ' A' ' 169' ' ' SER . 14.1 p -144.29 130.81 19.95 Favored 'General case' 0 N--CA 1.426 -1.645 0 C-N-CA 125.541 1.536 . . . . 0.0 109.652 -171.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 44.56 89.56 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 C-N-CA 124.632 1.173 . . . . 0.0 110.138 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.513 ' HZ2' ' HB2' ' A' ' 129' ' ' LYS . 69.5 t-105 -128.99 150.21 50.5 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -162.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -136.94 136.26 38.44 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.031 0.932 . . . . 0.0 109.893 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 22.6 pt -132.41 136.66 55.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 173.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -87.18 121.14 29.23 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.509 ' CE2' ' HG ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -149.61 161.74 41.56 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -175.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -164.16 158.94 19.71 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 117.889 0.313 . . . . 0.0 110.822 171.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.598 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 1.5 pt? -136.12 132.29 35.88 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-O 121.0 0.429 . . . . 0.0 109.96 176.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.566 ' HA ' ' HB3' ' A' ' 160' ' ' SER . 15.2 t70 -101.84 120.84 41.02 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 175.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.568 ' CG1' HG11 ' A' ' 49' ' ' VAL . 45.8 mm -100.66 133.07 45.02 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 CA-C-O 120.832 0.349 . . . . 0.0 110.693 -176.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -114.75 86.41 0.41 Allowed Glycine 0 N--CA 1.41 -3.096 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 174.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.729 HD13 ' H ' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -81.05 146.42 30.64 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 30.3 m -127.84 114.45 17.24 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 119.051 -1.06 . . . . 0.0 112.248 -176.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.441 ' CE1' HD21 ' A' ' 105' ' ' LEU . 50.3 m-85 -99.14 160.3 14.37 Favored 'General case' 0 C--O 1.246 0.875 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 174.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -121.37 126.85 50.41 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.846 174.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.7 125.33 18.36 Favored Pre-proline 0 C--N 1.301 -1.512 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.092 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.54 -28.68 22.5 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 C-N-CA 123.953 3.102 . . . . 0.0 113.737 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.94 -38.39 76.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.506 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 41.3 t -124.84 -45.29 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.264 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 129.15 -133.58 7.62 Favored Glycine 0 N--CA 1.428 -1.847 0 C-N-CA 121.026 -0.607 . . . . 0.0 111.758 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -100.33 117.34 34.32 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.857 0.863 . . . . 0.0 108.931 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.413 HD12 ' N ' ' A' ' 155' ' ' ILE . 2.7 mp -128.75 119.5 49.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.494 178.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 86.4 m -82.07 112.11 18.83 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 173.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.436 ' O ' HD13 ' A' ' 145' ' ' LEU . 70.0 mt -93.5 117.15 67.29 Favored Pre-proline 0 C--N 1.299 -1.587 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.285 -176.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.446 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.7 Cg_endo -82.83 133.87 7.03 Favored 'Trans proline' 0 CA--C 1.489 -1.774 0 C-N-CA 122.88 2.387 . . . . 0.0 112.728 176.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.443 HG22 HG22 ' A' ' 49' ' ' VAL . 2.7 p -146.28 131.4 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.106 0 CA-C-N 113.097 -1.865 . . . . 0.0 109.062 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.566 ' HB3' ' HA ' ' A' ' 142' ' ' ASP . 12.3 p -147.29 162.43 38.96 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.454 HG21 ' HA ' ' A' ' 50' ' ' ASP . 14.4 t -153.5 178.22 10.06 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 177.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -98.69 132.41 44.1 Favored 'General case' 0 N--CA 1.422 -1.864 0 C-N-CA 118.661 -1.215 . . . . 0.0 108.801 176.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.477 ' O ' ' HD1' ' A' ' 139' ' ' TYR . . . -97.1 76.82 0.67 Allowed Glycine 0 N--CA 1.399 -3.821 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -87.82 119.88 28.6 Favored 'General case' 0 C--N 1.271 -2.842 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.7 pt -117.55 108.38 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.765 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.236 -176.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.413 ' HG2' ' H ' ' A' ' 166' ' ' LYS . 16.7 pttt -98.41 98.61 9.81 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 113.195 -1.82 . . . . 0.0 109.571 -177.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 88.4 mt -87.14 127.62 58.6 Favored Pre-proline 0 C--N 1.282 -2.346 0 CA-C-N 112.228 -2.26 . . . . 0.0 111.935 -169.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -69.79 150.74 68.43 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.079 1.853 . . . . 0.0 108.334 173.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.615 ' CB ' ' HA ' ' A' ' 133' ' ' THR . 2.3 m -51.16 99.35 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -177.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -101.52 -27.31 13.18 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 170.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.53 -65.6 0.2 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.066 1.746 . . . . 0.0 109.943 -178.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -116.24 95.33 5.03 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 122.168 0.985 . . . . 0.0 109.592 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.49 ' CE1' ' HB ' ' A' ' 57' ' ' VAL . 72.7 t80 . . . . . 0 C--N 1.279 -2.494 0 N-CA-C 103.164 -2.902 . . . . 0.0 103.164 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 . . . . . 0 CA--C 1.495 -1.153 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -53.7 -35.14 60.8 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.324 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -74.88 -56.18 5.04 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.25 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.446 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 30.6 m -70.83 -34.72 57.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -172.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 p -68.46 -32.5 55.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.203 0.525 . . . . 0.0 110.349 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -74.89 -47.13 31.64 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.488 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.446 ' HG2' ' HA ' ' A' ' 16' ' ' VAL . 13.4 pt-20 -71.15 -36.99 72.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.413 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.402 ' O ' HG12 ' A' ' 24' ' ' ILE . 40.5 ttmt -65.17 -39.4 92.87 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.48 -37.72 88.38 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.986 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -59.94 -50.62 73.04 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.655 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 19' ' ' GLU . 95.7 t -59.66 -51.06 77.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.902 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.529 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 50.4 mm -63.28 -36.1 74.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.195 -177.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.8 t -62.77 -35.68 80.6 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.424 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.5 m -72.25 -35.85 68.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.097 0.475 . . . . 0.0 110.145 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.505 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 5.3 tt -66.78 -40.25 88.1 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 85.5 mt -61.8 -41.09 97.32 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -57.87 -45.82 85.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.669 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -66.23 -30.67 71.16 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-O 121.099 0.476 . . . . 0.0 110.955 -179.544 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.521 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -78.02 -34.73 50.54 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 120.987 0.423 . . . . 0.0 111.787 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 29.0 mtpp -69.11 9.44 0.42 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -177.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -113.08 -18.34 7.32 Favored Glycine 0 C--N 1.313 -0.723 0 C-N-CA 120.341 -0.933 . . . . 0.0 111.371 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.497 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 68.4 m-85 -80.25 -25.53 39.47 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.555 ' HA ' HD12 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -56.19 -29.96 61.62 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -171.592 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.71 -34.04 25.0 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -115.79 -46.81 2.82 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.497 ' HB3' ' HB3' ' A' ' 34' ' ' PHE . 5.4 tmmm? -82.71 -20.75 35.46 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-O 120.898 0.38 . . . . 0.0 110.311 -173.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.555 HD12 ' HA ' ' A' ' 35' ' ' PHE . 42.7 mt -96.3 0.06 50.3 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.299 176.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.88 -57.07 2.85 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.819 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -81.64 -2.81 51.65 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.228 0.537 . . . . 0.0 111.979 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 75.6 mt -121.46 125.17 26.94 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.97 107.03 0.32 Allowed 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.739 2.293 . . . . 0.0 111.704 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.7 p -134.33 153.06 79.13 Favored Pre-proline 0 C--N 1.302 -1.487 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.963 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.403 ' HB3' ' HB2' ' A' ' 72' ' ' ASN . 52.5 Cg_endo -79.25 164.41 24.36 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.544 2.163 . . . . 0.0 113.58 -176.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 71' ' ' LYS . 36.8 tt0 -112.86 143.01 44.85 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.93 152.22 50.5 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.128 -175.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.3 t -147.69 128.97 14.76 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.265 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.475 HG13 HG22 ' A' ' 161' ' ' THR . 7.5 p -94.09 141.7 14.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 175.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -118.05 -66.81 1.04 Allowed 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -170.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -158.58 167.07 30.56 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -171.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.574 HG11 ' OH ' ' A' ' 139' ' ' TYR . 14.5 p -126.97 132.68 69.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.723 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -104.71 135.84 45.34 Favored 'General case' 0 C--O 1.251 1.15 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.343 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.499 ' O ' ' HE2' ' A' ' 55' ' ' LYS . 48.7 p90 -60.45 140.76 57.1 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 174.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.549 ' HE2' ' HA ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -136.11 -66.72 0.54 Allowed 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.914 -171.157 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.09 -164.76 15.3 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.202 -176.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.24 128.31 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-O 121.452 0.644 . . . . 0.0 111.515 -177.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.505 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 44.9 m -152.29 126.51 9.23 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 173.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -69.82 -32.44 70.87 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -169.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -108.6 11.42 26.64 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.02 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . 170.1 86.95 0.06 OUTLIER Glycine 0 CA--C 1.492 -1.374 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -177.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.429 HG13 ' HB ' ' A' ' 119' ' ' VAL . 7.2 p -67.76 140.39 19.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.534 0.683 . . . . 0.0 110.991 -173.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -96.26 106.75 19.0 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 121.691 0.757 . . . . 0.0 112.02 -175.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.565 ' HB3' HG22 ' A' ' 52' ' ' VAL . 3.3 m-85 -100.97 165.36 11.37 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.246 174.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.452 ' CD2' ' HG2' ' A' ' 55' ' ' LYS . 20.0 m-70 -124.89 110.26 14.03 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.284 0.564 . . . . 0.0 109.553 176.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . . . -78.45 144.91 35.36 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.589 -177.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -90.46 112.61 24.3 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.556 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.2 t -118.33 114.61 45.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.4 m -98.2 131.29 44.68 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -177.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 95.4 t -118.84 133.0 67.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.533 0.682 . . . . 0.0 111.077 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 46' ' ' GLU . 78.3 tttt -102.78 109.97 21.73 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 45' ' ' PRO . 8.9 t30 -130.33 113.2 16.94 Favored Pre-proline 0 C--N 1.302 -1.497 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.95 -175.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -102.88 97.59 0.04 OUTLIER 'Trans proline' 0 N--CA 1.421 -2.755 0 C-N-CA 122.319 2.013 . . . . 0.0 113.081 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -176.52 150.78 0.9 Allowed 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 170.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.5 t -77.87 8.03 5.15 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 118.039 0.381 . . . . 0.0 111.487 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.428 ' CD ' HG12 ' A' ' 78' ' ' ILE . 6.4 tt0 -101.56 137.64 39.61 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.7 p -94.08 95.57 9.09 Favored 'General case' 0 N--CA 1.399 -2.98 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 170.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.533 ' HB ' HD12 ' A' ' 105' ' ' LEU . 33.6 mt -77.88 126.36 84.12 Favored Pre-proline 0 N--CA 1.434 -1.235 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -174.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.0 133.95 30.51 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.308 2.006 . . . . 0.0 110.538 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 67.7 mt -83.93 107.04 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 55.5 m -55.76 -51.82 66.06 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.853 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -160.55 155.2 23.85 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.253 0.549 . . . . 0.0 110.274 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.472 HG23 HG23 ' A' ' 143' ' ' ILE . 24.8 mm -114.95 113.85 44.81 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 172.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.3 m -93.48 117.28 29.88 Favored 'General case' 0 C--N 1.274 -2.687 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -107.89 129.56 55.08 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.519 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.625 ' HB ' ' HB2' ' A' ' 142' ' ' ASP . 3.0 mp -118.11 108.0 23.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.501 HD21 ' CE2' ' A' ' 139' ' ' TYR . 3.1 tm? -109.96 124.65 51.77 Favored 'General case' 0 C--N 1.27 -2.88 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.847 -175.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.575 ' HB2' ' HB2' ' A' ' 140' ' ' GLN . 29.9 mmtm -93.7 142.81 26.93 Favored 'General case' 0 CA--C 1.479 -1.774 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.738 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 92' ' ' ARG . 45.9 t -97.92 145.54 26.35 Favored 'General case' 0 C--N 1.267 -2.996 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.65 143.83 56.91 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.296 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.4 m 74.1 -61.03 0.51 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.455 1.102 . . . . 0.0 111.001 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.405 ' O ' ' HB3' ' A' ' 89' ' ' SER . 53.3 mtt180 -155.01 172.1 18.66 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.088 0.555 . . . . 0.0 110.165 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.0 m 77.52 160.33 0.21 Allowed 'General case' 0 CA--C 1.563 1.456 0 O-C-N 124.261 0.976 . . . . 0.0 113.207 172.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.418 HD13 ' N ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -147.91 149.26 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 123.727 0.811 . . . . 0.0 109.228 -176.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.494 ' HB2' ' OG ' ' A' ' 122' ' ' SER . . . -118.64 134.93 54.75 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.666 0.787 . . . . 0.0 109.221 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.0 p -129.64 158.86 38.16 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.95 162.61 26.03 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.8 p -124.89 128.77 49.16 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 117.054 0.427 . . . . 0.0 110.335 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.8 mt -99.64 105.35 33.43 Favored Pre-proline 0 C--N 1.308 -1.221 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -76.92 116.08 4.16 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.502 2.134 . . . . 0.0 111.722 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.5 t70 53.96 83.33 0.23 Allowed Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 124.95 1.3 . . . . 0.0 112.745 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -101.08 7.8 0.58 Allowed 'Trans proline' 0 N--CA 1.441 -1.613 0 C-N-CA 122.697 2.265 . . . . 0.0 112.015 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 153.77 -164.78 31.35 Favored Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 32.2 p -145.28 158.89 43.72 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.533 HD12 ' HB ' ' A' ' 78' ' ' ILE . 78.4 mt -73.08 157.13 37.9 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 121.209 0.528 . . . . 0.0 111.611 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.401 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 14.6 p -90.4 139.16 18.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.238 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.4 93.82 0.46 Allowed Glycine 0 C--N 1.3 -1.447 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.784 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 67.3 p 60.36 83.15 0.14 Allowed 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 125.697 1.599 . . . . 0.0 113.998 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.88 -160.06 33.61 Favored Glycine 0 N--CA 1.429 -1.785 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.0 t -118.89 142.0 48.15 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.401 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 4.4 t -134.87 138.87 44.56 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.577 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.9 m -91.04 126.24 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 173.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.8 mt -103.04 145.18 30.28 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.718 -176.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -100.79 116.33 32.42 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.175 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.403 ' HA ' ' HD2' ' A' ' 116' ' ' PRO . 29.2 m -126.74 117.77 22.56 Favored Pre-proline 0 C--N 1.316 -0.864 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 177.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 115' ' ' VAL . 33.4 Cg_endo -66.37 124.5 12.58 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.625 2.216 . . . . 0.0 111.579 174.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 97.3 t -124.67 141.01 46.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 120.854 0.359 . . . . 0.0 110.155 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.75 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -87.8 102.12 14.36 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.988 0.899 . . . . 0.0 111.045 178.275 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.429 ' HB ' HG13 ' A' ' 62' ' ' VAL . 48.1 t -97.6 148.39 5.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 75.07 -14.96 0.7 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.909 0.883 . . . . 0.0 111.932 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.409 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 34.4 t80 -56.06 -58.13 9.23 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 124.119 0.967 . . . . 0.0 109.961 -175.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.494 ' OG ' ' HB2' ' A' ' 95' ' ' ALA . 41.4 m -74.93 -26.84 59.91 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.96 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.429 HG21 ' HG2' ' A' ' 129' ' ' LYS . 58.4 mt -71.47 -50.24 41.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.116 -173.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.61 -49.37 75.49 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 123.516 0.51 . . . . 0.0 110.363 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 52.2 t -57.9 -39.39 71.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.217 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.8 t -82.25 -82.6 0.13 Allowed 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 128' ' ' MET . 2.0 pp -125.6 -27.0 3.45 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -173.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.445 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.1 tpt 69.9 125.76 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.955 0.902 . . . . 0.0 111.458 -174.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.429 ' HG2' HG21 ' A' ' 123' ' ' ILE . 27.0 mmmt -72.34 -36.28 68.78 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-O 122.057 0.932 . . . . 0.0 110.431 -177.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.8 t70 78.0 76.05 0.06 Allowed 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 112.072 -2.331 . . . . 0.0 106.512 -171.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.512 ' HG2' ' CD1' ' A' ' 135' ' ' TRP . 5.8 tmm? -69.69 114.69 8.13 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 112.859 -1.973 . . . . 0.0 109.599 -171.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 55.6 m -91.2 -179.67 5.48 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.124 -174.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 22.4 p -80.2 105.1 11.22 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-O 121.839 0.828 . . . . 0.0 110.785 178.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.5 t70 78.24 98.52 0.06 Allowed 'General case' 0 CA--C 1.487 -1.456 0 C-N-CA 126.553 1.941 . . . . 0.0 107.555 -170.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.512 ' CD1' ' HG2' ' A' ' 131' ' ' MET . 32.9 t-105 -148.89 148.45 29.86 Favored 'General case' 0 C--N 1.276 -2.591 0 CA-C-N 113.976 -1.466 . . . . 0.0 108.716 -171.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -125.87 141.16 52.11 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.56 132.29 54.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -105.58 109.65 21.69 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.574 ' OH ' HG11 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -113.01 172.07 7.16 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.287 -0.965 . . . . 0.0 108.971 173.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.575 ' HB2' ' HB2' ' A' ' 88' ' ' LYS . 63.2 mt-30 -118.29 130.79 56.24 Favored 'General case' 0 C--N 1.274 -2.685 0 C-N-CA 120.414 -0.514 . . . . 0.0 109.719 -174.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 35.6 tp -116.45 125.69 52.35 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.246 0.546 . . . . 0.0 112.043 -177.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.625 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 13.7 m-20 -120.0 119.69 34.16 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.472 HG23 HG23 ' A' ' 83' ' ' ILE . 42.4 mm -112.97 123.75 68.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -96.13 103.85 3.0 Favored Glycine 0 N--CA 1.418 -2.514 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 176.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 156' ' ' THR . 2.9 mm? -76.83 101.75 6.01 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 123.195 0.598 . . . . 0.0 110.026 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.9 m -91.37 115.58 28.14 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.101 0.477 . . . . 0.0 111.487 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.567 ' CE2' ' HB3' ' A' ' 145' ' ' LEU . 60.4 m-85 -126.67 153.03 45.94 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -158.31 140.83 14.43 Favored 'General case' 0 CA--C 1.479 -1.762 0 CA-C-O 121.463 0.649 . . . . 0.0 112.221 173.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 50.0 mm -121.6 128.31 25.69 Favored Pre-proline 0 C--N 1.292 -1.911 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -46.73 -43.55 23.22 Favored 'Trans proline' 0 N--CA 1.483 0.907 0 C-N-CA 123.633 2.889 . . . . 0.0 114.207 -176.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.18 -52.49 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 121.722 0.772 . . . . 0.0 109.313 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.467 HG22 ' HD3' ' A' ' 38' ' ' LYS . 7.2 p 173.04 140.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 C-N-CA 125.488 1.515 . . . . 0.0 107.072 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.455 ' H ' ' H ' ' A' ' 154' ' ' ASP . . . 150.54 15.22 0.08 OUTLIER Glycine 0 C--N 1.291 -1.969 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -177.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.455 ' H ' ' H ' ' A' ' 153' ' ' GLY . 10.6 p-10 -73.21 118.05 15.69 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 126.031 1.733 . . . . 0.0 110.254 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.538 HG12 HD11 ' A' ' 39' ' ' LEU . 8.2 tp -162.59 144.14 3.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.499 -178.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 96.3 m -123.02 104.1 9.01 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 166.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 58.2 mt -87.88 112.94 52.3 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.328 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 156' ' ' THR . 26.9 Cg_endo -84.06 111.07 1.61 Allowed 'Trans proline' 0 N--CA 1.436 -1.864 0 C-N-CA 122.214 1.943 . . . . 0.0 111.587 176.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.4 m -106.49 134.95 46.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.409 ' HB3' ' OD1' ' A' ' 142' ' ' ASP . 29.6 p -126.1 157.44 38.03 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -175.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.475 HG22 HG13 ' A' ' 49' ' ' VAL . 14.6 t -170.47 170.67 6.85 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 176.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -99.67 132.19 45.17 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -101.72 104.64 2.71 Favored Glycine 0 N--CA 1.415 -2.73 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -90.04 119.46 30.41 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.53 HD11 ' CE1' ' A' ' 139' ' ' TYR . 5.7 mm -106.82 119.08 55.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 -174.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 62.9 tttp -92.99 117.72 30.38 Favored 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.153 175.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 95.6 mt -108.44 93.1 10.97 Favored Pre-proline 0 C--N 1.284 -2.26 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.841 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 166' ' ' LYS . 10.0 Cg_endo -86.42 82.34 1.36 Allowed 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 122.885 2.39 . . . . 0.0 112.861 -174.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 79.3 p 55.91 15.9 1.89 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.083 1.353 . . . . 0.0 113.777 177.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 49.7 tp -59.57 -56.68 18.86 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.134 0.574 . . . . 0.0 111.238 -176.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.438 ' O ' ' HD1' ' A' ' 173' ' ' PHE . 47.8 mtm105 65.28 145.24 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 179.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 76.79 -4.68 2.31 Favored 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 124.794 1.237 . . . . 0.0 114.023 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.438 ' HD1' ' O ' ' A' ' 171' ' ' ARG . 27.1 m-85 . . . . . 0 C--N 1.303 -1.43 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 . . . . . 0 CA--C 1.507 -0.711 0 CA-C-O 121.068 0.461 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 18' ' ' GLU . 1.5 mp0 -66.81 -31.1 71.5 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.386 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -74.51 -41.0 61.44 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -176.283 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.6 m -66.83 -29.44 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.1 m -73.03 -29.59 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.86 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 48.6 mt-10 -69.09 -34.59 75.35 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 176.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 7.7 mm-40 -59.25 -46.98 87.04 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.58 175.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.16 -45.45 93.36 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.653 177.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.15 -36.33 77.31 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.739 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.4 t -65.45 -35.55 81.25 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.82 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 91.2 t -70.71 -33.29 52.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.573 0.702 . . . . 0.0 110.027 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.578 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 59.0 mt -69.56 -40.98 80.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 174.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.1 m -66.86 -29.0 68.79 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.106 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.3 p -70.54 -34.78 72.66 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 120.914 0.388 . . . . 0.0 110.532 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.413 ' HB3' HG21 ' A' ' 156' ' ' THR 0.263 7.9 mp -79.38 -18.57 52.07 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 119.227 -0.989 . . . . 0.0 112.991 172.129 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 81.2 mt -68.62 -34.24 75.41 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 171.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.48 -40.45 70.23 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.324 176.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -52.01 -59.75 3.99 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.986 173.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 35' ' ' PHE . . . -59.75 -39.9 86.34 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.365 177.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -55.36 -31.96 62.18 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 123.345 0.658 . . . . 0.0 111.165 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.484 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -95.36 -77.83 1.38 Allowed Glycine 0 N--CA 1.425 -2.044 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.975 177.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 48.1 t80 -63.64 -39.96 95.67 Favored 'General case' 0 C--O 1.209 -1.074 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -174.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.488 ' HA ' HD23 ' A' ' 39' ' ' LEU . 82.1 t80 -69.87 -42.42 73.53 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 118.25 -1.38 . . . . 0.0 111.016 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 40' ' ' ALA . . . -62.07 -44.68 96.15 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 33' ' ' GLY . 14.3 pt-20 -94.74 -41.74 9.1 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -176.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 34' ' ' PHE . 15.2 tppt? -75.32 -45.4 39.82 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 121.824 0.821 . . . . 0.0 109.28 -173.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.502 HD11 HG21 ' A' ' 152' ' ' VAL . 3.8 mm? -86.8 7.29 27.58 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.297 -1.319 . . . . 0.0 112.82 -174.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 36' ' ' ALA . . . -76.02 -10.6 59.55 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.606 0.717 . . . . 0.0 109.843 176.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -112.99 2.12 15.65 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.117 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.4 mp -124.45 118.11 26.37 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -71.61 94.11 0.69 Allowed 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 122.36 2.04 . . . . 0.0 112.927 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.496 ' HB ' ' HD2' ' A' ' 45' ' ' PRO . 21.8 p -91.5 170.59 9.3 Favored Pre-proline 0 C--N 1.307 -1.248 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.414 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.496 ' HD2' ' HB ' ' A' ' 44' ' ' THR . 55.6 Cg_endo -65.36 146.78 86.55 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.559 1.506 . . . . 0.0 110.547 174.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -97.45 126.11 42.52 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.539 ' O ' HG11 ' A' ' 159' ' ' VAL . . . -97.38 146.13 25.48 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.8 t -161.23 120.85 2.6 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.075 0.464 . . . . 0.0 110.712 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -83.84 138.02 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -97.51 -59.01 1.87 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.106 -1.037 . . . . 0.0 110.922 -168.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -173.85 -178.04 1.49 Allowed 'General case' 0 C--O 1.249 1.052 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.661 HG22 ' HB3' ' A' ' 64' ' ' TYR . 7.6 p -130.53 132.35 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.907 0 CA-C-O 121.315 0.579 . . . . 0.0 109.52 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -107.97 136.31 47.89 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.238 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.661 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 45.5 p90 -92.08 141.18 28.88 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.416 ' N ' ' HD3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -124.74 -70.36 0.76 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.066 0.46 . . . . 0.0 110.881 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -112.36 -165.11 17.03 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.984 -174.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.466 ' HB ' ' CD2' ' A' ' 173' ' ' PHE . 13.6 p -117.92 159.99 17.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.129 -0.536 . . . . 0.0 110.042 -176.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 34.0 m -148.19 152.22 36.87 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 173.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.0 ttt-85 -58.94 -40.85 85.89 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.403 0.621 . . . . 0.0 110.446 177.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -117.13 94.39 4.55 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.414 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . 98.3 166.42 31.24 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.57 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.8 t -104.4 148.73 8.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.46 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 29.6 t70 -84.85 107.01 16.79 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.127 0.489 . . . . 0.0 111.877 -175.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.661 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 28.7 m-85 -117.46 158.16 24.99 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.768 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -133.18 112.92 12.12 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.528 ' HB3' HG13 ' A' ' 115' ' ' VAL . . . -90.41 144.66 25.59 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -177.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.8 mtmp? -104.34 119.52 39.15 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.93 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.0 t -117.61 109.05 26.22 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.415 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.2 m -100.43 143.28 30.81 Favored 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 119.769 -0.772 . . . . 0.0 111.049 -175.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.31 119.14 51.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -96.28 109.69 22.14 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.584 ' ND2' HD21 ' A' ' 105' ' ' LEU . 6.5 t30 -123.02 115.23 29.2 Favored Pre-proline 0 C--N 1.292 -1.924 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -171.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -97.74 96.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.672 0 C-N-CA 121.742 1.628 . . . . 0.0 110.871 172.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.572 ' HB2' HD21 ' A' ' 72' ' ' ASN . 61.3 m-85 -175.84 119.25 0.16 Allowed 'General case' 0 CA--C 1.488 -1.414 0 C-N-CA 128.086 2.555 . . . . 0.0 105.152 178.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.4 m -69.85 -18.1 63.41 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 123.553 0.533 . . . . 0.0 112.108 -177.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.436 HE21 HG12 ' A' ' 78' ' ' ILE . 18.0 pt20 -80.18 134.45 36.14 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-O 121.072 0.463 . . . . 0.0 110.726 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.2 p -80.01 97.19 6.68 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.563 ' HB ' HD13 ' A' ' 105' ' ' LEU . 42.3 mt -81.88 127.05 73.68 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -177.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.73 123.38 13.67 Favored 'Trans proline' 0 C--O 1.241 0.675 0 C-N-CA 122.588 2.192 . . . . 0.0 110.827 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.425 HG12 ' CE2' ' A' ' 147' ' ' PHE . 60.7 mt -69.77 103.51 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-O 121.309 0.576 . . . . 0.0 109.95 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 49.2 t -66.78 -56.82 8.73 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.885 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.555 ' HG3' ' CG2' ' A' ' 98' ' ' THR . 25.8 tt0 -152.24 130.17 11.75 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -175.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.6 mm -118.84 113.91 43.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 170.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 98' ' ' THR . 12.3 t -118.5 142.69 47.34 Favored 'General case' 0 C--N 1.288 -2.085 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.317 -174.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -128.27 144.57 51.14 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 121.301 0.572 . . . . 0.0 111.442 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.433 ' HB ' ' HB2' ' A' ' 142' ' ' ASP . 56.0 mt -120.9 119.65 60.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 174.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.626 HD13 ' HB3' ' A' ' 95' ' ' ALA . 0.4 OUTLIER -103.09 122.29 44.36 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 178.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.593 ' HB2' ' HB2' ' A' ' 140' ' ' GLN . 98.5 mttt -123.21 157.3 33.36 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.678 175.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.8 t -152.24 109.02 3.48 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.409 ' O ' ' HB ' ' A' ' 91' ' ' THR . . . 68.6 -77.49 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.232 1.013 . . . . 0.0 110.993 -177.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.409 ' HB ' ' O ' ' A' ' 90' ' ' ALA . 9.0 t 172.5 -28.71 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.155 0.582 . . . . 0.0 110.438 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -64.85 -56.93 10.47 Favored 'General case' 0 C--N 1.345 0.392 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -174.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 51.3 m -125.22 143.92 50.71 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.911 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.556 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 2.1 pp -141.37 178.64 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.209 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -176.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.626 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -135.95 147.11 47.93 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 172.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 39.1 t -131.44 153.12 50.06 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -176.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.46 165.48 36.94 Favored Glycine 0 N--CA 1.426 -1.992 0 C-N-CA 119.697 -1.24 . . . . 0.0 112.131 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.555 ' CG2' ' HG3' ' A' ' 82' ' ' GLN . 86.7 m -149.99 131.72 15.0 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.407 HD12 ' N ' ' A' ' 99' ' ' ILE . 2.8 mp -107.6 115.86 58.57 Favored Pre-proline 0 C--O 1.248 0.996 0 C-N-CA 119.071 -1.052 . . . . 0.0 109.77 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.28 114.75 3.81 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.021 1.814 . . . . 0.0 109.604 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.3 t70 55.15 77.94 0.41 Allowed Pre-proline 0 N--CA 1.482 1.175 0 C-N-CA 124.068 0.947 . . . . 0.0 111.285 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -92.62 3.61 3.62 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.576 2.184 . . . . 0.0 111.875 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 175.32 -157.38 24.02 Favored Glycine 0 N--CA 1.424 -2.166 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.9 p -136.48 139.53 42.39 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 117.196 0.498 . . . . 0.0 110.847 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.584 HD21 ' ND2' ' A' ' 72' ' ' ASN . 7.3 tt -69.67 127.16 32.0 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.818 178.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.496 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 7.3 p -52.74 -45.3 49.16 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -173.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.566 ' H ' HD23 ' A' ' 105' ' ' LEU . . . 86.01 82.86 1.1 Allowed Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 109.201 -1.559 . . . . 0.0 109.201 -172.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.6 m 62.18 90.32 0.07 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.402 1.081 . . . . 0.0 112.561 -176.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 155.19 -173.96 33.4 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 176.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.7 m -108.1 123.66 49.04 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.496 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 3.6 t -117.41 132.01 56.65 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.087 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.6 t -95.99 109.98 23.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.1 mt -91.44 167.1 12.5 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -144.77 149.05 34.83 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.562 -174.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.528 HG13 ' HB3' ' A' ' 66' ' ' ALA . 4.4 p -136.6 127.18 16.36 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.69 176.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.17 113.12 3.6 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.971 1.78 . . . . 0.0 108.774 171.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.1 t -123.1 126.04 72.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -175.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.46 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 14.3 mmmm -88.51 103.93 16.34 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.335 -0.946 . . . . 0.0 108.492 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.626 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 97.5 t -93.72 146.13 6.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.988 -173.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 78.0 -5.93 2.03 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.952 1.301 . . . . 0.0 110.516 -176.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.503 ' O ' HG23 ' A' ' 125' ' ' VAL . 82.4 t80 -58.07 -57.11 14.29 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.825 176.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.2 m -56.27 -39.34 72.47 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.758 -176.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 10.8 tp -77.83 -30.21 16.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.244 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -66.67 -42.64 86.25 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 172.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 121' ' ' TYR . 68.9 t -57.35 -33.19 43.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.529 175.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -75.49 -81.07 0.08 Allowed 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.0 176.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.469 ' H ' HD23 ' A' ' 127' ' ' LEU . 1.9 pt? -126.65 -22.83 3.84 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -177.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.427 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER 70.13 121.83 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -170.234 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.624 ' C ' ' H ' ' A' ' 131' ' ' MET . 0.0 OUTLIER -59.48 -32.31 70.14 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -172.689 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.8 t70 80.95 -16.41 0.65 Allowed 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 -169.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.624 ' H ' ' C ' ' A' ' 129' ' ' LYS 0.343 13.9 tmm? 72.32 -102.1 0.03 OUTLIER 'General case' 0 N--CA 1.416 -2.131 0 C-N-CA 128.456 2.702 . . . . 0.0 113.277 175.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 131' ' ' MET . 48.7 t 150.58 -138.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 102.682 -3.081 . . . . 0.0 102.682 -175.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.9 p -133.92 99.1 4.34 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 164.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.67 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 16.2 t70 71.86 92.73 0.08 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.663 1.185 . . . . 0.0 112.805 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.442 ' HE1' ' HA ' ' A' ' 131' ' ' MET . 1.2 p-90 -154.96 159.77 40.64 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 176.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 166' ' ' LYS . 5.7 p-10 -103.55 142.49 34.2 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.22 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.55 HD12 HD21 ' A' ' 167' ' ' LEU . 0.2 OUTLIER -115.62 158.28 16.06 Favored 'Isoleucine or valine' 0 C--O 1.248 1.013 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.763 177.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.66 115.37 10.77 Favored 'General case' 0 C--O 1.252 1.204 0 CA-C-O 121.635 0.731 . . . . 0.0 112.186 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -133.39 151.35 51.82 Favored 'General case' 0 N--CA 1.411 -2.384 0 CA-C-N 114.02 -1.446 . . . . 0.0 107.989 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.593 ' HB2' ' HB2' ' A' ' 88' ' ' LYS . 58.1 mt-30 -139.45 150.2 44.92 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.8 tp -139.18 118.96 13.17 Favored 'General case' 0 N--CA 1.419 -1.989 0 O-C-N 124.002 0.814 . . . . 0.0 109.822 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.433 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 22.6 m-20 -122.31 136.35 54.89 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.5 mm -122.05 129.29 75.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.567 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -117.91 88.0 0.44 Allowed Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 176.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 156' ' ' THR . 2.3 pp -84.31 149.2 26.22 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.825 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.461 ' HB ' ' HB3' ' A' ' 82' ' ' GLN . 8.7 m -127.02 120.59 29.39 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -176.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.425 ' CE2' HG12 ' A' ' 80' ' ' ILE . 68.9 m-85 -132.67 141.66 48.71 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -108.46 124.79 50.96 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.634 0.731 . . . . 0.0 110.709 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.483 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -124.88 125.84 25.36 Favored Pre-proline 0 C--N 1.297 -1.711 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.058 178.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -41.06 -34.21 1.43 Allowed 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 124.915 3.744 . . . . 0.0 115.88 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 13.5 p -59.3 -35.22 56.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.502 HG21 HD11 ' A' ' 39' ' ' LEU . 31.3 m -132.03 -25.66 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 121.875 -0.516 . . . . 0.0 112.355 -178.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 111.04 -141.7 16.58 Favored Glycine 0 N--CA 1.421 -2.346 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -177.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -92.41 120.42 32.89 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.908 0.385 . . . . 0.0 111.456 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 2.3 pp -130.35 146.24 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.356 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 174.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 4.6 p -95.32 151.06 19.58 Favored 'General case' 0 N--CA 1.397 -3.088 0 CA-C-N 113.978 -1.465 . . . . 0.0 109.98 174.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 57.4 mt -125.34 110.35 26.37 Favored Pre-proline 0 C--N 1.295 -1.787 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 176.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.447 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 97.3 Cg_endo -89.88 114.58 0.57 Allowed 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 123.005 2.47 . . . . 0.0 113.662 -174.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.539 HG11 ' O ' ' A' ' 47' ' ' ALA . 29.1 m -118.13 128.16 75.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.955 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 63.0 p -114.24 144.2 43.61 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.931 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 53.3 m -153.13 136.69 15.95 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 121.114 0.483 . . . . 0.0 110.098 -177.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -98.99 119.47 37.83 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -100.53 115.05 5.19 Favored Glycine 0 N--CA 1.411 -2.974 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.399 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -89.71 118.6 29.44 Favored 'General case' 0 C--N 1.27 -2.86 0 N-CA-C 105.601 -1.999 . . . . 0.0 105.601 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 136' ' ' ASP . 50.3 mm -112.95 108.68 26.16 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.442 -172.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 136' ' ' ASP . 60.5 pttt -86.54 133.65 33.72 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.015 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 134' ' ' ASP . 0.4 OUTLIER -103.41 96.91 9.22 Favored Pre-proline 0 C--N 1.295 -1.779 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 173.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.66 78.84 0.95 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.28 1.987 . . . . 0.0 113.62 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.5 ' HA ' ' HE1' ' A' ' 131' ' ' MET . 76.2 p 39.26 79.55 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.707 1.603 . . . . 0.0 114.291 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.441 ' HG ' ' HB2' ' A' ' 173' ' ' PHE . 2.5 mm? -103.65 -61.84 1.37 Allowed 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.004 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 70.22 4.86 5.06 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 121.31 0.576 . . . . 0.0 112.177 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -136.29 -41.19 0.64 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.339 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.466 ' CD2' ' HB ' ' A' ' 57' ' ' VAL . 3.0 m-85 . . . . . 0 CA--C 1.494 -1.178 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 176.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.447 ' O ' HG23 ' A' ' 17' ' ' VAL . 24.2 t70 . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 121.21 0.528 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -77.78 -50.42 12.37 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.021 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.425 ' C ' ' HD3' ' A' ' 15' ' ' LYS . 12.7 tmtt? -57.32 -47.15 82.27 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.771 1.229 . . . . 0.0 112.539 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.0 m -63.22 -21.82 29.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 94' ' ' ILE . 92.8 t -67.34 -49.02 75.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 120.913 0.387 . . . . 0.0 110.14 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.95 -33.61 72.15 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.509 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -77.12 -39.26 50.04 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.831 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -75.45 -35.44 60.91 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 120.747 0.308 . . . . 0.0 111.0 -177.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.78 -35.78 73.36 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.46 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.4 t -63.08 -44.85 94.61 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.915 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.3 t -65.34 -48.55 82.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.965 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.547 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 64.0 mt -61.21 -44.62 98.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.238 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.7 m -62.95 -37.83 88.63 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.677 0.275 . . . . 0.0 111.161 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.5 m -66.03 -36.49 83.38 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.788 0.328 . . . . 0.0 110.629 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.423 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 5.0 tt -67.11 -43.21 83.06 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 83.5 mt -57.78 -46.46 84.55 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.661 177.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.74 -44.12 97.08 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.52 ' HD2' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -64.83 -33.24 75.53 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.583 -178.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.52 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -79.38 -40.44 30.11 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.396 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -51.07 -52.65 41.34 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.381 1.073 . . . . 0.0 112.598 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.38 -17.88 79.61 Favored Glycine 0 C--N 1.318 -0.439 0 C-N-CA 120.026 -1.083 . . . . 0.0 112.02 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -75.39 -26.23 58.28 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 123.448 0.699 . . . . 0.0 109.952 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.404 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 27.2 m-85 -79.15 -12.08 59.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -178.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.29 -51.35 70.34 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -174.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.657 ' HG2' ' HD3' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -117.27 -43.45 2.83 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -178.387 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.657 ' HD3' ' HG2' ' A' ' 37' ' ' GLU . 3.7 mppt? -64.52 -34.28 77.87 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.271 -175.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.413 HD13 ' HB ' ' A' ' 42' ' ' ILE . 2.8 mm? -102.95 17.97 22.73 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.725 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.83 -28.07 16.08 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 171.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -94.47 -48.31 6.17 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.815 175.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.413 ' HB ' HD13 ' A' ' 39' ' ' LEU . 75.1 mt -73.99 121.29 84.84 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.96 114.38 3.72 Favored 'Trans proline' 0 C--O 1.246 0.925 0 C-N-CA 122.445 2.097 . . . . 0.0 113.518 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.403 HG23 HD12 ' A' ' 39' ' ' LEU . 23.3 p -114.33 140.41 25.05 Favored Pre-proline 0 N--CA 1.429 -1.498 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.868 173.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -56.12 138.95 84.6 Favored 'Trans proline' 0 C--O 1.24 0.603 0 C-N-CA 122.465 2.11 . . . . 0.0 111.418 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -96.45 109.9 22.36 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-O 121.327 0.584 . . . . 0.0 110.251 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.437 ' CB ' ' HG ' ' A' ' 145' ' ' LEU . . . -98.8 140.26 33.24 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.617 -178.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.5 t -141.98 133.7 27.01 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.315 177.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.554 HG22 HG22 ' A' ' 159' ' ' VAL . 24.3 m -89.45 141.61 14.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -130.93 -48.44 1.02 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -170.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -161.99 169.57 20.85 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.822 -171.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 65' ' ' HIS . 13.0 m -132.24 112.73 20.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.487 0.66 . . . . 0.0 111.562 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -92.34 129.5 38.27 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.243 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -59.27 138.26 57.67 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.982 0.176 . . . . 0.0 111.01 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.592 ' HD3' ' C ' ' A' ' 55' ' ' LYS . 11.7 tmtt? -119.44 -55.7 2.11 Favored 'General case' 0 N--CA 1.411 -2.413 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.033 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.483 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . -176.63 -170.87 39.72 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 118.865 -1.636 . . . . 0.0 113.432 -173.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.6 p -102.61 151.99 5.85 Favored 'Isoleucine or valine' 0 C--O 1.249 1.057 0 CA-C-O 121.709 0.766 . . . . 0.0 112.308 -172.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.764 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 31.3 m -159.97 159.41 32.18 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 103.047 -2.946 . . . . 0.0 103.047 173.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.1 mtm180 -73.15 134.24 44.36 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 118.954 -1.099 . . . . 0.0 110.235 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 76.39 -66.21 0.27 Allowed 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 125.533 1.533 . . . . 0.0 110.989 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.764 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . -107.52 128.22 9.11 Favored Glycine 0 CA--C 1.479 -2.191 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 56' ' ' GLY . 35.5 m -99.75 152.83 4.54 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.425 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 45.8 m-20 -81.12 131.11 35.28 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -174.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -132.14 156.69 45.93 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 125.069 1.347 . . . . 0.0 109.491 174.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.435 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 18.0 m-70 -95.68 108.31 20.59 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 173.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.423 ' HA ' HG12 ' A' ' 52' ' ' VAL . . . -81.68 122.06 27.15 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 170.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -86.27 107.95 18.18 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.788 -174.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.6 t -114.02 109.17 27.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 56.3 p -103.05 128.74 49.79 Favored 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.555 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.2 t -114.66 120.58 64.72 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.262 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 36.2 ttpt -95.88 110.24 22.46 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 175.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -103.6 113.35 65.63 Favored Pre-proline 0 C--N 1.293 -1.878 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.853 -175.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -99.43 97.25 0.05 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.685 0 C-N-CA 122.007 1.805 . . . . 0.0 108.958 169.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -179.35 153.74 0.6 Allowed 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 102.951 -2.981 . . . . 0.0 102.951 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.1 t -79.22 -35.42 41.67 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -172.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -89.45 157.78 17.98 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.796 -0.762 . . . . 0.0 112.218 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.4 m -85.73 111.26 19.97 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 173.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.6 mt -87.97 128.95 52.03 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -175.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -87.19 118.86 1.41 Allowed 'Trans proline' 0 N--CA 1.433 -2.032 0 C-N-CA 122.098 1.865 . . . . 0.0 111.255 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.7 pt -72.04 113.06 8.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 48.5 t -58.43 -47.38 84.12 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.513 ' O ' ' HB ' ' A' ' 146' ' ' THR . 5.0 pp0? -156.29 157.95 36.64 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 174.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.485 ' CG2' HG23 ' A' ' 99' ' ' ILE . 11.8 tt -124.74 127.58 72.8 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.354 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 175.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.4 m -80.64 128.91 34.16 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-O 121.625 0.726 . . . . 0.0 110.963 -171.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -104.23 119.42 38.91 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.458 -175.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.0 mp -131.05 107.05 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 172.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.643 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 1.6 tm? -100.06 130.05 46.17 Favored 'General case' 0 C--N 1.268 -2.943 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -122.29 161.29 23.59 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.5 m -149.97 146.18 26.88 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -41.17 -71.42 0.08 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -174.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.558 ' C ' ' HD2' ' A' ' 92' ' ' ARG . 4.9 t -150.86 80.17 1.32 Allowed 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.558 ' HD2' ' C ' ' A' ' 91' ' ' THR . 3.8 mpt_? -140.0 -63.89 0.49 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 172.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.2 t 179.75 -174.18 0.24 Allowed 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.643 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 38.4 pt -132.1 -174.92 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . . . -132.0 130.33 41.28 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 33.5 p -106.25 179.68 4.2 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.789 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.02 170.14 12.77 Favored Glycine 0 N--CA 1.421 -2.355 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.005 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.9 p -134.46 128.96 34.5 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.485 HG23 ' CG2' ' A' ' 83' ' ' ILE . 7.5 tt -102.8 111.22 64.71 Favored Pre-proline 0 C--N 1.307 -1.255 0 C-N-CA 118.767 -1.173 . . . . 0.0 110.873 177.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.92 118.06 5.14 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 123.321 2.68 . . . . 0.0 113.563 -175.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.3 t70 45.19 79.15 0.35 Allowed Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 125.551 1.541 . . . . 0.0 113.546 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.428 ' HG3' ' CG2' ' A' ' 83' ' ' ILE . 68.4 Cg_endo -92.68 3.2 3.65 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.747 2.298 . . . . 0.0 111.915 175.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 165.85 -177.28 41.06 Favored Glycine 0 N--CA 1.427 -1.961 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.7 m -143.12 150.05 38.95 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.417 ' H ' HD23 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -103.51 142.76 33.72 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.235 -178.733 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.3 m -80.18 165.77 2.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 O-C-N 124.123 0.89 . . . . 0.0 110.504 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.39 133.16 11.56 Favored Glycine 0 N--CA 1.427 -1.902 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.7 p 54.78 75.85 0.28 Allowed 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 124.548 1.139 . . . . 0.0 113.015 -177.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.81 174.84 36.44 Favored Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.792 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 9.0 t -101.83 136.49 41.58 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.7 t -135.82 131.23 35.14 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 121.228 0.537 . . . . 0.0 110.204 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.3 t -95.74 119.28 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.7 mt -102.73 146.96 27.45 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.262 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -113.0 112.69 24.33 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.522 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 28.8 m -112.61 127.25 27.08 Favored Pre-proline 0 C--N 1.305 -1.364 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.249 175.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 12.8 Cg_exo -69.65 111.2 2.72 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.236 1.957 . . . . 0.0 110.598 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.7 t -108.91 134.47 50.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.904 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -91.25 102.19 14.9 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.0 m -93.07 140.12 16.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.388 -174.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 68.55 11.29 8.3 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.749 1.22 . . . . 0.0 109.852 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.414 ' O ' HG12 ' A' ' 125' ' ' VAL . 84.1 t80 -61.04 -44.13 97.86 Favored 'General case' 0 CA--C 1.485 -1.526 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.74 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.1 m -64.8 -31.56 72.84 Favored 'General case' 0 N--CA 1.436 -1.144 0 O-C-N 123.555 0.534 . . . . 0.0 111.878 -177.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 128' ' ' MET . 49.4 mt -77.33 -49.5 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.568 ' HA ' ' CA ' ' A' ' 128' ' ' MET . . . -66.95 -43.78 82.25 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -177.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 121' ' ' TYR . 8.1 p -65.21 -26.24 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.075 0.464 . . . . 0.0 110.079 -177.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.1 t -79.49 -62.17 1.77 Allowed 'General case' 0 N--CA 1.416 -2.167 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.418 ' H ' HD23 ' A' ' 127' ' ' LEU . 1.4 pt? -125.71 -64.19 1.08 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.886 176.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.568 ' CA ' ' HA ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER 173.84 151.21 0.09 Allowed 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 103.352 -2.833 . . . . 0.0 103.352 178.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.486 ' N ' ' SD ' ' A' ' 128' ' ' MET . 83.5 mttt -51.4 -51.25 56.3 Favored 'General case' 0 CA--C 1.465 -2.323 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 34.7 t70 174.54 -38.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 125.55 1.782 . . . . 0.0 111.555 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.609 ' HA ' ' CE ' ' A' ' 131' ' ' MET 0.33 2.7 mmt 64.05 99.16 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -171.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 84.4 m -156.03 179.87 8.8 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 173.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.461 ' CA ' ' HA ' ' A' ' 169' ' ' SER . 35.3 p -117.49 102.04 8.87 Favored 'General case' 0 N--CA 1.392 -3.354 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 172.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.6 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 19.2 t70 87.65 97.66 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.827 1.651 . . . . 0.0 110.907 -175.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.452 ' CZ2' HD22 ' A' ' 167' ' ' LEU . 6.9 p90 -156.21 159.46 38.96 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -122.08 151.24 41.1 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.4 pp -132.73 158.69 43.34 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -74.62 99.36 3.63 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.897 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.47 ' HE1' ' CD2' ' A' ' 87' ' ' LEU . 17.7 t80 -112.96 157.84 20.99 Favored 'General case' 0 N--CA 1.416 -2.127 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.15 176.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -164.26 159.16 19.69 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 171.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.567 HD13 HG12 ' A' ' 143' ' ' ILE . 1.0 OUTLIER -125.98 152.67 45.38 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.548 177.087 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.1 111.16 14.35 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 169.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.567 HG12 HD13 ' A' ' 141' ' ' LEU . 35.0 mm -115.23 140.7 35.28 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.988 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -119.98 104.04 0.99 Allowed Glycine 0 N--CA 1.434 -1.443 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.224 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 156' ' ' THR . 4.3 mm? -72.72 108.41 5.7 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 122.551 0.341 . . . . 0.0 110.573 177.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 82' ' ' GLN . 43.0 m -101.57 108.58 20.18 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-O 121.384 0.612 . . . . 0.0 110.251 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.459 ' CE2' ' HB3' ' A' ' 145' ' ' LEU . 68.2 m-85 -109.41 136.1 49.38 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.258 3.9 p30 -115.89 110.21 18.68 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 122.233 1.016 . . . . 0.0 110.521 175.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 67.3 mt -117.33 122.31 31.19 Favored Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.36 -19.81 18.29 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 123.713 2.942 . . . . 0.0 113.629 -176.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 62.1 t -72.17 -34.41 49.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.143 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 9.2 p -123.28 -34.39 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 121.82 -153.7 16.74 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -95.34 116.37 28.68 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.407 HD12 ' O ' ' A' ' 155' ' ' ILE . 2.3 pp -126.82 134.01 67.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 55.6 m -111.06 112.12 23.7 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.478 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.9 mp -85.8 117.45 68.75 Favored Pre-proline 0 C--O 1.238 0.471 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -82.37 120.05 3.18 Favored 'Trans proline' 0 CA--C 1.484 -2.001 0 C-N-CA 122.31 2.006 . . . . 0.0 111.496 175.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.554 HG22 HG22 ' A' ' 49' ' ' VAL . 3.1 p -126.95 114.98 39.8 Favored 'Isoleucine or valine' 1 N--CA 1.376 -4.135 0 CA-C-N 112.768 -2.015 . . . . 0.0 109.137 -178.321 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 33.3 p -127.05 162.53 25.82 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.304 -173.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.0 t -169.27 155.22 6.27 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -102.26 141.15 35.56 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -147.11 155.25 26.44 Favored Glycine 0 N--CA 1.422 -2.25 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -101.77 129.99 48.09 Favored 'General case' 0 C--N 1.273 -2.74 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.333 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.432 HD11 HG21 ' A' ' 52' ' ' VAL . 37.1 mm -97.86 108.43 21.8 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.641 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 174.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -105.56 114.35 28.46 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 134' ' ' ASP . 3.3 mp -104.25 105.6 49.99 Favored Pre-proline 0 C--N 1.307 -1.272 0 O-C-N 123.633 0.583 . . . . 0.0 110.459 -174.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -73.37 99.0 1.07 Allowed 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.749 2.299 . . . . 0.0 112.354 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.461 ' HA ' ' CA ' ' A' ' 133' ' ' THR . 47.6 t 64.37 -82.27 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 125.972 1.709 . . . . 0.0 113.624 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.483 ' HB3' ' HB3' ' A' ' 173' ' ' PHE . 42.7 mt 62.66 -72.65 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.695 1.598 . . . . 0.0 112.517 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 64.45 -68.25 0.1 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.125 1.77 . . . . 0.0 111.71 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -100.08 10.37 41.37 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.404 -0.81 . . . . 0.0 110.101 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.483 ' HB3' ' HB3' ' A' ' 170' ' ' LEU . 22.2 t80 . . . . . 0 C--N 1.3 -1.585 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -177.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 120.836 0.351 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.572 ' O ' ' HG3' ' A' ' 18' ' ' GLU . 9.8 pt-20 -58.25 -42.96 87.56 Favored 'General case' 0 C--O 1.206 -1.229 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.95 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.5 ' C ' ' HD2' ' A' ' 15' ' ' LYS . 3.3 tmmm? -72.02 -40.75 68.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.476 0.655 . . . . 0.0 110.004 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.7 t -61.89 -44.57 99.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.802 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.47 HG21 ' HA ' ' A' ' 95' ' ' ALA . 13.3 p -71.22 -27.7 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.99 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.572 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 47.0 mt-10 -75.64 -39.28 57.98 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.204 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.06 -37.94 89.25 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 120.7 0.286 . . . . 0.0 110.572 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -67.1 -45.48 77.08 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.959 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.59 -36.95 72.39 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.11 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.9 t -63.05 -44.9 94.56 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.445 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.06 -42.02 94.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 121.308 0.575 . . . . 0.0 110.072 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.3 mm -68.1 -44.59 84.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.391 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.44 ' HA ' HD12 ' A' ' 28' ' ' LEU . 23.2 t -61.72 -41.58 97.81 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.576 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.8 t -57.34 -37.12 72.05 Favored 'General case' 0 C--O 1.247 0.944 0 C-N-CA 122.9 0.48 . . . . 0.0 110.642 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 tt -73.7 -45.64 51.11 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 25' ' ' SER . 86.3 mt -54.1 -45.5 71.84 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.175 0.59 . . . . 0.0 111.074 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -53.86 -45.42 70.97 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -79.09 -31.73 44.44 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.269 -0.972 . . . . 0.0 111.735 -178.216 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.521 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -75.13 -32.05 61.25 Favored 'General case' 0 C--O 1.21 -1.006 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.95 -177.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -58.58 -47.05 85.6 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.045 0.45 . . . . 0.0 111.02 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.49 -32.99 67.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.124 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -74.57 -40.55 61.58 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 122.615 0.366 . . . . 0.0 110.718 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.456 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 48.6 t80 -64.48 -46.24 83.87 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.89 -14.69 63.02 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.045 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.76 -66.88 1.04 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.001 0.905 . . . . 0.0 110.947 -176.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.438 ' HE2' ' HB2' ' A' ' 38' ' ' LYS . 6.6 tppt? -74.51 -39.32 62.47 Favored 'General case' 0 CA--C 1.453 -2.782 0 CA-C-O 122.937 1.351 . . . . 0.0 107.632 -166.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.479 HD13 HD12 ' A' ' 155' ' ' ILE . 71.7 mt -89.66 0.56 56.88 Favored 'General case' 0 C--N 1.255 -3.516 0 CA-C-N 112.118 -2.31 . . . . 0.0 111.507 -171.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.12 -18.26 29.21 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 173.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -104.71 -39.91 6.17 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.187 -1.369 . . . . 0.0 109.782 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 84.1 mt -83.64 126.4 71.15 Favored Pre-proline 0 C--N 1.312 -1.037 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.73 113.08 1.22 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.987 2.458 . . . . 0.0 112.672 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.417 HG21 HD22 ' A' ' 39' ' ' LEU . 8.2 p -140.43 145.59 41.63 Favored Pre-proline 0 C--N 1.299 -1.602 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.115 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.502 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 37.5 Cg_endo -62.96 135.51 51.92 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.649 2.233 . . . . 0.0 111.888 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.27 106.34 17.98 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 -174.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -102.41 143.01 32.7 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 115.023 -0.989 . . . . 0.0 112.796 -173.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.582 ' HA ' HG21 ' A' ' 159' ' ' VAL . 11.8 t -138.32 144.15 40.26 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.002 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.497 ' HB ' HG22 ' A' ' 161' ' ' THR . 50.6 t -91.95 141.75 14.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 172.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -125.75 -46.54 1.71 Allowed 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 117.261 -1.776 . . . . 0.0 114.075 -169.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -173.96 167.11 4.33 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -172.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.548 ' HB ' ' CD2' ' A' ' 64' ' ' TYR . 2.5 m -127.9 126.71 67.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 C-N-CA 123.254 0.622 . . . . 0.0 111.437 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -104.82 144.75 31.34 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 123.766 0.826 . . . . 0.0 111.249 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.561 ' HA ' ' CE1' ' A' ' 64' ' ' TYR . 44.5 p90 -58.85 130.33 46.44 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.538 ' HD3' ' C ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -118.81 -52.06 2.34 Favored 'General case' 0 N--CA 1.391 -3.422 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -175.242 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.442 ' O ' ' HE1' ' A' ' 173' ' ' PHE . . . -145.17 -173.08 16.09 Favored Glycine 0 CA--C 1.472 -2.651 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 177.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.0 m -125.81 129.45 72.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 117.804 0.802 . . . . 0.0 110.177 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.0 m -161.15 135.5 7.11 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.33 154.44 19.22 Favored 'General case' 0 C--N 1.286 -2.186 0 C-N-CA 117.268 -1.773 . . . . 0.0 109.662 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 78.44 15.86 1.25 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 125.47 1.508 . . . . 0.0 111.042 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.407 ' HA3' ' CD2' ' A' ' 121' ' ' TYR . . . 138.16 98.41 0.46 Allowed Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.9 p -103.81 142.55 17.24 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-O 120.94 0.4 . . . . 0.0 111.475 -174.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -76.07 111.73 11.77 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 176.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.561 ' CE1' ' HA ' ' A' ' 54' ' ' PHE . 6.9 t80 -121.02 155.99 33.16 Favored 'General case' 0 N--CA 1.41 -2.47 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -169.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -90.98 108.43 19.86 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -174.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.524 ' HA ' HG12 ' A' ' 52' ' ' VAL . . . -99.42 118.69 36.59 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -94.18 125.05 38.58 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.899 -174.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.1 m -124.56 144.97 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 176.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.2 m -130.12 143.46 50.8 Favored 'General case' 0 C--N 1.268 -2.951 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.336 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.502 ' CG2' ' HB2' ' A' ' 45' ' ' PRO . 7.4 p -141.67 134.33 28.94 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.513 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 20.6 pttp -107.29 119.35 39.16 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.78 0.8 . . . . 0.0 109.843 175.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -106.87 116.3 58.89 Favored Pre-proline 0 C--N 1.28 -2.431 0 CA-C-N 114.015 -1.448 . . . . 0.0 111.495 -174.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -89.43 97.16 0.32 Allowed 'Trans proline' 0 N--CA 1.428 -2.35 0 C-N-CA 121.547 1.498 . . . . 0.0 110.943 173.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.411 ' HB3' ' H ' ' A' ' 76' ' ' GLN . 19.3 m-85 179.64 -169.07 0.11 Allowed 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 128.007 2.523 . . . . 0.0 106.15 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.501 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 48.7 m -135.3 17.37 3.41 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.43 HE21 HG12 ' A' ' 78' ' ' ILE . 23.4 tt0 -112.14 128.92 56.36 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.974 -177.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.5 p -75.29 98.51 3.82 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 173.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.613 ' H ' HD11 ' A' ' 105' ' ' LEU . 69.1 mt -72.22 121.9 85.96 Favored Pre-proline 0 C--N 1.302 -1.462 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.876 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.39 139.69 29.21 Favored 'Trans proline' 0 N--CA 1.44 -1.655 0 C-N-CA 122.264 1.976 . . . . 0.0 111.584 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.637 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -84.42 134.83 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.952 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.458 178.272 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 52.8 t -82.65 -41.36 19.52 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -174.0 154.04 2.23 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.389 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.401 HD13 ' CD ' ' A' ' 102' ' ' PRO . 1.7 mp -114.61 113.86 44.93 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 173.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.443 ' OG ' HG22 ' A' ' 98' ' ' THR . 19.8 m -93.63 117.53 30.21 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -112.47 140.35 47.28 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 2.0 mp -116.94 108.01 23.87 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.887 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 174.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.539 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 1.2 tm? -90.52 120.36 31.55 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 -172.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -125.92 155.96 40.48 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -172.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.4 t -109.59 147.58 32.78 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 112.133 -2.303 . . . . 0.0 105.483 174.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -50.8 -26.26 5.47 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -176.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 87.6 m -149.65 -53.19 0.16 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -106.55 120.71 42.66 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -170.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 27.5 m 72.42 132.45 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.908 1.283 . . . . 0.0 114.306 173.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.442 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.7 pp -135.03 165.37 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.539 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . . . -119.98 156.64 30.47 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 174.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 27.2 t -160.43 148.41 16.4 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.44 165.45 35.27 Favored Glycine 0 N--CA 1.426 -1.973 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.443 HG22 ' OG ' ' A' ' 84' ' ' SER . 68.3 p -115.62 120.4 39.27 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 61.2 mt -101.87 119.81 55.87 Favored Pre-proline 0 C--N 1.305 -1.331 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.623 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.73 124.7 5.22 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.805 2.336 . . . . 0.0 111.723 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.4 ' HA ' HD11 ' A' ' 80' ' ' ILE . 30.2 t70 52.1 72.08 1.3 Allowed Pre-proline 0 N--CA 1.481 1.099 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.401 ' CD ' HD13 ' A' ' 83' ' ' ILE . 55.9 Cg_endo -103.75 6.19 0.34 Allowed 'Trans proline' 0 N--CA 1.435 -1.944 0 C-N-CA 122.768 2.312 . . . . 0.0 111.595 173.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 156.26 135.04 1.9 Allowed Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.3 m -111.89 146.73 37.21 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.771 0.319 . . . . 0.0 110.397 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.613 HD11 ' H ' ' A' ' 78' ' ' ILE . 3.3 pp -80.41 146.33 31.52 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.78 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 27.5 m -54.84 -46.09 75.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 136.93 -43.28 1.24 Allowed Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.501 ' OG ' ' HA ' ' A' ' 75' ' ' SER . 28.9 m -136.17 115.91 13.02 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 122.164 0.186 . . . . 0.0 111.276 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 105.38 -167.21 14.69 Favored Glycine 0 C--N 1.306 -1.098 0 C-N-CA 120.242 -0.98 . . . . 0.0 114.118 172.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.424 ' OG1' ' HB3' ' A' ' 71' ' ' LYS . 42.1 m -84.62 121.17 27.26 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 121.409 0.623 . . . . 0.0 110.373 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.432 HG21 ' HB2' ' A' ' 105' ' ' LEU . 5.5 t -125.94 138.22 53.75 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.5 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.3 m -94.27 128.69 45.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.412 0.625 . . . . 0.0 110.781 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.1 mt -125.56 157.92 35.88 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -143.54 141.18 30.61 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.476 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 43.0 t -112.3 130.19 23.58 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -77.61 109.89 2.85 Favored 'Trans proline' 0 N--CA 1.419 -2.862 0 N-CA-C 107.578 -1.739 . . . . 0.0 107.578 169.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.6 m -113.17 151.6 15.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -87.22 101.29 13.38 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.406 HG22 ' HB2' ' A' ' 64' ' ' TYR . 21.6 m -93.06 146.89 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.485 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -177.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 69.35 3.56 4.2 Favored 'General case' 0 C--O 1.205 -1.238 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.597 -178.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.407 ' CD2' ' HA3' ' A' ' 61' ' ' GLY . 8.3 t80 -67.86 -37.62 82.07 Favored 'General case' 0 C--O 1.203 -1.349 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.5 p -79.27 -29.87 42.76 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.327 0.585 . . . . 0.0 110.271 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.0 mt -79.88 -50.95 17.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.08 -174.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.35 -38.97 85.69 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 123.339 0.656 . . . . 0.0 111.028 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 121' ' ' TYR . 25.1 t -71.5 -36.34 60.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.924 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.0 t -85.01 -69.19 0.67 Allowed 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.936 -176.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.515 ' H ' HD23 ' A' ' 127' ' ' LEU . 1.9 pt? -125.09 -29.26 3.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -172.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 68.31 166.86 0.26 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.707 0.765 . . . . 0.0 112.904 -173.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.433 ' N ' ' HD3' ' A' ' 129' ' ' LYS . 1.9 mppt? -101.66 -66.31 0.93 Allowed 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 177.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 162.49 -24.85 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 -177.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.9 tpt 65.52 93.11 0.07 Allowed 'General case' 0 C--N 1.347 0.461 0 CA-C-N 112.819 -1.991 . . . . 0.0 112.367 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.55 ' HB2' ' HB2' ' A' ' 135' ' ' TRP . 77.2 m -95.1 149.79 20.9 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.575 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.825 ' HB ' ' OG ' ' A' ' 169' ' ' SER . 22.1 p -82.27 118.49 23.17 Favored 'General case' 1 N--CA 1.339 -6.021 0 C-N-CA 124.89 1.276 . . . . 0.0 107.604 175.318 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 70.57 83.05 0.15 Allowed 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -173.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.55 ' HB2' ' HB2' ' A' ' 132' ' ' CYS . 42.4 t-105 -154.89 143.53 20.65 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.125 -167.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -108.82 144.08 37.16 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 175.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.417 ' CG2' ' HB ' ' A' ' 165' ' ' ILE . 0.0 OUTLIER -139.68 130.51 32.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.53 105.02 16.52 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 122.914 1.34 . . . . 0.0 111.811 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.42 ' HD1' ' O ' ' A' ' 163' ' ' GLY . 0.1 OUTLIER -108.08 161.14 15.23 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 113.826 -1.534 . . . . 0.0 107.954 177.402 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -138.47 158.55 44.06 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 121.42 -0.8 . . . . 0.0 111.079 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.582 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 2.3 pt? -154.53 122.88 6.05 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.857 167.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -102.25 140.29 36.72 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 158' ' ' PRO . 46.7 mt -125.28 149.17 29.77 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 C-N-CA 120.321 -0.551 . . . . 0.0 111.702 -173.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -119.41 89.94 0.47 Allowed Glycine 0 N--CA 1.421 -2.363 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 174.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -68.76 107.78 3.16 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.604 ' OG1' HG22 ' A' ' 156' ' ' THR . 11.0 m -92.12 107.94 19.57 Favored 'General case' 0 N--CA 1.421 -1.919 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.068 -176.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -109.25 141.2 41.88 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -109.8 109.92 20.75 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.535 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -115.12 145.98 35.31 Favored Pre-proline 0 C--N 1.314 -0.972 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.181 -178.394 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.63 -14.73 41.75 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.96 2.44 . . . . 0.0 113.159 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 43.4 t -71.7 -43.17 70.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 120.801 0.334 . . . . 0.0 110.667 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 49.0 t -127.81 -66.31 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.215 0.531 . . . . 0.0 110.59 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.454 ' O ' HD13 ' A' ' 149' ' ' ILE . . . 157.85 -139.9 6.68 Favored Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -177.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -90.0 117.52 28.86 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.722 0.772 . . . . 0.0 110.34 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 146' ' ' THR . 21.3 pt -117.35 128.53 74.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.483 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.604 HG22 ' OG1' ' A' ' 146' ' ' THR . 74.4 p -89.56 107.22 18.96 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 173.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 64.5 mt -80.42 112.75 33.67 Favored Pre-proline 0 C--N 1.295 -1.799 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 74.3 Cg_endo -82.17 151.81 16.03 Favored 'Trans proline' 0 CA--C 1.477 -2.346 0 C-N-CA 122.379 2.053 . . . . 0.0 112.804 -178.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.582 HG21 ' HA ' ' A' ' 48' ' ' THR . 2.7 p -161.7 123.15 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.387 -3.591 0 CA-C-N 112.721 -2.036 . . . . 0.0 108.149 -173.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 79.8 p -131.61 134.41 45.99 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.156 0.503 . . . . 0.0 111.716 -176.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.497 HG22 ' HB ' ' A' ' 49' ' ' VAL . 9.0 t -168.69 177.96 4.9 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 176.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -100.1 166.35 11.06 Favored 'General case' 0 N--CA 1.416 -2.156 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.213 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.42 ' O ' ' HD1' ' A' ' 139' ' ' TYR . . . -130.03 113.92 1.56 Allowed Glycine 0 N--CA 1.408 -3.199 0 N-CA-C 107.691 -2.164 . . . . 0.0 107.691 176.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -88.96 128.75 35.7 Favored 'General case' 0 C--N 1.262 -3.214 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -177.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.417 ' HB ' ' CG2' ' A' ' 137' ' ' ILE . 29.6 mm -97.18 114.03 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.064 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.615 ' HD2' ' H ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -86.58 99.07 11.44 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 114.317 -1.31 . . . . 0.0 109.435 -178.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 90.3 mt -103.01 106.09 49.0 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 114.877 -1.056 . . . . 0.0 113.224 -173.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 166' ' ' LYS . 10.2 Cg_exo -75.67 -177.85 3.88 Favored 'Trans proline' 0 CA--C 1.55 1.305 0 C-N-CA 122.259 1.973 . . . . 0.0 109.586 170.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.825 ' OG ' ' HB ' ' A' ' 133' ' ' THR . 20.2 m -64.43 90.62 0.07 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 175.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.63 -38.39 4.91 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.855 175.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 66.07 -55.78 0.37 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.976 0.91 . . . . 0.0 112.497 -173.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -115.93 99.51 7.33 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.442 ' HE1' ' O ' ' A' ' 56' ' ' GLY . 53.7 t80 . . . . . 0 N--CA 1.478 0.969 0 C-N-CA 123.545 0.738 . . . . 0.0 111.052 -174.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.455 ' HA ' HG22 ' A' ' 16' ' ' VAL . 23.3 t70 . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 120.755 0.312 . . . . 0.0 110.745 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 18' ' ' GLU . 1.2 mp0 -59.44 -40.09 85.66 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.704 175.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -66.96 -55.85 12.76 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.068 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.455 HG22 ' HA ' ' A' ' 13' ' ' ASP . 33.3 m -58.11 -39.66 73.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.042 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 p -66.69 -39.8 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.676 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 45.3 mt-10 -65.56 -39.22 91.44 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.4 ' HG2' ' HA ' ' A' ' 16' ' ' VAL . 13.1 pt-20 -74.29 -38.01 63.49 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.428 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 16' ' ' VAL . 75.1 mmtt -64.99 -45.49 85.42 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.832 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.544 ' HB2' HD11 ' A' ' 94' ' ' ILE . . . -58.04 -41.59 83.56 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.159 178.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.2 t -56.44 -44.34 80.37 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 123.836 0.71 . . . . 0.0 110.073 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.7 t -73.97 -51.14 25.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.555 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.5 mt -57.83 -48.22 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.836 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.7 t -62.32 -35.16 78.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.609 0.243 . . . . 0.0 110.51 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.3 m -71.63 -21.3 61.85 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.319 0.581 . . . . 0.0 110.907 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.606 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 6.6 tt -79.82 -41.15 27.01 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.439 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 6.2 mp -65.61 -33.18 75.31 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 118.824 -1.15 . . . . 0.0 108.553 173.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -57.9 -37.15 73.48 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.146 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -70.81 -30.76 67.29 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.471 0.653 . . . . 0.0 110.582 179.407 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.492 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -78.67 -32.07 46.95 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.276 -177.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 98.5 mttt -48.49 -46.42 38.2 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.164 0.586 . . . . 0.0 111.988 -178.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.98 -33.57 84.4 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.207 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -81.47 -45.65 15.69 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 49.6 t80 -62.18 -51.92 65.87 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -175.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.6 -44.79 62.96 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -174.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -117.05 -38.87 3.31 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -177.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.15 -32.17 15.93 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.9 -164.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 83.8 mt -85.27 -11.44 54.79 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.33 -178.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.3 -29.82 71.07 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.118 0.485 . . . . 0.0 111.368 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -105.89 16.85 24.56 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.442 0.639 . . . . 0.0 110.099 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.5 mt -127.31 124.61 23.75 Favored Pre-proline 0 C--N 1.309 -1.179 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -57.87 96.38 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.402 2.068 . . . . 0.0 112.782 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.9 p -128.43 144.49 52.17 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -51.79 120.05 6.52 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.21 1.94 . . . . 0.0 110.941 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.439 ' HB3' ' CG ' ' A' ' 71' ' ' LYS . 35.1 tt0 -96.43 111.62 23.66 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -173.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.84 146.85 35.72 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.216 -173.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.58 ' HA ' HG21 ' A' ' 159' ' ' VAL . 9.7 t -141.04 155.03 46.24 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 176.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.558 HG23 HG22 ' A' ' 159' ' ' VAL . 92.4 t -82.14 141.49 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 173.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -106.95 -56.09 2.24 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -166.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -170.21 -173.68 1.55 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -174.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.639 HG13 ' CD2' ' A' ' 64' ' ' TYR . 89.4 t -136.8 103.41 3.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 C-N-CA 123.342 0.657 . . . . 0.0 109.921 -175.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.433 ' HB3' ' HD3' ' A' ' 55' ' ' LYS . 28.0 m-20 -93.45 104.99 17.1 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.357 177.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.607 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 63.5 t80 -74.62 105.34 5.67 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.611 0.764 . . . . 0.0 109.344 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.607 ' HD2' ' C ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -147.75 116.04 6.57 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.119 0.568 . . . . 0.0 111.165 -176.646 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.11 163.29 15.54 Favored Glycine 0 C--N 1.295 -1.723 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.855 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.2 p -145.13 153.11 14.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.1 t -155.07 -177.28 6.42 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.427 ' NH2' ' HB3' ' A' ' 60' ' ' ASP . 3.2 tmm_? -80.74 -46.94 14.68 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -178.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.427 ' HB3' ' NH2' ' A' ' 59' ' ' ARG . 7.5 p-10 -99.77 95.16 6.74 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.726 0.774 . . . . 0.0 111.156 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.5 -166.14 29.08 Favored Glycine 0 N--CA 1.416 -2.659 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.508 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 81.4 t -143.89 124.72 9.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 178.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -68.04 137.84 55.36 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.248 0.546 . . . . 0.0 110.992 -178.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.714 ' CD1' ' HB ' ' A' ' 119' ' ' VAL . 29.4 p90 -144.3 167.05 23.38 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 172.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 39.2 m-70 -103.5 114.32 28.51 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -77.57 106.02 9.09 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 178.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.401 ' HE2' ' HB ' ' A' ' 112' ' ' VAL . 19.9 tptm -87.8 125.74 34.61 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.867 -171.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 49' ' ' VAL . 33.7 m -133.98 144.66 34.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.5 p -122.95 132.2 54.05 Favored 'General case' 0 C--N 1.282 -2.333 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.073 177.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.1 t -126.02 134.32 66.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.481 -174.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 22.1 ptmt -105.89 146.65 29.69 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 173.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.64 ' O ' ' HA ' ' A' ' 108' ' ' SER . 46.7 t-20 -128.51 121.96 21.54 Favored Pre-proline 0 C--N 1.28 -2.417 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.972 -173.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -98.46 96.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.568 0 C-N-CA 121.582 1.521 . . . . 0.0 109.549 167.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.459 ' HB2' ' OD1' ' A' ' 72' ' ' ASN . 26.1 m-85 175.77 179.58 0.16 Allowed 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 128.727 2.811 . . . . 0.0 105.356 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.3 t -126.02 5.58 7.23 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 120.316 -0.554 . . . . 0.0 109.699 176.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -100.95 140.16 35.63 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.869 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 63.1 m -76.7 97.87 4.59 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 171.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 64.9 mt -72.83 124.69 91.03 Favored Pre-proline 0 C--N 1.307 -1.279 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.719 -177.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -69.38 127.7 15.29 Favored 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 121.817 1.678 . . . . 0.0 109.38 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 58.1 mt -80.72 113.88 20.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 100' ' ' PRO . 49.6 t -56.2 -53.02 62.14 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.635 -178.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -167.8 162.4 13.73 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.595 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 98' ' ' THR . 13.4 tt -124.11 115.31 44.52 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 175.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.413 ' HB3' HG22 ' A' ' 98' ' ' THR . 65.5 p -94.08 118.1 31.05 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -108.41 135.09 50.28 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.307 178.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.411 ' HB ' ' HB3' ' A' ' 142' ' ' ASP . 2.9 mp -118.27 111.32 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 175.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.546 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -91.67 120.99 32.92 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 140' ' ' GLN . 39.6 ttmt -123.54 139.38 54.07 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.407 -177.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.547 ' OG ' ' HB2' ' A' ' 122' ' ' SER . 49.5 m -115.42 145.13 42.85 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.806 176.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.6 113.42 2.69 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.282 -176.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.7 m 69.23 9.81 7.51 Favored 'General case' 0 CA--C 1.57 1.718 0 C-N-CA 124.408 1.083 . . . . 0.0 112.252 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -121.46 -170.79 2.09 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 121.502 -0.748 . . . . 0.0 111.098 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.0 t -74.51 -172.96 1.63 Allowed 'General case' 0 C--O 1.253 1.277 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.546 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.6 pp -138.07 168.44 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -176.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . . . -119.09 140.62 49.78 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.7 p -141.25 140.33 33.89 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.689 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -165.63 153.35 23.3 Favored Glycine 0 N--CA 1.434 -1.498 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.416 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 27.2 p -118.28 122.6 43.32 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 178.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.416 HD12 ' N ' ' A' ' 99' ' ' ILE . 3.2 mp -102.91 108.26 57.8 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 118.301 -1.359 . . . . 0.0 109.717 176.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 98' ' ' THR . 11.7 Cg_exo -71.93 118.25 5.54 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.213 1.942 . . . . 0.0 109.389 174.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.9 t70 62.04 81.89 0.23 Allowed Pre-proline 0 N--CA 1.472 0.673 0 O-C-N 124.235 0.959 . . . . 0.0 111.577 -174.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -104.63 11.35 0.25 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.474 2.783 . . . . 0.0 110.461 176.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.1 -167.44 26.84 Favored Glycine 0 N--CA 1.422 -2.256 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 46.1 p -151.75 169.49 22.08 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 117.434 0.617 . . . . 0.0 110.641 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.587 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -115.56 131.41 56.94 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.338 0.589 . . . . 0.0 112.085 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.0 29.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 126.432 1.893 . . . . 0.0 115.087 -171.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.639 ' O ' ' HB3' ' A' ' 72' ' ' ASN . . . 71.79 -150.39 46.21 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.129 -177.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 29.7 p -54.42 90.04 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 124.498 1.119 . . . . 0.0 113.657 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 170.9 -166.4 39.59 Favored Glycine 0 CA--C 1.478 -2.262 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 174.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -119.51 135.9 54.57 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.425 HG21 ' HA ' ' A' ' 105' ' ' LEU . 5.0 t -134.58 137.88 44.12 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.105 -178.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.401 ' HB ' ' HE2' ' A' ' 67' ' ' LYS . 27.8 m -91.26 124.2 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.832 177.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.3 mt -120.91 158.9 26.66 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.437 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 4.9 p-10 -147.36 148.47 31.38 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 177.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.6 p -130.54 136.15 28.51 Favored Pre-proline 0 C--N 1.292 -1.897 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.817 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.45 130.5 21.14 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.875 2.383 . . . . 0.0 112.637 178.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.487 HG13 ' CZ ' ' A' ' 64' ' ' TYR . 1.8 p -161.48 150.55 4.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 124.157 0.983 . . . . 0.0 109.262 178.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 13.3 mptt -88.93 133.76 34.19 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.966 0.413 . . . . 0.0 111.708 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.714 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 12.8 p -95.12 145.75 7.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 68.87 0.74 2.84 Favored 'General case' 0 C--O 1.216 -0.694 0 C-N-CA 124.426 1.09 . . . . 0.0 112.482 175.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -49.85 -46.47 51.42 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.784 1.233 . . . . 0.0 111.144 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.547 ' HB2' ' OG ' ' A' ' 89' ' ' SER . 17.0 m -69.75 -38.54 76.84 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.166 -175.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.499 HD13 ' HA ' ' A' ' 129' ' ' LYS . 19.7 tt -80.25 -27.46 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 O-C-N 121.94 -0.475 . . . . 0.0 111.342 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.649 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -52.63 -51.57 59.45 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 124.207 1.003 . . . . 0.0 112.046 177.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.5 m -61.32 -21.88 26.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -175.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.8 m -95.79 -78.08 0.46 Allowed 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 120.746 -0.382 . . . . 0.0 112.004 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.558 ' H ' HD23 ' A' ' 127' ' ' LEU . 2.1 pt? -120.72 -0.89 10.1 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.554 -174.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.649 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 25.1 ttt 53.55 76.03 0.23 Allowed 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 124.159 0.984 . . . . 0.0 112.107 -178.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.771 ' HE2' ' SD ' ' A' ' 131' ' ' MET . 55.4 pttt 54.77 -74.25 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 126.591 1.956 . . . . 0.0 113.021 -177.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 36.6 t70 161.56 81.54 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 101.223 -3.621 . . . . 0.0 101.223 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.771 ' SD ' ' HE2' ' A' ' 129' ' ' LYS . 8.9 tpt -56.01 110.96 0.82 Allowed 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -166.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.573 ' SG ' ' HB2' ' A' ' 135' ' ' TRP . 7.1 p -147.09 -176.08 5.07 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 113.707 -1.588 . . . . 0.0 108.874 176.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.637 HG22 ' CB ' ' A' ' 169' ' ' SER . 5.6 m -126.59 107.58 10.34 Favored 'General case' 1 N--CA 1.367 -4.578 0 N-CA-C 103.145 -2.909 . . . . 0.0 103.145 -170.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 168' ' ' PRO . 28.9 t70 84.51 101.01 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 125.139 1.376 . . . . 0.0 108.343 -171.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.573 ' HB2' ' SG ' ' A' ' 132' ' ' CYS . 4.8 t-105 -163.94 136.17 4.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.232 -166.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -105.12 145.7 30.19 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.9 tt -155.28 151.08 10.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -114.7 123.25 48.81 Favored 'General case' 0 CA--C 1.498 -1.029 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.789 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -105.09 172.73 6.63 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 88' ' ' LYS . 49.0 mt-30 -119.35 139.96 51.12 Favored 'General case' 0 C--N 1.274 -2.713 0 O-C-N 121.178 -0.951 . . . . 0.0 111.864 -175.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.43 HD11 HD11 ' A' ' 143' ' ' ILE . 25.8 tp -128.45 130.69 47.94 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.697 -178.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.551 ' OD1' ' HB3' ' A' ' 160' ' ' SER . 21.5 t70 -135.41 123.97 23.58 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 141' ' ' LEU . 37.2 mm -115.01 148.41 17.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -121.54 99.1 0.68 Allowed Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 174.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.441 ' HB3' ' CE2' ' A' ' 147' ' ' PHE . 2.9 mm? -79.22 114.78 18.43 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.472 ' OG1' HG22 ' A' ' 156' ' ' THR . 8.2 m -96.36 108.3 20.8 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.441 ' CE2' ' HB3' ' A' ' 145' ' ' LEU . 75.4 m-85 -116.57 146.89 42.33 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -103.28 130.62 50.58 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.532 0.682 . . . . 0.0 110.123 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.01 130.0 16.16 Favored Pre-proline 0 C--N 1.291 -1.967 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -59.41 -21.57 61.8 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 C-N-CA 123.373 2.715 . . . . 0.0 113.668 -172.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.427 HG13 HG23 ' A' ' 152' ' ' VAL . 7.1 p -67.87 -28.27 40.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.598 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.427 HG23 HG13 ' A' ' 151' ' ' VAL . 97.2 t -134.37 -44.79 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.559 0.695 . . . . 0.0 110.613 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 118.79 -115.97 3.24 Favored Glycine 0 C--N 1.29 -1.983 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -174.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -102.32 117.64 35.17 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.081 0.467 . . . . 0.0 112.133 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.546 HD12 ' O ' ' A' ' 155' ' ' ILE 0.265 2.6 pp -123.59 118.57 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-O 121.316 0.579 . . . . 0.0 110.941 170.459 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.472 HG22 ' OG1' ' A' ' 146' ' ' THR . 23.3 p -85.85 108.88 18.34 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.677 177.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 68.5 mt -76.41 114.64 40.13 Favored Pre-proline 0 C--N 1.292 -1.932 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.768 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -82.98 137.22 8.48 Favored 'Trans proline' 0 CA--C 1.475 -2.452 0 C-N-CA 122.849 2.366 . . . . 0.0 111.954 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.58 HG21 ' HA ' ' A' ' 48' ' ' THR . 5.7 p -149.52 112.98 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.38 -3.962 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.096 -174.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.551 ' HB3' ' OD1' ' A' ' 142' ' ' ASP . 58.3 p -120.49 155.36 33.75 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.599 -177.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.3 t -163.0 171.79 15.99 Favored 'General case' 0 C--O 1.255 1.358 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -99.43 126.89 45.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -94.09 85.86 1.06 Allowed Glycine 0 N--CA 1.413 -2.885 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -88.5 119.55 29.05 Favored 'General case' 0 N--CA 1.42 -1.972 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 8.4 pt -140.11 177.07 4.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.542 -171.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.476 ' HD2' ' H ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -130.19 143.83 51.01 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.447 -176.326 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.0 mp -125.59 97.98 35.41 Favored Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 171.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.626 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 33.1 Cg_endo -64.06 170.11 9.52 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.613 2.209 . . . . 0.0 111.332 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.637 ' CB ' HG22 ' A' ' 133' ' ' THR . 26.5 p -40.37 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 173.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 168' ' ' PRO . 3.5 pp -162.01 132.12 4.77 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.951 177.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.429 ' NH2' ' HA ' ' A' ' 132' ' ' CYS . 64.9 mtt180 -132.86 85.67 2.24 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 172.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 23.9 t70 177.19 -38.34 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 O-C-N 123.835 0.709 . . . . 0.0 110.608 -174.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 CA--C 1.49 -1.333 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 176.564 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.648 ' O ' HG23 ' A' ' 17' ' ' VAL . 38.6 t70 . . . . . 0 CA--C 1.511 -0.539 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -58.79 -39.96 82.64 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.188 175.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 40.4 tttp -64.13 -56.9 11.56 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.698 176.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.594 HG22 ' HA ' ' A' ' 13' ' ' ASP . 25.6 m -58.96 -24.65 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 13' ' ' ASP . 67.2 t -67.26 -50.23 64.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 172.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -62.34 -30.12 70.94 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.336 -177.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.509 ' CG ' ' HA ' ' A' ' 16' ' ' VAL . 40.0 mm-40 -54.77 -52.15 63.48 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.624 176.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -78.49 -31.37 47.75 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 120.109 -0.636 . . . . 0.0 111.908 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.9 -42.79 80.55 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 123.271 0.357 . . . . 0.0 110.19 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.2 t -59.43 -41.72 90.2 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.667 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 67.2 t -66.93 -49.39 74.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-O 120.836 0.35 . . . . 0.0 110.45 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.526 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 68.0 mt -60.89 -42.77 93.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.22 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.8 m -65.58 -32.51 74.14 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.38 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.8 t -71.44 -34.67 70.48 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.542 HD22 ' OG1' ' A' ' 156' ' ' THR . 3.2 tt -65.84 -41.89 91.19 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 176.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 83.4 mt -57.77 -38.71 75.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.116 177.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -61.16 -41.98 97.73 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 27' ' ' LEU . 65.6 pttt -71.81 -38.81 70.15 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.838 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.05 -31.76 68.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.25 -176.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -62.58 -42.2 99.41 Favored 'General case' 0 C--O 1.246 0.888 0 CA-C-O 121.023 0.44 . . . . 0.0 110.809 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.95 -33.56 36.5 Favored Glycine 0 CA--C 1.51 -0.281 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.411 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 7.4 t80 -57.17 -46.31 82.9 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.617 ' HA ' HD13 ' A' ' 39' ' ' LEU . 10.5 t80 -52.9 -53.31 51.06 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.066 1.347 . . . . 0.0 111.326 174.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.37 -33.22 58.71 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -174.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -99.15 -64.25 1.05 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.281 0.562 . . . . 0.0 112.457 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.3 mtmm -79.95 -22.45 42.62 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -169.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.617 HD13 ' HA ' ' A' ' 35' ' ' PHE . 5.7 mp -98.86 6.96 46.53 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-O 121.679 0.752 . . . . 0.0 109.805 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.95 -35.72 11.88 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -90.48 -18.21 25.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.398 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.8 mt -115.12 112.95 44.01 Favored Pre-proline 0 C--N 1.309 -1.194 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.6 97.36 0.88 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.187 1.925 . . . . 0.0 113.076 -176.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.3 p -93.01 159.34 35.86 Favored Pre-proline 0 N--CA 1.43 -1.43 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.982 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.05 147.35 90.68 Favored 'Trans proline' 0 C--O 1.239 0.556 0 C-N-CA 122.946 2.43 . . . . 0.0 111.596 174.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 38.4 tt0 -110.27 109.63 20.15 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.45 138.42 35.69 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.581 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.8 t -135.14 129.23 33.53 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.318 0.58 . . . . 0.0 110.957 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.539 ' H ' HG11 ' A' ' 159' ' ' VAL . 48.1 t -105.48 141.01 21.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 177.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -158.08 -31.96 0.07 Allowed 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -170.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -145.69 151.65 38.37 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 118.923 -1.111 . . . . 0.0 111.755 -171.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.462 HG12 ' HB2' ' A' ' 66' ' ' ALA . 28.9 m -124.28 152.19 29.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 123.433 0.693 . . . . 0.0 110.712 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -114.86 117.0 29.47 Favored 'General case' 0 C--O 1.246 0.888 0 C-N-CA 122.841 0.456 . . . . 0.0 111.802 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -64.69 107.94 1.57 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 167.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 63' ' ' ASP . 14.6 ptmm? -107.05 -16.4 14.44 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.103 -0.639 . . . . 0.0 112.663 -176.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 159.65 -178.51 35.72 Favored Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 119.296 -1.431 . . . . 0.0 112.67 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.88 151.37 18.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 123.22 0.608 . . . . 0.0 110.007 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.4 t -153.19 -176.66 5.88 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -79.16 -53.52 6.9 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -175.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -97.78 80.61 2.79 Favored 'General case' 0 C--N 1.313 -1.015 0 O-C-N 122.167 -0.333 . . . . 0.0 111.683 -176.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.81 120.01 0.13 Allowed Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.146 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.456 HG11 ' O ' ' A' ' 173' ' ' PHE . 33.9 m -70.74 156.34 7.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 121.248 0.547 . . . . 0.0 111.812 -177.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 19.7 m-20 -96.06 126.23 41.15 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.08 -172.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.546 ' CD1' HG11 ' A' ' 119' ' ' VAL . 2.7 m-85 -121.04 122.62 40.47 Favored 'General case' 0 CA--C 1.471 -2.084 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.571 171.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -92.4 108.04 19.66 Favored 'General case' 0 C--N 1.273 -2.727 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.462 ' HB2' HG12 ' A' ' 52' ' ' VAL . . . -93.34 144.84 24.94 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -86.88 133.12 33.65 Favored 'General case' 0 C--O 1.251 1.143 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.734 176.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.462 HG22 HG22 ' A' ' 49' ' ' VAL . 48.6 t -130.97 106.52 12.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 168.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.2 p -106.91 134.84 49.46 Favored 'General case' 0 C--N 1.277 -2.552 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.424 -176.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 4.8 p -132.52 126.54 55.22 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.95 -176.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 89.1 tttt -96.6 119.38 34.98 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 175.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.452 ' HB2' HD12 ' A' ' 105' ' ' LEU . 52.7 t30 -111.45 115.7 51.56 Favored Pre-proline 0 C--N 1.301 -1.51 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.72 -175.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -95.81 96.92 0.1 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.612 0 C-N-CA 121.904 1.736 . . . . 0.0 111.025 172.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -170.19 -166.09 0.52 Allowed 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 126.515 1.926 . . . . 0.0 107.011 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.3 t -142.5 21.13 2.03 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 173.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.564 ' O ' ' HA2' ' A' ' 107' ' ' GLY . 17.2 pt20 -115.14 140.73 48.83 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.412 -178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.3 p -83.15 95.19 8.03 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-O 121.656 0.741 . . . . 0.0 109.308 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.494 ' HB ' HD21 ' A' ' 105' ' ' LEU . 72.5 mt -74.93 122.95 88.6 Favored Pre-proline 0 N--CA 1.433 -1.287 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.726 -176.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 78' ' ' ILE . 4.3 Cg_exo -76.78 122.64 6.45 Favored 'Trans proline' 0 N--CA 1.444 -1.438 0 C-N-CA 122.197 1.932 . . . . 0.0 110.666 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 50.0 mt -88.33 102.82 13.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 62.3 m -57.55 -60.37 3.76 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 124.133 0.895 . . . . 0.0 110.624 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -150.68 157.35 42.85 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-O 121.52 0.676 . . . . 0.0 111.868 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.568 ' HB ' HG23 ' A' ' 99' ' ' ILE . 46.4 mm -107.15 116.94 51.95 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 176.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.0 m -80.78 118.35 22.23 Favored 'General case' 0 N--CA 1.412 -2.375 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -103.06 121.42 42.55 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.992 -170.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' A' ' 142' ' ' ASP . 69.9 mt -134.9 109.8 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.24 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.623 ' O ' HD12 ' A' ' 94' ' ' ILE . 0.9 OUTLIER -113.03 120.61 41.95 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 176.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.569 ' HD2' ' O ' ' A' ' 93' ' ' THR . 53.4 tptt -121.38 135.53 55.06 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.5 m -142.38 145.36 33.79 Favored 'General case' 0 C--O 1.25 1.082 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.55 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 62.28 18.27 10.05 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.119 0.968 . . . . 0.0 111.197 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 m 59.16 14.01 3.3 Favored 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 123.986 0.915 . . . . 0.0 109.888 -175.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -127.63 -65.65 0.91 Allowed 'General case' 0 N--CA 1.432 -1.336 0 O-C-N 121.325 -0.859 . . . . 0.0 111.057 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.569 ' O ' ' HD2' ' A' ' 88' ' ' LYS . 11.1 t -76.92 165.56 24.51 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.823 -172.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.623 HD12 ' O ' ' A' ' 87' ' ' LEU . 3.8 tp -163.38 139.02 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.015 0 C-N-CA 123.195 0.598 . . . . 0.0 109.703 -168.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.11 121.47 26.42 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 171.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 78.0 p -139.76 160.12 40.62 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.292 0.568 . . . . 0.0 111.63 -176.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 167.41 -170.25 41.52 Favored Glycine 0 N--CA 1.417 -2.614 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.3 p -127.86 122.2 31.99 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.568 HG23 ' HB ' ' A' ' 83' ' ' ILE . 10.0 tt -102.86 108.45 58.33 Favored Pre-proline 0 C--N 1.318 -0.771 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.02 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -82.55 146.31 13.51 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 C-N-CA 122.889 2.393 . . . . 0.0 113.63 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 44.75 67.41 4.11 Favored Pre-proline 0 N--CA 1.477 0.911 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -101.24 1.05 0.58 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.465 2.11 . . . . 0.0 111.911 176.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 148.94 -179.0 26.12 Favored Glycine 0 N--CA 1.428 -1.874 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.6 m -150.38 175.72 11.57 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 117.509 0.655 . . . . 0.0 110.708 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.678 ' H ' HD23 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -104.62 131.96 51.43 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.443 0.64 . . . . 0.0 112.654 -175.093 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.2 m -63.59 18.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 -171.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 76' ' ' GLN . . . 85.09 -52.66 4.71 Favored Glycine 0 C--O 1.214 -1.1 0 C-N-CA 120.407 -0.902 . . . . 0.0 113.32 177.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.7 t -148.29 117.17 6.72 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -177.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 133.99 177.37 14.89 Favored Glycine 0 CA--C 1.49 -1.479 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.12 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 9.9 t -96.53 113.35 24.92 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 121.753 0.787 . . . . 0.0 109.421 177.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.9 t -112.28 138.07 49.51 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.376 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 25.0 t -96.94 107.56 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.8 mt -86.8 166.39 15.27 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 178.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -140.43 145.84 37.52 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.396 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.4 t -120.95 128.2 25.87 Favored Pre-proline 0 C--N 1.3 -1.581 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -74.54 109.6 2.94 Favored 'Trans proline' 0 N--CA 1.43 -2.224 0 N-CA-C 106.986 -1.967 . . . . 0.0 106.986 168.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.513 HG11 ' OH ' ' A' ' 139' ' ' TYR . 59.2 t -103.66 127.27 57.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -176.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.472 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 1.2 tpmt? -88.98 91.12 8.71 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.546 HG11 ' CD1' ' A' ' 64' ' ' TYR . 12.1 p -94.03 147.29 5.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.173 -172.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.482 ' HA ' HD12 ' A' ' 123' ' ' ILE . . . 72.47 -5.63 1.77 Allowed 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.211 1.004 . . . . 0.0 111.318 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.419 ' O ' HG23 ' A' ' 125' ' ' VAL . 76.1 t80 -63.55 -54.42 36.39 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.377 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.518 ' HB2' ' OG1' ' A' ' 93' ' ' THR . 13.1 p -63.42 -36.87 85.16 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.922 -176.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 120' ' ' ALA . 52.7 mt -64.6 -49.42 80.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.097 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.74 -36.12 82.67 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 123.484 0.49 . . . . 0.0 110.775 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 121' ' ' TYR . 52.6 t -62.11 -51.4 72.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.514 176.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.6 m -66.74 -73.83 0.13 Allowed 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.5 HD12 ' N ' ' A' ' 128' ' ' MET . 2.0 pp -125.16 -32.14 3.01 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -171.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.5 ' N ' HD12 ' A' ' 127' ' ' LEU . 0.0 OUTLIER 63.37 110.93 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -171.2 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.544 ' HG3' ' HE1' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -68.07 -0.02 4.07 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -171.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 17.8 t70 84.79 -26.41 0.11 Allowed 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 125.624 1.57 . . . . 0.0 110.592 173.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.643 ' HE1' HD13 ' A' ' 167' ' ' LEU . 9.1 tpt 70.89 149.7 0.09 Allowed 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 125.475 1.51 . . . . 0.0 113.47 174.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 72.0 m -153.69 160.76 42.45 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 40.2 p -78.78 125.74 29.78 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 175.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.621 ' H ' ' H ' ' A' ' 169' ' ' SER . 25.4 t70 69.47 89.02 0.1 Allowed 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -176.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.544 ' HE1' ' HG3' ' A' ' 129' ' ' LYS . 54.5 t-105 -158.19 149.79 21.39 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 114.032 -1.44 . . . . 0.0 109.732 -166.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -140.59 149.34 42.24 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.904 0.383 . . . . 0.0 110.386 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.459 HG21 ' CD1' ' A' ' 123' ' ' ILE . 2.9 mp -118.7 141.68 37.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -81.08 102.67 10.39 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 122.048 0.928 . . . . 0.0 109.473 174.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.513 ' OH ' HG11 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -130.69 144.58 51.53 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.251 -177.292 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.42 ' CB ' ' HA ' ' A' ' 162' ' ' GLN . 20.7 pt20 -131.52 157.8 42.6 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 38.2 tp -124.89 123.89 40.89 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.426 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 6.2 m-20 -121.88 120.3 34.12 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.171 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 46.6 mm -120.62 127.76 75.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.891 -178.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -95.6 89.94 1.19 Allowed Glycine 0 N--CA 1.427 -1.903 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 173.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.26 110.69 7.74 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.576 ' OG1' HG22 ' A' ' 156' ' ' THR . 27.8 m -95.89 108.4 20.76 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 120.861 0.363 . . . . 0.0 111.18 -176.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -101.76 132.04 47.72 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 176.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -101.98 109.36 21.07 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 65.0 mt -127.99 114.29 20.38 Favored Pre-proline 0 C--N 1.29 -1.995 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.21 -24.1 32.42 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.841 2.361 . . . . 0.0 113.662 -176.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.38 -36.18 76.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.222 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 10.2 p -125.3 -32.1 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -174.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 120.56 -151.51 17.14 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -101.02 125.18 47.62 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.264 -1.014 . . . . 0.0 108.264 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.455 HG21 HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -132.44 127.64 57.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.472 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.576 HG22 ' OG1' ' A' ' 146' ' ' THR . 74.8 p -91.84 108.95 20.28 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . 51.8 mt -77.77 114.47 41.65 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 157' ' ' ILE . 5.5 Cg_exo -76.58 101.02 1.45 Allowed 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 122.436 2.091 . . . . 0.0 111.587 -178.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.539 HG11 ' H ' ' A' ' 49' ' ' VAL . 18.0 t -101.83 113.18 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 53.1 p -110.14 145.22 37.56 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.194 -175.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.9 t -156.77 113.65 3.08 Favored 'General case' 0 N--CA 1.424 -1.768 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.296 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.42 ' HA ' ' CB ' ' A' ' 140' ' ' GLN . 11.4 pt20 -98.25 119.26 36.6 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -134.77 -130.92 3.02 Favored Glycine 0 N--CA 1.407 -3.284 0 C-N-CA 119.792 -1.194 . . . . 0.0 113.023 -174.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -158.14 133.1 8.52 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 115.219 -0.49 . . . . 0.0 109.918 -171.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.471 HG12 ' HB3' ' A' ' 139' ' ' TYR . 43.2 mm -107.02 108.59 25.56 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 171.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -110.94 128.89 55.98 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 121.791 0.805 . . . . 0.0 111.441 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.643 HD13 ' HE1' ' A' ' 131' ' ' MET . 96.0 mt -118.57 91.48 41.86 Favored Pre-proline 0 N--CA 1.411 -2.39 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.758 -172.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.468 ' O ' HD22 ' A' ' 170' ' ' LEU . 9.1 Cg_exo -71.64 100.82 1.09 Allowed 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.575 2.85 . . . . 0.0 112.992 -177.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.621 ' H ' ' H ' ' A' ' 134' ' ' ASP . 91.3 p 62.9 9.72 3.88 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 126.682 1.993 . . . . 0.0 115.528 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 168' ' ' PRO . 3.5 mm? -71.73 138.66 48.65 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.146 -0.621 . . . . 0.0 111.848 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -142.54 140.99 31.98 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 167.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 37.5 t70 74.85 5.44 4.38 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.385 1.088 . . . . 0.0 110.762 -174.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.468 ' CD1' HD12 ' A' ' 170' ' ' LEU . 78.0 m-85 . . . . . 0 C--N 1.315 -0.932 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.887 174.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 C--O 1.219 -0.506 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.77 -43.77 98.19 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.826 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -63.86 -50.69 67.83 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.388 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.4 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 90.2 t -66.29 -44.63 91.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 114.979 -1.009 . . . . 0.0 113.354 -176.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.0 p -64.19 -26.59 40.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -75.45 -44.01 46.5 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.571 -177.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.49 ' O ' HG23 ' A' ' 23' ' ' VAL . 10.8 pt-20 -64.0 -40.25 95.95 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.649 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -65.85 -40.68 91.93 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.375 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.69 -42.7 99.29 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.179 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.8 t -61.76 -41.85 98.22 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.979 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 19' ' ' GLU . 93.5 t -60.75 -49.63 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.234 0.54 . . . . 0.0 109.779 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.445 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 67.6 mt -67.34 -39.91 83.73 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.768 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.003 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.9 t -61.72 -41.08 97.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.878 0.37 . . . . 0.0 110.105 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 32.6 m -70.34 -32.09 69.66 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.122 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.561 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 4.4 tt -69.84 -47.53 62.35 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 176.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.578 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 96.3 mt -59.95 -32.74 71.08 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.9 0.381 . . . . 0.0 110.152 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' A' ' 26' ' ' SER . 12.4 t70 -57.69 -46.22 84.59 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.893 175.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.561 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -74.77 -33.63 62.32 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.238 0.542 . . . . 0.0 109.757 179.613 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.505 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -62.21 -39.63 93.41 Favored 'General case' 0 C--O 1.204 -1.337 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.729 -178.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 29.0 mtpp -60.76 -33.97 73.76 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.2 -51.1 4.06 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.066 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -61.92 -32.59 73.01 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 123.61 0.764 . . . . 0.0 112.592 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.443 ' HD1' HD12 ' A' ' 39' ' ' LEU . 49.0 t80 -72.62 -34.95 67.69 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 121.905 -0.497 . . . . 0.0 110.637 175.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.72 -27.33 58.12 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.731 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 38' ' ' LYS . 10.7 pt-20 -98.35 -49.32 4.72 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.437 ' N ' ' HG3' ' A' ' 37' ' ' GLU . 14.5 tppt? -76.84 -47.15 22.22 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 122.13 0.967 . . . . 0.0 109.333 -170.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.443 HD12 ' HD1' ' A' ' 35' ' ' PHE . 42.1 mt -89.36 16.93 6.68 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.45 -175.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.22 -20.21 19.41 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 172.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -97.69 -35.11 10.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.66 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.5 mt -103.47 118.56 57.35 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.078 -177.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.95 112.24 2.88 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.542 2.161 . . . . 0.0 111.092 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.423 ' HB ' ' CD ' ' A' ' 45' ' ' PRO . 4.0 p -116.88 171.22 5.04 Favored Pre-proline 0 C--N 1.301 -1.52 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.263 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.448 ' HB3' ' CB ' ' A' ' 72' ' ' ASN . 7.9 Cg_exo -72.95 145.97 41.04 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.477 2.118 . . . . 0.0 112.516 -177.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -97.75 119.02 35.58 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.999 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.21 141.28 37.01 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.1 t -136.46 143.03 43.64 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.5 t -97.91 132.34 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 175.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -112.69 -60.11 1.92 Allowed 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.059 -1.057 . . . . 0.0 113.745 -169.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -163.88 161.36 22.98 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -172.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.659 HG22 ' HB3' ' A' ' 64' ' ' TYR . 10.0 p -135.49 112.2 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.76 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -106.82 159.03 16.55 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.951 -175.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -71.36 126.81 30.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.419 0.628 . . . . 0.0 112.212 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.449 ' HD2' ' OD2' ' A' ' 63' ' ' ASP . 10.2 tmtt? -110.91 -44.84 3.55 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.352 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -178.5 -176.44 46.4 Favored Glycine 0 CA--C 1.484 -1.897 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 177.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.521 ' HA ' HG23 ' A' ' 62' ' ' VAL . 27.2 m -107.81 148.75 11.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.772 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.4 m -150.78 125.24 9.53 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 174.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -82.71 88.62 6.72 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 122.265 1.031 . . . . 0.0 113.407 -170.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -178.66 37.02 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 102.271 -3.233 . . . . 0.0 102.271 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.82 -133.07 10.63 Favored Glycine 0 N--CA 1.415 -2.723 0 N-CA-C 106.038 -2.825 . . . . 0.0 106.038 -170.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.521 HG23 ' HA ' ' A' ' 57' ' ' VAL . 9.8 p -152.24 136.89 9.84 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 172.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.449 ' OD2' ' HD2' ' A' ' 55' ' ' LYS . 35.3 t70 -85.62 105.04 15.9 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-O 121.629 0.728 . . . . 0.0 112.237 -169.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.659 ' HB3' HG22 ' A' ' 52' ' ' VAL . 3.2 m-85 -109.47 161.61 15.16 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 121.65 0.738 . . . . 0.0 112.144 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 39.2 t60 -102.51 106.44 17.15 Favored 'General case' 0 N--CA 1.413 -2.298 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.631 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . . . -90.22 124.87 35.23 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.801 174.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -100.41 125.27 46.67 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.386 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.0 m -121.44 144.58 30.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.3 m -120.83 136.0 55.02 Favored 'General case' 0 C--N 1.277 -2.581 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.033 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t -129.98 127.73 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-O 121.029 0.442 . . . . 0.0 110.27 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 19.3 ptpt -113.2 143.03 45.08 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 174.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.661 ' O ' ' HA ' ' A' ' 108' ' ' SER . 1.8 p-10 -142.63 138.49 16.27 Favored Pre-proline 0 C--N 1.287 -2.134 0 C-N-CA 118.906 -1.118 . . . . 0.0 110.266 -177.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -99.62 95.4 0.05 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.462 0 C-N-CA 120.852 1.035 . . . . 0.0 110.152 170.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -174.47 138.91 0.55 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.7 m -85.71 -5.3 59.28 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 118.827 0.74 . . . . 0.0 111.182 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -88.19 143.62 26.94 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.381 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.2 p -90.35 102.33 15.06 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.11 0.481 . . . . 0.0 109.902 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.402 ' H ' ' CD2' ' A' ' 105' ' ' LEU . 24.8 mt -92.01 130.25 38.92 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -177.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -75.92 142.5 25.24 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.897 1.731 . . . . 0.0 108.943 171.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.6 HG13 ' HD2' ' A' ' 102' ' ' PRO . 18.3 pt -82.5 102.62 8.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.318 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 6.6 m -43.47 -65.93 0.44 Allowed 'General case' 0 C--O 1.244 0.799 0 C-N-CA 126.945 2.098 . . . . 0.0 113.032 -172.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.525 ' C ' HD12 ' A' ' 83' ' ' ILE . 10.0 pt20 -147.34 150.82 35.49 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.588 HG23 HG23 ' A' ' 143' ' ' ILE . 1.8 mp -120.39 117.97 55.15 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.141 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.8 m -80.08 119.98 23.62 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.477 ' CE2' HG12 ' A' ' 117' ' ' VAL . 4.8 t80 -103.04 120.76 41.24 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.634 -170.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.401 ' HB ' ' HB3' ' A' ' 142' ' ' ASP . 39.8 mm -131.17 108.47 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.529 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 0.2 OUTLIER -106.22 126.98 52.89 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 179.433 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -124.41 147.1 48.49 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.965 -0.694 . . . . 0.0 112.314 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.7 m -151.93 97.9 2.39 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 64.73 -173.03 0.18 Allowed 'General case' 0 CA--C 1.541 0.609 0 O-C-N 123.975 0.797 . . . . 0.0 109.5 -174.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.3 p -98.54 14.55 27.93 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.805 -0.56 . . . . 0.0 111.681 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.6 -65.58 0.99 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.27 -177.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 122' ' ' SER . 35.1 m -130.54 141.3 50.48 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 122.05 -0.406 . . . . 0.0 111.177 -175.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.529 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.8 pp -137.06 168.79 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -178.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.61 147.81 49.17 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 176.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.7 p -144.16 164.81 29.62 Favored 'General case' 0 C--N 1.313 -0.992 0 O-C-N 122.438 -0.164 . . . . 0.0 110.859 -177.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 156.36 -170.57 33.97 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 176.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 35.5 p -132.99 127.39 34.06 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 117.331 0.566 . . . . 0.0 109.721 176.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.462 HG23 ' HB ' ' A' ' 83' ' ' ILE . 11.4 tt -103.36 116.91 61.36 Favored Pre-proline 0 C--N 1.318 -0.796 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.964 177.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -88.63 128.04 2.02 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.973 2.449 . . . . 0.0 113.561 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.2 t70 50.98 72.96 1.07 Allowed Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.6 ' HD2' HG13 ' A' ' 80' ' ' ILE . 84.2 Cg_endo -104.09 18.8 0.16 Allowed 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 123.729 2.953 . . . . 0.0 110.706 174.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.535 ' O ' HG12 ' A' ' 80' ' ' ILE . . . 155.23 172.7 23.15 Favored Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.9 m -145.65 149.12 33.91 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.555 HD13 ' H ' ' A' ' 105' ' ' LEU 0.37 0.0 OUTLIER -81.18 157.62 25.2 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 119.519 -0.873 . . . . 0.0 113.259 179.118 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.4 m -83.53 -3.14 7.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -172.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.97 75.95 0.93 Allowed Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.646 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.661 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 48.8 m 78.91 91.46 0.06 Allowed 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 124.852 1.261 . . . . 0.0 111.756 -178.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 158.55 172.42 25.66 Favored Glycine 0 N--CA 1.425 -2.037 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.42 HG22 ' HB3' ' A' ' 71' ' ' LYS . 45.4 p -100.26 113.42 26.11 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.9 t -124.22 138.75 54.37 Favored 'General case' 0 N--CA 1.42 -1.937 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.333 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.2 m -86.36 134.62 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-O 121.416 0.627 . . . . 0.0 109.837 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.459 HD13 HD13 ' A' ' 80' ' ' ILE . 79.0 mt -125.24 167.01 15.46 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -140.31 148.51 41.5 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.464 -0.895 . . . . 0.0 112.848 -175.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 91.8 t -133.93 122.58 16.5 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 173.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -77.6 109.03 2.68 Favored 'Trans proline' 0 N--CA 1.41 -3.383 0 N-CA-C 108.059 -1.554 . . . . 0.0 108.059 171.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.477 HG12 ' CE2' ' A' ' 85' ' ' TYR . 33.8 m -98.87 149.66 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 177.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -101.99 99.17 9.31 Favored 'General case' 0 C--N 1.273 -2.725 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.2 m -91.72 149.94 3.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.92 -171.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.4 ' HB3' HG12 ' A' ' 62' ' ' VAL . . . 76.05 12.46 2.83 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.282 0.633 . . . . 0.0 110.907 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.561 ' O ' HG23 ' A' ' 125' ' ' VAL . 81.4 t80 -59.88 -39.61 85.9 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 172.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.448 ' HB3' ' HB ' ' A' ' 93' ' ' THR . 16.4 m -58.83 -32.71 69.64 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 122.317 1.056 . . . . 0.0 109.58 178.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.855 HG23 ' HA ' ' A' ' 128' ' ' MET . 1.8 mp -80.58 -48.39 19.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 126.141 1.776 . . . . 0.0 112.803 -175.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.69 -29.37 26.23 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.208 1.003 . . . . 0.0 111.866 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 121' ' ' TYR . 91.6 t -53.7 -19.75 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.849 0 C-N-CA 125.722 1.609 . . . . 0.0 112.307 175.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.2 t 105.17 25.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 127.191 2.196 . . . . 0.0 110.427 -175.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 127' ' ' LEU . 27.7 tp -98.14 1.09 47.14 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.459 175.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.855 ' HA ' HG23 ' A' ' 123' ' ' ILE . 83.8 mtp -30.36 106.54 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 125.979 1.711 . . . . 0.0 111.646 179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.42 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -53.37 -41.62 66.05 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 114.0 -1.454 . . . . 0.0 112.602 -178.107 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.4 t70 176.1 -58.14 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.456 0.473 . . . . 0.0 111.104 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.536 ' SD ' ' HA ' ' A' ' 171' ' ' ARG 0.257 15.7 tpp 65.0 97.07 0.05 OUTLIER 'General case' 0 C--O 1.244 0.775 0 CA-C-O 122.146 0.974 . . . . 0.0 112.817 -173.436 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 45.4 t -141.88 164.43 30.22 Favored 'General case' 0 N--CA 1.415 -2.187 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 34.4 p -73.58 119.5 17.9 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.7 t70 71.81 88.2 0.1 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.25 1.02 . . . . 0.0 108.438 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 41.0 t-105 -160.36 158.64 30.0 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.658 -170.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -143.96 162.16 36.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 118.111 0.414 . . . . 0.0 111.139 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.41 HD12 ' HD2' ' A' ' 129' ' ' LYS . 5.5 tt -140.68 146.43 24.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 C-N-CA 123.442 0.697 . . . . 0.0 109.383 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -88.99 108.13 19.41 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.499 ' HB3' HG12 ' A' ' 165' ' ' ILE . 0.2 OUTLIER -125.58 155.97 39.86 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 124.137 0.975 . . . . 0.0 109.377 -179.222 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.0 pm0 -146.71 148.78 32.35 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.307 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 27.8 tp -121.02 126.72 50.61 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.275 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.401 ' HB3' ' HB ' ' A' ' 86' ' ' ILE . 15.4 t70 -127.94 130.08 47.86 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -176.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.588 HG23 HG23 ' A' ' 83' ' ' ILE . 37.7 mm -130.19 144.25 38.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 121.511 0.672 . . . . 0.0 112.484 -173.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -114.16 92.39 0.6 Allowed Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 172.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.9 121.85 24.7 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -174.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.574 ' OG1' HG22 ' A' ' 156' ' ' THR . 19.1 m -105.95 127.83 53.4 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 120.054 -0.658 . . . . 0.0 112.008 -177.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -121.13 140.28 52.21 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 173.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 154' ' ' ASP . 2.9 p30 -121.54 122.58 40.0 Favored 'General case' 0 CA--C 1.486 -1.514 0 C-N-CA 119.046 -1.062 . . . . 0.0 110.343 175.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 10.3 pt -140.43 143.34 32.63 Favored Pre-proline 0 C--N 1.301 -1.517 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.038 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.75 -5.3 10.15 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 123.472 2.781 . . . . 0.0 112.602 -178.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.16 -25.59 30.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.178 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 5.4 p -161.43 -39.44 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 140.56 -155.51 24.79 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 148' ' ' ASP . 7.1 p-10 -99.02 120.08 38.87 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.298 0.571 . . . . 0.0 109.743 177.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' ' 146' ' ' THR . 50.0 mt -123.35 132.23 71.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.136 -174.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.574 HG22 ' OG1' ' A' ' 146' ' ' THR . 44.1 p -91.0 113.46 25.73 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.425 174.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.0 mp -90.3 117.81 68.31 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -80.28 127.39 6.66 Favored 'Trans proline' 0 CA--C 1.487 -1.832 0 C-N-CA 122.104 1.869 . . . . 0.0 112.036 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.423 HG13 ' HB ' ' A' ' 143' ' ' ILE . 2.7 p -136.87 130.61 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.716 0 CA-C-N 112.706 -2.043 . . . . 0.0 108.669 -178.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 11.9 m -134.61 153.59 51.9 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.201 -174.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.4 t -147.24 137.21 23.13 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -99.57 122.44 42.63 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -139.3 -154.57 6.39 Favored Glycine 0 N--CA 1.405 -3.409 0 C-N-CA 119.465 -1.35 . . . . 0.0 110.71 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.04 159.5 29.39 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.499 HG12 ' HB3' ' A' ' 139' ' ' TYR . 52.0 mm -118.29 108.05 23.36 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.551 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 16.0 pttm -95.22 131.47 41.23 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.339 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 90.0 mt -110.73 91.8 13.16 Favored Pre-proline 0 C--N 1.283 -2.294 0 CA-C-N 114.64 -1.163 . . . . 0.0 110.212 -172.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' ' 166' ' ' LYS . 1.7 Cg_endo -83.0 82.93 2.05 Favored 'Trans proline' 0 N--CA 1.426 -2.448 0 C-N-CA 122.618 2.212 . . . . 0.0 112.251 -177.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 65.4 p 57.61 24.99 11.1 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.684 1.194 . . . . 0.0 114.182 174.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.463 ' HB3' ' CD1' ' A' ' 173' ' ' PHE . 38.7 mt -60.76 -62.0 2.18 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 120.665 0.269 . . . . 0.0 110.54 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.536 ' HA ' ' SD ' ' A' ' 131' ' ' MET . 78.3 mtp180 63.95 141.34 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 O-C-N 124.668 1.23 . . . . 0.0 111.5 -173.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 38.0 t70 78.08 1.84 2.79 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.69 0.796 . . . . 0.0 111.126 -177.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.463 ' CD1' ' HB3' ' A' ' 170' ' ' LEU . 72.5 m-85 . . . . . 0 C--O 1.22 -0.5 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.0 t70 . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 121.296 0.57 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.535 ' O ' ' HG3' ' A' ' 18' ' ' GLU . 42.7 tt0 -57.43 -47.31 82.11 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.516 176.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.464 ' C ' ' HD3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -74.57 -19.43 60.33 Favored 'General case' 0 CA--C 1.487 -1.464 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.531 -178.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.0 t -71.19 -32.93 49.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.455 HG11 ' O ' ' A' ' 94' ' ' ILE . 59.9 t -69.24 -43.22 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 170.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 41.9 mt-10 -64.52 -46.75 81.59 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.863 -173.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.433 ' O ' HG23 ' A' ' 23' ' ' VAL . 8.0 pt-20 -55.53 -48.23 75.02 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 119.929 -0.709 . . . . 0.0 111.214 173.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.415 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 24.9 ttmm -65.5 -47.8 74.76 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 122.808 0.443 . . . . 0.0 111.43 -176.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.68 -39.22 76.63 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.118 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.1 t -66.52 -42.31 87.49 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.605 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 19' ' ' GLU . 65.5 t -62.92 -46.65 95.79 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 CA-C-O 121.116 0.484 . . . . 0.0 109.73 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.485 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 69.1 mt -64.08 -49.88 79.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.863 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.0 t -60.06 -35.09 74.4 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 122.664 0.386 . . . . 0.0 111.018 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.6 m -68.91 -30.47 68.96 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.12 0.486 . . . . 0.0 110.877 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.1 tt -75.82 -42.29 50.25 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 87.0 mt -63.05 -31.1 72.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.528 178.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -68.29 -49.31 61.36 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.426 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.533 ' HD2' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -67.37 -36.49 81.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.29 -177.21 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.533 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -77.46 -31.85 54.03 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.479 -178.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -55.48 -53.45 56.19 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.166 0.291 . . . . 0.0 110.532 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.648 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -62.27 -53.08 44.91 Favored Glycine 0 N--CA 1.437 -1.269 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.477 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -53.83 -41.95 67.95 Favored 'General case' 0 C--O 1.252 1.204 0 C-N-CA 124.316 1.046 . . . . 0.0 111.674 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.486 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 90.8 t80 -66.43 -51.88 52.31 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.76 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.58 -22.98 67.19 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -176.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.648 ' HG2' ' O ' ' A' ' 33' ' ' GLY . 10.9 pt-20 -93.1 -51.49 5.01 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.484 ' HD3' ' HG3' ' A' ' 37' ' ' GLU . 3.9 mppt? -103.35 -39.13 6.92 Favored 'General case' 0 CA--C 1.484 -1.574 0 C-N-CA 118.553 -1.259 . . . . 0.0 112.764 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 2.7 mm? -79.63 -1.53 38.53 Favored 'General case' 0 C--N 1.286 -2.19 0 C-N-CA 119.783 -0.767 . . . . 0.0 112.535 -174.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.12 -8.87 58.44 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 172.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -109.22 -48.78 3.21 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.245 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.9 mp -77.15 117.83 67.83 Favored Pre-proline 0 C--O 1.244 0.808 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.77 118.73 4.74 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.357 2.705 . . . . 0.0 113.504 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.0 p -141.38 165.14 30.73 Favored Pre-proline 0 C--N 1.304 -1.392 0 C-N-CA 125.18 1.392 . . . . 0.0 108.185 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -70.21 135.08 28.53 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.022 1.815 . . . . 0.0 112.347 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -97.48 112.83 24.51 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.957 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.26 125.78 43.49 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.178 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -127.39 132.21 50.18 Favored 'General case' 0 N--CA 1.417 -2.093 0 CA-C-O 121.639 0.733 . . . . 0.0 110.588 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.46 HG13 HG22 ' A' ' 159' ' ' VAL . 11.7 m -83.44 144.17 10.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.663 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -119.34 -67.2 1.0 Allowed 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.433 -174.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -172.43 174.09 3.93 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -177.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.701 HG22 ' HB3' ' A' ' 64' ' ' TYR . 10.5 p -116.48 126.62 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -95.73 119.52 34.38 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.532 -172.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.697 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 37.2 p90 -63.12 125.8 25.27 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.911 0.386 . . . . 0.0 111.761 175.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.549 ' HG3' ' CD2' ' A' ' 65' ' ' HIS . 29.5 mmmt -109.11 -66.3 1.07 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.777 -176.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.32 177.84 21.9 Favored Glycine 0 N--CA 1.431 -1.67 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.864 -175.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 173' ' ' PHE . 6.5 p -98.4 136.94 27.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -177.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.651 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 59.6 m -137.45 146.13 43.95 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -59.35 -43.44 92.78 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.981 0.912 . . . . 0.0 112.235 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.422 ' HB3' ' CD1' ' A' ' 121' ' ' TYR . 19.6 m-20 -61.96 -56.68 16.63 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.171 0.986 . . . . 0.0 109.59 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.651 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . -165.77 165.89 38.26 Favored Glycine 0 N--CA 1.407 -3.299 0 N-CA-C 105.857 -2.897 . . . . 0.0 105.857 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.94 141.87 17.14 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-N 117.689 0.745 . . . . 0.0 111.733 -176.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -87.46 111.79 21.52 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.25 -173.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.701 ' HB3' HG22 ' A' ' 52' ' ' VAL . 7.0 m-85 -120.1 161.24 21.32 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-O 121.761 0.791 . . . . 0.0 111.479 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.549 ' CD2' ' HG3' ' A' ' 55' ' ' LYS . 19.7 m170 -116.9 117.92 31.02 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.015 172.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.566 ' HB3' ' HB ' ' A' ' 115' ' ' VAL . . . -77.78 122.79 25.88 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.433 ' HG3' ' CG1' ' A' ' 112' ' ' VAL . 40.1 ttmt -87.44 107.84 18.74 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.636 -175.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.4 t -112.47 109.15 27.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 114.538 -1.21 . . . . 0.0 107.931 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.0 p -101.16 119.34 38.61 Favored 'General case' 0 C--N 1.277 -2.556 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.967 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 110' ' ' THR . 78.0 t -106.28 119.48 55.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.267 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -97.91 109.57 22.3 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' A' ' 108' ' ' SER . 41.6 t30 -112.27 119.46 43.78 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -175.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -93.83 97.62 0.14 Allowed 'Trans proline' 0 N--CA 1.434 -2.025 0 C-N-CA 121.861 1.707 . . . . 0.0 112.089 173.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.568 ' O ' ' HB2' ' A' ' 108' ' ' SER . 34.1 m-85 -169.92 -160.3 0.23 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 127.209 2.204 . . . . 0.0 106.678 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.5 m -143.37 19.7 1.89 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.538 0.685 . . . . 0.0 109.297 172.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.427 ' O ' ' HA2' ' A' ' 107' ' ' GLY . 17.9 pt20 -113.68 143.62 44.29 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.842 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.1 p -85.41 86.05 7.4 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.091 0.472 . . . . 0.0 110.588 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 64.6 mt -72.88 119.52 75.88 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.461 -177.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -88.91 124.19 1.49 Allowed 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 122.27 1.98 . . . . 0.0 110.876 175.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.421 HG13 ' HD2' ' A' ' 102' ' ' PRO . 24.2 pt -77.29 130.26 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.292 177.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 41.8 t -72.34 -40.17 67.59 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.327 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -153.68 155.83 36.72 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.5 tt -124.27 120.31 58.92 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 172.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.9 m -99.41 128.85 45.56 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -174.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -127.39 141.11 51.77 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.189 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.565 ' HB ' ' HB3' ' A' ' 142' ' ' ASP . 68.0 mt -119.37 108.18 23.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 172.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.54 HD13 ' HB3' ' A' ' 95' ' ' ALA . 0.8 OUTLIER -101.74 122.65 44.34 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -179.095 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.438 ' HG3' ' HB ' ' A' ' 94' ' ' ILE . 67.5 tttt -123.29 154.37 38.94 Favored 'General case' 0 C--N 1.277 -2.547 0 C-N-CA 118.38 -1.328 . . . . 0.0 108.249 176.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.1 m -141.43 126.97 18.89 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.057 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 59.18 14.29 3.47 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.234 1.014 . . . . 0.0 111.094 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.41 ' O ' ' HE2' ' A' ' 88' ' ' LYS . 41.1 m 68.17 -2.69 1.44 Allowed 'General case' 0 CA--C 1.584 2.267 0 C-N-CA 124.451 1.101 . . . . 0.0 112.489 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.24 -80.81 0.24 Allowed 'General case' 0 C--O 1.237 0.408 0 O-C-N 121.199 -0.938 . . . . 0.0 111.346 176.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 94' ' ' ILE . 29.1 m -84.72 166.05 17.34 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.274 -176.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.52 HD13 ' N ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -159.88 148.54 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.468 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 -167.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.54 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -128.87 127.21 41.37 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 176.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.7 t -137.73 151.14 47.89 Favored 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.438 -177.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.85 174.4 46.53 Favored Glycine 0 N--CA 1.411 -3.027 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.411 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 41.4 p -128.46 137.26 51.73 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 99' ' ' ILE . 3.2 mp -102.09 108.03 55.07 Favored Pre-proline 0 C--N 1.308 -1.197 0 C-N-CA 118.15 -1.42 . . . . 0.0 108.575 173.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 98' ' ' THR . 10.3 Cg_exo -74.12 129.51 13.25 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 122.345 2.03 . . . . 0.0 109.848 175.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 56.21 68.77 2.1 Favored Pre-proline 0 N--CA 1.477 0.916 0 C-N-CA 124.153 0.981 . . . . 0.0 111.14 -175.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.421 ' HD2' HG13 ' A' ' 80' ' ' ILE . 64.2 Cg_endo -102.89 -0.25 0.36 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.384 2.723 . . . . 0.0 114.166 -176.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 152.31 179.29 27.79 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 56.3 m -149.82 156.46 41.84 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 116.934 0.367 . . . . 0.0 110.493 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.435 HD23 ' HB2' ' A' ' 72' ' ' ASN . 7.5 mp -79.5 143.4 34.93 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.343 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 27.0 m -68.33 -16.32 20.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.878 -1.056 . . . . 0.0 113.356 -177.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 76' ' ' GLN . . . 129.16 -57.92 0.71 Allowed Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.568 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 24.9 t -156.68 139.58 15.28 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 175.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 119.57 -177.8 16.44 Favored Glycine 0 C--N 1.292 -1.907 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 9.9 t -89.56 117.95 28.84 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.815 0.817 . . . . 0.0 110.407 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.434 HG21 ' HA ' ' A' ' 105' ' ' LEU . 5.0 t -114.87 132.83 56.39 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.095 177.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.433 ' CG1' ' HG3' ' A' ' 67' ' ' LYS . 39.6 t -92.46 121.69 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.831 -177.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.9 mt -106.96 148.14 29.01 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.152 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -110.7 122.31 47.49 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 86.0 t -100.22 116.6 64.33 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 169.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.76 108.96 2.54 Favored 'Trans proline' 0 N--CA 1.43 -2.244 0 N-CA-C 106.171 -2.281 . . . . 0.0 106.171 169.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.439 HG13 HG13 ' A' ' 119' ' ' VAL . 14.0 p -126.63 139.12 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.381 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -175.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -94.04 94.97 8.72 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.535 ' HA ' HD11 ' A' ' 87' ' ' LEU . 4.5 m -94.21 148.5 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.583 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -175.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 73.44 -4.28 2.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.369 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.422 ' CD1' ' HB3' ' A' ' 60' ' ' ASP . 61.7 t80 -58.94 -41.05 86.45 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 171.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.7 p -62.34 -32.19 72.92 Favored 'General case' 0 N--CA 1.417 -2.077 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.913 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 45.6 mm -80.9 -49.83 17.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.242 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.63 -42.85 95.2 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.438 0.461 . . . . 0.0 111.204 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.3 t -66.95 -29.04 44.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.562 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.6 t -86.47 -72.37 0.5 Allowed 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.628 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.583 HD12 ' N ' ' A' ' 128' ' ' MET . 3.0 pp -124.72 -35.3 2.73 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -172.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.583 ' N ' HD12 ' A' ' 127' ' ' LEU . 12.5 tpt 58.92 114.49 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.506 1.123 . . . . 0.0 112.398 -174.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -65.27 -75.42 0.09 Allowed 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.516 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.5 t70 159.78 -32.82 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 105.194 -2.151 . . . . 0.0 105.194 -175.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER 69.47 127.44 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 112.288 -2.233 . . . . 0.0 110.91 -177.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 42.0 t -128.16 150.72 49.87 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.561 HG22 ' HA ' ' A' ' 169' ' ' SER . 66.9 p -61.78 117.61 6.08 Favored 'General case' 0 N--CA 1.407 -2.608 0 C-N-CA 124.339 1.056 . . . . 0.0 109.678 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 75.86 80.91 0.1 Allowed 'General case' 0 CA--C 1.507 -0.673 0 CA-C-O 121.926 0.87 . . . . 0.0 110.63 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 15.8 t-105 -146.15 116.26 7.4 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.816 -1.538 . . . . 0.0 111.214 -175.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' A' ' 165' ' ' ILE . 5.7 p-10 -98.09 126.11 43.38 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 15.6 tt -112.28 145.82 17.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.3 -175.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -74.67 105.91 5.98 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 122.376 1.084 . . . . 0.0 111.043 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.47 150.85 51.99 Favored 'General case' 0 C--N 1.265 -3.095 0 CA-C-N 113.297 -1.774 . . . . 0.0 106.934 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . 0.304 0.1 OUTLIER -146.19 157.34 43.82 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.209 176.526 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.535 ' HB3' ' HB ' ' A' ' 161' ' ' THR . 28.4 tp -135.53 143.31 45.68 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -171.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.565 ' HB3' ' HB ' ' A' ' 86' ' ' ILE . 17.9 t70 -142.32 114.08 8.0 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 177.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 158' ' ' PRO . 49.1 mt -116.24 142.82 28.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.305 -174.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.405 ' HA3' ' CD2' ' A' ' 28' ' ' LEU . . . -120.62 108.39 1.4 Allowed Glycine 0 N--CA 1.421 -2.33 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 176.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 156' ' ' THR . 3.8 mm? -84.33 115.84 22.7 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 122.566 0.346 . . . . 0.0 110.873 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.425 ' OG1' HG22 ' A' ' 156' ' ' THR . 32.3 m -90.47 107.15 18.98 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.644 ' O ' ' HA ' ' A' ' 154' ' ' ASP . 93.8 m-85 -111.5 142.04 44.29 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 176.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -108.51 110.05 21.45 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.0 mp -121.7 126.58 26.37 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.19 -12.73 0.84 Allowed 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 124.481 3.454 . . . . 0.0 116.176 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 24.6 m -73.69 -22.98 18.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 O-C-N 122.065 -0.397 . . . . 0.0 111.203 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.2 p -148.46 -32.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.496 0.665 . . . . 0.0 111.417 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 115.39 -136.63 13.22 Favored Glycine 0 N--CA 1.416 -2.699 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 -175.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.644 ' HA ' ' O ' ' A' ' 147' ' ' PHE . 5.7 p-10 -95.73 131.03 42.44 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 121.376 0.608 . . . . 0.0 110.983 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.47 131.46 54.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 176.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.57 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 73.8 p -87.72 118.58 27.32 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.699 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.503 HD13 ' CD2' ' A' ' 147' ' ' PHE . 2.3 mp -81.35 110.99 21.12 Favored Pre-proline 0 C--N 1.316 -0.854 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 173.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 19.2 Cg_endo -88.02 113.38 0.81 Allowed 'Trans proline' 0 CA--C 1.475 -2.428 0 C-N-CA 122.489 2.126 . . . . 0.0 111.555 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.46 HG22 HG13 ' A' ' 49' ' ' VAL . 2.9 p -116.93 108.32 24.66 Favored 'Isoleucine or valine' 2 N--CA 1.361 -4.923 0 CA-C-N 112.174 -2.285 . . . . 0.0 109.231 -176.678 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 27.3 m -89.59 152.47 21.38 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.23 -173.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 141' ' ' LEU . 1.6 m -140.56 139.6 35.03 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -177.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -99.62 118.61 36.54 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 164.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -108.75 93.28 0.77 Allowed Glycine 0 N--CA 1.413 -2.869 0 C-N-CA 118.77 -1.681 . . . . 0.0 112.697 -171.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -89.22 118.91 29.25 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 175.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 136' ' ' ASP . 7.8 pt -124.33 121.05 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 CA-C-O 121.617 0.723 . . . . 0.0 110.678 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -91.46 104.05 16.6 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 114.229 -1.35 . . . . 0.0 110.95 -177.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 7.1 mp -82.45 111.93 32.5 Favored Pre-proline 0 C--N 1.295 -1.785 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 176.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -82.06 -160.89 0.13 Allowed 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 122.259 1.973 . . . . 0.0 110.189 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.561 ' HA ' HG22 ' A' ' 133' ' ' THR . 28.9 t -56.04 92.82 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 167.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 21.6 tp -144.9 27.54 1.31 Allowed 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 -177.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.488 ' NH1' ' HB2' ' A' ' 172' ' ' ASP . 2.5 tmm_? -63.41 122.56 16.54 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.534 -1.212 . . . . 0.0 107.897 -176.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.488 ' HB2' ' NH1' ' A' ' 171' ' ' ARG . 25.5 t70 79.97 73.78 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.815 0 C-N-CA 125.136 1.374 . . . . 0.0 108.954 -175.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.456 ' O ' HG23 ' A' ' 57' ' ' VAL . 12.1 t80 . . . . . 0 C--N 1.293 -1.874 0 N-CA-C 101.097 -3.668 . . . . 0.0 101.097 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.4 t70 . . . . . 0 C--O 1.238 0.477 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 18' ' ' GLU . 45.6 mt-10 -57.2 -41.61 79.7 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.053 176.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.511 ' C ' ' HD3' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -67.45 -49.0 65.58 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.291 0.567 . . . . 0.0 110.02 177.604 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.61 -35.85 75.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.333 -0.849 . . . . 0.0 113.023 -173.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 p -66.15 -29.59 47.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 65.1 mt-10 -76.79 -44.95 30.67 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 122.057 0.932 . . . . 0.0 108.597 178.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -55.3 -46.94 76.24 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.497 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.693 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -70.75 -36.17 73.0 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.275 177.6 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.67 90.88 Favored 'General case' 0 C--O 1.213 -0.817 0 O-C-N 123.282 0.363 . . . . 0.0 110.574 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.8 m -61.01 -38.19 85.2 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 120.727 0.299 . . . . 0.0 111.582 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.8 -34.94 73.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 20' ' ' LYS . 78.8 mt -69.27 -49.67 59.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.45 -0.795 . . . . 0.0 108.967 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.0 m -57.4 -33.82 68.25 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.992 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.2 t -57.68 -35.23 70.32 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.17 0.588 . . . . 0.0 111.721 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.441 HD23 ' HE2' ' A' ' 30' ' ' LYS . 4.5 tt -80.33 -43.77 20.63 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.496 HD23 ' HB3' ' A' ' 158' ' ' PRO . 9.1 mp -62.3 -34.56 76.83 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -62.41 -34.05 75.97 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.441 ' HE2' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -83.19 -18.66 38.53 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.712 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.22 -32.08 64.54 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.705 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -50.67 -52.75 36.96 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.679 0.791 . . . . 0.0 112.327 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -90.32 7.32 81.69 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.905 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.491 ' HA ' ' HE2' ' A' ' 38' ' ' LYS . 29.1 t80 -85.46 -26.18 26.48 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.63 ' CD1' HD12 ' A' ' 39' ' ' LEU . 44.8 m-85 -70.35 -41.08 73.63 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -174.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.29 -50.77 49.44 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -168.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.452 ' HG2' ' HG3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -117.78 -31.62 5.08 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.259 -0.576 . . . . 0.0 112.072 179.374 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 34' ' ' PHE . 36.7 mtmm -84.84 -9.71 57.88 Favored 'General case' 0 CA--C 1.486 -1.49 0 CA-C-O 121.484 0.659 . . . . 0.0 111.534 -168.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.63 HD12 ' CD1' ' A' ' 35' ' ' PHE . 88.5 mt -128.43 17.98 6.43 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.194 174.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.66 -44.32 21.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.735 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -95.26 11.37 32.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.623 0.725 . . . . 0.0 110.061 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.3 mm -115.57 117.2 40.66 Favored Pre-proline 0 N--CA 1.435 -1.204 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -65.03 113.92 2.59 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 121.991 1.794 . . . . 0.0 111.158 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.3 p -118.19 139.23 26.44 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.917 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.446 ' HB3' HD21 ' A' ' 105' ' ' LEU . 64.7 Cg_endo -74.71 143.88 30.65 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.563 2.175 . . . . 0.0 112.289 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -97.48 130.19 44.6 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -113.0 134.29 54.57 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.9 t -115.83 123.98 49.55 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 121.989 0.9 . . . . 0.0 111.416 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.549 HG22 HG12 ' A' ' 159' ' ' VAL . 26.0 m -102.39 143.87 14.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 114.288 -1.323 . . . . 0.0 109.958 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.575 24.2 t70 117.25 78.61 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 117.821 2.526 . . . . 0.0 117.821 176.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.617 ' HB2' ' HB3' ' A' ' 67' ' ' LYS . 31.9 m-20 -161.3 111.0 1.63 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 102.809 -3.034 . . . . 0.0 102.809 170.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.442 HG12 ' CD2' ' A' ' 64' ' ' TYR . 31.8 t -137.94 134.01 44.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.309 -168.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -137.42 137.26 38.6 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.256 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.599 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 37.8 p90 -91.83 141.82 28.25 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.093 0.557 . . . . 0.0 111.154 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.648 ' HD2' ' N ' ' A' ' 55' ' ' LYS . 3.0 mptp? -107.75 -52.23 2.79 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.89 178.55 40.55 Favored Glycine 0 C--N 1.293 -1.856 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.054 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.71 148.99 5.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 117.039 0.419 . . . . 0.0 110.508 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.6 p -131.28 179.15 6.19 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 176.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -75.6 -32.19 60.21 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.564 0.697 . . . . 0.0 109.328 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.22 83.44 3.6 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.81 176.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.92 -162.67 38.63 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.006 -176.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 p -107.59 145.04 15.37 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.703 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -84.97 121.74 28.2 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.628 0.728 . . . . 0.0 112.373 -170.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.652 ' CD1' ' HB ' ' A' ' 119' ' ' VAL . 28.2 m-85 -129.3 172.24 11.68 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.547 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -138.85 117.34 12.06 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 176.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.19 145.75 24.26 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.724 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.617 ' HB3' ' HB2' ' A' ' 51' ' ' ASP . 47.8 tttm -116.43 124.34 49.76 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.03 -177.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.497 HG12 HG12 ' A' ' 49' ' ' VAL . 34.1 m -128.43 111.64 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-O 121.784 0.802 . . . . 0.0 109.242 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.9 m -98.5 130.63 45.09 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.364 -175.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.18 124.97 66.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.035 0.445 . . . . 0.0 110.814 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -117.34 125.51 51.16 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.061 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 108' ' ' SER . 4.7 t30 -152.45 114.56 2.85 Favored Pre-proline 0 C--N 1.286 -2.165 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.277 176.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -99.41 96.37 0.05 OUTLIER 'Trans proline' 0 N--CA 1.418 -2.941 0 C-N-CA 121.812 1.674 . . . . 0.0 109.779 169.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 93.3 t80 178.23 111.9 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 177.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.7 p -56.86 85.12 0.01 OUTLIER 'General case' 0 C--O 1.242 0.686 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -156.07 105.0 2.31 Favored 'General case' 1 N--CA 1.369 -4.486 0 C-N-CA 126.552 1.941 . . . . 0.0 106.527 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.6 p -89.53 97.01 10.95 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.491 ' H ' HD13 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -103.85 134.93 19.46 Favored Pre-proline 0 C--N 1.31 -1.131 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.787 178.665 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -89.19 159.87 5.7 Favored 'Trans proline' 0 N--CA 1.438 -1.784 0 C-N-CA 122.427 2.085 . . . . 0.0 110.891 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 54.2 mt -91.03 114.91 29.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 100' ' ' PRO . 47.2 t -67.93 -37.94 82.27 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.267 0.556 . . . . 0.0 110.252 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -152.89 112.72 3.93 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.708 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 98' ' ' THR . 18.3 tt -95.77 119.43 43.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 175.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 143' ' ' ILE . 10.5 m -111.31 121.75 46.05 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.754 -172.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.438 ' CE1' HG13 ' A' ' 117' ' ' VAL . 23.7 p90 -109.65 136.41 49.05 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 175.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 63.7 mt -117.06 108.1 24.04 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.668 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 174.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -90.83 120.75 32.11 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 -174.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -118.83 163.78 16.38 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -172.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.1 t -105.57 147.41 28.43 Favored 'General case' 0 N--CA 1.41 -2.447 0 CA-C-N 112.181 -2.281 . . . . 0.0 106.59 172.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.13 -15.43 63.59 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 123.424 0.453 . . . . 0.0 110.873 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.0 t -143.93 -38.22 0.31 Allowed 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -176.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -148.31 128.27 13.56 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 118.785 -1.166 . . . . 0.0 112.687 -172.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.501 ' O ' ' HB3' ' A' ' 122' ' ' SER . 90.6 m 74.13 137.98 0.06 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.37 1.068 . . . . 0.0 113.093 177.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.443 HD12 ' C ' ' A' ' 94' ' ' ILE . 1.9 pp -134.06 171.76 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.5 172.82 12.39 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 176.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 64.1 p -152.82 175.59 12.72 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 122.079 -0.388 . . . . 0.0 110.7 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.03 144.45 4.51 Favored Glycine 0 N--CA 1.435 -1.376 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 41.9 p -132.36 136.63 46.97 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 117.023 0.411 . . . . 0.0 110.529 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.1 mp -113.3 107.11 54.02 Favored Pre-proline 0 C--N 1.313 -1.001 0 C-N-CA 119.419 -0.913 . . . . 0.0 109.167 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 81' ' ' CYS . 18.6 Cg_exo -69.4 116.65 4.62 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.515 2.143 . . . . 0.0 110.031 173.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.2 t70 62.35 79.1 0.27 Allowed Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 123.51 0.724 . . . . 0.0 111.533 -177.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -107.08 12.49 0.15 Allowed 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 124.291 3.327 . . . . 0.0 112.563 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 141.68 -174.22 23.14 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.8 m -151.07 170.82 18.47 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 117.578 0.689 . . . . 0.0 110.679 -177.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.446 HD21 ' HB3' ' A' ' 45' ' ' PRO . 10.3 mp -74.02 157.58 35.87 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 114.762 1.394 . . . . 0.0 114.762 177.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.56 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 7.1 p -79.0 -20.68 12.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 CA-C-N 112.338 -2.21 . . . . 0.0 110.737 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 106.15 -60.97 0.35 Allowed Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 23.2 t -152.81 84.57 1.23 Allowed 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.435 0.636 . . . . 0.0 109.548 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 161.95 -151.74 21.91 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 108.989 -1.645 . . . . 0.0 108.989 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.0 t -122.82 136.77 54.98 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.193 0.521 . . . . 0.0 110.135 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.56 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 4.4 t -130.79 138.3 49.84 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.694 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 50.8 t -91.55 113.53 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-O 121.048 0.452 . . . . 0.0 110.982 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.9 mt -103.3 166.92 10.15 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -147.28 149.83 33.62 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 119.804 -0.759 . . . . 0.0 112.501 -171.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.0 t -125.92 132.62 24.37 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -77.01 110.81 3.11 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 N-CA-C 107.417 -1.801 . . . . 0.0 107.417 167.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.438 HG13 ' CE1' ' A' ' 85' ' ' TYR . 66.3 t -119.99 136.18 57.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.326 -174.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -88.77 99.0 12.02 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 173.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.652 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 82.6 t -93.44 146.54 6.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.603 -173.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 72.7 1.07 3.86 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 124.646 1.179 . . . . 0.0 111.759 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.519 ' O ' HG12 ' A' ' 125' ' ' VAL . 83.8 t80 -54.26 -49.38 69.67 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 175.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.501 ' HB3' ' O ' ' A' ' 93' ' ' THR . 29.0 m -64.3 -29.34 70.42 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.727 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.6 mm -79.51 -50.68 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.455 ' HA ' ' HG2' ' A' ' 128' ' ' MET . . . -63.11 -49.33 74.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -175.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.519 HG12 ' O ' ' A' ' 121' ' ' TYR . 8.0 p -72.24 -22.28 20.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.938 0.399 . . . . 0.0 111.584 -175.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.0 t -99.51 -62.52 1.23 Allowed 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.513 ' H ' HD23 ' A' ' 127' ' ' LEU . 1.8 pt? -124.91 -41.61 2.09 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -171.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.455 ' HG2' ' HA ' ' A' ' 124' ' ' ALA . 81.3 mtp 65.88 -177.97 0.19 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -169.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -137.31 -78.31 0.39 Allowed 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.3 t70 178.59 93.28 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.181 0 CA-C-N 114.494 -1.23 . . . . 0.0 107.728 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.58 ' SD ' ' HB2' ' A' ' 170' ' ' LEU . 0.3 OUTLIER -52.18 101.66 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.344 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.822 175.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 82.1 m -108.27 167.66 9.86 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.433 0.635 . . . . 0.0 112.176 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.509 HG22 ' HB3' ' A' ' 169' ' ' SER . 40.3 p -77.63 127.55 32.66 Favored 'General case' 0 N--CA 1.404 -2.752 0 C-N-CA 124.921 1.288 . . . . 0.0 108.561 169.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.6 t70 54.91 91.69 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.65 1.18 . . . . 0.0 109.625 -172.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -148.69 158.97 44.52 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.908 -169.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -142.19 148.24 37.89 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.546 HG12 HD21 ' A' ' 167' ' ' LEU . 27.8 pt -128.97 145.3 35.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 120.865 0.364 . . . . 0.0 110.874 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -97.41 111.86 23.94 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -128.12 163.13 25.31 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.583 ' HG3' ' O ' ' A' ' 161' ' ' THR . 34.3 tt0 -136.45 150.01 48.51 Favored 'General case' 0 C--N 1.283 -2.314 0 O-C-N 121.68 -0.637 . . . . 0.0 111.053 -178.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 2.0 pt? -141.25 120.44 12.96 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 172.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.406 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 6.8 m-20 -84.14 122.63 29.1 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 84' ' ' SER . 34.5 mm -108.24 117.28 53.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 C-N-CA 118.799 -1.16 . . . . 0.0 109.644 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -94.07 96.84 2.11 Favored Glycine 0 N--CA 1.419 -2.46 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 156' ' ' THR . 2.7 mm? -79.16 108.72 12.87 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.446 ' OG1' HG22 ' A' ' 156' ' ' THR . 26.1 m -89.85 107.36 19.06 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.294 -0.962 . . . . 0.0 108.83 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.413 ' CE2' ' HB3' ' A' ' 145' ' ' LEU . 73.4 m-85 -114.55 131.31 56.71 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 154' ' ' ASP . 4.6 p-10 -108.78 112.17 24.3 Favored 'General case' 0 C--N 1.287 -2.122 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.757 173.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.454 HG22 HG22 ' A' ' 151' ' ' VAL . 2.5 mp -104.2 120.09 52.0 Favored Pre-proline 0 C--N 1.292 -1.904 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 176.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -41.85 -32.21 1.63 Allowed 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 124.386 3.391 . . . . 0.0 115.455 -174.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.454 HG22 HG22 ' A' ' 149' ' ' ILE . 33.8 m -74.78 -21.98 17.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 13.9 p -126.18 -28.69 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.818 -177.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 148' ' ' ASP . . . 107.34 -156.47 15.92 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 148' ' ' ASP . 7.2 p-10 -90.53 120.25 31.46 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.48 0.657 . . . . 0.0 111.47 -178.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 155' ' ' ILE . 2.4 pp -128.83 138.05 55.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.61 175.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.446 HG22 ' OG1' ' A' ' 146' ' ' THR . 67.3 p -94.21 127.29 39.96 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.196 177.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 51.2 mt -101.15 105.15 37.44 Favored Pre-proline 0 C--N 1.295 -1.79 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.496 ' HB3' HD23 ' A' ' 28' ' ' LEU . 3.2 Cg_exo -76.97 109.9 2.93 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 122.646 2.231 . . . . 0.0 111.305 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.549 HG12 HG22 ' A' ' 49' ' ' VAL . 19.0 t -103.97 124.6 58.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 175.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 14.7 m -126.78 152.14 47.32 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.154 -173.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.583 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 14.0 t -174.62 162.22 3.34 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.257 0.0 OUTLIER -99.46 135.84 40.29 Favored 'General case' 0 N--CA 1.409 -2.494 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.972 172.332 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -108.38 113.01 3.7 Favored Glycine 0 N--CA 1.397 -3.905 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -177.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -89.55 119.67 30.18 Favored 'General case' 0 N--CA 1.405 -2.702 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 174.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 10.0 pt -118.34 140.67 40.99 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.909 -176.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -90.72 136.49 33.03 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.536 -173.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.546 HD21 HG12 ' A' ' 137' ' ' ILE . 2.0 mm? -115.34 94.84 40.89 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.1 49.48 2.56 Favored 'Trans proline' 0 N--CA 1.486 1.08 0 C-N-CA 123.359 2.706 . . . . 0.0 112.944 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.509 ' HB3' HG22 ' A' ' 133' ' ' THR . 2.9 m 67.11 93.39 0.07 Allowed 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 125.108 1.363 . . . . 0.0 110.758 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.685 ' HB3' ' CD1' ' A' ' 173' ' ' PHE . 3.0 mm? -98.77 -59.48 1.73 Allowed 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.093 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 61.21 104.62 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.187 0.995 . . . . 0.0 111.602 -174.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 33.5 t70 70.49 64.19 0.2 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.866 1.266 . . . . 0.0 112.075 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.685 ' CD1' ' HB3' ' A' ' 170' ' ' LEU . 57.6 m-85 . . . . . 0 C--N 1.311 -1.08 0 C-N-CA 125.933 1.693 . . . . 0.0 106.565 178.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.533 ' O ' HG23 ' A' ' 17' ' ' VAL . 10.1 m-20 . . . . . 0 N--CA 1.443 -0.804 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -67.86 -29.86 69.1 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-O 121.355 0.598 . . . . 0.0 110.778 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 11.7 tmtt? -75.26 -54.25 7.42 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.792 0.806 . . . . 0.0 110.139 177.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.5 t -59.95 -41.76 87.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 CA-C-N 114.946 -1.025 . . . . 0.0 112.682 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 13' ' ' ASP . 40.2 t -68.5 -27.51 36.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 C-N-CA 118.842 -1.143 . . . . 0.0 109.077 176.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.457 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 33.0 tt0 -63.09 -34.78 78.33 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.974 0.892 . . . . 0.0 108.651 -177.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.38 -49.72 72.7 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.265 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -65.08 -43.05 93.44 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.2 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.74 -37.99 80.5 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.205 -178.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.2 t -60.73 -40.37 92.1 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 123.303 0.377 . . . . 0.0 110.29 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.13 -49.76 73.91 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.529 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 64.1 mt -68.85 -39.81 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.963 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 56.2 m -61.01 -37.8 83.83 Favored 'General case' 0 C--O 1.215 -0.744 0 O-C-N 122.299 -0.251 . . . . 0.0 110.643 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.9 m -67.19 -20.91 65.78 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.111 0.482 . . . . 0.0 111.348 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -78.04 -51.53 10.18 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.472 HD23 ' HB3' ' A' ' 158' ' ' PRO . 8.1 mp -60.85 -34.0 73.91 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.409 177.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -53.33 -49.47 67.0 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.524 0.73 . . . . 0.0 111.465 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -82.13 -31.64 30.51 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.07 -32.49 70.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.713 0.292 . . . . 0.0 111.638 177.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.487 ' CG ' ' HG2' ' A' ' 158' ' ' PRO . 56.6 mtmt -61.82 -25.77 67.71 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.568 176.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.48 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -73.48 -50.84 10.71 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 175.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -58.37 -40.67 82.89 Favored 'General case' 0 C--O 1.198 -1.611 0 CA-C-O 120.397 0.141 . . . . 0.0 111.113 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -60.11 -35.49 75.36 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.999 -0.681 . . . . 0.0 111.81 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.09 -39.2 50.54 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 33' ' ' GLY . 10.9 pt-20 -96.29 -40.07 9.33 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -176.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.435 ' HE2' ' HB2' ' A' ' 38' ' ' LYS . 8.2 tppt? -90.67 -47.93 7.36 Favored 'General case' 0 CA--C 1.479 -1.781 0 CA-C-O 122.74 1.257 . . . . 0.0 107.927 -167.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.491 HD13 HG21 ' A' ' 44' ' ' THR . 58.6 mt -82.91 6.2 19.32 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 112.91 -1.95 . . . . 0.0 111.331 -173.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.25 -38.54 30.75 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 173.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -88.41 -39.97 13.87 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.863 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.6 mt -73.5 135.91 78.39 Favored Pre-proline 0 N--CA 1.435 -1.178 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -72.6 94.65 0.78 Allowed 'Trans proline' 0 N--CA 1.441 -1.574 0 N-CA-C 106.404 -2.191 . . . . 0.0 106.404 171.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.491 HG21 HD13 ' A' ' 39' ' ' LEU . 4.9 m -100.27 137.16 19.95 Favored Pre-proline 0 N--CA 1.415 -2.216 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.814 -167.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.486 ' HB3' ' OD1' ' A' ' 72' ' ' ASN . 23.4 Cg_endo -60.11 124.59 15.56 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.041 2.494 . . . . 0.0 110.733 176.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -97.69 106.38 18.68 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.454 0.645 . . . . 0.0 110.843 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . . . -100.14 144.49 29.1 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.862 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 t -146.35 149.03 33.0 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.951 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.493 ' H ' HG11 ' A' ' 159' ' ' VAL . 90.0 t -82.52 141.22 15.28 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 175.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -133.08 -41.19 0.91 Allowed 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -170.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -160.42 163.33 33.17 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.38 -171.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.578 HG13 ' CD2' ' A' ' 64' ' ' TYR . 97.7 t -132.01 106.66 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 123.489 0.716 . . . . 0.0 110.72 -177.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.478 ' HB2' ' CD2' ' A' ' 65' ' ' HIS . 34.9 m-20 -100.83 107.51 19.08 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.44 ' HA ' ' CB ' ' A' ' 64' ' ' TYR . 49.6 p90 -63.48 138.94 58.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.581 ' HG2' ' HA ' ' A' ' 64' ' ' TYR . 14.5 mmmm -89.7 -72.91 0.54 Allowed 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -176.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.71 -88.06 0.06 OUTLIER Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 117.724 -2.179 . . . . 0.0 115.17 -175.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.72 138.71 25.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.67 0.747 . . . . 0.0 112.522 -173.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.693 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 39.8 m -152.75 157.36 40.73 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 105.021 -2.214 . . . . 0.0 105.021 173.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -102.31 -25.02 13.82 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.7 0.762 . . . . 0.0 109.884 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.467 ' H ' HG22 ' A' ' 58' ' ' THR . 32.6 t70 -99.66 23.0 10.11 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.217 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.693 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . 146.09 -162.9 28.39 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 -177.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.41 ' CG2' ' HB3' ' A' ' 173' ' ' PHE . 48.4 t -135.26 116.05 19.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 173.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -68.2 137.02 54.49 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.12 0.486 . . . . 0.0 110.98 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.714 ' CD1' HG13 ' A' ' 119' ' ' VAL . 23.9 p90 -143.02 173.02 11.92 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.478 ' CD2' ' HB2' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -124.57 122.06 36.5 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.823 -1.151 . . . . 0.0 108.815 173.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -78.83 131.02 36.32 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.74 -175.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -89.27 111.65 22.52 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.5 p -127.94 108.72 18.42 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-O 122.146 0.974 . . . . 0.0 108.458 175.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.435 ' HB3' HG22 ' A' ' 112' ' ' VAL . 28.8 p -101.16 133.94 44.94 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.658 -175.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 25.2 t -109.72 130.55 62.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.749 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -111.47 111.7 22.91 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 175.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.486 ' OD1' ' HB3' ' A' ' 45' ' ' PRO . 7.1 t30 -132.74 124.89 19.08 Favored Pre-proline 0 C--N 1.307 -1.249 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.656 -172.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 72' ' ' ASN . 57.3 Cg_endo -97.56 97.73 0.07 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.779 0 C-N-CA 122.078 1.852 . . . . 0.0 112.947 175.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.547 ' O ' ' HB2' ' A' ' 108' ' ' SER . 52.9 m-85 -157.84 -165.13 1.67 Allowed 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 126.425 1.89 . . . . 0.0 106.39 175.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.7 m -131.77 13.86 4.86 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-O 121.877 0.846 . . . . 0.0 109.425 175.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.453 ' O ' ' HA2' ' A' ' 107' ' ' GLY . 10.3 pt20 -118.55 134.96 54.69 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.258 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 105' ' ' LEU . 23.8 m -73.81 97.12 2.68 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.56 174.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.498 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 54.3 mt -85.19 120.95 73.91 Favored Pre-proline 0 C--O 1.244 0.813 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -84.1 158.46 13.37 Favored 'Trans proline' 0 N--CA 1.436 -1.893 0 C-N-CA 121.796 1.664 . . . . 0.0 110.022 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 29.7 pt -102.55 144.43 13.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.179 178.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 48.8 t -62.4 -55.58 26.46 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -177.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -154.31 145.74 23.08 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 171.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.437 ' CG2' ' HG3' ' A' ' 102' ' ' PRO . 14.2 tt -97.36 117.41 41.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.0 t -100.63 118.33 36.56 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -108.08 134.86 50.36 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.554 HG23 HD11 ' A' ' 94' ' ' ILE . 2.7 mp -117.45 107.31 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.028 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 178.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.462 ' CD2' ' HE2' ' A' ' 139' ' ' TYR . 2.0 tm? -101.92 121.34 41.94 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.428 -170.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.57 ' HB2' ' HB2' ' A' ' 140' ' ' GLN . 0.6 OUTLIER -102.41 150.08 23.72 Favored 'General case' 0 CA--C 1.487 -1.458 0 O-C-N 122.007 -0.433 . . . . 0.0 110.427 179.209 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.449 ' OG ' ' HB3' ' A' ' 122' ' ' SER . 68.6 m -132.87 94.42 3.38 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 177.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 53.03 -77.43 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 170.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.2 m -70.23 -72.93 0.18 Allowed 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -171.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.4 ' H ' ' H ' ' A' ' 93' ' ' THR . 99.5 mtt180 -153.63 -16.27 0.14 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.91 0.484 . . . . 0.0 109.858 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.454 HG22 ' OG ' ' A' ' 122' ' ' SER . 2.7 m -69.9 151.7 45.36 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.642 -171.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.554 HD11 HG23 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -145.11 149.42 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -174.158 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.467 ' N ' HD13 ' A' ' 94' ' ' ILE . . . -129.04 151.46 49.71 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 124.902 1.281 . . . . 0.0 108.07 175.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 35.0 p -136.67 166.48 23.46 Favored 'General case' 0 C--N 1.29 -2.006 0 O-C-N 122.232 -0.293 . . . . 0.0 111.107 -175.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 174.08 136.25 2.19 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.43 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.0 p -113.15 112.69 24.23 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.507 HD12 HG23 ' A' ' 115' ' ' VAL . 63.0 mt -99.27 109.75 55.71 Favored Pre-proline 0 C--N 1.32 -0.699 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.057 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.29 116.72 4.81 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 123.221 2.614 . . . . 0.0 111.613 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.7 t70 51.05 87.36 0.13 Allowed Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 124.929 1.291 . . . . 0.0 112.505 -177.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.437 ' HG3' ' CG2' ' A' ' 83' ' ' ILE . 11.8 Cg_endo -99.54 9.2 0.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.922 2.414 . . . . 0.0 110.766 175.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 147.32 -163.09 28.71 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -177.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.5 m -151.27 160.63 43.7 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 78' ' ' ILE . 3.8 pp -83.96 147.38 27.5 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 36.0 m -57.39 -45.52 85.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -175.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 76' ' ' GLN . . . 140.52 -55.37 0.63 Allowed Glycine 0 N--CA 1.418 -2.548 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -176.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.547 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 37.1 t -136.75 118.49 15.05 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.9 -162.6 12.31 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.933 174.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.5 t -89.26 138.83 31.09 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-O 121.729 0.776 . . . . 0.0 109.662 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.1 t -138.87 117.93 12.55 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.435 HG22 ' HB3' ' A' ' 69' ' ' SER . 47.8 t -87.25 115.83 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.188 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.516 -178.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.4 mt -100.87 149.9 23.39 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.45 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 7.7 p-10 -140.83 116.34 10.14 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.033 0.921 . . . . 0.0 112.467 -177.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.507 HG23 HD12 ' A' ' 99' ' ' ILE . 4.2 p -95.32 130.55 31.98 Favored Pre-proline 0 C--N 1.307 -1.24 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.479 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -72.41 112.58 3.49 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 121.833 1.689 . . . . 0.0 109.735 173.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.628 ' HB ' ' CE1' ' A' ' 64' ' ' TYR . 2.3 t -130.81 153.92 39.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 -175.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -116.46 133.33 56.14 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.714 HG13 ' CD1' ' A' ' 64' ' ' TYR . 15.7 m -92.86 148.81 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.764 0 C-N-CA 123.993 0.917 . . . . 0.0 108.84 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 76.27 -10.08 1.36 Allowed 'General case' 0 N--CA 1.481 1.121 0 O-C-N 124.136 0.898 . . . . 0.0 110.639 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.421 ' H ' ' C ' ' A' ' 119' ' ' VAL . 69.0 t80 -56.2 -52.31 64.86 Favored 'General case' 0 CA--C 1.484 -1.561 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.823 -178.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.454 ' OG ' HG22 ' A' ' 93' ' ' THR . 35.4 t -72.42 -43.2 64.19 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.475 -174.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 12.9 tt -71.77 -49.51 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 C-N-CA 119.192 -1.003 . . . . 0.0 112.891 -176.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -60.82 -32.51 71.89 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -176.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.0 p -71.92 -30.41 36.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.532 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.4 t -106.95 -43.87 4.55 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 119.358 -0.937 . . . . 0.0 112.24 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.9 tp -123.96 -52.95 1.76 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -175.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.413 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 25.1 ttt 76.03 138.08 0.06 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.103 1.361 . . . . 0.0 111.093 -176.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 130' ' ' ASP . 59.5 tptt -61.45 -73.08 0.1 Allowed 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 129' ' ' LYS . 22.4 t70 169.98 -13.26 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 O-C-N 124.218 0.949 . . . . 0.0 109.808 178.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.586 ' HA ' ' CE ' ' A' ' 131' ' ' MET . 0.0 OUTLIER 66.3 88.82 0.1 Allowed 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.99 0.9 . . . . 0.0 112.705 -169.435 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 47.2 t -105.86 155.69 19.08 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.5 -1.227 . . . . 0.0 107.718 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 20.9 p -96.57 100.57 12.14 Favored 'General case' 0 N--CA 1.402 -2.866 0 CA-C-O 121.089 0.471 . . . . 0.0 110.611 177.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.488 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 31.4 t70 74.95 99.96 0.07 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.18 0.992 . . . . 0.0 111.383 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -159.48 158.93 32.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.669 -1.151 . . . . 0.0 108.076 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -107.38 147.17 30.7 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.305 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 29.6 mm -128.68 130.59 68.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.923 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -102.04 101.53 11.91 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 172.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.481 ' HD1' ' O ' ' A' ' 163' ' ' GLY . 0.6 OUTLIER -104.66 170.4 7.9 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 179.723 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 88' ' ' LYS . 2.3 mp0 -120.42 147.23 45.36 Favored 'General case' 0 C--N 1.273 -2.726 0 C-N-CA 118.466 -1.294 . . . . 0.0 111.899 -177.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.4 tp -130.47 117.51 19.75 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-O 121.892 0.853 . . . . 0.0 110.368 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.54 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 3.9 m-20 -122.55 123.56 41.51 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 45.7 mt -122.14 131.1 73.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 119.004 -1.078 . . . . 0.0 111.028 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -106.18 86.95 0.5 Allowed Glycine 1 N--CA 1.394 -4.115 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 174.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.613 HD13 ' H ' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -85.81 141.4 29.67 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 176.292 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.1 t -128.63 122.01 29.92 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.409 -0.916 . . . . 0.0 111.457 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.464 ' CE2' HD23 ' A' ' 145' ' ' LEU . 77.7 m-85 -103.75 138.74 39.95 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -92.44 108.5 20.01 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 172.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.525 HG22 ' H ' ' A' ' 151' ' ' VAL . 51.2 mm -100.83 125.26 39.17 Favored Pre-proline 0 C--N 1.282 -2.359 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -178.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.11 -3.98 6.94 Favored 'Trans proline' 0 N--CA 1.481 0.788 0 C-N-CA 123.396 2.73 . . . . 0.0 113.46 -176.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.525 ' H ' HG22 ' A' ' 149' ' ' ILE . 59.9 t -76.0 -51.28 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.2 p -176.12 83.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 177.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 103.4 155.22 24.44 Favored Glycine 0 N--CA 1.413 -2.859 0 C-N-CA 120.589 -0.815 . . . . 0.0 114.27 165.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -97.52 114.19 26.03 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 170.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.648 HD13 ' H ' ' A' ' 155' ' ' ILE . 0.2 OUTLIER -121.44 150.84 24.61 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.888 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.672 -179.48 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 10.5 t -97.5 151.19 20.26 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 176.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 59.9 mt -113.97 110.73 48.57 Favored Pre-proline 0 N--CA 1.434 -1.226 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 176.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.487 ' HG2' ' CG ' ' A' ' 32' ' ' LYS . 26.3 Cg_exo -68.46 105.33 1.24 Allowed 'Trans proline' 0 C--O 1.241 0.671 0 C-N-CA 123.064 2.509 . . . . 0.0 112.836 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.493 HG11 ' H ' ' A' ' 49' ' ' VAL . 21.8 t -105.3 116.01 48.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 175.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 47.7 p -127.82 118.99 24.72 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -174.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.6 t -156.9 172.2 19.07 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -100.33 151.72 21.17 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.446 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.481 ' O ' ' HD1' ' A' ' 139' ' ' TYR . . . -111.74 101.83 1.33 Allowed Glycine 0 N--CA 1.406 -3.362 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 175.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.426 ' H ' ' HG2' ' A' ' 164' ' ' GLU . 7.8 pt-20 -95.28 120.51 35.63 Favored 'General case' 0 C--N 1.266 -3.031 0 CA-C-O 121.888 0.851 . . . . 0.0 109.755 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 6.6 pt -130.49 133.56 63.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.869 -172.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -99.6 128.63 45.71 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 134' ' ' ASP . 91.4 mt -114.19 117.76 43.02 Favored Pre-proline 0 C--N 1.297 -1.694 0 C-N-CA 120.454 -0.499 . . . . 0.0 111.191 -174.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -84.96 108.98 1.22 Allowed 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 122.567 2.178 . . . . 0.0 111.802 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 133' ' ' THR 0.27 79.2 p 52.31 -81.38 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 179.142 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 85.4 mt 69.51 -62.05 0.42 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.728 1.211 . . . . 0.0 111.686 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 76.8 mtm180 65.28 -3.15 0.67 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 173.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -142.94 1.33 1.27 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.35 0.595 . . . . 0.0 110.07 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.41 ' HB3' ' CG2' ' A' ' 62' ' ' VAL . 10.7 m-85 . . . . . 0 CA--C 1.551 0.999 0 N-CA-C 115.929 1.825 . . . . 0.0 115.929 -165.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 . . . . . 0 CA--C 1.511 -0.547 0 CA-C-O 120.336 0.113 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -59.34 -48.8 80.26 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -60.77 -40.17 91.56 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.598 176.696 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.557 HG12 ' HE2' ' A' ' 20' ' ' LYS . 40.7 t -64.65 -40.87 90.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.665 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.517 HG11 ' O ' ' A' ' 94' ' ' ILE . 54.6 t -59.13 -33.26 49.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.102 0.477 . . . . 0.0 110.004 175.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.06 -45.78 55.45 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 26.5 mm-40 -57.51 -52.47 65.26 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.733 176.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.557 ' HE2' HG12 ' A' ' 16' ' ' VAL . 68.1 mttm -58.12 -48.91 78.77 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.819 -178.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.11 -45.13 83.68 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 123.463 0.477 . . . . 0.0 111.395 -176.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 62.9 m -62.33 -49.51 75.32 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.015 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.8 t -61.57 -38.07 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.204 0.526 . . . . 0.0 110.296 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.506 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 86.0 mt -69.95 -46.86 72.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.172 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.1 t -59.68 -36.61 76.82 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.699 0.4 . . . . 0.0 110.676 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.1 t -62.84 -38.24 89.98 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.684 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.556 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 5.1 tt -76.72 -42.1 42.62 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 87.7 mt -57.05 -36.55 70.64 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.288 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -56.77 -41.44 77.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.814 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -83.29 -33.33 25.98 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.624 -178.227 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.21 -50.7 11.42 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -175.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -60.26 -47.04 87.67 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 122.514 0.326 . . . . 0.0 111.077 -175.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.641 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -59.63 -56.01 27.31 Favored Glycine 0 N--CA 1.444 -0.813 0 O-C-N 123.683 0.614 . . . . 0.0 111.996 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -58.4 -39.76 80.55 Favored 'General case' 0 C--O 1.255 1.348 0 C-N-CA 123.268 0.627 . . . . 0.0 110.923 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.538 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 89.1 t80 -67.76 -53.34 27.98 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.4 178.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.15 -29.69 68.82 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -174.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.641 ' HG2' ' O ' ' A' ' 33' ' ' GLY . 10.7 pt-20 -90.37 -42.39 10.96 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -177.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HD3' ' HG3' ' A' ' 37' ' ' GLU . 3.7 mppt? -107.4 -48.3 3.47 Favored 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 118.812 -1.155 . . . . 0.0 112.534 177.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.538 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 2.9 mm? -75.71 -12.67 60.24 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -169.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.56 -23.14 64.46 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 120.971 0.415 . . . . 0.0 110.095 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -115.22 17.48 16.62 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.222 0.534 . . . . 0.0 110.19 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.415 ' HB ' ' HA ' ' A' ' 39' ' ' LEU . 72.7 mt -127.98 134.6 26.4 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -40.82 103.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.317 0 C-N-CA 123.903 3.068 . . . . 0.0 114.591 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.0 p -146.5 155.08 49.43 Favored Pre-proline 0 C--N 1.31 -1.151 0 C-N-CA 124.802 1.241 . . . . 0.0 108.409 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.9 124.89 14.3 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.125 1.884 . . . . 0.0 111.468 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -97.03 111.55 23.72 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -178.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.37 143.18 33.9 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.86 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.594 ' HA ' HG21 ' A' ' 159' ' ' VAL . 10.4 t -143.18 140.59 30.83 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.553 HG23 HG22 ' A' ' 159' ' ' VAL . 45.3 t -83.63 141.26 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.829 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -108.23 -62.11 1.5 Allowed 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.844 -1.142 . . . . 0.0 114.023 -168.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.547 ' HB3' ' HD2' ' A' ' 67' ' ' LYS . 24.5 t70 -166.79 166.16 15.87 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.562 -169.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.649 HG13 ' CD2' ' A' ' 64' ' ' TYR . 97.4 t -118.55 119.54 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 124.248 1.019 . . . . 0.0 111.462 -176.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -121.95 106.4 11.2 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -82.06 134.02 35.32 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -176.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.08 78.84 1.72 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -175.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 122.64 -149.62 16.92 Favored Glycine 0 C--N 1.268 -3.212 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.217 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.4 p -143.54 154.88 16.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.0 m -135.35 164.1 28.51 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -58.31 -41.41 84.42 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.08 0.466 . . . . 0.0 110.6 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -133.23 105.0 6.75 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.76 -161.1 21.87 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.284 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 69.9 t -150.78 121.91 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -177.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.434 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 20.3 t70 -68.4 129.65 40.55 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.649 ' CD2' HG13 ' A' ' 52' ' ' VAL . 43.7 p90 -131.65 169.64 15.87 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -90.69 109.5 20.67 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 174.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.456 ' HB3' HG13 ' A' ' 115' ' ' VAL . . . -82.81 112.23 19.44 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 175.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.547 ' HD2' ' HB3' ' A' ' 51' ' ' ASP . 93.7 mttt -86.74 120.58 28.18 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.172 -176.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.0 t -127.04 109.1 19.89 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.673 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.6 p -99.55 123.66 44.03 Favored 'General case' 0 C--N 1.283 -2.314 0 C-N-CA 120.394 -0.523 . . . . 0.0 111.017 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.2 t -117.88 125.43 74.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.826 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.421 ' HG2' ' OG1' ' A' ' 110' ' ' THR . 51.7 mtpt -95.07 110.25 22.2 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.639 HD22 HD12 ' A' ' 105' ' ' LEU . 47.4 t-20 -108.39 113.79 59.92 Favored Pre-proline 0 C--N 1.302 -1.48 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.241 -176.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -111.55 97.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.152 0 C-N-CA 123.017 2.478 . . . . 0.0 110.408 166.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -168.94 -19.96 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.7 t 70.99 24.57 3.95 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.333 1.053 . . . . 0.0 109.651 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.565 ' HG3' HG12 ' A' ' 78' ' ' ILE . 9.5 tp60 -121.68 110.67 16.25 Favored 'General case' 0 N--CA 1.396 -3.173 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.987 -178.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.3 m -75.09 87.4 2.39 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.565 HG12 ' HG3' ' A' ' 76' ' ' GLN . 82.3 mt -72.77 122.02 86.51 Favored Pre-proline 0 C--N 1.294 -1.839 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.775 -170.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -70.86 109.95 2.65 Favored 'Trans proline' 0 N--CA 1.431 -2.187 0 N-CA-C 106.721 -2.069 . . . . 0.0 106.721 168.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.3 mt -62.95 119.49 7.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -173.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 41.8 t -56.64 -53.21 60.35 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -167.94 147.76 4.89 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.428 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 12.4 tt -110.85 113.93 45.65 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 175.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 98' ' ' THR . 26.5 t -92.65 148.17 22.28 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -140.57 139.42 34.97 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 176.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.582 HG23 ' HB2' ' A' ' 142' ' ' ASP . 11.8 tt -143.56 110.55 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 174.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.432 ' O ' HD12 ' A' ' 87' ' ' LEU . 3.4 pp -110.9 141.04 44.85 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.586 -178.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.45 ' HA ' HG22 ' A' ' 94' ' ' ILE . 97.3 mttt -103.62 153.08 21.01 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.837 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 55.8 m -135.29 132.18 37.43 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.682 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.78 86.87 2.79 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 121.951 0.881 . . . . 0.0 112.018 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.8 m -161.58 -53.61 0.05 OUTLIER 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 163.86 -52.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 125.268 1.605 . . . . 0.0 110.479 177.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.2 m -70.81 142.11 51.32 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.948 -177.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.517 ' O ' HG11 ' A' ' 17' ' ' VAL . 2.5 pp -125.04 177.25 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.036 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 86' ' ' ILE . . . -131.95 134.03 45.18 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 118.296 0.498 . . . . 0.0 109.778 177.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.4 p -135.09 158.47 44.28 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 176.22 168.42 36.38 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.574 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 40.5 p -135.02 116.58 14.79 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 122.717 0.407 . . . . 0.0 109.959 178.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 60.6 mt -98.57 108.78 50.0 Favored Pre-proline 0 C--N 1.323 -0.572 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.166 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.65 121.99 7.48 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.607 2.204 . . . . 0.0 111.692 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.4 t70 56.12 83.4 0.22 Allowed Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 124.008 0.923 . . . . 0.0 112.249 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -101.48 8.28 0.53 Allowed 'Trans proline' 0 CA--C 1.548 1.212 0 C-N-CA 123.073 2.515 . . . . 0.0 113.075 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 165.14 -124.33 1.24 Allowed Glycine 0 N--CA 1.441 -1.033 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.7 m -151.84 146.67 25.85 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 176.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.639 HD12 HD22 ' A' ' 72' ' ' ASN . 1.0 OUTLIER -104.44 98.13 7.95 Favored 'General case' 0 N--CA 1.423 -1.791 0 C-N-CA 117.859 -1.536 . . . . 0.0 109.119 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.517 ' HB ' ' HB ' ' A' ' 111' ' ' THR 0.255 14.8 p 10.55 -72.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 128.811 2.844 . . . . 0.0 117.501 178.308 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.463 ' H ' HG13 ' A' ' 106' ' ' VAL . . . 125.37 -51.12 0.84 Allowed Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -174.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.5 p -154.09 94.89 1.78 Allowed 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.334 0.587 . . . . 0.0 111.862 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 143.98 -175.17 24.0 Favored Glycine 0 CA--C 1.497 -1.081 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.883 176.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.421 ' OG1' ' HG2' ' A' ' 71' ' ' LYS . 56.3 m -95.35 116.93 29.45 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.517 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 9.6 t -113.78 137.12 52.08 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 25.5 t -99.4 115.08 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.3 mt -89.82 148.27 23.3 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.395 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -114.23 121.0 42.38 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.769 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 66' ' ' ALA . 10.3 p -128.18 125.55 23.42 Favored Pre-proline 0 C--N 1.302 -1.462 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.34 177.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.29 111.72 3.24 Favored 'Trans proline' 0 C--O 1.246 0.909 0 C-N-CA 123.117 2.545 . . . . 0.0 112.589 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.438 HG23 ' CE1' ' A' ' 64' ' ' TYR . 26.3 m -143.36 151.44 16.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.434 ' HG3' ' N ' ' A' ' 63' ' ' ASP . 3.3 mppt? -95.9 135.72 37.27 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.623 ' HB ' ' CE1' ' A' ' 64' ' ' TYR . 13.2 p -94.9 145.78 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 66.44 13.33 9.2 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 123.548 0.739 . . . . 0.0 110.332 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.505 ' O ' HG23 ' A' ' 125' ' ' VAL . 84.4 t80 -56.77 -50.38 72.48 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 124.786 1.235 . . . . 0.0 108.961 176.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.8 m -62.1 -40.74 96.89 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.856 -176.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.436 HD13 ' HG3' ' A' ' 129' ' ' LYS . 14.0 tt -79.06 -34.01 16.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.352 -177.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -60.85 -35.95 77.89 Favored 'General case' 0 C--N 1.358 0.937 0 CA-C-O 120.893 0.377 . . . . 0.0 110.031 174.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 121' ' ' TYR . 43.2 t -56.54 -37.79 53.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.42 175.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.2 m -95.52 -77.24 0.48 Allowed 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.582 HD12 ' H ' ' A' ' 129' ' ' LYS . 3.9 pp -119.03 -12.11 9.56 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -172.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.508 ' O ' ' HG2' ' A' ' 128' ' ' MET . 25.0 ttt 60.93 41.17 14.59 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.931 0.892 . . . . 0.0 113.399 173.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.582 ' H ' HD12 ' A' ' 127' ' ' LEU . 15.0 mtmt 60.1 -83.12 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.128 0.571 . . . . 0.0 111.28 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 164.21 -23.13 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 126.806 2.043 . . . . 0.0 106.469 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.509 ' HG3' ' HA ' ' A' ' 171' ' ' ARG . 0.3 OUTLIER 59.16 100.38 0.02 OUTLIER 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.253 -176.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 49.0 t -132.17 170.09 15.49 Favored 'General case' 0 CA--C 1.556 1.209 0 O-C-N 121.609 -0.682 . . . . 0.0 112.503 -175.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.462 HG22 ' HB3' ' A' ' 169' ' ' SER . 21.6 p -67.79 133.0 48.47 Favored 'General case' 0 N--CA 1.42 -1.949 0 C-N-CA 125.125 1.37 . . . . 0.0 109.886 170.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.6 t70 42.17 72.37 0.17 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.457 1.103 . . . . 0.0 110.206 -171.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.453 ' CZ2' ' HB3' ' A' ' 129' ' ' LYS . 33.1 t-105 -101.29 115.23 30.02 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.816 -173.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -107.39 126.26 52.25 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.114 -174.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.455 HD11 HD13 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -139.86 168.21 18.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-O 121.545 0.688 . . . . 0.0 112.083 -179.673 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -142.0 133.07 26.08 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.382 177.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.34 172.76 11.8 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 178.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -129.69 124.18 32.96 Favored 'General case' 0 C--N 1.287 -2.112 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.143 -175.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.2 tp -107.06 129.73 54.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.295 -174.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.582 ' HB2' HG23 ' A' ' 86' ' ' ILE . 10.7 m-20 -122.79 137.41 54.93 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 158' ' ' PRO . 42.1 mm -124.09 145.96 30.36 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -122.39 97.67 0.6 Allowed Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 177.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.508 ' HB3' ' CE2' ' A' ' 147' ' ' PHE . 2.9 mm? -81.68 110.26 16.86 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 -178.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 28.7 m -96.35 108.17 20.64 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.613 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.515 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 53.6 m-85 -120.7 144.79 48.03 Favored 'General case' 0 CA--C 1.494 -1.208 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 154' ' ' ASP . 6.4 p-10 -116.37 116.09 27.08 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.499 -0.88 . . . . 0.0 109.327 176.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.651 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -106.02 130.43 23.0 Favored Pre-proline 0 C--N 1.298 -1.645 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.618 -177.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -42.75 -32.89 2.69 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 125.03 3.82 . . . . 0.0 115.572 -176.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.4 m -60.21 -34.37 56.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 60.0 t -135.78 -68.06 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.026 0.441 . . . . 0.0 109.976 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 163.06 -146.14 11.38 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.15 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 148' ' ' ASP . 6.3 p-10 -83.7 120.26 25.79 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.554 0.692 . . . . 0.0 112.571 -176.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.497 HD12 ' O ' ' A' ' 155' ' ' ILE . 2.5 pp -127.12 124.05 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.817 173.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.493 ' O ' ' HD3' ' A' ' 158' ' ' PRO . 56.9 m -88.12 117.38 26.96 Favored 'General case' 0 N--CA 1.424 -1.775 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.823 176.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 60.5 mt -95.81 104.77 17.57 Favored Pre-proline 0 C--N 1.303 -1.42 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.875 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.0 OUTLIER -85.39 138.85 6.62 Favored 'Trans proline' 0 CA--C 1.485 -1.971 0 C-N-CA 122.66 2.24 . . . . 0.0 111.762 176.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.594 HG21 ' HA ' ' A' ' 48' ' ' THR . 2.6 p -138.05 132.9 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.556 0 CA-C-N 112.953 -1.93 . . . . 0.0 109.661 -173.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.482 ' HB3' ' OD1' ' A' ' 142' ' ' ASP . 58.1 p -120.59 161.93 20.5 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.491 -176.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.3 t -166.09 165.41 17.8 Favored 'General case' 0 C--O 1.252 1.216 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -98.48 126.71 44.13 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -108.69 82.64 0.31 Allowed Glycine 0 N--CA 1.419 -2.476 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.43 120.37 30.7 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.447 ' CD1' HG21 ' A' ' 119' ' ' VAL . 5.7 pt -145.14 121.22 3.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.119 -170.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -104.18 139.75 38.78 Favored 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 117.887 -1.525 . . . . 0.0 109.511 174.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.455 HD13 HD11 ' A' ' 137' ' ' ILE . 6.8 mp -108.8 103.39 51.6 Favored Pre-proline 0 N--CA 1.405 -2.678 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.631 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.26 92.76 0.82 Allowed 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 123.165 2.576 . . . . 0.0 114.893 -172.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.462 ' HB3' HG22 ' A' ' 133' ' ' THR . 5.0 m 50.37 89.33 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 125.399 1.48 . . . . 0.0 114.086 171.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.49 ' HB2' ' SD ' ' A' ' 131' ' ' MET . 99.1 mt -108.69 -39.83 5.25 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.048 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.509 ' HA ' ' HG3' ' A' ' 131' ' ' MET . 36.4 mmt180 54.88 18.82 2.35 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 177.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -178.7 -29.73 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -176.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 C--N 1.315 -0.915 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -172.872 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 17' ' ' VAL . 1.9 p30 . . . . . 0 CA--C 1.533 0.325 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.16 -42.42 99.41 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 123.504 0.722 . . . . 0.0 110.821 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -65.71 -46.25 79.68 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.9 m -71.79 -23.07 21.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.299 -176.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 13' ' ' ASP . 77.4 t -61.72 -47.22 94.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 172.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -59.53 -37.19 77.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.762 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -60.51 -56.78 17.29 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.36 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -65.97 -39.2 90.16 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.893 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.57 -37.31 80.88 Favored 'General case' 0 C--O 1.221 -0.439 0 O-C-N 123.286 0.366 . . . . 0.0 110.805 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.0 t -63.39 -50.34 70.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.865 0.364 . . . . 0.0 110.451 178.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.05 -45.11 99.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.391 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.491 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 83.7 mt -66.18 -43.23 92.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.171 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.2 t -62.02 -35.57 78.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.796 0.332 . . . . 0.0 110.463 177.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.8 t -63.45 -41.28 98.64 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.97 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.559 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 3.9 tt -71.09 -41.68 70.3 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 96.3 mt -59.24 -39.68 83.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.092 0.473 . . . . 0.0 110.366 177.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -62.54 -41.9 99.18 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.559 ' HG2' ' O ' ' A' ' 27' ' ' LEU . 61.4 pttt -63.52 -34.38 77.66 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 119.921 -0.711 . . . . 0.0 109.523 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.66 -31.66 52.75 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.692 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.554 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 39.7 ttmt -51.12 -40.08 57.68 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.059 0.944 . . . . 0.0 112.884 -175.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.46 -8.86 54.32 Favored Glycine 0 C--N 1.313 -0.698 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.614 178.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 19.3 t80 -81.45 -25.9 35.72 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 124.435 1.094 . . . . 0.0 108.418 -175.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.554 ' CE2' ' HA ' ' A' ' 32' ' ' LYS . 22.5 m-85 -56.96 -36.57 70.44 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.627 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.64 -50.05 55.34 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.766 0.666 . . . . 0.0 112.396 -173.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -98.88 -43.71 6.63 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.277 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.486 ' N ' ' HD3' ' A' ' 38' ' ' LYS 0.295 2.7 mppt? -75.19 -3.92 35.8 Favored 'General case' 0 C--O 1.206 -1.22 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 -171.042 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.3 mt -117.38 1.0 12.33 Favored 'General case' 0 C--N 1.284 -2.251 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.808 173.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.44 -55.74 2.42 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.09 0.471 . . . . 0.0 110.521 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -86.14 -4.5 59.18 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.496 -177.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.7 mm -119.06 126.85 26.83 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.03 104.21 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.448 2.099 . . . . 0.0 110.415 176.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.441 HG22 ' CD1' ' A' ' 149' ' ' ILE . 5.8 p -128.26 154.37 78.93 Favored Pre-proline 0 C--N 1.302 -1.493 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.464 -174.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.467 ' HB3' ' HB2' ' A' ' 72' ' ' ASN . 65.6 Cg_endo -84.73 154.94 11.75 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.888 2.392 . . . . 0.0 112.02 178.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -121.04 136.93 54.87 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.39 167.6 13.1 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.98 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.4 t -155.49 145.21 21.31 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 123.506 0.503 . . . . 0.0 110.518 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.479 HG23 HG23 ' A' ' 159' ' ' VAL . 45.4 t -83.99 141.9 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 173.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' A' ' 67' ' ' LYS . 18.4 t70 -122.2 -54.18 1.91 Allowed 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -172.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -162.03 162.59 28.87 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -172.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.3 m -122.98 108.15 20.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 121.438 0.637 . . . . 0.0 110.024 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -90.9 121.08 32.44 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.601 -177.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 53.3 p90 -69.3 120.21 14.77 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.536 177.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -83.36 -49.4 9.39 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.423 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 178.95 -147.36 7.72 Favored Glycine 0 N--CA 1.41 -3.046 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 173' ' ' PHE . 7.5 p -111.67 138.42 40.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-O 121.02 0.438 . . . . 0.0 110.487 -174.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 24.5 m -127.15 145.13 50.86 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 175.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.429 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 17.8 tpt180 -104.61 78.36 1.45 Allowed 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 118.661 -1.216 . . . . 0.0 108.327 178.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -175.32 -70.33 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 -175.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.433 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . -138.2 -138.53 3.72 Favored Glycine 0 N--CA 1.411 -3.024 0 N-CA-C 104.298 -3.521 . . . . 0.0 104.298 167.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.04 134.28 41.52 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-N 118.675 1.238 . . . . 0.0 110.288 174.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -93.43 107.27 19.14 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.063 -175.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.517 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 4.5 m-85 -100.45 161.09 13.83 Favored 'General case' 0 CA--C 1.486 -1.511 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.005 176.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.416 ' CD2' ' HB3' ' A' ' 114' ' ' ASP . 3.3 t-160 -114.75 107.73 15.83 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 178.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -92.86 140.78 29.15 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.0 0.428 . . . . 0.0 112.022 -176.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.413 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . 75.2 mmtt -89.64 121.33 31.72 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.77 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.88 111.28 29.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.5 m -98.85 139.25 34.81 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 120.319 -0.553 . . . . 0.0 109.94 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.2 t -131.45 131.61 62.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 63.5 pttt -114.59 132.32 56.38 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 175.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.848 ' O ' ' HA ' ' A' ' 108' ' ' SER . 5.8 t30 -142.73 114.75 6.07 Favored Pre-proline 0 C--N 1.294 -1.835 0 C-N-CA 119.743 -0.783 . . . . 0.0 112.949 -175.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -94.36 99.62 0.12 Allowed 'Trans proline' 0 N--CA 1.436 -1.865 0 C-N-CA 122.365 2.043 . . . . 0.0 109.487 170.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.539 ' HB3' HD21 ' A' ' 72' ' ' ASN . 48.8 t80 -170.32 -14.82 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -176.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.426 ' H ' ' H ' ' A' ' 74' ' ' TYR . 24.1 t 83.14 -56.24 0.16 Allowed 'General case' 0 C--O 1.233 0.232 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 172.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.604 HE21 HG12 ' A' ' 78' ' ' ILE . 6.6 pt20 -69.46 152.89 44.33 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-N 118.719 0.691 . . . . 0.0 112.744 -176.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.6 p -77.14 111.82 13.15 Favored 'General case' 0 N--CA 1.411 -2.375 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.279 174.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.604 HG12 HE21 ' A' ' 76' ' ' GLN . 70.0 mt -93.27 114.9 64.09 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -65.07 139.16 59.88 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.374 2.05 . . . . 0.0 110.241 175.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 54.5 mt -88.2 114.83 27.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 58.3 m -55.76 -56.14 24.05 Favored 'General case' 0 C--N 1.319 -0.742 0 O-C-N 123.811 0.695 . . . . 0.0 109.521 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -167.81 160.72 12.7 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.113 176.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.442 HG23 HG23 ' A' ' 143' ' ' ILE . 25.0 mt -120.14 113.75 41.6 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.959 176.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.422 ' HB3' HG22 ' A' ' 98' ' ' THR . 28.8 p -88.29 117.22 27.05 Favored 'General case' 0 N--CA 1.405 -2.72 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -111.45 143.05 42.92 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.501 HG23 ' HB3' ' A' ' 142' ' ' ASP . 9.9 tt -137.13 108.74 6.38 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 CA-C-O 121.727 0.775 . . . . 0.0 109.15 176.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.586 HD11 ' HB3' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -106.84 145.91 31.57 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.506 -179.443 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.469 ' HA ' HG22 ' A' ' 94' ' ' ILE . 40.1 ttmt -118.43 152.58 35.61 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.831 -175.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.7 t -126.96 97.86 5.12 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 175.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.445 ' HA ' ' OD2' ' A' ' 138' ' ' ASP . . . 53.51 -94.96 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.98 1.312 . . . . 0.0 111.357 -175.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 85.5 m -166.34 85.13 0.3 Allowed 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 124.669 1.187 . . . . 0.0 108.513 175.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -160.06 -62.9 0.07 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 49.6 m -136.73 151.94 49.79 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.469 HG22 ' HA ' ' A' ' 88' ' ' LYS . 37.2 pt -134.72 -176.34 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.393 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.586 ' HB3' HD11 ' A' ' 87' ' ' LEU . . . -145.54 146.2 31.32 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 172.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.0 t -148.38 144.52 27.55 Favored 'General case' 0 N--CA 1.412 -2.357 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -166.73 166.38 39.0 Favored Glycine 0 N--CA 1.426 -2.025 0 C-N-CA 120.648 -0.786 . . . . 0.0 111.296 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.422 HG22 ' HB3' ' A' ' 84' ' ' SER . 40.5 p -110.18 119.89 40.72 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.2 tt -103.3 104.55 41.65 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.912 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 98' ' ' THR . 11.5 Cg_exo -72.79 128.06 12.93 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.058 2.505 . . . . 0.0 111.97 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.3 t70 52.08 79.48 0.34 Allowed Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 124.633 1.173 . . . . 0.0 111.997 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -101.47 8.82 0.52 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.788 2.325 . . . . 0.0 111.487 176.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 149.58 -168.39 29.8 Favored Glycine 0 N--CA 1.422 -2.236 0 N-CA-C 108.221 -1.952 . . . . 0.0 108.221 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.5 m -145.51 149.89 35.46 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 118.3 1.05 . . . . 0.0 111.956 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.74 118.38 22.23 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 177.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 29.2 m -66.11 -35.96 76.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -174.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 140.31 -137.45 8.35 Favored Glycine 0 N--CA 1.416 -2.676 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.848 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 65.4 m -77.68 101.44 6.62 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.474 0.655 . . . . 0.0 111.555 178.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 164.99 -172.29 40.62 Favored Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 177.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.4 t -114.43 114.34 25.71 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.776 0.798 . . . . 0.0 109.684 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.6 t -110.26 132.94 53.73 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.157 -177.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 20.5 m -99.63 106.54 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-O 121.791 0.805 . . . . 0.0 110.031 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 66.4 mt -95.46 164.58 12.75 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.84 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 4.9 m-20 -133.99 135.62 43.56 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.143 -178.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.65 132.23 24.1 Favored Pre-proline 0 C--N 1.305 -1.353 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -73.46 110.63 3.1 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 N-CA-C 107.122 -1.915 . . . . 0.0 107.122 168.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.7 t -113.28 140.17 34.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.627 -172.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.663 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -88.1 98.95 11.82 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.2 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.3 m -102.58 147.49 9.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 71.78 -22.88 0.19 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.887 0.875 . . . . 0.0 113.212 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -55.7 -36.5 67.23 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.002 0.521 . . . . 0.0 110.963 177.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.9 p -59.12 -46.3 88.67 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.647 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 14.2 tt -79.08 -32.56 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.282 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.561 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -57.38 -43.31 83.49 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.704 0.802 . . . . 0.0 112.643 -178.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.3 m -72.09 -22.33 21.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.3 m -93.51 -73.03 0.58 Allowed 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -177.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.461 ' H ' HD23 ' A' ' 127' ' ' LEU . 1.8 pt? -124.52 -12.96 7.17 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -176.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.561 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER 73.63 140.61 0.06 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.507 1.123 . . . . 0.0 109.826 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.522 ' HE3' ' HB2' ' A' ' 131' ' ' MET . 46.6 pttt -59.42 -19.88 50.67 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.138 0.575 . . . . 0.0 111.43 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 23.8 t70 82.23 -22.73 0.24 Allowed 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 125.226 1.41 . . . . 0.0 109.577 177.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.522 ' HB2' ' HE3' ' A' ' 129' ' ' LYS . 15.4 tpt 51.08 97.24 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 112.678 -2.055 . . . . 0.0 115.388 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 64.4 m -92.94 140.41 29.52 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 171.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.8 p -71.19 100.71 2.13 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-O 121.482 0.658 . . . . 0.0 110.606 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.546 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 14.0 t70 86.37 88.55 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.627 0 C-N-CA 126.852 2.061 . . . . 0.0 110.312 -174.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.422 ' HZ2' ' HB2' ' A' ' 129' ' ' LYS . 0.8 OUTLIER -158.5 158.88 34.9 Favored 'General case' 0 N--CA 1.412 -2.33 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 176.312 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -117.7 134.6 54.73 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.481 ' CG2' ' HB ' ' A' ' 165' ' ' ILE . 9.8 tt -97.4 133.22 39.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 C-N-CA 120.594 -0.442 . . . . 0.0 109.856 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.445 ' OD2' ' HA ' ' A' ' 90' ' ' ALA . 38.9 t70 -70.39 90.44 0.71 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.532 178.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -108.77 152.81 24.35 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.526 177.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.414 ' HB2' ' HB3' ' A' ' 88' ' ' LYS . 21.8 mp0 -137.86 146.64 43.65 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 41.2 tp -128.74 126.52 40.19 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 123.461 0.475 . . . . 0.0 110.391 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.501 ' HB3' HG23 ' A' ' 86' ' ' ILE . 14.1 t70 -127.32 125.82 41.48 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.442 HG23 HG23 ' A' ' 83' ' ' ILE . 42.6 mm -111.83 118.76 58.41 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 CA-C-O 120.953 0.406 . . . . 0.0 109.98 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -95.95 86.85 0.95 Allowed Glycine 0 N--CA 1.42 -2.422 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 173.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.712 HD13 ' H ' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -74.73 134.26 41.91 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.438 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.8 m -110.74 108.32 18.15 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.477 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.531 ' O ' ' HA ' ' A' ' 154' ' ' ASP . 80.0 m-85 -114.66 129.7 56.71 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 175.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -94.49 109.69 21.55 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.441 ' CD1' HG22 ' A' ' 44' ' ' THR . 64.6 mt -98.15 129.38 30.94 Favored Pre-proline 0 C--N 1.291 -1.974 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.7 -176.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -52.26 -34.84 61.44 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 123.854 3.036 . . . . 0.0 112.944 -178.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.43 -51.07 76.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.374 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 39.0 t -119.9 -69.28 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.418 -175.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 163.37 -141.14 6.93 Favored Glycine 0 N--CA 1.431 -1.644 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.531 ' HA ' ' O ' ' A' ' 147' ' ' PHE . 4.2 p30 -94.25 131.17 40.12 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 117.331 0.566 . . . . 0.0 111.914 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.27 115.7 33.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 176.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.599 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 24.8 p -86.16 115.92 24.03 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.098 175.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 54.4 mt -97.11 106.93 34.79 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -74.27 107.24 2.39 Favored 'Trans proline' 0 C--O 1.251 1.162 0 C-N-CA 121.929 1.753 . . . . 0.0 111.106 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.479 HG23 HG23 ' A' ' 49' ' ' VAL . 30.6 m -110.48 126.95 67.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.841 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.473 ' HB3' ' OD2' ' A' ' 142' ' ' ASP . 48.3 p -129.38 162.7 27.43 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.143 0.497 . . . . 0.0 112.209 -176.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.9 t -159.51 -177.83 6.69 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 177.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -97.81 119.19 35.97 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -103.56 97.27 1.43 Allowed Glycine 0 N--CA 1.415 -2.746 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -178.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -88.95 119.47 29.5 Favored 'General case' 0 C--N 1.265 -3.103 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 -176.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.481 ' HB ' ' CG2' ' A' ' 137' ' ' ILE . 38.4 mm -101.77 107.14 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.418 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 176.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -113.29 126.72 55.71 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.215 0.531 . . . . 0.0 110.161 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 134' ' ' ASP . 67.1 mt -121.93 95.09 47.89 Favored Pre-proline 0 C--N 1.289 -2.046 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.851 -172.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.4 92.14 0.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.882 2.388 . . . . 0.0 112.978 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.422 ' H ' ' N ' ' A' ' 134' ' ' ASP . 78.0 p 53.34 27.42 6.22 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.435 1.494 . . . . 0.0 113.267 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.528 HD21 ' CD1' ' A' ' 173' ' ' PHE . 22.7 tp -75.45 83.39 2.53 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -83.13 105.39 14.07 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.639 -173.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.1 t70 75.0 91.84 0.08 Allowed 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 124.694 1.198 . . . . 0.0 110.023 177.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.528 ' CD1' HD21 ' A' ' 170' ' ' LEU . 37.4 t80 . . . . . 0 C--N 1.303 -1.439 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 -175.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.9 t70 . . . . . 0 CA--C 1.543 0.698 0 CA-C-O 121.057 0.456 . . . . 0.0 111.328 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.69 ' O ' HG12 ' A' ' 17' ' ' VAL . 41.1 tt0 -73.52 -32.35 64.2 Favored 'General case' 0 C--O 1.209 -1.059 0 CA-C-O 121.852 0.834 . . . . 0.0 108.923 177.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -71.14 -33.55 70.18 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.626 0.727 . . . . 0.0 109.916 174.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.8 t -69.77 -29.28 40.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.993 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.69 HG12 ' O ' ' A' ' 14' ' ' GLU . 9.1 p -66.03 -25.53 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 120.001 -0.679 . . . . 0.0 109.208 177.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -72.08 -45.72 59.61 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.51 -38.22 89.05 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.684 175.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.459 ' O ' HG13 ' A' ' 24' ' ' ILE . 58.5 tptt -55.72 -48.86 74.44 Favored 'General case' 0 N--CA 1.425 -1.705 0 C-N-CA 123.257 0.623 . . . . 0.0 109.415 174.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.1 -35.75 82.13 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.734 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -62.53 -45.2 94.07 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.153 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.3 m -70.75 -32.32 48.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.84 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 20' ' ' LYS . 85.3 mt -65.18 -46.01 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 173.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.1 m -65.21 -35.36 80.83 Favored 'General case' 0 C--O 1.186 -2.243 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.689 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -59.57 -44.79 93.2 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-O 121.069 0.462 . . . . 0.0 109.999 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.533 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 5.2 tt -74.41 -44.03 53.76 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.499 HD13 HG22 ' A' ' 156' ' ' THR . 56.0 tp -63.14 -31.55 72.72 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-O 120.927 0.394 . . . . 0.0 110.78 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -66.77 -45.73 77.58 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 123.172 0.589 . . . . 0.0 111.17 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -71.05 -30.55 66.75 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.84 -44.22 70.34 Favored 'General case' 0 C--O 1.198 -1.627 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.788 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -60.61 -48.68 80.69 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -177.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.22 -30.96 79.27 Favored Glycine 0 C--O 1.239 0.411 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.413 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.464 ' HA ' ' HE2' ' A' ' 38' ' ' LYS . 61.9 t80 -75.98 -43.34 45.02 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 177.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.505 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 65.7 t80 -58.82 -53.81 54.14 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.768 1.227 . . . . 0.0 113.789 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.79 -19.18 49.02 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -174.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.479 ' HB2' ' HD3' ' A' ' 38' ' ' LYS . 31.2 mt-10 -116.39 -54.98 2.43 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.651 ' O ' HG12 ' A' ' 42' ' ' ILE . 3.2 mppt? -87.62 -27.44 22.5 Favored 'General case' 0 CA--C 1.466 -2.286 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.134 -170.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.505 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 86.6 mt -87.07 9.15 20.65 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 118.731 -1.188 . . . . 0.0 111.671 -176.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.07 -25.9 31.61 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.263 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -113.23 10.58 18.56 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.03 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.651 HG12 ' O ' ' A' ' 38' ' ' LYS . 47.5 mm -114.9 115.83 43.23 Favored Pre-proline 0 C--O 1.244 0.769 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -57.56 110.52 0.63 Allowed 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 122.728 2.285 . . . . 0.0 111.027 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.7 p -139.3 158.5 68.86 Favored Pre-proline 0 C--N 1.308 -1.202 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.333 -177.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.41 ' HB3' ' HB3' ' A' ' 72' ' ' ASN . 18.0 Cg_exo -70.04 128.21 15.45 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.33 2.02 . . . . 0.0 109.92 174.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -100.99 130.72 47.02 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.482 ' CB ' ' HG ' ' A' ' 145' ' ' LEU . . . -121.59 153.2 38.38 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.1 t -147.15 143.69 28.44 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.392 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.63 ' H ' HG11 ' A' ' 159' ' ' VAL . 14.9 p -119.79 142.28 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -165.07 -18.85 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.656 -171.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.467 ' HB3' ' CG ' ' A' ' 67' ' ' LYS . 19.1 t70 -120.1 128.1 53.15 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.877 -176.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 67.9 t -110.94 120.31 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.802 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 178.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -112.14 125.5 54.19 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 123.327 0.651 . . . . 0.0 111.912 -175.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -70.25 141.09 52.49 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 124.151 0.98 . . . . 0.0 113.148 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.593 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 59.1 mtpt -122.13 -79.04 0.6 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.295 176.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.6 -147.87 6.54 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 119.63 -1.271 . . . . 0.0 113.323 -176.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.1 p -98.42 149.79 5.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.155 0.502 . . . . 0.0 111.477 -173.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.1 t -152.71 -174.53 4.95 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -67.04 -63.84 0.98 Allowed 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 120.931 0.396 . . . . 0.0 110.372 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.404 ' HB2' ' HE2' ' A' ' 118' ' ' LYS . 9.1 m-20 -92.15 95.68 9.89 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.943 -172.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.17 -131.18 10.7 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.353 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 173' ' ' PHE . 6.8 t -127.02 135.03 64.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -178.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.593 ' O ' ' HB2' ' A' ' 55' ' ' LYS . 13.8 t70 -90.01 120.08 30.91 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 2.5 m-85 -122.4 172.77 8.09 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.934 0.873 . . . . 0.0 113.128 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.521 ' HB2' ' HD2' ' A' ' 55' ' ' LYS . 8.4 t-160 -126.0 108.84 11.78 Favored 'General case' 0 N--CA 1.421 -1.875 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.602 -177.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.34 143.43 26.76 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.467 ' CG ' ' HB3' ' A' ' 51' ' ' ASP . 44.8 mmtm -92.02 114.65 27.24 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 176.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.403 HG11 HD11 ' A' ' 145' ' ' LEU . 64.7 t -111.86 108.67 26.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.2 m -104.02 129.05 51.61 Favored 'General case' 0 C--N 1.284 -2.242 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.217 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 t -116.32 128.84 73.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.846 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 59.0 pttt -120.61 121.91 39.37 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.606 0.717 . . . . 0.0 109.317 178.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.732 ' O ' ' HA ' ' A' ' 108' ' ' SER . 24.3 p-10 -129.94 115.64 17.85 Favored Pre-proline 0 C--N 1.277 -2.572 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.595 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -93.41 97.77 0.15 Allowed 'Trans proline' 0 N--CA 1.425 -2.533 0 N-CA-C 107.166 -1.898 . . . . 0.0 107.166 165.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.422 ' CD2' HD11 ' A' ' 78' ' ' ILE . 25.9 t80 -157.39 -5.72 0.09 Allowed 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.684 -174.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.2 m 73.34 -2.38 2.76 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 174.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.509 HE21 HG12 ' A' ' 78' ' ' ILE . 9.3 pt20 -132.85 147.12 52.3 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.301 -0.875 . . . . 0.0 112.33 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.9 m -83.68 107.37 16.08 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.509 HG12 HE21 ' A' ' 76' ' ' GLN . 45.9 mt -94.39 122.39 61.33 Favored Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -177.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -66.74 113.33 2.71 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.075 1.85 . . . . 0.0 109.623 174.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 10.4 tt -72.0 134.98 28.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 54.9 m -61.1 -58.85 6.65 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.504 0.669 . . . . 0.0 109.733 -177.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -163.6 150.05 11.87 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.435 -177.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.9 mt -101.67 114.15 40.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 171.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.4 m -102.68 117.4 34.57 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.418 ' CD1' HG23 ' A' ' 117' ' ' VAL . 54.8 p90 -106.35 136.73 45.58 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.409 -178.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 54.6 mt -123.34 108.8 21.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 176.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.593 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 0.5 OUTLIER -91.86 121.19 33.24 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -174.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.692 ' HB2' ' HB2' ' A' ' 140' ' ' GLN . 1.0 OUTLIER -94.27 116.29 28.66 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.284 0.564 . . . . 0.0 109.632 172.734 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.501 ' CB ' ' HB3' ' A' ' 122' ' ' SER . 22.7 t -100.16 94.07 6.04 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -176.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 61.37 -80.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.262 1.025 . . . . 0.0 110.662 -174.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.5 m -158.8 -36.17 0.06 Allowed 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -87.03 104.51 16.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.964 -177.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.498 ' HB ' ' OG ' ' A' ' 122' ' ' SER . 29.7 m 70.83 164.61 0.28 Allowed 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.289 1.036 . . . . 0.0 112.01 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.593 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 2.1 pp -144.09 170.68 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.749 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -173.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.466 ' HB3' ' CD1' ' A' ' 87' ' ' LEU . . . -121.96 154.88 36.61 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 172.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 t -159.87 168.05 26.69 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.172 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.59 151.57 8.76 Favored Glycine 0 N--CA 1.427 -1.941 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.533 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 20.3 p -109.06 116.84 32.73 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 54.6 mt -98.66 101.61 12.38 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 98' ' ' THR . 3.1 Cg_exo -78.28 123.24 5.99 Favored 'Trans proline' 0 C--O 1.241 0.661 0 C-N-CA 123.035 2.49 . . . . 0.0 111.21 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.3 t70 54.43 79.51 0.34 Allowed Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 124.83 1.252 . . . . 0.0 111.007 -174.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -104.74 25.06 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.676 2.918 . . . . 0.0 110.685 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.41 -172.9 18.09 Favored Glycine 0 N--CA 1.409 -3.122 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 -175.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 64.7 m -151.47 170.09 20.47 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 176.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.644 ' HA ' HG21 ' A' ' 111' ' ' THR 0.312 0.0 OUTLIER -98.88 158.15 15.83 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 179.863 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 22.9 m -72.2 -176.65 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 124.328 1.017 . . . . 0.0 110.989 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.42 -47.88 54.84 Favored Glycine 0 C--N 1.307 -1.068 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.24 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.732 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 21.3 t -160.07 94.01 1.09 Allowed 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 176.64 -168.83 41.05 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.318 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.5 m -113.04 114.06 26.33 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.644 HG21 ' HA ' ' A' ' 105' ' ' LEU . 10.2 t -113.34 138.41 50.09 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 26.4 t -96.89 118.04 42.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 121.013 0.435 . . . . 0.0 109.884 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.0 mt -98.25 159.56 14.86 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.967 -178.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -104.76 130.09 52.89 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.337 -175.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.2 t -125.72 114.36 24.84 Favored Pre-proline 0 CA--C 1.5 -0.978 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.431 172.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 2.7 Cg_exo -77.77 110.16 2.88 Favored 'Trans proline' 0 N--CA 1.423 -2.635 0 N-CA-C 107.528 -1.758 . . . . 0.0 107.528 168.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.418 HG23 ' CD1' ' A' ' 85' ' ' TYR . 12.3 p -115.81 137.52 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.404 ' HE2' ' HB2' ' A' ' 60' ' ' ASP . 50.1 mtpt -94.78 99.88 11.88 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -175.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.4 HG13 ' HB2' ' A' ' 64' ' ' TYR . 16.4 m -94.32 149.3 4.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -168.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 76.8 -12.8 1.0 Allowed 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 124.724 1.209 . . . . 0.0 113.334 172.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -48.2 -50.38 29.47 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 124.223 0.952 . . . . 0.0 112.987 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.501 ' HB3' ' CB ' ' A' ' 89' ' ' SER . 34.6 t -66.65 -43.49 84.48 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.438 -0.905 . . . . 0.0 112.382 -169.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.456 HD11 HD11 ' A' ' 137' ' ' ILE . 24.3 pt -79.02 -27.73 13.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.444 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -58.48 -41.14 84.59 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 174.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.6 t -56.98 -39.43 65.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.694 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 36.4 t -89.88 -84.94 0.22 Allowed 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.643 ' H ' HD23 ' A' ' 127' ' ' LEU . 1.9 pt? -106.84 -17.79 14.11 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 120.854 0.359 . . . . 0.0 111.963 -175.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.529 ' C ' ' HD3' ' A' ' 129' ' ' LYS . 23.8 ttt 58.22 39.24 25.99 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.02 0.928 . . . . 0.0 111.031 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.588 ' HG3' ' NE1' ' A' ' 135' ' ' TRP 0.306 0.0 OUTLIER 48.98 -73.1 0.0 OUTLIER 'General case' 0 C--N 1.363 1.156 0 C-N-CA 125.125 1.37 . . . . 0.0 114.169 -177.244 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -178.57 -32.15 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.62 ' SD ' ' HA ' ' A' ' 171' ' ' ARG . 0.7 OUTLIER 62.66 81.93 0.19 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.374 -178.127 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 29.0 m -108.98 172.31 6.92 Favored 'General case' 0 C--O 1.251 1.173 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.696 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 30.5 p -81.81 108.12 15.09 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 169.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.539 ' H ' ' H ' ' A' ' 169' ' ' SER . 24.8 m-20 76.36 98.04 0.07 Allowed 'General case' 0 CA--C 1.496 -1.118 0 O-C-N 124.167 0.917 . . . . 0.0 109.836 -175.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.588 ' NE1' ' HG3' ' A' ' 129' ' ' LYS . 69.9 t-105 -140.02 119.83 13.42 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.362 -174.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 166' ' ' LYS . 22.7 t70 -91.01 111.82 23.45 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 174.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.456 HD11 HD11 ' A' ' 123' ' ' ILE . 8.2 tt -97.42 149.27 5.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.238 -170.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -86.47 103.07 14.66 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.398 177.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.416 ' HD1' ' O ' ' A' ' 163' ' ' GLY . 7.0 t80 -137.66 150.24 47.21 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.692 ' HB2' ' HB2' ' A' ' 88' ' ' LYS . 48.9 mt-30 -139.74 158.82 43.47 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.9 tp -141.67 130.49 22.96 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.45 0.643 . . . . 0.0 112.232 -175.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.462 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 2.3 m-20 -125.92 129.51 49.45 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 54.3 mt -130.36 131.86 65.17 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.486 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.392 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -105.42 109.95 3.35 Favored Glycine 0 N--CA 1.405 -3.391 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 156' ' ' THR . 2.6 mm? -89.13 110.18 20.95 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 32.1 m -95.5 108.97 21.24 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.572 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -114.47 152.66 31.27 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -120.25 114.35 21.76 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 175.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 49.6 mm -110.94 116.28 52.02 Favored Pre-proline 0 C--N 1.287 -2.116 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -45.82 -33.0 9.86 Favored 'Trans proline' 0 N--CA 1.485 1.009 0 C-N-CA 123.892 3.061 . . . . 0.0 113.891 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 44.6 t -69.81 -23.66 25.97 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 123.198 0.599 . . . . 0.0 112.166 -177.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 9.1 p -136.86 -33.29 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -175.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 122.01 -151.11 16.95 Favored Glycine 0 N--CA 1.434 -1.498 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.185 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -87.52 117.9 26.62 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.429 0.633 . . . . 0.0 110.647 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.4 123.36 49.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.33 0.586 . . . . 0.0 110.711 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 40.9 m -99.19 127.12 45.12 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.551 177.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.1 mp -89.68 122.1 68.45 Favored Pre-proline 0 C--N 1.318 -0.804 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -83.4 113.59 2.04 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.818 2.345 . . . . 0.0 112.362 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.63 HG11 ' H ' ' A' ' 49' ' ' VAL . 21.9 t -111.89 119.12 59.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 173.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 67.9 p -128.41 127.15 42.02 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 123.13 0.269 . . . . 0.0 111.073 -175.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.1 t -158.64 177.36 11.29 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -98.66 148.75 23.51 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.416 ' O ' ' HD1' ' A' ' 139' ' ' TYR . . . -118.62 83.32 0.35 Allowed Glycine 0 N--CA 1.416 -2.669 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -88.82 119.92 29.75 Favored 'General case' 0 C--N 1.273 -2.729 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.4 HG13 ' CG2' ' A' ' 137' ' ' ILE . 4.9 pt -133.66 123.11 45.01 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-O 121.304 0.573 . . . . 0.0 111.915 -175.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.642 ' HD3' ' H ' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -89.69 109.81 20.76 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.925 178.249 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -90.5 107.44 20.15 Favored Pre-proline 0 C--N 1.288 -2.101 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.077 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -86.35 94.13 0.55 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 122.654 2.236 . . . . 0.0 112.996 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.539 ' H ' ' H ' ' A' ' 134' ' ' ASP . 78.2 p 50.83 105.24 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.351 1.46 . . . . 0.0 114.854 178.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -128.78 -70.82 0.66 Allowed 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.62 ' HA ' ' SD ' ' A' ' 131' ' ' MET . 81.0 mtp180 59.08 79.29 0.23 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 114.231 1.196 . . . . 0.0 114.231 177.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 171' ' ' ARG . 32.5 t70 172.8 -77.71 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 123.978 0.799 . . . . 0.0 111.332 173.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.446 ' O ' HG22 ' A' ' 62' ' ' VAL . 52.6 p90 . . . . . 0 C--N 1.315 -0.899 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -174.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.5 t70 . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 121.124 0.488 . . . . 0.0 110.389 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.412 ' HA ' HG12 ' A' ' 17' ' ' VAL . 40.8 tt0 -64.88 -46.11 83.17 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.682 176.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -54.29 -49.52 69.41 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 123.977 0.911 . . . . 0.0 111.679 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.3 m -77.96 -27.3 14.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 14' ' ' GLU . 7.1 p -72.8 -31.42 36.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 119.534 -0.867 . . . . 0.0 109.756 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -60.59 -42.18 96.21 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -59.13 -52.49 65.48 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.657 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -62.61 -44.58 95.93 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.55 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.43 ' HB2' HD11 ' A' ' 94' ' ' ILE . . . -60.83 -40.57 93.32 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.453 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.5 t -60.78 -44.89 96.21 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 123.439 0.462 . . . . 0.0 110.374 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.7 t -60.45 -46.0 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.213 0.53 . . . . 0.0 110.172 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.1 mm -64.95 -47.91 86.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.085 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.1 m -62.88 -29.67 70.94 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.048 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.2 t -65.19 -31.42 72.59 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 120.997 0.427 . . . . 0.0 110.207 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.2 tt -73.92 -42.1 61.1 Favored 'General case' 0 C--O 1.246 0.916 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.495 HD23 ' HB3' ' A' ' 158' ' ' PRO . 8.6 mp -58.89 -35.08 72.42 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.153 175.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -51.02 -49.27 60.82 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.414 ' HD2' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -75.56 -27.95 58.81 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.391 -178.316 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.428 ' HB1' ' O ' ' A' ' 156' ' ' THR . . . -77.36 -34.31 55.09 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.179 -176.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 99.5 mttt -59.14 -37.42 77.22 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 121.08 0.467 . . . . 0.0 109.779 177.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.99 -44.06 97.95 Favored Glycine 0 N--CA 1.431 -1.661 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.758 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -80.47 -39.27 28.38 Favored 'General case' 0 C--O 1.198 -1.648 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.685 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -58.57 -31.7 68.23 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.4 -37.38 83.02 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.754 0.311 . . . . 0.0 111.799 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -116.9 -48.32 2.66 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -175.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.436 ' HE2' ' HB2' ' A' ' 38' ' ' LYS . 12.8 tppt? -69.56 -48.55 59.9 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 122.364 1.078 . . . . 0.0 109.195 -169.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.48 HD22 HG21 ' A' ' 44' ' ' THR . 39.4 mt -88.51 0.87 55.85 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.187 -171.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.17 -20.03 18.23 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.712 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -110.4 -24.9 10.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.945 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 72.1 mt -93.54 142.03 24.64 Favored Pre-proline 0 N--CA 1.431 -1.395 0 N-CA-C 106.789 -1.559 . . . . 0.0 106.789 177.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -67.24 105.25 0.99 Allowed 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 121.888 1.725 . . . . 0.0 108.376 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.48 HG21 HD22 ' A' ' 39' ' ' LEU . 4.2 m -125.11 141.46 38.6 Favored Pre-proline 0 N--CA 1.415 -2.185 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -173.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.38 113.06 1.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.903 1.735 . . . . 0.0 111.079 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -96.84 121.98 39.3 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.185 0.517 . . . . 0.0 110.396 -174.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.507 ' HB2' HD21 ' A' ' 145' ' ' LEU . . . -98.71 157.88 15.98 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.076 -179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -148.72 129.1 13.84 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.924 176.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.408 ' H ' HG11 ' A' ' 159' ' ' VAL . 13.0 p -113.69 137.16 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 175.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -151.04 -35.67 0.14 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.735 -168.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -116.61 147.59 41.74 Favored 'General case' 0 CA--C 1.463 -2.373 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.49 -173.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.547 HG22 ' CB ' ' A' ' 64' ' ' TYR . 8.2 p -150.85 103.05 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.404 -2.765 0 CA-C-O 122.58 1.181 . . . . 0.0 107.885 175.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -96.51 129.56 43.86 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.095 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 44.3 p90 -59.62 122.19 13.48 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.261 0.553 . . . . 0.0 111.026 175.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -85.43 -56.05 3.71 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.138 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.48 -137.63 2.59 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -178.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.1 p -112.65 141.85 26.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.6 m -114.53 166.1 12.06 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -55.84 -54.83 39.77 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -99.25 -62.84 1.18 Allowed 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.635 -177.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -108.64 -130.07 6.08 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 175.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.563 HG21 ' CZ ' ' A' ' 173' ' ' PHE . 7.1 p -140.16 137.38 37.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.269 0.557 . . . . 0.0 111.271 177.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -104.04 122.97 46.36 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.789 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.547 ' CB ' HG22 ' A' ' 52' ' ' VAL . 3.7 m-30 -109.09 167.33 10.18 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.27 0.557 . . . . 0.0 110.665 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -106.29 106.79 17.47 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.08 144.87 26.69 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.604 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -107.83 125.12 51.06 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.042 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.2 t -126.89 107.78 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 176.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.5 m -98.57 139.7 33.91 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 110' ' ' THR . 22.8 t -124.56 127.13 72.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.486 -178.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 88.6 tttt -110.85 117.7 34.13 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.549 ' HB3' ' O ' ' A' ' 107' ' ' GLY . 37.0 t30 -118.99 127.13 26.69 Favored Pre-proline 0 CA--C 1.507 -0.676 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.088 -173.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 72' ' ' ASN . 11.3 Cg_endo -94.01 96.02 0.13 Allowed 'Trans proline' 0 N--CA 1.428 -2.326 0 C-N-CA 121.42 1.414 . . . . 0.0 110.074 169.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.502 ' HB2' HD21 ' A' ' 72' ' ' ASN . 42.7 m-85 175.81 162.27 0.32 Allowed 'General case' 0 CA--C 1.492 -1.273 0 C-N-CA 129.173 2.989 . . . . 0.0 104.21 -178.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 51.7 p -100.85 -16.43 17.26 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.605 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -79.77 149.92 30.94 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 121.573 0.701 . . . . 0.0 112.048 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.8 p -80.38 104.97 11.29 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.433 172.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.418 ' H ' HD22 ' A' ' 105' ' ' LEU . 52.9 mt -91.05 117.61 68.01 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -85.34 152.46 10.62 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.945 1.763 . . . . 0.0 112.531 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.636 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -88.29 143.7 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.598 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 51.0 t -78.47 -35.52 46.49 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -170.23 157.22 6.17 Favored 'General case' 0 C--O 1.252 1.223 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.5 mt -118.33 115.62 48.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 171.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 20.8 p -112.81 118.57 35.31 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.316 -176.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 96' ' ' SER . 37.9 p90 -104.15 143.2 33.25 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 58.2 mt -132.76 108.08 12.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 173.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 87' ' ' LEU . 4.2 pp -105.55 134.44 48.67 Favored 'General case' 0 C--N 1.282 -2.369 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.359 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.516 ' HA ' HG22 ' A' ' 94' ' ' ILE . 40.3 ttmt -110.93 123.98 51.21 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.06 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.486 ' OG ' ' HB2' ' A' ' 122' ' ' SER . 53.2 p -104.26 98.63 8.4 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 64.5 -79.94 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.264 1.426 . . . . 0.0 114.819 174.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.8 t -135.11 -29.65 1.1 Allowed 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -172.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -143.91 145.63 32.41 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.582 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 m 71.19 130.41 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.197 0 O-C-N 125.28 1.612 . . . . 0.0 110.836 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.516 HG22 ' HA ' ' A' ' 88' ' ' LYS . 1.8 pp -127.4 165.35 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.11 122.02 36.72 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 61.3 p -120.81 147.19 45.7 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -163.37 144.98 10.01 Favored Glycine 0 N--CA 1.432 -1.626 0 C-N-CA 119.844 -1.17 . . . . 0.0 112.248 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.8 p -107.97 115.63 30.48 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.5 tt -101.81 114.45 65.58 Favored Pre-proline 0 C--N 1.307 -1.25 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.764 177.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -85.71 129.49 3.56 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 122.617 2.211 . . . . 0.0 111.457 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.9 t70 50.45 79.38 0.35 Allowed Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 124.608 1.163 . . . . 0.0 113.21 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -99.71 2.45 0.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.126 2.55 . . . . 0.0 112.09 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 151.94 -166.62 30.97 Favored Glycine 0 N--CA 1.42 -2.382 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.3 p -137.76 155.7 48.77 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.255 0.55 . . . . 0.0 110.763 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.624 ' HA ' HG21 ' A' ' 111' ' ' THR . 6.3 tt -90.64 125.36 35.63 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.412 HG22 ' HB ' ' A' ' 111' ' ' THR . 33.7 m -65.36 -30.7 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -172.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.577 ' H ' HD23 ' A' ' 105' ' ' LEU . . . 135.26 -113.24 1.09 Allowed Glycine 0 N--CA 1.417 -2.598 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -176.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.8 p -91.85 97.85 11.24 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 124.25 1.02 . . . . 0.0 111.136 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 140.53 -164.07 26.37 Favored Glycine 0 N--CA 1.418 -2.555 0 C-N-CA 119.947 -1.12 . . . . 0.0 111.485 176.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 11.0 t -95.7 139.94 31.23 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-O 121.919 0.866 . . . . 0.0 111.104 -178.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.624 HG21 ' HA ' ' A' ' 105' ' ' LEU . 4.9 t -134.78 121.0 20.09 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 176.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.7 t -87.74 110.45 20.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.582 -177.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.3 mt -97.48 162.29 13.38 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -141.54 144.02 34.07 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.479 -0.489 . . . . 0.0 111.46 -175.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 51.7 t -135.01 136.41 24.92 Favored Pre-proline 0 C--O 1.241 0.606 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.557 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -79.5 111.34 2.81 Favored 'Trans proline' 0 N--CA 1.432 -2.135 0 N-CA-C 107.586 -1.736 . . . . 0.0 107.586 168.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 24.6 m -112.67 133.88 57.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -89.01 92.0 9.06 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.783 0.802 . . . . 0.0 110.183 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.492 ' C ' ' H ' ' A' ' 121' ' ' TYR . 3.2 m -95.24 149.73 4.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.383 -172.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 74.36 -20.15 0.33 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.54 0.736 . . . . 0.0 111.87 175.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.492 ' H ' ' C ' ' A' ' 119' ' ' VAL . 21.4 t80 -46.11 -45.29 16.29 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 126.461 1.904 . . . . 0.0 109.782 176.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.486 ' HB2' ' OG ' ' A' ' 89' ' ' SER . 18.0 m -68.21 -52.42 34.44 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-N 115.275 -0.875 . . . . 0.0 113.039 -174.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 12.6 tt -74.61 -36.08 39.86 Favored 'Isoleucine or valine' 0 C--O 1.251 1.178 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -174.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.38 -50.66 72.71 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 122.269 0.227 . . . . 0.0 111.294 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.2 m -72.7 -22.67 20.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.9 t -77.27 -69.86 0.5 Allowed 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.808 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.483 ' H ' HD23 ' A' ' 127' ' ' LEU . 1.7 pt? -124.1 -23.72 4.51 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -177.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.476 ' O ' ' HD2' ' A' ' 129' ' ' LYS . 0.0 OUTLIER 66.3 -176.55 0.19 Allowed 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -177.223 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.476 ' HD2' ' O ' ' A' ' 128' ' ' MET . 12.2 mmmm -133.31 -71.25 0.52 Allowed 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 178.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.409 ' H ' ' HB2' ' A' ' 129' ' ' LYS . 15.8 t70 152.85 80.93 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 128.978 2.911 . . . . 0.0 104.419 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.418 ' HE1' ' HB2' ' A' ' 170' ' ' LEU . 1.0 OUTLIER -91.31 115.47 28.06 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.509 -178.72 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 169' ' ' SER . 83.1 m -131.09 -81.04 0.53 Allowed 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -178.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 41.5 p -142.01 116.86 9.86 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 123.287 0.635 . . . . 0.0 109.915 -169.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.6 t70 59.97 82.07 0.16 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 122.08 0.943 . . . . 0.0 109.419 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -140.86 158.96 43.22 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.5 -172.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -147.72 154.89 41.14 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 118.683 0.674 . . . . 0.0 110.864 175.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.5 tt -148.63 149.68 14.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.139 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -114.14 134.17 55.08 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.452 ' HE2' HD22 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -125.49 170.76 11.09 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 178.014 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 162' ' ' GLN . 24.3 tt0 -119.17 137.41 53.63 Favored 'General case' 0 C--N 1.273 -2.741 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.297 -177.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 28.5 tp -119.57 128.23 53.71 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.975 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.62 ' OD1' ' HB3' ' A' ' 160' ' ' SER . 17.1 t70 -130.71 112.2 12.87 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 35.4 mt -113.31 122.57 67.7 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.31 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.962 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -106.68 101.95 1.81 Allowed Glycine 0 N--CA 1.398 -3.892 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.507 HD21 ' HB2' ' A' ' 47' ' ' ALA . 0.8 OUTLIER -91.77 143.07 26.91 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.87 174.289 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.8 m -114.4 111.34 21.29 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.316 -175.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.495 ' CE1' HG23 ' A' ' 80' ' ' ILE . 90.1 m-85 -106.71 163.43 12.92 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 172.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -146.64 131.44 18.01 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.357 177.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.26 135.71 15.28 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 176.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -48.92 -18.34 1.64 Allowed 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 124.393 3.395 . . . . 0.0 114.927 -178.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 55.7 t -57.23 -39.07 65.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 121.133 0.492 . . . . 0.0 110.332 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 5.8 p -136.69 -36.15 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.238 0.542 . . . . 0.0 111.238 -178.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 120.53 -142.52 15.89 Favored Glycine 0 N--CA 1.419 -2.499 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -178.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -92.04 126.45 37.13 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.164 0.507 . . . . 0.0 110.01 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.41 ' N ' HD13 ' A' ' 155' ' ' ILE . 0.2 OUTLIER -139.85 133.56 36.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.37 176.849 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 11.4 t -100.5 147.98 25.29 Favored 'General case' 0 N--CA 1.412 -2.345 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 173.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 60.0 mt -110.48 109.35 58.25 Favored Pre-proline 0 C--N 1.291 -1.94 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.495 ' HB3' HD23 ' A' ' 28' ' ' LEU . 17.1 Cg_exo -70.82 102.64 1.22 Allowed 'Trans proline' 0 C--O 1.244 0.806 0 C-N-CA 122.693 2.262 . . . . 0.0 111.376 177.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 142' ' ' ASP . 14.2 t -103.83 108.77 25.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.62 ' HB3' ' OD1' ' A' ' 142' ' ' ASP . 52.1 p -109.04 150.89 27.11 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.817 -177.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.8 t -168.07 151.97 6.11 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 140' ' ' GLN . 12.9 pt20 -107.69 119.23 38.84 Favored 'General case' 0 N--CA 1.42 -1.934 0 C-N-CA 119.296 -0.962 . . . . 0.0 109.345 174.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -92.96 118.76 5.7 Favored Glycine 0 N--CA 1.409 -3.126 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.696 -174.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -89.68 119.59 30.23 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 176.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.3 pt -129.59 111.95 23.38 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 CA-C-O 121.521 0.677 . . . . 0.0 111.524 -174.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -78.85 130.11 35.31 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.604 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 87.7 mt -106.39 109.17 62.94 Favored Pre-proline 0 C--N 1.293 -1.859 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.006 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.8 172.05 17.03 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.185 1.924 . . . . 0.0 111.765 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 49.1 p -53.28 105.65 0.14 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 123.253 0.621 . . . . 0.0 111.495 175.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.418 ' HB2' ' HE1' ' A' ' 131' ' ' MET . 79.7 mt -137.38 -50.31 0.62 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 62.75 113.93 0.02 OUTLIER 'General case' 0 C--N 1.355 0.843 0 O-C-N 124.213 0.945 . . . . 0.0 112.815 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 33.1 t70 87.23 8.95 0.18 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.762 1.225 . . . . 0.0 111.094 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.563 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 72.5 t80 . . . . . 0 CA--C 1.54 0.572 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.34 174.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.857 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -100.98 -15.67 17.41 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 117.305 0.553 . . . . 0.0 111.256 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.471 ' HB2' ' O ' ' A' ' 127' ' ' LEU . 44.6 m-70 -80.2 72.76 7.04 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.683 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -157.11 154.06 28.8 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 59.94 64.75 1.22 Allowed 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 124.239 1.016 . . . . 0.0 111.248 -178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -149.38 118.47 6.75 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 175.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . 0.256 21.1 p80 -132.57 89.56 2.66 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.7 tt -137.24 93.96 2.88 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 171.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 52.41 41.88 30.91 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.61 -1.632 . . . . 0.0 108.761 -173.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 74.4 -67.55 0.25 Allowed 'General case' 0 C--N 1.356 0.874 0 C-N-CA 126.124 1.77 . . . . 0.0 109.758 -173.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.5 m -158.89 122.38 3.82 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 176.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.57 -43.0 75.52 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.528 0.518 . . . . 0.0 112.122 -175.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.471 ' O ' HG23 ' A' ' 17' ' ' VAL . 7.8 m-20 -63.77 -49.96 70.92 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.928 0.394 . . . . 0.0 111.019 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.22 -40.66 86.53 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -177.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -70.28 -53.81 15.29 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.955 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.409 ' HA ' ' CG ' ' A' ' 19' ' ' GLU . 33.4 m -62.7 -27.96 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.543 HG11 ' O ' ' A' ' 94' ' ' ILE . 73.3 t -62.92 -41.23 91.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.024 175.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -66.93 -36.3 81.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.79 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.409 ' CG ' ' HA ' ' A' ' 16' ' ' VAL . 7.5 mm-40 -53.3 -54.0 42.8 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.36 0.664 . . . . 0.0 109.719 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -65.94 -47.86 73.29 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.258 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.69 -43.48 80.53 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.095 -176.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -57.19 -45.81 83.39 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 123.59 0.556 . . . . 0.0 111.045 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.01 -42.02 79.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.431 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 73.9 mt -58.22 -46.97 88.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.891 177.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.7 m -61.99 -30.87 71.24 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.868 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.6 m -67.69 -40.18 84.38 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.076 0.465 . . . . 0.0 110.575 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.643 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 6.5 tt -72.74 -33.62 66.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.071 0.462 . . . . 0.0 109.993 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 96.5 mt -65.86 -38.72 89.57 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.428 0.632 . . . . 0.0 109.485 175.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -66.31 -34.38 77.85 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.225 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.643 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -64.11 -33.55 76.02 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-O 121.533 0.682 . . . . 0.0 109.432 178.264 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.561 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -77.64 -32.47 53.36 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.933 -178.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -53.46 -52.91 57.98 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.21 -24.93 75.66 Favored Glycine 0 N--CA 1.468 0.806 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.667 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.612 ' CZ ' ' HD2' ' A' ' 38' ' ' LYS . 10.9 t80 -68.79 -40.1 79.78 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 124.165 0.986 . . . . 0.0 110.263 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.495 ' CD1' HD12 ' A' ' 39' ' ' LEU . 20.2 m-85 -62.27 -45.57 92.68 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.313 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.74 -48.72 63.54 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 124.505 1.128 . . . . 0.0 113.061 -174.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -104.61 -36.13 7.59 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 119.414 -0.914 . . . . 0.0 113.349 -176.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.612 ' HD2' ' CZ ' ' A' ' 34' ' ' PHE . 21.6 ttmm -87.01 -43.49 12.3 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.342 -173.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.495 HD12 ' CD1' ' A' ' 35' ' ' PHE . 22.7 mt -87.28 19.04 3.37 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.204 -0.998 . . . . 0.0 111.907 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.89 -18.24 13.98 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.43 ' N ' HD22 ' A' ' 41' ' ' ASN . 0.8 OUTLIER -107.46 -21.07 13.05 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.788 177.151 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.3 mm -111.59 107.21 56.8 Favored Pre-proline 0 N--CA 1.442 -0.845 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.454 ' HB2' ' OH ' ' A' ' 74' ' ' TYR . 24.8 Cg_exo -64.26 118.0 4.99 Favored 'Trans proline' 0 C--O 1.251 1.149 0 C-N-CA 122.643 2.229 . . . . 0.0 112.294 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.1 p -128.73 150.32 74.53 Favored Pre-proline 0 C--N 1.299 -1.629 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.213 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.484 ' HB3' ' HB2' ' A' ' 72' ' ' ASN . 34.7 Cg_endo -63.48 149.23 91.61 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.988 2.459 . . . . 0.0 112.155 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -110.85 137.79 48.06 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.448 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.529 ' O ' HG11 ' A' ' 159' ' ' VAL . . . -115.65 165.33 13.15 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.331 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.4 t -161.89 147.39 13.28 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 110.518 -0.178 . . . . 0.0 110.518 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.519 ' HB ' ' OG1' ' A' ' 161' ' ' THR . 89.8 t -91.32 140.93 15.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 174.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -116.07 -60.94 1.8 Allowed 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -175.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -161.66 165.91 27.54 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -167.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.482 HG12 ' HB2' ' A' ' 66' ' ' ALA . 26.1 m -124.15 137.72 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -96.18 126.63 41.54 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.436 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -58.61 109.19 0.75 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 168.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.51 -53.29 1.36 Allowed 'General case' 0 N--CA 1.426 -1.668 0 C-N-CA 119.029 -1.068 . . . . 0.0 112.677 -172.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.91 -172.88 31.93 Favored Glycine 0 N--CA 1.425 -2.078 0 C-N-CA 119.184 -1.484 . . . . 0.0 112.309 -174.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.459 ' HB ' ' CD1' ' A' ' 173' ' ' PHE . 12.2 p -128.77 155.69 40.85 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-O 121.129 0.49 . . . . 0.0 110.927 -175.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 48.4 m -125.88 149.47 48.66 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 173.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 60' ' ' ASP . 37.3 mmt180 -79.0 77.2 5.47 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 118.621 -1.232 . . . . 0.0 112.22 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 59' ' ' ARG . 9.9 t70 171.74 -48.08 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.163 1.385 . . . . 0.0 107.668 176.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -150.19 177.95 27.97 Favored Glycine 0 C--O 1.223 -0.549 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 119' ' ' VAL . 6.5 m -87.83 156.09 3.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 118.743 1.272 . . . . 0.0 110.842 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -111.5 105.37 13.93 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.312 0.577 . . . . 0.0 109.75 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -110.64 159.76 17.29 Favored 'General case' 0 CA--C 1.48 -1.726 0 CA-C-O 122.084 0.945 . . . . 0.0 112.588 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -107.61 106.63 17.08 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.482 ' HB2' HG12 ' A' ' 52' ' ' VAL . . . -97.87 144.81 27.06 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -94.72 135.53 36.09 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.175 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.9 t -130.93 108.49 15.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 174.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.0 m -102.38 133.64 46.98 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.057 -175.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.3 t -123.32 133.33 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -119.93 128.22 53.4 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.532 HD21 ' HB2' ' A' ' 74' ' ' TYR . 6.0 t30 -142.89 114.92 5.99 Favored Pre-proline 0 C--N 1.284 -2.257 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.585 -175.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -94.17 96.17 0.13 Allowed 'Trans proline' 0 N--CA 1.422 -2.726 0 C-N-CA 121.835 1.69 . . . . 0.0 110.248 172.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.532 ' HB2' HD21 ' A' ' 72' ' ' ASN . 68.9 m-85 -176.33 127.55 0.2 Allowed 'General case' 0 CA--C 1.482 -1.671 0 C-N-CA 128.105 2.562 . . . . 0.0 104.788 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.4 m -84.32 68.83 10.35 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.442 0.639 . . . . 0.0 111.012 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.447 HE21 HD11 ' A' ' 78' ' ' ILE . 12.9 pt20 -151.8 145.77 25.22 Favored 'General case' 0 N--CA 1.407 -2.612 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.82 176.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 44.6 p -86.76 101.56 13.44 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.776 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.447 HD11 HE21 ' A' ' 76' ' ' GLN . 28.1 mt -94.72 117.61 66.91 Favored Pre-proline 0 N--CA 1.441 -0.891 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -83.65 146.96 12.16 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 121.915 1.743 . . . . 0.0 110.59 176.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.435 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 2.1 mp -85.53 91.46 3.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.255 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.683 ' O ' ' HB ' ' A' ' 146' ' ' THR . 58.6 m -78.27 105.72 9.69 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.466 ' HB3' ' O ' ' A' ' 81' ' ' CYS . 24.7 tt0 76.3 109.66 0.07 Allowed 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.14 0.9 . . . . 0.0 111.754 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.617 ' CG2' ' HB ' ' A' ' 99' ' ' ILE . 15.5 tt -117.8 125.04 73.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.538 -0.726 . . . . 0.0 109.342 174.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.9 t -86.84 125.07 33.73 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-O 121.25 0.548 . . . . 0.0 109.86 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.545 ' OH ' ' HA ' ' A' ' 117' ' ' VAL . 56.5 t80 -107.69 120.38 42.06 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.26 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.5 mt -130.24 107.18 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 CA-C-O 122.063 0.935 . . . . 0.0 109.332 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.644 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 1.3 tm? -100.66 134.82 43.05 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 114.616 -1.174 . . . . 0.0 107.862 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.586 ' HB2' ' HB2' ' A' ' 140' ' ' GLN . 96.5 mttt -128.31 158.02 39.36 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -177.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.505 ' OG ' ' HB3' ' A' ' 122' ' ' SER . 57.5 m -143.91 97.67 3.1 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 52.71 -90.13 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 175.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.9 m -108.24 -53.99 2.56 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.097 0.475 . . . . 0.0 111.755 -171.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -126.06 154.84 42.45 Favored 'General case' 0 CA--C 1.472 -2.044 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 27.6 m 71.87 135.89 0.04 OUTLIER 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 113.363 -1.744 . . . . 0.0 112.895 175.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.644 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 38.4 pt -136.84 -179.2 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.382 0 CA-C-N 114.616 -1.175 . . . . 0.0 107.937 176.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . . . -130.75 121.31 25.19 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 172.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 36.8 p -112.49 159.06 19.15 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.534 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.21 178.3 47.55 Favored Glycine 0 N--CA 1.424 -2.15 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.9 m -146.25 120.06 9.27 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.617 ' HB ' ' CG2' ' A' ' 83' ' ' ILE . 71.5 mt -98.6 126.11 40.31 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -177.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -80.49 114.86 3.07 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.914 1.742 . . . . 0.0 111.278 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.8 t70 53.23 87.6 0.14 Allowed Pre-proline 0 N--CA 1.485 1.292 0 C-N-CA 124.937 1.295 . . . . 0.0 112.753 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.435 ' HD2' ' HB ' ' A' ' 80' ' ' ILE . 26.7 Cg_endo -91.15 -7.05 3.75 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.847 2.365 . . . . 0.0 112.188 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 160.93 -179.04 36.65 Favored Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.3 m -142.71 157.67 44.42 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.275 0.559 . . . . 0.0 111.038 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.473 HD23 ' CB ' ' A' ' 72' ' ' ASN . 7.5 mp -76.73 135.13 39.02 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.483 176.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 27.3 m -71.06 -17.5 20.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.11 113.1 1.51 Allowed Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 61.9 m 53.46 83.87 0.06 Allowed 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.916 0.886 . . . . 0.0 113.308 -177.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 155.71 -176.93 33.09 Favored Glycine 0 N--CA 1.432 -1.575 0 C-N-CA 119.956 -1.116 . . . . 0.0 112.391 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.7 t -105.38 135.71 46.26 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.5 t -139.44 130.37 26.29 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 120.865 0.364 . . . . 0.0 110.407 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.9 m -93.48 122.47 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-O 121.686 0.755 . . . . 0.0 110.024 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.9 mt -108.34 158.06 17.83 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -134.09 149.03 51.09 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 119.664 -0.815 . . . . 0.0 112.277 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.3 m -131.49 144.63 54.19 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.649 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -74.06 111.76 3.38 Favored 'Trans proline' 0 C--O 1.247 0.953 0 C-N-CA 122.12 1.88 . . . . 0.0 110.675 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.545 ' HA ' ' OH ' ' A' ' 85' ' ' TYR . 96.5 t -107.26 127.09 63.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-O 121.553 0.692 . . . . 0.0 112.814 -175.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.515 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 8.5 mmpt? -89.06 96.64 10.81 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.602 ' O ' HG22 ' A' ' 62' ' ' VAL . 99.7 t -93.52 138.94 19.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 72.19 -16.84 0.4 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.058 0.943 . . . . 0.0 111.416 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.512 ' H ' ' C ' ' A' ' 119' ' ' VAL . 53.1 t80 -51.49 -39.86 58.4 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 125.94 1.696 . . . . 0.0 110.1 176.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.505 ' HB3' ' OG ' ' A' ' 89' ' ' SER . 33.9 t -65.55 -51.79 57.26 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.557 -177.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.5 tt -67.25 -28.87 43.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.327 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.572 ' HB2' ' CE1' ' A' ' 174' ' ' PHE . . . -66.43 -50.65 62.66 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 177.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.77 -30.2 49.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.956 0.408 . . . . 0.0 110.928 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.0 t -70.69 -73.43 0.17 Allowed 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.48 ' H ' HD23 ' A' ' 127' ' ' LEU . 1.9 pt? -125.43 -41.33 2.04 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 24.1 ttt 64.15 100.03 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 124.299 1.04 . . . . 0.0 109.395 -172.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.568 ' HG3' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -48.89 -63.78 1.0 Allowed 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.732 -177.048 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.568 ' H ' ' HG3' ' A' ' 129' ' ' LYS . 21.4 t70 151.85 107.93 0.0 OUTLIER 'General case' 0 CA--C 1.471 -2.094 0 N-CA-C 102.649 -3.093 . . . . 0.0 102.649 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.471 ' HG3' ' HA ' ' A' ' 171' ' ' ARG . 13.1 tpt -53.07 123.58 12.05 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 123.519 0.512 . . . . 0.0 111.627 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 49.1 t -99.32 -158.74 0.69 Allowed 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.238 -176.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.696 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 21.8 p -131.01 114.11 14.79 Favored 'General case' 0 N--CA 1.385 -3.713 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.2 t70 70.43 89.9 0.1 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -172.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -133.58 115.74 15.05 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.522 -172.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.14 104.55 15.82 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.026 176.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.3 tt -102.2 138.2 27.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.55 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -82.49 100.14 9.9 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.753 0.787 . . . . 0.0 109.449 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.51 ' HB3' HG12 ' A' ' 165' ' ' ILE . 9.1 t80 -113.95 148.34 37.01 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.344 -176.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.586 ' HB2' ' HB2' ' A' ' 88' ' ' LYS . 1.8 mp0 -136.08 154.01 51.15 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.5 tp -141.86 123.07 14.73 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 123.246 0.618 . . . . 0.0 109.58 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -126.33 128.0 46.42 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 43.9 mt -130.4 130.34 65.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 C-N-CA 120.209 -0.596 . . . . 0.0 112.336 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 157' ' ' ILE . . . -114.88 90.76 0.54 Allowed Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.443 HD11 ' CE2' ' A' ' 147' ' ' PHE . 2.9 pp -84.57 151.54 24.46 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.897 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.683 ' HB ' ' O ' ' A' ' 81' ' ' CYS . 8.6 m -109.09 120.69 43.29 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.8 -176.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.443 ' CE2' HD11 ' A' ' 145' ' ' LEU . 73.6 m-85 -100.4 141.26 33.5 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 170.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -110.39 133.36 53.34 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 174.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.76 139.45 29.05 Favored Pre-proline 0 C--N 1.301 -1.53 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.659 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -63.46 -17.02 58.12 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.856 2.371 . . . . 0.0 112.051 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.67 -45.52 98.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.998 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 40.4 t -130.15 -78.04 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.059 0.457 . . . . 0.0 109.904 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 173.81 -112.66 0.43 Allowed Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -101.24 125.97 47.92 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.935 0.397 . . . . 0.0 111.202 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 146' ' ' THR . 34.1 pt -121.28 114.92 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 CA-C-O 121.008 0.433 . . . . 0.0 110.522 173.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.535 HG22 ' OG1' ' A' ' 146' ' ' THR . 37.9 p -96.1 105.27 17.29 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.691 175.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.466 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 60.7 mt -91.5 107.1 19.4 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 156' ' ' THR . 8.0 Cg_endo -85.42 100.74 0.69 Allowed 'Trans proline' 0 N--CA 1.43 -2.26 0 C-N-CA 122.6 2.2 . . . . 0.0 111.719 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.529 HG11 ' O ' ' A' ' 47' ' ' ALA . 18.0 m -94.74 110.03 23.19 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 CA-C-O 122.015 0.912 . . . . 0.0 109.542 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.5 p -88.89 146.13 25.12 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-N 114.352 -1.295 . . . . 0.0 111.318 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.519 ' OG1' ' HB ' ' A' ' 49' ' ' VAL . 98.5 m -146.64 127.39 14.34 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.134 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -121.4 143.07 49.42 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -164.42 -139.63 2.68 Favored Glycine 0 N--CA 1.422 -2.24 0 C-N-CA 119.728 -1.225 . . . . 0.0 112.121 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.21 148.59 15.14 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.51 HG12 ' HB3' ' A' ' 139' ' ' TYR . 47.8 mm -126.18 139.37 51.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -106.06 111.76 24.52 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.76 0.79 . . . . 0.0 110.146 175.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 15.6 tp -93.84 106.28 20.99 Favored Pre-proline 0 C--N 1.296 -1.751 0 CA-C-N 113.998 -1.455 . . . . 0.0 108.276 -174.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 167' ' ' LEU . 23.5 Cg_exo -64.65 156.89 58.65 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.416 2.744 . . . . 0.0 116.054 -171.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.696 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 31.1 p -48.41 25.32 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 129.19 2.996 . . . . 0.0 117.603 174.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 59.8 mt -71.63 -42.32 67.75 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.471 ' HA ' ' HG3' ' A' ' 131' ' ' MET . 59.8 ttt180 72.31 -27.12 0.18 Allowed 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 126.47 1.908 . . . . 0.0 112.48 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -113.74 61.2 0.66 Allowed 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 122.719 1.247 . . . . 0.0 108.121 173.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.517 ' O ' HG12 ' A' ' 62' ' ' VAL . 85.9 t80 -135.77 -1.18 2.51 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 113.398 -1.728 . . . . 0.0 106.569 174.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.572 ' CE1' ' HB2' ' A' ' 124' ' ' ALA . 27.6 t80 . . . . . 0 N--CA 1.411 -2.379 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.14 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -76.5 -20.47 56.91 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 117.244 0.522 . . . . 0.0 111.362 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -71.72 106.5 4.13 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -130.58 112.42 13.15 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -59.1 126.99 29.94 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -134.28 106.19 7.0 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.372 0.606 . . . . 0.0 111.841 -176.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -133.22 71.91 1.48 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.568 0.699 . . . . 0.0 110.861 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.2 mt -94.17 -70.1 0.72 Allowed 'General case' 0 CA--C 1.464 -2.328 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 171.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -89.96 149.51 22.55 Favored 'General case' 1 N--CA 1.364 -4.759 0 N-CA-C 103.533 -2.766 . . . . 0.0 103.533 168.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.76 93.38 0.17 Allowed 'General case' 1 C--N 1.236 -4.326 0 CA-C-O 121.511 0.672 . . . . 0.0 111.945 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.9 p -125.48 85.55 2.42 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.481 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.519 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -103.56 -31.76 9.77 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.55 ' O ' HG22 ' A' ' 17' ' ' VAL . 18.7 m-20 -56.05 -48.98 75.0 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -169.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.8 -34.71 65.56 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -178.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -75.29 -54.86 6.38 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 123.45 0.7 . . . . 0.0 110.314 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 12' ' ' ALA . 55.8 t -58.57 -45.81 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.05 0.94 . . . . 0.0 113.499 -174.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 13' ' ' ASP . 35.9 m -66.14 -27.28 40.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.656 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -76.6 -30.2 56.85 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.603 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -54.91 -42.99 72.88 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.509 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.28 -37.42 87.44 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.607 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.53 -36.33 82.43 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.6 t -61.91 -45.18 94.86 Favored 'General case' 0 C--O 1.252 1.231 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.859 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.03 -37.84 54.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.479 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.419 HD12 ' OG ' ' A' ' 96' ' ' SER . 79.3 mt -65.68 -41.1 89.77 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.746 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.5 t -58.41 -36.35 73.45 Favored 'General case' 0 C--O 1.243 0.715 0 O-C-N 123.54 0.525 . . . . 0.0 110.959 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.2 m -67.04 -39.58 87.0 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.053 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.551 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 5.2 tt -80.36 -40.54 26.41 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -54.09 -43.87 70.71 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.33 1.052 . . . . 0.0 109.673 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -65.0 -39.32 93.29 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.042 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.551 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -70.93 -37.41 72.87 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.077 -179.593 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.515 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -69.58 -32.46 71.23 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.662 -177.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.48 -40.24 82.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.2 175.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.14 -49.84 73.75 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.297 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.46 ' HD1' ' O ' ' A' ' 30' ' ' LYS . 10.5 m-85 -59.13 -46.89 87.18 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 120.562 0.22 . . . . 0.0 110.643 177.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.509 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 65.1 t80 -62.79 -41.16 99.15 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -176.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.3 -44.25 79.69 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -108.67 -27.65 9.7 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -173.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -101.26 -46.62 4.98 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.467 -171.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 36.8 mt -78.94 -0.48 31.14 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.79 -171.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.01 -33.15 63.67 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -101.42 -47.82 4.56 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 114.348 -1.296 . . . . 0.0 110.52 -173.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.69 126.54 92.85 Favored Pre-proline 0 C--O 1.24 0.601 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.313 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.63 106.67 0.17 Allowed 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 123.109 2.539 . . . . 0.0 112.578 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.501 HG21 HD22 ' A' ' 39' ' ' LEU . 8.3 p -130.85 166.4 27.68 Favored Pre-proline 0 N--CA 1.429 -1.484 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.725 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -79.6 138.35 13.54 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.819 2.346 . . . . 0.0 110.511 175.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -96.89 108.09 20.72 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.091 0.472 . . . . 0.0 109.823 -176.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.5 146.65 25.56 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.04 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.2 t -145.93 138.59 25.65 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 121.073 0.463 . . . . 0.0 110.553 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.446 HG13 HG23 ' A' ' 159' ' ' VAL . 12.7 m -90.53 142.55 12.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.207 175.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -130.22 -63.08 0.91 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.083 -1.047 . . . . 0.0 112.979 -174.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -161.13 164.52 30.58 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 -173.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.635 HG22 ' HB3' ' A' ' 64' ' ' TYR . 11.1 p -125.28 114.26 39.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 176.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -99.21 132.51 44.47 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -169.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.534 ' O ' ' HE3' ' A' ' 55' ' ' LYS . 50.2 p90 -58.52 129.1 40.46 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 123.969 0.793 . . . . 0.0 111.743 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.622 ' HE3' ' HA ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -130.0 -64.57 0.86 Allowed 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.689 -173.028 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -140.39 175.27 22.09 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.983 -175.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.431 HG22 ' CD1' ' A' ' 173' ' ' PHE . 28.8 t -99.07 147.46 7.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -175.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 74.2 m -129.58 160.29 33.71 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 174.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -45.95 62.09 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -104.15 97.76 7.68 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.549 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.504 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . 85.11 -170.53 45.28 Favored Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.539 HG21 ' CE2' ' A' ' 173' ' ' PHE . 7.1 p -124.4 153.14 30.76 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -93.99 112.18 23.98 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-O 121.581 0.705 . . . . 0.0 110.957 -175.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.635 ' HB3' HG22 ' A' ' 52' ' ' VAL . 3.5 m-30 -116.17 166.17 12.33 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.452 174.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.525 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 12.2 m-70 -116.93 112.87 21.62 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.513 174.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -77.47 123.43 26.56 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.981 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -87.48 108.46 19.03 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.301 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.2 t -122.39 108.81 22.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.4 m -100.05 134.0 43.61 Favored 'General case' 0 C--N 1.284 -2.266 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.509 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.72 112.43 36.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-O 121.251 0.548 . . . . 0.0 110.13 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 39.3 ttpt -95.25 110.75 22.7 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 175.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -119.18 116.93 33.66 Favored Pre-proline 0 N--CA 1.42 -1.963 0 C-N-CA 118.64 -1.224 . . . . 0.0 111.278 -174.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -95.75 98.83 0.1 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.451 0 C-N-CA 121.756 1.637 . . . . 0.0 109.551 169.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.7 t80 178.4 108.13 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.7 m -50.88 16.66 0.0 OUTLIER 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 119.342 3.09 . . . . 0.0 119.342 -166.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.524 HE21 HG12 ' A' ' 78' ' ' ILE . 7.3 pt20 -142.89 166.35 24.88 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 119.583 1.083 . . . . 0.0 111.45 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.1 p -88.51 101.13 13.63 Favored 'General case' 0 N--CA 1.417 -2.096 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 174.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.524 HG12 HE21 ' A' ' 76' ' ' GLN . 67.7 mt -73.65 129.58 85.12 Favored Pre-proline 0 C--N 1.31 -1.121 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.33 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.96 122.29 10.97 Favored 'Trans proline' 0 C--O 1.254 1.305 0 C-N-CA 122.726 2.284 . . . . 0.0 112.369 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.446 HG12 ' CE1' ' A' ' 147' ' ' PHE . 45.0 mt -89.91 107.87 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 57.3 m -53.98 -59.57 4.47 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 123.076 0.551 . . . . 0.0 110.37 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -165.45 150.21 8.82 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 98' ' ' THR . 15.7 tt -96.69 124.32 49.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 174.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.422 ' HA ' HG22 ' A' ' 98' ' ' THR . 48.0 m -100.61 118.66 37.21 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -175.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -119.91 139.86 51.77 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.293 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.448 ' HB ' ' HB2' ' A' ' 142' ' ' ASP . 64.7 mt -123.87 108.37 20.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 171.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.6 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 1.5 tm? -91.65 122.43 34.21 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -125.56 140.01 53.11 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -175.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 122' ' ' SER . 30.2 t -104.98 145.66 30.12 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.959 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.52 -12.93 55.61 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.872 175.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 68.8 p -97.51 17.8 16.82 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.152 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 81.21 163.01 0.16 Allowed 'General case' 0 C--O 1.25 1.081 0 C-N-CA 125.542 1.537 . . . . 0.0 111.984 -176.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.492 ' O ' ' HB3' ' A' ' 122' ' ' SER . 53.9 m 72.24 137.84 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.726 1.21 . . . . 0.0 110.259 -174.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.6 pp -129.87 172.75 15.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.6 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . . . -127.11 121.78 32.38 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 174.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.419 ' OG ' HD12 ' A' ' 24' ' ' ILE . 23.0 t -134.62 158.25 44.52 Favored 'General case' 0 C--N 1.282 -2.352 0 C-N-CA 118.641 -1.224 . . . . 0.0 110.726 -176.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.54 179.53 44.26 Favored Glycine 0 N--CA 1.429 -1.831 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.422 HG22 ' HA ' ' A' ' 84' ' ' SER . 23.0 p -135.11 134.17 39.99 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.747 0.273 . . . . 0.0 110.519 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.4 ' HB ' HG22 ' A' ' 83' ' ' ILE . 3.4 mp -104.79 107.35 58.18 Favored Pre-proline 0 C--O 1.244 0.782 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.475 174.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -66.05 121.8 9.21 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.736 2.291 . . . . 0.0 110.387 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 53.85 78.66 0.38 Allowed Pre-proline 0 N--CA 1.483 1.22 0 C-N-CA 123.921 0.888 . . . . 0.0 111.572 -175.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -97.96 6.01 1.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.932 2.421 . . . . 0.0 112.689 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 164.9 -168.76 39.26 Favored Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 56.1 m -143.27 159.13 42.89 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 120.795 0.331 . . . . 0.0 110.291 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.451 ' HA ' HG21 ' A' ' 111' ' ' THR . 82.7 mt -88.71 156.83 18.77 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.502 177.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 27.7 m -99.1 1.79 10.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 121.016 0.436 . . . . 0.0 111.841 -176.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.21 -52.22 4.63 Favored Glycine 0 C--O 1.217 -0.96 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.905 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.5 t -146.23 103.35 3.7 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 150.29 -175.0 29.54 Favored Glycine 0 N--CA 1.421 -2.359 0 C-N-CA 120.291 -0.957 . . . . 0.0 111.376 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 25.6 m -102.67 108.32 19.54 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.451 HG21 ' HA ' ' A' ' 105' ' ' LEU . 5.5 t -99.98 114.52 27.85 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 121.766 0.793 . . . . 0.0 109.466 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.2 t -85.36 113.76 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.5 mt -96.17 147.8 23.37 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 7.2 p-10 -136.91 123.03 20.38 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.443 0.639 . . . . 0.0 110.696 -176.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 69.3 t -102.26 122.22 47.49 Favored Pre-proline 0 C--N 1.299 -1.604 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.225 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -68.51 109.97 2.18 Favored 'Trans proline' 0 N--CA 1.439 -1.703 0 N-CA-C 105.815 -2.417 . . . . 0.0 105.815 167.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.7 p -126.94 148.39 31.76 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -172.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.476 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 9.0 mmpt? -88.86 98.26 11.63 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.457 HG12 HD21 ' A' ' 87' ' ' LEU . 10.6 m -94.65 149.02 4.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.678 ' HA ' HD13 ' A' ' 123' ' ' ILE . . . 72.15 0.72 3.67 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.031 0.533 . . . . 0.0 111.359 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -59.93 -51.26 70.46 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 173.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' ' 93' ' ' THR . 15.1 m -62.37 -27.44 69.07 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.152 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.678 HD13 ' HA ' ' A' ' 120' ' ' ALA . 2.6 mp -79.1 -47.8 22.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.905 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.78 -36.93 82.5 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.351 0.407 . . . . 0.0 110.994 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 54.0 t -65.68 -37.27 79.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.997 176.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 63.0 m -82.42 -75.81 0.29 Allowed 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.424 HD12 ' N ' ' A' ' 128' ' ' MET . 2.6 pp -124.56 -23.3 4.43 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -173.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.534 ' HG3' ' H ' ' A' ' 130' ' ' ASP . 11.7 tpt 74.51 133.56 0.05 OUTLIER 'General case' 0 C--O 1.211 -0.971 0 C-N-CA 123.944 0.898 . . . . 0.0 112.039 -177.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.703 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -87.54 7.54 29.08 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.757 -175.293 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.534 ' H ' ' HG3' ' A' ' 128' ' ' MET . 10.3 m-20 67.74 -0.84 1.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 172.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.408 ' HA ' ' CE ' ' A' ' 131' ' ' MET . 0.0 OUTLIER 62.84 30.31 16.62 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.216 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 53.4 t -56.26 129.96 42.49 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 123.675 0.61 . . . . 0.0 109.998 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 52.5 p -77.82 130.52 36.78 Favored 'General case' 0 N--CA 1.414 -2.258 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.454 ' H ' ' H ' ' A' ' 169' ' ' SER . 34.7 m-20 65.22 82.33 0.19 Allowed 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -174.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.548 ' HE1' ' HB2' ' A' ' 129' ' ' LYS . 64.0 t-105 -155.03 156.62 36.25 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.173 -170.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -148.5 148.05 29.79 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 176.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.9 tt -142.1 147.92 20.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.226 -174.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -63.14 122.14 15.37 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-O 121.931 0.872 . . . . 0.0 112.463 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.441 ' HE1' ' CD2' ' A' ' 87' ' ' LEU . 4.8 t80 -139.35 145.4 38.97 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.135 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 162' ' ' GLN . 68.2 mt-30 -141.17 155.43 46.07 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.083 -0.385 . . . . 0.0 110.738 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.429 HD13 HG13 ' A' ' 143' ' ' ILE . 1.7 pp -139.12 151.31 46.57 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-O 121.245 0.545 . . . . 0.0 110.815 173.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.448 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 10.3 m-20 -133.19 111.96 11.32 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 173.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.429 HG13 HD13 ' A' ' 141' ' ' LEU . 60.8 mt -125.06 138.28 54.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.17 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 157' ' ' ILE . . . -121.54 130.18 8.02 Favored Glycine 0 N--CA 1.418 -2.526 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.084 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 156' ' ' THR . 2.7 mm? -97.75 111.11 23.53 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.0 m -97.24 112.35 24.19 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.556 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.446 ' CE1' HG12 ' A' ' 80' ' ' ILE . 91.7 m-85 -115.19 140.07 49.4 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 154' ' ' ASP . 29.0 t70 -93.97 109.06 20.81 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 66.3 mt -118.99 117.5 33.57 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -52.48 -19.15 9.42 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 124.172 3.248 . . . . 0.0 114.982 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.24 -29.17 31.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 120.861 0.362 . . . . 0.0 111.009 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 61.1 t -131.94 -53.25 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.271 0.557 . . . . 0.0 110.725 -176.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 142.45 -155.59 25.77 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 108.451 -1.859 . . . . 0.0 108.451 -176.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 148' ' ' ASP . 4.9 p-10 -86.48 117.66 25.4 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 117.908 0.854 . . . . 0.0 109.748 175.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 2.1 pp -128.24 141.2 47.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.473 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 37.7 m -99.43 123.92 44.12 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.437 -178.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.415 ' O ' ' HA2' ' A' ' 144' ' ' GLY . 2.0 mp -86.57 112.0 43.5 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 174.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -86.7 114.95 1.22 Allowed 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.672 2.248 . . . . 0.0 113.18 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.446 HG23 HG13 ' A' ' 49' ' ' VAL . 9.9 m -125.74 127.86 71.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.251 176.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.4 t -128.28 156.31 43.22 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.658 -174.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.1 t -166.55 149.16 6.73 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 140' ' ' GLN . 28.8 pt20 -100.26 127.53 46.53 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 172.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -113.28 133.14 11.08 Favored Glycine 0 N--CA 1.405 -3.393 0 C-N-CA 119.924 -1.131 . . . . 0.0 112.811 -172.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -101.95 120.12 39.89 Favored 'General case' 0 C--N 1.269 -2.9 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.3 pt -114.9 111.69 36.92 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 CA-C-O 121.75 0.786 . . . . 0.0 110.89 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.534 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 4.9 ttmp? -81.06 119.75 23.94 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.712 -177.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.9 tt -102.24 98.8 11.12 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 166' ' ' LYS . 1.4 Cg_endo -83.57 81.27 2.29 Favored 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 122.677 2.251 . . . . 0.0 112.561 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 46.6 t 70.81 -76.48 0.06 Allowed 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.654 -1.157 . . . . 0.0 113.602 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.432 ' HG ' ' CD2' ' A' ' 173' ' ' PHE . 3.6 mm? 63.89 -65.7 0.12 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.28 1.032 . . . . 0.0 113.088 -176.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 63.9 91.62 0.07 Allowed 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.578 1.151 . . . . 0.0 110.405 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 74.37 90.76 0.08 Allowed 'General case' 0 CA--C 1.491 -1.317 0 C-N-CA 124.709 1.204 . . . . 0.0 109.349 -176.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.539 ' CE2' HG21 ' A' ' 62' ' ' VAL . 77.6 t80 -164.58 -35.1 0.03 OUTLIER 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 -175.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 CA--C 1.495 -1.147 0 C-N-CA 126.204 1.802 . . . . 0.0 112.978 175.563 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.253 0 N-CA-C 112.731 -0.148 . . . . 0.0 112.731 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -85.64 161.07 19.42 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 60.83 29.3 18.92 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -64.71 131.05 45.83 Favored 'General case' 0 C--O 1.246 0.888 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.618 -177.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.0 t60 62.93 81.53 0.2 Allowed 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.854 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -123.6 150.67 43.84 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 102.507 -3.146 . . . . 0.0 102.507 172.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 69.81 -167.0 0.17 Allowed 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -168.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -91.22 -60.08 1.99 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 173.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -144.12 -29.27 0.5 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.878 173.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.37 115.07 1.18 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.842 0.857 . . . . 0.0 113.091 -177.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.1 m 67.09 6.64 4.88 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.804 1.242 . . . . 0.0 112.727 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -92.68 -43.1 9.25 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.9 0.381 . . . . 0.0 110.008 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -75.55 -42.59 52.0 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.258 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.424 ' OE1' HG23 ' A' ' 93' ' ' THR . 12.4 mm-40 -54.6 -41.52 70.05 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.301 0.572 . . . . 0.0 110.84 176.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -65.52 -53.45 42.06 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.521 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.6 m -64.32 -33.72 64.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.8 t -69.6 -45.44 78.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 176.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -58.67 -48.0 82.55 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.094 -176.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.481 ' O ' HG23 ' A' ' 23' ' ' VAL . 12.3 pt-20 -66.37 -40.61 89.85 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.149 -177.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -64.4 -40.93 96.74 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.59 -37.16 85.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.252 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.3 t -66.18 -44.07 85.04 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.32 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 19' ' ' GLU . 89.3 t -59.97 -43.84 93.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 CA-C-O 121.044 0.45 . . . . 0.0 110.018 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.449 HG21 HD11 ' A' ' 86' ' ' ILE . 65.5 mt -70.95 -35.58 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.66 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.3 t -60.64 -41.36 94.75 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 122.267 -0.271 . . . . 0.0 110.294 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.527 ' HA ' ' OD2' ' A' ' 29' ' ' ASP . 50.9 m -65.32 -29.12 69.84 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.355 0.597 . . . . 0.0 110.384 176.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.659 ' O ' ' HB3' ' A' ' 30' ' ' LYS . 4.5 tt -69.97 -38.33 76.03 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 175.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.545 ' O ' ' HG3' ' A' ' 32' ' ' LYS 0.34 7.8 mp -67.37 -27.79 67.4 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 119.149 -1.02 . . . . 0.0 113.094 175.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.527 ' OD2' ' HA ' ' A' ' 26' ' ' SER . 53.1 m-20 -61.04 -45.44 94.76 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 172.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.659 ' HB3' ' O ' ' A' ' 27' ' ' LEU . 21.0 ttmm -54.99 -51.39 66.37 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.913 173.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.07 -44.77 91.89 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.44 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 95.0 mttt -60.07 -32.21 70.73 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.94 0.496 . . . . 0.0 110.33 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.498 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -62.67 -51.32 56.77 Favored Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.723 177.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -72.83 -38.64 67.06 Favored 'General case' 0 C--O 1.203 -1.393 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.752 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -62.41 -35.41 79.13 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -175.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.65 -27.1 64.76 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.655 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.502 ' HG3' ' N ' ' A' ' 38' ' ' LYS . 8.6 pt-20 -112.09 -57.28 2.29 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -175.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.502 ' N ' ' HG3' ' A' ' 37' ' ' GLU . 8.9 tppt? -73.69 -48.23 33.69 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-O 122.757 1.265 . . . . 0.0 109.803 -164.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.463 ' CD1' HG12 ' A' ' 157' ' ' ILE . 69.4 mt -83.07 4.86 24.47 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 113.11 -1.859 . . . . 0.0 111.575 -171.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.91 -7.9 11.96 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.981 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -110.42 -39.7 4.86 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.176 0.513 . . . . 0.0 110.19 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.438 HD12 ' HG3' ' A' ' 38' ' ' LYS . 54.7 mt -91.53 139.53 25.14 Favored Pre-proline 0 N--CA 1.432 -1.344 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.13 98.3 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.831 1.688 . . . . 0.0 108.328 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 m -127.62 148.94 68.81 Favored Pre-proline 0 C--N 1.297 -1.682 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -172.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.579 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 9.4 Cg_endo -51.88 129.06 28.86 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.857 2.372 . . . . 0.0 112.112 176.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 43.3 mt-10 -115.02 113.24 23.82 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.929 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.421 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . . . -108.5 148.54 30.1 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.464 -176.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.1 t -154.74 142.93 20.33 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.766 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.616 ' H ' HG11 ' A' ' 159' ' ' VAL . 11.7 p -108.39 141.09 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 176.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -157.04 -23.04 0.09 Allowed 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.646 -171.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.689 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . 9.6 t0 -121.26 117.23 26.5 Favored 'General case' 0 CA--C 1.485 -1.547 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.24 -168.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.663 HG12 ' CD2' ' A' ' 64' ' ' TYR . 48.4 t -119.36 110.64 30.2 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -130.03 127.97 41.04 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.186 -175.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 51.1 p90 -64.75 139.26 58.74 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -176.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.646 ' HD3' ' HB2' ' A' ' 65' ' ' HIS . 14.7 mmmm -88.51 -24.85 22.82 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.392 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.49 -158.55 31.46 Favored Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.4 m -101.03 145.84 10.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 117.134 0.467 . . . . 0.0 111.27 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.3 m -155.06 135.54 13.36 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -75.84 -42.25 50.13 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -173.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -61.94 -56.58 17.69 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.702 0.763 . . . . 0.0 110.808 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.431 ' HA3' ' HB2' ' A' ' 121' ' ' TYR . . . -160.81 137.3 4.89 Favored Glycine 0 N--CA 1.409 -3.126 0 N-CA-C 107.022 -2.431 . . . . 0.0 107.022 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.522 HG11 ' CZ ' ' A' ' 173' ' ' PHE . 23.3 t -72.79 131.86 34.23 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-N 117.209 0.505 . . . . 0.0 110.115 -173.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -81.79 117.21 21.91 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.899 -177.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.663 ' CD2' HG12 ' A' ' 52' ' ' VAL . 9.4 m-85 -118.09 154.55 31.89 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.646 ' HB2' ' HD3' ' A' ' 55' ' ' LYS . 49.9 t-80 -91.03 108.43 19.86 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 176.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -91.71 107.56 19.29 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.689 ' HB3' ' HB3' ' A' ' 51' ' ' ASP . 40.4 ttmt -87.38 110.97 20.63 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.907 0.384 . . . . 0.0 110.557 -176.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.4 t -113.15 108.38 25.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.41 ' HB3' HG12 ' A' ' 112' ' ' VAL . 42.6 p -102.7 140.36 37.08 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.883 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 3.1 p -142.02 126.56 16.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.927 -178.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 45' ' ' PRO . 25.5 pttm -99.15 141.73 31.53 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 174.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -134.39 116.89 13.15 Favored Pre-proline 0 C--N 1.287 -2.141 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.641 -174.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -91.8 95.52 0.2 Allowed 'Trans proline' 0 N--CA 1.42 -2.838 0 N-CA-C 109.106 -1.152 . . . . 0.0 109.106 170.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.514 ' HB3' ' HG2' ' A' ' 76' ' ' GLN . 50.1 m-85 170.54 130.14 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 129.19 2.996 . . . . 0.0 104.723 -176.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.8 m -81.96 -2.78 52.59 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 118.362 0.528 . . . . 0.0 112.104 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.514 ' HG2' ' HB3' ' A' ' 74' ' ' TYR . 18.8 pt20 -83.2 132.08 35.08 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 121.206 0.527 . . . . 0.0 111.095 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.4 p -75.95 93.78 3.29 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 172.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.455 ' HB ' ' CD2' ' A' ' 105' ' ' LEU . 75.0 mt -72.66 123.37 89.47 Favored Pre-proline 0 C--N 1.3 -1.553 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.007 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -79.12 118.26 4.0 Favored 'Trans proline' 0 N--CA 1.44 -1.644 0 C-N-CA 122.115 1.877 . . . . 0.0 110.856 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.416 HD12 ' N ' ' A' ' 80' ' ' ILE . 2.4 mp -72.44 111.53 6.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 57.0 m -50.31 -59.08 4.33 Favored 'General case' 0 C--O 1.244 0.791 0 O-C-N 123.899 0.749 . . . . 0.0 111.204 -176.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -150.94 154.02 36.35 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.537 HG22 ' HB ' ' A' ' 99' ' ' ILE . 11.1 tp -104.1 124.08 58.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 174.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.424 ' HB2' HG21 ' A' ' 24' ' ' ILE . 65.7 p -95.07 118.62 32.18 Favored 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 119.529 -0.869 . . . . 0.0 109.883 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.519 ' CE2' HG12 ' A' ' 117' ' ' VAL . 15.5 t80 -104.16 121.39 43.16 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 126.238 1.815 . . . . 0.0 111.067 -169.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' A' ' 142' ' ' ASP . 3.2 mp -127.25 108.08 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.605 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 1.8 tm? -101.71 121.58 42.31 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.552 ' HA ' HG22 ' A' ' 94' ' ' ILE . 39.8 ttmt -127.25 133.59 50.19 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 120.158 -0.617 . . . . 0.0 112.372 -175.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.5 m -123.18 147.3 47.0 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.434 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.98 -0.19 2.21 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.5 p -90.83 16.33 9.55 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 123.461 0.704 . . . . 0.0 110.834 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 70.86 -41.63 0.51 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 125.972 1.709 . . . . 0.0 113.388 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.594 ' O ' ' HB3' ' A' ' 122' ' ' SER . 99.9 m -62.26 137.75 58.31 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.605 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 47.1 pt -137.55 178.23 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.254 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.531 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . . . -127.88 130.11 48.0 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 174.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.7 t -126.78 147.13 50.02 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.89 172.21 37.14 Favored Glycine 0 N--CA 1.42 -2.403 0 C-N-CA 119.818 -1.182 . . . . 0.0 112.426 -176.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 63.2 m -153.07 109.76 3.43 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.537 ' HB ' HG22 ' A' ' 83' ' ' ILE . 3.1 mp -103.47 110.03 63.03 Favored Pre-proline 0 N--CA 1.467 0.424 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.674 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -68.11 127.45 15.97 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.611 2.207 . . . . 0.0 109.727 173.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.0 t70 57.29 81.42 0.26 Allowed Pre-proline 0 N--CA 1.482 1.154 0 CA-C-O 121.674 0.749 . . . . 0.0 110.234 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.448 ' HG3' ' HB ' ' A' ' 83' ' ' ILE . 22.7 Cg_endo -107.72 13.74 0.13 Allowed 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 123.028 2.485 . . . . 0.0 113.088 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 152.78 -172.26 31.85 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.6 p -135.2 143.72 46.55 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.957 0.378 . . . . 0.0 110.719 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.455 ' CD2' ' HB ' ' A' ' 78' ' ' ILE . 19.9 tp -82.42 129.48 34.9 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.549 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 11.6 p -57.61 -35.05 48.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -174.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.97 118.68 0.1 OUTLIER Glycine 0 CA--C 1.54 1.615 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.541 -174.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 34.5 t 67.56 11.51 8.41 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.669 1.188 . . . . 0.0 113.137 175.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -150.8 -164.52 12.05 Favored Glycine 0 CA--C 1.496 -1.141 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.558 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 10.0 t -116.68 138.54 51.38 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.549 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 7.0 t -133.65 138.8 46.1 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.03 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.41 HG12 ' HB3' ' A' ' 69' ' ' SER . 27.3 m -91.62 106.93 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-O 122.057 0.932 . . . . 0.0 110.269 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.7 mt -92.2 153.9 19.01 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 4.8 p-10 -144.58 148.16 34.05 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.482 -0.887 . . . . 0.0 112.013 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.8 t -126.7 128.44 24.28 Favored Pre-proline 0 C--N 1.289 -2.056 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 171.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 22.7 Cg_exo -69.16 109.43 2.19 Favored 'Trans proline' 0 N--CA 1.432 -2.144 0 N-CA-C 108.206 -1.498 . . . . 0.0 108.206 172.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.519 HG12 ' CE2' ' A' ' 85' ' ' TYR . 30.3 m -98.41 150.3 4.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.384 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.633 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -95.1 97.46 9.95 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.062 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.5 m -93.15 147.12 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.482 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -177.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.521 ' HB1' ' CE1' ' A' ' 174' ' ' PHE . . . 69.9 -3.9 1.61 Allowed 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.968 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.431 ' HB2' ' HA3' ' A' ' 61' ' ' GLY . 84.2 t80 -57.99 -47.35 83.27 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.594 ' HB3' ' O ' ' A' ' 93' ' ' THR . 19.1 m -66.79 -26.3 66.89 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.996 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.5 mt -79.14 -49.64 19.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.727 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.16 -49.3 78.41 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 122.962 0.505 . . . . 0.0 110.34 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.2 t -54.97 -43.26 68.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.223 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 44.0 t -75.04 -78.84 0.1 Allowed 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.044 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 128' ' ' MET . 3.8 pp -126.24 -40.09 2.01 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 115.111 1.522 . . . . 0.0 115.111 -173.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.553 ' N ' HD12 ' A' ' 127' ' ' LEU . 24.9 ttt 66.01 116.52 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.355 1.062 . . . . 0.0 110.632 -173.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.71 -72.8 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.741 0.816 . . . . 0.0 112.133 -178.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 24.0 t70 172.87 -30.56 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 -174.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.552 ' SD ' ' HB3' ' A' ' 174' ' ' PHE . 13.2 tpt 65.61 106.17 0.04 OUTLIER 'General case' 0 C--O 1.242 0.666 0 CA-C-N 113.235 -1.802 . . . . 0.0 112.573 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 44.7 t -128.53 173.52 10.17 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.108 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.408 ' CG2' ' HB2' ' A' ' 171' ' ' ARG . 30.8 p -82.69 115.74 21.76 Favored 'General case' 0 N--CA 1.413 -2.312 0 C-N-CA 123.257 0.623 . . . . 0.0 110.95 -178.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.5 ' H ' ' H ' ' A' ' 169' ' ' SER . 24.6 t70 74.21 95.61 0.07 Allowed 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 124.9 1.28 . . . . 0.0 108.835 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 -154.44 148.03 25.25 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.901 -170.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -118.62 143.58 46.71 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 67.2 mt -131.53 130.1 62.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 174.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.569 ' HA ' ' HA ' ' A' ' 164' ' ' GLU . 9.5 p-10 -99.34 120.41 39.53 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.401 ' HE2' ' CD2' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -127.74 170.56 12.59 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -179.226 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.476 ' HB2' ' HB3' ' A' ' 88' ' ' LYS . 1.6 mp0 -113.99 136.36 52.99 Favored 'General case' 0 C--N 1.279 -2.496 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.398 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.485 HD11 HD11 ' A' ' 143' ' ' ILE . 20.4 tp -122.05 116.21 23.86 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.76 176.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.491 ' HB3' ' HB ' ' A' ' 86' ' ' ILE . 15.4 t70 -126.63 120.89 30.65 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -175.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.485 HD11 HD11 ' A' ' 141' ' ' LEU . 43.0 mm -131.2 137.28 56.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 121.209 0.528 . . . . 0.0 110.594 -175.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -114.52 122.02 5.55 Favored Glycine 0 N--CA 1.419 -2.454 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 175.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.552 HD13 ' H ' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -115.37 160.2 20.15 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.387 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.7 t -136.02 142.24 44.43 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 119.834 -0.747 . . . . 0.0 111.799 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.478 ' CE2' HD23 ' A' ' 145' ' ' LEU . 68.1 m-85 -135.6 138.51 43.02 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 174.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -116.91 132.77 56.62 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.883 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.06 143.11 29.98 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -66.91 5.01 0.88 Allowed 'Trans proline' 0 N--CA 1.488 1.184 0 C-N-CA 123.411 2.741 . . . . 0.0 113.415 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.46 -28.88 36.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 11.7 p -160.19 -28.49 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.67 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 140.51 -143.56 13.66 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.347 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -94.97 132.09 40.2 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 155' ' ' ILE . 2.9 mp -122.54 129.73 75.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.454 HG21 HD21 ' A' ' 27' ' ' LEU . 33.9 p -95.77 140.44 30.55 Favored 'General case' 0 N--CA 1.406 -2.654 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 172.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.463 HG12 ' CD1' ' A' ' 39' ' ' LEU . 31.0 mt -114.11 129.26 24.98 Favored Pre-proline 0 C--N 1.308 -1.197 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -90.69 116.86 0.55 Allowed 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 122.734 2.289 . . . . 0.0 112.314 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.616 HG11 ' H ' ' A' ' 49' ' ' VAL . 21.9 t -118.96 103.76 14.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 59.0 p -107.91 128.56 54.73 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 95.3 m -145.88 131.02 18.37 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.152 0.501 . . . . 0.0 112.158 -173.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -99.53 124.48 44.75 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -126.94 128.04 6.12 Favored Glycine 0 N--CA 1.42 -2.428 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.095 -176.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 138' ' ' ASP . 39.3 tt0 -95.98 120.57 36.5 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 176.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 9.6 pt -112.53 140.84 30.26 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.635 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.926 -176.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -102.54 143.96 31.57 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 121.82 0.819 . . . . 0.0 112.15 -174.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.4 mp -112.39 86.03 7.72 Favored Pre-proline 0 C--N 1.285 -2.203 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -80.12 85.98 1.74 Allowed 'Trans proline' 0 C--N 1.367 1.52 0 C-N-CA 123.353 2.702 . . . . 0.0 116.034 -167.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.5 ' H ' ' H ' ' A' ' 134' ' ' ASP 0.26 46.2 t 63.72 -1.57 0.61 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 175.706 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.669 ' HB3' ' HB2' ' A' ' 173' ' ' PHE . 4.2 mm? -70.33 96.9 1.18 Allowed 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 168.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.408 ' HB2' ' CG2' ' A' ' 133' ' ' THR . 65.2 ttt180 -69.08 -23.6 64.04 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 118.754 -1.178 . . . . 0.0 109.802 176.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -117.79 102.16 8.89 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.669 ' HB2' ' HB3' ' A' ' 170' ' ' LEU . 57.8 t80 -161.42 -43.65 0.04 OUTLIER 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 -174.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.552 ' HB3' ' SD ' ' A' ' 131' ' ' MET . 16.9 t80 . . . . . 0 C--N 1.292 -1.911 0 CA-C-N 112.945 -1.934 . . . . 0.0 107.287 175.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.761 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 62.7 t60 68.45 -65.13 0.28 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.66 1.184 . . . . 0.0 112.88 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -80.18 109.16 14.39 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.257 0.551 . . . . 0.0 110.94 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -140.2 126.69 20.2 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.443 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -87.31 79.35 8.53 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.878 0.847 . . . . 0.0 111.527 -175.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 10' ' ' ALA . 15.4 m80 -128.23 22.52 6.1 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 122.268 1.032 . . . . 0.0 110.224 173.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -115.08 -178.75 3.44 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.335 173.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.2 mp 69.44 -85.95 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -172.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.42 98.16 0.9 Allowed 'General case' 0 N--CA 1.4 -2.928 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 171.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.416 ' HB3' ' HA ' ' A' ' 6' ' ' HIS . . . -150.48 22.14 0.82 Allowed 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 175.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.5 m -109.58 -47.2 3.41 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.324 -175.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.414 ' O ' ' HG2' ' A' ' 15' ' ' LYS . . . -80.77 -45.84 16.36 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -57.94 -30.83 66.28 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.287 0.565 . . . . 0.0 110.268 178.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -78.2 -47.99 16.83 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.851 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 12' ' ' ALA . 49.7 pttt -64.36 -36.15 83.19 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 116.761 -0.199 . . . . 0.0 110.73 -174.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.51 ' HA ' ' HG3' ' A' ' 19' ' ' GLU . 34.2 m -69.18 -20.39 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.275 0.56 . . . . 0.0 111.153 -177.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.461 HG11 ' O ' ' A' ' 94' ' ' ILE . 55.3 t -73.36 -52.22 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 171.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -65.21 -43.67 90.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.311 -175.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.51 ' HG3' ' HA ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -64.64 -33.28 75.56 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.546 -178.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -79.13 -43.43 24.04 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.719 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.09 82.89 Favored 'General case' 0 C--O 1.21 -0.981 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.32 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -59.35 -45.4 91.48 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.23 -49.79 81.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.087 0.47 . . . . 0.0 109.953 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.591 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 73.2 mt -62.3 -46.17 97.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.263 -178.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.4 t -66.97 -36.97 83.38 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.624 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.2 t -63.23 -37.63 87.98 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.18 0.514 . . . . 0.0 109.665 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -66.05 -45.26 82.01 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 87.7 mt -57.04 -41.21 78.22 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.239 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -55.46 -48.92 73.75 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -79.38 -36.38 39.31 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.88 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.723 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . . . -68.35 -35.99 78.57 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.634 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.431 ' HB2' ' HG2' ' A' ' 158' ' ' PRO . 40.4 ttmt -63.68 -35.74 81.56 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.33 -53.03 49.01 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.923 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.723 ' CE2' ' HA ' ' A' ' 31' ' ' ALA . 30.3 p90 -76.39 -24.56 54.11 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.383 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -57.19 -50.18 73.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.726 0.298 . . . . 0.0 110.834 175.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.1 -18.15 63.94 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.123 0.487 . . . . 0.0 110.987 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -91.69 -66.23 0.94 Allowed 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.469 ' HE2' ' HB2' ' A' ' 34' ' ' PHE . 49.7 mtmt -93.44 -35.66 12.86 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 121.189 0.518 . . . . 0.0 110.487 -171.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.47 HD22 HG21 ' A' ' 44' ' ' THR . 71.1 mt -82.52 2.26 33.82 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.527 0.68 . . . . 0.0 111.63 -174.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.62 -26.83 21.7 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -98.31 -32.93 11.28 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.129 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 74.5 mt -93.0 114.26 62.17 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.64 101.4 0.55 Allowed 'Trans proline' 0 C--O 1.24 0.62 0 C-N-CA 122.509 2.139 . . . . 0.0 112.975 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.47 HG21 HD22 ' A' ' 39' ' ' LEU . 2.0 p -112.56 167.92 8.46 Favored Pre-proline 0 C--N 1.298 -1.665 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.299 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.421 ' HD2' ' HB ' ' A' ' 44' ' ' THR . 18.8 Cg_endo -55.93 120.21 7.88 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 122.775 2.317 . . . . 0.0 111.463 177.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -102.45 114.27 28.33 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -174.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.507 ' HB2' HD21 ' A' ' 145' ' ' LEU . . . -97.63 148.98 22.75 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.94 -173.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.477 ' HA ' HG21 ' A' ' 159' ' ' VAL . 5.2 t -147.51 124.47 11.32 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.187 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.586 HG23 HG22 ' A' ' 159' ' ' VAL . 22.1 t -86.9 140.92 15.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -113.59 -72.65 0.69 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 -172.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 12.7 t70 -160.32 169.85 22.3 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.984 -162.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.523 HG21 ' CD1' ' A' ' 165' ' ' ILE . 34.5 m -129.53 146.61 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.379 0 C-N-CA 123.991 0.916 . . . . 0.0 109.872 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -123.72 126.33 46.34 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 118.204 -0.903 . . . . 0.0 108.618 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.476 ' O ' ' HE3' ' A' ' 55' ' ' LYS . 47.6 p90 -58.5 122.4 13.27 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 175.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.476 ' HE3' ' O ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -124.7 -20.37 5.08 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.972 -169.406 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.98 -159.51 20.55 Favored Glycine 0 N--CA 1.427 -1.939 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.153 -177.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.22 137.65 33.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.202 0.525 . . . . 0.0 111.241 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.3 m -117.95 170.05 9.15 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -83.73 -33.77 25.02 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 118.701 -1.2 . . . . 0.0 110.558 175.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.49 ' O ' ' HD1' ' A' ' 121' ' ' TYR . 24.8 m-20 -111.28 97.72 6.98 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 171.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.58 -168.36 27.89 Favored Glycine 0 C--N 1.303 -1.257 0 C-N-CA 120.493 -0.86 . . . . 0.0 110.965 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 3.5 m -147.12 140.74 19.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 C-N-CA 123.265 0.626 . . . . 0.0 110.718 -177.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -71.31 127.11 31.48 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 123.874 0.734 . . . . 0.0 112.026 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -131.62 143.87 50.63 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 124.513 1.125 . . . . 0.0 111.199 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -92.6 108.0 19.64 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.451 ' HB2' HG12 ' A' ' 52' ' ' VAL . . . -101.55 140.42 35.86 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.2 137.39 54.22 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.554 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.7 t -123.79 111.44 29.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.3 p -97.7 147.14 24.66 Favored 'General case' 0 C--N 1.277 -2.58 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.911 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.61 134.74 29.76 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 CA-C-O 121.36 0.6 . . . . 0.0 110.317 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 22.2 ptmt -105.77 144.48 32.45 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.477 ' ND2' HD13 ' A' ' 105' ' ' LEU . 1.5 p-10 -149.37 124.88 4.97 Favored Pre-proline 0 C--N 1.28 -2.437 0 C-N-CA 118.532 -1.267 . . . . 0.0 109.686 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 72' ' ' ASN . 38.0 Cg_endo -97.64 97.98 0.07 OUTLIER 'Trans proline' 0 N--CA 1.417 -3.009 0 C-N-CA 121.563 1.509 . . . . 0.0 110.696 173.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -138.63 -85.52 0.26 Allowed 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.9 p 170.24 -47.43 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.861 0.865 . . . . 0.0 110.9 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.612 ' O ' ' HA2' ' A' ' 107' ' ' GLY . 15.6 pt20 -104.01 163.69 12.21 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.845 -174.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.5 p -78.38 130.85 36.61 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 170.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.423 ' H ' ' CD1' ' A' ' 105' ' ' LEU . 75.3 mt -120.59 128.34 25.84 Favored Pre-proline 0 C--N 1.285 -2.213 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.47 150.3 69.79 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.298 1.999 . . . . 0.0 111.689 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.664 HG22 ' CE1' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -88.49 151.71 3.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 55.0 m -71.01 -50.94 28.69 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 174.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -166.03 163.35 18.27 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.62 -1.173 . . . . 0.0 107.977 171.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.6 tt -124.5 119.6 56.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 21.9 t -103.97 139.83 38.56 Favored 'General case' 0 N--CA 1.421 -1.899 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.667 -174.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.493 ' HA ' HD13 ' A' ' 143' ' ' ILE . 37.5 p90 -120.78 125.52 47.78 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 174.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 66.5 mt -118.64 107.35 21.48 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 174.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.49 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 3.0 pp -104.38 146.25 29.1 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.424 -175.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -116.77 155.45 28.9 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.192 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.9 m -140.11 109.55 6.23 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 66.47 -69.84 0.11 Allowed 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 125.612 1.565 . . . . 0.0 113.788 175.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.8 t -154.31 -46.27 0.09 Allowed 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -175.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -129.97 145.7 51.64 Favored 'General case' 0 C--N 1.314 -0.965 0 O-C-N 121.795 -0.566 . . . . 0.0 111.595 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 47.4 m 77.25 130.2 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 124.858 1.263 . . . . 0.0 112.22 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 42.5 pt -131.88 177.76 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.72 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.229 -178.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.461 ' HB3' HD11 ' A' ' 87' ' ' LEU . . . -133.99 148.74 51.17 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 173.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 70.2 p -143.01 160.75 39.76 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -177.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -176.87 164.51 34.05 Favored Glycine 0 N--CA 1.433 -1.527 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.435 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.9 p -132.15 115.47 15.77 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 124.217 1.007 . . . . 0.0 109.55 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.485 HD11 HG13 ' A' ' 115' ' ' VAL . 56.6 mt -94.95 125.09 52.22 Favored Pre-proline 0 C--O 1.244 0.78 0 C-N-CA 118.937 -1.105 . . . . 0.0 112.685 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -83.31 118.43 2.59 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.924 2.416 . . . . 0.0 111.739 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.42 ' HA ' HD11 ' A' ' 80' ' ' ILE . 24.1 m-20 48.36 68.55 3.41 Favored Pre-proline 0 N--CA 1.484 1.233 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -83.59 -21.44 4.24 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 N-CA-C 108.955 -1.21 . . . . 0.0 108.955 170.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -177.06 -166.63 34.29 Favored Glycine 0 N--CA 1.418 -2.51 0 N-CA-C 107.709 -2.157 . . . . 0.0 107.709 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 21.2 m -142.82 171.85 13.49 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.477 HD13 ' ND2' ' A' ' 72' ' ' ASN . 2.1 pp -75.96 153.2 36.75 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 117.697 -1.601 . . . . 0.0 108.791 172.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.56 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 8.9 p -70.98 -42.01 76.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -170.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.612 ' HA2' ' O ' ' A' ' 76' ' ' GLN . . . 129.58 -72.44 0.48 Allowed Glycine 0 N--CA 1.409 -3.124 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 -175.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.6 t -145.23 87.65 1.83 Allowed 'General case' 0 C--N 1.278 -2.52 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 160.83 -146.22 12.12 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 8.9 t -125.75 135.34 51.95 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 117.418 0.609 . . . . 0.0 111.008 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.56 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 2.7 t -127.5 138.98 53.07 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 122.924 0.49 . . . . 0.0 110.602 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.9 m -99.21 118.49 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-O 121.557 0.694 . . . . 0.0 110.551 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.8 mt -103.93 162.12 13.4 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -150.51 149.26 29.73 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.62 0.724 . . . . 0.0 112.383 -176.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.485 HG13 HD11 ' A' ' 99' ' ' ILE . 53.2 t -129.78 127.77 22.89 Favored Pre-proline 0 C--N 1.302 -1.457 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.084 176.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -79.18 110.01 2.65 Favored 'Trans proline' 0 N--CA 1.419 -2.884 0 N-CA-C 107.008 -1.958 . . . . 0.0 107.008 168.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.0 m -115.95 150.27 17.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 118' ' ' LYS 0.315 0.0 OUTLIER -97.87 122.6 41.17 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 118.245 -1.382 . . . . 0.0 109.976 166.014 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.2 m -91.99 142.14 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.211 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -174.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 69.23 10.81 7.99 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.876 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.49 ' HD1' ' O ' ' A' ' 60' ' ' ASP . 67.6 t80 -54.7 -40.89 69.63 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.895 0.878 . . . . 0.0 108.949 171.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.3 m -61.34 -45.47 94.28 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.591 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.7 tt -75.81 -34.5 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.248 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -53.73 -48.46 69.61 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 123.413 0.685 . . . . 0.0 112.1 176.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.5 m -71.87 -21.83 21.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.0 t -88.79 -69.06 0.73 Allowed 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 120.718 0.294 . . . . 0.0 111.253 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -124.84 -29.05 3.43 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.898 -0.501 . . . . 0.0 111.986 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.538 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 25.7 ttt 76.35 88.32 0.08 Allowed 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.645 ' HB2' ' CZ ' ' A' ' 174' ' ' PHE . 87.5 tttt 41.87 -86.54 0.01 OUTLIER 'General case' 0 C--N 1.345 0.375 0 O-C-N 125.138 1.524 . . . . 0.0 114.584 167.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 129' ' ' LYS . 29.7 t70 152.95 -25.36 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.136 1.774 . . . . 0.0 106.348 -175.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.406 ' H ' ' HG2' ' A' ' 129' ' ' LYS . 2.6 tpt 43.86 78.19 0.06 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-N 113.115 -1.857 . . . . 0.0 112.244 -169.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 54.0 t -110.22 140.87 43.9 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 176.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 19.3 p -68.69 122.93 19.57 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.1 t70 68.95 103.9 0.06 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.462 1.105 . . . . 0.0 108.694 -169.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.614 ' CD1' ' HE3' ' A' ' 129' ' ' LYS . 59.6 t-105 -150.69 134.81 16.88 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.752 -170.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -107.37 123.69 48.73 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.486 HG23 ' HB ' ' A' ' 165' ' ' ILE . 16.2 tt -123.53 134.34 66.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.743 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -85.11 114.35 22.18 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.511 -175.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -133.11 155.9 48.41 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.737 0.815 . . . . 0.0 110.945 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -151.14 155.1 38.21 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 87' ' ' LEU . 1.7 pt? -136.94 117.06 13.38 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.568 0.699 . . . . 0.0 109.152 169.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -91.86 117.26 29.63 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.493 HD13 ' HA ' ' A' ' 85' ' ' TYR . 41.4 mm -106.96 140.03 26.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.586 -0.845 . . . . 0.0 110.793 -173.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -127.99 102.54 0.59 Allowed Glycine 0 N--CA 1.423 -2.172 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.507 HD21 ' HB2' ' A' ' 47' ' ' ALA . 1.1 pp -94.97 137.76 33.6 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.219 -0.592 . . . . 0.0 111.051 178.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.2 m -116.89 127.23 54.07 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.74 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.664 ' CE1' HG22 ' A' ' 80' ' ' ILE . 87.0 m-85 -128.56 143.9 51.05 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.785 175.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -104.04 110.26 22.36 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 66.1 mt -123.54 114.55 28.65 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -41.79 -36.13 3.25 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 124.827 3.684 . . . . 0.0 115.08 -175.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 56.9 t -55.25 -40.55 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 122.942 0.497 . . . . 0.0 111.544 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 51.9 t -117.72 -45.93 3.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.925 0.393 . . . . 0.0 110.639 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 129.69 -150.89 19.12 Favored Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -81.07 116.99 21.28 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 177.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.408 HG22 ' CE1' ' A' ' 34' ' ' PHE . 28.7 pt -124.0 128.53 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 37.3 m -104.62 116.6 32.35 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 174.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . 70.1 mt -101.92 112.73 65.66 Favored Pre-proline 0 C--N 1.293 -1.891 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.005 -176.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 157' ' ' ILE . 6.6 Cg_endo -82.98 132.8 6.4 Favored 'Trans proline' 0 CA--C 1.482 -2.12 0 C-N-CA 122.863 2.375 . . . . 0.0 112.532 176.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.586 HG22 HG23 ' A' ' 49' ' ' VAL . 2.7 p -134.51 123.35 42.17 Favored 'Isoleucine or valine' 1 N--CA 1.372 -4.335 0 CA-C-N 112.582 -2.099 . . . . 0.0 108.918 -179.353 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 15.4 m -116.43 156.76 26.23 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.578 -174.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.458 ' CG2' ' HB ' ' A' ' 49' ' ' VAL . 9.9 t -173.82 171.36 3.75 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -113.5 145.82 40.59 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 120.915 0.388 . . . . 0.0 110.442 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -118.4 103.4 1.03 Allowed Glycine 0 N--CA 1.426 -2.023 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -88.61 121.13 30.66 Favored 'General case' 0 C--N 1.268 -2.978 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.523 ' CD1' HG21 ' A' ' 52' ' ' VAL . 30.4 mm -110.28 109.27 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.432 -173.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -94.4 126.23 39.54 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.65 172.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 95.2 mt -115.51 88.23 19.01 Favored Pre-proline 0 C--N 1.293 -1.858 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.066 -176.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -82.95 86.57 1.45 Allowed 'Trans proline' 0 N--CA 1.434 -2.0 0 C-N-CA 122.52 2.147 . . . . 0.0 113.109 -176.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 57.3 p 55.1 92.83 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 175.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 5.1 mp -108.51 -61.16 1.64 Allowed 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.326 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . 0.299 86.1 mtm180 62.26 109.11 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -176.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . 0.319 21.4 m-20 85.05 -9.34 0.85 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.171 1.788 . . . . 0.0 114.4 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -81.8 -69.09 0.64 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 169.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.645 ' CZ ' ' HB2' ' A' ' 129' ' ' LYS . 88.8 t80 . . . . . 0 N--CA 1.427 -1.579 0 C-N-CA 126.195 1.798 . . . . 0.0 106.456 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.308 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -96.81 102.33 14.09 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.745 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -147.87 107.07 3.87 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -82.72 46.36 1.07 Allowed 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.816 0.817 . . . . 0.0 109.059 -175.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.5 t60 -67.48 113.16 5.1 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.807 -177.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -130.16 155.18 46.65 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -173.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.3 m80 71.63 149.3 0.09 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.149 1.38 . . . . 0.0 112.216 -177.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.6 tp 71.84 -61.6 0.49 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.834 1.254 . . . . 0.0 112.461 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -73.85 -49.02 27.02 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.286 -176.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.68 99.47 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.215 0.531 . . . . 0.0 110.544 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.0 p -71.41 -19.25 62.28 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.894 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.82 -44.11 70.65 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 177.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.417 ' HA ' HG22 ' A' ' 16' ' ' VAL . 26.3 m-20 -68.78 -37.78 79.56 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.42 ' HG2' ' OG1' ' A' ' 93' ' ' THR . 1.3 tm-20 -56.73 -48.44 77.76 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.524 -1.217 . . . . 0.0 109.036 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -69.19 -47.09 65.84 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.487 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.417 HG22 ' HA ' ' A' ' 13' ' ' ASP . 35.2 m -65.51 -32.38 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -176.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.5 p -73.07 -28.63 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.845 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -70.25 -37.48 74.94 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.433 ' O ' HG23 ' A' ' 23' ' ' VAL . 18.2 mm-40 -56.27 -41.69 76.25 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.449 174.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.639 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 9.9 mmpt? -64.11 -46.56 83.64 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.577 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.87 -43.14 85.79 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.576 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.1 t -59.22 -31.77 69.34 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 19' ' ' GLU . 64.4 t -75.46 -48.78 29.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.6 mt -61.35 -52.32 62.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.924 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.5 m -65.63 -22.46 66.66 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.602 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.7 t -66.23 -44.85 82.61 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.415 ' O ' HD23 ' A' ' 27' ' ' LEU . 3.8 tt -75.73 -40.14 56.09 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.412 ' HA ' ' OG1' ' A' ' 156' ' ' THR . 6.1 tt -61.58 -35.18 77.09 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.686 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -67.11 -47.34 71.46 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.017 0.527 . . . . 0.0 112.018 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -66.18 -33.59 76.11 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.234 0.54 . . . . 0.0 110.947 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.86 -32.12 61.81 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.978 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.96 -46.45 89.22 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.611 0.243 . . . . 0.0 111.003 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.66 -32.59 82.04 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.971 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -78.98 -48.96 13.52 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.484 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 68.4 t80 -53.56 -38.75 64.17 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.59 -46.88 58.15 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 123.917 0.761 . . . . 0.0 113.006 -176.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.433 ' HG3' ' HG2' ' A' ' 38' ' ' LYS . 13.3 pt-20 -116.89 -36.51 3.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.362 0.601 . . . . 0.0 112.507 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.433 ' HG2' ' HG3' ' A' ' 37' ' ' GLU . 19.9 mmmt -77.43 -33.49 54.88 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -168.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 89.9 mt -100.06 13.46 34.0 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.874 0.845 . . . . 0.0 109.816 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.51 -37.07 12.11 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 172.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -73.53 -50.08 23.25 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.722 176.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.6 mt -80.49 119.46 76.4 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.917 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.54 120.27 8.0 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.45 2.1 . . . . 0.0 111.983 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 p -127.24 156.75 74.23 Favored Pre-proline 0 C--N 1.288 -2.079 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.266 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.66 133.12 40.74 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.372 2.048 . . . . 0.0 110.839 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.0 110.02 22.65 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -177.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.5 140.32 41.99 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.343 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 t -142.32 136.59 29.85 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 121.336 0.589 . . . . 0.0 110.738 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.5 t -83.98 141.25 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -115.42 -59.61 1.98 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.346 -0.942 . . . . 0.0 113.342 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -169.59 -173.61 1.69 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -175.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . 36.0 m -131.51 154.99 41.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 118.41 0.55 . . . . 0.0 111.069 -176.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -129.84 116.18 18.32 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.381 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.583 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 46.6 p90 -82.36 141.28 32.96 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.541 ' HE2' ' C ' ' A' ' 54' ' ' PHE . 0.4 OUTLIER -89.69 -78.15 0.37 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.986 175.196 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.59 -117.7 0.41 Allowed Glycine 0 C--O 1.211 -1.314 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.253 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.8 t -99.3 140.54 18.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.525 HG22 ' H ' ' A' ' 60' ' ' ASP . 57.4 m -147.08 149.77 33.71 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -72.3 -19.32 61.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.335 0.588 . . . . 0.0 111.336 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.525 ' H ' HG22 ' A' ' 58' ' ' THR . 7.4 m-20 -122.97 86.38 2.57 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.204 175.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.48 -133.89 30.5 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.356 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 93.0 t -134.45 143.2 38.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -89.65 105.49 17.83 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.675 0.75 . . . . 0.0 110.171 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.785 ' CD1' ' HB ' ' A' ' 119' ' ' VAL . 7.8 m-85 -102.63 141.46 35.42 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.487 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 15.6 m-70 -101.13 108.9 20.69 Favored 'General case' 0 C--N 1.282 -2.351 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.053 170.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -78.54 135.22 37.26 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.436 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -90.03 117.75 29.05 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.606 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.8 t -129.61 111.89 23.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.2 p -100.45 137.16 39.24 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.252 0.549 . . . . 0.0 111.979 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.6 t -127.66 132.41 69.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.881 -177.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 21.4 ptmt -116.8 142.87 46.35 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.589 HD22 ' HA2' ' A' ' 107' ' ' GLY . 38.1 t30 -140.93 115.76 7.27 Favored Pre-proline 0 C--N 1.286 -2.177 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.677 -175.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -90.33 97.38 0.27 Allowed 'Trans proline' 0 N--CA 1.426 -2.45 0 C-N-CA 121.406 1.404 . . . . 0.0 112.228 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.523 ' HB3' ' H ' ' A' ' 76' ' ' GLN . 18.8 m-85 -167.78 -168.65 1.03 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 126.967 2.107 . . . . 0.0 107.372 177.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.1 t -132.98 7.48 4.01 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 170.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.523 ' H ' ' HB3' ' A' ' 74' ' ' TYR . 11.5 pt20 -97.63 142.19 29.75 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.594 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.5 p -79.62 102.58 8.99 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-O 120.944 0.402 . . . . 0.0 110.33 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.547 ' HB ' HD23 ' A' ' 105' ' ' LEU . 78.7 mt -92.6 117.67 67.69 Favored Pre-proline 0 C--N 1.31 -1.145 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 177.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -78.22 130.37 10.13 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 122.162 1.908 . . . . 0.0 112.747 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.473 ' HB ' ' CE1' ' A' ' 147' ' ' PHE . 9.9 tt -82.6 94.38 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 174.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 57.9 m -58.79 -42.13 88.33 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.845 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -156.87 148.55 22.55 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.617 -171.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.5 tt -128.58 116.36 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 173.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 28.6 p -120.26 118.72 31.18 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.717 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.492 ' CE1' HG13 ' A' ' 117' ' ' VAL . 43.6 p90 -109.04 147.98 31.5 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.414 -176.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.429 HD12 ' N ' ' A' ' 86' ' ' ILE . 3.0 mp -120.31 113.26 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 175.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.704 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 0.9 OUTLIER -99.51 137.25 38.27 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.532 ' N ' HD23 ' A' ' 87' ' ' LEU . 45.4 mtpt -129.1 153.89 47.22 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 172.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.5 t -158.97 140.4 13.21 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 119.027 -1.069 . . . . 0.0 113.2 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 60.38 -79.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.805 1.642 . . . . 0.0 114.595 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -167.32 -32.48 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.099 0.476 . . . . 0.0 109.89 -175.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -129.09 141.94 51.05 Favored 'General case' 0 CA--C 1.49 -1.343 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.883 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.42 ' OG1' ' HG2' ' A' ' 14' ' ' GLU . 7.2 m 75.39 134.21 0.05 Allowed 'General case' 0 C--N 1.307 -1.25 0 O-C-N 125.177 1.548 . . . . 0.0 112.354 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.704 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.6 pp -138.2 174.79 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.199 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.668 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -132.63 162.01 32.42 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 119.095 0.862 . . . . 0.0 111.026 175.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.0 m -143.36 153.68 42.95 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -154.96 149.93 21.33 Favored Glycine 0 N--CA 1.419 -2.472 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 93.2 m -141.32 108.51 5.49 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.4 mt -115.03 110.21 46.16 Favored Pre-proline 0 C--N 1.306 -1.316 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.776 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -72.16 131.06 17.33 Favored 'Trans proline' 0 C--O 1.238 0.502 0 C-N-CA 122.533 2.155 . . . . 0.0 109.645 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.314 4.0 p30 44.72 77.94 0.42 Allowed Pre-proline 0 N--CA 1.487 1.394 0 C-N-CA 124.622 1.169 . . . . 0.0 114.107 -175.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -87.91 -8.71 5.77 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.874 2.383 . . . . 0.0 113.556 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 173.36 -161.77 32.71 Favored Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.592 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 46.2 m -119.86 142.03 49.02 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.209 0.528 . . . . 0.0 110.719 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.547 HD23 ' HB ' ' A' ' 78' ' ' ILE . 41.5 tp -97.04 141.37 30.28 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.447 HG23 ' HB ' ' A' ' 111' ' ' THR . 61.0 t -89.77 107.46 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.247 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 171.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.589 ' HA2' HD22 ' A' ' 72' ' ' ASN . . . -57.06 -22.49 42.79 Favored Glycine 0 C--N 1.292 -1.89 0 CA-C-N 114.317 -1.311 . . . . 0.0 113.627 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.4 p -120.23 11.72 11.63 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -156.57 -161.93 11.1 Favored Glycine 0 CA--C 1.498 -1.009 0 C-N-CA 117.135 -2.459 . . . . 0.0 114.996 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 41.4 m -101.7 129.85 47.95 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.447 ' HB ' HG23 ' A' ' 106' ' ' VAL . 10.0 t -127.47 133.21 49.91 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 40.1 t -97.78 115.92 39.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.1 mt -102.81 160.93 14.16 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 7.3 p-10 -133.45 130.81 39.14 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 9.6 t -104.78 126.18 31.91 Favored Pre-proline 0 C--N 1.305 -1.368 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -71.04 110.47 2.82 Favored 'Trans proline' 0 N--CA 1.433 -2.054 0 N-CA-C 106.818 -2.031 . . . . 0.0 106.818 168.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.492 HG13 ' CE1' ' A' ' 85' ' ' TYR . 97.6 t -116.69 141.39 34.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.708 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -87.17 88.4 7.69 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.17 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.785 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 94.5 t -94.04 145.99 7.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.664 -176.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 72.41 -1.99 2.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.141 0.976 . . . . 0.0 111.245 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -68.45 -43.38 77.19 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.41 ' O ' ' HB ' ' A' ' 93' ' ' THR . 14.4 m -62.0 -28.0 69.26 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 122.491 1.138 . . . . 0.0 109.578 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.6 mt -78.18 -49.45 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.22 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.455 -177.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.03 -36.27 72.47 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.324 0.649 . . . . 0.0 111.517 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.0 t -67.81 -34.72 69.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.421 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.0 t -93.39 -66.77 0.9 Allowed 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -176.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.501 ' H ' HD23 ' A' ' 127' ' ' LEU . 1.8 pt? -124.91 -23.85 4.2 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -176.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 24.2 ttt 56.89 35.59 26.55 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.283 1.033 . . . . 0.0 109.349 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.436 ' H ' ' HG ' ' A' ' 127' ' ' LEU . 61.6 mmtt 69.3 -70.5 0.14 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.033 1.733 . . . . 0.0 106.672 -172.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.446 ' H ' ' H ' ' A' ' 131' ' ' MET . 24.4 t70 149.58 18.71 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 130.855 3.662 . . . . 0.0 102.862 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.598 ' SD ' ' HA ' ' A' ' 171' ' ' ARG . 0.0 OUTLIER 58.53 76.79 0.33 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 113.05 -1.887 . . . . 0.0 106.778 -163.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.409 ' HB2' ' NE1' ' A' ' 135' ' ' TRP . 64.9 m -106.43 127.62 53.42 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.631 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 169' ' ' SER . 19.0 p -93.29 119.4 32.39 Favored 'General case' 0 N--CA 1.399 -2.982 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.078 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 5.9 m-20 72.85 89.14 0.1 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 176.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.409 ' NE1' ' HB2' ' A' ' 132' ' ' CYS . 1.2 p-90 -173.15 158.66 3.71 Favored 'General case' 0 C--O 1.246 0.894 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.254 174.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.595 ' HA ' ' HA ' ' A' ' 166' ' ' LYS . 5.1 p-10 -98.45 143.38 28.96 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.453 HD12 ' N ' ' A' ' 137' ' ' ILE . 3.1 mp -124.23 140.46 47.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -177.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -75.81 112.7 12.47 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 122.674 1.226 . . . . 0.0 111.791 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.451 ' CE2' ' HG ' ' A' ' 87' ' ' LEU . 1.2 t80 -125.23 152.01 45.13 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 113.501 -1.682 . . . . 0.0 107.261 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 162' ' ' GLN . 17.4 tt0 -134.08 150.46 51.18 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.1 tp -131.89 117.7 18.84 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 121.703 0.763 . . . . 0.0 110.163 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.424 ' HB3' ' HB ' ' A' ' 86' ' ' ILE . 13.3 t70 -124.76 130.2 51.94 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 -177.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.9 mt -136.81 140.48 42.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.159 -1.016 . . . . 0.0 111.761 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -108.32 93.15 0.78 Allowed Glycine 0 N--CA 1.426 -1.976 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.48 ' HB3' ' CE2' ' A' ' 147' ' ' PHE . 3.1 mm? -68.42 118.96 12.16 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 16.7 m -100.89 108.52 20.31 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.267 -177.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.48 ' CE2' ' HB3' ' A' ' 145' ' ' LEU . 96.3 m-85 -119.26 149.22 42.14 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 176.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 154' ' ' ASP . 4.5 p-10 -102.48 115.97 31.66 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.121 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.3 mp -108.02 105.46 56.44 Favored Pre-proline 0 C--N 1.296 -1.737 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -30.15 -51.14 0.2 Allowed 'Trans proline' 0 N--CA 1.485 1.029 1 C-N-CA 125.694 4.263 . . . . 0.0 116.984 -172.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.448 HG23 HG23 ' A' ' 152' ' ' VAL . 29.7 m -62.29 -21.17 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -177.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.448 HG23 HG23 ' A' ' 151' ' ' VAL . 48.4 t -121.86 -40.73 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.817 0.818 . . . . 0.0 109.754 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 112.8 -148.8 18.49 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 148' ' ' ASP . 6.7 p-10 -86.46 124.42 32.77 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.612 0.72 . . . . 0.0 110.811 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 146' ' ' THR . 2.2 pp -125.35 145.07 33.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.489 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.414 HG22 ' OG1' ' A' ' 146' ' ' THR . 46.4 p -94.7 119.57 33.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.652 0.263 . . . . 0.0 110.771 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.449 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . 55.3 mt -92.78 119.32 67.93 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 157' ' ' ILE . 19.8 Cg_exo -70.71 125.48 11.7 Favored 'Trans proline' 0 C--O 1.24 0.579 0 C-N-CA 123.596 2.864 . . . . 0.0 113.409 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 39.0 t -132.81 115.03 23.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 173.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.7 m -125.36 142.8 51.3 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 121.046 -0.262 . . . . 0.0 110.808 -174.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.1 t -176.97 157.11 1.39 Allowed 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 140' ' ' GLN . 30.2 pt20 -99.62 152.45 20.03 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.267 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -120.37 119.57 4.24 Favored Glycine 0 N--CA 1.417 -2.597 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -96.7 120.59 37.3 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 4.2 pt -131.16 112.82 22.42 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 CA-C-O 121.446 0.641 . . . . 0.0 112.191 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 136' ' ' ASP . 40.1 ttmt -90.87 128.24 36.68 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.102 178.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 134' ' ' ASP . 88.4 mt -110.38 107.23 58.4 Favored Pre-proline 0 C--N 1.286 -2.161 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.568 -173.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -71.58 105.09 1.7 Allowed 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.788 2.325 . . . . 0.0 111.835 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 133' ' ' THR 0.268 89.5 p 60.46 -83.96 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 126.025 1.73 . . . . 0.0 114.557 -175.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.401 HD22 HD13 ' A' ' 167' ' ' LEU . 10.9 mp 63.44 26.74 14.99 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-O 121.044 0.449 . . . . 0.0 112.189 -176.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.598 ' HA ' ' SD ' ' A' ' 131' ' ' MET . 47.1 ttt180 -77.23 99.08 5.34 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . 0.276 1.8 m-20 80.28 79.45 0.05 OUTLIER 'General case' 0 CA--C 1.49 -1.359 0 CA-C-O 123.089 1.423 . . . . 0.0 109.514 -168.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -170.16 -40.67 0.02 OUTLIER 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 100.718 -3.808 . . . . 0.0 100.718 -177.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 . . . . . 0 N--CA 1.425 -1.703 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 164.372 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.27 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 63.33 87.62 0.11 Allowed 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.573 0.749 . . . . 0.0 109.889 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 72.45 119.22 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.7 -172.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -64.49 -18.53 64.88 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.838 0.351 . . . . 0.0 110.373 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.3 m80 73.61 -74.84 0.08 Allowed 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 125.407 1.483 . . . . 0.0 111.898 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -144.03 179.5 7.16 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.911 0.386 . . . . 0.0 110.787 -177.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -152.94 -57.21 0.13 Allowed 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 171.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 50.1 tp 61.16 -77.58 0.02 OUTLIER 'General case' 0 C--N 1.355 0.82 0 C-N-CA 126.042 1.737 . . . . 0.0 112.571 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -126.08 108.34 11.26 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.19 103.82 3.46 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.184 -173.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.5 p -135.65 -67.03 0.54 Allowed 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 114.594 -1.184 . . . . 0.0 108.99 177.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.36 -33.38 37.31 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.198 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -56.65 -53.85 52.85 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.289 0.636 . . . . 0.0 112.268 -177.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.94 -28.44 62.43 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.218 0.532 . . . . 0.0 111.295 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.51 ' HE2' ' OE1' ' A' ' 19' ' ' GLU . 81.9 tttt -67.69 -55.3 13.75 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.539 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.453 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 32.3 m -60.27 -33.64 54.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -173.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -73.36 -33.43 40.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.093 0.473 . . . . 0.0 110.21 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -72.65 -49.34 32.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.144 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.51 ' OE1' ' HE2' ' A' ' 15' ' ' LYS . 8.9 pt-20 -64.36 -31.73 73.05 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.978 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.56 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 1.1 tpmt? -61.98 -48.78 78.82 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.83 -39.48 94.47 Favored 'General case' 0 C--O 1.21 -0.991 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.829 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.5 t -60.53 -44.51 95.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 66.6 t -69.47 -43.87 80.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 20' ' ' LYS . 78.7 mt -61.03 -45.25 98.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.397 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.7 t -57.42 -41.71 80.92 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 123.041 0.536 . . . . 0.0 110.055 177.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.8 t -66.79 -26.27 66.87 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-O 121.013 0.435 . . . . 0.0 110.912 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 tt -76.36 -55.19 5.78 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.574 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 8.4 mp -59.3 -36.39 75.51 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -51.23 -45.7 62.05 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.09 0.556 . . . . 0.0 111.843 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -82.95 -31.2 27.79 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 177.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.96 -32.27 73.56 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.116 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.574 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 61.4 mtpt -57.18 -27.85 62.3 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.484 0.713 . . . . 0.0 110.819 175.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.564 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -74.12 -55.77 5.58 Favored Glycine 0 N--CA 1.438 -1.228 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 178.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -56.1 -40.98 74.52 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.763 0.316 . . . . 0.0 110.836 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.456 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 48.7 t80 -67.21 -37.48 83.7 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.27 -34.75 63.66 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.987 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.564 ' HG2' ' O ' ' A' ' 33' ' ' GLY . 11.1 pt-20 -104.72 -44.37 4.88 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -176.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.414 ' HG2' HD12 ' A' ' 42' ' ' ILE . 21.6 ttmm -87.93 -43.94 11.4 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.682 0.753 . . . . 0.0 109.659 -170.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 67.2 mt -87.16 12.13 12.35 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.647 -176.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.05 -40.72 15.47 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 173.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.54 ' OD1' HG13 ' A' ' 42' ' ' ILE . 8.4 p30 -87.72 -36.43 17.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.452 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.54 HG13 ' OD1' ' A' ' 41' ' ' ASN . 85.4 mt -88.84 113.8 57.38 Favored Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -79.0 101.04 1.4 Allowed 'Trans proline' 0 N--CA 1.435 -1.97 0 C-N-CA 121.955 1.77 . . . . 0.0 113.628 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.9 p -93.04 149.94 38.4 Favored Pre-proline 0 N--CA 1.419 -1.987 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.463 ' HB3' ' HA ' ' A' ' 72' ' ' ASN . 10.9 Cg_endo -53.37 141.87 59.52 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.279 1.986 . . . . 0.0 110.246 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -96.53 141.99 29.15 Favored 'General case' 0 CA--C 1.484 -1.563 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.685 -172.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.48 137.35 53.24 Favored 'General case' 0 N--CA 1.414 -2.254 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.877 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.2 t -134.34 126.03 28.82 Favored 'General case' 0 C--N 1.272 -2.779 0 CA-C-O 121.635 0.731 . . . . 0.0 109.985 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.568 HG11 ' CG1' ' A' ' 143' ' ' ILE . 35.5 m -107.38 141.72 21.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.164 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 49' ' ' VAL . 27.5 t70 161.8 66.81 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 124.898 1.374 . . . . 0.0 112.684 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 67' ' ' LYS . 20.5 t70 -177.47 117.86 0.1 Allowed 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 168.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.2 t -132.03 112.69 20.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -121.53 141.88 50.62 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.9 -176.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 41.9 p90 -77.0 128.14 33.96 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.732 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -120.22 -3.09 10.05 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.656 -0.818 . . . . 0.0 112.047 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.0 158.29 25.92 Favored Glycine 0 CA--C 1.489 -1.567 0 C-N-CA 119.214 -1.469 . . . . 0.0 112.84 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.49 ' HB ' ' CE1' ' A' ' 173' ' ' PHE . 7.5 p -106.8 116.29 50.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.716 0.77 . . . . 0.0 112.336 -176.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.564 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 88.4 m -132.55 130.67 40.65 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 174.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -82.01 -12.2 58.43 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.211 0.529 . . . . 0.0 111.196 -174.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.405 ' H ' HG22 ' A' ' 58' ' ' THR . 20.1 t70 -114.33 69.16 0.7 Allowed 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 172.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.564 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . 100.33 101.37 2.41 Favored Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.117 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.0 p -76.2 143.07 13.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 121.164 0.507 . . . . 0.0 110.889 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -89.45 114.89 26.44 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -172.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.635 ' CD1' ' HB ' ' A' ' 119' ' ' VAL . 32.9 m-85 -120.87 151.26 39.87 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.056 173.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -120.51 109.19 14.99 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.93 144.75 34.53 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.933 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 31.6 mmtp -102.4 118.76 37.56 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.599 -176.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.6 t -111.06 108.37 25.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 175.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.6 p -99.85 123.83 44.51 Favored 'General case' 0 C--N 1.285 -2.201 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.713 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.7 t -114.96 128.01 72.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.722 -176.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 71' ' ' LYS . 19.2 ptpt -102.35 110.48 22.45 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.568 ' O ' ' HA ' ' A' ' 108' ' ' SER . 34.1 t30 -109.98 113.9 56.67 Favored Pre-proline 0 C--N 1.265 -3.075 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.107 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -97.67 95.97 0.07 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.686 0 C-N-CA 121.605 1.537 . . . . 0.0 109.65 169.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -176.19 156.29 1.63 Allowed 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 127.468 2.307 . . . . 0.0 106.54 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.5 m -82.92 -18.59 39.57 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.656 0.741 . . . . 0.0 109.242 176.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.554 HE21 HG12 ' A' ' 78' ' ' ILE . 11.0 pt20 -96.83 146.78 24.6 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.674 -178.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.4 m -84.59 106.43 16.15 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 171.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.554 HG12 HE21 ' A' ' 76' ' ' GLN . 59.1 mt -76.19 116.15 53.4 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -56.99 137.02 80.12 Favored 'Trans proline' 0 C--O 1.239 0.569 0 C-N-CA 123.228 2.618 . . . . 0.0 113.757 -175.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 146' ' ' THR . 9.4 pt -112.64 98.59 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.952 175.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 51.6 t -52.6 -54.9 26.84 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.188 -177.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -145.71 160.64 41.43 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.524 ' CG2' ' HB ' ' A' ' 99' ' ' ILE . 14.9 tt -134.87 113.83 16.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 175.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 55.0 p -94.63 123.3 37.99 Favored 'General case' 0 C--N 1.287 -2.144 0 O-C-N 121.956 -0.465 . . . . 0.0 111.421 -175.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.526 ' HA ' HD13 ' A' ' 143' ' ' ILE . 36.4 p90 -103.81 129.86 51.3 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 2.5 mp -117.12 107.17 21.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 176.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.629 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 1.3 tt -92.35 132.56 36.63 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.474 ' N ' HD23 ' A' ' 87' ' ' LEU . 62.1 tttm -130.46 143.48 50.79 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.483 ' HB2' HD11 ' A' ' 123' ' ' ILE . 58.1 p -144.05 95.39 2.72 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 55.59 -81.84 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 171.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.6 p -83.98 -71.68 0.5 Allowed 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 -168.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -137.31 -64.92 0.55 Allowed 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 m -66.76 139.55 57.81 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 121.513 0.673 . . . . 0.0 112.086 -173.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.629 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.7 pp -139.7 170.65 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.484 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 -178.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.629 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -138.06 136.5 36.89 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.3 t -149.08 159.85 43.86 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.909 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.56 161.08 24.35 Favored Glycine 0 N--CA 1.422 -2.262 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 64.6 p -101.34 127.23 48.06 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.524 ' HB ' ' CG2' ' A' ' 83' ' ' ILE . 66.4 mt -97.15 110.07 52.44 Favored Pre-proline 0 C--N 1.306 -1.303 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.853 175.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -78.31 115.56 3.73 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.097 1.864 . . . . 0.0 110.828 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.7 t70 60.4 86.05 0.16 Allowed Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.868 -176.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.402 ' HG3' ' CG2' ' A' ' 83' ' ' ILE . 19.0 Cg_endo -97.05 5.42 1.58 Allowed 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.903 2.402 . . . . 0.0 111.581 177.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 145.59 -164.71 28.06 Favored Glycine 0 N--CA 1.419 -2.484 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.3 m -137.95 155.59 48.73 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.441 HD21 ' CE1' ' A' ' 147' ' ' PHE . 6.9 mp -72.02 150.84 43.64 Favored 'General case' 0 CA--C 1.485 -1.555 0 CA-C-O 121.803 0.811 . . . . 0.0 111.149 176.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 11.1 p -88.2 139.13 17.85 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.143 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.274 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -66.49 90.77 0.16 Allowed Glycine 0 C--N 1.304 -1.231 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 72' ' ' ASN 0.252 79.6 p 63.09 86.74 0.11 Allowed 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 125.973 1.709 . . . . 0.0 113.537 -178.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 169.35 -163.86 37.46 Favored Glycine 0 N--CA 1.431 -1.669 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.5 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.7 m -119.29 115.99 25.31 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.474 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 5.1 t -110.23 132.2 54.38 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.106 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.2 t -95.72 113.09 29.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.6 mt -92.67 150.09 20.91 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.312 -177.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -105.02 119.66 39.57 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.365 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.54 117.84 30.01 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-O 121.17 0.51 . . . . 0.0 111.319 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.37 123.13 10.2 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.208 1.939 . . . . 0.0 111.143 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 57.4 t -125.26 136.64 60.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -88.17 93.56 9.54 Favored 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.635 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 96.2 t -93.76 146.44 6.55 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.826 -171.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 72.31 -4.29 2.07 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.121 1.368 . . . . 0.0 112.799 174.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.52 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . 44.9 t80 -67.13 -32.46 73.6 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.7 p -64.86 -35.2 80.36 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.041 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.483 HD11 ' HB2' ' A' ' 89' ' ' SER . 33.8 mm -71.78 -46.98 58.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.021 176.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.4 -48.02 83.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.471 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.8 p -72.26 -25.46 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 CA-C-O 121.013 0.435 . . . . 0.0 111.35 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 39.2 t -80.8 -76.04 0.25 Allowed 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.825 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.576 HD12 ' N ' ' A' ' 128' ' ' MET . 2.5 pp -124.68 -37.26 2.5 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -175.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.576 ' N ' HD12 ' A' ' 127' ' ' LEU . 9.8 tpt 61.94 109.97 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.486 0.714 . . . . 0.0 111.49 -176.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.513 ' HB2' ' HZ2' ' A' ' 135' ' ' TRP . 1.4 mptp? -78.47 -30.07 47.16 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 80.15 97.78 0.06 Allowed 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 113.533 -1.667 . . . . 0.0 110.76 -175.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.33 139.83 58.81 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.133 -1.394 . . . . 0.0 110.395 -176.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 49.7 t -138.37 -81.54 0.32 Allowed 'General case' 0 CA--C 1.56 1.364 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.615 ' HA ' ' CB ' ' A' ' 169' ' ' SER . 14.1 p -144.29 130.81 19.95 Favored 'General case' 0 N--CA 1.426 -1.645 0 C-N-CA 125.541 1.536 . . . . 0.0 109.652 -171.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 44.56 89.56 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 C-N-CA 124.632 1.173 . . . . 0.0 110.138 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.513 ' HZ2' ' HB2' ' A' ' 129' ' ' LYS . 69.5 t-105 -128.99 150.21 50.5 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -162.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -136.94 136.26 38.44 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.031 0.932 . . . . 0.0 109.893 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 22.6 pt -132.41 136.66 55.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 173.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -87.18 121.14 29.23 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.509 ' CE2' ' HG ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -149.61 161.74 41.56 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -175.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -164.16 158.94 19.71 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 117.889 0.313 . . . . 0.0 110.822 171.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.598 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 1.5 pt? -136.12 132.29 35.88 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-O 121.0 0.429 . . . . 0.0 109.96 176.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.566 ' HA ' ' HB3' ' A' ' 160' ' ' SER . 15.2 t70 -101.84 120.84 41.02 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 175.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.568 ' CG1' HG11 ' A' ' 49' ' ' VAL . 45.8 mm -100.66 133.07 45.02 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 CA-C-O 120.832 0.349 . . . . 0.0 110.693 -176.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -114.75 86.41 0.41 Allowed Glycine 0 N--CA 1.41 -3.096 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 174.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.729 HD13 ' H ' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -81.05 146.42 30.64 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 30.3 m -127.84 114.45 17.24 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 119.051 -1.06 . . . . 0.0 112.248 -176.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.441 ' CE1' HD21 ' A' ' 105' ' ' LEU . 50.3 m-85 -99.14 160.3 14.37 Favored 'General case' 0 C--O 1.246 0.875 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 174.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -121.37 126.85 50.41 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.846 174.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.7 125.33 18.36 Favored Pre-proline 0 C--N 1.301 -1.512 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.092 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.54 -28.68 22.5 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 C-N-CA 123.953 3.102 . . . . 0.0 113.737 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.94 -38.39 76.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.506 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 41.3 t -124.84 -45.29 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.264 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 129.15 -133.58 7.62 Favored Glycine 0 N--CA 1.428 -1.847 0 C-N-CA 121.026 -0.607 . . . . 0.0 111.758 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -100.33 117.34 34.32 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.857 0.863 . . . . 0.0 108.931 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.413 HD12 ' N ' ' A' ' 155' ' ' ILE . 2.7 mp -128.75 119.5 49.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.494 178.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 86.4 m -82.07 112.11 18.83 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 173.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.436 ' O ' HD13 ' A' ' 145' ' ' LEU . 70.0 mt -93.5 117.15 67.29 Favored Pre-proline 0 C--N 1.299 -1.587 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.285 -176.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.446 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.7 Cg_endo -82.83 133.87 7.03 Favored 'Trans proline' 0 CA--C 1.489 -1.774 0 C-N-CA 122.88 2.387 . . . . 0.0 112.728 176.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.443 HG22 HG22 ' A' ' 49' ' ' VAL . 2.7 p -146.28 131.4 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.106 0 CA-C-N 113.097 -1.865 . . . . 0.0 109.062 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.566 ' HB3' ' HA ' ' A' ' 142' ' ' ASP . 12.3 p -147.29 162.43 38.96 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.454 HG21 ' HA ' ' A' ' 50' ' ' ASP . 14.4 t -153.5 178.22 10.06 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 177.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -98.69 132.41 44.1 Favored 'General case' 0 N--CA 1.422 -1.864 0 C-N-CA 118.661 -1.215 . . . . 0.0 108.801 176.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.477 ' O ' ' HD1' ' A' ' 139' ' ' TYR . . . -97.1 76.82 0.67 Allowed Glycine 0 N--CA 1.399 -3.821 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -87.82 119.88 28.6 Favored 'General case' 0 C--N 1.271 -2.842 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.7 pt -117.55 108.38 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.765 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.236 -176.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.413 ' HG2' ' H ' ' A' ' 166' ' ' LYS . 16.7 pttt -98.41 98.61 9.81 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 113.195 -1.82 . . . . 0.0 109.571 -177.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 88.4 mt -87.14 127.62 58.6 Favored Pre-proline 0 C--N 1.282 -2.346 0 CA-C-N 112.228 -2.26 . . . . 0.0 111.935 -169.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -69.79 150.74 68.43 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.079 1.853 . . . . 0.0 108.334 173.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.615 ' CB ' ' HA ' ' A' ' 133' ' ' THR . 2.3 m -51.16 99.35 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -177.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -101.52 -27.31 13.18 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 170.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.53 -65.6 0.2 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.066 1.746 . . . . 0.0 109.943 -178.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -116.24 95.33 5.03 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 122.168 0.985 . . . . 0.0 109.592 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.49 ' CE1' ' HB ' ' A' ' 57' ' ' VAL . 72.7 t80 -157.47 -47.61 0.07 Allowed 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 103.164 -2.902 . . . . 0.0 103.164 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 41.4 t80 . . . . . 0 N--CA 1.416 -2.173 0 CA-C-N 113.206 -1.816 . . . . 0.0 106.3 167.929 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.958 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -148.13 137.91 22.42 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -177.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 72.3 -47.59 0.67 Allowed 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 175.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 33.7 p80 51.83 94.09 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.878 1.271 . . . . 0.0 112.193 -175.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -71.84 65.37 0.52 Allowed 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -173.09 154.93 2.88 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 127.472 2.309 . . . . 0.0 108.029 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 47.6 m80 66.76 35.45 5.07 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 123.964 0.79 . . . . 0.0 110.858 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.568 HD22 ' HG3' ' A' ' 9' ' ' GLU . 4.4 tt -65.3 -59.27 4.23 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.568 ' HG3' HD22 ' A' ' 8' ' ' LEU . 48.2 mt-10 -121.65 -21.38 6.19 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.93 174.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 63.24 82.39 0.18 Allowed 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -172.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.0 m -78.27 163.97 25.29 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.58 -173.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.26 -35.51 81.27 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.81 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -57.25 -55.67 31.74 Favored 'General case' 0 CA--C 1.495 -1.153 0 O-C-N 123.76 0.662 . . . . 0.0 109.428 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -53.7 -35.14 60.8 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.324 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -74.88 -56.18 5.04 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.25 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.446 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 30.6 m -70.83 -34.72 57.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -172.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 p -68.46 -32.5 55.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.203 0.525 . . . . 0.0 110.349 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -74.89 -47.13 31.64 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.488 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.446 ' HG2' ' HA ' ' A' ' 16' ' ' VAL . 13.4 pt-20 -71.15 -36.99 72.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.413 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.402 ' O ' HG12 ' A' ' 24' ' ' ILE . 40.5 ttmt -65.17 -39.4 92.87 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.48 -37.72 88.38 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.986 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -59.94 -50.62 73.04 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.655 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 19' ' ' GLU . 95.7 t -59.66 -51.06 77.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.902 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.529 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 50.4 mm -63.28 -36.1 74.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.195 -177.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.8 t -62.77 -35.68 80.6 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.424 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.5 m -72.25 -35.85 68.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.097 0.475 . . . . 0.0 110.145 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.505 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 5.3 tt -66.78 -40.25 88.1 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 85.5 mt -61.8 -41.09 97.32 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -57.87 -45.82 85.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.669 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -66.23 -30.67 71.16 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-O 121.099 0.476 . . . . 0.0 110.955 -179.544 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.521 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -78.02 -34.73 50.54 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 120.987 0.423 . . . . 0.0 111.787 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 29.0 mtpp -69.11 9.44 0.42 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -177.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -113.08 -18.34 7.32 Favored Glycine 0 C--N 1.313 -0.723 0 C-N-CA 120.341 -0.933 . . . . 0.0 111.371 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.497 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 68.4 m-85 -80.25 -25.53 39.47 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.555 ' HA ' HD12 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -56.19 -29.96 61.62 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -171.592 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.71 -34.04 25.0 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -115.79 -46.81 2.82 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.497 ' HB3' ' HB3' ' A' ' 34' ' ' PHE . 5.4 tmmm? -82.71 -20.75 35.46 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-O 120.898 0.38 . . . . 0.0 110.311 -173.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.555 HD12 ' HA ' ' A' ' 35' ' ' PHE . 42.7 mt -96.3 0.06 50.3 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.299 176.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.88 -57.07 2.85 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.819 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -81.64 -2.81 51.65 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.228 0.537 . . . . 0.0 111.979 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 75.6 mt -121.46 125.17 26.94 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.97 107.03 0.32 Allowed 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.739 2.293 . . . . 0.0 111.704 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.7 p -134.33 153.06 79.13 Favored Pre-proline 0 C--N 1.302 -1.487 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.963 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.403 ' HB3' ' HB2' ' A' ' 72' ' ' ASN . 52.5 Cg_endo -79.25 164.41 24.36 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.544 2.163 . . . . 0.0 113.58 -176.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 71' ' ' LYS . 36.8 tt0 -112.86 143.01 44.85 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.93 152.22 50.5 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.128 -175.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.3 t -147.69 128.97 14.76 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.265 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.475 HG13 HG22 ' A' ' 161' ' ' THR . 7.5 p -94.09 141.7 14.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 175.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -118.05 -66.81 1.04 Allowed 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -170.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -158.58 167.07 30.56 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -171.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.574 HG11 ' OH ' ' A' ' 139' ' ' TYR . 14.5 p -126.97 132.68 69.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.723 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -104.71 135.84 45.34 Favored 'General case' 0 C--O 1.251 1.15 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.343 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.499 ' O ' ' HE2' ' A' ' 55' ' ' LYS . 48.7 p90 -60.45 140.76 57.1 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 174.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.549 ' HE2' ' HA ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -136.11 -66.72 0.54 Allowed 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.914 -171.157 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.09 -164.76 15.3 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.202 -176.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.24 128.31 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-O 121.452 0.644 . . . . 0.0 111.515 -177.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.505 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 44.9 m -152.29 126.51 9.23 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 173.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -69.82 -32.44 70.87 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -169.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -108.6 11.42 26.64 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.02 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . 170.1 86.95 0.06 OUTLIER Glycine 0 CA--C 1.492 -1.374 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -177.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.429 HG13 ' HB ' ' A' ' 119' ' ' VAL . 7.2 p -67.76 140.39 19.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.534 0.683 . . . . 0.0 110.991 -173.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -96.26 106.75 19.0 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 121.691 0.757 . . . . 0.0 112.02 -175.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.565 ' HB3' HG22 ' A' ' 52' ' ' VAL . 3.3 m-85 -100.97 165.36 11.37 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.246 174.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.452 ' CD2' ' HG2' ' A' ' 55' ' ' LYS . 20.0 m-70 -124.89 110.26 14.03 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.284 0.564 . . . . 0.0 109.553 176.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . . . -78.45 144.91 35.36 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.589 -177.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -90.46 112.61 24.3 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.556 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.2 t -118.33 114.61 45.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.4 m -98.2 131.29 44.68 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -177.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 95.4 t -118.84 133.0 67.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.533 0.682 . . . . 0.0 111.077 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 46' ' ' GLU . 78.3 tttt -102.78 109.97 21.73 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 45' ' ' PRO . 8.9 t30 -130.33 113.2 16.94 Favored Pre-proline 0 C--N 1.302 -1.497 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.95 -175.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -102.88 97.59 0.04 OUTLIER 'Trans proline' 0 N--CA 1.421 -2.755 0 C-N-CA 122.319 2.013 . . . . 0.0 113.081 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -176.52 150.78 0.9 Allowed 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 170.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.5 t -77.87 8.03 5.15 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 118.039 0.381 . . . . 0.0 111.487 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.428 ' CD ' HG12 ' A' ' 78' ' ' ILE . 6.4 tt0 -101.56 137.64 39.61 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.7 p -94.08 95.57 9.09 Favored 'General case' 0 N--CA 1.399 -2.98 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 170.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.533 ' HB ' HD12 ' A' ' 105' ' ' LEU . 33.6 mt -77.88 126.36 84.12 Favored Pre-proline 0 N--CA 1.434 -1.235 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -174.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.0 133.95 30.51 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.308 2.006 . . . . 0.0 110.538 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 67.7 mt -83.93 107.04 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 55.5 m -55.76 -51.82 66.06 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.853 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -160.55 155.2 23.85 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.253 0.549 . . . . 0.0 110.274 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.472 HG23 HG23 ' A' ' 143' ' ' ILE . 24.8 mm -114.95 113.85 44.81 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 172.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.3 m -93.48 117.28 29.88 Favored 'General case' 0 C--N 1.274 -2.687 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -107.89 129.56 55.08 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.519 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.625 ' HB ' ' HB2' ' A' ' 142' ' ' ASP . 3.0 mp -118.11 108.0 23.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.501 HD21 ' CE2' ' A' ' 139' ' ' TYR . 3.1 tm? -109.96 124.65 51.77 Favored 'General case' 0 C--N 1.27 -2.88 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.847 -175.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.575 ' HB2' ' HB2' ' A' ' 140' ' ' GLN . 29.9 mmtm -93.7 142.81 26.93 Favored 'General case' 0 CA--C 1.479 -1.774 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.738 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 92' ' ' ARG . 45.9 t -97.92 145.54 26.35 Favored 'General case' 0 C--N 1.267 -2.996 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.65 143.83 56.91 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.296 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.4 m 74.1 -61.03 0.51 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.455 1.102 . . . . 0.0 111.001 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.405 ' O ' ' HB3' ' A' ' 89' ' ' SER . 53.3 mtt180 -155.01 172.1 18.66 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.088 0.555 . . . . 0.0 110.165 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.0 m 77.52 160.33 0.21 Allowed 'General case' 0 CA--C 1.563 1.456 0 O-C-N 124.261 0.976 . . . . 0.0 113.207 172.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.418 HD13 ' N ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -147.91 149.26 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 123.727 0.811 . . . . 0.0 109.228 -176.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.494 ' HB2' ' OG ' ' A' ' 122' ' ' SER . . . -118.64 134.93 54.75 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.666 0.787 . . . . 0.0 109.221 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.0 p -129.64 158.86 38.16 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.95 162.61 26.03 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.8 p -124.89 128.77 49.16 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 117.054 0.427 . . . . 0.0 110.335 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.8 mt -99.64 105.35 33.43 Favored Pre-proline 0 C--N 1.308 -1.221 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -76.92 116.08 4.16 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.502 2.134 . . . . 0.0 111.722 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.5 t70 53.96 83.33 0.23 Allowed Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 124.95 1.3 . . . . 0.0 112.745 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -101.08 7.8 0.58 Allowed 'Trans proline' 0 N--CA 1.441 -1.613 0 C-N-CA 122.697 2.265 . . . . 0.0 112.015 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 153.77 -164.78 31.35 Favored Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 32.2 p -145.28 158.89 43.72 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.533 HD12 ' HB ' ' A' ' 78' ' ' ILE . 78.4 mt -73.08 157.13 37.9 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 121.209 0.528 . . . . 0.0 111.611 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.401 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 14.6 p -90.4 139.16 18.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.238 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.4 93.82 0.46 Allowed Glycine 0 C--N 1.3 -1.447 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.784 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 67.3 p 60.36 83.15 0.14 Allowed 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 125.697 1.599 . . . . 0.0 113.998 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.88 -160.06 33.61 Favored Glycine 0 N--CA 1.429 -1.785 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.0 t -118.89 142.0 48.15 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.401 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 4.4 t -134.87 138.87 44.56 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.577 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.9 m -91.04 126.24 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 173.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.8 mt -103.04 145.18 30.28 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.718 -176.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -100.79 116.33 32.42 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.175 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.403 ' HA ' ' HD2' ' A' ' 116' ' ' PRO . 29.2 m -126.74 117.77 22.56 Favored Pre-proline 0 C--N 1.316 -0.864 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 177.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 115' ' ' VAL . 33.4 Cg_endo -66.37 124.5 12.58 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.625 2.216 . . . . 0.0 111.579 174.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 97.3 t -124.67 141.01 46.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 120.854 0.359 . . . . 0.0 110.155 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.75 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -87.8 102.12 14.36 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.988 0.899 . . . . 0.0 111.045 178.275 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.429 ' HB ' HG13 ' A' ' 62' ' ' VAL . 48.1 t -97.6 148.39 5.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.462 ' HB2' ' OXT' ' A' ' 174' ' ' PHE . . . 75.07 -14.96 0.7 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.909 0.883 . . . . 0.0 111.932 -178.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.409 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 34.4 t80 -56.06 -58.13 9.23 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 124.119 0.967 . . . . 0.0 109.961 -175.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.494 ' OG ' ' HB2' ' A' ' 95' ' ' ALA . 41.4 m -74.93 -26.84 59.91 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.96 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.429 HG21 ' HG2' ' A' ' 129' ' ' LYS . 58.4 mt -71.47 -50.24 41.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.116 -173.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.61 -49.37 75.49 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 123.516 0.51 . . . . 0.0 110.363 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 52.2 t -57.9 -39.39 71.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.217 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.8 t -82.25 -82.6 0.13 Allowed 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 128' ' ' MET . 2.0 pp -125.6 -27.0 3.45 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -173.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.445 ' N ' HD12 ' A' ' 127' ' ' LEU . 10.1 tpt 69.9 125.76 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.955 0.902 . . . . 0.0 111.458 -174.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.429 ' HG2' HG21 ' A' ' 123' ' ' ILE . 27.0 mmmt -72.34 -36.28 68.78 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-O 122.057 0.932 . . . . 0.0 110.431 -177.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.8 t70 78.0 76.05 0.06 Allowed 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 112.072 -2.331 . . . . 0.0 106.512 -171.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.512 ' HG2' ' CD1' ' A' ' 135' ' ' TRP . 5.8 tmm? -69.69 114.69 8.13 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 112.859 -1.973 . . . . 0.0 109.599 -171.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 55.6 m -91.2 -179.67 5.48 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.124 -174.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 22.4 p -80.2 105.1 11.22 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-O 121.839 0.828 . . . . 0.0 110.785 178.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.5 t70 78.24 98.52 0.06 Allowed 'General case' 0 CA--C 1.487 -1.456 0 C-N-CA 126.553 1.941 . . . . 0.0 107.555 -170.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.512 ' CD1' ' HG2' ' A' ' 131' ' ' MET . 32.9 t-105 -148.89 148.45 29.86 Favored 'General case' 0 C--N 1.276 -2.591 0 CA-C-N 113.976 -1.466 . . . . 0.0 108.716 -171.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -125.87 141.16 52.11 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.56 132.29 54.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -105.58 109.65 21.69 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.574 ' OH ' HG11 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -113.01 172.07 7.16 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.287 -0.965 . . . . 0.0 108.971 173.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.575 ' HB2' ' HB2' ' A' ' 88' ' ' LYS . 63.2 mt-30 -118.29 130.79 56.24 Favored 'General case' 0 C--N 1.274 -2.685 0 C-N-CA 120.414 -0.514 . . . . 0.0 109.719 -174.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 35.6 tp -116.45 125.69 52.35 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.246 0.546 . . . . 0.0 112.043 -177.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.625 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 13.7 m-20 -120.0 119.69 34.16 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.472 HG23 HG23 ' A' ' 83' ' ' ILE . 42.4 mm -112.97 123.75 68.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -96.13 103.85 3.0 Favored Glycine 0 N--CA 1.418 -2.514 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 176.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 156' ' ' THR . 2.9 mm? -76.83 101.75 6.01 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 123.195 0.598 . . . . 0.0 110.026 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.9 m -91.37 115.58 28.14 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.101 0.477 . . . . 0.0 111.487 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.567 ' CE2' ' HB3' ' A' ' 145' ' ' LEU . 60.4 m-85 -126.67 153.03 45.94 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -158.31 140.83 14.43 Favored 'General case' 0 CA--C 1.479 -1.762 0 CA-C-O 121.463 0.649 . . . . 0.0 112.221 173.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 50.0 mm -121.6 128.31 25.69 Favored Pre-proline 0 C--N 1.292 -1.911 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -46.73 -43.55 23.22 Favored 'Trans proline' 0 N--CA 1.483 0.907 0 C-N-CA 123.633 2.889 . . . . 0.0 114.207 -176.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.18 -52.49 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 121.722 0.772 . . . . 0.0 109.313 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.467 HG22 ' HD3' ' A' ' 38' ' ' LYS . 7.2 p 173.04 140.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 C-N-CA 125.488 1.515 . . . . 0.0 107.072 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.455 ' H ' ' H ' ' A' ' 154' ' ' ASP . . . 150.54 15.22 0.08 OUTLIER Glycine 0 C--N 1.291 -1.969 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -177.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.455 ' H ' ' H ' ' A' ' 153' ' ' GLY . 10.6 p-10 -73.21 118.05 15.69 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 126.031 1.733 . . . . 0.0 110.254 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.538 HG12 HD11 ' A' ' 39' ' ' LEU . 8.2 tp -162.59 144.14 3.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.499 -178.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 96.3 m -123.02 104.1 9.01 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 166.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 58.2 mt -87.88 112.94 52.3 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.328 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 156' ' ' THR . 26.9 Cg_endo -84.06 111.07 1.61 Allowed 'Trans proline' 0 N--CA 1.436 -1.864 0 C-N-CA 122.214 1.943 . . . . 0.0 111.587 176.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.4 m -106.49 134.95 46.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.409 ' HB3' ' OD1' ' A' ' 142' ' ' ASP . 29.6 p -126.1 157.44 38.03 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -175.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.475 HG22 HG13 ' A' ' 49' ' ' VAL . 14.6 t -170.47 170.67 6.85 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 176.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -99.67 132.19 45.17 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -101.72 104.64 2.71 Favored Glycine 0 N--CA 1.415 -2.73 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -90.04 119.46 30.41 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.53 HD11 ' CE1' ' A' ' 139' ' ' TYR . 5.7 mm -106.82 119.08 55.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 -174.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 62.9 tttp -92.99 117.72 30.38 Favored 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.153 175.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 95.6 mt -108.44 93.1 10.97 Favored Pre-proline 0 C--N 1.284 -2.26 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.841 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 166' ' ' LYS . 10.0 Cg_endo -86.42 82.34 1.36 Allowed 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 122.885 2.39 . . . . 0.0 112.861 -174.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 79.3 p 55.91 15.9 1.89 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.083 1.353 . . . . 0.0 113.777 177.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 49.7 tp -59.57 -56.68 18.86 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.134 0.574 . . . . 0.0 111.238 -176.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.438 ' O ' ' HD1' ' A' ' 173' ' ' PHE . 47.8 mtm105 65.28 145.24 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 179.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 76.79 -4.68 2.31 Favored 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 124.794 1.237 . . . . 0.0 114.023 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.438 ' HD1' ' O ' ' A' ' 171' ' ' ARG . 27.1 m-85 -111.57 -66.69 1.06 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.472 ' HB3' ' HG3' ' A' ' 131' ' ' MET 0.331 8.4 p90 . . . . . 0 C--O 1.26 1.622 0 C-N-CA 126.03 1.732 . . . . 0.0 114.244 -178.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.422 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -142.63 101.14 3.81 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -162.09 98.42 1.05 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.313 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -130.18 -175.27 3.57 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.345 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 61.3 t60 74.67 -29.82 0.2 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.647 1.579 . . . . 0.0 113.843 175.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -74.07 77.62 1.73 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.738 0.78 . . . . 0.0 112.508 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.2 p80 177.47 97.05 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 125.914 1.686 . . . . 0.0 107.749 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -72.82 -48.47 37.64 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -116.11 -57.87 2.16 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.544 171.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -155.75 -60.94 0.11 Allowed 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.481 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.485 ' HB3' ' HB2' ' A' ' 14' ' ' GLU . 67.7 m -87.46 98.52 11.43 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -176.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -101.75 -47.86 4.48 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 172.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -68.12 -43.35 78.59 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.051 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 11' ' ' SER . 1.5 mp0 -66.81 -31.1 71.5 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.386 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -74.51 -41.0 61.44 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -176.283 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.6 m -66.83 -29.44 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.1 m -73.03 -29.59 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.86 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 48.6 mt-10 -69.09 -34.59 75.35 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 176.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 7.7 mm-40 -59.25 -46.98 87.04 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.58 175.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.16 -45.45 93.36 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.653 177.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.15 -36.33 77.31 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.739 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.4 t -65.45 -35.55 81.25 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.82 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 91.2 t -70.71 -33.29 52.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.573 0.702 . . . . 0.0 110.027 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.578 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 59.0 mt -69.56 -40.98 80.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 174.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.1 m -66.86 -29.0 68.79 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.106 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.3 p -70.54 -34.78 72.66 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 120.914 0.388 . . . . 0.0 110.532 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.413 ' HB3' HG21 ' A' ' 156' ' ' THR 0.263 7.9 mp -79.38 -18.57 52.07 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 119.227 -0.989 . . . . 0.0 112.991 172.129 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 81.2 mt -68.62 -34.24 75.41 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 171.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.48 -40.45 70.23 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.324 176.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -52.01 -59.75 3.99 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.986 173.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 35' ' ' PHE . . . -59.75 -39.9 86.34 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.365 177.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -55.36 -31.96 62.18 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 123.345 0.658 . . . . 0.0 111.165 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.484 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -95.36 -77.83 1.38 Allowed Glycine 0 N--CA 1.425 -2.044 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.975 177.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 48.1 t80 -63.64 -39.96 95.67 Favored 'General case' 0 C--O 1.209 -1.074 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -174.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.488 ' HA ' HD23 ' A' ' 39' ' ' LEU . 82.1 t80 -69.87 -42.42 73.53 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 118.25 -1.38 . . . . 0.0 111.016 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 40' ' ' ALA . . . -62.07 -44.68 96.15 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 33' ' ' GLY . 14.3 pt-20 -94.74 -41.74 9.1 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -176.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 34' ' ' PHE . 15.2 tppt? -75.32 -45.4 39.82 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 121.824 0.821 . . . . 0.0 109.28 -173.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.502 HD11 HG21 ' A' ' 152' ' ' VAL . 3.8 mm? -86.8 7.29 27.58 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.297 -1.319 . . . . 0.0 112.82 -174.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 36' ' ' ALA . . . -76.02 -10.6 59.55 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.606 0.717 . . . . 0.0 109.843 176.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -112.99 2.12 15.65 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.117 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.4 mp -124.45 118.11 26.37 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -71.61 94.11 0.69 Allowed 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 122.36 2.04 . . . . 0.0 112.927 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.496 ' HB ' ' HD2' ' A' ' 45' ' ' PRO . 21.8 p -91.5 170.59 9.3 Favored Pre-proline 0 C--N 1.307 -1.248 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.414 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.496 ' HD2' ' HB ' ' A' ' 44' ' ' THR . 55.6 Cg_endo -65.36 146.78 86.55 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.559 1.506 . . . . 0.0 110.547 174.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -97.45 126.11 42.52 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.539 ' O ' HG11 ' A' ' 159' ' ' VAL . . . -97.38 146.13 25.48 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.8 t -161.23 120.85 2.6 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.075 0.464 . . . . 0.0 110.712 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -83.84 138.02 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -97.51 -59.01 1.87 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.106 -1.037 . . . . 0.0 110.922 -168.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -173.85 -178.04 1.49 Allowed 'General case' 0 C--O 1.249 1.052 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.661 HG22 ' HB3' ' A' ' 64' ' ' TYR . 7.6 p -130.53 132.35 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.907 0 CA-C-O 121.315 0.579 . . . . 0.0 109.52 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -107.97 136.31 47.89 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.238 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.661 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 45.5 p90 -92.08 141.18 28.88 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.416 ' N ' ' HD3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -124.74 -70.36 0.76 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.066 0.46 . . . . 0.0 110.881 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -112.36 -165.11 17.03 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.984 -174.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.466 ' HB ' ' CD2' ' A' ' 173' ' ' PHE . 13.6 p -117.92 159.99 17.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.129 -0.536 . . . . 0.0 110.042 -176.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 34.0 m -148.19 152.22 36.87 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 173.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.0 ttt-85 -58.94 -40.85 85.89 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.403 0.621 . . . . 0.0 110.446 177.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -117.13 94.39 4.55 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.414 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . 98.3 166.42 31.24 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.57 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.8 t -104.4 148.73 8.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.46 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 29.6 t70 -84.85 107.01 16.79 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.127 0.489 . . . . 0.0 111.877 -175.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.661 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 28.7 m-85 -117.46 158.16 24.99 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.768 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -133.18 112.92 12.12 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.528 ' HB3' HG13 ' A' ' 115' ' ' VAL . . . -90.41 144.66 25.59 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -177.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.8 mtmp? -104.34 119.52 39.15 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.93 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.0 t -117.61 109.05 26.22 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.415 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.2 m -100.43 143.28 30.81 Favored 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 119.769 -0.772 . . . . 0.0 111.049 -175.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.31 119.14 51.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -96.28 109.69 22.14 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.584 ' ND2' HD21 ' A' ' 105' ' ' LEU . 6.5 t30 -123.02 115.23 29.2 Favored Pre-proline 0 C--N 1.292 -1.924 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -171.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -97.74 96.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.672 0 C-N-CA 121.742 1.628 . . . . 0.0 110.871 172.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.572 ' HB2' HD21 ' A' ' 72' ' ' ASN . 61.3 m-85 -175.84 119.25 0.16 Allowed 'General case' 0 CA--C 1.488 -1.414 0 C-N-CA 128.086 2.555 . . . . 0.0 105.152 178.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.4 m -69.85 -18.1 63.41 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 123.553 0.533 . . . . 0.0 112.108 -177.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.436 HE21 HG12 ' A' ' 78' ' ' ILE . 18.0 pt20 -80.18 134.45 36.14 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-O 121.072 0.463 . . . . 0.0 110.726 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.2 p -80.01 97.19 6.68 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.563 ' HB ' HD13 ' A' ' 105' ' ' LEU . 42.3 mt -81.88 127.05 73.68 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -177.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.73 123.38 13.67 Favored 'Trans proline' 0 C--O 1.241 0.675 0 C-N-CA 122.588 2.192 . . . . 0.0 110.827 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.425 HG12 ' CE2' ' A' ' 147' ' ' PHE . 60.7 mt -69.77 103.51 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-O 121.309 0.576 . . . . 0.0 109.95 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 49.2 t -66.78 -56.82 8.73 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.885 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.555 ' HG3' ' CG2' ' A' ' 98' ' ' THR . 25.8 tt0 -152.24 130.17 11.75 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -175.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.6 mm -118.84 113.91 43.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 170.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 98' ' ' THR . 12.3 t -118.5 142.69 47.34 Favored 'General case' 0 C--N 1.288 -2.085 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.317 -174.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -128.27 144.57 51.14 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 121.301 0.572 . . . . 0.0 111.442 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.433 ' HB ' ' HB2' ' A' ' 142' ' ' ASP . 56.0 mt -120.9 119.65 60.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 174.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.626 HD13 ' HB3' ' A' ' 95' ' ' ALA . 0.4 OUTLIER -103.09 122.29 44.36 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 178.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.593 ' HB2' ' HB2' ' A' ' 140' ' ' GLN . 98.5 mttt -123.21 157.3 33.36 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.678 175.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.8 t -152.24 109.02 3.48 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.409 ' O ' ' HB ' ' A' ' 91' ' ' THR . . . 68.6 -77.49 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.232 1.013 . . . . 0.0 110.993 -177.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.409 ' HB ' ' O ' ' A' ' 90' ' ' ALA . 9.0 t 172.5 -28.71 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.155 0.582 . . . . 0.0 110.438 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -64.85 -56.93 10.47 Favored 'General case' 0 C--N 1.345 0.392 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -174.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 51.3 m -125.22 143.92 50.71 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.911 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.556 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 2.1 pp -141.37 178.64 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.209 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -176.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.626 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -135.95 147.11 47.93 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 172.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 39.1 t -131.44 153.12 50.06 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -176.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.46 165.48 36.94 Favored Glycine 0 N--CA 1.426 -1.992 0 C-N-CA 119.697 -1.24 . . . . 0.0 112.131 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.555 ' CG2' ' HG3' ' A' ' 82' ' ' GLN . 86.7 m -149.99 131.72 15.0 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.407 HD12 ' N ' ' A' ' 99' ' ' ILE . 2.8 mp -107.6 115.86 58.57 Favored Pre-proline 0 C--O 1.248 0.996 0 C-N-CA 119.071 -1.052 . . . . 0.0 109.77 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.28 114.75 3.81 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.021 1.814 . . . . 0.0 109.604 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.3 t70 55.15 77.94 0.41 Allowed Pre-proline 0 N--CA 1.482 1.175 0 C-N-CA 124.068 0.947 . . . . 0.0 111.285 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -92.62 3.61 3.62 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.576 2.184 . . . . 0.0 111.875 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 175.32 -157.38 24.02 Favored Glycine 0 N--CA 1.424 -2.166 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.9 p -136.48 139.53 42.39 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 117.196 0.498 . . . . 0.0 110.847 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.584 HD21 ' ND2' ' A' ' 72' ' ' ASN . 7.3 tt -69.67 127.16 32.0 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.818 178.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.496 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 7.3 p -52.74 -45.3 49.16 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -173.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.566 ' H ' HD23 ' A' ' 105' ' ' LEU . . . 86.01 82.86 1.1 Allowed Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 109.201 -1.559 . . . . 0.0 109.201 -172.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.6 m 62.18 90.32 0.07 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.402 1.081 . . . . 0.0 112.561 -176.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 155.19 -173.96 33.4 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 176.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.7 m -108.1 123.66 49.04 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.496 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 3.6 t -117.41 132.01 56.65 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.087 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.6 t -95.99 109.98 23.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.1 mt -91.44 167.1 12.5 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -144.77 149.05 34.83 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.562 -174.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.528 HG13 ' HB3' ' A' ' 66' ' ' ALA . 4.4 p -136.6 127.18 16.36 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.69 176.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.17 113.12 3.6 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.971 1.78 . . . . 0.0 108.774 171.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.1 t -123.1 126.04 72.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -175.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.46 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 14.3 mmmm -88.51 103.93 16.34 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.335 -0.946 . . . . 0.0 108.492 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.626 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 97.5 t -93.72 146.13 6.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.988 -173.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 78.0 -5.93 2.03 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.952 1.301 . . . . 0.0 110.516 -176.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.503 ' O ' HG23 ' A' ' 125' ' ' VAL . 82.4 t80 -58.07 -57.11 14.29 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.825 176.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.2 m -56.27 -39.34 72.47 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.758 -176.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 10.8 tp -77.83 -30.21 16.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.244 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -66.67 -42.64 86.25 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 172.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 121' ' ' TYR . 68.9 t -57.35 -33.19 43.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.529 175.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -75.49 -81.07 0.08 Allowed 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.0 176.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.469 ' H ' HD23 ' A' ' 127' ' ' LEU . 1.9 pt? -126.65 -22.83 3.84 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -177.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.427 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER 70.13 121.83 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -170.234 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.624 ' C ' ' H ' ' A' ' 131' ' ' MET . 0.0 OUTLIER -59.48 -32.31 70.14 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -172.689 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.8 t70 80.95 -16.41 0.65 Allowed 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 -169.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.624 ' H ' ' C ' ' A' ' 129' ' ' LYS 0.343 13.9 tmm? 72.32 -102.1 0.03 OUTLIER 'General case' 0 N--CA 1.416 -2.131 0 C-N-CA 128.456 2.702 . . . . 0.0 113.277 175.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 131' ' ' MET . 48.7 t 150.58 -138.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 102.682 -3.081 . . . . 0.0 102.682 -175.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 36.9 p -133.92 99.1 4.34 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 164.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.67 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 16.2 t70 71.86 92.73 0.08 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.663 1.185 . . . . 0.0 112.805 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.442 ' HE1' ' HA ' ' A' ' 131' ' ' MET . 1.2 p-90 -154.96 159.77 40.64 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 176.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 166' ' ' LYS . 5.7 p-10 -103.55 142.49 34.2 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.22 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.55 HD12 HD21 ' A' ' 167' ' ' LEU . 0.2 OUTLIER -115.62 158.28 16.06 Favored 'Isoleucine or valine' 0 C--O 1.248 1.013 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.763 177.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.66 115.37 10.77 Favored 'General case' 0 C--O 1.252 1.204 0 CA-C-O 121.635 0.731 . . . . 0.0 112.186 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -133.39 151.35 51.82 Favored 'General case' 0 N--CA 1.411 -2.384 0 CA-C-N 114.02 -1.446 . . . . 0.0 107.989 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.593 ' HB2' ' HB2' ' A' ' 88' ' ' LYS . 58.1 mt-30 -139.45 150.2 44.92 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.8 tp -139.18 118.96 13.17 Favored 'General case' 0 N--CA 1.419 -1.989 0 O-C-N 124.002 0.814 . . . . 0.0 109.822 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.433 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 22.6 m-20 -122.31 136.35 54.89 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.5 mm -122.05 129.29 75.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.567 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -117.91 88.0 0.44 Allowed Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 176.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 156' ' ' THR . 2.3 pp -84.31 149.2 26.22 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.825 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.461 ' HB ' ' HB3' ' A' ' 82' ' ' GLN . 8.7 m -127.02 120.59 29.39 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -176.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.425 ' CE2' HG12 ' A' ' 80' ' ' ILE . 68.9 m-85 -132.67 141.66 48.71 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -108.46 124.79 50.96 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.634 0.731 . . . . 0.0 110.709 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.483 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -124.88 125.84 25.36 Favored Pre-proline 0 C--N 1.297 -1.711 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.058 178.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -41.06 -34.21 1.43 Allowed 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 124.915 3.744 . . . . 0.0 115.88 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 13.5 p -59.3 -35.22 56.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.502 HG21 HD11 ' A' ' 39' ' ' LEU . 31.3 m -132.03 -25.66 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 121.875 -0.516 . . . . 0.0 112.355 -178.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 111.04 -141.7 16.58 Favored Glycine 0 N--CA 1.421 -2.346 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -177.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -92.41 120.42 32.89 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.908 0.385 . . . . 0.0 111.456 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 2.3 pp -130.35 146.24 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.356 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 174.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 4.6 p -95.32 151.06 19.58 Favored 'General case' 0 N--CA 1.397 -3.088 0 CA-C-N 113.978 -1.465 . . . . 0.0 109.98 174.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 57.4 mt -125.34 110.35 26.37 Favored Pre-proline 0 C--N 1.295 -1.787 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 176.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.447 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 97.3 Cg_endo -89.88 114.58 0.57 Allowed 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 123.005 2.47 . . . . 0.0 113.662 -174.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.539 HG11 ' O ' ' A' ' 47' ' ' ALA . 29.1 m -118.13 128.16 75.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.955 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 63.0 p -114.24 144.2 43.61 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.931 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 53.3 m -153.13 136.69 15.95 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 121.114 0.483 . . . . 0.0 110.098 -177.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -98.99 119.47 37.83 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -100.53 115.05 5.19 Favored Glycine 0 N--CA 1.411 -2.974 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.399 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -89.71 118.6 29.44 Favored 'General case' 0 C--N 1.27 -2.86 0 N-CA-C 105.601 -1.999 . . . . 0.0 105.601 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 136' ' ' ASP . 50.3 mm -112.95 108.68 26.16 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.442 -172.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 136' ' ' ASP . 60.5 pttt -86.54 133.65 33.72 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.015 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 134' ' ' ASP . 0.4 OUTLIER -103.41 96.91 9.22 Favored Pre-proline 0 C--N 1.295 -1.779 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 173.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.66 78.84 0.95 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.28 1.987 . . . . 0.0 113.62 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 76.2 p 39.26 79.55 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.707 1.603 . . . . 0.0 114.291 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.516 ' H ' ' HE2' ' A' ' 131' ' ' MET . 2.5 mm? -103.65 -61.84 1.37 Allowed 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.004 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 70.22 4.86 5.06 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 121.31 0.576 . . . . 0.0 112.177 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -136.29 -41.19 0.64 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.339 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.466 ' CD2' ' HB ' ' A' ' 57' ' ' VAL . 3.0 m-85 -81.04 -43.43 19.55 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 176.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.4 -2.953 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.187 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -130.88 98.94 4.75 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.369 0.604 . . . . 0.0 110.609 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -121.27 100.96 7.34 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.496 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -101.45 101.78 12.45 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.741 0.781 . . . . 0.0 112.709 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -151.71 140.35 20.74 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 102.625 -3.102 . . . . 0.0 102.625 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . 0.37 24.1 p-80 -75.63 72.6 2.59 Favored 'General case' 0 C--O 1.217 -0.607 0 N-CA-C 116.353 1.982 . . . . 0.0 116.353 -169.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -136.61 75.14 1.52 Allowed 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.478 171.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.43 ' O ' HD22 ' A' ' 8' ' ' LEU 0.286 0.0 OUTLIER -135.9 83.0 1.98 Allowed 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.875 176.116 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 64.09 18.34 11.17 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 113.502 -1.681 . . . . 0.0 109.666 -173.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.99 142.02 50.99 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.883 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.8 m 71.6 -38.89 0.43 Allowed 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 124.439 1.096 . . . . 0.0 111.78 -175.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.37 -39.73 89.31 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 173.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.447 ' O ' HG23 ' A' ' 17' ' ' VAL . 24.2 t70 -60.54 -29.79 69.35 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.146 177.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -77.78 -50.42 12.37 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.021 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.425 ' C ' ' HD3' ' A' ' 15' ' ' LYS . 12.7 tmtt? -57.32 -47.15 82.27 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.771 1.229 . . . . 0.0 112.539 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.0 m -63.22 -21.82 29.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 94' ' ' ILE . 92.8 t -67.34 -49.02 75.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 120.913 0.387 . . . . 0.0 110.14 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.95 -33.61 72.15 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.509 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -77.12 -39.26 50.04 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.831 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -75.45 -35.44 60.91 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 120.747 0.308 . . . . 0.0 111.0 -177.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.78 -35.78 73.36 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.46 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.4 t -63.08 -44.85 94.61 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.915 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.3 t -65.34 -48.55 82.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.965 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.547 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 64.0 mt -61.21 -44.62 98.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.238 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.7 m -62.95 -37.83 88.63 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.677 0.275 . . . . 0.0 111.161 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.5 m -66.03 -36.49 83.38 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.788 0.328 . . . . 0.0 110.629 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.423 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 5.0 tt -67.11 -43.21 83.06 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 83.5 mt -57.78 -46.46 84.55 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.661 177.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.74 -44.12 97.08 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.52 ' HD2' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -64.83 -33.24 75.53 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.583 -178.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.52 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -79.38 -40.44 30.11 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.396 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -51.07 -52.65 41.34 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.381 1.073 . . . . 0.0 112.598 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.38 -17.88 79.61 Favored Glycine 0 C--N 1.318 -0.439 0 C-N-CA 120.026 -1.083 . . . . 0.0 112.02 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -75.39 -26.23 58.28 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 123.448 0.699 . . . . 0.0 109.952 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.404 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 27.2 m-85 -79.15 -12.08 59.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -178.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.29 -51.35 70.34 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -174.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.657 ' HG2' ' HD3' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -117.27 -43.45 2.83 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -178.387 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.657 ' HD3' ' HG2' ' A' ' 37' ' ' GLU . 3.7 mppt? -64.52 -34.28 77.87 Favored 'General case' 0 CA--C 1.489 -1.376 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.271 -175.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.413 HD13 ' HB ' ' A' ' 42' ' ' ILE . 2.8 mm? -102.95 17.97 22.73 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.725 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.83 -28.07 16.08 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 171.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -94.47 -48.31 6.17 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.815 175.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.413 ' HB ' HD13 ' A' ' 39' ' ' LEU . 75.1 mt -73.99 121.29 84.84 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.96 114.38 3.72 Favored 'Trans proline' 0 C--O 1.246 0.925 0 C-N-CA 122.445 2.097 . . . . 0.0 113.518 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.403 HG23 HD12 ' A' ' 39' ' ' LEU . 23.3 p -114.33 140.41 25.05 Favored Pre-proline 0 N--CA 1.429 -1.498 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.868 173.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -56.12 138.95 84.6 Favored 'Trans proline' 0 C--O 1.24 0.603 0 C-N-CA 122.465 2.11 . . . . 0.0 111.418 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -96.45 109.9 22.36 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-O 121.327 0.584 . . . . 0.0 110.251 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.437 ' CB ' ' HG ' ' A' ' 145' ' ' LEU . . . -98.8 140.26 33.24 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.617 -178.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.5 t -141.98 133.7 27.01 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.315 177.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.554 HG22 HG22 ' A' ' 159' ' ' VAL . 24.3 m -89.45 141.61 14.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -130.93 -48.44 1.02 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -170.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -161.99 169.57 20.85 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.822 -171.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 65' ' ' HIS . 13.0 m -132.24 112.73 20.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.487 0.66 . . . . 0.0 111.562 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -92.34 129.5 38.27 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.243 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -59.27 138.26 57.67 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.982 0.176 . . . . 0.0 111.01 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.592 ' HD3' ' C ' ' A' ' 55' ' ' LYS . 11.7 tmtt? -119.44 -55.7 2.11 Favored 'General case' 0 N--CA 1.411 -2.413 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.033 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.483 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . -176.63 -170.87 39.72 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 118.865 -1.636 . . . . 0.0 113.432 -173.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.6 p -102.61 151.99 5.85 Favored 'Isoleucine or valine' 0 C--O 1.249 1.057 0 CA-C-O 121.709 0.766 . . . . 0.0 112.308 -172.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.764 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 31.3 m -159.97 159.41 32.18 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 103.047 -2.946 . . . . 0.0 103.047 173.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.483 ' HA ' ' CE2' ' A' ' 174' ' ' PHE . 34.1 mtm180 -73.15 134.24 44.36 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 118.954 -1.099 . . . . 0.0 110.235 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 76.39 -66.21 0.27 Allowed 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 125.533 1.533 . . . . 0.0 110.989 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.764 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . -107.52 128.22 9.11 Favored Glycine 0 CA--C 1.479 -2.191 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 56' ' ' GLY . 35.5 m -99.75 152.83 4.54 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.425 ' O ' ' HB3' ' A' ' 55' ' ' LYS . 45.8 m-20 -81.12 131.11 35.28 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -174.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -132.14 156.69 45.93 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 125.069 1.347 . . . . 0.0 109.491 174.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.435 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 18.0 m-70 -95.68 108.31 20.59 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 173.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.423 ' HA ' HG12 ' A' ' 52' ' ' VAL . . . -81.68 122.06 27.15 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 170.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -86.27 107.95 18.18 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.788 -174.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.6 t -114.02 109.17 27.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 56.3 p -103.05 128.74 49.79 Favored 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.555 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.2 t -114.66 120.58 64.72 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.262 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 36.2 ttpt -95.88 110.24 22.46 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 175.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -103.6 113.35 65.63 Favored Pre-proline 0 C--N 1.293 -1.878 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.853 -175.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -99.43 97.25 0.05 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.685 0 C-N-CA 122.007 1.805 . . . . 0.0 108.958 169.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -179.35 153.74 0.6 Allowed 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 102.951 -2.981 . . . . 0.0 102.951 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.1 t -79.22 -35.42 41.67 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -172.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -89.45 157.78 17.98 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.796 -0.762 . . . . 0.0 112.218 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.4 m -85.73 111.26 19.97 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 173.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.6 mt -87.97 128.95 52.03 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -175.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -87.19 118.86 1.41 Allowed 'Trans proline' 0 N--CA 1.433 -2.032 0 C-N-CA 122.098 1.865 . . . . 0.0 111.255 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.7 pt -72.04 113.06 8.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 48.5 t -58.43 -47.38 84.12 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.513 ' O ' ' HB ' ' A' ' 146' ' ' THR . 5.0 pp0? -156.29 157.95 36.64 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 174.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.485 ' CG2' HG23 ' A' ' 99' ' ' ILE . 11.8 tt -124.74 127.58 72.8 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.354 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 175.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.4 m -80.64 128.91 34.16 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-O 121.625 0.726 . . . . 0.0 110.963 -171.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -104.23 119.42 38.91 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.458 -175.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.0 mp -131.05 107.05 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 172.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.643 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 1.6 tm? -100.06 130.05 46.17 Favored 'General case' 0 C--N 1.268 -2.943 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -122.29 161.29 23.59 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.5 m -149.97 146.18 26.88 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -41.17 -71.42 0.08 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -174.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.558 ' C ' ' HD2' ' A' ' 92' ' ' ARG . 4.9 t -150.86 80.17 1.32 Allowed 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.558 ' HD2' ' C ' ' A' ' 91' ' ' THR . 3.8 mpt_? -140.0 -63.89 0.49 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 172.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.2 t 179.75 -174.18 0.24 Allowed 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.643 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 38.4 pt -132.1 -174.92 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . . . -132.0 130.33 41.28 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 33.5 p -106.25 179.68 4.2 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.789 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.02 170.14 12.77 Favored Glycine 0 N--CA 1.421 -2.355 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.005 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.9 p -134.46 128.96 34.5 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.485 HG23 ' CG2' ' A' ' 83' ' ' ILE . 7.5 tt -102.8 111.22 64.71 Favored Pre-proline 0 C--N 1.307 -1.255 0 C-N-CA 118.767 -1.173 . . . . 0.0 110.873 177.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.92 118.06 5.14 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 123.321 2.68 . . . . 0.0 113.563 -175.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.3 t70 45.19 79.15 0.35 Allowed Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 125.551 1.541 . . . . 0.0 113.546 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.428 ' HG3' ' CG2' ' A' ' 83' ' ' ILE . 68.4 Cg_endo -92.68 3.2 3.65 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.747 2.298 . . . . 0.0 111.915 175.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 165.85 -177.28 41.06 Favored Glycine 0 N--CA 1.427 -1.961 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.7 m -143.12 150.05 38.95 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.417 ' H ' HD23 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -103.51 142.76 33.72 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.235 -178.733 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.3 m -80.18 165.77 2.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 O-C-N 124.123 0.89 . . . . 0.0 110.504 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.39 133.16 11.56 Favored Glycine 0 N--CA 1.427 -1.902 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.7 p 54.78 75.85 0.28 Allowed 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 124.548 1.139 . . . . 0.0 113.015 -177.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.81 174.84 36.44 Favored Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.792 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 9.0 t -101.83 136.49 41.58 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.7 t -135.82 131.23 35.14 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 121.228 0.537 . . . . 0.0 110.204 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.3 t -95.74 119.28 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.7 mt -102.73 146.96 27.45 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.262 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -113.0 112.69 24.33 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.522 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 28.8 m -112.61 127.25 27.08 Favored Pre-proline 0 C--N 1.305 -1.364 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.249 175.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 12.8 Cg_exo -69.65 111.2 2.72 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.236 1.957 . . . . 0.0 110.598 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.7 t -108.91 134.47 50.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.904 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -91.25 102.19 14.9 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.0 m -93.07 140.12 16.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.388 -174.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 68.55 11.29 8.3 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.749 1.22 . . . . 0.0 109.852 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.414 ' O ' HG12 ' A' ' 125' ' ' VAL . 84.1 t80 -61.04 -44.13 97.86 Favored 'General case' 0 CA--C 1.485 -1.526 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.74 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.1 m -64.8 -31.56 72.84 Favored 'General case' 0 N--CA 1.436 -1.144 0 O-C-N 123.555 0.534 . . . . 0.0 111.878 -177.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 128' ' ' MET . 49.4 mt -77.33 -49.5 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.568 ' HA ' ' CA ' ' A' ' 128' ' ' MET . . . -66.95 -43.78 82.25 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -177.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 121' ' ' TYR . 8.1 p -65.21 -26.24 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.075 0.464 . . . . 0.0 110.079 -177.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.1 t -79.49 -62.17 1.77 Allowed 'General case' 0 N--CA 1.416 -2.167 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.418 ' H ' HD23 ' A' ' 127' ' ' LEU . 1.4 pt? -125.71 -64.19 1.08 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.886 176.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.568 ' CA ' ' HA ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER 173.84 151.21 0.09 Allowed 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 103.352 -2.833 . . . . 0.0 103.352 178.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.486 ' N ' ' SD ' ' A' ' 128' ' ' MET . 83.5 mttt -51.4 -51.25 56.3 Favored 'General case' 0 CA--C 1.465 -2.323 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 34.7 t70 174.54 -38.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 125.55 1.782 . . . . 0.0 111.555 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.609 ' HA ' ' CE ' ' A' ' 131' ' ' MET 0.33 2.7 mmt 64.05 99.16 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -171.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 84.4 m -156.03 179.87 8.8 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 173.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.461 ' CA ' ' HA ' ' A' ' 169' ' ' SER . 35.3 p -117.49 102.04 8.87 Favored 'General case' 0 N--CA 1.392 -3.354 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 172.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.6 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 19.2 t70 87.65 97.66 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.827 1.651 . . . . 0.0 110.907 -175.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.452 ' CZ2' HD22 ' A' ' 167' ' ' LEU . 6.9 p90 -156.21 159.46 38.96 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -122.08 151.24 41.1 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.4 pp -132.73 158.69 43.34 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -74.62 99.36 3.63 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.897 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.47 ' HE1' ' CD2' ' A' ' 87' ' ' LEU . 17.7 t80 -112.96 157.84 20.99 Favored 'General case' 0 N--CA 1.416 -2.127 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.15 176.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -164.26 159.16 19.69 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 171.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.567 HD13 HG12 ' A' ' 143' ' ' ILE . 1.0 OUTLIER -125.98 152.67 45.38 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.548 177.087 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.1 111.16 14.35 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 169.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.567 HG12 HD13 ' A' ' 141' ' ' LEU . 35.0 mm -115.23 140.7 35.28 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.988 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -119.98 104.04 0.99 Allowed Glycine 0 N--CA 1.434 -1.443 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.224 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 156' ' ' THR . 4.3 mm? -72.72 108.41 5.7 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 122.551 0.341 . . . . 0.0 110.573 177.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 82' ' ' GLN . 43.0 m -101.57 108.58 20.18 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-O 121.384 0.612 . . . . 0.0 110.251 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.459 ' CE2' ' HB3' ' A' ' 145' ' ' LEU . 68.2 m-85 -109.41 136.1 49.38 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.258 3.9 p30 -115.89 110.21 18.68 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 122.233 1.016 . . . . 0.0 110.521 175.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 67.3 mt -117.33 122.31 31.19 Favored Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.36 -19.81 18.29 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 123.713 2.942 . . . . 0.0 113.629 -176.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 62.1 t -72.17 -34.41 49.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.143 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 9.2 p -123.28 -34.39 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 121.82 -153.7 16.74 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -95.34 116.37 28.68 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.407 HD12 ' O ' ' A' ' 155' ' ' ILE . 2.3 pp -126.82 134.01 67.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 55.6 m -111.06 112.12 23.7 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.478 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.9 mp -85.8 117.45 68.75 Favored Pre-proline 0 C--O 1.238 0.471 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -82.37 120.05 3.18 Favored 'Trans proline' 0 CA--C 1.484 -2.001 0 C-N-CA 122.31 2.006 . . . . 0.0 111.496 175.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.554 HG22 HG22 ' A' ' 49' ' ' VAL . 3.1 p -126.95 114.98 39.8 Favored 'Isoleucine or valine' 1 N--CA 1.376 -4.135 0 CA-C-N 112.768 -2.015 . . . . 0.0 109.137 -178.321 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 33.3 p -127.05 162.53 25.82 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.304 -173.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.0 t -169.27 155.22 6.27 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -102.26 141.15 35.56 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -147.11 155.25 26.44 Favored Glycine 0 N--CA 1.422 -2.25 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -101.77 129.99 48.09 Favored 'General case' 0 C--N 1.273 -2.74 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.333 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.432 HD11 HG21 ' A' ' 52' ' ' VAL . 37.1 mm -97.86 108.43 21.8 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.641 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 174.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -105.56 114.35 28.46 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 134' ' ' ASP . 3.3 mp -104.25 105.6 49.99 Favored Pre-proline 0 C--N 1.307 -1.272 0 O-C-N 123.633 0.583 . . . . 0.0 110.459 -174.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -73.37 99.0 1.07 Allowed 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.749 2.299 . . . . 0.0 112.354 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.461 ' HA ' ' CA ' ' A' ' 133' ' ' THR . 47.6 t 64.37 -82.27 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 125.972 1.709 . . . . 0.0 113.624 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.483 ' HB3' ' HB3' ' A' ' 173' ' ' PHE . 42.7 mt 62.66 -72.65 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.695 1.598 . . . . 0.0 112.517 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 64.45 -68.25 0.1 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.125 1.77 . . . . 0.0 111.71 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -100.08 10.37 41.37 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.404 -0.81 . . . . 0.0 110.101 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.483 ' HB3' ' HB3' ' A' ' 170' ' ' LEU . 22.2 t80 -113.92 10.24 17.61 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.483 ' CE2' ' HA ' ' A' ' 59' ' ' ARG . 75.0 m-85 . . . . . 0 CA--C 1.493 -1.228 0 CA-C-N 114.077 -1.42 . . . . 0.0 112.977 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.427 0 CA-C-O 120.238 -0.201 . . . . 0.0 113.044 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -139.95 124.44 18.07 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 117.199 0.499 . . . . 0.0 111.127 -175.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 66.43 80.46 0.22 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.913 0.885 . . . . 0.0 110.378 -176.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -83.01 95.05 7.91 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.022 -174.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.48 ' HB2' ' CB ' ' A' ' 8' ' ' LEU . 38.9 m-70 -113.89 165.32 12.71 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.961 172.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -44.0 -59.68 2.19 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.028 1.331 . . . . 0.0 113.57 -174.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -114.99 -2.79 12.74 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.919 -178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.48 ' CB ' ' HB2' ' A' ' 5' ' ' HIS . 5.4 tt -64.5 -49.89 69.55 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -117.09 -84.06 0.64 Allowed 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 173.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.0 153.44 4.71 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.3 m -137.84 -66.76 0.49 Allowed 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.018 0.437 . . . . 0.0 109.883 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.548 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -98.57 -17.85 18.44 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.569 0.7 . . . . 0.0 109.515 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -56.58 -35.06 67.78 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.674 1.59 . . . . 0.0 110.923 -174.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.572 ' O ' ' HG3' ' A' ' 18' ' ' GLU . 9.8 pt-20 -58.25 -42.96 87.56 Favored 'General case' 0 C--O 1.206 -1.229 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.95 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.5 ' C ' ' HD2' ' A' ' 15' ' ' LYS . 3.3 tmmm? -72.02 -40.75 68.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.476 0.655 . . . . 0.0 110.004 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 12' ' ' ALA . 40.7 t -61.89 -44.57 99.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.802 -174.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.47 HG21 ' HA ' ' A' ' 95' ' ' ALA . 13.3 p -71.22 -27.7 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.99 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.572 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 47.0 mt-10 -75.64 -39.28 57.98 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.204 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.06 -37.94 89.25 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 120.7 0.286 . . . . 0.0 110.572 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -67.1 -45.48 77.08 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.959 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.59 -36.95 72.39 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.11 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.9 t -63.05 -44.9 94.56 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.445 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.06 -42.02 94.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 121.308 0.575 . . . . 0.0 110.072 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.3 mm -68.1 -44.59 84.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.391 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.44 ' HA ' HD12 ' A' ' 28' ' ' LEU . 23.2 t -61.72 -41.58 97.81 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.576 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.8 t -57.34 -37.12 72.05 Favored 'General case' 0 C--O 1.247 0.944 0 C-N-CA 122.9 0.48 . . . . 0.0 110.642 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 tt -73.7 -45.64 51.11 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 25' ' ' SER . 86.3 mt -54.1 -45.5 71.84 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.175 0.59 . . . . 0.0 111.074 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -53.86 -45.42 70.97 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -79.09 -31.73 44.44 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.269 -0.972 . . . . 0.0 111.735 -178.216 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.521 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -75.13 -32.05 61.25 Favored 'General case' 0 C--O 1.21 -1.006 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.95 -177.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -58.58 -47.05 85.6 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.045 0.45 . . . . 0.0 111.02 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.49 -32.99 67.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.124 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -74.57 -40.55 61.58 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 122.615 0.366 . . . . 0.0 110.718 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.456 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 48.6 t80 -64.48 -46.24 83.87 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.89 -14.69 63.02 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.045 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.76 -66.88 1.04 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.001 0.905 . . . . 0.0 110.947 -176.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.438 ' HE2' ' HB2' ' A' ' 38' ' ' LYS . 6.6 tppt? -74.51 -39.32 62.47 Favored 'General case' 0 CA--C 1.453 -2.782 0 CA-C-O 122.937 1.351 . . . . 0.0 107.632 -166.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.479 HD13 HD12 ' A' ' 155' ' ' ILE . 71.7 mt -89.66 0.56 56.88 Favored 'General case' 0 C--N 1.255 -3.516 0 CA-C-N 112.118 -2.31 . . . . 0.0 111.507 -171.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.12 -18.26 29.21 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 173.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -104.71 -39.91 6.17 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.187 -1.369 . . . . 0.0 109.782 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 84.1 mt -83.64 126.4 71.15 Favored Pre-proline 0 C--N 1.312 -1.037 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.73 113.08 1.22 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.987 2.458 . . . . 0.0 112.672 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.417 HG21 HD22 ' A' ' 39' ' ' LEU . 8.2 p -140.43 145.59 41.63 Favored Pre-proline 0 C--N 1.299 -1.602 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.115 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.502 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 37.5 Cg_endo -62.96 135.51 51.92 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.649 2.233 . . . . 0.0 111.888 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.27 106.34 17.98 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 -174.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -102.41 143.01 32.7 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 115.023 -0.989 . . . . 0.0 112.796 -173.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.582 ' HA ' HG21 ' A' ' 159' ' ' VAL . 11.8 t -138.32 144.15 40.26 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.002 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.497 ' HB ' HG22 ' A' ' 161' ' ' THR . 50.6 t -91.95 141.75 14.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 172.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -125.75 -46.54 1.71 Allowed 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 117.261 -1.776 . . . . 0.0 114.075 -169.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -173.96 167.11 4.33 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -172.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.548 ' HB ' ' CD2' ' A' ' 64' ' ' TYR . 2.5 m -127.9 126.71 67.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 C-N-CA 123.254 0.622 . . . . 0.0 111.437 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -104.82 144.75 31.34 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 123.766 0.826 . . . . 0.0 111.249 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.561 ' HA ' ' CE1' ' A' ' 64' ' ' TYR . 44.5 p90 -58.85 130.33 46.44 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.538 ' HD3' ' C ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -118.81 -52.06 2.34 Favored 'General case' 0 N--CA 1.391 -3.422 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -175.242 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.442 ' O ' ' HE1' ' A' ' 173' ' ' PHE . . . -145.17 -173.08 16.09 Favored Glycine 0 CA--C 1.472 -2.651 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 177.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.0 m -125.81 129.45 72.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 117.804 0.802 . . . . 0.0 110.177 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.0 m -161.15 135.5 7.11 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.33 154.44 19.22 Favored 'General case' 0 C--N 1.286 -2.186 0 C-N-CA 117.268 -1.773 . . . . 0.0 109.662 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 78.44 15.86 1.25 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 125.47 1.508 . . . . 0.0 111.042 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.407 ' HA3' ' CD2' ' A' ' 121' ' ' TYR . . . 138.16 98.41 0.46 Allowed Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.9 p -103.81 142.55 17.24 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-O 120.94 0.4 . . . . 0.0 111.475 -174.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -76.07 111.73 11.77 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 176.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.561 ' CE1' ' HA ' ' A' ' 54' ' ' PHE . 6.9 t80 -121.02 155.99 33.16 Favored 'General case' 0 N--CA 1.41 -2.47 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -169.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -90.98 108.43 19.86 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -174.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.524 ' HA ' HG12 ' A' ' 52' ' ' VAL . . . -99.42 118.69 36.59 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -94.18 125.05 38.58 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.899 -174.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.1 m -124.56 144.97 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 176.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.2 m -130.12 143.46 50.8 Favored 'General case' 0 C--N 1.268 -2.951 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.336 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.502 ' CG2' ' HB2' ' A' ' 45' ' ' PRO . 7.4 p -141.67 134.33 28.94 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.513 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 20.6 pttp -107.29 119.35 39.16 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.78 0.8 . . . . 0.0 109.843 175.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -106.87 116.3 58.89 Favored Pre-proline 0 C--N 1.28 -2.431 0 CA-C-N 114.015 -1.448 . . . . 0.0 111.495 -174.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -89.43 97.16 0.32 Allowed 'Trans proline' 0 N--CA 1.428 -2.35 0 C-N-CA 121.547 1.498 . . . . 0.0 110.943 173.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.411 ' HB3' ' H ' ' A' ' 76' ' ' GLN . 19.3 m-85 179.64 -169.07 0.11 Allowed 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 128.007 2.523 . . . . 0.0 106.15 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.501 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 48.7 m -135.3 17.37 3.41 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.43 HE21 HG12 ' A' ' 78' ' ' ILE . 23.4 tt0 -112.14 128.92 56.36 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.974 -177.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.5 p -75.29 98.51 3.82 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 173.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.613 ' H ' HD11 ' A' ' 105' ' ' LEU . 69.1 mt -72.22 121.9 85.96 Favored Pre-proline 0 C--N 1.302 -1.462 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.876 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.39 139.69 29.21 Favored 'Trans proline' 0 N--CA 1.44 -1.655 0 C-N-CA 122.264 1.976 . . . . 0.0 111.584 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.637 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -84.42 134.83 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.952 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.458 178.272 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 52.8 t -82.65 -41.36 19.52 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -174.0 154.04 2.23 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.389 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.401 HD13 ' CD ' ' A' ' 102' ' ' PRO . 1.7 mp -114.61 113.86 44.93 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 173.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.443 ' OG ' HG22 ' A' ' 98' ' ' THR . 19.8 m -93.63 117.53 30.21 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -112.47 140.35 47.28 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 2.0 mp -116.94 108.01 23.87 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.887 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 174.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.539 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 1.2 tm? -90.52 120.36 31.55 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 -172.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -125.92 155.96 40.48 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -172.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.4 t -109.59 147.58 32.78 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 112.133 -2.303 . . . . 0.0 105.483 174.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -50.8 -26.26 5.47 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -176.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 87.6 m -149.65 -53.19 0.16 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -106.55 120.71 42.66 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -170.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 27.5 m 72.42 132.45 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.908 1.283 . . . . 0.0 114.306 173.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.442 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.7 pp -135.03 165.37 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.539 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . . . -119.98 156.64 30.47 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 174.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 27.2 t -160.43 148.41 16.4 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.44 165.45 35.27 Favored Glycine 0 N--CA 1.426 -1.973 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.443 HG22 ' OG ' ' A' ' 84' ' ' SER . 68.3 p -115.62 120.4 39.27 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 61.2 mt -101.87 119.81 55.87 Favored Pre-proline 0 C--N 1.305 -1.331 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.623 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.73 124.7 5.22 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.805 2.336 . . . . 0.0 111.723 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.4 ' HA ' HD11 ' A' ' 80' ' ' ILE . 30.2 t70 52.1 72.08 1.3 Allowed Pre-proline 0 N--CA 1.481 1.099 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.401 ' CD ' HD13 ' A' ' 83' ' ' ILE . 55.9 Cg_endo -103.75 6.19 0.34 Allowed 'Trans proline' 0 N--CA 1.435 -1.944 0 C-N-CA 122.768 2.312 . . . . 0.0 111.595 173.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 156.26 135.04 1.9 Allowed Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.3 m -111.89 146.73 37.21 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.771 0.319 . . . . 0.0 110.397 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.613 HD11 ' H ' ' A' ' 78' ' ' ILE . 3.3 pp -80.41 146.33 31.52 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.78 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 27.5 m -54.84 -46.09 75.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 136.93 -43.28 1.24 Allowed Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.501 ' OG ' ' HA ' ' A' ' 75' ' ' SER . 28.9 m -136.17 115.91 13.02 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 122.164 0.186 . . . . 0.0 111.276 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 105.38 -167.21 14.69 Favored Glycine 0 C--N 1.306 -1.098 0 C-N-CA 120.242 -0.98 . . . . 0.0 114.118 172.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.424 ' OG1' ' HB3' ' A' ' 71' ' ' LYS . 42.1 m -84.62 121.17 27.26 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 121.409 0.623 . . . . 0.0 110.373 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.432 HG21 ' HB2' ' A' ' 105' ' ' LEU . 5.5 t -125.94 138.22 53.75 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.5 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.3 m -94.27 128.69 45.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.412 0.625 . . . . 0.0 110.781 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.1 mt -125.56 157.92 35.88 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -143.54 141.18 30.61 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.476 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 43.0 t -112.3 130.19 23.58 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -77.61 109.89 2.85 Favored 'Trans proline' 0 N--CA 1.419 -2.862 0 N-CA-C 107.578 -1.739 . . . . 0.0 107.578 169.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.6 m -113.17 151.6 15.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -87.22 101.29 13.38 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.406 HG22 ' HB2' ' A' ' 64' ' ' TYR . 21.6 m -93.06 146.89 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.485 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -177.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 174' ' ' PHE . . . 69.35 3.56 4.2 Favored 'General case' 0 C--O 1.205 -1.238 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.597 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.407 ' CD2' ' HA3' ' A' ' 61' ' ' GLY . 8.3 t80 -67.86 -37.62 82.07 Favored 'General case' 0 C--O 1.203 -1.349 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.5 p -79.27 -29.87 42.76 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.327 0.585 . . . . 0.0 110.271 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.0 mt -79.88 -50.95 17.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.08 -174.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.35 -38.97 85.69 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 123.339 0.656 . . . . 0.0 111.028 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 121' ' ' TYR . 25.1 t -71.5 -36.34 60.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.924 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.0 t -85.01 -69.19 0.67 Allowed 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.936 -176.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.515 ' H ' HD23 ' A' ' 127' ' ' LEU . 1.9 pt? -125.09 -29.26 3.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -172.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 68.31 166.86 0.26 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.707 0.765 . . . . 0.0 112.904 -173.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.433 ' N ' ' HD3' ' A' ' 129' ' ' LYS . 1.9 mppt? -101.66 -66.31 0.93 Allowed 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 177.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 162.49 -24.85 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 -177.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.9 tpt 65.52 93.11 0.07 Allowed 'General case' 0 C--N 1.347 0.461 0 CA-C-N 112.819 -1.991 . . . . 0.0 112.367 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.55 ' HB2' ' HB2' ' A' ' 135' ' ' TRP . 77.2 m -95.1 149.79 20.9 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.575 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.825 ' HB ' ' OG ' ' A' ' 169' ' ' SER . 22.1 p -82.27 118.49 23.17 Favored 'General case' 1 N--CA 1.339 -6.021 0 C-N-CA 124.89 1.276 . . . . 0.0 107.604 175.318 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 70.57 83.05 0.15 Allowed 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -173.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.55 ' HB2' ' HB2' ' A' ' 132' ' ' CYS . 42.4 t-105 -154.89 143.53 20.65 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.125 -167.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -108.82 144.08 37.16 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 175.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.417 ' CG2' ' HB ' ' A' ' 165' ' ' ILE . 0.0 OUTLIER -139.68 130.51 32.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.53 105.02 16.52 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 122.914 1.34 . . . . 0.0 111.811 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.42 ' HD1' ' O ' ' A' ' 163' ' ' GLY . 0.1 OUTLIER -108.08 161.14 15.23 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 113.826 -1.534 . . . . 0.0 107.954 177.402 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -138.47 158.55 44.06 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 121.42 -0.8 . . . . 0.0 111.079 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.582 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 2.3 pt? -154.53 122.88 6.05 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.857 167.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -102.25 140.29 36.72 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 158' ' ' PRO . 46.7 mt -125.28 149.17 29.77 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 C-N-CA 120.321 -0.551 . . . . 0.0 111.702 -173.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -119.41 89.94 0.47 Allowed Glycine 0 N--CA 1.421 -2.363 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 174.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -68.76 107.78 3.16 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.604 ' OG1' HG22 ' A' ' 156' ' ' THR . 11.0 m -92.12 107.94 19.57 Favored 'General case' 0 N--CA 1.421 -1.919 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.068 -176.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -109.25 141.2 41.88 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -109.8 109.92 20.75 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.535 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -115.12 145.98 35.31 Favored Pre-proline 0 C--N 1.314 -0.972 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.181 -178.394 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.63 -14.73 41.75 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.96 2.44 . . . . 0.0 113.159 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 43.4 t -71.7 -43.17 70.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 120.801 0.334 . . . . 0.0 110.667 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 49.0 t -127.81 -66.31 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.215 0.531 . . . . 0.0 110.59 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.454 ' O ' HD13 ' A' ' 149' ' ' ILE . . . 157.85 -139.9 6.68 Favored Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -177.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -90.0 117.52 28.86 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.722 0.772 . . . . 0.0 110.34 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 146' ' ' THR . 21.3 pt -117.35 128.53 74.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.483 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.604 HG22 ' OG1' ' A' ' 146' ' ' THR . 74.4 p -89.56 107.22 18.96 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 173.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 64.5 mt -80.42 112.75 33.67 Favored Pre-proline 0 C--N 1.295 -1.799 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 74.3 Cg_endo -82.17 151.81 16.03 Favored 'Trans proline' 0 CA--C 1.477 -2.346 0 C-N-CA 122.379 2.053 . . . . 0.0 112.804 -178.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.582 HG21 ' HA ' ' A' ' 48' ' ' THR . 2.7 p -161.7 123.15 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.387 -3.591 0 CA-C-N 112.721 -2.036 . . . . 0.0 108.149 -173.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 79.8 p -131.61 134.41 45.99 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.156 0.503 . . . . 0.0 111.716 -176.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.497 HG22 ' HB ' ' A' ' 49' ' ' VAL . 9.0 t -168.69 177.96 4.9 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 176.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -100.1 166.35 11.06 Favored 'General case' 0 N--CA 1.416 -2.156 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.213 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.42 ' O ' ' HD1' ' A' ' 139' ' ' TYR . . . -130.03 113.92 1.56 Allowed Glycine 0 N--CA 1.408 -3.199 0 N-CA-C 107.691 -2.164 . . . . 0.0 107.691 176.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -88.96 128.75 35.7 Favored 'General case' 0 C--N 1.262 -3.214 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -177.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.452 HG21 ' CE1' ' A' ' 174' ' ' PHE . 29.6 mm -97.18 114.03 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.064 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.615 ' HD2' ' H ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -86.58 99.07 11.44 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 114.317 -1.31 . . . . 0.0 109.435 -178.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.403 HD11 ' CD2' ' A' ' 174' ' ' PHE . 90.3 mt -103.01 106.09 49.0 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 114.877 -1.056 . . . . 0.0 113.224 -173.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 166' ' ' LYS . 10.2 Cg_exo -75.67 -177.85 3.88 Favored 'Trans proline' 0 CA--C 1.55 1.305 0 C-N-CA 122.259 1.973 . . . . 0.0 109.586 170.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.825 ' OG ' ' HB ' ' A' ' 133' ' ' THR . 20.2 m -64.43 90.62 0.07 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 175.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.63 -38.39 4.91 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.855 175.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 66.07 -55.78 0.37 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.976 0.91 . . . . 0.0 112.497 -173.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -115.93 99.51 7.33 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.442 ' HE1' ' O ' ' A' ' 56' ' ' GLY . 53.7 t80 179.42 -37.16 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.545 0.738 . . . . 0.0 111.052 -174.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 120' ' ' ALA . 39.7 t80 . . . . . 0 C--O 1.259 1.594 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.959 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 70.71 158.06 0.18 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -176.92 143.43 0.42 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -74.7 109.62 8.33 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.207 0.527 . . . . 0.0 111.281 -178.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -88.6 108.19 19.31 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -99.09 177.12 5.33 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 120.855 0.359 . . . . 0.0 110.731 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 62.92 57.75 1.63 Allowed 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.9 mp -91.39 -51.69 5.16 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 170.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -78.1 82.12 4.45 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 113.654 -1.612 . . . . 0.0 107.227 174.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 165.04 93.4 0.0 OUTLIER 'General case' 0 C--O 1.243 0.74 0 C-N-CA 126.219 1.808 . . . . 0.0 108.004 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.8 m 72.35 -52.52 0.7 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.598 1.159 . . . . 0.0 112.567 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.99 -56.67 13.44 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -174.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.455 ' HA ' HG22 ' A' ' 16' ' ' VAL . 23.3 t70 -63.78 -40.08 95.81 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.755 0.312 . . . . 0.0 110.745 -177.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 18' ' ' GLU . 1.2 mp0 -59.44 -40.09 85.66 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.704 175.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -66.96 -55.85 12.76 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.068 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.455 HG22 ' HA ' ' A' ' 13' ' ' ASP . 33.3 m -58.11 -39.66 73.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.042 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 p -66.69 -39.8 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.676 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 45.3 mt-10 -65.56 -39.22 91.44 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.4 ' HG2' ' HA ' ' A' ' 16' ' ' VAL . 13.1 pt-20 -74.29 -38.01 63.49 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.428 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 16' ' ' VAL . 75.1 mmtt -64.99 -45.49 85.42 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.832 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.544 ' HB2' HD11 ' A' ' 94' ' ' ILE . . . -58.04 -41.59 83.56 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.159 178.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.2 t -56.44 -44.34 80.37 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 123.836 0.71 . . . . 0.0 110.073 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.7 t -73.97 -51.14 25.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.555 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.5 mt -57.83 -48.22 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.836 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.7 t -62.32 -35.16 78.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.609 0.243 . . . . 0.0 110.51 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.3 m -71.63 -21.3 61.85 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.319 0.581 . . . . 0.0 110.907 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.606 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 6.6 tt -79.82 -41.15 27.01 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.439 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 6.2 mp -65.61 -33.18 75.31 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 118.824 -1.15 . . . . 0.0 108.553 173.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -57.9 -37.15 73.48 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.146 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -70.81 -30.76 67.29 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.471 0.653 . . . . 0.0 110.582 179.407 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.492 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -78.67 -32.07 46.95 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.276 -177.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 98.5 mttt -48.49 -46.42 38.2 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.164 0.586 . . . . 0.0 111.988 -178.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.98 -33.57 84.4 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.207 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -81.47 -45.65 15.69 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 49.6 t80 -62.18 -51.92 65.87 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -175.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.6 -44.79 62.96 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -174.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -117.05 -38.87 3.31 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -177.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.15 -32.17 15.93 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.9 -164.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 83.8 mt -85.27 -11.44 54.79 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.33 -178.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.3 -29.82 71.07 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.118 0.485 . . . . 0.0 111.368 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -105.89 16.85 24.56 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.442 0.639 . . . . 0.0 110.099 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.5 mt -127.31 124.61 23.75 Favored Pre-proline 0 C--N 1.309 -1.179 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -57.87 96.38 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.402 2.068 . . . . 0.0 112.782 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.9 p -128.43 144.49 52.17 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -51.79 120.05 6.52 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.21 1.94 . . . . 0.0 110.941 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.439 ' HB3' ' CG ' ' A' ' 71' ' ' LYS . 35.1 tt0 -96.43 111.62 23.66 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -173.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.84 146.85 35.72 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.216 -173.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.58 ' HA ' HG21 ' A' ' 159' ' ' VAL . 9.7 t -141.04 155.03 46.24 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 176.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.558 HG23 HG22 ' A' ' 159' ' ' VAL . 92.4 t -82.14 141.49 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 173.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -106.95 -56.09 2.24 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -166.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -170.21 -173.68 1.55 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -174.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.639 HG13 ' CD2' ' A' ' 64' ' ' TYR . 89.4 t -136.8 103.41 3.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 C-N-CA 123.342 0.657 . . . . 0.0 109.921 -175.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.433 ' HB3' ' HD3' ' A' ' 55' ' ' LYS . 28.0 m-20 -93.45 104.99 17.1 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.357 177.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.607 ' C ' ' HD2' ' A' ' 55' ' ' LYS . 63.5 t80 -74.62 105.34 5.67 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.611 0.764 . . . . 0.0 109.344 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.607 ' HD2' ' C ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -147.75 116.04 6.57 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.119 0.568 . . . . 0.0 111.165 -176.646 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.11 163.29 15.54 Favored Glycine 0 C--N 1.295 -1.723 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.855 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.2 p -145.13 153.11 14.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.1 t -155.07 -177.28 6.42 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.427 ' NH2' ' HB3' ' A' ' 60' ' ' ASP . 3.2 tmm_? -80.74 -46.94 14.68 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -178.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.427 ' HB3' ' NH2' ' A' ' 59' ' ' ARG . 7.5 p-10 -99.77 95.16 6.74 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.726 0.774 . . . . 0.0 111.156 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.5 -166.14 29.08 Favored Glycine 0 N--CA 1.416 -2.659 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.508 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.549 HG21 ' HB2' ' A' ' 174' ' ' PHE . 81.4 t -143.89 124.72 9.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 178.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -68.04 137.84 55.36 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.248 0.546 . . . . 0.0 110.992 -178.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.714 ' CD1' ' HB ' ' A' ' 119' ' ' VAL . 29.4 p90 -144.3 167.05 23.38 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 172.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 39.2 m-70 -103.5 114.32 28.51 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -77.57 106.02 9.09 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 178.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.401 ' HE2' ' HB ' ' A' ' 112' ' ' VAL . 19.9 tptm -87.8 125.74 34.61 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.867 -171.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 49' ' ' VAL . 33.7 m -133.98 144.66 34.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.5 p -122.95 132.2 54.05 Favored 'General case' 0 C--N 1.282 -2.333 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.073 177.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.1 t -126.02 134.32 66.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.481 -174.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 22.1 ptmt -105.89 146.65 29.69 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 173.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.64 ' O ' ' HA ' ' A' ' 108' ' ' SER . 46.7 t-20 -128.51 121.96 21.54 Favored Pre-proline 0 C--N 1.28 -2.417 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.972 -173.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -98.46 96.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.568 0 C-N-CA 121.582 1.521 . . . . 0.0 109.549 167.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.459 ' HB2' ' OD1' ' A' ' 72' ' ' ASN . 26.1 m-85 175.77 179.58 0.16 Allowed 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 128.727 2.811 . . . . 0.0 105.356 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.3 t -126.02 5.58 7.23 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 120.316 -0.554 . . . . 0.0 109.699 176.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -100.95 140.16 35.63 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.869 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 63.1 m -76.7 97.87 4.59 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 171.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 64.9 mt -72.83 124.69 91.03 Favored Pre-proline 0 C--N 1.307 -1.279 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.719 -177.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -69.38 127.7 15.29 Favored 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 121.817 1.678 . . . . 0.0 109.38 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 58.1 mt -80.72 113.88 20.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 100' ' ' PRO . 49.6 t -56.2 -53.02 62.14 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.635 -178.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -167.8 162.4 13.73 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.595 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 98' ' ' THR . 13.4 tt -124.11 115.31 44.52 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 175.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.413 ' HB3' HG22 ' A' ' 98' ' ' THR . 65.5 p -94.08 118.1 31.05 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -108.41 135.09 50.28 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.307 178.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.411 ' HB ' ' HB3' ' A' ' 142' ' ' ASP . 2.9 mp -118.27 111.32 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 175.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.546 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -91.67 120.99 32.92 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 140' ' ' GLN . 39.6 ttmt -123.54 139.38 54.07 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.407 -177.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.547 ' OG ' ' HB2' ' A' ' 122' ' ' SER . 49.5 m -115.42 145.13 42.85 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.806 176.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.6 113.42 2.69 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.282 -176.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.7 m 69.23 9.81 7.51 Favored 'General case' 0 CA--C 1.57 1.718 0 C-N-CA 124.408 1.083 . . . . 0.0 112.252 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -121.46 -170.79 2.09 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 121.502 -0.748 . . . . 0.0 111.098 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.0 t -74.51 -172.96 1.63 Allowed 'General case' 0 C--O 1.253 1.277 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.546 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.6 pp -138.07 168.44 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -176.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . . . -119.09 140.62 49.78 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.7 p -141.25 140.33 33.89 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.689 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -165.63 153.35 23.3 Favored Glycine 0 N--CA 1.434 -1.498 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.416 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 27.2 p -118.28 122.6 43.32 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 178.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.416 HD12 ' N ' ' A' ' 99' ' ' ILE . 3.2 mp -102.91 108.26 57.8 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 118.301 -1.359 . . . . 0.0 109.717 176.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 98' ' ' THR . 11.7 Cg_exo -71.93 118.25 5.54 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.213 1.942 . . . . 0.0 109.389 174.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.9 t70 62.04 81.89 0.23 Allowed Pre-proline 0 N--CA 1.472 0.673 0 O-C-N 124.235 0.959 . . . . 0.0 111.577 -174.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -104.63 11.35 0.25 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.474 2.783 . . . . 0.0 110.461 176.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.1 -167.44 26.84 Favored Glycine 0 N--CA 1.422 -2.256 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 46.1 p -151.75 169.49 22.08 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 117.434 0.617 . . . . 0.0 110.641 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.587 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -115.56 131.41 56.94 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.338 0.589 . . . . 0.0 112.085 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.0 29.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 126.432 1.893 . . . . 0.0 115.087 -171.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.639 ' O ' ' HB3' ' A' ' 72' ' ' ASN . . . 71.79 -150.39 46.21 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.129 -177.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 29.7 p -54.42 90.04 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 124.498 1.119 . . . . 0.0 113.657 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 170.9 -166.4 39.59 Favored Glycine 0 CA--C 1.478 -2.262 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 174.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -119.51 135.9 54.57 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.425 HG21 ' HA ' ' A' ' 105' ' ' LEU . 5.0 t -134.58 137.88 44.12 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.105 -178.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.401 ' HB ' ' HE2' ' A' ' 67' ' ' LYS . 27.8 m -91.26 124.2 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.832 177.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.3 mt -120.91 158.9 26.66 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.437 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 4.9 p-10 -147.36 148.47 31.38 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 177.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.6 p -130.54 136.15 28.51 Favored Pre-proline 0 C--N 1.292 -1.897 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.817 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.45 130.5 21.14 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.875 2.383 . . . . 0.0 112.637 178.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.487 HG13 ' CZ ' ' A' ' 64' ' ' TYR . 1.8 p -161.48 150.55 4.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 124.157 0.983 . . . . 0.0 109.262 178.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 13.3 mptt -88.93 133.76 34.19 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.966 0.413 . . . . 0.0 111.708 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.714 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 12.8 p -95.12 145.75 7.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 68.87 0.74 2.84 Favored 'General case' 0 C--O 1.216 -0.694 0 C-N-CA 124.426 1.09 . . . . 0.0 112.482 175.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -49.85 -46.47 51.42 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.784 1.233 . . . . 0.0 111.144 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.547 ' HB2' ' OG ' ' A' ' 89' ' ' SER . 17.0 m -69.75 -38.54 76.84 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.166 -175.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.499 HD13 ' HA ' ' A' ' 129' ' ' LYS . 19.7 tt -80.25 -27.46 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 O-C-N 121.94 -0.475 . . . . 0.0 111.342 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.649 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -52.63 -51.57 59.45 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 124.207 1.003 . . . . 0.0 112.046 177.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.5 m -61.32 -21.88 26.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -175.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.8 m -95.79 -78.08 0.46 Allowed 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 120.746 -0.382 . . . . 0.0 112.004 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.558 ' H ' HD23 ' A' ' 127' ' ' LEU . 2.1 pt? -120.72 -0.89 10.1 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.554 -174.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.649 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 25.1 ttt 53.55 76.03 0.23 Allowed 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 124.159 0.984 . . . . 0.0 112.107 -178.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.771 ' HE2' ' SD ' ' A' ' 131' ' ' MET . 55.4 pttt 54.77 -74.25 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 126.591 1.956 . . . . 0.0 113.021 -177.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 36.6 t70 161.56 81.54 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 101.223 -3.621 . . . . 0.0 101.223 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.771 ' SD ' ' HE2' ' A' ' 129' ' ' LYS . 8.9 tpt -56.01 110.96 0.82 Allowed 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -166.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.573 ' SG ' ' HB2' ' A' ' 135' ' ' TRP . 7.1 p -147.09 -176.08 5.07 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 113.707 -1.588 . . . . 0.0 108.874 176.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.637 HG22 ' CB ' ' A' ' 169' ' ' SER . 5.6 m -126.59 107.58 10.34 Favored 'General case' 1 N--CA 1.367 -4.578 0 N-CA-C 103.145 -2.909 . . . . 0.0 103.145 -170.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 168' ' ' PRO . 28.9 t70 84.51 101.01 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 125.139 1.376 . . . . 0.0 108.343 -171.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.573 ' HB2' ' SG ' ' A' ' 132' ' ' CYS . 4.8 t-105 -163.94 136.17 4.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.232 -166.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -105.12 145.7 30.19 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.9 tt -155.28 151.08 10.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -114.7 123.25 48.81 Favored 'General case' 0 CA--C 1.498 -1.029 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.789 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -105.09 172.73 6.63 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 88' ' ' LYS . 49.0 mt-30 -119.35 139.96 51.12 Favored 'General case' 0 C--N 1.274 -2.713 0 O-C-N 121.178 -0.951 . . . . 0.0 111.864 -175.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.43 HD11 HD11 ' A' ' 143' ' ' ILE . 25.8 tp -128.45 130.69 47.94 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.697 -178.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.551 ' OD1' ' HB3' ' A' ' 160' ' ' SER . 21.5 t70 -135.41 123.97 23.58 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 141' ' ' LEU . 37.2 mm -115.01 148.41 17.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -121.54 99.1 0.68 Allowed Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 174.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.441 ' HB3' ' CE2' ' A' ' 147' ' ' PHE . 2.9 mm? -79.22 114.78 18.43 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.472 ' OG1' HG22 ' A' ' 156' ' ' THR . 8.2 m -96.36 108.3 20.8 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.441 ' CE2' ' HB3' ' A' ' 145' ' ' LEU . 75.4 m-85 -116.57 146.89 42.33 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -103.28 130.62 50.58 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.532 0.682 . . . . 0.0 110.123 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.01 130.0 16.16 Favored Pre-proline 0 C--N 1.291 -1.967 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -59.41 -21.57 61.8 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 C-N-CA 123.373 2.715 . . . . 0.0 113.668 -172.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.427 HG13 HG23 ' A' ' 152' ' ' VAL . 7.1 p -67.87 -28.27 40.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.598 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.427 HG23 HG13 ' A' ' 151' ' ' VAL . 97.2 t -134.37 -44.79 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.559 0.695 . . . . 0.0 110.613 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 118.79 -115.97 3.24 Favored Glycine 0 C--N 1.29 -1.983 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -174.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -102.32 117.64 35.17 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.081 0.467 . . . . 0.0 112.133 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.546 HD12 ' O ' ' A' ' 155' ' ' ILE 0.265 2.6 pp -123.59 118.57 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-O 121.316 0.579 . . . . 0.0 110.941 170.459 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.472 HG22 ' OG1' ' A' ' 146' ' ' THR . 23.3 p -85.85 108.88 18.34 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.677 177.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 68.5 mt -76.41 114.64 40.13 Favored Pre-proline 0 C--N 1.292 -1.932 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.768 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -82.98 137.22 8.48 Favored 'Trans proline' 0 CA--C 1.475 -2.452 0 C-N-CA 122.849 2.366 . . . . 0.0 111.954 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.58 HG21 ' HA ' ' A' ' 48' ' ' THR . 5.7 p -149.52 112.98 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.38 -3.962 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.096 -174.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.551 ' HB3' ' OD1' ' A' ' 142' ' ' ASP . 58.3 p -120.49 155.36 33.75 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.599 -177.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.3 t -163.0 171.79 15.99 Favored 'General case' 0 C--O 1.255 1.358 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -99.43 126.89 45.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -94.09 85.86 1.06 Allowed Glycine 0 N--CA 1.413 -2.885 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -88.5 119.55 29.05 Favored 'General case' 0 N--CA 1.42 -1.972 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 8.4 pt -140.11 177.07 4.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.542 -171.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.476 ' HD2' ' H ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -130.19 143.83 51.01 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.447 -176.326 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.0 mp -125.59 97.98 35.41 Favored Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 171.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.626 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 33.1 Cg_endo -64.06 170.11 9.52 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.613 2.209 . . . . 0.0 111.332 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.637 ' CB ' HG22 ' A' ' 133' ' ' THR . 26.5 p -40.37 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 173.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 168' ' ' PRO . 3.5 pp -162.01 132.12 4.77 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.951 177.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.429 ' NH2' ' HA ' ' A' ' 132' ' ' CYS . 64.9 mtt180 -132.86 85.67 2.24 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 172.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 23.9 t70 177.19 -38.34 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 O-C-N 123.835 0.709 . . . . 0.0 110.608 -174.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -81.81 -51.66 7.91 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 176.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.549 ' HB2' HG21 ' A' ' 62' ' ' VAL . 39.7 t80 . . . . . 0 N--CA 1.399 -3.024 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 172.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.935 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -96.57 -18.85 19.49 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 117.899 0.849 . . . . 0.0 112.587 -178.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -86.54 100.98 12.78 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.898 0.38 . . . . 0.0 111.091 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 -119.77 88.97 3.04 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -93.17 79.0 4.52 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.78 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -151.45 -72.98 0.15 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.232 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -140.52 20.11 2.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.753 0.311 . . . . 0.0 110.353 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.47 -37.32 86.5 Favored 'General case' 0 C--O 1.201 -1.498 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -87.12 16.75 4.77 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.224 0.535 . . . . 0.0 110.589 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -129.46 97.85 4.68 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.433 ' HA ' ' OE2' ' A' ' 14' ' ' GLU . 35.4 m 76.13 -37.84 0.32 Allowed 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 125.713 1.605 . . . . 0.0 113.025 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.6 -30.28 64.23 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.648 ' O ' HG23 ' A' ' 17' ' ' VAL . 38.6 t70 -70.94 -34.71 71.75 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.433 ' OE2' ' HA ' ' A' ' 11' ' ' SER . 44.1 mt-10 -58.79 -39.96 82.64 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.188 175.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 40.4 tttp -64.13 -56.9 11.56 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.698 176.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.594 HG22 ' HA ' ' A' ' 13' ' ' ASP . 25.6 m -58.96 -24.65 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 13' ' ' ASP . 67.2 t -67.26 -50.23 64.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 172.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -62.34 -30.12 70.94 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.336 -177.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.509 ' CG ' ' HA ' ' A' ' 16' ' ' VAL . 40.0 mm-40 -54.77 -52.15 63.48 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.624 176.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -78.49 -31.37 47.75 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 120.109 -0.636 . . . . 0.0 111.908 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.9 -42.79 80.55 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 123.271 0.357 . . . . 0.0 110.19 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.2 t -59.43 -41.72 90.2 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.667 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 67.2 t -66.93 -49.39 74.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-O 120.836 0.35 . . . . 0.0 110.45 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.526 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 68.0 mt -60.89 -42.77 93.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.22 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.8 m -65.58 -32.51 74.14 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.38 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.8 t -71.44 -34.67 70.48 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.542 HD22 ' OG1' ' A' ' 156' ' ' THR . 3.2 tt -65.84 -41.89 91.19 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 176.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 83.4 mt -57.77 -38.71 75.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.116 177.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -61.16 -41.98 97.73 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 27' ' ' LEU . 65.6 pttt -71.81 -38.81 70.15 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.838 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.05 -31.76 68.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.25 -176.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -62.58 -42.2 99.41 Favored 'General case' 0 C--O 1.246 0.888 0 CA-C-O 121.023 0.44 . . . . 0.0 110.809 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.95 -33.56 36.5 Favored Glycine 0 CA--C 1.51 -0.281 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.411 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 7.4 t80 -57.17 -46.31 82.9 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.617 ' HA ' HD13 ' A' ' 39' ' ' LEU . 10.5 t80 -52.9 -53.31 51.06 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.066 1.347 . . . . 0.0 111.326 174.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.37 -33.22 58.71 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -174.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -99.15 -64.25 1.05 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.281 0.562 . . . . 0.0 112.457 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.3 mtmm -79.95 -22.45 42.62 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -169.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.617 HD13 ' HA ' ' A' ' 35' ' ' PHE . 5.7 mp -98.86 6.96 46.53 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-O 121.679 0.752 . . . . 0.0 109.805 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.95 -35.72 11.88 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -90.48 -18.21 25.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.398 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.8 mt -115.12 112.95 44.01 Favored Pre-proline 0 C--N 1.309 -1.194 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.6 97.36 0.88 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.187 1.925 . . . . 0.0 113.076 -176.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.3 p -93.01 159.34 35.86 Favored Pre-proline 0 N--CA 1.43 -1.43 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.982 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.05 147.35 90.68 Favored 'Trans proline' 0 C--O 1.239 0.556 0 C-N-CA 122.946 2.43 . . . . 0.0 111.596 174.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 38.4 tt0 -110.27 109.63 20.15 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.45 138.42 35.69 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.581 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.8 t -135.14 129.23 33.53 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.318 0.58 . . . . 0.0 110.957 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.539 ' H ' HG11 ' A' ' 159' ' ' VAL . 48.1 t -105.48 141.01 21.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 177.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -158.08 -31.96 0.07 Allowed 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -170.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -145.69 151.65 38.37 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 118.923 -1.111 . . . . 0.0 111.755 -171.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.462 HG12 ' HB2' ' A' ' 66' ' ' ALA . 28.9 m -124.28 152.19 29.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 123.433 0.693 . . . . 0.0 110.712 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -114.86 117.0 29.47 Favored 'General case' 0 C--O 1.246 0.888 0 C-N-CA 122.841 0.456 . . . . 0.0 111.802 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -64.69 107.94 1.57 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 167.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 63' ' ' ASP . 14.6 ptmm? -107.05 -16.4 14.44 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.103 -0.639 . . . . 0.0 112.663 -176.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 159.65 -178.51 35.72 Favored Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 119.296 -1.431 . . . . 0.0 112.67 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.88 151.37 18.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 123.22 0.608 . . . . 0.0 110.007 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.4 t -153.19 -176.66 5.88 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -79.16 -53.52 6.9 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -175.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -97.78 80.61 2.79 Favored 'General case' 0 C--N 1.313 -1.015 0 O-C-N 122.167 -0.333 . . . . 0.0 111.683 -176.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.81 120.01 0.13 Allowed Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.146 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.456 HG11 ' O ' ' A' ' 173' ' ' PHE . 33.9 m -70.74 156.34 7.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 121.248 0.547 . . . . 0.0 111.812 -177.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 19.7 m-20 -96.06 126.23 41.15 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.08 -172.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.546 ' CD1' HG11 ' A' ' 119' ' ' VAL . 2.7 m-85 -121.04 122.62 40.47 Favored 'General case' 0 CA--C 1.471 -2.084 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.571 171.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -92.4 108.04 19.66 Favored 'General case' 0 C--N 1.273 -2.727 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.462 ' HB2' HG12 ' A' ' 52' ' ' VAL . . . -93.34 144.84 24.94 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -86.88 133.12 33.65 Favored 'General case' 0 C--O 1.251 1.143 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.734 176.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.462 HG22 HG22 ' A' ' 49' ' ' VAL . 48.6 t -130.97 106.52 12.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 168.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.2 p -106.91 134.84 49.46 Favored 'General case' 0 C--N 1.277 -2.552 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.424 -176.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 4.8 p -132.52 126.54 55.22 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.95 -176.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 89.1 tttt -96.6 119.38 34.98 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 175.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.452 ' HB2' HD12 ' A' ' 105' ' ' LEU . 52.7 t30 -111.45 115.7 51.56 Favored Pre-proline 0 C--N 1.301 -1.51 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.72 -175.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -95.81 96.92 0.1 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.612 0 C-N-CA 121.904 1.736 . . . . 0.0 111.025 172.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -170.19 -166.09 0.52 Allowed 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 126.515 1.926 . . . . 0.0 107.011 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.3 t -142.5 21.13 2.03 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 173.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.564 ' O ' ' HA2' ' A' ' 107' ' ' GLY . 17.2 pt20 -115.14 140.73 48.83 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.412 -178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.3 p -83.15 95.19 8.03 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-O 121.656 0.741 . . . . 0.0 109.308 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.494 ' HB ' HD21 ' A' ' 105' ' ' LEU . 72.5 mt -74.93 122.95 88.6 Favored Pre-proline 0 N--CA 1.433 -1.287 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.726 -176.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 78' ' ' ILE . 4.3 Cg_exo -76.78 122.64 6.45 Favored 'Trans proline' 0 N--CA 1.444 -1.438 0 C-N-CA 122.197 1.932 . . . . 0.0 110.666 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 50.0 mt -88.33 102.82 13.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 62.3 m -57.55 -60.37 3.76 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 124.133 0.895 . . . . 0.0 110.624 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -150.68 157.35 42.85 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-O 121.52 0.676 . . . . 0.0 111.868 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.568 ' HB ' HG23 ' A' ' 99' ' ' ILE . 46.4 mm -107.15 116.94 51.95 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 176.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.0 m -80.78 118.35 22.23 Favored 'General case' 0 N--CA 1.412 -2.375 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -103.06 121.42 42.55 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.992 -170.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' A' ' 142' ' ' ASP . 69.9 mt -134.9 109.8 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.24 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.623 ' O ' HD12 ' A' ' 94' ' ' ILE . 0.9 OUTLIER -113.03 120.61 41.95 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 176.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.569 ' HD2' ' O ' ' A' ' 93' ' ' THR . 53.4 tptt -121.38 135.53 55.06 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.5 m -142.38 145.36 33.79 Favored 'General case' 0 C--O 1.25 1.082 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.55 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 62.28 18.27 10.05 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.119 0.968 . . . . 0.0 111.197 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 m 59.16 14.01 3.3 Favored 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 123.986 0.915 . . . . 0.0 109.888 -175.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -127.63 -65.65 0.91 Allowed 'General case' 0 N--CA 1.432 -1.336 0 O-C-N 121.325 -0.859 . . . . 0.0 111.057 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.569 ' O ' ' HD2' ' A' ' 88' ' ' LYS . 11.1 t -76.92 165.56 24.51 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.823 -172.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.623 HD12 ' O ' ' A' ' 87' ' ' LEU . 3.8 tp -163.38 139.02 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.015 0 C-N-CA 123.195 0.598 . . . . 0.0 109.703 -168.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.11 121.47 26.42 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 171.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 78.0 p -139.76 160.12 40.62 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.292 0.568 . . . . 0.0 111.63 -176.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 167.41 -170.25 41.52 Favored Glycine 0 N--CA 1.417 -2.614 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.3 p -127.86 122.2 31.99 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.568 HG23 ' HB ' ' A' ' 83' ' ' ILE . 10.0 tt -102.86 108.45 58.33 Favored Pre-proline 0 C--N 1.318 -0.771 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.02 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -82.55 146.31 13.51 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 C-N-CA 122.889 2.393 . . . . 0.0 113.63 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 44.75 67.41 4.11 Favored Pre-proline 0 N--CA 1.477 0.911 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -101.24 1.05 0.58 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.465 2.11 . . . . 0.0 111.911 176.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 148.94 -179.0 26.12 Favored Glycine 0 N--CA 1.428 -1.874 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.6 m -150.38 175.72 11.57 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 117.509 0.655 . . . . 0.0 110.708 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.678 ' H ' HD23 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -104.62 131.96 51.43 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.443 0.64 . . . . 0.0 112.654 -175.093 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.2 m -63.59 18.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 -171.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 76' ' ' GLN . . . 85.09 -52.66 4.71 Favored Glycine 0 C--O 1.214 -1.1 0 C-N-CA 120.407 -0.902 . . . . 0.0 113.32 177.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.7 t -148.29 117.17 6.72 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -177.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 133.99 177.37 14.89 Favored Glycine 0 CA--C 1.49 -1.479 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.12 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 71' ' ' LYS . 9.9 t -96.53 113.35 24.92 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 121.753 0.787 . . . . 0.0 109.421 177.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.9 t -112.28 138.07 49.51 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.376 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 25.0 t -96.94 107.56 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.8 mt -86.8 166.39 15.27 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 178.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -140.43 145.84 37.52 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.396 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.4 t -120.95 128.2 25.87 Favored Pre-proline 0 C--N 1.3 -1.581 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -74.54 109.6 2.94 Favored 'Trans proline' 0 N--CA 1.43 -2.224 0 N-CA-C 106.986 -1.967 . . . . 0.0 106.986 168.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.513 HG11 ' OH ' ' A' ' 139' ' ' TYR . 59.2 t -103.66 127.27 57.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -176.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.472 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 1.2 tpmt? -88.98 91.12 8.71 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.546 HG11 ' CD1' ' A' ' 64' ' ' TYR . 12.1 p -94.03 147.29 5.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.173 -172.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.482 ' HA ' HD12 ' A' ' 123' ' ' ILE . . . 72.47 -5.63 1.77 Allowed 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.211 1.004 . . . . 0.0 111.318 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.419 ' O ' HG23 ' A' ' 125' ' ' VAL . 76.1 t80 -63.55 -54.42 36.39 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.377 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.518 ' HB2' ' OG1' ' A' ' 93' ' ' THR . 13.1 p -63.42 -36.87 85.16 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.922 -176.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 120' ' ' ALA . 52.7 mt -64.6 -49.42 80.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.097 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.74 -36.12 82.67 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 123.484 0.49 . . . . 0.0 110.775 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 121' ' ' TYR . 52.6 t -62.11 -51.4 72.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.514 176.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.6 m -66.74 -73.83 0.13 Allowed 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.5 HD12 ' N ' ' A' ' 128' ' ' MET . 2.0 pp -125.16 -32.14 3.01 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -171.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.5 ' N ' HD12 ' A' ' 127' ' ' LEU . 0.0 OUTLIER 63.37 110.93 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -171.2 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.544 ' HG3' ' HE1' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -68.07 -0.02 4.07 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -171.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 17.8 t70 84.79 -26.41 0.11 Allowed 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 125.624 1.57 . . . . 0.0 110.592 173.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.643 ' HE1' HD13 ' A' ' 167' ' ' LEU . 9.1 tpt 70.89 149.7 0.09 Allowed 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 125.475 1.51 . . . . 0.0 113.47 174.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 72.0 m -153.69 160.76 42.45 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 40.2 p -78.78 125.74 29.78 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 175.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.621 ' H ' ' H ' ' A' ' 169' ' ' SER . 25.4 t70 69.47 89.02 0.1 Allowed 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -176.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.544 ' HE1' ' HG3' ' A' ' 129' ' ' LYS . 54.5 t-105 -158.19 149.79 21.39 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 114.032 -1.44 . . . . 0.0 109.732 -166.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -140.59 149.34 42.24 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.904 0.383 . . . . 0.0 110.386 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.459 HG21 ' CD1' ' A' ' 123' ' ' ILE . 2.9 mp -118.7 141.68 37.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -81.08 102.67 10.39 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 122.048 0.928 . . . . 0.0 109.473 174.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.513 ' OH ' HG11 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -130.69 144.58 51.53 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.251 -177.292 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.42 ' CB ' ' HA ' ' A' ' 162' ' ' GLN . 20.7 pt20 -131.52 157.8 42.6 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 38.2 tp -124.89 123.89 40.89 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.426 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 6.2 m-20 -121.88 120.3 34.12 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.171 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 46.6 mm -120.62 127.76 75.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.891 -178.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -95.6 89.94 1.19 Allowed Glycine 0 N--CA 1.427 -1.903 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 173.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.26 110.69 7.74 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.576 ' OG1' HG22 ' A' ' 156' ' ' THR . 27.8 m -95.89 108.4 20.76 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 120.861 0.363 . . . . 0.0 111.18 -176.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -101.76 132.04 47.72 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 176.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -101.98 109.36 21.07 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 65.0 mt -127.99 114.29 20.38 Favored Pre-proline 0 C--N 1.29 -1.995 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.21 -24.1 32.42 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.841 2.361 . . . . 0.0 113.662 -176.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.38 -36.18 76.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.222 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 10.2 p -125.3 -32.1 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -174.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 120.56 -151.51 17.14 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -101.02 125.18 47.62 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.264 -1.014 . . . . 0.0 108.264 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.455 HG21 HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -132.44 127.64 57.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.472 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.576 HG22 ' OG1' ' A' ' 146' ' ' THR . 74.8 p -91.84 108.95 20.28 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . 51.8 mt -77.77 114.47 41.65 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 157' ' ' ILE . 5.5 Cg_exo -76.58 101.02 1.45 Allowed 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 122.436 2.091 . . . . 0.0 111.587 -178.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.539 HG11 ' H ' ' A' ' 49' ' ' VAL . 18.0 t -101.83 113.18 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 53.1 p -110.14 145.22 37.56 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.194 -175.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.9 t -156.77 113.65 3.08 Favored 'General case' 0 N--CA 1.424 -1.768 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.296 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.42 ' HA ' ' CB ' ' A' ' 140' ' ' GLN . 11.4 pt20 -98.25 119.26 36.6 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -134.77 -130.92 3.02 Favored Glycine 0 N--CA 1.407 -3.284 0 C-N-CA 119.792 -1.194 . . . . 0.0 113.023 -174.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -158.14 133.1 8.52 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 115.219 -0.49 . . . . 0.0 109.918 -171.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.471 HG12 ' HB3' ' A' ' 139' ' ' TYR . 43.2 mm -107.02 108.59 25.56 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 171.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -110.94 128.89 55.98 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 121.791 0.805 . . . . 0.0 111.441 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.643 HD13 ' HE1' ' A' ' 131' ' ' MET . 96.0 mt -118.57 91.48 41.86 Favored Pre-proline 0 N--CA 1.411 -2.39 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.758 -172.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.468 ' O ' HD22 ' A' ' 170' ' ' LEU . 9.1 Cg_exo -71.64 100.82 1.09 Allowed 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.575 2.85 . . . . 0.0 112.992 -177.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.621 ' H ' ' H ' ' A' ' 134' ' ' ASP . 91.3 p 62.9 9.72 3.88 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 126.682 1.993 . . . . 0.0 115.528 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 168' ' ' PRO . 3.5 mm? -71.73 138.66 48.65 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.146 -0.621 . . . . 0.0 111.848 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -142.54 140.99 31.98 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 167.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 37.5 t70 74.85 5.44 4.38 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.385 1.088 . . . . 0.0 110.762 -174.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.468 ' CD1' HD12 ' A' ' 170' ' ' LEU . 78.0 m-85 -104.45 5.1 33.93 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.887 174.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.454 ' C ' ' HZ1' ' A' ' 129' ' ' LYS . 80.3 m-85 . . . . . 0 CA--C 1.487 -1.454 0 CA-C-N 114.051 -1.431 . . . . 0.0 113.887 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.969 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -88.34 123.28 32.76 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -99.99 133.5 44.28 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 120.85 0.357 . . . . 0.0 110.669 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -141.08 92.0 2.45 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.748 0.785 . . . . 0.0 109.561 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -134.52 -70.11 0.51 Allowed 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.109 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 47.5 m80 62.06 170.91 0.12 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.972 0.909 . . . . 0.0 111.69 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -179.57 -36.37 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.199 0 C-N-CA 123.546 0.738 . . . . 0.0 111.364 174.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.26 34.9 mt 42.28 71.26 0.23 Allowed 'General case' 0 CA--C 1.483 -1.625 0 CA-C-O 123.036 1.398 . . . . 0.0 112.172 -175.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 71.94 -70.52 0.16 Allowed 'General case' 0 C--N 1.261 -3.24 0 CA-C-N 111.31 -2.677 . . . . 0.0 111.785 -174.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 66.26 34.93 6.23 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 121.763 0.792 . . . . 0.0 110.373 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.9 t -144.33 -54.78 0.34 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.113 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -57.18 -36.93 71.41 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-O 121.016 0.436 . . . . 0.0 110.299 176.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -56.15 -44.95 79.76 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 124.357 1.063 . . . . 0.0 110.355 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.77 -43.77 98.19 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.826 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -63.86 -50.69 67.83 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.388 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 12' ' ' ALA . 90.2 t -66.29 -44.63 91.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 114.979 -1.009 . . . . 0.0 113.354 -176.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.0 p -64.19 -26.59 40.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -75.45 -44.01 46.5 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.571 -177.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.49 ' O ' HG23 ' A' ' 23' ' ' VAL . 10.8 pt-20 -64.0 -40.25 95.95 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.649 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -65.85 -40.68 91.93 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.375 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.69 -42.7 99.29 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.179 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.8 t -61.76 -41.85 98.22 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.979 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 19' ' ' GLU . 93.5 t -60.75 -49.63 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.234 0.54 . . . . 0.0 109.779 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.445 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 67.6 mt -67.34 -39.91 83.73 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.768 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.003 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.9 t -61.72 -41.08 97.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.878 0.37 . . . . 0.0 110.105 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' A' ' 29' ' ' ASP . 32.6 m -70.34 -32.09 69.66 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.122 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.561 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 4.4 tt -69.84 -47.53 62.35 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 176.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.578 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 96.3 mt -59.95 -32.74 71.08 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.9 0.381 . . . . 0.0 110.152 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' A' ' 26' ' ' SER . 12.4 t70 -57.69 -46.22 84.59 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.893 175.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.561 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -74.77 -33.63 62.32 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.238 0.542 . . . . 0.0 109.757 179.613 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.505 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -62.21 -39.63 93.41 Favored 'General case' 0 C--O 1.204 -1.337 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.729 -178.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 29.0 mtpp -60.76 -33.97 73.76 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.2 -51.1 4.06 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.066 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -61.92 -32.59 73.01 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 123.61 0.764 . . . . 0.0 112.592 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.443 ' HD1' HD12 ' A' ' 39' ' ' LEU . 49.0 t80 -72.62 -34.95 67.69 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 121.905 -0.497 . . . . 0.0 110.637 175.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.72 -27.33 58.12 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.731 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 38' ' ' LYS . 10.7 pt-20 -98.35 -49.32 4.72 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.437 ' N ' ' HG3' ' A' ' 37' ' ' GLU . 14.5 tppt? -76.84 -47.15 22.22 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 122.13 0.967 . . . . 0.0 109.333 -170.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.443 HD12 ' HD1' ' A' ' 35' ' ' PHE . 42.1 mt -89.36 16.93 6.68 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.45 -175.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.22 -20.21 19.41 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 172.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -97.69 -35.11 10.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.66 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.5 mt -103.47 118.56 57.35 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.078 -177.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.95 112.24 2.88 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.542 2.161 . . . . 0.0 111.092 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.423 ' HB ' ' CD ' ' A' ' 45' ' ' PRO . 4.0 p -116.88 171.22 5.04 Favored Pre-proline 0 C--N 1.301 -1.52 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.263 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.448 ' HB3' ' CB ' ' A' ' 72' ' ' ASN . 7.9 Cg_exo -72.95 145.97 41.04 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.477 2.118 . . . . 0.0 112.516 -177.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -97.75 119.02 35.58 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.999 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.21 141.28 37.01 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.1 t -136.46 143.03 43.64 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.5 t -97.91 132.34 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 175.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -112.69 -60.11 1.92 Allowed 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.059 -1.057 . . . . 0.0 113.745 -169.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -163.88 161.36 22.98 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -172.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.659 HG22 ' HB3' ' A' ' 64' ' ' TYR . 10.0 p -135.49 112.2 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.76 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -106.82 159.03 16.55 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.951 -175.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -71.36 126.81 30.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.419 0.628 . . . . 0.0 112.212 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.449 ' HD2' ' OD2' ' A' ' 63' ' ' ASP . 10.2 tmtt? -110.91 -44.84 3.55 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.352 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -178.5 -176.44 46.4 Favored Glycine 0 CA--C 1.484 -1.897 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 177.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.521 ' HA ' HG23 ' A' ' 62' ' ' VAL . 27.2 m -107.81 148.75 11.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.772 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.4 m -150.78 125.24 9.53 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 174.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -82.71 88.62 6.72 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 122.265 1.031 . . . . 0.0 113.407 -170.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -178.66 37.02 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 102.271 -3.233 . . . . 0.0 102.271 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.82 -133.07 10.63 Favored Glycine 0 N--CA 1.415 -2.723 0 N-CA-C 106.038 -2.825 . . . . 0.0 106.038 -170.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.521 HG23 ' HA ' ' A' ' 57' ' ' VAL . 9.8 p -152.24 136.89 9.84 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 172.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.449 ' OD2' ' HD2' ' A' ' 55' ' ' LYS . 35.3 t70 -85.62 105.04 15.9 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-O 121.629 0.728 . . . . 0.0 112.237 -169.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.659 ' HB3' HG22 ' A' ' 52' ' ' VAL . 3.2 m-85 -109.47 161.61 15.16 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 121.65 0.738 . . . . 0.0 112.144 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 39.2 t60 -102.51 106.44 17.15 Favored 'General case' 0 N--CA 1.413 -2.298 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.631 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . . . -90.22 124.87 35.23 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.801 174.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -100.41 125.27 46.67 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.386 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.0 m -121.44 144.58 30.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.3 m -120.83 136.0 55.02 Favored 'General case' 0 C--N 1.277 -2.581 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.033 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t -129.98 127.73 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-O 121.029 0.442 . . . . 0.0 110.27 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 19.3 ptpt -113.2 143.03 45.08 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 174.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.661 ' O ' ' HA ' ' A' ' 108' ' ' SER . 1.8 p-10 -142.63 138.49 16.27 Favored Pre-proline 0 C--N 1.287 -2.134 0 C-N-CA 118.906 -1.118 . . . . 0.0 110.266 -177.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -99.62 95.4 0.05 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.462 0 C-N-CA 120.852 1.035 . . . . 0.0 110.152 170.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -174.47 138.91 0.55 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.7 m -85.71 -5.3 59.28 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 118.827 0.74 . . . . 0.0 111.182 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -88.19 143.62 26.94 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.381 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.2 p -90.35 102.33 15.06 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.11 0.481 . . . . 0.0 109.902 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.402 ' H ' ' CD2' ' A' ' 105' ' ' LEU . 24.8 mt -92.01 130.25 38.92 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -177.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -75.92 142.5 25.24 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.897 1.731 . . . . 0.0 108.943 171.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.6 HG13 ' HD2' ' A' ' 102' ' ' PRO . 18.3 pt -82.5 102.62 8.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.318 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 6.6 m -43.47 -65.93 0.44 Allowed 'General case' 0 C--O 1.244 0.799 0 C-N-CA 126.945 2.098 . . . . 0.0 113.032 -172.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.525 ' C ' HD12 ' A' ' 83' ' ' ILE . 10.0 pt20 -147.34 150.82 35.49 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.588 HG23 HG23 ' A' ' 143' ' ' ILE . 1.8 mp -120.39 117.97 55.15 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.141 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.8 m -80.08 119.98 23.62 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.477 ' CE2' HG12 ' A' ' 117' ' ' VAL . 4.8 t80 -103.04 120.76 41.24 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.634 -170.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.401 ' HB ' ' HB3' ' A' ' 142' ' ' ASP . 39.8 mm -131.17 108.47 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.529 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 0.2 OUTLIER -106.22 126.98 52.89 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 179.433 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -124.41 147.1 48.49 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.965 -0.694 . . . . 0.0 112.314 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.7 m -151.93 97.9 2.39 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 64.73 -173.03 0.18 Allowed 'General case' 0 CA--C 1.541 0.609 0 O-C-N 123.975 0.797 . . . . 0.0 109.5 -174.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.3 p -98.54 14.55 27.93 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.805 -0.56 . . . . 0.0 111.681 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.6 -65.58 0.99 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.27 -177.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 122' ' ' SER . 35.1 m -130.54 141.3 50.48 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 122.05 -0.406 . . . . 0.0 111.177 -175.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.529 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 1.8 pp -137.06 168.79 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -178.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.61 147.81 49.17 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 176.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.7 p -144.16 164.81 29.62 Favored 'General case' 0 C--N 1.313 -0.992 0 O-C-N 122.438 -0.164 . . . . 0.0 110.859 -177.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 156.36 -170.57 33.97 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 176.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 35.5 p -132.99 127.39 34.06 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 117.331 0.566 . . . . 0.0 109.721 176.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.462 HG23 ' HB ' ' A' ' 83' ' ' ILE . 11.4 tt -103.36 116.91 61.36 Favored Pre-proline 0 C--N 1.318 -0.796 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.964 177.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -88.63 128.04 2.02 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.973 2.449 . . . . 0.0 113.561 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.2 t70 50.98 72.96 1.07 Allowed Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.6 ' HD2' HG13 ' A' ' 80' ' ' ILE . 84.2 Cg_endo -104.09 18.8 0.16 Allowed 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 123.729 2.953 . . . . 0.0 110.706 174.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.535 ' O ' HG12 ' A' ' 80' ' ' ILE . . . 155.23 172.7 23.15 Favored Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.9 m -145.65 149.12 33.91 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.555 HD13 ' H ' ' A' ' 105' ' ' LEU 0.37 0.0 OUTLIER -81.18 157.62 25.2 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 119.519 -0.873 . . . . 0.0 113.259 179.118 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.4 m -83.53 -3.14 7.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -172.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.97 75.95 0.93 Allowed Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.646 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.661 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 48.8 m 78.91 91.46 0.06 Allowed 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 124.852 1.261 . . . . 0.0 111.756 -178.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 158.55 172.42 25.66 Favored Glycine 0 N--CA 1.425 -2.037 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.42 HG22 ' HB3' ' A' ' 71' ' ' LYS . 45.4 p -100.26 113.42 26.11 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.9 t -124.22 138.75 54.37 Favored 'General case' 0 N--CA 1.42 -1.937 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.333 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.2 m -86.36 134.62 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-O 121.416 0.627 . . . . 0.0 109.837 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.459 HD13 HD13 ' A' ' 80' ' ' ILE . 79.0 mt -125.24 167.01 15.46 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -140.31 148.51 41.5 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.464 -0.895 . . . . 0.0 112.848 -175.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 91.8 t -133.93 122.58 16.5 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 173.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -77.6 109.03 2.68 Favored 'Trans proline' 0 N--CA 1.41 -3.383 0 N-CA-C 108.059 -1.554 . . . . 0.0 108.059 171.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.477 HG12 ' CE2' ' A' ' 85' ' ' TYR . 33.8 m -98.87 149.66 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 177.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -101.99 99.17 9.31 Favored 'General case' 0 C--N 1.273 -2.725 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.2 m -91.72 149.94 3.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.92 -171.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.4 ' HB3' HG12 ' A' ' 62' ' ' VAL . . . 76.05 12.46 2.83 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.282 0.633 . . . . 0.0 110.907 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.561 ' O ' HG23 ' A' ' 125' ' ' VAL . 81.4 t80 -59.88 -39.61 85.9 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 172.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.448 ' HB3' ' HB ' ' A' ' 93' ' ' THR . 16.4 m -58.83 -32.71 69.64 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 122.317 1.056 . . . . 0.0 109.58 178.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.855 HG23 ' HA ' ' A' ' 128' ' ' MET . 1.8 mp -80.58 -48.39 19.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 126.141 1.776 . . . . 0.0 112.803 -175.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.69 -29.37 26.23 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.208 1.003 . . . . 0.0 111.866 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 121' ' ' TYR . 91.6 t -53.7 -19.75 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.849 0 C-N-CA 125.722 1.609 . . . . 0.0 112.307 175.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.2 t 105.17 25.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 127.191 2.196 . . . . 0.0 110.427 -175.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 127' ' ' LEU . 27.7 tp -98.14 1.09 47.14 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.459 175.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.855 ' HA ' HG23 ' A' ' 123' ' ' ILE . 83.8 mtp -30.36 106.54 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 125.979 1.711 . . . . 0.0 111.646 179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.42 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -53.37 -41.62 66.05 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 114.0 -1.454 . . . . 0.0 112.602 -178.107 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.4 t70 176.1 -58.14 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.456 0.473 . . . . 0.0 111.104 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.536 ' SD ' ' HA ' ' A' ' 171' ' ' ARG 0.257 15.7 tpp 65.0 97.07 0.05 OUTLIER 'General case' 0 C--O 1.244 0.775 0 CA-C-O 122.146 0.974 . . . . 0.0 112.817 -173.436 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 45.4 t -141.88 164.43 30.22 Favored 'General case' 0 N--CA 1.415 -2.187 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 34.4 p -73.58 119.5 17.9 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.7 t70 71.81 88.2 0.1 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.25 1.02 . . . . 0.0 108.438 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 41.0 t-105 -160.36 158.64 30.0 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.658 -170.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -143.96 162.16 36.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 118.111 0.414 . . . . 0.0 111.139 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.41 HD12 ' HD2' ' A' ' 129' ' ' LYS . 5.5 tt -140.68 146.43 24.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 C-N-CA 123.442 0.697 . . . . 0.0 109.383 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -88.99 108.13 19.41 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.499 ' HB3' HG12 ' A' ' 165' ' ' ILE . 0.2 OUTLIER -125.58 155.97 39.86 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 124.137 0.975 . . . . 0.0 109.377 -179.222 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.0 pm0 -146.71 148.78 32.35 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.307 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 27.8 tp -121.02 126.72 50.61 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.275 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.401 ' HB3' ' HB ' ' A' ' 86' ' ' ILE . 15.4 t70 -127.94 130.08 47.86 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -176.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.588 HG23 HG23 ' A' ' 83' ' ' ILE . 37.7 mm -130.19 144.25 38.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 121.511 0.672 . . . . 0.0 112.484 -173.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -114.16 92.39 0.6 Allowed Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 172.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.9 121.85 24.7 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -174.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.574 ' OG1' HG22 ' A' ' 156' ' ' THR . 19.1 m -105.95 127.83 53.4 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 120.054 -0.658 . . . . 0.0 112.008 -177.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -121.13 140.28 52.21 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 173.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 154' ' ' ASP . 2.9 p30 -121.54 122.58 40.0 Favored 'General case' 0 CA--C 1.486 -1.514 0 C-N-CA 119.046 -1.062 . . . . 0.0 110.343 175.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 10.3 pt -140.43 143.34 32.63 Favored Pre-proline 0 C--N 1.301 -1.517 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.038 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.75 -5.3 10.15 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 123.472 2.781 . . . . 0.0 112.602 -178.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.16 -25.59 30.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.178 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 5.4 p -161.43 -39.44 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 140.56 -155.51 24.79 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 148' ' ' ASP . 7.1 p-10 -99.02 120.08 38.87 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.298 0.571 . . . . 0.0 109.743 177.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' ' 146' ' ' THR . 50.0 mt -123.35 132.23 71.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.136 -174.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.574 HG22 ' OG1' ' A' ' 146' ' ' THR . 44.1 p -91.0 113.46 25.73 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.425 174.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.0 mp -90.3 117.81 68.31 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -80.28 127.39 6.66 Favored 'Trans proline' 0 CA--C 1.487 -1.832 0 C-N-CA 122.104 1.869 . . . . 0.0 112.036 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.423 HG13 ' HB ' ' A' ' 143' ' ' ILE . 2.7 p -136.87 130.61 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.716 0 CA-C-N 112.706 -2.043 . . . . 0.0 108.669 -178.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 11.9 m -134.61 153.59 51.9 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.201 -174.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.4 t -147.24 137.21 23.13 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -99.57 122.44 42.63 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -139.3 -154.57 6.39 Favored Glycine 0 N--CA 1.405 -3.409 0 C-N-CA 119.465 -1.35 . . . . 0.0 110.71 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.04 159.5 29.39 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.499 HG12 ' HB3' ' A' ' 139' ' ' TYR . 52.0 mm -118.29 108.05 23.36 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.551 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 16.0 pttm -95.22 131.47 41.23 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.339 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 90.0 mt -110.73 91.8 13.16 Favored Pre-proline 0 C--N 1.283 -2.294 0 CA-C-N 114.64 -1.163 . . . . 0.0 110.212 -172.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' ' 166' ' ' LYS . 1.7 Cg_endo -83.0 82.93 2.05 Favored 'Trans proline' 0 N--CA 1.426 -2.448 0 C-N-CA 122.618 2.212 . . . . 0.0 112.251 -177.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 65.4 p 57.61 24.99 11.1 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.684 1.194 . . . . 0.0 114.182 174.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.463 ' HB3' ' CD1' ' A' ' 173' ' ' PHE . 38.7 mt -60.76 -62.0 2.18 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 120.665 0.269 . . . . 0.0 110.54 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.536 ' HA ' ' SD ' ' A' ' 131' ' ' MET . 78.3 mtp180 63.95 141.34 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 O-C-N 124.668 1.23 . . . . 0.0 111.5 -173.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 38.0 t70 78.08 1.84 2.79 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.69 0.796 . . . . 0.0 111.126 -177.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.463 ' CD1' ' HB3' ' A' ' 170' ' ' LEU . 72.5 m-85 -111.74 -6.49 14.31 Favored 'General case' 0 C--O 1.22 -0.5 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 175.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.49 ' HB2' ' HE2' ' A' ' 128' ' ' MET 0.318 42.9 p90 . . . . . 0 N--CA 1.439 -1.002 0 N-CA-C 118.544 2.794 . . . . 0.0 118.544 173.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.093 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -142.0 122.38 14.02 Favored 'General case' 0 CA--C 1.498 -1.036 0 C-N-CA 122.883 0.473 . . . . 0.0 109.848 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -100.55 105.65 17.09 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.565 0.697 . . . . 0.0 110.231 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -161.22 172.49 16.59 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -157.34 148.84 22.02 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.02 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -68.48 140.9 55.72 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 71.3 92.9 0.08 Allowed 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 123.955 0.902 . . . . 0.0 110.485 -174.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -68.44 98.72 0.87 Allowed 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 41.68 70.54 0.27 Allowed 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 125.765 1.626 . . . . 0.0 114.031 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -132.46 165.96 23.11 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.901 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.3 m -59.81 -31.76 70.01 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -174.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.575 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -74.93 -17.75 60.51 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -177.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -58.88 -27.3 65.07 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.296 0.57 . . . . 0.0 110.831 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.535 ' O ' ' HG3' ' A' ' 18' ' ' GLU . 42.7 tt0 -57.43 -47.31 82.11 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.516 176.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -74.57 -19.43 60.33 Favored 'General case' 0 CA--C 1.487 -1.464 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.531 -178.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 12' ' ' ALA . 22.0 t -71.19 -32.93 49.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.455 HG11 ' O ' ' A' ' 94' ' ' ILE . 59.9 t -69.24 -43.22 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 170.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 41.9 mt-10 -64.52 -46.75 81.59 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.863 -173.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.433 ' O ' HG23 ' A' ' 23' ' ' VAL . 8.0 pt-20 -55.53 -48.23 75.02 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 119.929 -0.709 . . . . 0.0 111.214 173.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.415 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 24.9 ttmm -65.5 -47.8 74.76 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 122.808 0.443 . . . . 0.0 111.43 -176.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.68 -39.22 76.63 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.118 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.1 t -66.52 -42.31 87.49 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.605 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 19' ' ' GLU . 65.5 t -62.92 -46.65 95.79 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 CA-C-O 121.116 0.484 . . . . 0.0 109.73 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.485 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 69.1 mt -64.08 -49.88 79.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.863 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.0 t -60.06 -35.09 74.4 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 122.664 0.386 . . . . 0.0 111.018 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.6 m -68.91 -30.47 68.96 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.12 0.486 . . . . 0.0 110.877 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.1 tt -75.82 -42.29 50.25 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 87.0 mt -63.05 -31.1 72.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.528 178.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -68.29 -49.31 61.36 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.426 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.533 ' HD2' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -67.37 -36.49 81.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.29 -177.21 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.533 ' N ' ' HD2' ' A' ' 30' ' ' LYS . . . -77.46 -31.85 54.03 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.479 -178.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -55.48 -53.45 56.19 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.166 0.291 . . . . 0.0 110.532 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.648 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -62.27 -53.08 44.91 Favored Glycine 0 N--CA 1.437 -1.269 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.477 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -53.83 -41.95 67.95 Favored 'General case' 0 C--O 1.252 1.204 0 C-N-CA 124.316 1.046 . . . . 0.0 111.674 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.486 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 90.8 t80 -66.43 -51.88 52.31 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.76 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.58 -22.98 67.19 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -176.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.648 ' HG2' ' O ' ' A' ' 33' ' ' GLY . 10.9 pt-20 -93.1 -51.49 5.01 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.484 ' HD3' ' HG3' ' A' ' 37' ' ' GLU . 3.9 mppt? -103.35 -39.13 6.92 Favored 'General case' 0 CA--C 1.484 -1.574 0 C-N-CA 118.553 -1.259 . . . . 0.0 112.764 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 2.7 mm? -79.63 -1.53 38.53 Favored 'General case' 0 C--N 1.286 -2.19 0 C-N-CA 119.783 -0.767 . . . . 0.0 112.535 -174.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.12 -8.87 58.44 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 172.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -109.22 -48.78 3.21 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.245 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.9 mp -77.15 117.83 67.83 Favored Pre-proline 0 C--O 1.244 0.808 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.77 118.73 4.74 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.357 2.705 . . . . 0.0 113.504 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.0 p -141.38 165.14 30.73 Favored Pre-proline 0 C--N 1.304 -1.392 0 C-N-CA 125.18 1.392 . . . . 0.0 108.185 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -70.21 135.08 28.53 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.022 1.815 . . . . 0.0 112.347 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -97.48 112.83 24.51 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.957 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.26 125.78 43.49 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.178 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -127.39 132.21 50.18 Favored 'General case' 0 N--CA 1.417 -2.093 0 CA-C-O 121.639 0.733 . . . . 0.0 110.588 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.46 HG13 HG22 ' A' ' 159' ' ' VAL . 11.7 m -83.44 144.17 10.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.663 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -119.34 -67.2 1.0 Allowed 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.433 -174.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -172.43 174.09 3.93 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -177.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.701 HG22 ' HB3' ' A' ' 64' ' ' TYR . 10.5 p -116.48 126.62 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -95.73 119.52 34.38 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.532 -172.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.697 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 37.2 p90 -63.12 125.8 25.27 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.911 0.386 . . . . 0.0 111.761 175.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.549 ' HG3' ' CD2' ' A' ' 65' ' ' HIS . 29.5 mmmt -109.11 -66.3 1.07 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.777 -176.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.32 177.84 21.9 Favored Glycine 0 N--CA 1.431 -1.67 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.864 -175.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 173' ' ' PHE . 6.5 p -98.4 136.94 27.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -177.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.651 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 59.6 m -137.45 146.13 43.95 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -59.35 -43.44 92.78 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.981 0.912 . . . . 0.0 112.235 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.422 ' HB3' ' CD1' ' A' ' 121' ' ' TYR . 19.6 m-20 -61.96 -56.68 16.63 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.171 0.986 . . . . 0.0 109.59 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.651 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . -165.77 165.89 38.26 Favored Glycine 0 N--CA 1.407 -3.299 0 N-CA-C 105.857 -2.897 . . . . 0.0 105.857 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.94 141.87 17.14 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-N 117.689 0.745 . . . . 0.0 111.733 -176.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -87.46 111.79 21.52 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.25 -173.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.701 ' HB3' HG22 ' A' ' 52' ' ' VAL . 7.0 m-85 -120.1 161.24 21.32 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-O 121.761 0.791 . . . . 0.0 111.479 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.549 ' CD2' ' HG3' ' A' ' 55' ' ' LYS . 19.7 m170 -116.9 117.92 31.02 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.015 172.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.566 ' HB3' ' HB ' ' A' ' 115' ' ' VAL . . . -77.78 122.79 25.88 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.433 ' HG3' ' CG1' ' A' ' 112' ' ' VAL . 40.1 ttmt -87.44 107.84 18.74 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.636 -175.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.4 t -112.47 109.15 27.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 114.538 -1.21 . . . . 0.0 107.931 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.0 p -101.16 119.34 38.61 Favored 'General case' 0 C--N 1.277 -2.556 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.967 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 110' ' ' THR . 78.0 t -106.28 119.48 55.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.267 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -97.91 109.57 22.3 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' A' ' 108' ' ' SER . 41.6 t30 -112.27 119.46 43.78 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -175.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -93.83 97.62 0.14 Allowed 'Trans proline' 0 N--CA 1.434 -2.025 0 C-N-CA 121.861 1.707 . . . . 0.0 112.089 173.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.568 ' O ' ' HB2' ' A' ' 108' ' ' SER . 34.1 m-85 -169.92 -160.3 0.23 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 127.209 2.204 . . . . 0.0 106.678 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.5 m -143.37 19.7 1.89 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.538 0.685 . . . . 0.0 109.297 172.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.427 ' O ' ' HA2' ' A' ' 107' ' ' GLY . 17.9 pt20 -113.68 143.62 44.29 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.842 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.1 p -85.41 86.05 7.4 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.091 0.472 . . . . 0.0 110.588 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 64.6 mt -72.88 119.52 75.88 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.461 -177.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -88.91 124.19 1.49 Allowed 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 122.27 1.98 . . . . 0.0 110.876 175.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.421 HG13 ' HD2' ' A' ' 102' ' ' PRO . 24.2 pt -77.29 130.26 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.292 177.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 41.8 t -72.34 -40.17 67.59 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.327 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -153.68 155.83 36.72 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.5 tt -124.27 120.31 58.92 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 172.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.9 m -99.41 128.85 45.56 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -174.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -127.39 141.11 51.77 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.189 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.565 ' HB ' ' HB3' ' A' ' 142' ' ' ASP . 68.0 mt -119.37 108.18 23.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 172.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.54 HD13 ' HB3' ' A' ' 95' ' ' ALA . 0.8 OUTLIER -101.74 122.65 44.34 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -179.095 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.438 ' HG3' ' HB ' ' A' ' 94' ' ' ILE . 67.5 tttt -123.29 154.37 38.94 Favored 'General case' 0 C--N 1.277 -2.547 0 C-N-CA 118.38 -1.328 . . . . 0.0 108.249 176.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.1 m -141.43 126.97 18.89 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.057 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 59.18 14.29 3.47 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.234 1.014 . . . . 0.0 111.094 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.41 ' O ' ' HE2' ' A' ' 88' ' ' LYS . 41.1 m 68.17 -2.69 1.44 Allowed 'General case' 0 CA--C 1.584 2.267 0 C-N-CA 124.451 1.101 . . . . 0.0 112.489 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.24 -80.81 0.24 Allowed 'General case' 0 C--O 1.237 0.408 0 O-C-N 121.199 -0.938 . . . . 0.0 111.346 176.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 94' ' ' ILE . 29.1 m -84.72 166.05 17.34 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.274 -176.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.52 HD13 ' N ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -159.88 148.54 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.468 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 -167.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.54 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -128.87 127.21 41.37 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 176.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.7 t -137.73 151.14 47.89 Favored 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.438 -177.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.85 174.4 46.53 Favored Glycine 0 N--CA 1.411 -3.027 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.411 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 41.4 p -128.46 137.26 51.73 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 99' ' ' ILE . 3.2 mp -102.09 108.03 55.07 Favored Pre-proline 0 C--N 1.308 -1.197 0 C-N-CA 118.15 -1.42 . . . . 0.0 108.575 173.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 98' ' ' THR . 10.3 Cg_exo -74.12 129.51 13.25 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 122.345 2.03 . . . . 0.0 109.848 175.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 56.21 68.77 2.1 Favored Pre-proline 0 N--CA 1.477 0.916 0 C-N-CA 124.153 0.981 . . . . 0.0 111.14 -175.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.421 ' HD2' HG13 ' A' ' 80' ' ' ILE . 64.2 Cg_endo -102.89 -0.25 0.36 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.384 2.723 . . . . 0.0 114.166 -176.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 152.31 179.29 27.79 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 56.3 m -149.82 156.46 41.84 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 116.934 0.367 . . . . 0.0 110.493 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.435 HD23 ' HB2' ' A' ' 72' ' ' ASN . 7.5 mp -79.5 143.4 34.93 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.343 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 27.0 m -68.33 -16.32 20.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.878 -1.056 . . . . 0.0 113.356 -177.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 76' ' ' GLN . . . 129.16 -57.92 0.71 Allowed Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.568 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 24.9 t -156.68 139.58 15.28 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 175.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 119.57 -177.8 16.44 Favored Glycine 0 C--N 1.292 -1.907 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 9.9 t -89.56 117.95 28.84 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.815 0.817 . . . . 0.0 110.407 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.434 HG21 ' HA ' ' A' ' 105' ' ' LEU . 5.0 t -114.87 132.83 56.39 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.095 177.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.433 ' CG1' ' HG3' ' A' ' 67' ' ' LYS . 39.6 t -92.46 121.69 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.831 -177.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.9 mt -106.96 148.14 29.01 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.152 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -110.7 122.31 47.49 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 86.0 t -100.22 116.6 64.33 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 169.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.76 108.96 2.54 Favored 'Trans proline' 0 N--CA 1.43 -2.244 0 N-CA-C 106.171 -2.281 . . . . 0.0 106.171 169.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.439 HG13 HG13 ' A' ' 119' ' ' VAL . 14.0 p -126.63 139.12 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.381 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -175.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -94.04 94.97 8.72 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.535 ' HA ' HD11 ' A' ' 87' ' ' LEU . 4.5 m -94.21 148.5 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.583 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -175.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.473 ' HB1' ' CE1' ' A' ' 174' ' ' PHE . . . 73.44 -4.28 2.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.369 -178.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.422 ' CD1' ' HB3' ' A' ' 60' ' ' ASP . 61.7 t80 -58.94 -41.05 86.45 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 171.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.7 p -62.34 -32.19 72.92 Favored 'General case' 0 N--CA 1.417 -2.077 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.913 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 45.6 mm -80.9 -49.83 17.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.242 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.63 -42.85 95.2 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.438 0.461 . . . . 0.0 111.204 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.3 t -66.95 -29.04 44.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.562 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.6 t -86.47 -72.37 0.5 Allowed 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.628 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.583 HD12 ' N ' ' A' ' 128' ' ' MET . 3.0 pp -124.72 -35.3 2.73 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -172.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.583 ' N ' HD12 ' A' ' 127' ' ' LEU . 12.5 tpt 58.92 114.49 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.506 1.123 . . . . 0.0 112.398 -174.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -65.27 -75.42 0.09 Allowed 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.516 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.5 t70 159.78 -32.82 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 105.194 -2.151 . . . . 0.0 105.194 -175.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER 69.47 127.44 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 112.288 -2.233 . . . . 0.0 110.91 -177.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 42.0 t -128.16 150.72 49.87 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.561 HG22 ' HA ' ' A' ' 169' ' ' SER . 66.9 p -61.78 117.61 6.08 Favored 'General case' 0 N--CA 1.407 -2.608 0 C-N-CA 124.339 1.056 . . . . 0.0 109.678 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 75.86 80.91 0.1 Allowed 'General case' 0 CA--C 1.507 -0.673 0 CA-C-O 121.926 0.87 . . . . 0.0 110.63 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 15.8 t-105 -146.15 116.26 7.4 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.816 -1.538 . . . . 0.0 111.214 -175.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' A' ' 165' ' ' ILE . 5.7 p-10 -98.09 126.11 43.38 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 15.6 tt -112.28 145.82 17.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.3 -175.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -74.67 105.91 5.98 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 122.376 1.084 . . . . 0.0 111.043 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.47 150.85 51.99 Favored 'General case' 0 C--N 1.265 -3.095 0 CA-C-N 113.297 -1.774 . . . . 0.0 106.934 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . 0.304 0.1 OUTLIER -146.19 157.34 43.82 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.209 176.526 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.535 ' HB3' ' HB ' ' A' ' 161' ' ' THR . 28.4 tp -135.53 143.31 45.68 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -171.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.565 ' HB3' ' HB ' ' A' ' 86' ' ' ILE . 17.9 t70 -142.32 114.08 8.0 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 177.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 158' ' ' PRO . 49.1 mt -116.24 142.82 28.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.305 -174.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.405 ' HA3' ' CD2' ' A' ' 28' ' ' LEU . . . -120.62 108.39 1.4 Allowed Glycine 0 N--CA 1.421 -2.33 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 176.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 156' ' ' THR . 3.8 mm? -84.33 115.84 22.7 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 122.566 0.346 . . . . 0.0 110.873 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.425 ' OG1' HG22 ' A' ' 156' ' ' THR . 32.3 m -90.47 107.15 18.98 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.644 ' O ' ' HA ' ' A' ' 154' ' ' ASP . 93.8 m-85 -111.5 142.04 44.29 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 176.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -108.51 110.05 21.45 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.0 mp -121.7 126.58 26.37 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.19 -12.73 0.84 Allowed 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 124.481 3.454 . . . . 0.0 116.176 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 24.6 m -73.69 -22.98 18.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 O-C-N 122.065 -0.397 . . . . 0.0 111.203 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.2 p -148.46 -32.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.496 0.665 . . . . 0.0 111.417 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 115.39 -136.63 13.22 Favored Glycine 0 N--CA 1.416 -2.699 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 -175.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.644 ' HA ' ' O ' ' A' ' 147' ' ' PHE . 5.7 p-10 -95.73 131.03 42.44 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 121.376 0.608 . . . . 0.0 110.983 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.47 131.46 54.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 176.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.57 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 73.8 p -87.72 118.58 27.32 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.699 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.503 HD13 ' CD2' ' A' ' 147' ' ' PHE . 2.3 mp -81.35 110.99 21.12 Favored Pre-proline 0 C--N 1.316 -0.854 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 173.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 19.2 Cg_endo -88.02 113.38 0.81 Allowed 'Trans proline' 0 CA--C 1.475 -2.428 0 C-N-CA 122.489 2.126 . . . . 0.0 111.555 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.46 HG22 HG13 ' A' ' 49' ' ' VAL . 2.9 p -116.93 108.32 24.66 Favored 'Isoleucine or valine' 2 N--CA 1.361 -4.923 0 CA-C-N 112.174 -2.285 . . . . 0.0 109.231 -176.678 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 27.3 m -89.59 152.47 21.38 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.23 -173.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 141' ' ' LEU . 1.6 m -140.56 139.6 35.03 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -177.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -99.62 118.61 36.54 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 164.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -108.75 93.28 0.77 Allowed Glycine 0 N--CA 1.413 -2.869 0 C-N-CA 118.77 -1.681 . . . . 0.0 112.697 -171.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -89.22 118.91 29.25 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 175.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 136' ' ' ASP . 7.8 pt -124.33 121.05 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 CA-C-O 121.617 0.723 . . . . 0.0 110.678 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -91.46 104.05 16.6 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 114.229 -1.35 . . . . 0.0 110.95 -177.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 7.1 mp -82.45 111.93 32.5 Favored Pre-proline 0 C--N 1.295 -1.785 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 176.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -82.06 -160.89 0.13 Allowed 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 122.259 1.973 . . . . 0.0 110.189 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.561 ' HA ' HG22 ' A' ' 133' ' ' THR . 28.9 t -56.04 92.82 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 167.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 21.6 tp -144.9 27.54 1.31 Allowed 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 -177.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.488 ' NH1' ' HB2' ' A' ' 172' ' ' ASP . 2.5 tmm_? -63.41 122.56 16.54 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.534 -1.212 . . . . 0.0 107.897 -176.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.488 ' HB2' ' NH1' ' A' ' 171' ' ' ARG . 25.5 t70 79.97 73.78 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.815 0 C-N-CA 125.136 1.374 . . . . 0.0 108.954 -175.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.456 ' O ' HG23 ' A' ' 57' ' ' VAL . 12.1 t80 -171.91 -47.97 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 101.097 -3.668 . . . . 0.0 101.097 -178.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.473 ' CE1' ' HB1' ' A' ' 120' ' ' ALA . 35.2 t80 . . . . . 0 N--CA 1.423 -1.786 0 CA-C-N 113.058 -1.883 . . . . 0.0 106.408 163.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.743 0 N-CA-C 111.701 -0.56 . . . . 0.0 111.701 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -140.97 29.34 1.87 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -177.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -61.2 115.43 3.8 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -102.1 119.54 38.96 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 116.758 2.133 . . . . 0.0 116.758 -165.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -115.72 21.55 13.81 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.88 169.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -71.84 87.6 1.0 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -109.23 76.41 1.0 Allowed 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.102 -169.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.5 mp 39.62 -94.24 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.524 1.93 . . . . 0.0 115.795 173.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -101.99 96.12 6.82 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.782 -177.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.45 152.11 1.67 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.46 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.426 ' HA ' ' OE2' ' A' ' 14' ' ' GLU . 57.4 m -73.96 -17.54 60.99 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.297 0.57 . . . . 0.0 110.327 176.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.602 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -64.41 -47.28 79.78 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 171.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -57.5 -43.67 84.37 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.884 0.874 . . . . 0.0 109.749 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 18' ' ' GLU . 45.6 mt-10 -57.2 -41.61 79.7 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.053 176.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.511 ' C ' ' HD3' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -67.45 -49.0 65.58 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.291 0.567 . . . . 0.0 110.02 177.604 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 12' ' ' ALA . 57.7 t -64.61 -35.85 75.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.333 -0.849 . . . . 0.0 113.023 -173.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 p -66.15 -29.59 47.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 14' ' ' GLU . 65.1 mt-10 -76.79 -44.95 30.67 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 122.057 0.932 . . . . 0.0 108.597 178.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -55.3 -46.94 76.24 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.497 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.693 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -70.75 -36.17 73.0 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.275 177.6 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.67 90.88 Favored 'General case' 0 C--O 1.213 -0.817 0 O-C-N 123.282 0.363 . . . . 0.0 110.574 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.8 m -61.01 -38.19 85.2 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 120.727 0.299 . . . . 0.0 111.582 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.8 -34.94 73.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 20' ' ' LYS . 78.8 mt -69.27 -49.67 59.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.45 -0.795 . . . . 0.0 108.967 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.0 m -57.4 -33.82 68.25 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.992 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.2 t -57.68 -35.23 70.32 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.17 0.588 . . . . 0.0 111.721 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.441 HD23 ' HE2' ' A' ' 30' ' ' LYS . 4.5 tt -80.33 -43.77 20.63 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.496 HD23 ' HB3' ' A' ' 158' ' ' PRO . 9.1 mp -62.3 -34.56 76.83 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -62.41 -34.05 75.97 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.441 ' HE2' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -83.19 -18.66 38.53 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.712 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.22 -32.08 64.54 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.705 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -50.67 -52.75 36.96 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.679 0.791 . . . . 0.0 112.327 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -90.32 7.32 81.69 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.905 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.491 ' HA ' ' HE2' ' A' ' 38' ' ' LYS . 29.1 t80 -85.46 -26.18 26.48 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.63 ' CD1' HD12 ' A' ' 39' ' ' LEU . 44.8 m-85 -70.35 -41.08 73.63 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -174.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.29 -50.77 49.44 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -168.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.452 ' HG2' ' HG3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -117.78 -31.62 5.08 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.259 -0.576 . . . . 0.0 112.072 179.374 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 34' ' ' PHE . 36.7 mtmm -84.84 -9.71 57.88 Favored 'General case' 0 CA--C 1.486 -1.49 0 CA-C-O 121.484 0.659 . . . . 0.0 111.534 -168.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.63 HD12 ' CD1' ' A' ' 35' ' ' PHE . 88.5 mt -128.43 17.98 6.43 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.194 174.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.66 -44.32 21.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.735 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -95.26 11.37 32.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.623 0.725 . . . . 0.0 110.061 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.3 mm -115.57 117.2 40.66 Favored Pre-proline 0 N--CA 1.435 -1.204 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -65.03 113.92 2.59 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 121.991 1.794 . . . . 0.0 111.158 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.3 p -118.19 139.23 26.44 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.917 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.446 ' HB3' HD21 ' A' ' 105' ' ' LEU . 64.7 Cg_endo -74.71 143.88 30.65 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.563 2.175 . . . . 0.0 112.289 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -97.48 130.19 44.6 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -113.0 134.29 54.57 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.9 t -115.83 123.98 49.55 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 121.989 0.9 . . . . 0.0 111.416 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.549 HG22 HG12 ' A' ' 159' ' ' VAL . 26.0 m -102.39 143.87 14.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 114.288 -1.323 . . . . 0.0 109.958 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.575 24.2 t70 117.25 78.61 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 117.821 2.526 . . . . 0.0 117.821 176.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.617 ' HB2' ' HB3' ' A' ' 67' ' ' LYS . 31.9 m-20 -161.3 111.0 1.63 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 102.809 -3.034 . . . . 0.0 102.809 170.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.442 HG12 ' CD2' ' A' ' 64' ' ' TYR . 31.8 t -137.94 134.01 44.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.309 -168.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -137.42 137.26 38.6 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.256 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.599 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 37.8 p90 -91.83 141.82 28.25 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.093 0.557 . . . . 0.0 111.154 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.648 ' HD2' ' N ' ' A' ' 55' ' ' LYS . 3.0 mptp? -107.75 -52.23 2.79 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.89 178.55 40.55 Favored Glycine 0 C--N 1.293 -1.856 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.054 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.71 148.99 5.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 117.039 0.419 . . . . 0.0 110.508 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.6 p -131.28 179.15 6.19 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 176.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -75.6 -32.19 60.21 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.564 0.697 . . . . 0.0 109.328 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.22 83.44 3.6 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.81 176.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.92 -162.67 38.63 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.006 -176.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 p -107.59 145.04 15.37 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.703 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -84.97 121.74 28.2 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.628 0.728 . . . . 0.0 112.373 -170.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.652 ' CD1' ' HB ' ' A' ' 119' ' ' VAL . 28.2 m-85 -129.3 172.24 11.68 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.547 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -138.85 117.34 12.06 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 176.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.19 145.75 24.26 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.724 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.617 ' HB3' ' HB2' ' A' ' 51' ' ' ASP . 47.8 tttm -116.43 124.34 49.76 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.03 -177.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.497 HG12 HG12 ' A' ' 49' ' ' VAL . 34.1 m -128.43 111.64 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-O 121.784 0.802 . . . . 0.0 109.242 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.9 m -98.5 130.63 45.09 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.364 -175.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.18 124.97 66.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.035 0.445 . . . . 0.0 110.814 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -117.34 125.51 51.16 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.061 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 108' ' ' SER . 4.7 t30 -152.45 114.56 2.85 Favored Pre-proline 0 C--N 1.286 -2.165 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.277 176.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -99.41 96.37 0.05 OUTLIER 'Trans proline' 0 N--CA 1.418 -2.941 0 C-N-CA 121.812 1.674 . . . . 0.0 109.779 169.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 93.3 t80 178.23 111.9 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 177.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.7 p -56.86 85.12 0.01 OUTLIER 'General case' 0 C--O 1.242 0.686 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -156.07 105.0 2.31 Favored 'General case' 1 N--CA 1.369 -4.486 0 C-N-CA 126.552 1.941 . . . . 0.0 106.527 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.6 p -89.53 97.01 10.95 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.491 ' H ' HD13 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -103.85 134.93 19.46 Favored Pre-proline 0 C--N 1.31 -1.131 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.787 178.665 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -89.19 159.87 5.7 Favored 'Trans proline' 0 N--CA 1.438 -1.784 0 C-N-CA 122.427 2.085 . . . . 0.0 110.891 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 54.2 mt -91.03 114.91 29.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 100' ' ' PRO . 47.2 t -67.93 -37.94 82.27 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.267 0.556 . . . . 0.0 110.252 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -152.89 112.72 3.93 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.708 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 98' ' ' THR . 18.3 tt -95.77 119.43 43.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 175.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 143' ' ' ILE . 10.5 m -111.31 121.75 46.05 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.754 -172.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.438 ' CE1' HG13 ' A' ' 117' ' ' VAL . 23.7 p90 -109.65 136.41 49.05 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 175.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 63.7 mt -117.06 108.1 24.04 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.668 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 174.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -90.83 120.75 32.11 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 -174.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -118.83 163.78 16.38 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -172.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.1 t -105.57 147.41 28.43 Favored 'General case' 0 N--CA 1.41 -2.447 0 CA-C-N 112.181 -2.281 . . . . 0.0 106.59 172.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.13 -15.43 63.59 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 123.424 0.453 . . . . 0.0 110.873 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.0 t -143.93 -38.22 0.31 Allowed 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -176.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -148.31 128.27 13.56 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 118.785 -1.166 . . . . 0.0 112.687 -172.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.501 ' O ' ' HB3' ' A' ' 122' ' ' SER . 90.6 m 74.13 137.98 0.06 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.37 1.068 . . . . 0.0 113.093 177.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.443 HD12 ' C ' ' A' ' 94' ' ' ILE . 1.9 pp -134.06 171.76 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.5 172.82 12.39 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 176.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 64.1 p -152.82 175.59 12.72 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 122.079 -0.388 . . . . 0.0 110.7 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.03 144.45 4.51 Favored Glycine 0 N--CA 1.435 -1.376 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 83' ' ' ILE . 41.9 p -132.36 136.63 46.97 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 117.023 0.411 . . . . 0.0 110.529 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.1 mp -113.3 107.11 54.02 Favored Pre-proline 0 C--N 1.313 -1.001 0 C-N-CA 119.419 -0.913 . . . . 0.0 109.167 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 81' ' ' CYS . 18.6 Cg_exo -69.4 116.65 4.62 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.515 2.143 . . . . 0.0 110.031 173.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.2 t70 62.35 79.1 0.27 Allowed Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 123.51 0.724 . . . . 0.0 111.533 -177.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -107.08 12.49 0.15 Allowed 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 124.291 3.327 . . . . 0.0 112.563 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 141.68 -174.22 23.14 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.8 m -151.07 170.82 18.47 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 117.578 0.689 . . . . 0.0 110.679 -177.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.446 HD21 ' HB3' ' A' ' 45' ' ' PRO . 10.3 mp -74.02 157.58 35.87 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 114.762 1.394 . . . . 0.0 114.762 177.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.56 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 7.1 p -79.0 -20.68 12.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 CA-C-N 112.338 -2.21 . . . . 0.0 110.737 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 106.15 -60.97 0.35 Allowed Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 23.2 t -152.81 84.57 1.23 Allowed 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.435 0.636 . . . . 0.0 109.548 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 161.95 -151.74 21.91 Favored Glycine 0 N--CA 1.428 -1.876 0 N-CA-C 108.989 -1.645 . . . . 0.0 108.989 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.0 t -122.82 136.77 54.98 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.193 0.521 . . . . 0.0 110.135 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.56 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 4.4 t -130.79 138.3 49.84 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.694 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 50.8 t -91.55 113.53 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-O 121.048 0.452 . . . . 0.0 110.982 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.9 mt -103.3 166.92 10.15 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -147.28 149.83 33.62 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 119.804 -0.759 . . . . 0.0 112.501 -171.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.0 t -125.92 132.62 24.37 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -77.01 110.81 3.11 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 N-CA-C 107.417 -1.801 . . . . 0.0 107.417 167.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.438 HG13 ' CE1' ' A' ' 85' ' ' TYR . 66.3 t -119.99 136.18 57.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.326 -174.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -88.77 99.0 12.02 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 173.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.652 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 82.6 t -93.44 146.54 6.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.603 -173.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 72.7 1.07 3.86 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 124.646 1.179 . . . . 0.0 111.759 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.519 ' O ' HG12 ' A' ' 125' ' ' VAL . 83.8 t80 -54.26 -49.38 69.67 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 175.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.501 ' HB3' ' O ' ' A' ' 93' ' ' THR . 29.0 m -64.3 -29.34 70.42 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.727 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.6 mm -79.51 -50.68 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.455 ' HA ' ' HG2' ' A' ' 128' ' ' MET . . . -63.11 -49.33 74.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -175.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.519 HG12 ' O ' ' A' ' 121' ' ' TYR . 8.0 p -72.24 -22.28 20.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.938 0.399 . . . . 0.0 111.584 -175.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.0 t -99.51 -62.52 1.23 Allowed 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.513 ' H ' HD23 ' A' ' 127' ' ' LEU . 1.8 pt? -124.91 -41.61 2.09 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -171.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.455 ' HG2' ' HA ' ' A' ' 124' ' ' ALA . 81.3 mtp 65.88 -177.97 0.19 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -169.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -137.31 -78.31 0.39 Allowed 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.3 t70 178.59 93.28 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.181 0 CA-C-N 114.494 -1.23 . . . . 0.0 107.728 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.58 ' SD ' ' HB2' ' A' ' 170' ' ' LEU . 0.3 OUTLIER -52.18 101.66 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.344 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.822 175.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 82.1 m -108.27 167.66 9.86 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.433 0.635 . . . . 0.0 112.176 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.509 HG22 ' HB3' ' A' ' 169' ' ' SER . 40.3 p -77.63 127.55 32.66 Favored 'General case' 0 N--CA 1.404 -2.752 0 C-N-CA 124.921 1.288 . . . . 0.0 108.561 169.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.6 t70 54.91 91.69 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.65 1.18 . . . . 0.0 109.625 -172.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -148.69 158.97 44.52 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.908 -169.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -142.19 148.24 37.89 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.546 HG12 HD21 ' A' ' 167' ' ' LEU . 27.8 pt -128.97 145.3 35.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 120.865 0.364 . . . . 0.0 110.874 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -97.41 111.86 23.94 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -128.12 163.13 25.31 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.583 ' HG3' ' O ' ' A' ' 161' ' ' THR . 34.3 tt0 -136.45 150.01 48.51 Favored 'General case' 0 C--N 1.283 -2.314 0 O-C-N 121.68 -0.637 . . . . 0.0 111.053 -178.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 2.0 pt? -141.25 120.44 12.96 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 172.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.406 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 6.8 m-20 -84.14 122.63 29.1 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 84' ' ' SER . 34.5 mm -108.24 117.28 53.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 C-N-CA 118.799 -1.16 . . . . 0.0 109.644 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -94.07 96.84 2.11 Favored Glycine 0 N--CA 1.419 -2.46 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 156' ' ' THR . 2.7 mm? -79.16 108.72 12.87 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.446 ' OG1' HG22 ' A' ' 156' ' ' THR . 26.1 m -89.85 107.36 19.06 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.294 -0.962 . . . . 0.0 108.83 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.413 ' CE2' ' HB3' ' A' ' 145' ' ' LEU . 73.4 m-85 -114.55 131.31 56.71 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 154' ' ' ASP . 4.6 p-10 -108.78 112.17 24.3 Favored 'General case' 0 C--N 1.287 -2.122 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.757 173.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.454 HG22 HG22 ' A' ' 151' ' ' VAL . 2.5 mp -104.2 120.09 52.0 Favored Pre-proline 0 C--N 1.292 -1.904 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 176.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -41.85 -32.21 1.63 Allowed 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 124.386 3.391 . . . . 0.0 115.455 -174.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.454 HG22 HG22 ' A' ' 149' ' ' ILE . 33.8 m -74.78 -21.98 17.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 13.9 p -126.18 -28.69 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.818 -177.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 148' ' ' ASP . . . 107.34 -156.47 15.92 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 148' ' ' ASP . 7.2 p-10 -90.53 120.25 31.46 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.48 0.657 . . . . 0.0 111.47 -178.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 155' ' ' ILE . 2.4 pp -128.83 138.05 55.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.61 175.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.446 HG22 ' OG1' ' A' ' 146' ' ' THR . 67.3 p -94.21 127.29 39.96 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.196 177.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 51.2 mt -101.15 105.15 37.44 Favored Pre-proline 0 C--N 1.295 -1.79 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.496 ' HB3' HD23 ' A' ' 28' ' ' LEU . 3.2 Cg_exo -76.97 109.9 2.93 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 122.646 2.231 . . . . 0.0 111.305 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.549 HG12 HG22 ' A' ' 49' ' ' VAL . 19.0 t -103.97 124.6 58.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 175.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 14.7 m -126.78 152.14 47.32 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.154 -173.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.583 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 14.0 t -174.62 162.22 3.34 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.257 0.0 OUTLIER -99.46 135.84 40.29 Favored 'General case' 0 N--CA 1.409 -2.494 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.972 172.332 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -108.38 113.01 3.7 Favored Glycine 0 N--CA 1.397 -3.905 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -177.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -89.55 119.67 30.18 Favored 'General case' 0 N--CA 1.405 -2.702 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 174.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 10.0 pt -118.34 140.67 40.99 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.909 -176.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -90.72 136.49 33.03 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.536 -173.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.546 HD21 HG12 ' A' ' 137' ' ' ILE . 2.0 mm? -115.34 94.84 40.89 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.1 49.48 2.56 Favored 'Trans proline' 0 N--CA 1.486 1.08 0 C-N-CA 123.359 2.706 . . . . 0.0 112.944 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.509 ' HB3' HG22 ' A' ' 133' ' ' THR . 2.9 m 67.11 93.39 0.07 Allowed 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 125.108 1.363 . . . . 0.0 110.758 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.685 ' HB3' ' CD1' ' A' ' 173' ' ' PHE . 3.0 mm? -98.77 -59.48 1.73 Allowed 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.093 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 61.21 104.62 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.187 0.995 . . . . 0.0 111.602 -174.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 33.5 t70 70.49 64.19 0.2 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.866 1.266 . . . . 0.0 112.075 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.685 ' CD1' ' HB3' ' A' ' 170' ' ' LEU . 57.6 m-85 -153.83 -47.7 0.09 Allowed 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 125.933 1.693 . . . . 0.0 106.565 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.534 ' HB3' ' SD ' ' A' ' 131' ' ' MET . 87.9 t80 . . . . . 0 N--CA 1.433 -1.293 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 173.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.768 0 N-CA-C 111.689 -0.565 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -120.0 104.09 9.85 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 122.412 -0.464 . . . . 0.0 110.561 178.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.6 m80 -104.14 131.36 51.51 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 175.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -73.01 131.35 42.03 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -152.15 113.66 4.33 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.394 0.616 . . . . 0.0 112.032 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -138.04 112.01 8.42 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.615 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . 0.303 89.8 m-70 61.59 83.19 0.15 Allowed 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.23 39.68 3.07 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 174.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 83.86 -84.24 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 111.836 -2.438 . . . . 0.0 105.753 -163.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 153.43 148.52 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.626 1.57 . . . . 0.0 109.098 174.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 40.5 m -80.17 86.54 5.58 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 166.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.552 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -49.58 -56.09 11.19 Favored 'General case' 0 CA--C 1.495 -1.141 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.873 -168.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.533 ' O ' HG23 ' A' ' 17' ' ' VAL . 10.1 m-20 -56.78 -43.5 80.91 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -174.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -67.86 -29.86 69.1 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-O 121.355 0.598 . . . . 0.0 110.778 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 11.7 tmtt? -75.26 -54.25 7.42 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.792 0.806 . . . . 0.0 110.139 177.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 12' ' ' ALA . 47.5 t -59.95 -41.76 87.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 CA-C-N 114.946 -1.025 . . . . 0.0 112.682 -177.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 13' ' ' ASP . 40.2 t -68.5 -27.51 36.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 C-N-CA 118.842 -1.143 . . . . 0.0 109.077 176.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.457 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 33.0 tt0 -63.09 -34.78 78.33 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.974 0.892 . . . . 0.0 108.651 -177.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.38 -49.72 72.7 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.265 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -65.08 -43.05 93.44 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.2 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.74 -37.99 80.5 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.205 -178.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.2 t -60.73 -40.37 92.1 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 123.303 0.377 . . . . 0.0 110.29 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.13 -49.76 73.91 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.529 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 64.1 mt -68.85 -39.81 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.963 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 56.2 m -61.01 -37.8 83.83 Favored 'General case' 0 C--O 1.215 -0.744 0 O-C-N 122.299 -0.251 . . . . 0.0 110.643 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.9 m -67.19 -20.91 65.78 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.111 0.482 . . . . 0.0 111.348 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -78.04 -51.53 10.18 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.472 HD23 ' HB3' ' A' ' 158' ' ' PRO . 8.1 mp -60.85 -34.0 73.91 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.409 177.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -53.33 -49.47 67.0 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.524 0.73 . . . . 0.0 111.465 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -82.13 -31.64 30.51 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.07 -32.49 70.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.713 0.292 . . . . 0.0 111.638 177.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.487 ' CG ' ' HG2' ' A' ' 158' ' ' PRO . 56.6 mtmt -61.82 -25.77 67.71 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.568 176.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.48 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -73.48 -50.84 10.71 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 175.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -58.37 -40.67 82.89 Favored 'General case' 0 C--O 1.198 -1.611 0 CA-C-O 120.397 0.141 . . . . 0.0 111.113 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -60.11 -35.49 75.36 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.999 -0.681 . . . . 0.0 111.81 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.09 -39.2 50.54 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 33' ' ' GLY . 10.9 pt-20 -96.29 -40.07 9.33 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -176.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.435 ' HE2' ' HB2' ' A' ' 38' ' ' LYS . 8.2 tppt? -90.67 -47.93 7.36 Favored 'General case' 0 CA--C 1.479 -1.781 0 CA-C-O 122.74 1.257 . . . . 0.0 107.927 -167.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.491 HD13 HG21 ' A' ' 44' ' ' THR . 58.6 mt -82.91 6.2 19.32 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 112.91 -1.95 . . . . 0.0 111.331 -173.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.25 -38.54 30.75 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 173.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -88.41 -39.97 13.87 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.863 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.6 mt -73.5 135.91 78.39 Favored Pre-proline 0 N--CA 1.435 -1.178 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -72.6 94.65 0.78 Allowed 'Trans proline' 0 N--CA 1.441 -1.574 0 N-CA-C 106.404 -2.191 . . . . 0.0 106.404 171.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.491 HG21 HD13 ' A' ' 39' ' ' LEU . 4.9 m -100.27 137.16 19.95 Favored Pre-proline 0 N--CA 1.415 -2.216 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.814 -167.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.486 ' HB3' ' OD1' ' A' ' 72' ' ' ASN . 23.4 Cg_endo -60.11 124.59 15.56 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.041 2.494 . . . . 0.0 110.733 176.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -97.69 106.38 18.68 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.454 0.645 . . . . 0.0 110.843 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . . . -100.14 144.49 29.1 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.862 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 t -146.35 149.03 33.0 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.951 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.493 ' H ' HG11 ' A' ' 159' ' ' VAL . 90.0 t -82.52 141.22 15.28 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 175.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -133.08 -41.19 0.91 Allowed 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -170.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -160.42 163.33 33.17 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.38 -171.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.578 HG13 ' CD2' ' A' ' 64' ' ' TYR . 97.7 t -132.01 106.66 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 123.489 0.716 . . . . 0.0 110.72 -177.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.478 ' HB2' ' CD2' ' A' ' 65' ' ' HIS . 34.9 m-20 -100.83 107.51 19.08 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.44 ' HA ' ' CB ' ' A' ' 64' ' ' TYR . 49.6 p90 -63.48 138.94 58.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.581 ' HG2' ' HA ' ' A' ' 64' ' ' TYR . 14.5 mmmm -89.7 -72.91 0.54 Allowed 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -176.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.71 -88.06 0.06 OUTLIER Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 117.724 -2.179 . . . . 0.0 115.17 -175.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.72 138.71 25.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.67 0.747 . . . . 0.0 112.522 -173.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.693 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 39.8 m -152.75 157.36 40.73 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 105.021 -2.214 . . . . 0.0 105.021 173.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -102.31 -25.02 13.82 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.7 0.762 . . . . 0.0 109.884 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.467 ' H ' HG22 ' A' ' 58' ' ' THR . 32.6 t70 -99.66 23.0 10.11 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.217 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.693 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . 146.09 -162.9 28.39 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 -177.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.41 ' CG2' ' HB3' ' A' ' 173' ' ' PHE . 48.4 t -135.26 116.05 19.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 173.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -68.2 137.02 54.49 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.12 0.486 . . . . 0.0 110.98 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.714 ' CD1' HG13 ' A' ' 119' ' ' VAL . 23.9 p90 -143.02 173.02 11.92 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.478 ' CD2' ' HB2' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -124.57 122.06 36.5 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.823 -1.151 . . . . 0.0 108.815 173.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -78.83 131.02 36.32 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.74 -175.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -89.27 111.65 22.52 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.5 p -127.94 108.72 18.42 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-O 122.146 0.974 . . . . 0.0 108.458 175.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.435 ' HB3' HG22 ' A' ' 112' ' ' VAL . 28.8 p -101.16 133.94 44.94 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.658 -175.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 47' ' ' ALA . 25.2 t -109.72 130.55 62.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.749 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -111.47 111.7 22.91 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 175.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.486 ' OD1' ' HB3' ' A' ' 45' ' ' PRO . 7.1 t30 -132.74 124.89 19.08 Favored Pre-proline 0 C--N 1.307 -1.249 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.656 -172.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 72' ' ' ASN . 57.3 Cg_endo -97.56 97.73 0.07 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.779 0 C-N-CA 122.078 1.852 . . . . 0.0 112.947 175.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.547 ' O ' ' HB2' ' A' ' 108' ' ' SER . 52.9 m-85 -157.84 -165.13 1.67 Allowed 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 126.425 1.89 . . . . 0.0 106.39 175.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.7 m -131.77 13.86 4.86 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-O 121.877 0.846 . . . . 0.0 109.425 175.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.453 ' O ' ' HA2' ' A' ' 107' ' ' GLY . 10.3 pt20 -118.55 134.96 54.69 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.258 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 105' ' ' LEU . 23.8 m -73.81 97.12 2.68 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.56 174.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.498 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 54.3 mt -85.19 120.95 73.91 Favored Pre-proline 0 C--O 1.244 0.813 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -84.1 158.46 13.37 Favored 'Trans proline' 0 N--CA 1.436 -1.893 0 C-N-CA 121.796 1.664 . . . . 0.0 110.022 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 29.7 pt -102.55 144.43 13.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.179 178.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 48.8 t -62.4 -55.58 26.46 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -177.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -154.31 145.74 23.08 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 171.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.437 ' CG2' ' HG3' ' A' ' 102' ' ' PRO . 14.2 tt -97.36 117.41 41.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.0 t -100.63 118.33 36.56 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -108.08 134.86 50.36 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.554 HG23 HD11 ' A' ' 94' ' ' ILE . 2.7 mp -117.45 107.31 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.028 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 178.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.462 ' CD2' ' HE2' ' A' ' 139' ' ' TYR . 2.0 tm? -101.92 121.34 41.94 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.428 -170.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.57 ' HB2' ' HB2' ' A' ' 140' ' ' GLN . 0.6 OUTLIER -102.41 150.08 23.72 Favored 'General case' 0 CA--C 1.487 -1.458 0 O-C-N 122.007 -0.433 . . . . 0.0 110.427 179.209 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.449 ' OG ' ' HB3' ' A' ' 122' ' ' SER . 68.6 m -132.87 94.42 3.38 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 177.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 53.03 -77.43 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 170.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.2 m -70.23 -72.93 0.18 Allowed 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -171.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.4 ' H ' ' H ' ' A' ' 93' ' ' THR . 99.5 mtt180 -153.63 -16.27 0.14 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.91 0.484 . . . . 0.0 109.858 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.454 HG22 ' OG ' ' A' ' 122' ' ' SER . 2.7 m -69.9 151.7 45.36 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.642 -171.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.554 HD11 HG23 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -145.11 149.42 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -174.158 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.467 ' N ' HD13 ' A' ' 94' ' ' ILE . . . -129.04 151.46 49.71 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 124.902 1.281 . . . . 0.0 108.07 175.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 35.0 p -136.67 166.48 23.46 Favored 'General case' 0 C--N 1.29 -2.006 0 O-C-N 122.232 -0.293 . . . . 0.0 111.107 -175.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 174.08 136.25 2.19 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.43 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.0 p -113.15 112.69 24.23 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.507 HD12 HG23 ' A' ' 115' ' ' VAL . 63.0 mt -99.27 109.75 55.71 Favored Pre-proline 0 C--N 1.32 -0.699 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.057 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.29 116.72 4.81 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 123.221 2.614 . . . . 0.0 111.613 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.7 t70 51.05 87.36 0.13 Allowed Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 124.929 1.291 . . . . 0.0 112.505 -177.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.437 ' HG3' ' CG2' ' A' ' 83' ' ' ILE . 11.8 Cg_endo -99.54 9.2 0.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.922 2.414 . . . . 0.0 110.766 175.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 147.32 -163.09 28.71 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -177.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.5 m -151.27 160.63 43.7 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 78' ' ' ILE . 3.8 pp -83.96 147.38 27.5 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 36.0 m -57.39 -45.52 85.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -175.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 76' ' ' GLN . . . 140.52 -55.37 0.63 Allowed Glycine 0 N--CA 1.418 -2.548 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -176.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.547 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 37.1 t -136.75 118.49 15.05 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 112.9 -162.6 12.31 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.933 174.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.5 t -89.26 138.83 31.09 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-O 121.729 0.776 . . . . 0.0 109.662 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.1 t -138.87 117.93 12.55 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.435 HG22 ' HB3' ' A' ' 69' ' ' SER . 47.8 t -87.25 115.83 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.188 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.516 -178.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.4 mt -100.87 149.9 23.39 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.45 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 7.7 p-10 -140.83 116.34 10.14 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.033 0.921 . . . . 0.0 112.467 -177.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.507 HG23 HD12 ' A' ' 99' ' ' ILE . 4.2 p -95.32 130.55 31.98 Favored Pre-proline 0 C--N 1.307 -1.24 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.479 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -72.41 112.58 3.49 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 121.833 1.689 . . . . 0.0 109.735 173.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.628 ' HB ' ' CE1' ' A' ' 64' ' ' TYR . 2.3 t -130.81 153.92 39.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 -175.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -116.46 133.33 56.14 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.714 HG13 ' CD1' ' A' ' 64' ' ' TYR . 15.7 m -92.86 148.81 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.764 0 C-N-CA 123.993 0.917 . . . . 0.0 108.84 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.581 ' HB2' ' CD2' ' A' ' 174' ' ' PHE . . . 76.27 -10.08 1.36 Allowed 'General case' 0 N--CA 1.481 1.121 0 O-C-N 124.136 0.898 . . . . 0.0 110.639 -177.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.421 ' H ' ' C ' ' A' ' 119' ' ' VAL . 69.0 t80 -56.2 -52.31 64.86 Favored 'General case' 0 CA--C 1.484 -1.561 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.823 -178.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.454 ' OG ' HG22 ' A' ' 93' ' ' THR . 35.4 t -72.42 -43.2 64.19 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.475 -174.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 12.9 tt -71.77 -49.51 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 C-N-CA 119.192 -1.003 . . . . 0.0 112.891 -176.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -60.82 -32.51 71.89 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -176.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.0 p -71.92 -30.41 36.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.532 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.4 t -106.95 -43.87 4.55 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 119.358 -0.937 . . . . 0.0 112.24 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.9 tp -123.96 -52.95 1.76 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -175.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.413 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 25.1 ttt 76.03 138.08 0.06 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.103 1.361 . . . . 0.0 111.093 -176.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 130' ' ' ASP . 59.5 tptt -61.45 -73.08 0.1 Allowed 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 129' ' ' LYS . 22.4 t70 169.98 -13.26 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 O-C-N 124.218 0.949 . . . . 0.0 109.808 178.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.586 ' HA ' ' CE ' ' A' ' 131' ' ' MET . 0.0 OUTLIER 66.3 88.82 0.1 Allowed 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.99 0.9 . . . . 0.0 112.705 -169.435 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 47.2 t -105.86 155.69 19.08 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.5 -1.227 . . . . 0.0 107.718 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 20.9 p -96.57 100.57 12.14 Favored 'General case' 0 N--CA 1.402 -2.866 0 CA-C-O 121.089 0.471 . . . . 0.0 110.611 177.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.488 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 31.4 t70 74.95 99.96 0.07 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.18 0.992 . . . . 0.0 111.383 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -159.48 158.93 32.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.669 -1.151 . . . . 0.0 108.076 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -107.38 147.17 30.7 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.305 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 29.6 mm -128.68 130.59 68.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.923 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -102.04 101.53 11.91 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 172.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.481 ' HD1' ' O ' ' A' ' 163' ' ' GLY . 0.6 OUTLIER -104.66 170.4 7.9 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 179.723 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 88' ' ' LYS . 2.3 mp0 -120.42 147.23 45.36 Favored 'General case' 0 C--N 1.273 -2.726 0 C-N-CA 118.466 -1.294 . . . . 0.0 111.899 -177.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.4 tp -130.47 117.51 19.75 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-O 121.892 0.853 . . . . 0.0 110.368 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.54 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 3.9 m-20 -122.55 123.56 41.51 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 45.7 mt -122.14 131.1 73.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 119.004 -1.078 . . . . 0.0 111.028 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -106.18 86.95 0.5 Allowed Glycine 1 N--CA 1.394 -4.115 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 174.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.613 HD13 ' H ' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -85.81 141.4 29.67 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 176.292 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.1 t -128.63 122.01 29.92 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.409 -0.916 . . . . 0.0 111.457 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.464 ' CE2' HD23 ' A' ' 145' ' ' LEU . 77.7 m-85 -103.75 138.74 39.95 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -92.44 108.5 20.01 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 172.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.525 HG22 ' H ' ' A' ' 151' ' ' VAL . 51.2 mm -100.83 125.26 39.17 Favored Pre-proline 0 C--N 1.282 -2.359 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -178.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.11 -3.98 6.94 Favored 'Trans proline' 0 N--CA 1.481 0.788 0 C-N-CA 123.396 2.73 . . . . 0.0 113.46 -176.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.525 ' H ' HG22 ' A' ' 149' ' ' ILE . 59.9 t -76.0 -51.28 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.2 p -176.12 83.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 177.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 103.4 155.22 24.44 Favored Glycine 0 N--CA 1.413 -2.859 0 C-N-CA 120.589 -0.815 . . . . 0.0 114.27 165.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -97.52 114.19 26.03 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 170.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.648 HD13 ' H ' ' A' ' 155' ' ' ILE . 0.2 OUTLIER -121.44 150.84 24.61 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.888 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.672 -179.48 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 10.5 t -97.5 151.19 20.26 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 176.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 59.9 mt -113.97 110.73 48.57 Favored Pre-proline 0 N--CA 1.434 -1.226 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 176.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.487 ' HG2' ' CG ' ' A' ' 32' ' ' LYS . 26.3 Cg_exo -68.46 105.33 1.24 Allowed 'Trans proline' 0 C--O 1.241 0.671 0 C-N-CA 123.064 2.509 . . . . 0.0 112.836 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.493 HG11 ' H ' ' A' ' 49' ' ' VAL . 21.8 t -105.3 116.01 48.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 175.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 47.7 p -127.82 118.99 24.72 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -174.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.6 t -156.9 172.2 19.07 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -100.33 151.72 21.17 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.446 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.481 ' O ' ' HD1' ' A' ' 139' ' ' TYR . . . -111.74 101.83 1.33 Allowed Glycine 0 N--CA 1.406 -3.362 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 175.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.426 ' H ' ' HG2' ' A' ' 164' ' ' GLU . 7.8 pt-20 -95.28 120.51 35.63 Favored 'General case' 0 C--N 1.266 -3.031 0 CA-C-O 121.888 0.851 . . . . 0.0 109.755 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 6.6 pt -130.49 133.56 63.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.869 -172.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -99.6 128.63 45.71 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 134' ' ' ASP . 91.4 mt -114.19 117.76 43.02 Favored Pre-proline 0 C--N 1.297 -1.694 0 C-N-CA 120.454 -0.499 . . . . 0.0 111.191 -174.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -84.96 108.98 1.22 Allowed 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 122.567 2.178 . . . . 0.0 111.802 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 133' ' ' THR 0.27 79.2 p 52.31 -81.38 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 179.142 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 85.4 mt 69.51 -62.05 0.42 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.728 1.211 . . . . 0.0 111.686 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 76.8 mtm180 65.28 -3.15 0.67 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 173.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -142.94 1.33 1.27 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.35 0.595 . . . . 0.0 110.07 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.41 ' HB3' ' CG2' ' A' ' 62' ' ' VAL . 10.7 m-85 -114.21 -13.14 12.39 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 115.929 1.825 . . . . 0.0 115.929 -165.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.581 ' CD2' ' HB2' ' A' ' 120' ' ' ALA . 4.1 t80 . . . . . 0 C--O 1.268 2.048 0 C-N-CA 118.178 -1.409 . . . . 0.0 111.123 -173.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 5' ' ' HIS . . . . . . . . 0 CA--C 1.503 -0.682 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 64.97 -82.15 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.937 0.895 . . . . 0.0 112.694 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -106.76 -24.7 12.01 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -147.12 147.26 30.39 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.455 ' O ' ' HA2' ' A' ' 1' ' ' GLY . 67.5 m-70 78.7 87.79 0.06 Allowed 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 124.381 1.072 . . . . 0.0 110.67 -173.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 46.1 m-70 71.1 -26.87 0.17 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.179 1.392 . . . . 0.0 114.332 175.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.3 t60 68.66 -73.87 0.08 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.664 1.186 . . . . 0.0 111.534 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 pp -88.32 -19.13 27.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -174.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 6' ' ' HIS . 43.9 mt-10 -80.58 66.92 6.27 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.665 0.745 . . . . 0.0 111.162 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -171.9 17.63 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 125.692 1.597 . . . . 0.0 107.181 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.9 m 58.07 71.19 0.59 Allowed 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.658 -174.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.672 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -73.25 -42.99 61.9 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.007 -178.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -57.77 -35.8 71.25 Favored 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 123.626 0.579 . . . . 0.0 111.072 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -59.34 -48.8 80.26 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -60.77 -40.17 91.56 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.598 176.696 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 12' ' ' ALA . 40.7 t -64.65 -40.87 90.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.665 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.517 HG11 ' O ' ' A' ' 94' ' ' ILE . 54.6 t -59.13 -33.26 49.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.102 0.477 . . . . 0.0 110.004 175.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.06 -45.78 55.45 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 26.5 mm-40 -57.51 -52.47 65.26 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.733 176.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.557 ' HE2' HG12 ' A' ' 16' ' ' VAL . 68.1 mttm -58.12 -48.91 78.77 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.819 -178.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.11 -45.13 83.68 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 123.463 0.477 . . . . 0.0 111.395 -176.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 62.9 m -62.33 -49.51 75.32 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.015 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.8 t -61.57 -38.07 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.204 0.526 . . . . 0.0 110.296 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.506 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 86.0 mt -69.95 -46.86 72.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.172 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.1 t -59.68 -36.61 76.82 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.699 0.4 . . . . 0.0 110.676 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.1 t -62.84 -38.24 89.98 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.684 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.556 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 5.1 tt -76.72 -42.1 42.62 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 87.7 mt -57.05 -36.55 70.64 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.288 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -56.77 -41.44 77.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.814 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -83.29 -33.33 25.98 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.624 -178.227 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.21 -50.7 11.42 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -175.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -60.26 -47.04 87.67 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 122.514 0.326 . . . . 0.0 111.077 -175.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.641 ' O ' ' HG2' ' A' ' 37' ' ' GLU . . . -59.63 -56.01 27.31 Favored Glycine 0 N--CA 1.444 -0.813 0 O-C-N 123.683 0.614 . . . . 0.0 111.996 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -58.4 -39.76 80.55 Favored 'General case' 0 C--O 1.255 1.348 0 C-N-CA 123.268 0.627 . . . . 0.0 110.923 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.538 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 89.1 t80 -67.76 -53.34 27.98 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.4 178.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.15 -29.69 68.82 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -174.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.641 ' HG2' ' O ' ' A' ' 33' ' ' GLY . 10.7 pt-20 -90.37 -42.39 10.96 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -177.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HD3' ' HG3' ' A' ' 37' ' ' GLU . 3.7 mppt? -107.4 -48.3 3.47 Favored 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 118.812 -1.155 . . . . 0.0 112.534 177.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.538 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 2.9 mm? -75.71 -12.67 60.24 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -169.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.56 -23.14 64.46 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 120.971 0.415 . . . . 0.0 110.095 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -115.22 17.48 16.62 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.222 0.534 . . . . 0.0 110.19 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.415 ' HB ' ' HA ' ' A' ' 39' ' ' LEU . 72.7 mt -127.98 134.6 26.4 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -40.82 103.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.317 0 C-N-CA 123.903 3.068 . . . . 0.0 114.591 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.0 p -146.5 155.08 49.43 Favored Pre-proline 0 C--N 1.31 -1.151 0 C-N-CA 124.802 1.241 . . . . 0.0 108.409 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.9 124.89 14.3 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.125 1.884 . . . . 0.0 111.468 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -97.03 111.55 23.72 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -178.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.37 143.18 33.9 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.86 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.594 ' HA ' HG21 ' A' ' 159' ' ' VAL . 10.4 t -143.18 140.59 30.83 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.553 HG23 HG22 ' A' ' 159' ' ' VAL . 45.3 t -83.63 141.26 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.829 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -108.23 -62.11 1.5 Allowed 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.844 -1.142 . . . . 0.0 114.023 -168.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.547 ' HB3' ' HD2' ' A' ' 67' ' ' LYS . 24.5 t70 -166.79 166.16 15.87 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.562 -169.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.649 HG13 ' CD2' ' A' ' 64' ' ' TYR . 97.4 t -118.55 119.54 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 124.248 1.019 . . . . 0.0 111.462 -176.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -121.95 106.4 11.2 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -82.06 134.02 35.32 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -176.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.08 78.84 1.72 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -175.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 122.64 -149.62 16.92 Favored Glycine 0 C--N 1.268 -3.212 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.217 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.4 p -143.54 154.88 16.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.0 m -135.35 164.1 28.51 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -58.31 -41.41 84.42 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.08 0.466 . . . . 0.0 110.6 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -133.23 105.0 6.75 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.76 -161.1 21.87 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.284 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 69.9 t -150.78 121.91 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -177.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.434 ' N ' ' HG3' ' A' ' 118' ' ' LYS . 20.3 t70 -68.4 129.65 40.55 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.649 ' CD2' HG13 ' A' ' 52' ' ' VAL . 43.7 p90 -131.65 169.64 15.87 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -90.69 109.5 20.67 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 174.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.456 ' HB3' HG13 ' A' ' 115' ' ' VAL . . . -82.81 112.23 19.44 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 175.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.547 ' HD2' ' HB3' ' A' ' 51' ' ' ASP . 93.7 mttt -86.74 120.58 28.18 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.172 -176.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.0 t -127.04 109.1 19.89 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.673 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.6 p -99.55 123.66 44.03 Favored 'General case' 0 C--N 1.283 -2.314 0 C-N-CA 120.394 -0.523 . . . . 0.0 111.017 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.2 t -117.88 125.43 74.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.826 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.421 ' HG2' ' OG1' ' A' ' 110' ' ' THR . 51.7 mtpt -95.07 110.25 22.2 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.639 HD22 HD12 ' A' ' 105' ' ' LEU . 47.4 t-20 -108.39 113.79 59.92 Favored Pre-proline 0 C--N 1.302 -1.48 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.241 -176.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -111.55 97.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.152 0 C-N-CA 123.017 2.478 . . . . 0.0 110.408 166.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -168.94 -19.96 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.7 t 70.99 24.57 3.95 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.333 1.053 . . . . 0.0 109.651 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.565 ' HG3' HG12 ' A' ' 78' ' ' ILE . 9.5 tp60 -121.68 110.67 16.25 Favored 'General case' 0 N--CA 1.396 -3.173 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.987 -178.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.3 m -75.09 87.4 2.39 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.565 HG12 ' HG3' ' A' ' 76' ' ' GLN . 82.3 mt -72.77 122.02 86.51 Favored Pre-proline 0 C--N 1.294 -1.839 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.775 -170.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -70.86 109.95 2.65 Favored 'Trans proline' 0 N--CA 1.431 -2.187 0 N-CA-C 106.721 -2.069 . . . . 0.0 106.721 168.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.3 mt -62.95 119.49 7.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -173.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 41.8 t -56.64 -53.21 60.35 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -167.94 147.76 4.89 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.428 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 12.4 tt -110.85 113.93 45.65 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 175.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 98' ' ' THR . 26.5 t -92.65 148.17 22.28 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -140.57 139.42 34.97 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 176.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.582 HG23 ' HB2' ' A' ' 142' ' ' ASP . 11.8 tt -143.56 110.55 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 174.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.432 ' O ' HD12 ' A' ' 87' ' ' LEU . 3.4 pp -110.9 141.04 44.85 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.586 -178.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.45 ' HA ' HG22 ' A' ' 94' ' ' ILE . 97.3 mttt -103.62 153.08 21.01 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.837 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 55.8 m -135.29 132.18 37.43 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.682 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.78 86.87 2.79 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 121.951 0.881 . . . . 0.0 112.018 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.8 m -161.58 -53.61 0.05 OUTLIER 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 163.86 -52.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 125.268 1.605 . . . . 0.0 110.479 177.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.2 m -70.81 142.11 51.32 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.948 -177.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.517 ' O ' HG11 ' A' ' 17' ' ' VAL . 2.5 pp -125.04 177.25 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.036 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 86' ' ' ILE . . . -131.95 134.03 45.18 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 118.296 0.498 . . . . 0.0 109.778 177.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.4 p -135.09 158.47 44.28 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 176.22 168.42 36.38 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.574 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 40.5 p -135.02 116.58 14.79 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 122.717 0.407 . . . . 0.0 109.959 178.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 60.6 mt -98.57 108.78 50.0 Favored Pre-proline 0 C--N 1.323 -0.572 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.166 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.65 121.99 7.48 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.607 2.204 . . . . 0.0 111.692 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.4 t70 56.12 83.4 0.22 Allowed Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 124.008 0.923 . . . . 0.0 112.249 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -101.48 8.28 0.53 Allowed 'Trans proline' 0 CA--C 1.548 1.212 0 C-N-CA 123.073 2.515 . . . . 0.0 113.075 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 165.14 -124.33 1.24 Allowed Glycine 0 N--CA 1.441 -1.033 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.7 m -151.84 146.67 25.85 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 176.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.639 HD12 HD22 ' A' ' 72' ' ' ASN . 1.0 OUTLIER -104.44 98.13 7.95 Favored 'General case' 0 N--CA 1.423 -1.791 0 C-N-CA 117.859 -1.536 . . . . 0.0 109.119 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.517 ' HB ' ' HB ' ' A' ' 111' ' ' THR 0.255 14.8 p 10.55 -72.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 128.811 2.844 . . . . 0.0 117.501 178.308 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.463 ' H ' HG13 ' A' ' 106' ' ' VAL . . . 125.37 -51.12 0.84 Allowed Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -174.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.5 p -154.09 94.89 1.78 Allowed 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.334 0.587 . . . . 0.0 111.862 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 143.98 -175.17 24.0 Favored Glycine 0 CA--C 1.497 -1.081 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.883 176.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.421 ' OG1' ' HG2' ' A' ' 71' ' ' LYS . 56.3 m -95.35 116.93 29.45 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.517 ' HB ' ' HB ' ' A' ' 106' ' ' VAL . 9.6 t -113.78 137.12 52.08 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 25.5 t -99.4 115.08 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 74.3 mt -89.82 148.27 23.3 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.395 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -114.23 121.0 42.38 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.769 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 66' ' ' ALA . 10.3 p -128.18 125.55 23.42 Favored Pre-proline 0 C--N 1.302 -1.462 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.34 177.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.29 111.72 3.24 Favored 'Trans proline' 0 C--O 1.246 0.909 0 C-N-CA 123.117 2.545 . . . . 0.0 112.589 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.438 HG23 ' CE1' ' A' ' 64' ' ' TYR . 26.3 m -143.36 151.44 16.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.434 ' HG3' ' N ' ' A' ' 63' ' ' ASP . 3.3 mppt? -95.9 135.72 37.27 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.623 ' HB ' ' CE1' ' A' ' 64' ' ' TYR . 13.2 p -94.9 145.78 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 66.44 13.33 9.2 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 123.548 0.739 . . . . 0.0 110.332 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.505 ' O ' HG23 ' A' ' 125' ' ' VAL . 84.4 t80 -56.77 -50.38 72.48 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 124.786 1.235 . . . . 0.0 108.961 176.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.8 m -62.1 -40.74 96.89 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.856 -176.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.436 HD13 ' HG3' ' A' ' 129' ' ' LYS . 14.0 tt -79.06 -34.01 16.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.352 -177.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -60.85 -35.95 77.89 Favored 'General case' 0 C--N 1.358 0.937 0 CA-C-O 120.893 0.377 . . . . 0.0 110.031 174.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 121' ' ' TYR . 43.2 t -56.54 -37.79 53.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.42 175.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.2 m -95.52 -77.24 0.48 Allowed 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.582 HD12 ' H ' ' A' ' 129' ' ' LYS . 3.9 pp -119.03 -12.11 9.56 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -172.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.508 ' O ' ' HG2' ' A' ' 128' ' ' MET . 25.0 ttt 60.93 41.17 14.59 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.931 0.892 . . . . 0.0 113.399 173.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.582 ' H ' HD12 ' A' ' 127' ' ' LEU . 15.0 mtmt 60.1 -83.12 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.128 0.571 . . . . 0.0 111.28 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 164.21 -23.13 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 126.806 2.043 . . . . 0.0 106.469 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.535 ' SD ' ' HB3' ' A' ' 174' ' ' PHE . 0.3 OUTLIER 59.16 100.38 0.02 OUTLIER 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.253 -176.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 49.0 t -132.17 170.09 15.49 Favored 'General case' 0 CA--C 1.556 1.209 0 O-C-N 121.609 -0.682 . . . . 0.0 112.503 -175.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.462 HG22 ' HB3' ' A' ' 169' ' ' SER . 21.6 p -67.79 133.0 48.47 Favored 'General case' 0 N--CA 1.42 -1.949 0 C-N-CA 125.125 1.37 . . . . 0.0 109.886 170.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.6 t70 42.17 72.37 0.17 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.457 1.103 . . . . 0.0 110.206 -171.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.453 ' CZ2' ' HB3' ' A' ' 129' ' ' LYS . 33.1 t-105 -101.29 115.23 30.02 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.816 -173.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -107.39 126.26 52.25 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.114 -174.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.455 HD11 HD13 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -139.86 168.21 18.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-O 121.545 0.688 . . . . 0.0 112.083 -179.673 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -142.0 133.07 26.08 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.382 177.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.34 172.76 11.8 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 178.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -129.69 124.18 32.96 Favored 'General case' 0 C--N 1.287 -2.112 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.143 -175.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.2 tp -107.06 129.73 54.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.295 -174.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.582 ' HB2' HG23 ' A' ' 86' ' ' ILE . 10.7 m-20 -122.79 137.41 54.93 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 158' ' ' PRO . 42.1 mm -124.09 145.96 30.36 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -122.39 97.67 0.6 Allowed Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 177.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.508 ' HB3' ' CE2' ' A' ' 147' ' ' PHE . 2.9 mm? -81.68 110.26 16.86 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 -178.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 28.7 m -96.35 108.17 20.64 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.613 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.515 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 53.6 m-85 -120.7 144.79 48.03 Favored 'General case' 0 CA--C 1.494 -1.208 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 154' ' ' ASP . 6.4 p-10 -116.37 116.09 27.08 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.499 -0.88 . . . . 0.0 109.327 176.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.651 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -106.02 130.43 23.0 Favored Pre-proline 0 C--N 1.298 -1.645 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.618 -177.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -42.75 -32.89 2.69 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 125.03 3.82 . . . . 0.0 115.572 -176.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.4 m -60.21 -34.37 56.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 60.0 t -135.78 -68.06 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.026 0.441 . . . . 0.0 109.976 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 163.06 -146.14 11.38 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.15 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 148' ' ' ASP . 6.3 p-10 -83.7 120.26 25.79 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.554 0.692 . . . . 0.0 112.571 -176.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.497 HD12 ' O ' ' A' ' 155' ' ' ILE . 2.5 pp -127.12 124.05 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.817 173.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.493 ' O ' ' HD3' ' A' ' 158' ' ' PRO . 56.9 m -88.12 117.38 26.96 Favored 'General case' 0 N--CA 1.424 -1.775 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.823 176.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 60.5 mt -95.81 104.77 17.57 Favored Pre-proline 0 C--N 1.303 -1.42 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.875 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.0 OUTLIER -85.39 138.85 6.62 Favored 'Trans proline' 0 CA--C 1.485 -1.971 0 C-N-CA 122.66 2.24 . . . . 0.0 111.762 176.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.594 HG21 ' HA ' ' A' ' 48' ' ' THR . 2.6 p -138.05 132.9 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.556 0 CA-C-N 112.953 -1.93 . . . . 0.0 109.661 -173.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.482 ' HB3' ' OD1' ' A' ' 142' ' ' ASP . 58.1 p -120.59 161.93 20.5 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.491 -176.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.3 t -166.09 165.41 17.8 Favored 'General case' 0 C--O 1.252 1.216 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -98.48 126.71 44.13 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -108.69 82.64 0.31 Allowed Glycine 0 N--CA 1.419 -2.476 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.43 120.37 30.7 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.447 ' CD1' HG21 ' A' ' 119' ' ' VAL . 5.7 pt -145.14 121.22 3.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.119 -170.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -104.18 139.75 38.78 Favored 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 117.887 -1.525 . . . . 0.0 109.511 174.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.574 HD22 ' CG ' ' A' ' 174' ' ' PHE . 6.8 mp -108.8 103.39 51.6 Favored Pre-proline 0 N--CA 1.405 -2.678 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.631 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.26 92.76 0.82 Allowed 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 123.165 2.576 . . . . 0.0 114.893 -172.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.462 ' HB3' HG22 ' A' ' 133' ' ' THR . 5.0 m 50.37 89.33 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 125.399 1.48 . . . . 0.0 114.086 171.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.49 ' HB2' ' SD ' ' A' ' 131' ' ' MET . 99.1 mt -108.69 -39.83 5.25 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.048 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.509 ' HA ' ' HG3' ' A' ' 131' ' ' MET . 36.4 mmt180 54.88 18.82 2.35 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 177.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -178.7 -29.73 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -176.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -99.95 21.1 13.17 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -172.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.574 ' CG ' HD22 ' A' ' 167' ' ' LEU . 40.6 t80 . . . . . 0 CA--C 1.501 -0.917 0 C-N-CA 119.062 -1.055 . . . . 0.0 113.383 -177.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.889 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -123.5 87.1 2.68 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -156.33 112.81 3.08 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -86.76 144.2 27.18 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 177.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.9 t60 -67.52 151.09 47.96 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -60.03 110.66 1.25 Allowed 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -107.28 -9.68 16.01 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.59 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 tt 73.41 -48.39 0.68 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.716 1.206 . . . . 0.0 109.91 -177.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -75.67 -54.18 7.38 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 174.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 56.45 71.65 0.55 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.769 1.227 . . . . 0.0 113.395 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.4 m 53.31 88.62 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.856 1.262 . . . . 0.0 113.034 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.435 ' O ' HG22 ' A' ' 16' ' ' VAL . . . -56.62 -44.67 81.41 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.546 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 17' ' ' VAL . 1.9 p30 -56.57 -56.26 23.51 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 124.052 0.845 . . . . 0.0 112.172 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.16 -42.42 99.41 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 123.504 0.722 . . . . 0.0 110.821 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -65.71 -46.25 79.68 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 12' ' ' ALA . 29.9 m -71.79 -23.07 21.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.299 -176.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 13' ' ' ASP . 77.4 t -61.72 -47.22 94.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 172.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -59.53 -37.19 77.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.762 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -60.51 -56.78 17.29 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.36 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -65.97 -39.2 90.16 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.893 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.57 -37.31 80.88 Favored 'General case' 0 C--O 1.221 -0.439 0 O-C-N 123.286 0.366 . . . . 0.0 110.805 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.0 t -63.39 -50.34 70.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.865 0.364 . . . . 0.0 110.451 178.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.05 -45.11 99.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.391 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.491 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 83.7 mt -66.18 -43.23 92.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.171 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.2 t -62.02 -35.57 78.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.796 0.332 . . . . 0.0 110.463 177.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.8 t -63.45 -41.28 98.64 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.97 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.559 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 3.9 tt -71.09 -41.68 70.3 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 24' ' ' ILE . 96.3 mt -59.24 -39.68 83.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.092 0.473 . . . . 0.0 110.366 177.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -62.54 -41.9 99.18 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.559 ' HG2' ' O ' ' A' ' 27' ' ' LEU . 61.4 pttt -63.52 -34.38 77.66 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 119.921 -0.711 . . . . 0.0 109.523 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.66 -31.66 52.75 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.692 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.554 ' HA ' ' CE2' ' A' ' 35' ' ' PHE . 39.7 ttmt -51.12 -40.08 57.68 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.059 0.944 . . . . 0.0 112.884 -175.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.46 -8.86 54.32 Favored Glycine 0 C--N 1.313 -0.698 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.614 178.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 19.3 t80 -81.45 -25.9 35.72 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 124.435 1.094 . . . . 0.0 108.418 -175.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.554 ' CE2' ' HA ' ' A' ' 32' ' ' LYS . 22.5 m-85 -56.96 -36.57 70.44 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.627 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.64 -50.05 55.34 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.766 0.666 . . . . 0.0 112.396 -173.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -98.88 -43.71 6.63 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.277 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.486 ' N ' ' HD3' ' A' ' 38' ' ' LYS 0.295 2.7 mppt? -75.19 -3.92 35.8 Favored 'General case' 0 C--O 1.206 -1.22 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 -171.042 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.3 mt -117.38 1.0 12.33 Favored 'General case' 0 C--N 1.284 -2.251 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.808 173.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.44 -55.74 2.42 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.09 0.471 . . . . 0.0 110.521 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -86.14 -4.5 59.18 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.496 -177.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.7 mm -119.06 126.85 26.83 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.03 104.21 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.448 2.099 . . . . 0.0 110.415 176.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.441 HG22 ' CD1' ' A' ' 149' ' ' ILE . 5.8 p -128.26 154.37 78.93 Favored Pre-proline 0 C--N 1.302 -1.493 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.464 -174.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.467 ' HB3' ' HB2' ' A' ' 72' ' ' ASN . 65.6 Cg_endo -84.73 154.94 11.75 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.888 2.392 . . . . 0.0 112.02 178.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -121.04 136.93 54.87 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.39 167.6 13.1 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.98 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.4 t -155.49 145.21 21.31 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 123.506 0.503 . . . . 0.0 110.518 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.479 HG23 HG23 ' A' ' 159' ' ' VAL . 45.4 t -83.99 141.9 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 173.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' A' ' 67' ' ' LYS . 18.4 t70 -122.2 -54.18 1.91 Allowed 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -172.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -162.03 162.59 28.87 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -172.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.3 m -122.98 108.15 20.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 121.438 0.637 . . . . 0.0 110.024 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -90.9 121.08 32.44 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.601 -177.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 53.3 p90 -69.3 120.21 14.77 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.536 177.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -83.36 -49.4 9.39 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.423 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 178.95 -147.36 7.72 Favored Glycine 0 N--CA 1.41 -3.046 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 173' ' ' PHE . 7.5 p -111.67 138.42 40.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-O 121.02 0.438 . . . . 0.0 110.487 -174.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 24.5 m -127.15 145.13 50.86 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 175.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.429 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 17.8 tpt180 -104.61 78.36 1.45 Allowed 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 118.661 -1.216 . . . . 0.0 108.327 178.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -175.32 -70.33 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 -175.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.433 ' O ' ' HB ' ' A' ' 58' ' ' THR . . . -138.2 -138.53 3.72 Favored Glycine 0 N--CA 1.411 -3.024 0 N-CA-C 104.298 -3.521 . . . . 0.0 104.298 167.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.04 134.28 41.52 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-N 118.675 1.238 . . . . 0.0 110.288 174.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -93.43 107.27 19.14 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.063 -175.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.517 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 4.5 m-85 -100.45 161.09 13.83 Favored 'General case' 0 CA--C 1.486 -1.511 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.005 176.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.416 ' CD2' ' HB3' ' A' ' 114' ' ' ASP . 3.3 t-160 -114.75 107.73 15.83 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 178.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -92.86 140.78 29.15 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.0 0.428 . . . . 0.0 112.022 -176.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.413 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . 75.2 mmtt -89.64 121.33 31.72 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.77 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.88 111.28 29.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.5 m -98.85 139.25 34.81 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 120.319 -0.553 . . . . 0.0 109.94 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.2 t -131.45 131.61 62.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 63.5 pttt -114.59 132.32 56.38 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 175.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.848 ' O ' ' HA ' ' A' ' 108' ' ' SER . 5.8 t30 -142.73 114.75 6.07 Favored Pre-proline 0 C--N 1.294 -1.835 0 C-N-CA 119.743 -0.783 . . . . 0.0 112.949 -175.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -94.36 99.62 0.12 Allowed 'Trans proline' 0 N--CA 1.436 -1.865 0 C-N-CA 122.365 2.043 . . . . 0.0 109.487 170.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.539 ' HB3' HD21 ' A' ' 72' ' ' ASN . 48.8 t80 -170.32 -14.82 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -176.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.426 ' H ' ' H ' ' A' ' 74' ' ' TYR . 24.1 t 83.14 -56.24 0.16 Allowed 'General case' 0 C--O 1.233 0.232 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 172.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.604 HE21 HG12 ' A' ' 78' ' ' ILE . 6.6 pt20 -69.46 152.89 44.33 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-N 118.719 0.691 . . . . 0.0 112.744 -176.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.6 p -77.14 111.82 13.15 Favored 'General case' 0 N--CA 1.411 -2.375 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.279 174.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.604 HG12 HE21 ' A' ' 76' ' ' GLN . 70.0 mt -93.27 114.9 64.09 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -65.07 139.16 59.88 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.374 2.05 . . . . 0.0 110.241 175.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 54.5 mt -88.2 114.83 27.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 58.3 m -55.76 -56.14 24.05 Favored 'General case' 0 C--N 1.319 -0.742 0 O-C-N 123.811 0.695 . . . . 0.0 109.521 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -167.81 160.72 12.7 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.113 176.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.442 HG23 HG23 ' A' ' 143' ' ' ILE . 25.0 mt -120.14 113.75 41.6 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.959 176.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.422 ' HB3' HG22 ' A' ' 98' ' ' THR . 28.8 p -88.29 117.22 27.05 Favored 'General case' 0 N--CA 1.405 -2.72 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -111.45 143.05 42.92 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.501 HG23 ' HB3' ' A' ' 142' ' ' ASP . 9.9 tt -137.13 108.74 6.38 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 CA-C-O 121.727 0.775 . . . . 0.0 109.15 176.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.586 HD11 ' HB3' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -106.84 145.91 31.57 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.506 -179.443 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.469 ' HA ' HG22 ' A' ' 94' ' ' ILE . 40.1 ttmt -118.43 152.58 35.61 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.831 -175.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.7 t -126.96 97.86 5.12 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 175.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.445 ' HA ' ' OD2' ' A' ' 138' ' ' ASP . . . 53.51 -94.96 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.98 1.312 . . . . 0.0 111.357 -175.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 85.5 m -166.34 85.13 0.3 Allowed 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 124.669 1.187 . . . . 0.0 108.513 175.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -160.06 -62.9 0.07 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 49.6 m -136.73 151.94 49.79 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.469 HG22 ' HA ' ' A' ' 88' ' ' LYS . 37.2 pt -134.72 -176.34 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.393 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.586 ' HB3' HD11 ' A' ' 87' ' ' LEU . . . -145.54 146.2 31.32 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 172.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.0 t -148.38 144.52 27.55 Favored 'General case' 0 N--CA 1.412 -2.357 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -166.73 166.38 39.0 Favored Glycine 0 N--CA 1.426 -2.025 0 C-N-CA 120.648 -0.786 . . . . 0.0 111.296 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.422 HG22 ' HB3' ' A' ' 84' ' ' SER . 40.5 p -110.18 119.89 40.72 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.2 tt -103.3 104.55 41.65 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.912 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 98' ' ' THR . 11.5 Cg_exo -72.79 128.06 12.93 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.058 2.505 . . . . 0.0 111.97 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.3 t70 52.08 79.48 0.34 Allowed Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 124.633 1.173 . . . . 0.0 111.997 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -101.47 8.82 0.52 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.788 2.325 . . . . 0.0 111.487 176.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 149.58 -168.39 29.8 Favored Glycine 0 N--CA 1.422 -2.236 0 N-CA-C 108.221 -1.952 . . . . 0.0 108.221 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.5 m -145.51 149.89 35.46 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 118.3 1.05 . . . . 0.0 111.956 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.4 tt -80.74 118.38 22.23 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 177.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 29.2 m -66.11 -35.96 76.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -174.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 140.31 -137.45 8.35 Favored Glycine 0 N--CA 1.416 -2.676 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.848 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 65.4 m -77.68 101.44 6.62 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.474 0.655 . . . . 0.0 111.555 178.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 164.99 -172.29 40.62 Favored Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 177.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.4 t -114.43 114.34 25.71 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.776 0.798 . . . . 0.0 109.684 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.6 t -110.26 132.94 53.73 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.157 -177.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 20.5 m -99.63 106.54 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-O 121.791 0.805 . . . . 0.0 110.031 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 66.4 mt -95.46 164.58 12.75 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.84 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 4.9 m-20 -133.99 135.62 43.56 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.143 -178.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.65 132.23 24.1 Favored Pre-proline 0 C--N 1.305 -1.353 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -73.46 110.63 3.1 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 N-CA-C 107.122 -1.915 . . . . 0.0 107.122 168.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.7 t -113.28 140.17 34.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.627 -172.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.663 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -88.1 98.95 11.82 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.2 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.3 m -102.58 147.49 9.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 71.78 -22.88 0.19 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.887 0.875 . . . . 0.0 113.212 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -55.7 -36.5 67.23 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.002 0.521 . . . . 0.0 110.963 177.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.9 p -59.12 -46.3 88.67 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.647 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 14.2 tt -79.08 -32.56 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.282 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.561 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -57.38 -43.31 83.49 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.704 0.802 . . . . 0.0 112.643 -178.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.3 m -72.09 -22.33 21.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.3 m -93.51 -73.03 0.58 Allowed 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -177.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.461 ' H ' HD23 ' A' ' 127' ' ' LEU . 1.8 pt? -124.52 -12.96 7.17 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -176.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.561 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER 73.63 140.61 0.06 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.507 1.123 . . . . 0.0 109.826 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.522 ' HE3' ' HB2' ' A' ' 131' ' ' MET . 46.6 pttt -59.42 -19.88 50.67 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.138 0.575 . . . . 0.0 111.43 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 23.8 t70 82.23 -22.73 0.24 Allowed 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 125.226 1.41 . . . . 0.0 109.577 177.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.522 ' HB2' ' HE3' ' A' ' 129' ' ' LYS . 15.4 tpt 51.08 97.24 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 112.678 -2.055 . . . . 0.0 115.388 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 64.4 m -92.94 140.41 29.52 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 171.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.8 p -71.19 100.71 2.13 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-O 121.482 0.658 . . . . 0.0 110.606 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.546 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 14.0 t70 86.37 88.55 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.627 0 C-N-CA 126.852 2.061 . . . . 0.0 110.312 -174.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.422 ' HZ2' ' HB2' ' A' ' 129' ' ' LYS . 0.8 OUTLIER -158.5 158.88 34.9 Favored 'General case' 0 N--CA 1.412 -2.33 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 176.312 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -117.7 134.6 54.73 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.481 ' CG2' ' HB ' ' A' ' 165' ' ' ILE . 9.8 tt -97.4 133.22 39.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 C-N-CA 120.594 -0.442 . . . . 0.0 109.856 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.445 ' OD2' ' HA ' ' A' ' 90' ' ' ALA . 38.9 t70 -70.39 90.44 0.71 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.532 178.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -108.77 152.81 24.35 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.526 177.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.414 ' HB2' ' HB3' ' A' ' 88' ' ' LYS . 21.8 mp0 -137.86 146.64 43.65 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 41.2 tp -128.74 126.52 40.19 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 123.461 0.475 . . . . 0.0 110.391 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.501 ' HB3' HG23 ' A' ' 86' ' ' ILE . 14.1 t70 -127.32 125.82 41.48 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.442 HG23 HG23 ' A' ' 83' ' ' ILE . 42.6 mm -111.83 118.76 58.41 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 CA-C-O 120.953 0.406 . . . . 0.0 109.98 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -95.95 86.85 0.95 Allowed Glycine 0 N--CA 1.42 -2.422 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 173.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.712 HD13 ' H ' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -74.73 134.26 41.91 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.438 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.8 m -110.74 108.32 18.15 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.477 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.531 ' O ' ' HA ' ' A' ' 154' ' ' ASP . 80.0 m-85 -114.66 129.7 56.71 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 175.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -94.49 109.69 21.55 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.441 ' CD1' HG22 ' A' ' 44' ' ' THR . 64.6 mt -98.15 129.38 30.94 Favored Pre-proline 0 C--N 1.291 -1.974 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.7 -176.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -52.26 -34.84 61.44 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 123.854 3.036 . . . . 0.0 112.944 -178.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.43 -51.07 76.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.374 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 39.0 t -119.9 -69.28 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.418 -175.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 163.37 -141.14 6.93 Favored Glycine 0 N--CA 1.431 -1.644 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.531 ' HA ' ' O ' ' A' ' 147' ' ' PHE . 4.2 p30 -94.25 131.17 40.12 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 117.331 0.566 . . . . 0.0 111.914 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.27 115.7 33.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 176.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.599 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 24.8 p -86.16 115.92 24.03 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.098 175.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 54.4 mt -97.11 106.93 34.79 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -74.27 107.24 2.39 Favored 'Trans proline' 0 C--O 1.251 1.162 0 C-N-CA 121.929 1.753 . . . . 0.0 111.106 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.479 HG23 HG23 ' A' ' 49' ' ' VAL . 30.6 m -110.48 126.95 67.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.841 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.473 ' HB3' ' OD2' ' A' ' 142' ' ' ASP . 48.3 p -129.38 162.7 27.43 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.143 0.497 . . . . 0.0 112.209 -176.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.9 t -159.51 -177.83 6.69 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 177.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -97.81 119.19 35.97 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -103.56 97.27 1.43 Allowed Glycine 0 N--CA 1.415 -2.746 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -178.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -88.95 119.47 29.5 Favored 'General case' 0 C--N 1.265 -3.103 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 -176.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.481 ' HB ' ' CG2' ' A' ' 137' ' ' ILE . 38.4 mm -101.77 107.14 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.418 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 176.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -113.29 126.72 55.71 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.215 0.531 . . . . 0.0 110.161 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 134' ' ' ASP . 67.1 mt -121.93 95.09 47.89 Favored Pre-proline 0 C--N 1.289 -2.046 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.851 -172.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.4 92.14 0.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.882 2.388 . . . . 0.0 112.978 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.422 ' H ' ' N ' ' A' ' 134' ' ' ASP . 78.0 p 53.34 27.42 6.22 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.435 1.494 . . . . 0.0 113.267 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.528 HD21 ' CD1' ' A' ' 173' ' ' PHE . 22.7 tp -75.45 83.39 2.53 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -83.13 105.39 14.07 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.639 -173.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.1 t70 75.0 91.84 0.08 Allowed 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 124.694 1.198 . . . . 0.0 110.023 177.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.528 ' CD1' HD21 ' A' ' 170' ' ' LEU . 37.4 t80 -173.02 -43.26 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 -175.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.428 ' HA ' ' NZ ' ' A' ' 129' ' ' LYS 0.301 58.9 m-85 . . . . . 0 CA--C 1.492 -1.277 0 CA-C-N 113.033 -1.894 . . . . 0.0 112.787 173.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.188 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -110.66 134.22 52.63 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.8 t60 72.71 -37.68 0.4 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.306 1.042 . . . . 0.0 111.986 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -156.11 155.04 31.87 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.1 p80 -128.59 173.5 10.22 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -84.12 161.13 20.74 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.132 0.491 . . . . 0.0 111.268 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -133.51 118.28 18.13 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.728 176.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 65.6 tp -71.29 -71.35 0.26 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.359 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -159.54 106.7 1.71 Allowed 'General case' 0 N--CA 1.407 -2.589 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -179.11 164.89 1.46 Allowed 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.2 m -84.58 25.22 0.92 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.245 0.545 . . . . 0.0 110.735 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.627 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -58.92 -46.16 88.62 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.604 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -61.2 -31.28 71.04 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.038 0.935 . . . . 0.0 111.328 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.69 ' O ' HG12 ' A' ' 17' ' ' VAL . 41.1 tt0 -73.52 -32.35 64.2 Favored 'General case' 0 C--O 1.209 -1.059 0 CA-C-O 121.852 0.834 . . . . 0.0 108.923 177.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -71.14 -33.55 70.18 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.626 0.727 . . . . 0.0 109.916 174.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 12' ' ' ALA . 90.8 t -69.77 -29.28 40.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.993 -178.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.69 HG12 ' O ' ' A' ' 14' ' ' GLU . 9.1 p -66.03 -25.53 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 120.001 -0.679 . . . . 0.0 109.208 177.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -72.08 -45.72 59.61 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.51 -38.22 89.05 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.684 175.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.459 ' O ' HG13 ' A' ' 24' ' ' ILE . 58.5 tptt -55.72 -48.86 74.44 Favored 'General case' 0 N--CA 1.425 -1.705 0 C-N-CA 123.257 0.623 . . . . 0.0 109.415 174.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.1 -35.75 82.13 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.734 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -62.53 -45.2 94.07 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.153 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.3 m -70.75 -32.32 48.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.84 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 20' ' ' LYS . 85.3 mt -65.18 -46.01 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 173.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.1 m -65.21 -35.36 80.83 Favored 'General case' 0 C--O 1.186 -2.243 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.689 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -59.57 -44.79 93.2 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-O 121.069 0.462 . . . . 0.0 109.999 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.533 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 5.2 tt -74.41 -44.03 53.76 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.499 HD13 HG22 ' A' ' 156' ' ' THR . 56.0 tp -63.14 -31.55 72.72 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-O 120.927 0.394 . . . . 0.0 110.78 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -66.77 -45.73 77.58 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 123.172 0.589 . . . . 0.0 111.17 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -71.05 -30.55 66.75 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.84 -44.22 70.34 Favored 'General case' 0 C--O 1.198 -1.627 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.788 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -60.61 -48.68 80.69 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -177.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.22 -30.96 79.27 Favored Glycine 0 C--O 1.239 0.411 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.413 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.464 ' HA ' ' HE2' ' A' ' 38' ' ' LYS . 61.9 t80 -75.98 -43.34 45.02 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 177.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.505 ' HA ' ' HB2' ' A' ' 39' ' ' LEU . 65.7 t80 -58.82 -53.81 54.14 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.768 1.227 . . . . 0.0 113.789 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.79 -19.18 49.02 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -174.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.479 ' HB2' ' HD3' ' A' ' 38' ' ' LYS . 31.2 mt-10 -116.39 -54.98 2.43 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.651 ' O ' HG12 ' A' ' 42' ' ' ILE . 3.2 mppt? -87.62 -27.44 22.5 Favored 'General case' 0 CA--C 1.466 -2.286 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.134 -170.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.505 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 86.6 mt -87.07 9.15 20.65 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 118.731 -1.188 . . . . 0.0 111.671 -176.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.07 -25.9 31.61 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.263 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -113.23 10.58 18.56 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.03 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.651 HG12 ' O ' ' A' ' 38' ' ' LYS . 47.5 mm -114.9 115.83 43.23 Favored Pre-proline 0 C--O 1.244 0.769 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -57.56 110.52 0.63 Allowed 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 122.728 2.285 . . . . 0.0 111.027 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.7 p -139.3 158.5 68.86 Favored Pre-proline 0 C--N 1.308 -1.202 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.333 -177.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.41 ' HB3' ' HB3' ' A' ' 72' ' ' ASN . 18.0 Cg_exo -70.04 128.21 15.45 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.33 2.02 . . . . 0.0 109.92 174.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -100.99 130.72 47.02 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.482 ' CB ' ' HG ' ' A' ' 145' ' ' LEU . . . -121.59 153.2 38.38 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.1 t -147.15 143.69 28.44 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.392 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.63 ' H ' HG11 ' A' ' 159' ' ' VAL . 14.9 p -119.79 142.28 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -165.07 -18.85 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.656 -171.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.467 ' HB3' ' CG ' ' A' ' 67' ' ' LYS . 19.1 t70 -120.1 128.1 53.15 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.877 -176.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 67.9 t -110.94 120.31 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.802 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 178.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -112.14 125.5 54.19 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 123.327 0.651 . . . . 0.0 111.912 -175.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -70.25 141.09 52.49 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 124.151 0.98 . . . . 0.0 113.148 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.593 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 59.1 mtpt -122.13 -79.04 0.6 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.295 176.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.6 -147.87 6.54 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 119.63 -1.271 . . . . 0.0 113.323 -176.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.1 p -98.42 149.79 5.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.155 0.502 . . . . 0.0 111.477 -173.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.1 t -152.71 -174.53 4.95 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -67.04 -63.84 0.98 Allowed 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 120.931 0.396 . . . . 0.0 110.372 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.404 ' HB2' ' HE2' ' A' ' 118' ' ' LYS . 9.1 m-20 -92.15 95.68 9.89 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.943 -172.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.17 -131.18 10.7 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.353 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 173' ' ' PHE . 6.8 t -127.02 135.03 64.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -178.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.593 ' O ' ' HB2' ' A' ' 55' ' ' LYS . 13.8 t70 -90.01 120.08 30.91 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 2.5 m-85 -122.4 172.77 8.09 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.934 0.873 . . . . 0.0 113.128 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.521 ' HB2' ' HD2' ' A' ' 55' ' ' LYS . 8.4 t-160 -126.0 108.84 11.78 Favored 'General case' 0 N--CA 1.421 -1.875 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.602 -177.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.34 143.43 26.76 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.467 ' CG ' ' HB3' ' A' ' 51' ' ' ASP . 44.8 mmtm -92.02 114.65 27.24 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 176.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.403 HG11 HD11 ' A' ' 145' ' ' LEU . 64.7 t -111.86 108.67 26.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.2 m -104.02 129.05 51.61 Favored 'General case' 0 C--N 1.284 -2.242 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.217 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 t -116.32 128.84 73.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.846 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 59.0 pttt -120.61 121.91 39.37 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.606 0.717 . . . . 0.0 109.317 178.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.732 ' O ' ' HA ' ' A' ' 108' ' ' SER . 24.3 p-10 -129.94 115.64 17.85 Favored Pre-proline 0 C--N 1.277 -2.572 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.595 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -93.41 97.77 0.15 Allowed 'Trans proline' 0 N--CA 1.425 -2.533 0 N-CA-C 107.166 -1.898 . . . . 0.0 107.166 165.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.422 ' CD2' HD11 ' A' ' 78' ' ' ILE . 25.9 t80 -157.39 -5.72 0.09 Allowed 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.684 -174.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.2 m 73.34 -2.38 2.76 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 174.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.509 HE21 HG12 ' A' ' 78' ' ' ILE . 9.3 pt20 -132.85 147.12 52.3 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.301 -0.875 . . . . 0.0 112.33 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.9 m -83.68 107.37 16.08 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.509 HG12 HE21 ' A' ' 76' ' ' GLN . 45.9 mt -94.39 122.39 61.33 Favored Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -177.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -66.74 113.33 2.71 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.075 1.85 . . . . 0.0 109.623 174.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 10.4 tt -72.0 134.98 28.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 54.9 m -61.1 -58.85 6.65 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.504 0.669 . . . . 0.0 109.733 -177.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -163.6 150.05 11.87 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.435 -177.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.9 mt -101.67 114.15 40.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 171.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.4 m -102.68 117.4 34.57 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.418 ' CD1' HG23 ' A' ' 117' ' ' VAL . 54.8 p90 -106.35 136.73 45.58 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.409 -178.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 54.6 mt -123.34 108.8 21.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 176.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.593 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 0.5 OUTLIER -91.86 121.19 33.24 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -174.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.692 ' HB2' ' HB2' ' A' ' 140' ' ' GLN . 1.0 OUTLIER -94.27 116.29 28.66 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.284 0.564 . . . . 0.0 109.632 172.734 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.501 ' CB ' ' HB3' ' A' ' 122' ' ' SER . 22.7 t -100.16 94.07 6.04 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -176.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 61.37 -80.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.262 1.025 . . . . 0.0 110.662 -174.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.5 m -158.8 -36.17 0.06 Allowed 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -87.03 104.51 16.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.964 -177.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.498 ' HB ' ' OG ' ' A' ' 122' ' ' SER . 29.7 m 70.83 164.61 0.28 Allowed 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.289 1.036 . . . . 0.0 112.01 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.593 ' HB ' ' O ' ' A' ' 87' ' ' LEU . 2.1 pp -144.09 170.68 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.749 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -173.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.466 ' HB3' ' CD1' ' A' ' 87' ' ' LEU . . . -121.96 154.88 36.61 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 172.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 t -159.87 168.05 26.69 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.172 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.59 151.57 8.76 Favored Glycine 0 N--CA 1.427 -1.941 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.533 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 20.3 p -109.06 116.84 32.73 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 54.6 mt -98.66 101.61 12.38 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 98' ' ' THR . 3.1 Cg_exo -78.28 123.24 5.99 Favored 'Trans proline' 0 C--O 1.241 0.661 0 C-N-CA 123.035 2.49 . . . . 0.0 111.21 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.3 t70 54.43 79.51 0.34 Allowed Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 124.83 1.252 . . . . 0.0 111.007 -174.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -104.74 25.06 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.676 2.918 . . . . 0.0 110.685 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.41 -172.9 18.09 Favored Glycine 0 N--CA 1.409 -3.122 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 -175.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 64.7 m -151.47 170.09 20.47 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 176.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.644 ' HA ' HG21 ' A' ' 111' ' ' THR 0.312 0.0 OUTLIER -98.88 158.15 15.83 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 179.863 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 22.9 m -72.2 -176.65 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 124.328 1.017 . . . . 0.0 110.989 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.42 -47.88 54.84 Favored Glycine 0 C--N 1.307 -1.068 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.24 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.732 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 21.3 t -160.07 94.01 1.09 Allowed 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 176.64 -168.83 41.05 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.318 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.5 m -113.04 114.06 26.33 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.644 HG21 ' HA ' ' A' ' 105' ' ' LEU . 10.2 t -113.34 138.41 50.09 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 26.4 t -96.89 118.04 42.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 121.013 0.435 . . . . 0.0 109.884 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.0 mt -98.25 159.56 14.86 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.967 -178.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -104.76 130.09 52.89 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.337 -175.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.2 t -125.72 114.36 24.84 Favored Pre-proline 0 CA--C 1.5 -0.978 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.431 172.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 2.7 Cg_exo -77.77 110.16 2.88 Favored 'Trans proline' 0 N--CA 1.423 -2.635 0 N-CA-C 107.528 -1.758 . . . . 0.0 107.528 168.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.418 HG23 ' CD1' ' A' ' 85' ' ' TYR . 12.3 p -115.81 137.52 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.404 ' HE2' ' HB2' ' A' ' 60' ' ' ASP . 50.1 mtpt -94.78 99.88 11.88 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -175.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.4 HG13 ' HB2' ' A' ' 64' ' ' TYR . 16.4 m -94.32 149.3 4.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -168.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 76.8 -12.8 1.0 Allowed 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 124.724 1.209 . . . . 0.0 113.334 172.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -48.2 -50.38 29.47 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 124.223 0.952 . . . . 0.0 112.987 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.501 ' HB3' ' CB ' ' A' ' 89' ' ' SER . 34.6 t -66.65 -43.49 84.48 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.438 -0.905 . . . . 0.0 112.382 -169.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.456 HD11 HD11 ' A' ' 137' ' ' ILE . 24.3 pt -79.02 -27.73 13.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.444 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 128' ' ' MET . . . -58.48 -41.14 84.59 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 174.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.6 t -56.98 -39.43 65.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.694 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 36.4 t -89.88 -84.94 0.22 Allowed 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.643 ' H ' HD23 ' A' ' 127' ' ' LEU . 1.9 pt? -106.84 -17.79 14.11 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 120.854 0.359 . . . . 0.0 111.963 -175.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.529 ' C ' ' HD3' ' A' ' 129' ' ' LYS . 23.8 ttt 58.22 39.24 25.99 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.02 0.928 . . . . 0.0 111.031 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.588 ' HG3' ' NE1' ' A' ' 135' ' ' TRP 0.306 0.0 OUTLIER 48.98 -73.1 0.0 OUTLIER 'General case' 0 C--N 1.363 1.156 0 C-N-CA 125.125 1.37 . . . . 0.0 114.169 -177.244 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -178.57 -32.15 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.62 ' SD ' ' HA ' ' A' ' 171' ' ' ARG . 0.7 OUTLIER 62.66 81.93 0.19 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.374 -178.127 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 29.0 m -108.98 172.31 6.92 Favored 'General case' 0 C--O 1.251 1.173 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.696 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 30.5 p -81.81 108.12 15.09 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 169.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.539 ' H ' ' H ' ' A' ' 169' ' ' SER . 24.8 m-20 76.36 98.04 0.07 Allowed 'General case' 0 CA--C 1.496 -1.118 0 O-C-N 124.167 0.917 . . . . 0.0 109.836 -175.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.588 ' NE1' ' HG3' ' A' ' 129' ' ' LYS . 69.9 t-105 -140.02 119.83 13.42 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.362 -174.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 166' ' ' LYS . 22.7 t70 -91.01 111.82 23.45 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 174.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.456 HD11 HD11 ' A' ' 123' ' ' ILE . 8.2 tt -97.42 149.27 5.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.238 -170.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -86.47 103.07 14.66 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.398 177.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.416 ' HD1' ' O ' ' A' ' 163' ' ' GLY . 7.0 t80 -137.66 150.24 47.21 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.692 ' HB2' ' HB2' ' A' ' 88' ' ' LYS . 48.9 mt-30 -139.74 158.82 43.47 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.9 tp -141.67 130.49 22.96 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.45 0.643 . . . . 0.0 112.232 -175.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.462 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 2.3 m-20 -125.92 129.51 49.45 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 54.3 mt -130.36 131.86 65.17 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.486 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.392 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -105.42 109.95 3.35 Favored Glycine 0 N--CA 1.405 -3.391 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 156' ' ' THR . 2.6 mm? -89.13 110.18 20.95 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 32.1 m -95.5 108.97 21.24 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.572 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -114.47 152.66 31.27 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -120.25 114.35 21.76 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 175.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 49.6 mm -110.94 116.28 52.02 Favored Pre-proline 0 C--N 1.287 -2.116 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -45.82 -33.0 9.86 Favored 'Trans proline' 0 N--CA 1.485 1.009 0 C-N-CA 123.892 3.061 . . . . 0.0 113.891 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 44.6 t -69.81 -23.66 25.97 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 123.198 0.599 . . . . 0.0 112.166 -177.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 9.1 p -136.86 -33.29 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -175.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 122.01 -151.11 16.95 Favored Glycine 0 N--CA 1.434 -1.498 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.185 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -87.52 117.9 26.62 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.429 0.633 . . . . 0.0 110.647 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.4 123.36 49.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.33 0.586 . . . . 0.0 110.711 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 40.9 m -99.19 127.12 45.12 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.551 177.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.1 mp -89.68 122.1 68.45 Favored Pre-proline 0 C--N 1.318 -0.804 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -83.4 113.59 2.04 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.818 2.345 . . . . 0.0 112.362 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.63 HG11 ' H ' ' A' ' 49' ' ' VAL . 21.9 t -111.89 119.12 59.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 173.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 67.9 p -128.41 127.15 42.02 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 123.13 0.269 . . . . 0.0 111.073 -175.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.1 t -158.64 177.36 11.29 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -98.66 148.75 23.51 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.416 ' O ' ' HD1' ' A' ' 139' ' ' TYR . . . -118.62 83.32 0.35 Allowed Glycine 0 N--CA 1.416 -2.669 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -88.82 119.92 29.75 Favored 'General case' 0 C--N 1.273 -2.729 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.4 HG13 ' CG2' ' A' ' 137' ' ' ILE . 4.9 pt -133.66 123.11 45.01 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-O 121.304 0.573 . . . . 0.0 111.915 -175.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.642 ' HD3' ' H ' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -89.69 109.81 20.76 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.925 178.249 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -90.5 107.44 20.15 Favored Pre-proline 0 C--N 1.288 -2.101 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.077 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -86.35 94.13 0.55 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 122.654 2.236 . . . . 0.0 112.996 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.539 ' H ' ' H ' ' A' ' 134' ' ' ASP . 78.2 p 50.83 105.24 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.351 1.46 . . . . 0.0 114.854 178.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -128.78 -70.82 0.66 Allowed 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.62 ' HA ' ' SD ' ' A' ' 131' ' ' MET . 81.0 mtp180 59.08 79.29 0.23 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 114.231 1.196 . . . . 0.0 114.231 177.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 171' ' ' ARG . 32.5 t70 172.8 -77.71 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 123.978 0.799 . . . . 0.0 111.332 173.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.446 ' O ' HG22 ' A' ' 62' ' ' VAL . 52.6 p90 -100.14 10.76 40.77 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -174.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.464 ' HB3' ' SD ' ' A' ' 131' ' ' MET . 62.0 t80 . . . . . 0 C--N 1.3 -1.569 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.789 -176.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.303 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -171.12 89.58 0.13 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.733 0.778 . . . . 0.0 110.092 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.5 m80 -102.69 142.93 33.02 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.378 -177.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 42.9 m-70 -92.95 71.36 4.69 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.724 0.773 . . . . 0.0 110.71 174.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -146.74 92.51 2.16 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-N 114.108 -1.405 . . . . 0.0 108.402 174.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -126.28 -68.86 0.8 Allowed 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.164 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 39.7 m80 65.29 112.25 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 O-C-N 124.36 1.037 . . . . 0.0 111.788 -178.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.614 HD13 ' H ' ' A' ' 8' ' ' LEU 0.331 0.0 OUTLIER -63.0 -47.48 82.93 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 179.945 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.428 ' N ' HD22 ' A' ' 8' ' ' LEU . 21.6 mm-40 -99.54 72.98 1.81 Allowed 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 122.542 1.163 . . . . 0.0 111.123 176.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.91 -165.87 1.49 Allowed 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.016 176.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 m -61.7 110.52 1.53 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.469 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . . . -57.04 -56.11 26.01 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 -170.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -65.32 -36.3 83.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.124 0.488 . . . . 0.0 110.389 -175.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.412 ' HA ' HG12 ' A' ' 17' ' ' VAL . 40.8 tt0 -64.88 -46.11 83.17 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.682 176.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.469 ' HE2' ' HA ' ' A' ' 12' ' ' ALA . 37.1 ttpt -54.29 -49.52 69.41 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 123.977 0.911 . . . . 0.0 111.679 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.3 m -77.96 -27.3 14.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 14' ' ' GLU . 7.1 p -72.8 -31.42 36.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 119.534 -0.867 . . . . 0.0 109.756 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -60.59 -42.18 96.21 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -59.13 -52.49 65.48 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.657 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -62.61 -44.58 95.93 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.55 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.43 ' HB2' HD11 ' A' ' 94' ' ' ILE . . . -60.83 -40.57 93.32 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.453 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.5 t -60.78 -44.89 96.21 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 123.439 0.462 . . . . 0.0 110.374 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.7 t -60.45 -46.0 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.213 0.53 . . . . 0.0 110.172 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.1 mm -64.95 -47.91 86.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.085 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.1 m -62.88 -29.67 70.94 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.048 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.2 t -65.19 -31.42 72.59 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 120.997 0.427 . . . . 0.0 110.207 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.2 tt -73.92 -42.1 61.1 Favored 'General case' 0 C--O 1.246 0.916 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.495 HD23 ' HB3' ' A' ' 158' ' ' PRO . 8.6 mp -58.89 -35.08 72.42 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.153 175.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -51.02 -49.27 60.82 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.414 ' HD2' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -75.56 -27.95 58.81 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.391 -178.316 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.428 ' HB1' ' O ' ' A' ' 156' ' ' THR . . . -77.36 -34.31 55.09 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.179 -176.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 28' ' ' LEU . 99.5 mttt -59.14 -37.42 77.22 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 121.08 0.467 . . . . 0.0 109.779 177.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.99 -44.06 97.95 Favored Glycine 0 N--CA 1.431 -1.661 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.758 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -80.47 -39.27 28.38 Favored 'General case' 0 C--O 1.198 -1.648 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.685 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -58.57 -31.7 68.23 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.4 -37.38 83.02 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.754 0.311 . . . . 0.0 111.799 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -116.9 -48.32 2.66 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -175.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.436 ' HE2' ' HB2' ' A' ' 38' ' ' LYS . 12.8 tppt? -69.56 -48.55 59.9 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 122.364 1.078 . . . . 0.0 109.195 -169.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.48 HD22 HG21 ' A' ' 44' ' ' THR . 39.4 mt -88.51 0.87 55.85 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.187 -171.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.17 -20.03 18.23 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.712 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -110.4 -24.9 10.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.945 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 72.1 mt -93.54 142.03 24.64 Favored Pre-proline 0 N--CA 1.431 -1.395 0 N-CA-C 106.789 -1.559 . . . . 0.0 106.789 177.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -67.24 105.25 0.99 Allowed 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 121.888 1.725 . . . . 0.0 108.376 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.48 HG21 HD22 ' A' ' 39' ' ' LEU . 4.2 m -125.11 141.46 38.6 Favored Pre-proline 0 N--CA 1.415 -2.185 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -173.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.38 113.06 1.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.903 1.735 . . . . 0.0 111.079 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -96.84 121.98 39.3 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.185 0.517 . . . . 0.0 110.396 -174.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.507 ' HB2' HD21 ' A' ' 145' ' ' LEU . . . -98.71 157.88 15.98 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.076 -179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -148.72 129.1 13.84 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.924 176.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.408 ' H ' HG11 ' A' ' 159' ' ' VAL . 13.0 p -113.69 137.16 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 175.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -151.04 -35.67 0.14 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.735 -168.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -116.61 147.59 41.74 Favored 'General case' 0 CA--C 1.463 -2.373 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.49 -173.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.547 HG22 ' CB ' ' A' ' 64' ' ' TYR . 8.2 p -150.85 103.05 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.404 -2.765 0 CA-C-O 122.58 1.181 . . . . 0.0 107.885 175.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -96.51 129.56 43.86 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.095 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 44.3 p90 -59.62 122.19 13.48 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.261 0.553 . . . . 0.0 111.026 175.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -85.43 -56.05 3.71 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.138 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.48 -137.63 2.59 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -178.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.1 p -112.65 141.85 26.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.6 m -114.53 166.1 12.06 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -55.84 -54.83 39.77 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -99.25 -62.84 1.18 Allowed 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.635 -177.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -108.64 -130.07 6.08 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 175.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.563 HG21 ' CZ ' ' A' ' 173' ' ' PHE . 7.1 p -140.16 137.38 37.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.269 0.557 . . . . 0.0 111.271 177.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -104.04 122.97 46.36 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.789 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.547 ' CB ' HG22 ' A' ' 52' ' ' VAL . 3.7 m-30 -109.09 167.33 10.18 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.27 0.557 . . . . 0.0 110.665 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -106.29 106.79 17.47 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.08 144.87 26.69 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.604 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -107.83 125.12 51.06 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.042 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.2 t -126.89 107.78 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 176.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.5 m -98.57 139.7 33.91 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 110' ' ' THR . 22.8 t -124.56 127.13 72.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.486 -178.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 109' ' ' GLY . 88.6 tttt -110.85 117.7 34.13 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.549 ' HB3' ' O ' ' A' ' 107' ' ' GLY . 37.0 t30 -118.99 127.13 26.69 Favored Pre-proline 0 CA--C 1.507 -0.676 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.088 -173.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 72' ' ' ASN . 11.3 Cg_endo -94.01 96.02 0.13 Allowed 'Trans proline' 0 N--CA 1.428 -2.326 0 C-N-CA 121.42 1.414 . . . . 0.0 110.074 169.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.502 ' HB2' HD21 ' A' ' 72' ' ' ASN . 42.7 m-85 175.81 162.27 0.32 Allowed 'General case' 0 CA--C 1.492 -1.273 0 C-N-CA 129.173 2.989 . . . . 0.0 104.21 -178.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 51.7 p -100.85 -16.43 17.26 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.605 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -79.77 149.92 30.94 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 121.573 0.701 . . . . 0.0 112.048 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.8 p -80.38 104.97 11.29 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.433 172.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.418 ' H ' HD22 ' A' ' 105' ' ' LEU . 52.9 mt -91.05 117.61 68.01 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -85.34 152.46 10.62 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.945 1.763 . . . . 0.0 112.531 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.636 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -88.29 143.7 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.183 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.598 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 51.0 t -78.47 -35.52 46.49 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -170.23 157.22 6.17 Favored 'General case' 0 C--O 1.252 1.223 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.5 mt -118.33 115.62 48.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 171.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 20.8 p -112.81 118.57 35.31 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.316 -176.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 96' ' ' SER . 37.9 p90 -104.15 143.2 33.25 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 58.2 mt -132.76 108.08 12.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 173.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.476 ' O ' HD12 ' A' ' 87' ' ' LEU . 4.2 pp -105.55 134.44 48.67 Favored 'General case' 0 C--N 1.282 -2.369 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.359 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.516 ' HA ' HG22 ' A' ' 94' ' ' ILE . 40.3 ttmt -110.93 123.98 51.21 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.06 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.486 ' OG ' ' HB2' ' A' ' 122' ' ' SER . 53.2 p -104.26 98.63 8.4 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 64.5 -79.94 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.264 1.426 . . . . 0.0 114.819 174.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.8 t -135.11 -29.65 1.1 Allowed 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -172.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -143.91 145.63 32.41 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.582 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 m 71.19 130.41 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.197 0 O-C-N 125.28 1.612 . . . . 0.0 110.836 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.516 HG22 ' HA ' ' A' ' 88' ' ' LYS . 1.8 pp -127.4 165.35 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.11 122.02 36.72 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 61.3 p -120.81 147.19 45.7 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -163.37 144.98 10.01 Favored Glycine 0 N--CA 1.432 -1.626 0 C-N-CA 119.844 -1.17 . . . . 0.0 112.248 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.8 p -107.97 115.63 30.48 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.5 tt -101.81 114.45 65.58 Favored Pre-proline 0 C--N 1.307 -1.25 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.764 177.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -85.71 129.49 3.56 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 122.617 2.211 . . . . 0.0 111.457 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.9 t70 50.45 79.38 0.35 Allowed Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 124.608 1.163 . . . . 0.0 113.21 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -99.71 2.45 0.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.126 2.55 . . . . 0.0 112.09 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 151.94 -166.62 30.97 Favored Glycine 0 N--CA 1.42 -2.382 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.3 p -137.76 155.7 48.77 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.255 0.55 . . . . 0.0 110.763 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.624 ' HA ' HG21 ' A' ' 111' ' ' THR . 6.3 tt -90.64 125.36 35.63 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.412 HG22 ' HB ' ' A' ' 111' ' ' THR . 33.7 m -65.36 -30.7 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -172.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.577 ' H ' HD23 ' A' ' 105' ' ' LEU . . . 135.26 -113.24 1.09 Allowed Glycine 0 N--CA 1.417 -2.598 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -176.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.8 p -91.85 97.85 11.24 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 124.25 1.02 . . . . 0.0 111.136 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 71' ' ' LYS . . . 140.53 -164.07 26.37 Favored Glycine 0 N--CA 1.418 -2.555 0 C-N-CA 119.947 -1.12 . . . . 0.0 111.485 176.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 11.0 t -95.7 139.94 31.23 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-O 121.919 0.866 . . . . 0.0 111.104 -178.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.624 HG21 ' HA ' ' A' ' 105' ' ' LEU . 4.9 t -134.78 121.0 20.09 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 176.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.7 t -87.74 110.45 20.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.582 -177.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.3 mt -97.48 162.29 13.38 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -141.54 144.02 34.07 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.479 -0.489 . . . . 0.0 111.46 -175.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 51.7 t -135.01 136.41 24.92 Favored Pre-proline 0 C--O 1.241 0.606 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.557 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -79.5 111.34 2.81 Favored 'Trans proline' 0 N--CA 1.432 -2.135 0 N-CA-C 107.586 -1.736 . . . . 0.0 107.586 168.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 24.6 m -112.67 133.88 57.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -89.01 92.0 9.06 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.783 0.802 . . . . 0.0 110.183 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.492 ' C ' ' H ' ' A' ' 121' ' ' TYR . 3.2 m -95.24 149.73 4.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.383 -172.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.504 ' HB1' ' CE1' ' A' ' 174' ' ' PHE . . . 74.36 -20.15 0.33 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.54 0.736 . . . . 0.0 111.87 175.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.492 ' H ' ' C ' ' A' ' 119' ' ' VAL . 21.4 t80 -46.11 -45.29 16.29 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 126.461 1.904 . . . . 0.0 109.782 176.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.486 ' HB2' ' OG ' ' A' ' 89' ' ' SER . 18.0 m -68.21 -52.42 34.44 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-N 115.275 -0.875 . . . . 0.0 113.039 -174.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 12.6 tt -74.61 -36.08 39.86 Favored 'Isoleucine or valine' 0 C--O 1.251 1.178 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -174.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.38 -50.66 72.71 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 122.269 0.227 . . . . 0.0 111.294 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.2 m -72.7 -22.67 20.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.9 t -77.27 -69.86 0.5 Allowed 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.808 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.483 ' H ' HD23 ' A' ' 127' ' ' LEU . 1.7 pt? -124.1 -23.72 4.51 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -177.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.476 ' O ' ' HD2' ' A' ' 129' ' ' LYS . 0.0 OUTLIER 66.3 -176.55 0.19 Allowed 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -177.223 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.476 ' HD2' ' O ' ' A' ' 128' ' ' MET . 12.2 mmmm -133.31 -71.25 0.52 Allowed 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 178.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.409 ' H ' ' HB2' ' A' ' 129' ' ' LYS . 15.8 t70 152.85 80.93 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 128.978 2.911 . . . . 0.0 104.419 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.418 ' HE1' ' HB2' ' A' ' 170' ' ' LEU . 1.0 OUTLIER -91.31 115.47 28.06 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.509 -178.72 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 169' ' ' SER . 83.1 m -131.09 -81.04 0.53 Allowed 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -178.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 169' ' ' SER . 41.5 p -142.01 116.86 9.86 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 123.287 0.635 . . . . 0.0 109.915 -169.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.6 t70 59.97 82.07 0.16 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 122.08 0.943 . . . . 0.0 109.419 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -140.86 158.96 43.22 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.5 -172.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -147.72 154.89 41.14 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 118.683 0.674 . . . . 0.0 110.864 175.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.5 tt -148.63 149.68 14.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.139 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -114.14 134.17 55.08 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.452 ' HE2' HD22 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -125.49 170.76 11.09 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 178.014 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 162' ' ' GLN . 24.3 tt0 -119.17 137.41 53.63 Favored 'General case' 0 C--N 1.273 -2.741 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.297 -177.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 28.5 tp -119.57 128.23 53.71 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.975 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.62 ' OD1' ' HB3' ' A' ' 160' ' ' SER . 17.1 t70 -130.71 112.2 12.87 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 35.4 mt -113.31 122.57 67.7 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.31 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.962 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -106.68 101.95 1.81 Allowed Glycine 0 N--CA 1.398 -3.892 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.507 HD21 ' HB2' ' A' ' 47' ' ' ALA . 0.8 OUTLIER -91.77 143.07 26.91 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.87 174.289 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.8 m -114.4 111.34 21.29 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.316 -175.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.495 ' CE1' HG23 ' A' ' 80' ' ' ILE . 90.1 m-85 -106.71 163.43 12.92 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 172.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -146.64 131.44 18.01 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.357 177.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.26 135.71 15.28 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 176.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -48.92 -18.34 1.64 Allowed 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 124.393 3.395 . . . . 0.0 114.927 -178.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 55.7 t -57.23 -39.07 65.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 121.133 0.492 . . . . 0.0 110.332 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 5.8 p -136.69 -36.15 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.238 0.542 . . . . 0.0 111.238 -178.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 120.53 -142.52 15.89 Favored Glycine 0 N--CA 1.419 -2.499 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -178.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -92.04 126.45 37.13 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.164 0.507 . . . . 0.0 110.01 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.41 ' N ' HD13 ' A' ' 155' ' ' ILE . 0.2 OUTLIER -139.85 133.56 36.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.37 176.849 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 11.4 t -100.5 147.98 25.29 Favored 'General case' 0 N--CA 1.412 -2.345 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 173.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 60.0 mt -110.48 109.35 58.25 Favored Pre-proline 0 C--N 1.291 -1.94 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.495 ' HB3' HD23 ' A' ' 28' ' ' LEU . 17.1 Cg_exo -70.82 102.64 1.22 Allowed 'Trans proline' 0 C--O 1.244 0.806 0 C-N-CA 122.693 2.262 . . . . 0.0 111.376 177.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 142' ' ' ASP . 14.2 t -103.83 108.77 25.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.62 ' HB3' ' OD1' ' A' ' 142' ' ' ASP . 52.1 p -109.04 150.89 27.11 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.817 -177.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.8 t -168.07 151.97 6.11 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 140' ' ' GLN . 12.9 pt20 -107.69 119.23 38.84 Favored 'General case' 0 N--CA 1.42 -1.934 0 C-N-CA 119.296 -0.962 . . . . 0.0 109.345 174.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -92.96 118.76 5.7 Favored Glycine 0 N--CA 1.409 -3.126 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.696 -174.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -89.68 119.59 30.23 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 176.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.3 pt -129.59 111.95 23.38 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 CA-C-O 121.521 0.677 . . . . 0.0 111.524 -174.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -78.85 130.11 35.31 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.604 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 87.7 mt -106.39 109.17 62.94 Favored Pre-proline 0 C--N 1.293 -1.859 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.006 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.8 172.05 17.03 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.185 1.924 . . . . 0.0 111.765 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 133' ' ' THR . 49.1 p -53.28 105.65 0.14 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 123.253 0.621 . . . . 0.0 111.495 175.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.418 ' HB2' ' HE1' ' A' ' 131' ' ' MET . 79.7 mt -137.38 -50.31 0.62 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 62.75 113.93 0.02 OUTLIER 'General case' 0 C--N 1.355 0.843 0 O-C-N 124.213 0.945 . . . . 0.0 112.815 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 33.1 t70 87.23 8.95 0.18 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.762 1.225 . . . . 0.0 111.094 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.563 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 72.5 t80 -80.63 -40.09 26.26 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.34 174.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.504 ' CE1' ' HB1' ' A' ' 120' ' ' ALA . 72.1 t80 . . . . . 0 C--N 1.313 -0.99 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -179.089 . . . . . . . . 1 1 . 1 stop_ save_